--MariaDB dump 10.19  Distrib 10.4.24-MariaDB, for Win64 (AMD64)
--
-- Host: localhost    Database: csart_db
-- ------------------------------------------------------
-- Server version	10.4.24-MariaDB

/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!40101 SET NAMES utf8mb4 */;
/*!40103 SET @OLD_TIME_ZONE=@@TIME_ZONE */;
/*!40103 SET TIME_ZONE='+00:00' */;
/*!40014 SET @OLD_UNIQUE_CHECKS=@@UNIQUE_CHECKS, UNIQUE_CHECKS=0 */;
/*!40014 SET @OLD_FOREIGN_KEY_CHECKS=@@FOREIGN_KEY_CHECKS, FOREIGN_KEY_CHECKS=0 */;
/*!40101 SET @OLD_SQL_MODE=@@SQL_MODE, SQL_MODE='NO_AUTO_VALUE_ON_ZERO' */;
/*!40111 SET @OLD_SQL_NOTES=@@SQL_NOTES, SQL_NOTES=0 */;

--
-- Table structure for table `authors`
--

DROP TABLE IF EXISTS `authors`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `authors` (
  `author_id` int(11) NOT NULL AUTO_INCREMENT,
  `author_name` varchar(255) DEFAULT NULL,
  `email` varchar(255) DEFAULT NULL,
  `website` varchar(255) DEFAULT NULL,
  `affiliations` text DEFAULT NULL,
  `statement` text DEFAULT NULL,
  PRIMARY KEY (`author_id`)
) ENGINE=InnoDB AUTO_INCREMENT=7298 DEFAULT CHARSET=utf8mb4;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `authors`
--

LOCK TABLES `authors` WRITE;
/*!40000 ALTER TABLE `authors` DISABLE KEYS */;
INSERT INTO `authors` VALUES (1,'Ante Prodan','A.Prodan@westernsydney.edu.au','http://www.csart-world.com/','Association for Computing Machinery, Monash University, Sax Institute, The University of Sydney Brain and Mind Centre, University of Technology Sydney, Western Sydney University',NULL),(2,'Jo-An Occhipinti',NULL,NULL,NULL,NULL),(3,'Nathaniel Osgood',NULL,NULL,NULL,NULL),(4,'Paulo Gon├ºalves',NULL,NULL,NULL,NULL),(5,'Patricia Mabry',NULL,NULL,NULL,NULL),(6,'Robin Purshouse',NULL,NULL,NULL,NULL),(15,'Frank Iorfino',NULL,NULL,NULL,NULL),(16,'Adam Skinner',NULL,NULL,NULL,NULL),(17,'Tracey Davenport',NULL,NULL,NULL,NULL),(18,'Shelley Rowe',NULL,NULL,NULL,NULL),(19,'Julie Sturgess',NULL,NULL,NULL,NULL),(20,'Ian Hickie','ian.hickie@sydney.edu.au',NULL,'RANZCP, University of New South Wales, University of Sydney','Prof Hickie has just been reappointed an NHMRC Senior Principal Research Fellow (2018-22, previously SPRF 2013-17) and was previously an NHMRC Australian Research Fellow (2007-12). He is a Fellow of the Academy of Social Sciences in Australia and Co-Director, Health and Policy, of the Brain & Mind Centre (BMC), University of Sydney. From 2012 to 2018, he was a Commissioner of the Australian National Mental Health Commission (NMHC), with a major focus on improving outcome measurement and improved accountability for AustraliaΓÇÖs investments in mental health services. In partnership with the Mental Health Council of Australia, the Human Rights and Equal Opportunities Commission, Orygen Youth Health, the Young & Well CRC and the National Mental Health Commission, he has authored major national reports on community experiences of mental health services. Prof Hickie was a key participant in the most recent 2014 NMHC review of Mental Health Programmes and Services, which served as the template for the 2015 Turnbull Government initiatives in Mental Health Reform (total value $190M), including specifically the $30M Project Synergy investment in new technologies and the new $90M investment in 12 large regional trials of suicide prevention. His long-standing commitment to the impact of mental health research on mental health service improvement, through active engagement with those with lived experiences (patients, families and communities) in Australia is evident in his: i) capacity to facilitate public engagement with mental health issues, notably through his initial CEO role with beyondblue (2000-03); ii) engagement with major national mental health service reports over two decades (notably 2006, Not For Service Report with Human Rights and Equal Opportunities Commission); iii) continuous public commentary on contemporary mental health and suicide prevention issues; and iv) role in implementation of substantive health services reform in Australia (e.g. headspace and Young&Well CRC and now Project Synergy). He has been recognised nationally for his role over the last two decades in using clinical, health services and population health data to drive enhanced primary care services, increased access to psychological treatments and better interventions for those with severe mood disorders. In partnership with Prof Pat McGorry, he has been at the forefront of development and systematic evaluation of the new primary care based national youth mental health services (headspace). He has been a critical voice in the advocacy for enhanced social and health services for those with persistent mental illness and increased accountability for delivery of those services.'),(47,'Danya Rose',NULL,NULL,NULL,NULL),(48,'Daniel Rock',NULL,NULL,NULL,NULL),(49,'Yun Ju Christine Song',NULL,NULL,NULL,NULL),(50,'Sebastian Rosenberg',NULL,NULL,NULL,NULL),(51,'Louise Freebairn',NULL,NULL,NULL,NULL),(52,'Catherine Vacher',NULL,NULL,NULL,NULL),(58,'Andrew Page',NULL,NULL,NULL,NULL),(59,'Geoff McDonnell',NULL,NULL,NULL,NULL),(60,'Mark Heffernan',NULL,NULL,NULL,NULL),(61,'Bill Campos',NULL,NULL,NULL,NULL),(62,'Graham Meadows',NULL,NULL,NULL,NULL),(63,'Dylan Knowles',NULL,NULL,NULL,NULL),(64,'John Wiggers',NULL,NULL,NULL,NULL),(65,'Michael Livingston',NULL,NULL,NULL,NULL),(66,'Robin Room',NULL,NULL,NULL,NULL),(67,'Eloise O\'Donnell',NULL,NULL,NULL,NULL),(68,'Sandra Jones',NULL,NULL,NULL,NULL),(69,'Paul S Haber',NULL,NULL,NULL,NULL),(70,'David Muscatello',NULL,NULL,NULL,NULL),(71,'Nadine Ezard',NULL,NULL,NULL,NULL),(72,'Nghi Phung',NULL,NULL,NULL,NULL),(73,'Devon Indig',NULL,NULL,NULL,NULL),(74,'Lucie Rychetnik',NULL,NULL,NULL,NULL),(75,'Jaithri Ananthapavan',NULL,NULL,NULL,NULL),(76,'Sonia Wutzke',NULL,NULL,NULL,NULL),(77,'Jan Scott',NULL,NULL,NULL,NULL),(78,'Kirill Glavatsky',NULL,NULL,NULL,NULL),(108,'Nicholas Ho',NULL,NULL,NULL,NULL),(109,'Jo Robinson',NULL,NULL,NULL,NULL),(110,'Grace Yeeun Lee',NULL,NULL,NULL,NULL),(111,'Christopher J Nolan',NULL,NULL,NULL,NULL),(112,'Paul M Kelly',NULL,NULL,NULL,NULL),(113,'Yang Qin',NULL,NULL,NULL,NULL),(114,'Weicheng Qian',NULL,NULL,NULL,NULL),(115,'Anahita Safarishahrbijari',NULL,NULL,NULL,NULL),(116,'Luke Penza',NULL,NULL,NULL,NULL),(117,'Allen McLean',NULL,NULL,NULL,NULL),(118,'Alison L Kent',NULL,NULL,NULL,NULL),(119,'Roland Dyck',NULL,NULL,NULL,NULL),(120,'Louise Maple-Brown',NULL,NULL,NULL,NULL),(121,'Vincy Li',NULL,NULL,NULL,NULL),(122,'Nick Roberts',NULL,NULL,NULL,NULL),(123,'Thomas Lung',NULL,NULL,NULL,NULL),(124,'Suzanne Nieuwenhuizen',NULL,NULL,NULL,NULL),(125,'Bev Lloyd',NULL,NULL,NULL,NULL),(126,'Jo Mitchell',NULL,NULL,NULL,NULL),(127,'Lennert Veerman',NULL,NULL,NULL,NULL),(128,'Margaret Bright',NULL,NULL,NULL,NULL),(129,'Pippy Walker',NULL,NULL,NULL,NULL),(130,'Rebecca Whitehead',NULL,NULL,NULL,NULL),(131,'Suzan Burton',NULL,NULL,NULL,NULL),(132,'Tim Roselli',NULL,NULL,NULL,NULL),(133,'David P Thomas',NULL,NULL,NULL,NULL),(134,'Mark West',NULL,NULL,NULL,NULL),(135,'Elizabeth M Scott',NULL,NULL,NULL,NULL),(136,'Haley M LaMonica',NULL,NULL,NULL,NULL),(137,'Anna E Roberts',NULL,NULL,NULL,NULL),(613,'Abdel Abdellaoui',NULL,NULL,NULL,NULL),(614,'Ayedh Alqarni',NULL,NULL,NULL,NULL),(615,'A Brown',NULL,NULL,NULL,NULL),(616,'A Campbell',NULL,NULL,NULL,NULL),(617,'Angela Carballedo',NULL,NULL,NULL,NULL),(618,'A Cottrill',NULL,NULL,NULL,NULL),(619,'Anna Flego',NULL,NULL,NULL,NULL),(620,'Adam John Guastella',NULL,NULL,NULL,NULL),(621,'Ashley D Harris',NULL,NULL,NULL,NULL),(622,'A Hettiaratchi',NULL,NULL,NULL,NULL),(623,'A Jablensky',NULL,NULL,NULL,NULL),(624,'Amanda R Kenyon',NULL,NULL,NULL,NULL),(625,'Axel Krug',NULL,NULL,NULL,NULL),(626,'Andrew R Lloyd',NULL,NULL,NULL,NULL),(627,'Ashleigh Lin',NULL,NULL,NULL,NULL),(628,'A Lloyd AM',NULL,NULL,NULL,NULL),(629,'A Lyall',NULL,NULL,NULL,NULL),(630,'Anne Masi',NULL,NULL,NULL,NULL),(631,'A Pereira',NULL,NULL,NULL,NULL),(632,'Andrea Polari',NULL,NULL,NULL,NULL),(633,'Anita Riecher-R├â┬╢ssler',NULL,NULL,NULL,NULL),(634,'Andrew Scott',NULL,NULL,NULL,NULL),(635,'Alexander Teumer',NULL,NULL,NULL,NULL),(636,'A Verhoeven',NULL,NULL,NULL,NULL),(637,'Aristotle Voineskos',NULL,NULL,NULL,NULL),(638,'Anja C Huizink',NULL,NULL,NULL,NULL),(639,'Anthony F Jorm',NULL,NULL,NULL,NULL),(640,'Aartjan TF Beekman',NULL,NULL,NULL,NULL),(641,'Andrew Whitehouse',NULL,NULL,NULL,NULL),(642,'Albert M van Hemert',NULL,NULL,NULL,NULL),(643,'Alison Yung',NULL,NULL,NULL,NULL),(644,'Aiden Corvin',NULL,NULL,NULL,NULL),(645,'AW Maclean',NULL,NULL,NULL,NULL),(646,'Aaron F Alexander-Bloch',NULL,NULL,NULL,NULL),(647,'Aaron Schokman',NULL,NULL,NULL,NULL),(648,'Abigail Powers',NULL,NULL,NULL,NULL),(649,'Adam Bryant Miller',NULL,NULL,NULL,NULL),(650,'Adam Guestella',NULL,NULL,NULL,NULL),(651,'Adam Walker',NULL,NULL,NULL,NULL),(652,'Adam W Finch',NULL,NULL,NULL,NULL),(653,'Adebayo Anjorin',NULL,NULL,NULL,NULL),(654,'Adolfo M├â┬¡nguez',NULL,NULL,NULL,NULL),(655,'Adrian Carter',NULL,NULL,NULL,NULL),(656,'Adri├ín I Campos',NULL,NULL,NULL,NULL),(657,'Adrian Power',NULL,NULL,NULL,NULL),(658,'Adriana Lori',NULL,NULL,NULL,NULL),(659,'Adriane Martin Hilber',NULL,NULL,NULL,NULL),(660,'Adriano Jimenez-Escrig',NULL,NULL,NULL,NULL),(661,'Adri├â┬ín Campos-Gonz├â┬ílez',NULL,NULL,NULL,NULL),(662,'Affrica McCarthy',NULL,NULL,NULL,NULL),(663,'Agatino Battaglia',NULL,NULL,NULL,NULL),(664,'Agnieszka Tymula',NULL,NULL,NULL,NULL),(665,'Agustin Ruiz',NULL,NULL,NULL,NULL),(666,'Ahmad R Hariri',NULL,NULL,NULL,NULL),(667,'Ahmed A Moustafa',NULL,NULL,NULL,NULL),(668,'Ajeet Singh',NULL,NULL,NULL,NULL),(669,'Akbota Aitkulova',NULL,NULL,NULL,NULL),(670,'Akira Sawa',NULL,NULL,NULL,NULL),(671,'Akitoyo Hishimoto',NULL,NULL,NULL,NULL),(672,'Alan Anticevic',NULL,NULL,NULL,NULL),(673,'Alan Breier',NULL,NULL,NULL,NULL),(674,'Alan Brichta',NULL,NULL,NULL,NULL),(675,'Alan Brockman',NULL,NULL,NULL,NULL),(676,'Alan Harvey',NULL,NULL,NULL,NULL),(677,'Alan Headey',NULL,NULL,NULL,NULL),(678,'Alan McLean',NULL,NULL,NULL,NULL),(679,'Andrew Simmons',NULL,NULL,NULL,NULL),(680,'Alan Rosen',NULL,NULL,NULL,NULL),(681,'Alastair J Noyce',NULL,NULL,NULL,NULL),(682,'Albertine J Oldehinkel',NULL,NULL,NULL,NULL),(683,'Alberto Freitas',NULL,NULL,NULL,NULL),(684,'Alejandro Arias Vasquez',NULL,NULL,NULL,NULL),(685,'Aleksey Shatunov',NULL,NULL,NULL,NULL),(686,'Alena Stanc├â┬íkov├â┬í',NULL,NULL,NULL,NULL),(687,'Alessandra Radovini',NULL,NULL,NULL,NULL),(688,'Alessandro Bertolino',NULL,NULL,NULL,NULL),(689,'Alessandro Serretti',NULL,NULL,NULL,NULL),(690,'Alex Blaszczynski',NULL,NULL,NULL,NULL),(691,'Alex J Tahmindjis',NULL,NULL,NULL,NULL),(692,'Alex W Hewitt',NULL,NULL,NULL,NULL),(693,'Alexa Beiser',NULL,NULL,NULL,NULL),(694,'Alexander Fornito',NULL,NULL,NULL,NULL),(695,'Alexander I Stiby',NULL,NULL,NULL,NULL),(696,'Alexander P Reiner',NULL,NULL,NULL,NULL),(697,'Alexander S Hatoum',NULL,NULL,NULL,NULL),(698,'Alexander S Tomyshev',NULL,NULL,NULL,NULL),(699,'Alexander Viktorin',NULL,NULL,NULL,NULL),(700,'Alexander W Charney',NULL,NULL,NULL,NULL),(701,'Alexandra Aiken',NULL,NULL,NULL,NULL),(702,'Alexandra Garland',NULL,NULL,NULL,NULL),(703,'Alexandra Martiniuk',NULL,NULL,NULL,NULL),(704,'Alexandra Parker',NULL,NULL,NULL,NULL),(705,'Alexandra Portenhauser',NULL,NULL,NULL,NULL),(706,'Alexandra Winter',NULL,NULL,NULL,NULL),(707,'Alexis Brice',NULL,NULL,NULL,NULL),(708,'Alexis Edwards',NULL,NULL,NULL,NULL),(709,'Alexis E Whitton',NULL,NULL,NULL,NULL),(710,'Alfons Macaya',NULL,NULL,NULL,NULL),(711,'Alfredo Iacoangeli',NULL,NULL,NULL,NULL),(712,'Ali Saffet Gonul',NULL,NULL,NULL,NULL),(713,'Alice Gibson',NULL,NULL,NULL,NULL),(714,'Anthony Mason',NULL,NULL,NULL,NULL),(715,'Alice Norton',NULL,NULL,NULL,NULL),(716,'Alireza Jalali',NULL,NULL,NULL,NULL),(717,'Alison D Murray',NULL,NULL,NULL,NULL),(718,'Alison K Merikangas',NULL,NULL,NULL,NULL),(719,'Alison L Calear',NULL,NULL,NULL,NULL),(720,'Alison M Goate',NULL,NULL,NULL,NULL),(721,'Alison McLaverty',NULL,NULL,NULL,NULL),(722,'Ashleigh E Smith',NULL,NULL,NULL,NULL),(723,'Andrrewn Wilson',NULL,NULL,NULL,NULL),(724,'Alissa Nichles',NULL,NULL,NULL,NULL),(725,'Alistair S Hall',NULL,NULL,NULL,NULL),(726,'Alix Woolard',NULL,NULL,NULL,NULL),(727,'Allan F Mcrae',NULL,NULL,NULL,NULL),(728,'Allan I Levey',NULL,NULL,NULL,NULL),(729,'Allan S Kaplan',NULL,NULL,NULL,NULL),(730,'Allison Waters',NULL,NULL,NULL,NULL),(731,'Altynay Karimova',NULL,NULL,NULL,NULL),(732,'Alvaro Andres Navarro Mancilla',NULL,NULL,NULL,NULL),(733,'Alvaro Navarro-Mancilla',NULL,NULL,NULL,NULL),(734,'Alysa E Doyle',NULL,NULL,NULL,NULL),(735,'Alyssa Milton',NULL,NULL,NULL,NULL),(736,'Alyssa Zhu',NULL,NULL,NULL,NULL),(737,'Amanda Glasgow',NULL,NULL,NULL,NULL),(738,'Amanda L Dobbyn',NULL,NULL,NULL,NULL),(739,'Amanda Urbanc',NULL,NULL,NULL,NULL),(740,'Amar Ojha',NULL,NULL,NULL,NULL),(741,'Amelia English',NULL,NULL,NULL,NULL),(742,'Amelia Gulliver',NULL,NULL,NULL,NULL),(743,'Amit Lampit',NULL,NULL,NULL,NULL),(744,'Ammar Al-Chalabi',NULL,NULL,NULL,NULL),(745,'Amy E Adkins',NULL,NULL,NULL,NULL),(746,'Amy Burton',NULL,NULL,NULL,NULL),(747,'Amy C Abelmann',NULL,NULL,NULL,NULL),(748,'Amy Corderoy',NULL,NULL,NULL,NULL),(749,'Amy E Taylor',NULL,NULL,NULL,NULL),(750,'Amy Tedja',NULL,NULL,NULL,NULL),(751,'Ana C Andreazza',NULL,NULL,NULL,NULL),(752,'Ana C├â┬ímara',NULL,NULL,NULL,NULL),(753,'Ana Ferreira',NULL,NULL,NULL,NULL),(754,'Ana Gorostidi Pagola',NULL,NULL,NULL,NULL),(755,'Ana Radovic',NULL,NULL,NULL,NULL),(756,'Anbupalam Thalamuthu',NULL,NULL,NULL,NULL),(757,'Anda Preda',NULL,NULL,NULL,NULL),(758,'Anders Jur├â┬⌐us',NULL,NULL,NULL,NULL),(759,'Anders M Dale',NULL,NULL,NULL,NULL),(760,'Andiara Saloma',NULL,NULL,NULL,NULL),(761,'Andr├â┬⌐ Aleman',NULL,NULL,NULL,NULL),(762,'Andre Altmann',NULL,NULL,NULL,NULL),(763,'Andrea Block',NULL,NULL,NULL,NULL),(764,'Andrea C Belin',NULL,NULL,NULL,NULL),(765,'Andrea Christoforou',NULL,NULL,NULL,NULL),(766,'Andrea Hofman',NULL,NULL,NULL,NULL),(767,'Andrea Mant',NULL,NULL,NULL,NULL),(768,'Andrea S Fogarty',NULL,NULL,NULL,NULL),(769,'Andrea Schulz',NULL,NULL,NULL,NULL),(770,'Andreas Bechdolf',NULL,NULL,NULL,NULL),(771,'Andreas Heinz',NULL,NULL,NULL,NULL),(772,'Andreas J Forstner',NULL,NULL,NULL,NULL),(773,'Andreas Jansen',NULL,NULL,NULL,NULL),(774,'Andreas Menke',NULL,NULL,NULL,NULL),(775,'Andreas Reif',NULL,NULL,NULL,NULL),(776,'Andreas Ruepp',NULL,NULL,NULL,NULL),(777,'Andreas Schloenhardt',NULL,NULL,NULL,NULL),(778,'Andreja Avbersek',NULL,NULL,NULL,NULL),(779,'Andres M Rangel',NULL,NULL,NULL,NULL),(780,'Andres Metspalu',NULL,NULL,NULL,NULL),(781,'Andrew A Crawford',NULL,NULL,NULL,NULL),(782,'Andrew B Singleton',NULL,NULL,NULL,NULL),(783,'Andrew Brickman',NULL,NULL,NULL,NULL),(784,'Anna McKinnon',NULL,NULL,NULL,NULL),(785,'Andrew Chanen',NULL,NULL,NULL,NULL),(786,'Andrew Geczy',NULL,NULL,NULL,NULL),(787,'Andrew Grotzinger',NULL,NULL,NULL,NULL),(788,'Andrew H Kemp',NULL,NULL,NULL,NULL),(789,'Andrew Heath',NULL,NULL,NULL,NULL),(790,'Andrew J Kalnin',NULL,NULL,NULL,NULL),(791,'Andrew J Lawrence',NULL,NULL,NULL,NULL),(792,'Andrew Mackinnon',NULL,NULL,NULL,NULL),(793,'Andrew J Saykin',NULL,NULL,NULL,NULL),(794,'Ashley R Jones',NULL,NULL,NULL,NULL),(795,'Andrew M Tonkin',NULL,NULL,NULL,NULL),(796,'Andrew McIntosh',NULL,NULL,NULL,NULL),(797,'Andrew McQuillin',NULL,NULL,NULL,NULL),(798,'Andrew P Bradley',NULL,NULL,NULL,NULL),(799,'Andrew P Lieberman',NULL,NULL,NULL,NULL),(800,'Andrew Thompson',NULL,NULL,NULL,NULL),(801,'Andrew W Bergen',NULL,NULL,NULL,NULL),(802,'Andrew Zalesky',NULL,NULL,NULL,NULL),(803,'Andrey Khrunin',NULL,NULL,NULL,NULL),(804,'Andrey Shabalin',NULL,NULL,NULL,NULL),(805,'Andr├â┬⌐ G Uitterlinden',NULL,NULL,NULL,NULL),(806,'Andr├â┬⌐ van Schaik',NULL,NULL,NULL,NULL),(807,'Andr├â┬⌐e-Ann Cyr',NULL,NULL,NULL,NULL),(808,'Andr├â┬⌐s Camilo Cardozo Alarc├â┬│n',NULL,NULL,NULL,NULL),(809,'Andr├â┬⌐s Ingason',NULL,NULL,NULL,NULL),(810,'Andy Lopez-Williams',NULL,NULL,NULL,NULL),(811,'Angela D\'Rozario',NULL,NULL,NULL,NULL),(812,'Angela Wenzlaff',NULL,NULL,NULL,NULL),(813,'Angelika Erhardt',NULL,NULL,NULL,NULL),(814,'Angli Xue',NULL,NULL,NULL,NULL),(815,'Angus Macbeth',NULL,NULL,NULL,NULL),(816,'Angus Wallace',NULL,NULL,NULL,NULL),(817,'Ang├⌐ Weinrabe',NULL,NULL,NULL,NULL),(818,'Ania Korszun',NULL,NULL,NULL,NULL),(819,'Anita Pandit',NULL,NULL,NULL,NULL),(820,'Anita Riecher-Roessler',NULL,NULL,NULL,NULL),(821,'Anita Riecher-Rossler',NULL,NULL,NULL,NULL),(822,'Anita van Zwieten',NULL,NULL,NULL,NULL),(823,'Anjalee Cohen',NULL,NULL,NULL,NULL),(824,'Anjali K Henders',NULL,NULL,NULL,NULL),(825,'Anjali Tarun',NULL,NULL,NULL,NULL),(826,'Ann G Schwartz',NULL,NULL,NULL,NULL),(827,'Ann Kelley',NULL,NULL,NULL,NULL),(828,'Ann-Maree Vallence',NULL,NULL,NULL,NULL),(829,'Anna C Koller',NULL,NULL,NULL,NULL),(830,'Anna R Docherty',NULL,NULL,NULL,NULL),(831,'Anna Hunt',NULL,NULL,NULL,NULL),(832,'Anna J Stevenson',NULL,NULL,NULL,NULL),(833,'Anna K K├â┬ñhler',NULL,NULL,NULL,NULL),(834,'Anna K Nowak',NULL,NULL,NULL,NULL),(835,'Anna Scimone',NULL,NULL,NULL,NULL),(836,'Anna Sidis',NULL,NULL,NULL,NULL),(837,'Anna Stark',NULL,NULL,NULL,NULL),(838,'Anna Starnawska',NULL,NULL,NULL,NULL),(839,'Anna Vinkhuyzen',NULL,NULL,NULL,NULL),(840,'Anna Wheatley',NULL,NULL,NULL,NULL),(841,'Annabella Di Giorgio',NULL,NULL,NULL,NULL),(842,'Annamaria Cattaneo',NULL,NULL,NULL,NULL),(843,'Anne Boland',NULL,NULL,NULL,NULL),(844,'Anne Castles',NULL,NULL,NULL,NULL),(845,'Anne Deveson',NULL,NULL,NULL,NULL),(846,'Anne E Farmer',NULL,NULL,NULL,NULL),(847,'Anne Heidi Skogholt',NULL,NULL,NULL,NULL),(848,'Anne Kyle',NULL,NULL,NULL,NULL),(849,'Anne Uhlmann',NULL,NULL,NULL,NULL),(850,'Anne-Laura van Harmelen',NULL,NULL,NULL,NULL),(851,'Annelie Nordin Adolfsson',NULL,NULL,NULL,NULL),(852,'Annerine Roos',NULL,NULL,NULL,NULL),(853,'Annette Conzelmann',NULL,NULL,NULL,NULL),(854,'Annette Koschera',NULL,NULL,NULL,NULL),(855,'Annette M Hartmann',NULL,NULL,NULL,NULL),(856,'Annette Schmiede',NULL,NULL,NULL,NULL),(857,'Anouk Schrantee',NULL,NULL,NULL,NULL),(858,'Anouk den Braber',NULL,NULL,NULL,NULL),(859,'Anthony Batzler',NULL,NULL,NULL,NULL),(860,'Anthony Bayer',NULL,NULL,NULL,NULL),(861,'Anthony C James',NULL,NULL,NULL,NULL),(862,'Anthony Duggan',NULL,NULL,NULL,NULL),(863,'Anthony J Bailey',NULL,NULL,NULL,NULL),(864,'Anthony J Balmforth',NULL,NULL,NULL,NULL),(865,'Anthony J Hannan',NULL,NULL,NULL,NULL),(866,'Anthony Komaroff',NULL,NULL,NULL,NULL),(867,'Antoinette Scaffidi',NULL,NULL,NULL,NULL),(868,'Anton Albajes-Eizagirre',NULL,NULL,NULL,NULL),(869,'Antonella Mulas',NULL,NULL,NULL,NULL),(870,'Antonia Ottavio',NULL,NULL,NULL,NULL),(871,'Antonio Juli├â',NULL,NULL,NULL,NULL),(872,'Antonio Mendoza Diaz',NULL,NULL,NULL,NULL),(873,'Antony Kidman',NULL,NULL,NULL,NULL),(874,'Anu Loukola',NULL,NULL,NULL,NULL),(875,'Aoibhe Mulcahy',NULL,NULL,NULL,NULL),(876,'Aravinda Chakravarti',NULL,NULL,NULL,NULL),(877,'Arden Moscati',NULL,NULL,NULL,NULL),(878,'Ari Siitonen',NULL,NULL,NULL,NULL),(879,'Arn MJM van den Maagdenberg',NULL,NULL,NULL,NULL),(880,'Arnab Ahmed',NULL,NULL,NULL,NULL),(881,'Arnstein Mykeltun',NULL,NULL,NULL,NULL),(882,'Arnt FA Schellekens',NULL,NULL,NULL,NULL),(883,'Arthur W Toga',NULL,NULL,NULL,NULL),(884,'Arun K Tiwari',NULL,NULL,NULL,NULL),(885,'Ary Gadelha',NULL,NULL,NULL,NULL),(886,'Ashlea Hambleton',NULL,NULL,NULL,NULL),(887,'Ashlee Grierson',NULL,NULL,NULL,NULL),(888,'Ashlee Turner',NULL,NULL,NULL,NULL),(889,'Ashleigh Tickell',NULL,NULL,NULL,NULL),(890,'Ashleigh W Hooker',NULL,NULL,NULL,NULL),(891,'Ashley Dumont',NULL,NULL,NULL,NULL),(892,'Ashley Nixon',NULL,NULL,NULL,NULL),(893,'Ashok Malla',NULL,NULL,NULL,NULL),(894,'Aslihan Uyar-Demir',NULL,NULL,NULL,NULL),(895,'Astrid D Adarmes-G├â┬│mez',NULL,NULL,NULL,NULL),(896,'Astrid Rogoz',NULL,NULL,NULL,NULL),(897,'Aswin Ratheesh',NULL,NULL,NULL,NULL),(898,'Aurora Bonvino',NULL,NULL,NULL,NULL),(899,'Authors',NULL,NULL,NULL,NULL),(900,'Avram J Holmes',NULL,NULL,NULL,NULL),(901,'Ayman H Fanous',NULL,NULL,NULL,NULL),(902,'Ayse Sengoz',NULL,NULL,NULL,NULL),(903,'B Cao',NULL,NULL,NULL,NULL),(904,'Baptiste Couvy-Duchesne',NULL,NULL,NULL,NULL),(905,'B Everett',NULL,NULL,NULL,NULL),(906,'B Hopper',NULL,NULL,NULL,NULL),(907,'B Kraemer',NULL,NULL,NULL,NULL),(908,'B Morton',NULL,NULL,NULL,NULL),(909,'B Mowry',NULL,NULL,NULL,NULL),(910,'B Mueller-Myhsok',NULL,NULL,NULL,NULL),(911,'Bertram M├â┬╝ller-Myhsok',NULL,NULL,NULL,NULL),(912,'Barnaby Nelson',NULL,NULL,NULL,NULL),(913,'Brenda WJH Penninx',NULL,NULL,NULL,NULL),(914,'B Phillips',NULL,NULL,NULL,NULL),(915,'Beenish Qaiser',NULL,NULL,NULL,NULL),(916,'B Redican',NULL,NULL,NULL,NULL),(917,'B Ross',NULL,NULL,NULL,NULL),(918,'Bartosz Zurowski',NULL,NULL,NULL,NULL),(919,'Ben J Harrison',NULL,NULL,NULL,NULL),(920,'Barbara J Meyer',NULL,NULL,NULL,NULL),(921,'BP McEvoy',NULL,NULL,NULL,NULL),(922,'Brien P Riley',NULL,NULL,NULL,NULL),(923,'Bradley T Webb',NULL,NULL,NULL,NULL),(924,'Bernard W Balleine',NULL,NULL,NULL,NULL),(925,'Badri N Vardarajan',NULL,NULL,NULL,NULL),(926,'Bao-Zhu Yang',NULL,NULL,NULL,NULL),(927,'Barbara A Cornblatt',NULL,NULL,NULL,NULL),(928,'Barbara Kaye Bennett',NULL,NULL,NULL,NULL),(929,'Barbara Cameron',NULL,NULL,NULL,NULL),(930,'Barbara Dooley',NULL,NULL,NULL,NULL),(931,'Barbara F Piraino',NULL,NULL,NULL,NULL),(932,'Barbara Franke',NULL,NULL,NULL,NULL),(933,'Barbara Hocking',NULL,NULL,NULL,NULL),(934,'Beata R Godlewska',NULL,NULL,NULL,NULL),(935,'Beate Ritz',NULL,NULL,NULL,NULL),(936,'Beathe Haatveit',NULL,NULL,NULL,NULL),(937,'Beatriz Luna',NULL,NULL,NULL,NULL),(938,'Bela Melegh',NULL,NULL,NULL,NULL),(939,'Belinda Thewes',NULL,NULL,NULL,NULL),(940,'Ben DA Gorman',NULL,NULL,NULL,NULL),(941,'Ben Gu',NULL,NULL,NULL,NULL),(942,'Ben Larke',NULL,NULL,NULL,NULL),(943,'Ben Middlehurst',NULL,NULL,NULL,NULL),(944,'Ben Wickham',NULL,NULL,NULL,NULL),(945,'Bendik Winsvold',NULL,NULL,NULL,NULL),(946,'Benedicto Crespo-Facorro',NULL,NULL,NULL,NULL),(947,'Beng-Choon Ho',NULL,NULL,NULL,NULL),(948,'Benjamin A Gill',NULL,NULL,NULL,NULL),(949,'Benjamin Aribisala',NULL,NULL,NULL,NULL),(950,'Benjamin Grenier-Boley',NULL,NULL,NULL,NULL),(951,'Benjamin Neale',NULL,NULL,NULL,NULL),(952,'Benjamin N Ubani',NULL,NULL,NULL,NULL),(953,'Benjamin W Domingue',NULL,NULL,NULL,NULL),(954,'Bennett A Landman',NULL,NULL,NULL,NULL),(955,'Benoit H Mulsant',NULL,NULL,NULL,NULL),(956,'Benson Irungu',NULL,NULL,NULL,NULL),(957,'Benson Mwangi',NULL,NULL,NULL,NULL),(958,'Bernadette M Fitzgibbon',NULL,NULL,NULL,NULL),(959,'Bernard G McNair',NULL,NULL,NULL,NULL),(960,'Bernard Lerer',NULL,NULL,NULL,NULL),(961,'Bernard Mazoyer',NULL,NULL,NULL,NULL),(962,'Bernard Ng',NULL,NULL,NULL,NULL),(963,'Bernhard Kr├â┬ñmer',NULL,NULL,NULL,NULL),(964,'Bernd Weber',NULL,NULL,NULL,NULL),(965,'Bernhard T Baune',NULL,NULL,NULL,NULL),(966,'Bernice Porjesz',NULL,NULL,NULL,NULL),(967,'Bernie Devlin',NULL,NULL,NULL,NULL),(968,'Bertram Muller-Myhsok',NULL,NULL,NULL,NULL),(969,'Bettina Konte',NULL,NULL,NULL,NULL),(970,'Bettina Meiser',NULL,NULL,NULL,NULL),(971,'Bill Lyndon',NULL,NULL,NULL,NULL),(972,'Blake F Dear',NULL,NULL,NULL,NULL),(973,'Blake Hamilton',NULL,NULL,NULL,NULL),(974,'Blanca Gutierrez',NULL,NULL,NULL,NULL),(975,'Boe Rambaldini',NULL,NULL,NULL,NULL),(976,'Bonnie Klimes-Dougan',NULL,NULL,NULL,NULL),(977,'Boris A Gutman',NULL,NULL,NULL,NULL),(978,'Boris Chaumette',NULL,NULL,NULL,NULL),(979,'Brad Verhulst',NULL,NULL,NULL,NULL),(980,'Bradley Jermy',NULL,NULL,NULL,NULL),(981,'Bradley T Hyman',NULL,NULL,NULL,NULL),(982,'Bradley Whitwell',NULL,NULL,NULL,NULL),(983,'Brainstorm Consortium',NULL,NULL,NULL,NULL),(984,'Braulio M Valencia',NULL,NULL,NULL,NULL),(985,'Brendan Bulik-Sullivan',NULL,NULL,NULL,NULL),(986,'Brendan P Zietsch',NULL,NULL,NULL,NULL),(987,'Brendon J Yee',NULL,NULL,NULL,NULL),(988,'Brenna C McDonald',NULL,NULL,NULL,NULL),(989,'Brent Hedley',NULL,NULL,NULL,NULL),(990,'Brett Johnson',NULL,NULL,NULL,NULL),(991,'Brian F Oldenburg',NULL,NULL,NULL,NULL),(992,'Brian Lawlor',NULL,NULL,NULL,NULL),(993,'Brian O├éΓÇÖDonoghue',NULL,NULL,NULL,NULL),(994,'Brian Parsonage',NULL,NULL,NULL,NULL),(995,'Brian R Walker',NULL,NULL,NULL,NULL),(996,'Bridget Bassilios',NULL,NULL,NULL,NULL),(997,'Bridianne O\'Dea',NULL,NULL,NULL,NULL),(998,'Bridianne O├éΓÇÖDea',NULL,NULL,NULL,NULL),(999,'Brion S Maher',NULL,NULL,NULL,NULL),(1000,'Brittany Mitchell',NULL,NULL,NULL,NULL),(1001,'Brittany R Smith',NULL,NULL,NULL,NULL),(1002,'Bronwyn J Overs',NULL,NULL,NULL,NULL),(1003,'Bronwyn Quigley',NULL,NULL,NULL,NULL),(1004,'Bru Cormand',NULL,NULL,NULL,NULL),(1005,'Bruce J Tonge',NULL,NULL,NULL,NULL),(1006,'Bruce Neal',NULL,NULL,NULL,NULL),(1007,'Bruno Etain',NULL,NULL,NULL,NULL),(1008,'Bruno Vellas',NULL,NULL,NULL,NULL),(1009,'Bryan Rodgers',NULL,NULL,NULL,NULL),(1010,'Bryce Vissel',NULL,NULL,NULL,NULL),(1011,'Bryon A Mueller',NULL,NULL,NULL,NULL),(1012,'C Alloza',NULL,NULL,NULL,NULL),(1013,'C Arango',NULL,NULL,NULL,NULL),(1014,'C Bierl',NULL,NULL,NULL,NULL),(1015,'Catherine M Brennan',NULL,NULL,NULL,NULL),(1016,'C Chan',NULL,NULL,NULL,NULL),(1017,'C Chiapponi',NULL,NULL,NULL,NULL),(1018,'C Dalton',NULL,NULL,NULL,NULL),(1019,'Carolyn Doughty',NULL,NULL,NULL,NULL),(1020,'C Ellis',NULL,NULL,NULL,NULL),(1021,'Chrysa Fazou',NULL,NULL,NULL,NULL),(1022,'C Ferry',NULL,NULL,NULL,NULL),(1023,'Christopher Gordon',NULL,NULL,NULL,NULL),(1024,'Caroline Hayward',NULL,NULL,NULL,NULL),(1025,'Colm Healy',NULL,NULL,NULL,NULL),(1026,'Camilla Hoyos',NULL,NULL,NULL,NULL),(1027,'C Jones',NULL,NULL,NULL,NULL),(1028,'C Kn├â┬╢chel',NULL,NULL,NULL,NULL),(1029,'Carsten Konrad',NULL,NULL,NULL,NULL),(1030,'C Lopez-Jaramillo',NULL,NULL,NULL,NULL),(1031,'C Normann',NULL,NULL,NULL,NULL),(1032,'Cristina S Ricci',NULL,NULL,NULL,NULL),(1033,'C Robert Cloninger',NULL,NULL,NULL,NULL),(1034,'Cynthia Shannon Weickert',NULL,NULL,NULL,NULL),(1035,'CA Bousman',NULL,NULL,NULL,NULL),(1036,'CA Rietveld',NULL,NULL,NULL,NULL),(1037,'Camelia C Minica',NULL,NULL,NULL,NULL),(1038,'CCN',NULL,NULL,NULL,NULL),(1039,'CD Vargas',NULL,NULL,NULL,NULL),(1040,'CD Whelan',NULL,NULL,NULL,NULL),(1041,'CJ Yatawara',NULL,NULL,NULL,NULL),(1042,'CM Diaz-Caneja',NULL,NULL,NULL,NULL),(1043,'Christel M Middeldorp',NULL,NULL,NULL,NULL),(1044,'Caroline X Gao',NULL,NULL,NULL,NULL),(1045,'Caitlin E Carey',NULL,NULL,NULL,NULL),(1046,'Caleb Webber',NULL,NULL,NULL,NULL),(1047,'Cameron Fox',NULL,NULL,NULL,NULL),(1048,'Cameron J Dunn',NULL,NULL,NULL,NULL),(1049,'Camiel M Van der Laan',NULL,NULL,NULL,NULL),(1050,'Camille Nebeker',NULL,NULL,NULL,NULL),(1051,'Candace Carter',NULL,NULL,NULL,NULL),(1052,'Cara Wong',NULL,NULL,NULL,NULL),(1053,'Carin J Meijer',NULL,NULL,NULL,NULL),(1054,'Carl Clarke',NULL,NULL,NULL,NULL),(1055,'Carl Johan Ekman',NULL,NULL,NULL,NULL),(1056,'Carles Soriano-Mas',NULL,NULL,NULL,NULL),(1057,'Carlos Zarate',NULL,NULL,NULL,NULL),(1058,'Carlos A Zarate Jr',NULL,NULL,NULL,NULL),(1059,'Carlos Cruchaga',NULL,NULL,NULL,NULL),(1060,'Carlos Gomez Restrepo',NULL,NULL,NULL,NULL),(1061,'Carlos Gomez-Restrepo',NULL,NULL,NULL,NULL),(1062,'Carlota M├â┬⌐ndez-del-Barrio',NULL,NULL,NULL,NULL),(1063,'Carmel M Loughland',NULL,NULL,NULL,NULL),(1064,'Caro-Anne Badcock',NULL,NULL,NULL,NULL),(1065,'Carol E Franz',NULL,NULL,NULL,NULL),(1066,'Carolien GF De Kovel',NULL,NULL,NULL,NULL),(1067,'Caroline Fisher',NULL,NULL,NULL,NULL),(1068,'Caroline Johnston',NULL,NULL,NULL,NULL),(1069,'Caroline M Keating',NULL,NULL,NULL,NULL),(1070,'Caroline Ran',NULL,NULL,NULL,NULL),(1071,'Carolyn Langen',NULL,NULL,NULL,NULL),(1072,'Carolyn Mutch',NULL,NULL,NULL,NULL),(1073,'Carolyn Windler',NULL,NULL,NULL,NULL),(1074,'Caron Beaton-Wells',NULL,NULL,NULL,NULL),(1075,'Carrie E Beaden',NULL,NULL,NULL,NULL),(1076,'Carrie E Bearden',NULL,NULL,NULL,NULL),(1077,'Carsten B├â┬╕cker Pedersen',NULL,NULL,NULL,NULL),(1078,'Carsten Horn',NULL,NULL,NULL,NULL),(1079,'Casey Paquola',NULL,NULL,NULL,NULL),(1080,'Cassandra Long',NULL,NULL,NULL,NULL),(1081,'Catalina Betancur',NULL,NULL,NULL,NULL),(1082,'Catharina A Hartman',NULL,NULL,NULL,NULL),(1083,'Catharina Lavebratt',NULL,NULL,NULL,NULL),(1084,'Catherine A Howell',NULL,NULL,NULL,NULL),(1085,'Catherine Adams',NULL,NULL,NULL,NULL),(1086,'Catherine Bois',NULL,NULL,NULL,NULL),(1087,'Catherine Chudleigh',NULL,NULL,NULL,NULL),(1088,'Catherine Hickie',NULL,NULL,NULL,NULL),(1089,'Catherine McHugh',NULL,NULL,NULL,NULL),(1090,'Catherine Olsen',NULL,NULL,NULL,NULL),(1091,'Catherine Roca',NULL,NULL,NULL,NULL),(1092,'Cathrin Rohleder',NULL,NULL,NULL,NULL),(1093,'Cathrine Mihalopoulos',NULL,NULL,NULL,NULL),(1094,'Cathryn M Lewis',NULL,NULL,NULL,NULL),(1095,'Cathy Issakidis',NULL,NULL,NULL,NULL),(1096,'Catherine Mason',NULL,NULL,NULL,NULL),(1097,'Catriona Ireland',NULL,NULL,NULL,NULL),(1098,'Celia Brenchley',NULL,NULL,NULL,NULL),(1099,'Chaim Huyser',NULL,NULL,NULL,NULL),(1100,'Chanaka Wijeratne',NULL,NULL,NULL,NULL),(1101,'Chantal Depondt',NULL,NULL,NULL,NULL),(1102,'Chantal Henry',NULL,NULL,NULL,NULL),(1103,'Chao Tian',NULL,NULL,NULL,NULL),(1104,'Charles B Eaton',NULL,NULL,NULL,NULL),(1105,'Charles Curtis',NULL,NULL,NULL,NULL),(1106,'Charles F Reynolds III',NULL,NULL,NULL,NULL),(1107,'Charles Kooperberg',NULL,NULL,NULL,NULL),(1108,'Christian R Marshall',NULL,NULL,NULL,NULL),(1109,'Charlotte K Bainomugisa',NULL,NULL,NULL,NULL),(1110,'Chaturaka Rodrigo',NULL,NULL,NULL,NULL),(1111,'Chenhui Jiang',NULL,NULL,NULL,NULL),(1112,'Chenyu Wang',NULL,NULL,NULL,NULL),(1113,'Cherrie Galletly',NULL,NULL,NULL,NULL),(1114,'Chester Pabiniak',NULL,NULL,NULL,NULL),(1115,'Cheynna A Crowley',NULL,NULL,NULL,NULL),(1116,'Chiara Fabbri',NULL,NULL,NULL,NULL),(1117,'Chih-Min Liu',NULL,NULL,NULL,NULL),(1118,'Chloe Yap',NULL,NULL,NULL,NULL),(1119,'Chris Amos',NULL,NULL,NULL,NULL),(1120,'Chris Cotsapas',NULL,NULL,NULL,NULL),(1121,'Chris Hatherly',NULL,NULL,NULL,NULL),(1122,'Chris Platania-Phung',NULL,NULL,NULL,NULL),(1123,'Chris Tanti',NULL,NULL,NULL,NULL),(1124,'Christiaan A de Leeuw',NULL,NULL,NULL,NULL),(1125,'Christian Hammer',NULL,NULL,NULL,NULL),(1126,'Christian J Hopfer',NULL,NULL,NULL,NULL),(1127,'Christian Kubisch',NULL,NULL,NULL,NULL),(1128,'Christian Schmahl',NULL,NULL,NULL,NULL),(1129,'Christian Unkelbach',NULL,NULL,NULL,NULL),(1130,'Christiane Reitz',NULL,NULL,NULL,NULL),(1131,'Christina M Hultman',NULL,NULL,NULL,NULL),(1132,'Christina Phassouliotis',NULL,NULL,NULL,NULL),(1133,'Christine Burke',NULL,NULL,NULL,NULL),(1134,'Christine Fraser',NULL,NULL,NULL,NULL),(1135,'Christine Lochner',NULL,NULL,NULL,NULL),(1136,'Christine M Freitag',NULL,NULL,NULL,NULL),(1137,'Christine M Hulette',NULL,NULL,NULL,NULL),(1138,'Christine S├â┬╕holm Hansen',NULL,NULL,NULL,NULL),(1139,'Christine Y Song',NULL,NULL,NULL,NULL),(1140,'Christoph Dockweiler',NULL,NULL,NULL,NULL),(1141,'Christoph Karlheim',NULL,NULL,NULL,NULL),(1142,'Christoph U Correll',NULL,NULL,NULL,NULL),(1143,'Christopher C Tennant',NULL,NULL,NULL,NULL),(1144,'Christopher G Davey',NULL,NULL,NULL,NULL),(1145,'Christopher J Lennings',NULL,NULL,NULL,NULL),(1146,'Christopher James Ryan',NULL,NULL,NULL,NULL),(1147,'Christopher RK Ching',NULL,NULL,NULL,NULL),(1148,'Christopher S Haley',NULL,NULL,NULL,NULL),(1149,'Christos Pantelis',NULL,NULL,NULL,NULL),(1150,'Chronogen Consortium',NULL,NULL,NULL,NULL),(1151,'Chun Chieh Fan',NULL,NULL,NULL,NULL),(1152,'Chun-Hsin Chen',NULL,NULL,NULL,NULL),(1153,'Ciara Garcia',NULL,NULL,NULL,NULL),(1154,'Ciaran Pier',NULL,NULL,NULL,NULL),(1155,'Cici Feliz',NULL,NULL,NULL,NULL),(1156,'Cinnamon S Bloss',NULL,NULL,NULL,NULL),(1157,'Ciprian Crainiceanu',NULL,NULL,NULL,NULL),(1158,'Ciro Marangoni',NULL,NULL,NULL,NULL),(1159,'Claas Flint',NULL,NULL,NULL,NULL),(1160,'Claire Churchhouse',NULL,NULL,NULL,NULL),(1161,'Claire Eagleson',NULL,NULL,NULL,NULL),(1162,'Claire H Stewart',NULL,NULL,NULL,NULL),(1163,'Claire Henderson',NULL,NULL,NULL,NULL),(1164,'Claiton HD Bau',NULL,NULL,NULL,NULL),(1165,'Clare Kelly',NULL,NULL,NULL,NULL),(1166,'Claudia Giambartolomei',NULL,NULL,NULL,NULL),(1167,'Claudia Manzoni',NULL,NULL,NULL,NULL),(1168,'Claudia Schulte',NULL,NULL,NULL,NULL),(1169,'Claudine Berr',NULL,NULL,NULL,NULL),(1170,'Claudine Laurent',NULL,NULL,NULL,NULL),(1171,'Clement C Zai',NULL,NULL,NULL,NULL),(1172,'Clement R Boughton',NULL,NULL,NULL,NULL),(1173,'Clifford R Jack',NULL,NULL,NULL,NULL),(1174,'Clyde Francks',NULL,NULL,NULL,NULL),(1175,'Codrin Lungu',NULL,NULL,NULL,NULL),(1176,'Colin Craig',NULL,NULL,NULL,NULL),(1177,'Colin Depp',NULL,NULL,NULL,NULL),(1178,'Colin G James',NULL,NULL,NULL,NULL),(1179,'Colin Hodgkinson',NULL,NULL,NULL,NULL),(1180,'Colin MacLeod',NULL,NULL,NULL,NULL),(1181,'Colm G Connolly',NULL,NULL,NULL,NULL),(1182,'Colm McDonald',NULL,NULL,NULL,NULL),(1183,'Cong Sun',NULL,NULL,NULL,NULL),(1184,'Connie Henson',NULL,NULL,NULL,NULL),(1185,'Connie Markulev',NULL,NULL,NULL,NULL),(1186,'Conor V Dolan',NULL,NULL,NULL,NULL),(1187,'Constance Turman',NULL,NULL,NULL,NULL),(1188,'Constance Weisner',NULL,NULL,NULL,NULL),(1189,'Coralie Wilson',NULL,NULL,NULL,NULL),(1190,'Cornelia M Van Duijn',NULL,NULL,NULL,NULL),(1191,'Cornelis Blauwendraat',NULL,NULL,NULL,NULL),(1192,'Corrado Sandini',NULL,NULL,NULL,NULL),(1193,'Costanza L Vallerga',NULL,NULL,NULL,NULL),(1194,'Craig A Stockmeier',NULL,NULL,NULL,NULL),(1195,'Craig Donnelly',NULL,NULL,NULL,NULL),(1196,'Craig Johnson',NULL,NULL,NULL,NULL),(1197,'Craig L Hyde',NULL,NULL,NULL,NULL),(1198,'Craig Little',NULL,NULL,NULL,NULL),(1199,'Craig Martin',NULL,NULL,NULL,NULL),(1200,'Criminal Code Cth',NULL,NULL,NULL,NULL),(1201,'Cristal Oxley',NULL,NULL,NULL,NULL),(1202,'Cristen J Willer',NULL,NULL,NULL,NULL),(1203,'Cristiana Cruceanu',NULL,NULL,NULL,NULL),(1204,'Cristiano Noto',NULL,NULL,NULL,NULL),(1205,'Cristina Cacciotti-Saija',NULL,NULL,NULL,NULL),(1206,'Cristina Mei',NULL,NULL,NULL,NULL),(1207,'Cristina S├â┬ínchez-Mora',NULL,NULL,NULL,NULL),(1208,'Cristopher E Shaw',NULL,NULL,NULL,NULL),(1209,'Cyndi Shannon-Weickert',NULL,NULL,NULL,NULL),(1210,'Cynthia CH Hsu',NULL,NULL,NULL,NULL),(1211,'Cynthia Forlini',NULL,NULL,NULL,NULL),(1212,'Cynthia HY Fu',NULL,NULL,NULL,NULL),(1213,'Cynthia Sandor',NULL,NULL,NULL,NULL),(1214,'Delwyn Bartlett',NULL,NULL,NULL,NULL),(1215,'D Blake Woodside',NULL,NULL,NULL,NULL),(1216,'Dianne L Brown',NULL,NULL,NULL,NULL),(1217,'David M Colquhoun',NULL,NULL,NULL,NULL),(1218,'D Cook',NULL,NULL,NULL,NULL),(1219,'Dimity Crisp',NULL,NULL,NULL,NULL),(1220,'Darina Czamara',NULL,NULL,NULL,NULL),(1221,'D Gillis',NULL,NULL,NULL,NULL),(1222,'David Goldstein',NULL,NULL,NULL,NULL),(1223,'Dominik Grotegerd',NULL,NULL,NULL,NULL),(1224,'Dusan Hadzi-Pavlovic',NULL,NULL,NULL,NULL),(1225,'David Hoehn',NULL,NULL,NULL,NULL),(1226,'Dmitry Isaev',NULL,NULL,NULL,NULL),(1227,'Dagmar Koethe',NULL,NULL,NULL,NULL),(1228,'D Lameira',NULL,NULL,NULL,NULL),(1229,'D Pandit',NULL,NULL,NULL,NULL),(1230,'D Peiris',NULL,NULL,NULL,NULL),(1231,'D Rotenberg',NULL,NULL,NULL,NULL),(1232,'Dieter Schoepf',NULL,NULL,NULL,NULL),(1233,'D Schofield',NULL,NULL,NULL,NULL),(1234,'Daniela Spiliotacopoulos',NULL,NULL,NULL,NULL),(1235,'David R Thompson',NULL,NULL,NULL,NULL),(1236,'D Vecchio',NULL,NULL,NULL,NULL),(1237,'Dennis Velakoulis',NULL,NULL,NULL,NULL),(1238,'D Wei',NULL,NULL,NULL,NULL),(1239,'David C Glahn',NULL,NULL,NULL,NULL),(1240,'Denis Wakefield',NULL,NULL,NULL,NULL),(1241,'Daniel Hermens',NULL,NULL,NULL,NULL),(1242,'Donald MacIntyre',NULL,NULL,NULL,NULL),(1243,'Dan Stein',NULL,NULL,NULL,NULL),(1244,'DK McKenzie',NULL,NULL,NULL,NULL),(1245,'DL Basset',NULL,NULL,NULL,NULL),(1246,'DO Watson',NULL,NULL,NULL,NULL),(1247,'Derrek P Hibar',NULL,NULL,NULL,NULL),(1248,'DR Roalf',NULL,NULL,NULL,NULL),(1249,'Daniel S Quintana',NULL,NULL,NULL,NULL),(1250,'DT Newell',NULL,NULL,NULL,NULL),(1251,'Dag Aln├â┬ªs',NULL,NULL,NULL,NULL),(1252,'Dahn Jeong',NULL,NULL,NULL,NULL),(1253,'Dajiang J Liu',NULL,NULL,NULL,NULL),(1254,'Dale R Nyholt',NULL,NULL,NULL,NULL),(1255,'Dalia Kasperaviciute',NULL,NULL,NULL,NULL),(1256,'Dalila Pinto',NULL,NULL,NULL,NULL),(1257,'Dan E Arking',NULL,NULL,NULL,NULL),(1258,'Dan Lubman',NULL,NULL,NULL,NULL),(1259,'Dan Rujescu',NULL,NULL,NULL,NULL),(1260,'Dan Siskind',NULL,NULL,NULL,NULL),(1261,'Dan V Iosifescu',NULL,NULL,NULL,NULL),(1262,'Dana B Hancock',NULL,NULL,NULL,NULL),(1263,'Dana Schultchen',NULL,NULL,NULL,NULL),(1264,'Danai Dima',NULL,NULL,NULL,NULL),(1265,'Danfeng Chen',NULL,NULL,NULL,NULL),(1266,'Danica Hudson',NULL,NULL,NULL,NULL),(1267,'Daniel Bos',NULL,NULL,NULL,NULL),(1268,'Daniel Brandeis',NULL,NULL,NULL,NULL),(1269,'Daniel E Adkins',NULL,NULL,NULL,NULL),(1270,'Daniel E Irons',NULL,NULL,NULL,NULL),(1271,'Daniel F Gudbjartsson',NULL,NULL,NULL,NULL),(1272,'Daniel F Levey',NULL,NULL,NULL,NULL),(1273,'Daniel H Geschwind',NULL,NULL,NULL,NULL),(1274,'Daniel H Mathalon',NULL,NULL,NULL,NULL),(1275,'Daniel I Chasman',NULL,NULL,NULL,NULL),(1276,'Daniel J Benjamin',NULL,NULL,NULL,NULL),(1277,'Daniel J Biddle',NULL,NULL,NULL,NULL),(1278,'Daniel J M├â┬╝ller',NULL,NULL,NULL,NULL),(1279,'Daniel Johnson',NULL,NULL,NULL,NULL),(1280,'Daniel Macias',NULL,NULL,NULL,NULL),(1281,'Daniel McGuire',NULL,NULL,NULL,NULL),(1282,'Daniel Pellen',NULL,NULL,NULL,NULL),(1283,'Don AR Smith',NULL,NULL,NULL,NULL),(1284,'Daniel Souery',NULL,NULL,NULL,NULL),(1285,'Daniel Umbricht',NULL,NULL,NULL,NULL),(1286,'Daniel W McNeil',NULL,NULL,NULL,NULL),(1287,'Daniela Z├â┬╢ller',NULL,NULL,NULL,NULL),(1288,'Daniella Vuletic',NULL,NULL,NULL,NULL),(1289,'Danielle Clode',NULL,NULL,NULL,NULL),(1290,'Danielle M Dick',NULL,NULL,NULL,NULL),(1291,'Danielle Posthuma',NULL,NULL,NULL,NULL),(1292,'Danit Saks',NULL,NULL,NULL,NULL),(1293,'Danyu Lin',NULL,NULL,NULL,NULL),(1294,'Dara M Cannon',NULL,NULL,NULL,NULL),(1295,'Dario Zaremba',NULL,NULL,NULL,NULL),(1296,'Darryl L Bassett',NULL,NULL,NULL,NULL),(1297,'Dashiell D Sacks',NULL,NULL,NULL,NULL),(1298,'David A Collier',NULL,NULL,NULL,NULL),(1299,'David A Hinds',NULL,NULL,NULL,NULL),(1300,'David A Mackey',NULL,NULL,NULL,NULL),(1301,'David AA Baranger',NULL,NULL,NULL,NULL),(1302,'David Barton',NULL,NULL,NULL,NULL),(1303,'David Berle',NULL,NULL,NULL,NULL),(1304,'David Burke',NULL,NULL,NULL,NULL),(1305,'David C Rubinsztein',NULL,NULL,NULL,NULL),(1306,'David Cesarini',NULL,NULL,NULL,NULL),(1307,'David Coghill',NULL,NULL,NULL,NULL),(1308,'David Cohen',NULL,NULL,NULL,NULL),(1309,'David Cotter',NULL,NULL,NULL,NULL),(1310,'David Couper',NULL,NULL,NULL,NULL),(1311,'David W Craig',NULL,NULL,NULL,NULL),(1312,'David Curtis',NULL,NULL,NULL,NULL),(1313,'David EJ Linden',NULL,NULL,NULL,NULL),(1314,'David Fowler',NULL,NULL,NULL,NULL),(1315,'David G Brohawn',NULL,NULL,NULL,NULL),(1316,'David HK Shum',NULL,NULL,NULL,NULL),(1317,'David Hughes',NULL,NULL,NULL,NULL),(1318,'David Hunt',NULL,NULL,NULL,NULL),(1319,'David J Hawes',NULL,NULL,NULL,NULL),(1320,'David J Hunter',NULL,NULL,NULL,NULL),(1321,'David Kavanagh',NULL,NULL,NULL,NULL),(1322,'David J Porteous',NULL,NULL,NULL,NULL),(1323,'David Kohn',NULL,NULL,NULL,NULL),(1324,'David Kupfer',NULL,NULL,NULL,NULL),(1325,'David L Braff',NULL,NULL,NULL,NULL),(1326,'David L Duffy',NULL,NULL,NULL,NULL),(1327,'David L Hare',NULL,NULL,NULL,NULL),(1328,'David M Brazel',NULL,NULL,NULL,NULL),(1329,'David M Clarke',NULL,NULL,NULL,NULL),(1330,'David M Evans',NULL,NULL,NULL,NULL),(1331,'David M Hougaard',NULL,NULL,NULL,NULL),(1332,'David M Howard',NULL,NULL,NULL,NULL),(1333,'David M Kaye',NULL,NULL,NULL,NULL),(1334,'David Mataix-Cols',NULL,NULL,NULL,NULL),(1335,'David McCluskey',NULL,NULL,NULL,NULL),(1336,'David Meharg',NULL,NULL,NULL,NULL),(1337,'David Mehler',NULL,NULL,NULL,NULL),(1338,'David Miklowitz',NULL,NULL,NULL,NULL),(1339,'David Milne',NULL,NULL,NULL,NULL),(1340,'David Mongan',NULL,NULL,NULL,NULL),(1341,'David Pierce',NULL,NULL,NULL,NULL),(1342,'David R Badcock',NULL,NULL,NULL,NULL),(1343,'David R Weir',NULL,NULL,NULL,NULL),(1344,'David Ravine',NULL,NULL,NULL,NULL),(1345,'David St Clair',NULL,NULL,NULL,NULL),(1346,'David W Crosbie',NULL,NULL,NULL,NULL),(1347,'David Whiteman',NULL,NULL,NULL,NULL),(1348,'David Whitten',NULL,NULL,NULL,NULL),(1349,'David Wyld',NULL,NULL,NULL,NULL),(1350,'Dean F MacKinnon',NULL,NULL,NULL,NULL),(1351,'Dean S Carson',NULL,NULL,NULL,NULL),(1352,'Debora Cerdan',NULL,NULL,NULL,NULL),(1353,'Deborah A Turnbull',NULL,NULL,NULL,NULL),(1354,'Deborah Apthorp',NULL,NULL,NULL,NULL),(1355,'Deborah Janowitz',NULL,NULL,NULL,NULL),(1356,'Deborah McRitchie',NULL,NULL,NULL,NULL),(1357,'Deborah Vollmer Dahlke',NULL,NULL,NULL,NULL),(1358,'Debra Rickwood',NULL,NULL,NULL,NULL),(1359,'Deepak Haikerwal',NULL,NULL,NULL,NULL),(1360,'Demis A Kia',NULL,NULL,NULL,NULL),(1361,'Dena G Hernandez',NULL,NULL,NULL,NULL),(1362,'Denise Harold',NULL,NULL,NULL,NULL),(1363,'Denise Ruth',NULL,NULL,NULL,NULL),(1364,'Dennis Van der Meer',NULL,NULL,NULL,NULL),(1365,'Dennis Van\'t Ent',NULL,NULL,NULL,NULL),(1366,'Derek Narendra',NULL,NULL,NULL,NULL),(1367,'Derrick Silove',NULL,NULL,NULL,NULL),(1368,'Detelina Grozeva',NULL,NULL,NULL,NULL),(1369,'Devin Absher',NULL,NULL,NULL,NULL),(1370,'Dhayana Dallmeier',NULL,NULL,NULL,NULL),(1371,'Diana Chang',NULL,NULL,NULL,NULL),(1372,'Diana Naehrig',NULL,NULL,NULL,NULL),(1373,'Diana O Perkins',NULL,NULL,NULL,NULL),(1374,'Diana Paksarian',NULL,NULL,NULL,NULL),(1375,'Diana Tordesillas-Gutierrez',NULL,NULL,NULL,NULL),(1376,'Diana Tordesillas-Guti├â┬⌐rrez',NULL,NULL,NULL,NULL),(1377,'Diane Gage',NULL,NULL,NULL,NULL),(1378,'Dick J Veltman',NULL,NULL,NULL,NULL),(1379,'Didier Hannequin',NULL,NULL,NULL,NULL),(1380,'Diego Albani',NULL,NULL,NULL,NULL),(1381,'Dietrich Tr├â┬╝mbach',NULL,NULL,NULL,NULL),(1382,'Dilara J├â┬╝ksel',NULL,NULL,NULL,NULL),(1383,'Dilara Y├â┬╝ksel',NULL,NULL,NULL,NULL),(1384,'Dilip Jeste',NULL,NULL,NULL,NULL),(1385,'Dimitri Van De Ville',NULL,NULL,NULL,NULL),(1386,'Dimitris Dikeos',NULL,NULL,NULL,NULL),(1387,'Dimity C Pond',NULL,NULL,NULL,NULL),(1388,'Diogo Abrantes',NULL,NULL,NULL,NULL),(1389,'Dirk J Heslenfeld',NULL,NULL,NULL,NULL),(1390,'Ditte Demontis',NULL,NULL,NULL,NULL),(1391,'Divya Mehta',NULL,NULL,NULL,NULL),(1392,'Dixie J Statham',NULL,NULL,NULL,NULL),(1393,'Django White',NULL,NULL,NULL,NULL),(1394,'Dolores Buiza-Rueda',NULL,NULL,NULL,NULL),(1395,'Domenic Soligo',NULL,NULL,NULL,NULL),(1396,'Dominic B Rowe',NULL,NULL,NULL,NULL),(1397,'Dominic Holland',NULL,NULL,NULL,NULL),(1398,'Dominique Campion',NULL,NULL,NULL,NULL),(1399,'Dominique F Maciejewski',NULL,NULL,NULL,NULL),(1400,'Don Goldenberg',NULL,NULL,NULL,NULL),(1401,'Donald W Black',NULL,NULL,NULL,NULL),(1402,'Dong Li',NULL,NULL,NULL,NULL),(1403,'Dongbing Lai',NULL,NULL,NULL,NULL),(1404,'Dongmei Yu',NULL,NULL,NULL,NULL),(1405,'Dongsheng Fan',NULL,NULL,NULL,NULL),(1406,'Donna McCade',NULL,NULL,NULL,NULL),(1407,'Dorien Nieman',NULL,NULL,NULL,NULL),(1408,'Dorothy E Grice',NULL,NULL,NULL,NULL),(1409,'Dorothy Hatsukami',NULL,NULL,NULL,NULL),(1410,'Dorret I Boomsma',NULL,NULL,NULL,NULL),(1411,'Dost ├âΓÇông├â┬╝r',NULL,NULL,NULL,NULL),(1412,'Douglas F Levinson',NULL,NULL,NULL,NULL),(1413,'Douglas RH Blackwood',NULL,NULL,NULL,NULL),(1414,'Douglas Holmes',NULL,NULL,NULL,NULL),(1415,'Dubbo Infective Outcomes Study Group',NULL,NULL,NULL,NULL),(1416,'Dusan Hadzi Pavlovic',NULL,NULL,NULL,NULL),(1417,'Dusan Hadzi-Paviovic',NULL,NULL,NULL,NULL),(1418,'Esben Agerbo',NULL,NULL,NULL,NULL),(1419,'E Bell',NULL,NULL,NULL,NULL),(1420,'Edmond J Breen',NULL,NULL,NULL,NULL),(1421,'E Jagger',NULL,NULL,NULL,NULL),(1422,'E├â┬│in Killackey',NULL,NULL,NULL,NULL),(1423,'Elizabeth Loehrer',NULL,NULL,NULL,NULL),(1424,'Elena Pozzi',NULL,NULL,NULL,NULL),(1425,'Egle Simulionyte',NULL,NULL,NULL,NULL),(1426,'E Sprooten',NULL,NULL,NULL,NULL),(1427,'Erin C Dunn',NULL,NULL,NULL,NULL),(1428,'ED Goudzwaard',NULL,NULL,NULL,NULL),(1429,'Eco JC de Geus',NULL,NULL,NULL,NULL),(1430,'Eus JW Van Someren',NULL,NULL,NULL,NULL),(1431,'EL Werry',NULL,NULL,NULL,NULL),(1432,'ENIGMA-MDD working group',NULL,NULL,NULL,NULL),(1433,'Erin W Dickie',NULL,NULL,NULL,NULL),(1434,'Eric Yu Hai Chen',NULL,NULL,NULL,NULL),(1435,'Edith Pomarol-Clotet',NULL,NULL,NULL,NULL),(1436,'Edoardo Fiorillo',NULL,NULL,NULL,NULL),(1437,'Eduard Vieta',NULL,NULL,NULL,NULL),(1438,'Edwin H Cook',NULL,NULL,NULL,NULL),(1439,'Edwin JCG van den Oord',NULL,NULL,NULL,NULL),(1440,'Eftichia Duketis',NULL,NULL,NULL,NULL),(1441,'Ehsan Pishva',NULL,NULL,NULL,NULL),(1442,'Ehtesham A Abdi',NULL,NULL,NULL,NULL),(1443,'Eija H├â┬ñm├â┬ñl├â┬ñinen',NULL,NULL,NULL,NULL),(1444,'Eilis Hannon',NULL,NULL,NULL,NULL),(1445,'Ekaterina Rogaeva',NULL,NULL,NULL,NULL),(1446,'Elaine Barrett',NULL,NULL,NULL,NULL),(1447,'Elaine Edwards',NULL,NULL,NULL,NULL),(1448,'Elaine F Walker',NULL,NULL,NULL,NULL),(1449,'Elaine K Green',NULL,NULL,NULL,NULL),(1450,'Eleanor M Wigmore',NULL,NULL,NULL,NULL),(1451,'Elena Filimonova',NULL,NULL,NULL,NULL),(1452,'Eleni Andrea Demetriou',NULL,NULL,NULL,NULL),(1453,'Eleni A Papagiannopoulou',NULL,NULL,NULL,NULL),(1454,'Eli A Stahl',NULL,NULL,NULL,NULL),(1455,'Elisa Brietzke',NULL,NULL,NULL,NULL),(1456,'Elisabet Mondragon Rezola',NULL,NULL,NULL,NULL),(1457,'Elisabeth A Lambert',NULL,NULL,NULL,NULL),(1458,'Elisabeth B Binder',NULL,NULL,NULL,NULL),(1459,'Elisabeth J Leehr',NULL,NULL,NULL,NULL),(1460,'Elisabeth Schramm',NULL,NULL,NULL,NULL),(1461,'Elisha London',NULL,NULL,NULL,NULL),(1462,'Elizabeth A Woods',NULL,NULL,NULL,NULL),(1463,'Elizabeth Bennett',NULL,NULL,NULL,NULL),(1464,'Elizabeth Bevilacqua',NULL,NULL,NULL,NULL),(1465,'Elizabeth C Long',NULL,NULL,NULL,NULL),(1466,'Elizabeth Head',NULL,NULL,NULL,NULL),(1467,'Elizabeth Mackenzie',NULL,NULL,NULL,NULL),(1468,'Elizabeth Pellicano',NULL,NULL,NULL,NULL),(1469,'Elizabeth Spencer',NULL,NULL,NULL,NULL),(1470,'Elizabeth Stewart',NULL,NULL,NULL,NULL),(1471,'Elizabeth Stratton',NULL,NULL,NULL,NULL),(1472,'Elizabeth TC Lippard',NULL,NULL,NULL,NULL),(1473,'Ellen Frank',NULL,NULL,NULL,NULL),(1474,'Ellen Lee',NULL,NULL,NULL,NULL),(1475,'Elliot C Nelson',NULL,NULL,NULL,NULL),(1476,'Elliot S Gershon',NULL,NULL,NULL,NULL),(1477,'Elliot Tucker-Drob',NULL,NULL,NULL,NULL),(1478,'Elodie Drapeau',NULL,NULL,NULL,NULL),(1479,'Emily DiBlasi',NULL,NULL,NULL,NULL),(1480,'Emily Drabant Conley',NULL,NULL,NULL,NULL),(1481,'Emily Feig',NULL,NULL,NULL,NULL),(1482,'Emily L Dennis',NULL,NULL,NULL,NULL),(1483,'Emily R Bemmer',NULL,NULL,NULL,NULL),(1484,'Emily Young',NULL,NULL,NULL,NULL),(1485,'Emma Birrell',NULL,NULL,NULL,NULL),(1486,'Emma Thomas',NULL,NULL,NULL,NULL),(1487,'Emma L Elcombe',NULL,NULL,NULL,NULL),(1488,'Emma L Hawkins',NULL,NULL,NULL,NULL),(1489,'Emma Pallister',NULL,NULL,NULL,NULL),(1490,'Emmanuelle Corruble',NULL,NULL,NULL,NULL),(1491,'Emmanuelle Duron',NULL,NULL,NULL,NULL),(1492,'Enda M Byrne',NULL,NULL,NULL,NULL),(1493,'Engilbert Sigurdsson',NULL,NULL,NULL,NULL),(1494,'Enrique Castelao',NULL,NULL,NULL,NULL),(1495,'Eoin Killacky',NULL,NULL,NULL,NULL),(1496,'Eric B Larson',NULL,NULL,NULL,NULL),(1497,'Eric Boerwinkle',NULL,NULL,NULL,NULL),(1498,'Eric FC Cheung',NULL,NULL,NULL,NULL),(1499,'Eric Fombonne',NULL,NULL,NULL,NULL),(1500,'Eric G Benotsch',NULL,NULL,NULL,NULL),(1501,'Eric J Lenze',NULL,NULL,NULL,NULL),(1502,'Eric Jorgenson',NULL,NULL,NULL,NULL),(1503,'Eric O Johnson',NULL,NULL,NULL,NULL),(1504,'Eric Rimm',NULL,NULL,NULL,NULL),(1505,'Eric T Monson',NULL,NULL,NULL,NULL),(1506,'Erick J Canales-Rodr├â┬¡guez',NULL,NULL,NULL,NULL),(1507,'Erik A Ehli',NULL,NULL,NULL,NULL),(1508,'Erik G J├â┬╢nsson',NULL,NULL,NULL,NULL),(1509,'Erik Pettersson',NULL,NULL,NULL,NULL),(1510,'Erin B Ware',NULL,NULL,NULL,NULL),(1511,'Erin Cvejic',NULL,NULL,NULL,NULL),(1512,'Erlend B├â┬╕en',NULL,NULL,NULL,NULL),(1513,'Eske M Derks',NULL,NULL,NULL,NULL),(1514,'Esteban Mu├â┬▒oz',NULL,NULL,NULL,NULL),(1515,'Ester Cuenca-Leon',NULL,NULL,NULL,NULL),(1516,'Esther HC Chan',NULL,NULL,NULL,NULL),(1517,'Eugenio H Grevet',NULL,NULL,NULL,NULL),(1518,'Euijung Ryu',NULL,NULL,NULL,NULL),(1519,'Eva C Schulte',NULL,NULL,NULL,NULL),(1520,'Eva Castaldi',NULL,NULL,NULL,NULL),(1521,'Eva Hilland',NULL,NULL,NULL,NULL),(1522,'Eva Maria Frey',NULL,NULL,NULL,NULL),(1523,'Eva Trompetter',NULL,NULL,NULL,NULL),(1524,'Eva-Maria Messner',NULL,NULL,NULL,NULL),(1525,'Evelin Mihailov',NULL,NULL,NULL,NULL),(1526,'Evgeny Osipov',NULL,NULL,NULL,NULL),(1527,'Ezra S Susser',NULL,NULL,NULL,NULL),(1528,'Francesco Giorlando',NULL,NULL,NULL,NULL),(1529,'Femke Lamers',NULL,NULL,NULL,NULL),(1530,'FM Leweke',NULL,NULL,NULL,NULL),(1531,'F Pedic',NULL,NULL,NULL,NULL),(1532,'F Spaniel',NULL,NULL,NULL,NULL),(1533,'Fabian Streit',NULL,NULL,NULL,NULL),(1534,'F Turkheimer',NULL,NULL,NULL,NULL),(1535,'Francisco X Castellanos',NULL,NULL,NULL,NULL),(1536,'F Yesim Demirci',NULL,NULL,NULL,NULL),(1537,'FH Fischer',NULL,NULL,NULL,NULL),(1538,'FM Fan',NULL,NULL,NULL,NULL),(1539,'Fleur M Howells',NULL,NULL,NULL,NULL),(1540,'Frank P MacMaster',NULL,NULL,NULL,NULL),(1541,'Fabrice Crivello',NULL,NULL,NULL,NULL),(1542,'Fabrice Danjou',NULL,NULL,NULL,NULL),(1543,'Fabrice Jollant',NULL,NULL,NULL,NULL),(1544,'Fabrizio Piras',NULL,NULL,NULL,NULL),(1545,'Faisal Rashid',NULL,NULL,NULL,NULL),(1546,'Fallon Cluxton-Keller',NULL,NULL,NULL,NULL),(1547,'Fang Chen',NULL,NULL,NULL,NULL),(1548,'Fangyi Gu',NULL,NULL,NULL,NULL),(1549,'Faraz Faghri',NULL,NULL,NULL,NULL),(1550,'Farnush Hassan Farhadi Kiadeh',NULL,NULL,NULL,NULL),(1551,'Farooq Amin',NULL,NULL,NULL,NULL),(1552,'Fay Kohn',NULL,NULL,NULL,NULL),(1553,'Fazil Aliev',NULL,NULL,NULL,NULL),(1554,'Federica Tozzi',NULL,NULL,NULL,NULL),(1555,'Felecia Cerrato',NULL,NULL,NULL,NULL),(1556,'Fernando Calamante',NULL,NULL,NULL,NULL),(1557,'Fernando Fern├â┬índez-Aranda',NULL,NULL,NULL,NULL),(1558,'Fernando S Goes',NULL,NULL,NULL,NULL),(1559,'Fiona K Judd',NULL,NULL,NULL,NULL),(1560,'Fiona Stanley',NULL,NULL,NULL,NULL),(1561,'Fleur C Garton',NULL,NULL,NULL,NULL),(1562,'Florentia Socratous',NULL,NULL,NULL,NULL),(1563,'Florian Holsboer',NULL,NULL,NULL,NULL),(1564,'Fl├â┬ívio Kapczinski',NULL,NULL,NULL,NULL),(1565,'Folau Talbot',NULL,NULL,NULL,NULL),(1566,'Frada Burstein',NULL,NULL,NULL,NULL),(1567,'Fran Boyle',NULL,NULL,NULL,NULL),(1568,'Frances J Kay-Lambkin',NULL,NULL,NULL,NULL),(1569,'Frances M Yeo',NULL,NULL,NULL,NULL),(1570,'Frances Thorndike',NULL,NULL,NULL,NULL),(1571,'Francesc Colom',NULL,NULL,NULL,NULL),(1572,'Francesca Ducci',NULL,NULL,NULL,NULL),(1573,'Francesco Cucca',NULL,NULL,NULL,NULL),(1574,'Francis Gibbon',NULL,NULL,NULL,NULL),(1575,'Francis M Mondimore',NULL,NULL,NULL,NULL),(1576,'Francisco Cardoso',NULL,NULL,NULL,NULL),(1577,'Francisco Escamilla-Sevilla',NULL,NULL,NULL,NULL),(1578,'Francisco Javier Barrero',NULL,NULL,NULL,NULL),(1579,'Francisco Perez Errazquin',NULL,NULL,NULL,NULL),(1580,'Frank Bellivier',NULL,NULL,NULL,NULL),(1581,'Frank Deane',NULL,NULL,NULL,NULL),(1582,'Frank Dudbridge',NULL,NULL,NULL,NULL),(1583,'Frank Wendt',NULL,NULL,NULL,NULL),(1584,'Frans A Henskens',NULL,NULL,NULL,NULL),(1585,'Frans G Zitman',NULL,NULL,NULL,NULL),(1586,'Frans Verhey',NULL,NULL,NULL,NULL),(1587,'Franziska Degenhardt',NULL,NULL,NULL,NULL),(1588,'Frauke Schultze-Lutter',NULL,NULL,NULL,NULL),(1589,'Frederick Rohan Walker',NULL,NULL,NULL,NULL),(1590,'Frederik J Steyn',NULL,NULL,NULL,NULL),(1591,'Frederike Stein',NULL,NULL,NULL,NULL),(1592,'Fulai Jin',NULL,NULL,NULL,NULL),(1593,'Futao Zhang',NULL,NULL,NULL,NULL),(1594,'F├â┬ítima Carrillo',NULL,NULL,NULL,NULL),(1595,'G Grooms',NULL,NULL,NULL,NULL),(1596,'G├â┬╝nter Paul Amminger',NULL,NULL,NULL,NULL),(1597,'G Pearlson',NULL,NULL,NULL,NULL),(1598,'G Salkeld',NULL,NULL,NULL,NULL),(1599,'G Stewart',NULL,NULL,NULL,NULL),(1600,'Geoffrey H Tofler',NULL,NULL,NULL,NULL),(1601,'Gerard Van Grootheest',NULL,NULL,NULL,NULL),(1602,'G Van der Linden',NULL,NULL,NULL,NULL),(1603,'Gonneke Willemsen',NULL,NULL,NULL,NULL),(1604,'Gail Alvares',NULL,NULL,NULL,NULL),(1605,'GJ Liu',NULL,NULL,NULL,NULL),(1606,'GM Allen',NULL,NULL,NULL,NULL),(1607,'Glenda MacQueen',NULL,NULL,NULL,NULL),(1608,'GR Pellicano',NULL,NULL,NULL,NULL),(1609,'Gin S Malhi',NULL,NULL,NULL,NULL),(1610,'GSCAN Consortium',NULL,NULL,NULL,NULL),(1611,'Grant W Montgomery',NULL,NULL,NULL,NULL),(1612,'Gabriel Cu├â┬⌐llar-Partida',NULL,NULL,NULL,NULL),(1613,'Gabri├½lla AM Blokland',NULL,NULL,NULL,NULL),(1614,'Gaelle E Doucet',NULL,NULL,NULL,NULL),(1615,'Gail P Gilchrist',NULL,NULL,NULL,NULL),(1616,'Gareth E Davies',NULL,NULL,NULL,NULL),(1617,'Gargi Datta',NULL,NULL,NULL,NULL),(1618,'Garth Nicholson',NULL,NULL,NULL,NULL),(1619,'Gary J Donohoe',NULL,NULL,NULL,NULL),(1620,'Gary E Swan',NULL,NULL,NULL,NULL),(1621,'Gary F Egan',NULL,NULL,NULL,NULL),(1622,'Gavin Andrews',NULL,NULL,NULL,NULL),(1623,'Gavin Dixon',NULL,NULL,NULL,NULL),(1624,'Gavin W Lambert',NULL,NULL,NULL,NULL),(1625,'Gemma Gladstone',NULL,NULL,NULL,NULL),(1626,'Genevieve McPhilemy',NULL,NULL,NULL,NULL),(1627,'Genevi├â┬¿ve Richard',NULL,NULL,NULL,NULL),(1628,'Geoff Gallop',NULL,NULL,NULL,NULL),(1629,'Geoff Mackellar',NULL,NULL,NULL,NULL),(1630,'Geoffrey B Hall',NULL,NULL,NULL,NULL),(1631,'Geoffrey R Hansen',NULL,NULL,NULL,NULL),(1632,'Georg Homuth',NULL,NULL,NULL,NULL),(1633,'Georg Romer',NULL,NULL,NULL,NULL),(1634,'Georg Woditsch',NULL,NULL,NULL,NULL),(1635,'George D Mellick',NULL,NULL,NULL,NULL),(1636,'George Davey-Smith',NULL,NULL,NULL,NULL),(1637,'George McMahon',NULL,NULL,NULL,NULL),(1638,'George Patton',NULL,NULL,NULL,NULL),(1639,'George Smythe',NULL,NULL,NULL,NULL),(1640,'Georgia Balsevich',NULL,NULL,NULL,NULL),(1641,'Georgina M Luscombe',NULL,NULL,NULL,NULL),(1642,'Geraldine Dawson',NULL,NULL,NULL,NULL),(1643,'Geraldo Busatto Filho',NULL,NULL,NULL,NULL),(1644,'Geraldo F Busatto',NULL,NULL,NULL,NULL),(1645,'Gerard Cagney',NULL,NULL,NULL,NULL),(1646,'Gerhard Moser',NULL,NULL,NULL,NULL),(1647,'Gerhard Ransmayr',NULL,NULL,NULL,NULL),(1648,'German Eduardo Rueda-Jaimes',NULL,NULL,NULL,NULL),(1649,'German Rueda Jaimes',NULL,NULL,NULL,NULL),(1650,'Gerome Breen',NULL,NULL,NULL,NULL),(1651,'Gerrit Elia├â┼╕',NULL,NULL,NULL,NULL),(1652,'Giana I Teresi',NULL,NULL,NULL,NULL),(1653,'Giancarlo Russo',NULL,NULL,NULL,NULL),(1654,'Gianfranco Spalletta',NULL,NULL,NULL,NULL),(1655,'Gianluigi Forloni',NULL,NULL,NULL,NULL),(1656,'Gianpiero L Cavalleri',NULL,NULL,NULL,NULL),(1657,'Gibran Hemani',NULL,NULL,NULL,NULL),(1658,'Giorgio Pistis',NULL,NULL,NULL,NULL),(1659,'Giovana B Zunta-Soares',NULL,NULL,NULL,NULL),(1660,'Giovanni Coppola',NULL,NULL,NULL,NULL),(1661,'Gisela M Terwindt',NULL,NULL,NULL,NULL),(1662,'Gitta H Lubke',NULL,NULL,NULL,NULL),(1663,'Giulio Genovese',NULL,NULL,NULL,NULL),(1664,'Giulio Pergola',NULL,NULL,NULL,NULL),(1665,'Giuseppe Delvecchio',NULL,NULL,NULL,NULL),(1666,'Glenda Halliday',NULL,NULL,NULL,NULL),(1667,'Glenys Dore',NULL,NULL,NULL,NULL),(1668,'Gloria Roberts',NULL,NULL,NULL,NULL),(1669,'Glyn Lewis',NULL,NULL,NULL,NULL),(1670,'Goar Frishman',NULL,NULL,NULL,NULL),(1671,'Gonzalo Laje',NULL,NULL,NULL,NULL),(1672,'Gon├â┬ºalo Abecasis',NULL,NULL,NULL,NULL),(1673,'Gordon Parker',NULL,NULL,NULL,NULL),(1674,'Grace L Groom',NULL,NULL,NULL,NULL),(1675,'Graeme C Smith',NULL,NULL,NULL,NULL),(1676,'Graeme O\'keefe',NULL,NULL,NULL,NULL),(1677,'Graham Jones',NULL,NULL,NULL,NULL),(1678,'Graham Martin',NULL,NULL,NULL,NULL),(1679,'Grant Blashki',NULL,NULL,NULL,NULL),(1680,'Grant CB Sinnamon',NULL,NULL,NULL,NULL),(1681,'Greg J Stuart',NULL,NULL,NULL,NULL),(1682,'Greg Murray',NULL,NULL,NULL,NULL),(1683,'Greg Savage',NULL,NULL,NULL,NULL),(1684,'Greig de Zubicaray',NULL,NULL,NULL,NULL),(1685,'Gregor Emanuel Berger',NULL,NULL,NULL,NULL),(1686,'Gregory A Jicha',NULL,NULL,NULL,NULL),(1687,'Gregory E Crawford',NULL,NULL,NULL,NULL),(1688,'Gregory JM Zajac',NULL,NULL,NULL,NULL),(1689,'Gregory Leigh Carter',NULL,NULL,NULL,NULL),(1690,'Gregory M Brown',NULL,NULL,NULL,NULL),(1691,'Gu Zhu',NULL,NULL,NULL,NULL),(1692,'Guido Bondolfi',NULL,NULL,NULL,NULL),(1693,'Guido J Falcone',NULL,NULL,NULL,NULL),(1694,'Guill├â┬⌐n Fern├â┬índez',NULL,NULL,NULL,NULL),(1695,'Guiqing Cai',NULL,NULL,NULL,NULL),(1696,'Guiyan Ni',NULL,NULL,NULL,NULL),(1697,'Gulnaz Kaishybayeva',NULL,NULL,NULL,NULL),(1698,'Gunnar Morken',NULL,NULL,NULL,NULL),(1699,'Gunnar W Reginsson',NULL,NULL,NULL,NULL),(1700,'Gunter Schumann',NULL,NULL,NULL,NULL),(1701,'Guntram Borck',NULL,NULL,NULL,NULL),(1702,'Guo-Bo Chen',NULL,NULL,NULL,NULL),(1703,'Gustavo Turecki',NULL,NULL,NULL,NULL),(1704,'Gwynneth Hinds',NULL,NULL,NULL,NULL),(1705,'Gyda Bjornsdottir',NULL,NULL,NULL,NULL),(1706,'Henry Brodaty',NULL,NULL,NULL,NULL),(1707,'H Carol',NULL,NULL,NULL,NULL),(1708,'Henrik Dobrowolny',NULL,NULL,NULL,NULL),(1709,'H Fatouros-Bergman',NULL,NULL,NULL,NULL),(1710,'H Gotsopoulos',NULL,NULL,NULL,NULL),(1711,'H Guo',NULL,NULL,NULL,NULL),(1712,'H Hadar',NULL,NULL,NULL,NULL),(1713,'H Hazan',NULL,NULL,NULL,NULL),(1714,'H La Monica',NULL,NULL,NULL,NULL),(1715,'Hui Li',NULL,NULL,NULL,NULL),(1716,'H McKay',NULL,NULL,NULL,NULL),(1717,'Haochang Shou',NULL,NULL,NULL,NULL),(1718,'Henry Volzke',NULL,NULL,NULL,NULL),(1719,'Henry V├â┬╢lzke',NULL,NULL,NULL,NULL),(1720,'Henrik Walter',NULL,NULL,NULL,NULL),(1721,'H Xiang',NULL,NULL,NULL,NULL),(1722,'H Yamamori',NULL,NULL,NULL,NULL),(1723,'Hannah Yee',NULL,NULL,NULL,NULL),(1724,'H Zhang',NULL,NULL,NULL,NULL),(1725,'Heather Whalley',NULL,NULL,NULL,NULL),(1726,'Hilleke E Hulshoff Pol',NULL,NULL,NULL,NULL),(1727,'Hirosha K Jayaweera',NULL,NULL,NULL,NULL),(1728,'Hans M Koot',NULL,NULL,NULL,NULL),(1729,'Henriette N  Buttensch├╕n',NULL,NULL,NULL,NULL),(1730,'Hok Pan Yuen',NULL,NULL,NULL,NULL),(1731,'Henry R Kranzler',NULL,NULL,NULL,NULL),(1732,'Henk S Temmingh',NULL,NULL,NULL,NULL),(1733,'Hai-Gwo Hwu',NULL,NULL,NULL,NULL),(1734,'Hak-Kim Chan',NULL,NULL,NULL,NULL),(1735,'Hakon Hakonarson',NULL,NULL,NULL,NULL),(1736,'Hakuei Fujiyama',NULL,NULL,NULL,NULL),(1737,'Hamdi Mbarek',NULL,NULL,NULL,NULL),(1738,'Hamel Patel',NULL,NULL,NULL,NULL),(1739,'Hamish Ward',NULL,NULL,NULL,NULL),(1740,'Hampton Leonard',NULL,NULL,NULL,NULL),(1741,'Han G Brunner',NULL,NULL,NULL,NULL),(1742,'Hana Kuzelova-Ptackova',NULL,NULL,NULL,NULL),(1743,'Hang Zhou',NULL,NULL,NULL,NULL),(1744,'Hanga Galfalvy',NULL,NULL,NULL,NULL),(1745,'Hannah Christie',NULL,NULL,NULL,NULL),(1746,'Hannah Lemke',NULL,NULL,NULL,NULL),(1747,'Hannah M Disinger',NULL,NULL,NULL,NULL),(1748,'Hannah S Savage',NULL,NULL,NULL,NULL),(1749,'Hannah Stewart-Weeks',NULL,NULL,NULL,NULL),(1750,'Hannah Young',NULL,NULL,NULL,NULL),(1751,'Hans J├â┬╢rgen Grabe',NULL,NULL,NULL,NULL),(1752,'Harald Baumeister',NULL,NULL,NULL,NULL),(1753,'Harald HH G├â┬╢ring',NULL,NULL,NULL,NULL),(1754,'Harald Hampel',NULL,NULL,NULL,NULL),(1755,'Harald Kugel',NULL,NULL,NULL,NULL),(1756,'Harold Snieder',NULL,NULL,NULL,NULL),(1757,'Harry Brandt',NULL,NULL,NULL,NULL),(1758,'Hartmut G├â┬╢bel',NULL,NULL,NULL,NULL),(1759,'Harvey A Whiteford',NULL,NULL,NULL,NULL),(1760,'Harvey Jones',NULL,NULL,NULL,NULL),(1761,'Haryana Dhillon',NULL,NULL,NULL,NULL),(1762,'Hassan S Dashti',NULL,NULL,NULL,NULL),(1763,'Havard Kallestad',NULL,NULL,NULL,NULL),(1764,'Heather Dunckley',NULL,NULL,NULL,NULL),(1765,'Hedley G Peach',NULL,NULL,NULL,NULL),(1766,'Heidi G Sutherland',NULL,NULL,NULL,NULL),(1767,'Heidi Sumich',NULL,NULL,NULL,NULL),(1768,'Henrik Christensen',NULL,NULL,NULL,NULL),(1769,'Helen Herrman',NULL,NULL,NULL,NULL),(1770,'Helen Heussler',NULL,NULL,NULL,NULL),(1771,'Helen L Fisher',NULL,NULL,NULL,NULL),(1772,'Helena Furberg',NULL,NULL,NULL,NULL),(1773,'Helene Plun-Favreau',NULL,NULL,NULL,NULL),(1774,'Helga K Ising',NULL,NULL,NULL,NULL),(1775,'Hellen Geros',NULL,NULL,NULL,NULL),(1776,'Henning Teismann',NULL,NULL,NULL,NULL),(1777,'Henning Tiemeier',NULL,NULL,NULL,NULL),(1778,'Henriette C Dohnt',NULL,NULL,NULL,NULL),(1779,'Henry Houlden',NULL,NULL,NULL,NULL),(1780,'Henry J Bockholt',NULL,NULL,NULL,NULL),(1781,'Henry J Jackson',NULL,NULL,NULL,NULL),(1782,'Henry J Waldvogel',NULL,NULL,NULL,NULL),(1783,'Hermine H Maes',NULL,NULL,NULL,NULL),(1784,'Hieab HH Adams',NULL,NULL,NULL,NULL),(1785,'Hilary A Tindle',NULL,NULL,NULL,NULL),(1786,'Hilary Coon',NULL,NULL,NULL,NULL),(1787,'Hilary K Finucane',NULL,NULL,NULL,NULL),(1788,'Hilary P Blumberg',NULL,NULL,NULL,NULL),(1789,'Hilkka Soininen',NULL,NULL,NULL,NULL),(1790,'Hirotaka Iwaki',NULL,NULL,NULL,NULL),(1791,'Ho-Cheol Kim',NULL,NULL,NULL,NULL),(1792,'H├â┬╢gni Oskarsson',NULL,NULL,NULL,NULL),(1793,'Holly Sizer',NULL,NULL,NULL,NULL),(1794,'Hongwei Dong',NULL,NULL,NULL,NULL),(1795,'Hongyan Huang',NULL,NULL,NULL,NULL),(1796,'Hongyu Zhao',NULL,NULL,NULL,NULL),(1797,'Howard J Edenberg',NULL,NULL,NULL,NULL),(1798,'Hreinn Stefansson',NULL,NULL,NULL,NULL),(1799,'Hsi-Chung Chen',NULL,NULL,NULL,NULL),(1800,'Hualin S Xi',NULL,NULL,NULL,NULL),(1801,'Huda Akil',NULL,NULL,NULL,NULL),(1802,'Hugh Durrant-Whyte',NULL,NULL,NULL,NULL),(1803,'Hugh Garavan',NULL,NULL,NULL,NULL),(1804,'Hugh Gurling',NULL,NULL,NULL,NULL),(1805,'Hugh Morgan',NULL,NULL,NULL,NULL),(1806,'Hugo G Schnack',NULL,NULL,NULL,NULL),(1807,'Hui-Kuan Chung',NULL,NULL,NULL,NULL),(1808,'Huibert Tange',NULL,NULL,NULL,NULL),(1809,'Hunna J Watson',NULL,NULL,NULL,NULL),(1810,'Huw R Morris',NULL,NULL,NULL,NULL),(1811,'Hyei-Won Moon',NULL,NULL,NULL,NULL),(1812,'Hyman Hops',NULL,NULL,NULL,NULL),(1813,'H├â┬⌐l├â┬¿ne Choquet',NULL,NULL,NULL,NULL),(1814,'H├â┬⌐l├â┬⌐na A Gaspar',NULL,NULL,NULL,NULL),(1815,'Ivan Brack',NULL,NULL,NULL,NULL),(1816,'Ian Jones',NULL,NULL,NULL,NULL),(1817,'I Nicol Ferrier',NULL,NULL,NULL,NULL),(1818,'I Ozols',NULL,NULL,NULL,NULL),(1819,'I Steven',NULL,NULL,NULL,NULL),(1820,'Ian J Deary',NULL,NULL,NULL,NULL),(1821,'Ian Everall',NULL,NULL,NULL,NULL),(1822,'IR Neering',NULL,NULL,NULL,NULL),(1823,'Iain Macmillan',NULL,NULL,NULL,NULL),(1824,'Iain S McGregor',NULL,NULL,NULL,NULL),(1825,'Ian C Duguid',NULL,NULL,NULL,NULL),(1826,'Ian D Caterson',NULL,NULL,NULL,NULL),(1827,'Ian Fyfe',NULL,NULL,NULL,NULL),(1828,'Ian H Gotlib',NULL,NULL,NULL,NULL),(1829,'Ian J Bowman',NULL,NULL,NULL,NULL),(1830,'Ian Manion',NULL,NULL,NULL,NULL),(1831,'Ian P Blair',NULL,NULL,NULL,NULL),(1832,'Ian Rosenberg',NULL,NULL,NULL,NULL),(1833,'Ian W Craig',NULL,NULL,NULL,NULL),(1834,'Ignacio Alvarez',NULL,NULL,NULL,NULL),(1835,'Ignacio Mart├â┬¡nez-Zalaca├â┬¡n',NULL,NULL,NULL,NULL),(1836,'Igor Nenadic',NULL,NULL,NULL,NULL),(1837,'Ikuo Otsuka',NULL,NULL,NULL,NULL),(1838,'Ilja M Nolte',NULL,NULL,NULL,NULL),(1839,'Ilya M Veer',NULL,NULL,NULL,NULL),(1840,'Immigration Refugees',NULL,NULL,NULL,NULL),(1841,'Ina Giegling',NULL,NULL,NULL,NULL),(1842,'Indra Sadeli',NULL,NULL,NULL,NULL),(1843,'Indra Sedeli',NULL,NULL,NULL,NULL),(1844,'Inge Joa',NULL,NULL,NULL,NULL),(1845,'Ingo Ruczinski',NULL,NULL,NULL,NULL),(1846,'Ingrid Agartz',NULL,NULL,NULL,NULL),(1847,'Inmaculada Bernal-Bernal',NULL,NULL,NULL,NULL),(1848,'International Chronic Fatigue Syndrome Study Group',NULL,NULL,NULL,NULL),(1849,'International Chronic Fatigue Syndrome Study Group.',NULL,NULL,NULL,NULL),(1850,'Iona Y Millwood',NULL,NULL,NULL,NULL),(1851,'Irene Mart├â┬¡nez Torres',NULL,NULL,NULL,NULL),(1852,'Irfahan Kassam',NULL,NULL,NULL,NULL),(1853,'Irina S Lebedeva',NULL,NULL,NULL,NULL),(1854,'Iris E Sommer',NULL,NULL,NULL,NULL),(1855,'Iris Garcia-Martinez',NULL,NULL,NULL,NULL),(1856,'Iris Garcia-Mart├â┬¡nez',NULL,NULL,NULL,NULL),(1857,'Iryna O Fedko',NULL,NULL,NULL,NULL),(1858,'Isaac S Kohane',NULL,NULL,NULL,NULL),(1859,'Isaac Schweitzer',NULL,NULL,NULL,NULL),(1860,'Isabel Gonzalez-Aramburu',NULL,NULL,NULL,NULL),(1861,'Isabell Kiral-Kornek',NULL,NULL,NULL,NULL),(1862,'Isabella Choi',NULL,NULL,NULL,NULL),(1863,'Isabella Hoi Kei Leung',NULL,NULL,NULL,NULL),(1864,'Ivan V Brak',NULL,NULL,NULL,NULL),(1865,'Iwona Kloszewska',NULL,NULL,NULL,NULL),(1866,'Izabella Pokorski',NULL,NULL,NULL,NULL),(1867,'Jennifer Batchelor',NULL,NULL,NULL,NULL),(1868,'J Bertouch',NULL,NULL,NULL,NULL),(1869,'J Bruggemann',NULL,NULL,NULL,NULL),(1870,'Jane M Burns',NULL,NULL,NULL,NULL),(1871,'J De Konink',NULL,NULL,NULL,NULL),(1872,'J Denis Wakefield',NULL,NULL,NULL,NULL),(1873,'John Dwyer',NULL,NULL,NULL,NULL),(1874,'J Flint',NULL,NULL,NULL,NULL),(1875,'J Gander',NULL,NULL,NULL,NULL),(1876,'J Gillespie',NULL,NULL,NULL,NULL),(1877,'Jessica Hartmann',NULL,NULL,NULL,NULL),(1878,'J Horacek',NULL,NULL,NULL,NULL),(1879,'Jana M Menssink',NULL,NULL,NULL,NULL),(1880,'J Middleton',NULL,NULL,NULL,NULL),(1881,'J Murray Wright',NULL,NULL,NULL,NULL),(1882,'James Olver',NULL,NULL,NULL,NULL),(1883,'J Park',NULL,NULL,NULL,NULL),(1884,'Jenni Parsons',NULL,NULL,NULL,NULL),(1885,'J Pineda Zapata',NULL,NULL,NULL,NULL),(1886,'Jane Pirkis',NULL,NULL,NULL,NULL),(1887,'J Raphael Gibbs',NULL,NULL,NULL,NULL),(1888,'J Raymond DePaulo',NULL,NULL,NULL,NULL),(1889,'J Roussos',NULL,NULL,NULL,NULL),(1890,'Jianxin Shi',NULL,NULL,NULL,NULL),(1891,'J Stenos',NULL,NULL,NULL,NULL),(1892,'James Tatoulis',NULL,NULL,NULL,NULL),(1893,'John Tiller',NULL,NULL,NULL,NULL),(1894,'J Vaidya',NULL,NULL,NULL,NULL),(1895,'John B Whitfield',NULL,NULL,NULL,NULL),(1896,'Julius van der Werf',NULL,NULL,NULL,NULL),(1897,'James A Knowles',NULL,NULL,NULL,NULL),(1898,'JAMJL Janssen',NULL,NULL,NULL,NULL),(1899,'Jeffrey Richards',NULL,NULL,NULL,NULL),(1900,'JD Wojcik',NULL,NULL,NULL,NULL),(1901,'JE Sussmann',NULL,NULL,NULL,NULL),(1902,'James G Dobbins',NULL,NULL,NULL,NULL),(1903,'Janine Walker',NULL,NULL,NULL,NULL),(1904,'Johannes H Smit',NULL,NULL,NULL,NULL),(1905,'JL Treur',NULL,NULL,NULL,NULL),(1906,'JM Ford',NULL,NULL,NULL,NULL),(1907,'JQ Voyvodic',NULL,NULL,NULL,NULL),(1908,'JS Kwon',NULL,NULL,NULL,NULL),(1909,'JW Cheung',NULL,NULL,NULL,NULL),(1910,'Jordan W Smoller',NULL,NULL,NULL,NULL),(1911,'Jason Liu',NULL,NULL,NULL,NULL),(1912,'Jaakko Kaprio',NULL,NULL,NULL,NULL),(1913,'Jaap Oosterlaan',NULL,NULL,NULL,NULL),(1914,'Jacinta Heath',NULL,NULL,NULL,NULL),(1915,'Jacinto Duarte',NULL,NULL,NULL,NULL),(1916,'Jack D Barchas',NULL,NULL,NULL,NULL),(1917,'Jack Euesden',NULL,NULL,NULL,NULL),(1918,'Jackson Thorp',NULL,NULL,NULL,NULL),(1919,'Jacob Gratten',NULL,NULL,NULL,NULL),(1920,'Jacob J Crouse',NULL,NULL,NULL,NULL),(1921,'Jacob Lawrence',NULL,NULL,NULL,NULL),(1922,'Jacobine van Kessel',NULL,NULL,NULL,NULL),(1923,'Jacqueline Burrows',NULL,NULL,NULL,NULL),(1924,'Jaqueline Goldstein',NULL,NULL,NULL,NULL),(1925,'Jacqueline Kiewa',NULL,NULL,NULL,NULL),(1926,'Jacqueline M Lane',NULL,NULL,NULL,NULL),(1927,'Jacqueline M Vink',NULL,NULL,NULL,NULL),(1928,'Jacquelyn Meyers',NULL,NULL,NULL,NULL),(1929,'Jacques Mallet',NULL,NULL,NULL,NULL),(1930,'Jai L Shah',NULL,NULL,NULL,NULL),(1931,'Jaime Derringer',NULL,NULL,NULL,NULL),(1932,'Jaime Kulisevsky',NULL,NULL,NULL,NULL),(1933,'Jair C Soares',NULL,NULL,NULL,NULL),(1934,'Jake Robert Palmer',NULL,NULL,NULL,NULL),(1935,'Jakob Grove',NULL,NULL,NULL,NULL),(1936,'James A Bourne',NULL,NULL,NULL,NULL),(1937,'James Dunbar',NULL,NULL,NULL,NULL),(1938,'James B Leverenz',NULL,NULL,NULL,NULL),(1939,'James P Potash',NULL,NULL,NULL,NULL),(1940,'James Boocock',NULL,NULL,NULL,NULL),(1941,'James Cole',NULL,NULL,NULL,NULL),(1942,'James G Colebatch',NULL,NULL,NULL,NULL),(1943,'James J Crowley',NULL,NULL,NULL,NULL),(1944,'Jimmy Lee',NULL,NULL,NULL,NULL),(1945,'James L Kennedy',NULL,NULL,NULL,NULL),(1946,'James Macquarie Shine',NULL,NULL,NULL,NULL),(1947,'James Ralston',NULL,NULL,NULL,NULL),(1948,'James Southan',NULL,NULL,NULL,NULL),(1949,'James TR Walters',NULL,NULL,NULL,NULL),(1950,'James Tran',NULL,NULL,NULL,NULL),(1951,'James W Lance',NULL,NULL,NULL,NULL),(1952,'James Wiley',NULL,NULL,NULL,NULL),(1953,'Jan K Buitelaar',NULL,NULL,NULL,NULL),(1954,'Jan Copeland',NULL,NULL,NULL,NULL),(1955,'Jan H Veldink',NULL,NULL,NULL,NULL),(1956,'Jan Lubinski',NULL,NULL,NULL,NULL),(1957,'Jan Miller',NULL,NULL,NULL,NULL),(1958,'Jana Strohmaier',NULL,NULL,NULL,NULL),(1959,'Jane Hvarregaard Christensen',NULL,NULL,NULL,NULL),(1960,'Jane L Ebejer',NULL,NULL,NULL,NULL),(1961,'Jane M Gunn',NULL,NULL,NULL,NULL),(1962,'Jane McAdam',NULL,NULL,NULL,NULL),(1963,'Jane Turner',NULL,NULL,NULL,NULL),(1964,'Janet Dale',NULL,NULL,NULL,NULL),(1965,'Janet Hoenicka',NULL,NULL,NULL,NULL),(1966,'Janet PY Tong',NULL,NULL,NULL,NULL),(1967,'Janet Treasure',NULL,NULL,NULL,NULL),(1968,'Janice M Fullerton',NULL,NULL,NULL,NULL),(1969,'Janik Goltermann',NULL,NULL,NULL,NULL),(1970,'Janine Arloth',NULL,NULL,NULL,NULL),(1971,'Janis Klovins',NULL,NULL,NULL,NULL),(1972,'Janita Bralten',NULL,NULL,NULL,NULL),(1973,'Janou AY Roubroeks',NULL,NULL,NULL,NULL),(1974,'Jari Lahti',NULL,NULL,NULL,NULL),(1975,'Jason B Mattingley',NULL,NULL,NULL,NULL),(1976,'Jason D Boardman',NULL,NULL,NULL,NULL),(1977,'Jason L Stein',NULL,NULL,NULL,NULL),(1978,'Javed Fowdar',NULL,NULL,NULL,NULL),(1979,'Javed Fowder',NULL,NULL,NULL,NULL),(1980,'Javier Sim├â┬│n-S├â┬ínchez',NULL,NULL,NULL,NULL),(1981,'Jayashri Kulkarni',NULL,NULL,NULL,NULL),(1982,'Jean Addington',NULL,NULL,NULL,NULL),(1983,'Jean Shin',NULL,NULL,NULL,NULL),(1984,'Jean-Christophe Corvol',NULL,NULL,NULL,NULL),(1985,'Jean-Fran├â┬ºois Deleuze',NULL,NULL,NULL,NULL),(1986,'Jean-Paul Fouche',NULL,NULL,NULL,NULL),(1987,'Jeanette Kennett',NULL,NULL,NULL,NULL),(1988,'Jeanette Milgrom',NULL,NULL,NULL,NULL),(1989,'Jeanette N McClintick',NULL,NULL,NULL,NULL),(1990,'Jeanne Gehue',NULL,NULL,NULL,NULL),(1991,'Jeanne Leerssen',NULL,NULL,NULL,NULL),(1992,'Jeffrey A Kaye',NULL,NULL,NULL,NULL),(1993,'Jeffrey B Weilburg',NULL,NULL,NULL,NULL),(1994,'Jeffrey Haessler',NULL,NULL,NULL,NULL),(1995,'Jeffrey Lieberman',NULL,NULL,NULL,NULL),(1996,'Jeffrey M Craig',NULL,NULL,NULL,NULL),(1997,'Jeffry Alexander',NULL,NULL,NULL,NULL),(1998,'Jen-Chyong Wang',NULL,NULL,NULL,NULL),(1999,'Jenni H├â┬ñllfors',NULL,NULL,NULL,NULL),(2000,'Jennie Hui',NULL,NULL,NULL,NULL),(2001,'Jennifer A Smith',NULL,NULL,NULL,NULL),(2002,'Jennifer Buteau',NULL,NULL,NULL,NULL),(2003,'Jennifer Cornish',NULL,NULL,NULL,NULL),(2004,'Jennifer Crosbie',NULL,NULL,NULL,NULL),(2005,'Jennifer Dixon',NULL,NULL,NULL,NULL),(2006,'Jennifer W Evans',NULL,NULL,NULL,NULL),(2007,'Jennifer J Ware',NULL,NULL,NULL,NULL),(2008,'Jennifer M Boldero',NULL,NULL,NULL,NULL),(2009,'Jennifer M Whitehead Pavlides',NULL,NULL,NULL,NULL),(2010,'Jennifer Mackenzie',NULL,NULL,NULL,NULL),(2011,'Jennifer Melsness',NULL,NULL,NULL,NULL),(2012,'Jens Treutlein',NULL,NULL,NULL,NULL),(2013,'Jeremy FJ O\'Dea',NULL,NULL,NULL,NULL),(2014,'Jeremy Hall',NULL,NULL,NULL,NULL),(2015,'Jerome Foo',NULL,NULL,NULL,NULL),(2016,'Jerome I Rotter',NULL,NULL,NULL,NULL),(2017,'Jerome Yu Ting Ip',NULL,NULL,NULL,NULL),(2018,'Jerry A Stitzel',NULL,NULL,NULL,NULL),(2019,'Jerry Guintivano',NULL,NULL,NULL,NULL),(2020,'Jes Olesen',NULL,NULL,NULL,NULL),(2021,'Jesen Fagerness',NULL,NULL,NULL,NULL),(2022,'Jesper Krogh',NULL,NULL,NULL,NULL),(2023,'Jess Nithianantharajah',NULL,NULL,NULL,NULL),(2024,'Jess Tyrrell',NULL,NULL,NULL,NULL),(2025,'Jessica D Faul',NULL,NULL,NULL,NULL),(2026,'Jessica Daly',NULL,NULL,NULL,NULL),(2027,'Jessica Kate Hughes',NULL,NULL,NULL,NULL),(2028,'Jessica S Johnson',NULL,NULL,NULL,NULL),(2029,'Jessica Salvatore',NULL,NULL,NULL,NULL),(2030,'Jes├â┬║s Alberto Bergareche Yarza',NULL,NULL,NULL,NULL),(2031,'June He',NULL,NULL,NULL,NULL),(2032,'Jian Yang',NULL,NULL,NULL,NULL),(2033,'Jian Zeng',NULL,NULL,NULL,NULL),(2034,'Juchen Li',NULL,NULL,NULL,NULL),(2035,'Jie Huang',NULL,NULL,NULL,NULL),(2036,'Jie Yin',NULL,NULL,NULL,NULL),(2037,'Jihui Zhang',NULL,NULL,NULL,NULL),(2038,'Jilly Naaijen',NULL,NULL,NULL,NULL),(2039,'Jim Lagopoulos',NULL,NULL,NULL,NULL),(2040,'Jim Lemon',NULL,NULL,NULL,NULL),(2041,'Jimmy Lee Chee Keong',NULL,NULL,NULL,NULL),(2042,'Jinman Kim',NULL,NULL,NULL,NULL),(2043,'Jiyang Jiang',NULL,NULL,NULL,NULL),(2044,'Joachim Hallmayer',NULL,NULL,NULL,NULL),(2045,'Joachim Klosterkoetter',NULL,NULL,NULL,NULL),(2046,'Joachim Klosterk├â┬╢tter',NULL,NULL,NULL,NULL),(2047,'Joana A Revez',NULL,NULL,NULL,NULL),(2048,'Joanna Atkins',NULL,NULL,NULL,NULL),(2049,'Joanna M Biernacka',NULL,NULL,NULL,NULL),(2050,'Joanna Fitzsimons',NULL,NULL,NULL,NULL),(2051,'Joanna Hauser',NULL,NULL,NULL,NULL),(2052,'Joanna K Bright',NULL,NULL,NULL,NULL),(2053,'Joanne E Curran',NULL,NULL,NULL,NULL),(2054,'Joanne Sarah Carpenter',NULL,NULL,NULL,NULL),(2055,'Joaquim Radua',NULL,NULL,NULL,NULL),(2056,'Jocelyn Lowinger',NULL,NULL,NULL,NULL),(2057,'Jochen Bauer',NULL,NULL,NULL,NULL),(2058,'Jodie N Painter',NULL,NULL,NULL,NULL),(2059,'Joel Gelernter',NULL,NULL,NULL,NULL),(2060,'Joel N Hirschhorn',NULL,NULL,NULL,NULL),(2061,'Joel Swendsen',NULL,NULL,NULL,NULL),(2062,'Johan Eriksson',NULL,NULL,NULL,NULL),(2063,'Johan Marinus',NULL,NULL,NULL,NULL),(2064,'Johanna Hass',NULL,NULL,NULL,NULL),(2065,'Johanna Klinger-K├â┬╢nig',NULL,NULL,NULL,NULL),(2066,'Johanna Meyer',NULL,NULL,NULL,NULL),(2067,'Johanna R Foerster',NULL,NULL,NULL,NULL),(2068,'Johanna Wyn',NULL,NULL,NULL,NULL),(2069,'Johannes Kornhuber',NULL,NULL,NULL,NULL),(2070,'John A Gosling',NULL,NULL,NULL,NULL),(2071,'John Hardy',NULL,NULL,NULL,NULL),(2072,'John A Joska',NULL,NULL,NULL,NULL),(2073,'John Mendoza',NULL,NULL,NULL,NULL),(2074,'John BJ Kwok',NULL,NULL,NULL,NULL),(2075,'John Blangero',NULL,NULL,NULL,NULL),(2076,'John Buchanan',NULL,NULL,NULL,NULL),(2077,'John D West',NULL,NULL,NULL,NULL),(2078,'John Dalrymple-Alford',NULL,NULL,NULL,NULL),(2079,'John E Hokanson',NULL,NULL,NULL,NULL),(2080,'John Pearson',NULL,NULL,NULL,NULL),(2081,'John Farhall',NULL,NULL,NULL,NULL),(2082,'John Franklin',NULL,NULL,NULL,NULL),(2083,'John Gleeson',NULL,NULL,NULL,NULL),(2084,'John H Gilmore',NULL,NULL,NULL,NULL),(2085,'John Horwood',NULL,NULL,NULL,NULL),(2086,'John J McNeil',NULL,NULL,NULL,NULL),(2087,'John K Hewitt',NULL,NULL,NULL,NULL),(2088,'John Kane',NULL,NULL,NULL,NULL),(2089,'John Lauriello',NULL,NULL,NULL,NULL),(2090,'John M Bekkers',NULL,NULL,NULL,NULL),(2091,'John McGrath',NULL,NULL,NULL,NULL),(2092,'John Mccallum',NULL,NULL,NULL,NULL),(2093,'John Moran',NULL,NULL,NULL,NULL),(2094,'John P Rice',NULL,NULL,NULL,NULL),(2095,'John Parker',NULL,NULL,NULL,NULL),(2096,'John R Hodges',NULL,NULL,NULL,NULL),(2097,'John R Kelsoe',NULL,NULL,NULL,NULL),(2098,'John R Shaffer',NULL,NULL,NULL,NULL),(2099,'John R Thompson',NULL,NULL,NULL,NULL),(2100,'John Rolley',NULL,NULL,NULL,NULL),(2101,'John SK Kauwe',NULL,NULL,NULL,NULL),(2102,'John W Newcomer',NULL,NULL,NULL,NULL),(2103,'John W Toumbourou',NULL,NULL,NULL,NULL),(2104,'John Wakerman',NULL,NULL,NULL,NULL),(2105,'John Wray',NULL,NULL,NULL,NULL),(2106,'John-Anker Zwart',NULL,NULL,NULL,NULL),(2107,'Jon Infante',NULL,NULL,NULL,NULL),(2108,'Jon Jureidini',NULL,NULL,NULL,NULL),(2109,'Jon Paul Khoo',NULL,NULL,NULL,NULL),(2110,'Jonah F Byrne',NULL,NULL,NULL,NULL),(2111,'Jonas B Nielsen',NULL,NULL,NULL,NULL),(2112,'Jonas Bybjerg-Grauholm',NULL,NULL,NULL,NULL),(2113,'Jonathan D Hafferty',NULL,NULL,NULL,NULL),(2114,'Jonathan L Haines',NULL,NULL,NULL,NULL),(2115,'Jonathan M Payne',NULL,NULL,NULL,NULL),(2116,'Jonathan M Schott',NULL,NULL,NULL,NULL),(2117,'Jonathan Marchini',NULL,NULL,NULL,NULL),(2118,'Jonathan Mill',NULL,NULL,NULL,NULL),(2119,'Jonathan Nicholas',NULL,NULL,NULL,NULL),(2120,'Jonathan RI Coleman',NULL,NULL,NULL,NULL),(2121,'Jonathan Repple',NULL,NULL,NULL,NULL),(2122,'Jonathan Tapson',NULL,NULL,NULL,NULL),(2123,'Jonna Kuntsi',NULL,NULL,NULL,NULL),(2124,'JooEun Kang',NULL,NULL,NULL,NULL),(2125,'Jordi Clarim├â┬│n',NULL,NULL,NULL,NULL),(2126,'Jorge A Cervilla',NULL,NULL,NULL,NULL),(2127,'Jorge A Quiroz',NULL,NULL,NULL,NULL),(2128,'Jorge Almeida',NULL,NULL,NULL,NULL),(2129,'Jorma Viikari',NULL,NULL,NULL,NULL),(2130,'Jose Bras',NULL,NULL,NULL,NULL),(2131,'Jose Davila-Velderrain',NULL,NULL,NULL,NULL),(2132,'Jose Guzman-Parra',NULL,NULL,NULL,NULL),(2133,'Jose Luis Lopez-Sendon',NULL,NULL,NULL,NULL),(2134,'Josef Frank',NULL,NULL,NULL,NULL),(2135,'Josep A Ramos-Quiroga',NULL,NULL,NULL,NULL),(2136,'Joseph Biederman',NULL,NULL,NULL,NULL),(2137,'Joseph Boden',NULL,NULL,NULL,NULL),(2138,'Joseph D Buxbaum',NULL,NULL,NULL,NULL),(2139,'Joseph De Koninck',NULL,NULL,NULL,NULL),(2140,'Joseph F Quinn',NULL,NULL,NULL,NULL),(2141,'Joseph I Friedman',NULL,NULL,NULL,NULL),(2142,'Joseph Jankovic',NULL,NULL,NULL,NULL),(2143,'Joseph Zohar',NULL,NULL,NULL,NULL),(2144,'Josephine Elia',NULL,NULL,NULL,NULL),(2145,'Joshua A Sonnen',NULL,NULL,NULL,NULL),(2146,'Joshua C Bis',NULL,NULL,NULL,NULL),(2147,'Joshua D Isen',NULL,NULL,NULL,NULL),(2148,'Joshua I Faskowitz',NULL,NULL,NULL,NULL),(2149,'Joshua L Roffman',NULL,NULL,NULL,NULL),(2150,'Joshua M Shulman',NULL,NULL,NULL,NULL),(2151,'Josiane Bourque',NULL,NULL,NULL,NULL),(2152,'Josine Groot',NULL,NULL,NULL,NULL),(2153,'Jos├â┬⌐ J Morosoli-Garc├â┬¡a',NULL,NULL,NULL,NULL),(2154,'Jos├â┬⌐ M Mench├â┬│n',NULL,NULL,NULL,NULL),(2155,'Jouke-Jan Hottenga',NULL,NULL,NULL,NULL),(2156,'Jouko L├â┬╢nnqvist',NULL,NULL,NULL,NULL),(2157,'Jo├â┬½lle A Pasman',NULL,NULL,NULL,NULL),(2158,'Juan A Botia',NULL,NULL,NULL,NULL),(2159,'Juan A Bot├â┬¡a',NULL,NULL,NULL,NULL),(2160,'Juan Carlos Mart├â┬¡nez-Castrillo',NULL,NULL,NULL,NULL),(2161,'Juan Mar├â┬¡n',NULL,NULL,NULL,NULL),(2162,'Juan R Bustillo',NULL,NULL,NULL,NULL),(2163,'Jubao Duan',NULL,NULL,NULL,NULL),(2164,'Jude Gibson',NULL,NULL,NULL,NULL),(2165,'Judit Bene',NULL,NULL,NULL,NULL),(2166,'Judith A Badner',NULL,NULL,NULL,NULL),(2167,'Judith Gullifer',NULL,NULL,NULL,NULL),(2168,'Judith Simons',NULL,NULL,NULL,NULL),(2169,'Judith Verduijn',NULL,NULL,NULL,NULL),(2170,'Judy Chan',NULL,NULL,NULL,NULL),(2171,'Judy L Silberg',NULL,NULL,NULL,NULL),(2172,'Juha Karjalainen',NULL,NULL,NULL,NULL),(2173,'Juha Veijola',NULL,NULL,NULL,NULL),(2174,'Juho Wedenoja',NULL,NULL,NULL,NULL),(2175,'Jules Angst',NULL,NULL,NULL,NULL),(2176,'Julia E Pye',NULL,NULL,NULL,NULL),(2177,'Julia H White',NULL,NULL,NULL,NULL),(2178,'Julia Kraft',NULL,NULL,NULL,NULL),(2179,'Julia Reynolds',NULL,NULL,NULL,NULL),(2180,'Julia-Katharina Pfarr',NULL,NULL,NULL,NULL),(2181,'Julian G Simmons',NULL,NULL,NULL,NULL),(2182,'Julian N Trollor',NULL,NULL,NULL,NULL),(2183,'Julie Aitken Schermer',NULL,NULL,NULL,NULL),(2184,'Julie E Buring',NULL,NULL,NULL,NULL),(2185,'Julie Garnham',NULL,NULL,NULL,NULL),(2186,'Julie L Fisher',NULL,NULL,NULL,NULL),(2187,'Julie Robotham',NULL,NULL,NULL,NULL),(2188,'Julie-Anne Tarr',NULL,NULL,NULL,NULL),(2189,'Julien Bryois',NULL,NULL,NULL,NULL),(2190,'Julien Mendlewicz',NULL,NULL,NULL,NULL),(2191,'Juliette M Harris',NULL,NULL,NULL,NULL),(2192,'Juliette Tobias-Webb',NULL,NULL,NULL,NULL),(2193,'Julio Licinio',NULL,NULL,NULL,NULL),(2194,'Junie McCourt',NULL,NULL,NULL,NULL),(2195,'Jurgen Del Favero',NULL,NULL,NULL,NULL),(2196,'Jurgen Del-Favero',NULL,NULL,NULL,NULL),(2197,'Jurjen J Luykx',NULL,NULL,NULL,NULL),(2198,'Justin J Beilby',NULL,NULL,NULL,NULL),(2199,'Justin Kenardy',NULL,NULL,NULL,NULL),(2200,'Justine M Gatt',NULL,NULL,NULL,NULL),(2201,'Justine R Fletcher',NULL,NULL,NULL,NULL),(2202,'Juzhong Sun',NULL,NULL,NULL,NULL),(2203,'Jx Chen',NULL,NULL,NULL,NULL),(2204,'J├â┬╝rgen G├â┬╢tz',NULL,NULL,NULL,NULL),(2205,'J├â┬╝rgen Wellmann',NULL,NULL,NULL,NULL),(2206,'Klaus Berger',NULL,NULL,NULL,NULL),(2207,'Katharine Braunstein',NULL,NULL,NULL,NULL),(2208,'KL Fields',NULL,NULL,NULL,NULL),(2209,'Kate M Filia',NULL,NULL,NULL,NULL),(2210,'K Goldston',NULL,NULL,NULL,NULL),(2211,'Katrin Hegenscheid',NULL,NULL,NULL,NULL),(2212,'K Isabelle-Nolet',NULL,NULL,NULL,NULL),(2213,'Katherine M Kirk',NULL,NULL,NULL,NULL),(2214,'Kenny Lawson',NULL,NULL,NULL,NULL),(2215,'K Liu',NULL,NULL,NULL,NULL),(2216,'Katie McMahon',NULL,NULL,NULL,NULL),(2217,'K Rowe',NULL,NULL,NULL,NULL),(2218,'Knut Schnell',NULL,NULL,NULL,NULL),(2219,'KA McGhee',NULL,NULL,NULL,NULL),(2220,'Karen L Pepper',NULL,NULL,NULL,NULL),(2221,'KM Kelleher',NULL,NULL,NULL,NULL),(2222,'KO Lim',NULL,NULL,NULL,NULL),(2223,'Kathleen Ries Merikangas',NULL,NULL,NULL,NULL),(2224,'Kai G Ringwald',NULL,NULL,NULL,NULL),(2225,'Kai-How Farh',NULL,NULL,NULL,NULL),(2226,'Kaja Z LeWinn',NULL,NULL,NULL,NULL),(2227,'Kang Sim',NULL,NULL,NULL,NULL),(2228,'Kanupriya Kalia',NULL,NULL,NULL,NULL),(2229,'Kanupriya Kalia Hehir',NULL,NULL,NULL,NULL),(2230,'Karen A Mather',NULL,NULL,NULL,NULL),(2231,'Karen Barlow',NULL,NULL,NULL,NULL),(2232,'Karen Caeyenberghs',NULL,NULL,NULL,NULL),(2233,'Karen E Morrison',NULL,NULL,NULL,NULL),(2234,'Karen Hodgson',NULL,NULL,NULL,NULL),(2235,'Karen L Mohlke',NULL,NULL,NULL,NULL),(2236,'Karestan C Koenen',NULL,NULL,NULL,NULL),(2237,'Kari E North',NULL,NULL,NULL,NULL),(2238,'Kari Majamaa',NULL,NULL,NULL,NULL),(2239,'Kari Stefansson',NULL,NULL,NULL,NULL),(2240,'Karin JH Verweij',NULL,NULL,NULL,NULL),(2241,'Karin Peters',NULL,NULL,NULL,NULL),(2242,'Karina Blair',NULL,NULL,NULL,NULL),(2243,'Karl Heilbron',NULL,NULL,NULL,NULL),(2244,'Karoline Kuchenbaecker',NULL,NULL,NULL,NULL),(2245,'Karolinska Schizophrenia Project (KaSP) Consortium',NULL,NULL,NULL,NULL),(2246,'Karri Gillespie-Smith',NULL,NULL,NULL,NULL),(2247,'Karsten Klein',NULL,NULL,NULL,NULL),(2248,'Kate Carnell',NULL,NULL,NULL,NULL),(2249,'Kate E Hoy',NULL,NULL,NULL,NULL),(2250,'Kate Harel',NULL,NULL,NULL,NULL),(2251,'Kate M Chitty',NULL,NULL,NULL,NULL),(2252,'Kate Webber',NULL,NULL,NULL,NULL),(2253,'Katharina Brosch',NULL,NULL,NULL,NULL),(2254,'Katharina Dohm',NULL,NULL,NULL,NULL),(2255,'Katharina Domschke',NULL,NULL,NULL,NULL),(2256,'Katharina F├â┬╢rster',NULL,NULL,NULL,NULL),(2257,'Katharina Wittfeld',NULL,NULL,NULL,NULL),(2258,'Katherine A Halmi',NULL,NULL,NULL,NULL),(2259,'Katherine E Tansey',NULL,NULL,NULL,NULL),(2260,'Katherine Gordon-Smith',NULL,NULL,NULL,NULL),(2261,'Katherine J Aitchison',NULL,NULL,NULL,NULL),(2262,'Katherine McGill',NULL,NULL,NULL,NULL),(2263,'Kathie Tymms',NULL,NULL,NULL,NULL),(2264,'Kathleen C Barnes',NULL,NULL,NULL,NULL),(2265,'Kathleen K Bucholz',NULL,NULL,NULL,NULL),(2266,'Kathleen Mullan Harris',NULL,NULL,NULL,NULL),(2267,'Kathrin Brockmann',NULL,NULL,NULL,NULL),(2268,'Kathryn I Alpert',NULL,NULL,NULL,NULL),(2269,'Kathryn Fletcher',NULL,NULL,NULL,NULL),(2270,'Kathryn L Evans',NULL,NULL,NULL,NULL),(2271,'Kathryn McCabe',NULL,NULL,NULL,NULL),(2272,'Kathryn Lovric',NULL,NULL,NULL,NULL),(2273,'Kathryn Mary Broadhouse',NULL,NULL,NULL,NULL),(2274,'Kathryn R Cullen',NULL,NULL,NULL,NULL),(2275,'Kathy Tucker',NULL,NULL,NULL,NULL),(2276,'Katie A McLaughlin',NULL,NULL,NULL,NULL),(2277,'Katie Lunnon',NULL,NULL,NULL,NULL),(2278,'Katja Appel',NULL,NULL,NULL,NULL),(2279,'Katrin Gade',NULL,NULL,NULL,NULL),(2280,'Katrina L Grasby',NULL,NULL,NULL,NULL),(2281,'Kauko Heikkil├â┬ñ',NULL,NULL,NULL,NULL),(2282,'Kay Cook',NULL,NULL,NULL,NULL),(2283,'Kay Roy',NULL,NULL,NULL,NULL),(2284,'Kay Wilhelm',NULL,NULL,NULL,NULL),(2285,'Kazima Bulayeva',NULL,NULL,NULL,NULL),(2286,'Keelin Turner',NULL,NULL,NULL,NULL),(2287,'Keiji Fukuda',NULL,NULL,NULL,NULL),(2288,'Keith BG Dear',NULL,NULL,NULL,NULL),(2289,'Keith Wilson',NULL,NULL,NULL,NULL),(2290,'Kellie Vella',NULL,NULL,NULL,NULL),(2291,'Kelly Allott',NULL,NULL,NULL,NULL),(2292,'Kelly A Blewitt',NULL,NULL,NULL,NULL),(2293,'Kelly Hansen',NULL,NULL,NULL,NULL),(2294,'Kelly L Klump',NULL,NULL,NULL,NULL),(2295,'Kelly L Williams',NULL,NULL,NULL,NULL),(2296,'Kelsey L Hegarty',NULL,NULL,NULL,NULL),(2297,'Kelsie Boulton',NULL,NULL,NULL,NULL),(2298,'Ken B Hanscombe',NULL,NULL,NULL,NULL),(2299,'Kenneth S Krauter',NULL,NULL,NULL,NULL),(2300,'Kendra A Young',NULL,NULL,NULL,NULL),(2301,'Kenneth L Davis',NULL,NULL,NULL,NULL),(2302,'Kenneth Rice',NULL,NULL,NULL,NULL),(2303,'Kenneth S Kendler',NULL,NULL,NULL,NULL),(2304,'Kerry Eyers',NULL,NULL,NULL,NULL),(2305,'Kerri Diamond',NULL,NULL,NULL,NULL),(2306,'Kerri J Kinghorn',NULL,NULL,NULL,NULL),(2307,'Kerrie A Shandley',NULL,NULL,NULL,NULL),(2308,'Kerrie Clover',NULL,NULL,NULL,NULL),(2309,'Kerrie McAloney',NULL,NULL,NULL,NULL),(2310,'Kerrie Pearson',NULL,NULL,NULL,NULL),(2311,'Kerry Jamieson',NULL,NULL,NULL,NULL),(2312,'Kerry Murphy',NULL,NULL,NULL,NULL),(2313,'Kerryn Pennell',NULL,NULL,NULL,NULL),(2314,'Kevin Bird',NULL,NULL,NULL,NULL),(2315,'Kevin McGeechan',NULL,NULL,NULL,NULL),(2316,'Kevin Morgan',NULL,NULL,NULL,NULL),(2317,'Khaled Chakli',NULL,NULL,NULL,NULL),(2318,'Khalid Choudhury',NULL,NULL,NULL,NULL),(2319,'Khanh K Thai',NULL,NULL,NULL,NULL),(2320,'Khaoula Louati',NULL,NULL,NULL,NULL),(2321,'Kieran Wynne',NULL,NULL,NULL,NULL),(2322,'Kiki D Chang',NULL,NULL,NULL,NULL),(2323,'Kim Cornish',NULL,NULL,NULL,NULL),(2324,'Kimberlee Weatherall',NULL,NULL,NULL,NULL),(2325,'Kimberley Billingsley',NULL,NULL,NULL,NULL),(2326,'Kimberly D Chambert',NULL,NULL,NULL,NULL),(2327,'Kin Y Mok',NULL,NULL,NULL,NULL),(2328,'Kiran Ijaz',NULL,NULL,NULL,NULL),(2329,'Kirsten Harvey',NULL,NULL,NULL,NULL),(2330,'Kirstin L Purves',NULL,NULL,NULL,NULL),(2331,'Kitty Rahilly',NULL,NULL,NULL,NULL),(2332,'Kjartan Nordbo',NULL,NULL,NULL,NULL),(2333,'Kl K Cho',NULL,NULL,NULL,NULL),(2334,'Klaus Lieb',NULL,NULL,NULL,NULL),(2335,'Klaus V Wagner',NULL,NULL,NULL,NULL),(2336,'Knut K Kolsk├â┬Ñr',NULL,NULL,NULL,NULL),(2337,'Konstantin V Danilenko',NULL,NULL,NULL,NULL),(2338,'Kori Johnson',NULL,NULL,NULL,NULL),(2339,'Kristel R van Eijk',NULL,NULL,NULL,NULL),(2340,'Kristi R Griffiths',NULL,NULL,NULL,NULL),(2341,'Kristi Singletary',NULL,NULL,NULL,NULL),(2342,'Kristian Hveem',NULL,NULL,NULL,NULL),(2343,'Kristie Leigh Smith',NULL,NULL,NULL,NULL),(2344,'Kristin Baer',NULL,NULL,NULL,NULL),(2345,'Kristin S Cadenhead',NULL,NULL,NULL,NULL),(2346,'Kristoffer Romero',NULL,NULL,NULL,NULL),(2347,'Kristy S Hwang',NULL,NULL,NULL,NULL),(2348,'Kristy-Lee Feilds',NULL,NULL,NULL,NULL),(2349,'Kuang Lin',NULL,NULL,NULL,NULL),(2350,'Kung-Yee Liang',NULL,NULL,NULL,NULL),(2351,'Kylie Bennett',NULL,NULL,NULL,NULL),(2352,'Kylie Gwynne',NULL,NULL,NULL,NULL),(2353,'Kylie M Gray',NULL,NULL,NULL,NULL),(2354,'Kylie P Glanville',NULL,NULL,NULL,NULL),(2355,'Kypros Kypri',NULL,NULL,NULL,NULL),(2356,'Lihong Cui',NULL,NULL,NULL,NULL),(2357,'L Flyckt',NULL,NULL,NULL,NULL),(2358,'L Keogh',NULL,NULL,NULL,NULL),(2359,'L Laskaris',NULL,NULL,NULL,NULL),(2360,'L Luck',NULL,NULL,NULL,NULL),(2361,'Loren Rina Mowszowski',NULL,NULL,NULL,NULL),(2362,'Laura Mundy',NULL,NULL,NULL,NULL),(2363,'L Oestreich',NULL,NULL,NULL,NULL),(2364,'Lara Taylor',NULL,NULL,NULL,NULL),(2365,'Lieuwe de Haan',NULL,NULL,NULL,NULL),(2366,'LA Jung',NULL,NULL,NULL,NULL),(2367,'LE Hong',NULL,NULL,NULL,NULL),(2368,'Larry J Seidman',NULL,NULL,NULL,NULL),(2369,'Laura S van Velzen',NULL,NULL,NULL,NULL),(2370,'Lachlan McLeod',NULL,NULL,NULL,NULL),(2371,'Lachlan T Strike',NULL,NULL,NULL,NULL),(2372,'Lannie Ligthart',NULL,NULL,NULL,NULL),(2373,'Lara M Wierenga',NULL,NULL,NULL,NULL),(2374,'Laramie Duncan',NULL,NULL,NULL,NULL),(2375,'Larisa M Haupt',NULL,NULL,NULL,NULL),(2376,'Larisa T McLoughlin',NULL,NULL,NULL,NULL),(2377,'Lars Alfredsson',NULL,NULL,NULL,NULL),(2378,'Lars G Fritsche',NULL,NULL,NULL,NULL),(2379,'Lars Nyberg',NULL,NULL,NULL,NULL),(2380,'Lars T Westlye',NULL,NULL,NULL,NULL),(2381,'Lasse Pihlstrom',NULL,NULL,NULL,NULL),(2382,'Lasse Pihlstr├â┬╕m',NULL,NULL,NULL,NULL),(2383,'Lasse Sander',NULL,NULL,NULL,NULL),(2384,'Laura Almasy',NULL,NULL,NULL,NULL),(2385,'Laura Galin-Corini',NULL,NULL,NULL,NULL),(2386,'Laura Huckins',NULL,NULL,NULL,NULL),(2387,'Laura J Bierut',NULL,NULL,NULL,NULL),(2388,'Laura J Scott',NULL,NULL,NULL,NULL),(2389,'Laura KM Han',NULL,NULL,NULL,NULL),(2390,'Laura Koenders',NULL,NULL,NULL,NULL),(2391,'Laura M Hack',NULL,NULL,NULL,NULL),(2392,'Louise Thornton',NULL,NULL,NULL,NULL),(2393,'Laura Nawijn',NULL,NULL,NULL,NULL),(2394,'Laura Ospina Pinillos',NULL,NULL,NULL,NULL),(2395,'Laura Ospina-Pinillos',NULL,NULL,NULL,NULL),(2396,'Laura Poole-Warren',NULL,NULL,NULL,NULL),(2397,'Laura Ray',NULL,NULL,NULL,NULL),(2398,'Laura S van Veltzen',NULL,NULL,NULL,NULL),(2399,'Laura Vuillier',NULL,NULL,NULL,NULL),(2400,'Lauren A Durkin',NULL,NULL,NULL,NULL),(2401,'Lauren A Weiss',NULL,NULL,NULL,NULL),(2402,'Lauren Salminen',NULL,NULL,NULL,NULL),(2403,'Laurenn Maree Thomas',NULL,NULL,NULL,NULL),(2404,'Laurent Essioux',NULL,NULL,NULL,NULL),(2405,'Lea R\'Bibo',NULL,NULL,NULL,NULL),(2406,'Lea Zillich',NULL,NULL,NULL,NULL),(2407,'Leah Boyle',NULL,NULL,NULL,NULL),(2408,'Leah Wetherill',NULL,NULL,NULL,NULL),(2409,'Leanne Dalley-Trim',NULL,NULL,NULL,NULL),(2410,'Leanne Prenter',NULL,NULL,NULL,NULL),(2411,'Leanne Wallace',NULL,NULL,NULL,NULL),(2412,'Lee Allen',NULL,NULL,NULL,NULL),(2413,'Lee Ritterband',NULL,NULL,NULL,NULL),(2414,'Leeanne Fisher',NULL,NULL,NULL,NULL),(2415,'Lefkos Middleton',NULL,NULL,NULL,NULL),(2416,'Lin Wang',NULL,NULL,NULL,NULL),(2417,'Leina Lu',NULL,NULL,NULL,NULL),(2418,'Lejla Colic',NULL,NULL,NULL,NULL),(2419,'Lena Backlund',NULL,NULL,NULL,NULL),(2420,'Lena Waltemate',NULL,NULL,NULL,NULL),(2421,'Lenore Sullivan',NULL,NULL,NULL,NULL),(2422,'Leo-Pekka Lyytik├â┬ñinen',NULL,NULL,NULL,NULL),(2423,'Leon Piterman',NULL,NULL,NULL,NULL),(2424,'Leon Simons',NULL,NULL,NULL,NULL),(2425,'Leonard H Van Den Berg',NULL,NULL,NULL,NULL),(2426,'Leonardo Tozzi',NULL,NULL,NULL,NULL),(2427,'Leonie Roos',NULL,NULL,NULL,NULL),(2428,'Leonie Young',NULL,NULL,NULL,NULL),(2429,'Lesley M Russell',NULL,NULL,NULL,NULL),(2430,'Levi Roach',NULL,NULL,NULL,NULL),(2431,'Luxin Chen',NULL,NULL,NULL,NULL),(2432,'Liam Abbott',NULL,NULL,NULL,NULL),(2433,'Liana G Apostolova',NULL,NULL,NULL,NULL),(2434,'Lianne Schmaal',NULL,NULL,NULL,NULL),(2435,'Liesbeth Reneman',NULL,NULL,NULL,NULL),(2436,'Liesje Donkin',NULL,NULL,NULL,NULL),(2437,'Lieuwe de Hann',NULL,NULL,NULL,NULL),(2438,'Lili Milani',NULL,NULL,NULL,NULL),(2439,'Liliana Capit├â┬úo',NULL,NULL,NULL,NULL),(2440,'Lillian Jean Gehue',NULL,NULL,NULL,NULL),(2441,'Lina Gomez',NULL,NULL,NULL,NULL),(2442,'Lina Jonsson',NULL,NULL,NULL,NULL),(2443,'Linda J Richards',NULL,NULL,NULL,NULL),(2444,'Linda J Van Eldik',NULL,NULL,NULL,NULL),(2445,'Linda O\'Malley',NULL,NULL,NULL,NULL),(2446,'Linda Teri',NULL,NULL,NULL,NULL),(2447,'Lindsay Farrer',NULL,NULL,NULL,NULL),(2448,'Lindsay M Melhuish Beaupre',NULL,NULL,NULL,NULL),(2449,'Ling Shen',NULL,NULL,NULL,NULL),(2450,'Lisa Dixon',NULL,NULL,NULL,NULL),(2451,'Lisa Garczarek',NULL,NULL,NULL,NULL),(2452,'Lisa Jones',NULL,NULL,NULL,NULL),(2453,'Lisa Juckes',NULL,NULL,NULL,NULL),(2454,'Lisa L Barnes',NULL,NULL,NULL,NULL),(2455,'Lisa Lilenfeld',NULL,NULL,NULL,NULL),(2456,'Lisa M Shulman',NULL,NULL,NULL,NULL),(2457,'Lisa Parker',NULL,NULL,NULL,NULL),(2458,'Lisa Phillips',NULL,NULL,NULL,NULL),(2459,'Lisa Sindermann',NULL,NULL,NULL,NULL),(2460,'Lisa Whittle',NULL,NULL,NULL,NULL),(2461,'Liz Forty',NULL,NULL,NULL,NULL),(2462,'Liz Pellicano',NULL,NULL,NULL,NULL),(2463,'Liz Rietschel',NULL,NULL,NULL,NULL),(2464,'Lizzy Boots',NULL,NULL,NULL,NULL),(2465,'Loic Yengo',NULL,NULL,NULL,NULL),(2466,'Lon S Schneider',NULL,NULL,NULL,NULL),(2467,'Loretta Moore',NULL,NULL,NULL,NULL),(2468,'Louis Fox',NULL,NULL,NULL,NULL),(2469,'Louisa Degenhardt',NULL,NULL,NULL,NULL),(2470,'Louisa Norrie',NULL,NULL,NULL,NULL),(2471,'Louise Ellis',NULL,NULL,NULL,NULL),(2472,'Louise Emsell',NULL,NULL,NULL,NULL),(2473,'Louise Fris├â┬⌐n',NULL,NULL,NULL,NULL),(2474,'Louise Gallagher',NULL,NULL,NULL,NULL),(2475,'Louise R├â┬⌐mond',NULL,NULL,NULL,NULL),(2476,'Luba Kalaydjieva',NULL,NULL,NULL,NULL),(2477,'Luc Evans',NULL,NULL,NULL,NULL),(2478,'Luc Letenneur',NULL,NULL,NULL,NULL),(2479,'Luca M Villa',NULL,NULL,NULL,NULL),(2480,'Lucia Colodro Conde',NULL,NULL,NULL,NULL),(2481,'Lucija Abramovic',NULL,NULL,NULL,NULL),(2482,'Lucio Naccarella',NULL,NULL,NULL,NULL),(2483,'Luc├¡a Colodro-Conde',NULL,NULL,NULL,NULL),(2484,'Lude Franke',NULL,NULL,NULL,NULL),(2485,'Luis M Garcia-Marin',NULL,NULL,NULL,NULL),(2486,'Luis M Garc├â┬¡a-Marin',NULL,NULL,NULL,NULL),(2487,'Luis M Garc├â┬¡a-Mar├â┬¡n',NULL,NULL,NULL,NULL),(2488,'Luis Salvador-Carulla',NULL,NULL,NULL,NULL),(2489,'Luisa Lazaro',NULL,NULL,NULL,NULL),(2490,'Luisa Zuccolo',NULL,NULL,NULL,NULL),(2491,'Luke K Bolt',NULL,NULL,NULL,NULL),(2492,'Lun-Hsien Chang',NULL,NULL,NULL,NULL),(2493,'Lyubomir I Aftanas',NULL,NULL,NULL,NULL),(2494,'Lydia Quaye',NULL,NULL,NULL,NULL),(2495,'Lyn R Griffiths',NULL,NULL,NULL,NULL),(2496,'Lyndel K Littlefield',NULL,NULL,NULL,NULL),(2497,'Lynne Dunbar',NULL,NULL,NULL,NULL),(2498,'Lynne Harris',NULL,NULL,NULL,NULL),(2499,'Lynne Krohn',NULL,NULL,NULL,NULL),(2500,'Lynne Malcolm',NULL,NULL,NULL,NULL),(2501,'Lynsey S Hall',NULL,NULL,NULL,NULL),(2502,'Lyudmila Georgieva',NULL,NULL,NULL,NULL),(2503,'Marie Antoinette Redoblado-Hodge',NULL,NULL,NULL,NULL),(2504,'Marcel Bruinenberg',NULL,NULL,NULL,NULL),(2505,'Marie B├â┬ªkvad-Hansen',NULL,NULL,NULL,NULL),(2506,'Miquel Casas',NULL,NULL,NULL,NULL),(2507,'M Cearns',NULL,NULL,NULL,NULL),(2508,'M DiGiacomo',NULL,NULL,NULL,NULL),(2509,'M Dudley',NULL,NULL,NULL,NULL),(2510,'Michael Fenech',NULL,NULL,NULL,NULL),(2511,'Maria H Azevedo',NULL,NULL,NULL,NULL),(2512,'M Ilyas Kamboh',NULL,NULL,NULL,NULL),(2513,'Marcus Ising',NULL,NULL,NULL,NULL),(2514,'Marjan Kljakovic',NULL,NULL,NULL,NULL),(2515,'M Kubicki',NULL,NULL,NULL,NULL),(2516,'M Lang',NULL,NULL,NULL,NULL),(2517,'M Mallar Chakravarty',NULL,NULL,NULL,NULL),(2518,'M Milic',NULL,NULL,NULL,NULL),(2519,'Merete Nordentoft',NULL,NULL,NULL,NULL),(2520,'M Pereira',NULL,NULL,NULL,NULL),(2521,'Marcella Rietschel',NULL,NULL,NULL,NULL),(2522,'Margarita Rivera',NULL,NULL,NULL,NULL),(2523,'M Rose',NULL,NULL,NULL,NULL),(2524,'Miriam Schaefer',NULL,NULL,NULL,NULL),(2525,'Monika Schl├â┬╢gelhofer',NULL,NULL,NULL,NULL),(2526,'M Selonke',NULL,NULL,NULL,NULL),(2527,'M St├â┬ñblein',NULL,NULL,NULL,NULL),(2528,'Michael Theodoros',NULL,NULL,NULL,NULL),(2529,'Martin Walter',NULL,NULL,NULL,NULL),(2530,'M Yaqub',NULL,NULL,NULL,NULL),(2531,'Marie-Paule Austin',NULL,NULL,NULL,NULL),(2532,'Mohammad A Ikram',NULL,NULL,NULL,NULL),(2533,'Melanie A Porter',NULL,NULL,NULL,NULL),(2534,'MAPS',NULL,NULL,NULL,NULL),(2535,'Michael Sharpe',NULL,NULL,NULL,NULL),(2536,'MD Lovelace',NULL,NULL,NULL,NULL),(2537,'Miguel E Renter├â┬¡a',NULL,NULL,NULL,NULL),(2538,'ME Shenton',NULL,NULL,NULL,NULL),(2539,'MIPH Navarro-Mancilla',NULL,NULL,NULL,NULL),(2540,'Maria J Portella',NULL,NULL,NULL,NULL),(2541,'ML Seal',NULL,NULL,NULL,NULL),(2542,'Marilena M DeMayo',NULL,NULL,NULL,NULL),(2543,'Markus M Noethen',NULL,NULL,NULL,NULL),(2544,'Maxwell R Bennett',NULL,NULL,NULL,NULL),(2545,'Meike W Vernooij',NULL,NULL,NULL,NULL),(2546,'Maciej Trzaskowski',NULL,NULL,NULL,NULL),(2547,'Madelaine Daianu',NULL,NULL,NULL,NULL),(2548,'Madeline Alexander',NULL,NULL,NULL,NULL),(2549,'Madeline H Meier',NULL,NULL,NULL,NULL),(2550,'Madeline Han',NULL,NULL,NULL,NULL),(2551,'Mads V Hollegaard',NULL,NULL,NULL,NULL),(2552,'Maeve Clair',NULL,NULL,NULL,NULL),(2553,'Magaly Ramirez',NULL,NULL,NULL,NULL),(2554,'Magda Tsolaki',NULL,NULL,NULL,NULL),(2555,'Magdalena Gross',NULL,NULL,NULL,NULL),(2556,'Maggie Monroe-Cassel',NULL,NULL,NULL,NULL),(2557,'Magnus Johannesson',NULL,NULL,NULL,NULL),(2558,'Maike Richter',NULL,NULL,NULL,NULL),(2559,'Maiken Elvestad Gabrielsen',NULL,NULL,NULL,NULL),(2560,'Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium',NULL,NULL,NULL,NULL),(2561,'Malcolm W Battersby',NULL,NULL,NULL,NULL),(2562,'Mandvi Bharadwaj',NULL,NULL,NULL,NULL),(2563,'Mandy Johnstone',NULL,NULL,NULL,NULL),(2564,'Manel Fern├â┬índez',NULL,NULL,NULL,NULL),(2565,'Manfred M Fichter',NULL,NULL,NULL,NULL),(2566,'Manfred Uhr',NULL,NULL,NULL,NULL),(2567,'Manolis Kellis',NULL,NULL,NULL,NULL),(2568,'Manolis Kogevinas',NULL,NULL,NULL,NULL),(2569,'Manon Bernard',NULL,NULL,NULL,NULL),(2570,'Manreena Kaur',NULL,NULL,NULL,NULL),(2571,'Manu Sharma',NULL,NULL,NULL,NULL),(2572,'Manuel Benedikt Graeber',NULL,NULL,NULL,NULL),(2573,'Manuel Mattheisen',NULL,NULL,NULL,NULL),(2574,'Manuel Men├â┬⌐ndez Gonz├â┬ílez',NULL,NULL,NULL,NULL),(2575,'Manuela Tan',NULL,NULL,NULL,NULL),(2576,'Marc Udina',NULL,NULL,NULL,NULL),(2577,'Marcela Cespedes',NULL,NULL,NULL,NULL),(2578,'Marcia Ory',NULL,NULL,NULL,NULL),(2579,'Marco Armando',NULL,NULL,NULL,NULL),(2580,'Marco P Boks',NULL,NULL,NULL,NULL),(2581,'Marco Hermesdorf',NULL,NULL,NULL,NULL),(2582,'Marcos L Santoro',NULL,NULL,NULL,NULL),(2583,'Marcus R Munaf├â┬▓',NULL,NULL,NULL,NULL),(2584,'Marcus Sokolowski',NULL,NULL,NULL,NULL),(2585,'Maree G Branagan',NULL,NULL,NULL,NULL),(2586,'Maree Teesson',NULL,NULL,NULL,NULL),(2587,'Margaret A Sheridan',NULL,NULL,NULL,NULL),(2588,'Margaret Anderson',NULL,NULL,NULL,NULL),(2589,'Margie Wright',NULL,NULL,NULL,NULL),(2590,'Margaret Leggatt',NULL,NULL,NULL,NULL),(2591,'Margaret M McGuinness',NULL,NULL,NULL,NULL),(2592,'Margaret Sloan',NULL,NULL,NULL,NULL),(2593,'Margaret Spitz',NULL,NULL,NULL,NULL),(2594,'Margaret Sutherland',NULL,NULL,NULL,NULL),(2595,'Margaret Thornton',NULL,NULL,NULL,NULL),(2596,'Margaret Tobin',NULL,NULL,NULL,NULL),(2597,'Margie Rowe',NULL,NULL,NULL,NULL),(2598,'Margit Burmeister',NULL,NULL,NULL,NULL),(2599,'Margot Albus',NULL,NULL,NULL,NULL),(2600,'Mari Kaunisto',NULL,NULL,NULL,NULL),(2601,'Maria Di Biase',NULL,NULL,NULL,NULL),(2602,'Maria Grigoroiu-Serbanescu',NULL,NULL,NULL,NULL),(2603,'Maria Hipolito',NULL,NULL,NULL,NULL),(2604,'Maria Hrafnsdottir',NULL,NULL,NULL,NULL),(2605,'Maria Jose Gomez Heredia',NULL,NULL,NULL,NULL),(2606,'Maria Jose Marti',NULL,NULL,NULL,NULL),(2607,'Maria Martinez',NULL,NULL,NULL,NULL),(2608,'Maria R Dauvermann',NULL,NULL,NULL,NULL),(2609,'Maria-Teresa Landi',NULL,NULL,NULL,NULL),(2610,'Marian L Hamshere',NULL,NULL,NULL,NULL),(2611,'Marianne Gi├â┬╕rtz Pedersen',NULL,NULL,NULL,NULL),(2612,'Marianne Webb',NULL,NULL,NULL,NULL),(2613,'Marie Antoinette Redoblado Hodge',NULL,NULL,NULL,NULL),(2614,'Marie Bismark',NULL,NULL,NULL,NULL),(2615,'Matthew B Thompson',NULL,NULL,NULL,NULL),(2616,'Marie Vidailhet',NULL,NULL,NULL,NULL),(2617,'Marie-Jos├â┬⌐ van Tol',NULL,NULL,NULL,NULL),(2618,'Marie-Odile Krebs',NULL,NULL,NULL,NULL),(2619,'Marieke Klein',NULL,NULL,NULL,NULL),(2620,'Mariesa Nicholas',NULL,NULL,NULL,NULL),(2621,'Marika Kaakinen',NULL,NULL,NULL,NULL),(2622,'Marilyn C Cornelis',NULL,NULL,NULL,NULL),(2623,'Marina Mata',NULL,NULL,NULL,NULL),(2624,'Marinka MG Koenis',NULL,NULL,NULL,NULL),(2625,'Mario Alvarez-Jimenez',NULL,NULL,NULL,NULL),(2626,'Mario Carri├â┬│n-Claro',NULL,NULL,NULL,NULL),(2627,'Mario Ezquerra',NULL,NULL,NULL,NULL),(2628,'Marion Friedl',NULL,NULL,NULL,NULL),(2629,'Marion Leboyer',NULL,NULL,NULL,NULL),(2630,'Marisa Hollinshead',NULL,NULL,NULL,NULL),(2631,'Marise WJ Machielsen',NULL,NULL,NULL,NULL),(2632,'Marissa A Ehringer',NULL,NULL,NULL,NULL),(2633,'Marita P Mccabe',NULL,NULL,NULL,NULL),(2634,'Marius Lahti-Pulkkinen',NULL,NULL,NULL,NULL),(2635,'Marjo-Riitta Jarvelin',NULL,NULL,NULL,NULL),(2636,'Marjolein de Vugt',NULL,NULL,NULL,NULL),(2637,'Mark J Adams',NULL,NULL,NULL,NULL),(2638,'Mark Dadds',NULL,NULL,NULL,NULL),(2639,'Mark Demitrack',NULL,NULL,NULL,NULL),(2640,'Mark E Bastin',NULL,NULL,NULL,NULL),(2641,'Mark E Larsen',NULL,NULL,NULL,NULL),(2642,'Mark Frye',NULL,NULL,NULL,NULL),(2643,'Mark Hansen',NULL,NULL,NULL,NULL),(2644,'Mark I Rees',NULL,NULL,NULL,NULL),(2645,'Mark J Daly',NULL,NULL,NULL,NULL),(2646,'Mark Jenkinson',NULL,NULL,NULL,NULL),(2647,'Mark Leppert',NULL,NULL,NULL,NULL),(2648,'Mark Pearson',NULL,NULL,NULL,NULL),(2649,'Mark R Cookson',NULL,NULL,NULL,NULL),(2650,'Mark R Nelson',NULL,NULL,NULL,NULL),(2651,'Mark Slee',NULL,NULL,NULL,NULL),(2652,'Mark Stevenson',NULL,NULL,NULL,NULL),(2653,'Mark Woodward',NULL,NULL,NULL,NULL),(2654,'Mark Yim',NULL,NULL,NULL,NULL),(2655,'Mark van der Gaag',NULL,NULL,NULL,NULL),(2656,'Markku Laakso',NULL,NULL,NULL,NULL),(2657,'Markus M N├â┬╢then',NULL,NULL,NULL,NULL),(2658,'Markus P Schlaich',NULL,NULL,NULL,NULL),(2659,'Markus R Baumgartner',NULL,NULL,NULL,NULL),(2660,'Markus Sch├â┬╝rks',NULL,NULL,NULL,NULL),(2661,'Marsal Sanches',NULL,NULL,NULL,NULL),(2662,'Marta Blazquez',NULL,NULL,NULL,NULL),(2663,'Marta Bonilla-Toribio',NULL,NULL,NULL,NULL),(2664,'Marta F Nabais',NULL,NULL,NULL,NULL),(2665,'Marta Lynch',NULL,NULL,NULL,NULL),(2666,'Marta Ribas├â┬⌐s',NULL,NULL,NULL,NULL),(2667,'Martha Bruce',NULL,NULL,NULL,NULL),(2668,'Martha Michel',NULL,NULL,NULL,NULL),(2669,'Martilias S Farrell',NULL,NULL,NULL,NULL),(2670,'Martin A Kohli',NULL,NULL,NULL,NULL),(2671,'Martin Alda',NULL,NULL,NULL,NULL),(2672,'Martin Begemann',NULL,NULL,NULL,NULL),(2673,'Martin Bohus',NULL,NULL,NULL,NULL),(2674,'Martin HAUSBERG',NULL,NULL,NULL,NULL),(2675,'Martin Hautzinger',NULL,NULL,NULL,NULL),(2676,'Martin Kennedy',NULL,NULL,NULL,NULL),(2677,'Martin Preisig',NULL,NULL,NULL,NULL),(2678,'Martin R Stockler',NULL,NULL,NULL,NULL),(2679,'Martin Rossor',NULL,NULL,NULL,NULL),(2680,'Martin Whitely',NULL,NULL,NULL,NULL),(2681,'Martina Papmeyer',NULL,NULL,NULL,NULL),(2682,'Martine Hoogman',NULL,NULL,NULL,NULL),(2683,'Mary Cannon',NULL,NULL,NULL,NULL),(2684,'Mary L Marazita',NULL,NULL,NULL,NULL),(2685,'Maryann Davis',NULL,NULL,NULL,NULL),(2686,'Mar├â┬¡a Soler Artigas',NULL,NULL,NULL,NULL),(2687,'Mar├â┬¡a Teresa Boungiorno',NULL,NULL,NULL,NULL),(2688,'Masaki Fukunaga',NULL,NULL,NULL,NULL),(2689,'Masaki Kato',NULL,NULL,NULL,NULL),(2690,'Masashi Ikeda',NULL,NULL,NULL,NULL),(2691,'Matcheri S Keshavan',NULL,NULL,NULL,NULL),(2692,'Mateus Jose Abdalla Diniz',NULL,NULL,NULL,NULL),(2693,'Meredith G Harris',NULL,NULL,NULL,NULL),(2694,'Mathias Toft',NULL,NULL,NULL,NULL),(2695,'Mathias V Schmidt',NULL,NULL,NULL,NULL),(2696,'Matthew Paradise',NULL,NULL,NULL,NULL),(2697,'Matthew McGue',NULL,NULL,NULL,NULL),(2698,'Matthew C Keller',NULL,NULL,NULL,NULL),(2699,'Matthew Cullen',NULL,NULL,NULL,NULL),(2700,'Matthew D Sacchet',NULL,NULL,NULL,NULL),(2701,'Matthew Flickinger',NULL,NULL,NULL,NULL),(2702,'Matthew Hickman',NULL,NULL,NULL,NULL),(2703,'Matthew J Huentelman',NULL,NULL,NULL,NULL),(2704,'Matthew Kiernan',NULL,NULL,NULL,NULL),(2705,'Matthew Michael Large',NULL,NULL,NULL,NULL),(2706,'Matthew McQueen',NULL,NULL,NULL,NULL),(2707,'Matthew P Hamilton',NULL,NULL,NULL,NULL),(2708,'Matthew P Hyett',NULL,NULL,NULL,NULL),(2709,'Matthew S Panizzon',NULL,NULL,NULL,NULL),(2710,'Matthew Smith',NULL,NULL,NULL,NULL),(2711,'Matthew Traylor',NULL,NULL,NULL,NULL),(2712,'Matthias Nauck',NULL,NULL,NULL,NULL),(2713,'Matthias Riemenschneider',NULL,NULL,NULL,NULL),(2714,'Matthijs D van der Zee',NULL,NULL,NULL,NULL),(2715,'Maude Schneider',NULL,NULL,NULL,NULL),(2716,'Maureen D Reynolds',NULL,NULL,NULL,NULL),(2717,'Mauricio H Serpa',NULL,NULL,NULL,NULL),(2718,'Maurizio Fava',NULL,NULL,NULL,NULL),(2719,'Max Birchwood',NULL,NULL,NULL,NULL),(2720,'Maximus Berger',NULL,NULL,NULL,NULL),(2721,'Mayuresh S Korgaonkar',NULL,NULL,NULL,NULL),(2722,'Megan Brown',NULL,NULL,NULL,NULL),(2723,'Meggan Porteous',NULL,NULL,NULL,NULL),(2724,'Mei-Hsin Su',NULL,NULL,NULL,NULL),(2725,'Melanie A Carless',NULL,NULL,NULL,NULL),(2726,'Melanie F├â┬╢cking',NULL,NULL,NULL,NULL),(2727,'Melanie K Strike',NULL,NULL,NULL,NULL),(2728,'Melanie Price',NULL,NULL,NULL,NULL),(2729,'Melanie Schwandt',NULL,NULL,NULL,NULL),(2730,'Melina Ramp',NULL,NULL,NULL,NULL),(2731,'Melinda Westlund Schreiner',NULL,NULL,NULL,NULL),(2732,'Melissa Boglis',NULL,NULL,NULL,NULL),(2733,'Melissa Connell',NULL,NULL,NULL,NULL),(2734,'Melissa J Green',NULL,NULL,NULL,NULL),(2735,'Melissa K Licari',NULL,NULL,NULL,NULL),(2736,'Melissa K Weinberg',NULL,NULL,NULL,NULL),(2737,'Melissa Kirkovski',NULL,NULL,NULL,NULL),(2738,'Melissa Klug',NULL,NULL,NULL,NULL),(2739,'Melissa M Norberg',NULL,NULL,NULL,NULL),(2740,'Melissa Otis',NULL,NULL,NULL,NULL),(2741,'Melissa Raven',NULL,NULL,NULL,NULL),(2742,'Melissa Tanner',NULL,NULL,NULL,NULL),(2743,'Melony Williams',NULL,NULL,NULL,NULL),(2744,'Menachem Fromer',NULL,NULL,NULL,NULL),(2745,'Miaoxin Li',NULL,NULL,NULL,NULL),(2746,'Mengzhen Liu',NULL,NULL,NULL,NULL),(2747,'Mengxin He',NULL,NULL,NULL,NULL),(2748,'Merc├â┬¿ Boada',NULL,NULL,NULL,NULL),(2749,'Meredith McHugh',NULL,NULL,NULL,NULL),(2750,'Merrilee Needham',NULL,NULL,NULL,NULL),(2751,'Mervi Alanne-Kinnunen',NULL,NULL,NULL,NULL),(2752,'Michael A Easton',NULL,NULL,NULL,NULL),(2753,'Michael B Miller',NULL,NULL,NULL,NULL),(2754,'Michael Bauer',NULL,NULL,NULL,NULL),(2755,'Michael Berk',NULL,NULL,NULL,NULL),(2756,'Michael Boehnke',NULL,NULL,NULL,NULL),(2757,'Michael Breakspear',NULL,NULL,NULL,NULL),(2758,'Michael C Neale',NULL,NULL,NULL,NULL),(2759,'Michael C O\'Donovan',NULL,NULL,NULL,NULL),(2760,'Michael C Stallings',NULL,NULL,NULL,NULL),(2761,'Michael Cheng',NULL,NULL,NULL,NULL),(2762,'Michael Czisch',NULL,NULL,NULL,NULL),(2763,'Michael Davidson',NULL,NULL,NULL,NULL),(2764,'Michael Denkinger',NULL,NULL,NULL,NULL),(2765,'Michael Friedlander',NULL,NULL,NULL,NULL),(2766,'Michael Gandal',NULL,NULL,NULL,NULL),(2767,'Michael Gill',NULL,NULL,NULL,NULL),(2768,'Michael J Owen',NULL,NULL,NULL,NULL),(2769,'Michael Jefford',NULL,NULL,NULL,NULL),(2770,'Michael L Cuccaro',NULL,NULL,NULL,NULL),(2771,'Michael M Vanyukov',NULL,NULL,NULL,NULL),(2772,'Michael Moore',NULL,NULL,NULL,NULL),(2774,'Michael P Douglas',NULL,NULL,NULL,NULL),(2775,'Michael P Milham',NULL,NULL,NULL,NULL),(2776,'Michael R Barnes',NULL,NULL,NULL,NULL),(2777,'Michael Stach',NULL,NULL,NULL,NULL),(2778,'Michael Steffens',NULL,NULL,NULL,NULL),(2779,'Michael Strober',NULL,NULL,NULL,NULL),(2780,'Michael de Ridder',NULL,NULL,NULL,NULL),(2781,'Michel D Ferrari',NULL,NULL,NULL,NULL),(2782,'Michel Nivard',NULL,NULL,NULL,NULL),(2783,'Michel Guipponi',NULL,NULL,NULL,NULL),(2784,'Michele Pergadia',NULL,NULL,NULL,NULL),(2785,'Michelle Chen',NULL,NULL,NULL,NULL),(2786,'Michelle K Lupton',NULL,NULL,NULL,NULL),(2787,'Michelle Taylor',NULL,NULL,NULL,NULL),(2788,'Mie Rizig',NULL,NULL,NULL,NULL),(2789,'Miguel A Labrador-Espinosa',NULL,NULL,NULL,NULL),(2790,'Miguel E Renteria',NULL,NULL,NULL,NULL),(2791,'Mika K├â┬ñh├â┬╢nen',NULL,NULL,NULL,NULL),(2792,'Mikael Landen',NULL,NULL,NULL,NULL),(2793,'Mikael Land├â┬⌐n',NULL,NULL,NULL,NULL),(2794,'Mike A Nalls',NULL,NULL,NULL,NULL),(2795,'Mike Kyrios',NULL,NULL,NULL,NULL),(2796,'Milan Macek',NULL,NULL,NULL,NULL),(2797,'Milan Macek Jr',NULL,NULL,NULL,NULL),(2798,'Ming Hu',NULL,NULL,NULL,NULL),(2799,'Ming T Tsuang',NULL,NULL,NULL,NULL),(2800,'Ming-Chang Chiang',NULL,NULL,NULL,NULL),(2801,'Ming-Chyi Huang',NULL,NULL,NULL,NULL),(2802,'Minsoo Kim',NULL,NULL,NULL,NULL),(2803,'Miquel Aguilar',NULL,NULL,NULL,NULL),(2804,'Mireille St-Jean',NULL,NULL,NULL,NULL),(2805,'Miriam Schafer',NULL,NULL,NULL,NULL),(2806,'Miriam Sch├â┬ñfer',NULL,NULL,NULL,NULL),(2807,'Miriana Duran',NULL,NULL,NULL,NULL),(2808,'Mirko Bagaric',NULL,NULL,NULL,NULL),(2809,'Miruna C Barbu',NULL,NULL,NULL,NULL),(2810,'Mitchell J Dowling',NULL,NULL,NULL,NULL),(2811,'Mitja I Kurki',NULL,NULL,NULL,NULL),(2812,'Mohammed Sazzad Hussain',NULL,NULL,NULL,NULL),(2813,'Mojca Z Dernovsek',NULL,NULL,NULL,NULL),(2814,'Moji Aghajani',NULL,NULL,NULL,NULL),(2815,'Mon-Ju Wu',NULL,NULL,NULL,NULL),(2816,'Mong-Liang Lu',NULL,NULL,NULL,NULL),(2817,'Monica Diez-Fairen',NULL,NULL,NULL,NULL),(2818,'Monica R Sch├â┬ñffer',NULL,NULL,NULL,NULL),(2819,'Monika Budde',NULL,NULL,NULL,NULL),(2820,'Monika Schloegelhofer',NULL,NULL,NULL,NULL),(2821,'Monika Schlogelhofer',NULL,NULL,NULL,NULL),(2822,'Montserrat Alegret',NULL,NULL,NULL,NULL),(2823,'Morgan H James',NULL,NULL,NULL,NULL),(2824,'Morten Mattingsdal',NULL,NULL,NULL,NULL),(2825,'Mostafa Rahimi Azghadi',NULL,NULL,NULL,NULL),(2826,'Murat Y├â┬╝cel',NULL,NULL,NULL,NULL),(2827,'Murray B Stein',NULL,NULL,NULL,NULL),(2828,'Murray D Esler',NULL,NULL,NULL,NULL),(2829,'Myles McGregor-Lowndes',NULL,NULL,NULL,NULL),(2830,'Myrna M Weissman',NULL,NULL,NULL,NULL),(2831,'M├â┬▓nica Bay├â┬⌐s',NULL,NULL,NULL,NULL),(2832,'Nathan Gillespie',NULL,NULL,NULL,NULL),(2833,'Neda Jahanshad',NULL,NULL,NULL,NULL),(2834,'Nils Opel',NULL,NULL,NULL,NULL),(2835,'Naomi Rogers',NULL,NULL,NULL,NULL),(2836,'Nic Telford',NULL,NULL,NULL,NULL),(2837,'Nicholas RC Wilcken',NULL,NULL,NULL,NULL),(2838,'Natalia Zmicerevska',NULL,NULL,NULL,NULL),(2839,'NA Bokhan',NULL,NULL,NULL,NULL),(2840,'NEM Van Haren',NULL,NULL,NULL,NULL),(2841,'Nicole J Highet',NULL,NULL,NULL,NULL),(2842,'Nic van der Wee',NULL,NULL,NULL,NULL),(2843,'Narelle K Hansell',NULL,NULL,NULL,NULL),(2844,'NT Doan',NULL,NULL,NULL,NULL),(2845,'Natalie T Mills',NULL,NULL,NULL,NULL),(2846,'Na Cai',NULL,NULL,NULL,NULL),(2847,'Nader Perroud',NULL,NULL,NULL,NULL),(2848,'Nadia N Hansel',NULL,NULL,NULL,NULL),(2849,'Nadia Solowij',NULL,NULL,NULL,NULL),(2850,'Nadine Cohen',NULL,NULL,NULL,NULL),(2851,'Nahid Banihashemi',NULL,NULL,NULL,NULL),(2852,'Nana Matoba',NULL,NULL,NULL,NULL),(2853,'Nancy Briggs',NULL,NULL,NULL,NULL),(2854,'Nancy C Andreasen',NULL,NULL,NULL,NULL),(2855,'Nancy G Buccola',NULL,NULL,NULL,NULL),(2856,'Nancy Pedersen',NULL,NULL,NULL,NULL),(2857,'Nancy Saccone',NULL,NULL,NULL,NULL),(2858,'Naomi Breslau',NULL,NULL,NULL,NULL),(2859,'Naomi Wray',NULL,NULL,NULL,NULL),(2860,'Naseem Ahmadpour',NULL,NULL,NULL,NULL),(2861,'Naser Durmishi',NULL,NULL,NULL,NULL),(2862,'Natalia Albein-Urios',NULL,NULL,NULL,NULL),(2863,'Natalia Jaworska',NULL,NULL,NULL,NULL),(2864,'Natalie Healey',NULL,NULL,NULL,NULL),(2865,'Natalie Johnson',NULL,NULL,NULL,NULL),(2866,'Natalie Silver',NULL,NULL,NULL,NULL),(2867,'Natalie Waldherr',NULL,NULL,NULL,NULL),(2868,'Nathan E Cross',NULL,NULL,NULL,NULL),(2869,'Nathan G Mifsud',NULL,NULL,NULL,NULL),(2870,'Nathaniel Thomas',NULL,NULL,NULL,NULL),(2871,'Nazanin Karbalai',NULL,NULL,NULL,NULL),(2872,'Negar Memarian',NULL,NULL,NULL,NULL),(2873,'Neil Caporaso',NULL,NULL,NULL,NULL),(2874,'Neil Levy',NULL,NULL,NULL,NULL),(2875,'Nelson B Freimer',NULL,NULL,NULL,NULL),(2876,'Nereus Maranan',NULL,NULL,NULL,NULL),(2877,'Nerisa Banaj',NULL,NULL,NULL,NULL),(2878,'Nese Direk',NULL,NULL,NULL,NULL),(2879,'Neven Henigsberg',NULL,NULL,NULL,NULL),(2880,'Ney Alliey-Rodriguez',NULL,NULL,NULL,NULL),(2881,'Niamh Mullins',NULL,NULL,NULL,NULL),(2882,'Niccolo E Mencacci',NULL,NULL,NULL,NULL),(2883,'Nicholas B Allen',NULL,NULL,NULL,NULL),(2884,'Nick Bass',NULL,NULL,NULL,NULL),(2885,'Nicholas Eriksson',NULL,NULL,NULL,NULL),(2886,'Nicholas Furlotte',NULL,NULL,NULL,NULL),(2887,'Nick Martin',NULL,NULL,NULL,NULL),(2888,'Nicholas W Wood',NULL,NULL,NULL,NULL),(2889,'Nicholas Wilken',NULL,NULL,NULL,NULL),(2890,'Nick C Fox',NULL,NULL,NULL,NULL),(2891,'Nick Craddock',NULL,NULL,NULL,NULL),(2892,'Nick S Glozier',NULL,NULL,NULL,NULL),(2893,'Nickolai Titov',NULL,NULL,NULL,NULL),(2894,'Nicola J Armstrong',NULL,NULL,NULL,NULL),(2895,'Nicola Lacey',NULL,NULL,NULL,NULL),(2896,'Nicolas Ramoz',NULL,NULL,NULL,NULL),(2897,'Nicole A Vincent',NULL,NULL,NULL,NULL),(2898,'Nicole L Cockayne',NULL,NULL,NULL,NULL),(2899,'Nicole Dueker',NULL,NULL,NULL,NULL),(2900,'Nicole Espinosa',NULL,NULL,NULL,NULL),(2901,'Nicole J Rinehart',NULL,NULL,NULL,NULL),(2902,'Nicole Peever',NULL,NULL,NULL,NULL),(2903,'Nicole Pesa',NULL,NULL,NULL,NULL),(2904,'Nicole R Hoft',NULL,NULL,NULL,NULL),(2905,'Nicole Rogerson',NULL,NULL,NULL,NULL),(2906,'Nicole Vogelzangs',NULL,NULL,NULL,NULL),(2907,'Nigel C Rogasch',NULL,NULL,NULL,NULL),(2908,'Nigel Lovell',NULL,NULL,NULL,NULL),(2909,'Nigel Teik Ming Chen',NULL,NULL,NULL,NULL),(2910,'Nikolaos A Patsopoulos',NULL,NULL,NULL,NULL),(2911,'Nilanjan Chatterjee',NULL,NULL,NULL,NULL),(2912,'Nilesh J Samani',NULL,NULL,NULL,NULL),(2913,'Nils Inge Landr├â┬╕',NULL,NULL,NULL,NULL),(2914,'Nils Winter',NULL,NULL,NULL,NULL),(2915,'Nilufar Mossaheb',NULL,NULL,NULL,NULL),(2916,'Nitin Gogtay',NULL,NULL,NULL,NULL),(2917,'Njideka U Okubadejo',NULL,NULL,NULL,NULL),(2918,'Noa Carrera',NULL,NULL,NULL,NULL),(2919,'Noeline Latt',NULL,NULL,NULL,NULL),(2920,'Nola Alloway',NULL,NULL,NULL,NULL),(2921,'Nora D Volkow',NULL,NULL,NULL,NULL),(2922,'Nora Franceschini',NULL,NULL,NULL,NULL),(2923,'Norbert Hosten',NULL,NULL,NULL,NULL),(2924,'Norbert Mueller',NULL,NULL,NULL,NULL),(2925,'Norio Watanabe',NULL,NULL,NULL,NULL),(2926,'Norm Kelk',NULL,NULL,NULL,NULL),(2927,'Nuria Bargallo',NULL,NULL,NULL,NULL),(2928,'Nynke A Groenewold',NULL,NULL,NULL,NULL),(2929,'Oliver Gruber',NULL,NULL,NULL,NULL),(2930,'O Hardiman',NULL,NULL,NULL,NULL),(2931,'Ole Mors',NULL,NULL,NULL,NULL),(2932,'O Pasternak',NULL,NULL,NULL,NULL),(2933,'Ole A Andreassen',NULL,NULL,NULL,NULL),(2934,'Odile A Van den Heuvel',NULL,NULL,NULL,NULL),(2935,'Olaf Steinstr├â┬ñter',NULL,NULL,NULL,NULL),(2936,'Olga Giannakopoulou',NULL,NULL,NULL,NULL),(2937,'Olga Shimoni',NULL,NULL,NULL,NULL),(2938,'Oliver Grimm',NULL,NULL,NULL,NULL),(2939,'Oliver Pain',NULL,NULL,NULL,NULL),(2940,'Olivia Carter',NULL,NULL,NULL,NULL),(2941,'Olivia M Dean',NULL,NULL,NULL,NULL),(2942,'Olli Raitakari',NULL,NULL,NULL,NULL),(2943,'Oluwadamilola O Ojo',NULL,NULL,NULL,NULL),(2944,'Oren Civier',NULL,NULL,NULL,NULL),(2945,'Oriol Dols-Icardo',NULL,NULL,NULL,NULL),(2946,'Owen Spencer',NULL,NULL,NULL,NULL),(2947,'Peter A Cistulli',NULL,NULL,NULL,NULL),(2948,'PJ Cowen',NULL,NULL,NULL,NULL),(2949,'P Darveniza',NULL,NULL,NULL,NULL),(2950,'P Davidson',NULL,NULL,NULL,NULL),(2951,'P De Rossi',NULL,NULL,NULL,NULL),(2952,'P DeSouza',NULL,NULL,NULL,NULL),(2953,'P Gatenby',NULL,NULL,NULL,NULL),(2954,'Philip Hazell',NULL,NULL,NULL,NULL),(2955,'P Klauser',NULL,NULL,NULL,NULL),(2956,'Peter Kochunov',NULL,NULL,NULL,NULL),(2957,'Peter McGuffin',NULL,NULL,NULL,NULL),(2958,'P Murali Doraiswamy',NULL,NULL,NULL,NULL),(2959,'P Newton',NULL,NULL,NULL,NULL),(2960,'P O\'donnell',NULL,NULL,NULL,NULL),(2961,'P Savadjiev',NULL,NULL,NULL,NULL),(2962,'P Sham',NULL,NULL,NULL,NULL),(2963,'P Wan',NULL,NULL,NULL,NULL),(2964,'Pamela Madden',NULL,NULL,NULL,NULL),(2965,'Philip Mitchell',NULL,NULL,NULL,NULL),(2966,'PD WHITE',NULL,NULL,NULL,NULL),(2967,'Phoebe L Carter',NULL,NULL,NULL,NULL),(2968,'PE Rasser',NULL,NULL,NULL,NULL),(2969,'PG Saemann',NULL,NULL,NULL,NULL),(2970,'Philip J Batterham',NULL,NULL,NULL,NULL),(2971,'PK Peterson',NULL,NULL,NULL,NULL),(2972,'Philip Boyce',NULL,NULL,NULL,NULL),(2973,'PM Shane',NULL,NULL,NULL,NULL),(2974,'Paul Thompson',NULL,NULL,NULL,NULL),(2975,'Philip R Jansen',NULL,NULL,NULL,NULL),(2976,'Patricia T Michie',NULL,NULL,NULL,NULL),(2977,'Pablo Cervantes',NULL,NULL,NULL,NULL),(2978,'Pablo Mir',NULL,NULL,NULL,NULL),(2979,'Pablo V Gejman',NULL,NULL,NULL,NULL),(2980,'Paddy Power',NULL,NULL,NULL,NULL),(2981,'Padhraig Gormley',NULL,NULL,NULL,NULL),(2982,'Pamela A McCombe',NULL,NULL,NULL,NULL),(2983,'Pamela J Shaw',NULL,NULL,NULL,NULL),(2984,'Pamela K Keel',NULL,NULL,NULL,NULL),(2985,'Pamela Sklar',NULL,NULL,NULL,NULL),(2986,'Panagiotis Ferentinos',NULL,NULL,NULL,NULL),(2987,'Pankaj Sah',NULL,NULL,NULL,NULL),(2988,'Paola Fuentes-Claramonte',NULL,NULL,NULL,NULL),(2989,'Paola Giusti-Rodr├â┬¡guez',NULL,NULL,NULL,NULL),(2990,'Parker Gordon',NULL,NULL,NULL,NULL),(2991,'Pat Dudgeon',NULL,NULL,NULL,NULL),(2992,'Patience J Gallagher',NULL,NULL,NULL,NULL),(2993,'Patricia J Conrod',NULL,NULL,NULL,NULL),(2994,'Patricia Gruner',NULL,NULL,NULL,NULL),(2995,'Patricia Pozo-Rosich',NULL,NULL,NULL,NULL),(2996,'Patricia Stolte',NULL,NULL,NULL,NULL),(2997,'Patricia Worth',NULL,NULL,NULL,NULL),(2998,'Patrick F Sullivan',NULL,NULL,NULL,NULL),(2999,'Patrick Gorman',NULL,NULL,NULL,NULL),(3000,'Patrick J Hurley',NULL,NULL,NULL,NULL),(3001,'Patrick McGrath',NULL,NULL,NULL,NULL),(3002,'Patrick Joseph Fraser Clarke',NULL,NULL,NULL,NULL),(3003,'Patrick Lewis',NULL,NULL,NULL,NULL),(3004,'Patrick McGorry',NULL,NULL,NULL,NULL),(3005,'Patrick Turley',NULL,NULL,NULL,NULL),(3006,'Patrik Magnusson',NULL,NULL,NULL,NULL),(3007,'Patrizia Mecocci',NULL,NULL,NULL,NULL),(3008,'Patty Chondros',NULL,NULL,NULL,NULL),(3009,'Pau Pastor',NULL,NULL,NULL,NULL),(3010,'Paul Fitzgerald',NULL,NULL,NULL,NULL),(3011,'Paul Cormican',NULL,NULL,NULL,NULL),(3012,'Paul L De Souza',NULL,NULL,NULL,NULL),(3013,'Paul Denborough',NULL,NULL,NULL,NULL),(3014,'Paul E O├éΓÇÖBrien',NULL,NULL,NULL,NULL),(3015,'Paul F O\'Reilly',NULL,NULL,NULL,NULL),(3016,'Paul F OReilly',NULL,NULL,NULL,NULL),(3017,'Paul F O├éΓÇÖReilly',NULL,NULL,NULL,NULL),(3018,'Paul G Amminger',NULL,NULL,NULL,NULL),(3019,'Paul J Hop',NULL,NULL,NULL,NULL),(3020,'Paul Lichtenstein',NULL,NULL,NULL,NULL),(3021,'Paul Maruff',NULL,NULL,NULL,NULL),(3022,'Paul Pauli',NULL,NULL,NULL,NULL),(3023,'Paul Redmond',NULL,NULL,NULL,NULL),(3024,'Paul Ryan',NULL,NULL,NULL,NULL),(3025,'Pearl Price',NULL,NULL,NULL,NULL),(3026,'Pedro GP Rosa',NULL,NULL,NULL,NULL),(3027,'Pedro Garc├â┬¡a-Ruiz',NULL,NULL,NULL,NULL),(3028,'Pedro Vieira-Marques',NULL,NULL,NULL,NULL),(3029,'Pekka Jousilahti',NULL,NULL,NULL,NULL),(3030,'Penelope Lind',NULL,NULL,NULL,NULL),(3031,'Penelope Murie',NULL,NULL,NULL,NULL),(3032,'Pengyi Yang',NULL,NULL,NULL,NULL),(3033,'Pentti Tienari',NULL,NULL,NULL,NULL),(3034,'Per Hoffman',NULL,NULL,NULL,NULL),(3035,'Per Hoffmann',NULL,NULL,NULL,NULL),(3036,'Per Qvist',NULL,NULL,NULL,NULL),(3037,'Perminder S Sachdev',NULL,NULL,NULL,NULL),(3038,'Peta S Eggins',NULL,NULL,NULL,NULL),(3039,'Pete M Ellis',NULL,NULL,NULL,NULL),(3040,'Peter A Bandettini',NULL,NULL,NULL,NULL),(3041,'Peter D Par├â┬⌐',NULL,NULL,NULL,NULL),(3042,'Peter Danckwerts',NULL,NULL,NULL,NULL),(3043,'Peter Eichhammer',NULL,NULL,NULL,NULL),(3044,'Peter G Enticott',NULL,NULL,NULL,NULL),(3045,'Peter H Donaldson',NULL,NULL,NULL,NULL),(3046,'Peter Heutink',NULL,NULL,NULL,NULL),(3047,'Peter Holmans',NULL,NULL,NULL,NULL),(3048,'Peter J van der Most',NULL,NULL,NULL,NULL),(3049,'Peter Joyce',NULL,NULL,NULL,NULL),(3050,'Peter Kraft',NULL,NULL,NULL,NULL),(3051,'Peter M Visscher',NULL,NULL,NULL,NULL),(3052,'Peter R McManus',NULL,NULL,NULL,NULL),(3053,'Peter Passmore',NULL,NULL,NULL,NULL),(3054,'Peter R Schofield',NULL,NULL,NULL,NULL),(3055,'Peter Robertson',NULL,NULL,NULL,NULL),(3056,'Peter Silburn',NULL,NULL,NULL,NULL),(3057,'Peter St George-Hyslop',NULL,NULL,NULL,NULL),(3058,'Peter T Fox',NULL,NULL,NULL,NULL),(3059,'Peter Weber',NULL,NULL,NULL,NULL),(3060,'Petra Proitsi',NULL,NULL,NULL,NULL),(3061,'Phil Lee',NULL,NULL,NULL,NULL),(3062,'Philibert Duriez',NULL,NULL,NULL,NULL),(3063,'Philip Asherson',NULL,NULL,NULL,NULL),(3064,'Philip Gorwood',NULL,NULL,NULL,NULL),(3065,'Philip J Beale',NULL,NULL,NULL,NULL),(3066,'Philip L De Jager',NULL,NULL,NULL,NULL),(3067,'Philip M Burgess',NULL,NULL,NULL,NULL),(3068,'Philip R Gehrman',NULL,NULL,NULL,NULL),(3069,'Philip R Szeszko',NULL,NULL,NULL,NULL),(3070,'Phillip Ward',NULL,NULL,NULL,NULL),(3071,'Philipp D Koellinger',NULL,NULL,NULL,NULL),(3072,'Philipp G Samann',NULL,NULL,NULL,NULL),(3073,'Philipp G S├â┬ñmann',NULL,NULL,NULL,NULL),(3074,'Philippa Collin',NULL,NULL,NULL,NULL),(3075,'Philippa Quinn',NULL,NULL,NULL,NULL),(3076,'Philippe Amouyel',NULL,NULL,NULL,NULL),(3077,'Philippe Conus',NULL,NULL,NULL,NULL),(3078,'Phillip McGuire',NULL,NULL,NULL,NULL),(3079,'Phyllis Butow',NULL,NULL,NULL,NULL),(3080,'Pierandrea Muglia',NULL,NULL,NULL,NULL),(3081,'Pierre Fontanillas',NULL,NULL,NULL,NULL),(3082,'Pierre J Magistretti',NULL,NULL,NULL,NULL),(3083,'Pieter J Hoekstra',NULL,NULL,NULL,NULL),(3084,'Pilar G├â┬│mez-Garre',NULL,NULL,NULL,NULL),(3085,'Piotr M Czerski',NULL,NULL,NULL,NULL),(3086,'Pippa A Thomson',NULL,NULL,NULL,NULL),(3087,'Po-Hsiu Kuo',NULL,NULL,NULL,NULL),(3088,'Pol AC van Lier',NULL,NULL,NULL,NULL),(3089,'Prasuna Reddy',NULL,NULL,NULL,NULL),(3090,'Preben B Mortensen',NULL,NULL,NULL,NULL),(3091,'Priit Palta',NULL,NULL,NULL,NULL),(3092,'Qian Zhang',NULL,NULL,NULL,NULL),(3093,'Qingqin S Li',NULL,NULL,NULL,NULL),(3094,'Qingyi Wei',NULL,NULL,NULL,NULL),(3095,'Quinn McLellan',NULL,NULL,NULL,NULL),(3096,'R Cameron Craddock',NULL,NULL,NULL,NULL),(3097,'Rebekah Carney',NULL,NULL,NULL,NULL),(3098,'R John Simes',NULL,NULL,NULL,NULL),(3099,'R Jones',NULL,NULL,NULL,NULL),(3100,'R King',NULL,NULL,NULL,NULL),(3101,'Rico Sze Chun Lee',NULL,NULL,NULL,NULL),(3102,'Robert H Loblay',NULL,NULL,NULL,NULL),(3103,'R Nagarajah',NULL,NULL,NULL,NULL),(3104,'R Roiz',NULL,NULL,NULL,NULL),(3105,'R Schweitzer',NULL,NULL,NULL,NULL),(3106,'Richard Sherva',NULL,NULL,NULL,NULL),(3107,'Ryan Wallis',NULL,NULL,NULL,NULL),(3108,'R Warwick Blood',NULL,NULL,NULL,NULL),(3109,'RC Dale',NULL,NULL,NULL,NULL),(3110,'RCW Mandl',NULL,NULL,NULL,NULL),(3111,'Roseann Peterson',NULL,NULL,NULL,NULL),(3112,'RI Mesholam-Gately',NULL,NULL,NULL,NULL),(3113,'RJ Scott',NULL,NULL,NULL,NULL),(3114,'RK Lenroot',NULL,NULL,NULL,NULL),(3115,'Rachael Degabriele',NULL,NULL,NULL,NULL),(3116,'Rachael Murrihy',NULL,NULL,NULL,NULL),(3117,'Rachel M Arends',NULL,NULL,NULL,NULL),(3118,'Rachel M Brouwer',NULL,NULL,NULL,NULL),(3119,'Rachel O\'Connell',NULL,NULL,NULL,NULL),(3120,'Radhika Kandaswamy',NULL,NULL,NULL,NULL),(3121,'Rafael Calvo',NULL,NULL,NULL,NULL),(3122,'Rainer Malik',NULL,NULL,NULL,NULL),(3123,'Rainer von Coelln',NULL,NULL,NULL,NULL),(3124,'Rajiv Khanna',NULL,NULL,NULL,NULL),(3125,'Rali Dimitrova',NULL,NULL,NULL,NULL),(3126,'Ralph E Tarter',NULL,NULL,NULL,NULL),(3127,'Ralph Kupka',NULL,NULL,NULL,NULL),(3128,'Ramona AJ Zwamborn',NULL,NULL,NULL,NULL),(3129,'Ramona Baur-Streubel',NULL,NULL,NULL,NULL),(3130,'Ramona Leenings',NULL,NULL,NULL,NULL),(3131,'Randy L Gollub',NULL,NULL,NULL,NULL),(3132,'Randy L Buckner',NULL,NULL,NULL,NULL),(3133,'Raquel Duran',NULL,NULL,NULL,NULL),(3134,'Rasika A Mathias',NULL,NULL,NULL,NULL),(3135,'Rathi Mahendran',NULL,NULL,NULL,NULL),(3136,'Rauan Kaiyrzhanov',NULL,NULL,NULL,NULL),(3137,'Ravindranath Duggirala',NULL,NULL,NULL,NULL),(3138,'Raymond CK Chan',NULL,NULL,NULL,NULL),(3139,'Raymond F Martyres',NULL,NULL,NULL,NULL),(3140,'Raymond Salvador',NULL,NULL,NULL,NULL),(3141,'Raymond Schwartz',NULL,NULL,NULL,NULL),(3142,'Robin G Walters',NULL,NULL,NULL,NULL),(3143,'Rebecca Ivers',NULL,NULL,NULL,NULL),(3144,'Rebecca-Lee Kuhnert',NULL,NULL,NULL,NULL),(3145,'Rebekah Street',NULL,NULL,NULL,NULL),(3146,'Rebekka Tuqiri',NULL,NULL,NULL,NULL),(3147,'Reedik M├â┬ñgi',NULL,NULL,NULL,NULL),(3148,'Reginald Westbrook',NULL,NULL,NULL,NULL),(3149,'Renato Polimanti',NULL,NULL,NULL,NULL),(3150,'Rene G Pols',NULL,NULL,NULL,NULL),(3151,'Ren├â┬⌐ Breuer',NULL,NULL,NULL,NULL),(3152,'Ren├â┬⌐ Pool',NULL,NULL,NULL,NULL),(3153,'Ren├â┬⌐ S Kahn',NULL,NULL,NULL,NULL),(3154,'Restuadi Restuadi',NULL,NULL,NULL,NULL),(3155,'Riccardo E Marioni',NULL,NULL,NULL,NULL),(3156,'Richa Saxena',NULL,NULL,NULL,NULL),(3157,'Richard A Belliveau Jr',NULL,NULL,NULL,NULL),(3158,'Richard Grucza',NULL,NULL,NULL,NULL),(3159,'Richard Anney',NULL,NULL,NULL,NULL),(3160,'Richard Banati',NULL,NULL,NULL,NULL),(3161,'Richard Belliveau',NULL,NULL,NULL,NULL),(3162,'Richard Bruggeman',NULL,NULL,NULL,NULL),(3163,'Richard Bryant',NULL,NULL,NULL,NULL),(3164,'Richard Day',NULL,NULL,NULL,NULL),(3165,'Richard Delorme',NULL,NULL,NULL,NULL),(3166,'Richard Fraser',NULL,NULL,NULL,NULL),(3167,'Richard J Rose',NULL,NULL,NULL,NULL),(3168,'Richard M Myers',NULL,NULL,NULL,NULL),(3169,'Richard Morriss',NULL,NULL,NULL,NULL),(3170,'Richard P Ebstein',NULL,NULL,NULL,NULL),(3171,'Richard Parker',NULL,NULL,NULL,NULL),(3172,'Richard Weinshilboum',NULL,NULL,NULL,NULL),(3173,'Rick Jansen',NULL,NULL,NULL,NULL),(3174,'Rick Leventer',NULL,NULL,NULL,NULL),(3175,'Rinku Thapa',NULL,NULL,NULL,NULL),(3176,'Rita Guerreiro',NULL,NULL,NULL,NULL),(3177,'Rita M Cantor',NULL,NULL,NULL,NULL),(3178,'Rita Tavares de Sousa',NULL,NULL,NULL,NULL),(3179,'Rita Z Goldstein',NULL,NULL,NULL,NULL),(3180,'Rob Hester',NULL,NULL,NULL,NULL),(3181,'Robbee Wedow',NULL,NULL,NULL,NULL),(3182,'Robert A Battisti',NULL,NULL,NULL,NULL),(3183,'Robert A Stern',NULL,NULL,NULL,NULL),(3184,'Robert B Weiss',NULL,NULL,NULL,NULL),(3185,'Robert Burrell',NULL,NULL,NULL,NULL),(3186,'Robert D Henderson',NULL,NULL,NULL,NULL),(3187,'Robert F Hillary',NULL,NULL,NULL,NULL),(3188,'Robert Freedman',NULL,NULL,NULL,NULL),(3189,'Robert H Yolken',NULL,NULL,NULL,NULL),(3190,'Robert Handa',NULL,NULL,NULL,NULL),(3191,'Robert Heard',NULL,NULL,NULL,NULL),(3192,'Robert J Harvey',NULL,NULL,NULL,NULL),(3193,'Robert J Ursano',NULL,NULL,NULL,NULL),(3194,'Robert James Blair',NULL,NULL,NULL,NULL),(3195,'Robert Karlsson',NULL,NULL,NULL,NULL),(3196,'Robert M Kirkpatrick',NULL,NULL,NULL,NULL),(3197,'Robert Maier',NULL,NULL,NULL,NULL),(3198,'Robert Penfold',NULL,NULL,NULL,NULL),(3199,'Robert R Graham',NULL,NULL,NULL,NULL),(3200,'Robert Schoevers',NULL,NULL,NULL,NULL),(3201,'Robert Vermeiren',NULL,NULL,NULL,NULL),(3202,'Robert W McCarley',NULL,NULL,NULL,NULL),(3203,'Roberto Goya-Maldonado',NULL,NULL,NULL,NULL),(3204,'Roberto Toro',NULL,NULL,NULL,NULL),(3205,'Robin B├â┬╝low',NULL,NULL,NULL,NULL),(3206,'Robin P Corley',NULL,NULL,NULL,NULL),(3207,'Robyn Langdon',NULL,NULL,NULL,NULL),(3208,'Robyn Norton',NULL,NULL,NULL,NULL),(3209,'Rod McClure',NULL,NULL,NULL,NULL),(3210,'Rodrigo A Bressan',NULL,NULL,NULL,NULL),(3211,'Rodrigo Machado-Vieira',NULL,NULL,NULL,NULL),(3212,'Roger Gurr',NULL,NULL,NULL,NULL),(3213,'Roger Pamphlett',NULL,NULL,NULL,NULL),(3214,'Rolf Adolfsson',NULL,NULL,NULL,NULL),(3215,'Romain Colle',NULL,NULL,NULL,NULL),(3216,'Romalpa Agreements Post-PPSA',NULL,NULL,NULL,NULL),(3217,'Roman Marchant',NULL,NULL,NULL,NULL),(3218,'Rona Macniven',NULL,NULL,NULL,NULL),(3219,'Ronald C Kessler',NULL,NULL,NULL,NULL),(3220,'Ronald Epstein',NULL,NULL,NULL,NULL),(3221,'Ronald R Grunstein',NULL,NULL,NULL,NULL),(3222,'Ronald YL Chen',NULL,NULL,NULL,NULL),(3223,'Ronny Redlich',NULL,NULL,NULL,NULL),(3224,'Rosa Ayesa-Arriola',NULL,NULL,NULL,NULL),(3225,'Rosa Bosch',NULL,NULL,NULL,NULL),(3226,'Rosalind Bonomally',NULL,NULL,NULL,NULL),(3227,'Rosane Nisenbaum',NULL,NULL,NULL,NULL),(3228,'Rosemary Ffrench',NULL,NULL,NULL,NULL),(3229,'Rosie M Walker',NULL,NULL,NULL,NULL),(3230,'Rosie Purcell',NULL,NULL,NULL,NULL),(3231,'Ross Kalucy',NULL,NULL,NULL,NULL),(3232,'Ross Whybin',NULL,NULL,NULL,NULL),(3233,'Roy H Perlis',NULL,NULL,NULL,NULL),(3234,'Roy N Alcalay',NULL,NULL,NULL,NULL),(3235,'Ruben C Gur',NULL,NULL,NULL,NULL),(3236,'Rub├â┬⌐n Fern├â┬índez-Santiago',NULL,NULL,NULL,NULL),(3237,'Rudolf Uher',NULL,NULL,NULL,NULL),(3238,'Ruhrmann Stephan',NULL,NULL,NULL,NULL),(3239,'Rune Jonassen',NULL,NULL,NULL,NULL),(3240,'Russell G Snell',NULL,NULL,NULL,NULL),(3241,'Ruth A Parslow',NULL,NULL,NULL,NULL),(3242,'Ruth JF Loos',NULL,NULL,NULL,NULL),(3243,'Ruth Lovering',NULL,NULL,NULL,NULL),(3244,'Ruth Toppler',NULL,NULL,NULL,NULL),(3245,'Ruth Yung',NULL,NULL,NULL,NULL),(3246,'Ryan Bogdan',NULL,NULL,NULL,NULL),(3247,'Ryan Mace',NULL,NULL,NULL,NULL),(3248,'Ryan Stokes',NULL,NULL,NULL,NULL),(3249,'Ryne Estabrook',NULL,NULL,NULL,NULL),(3250,'Ryota Hashimoto',NULL,NULL,NULL,NULL),(3251,'R├⌐becca Robillard',NULL,NULL,NULL,NULL),(3252,'S Blum',NULL,NULL,NULL,NULL),(3253,'S Bouix',NULL,NULL,NULL,NULL),(3254,'Sven Cichon',NULL,NULL,NULL,NULL),(3255,'Sally Cripps',NULL,NULL,NULL,NULL),(3256,'Simone Cross',NULL,NULL,NULL,NULL),(3257,'S Due',NULL,NULL,NULL,NULL),(3258,'S Duncan',NULL,NULL,NULL,NULL),(3259,'S Graves',NULL,NULL,NULL,NULL),(3260,'S Heistaro',NULL,NULL,NULL,NULL),(3261,'Stefan Herms',NULL,NULL,NULL,NULL),(3262,'Samantha Huntley',NULL,NULL,NULL,NULL),(3263,'S Jan',NULL,NULL,NULL,NULL),(3264,'Suzie Lavoie',NULL,NULL,NULL,NULL),(3265,'Simon Lewis',NULL,NULL,NULL,NULL),(3266,'Susanne Lucae',NULL,NULL,NULL,NULL),(3267,'Stuart MacGregor',NULL,NULL,NULL,NULL),(3268,'S McCarthy-Jones',NULL,NULL,NULL,NULL),(3269,'S McEwen',NULL,NULL,NULL,NULL),(3270,'Sarah Medland',NULL,NULL,NULL,NULL),(3271,'S Moore',NULL,NULL,NULL,NULL),(3272,'S Padmanabhan',NULL,NULL,NULL,NULL),(3273,'Shrujna Patel',NULL,NULL,NULL,NULL),(3274,'S Pates',NULL,NULL,NULL,NULL),(3275,'S Perera',NULL,NULL,NULL,NULL),(3276,'Shanthakumar W Rajaratnam',NULL,NULL,NULL,NULL),(3277,'S Redman',NULL,NULL,NULL,NULL),(3278,'Stephan Ripke',NULL,NULL,NULL,NULL),(3279,'S Sundram',NULL,NULL,NULL,NULL),(3280,'S Tan',NULL,NULL,NULL,NULL),(3281,'Stephen Tang',NULL,NULL,NULL,NULL),(3282,'S T├â┬╕nnesen',NULL,NULL,NULL,NULL),(3283,'Sandra van der Auwera',NULL,NULL,NULL,NULL),(3284,'Swapna Verma',NULL,NULL,NULL,NULL),(3285,'Suzanne Vernon',NULL,NULL,NULL,NULL),(3286,'Suzanne Wiltink',NULL,NULL,NULL,NULL),(3287,'S Youn',NULL,NULL,NULL,NULL),(3288,'Silviu-Alin Bacanu',NULL,NULL,NULL,NULL),(3289,'Sandra A Brown',NULL,NULL,NULL,NULL),(3290,'SA Paciga',NULL,NULL,NULL,NULL),(3291,'SC Gandevia',NULL,NULL,NULL,NULL),(3292,'SE Hall',NULL,NULL,NULL,NULL),(3293,'Steven E Straus',NULL,NULL,NULL,NULL),(3294,'SG Potkin',NULL,NULL,NULL,NULL),(3295,'Sue M Cotton',NULL,NULL,NULL,NULL),(3296,'Sagit Shiran',NULL,NULL,NULL,NULL),(3297,'Saira Saeed Mirza',NULL,NULL,NULL,NULL),(3298,'Salli Veps├â┬ñl├â┬ñinen',NULL,NULL,NULL,NULL),(3299,'Sally Beadle',NULL,NULL,NULL,NULL),(3300,'Sally Galbraith',NULL,NULL,NULL,NULL),(3301,'Sally Sinclair',NULL,NULL,NULL,NULL),(3302,'Salvador Camacho',NULL,NULL,NULL,NULL),(3303,'Salvador Sarr├â┬│',NULL,NULL,NULL,NULL),(3304,'Samuel Bolitho',NULL,NULL,NULL,NULL),(3305,'Samantha Carter',NULL,NULL,NULL,NULL),(3306,'Samantha Fearns',NULL,NULL,NULL,NULL),(3307,'Samantha Hollingworth',NULL,NULL,NULL,NULL),(3308,'Samantha Jane Brooks',NULL,NULL,NULL,NULL),(3309,'Samantha Meltzer-Brody',NULL,NULL,NULL,NULL),(3310,'Samuel B Harvey',NULL,NULL,NULL,NULL),(3311,'Samuel J Hockey',NULL,NULL,NULL,NULL),(3312,'Samuli Ripatti',NULL,NULL,NULL,NULL),(3313,'Sandra C Jones',NULL,NULL,NULL,NULL),(3314,'Sandra Meier',NULL,NULL,NULL,NULL),(3315,'Sandra Sanchez-Roige',NULL,NULL,NULL,NULL),(3316,'Sandy Beynon',NULL,NULL,NULL,NULL),(3317,'Sanjay Shete',NULL,NULL,NULL,NULL),(3318,'Santiago D├â┬¡az-Torres',NULL,NULL,NULL,NULL),(3319,'Sara Bandres-Ciga',NULL,NULL,NULL,NULL),(3320,'Sara Marsal',NULL,NULL,NULL,NULL),(3321,'Sara Mostafavi',NULL,NULL,NULL,NULL),(3322,'Sara Shahrestani',NULL,NULL,NULL,NULL),(3323,'Sarah Bertelsen',NULL,NULL,NULL,NULL),(3324,'Sarah Cohen-Woods',NULL,NULL,NULL,NULL),(3325,'Sarah E Bergen',NULL,NULL,NULL,NULL),(3326,'Sarah E Harris',NULL,NULL,NULL,NULL),(3327,'Sarah E Hetrick',NULL,NULL,NULL,NULL),(3328,'Sarah E Paul',NULL,NULL,NULL,NULL),(3329,'Sarah Piper',NULL,NULL,NULL,NULL),(3330,'Sarah Fares',NULL,NULL,NULL,NULL),(3331,'Sarah Furlong',NULL,NULL,NULL,NULL),(3332,'Sarah Graham',NULL,NULL,NULL,NULL),(3333,'Sarah H Stephens',NULL,NULL,NULL,NULL),(3334,'Sarah Hohmann',NULL,NULL,NULL,NULL),(3335,'Sarah Kittel-Schneider',NULL,NULL,NULL,NULL),(3336,'Sarah M Hartz',NULL,NULL,NULL,NULL),(3337,'Sarah Palmdorf',NULL,NULL,NULL,NULL),(3338,'Sarah Swannell',NULL,NULL,NULL,NULL),(3339,'Sarah Whittle',NULL,NULL,NULL,NULL),(3340,'Sascha B Fischer',NULL,NULL,NULL,NULL),(3341,'Saskia Hagenaars',NULL,NULL,NULL,NULL),(3342,'Satoshi Okazaki',NULL,NULL,NULL,NULL),(3343,'Saud Alhusaini',NULL,NULL,NULL,NULL),(3344,'Scott Crow',NULL,NULL,NULL,NULL),(3345,'Scott Gordon',NULL,NULL,NULL,NULL),(3346,'Scott Fears',NULL,NULL,NULL,NULL),(3347,'Scott Vrieze',NULL,NULL,NULL,NULL),(3348,'Scott W Woods',NULL,NULL,NULL,NULL),(3349,'Sean Ennis',NULL,NULL,NULL,NULL),(3350,'Sean N Hatton',NULL,NULL,NULL,NULL),(3351,'Sean P David',NULL,NULL,NULL,NULL),(3352,'Sebastian E Baumeister',NULL,NULL,NULL,NULL),(3353,'Sebastian Guelfi',NULL,NULL,NULL,NULL),(3354,'Seetal Dodd',NULL,NULL,NULL,NULL),(3355,'Sena Karachanak-Yankova',NULL,NULL,NULL,NULL),(3356,'Seon-Kyeong Jang',NULL,NULL,NULL,NULL),(3357,'Sergey Goryachev',NULL,NULL,NULL,NULL),(3358,'Shahana Ferdousi',NULL,NULL,NULL,NULL),(3359,'Shantel L Duffey',NULL,NULL,NULL,NULL),(3360,'Shantel Leigh Duffy',NULL,NULL,NULL,NULL),(3361,'Shantel Marie Weinsheimer',NULL,NULL,NULL,NULL),(3362,'Sharath Sriram',NULL,NULL,NULL,NULL),(3363,'Sharon Hassin-Baer',NULL,NULL,NULL,NULL),(3364,'Sharon J Mullin',NULL,NULL,NULL,NULL),(3365,'Sharon L Coleman',NULL,NULL,NULL,NULL),(3366,'Sharon Naismith',NULL,NULL,NULL,NULL),(3367,'Sharon L Naismith D Psych(Neuro)',NULL,NULL,NULL,NULL),(3368,'Sharon LR Kardia',NULL,NULL,NULL,NULL),(3369,'Sharon M Lutz',NULL,NULL,NULL,NULL),(3370,'Sharon Medlow',NULL,NULL,NULL,NULL),(3371,'Susie Purcell',NULL,NULL,NULL,NULL),(3372,'Shaunna L Clark',NULL,NULL,NULL,NULL),(3373,'Shawn DX Kong',NULL,NULL,NULL,NULL),(3374,'Shawn N Murphy',NULL,NULL,NULL,NULL),(3375,'Shekhar Saxena',NULL,NULL,NULL,NULL),(3376,'Shelli Avenevoli',NULL,NULL,NULL,NULL),(3377,'Sherilyn Goldstone',NULL,NULL,NULL,NULL),(3378,'Shih-Cheng Liao',NULL,NULL,NULL,NULL),(3379,'Shih-Jen Tsai',NULL,NULL,NULL,NULL),(3380,'Shin Ho Park',NULL,NULL,NULL,NULL),(3381,'Sven J van der Lee',NULL,NULL,NULL,NULL),(3382,'Shing Wan Choi',NULL,NULL,NULL,NULL),(3383,'Shizhong Han',NULL,NULL,NULL,NULL),(3384,'Shona M Francey',NULL,NULL,NULL,NULL),(3385,'Shyuan T Ngo',NULL,NULL,NULL,NULL),(3386,'Sian Caesar',NULL,NULL,NULL,NULL),(3387,'Siegfried Kasper',NULL,NULL,NULL,NULL),(3388,'Silvia Jes├â┬║s',NULL,NULL,NULL,NULL),(3389,'Simon Chapman',NULL,NULL,NULL,NULL),(3390,'Simon Davidson',NULL,NULL,NULL,NULL),(3391,'Simon E Fisher',NULL,NULL,NULL,NULL),(3392,'Simon J Conn',NULL,NULL,NULL,NULL),(3393,'Simon Lovestone',NULL,NULL,NULL,NULL),(3394,'Simon M Laws',NULL,NULL,NULL,NULL),(3395,'Simon Mead',NULL,NULL,NULL,NULL),(3396,'Simon Overland',NULL,NULL,NULL,NULL),(3397,'Simon R Cox',NULL,NULL,NULL,NULL),(3398,'Simon Rice',NULL,NULL,NULL,NULL),(3399,'Simon Schmitt',NULL,NULL,NULL,NULL),(3400,'Simon Wessely',NULL,NULL,NULL,NULL),(3401,'Simone de Jong',NULL,NULL,NULL,NULL),(3402,'Sinead Kelly',NULL,NULL,NULL,NULL),(3403,'Sintia I Belangero',NULL,NULL,NULL,NULL),(3404,'Siow Ann Chong',NULL,NULL,NULL,NULL),(3405,'Slade Matthews',NULL,NULL,NULL,NULL),(3406,'Smita Thatte',NULL,NULL,NULL,NULL),(3407,'Sonia Ambrogi',NULL,NULL,NULL,NULL),(3408,'Sonia Jain',NULL,NULL,NULL,NULL),(3409,'Sonia Sharmin',NULL,NULL,NULL,NULL),(3410,'Sonja March',NULL,NULL,NULL,NULL),(3411,'Sonja W Scholz',NULL,NULL,NULL,NULL),(3412,'Sophia ER Bogaty',NULL,NULL,NULL,NULL),(3413,'Sophia Frangou',NULL,NULL,NULL,NULL),(3414,'Sophia I Thomopoulos',NULL,NULL,NULL,NULL),(3415,'Sophie E Legge',NULL,NULL,NULL,NULL),(3416,'Sophie Maingault',NULL,NULL,NULL,NULL),(3417,'Soraia Teles',NULL,NULL,NULL,NULL),(3418,'Soukayna Bekkali',NULL,NULL,NULL,NULL),(3419,'Srdjan Djurovic',NULL,NULL,NULL,NULL),(3420,'Srihari Gopal',NULL,NULL,NULL,NULL),(3421,'Srijan Sen',NULL,NULL,NULL,NULL),(3422,'Srividya Iyer',NULL,NULL,NULL,NULL),(3423,'Stacey West',NULL,NULL,NULL,NULL),(3424,'Stacy Steinberg',NULL,NULL,NULL,NULL),(3425,'Stanley V Catts',NULL,NULL,NULL,NULL),(3426,'Stanley I Shyn',NULL,NULL,NULL,NULL),(3427,'Stefan Borgwardt',NULL,NULL,NULL,NULL),(3428,'Stefan Ehrlich',NULL,NULL,NULL,NULL),(3429,'Stefan Harrer',NULL,NULL,NULL,NULL),(3430,'Stefan Kloiber',NULL,NULL,NULL,NULL),(3431,'Stefan Kreisel',NULL,NULL,NULL,NULL),(3432,'Stefan Roepke',NULL,NULL,NULL,NULL),(3433,'Stefan Schreiber',NULL,NULL,NULL,NULL),(3434,'Stefan Smesmy',NULL,NULL,NULL,NULL),(3435,'Stefan W├â┬╝st',NULL,NULL,NULL,NULL),(3436,'Stefanie Heilmann-Heimbach',NULL,NULL,NULL,NULL),(3437,'Stefanie J Schmidt',NULL,NULL,NULL,NULL),(3438,'Steffi Riedel-Heller',NULL,NULL,NULL,NULL),(3439,'Stella M Fingas',NULL,NULL,NULL,NULL),(3440,'Stephan Eliez',NULL,NULL,NULL,NULL),(3441,'Stephan Nadolny',NULL,NULL,NULL,NULL),(3442,'Stephan Ruhrmann',NULL,NULL,NULL,NULL),(3443,'Stephan Smesny',NULL,NULL,NULL,NULL),(3444,'Stephane Heritier',NULL,NULL,NULL,NULL),(3445,'Stephanie Godard',NULL,NULL,NULL,NULL),(3446,'Stephanie H Witt',NULL,NULL,NULL,NULL),(3447,'Stephanie Le Hellard',NULL,NULL,NULL,NULL),(3448,'Stephanie Smale',NULL,NULL,NULL,NULL),(3449,'Stephanie Zellers',NULL,NULL,NULL,NULL),(3450,'Stephen J Bunker',NULL,NULL,NULL,NULL),(3451,'Stephen J Glatt',NULL,NULL,NULL,NULL),(3452,'Stephen J Newhouse',NULL,NULL,NULL,NULL),(3453,'Stephen Wood',NULL,NULL,NULL,NULL),(3454,'Stephen Kittner',NULL,NULL,NULL,NULL),(3455,'Stephen M Lawrie',NULL,NULL,NULL,NULL),(3456,'Stephen MacMahon',NULL,NULL,NULL,NULL),(3457,'Stephen Popovich',NULL,NULL,NULL,NULL),(3458,'Stephen V Faraone',NULL,NULL,NULL,NULL),(3459,'Stephen W Scherer',NULL,NULL,NULL,NULL),(3460,'Steve GA van de Weijer',NULL,NULL,NULL,NULL),(3461,'Steve Horvath',NULL,NULL,NULL,NULL),(3462,'Steve Mathias',NULL,NULL,NULL,NULL),(3463,'Steven CR Williams',NULL,NULL,NULL,NULL),(3464,'Steven Crawford',NULL,NULL,NULL,NULL),(3465,'Steven Finkbeiner',NULL,NULL,NULL,NULL),(3466,'Steven Gallinger',NULL,NULL,NULL,NULL),(3467,'Steven H Aggen',NULL,NULL,NULL,NULL),(3468,'Steven JA van der Werff',NULL,NULL,NULL,NULL),(3469,'Steven Lubbe',NULL,NULL,NULL,NULL),(3470,'Steven M Levy',NULL,NULL,NULL,NULL),(3471,'Steven Marwaha',NULL,NULL,NULL,NULL),(3472,'Steven Moylan',NULL,NULL,NULL,NULL),(3473,'Steven P Hamilton',NULL,NULL,NULL,NULL),(3474,'Steven R Bentley',NULL,NULL,NULL,NULL),(3475,'Steven Tahtalian',NULL,NULL,NULL,NULL),(3476,'Stewart L Einfeld',NULL,NULL,NULL,NULL),(3477,'Stuart Fogel',NULL,NULL,NULL,NULL),(3478,'Stuart Montgomery',NULL,NULL,NULL,NULL),(3479,'Stuart Tobet',NULL,NULL,NULL,NULL),(3480,'St├â┬⌐phane Jamain',NULL,NULL,NULL,NULL),(3481,'Subash Raj Susai',NULL,NULL,NULL,NULL),(3482,'Sudha Seshadri',NULL,NULL,NULL,NULL),(3483,'Sudheer Giddaluru',NULL,NULL,NULL,NULL),(3484,'Sue Headley',NULL,NULL,NULL,NULL),(3485,'Sulev Koks',NULL,NULL,NULL,NULL),(3486,'Sumudu Rasangi Mallawaarachchi',NULL,NULL,NULL,NULL),(3487,'Suncica Lah',NULL,NULL,NULL,NULL),(3488,'Sungeun Kim',NULL,NULL,NULL,NULL),(3489,'Susan E Short',NULL,NULL,NULL,NULL),(3490,'Susan JT Branje',NULL,NULL,NULL,NULL),(3491,'Susan L Slager',NULL,NULL,NULL,NULL),(3492,'Susan Mathers',NULL,NULL,NULL,NULL),(3493,'Susan McCurry',NULL,NULL,NULL,NULL),(3494,'Susana Jim├â┬⌐nez-Murcia',NULL,NULL,NULL,NULL),(3495,'Susanne E Churchill',NULL,NULL,NULL,NULL),(3496,'Susanne Erk',NULL,NULL,NULL,NULL),(3497,'Susanne Hoefels',NULL,NULL,NULL,NULL),(3498,'Susanne Meares',NULL,NULL,NULL,NULL),(3499,'Susanne Meinert',NULL,NULL,NULL,NULL),(3500,'Sushmita Shome',NULL,NULL,NULL,NULL),(3501,'Susmita Datta',NULL,NULL,NULL,NULL),(3502,'Susy Harrigan',NULL,NULL,NULL,NULL),(3503,'Suzanne C Swagerman',NULL,NULL,NULL,NULL),(3504,'Suzanne Lesage',NULL,NULL,NULL,NULL),(3505,'Sven Stringer',NULL,NULL,NULL,NULL),(3506,'Svetlana Limborska',NULL,NULL,NULL,NULL),(3507,'Swapnil Awasthi',NULL,NULL,NULL,NULL),(3508,'Swaran Singh',NULL,NULL,NULL,NULL),(3509,'Timothy Bradshaw',NULL,NULL,NULL,NULL),(3510,'T Chalder',NULL,NULL,NULL,NULL),(3511,'Thomas Frodl',NULL,NULL,NULL,NULL),(3512,'T Gill',NULL,NULL,NULL,NULL),(3513,'Tilo Kircher',NULL,NULL,NULL,NULL),(3514,'T Melicher',NULL,NULL,NULL,NULL),(3515,'T Nickson',NULL,NULL,NULL,NULL),(3516,'Tomas Paus',NULL,NULL,NULL,NULL),(3517,'Tracey L Sletten',NULL,NULL,NULL,NULL),(3518,'T Spelman',NULL,NULL,NULL,NULL),(3519,'Tim Usherwood',NULL,NULL,NULL,NULL),(3520,'Timothy B Bigdeli',NULL,NULL,NULL,NULL),(3521,'Theo van Erp',NULL,NULL,NULL,NULL),(3522,'TJ Whitford',NULL,NULL,NULL,NULL),(3523,'TL Laba',NULL,NULL,NULL,NULL),(3524,'Tamara L Wall',NULL,NULL,NULL,NULL),(3525,'Tracy M Air',NULL,NULL,NULL,NULL),(3526,'Tiril P Gurholt',NULL,NULL,NULL,NULL),(3527,'TW Weickert',NULL,NULL,NULL,NULL),(3528,'Talitha C Ford',NULL,NULL,NULL,NULL),(3529,'Tamara De Regt',NULL,NULL,NULL,NULL),(3530,'Tamara L Watson',NULL,NULL,NULL,NULL),(3531,'Tanda Murray',NULL,NULL,NULL,NULL),(3532,'Tania Carrillo-Roa',NULL,NULL,NULL,NULL),(3533,'Tania Cartmill',NULL,NULL,NULL,NULL),(3534,'Tanya Jackson',NULL,NULL,NULL,NULL),(3535,'Tanya M Caldwell',NULL,NULL,NULL,NULL),(3536,'Tao Li',NULL,NULL,NULL,NULL),(3537,'Tatiana M Foroud',NULL,NULL,NULL,NULL),(3538,'Teemu Palviainen',NULL,NULL,NULL,NULL),(3539,'Tellervo Korhonen',NULL,NULL,NULL,NULL),(3540,'Teresa Peri├â┬▒├â┬ín-Tocino',NULL,NULL,NULL,NULL),(3541,'Teresa Senserrick',NULL,NULL,NULL,NULL),(3542,'Terho Lehtim├â┬ñki',NULL,NULL,NULL,NULL),(3543,'Terri H Beaty',NULL,NULL,NULL,NULL),(3544,'Tessa F Blanken',NULL,NULL,NULL,NULL),(3545,'Test Name',NULL,NULL,NULL,NULL),(3546,'Thalia C Eley',NULL,NULL,NULL,NULL),(3547,'Theo Alexander',NULL,NULL,NULL,NULL),(3548,'Theodore D Satterthwaite',NULL,NULL,NULL,NULL),(3549,'Theophilus N Akudjedu',NULL,NULL,NULL,NULL),(3550,'Thomas B Barrett',NULL,NULL,NULL,NULL),(3551,'Thomas Bettecken',NULL,NULL,NULL,NULL),(3552,'Thomas D Als',NULL,NULL,NULL,NULL),(3553,'Thomas D Dyer',NULL,NULL,NULL,NULL),(3554,'Thomas Espeseth',NULL,NULL,NULL,NULL),(3555,'Thomas Hansen',NULL,NULL,NULL,NULL),(3556,'Thomas Foltynie',NULL,NULL,NULL,NULL),(3557,'Thomas G Beach',NULL,NULL,NULL,NULL),(3558,'Thomas G Schulze',NULL,NULL,NULL,NULL),(3559,'Thomas Gasser',NULL,NULL,NULL,NULL),(3560,'Thomas H McGlashan',NULL,NULL,NULL,NULL),(3561,'Thomas Lee Jeffries Jr',NULL,NULL,NULL,NULL),(3562,'Thomas S Kubarych',NULL,NULL,NULL,NULL),(3563,'Thomas Torda',NULL,NULL,NULL,NULL),(3564,'Thomas Werge',NULL,NULL,NULL,NULL),(3565,'Thorarinn Tyrfingsson',NULL,NULL,NULL,NULL),(3566,'Thorgeir Thorgeirsson',NULL,NULL,NULL,NULL),(3567,'Tian Ge',NULL,NULL,NULL,NULL),(3568,'Tian Lin',NULL,NULL,NULL,NULL),(3569,'Toby Wong',NULL,NULL,NULL,NULL),(3570,'Tiffany A Greenwood',NULL,NULL,NULL,NULL),(3571,'Tiffany C Ho',NULL,NULL,NULL,NULL),(3572,'Tiffany M Chaim-Avancini',NULL,NULL,NULL,NULL),(3573,'Tiffany Shubert',NULL,NULL,NULL,NULL),(3574,'Tiina Laatikainen',NULL,NULL,NULL,NULL),(3575,'Till MF Andlauer',NULL,NULL,NULL,NULL),(3576,'Tim Hahn',NULL,NULL,NULL,NULL),(3577,'Tim J Anderson',NULL,NULL,NULL,NULL),(3578,'Tim Outhred',NULL,NULL,NULL,NULL),(3579,'Timothy Tim Shaw',NULL,NULL,NULL,NULL),(3580,'Tim Silk',NULL,NULL,NULL,NULL),(3581,'Tim Spector',NULL,NULL,NULL,NULL),(3582,'Timothy C Bates',NULL,NULL,NULL,NULL),(3583,'Timothy Dinan',NULL,NULL,NULL,NULL),(3584,'Timothy F Chen',NULL,NULL,NULL,NULL),(3585,'Timothy Lambert',NULL,NULL,NULL,NULL),(3586,'Timothy J Trull',NULL,NULL,NULL,NULL),(3587,'Tina M Binz',NULL,NULL,NULL,NULL),(3588,'Tina Meller',NULL,NULL,NULL,NULL),(3589,'Tina Soulis',NULL,NULL,NULL,NULL),(3590,'Tinca JC Polderman',NULL,NULL,NULL,NULL),(3591,'Ting Qi',NULL,NULL,NULL,NULL),(3592,'Tobias Banaschewski',NULL,NULL,NULL,NULL),(3593,'Tobias Freilinger',NULL,NULL,NULL,NULL),(3594,'Tobias Kurth',NULL,NULL,NULL,NULL),(3595,'Todd W Mitchell',NULL,NULL,NULL,NULL),(3596,'Tom Booth',NULL,NULL,NULL,NULL),(3597,'Tomas Hajek',NULL,NULL,NULL,NULL),(3598,'Toni Pitcher',NULL,NULL,NULL,NULL),(3599,'Toni Whistler',NULL,NULL,NULL,NULL),(3600,'Toni-Kim Clarke',NULL,NULL,NULL,NULL),(3601,'Tony Blakely',NULL,NULL,NULL,NULL),(3602,'Tony Foley',NULL,NULL,NULL,NULL),(3603,'Tony KC Ip',NULL,NULL,NULL,NULL),(3604,'Tony M Florio',NULL,NULL,NULL,NULL),(3605,'Tony T Yang',NULL,NULL,NULL,NULL),(3606,'Tonya White',NULL,NULL,NULL,NULL),(3607,'Tooba A Zaidi',NULL,NULL,NULL,NULL),(3608,'Toomas Haller',NULL,NULL,NULL,NULL),(3609,'Torbj├â┬╕rn Elvs├â┬Ñshagen',NULL,NULL,NULL,NULL),(3610,'Torsten Klengel',NULL,NULL,NULL,NULL),(3611,'Tracey Mackle',NULL,NULL,NULL,NULL),(3612,'Tracy Erwin-Grabner',NULL,NULL,NULL,NULL),(3613,'Trevor G Smart',NULL,NULL,NULL,NULL),(3614,'Trevor Kilpatrick',NULL,NULL,NULL,NULL),(3615,'Tristan Gruschka',NULL,NULL,NULL,NULL),(3616,'Tristram A Lett',NULL,NULL,NULL,NULL),(3617,'Trung Thanh Ngo',NULL,NULL,NULL,NULL),(3618,'Tulio Guadalupe',NULL,NULL,NULL,NULL),(3619,'Tune H Pers',NULL,NULL,NULL,NULL),(3620,'Tushar Bangale',NULL,NULL,NULL,NULL),(3621,'Tye Dawood',NULL,NULL,NULL,NULL),(3622,'Tyrone D Cannon',NULL,NULL,NULL,NULL),(3623,'Tzeng Jung-Ying',NULL,NULL,NULL,NULL),(3624,'T├â┬╡nu Esko',NULL,NULL,NULL,NULL),(3625,'U Schall',NULL,NULL,NULL,NULL),(3626,'Udo Dannlowski',NULL,NULL,NULL,NULL),(3627,'Ulla Broms',NULL,NULL,NULL,NULL),(3628,'Ulrike Peters',NULL,NULL,NULL,NULL),(3629,'Unn K Haukvik',NULL,NULL,NULL,NULL),(3630,'Urs Heilbronner',NULL,NULL,NULL,NULL),(3631,'Uta HILLEBRAND',NULL,NULL,NULL,NULL),(3632,'Ut├⌐ Vollmer-Conna',NULL,NULL,NULL,NULL),(3633,'V Ciullo',NULL,NULL,NULL,NULL),(3634,'Vanessa Cropley',NULL,NULL,NULL,NULL),(3635,'V Magnotta',NULL,NULL,NULL,NULL),(3636,'V Michael Jelinek',NULL,NULL,NULL,NULL),(3637,'V Oertel-Kn├â┬╢chel',NULL,NULL,NULL,NULL),(3638,'V Perkovic',NULL,NULL,NULL,NULL),(3639,'Vanesa Richarte',NULL,NULL,NULL,NULL),(3640,'V Toulkidis',NULL,NULL,NULL,NULL),(3641,'Vadim Zipunnikov',NULL,NULL,NULL,NULL),(3642,'Vadim Akhmetzhanov',NULL,NULL,NULL,NULL),(3643,'Vahram Haroutunian',NULL,NULL,NULL,NULL),(3644,'Vaidutis Kucinskas',NULL,NULL,NULL,NULL),(3645,'Valentina Escott-Price',NULL,NULL,NULL,NULL),(3646,'Valeria Orr├â┬╣',NULL,NULL,NULL,NULL),(3647,'Valerie A Rendle',NULL,NULL,NULL,NULL),(3648,'Valgerdur Runarsdottir',NULL,NULL,NULL,NULL),(3649,'Vanessa F Gon├â┬ºalves',NULL,NULL,NULL,NULL),(3650,'Vanessa Hus',NULL,NULL,NULL,NULL),(3651,'Vanessa K Ota',NULL,NULL,NULL,NULL),(3652,'Vanessa Wan Sze Cheng',NULL,NULL,NULL,NULL),(3653,'Vassily Trubetskoy',NULL,NULL,NULL,NULL),(3654,'Vasuki Prabaharan',NULL,NULL,NULL,NULL),(3655,'Vaughan J Carr',NULL,NULL,NULL,NULL),(3656,'Veikko Salomaa',NULL,NULL,NULL,NULL),(3657,'Vera Golimbet',NULL,NULL,NULL,NULL),(3658,'Verena Enneking',NULL,NULL,NULL,NULL),(3659,'Verneri Antilla',NULL,NULL,NULL,NULL),(3660,'Verneri Anttila',NULL,NULL,NULL,NULL),(3661,'Vernon S Pankratz',NULL,NULL,NULL,NULL),(3662,'Veronica Vatiliotis',NULL,NULL,NULL,NULL),(3663,'Vicki A Johnson',NULL,NULL,NULL,NULL),(3664,'Vicki Gibbs',NULL,NULL,NULL,NULL),(3665,'Victor Hesselbrock',NULL,NULL,NULL,NULL),(3666,'Victor M Castro',NULL,NULL,NULL,NULL),(3667,'Victoria Alvarez',NULL,NULL,NULL,NULL),(3668,'Victoria L Stevens',NULL,NULL,NULL,NULL),(3669,'Victoria O\'Callaghan',NULL,NULL,NULL,NULL),(3670,'Victoria S O├éΓÇÖCallaghan',NULL,NULL,NULL,NULL),(3671,'Victoria S Marshe',NULL,NULL,NULL,NULL),(3672,'Vilas Sawrikar',NULL,NULL,NULL,NULL),(3673,'Ville Artto',NULL,NULL,NULL,NULL),(3674,'Vince D Calhoun',NULL,NULL,NULL,NULL),(3675,'Vincent Chouraki',NULL,NULL,NULL,NULL),(3676,'Vincent Frouin',NULL,NULL,NULL,NULL),(3677,'Vincent P Clark',NULL,NULL,NULL,NULL),(3678,'Vincent Pedergnana',NULL,NULL,NULL,NULL),(3679,'Viorica Chelban',NULL,NULL,NULL,NULL),(3680,'Virginia Winter',NULL,NULL,NULL,NULL),(3681,'Vivek Appadurai',NULL,NULL,NULL,NULL),(3682,'Vivian S Gainer',NULL,NULL,NULL,NULL),(3683,'Viviana Wuthrich',NULL,NULL,NULL,NULL),(3684,'Vivianna M Van Deerlin',NULL,NULL,NULL,NULL),(3685,'Vivien Bubb',NULL,NULL,NULL,NULL),(3686,'Vivien Holmes',NULL,NULL,NULL,NULL),(3687,'Vivienne Browne',NULL,NULL,NULL,NULL),(3688,'Vivienne Miller',NULL,NULL,NULL,NULL),(3689,'Volker Arolt',NULL,NULL,NULL,NULL),(3690,'Vollmer-Conna Ut├â┬⌐',NULL,NULL,NULL,NULL),(3691,'Vsevolod Rozanov',NULL,NULL,NULL,NULL),(3692,'W Heindel',NULL,NULL,NULL,NULL),(3693,'W Phoon',NULL,NULL,NULL,NULL),(3694,'WJ Niessen',NULL,NULL,NULL,NULL),(3695,'WJ Ryder',NULL,NULL,NULL,NULL),(3696,'Wade H Berrettini',NULL,NULL,NULL,NULL),(3697,'Walter A Kukull',NULL,NULL,NULL,NULL),(3698,'Walter H Kaye',NULL,NULL,NULL,NULL),(3699,'Walter Haindl',NULL,NULL,NULL,NULL),(3700,'Warren Burgess',NULL,NULL,NULL,NULL),(3701,'Warren W Kretzschmar',NULL,NULL,NULL,NULL),(3702,'Warrick J Brewer',NULL,NULL,NULL,NULL),(3703,'Warwick Blood',NULL,NULL,NULL,NULL),(3704,'Wayne Hall',NULL,NULL,NULL,NULL),(3705,'Wayne W Poon',NULL,NULL,NULL,NULL),(3706,'Wei Cheng',NULL,NULL,NULL,NULL),(3707,'Wei Guo',NULL,NULL,NULL,NULL),(3708,'Wei J Chen',NULL,NULL,NULL,NULL),(3709,'Wei Wen',NULL,NULL,NULL,NULL),(3710,'Wei Zhao',NULL,NULL,NULL,NULL),(3711,'Wei Zhou',NULL,NULL,NULL,NULL),(3712,'Weihua Guan',NULL,NULL,NULL,NULL),(3713,'Wendy A Brown',NULL,NULL,NULL,NULL),(3714,'Wendy A Longley',NULL,NULL,NULL,NULL),(3715,'Wendy L Newbury',NULL,NULL,NULL,NULL),(3716,'Wendy Orlay',NULL,NULL,NULL,NULL),(3717,'Wesley Thompson',NULL,NULL,NULL,NULL),(3718,'Wiepke Cahn',NULL,NULL,NULL,NULL),(3719,'Willem A Nolen',NULL,NULL,NULL,NULL),(3720,'William A Scheftner',NULL,NULL,NULL,NULL),(3721,'William B Lawson',NULL,NULL,NULL,NULL),(3722,'William E Bunney',NULL,NULL,NULL,NULL),(3723,'William C Reeves',NULL,NULL,NULL,NULL),(3724,'William Campos',NULL,NULL,NULL,NULL),(3725,'William Capon',NULL,NULL,NULL,NULL),(3726,'William H Coryell',NULL,NULL,NULL,NULL),(3727,'William Dunsmuir',NULL,NULL,NULL,NULL),(3728,'William E Copeland',NULL,NULL,NULL,NULL),(3729,'William F Byerley',NULL,NULL,NULL,NULL),(3730,'William G Iacono',NULL,NULL,NULL,NULL),(3731,'William H Roughan',NULL,NULL,NULL,NULL),(3732,'William Mansbach',NULL,NULL,NULL,NULL),(3733,'William S Kremen',NULL,NULL,NULL,NULL),(3734,'William S Montgomery',NULL,NULL,NULL,NULL),(3735,'William Wheeler',NULL,NULL,NULL,NULL),(3736,'Wim HJ Meeus',NULL,NULL,NULL,NULL),(3737,'Witte J Hoogendijk',NULL,NULL,NULL,NULL),(3738,'Wolfgang Maier',NULL,NULL,NULL,NULL),(3739,'Wolfgang Wurst',NULL,NULL,NULL,NULL),(3740,'Working group of the Royal Australasian College of Physicians',NULL,NULL,NULL,NULL),(3741,'Wouter J Peyrot',NULL,NULL,NULL,NULL),(3742,'Wouter Van Rheenen',NULL,NULL,NULL,NULL),(3743,'Xavier Caseras',NULL,NULL,NULL,NULL),(3744,'Xi-Nian Zuo',NULL,NULL,NULL,NULL),(3745,'Xiangning Chen',NULL,NULL,NULL,NULL),(3746,'Xiangrui Meng',NULL,NULL,NULL,NULL),(3747,'Xiao Chang',NULL,NULL,NULL,NULL),(3748,'Xiaowei Zhan',NULL,NULL,NULL,NULL),(3749,'Xiaoxiao Liu',NULL,NULL,NULL,NULL),(3750,'Xin Tan',NULL,NULL,NULL,NULL),(3751,'Xu Feng Huang',NULL,NULL,NULL,NULL),(3752,'Xue Hua',NULL,NULL,NULL,NULL),(3753,'Xueyi Shen',NULL,NULL,NULL,NULL),(3754,'Xylena Reed',NULL,NULL,NULL,NULL),(3755,'Yuri Milaneschi',NULL,NULL,NULL,NULL),(3756,'Y Tan',NULL,NULL,NULL,NULL),(3757,'Yan Jin',NULL,NULL,NULL,NULL),(3758,'Yanni Zeng',NULL,NULL,NULL,NULL),(3759,'Yannik Terhorst',NULL,NULL,NULL,NULL),(3760,'Yannis Paloyelis',NULL,NULL,NULL,NULL),(3761,'Yara J Toenders',NULL,NULL,NULL,NULL),(3762,'Yaroslau Compta',NULL,NULL,NULL,NULL),(3763,'Ye Rong',NULL,NULL,NULL,NULL),(3764,'Yeda Wu',NULL,NULL,NULL,NULL),(3765,'Yi Lu',NULL,NULL,NULL,NULL),(3766,'Yi-Ling Chou',NULL,NULL,NULL,NULL),(3767,'Yun Li',NULL,NULL,NULL,NULL),(3768,'Yiping Chen',NULL,NULL,NULL,NULL),(3769,'Yiran Guo',NULL,NULL,NULL,NULL),(3770,'Yoichiro Kamatani',NULL,NULL,NULL,NULL),(3771,'Yolanda Vives-Gilabert',NULL,NULL,NULL,NULL),(3772,'Younghun Han',NULL,NULL,NULL,NULL),(3773,'Youth Studies Australia',NULL,NULL,NULL,NULL),(3774,'Yu Fang',NULL,NULL,NULL,NULL),(3775,'Yunxuan Jiang',NULL,NULL,NULL,NULL),(3776,'Yu-Hsuan Chuang',NULL,NULL,NULL,NULL),(3777,'Yu-Li Liu',NULL,NULL,NULL,NULL),(3778,'Yueh Ling',NULL,NULL,NULL,NULL),(3779,'Yueqin Huang',NULL,NULL,NULL,NULL),(3780,'Yukinori Okada',NULL,NULL,NULL,NULL),(3781,'Yun Zhang',NULL,NULL,NULL,NULL),(3782,'Yunjung Kim',NULL,NULL,NULL,NULL),(3783,'Yunpeng Wang',NULL,NULL,NULL,NULL),(3784,'Yuqi Cheng',NULL,NULL,NULL,NULL),(3785,'Z Kikinis',NULL,NULL,NULL,NULL),(3786,'Zolt├â┬ín Kutalik',NULL,NULL,NULL,NULL),(3787,'Zo├½ Terpening',NULL,NULL,NULL,NULL),(3788,'Z Wang',NULL,NULL,NULL,NULL),(3789,'Z Xie',NULL,NULL,NULL,NULL),(3790,'Z Zhu',NULL,NULL,NULL,NULL),(3791,'Zahava Ambarchi',NULL,NULL,NULL,NULL),(3792,'Zdenka Pausova',NULL,NULL,NULL,NULL),(3793,'Zeynep Ba┼ƒg├╢ze',NULL,NULL,NULL,NULL),(3794,'Zeynep Yilmaz',NULL,NULL,NULL,NULL),(3795,'Zhengming Chen',NULL,NULL,NULL,NULL),(3796,'Zhi Wei',NULL,NULL,NULL,NULL),(3797,'Zhi Yang',NULL,NULL,NULL,NULL),(3798,'Zhili Zheng',NULL,NULL,NULL,NULL),(3799,'Zhongming Zhao',NULL,NULL,NULL,NULL),(3800,'Zita Ausrele Kucinskiene',NULL,NULL,NULL,NULL),(3801,'Ziv Gan-Or',NULL,NULL,NULL,NULL),(3802,'Zoe AM Griffin',NULL,NULL,NULL,NULL),(3803,'Zoltan Sarnyai',NULL,NULL,NULL,NULL),(3804,'et AJ Guastella',NULL,NULL,NULL,NULL),(3805,'├â╦£rjan Bergmann',NULL,NULL,NULL,NULL),(3806,'Anne Smith',NULL,NULL,NULL,NULL),(3807,'Yue Li',NULL,NULL,NULL,NULL),(3808,'Yihan Li',NULL,NULL,NULL,NULL),(3809,'Amanda G Smith',NULL,NULL,NULL,NULL),(3810,'Jeong Lee',NULL,NULL,NULL,NULL),(3811,'Jianping He',NULL,NULL,NULL,NULL),(3812,'Jianghong Li',NULL,NULL,NULL,NULL),(3813,'Jonathon Pye',NULL,NULL,NULL,NULL),(3814,'Larry J Young',NULL,NULL,NULL,NULL),(3815,'Meng Li',NULL,NULL,NULL,NULL),(3816,'Renick Lee',NULL,NULL,NULL,NULL),(3817,'Rachael Lee',NULL,NULL,NULL,NULL),(3818,'Scott R Clark',NULL,NULL,NULL,NULL),(3819,'Shinduk Lee',NULL,NULL,NULL,NULL),(3820,'Sang Hong Lee',NULL,NULL,NULL,NULL),(3821,'Alice Mason',NULL,NULL,NULL,NULL),(3822,'Alison Smith',NULL,NULL,NULL,NULL),(3823,'Alison Wilson',NULL,NULL,NULL,NULL),(3824,'Andrew Jones',NULL,NULL,NULL,NULL),(3825,'Daniel J Smith',NULL,NULL,NULL,NULL),(3826,'James J Lee',NULL,NULL,NULL,NULL),(3827,'John P Beilby',NULL,NULL,NULL,NULL),(3828,'Albert Hofman',NULL,NULL,NULL,NULL),(3829,'Charlotte A Marshall',NULL,NULL,NULL,NULL),(3830,'Chia-Yen Chen',NULL,NULL,NULL,NULL),(3831,'Hailiang Huang',NULL,NULL,NULL,NULL),(3832,'Kathleen M Griffiths',NULL,NULL,NULL,NULL),(3833,'Matthew A Harris',NULL,NULL,NULL,NULL),(3834,'Shane PM Cross',NULL,NULL,NULL,NULL),(3835,'Yu-Ching Cheng',NULL,NULL,NULL,NULL),(3836,'James G Scott',NULL,NULL,NULL,NULL),(3837,'Aditya Singh',NULL,NULL,NULL,NULL),(3838,'Alan N Simmons',NULL,NULL,NULL,NULL),(3839,'Brenda Walker',NULL,NULL,NULL,NULL),(3840,'Braxton D Mitchell',NULL,NULL,NULL,NULL),(3841,'Chu Chen',NULL,NULL,NULL,NULL),(3842,'Chloe E Wilson',NULL,NULL,NULL,NULL),(3843,'Emma Johnson',NULL,NULL,NULL,NULL),(3844,'Gail Davies',NULL,NULL,NULL,NULL),(3845,'Jingchun Chen',NULL,NULL,NULL,NULL),(3846,'Kerry Schnell',NULL,NULL,NULL,NULL),(3847,'Laura M Thornton',NULL,NULL,NULL,NULL),(3848,'Li-Shiun Chen',NULL,NULL,NULL,NULL),(3849,'Margaret Jane Wright',NULL,NULL,NULL,NULL),(3850,'Matt Bennett Paradise',NULL,NULL,NULL,NULL),(3851,'Nicholas Bass',NULL,NULL,NULL,NULL),(3852,'Nicholas G Martin',NULL,NULL,NULL,NULL),(3853,'Qiang Li',NULL,NULL,NULL,NULL),(3854,'Raymond Walters',NULL,NULL,NULL,NULL),(3855,'Raquel E Gur',NULL,NULL,NULL,NULL),(3856,'Shaun M Purcell',NULL,NULL,NULL,NULL),(3857,'Tien Y Wong',NULL,NULL,NULL,NULL),(3858,'Yang Wu',NULL,NULL,NULL,NULL),(3890,'Cathy Mason',NULL,NULL,NULL,NULL),(3891,'Dale S Cannon',NULL,NULL,NULL,NULL),(3892,'Helen Margaret Christensen',NULL,NULL,NULL,NULL),(3893,'Jianbin Zhang',NULL,NULL,NULL,NULL),(3894,'John Quinn',NULL,NULL,NULL,NULL),(3895,'Marie Thompson',NULL,NULL,NULL,NULL),(3896,'Shantha MW Rajaratnam',NULL,NULL,NULL,NULL),(3897,'Sarah Baumeister',NULL,NULL,NULL,NULL),(3898,'Tim JR Lambert',NULL,NULL,NULL,NULL),(3899,'Ying Wang',NULL,NULL,NULL,NULL),(3900,'Yang Wang',NULL,NULL,NULL,NULL),(3901,'A Fels',NULL,NULL,NULL,NULL),(3902,'L Fitzpatrick',NULL,NULL,NULL,NULL),(3903,'L Engel',NULL,NULL,NULL,NULL),(3904,'C Klinner',NULL,NULL,NULL,NULL),(3905,'L Acland',NULL,NULL,NULL,NULL),(3906,'B Goodger',NULL,NULL,NULL,NULL),(3907,'C.X Sandler',NULL,NULL,NULL,NULL),(3908,'M.J Song',NULL,NULL,NULL,NULL),(3909,'N.J Sasson',NULL,NULL,NULL,NULL),(3910,'M Barnett',NULL,NULL,NULL,NULL),(3911,'S.W Cain',NULL,NULL,NULL,NULL),(3912,'M Montazerolghaem',NULL,NULL,NULL,NULL),(3914,'K.O Schubert',NULL,NULL,NULL,NULL),(3915,'L Hou',NULL,NULL,NULL,NULL),(3916,'S Papiol',NULL,NULL,NULL,NULL),(3917,'F Tekola-Ayele',NULL,NULL,NULL,NULL),(3918,'Y.-H Hsu',NULL,NULL,NULL,NULL),(3919,'T Shekhtman',NULL,NULL,NULL,NULL),(3920,'M Adli',NULL,NULL,NULL,NULL),(3921,'N Akula',NULL,NULL,NULL,NULL),(3922,'K Akiyama',NULL,NULL,NULL,NULL),(3923,'R Ardau',NULL,NULL,NULL,NULL),(3924,'B Arias',NULL,NULL,NULL,NULL),(3925,'J.-M Aubry',NULL,NULL,NULL,NULL),(3926,'A.K Bhattacharjee',NULL,NULL,NULL,NULL),(3927,'A Benabarre',NULL,NULL,NULL,NULL),(3928,'S Bengesser',NULL,NULL,NULL,NULL),(3929,'A Birner',NULL,NULL,NULL,NULL),(3930,'C Brichant-Petitjean',NULL,NULL,NULL,NULL),(3931,'C Chillotti',NULL,NULL,NULL,NULL),(3932,'N Dalkner',NULL,NULL,NULL,NULL),(5831,'A.T Amare',NULL,NULL,NULL,NULL),(5832,'A Dayer',NULL,NULL,NULL,NULL),(5833,'M Del Zompo',NULL,NULL,NULL,NULL),(5834,'P Falkai',NULL,NULL,NULL,NULL),(5835,'L Frisen',NULL,NULL,NULL,NULL),(5836,'S Gard',NULL,NULL,NULL,NULL),(5837,'P Grof',NULL,NULL,NULL,NULL),(5838,'A Hofmann',NULL,NULL,NULL,NULL),(5839,'E Jim├⌐nez',NULL,NULL,NULL,NULL),(5840,'J.-P Kahn',NULL,NULL,NULL,NULL),(5841,'L Kassem',NULL,NULL,NULL,NULL),(5842,'T Kato',NULL,NULL,NULL,NULL),(5843,'S Kliwicki',NULL,NULL,NULL,NULL),(5844,'B K├╢nig',NULL,NULL,NULL,NULL),(5845,'I Kusumi',NULL,NULL,NULL,NULL),(5846,'S.G Leckband',NULL,NULL,NULL,NULL),(5847,'A Tortorella',NULL,NULL,NULL,NULL),(5848,'M Manchia',NULL,NULL,NULL,NULL),(5849,'L Martinsson',NULL,NULL,NULL,NULL),(5850,'M.J McCarthy',NULL,NULL,NULL,NULL),(5851,'S.L McElroy',NULL,NULL,NULL,NULL),(5852,'M Mitjans',NULL,NULL,NULL,NULL),(5853,'P Monteleone',NULL,NULL,NULL,NULL),(5854,'C.M Nievergelt',NULL,NULL,NULL,NULL),(5855,'M.M N├╢then',NULL,NULL,NULL,NULL),(5856,'T Nov├ík',NULL,NULL,NULL,NULL),(5857,'C OΓÇÖDonovan',NULL,NULL,NULL,NULL),(5858,'N Ozaki',NULL,NULL,NULL,NULL),(5859,'U ├ûsby',NULL,NULL,NULL,NULL),(5860,'A Pfennig',NULL,NULL,NULL,NULL),(5861,'M B├ªkvad-Hansen',NULL,NULL,NULL,NULL),(5862,'H.N Buttensch├╕n',NULL,NULL,NULL,NULL),(5863,'P.F OΓÇÖReilly',NULL,NULL,NULL,NULL),(5864,'C.B Pedersen',NULL,NULL,NULL,NULL),(5865,'M.G Pedersen',NULL,NULL,NULL,NULL),(5866,'E Domenici',NULL,NULL,NULL,NULL),(5867,NULL,NULL,NULL,NULL,NULL),(5868,'C Schaefer',NULL,NULL,NULL,NULL),(5869,'A.D B├╕rglum',NULL,NULL,NULL,NULL),(5870,'E Reininghaus',NULL,NULL,NULL,NULL),(5871,'G.A Rouleau',NULL,NULL,NULL,NULL),(5872,'J.K Rybakowski',NULL,NULL,NULL,NULL),(5873,'M Schalling',NULL,NULL,NULL,NULL),(5874,'B.W Schweizer',NULL,NULL,NULL,NULL),(5875,'G Severino',NULL,NULL,NULL,NULL),(5876,'P.D Shilling',NULL,NULL,NULL,NULL),(5877,'K Shimoda',NULL,NULL,NULL,NULL),(5878,'C Simhandl',NULL,NULL,NULL,NULL),(5879,'C.M Slaney',NULL,NULL,NULL,NULL),(5880,'A Squassina',NULL,NULL,NULL,NULL),(5881,'T Stamm',NULL,NULL,NULL,NULL),(5882,'P Stopkova',NULL,NULL,NULL,NULL),(5883,'M Maj',NULL,NULL,NULL,NULL),(5884,'J Veeh',NULL,NULL,NULL,NULL),(5885,'A Wright',NULL,NULL,NULL,NULL),(5886,'P.P Zandi',NULL,NULL,NULL,NULL),(5887,'F.J McMahon',NULL,NULL,NULL,NULL),(5888,'M.J Gonz├ílez',NULL,NULL,NULL,NULL),(5889,'S Gil Flores',NULL,NULL,NULL,NULL),(5890,'F.J Cabaleiro Fabeiro',NULL,NULL,NULL,NULL),(5891,'F del R├¡o Noriega',NULL,NULL,NULL,NULL),(5892,'F.P Perez',NULL,NULL,NULL,NULL),(5893,'J Haro Gonz├ílez',NULL,NULL,NULL,NULL),(5894,'G Orozco Diaz',NULL,NULL,NULL,NULL),(5895,'Y de Diego-Otero',NULL,NULL,NULL,NULL),(5896,'B Moreno-K├╝stner',NULL,NULL,NULL,NULL),(5897,'G Auburger',NULL,NULL,NULL,NULL),(5898,'E B├╕en',NULL,NULL,NULL,NULL),(5899,'T Elvs├Ñshagen',NULL,NULL,NULL,NULL),(5900,'A Jur├⌐us',NULL,NULL,NULL,NULL),(5901,'M Leber',NULL,NULL,NULL,NULL),(5902,'S.E Levy',NULL,NULL,NULL,NULL),(5903,'A Maaser',NULL,NULL,NULL,NULL),(5904,'P.B Mahon',NULL,NULL,NULL,NULL),(5905,'S McCarroll',NULL,NULL,NULL,NULL),(5906,'M.G McInnis',NULL,NULL,NULL,NULL),(5907,'J.D McKay',NULL,NULL,NULL,NULL),(5908,'H Medeiros',NULL,NULL,NULL,NULL),(5909,'F Meng',NULL,NULL,NULL,NULL),(5910,'D.W Morris',NULL,NULL,NULL,NULL),(5911,'T.W M├╝hleisen',NULL,NULL,NULL,NULL),(5912,'H Nguyen',NULL,NULL,NULL,NULL),(5913,'E.A Nwulia',NULL,NULL,NULL,NULL),(5914,'L.M.O Loohuis',NULL,NULL,NULL,NULL),(5915,'A.P.S Ori',NULL,NULL,NULL,NULL),(5916,'L Oruc',NULL,NULL,NULL,NULL),(5917,'A Perry',NULL,NULL,NULL,NULL),(5918,'E.J Regeer',NULL,NULL,NULL,NULL),(5919,'C.S Reinbold',NULL,NULL,NULL,NULL),(5920,'A.L Richards',NULL,NULL,NULL,NULL),(5921,'F Rivas',NULL,NULL,NULL,NULL),(5922,'P Roussos',NULL,NULL,NULL,NULL),(5923,'D.M Ruderfer',NULL,NULL,NULL,NULL),(5924,'C S├ínchez-Mora',NULL,NULL,NULL,NULL),(5925,'A.F Schatzberg',NULL,NULL,NULL,NULL),(5926,'N.J Schork',NULL,NULL,NULL,NULL),(5927,'T Shehktman',NULL,NULL,NULL,NULL),(5928,'O.B Smeland',NULL,NULL,NULL,NULL),(5929,'J.L Sobell',NULL,NULL,NULL,NULL),(5930,'A.T Spijker',NULL,NULL,NULL,NULL),(5931,'J.S Strauss',NULL,NULL,NULL,NULL),(5932,'S Szelinger',NULL,NULL,NULL,NULL),(5933,'R.C Thompson',NULL,NULL,NULL,NULL),(5934,'T EThorgeirsson',NULL,NULL,NULL,NULL),(5935,'H Vedde',NULL,NULL,NULL,NULL),(5936,'W Wang',NULL,NULL,NULL,NULL),(5937,'S.J Watson',NULL,NULL,NULL,NULL),(5938,'S Xi',NULL,NULL,NULL,NULL),(5939,'W Xu',NULL,NULL,NULL,NULL),(5940,'A.H Young',NULL,NULL,NULL,NULL),(5941,'P Zhang',NULL,NULL,NULL,NULL),(5942,'S Zollner',NULL,NULL,NULL,NULL),(5943,'G Kirov',NULL,NULL,NULL,NULL),(5944,'J Lissowska',NULL,NULL,NULL,NULL),(5945,'F Mayoral',NULL,NULL,NULL,NULL),(5946,'I Melle',NULL,NULL,NULL,NULL),(5947,'V Nimgaonkar',NULL,NULL,NULL,NULL),(5948,'K.J Oedegaard',NULL,NULL,NULL,NULL),(5949,'C Pato',NULL,NULL,NULL,NULL),(5950,'M.T Pato',NULL,NULL,NULL,NULL),(5951,'M Ribas├⌐s',NULL,NULL,NULL,NULL),(5952,'E Stordal',NULL,NULL,NULL,NULL),(5953,'A.E Vaaler',NULL,NULL,NULL,NULL),(5954,'J.B Vincent',NULL,NULL,NULL,NULL),(5955,'J.I Nurnberger',NULL,NULL,NULL,NULL),(5956,'A.D Florio',NULL,NULL,NULL,NULL),(5957,'R.A Ophoff',NULL,NULL,NULL,NULL),(5958,'J Kraft Hill',NULL,NULL,NULL,NULL),(5959,'L.K.M Han',NULL,NULL,NULL,NULL),(5960,'R Dinga',NULL,NULL,NULL,NULL),(5961,'L.T Eyler',NULL,NULL,NULL,NULL),(5962,'F.L.S Duran',NULL,NULL,NULL,NULL),(5963,'S Frenzel',NULL,NULL,NULL,NULL),(5964,'C.H.Y Fu',NULL,NULL,NULL,NULL),(5965,'C K├ñhler',NULL,NULL,NULL,NULL),(5966,'B Kr├ñmer',NULL,NULL,NULL,NULL),(5967,'P.G S├ñmann',NULL,NULL,NULL,NULL),(5968,'J Sommer',NULL,NULL,NULL,NULL),(5969,'O Steinstr├ñter',NULL,NULL,NULL,NULL),(5970,'V Zannias',NULL,NULL,NULL,NULL),(5971,'C Ab├⌐',NULL,NULL,NULL,NULL),(5972,'C.M Bonnin',NULL,NULL,NULL,NULL),(5973,'E.J Canales-Rodriguez',NULL,NULL,NULL,NULL),(5974,'P Favre',NULL,NULL,NULL,NULL),(5975,'S.F Foley',NULL,NULL,NULL,NULL),(5976,'J.M Goikolea',NULL,NULL,NULL,NULL),(5977,'B.C.M Haarman',NULL,NULL,NULL,NULL),(5978,'J Houenou',NULL,NULL,NULL,NULL),(5979,'M Ingvar',NULL,NULL,NULL,NULL),(5980,'R Kuplicki',NULL,NULL,NULL,NULL),(5981,'B Lafer',NULL,NULL,NULL,NULL),(5982,'U.F Malt',NULL,NULL,NULL,NULL),(5983,'L Nabulsi',NULL,NULL,NULL,NULL),(5984,'M.C.G Otaduy',NULL,NULL,NULL,NULL),(5985,'M Polosan',NULL,NULL,NULL,NULL),(5986,'M.M Rive',NULL,NULL,NULL,NULL),(5987,'H.G Ruhe',NULL,NULL,NULL,NULL),(5988,'S Sarr├│',NULL,NULL,NULL,NULL),(5989,'J Savitz',NULL,NULL,NULL,NULL),(5990,'A.H Schene',NULL,NULL,NULL,NULL),(5991,'M.G Soeiro-de-Souza',NULL,NULL,NULL,NULL),(5992,'A.N Sutherland',NULL,NULL,NULL,NULL),(5993,'G.M Timmons',NULL,NULL,NULL,NULL),(5994,'D.H Wolf',NULL,NULL,NULL,NULL),(5995,'M.V Zanetti',NULL,NULL,NULL,NULL),(5996,'A.F Marquand',NULL,NULL,NULL,NULL),(5997,'B OΓÇÖDonoghue',NULL,NULL,NULL,NULL),(5998,'D Z├╢ller',NULL,NULL,NULL,NULL),(5999,'M Armondo',NULL,NULL,NULL,NULL),(6000,'M.R Sch├ñffer',NULL,NULL,NULL,NULL),(6001,'A Tong',NULL,NULL,NULL,NULL),(6002,'T.C Sorrell',NULL,NULL,NULL,NULL),(6003,'A.J Black',NULL,NULL,NULL,NULL),(6004,'C Caillaud',NULL,NULL,NULL,NULL),(6005,'W Chrzanowski',NULL,NULL,NULL,NULL),(6006,'E Li',NULL,NULL,NULL,NULL),(6007,'D Martinez-Martin',NULL,NULL,NULL,NULL),(6008,'A McEwan',NULL,NULL,NULL,NULL),(6009,'R Wang',NULL,NULL,NULL,NULL),(6010,'A Motion',NULL,NULL,NULL,NULL),(6011,'A.C Bedoya',NULL,NULL,NULL,NULL),(6012,'L Azizi',NULL,NULL,NULL,NULL),(6013,'B.J Eggleton',NULL,NULL,NULL,NULL),(6014,'S Al-Horani',NULL,NULL,NULL,NULL),(6015,'T Andersen',NULL,NULL,NULL,NULL),(6016,'R Aggett',NULL,NULL,NULL,NULL),(6017,'A Baillie',NULL,NULL,NULL,NULL),(6018,'A Barratt',NULL,NULL,NULL,NULL),(6019,'C Boehm',NULL,NULL,NULL,NULL),(6020,'P Britton',NULL,NULL,NULL,NULL),(6021,'M Burger',NULL,NULL,NULL,NULL),(6022,'S Chadban',NULL,NULL,NULL,NULL),(6023,'N.S Chandrashekar',NULL,NULL,NULL,NULL),(6024,'C Chow',NULL,NULL,NULL,NULL),(6025,'G Clerc',NULL,NULL,NULL,NULL),(6026,'C Douglas',NULL,NULL,NULL,NULL),(6027,'S Fleming',NULL,NULL,NULL,NULL),(6028,'G Fox',NULL,NULL,NULL,NULL),(6029,'N Gilroy',NULL,NULL,NULL,NULL),(6030,'L Gordon',NULL,NULL,NULL,NULL),(6031,'N Haskins',NULL,NULL,NULL,NULL),(6032,'A Ho-Baillie',NULL,NULL,NULL,NULL),(6033,'M Howell',NULL,NULL,NULL,NULL),(6034,'N Hunt',NULL,NULL,NULL,NULL),(6035,'O Hutchings',NULL,NULL,NULL,NULL),(6036,'J Iredell',NULL,NULL,NULL,NULL),(6037,'G Jennings',NULL,NULL,NULL,NULL),(6038,'C Jin',NULL,NULL,NULL,NULL),(6039,'K Kairaitis',NULL,NULL,NULL,NULL),(6040,'O Kavehei',NULL,NULL,NULL,NULL),(6041,'P Kennedy',NULL,NULL,NULL,NULL),(6042,'P Kilham',NULL,NULL,NULL,NULL),(6043,'L Kritharides',NULL,NULL,NULL,NULL),(6044,'B Kwan',NULL,NULL,NULL,NULL),(6045,'S Leon-Saval',NULL,NULL,NULL,NULL),(6046,'R Lindley',NULL,NULL,NULL,NULL),(6047,'D Lynch',NULL,NULL,NULL,NULL),(6048,'S Maguire',NULL,NULL,NULL,NULL),(6049,'A McCluskey',NULL,NULL,NULL,NULL),(6050,'N McKay',NULL,NULL,NULL,NULL),(6051,'G Mifsud',NULL,NULL,NULL,NULL),(6052,'J Morgans',NULL,NULL,NULL,NULL),(6053,'S Palomba',NULL,NULL,NULL,NULL),(6054,'A Pettigrew',NULL,NULL,NULL,NULL),(6055,'S Postnova',NULL,NULL,NULL,NULL),(6056,'J Prinable',NULL,NULL,NULL,NULL),(6057,'C Quinlan',NULL,NULL,NULL,NULL),(6058,'J Rabeau',NULL,NULL,NULL,NULL),(6059,'K Richmond',NULL,NULL,NULL,NULL),(6060,'D Rothstein',NULL,NULL,NULL,NULL),(6061,'R Savoie',NULL,NULL,NULL,NULL),(6062,'N Scholes-Robertson',NULL,NULL,NULL,NULL),(6063,'I Seppelt',NULL,NULL,NULL,NULL),(6064,'V Sintchenko',NULL,NULL,NULL,NULL),(6065,'T Snelling',NULL,NULL,NULL,NULL),(6066,'A Teixeira-Pinto',NULL,NULL,NULL,NULL),(6067,'E Tovey',NULL,NULL,NULL,NULL),(6068,'A Tuniz',NULL,NULL,NULL,NULL),(6069,'P Varamini',NULL,NULL,NULL,NULL),(6070,'K Varshney',NULL,NULL,NULL,NULL),(6071,'A.P Wang',NULL,NULL,NULL,NULL),(6072,'K Wang',NULL,NULL,NULL,NULL),(6073,'S Wise',NULL,NULL,NULL,NULL),(6074,'A Witherden',NULL,NULL,NULL,NULL),(6075,'B Wright',NULL,NULL,NULL,NULL),(6076,'W Yeung',NULL,NULL,NULL,NULL),(6077,'H. Zoellner',NULL,NULL,NULL,NULL),(6078,'A.C.C Alarc├│n',NULL,NULL,NULL,NULL),(6079,'K F├╢rster',NULL,NULL,NULL,NULL),(6080,'D ├ûng├╝r',NULL,NULL,NULL,NULL),(6081,'J Sinclair',NULL,NULL,NULL,NULL),(6083,'C O\'Donovan',NULL,NULL,NULL,NULL),(6084,'H Vedder',NULL,NULL,NULL,NULL),(6085,'K.A.S Davis',NULL,NULL,NULL,NULL),(6086,'C Rayner',NULL,NULL,NULL,NULL),(6087,'C H├╝bel',NULL,NULL,NULL,NULL),(6088,'C Kan',NULL,NULL,NULL,NULL),(6089,'D.M Lyall',NULL,NULL,NULL,NULL),(6090,'K.W Choi',NULL,NULL,NULL,NULL),(6091,'E Vassos',NULL,NULL,NULL,NULL),(6092,'A Danese',NULL,NULL,NULL,NULL),(6093,'B Maughan',NULL,NULL,NULL,NULL),(6094,'M Hotopf',NULL,NULL,NULL,NULL),(6095,'L Fachal',NULL,NULL,NULL,NULL),(6096,'H Aschard',NULL,NULL,NULL,NULL),(6097,'J Beesley',NULL,NULL,NULL,NULL),(6098,'D.R Barnes',NULL,NULL,NULL,NULL),(6099,'J Allen',NULL,NULL,NULL,NULL),(6100,'S Kar',NULL,NULL,NULL,NULL),(6101,'K.A Pooley',NULL,NULL,NULL,NULL),(6102,'J Dennis',NULL,NULL,NULL,NULL),(6103,'K Michailidou',NULL,NULL,NULL,NULL),(6104,'P Soucy',NULL,NULL,NULL,NULL),(6105,'A Lema├ºon',NULL,NULL,NULL,NULL),(6106,'M Lush',NULL,NULL,NULL,NULL),(6107,'J.P Tyrer',NULL,NULL,NULL,NULL),(6108,'M Ghoussaini',NULL,NULL,NULL,NULL),(6109,'M.M Marjaneh',NULL,NULL,NULL,NULL),(6110,'X Jiang',NULL,NULL,NULL,NULL),(6111,'S Agata',NULL,NULL,NULL,NULL),(6112,'K Aittom├ñki',NULL,NULL,NULL,NULL),(6113,'M.R Alonso',NULL,NULL,NULL,NULL),(6114,'I.L Andrulis',NULL,NULL,NULL,NULL),(6115,'H Anton-Culver',NULL,NULL,NULL,NULL),(6116,'N.N Antonenkova',NULL,NULL,NULL,NULL),(6117,'A Arason',NULL,NULL,NULL,NULL),(6118,'V Arndt',NULL,NULL,NULL,NULL),(6119,'K.J Aronson',NULL,NULL,NULL,NULL),(6120,'B.K Arun',NULL,NULL,NULL,NULL),(6121,'B Auber',NULL,NULL,NULL,NULL),(6122,'P.L Auer',NULL,NULL,NULL,NULL),(6123,'J Azzollini',NULL,NULL,NULL,NULL),(6124,'J Balma├▒a',NULL,NULL,NULL,NULL),(6125,'R.B Barkardottir',NULL,NULL,NULL,NULL),(6126,'D Barrowdale',NULL,NULL,NULL,NULL),(6127,'A Beeghly-Fadiel',NULL,NULL,NULL,NULL),(6128,'J Benitez',NULL,NULL,NULL,NULL),(6129,'M Bermisheva',NULL,NULL,NULL,NULL),(6130,'K Bialkowska',NULL,NULL,NULL,NULL),(6131,'A.M Blanco',NULL,NULL,NULL,NULL),(6132,'C Blomqvist',NULL,NULL,NULL,NULL),(6133,'W Blot',NULL,NULL,NULL,NULL),(6134,'N.V Bogdanova',NULL,NULL,NULL,NULL),(6135,'S.E Bojesen',NULL,NULL,NULL,NULL),(6136,'M.K Bolla',NULL,NULL,NULL,NULL),(6137,'B Bonanni',NULL,NULL,NULL,NULL),(6138,'A Borg',NULL,NULL,NULL,NULL),(6139,'K Bosse',NULL,NULL,NULL,NULL),(6140,'H Brauch',NULL,NULL,NULL,NULL),(6141,'H Brenner',NULL,NULL,NULL,NULL),(6142,'I Briceno',NULL,NULL,NULL,NULL),(6143,'I.W Brock',NULL,NULL,NULL,NULL),(6144,'A Brooks-Wilson',NULL,NULL,NULL,NULL),(6145,'T Br├╝ning',NULL,NULL,NULL,NULL),(6146,'B Burwinkel',NULL,NULL,NULL,NULL),(6147,'S.S Buys',NULL,NULL,NULL,NULL),(6148,'Q Cai',NULL,NULL,NULL,NULL),(6149,'T Cald├⌐s',NULL,NULL,NULL,NULL),(6150,'M.A Caligo',NULL,NULL,NULL,NULL),(6151,'N.J Camp',NULL,NULL,NULL,NULL),(6152,'I Campbell',NULL,NULL,NULL,NULL),(6153,'F Canzian',NULL,NULL,NULL,NULL),(6154,'J.S Carroll',NULL,NULL,NULL,NULL),(6155,'B.D Carter',NULL,NULL,NULL,NULL),(6156,'J.E Castelao',NULL,NULL,NULL,NULL),(6157,'J Chiquette',NULL,NULL,NULL,NULL),(6158,'H Christiansen',NULL,NULL,NULL,NULL),(6159,'W.K Chung',NULL,NULL,NULL,NULL),(6160,'K.B.M Claes',NULL,NULL,NULL,NULL),(6161,'V Mari',NULL,NULL,NULL,NULL),(6162,'P Berthet',NULL,NULL,NULL,NULL),(6163,'L Castera',NULL,NULL,NULL,NULL),(6164,'D Vaur',NULL,NULL,NULL,NULL),(6165,'H Lallaoui',NULL,NULL,NULL,NULL),(6166,'Y.-J Bignon',NULL,NULL,NULL,NULL),(6167,'N Uhrhammer',NULL,NULL,NULL,NULL),(6168,'V Bonadona',NULL,NULL,NULL,NULL),(6169,'C Lasset',NULL,NULL,NULL,NULL),(6170,'F R├⌐villion',NULL,NULL,NULL,NULL),(6171,'P Vennin',NULL,NULL,NULL,NULL),(6172,'D Muller',NULL,NULL,NULL,NULL),(6173,'D.M Gomes',NULL,NULL,NULL,NULL),(6174,'O Ingster',NULL,NULL,NULL,NULL),(6175,'I Coupier',NULL,NULL,NULL,NULL),(6176,'P Pujol',NULL,NULL,NULL,NULL),(6177,'M.-A Collonge-Rame',NULL,NULL,NULL,NULL),(6178,'I Mortemousque',NULL,NULL,NULL,NULL),(6179,'O Bera',NULL,NULL,NULL,NULL),(6180,'A Baurand',NULL,NULL,NULL,NULL),(6181,'G Bertolone',NULL,NULL,NULL,NULL),(6182,'L Faivre',NULL,NULL,NULL,NULL),(6183,'H Dreyfus',NULL,NULL,NULL,NULL),(6184,'D Leroux',NULL,NULL,NULL,NULL),(6185,'L Venat-Bouvet',NULL,NULL,NULL,NULL),(6186,'S B├⌐zieau',NULL,NULL,NULL,NULL),(6187,'C Delnatte',NULL,NULL,NULL,NULL),(6188,'J Chiesa',NULL,NULL,NULL,NULL),(6189,'B Gilbert-Dussardier',NULL,NULL,NULL,NULL),(6190,'P Gesta',NULL,NULL,NULL,NULL),(6191,'F.P Prieur',NULL,NULL,NULL,NULL),(6192,'M Bronner',NULL,NULL,NULL,NULL),(6193,'J Sokolowska',NULL,NULL,NULL,NULL),(6194,'F Coulet',NULL,NULL,NULL,NULL),(6195,'N Boutry-Kryza',NULL,NULL,NULL,NULL),(6196,'A Calender',NULL,NULL,NULL,NULL),(6197,'S Giraud',NULL,NULL,NULL,NULL),(6198,'M Leone',NULL,NULL,NULL,NULL),(6199,'S Fert-Ferrer',NULL,NULL,NULL,NULL),(6200,'D Stoppa-Lyonnet',NULL,NULL,NULL,NULL),(6201,'Y Jiao',NULL,NULL,NULL,NULL),(6202,'F.L Lesueur',NULL,NULL,NULL,NULL),(6203,'N Mebirouk',NULL,NULL,NULL,NULL),(6204,'E Barouk-Simonet',NULL,NULL,NULL,NULL),(6205,'V Bubien',NULL,NULL,NULL,NULL),(6206,'M Longy',NULL,NULL,NULL,NULL),(6207,'N Sevenet',NULL,NULL,NULL,NULL),(6208,'L Gladieff',NULL,NULL,NULL,NULL),(6209,'C Toulas',NULL,NULL,NULL,NULL),(6210,'A Reimineras',NULL,NULL,NULL,NULL),(6211,'H Sobol',NULL,NULL,NULL,NULL),(6212,'B.B.-D Paillerets',NULL,NULL,NULL,NULL),(6213,'O Cabaret',NULL,NULL,NULL,NULL),(6214,'O Caron',NULL,NULL,NULL,NULL),(6215,'M Guillaud-Bataille',NULL,NULL,NULL,NULL),(6216,'E Rouleau',NULL,NULL,NULL,NULL),(6217,'M Belotti',NULL,NULL,NULL,NULL),(6218,'B Buecher',NULL,NULL,NULL,NULL),(6219,'S Caputo',NULL,NULL,NULL,NULL),(6220,'C Colas',NULL,NULL,NULL,NULL),(6221,'A.D Pauw',NULL,NULL,NULL,NULL),(6222,'E Fourme',NULL,NULL,NULL,NULL),(6223,'M Gauthier-Villars',NULL,NULL,NULL,NULL),(6224,'L Golmard',NULL,NULL,NULL,NULL),(6225,'V Moncoutier',NULL,NULL,NULL,NULL),(6226,'C Saule',NULL,NULL,NULL,NULL),(6227,'A Donaldson',NULL,NULL,NULL,NULL),(6228,'A Brady',NULL,NULL,NULL,NULL),(6229,'C Brewer',NULL,NULL,NULL,NULL),(6230,'C Pottinger',NULL,NULL,NULL,NULL),(6231,'C Miller',NULL,NULL,NULL,NULL),(6232,'D Gallagher',NULL,NULL,NULL,NULL),(6233,'H Gregory',NULL,NULL,NULL,NULL),(6234,'J Cook',NULL,NULL,NULL,NULL),(6235,'J Eason',NULL,NULL,NULL,NULL),(6236,'J Adlard',NULL,NULL,NULL,NULL),(6237,'J Barwell',NULL,NULL,NULL,NULL),(6238,'K.-R Ong',NULL,NULL,NULL,NULL),(6239,'K Snape',NULL,NULL,NULL,NULL),(6240,'L Walker',NULL,NULL,NULL,NULL),(6241,'L Izatt',NULL,NULL,NULL,NULL),(6242,'L Side',NULL,NULL,NULL,NULL),(6243,'M Tischkowitz',NULL,NULL,NULL,NULL),(6244,'M.T Rogers',NULL,NULL,NULL,NULL),(6245,'M Ahmed',NULL,NULL,NULL,NULL),(6246,'P.J Morrison',NULL,NULL,NULL,NULL),(6247,'P Brennan',NULL,NULL,NULL,NULL),(6248,'R Eeles',NULL,NULL,NULL,NULL),(6249,'R Davidson',NULL,NULL,NULL,NULL),(6250,'J.M Coll├⌐e',NULL,NULL,NULL,NULL),(6251,'S Cornelissen',NULL,NULL,NULL,NULL),(6252,'F.J Couch',NULL,NULL,NULL,NULL),(6253,'A Cox',NULL,NULL,NULL,NULL),(6254,'C Cybulski',NULL,NULL,NULL,NULL),(6255,'K Czene',NULL,NULL,NULL,NULL),(6256,'M.B Daly',NULL,NULL,NULL,NULL),(6257,'M de la Hoya',NULL,NULL,NULL,NULL),(6258,'P Devilee',NULL,NULL,NULL,NULL),(6259,'O Diez',NULL,NULL,NULL,NULL),(6260,'Y.C Ding',NULL,NULL,NULL,NULL),(6261,'G.S Dite',NULL,NULL,NULL,NULL),(6262,'S.M Domchek',NULL,NULL,NULL,NULL),(6263,'T D├╢rk',NULL,NULL,NULL,NULL),(6264,'I dos-Santos-Silva',NULL,NULL,NULL,NULL),(6265,'A Droit',NULL,NULL,NULL,NULL),(6266,'S Dubois',NULL,NULL,NULL,NULL),(6267,'M Dumont',NULL,NULL,NULL,NULL),(6268,'L Durcan',NULL,NULL,NULL,NULL),(6269,'M Dwek',NULL,NULL,NULL,NULL),(6270,'D.M Eccles',NULL,NULL,NULL,NULL),(6271,'C Engel',NULL,NULL,NULL,NULL),(6272,'M Eriksson',NULL,NULL,NULL,NULL),(6273,'D.G Evans',NULL,NULL,NULL,NULL),(6274,'P.A Fasching',NULL,NULL,NULL,NULL),(6275,'O Fletcher',NULL,NULL,NULL,NULL),(6276,'G Floris',NULL,NULL,NULL,NULL),(6277,'H Flyger',NULL,NULL,NULL,NULL),(6278,'L Foretova',NULL,NULL,NULL,NULL),(6279,'W.D Foulkes',NULL,NULL,NULL,NULL),(6280,'E Friedman',NULL,NULL,NULL,NULL),(6281,'L Fritschi',NULL,NULL,NULL,NULL),(6282,'D Frost',NULL,NULL,NULL,NULL),(6283,'M Gabrielson',NULL,NULL,NULL,NULL),(6284,'M Gago-Dominguez',NULL,NULL,NULL,NULL),(6285,'G Gambino',NULL,NULL,NULL,NULL),(6286,'P.A Ganz',NULL,NULL,NULL,NULL),(6287,'S.M Gapstur',NULL,NULL,NULL,NULL),(6288,'J Garber',NULL,NULL,NULL,NULL),(6289,'J.A Garc├¡a-S├íenz',NULL,NULL,NULL,NULL),(6290,'M.M Gaudet',NULL,NULL,NULL,NULL),(6291,'V Georgoulias',NULL,NULL,NULL,NULL),(6292,'G.G Giles',NULL,NULL,NULL,NULL),(6293,'G Glendon',NULL,NULL,NULL,NULL),(6294,'A.K Godwin',NULL,NULL,NULL,NULL),(6295,'M.S Goldberg',NULL,NULL,NULL,NULL),(6296,'D.E Goldgar',NULL,NULL,NULL,NULL),(6297,'A Gonz├ílez-Neira',NULL,NULL,NULL,NULL),(6298,'M.G Tibiletti',NULL,NULL,NULL,NULL),(6299,'M.H Greene',NULL,NULL,NULL,NULL),(6300,'M Grip',NULL,NULL,NULL,NULL),(6301,'J Gronwald',NULL,NULL,NULL,NULL),(6302,'A Grundy',NULL,NULL,NULL,NULL),(6303,'P Gu├⌐nel',NULL,NULL,NULL,NULL),(6304,'E Hahnen',NULL,NULL,NULL,NULL),(6305,'C.A Haiman',NULL,NULL,NULL,NULL),(6306,'N H├Ñkansson',NULL,NULL,NULL,NULL),(6307,'P Hall',NULL,NULL,NULL,NULL),(6308,'U Hamann',NULL,NULL,NULL,NULL),(6309,'P.A Harrington',NULL,NULL,NULL,NULL),(6310,'J.M Hartikainen',NULL,NULL,NULL,NULL),(6311,'M Hartman',NULL,NULL,NULL,NULL),(6312,'W He',NULL,NULL,NULL,NULL),(6313,'C.S Healey',NULL,NULL,NULL,NULL),(6314,'B.A.M Heemskerk-Gerritsen',NULL,NULL,NULL,NULL),(6315,'J Heyworth',NULL,NULL,NULL,NULL),(6316,'P Hillemanns',NULL,NULL,NULL,NULL),(6317,'F.B.L Hogervorst',NULL,NULL,NULL,NULL),(6318,'A Hollestelle',NULL,NULL,NULL,NULL),(6319,'M.J Hooning',NULL,NULL,NULL,NULL),(6320,'J.L Hopper',NULL,NULL,NULL,NULL),(6321,'A Howell',NULL,NULL,NULL,NULL),(6322,'G Huang',NULL,NULL,NULL,NULL),(6323,'P.J Hulick',NULL,NULL,NULL,NULL),(6324,'E.N Imyanitov',NULL,NULL,NULL,NULL),(6325,'A Sexton',NULL,NULL,NULL,NULL),(6326,'A Christian',NULL,NULL,NULL,NULL),(6327,'A Trainer',NULL,NULL,NULL,NULL),(6328,'A Spigelman',NULL,NULL,NULL,NULL),(6329,'A Fellows',NULL,NULL,NULL,NULL),(6330,'A Shelling',NULL,NULL,NULL,NULL),(6331,'A.D Fazio',NULL,NULL,NULL,NULL),(6332,'A Blackburn',NULL,NULL,NULL,NULL),(6333,'A Crook',NULL,NULL,NULL,NULL),(6334,'B Patterson',NULL,NULL,NULL,NULL),(6335,'C Saunders',NULL,NULL,NULL,NULL),(6336,'C Hunt',NULL,NULL,NULL,NULL),(6337,'C Scott',NULL,NULL,NULL,NULL),(6338,'D Amor',NULL,NULL,NULL,NULL),(6339,'D Marsh',NULL,NULL,NULL,NULL),(6340,'E Edkins',NULL,NULL,NULL,NULL),(6341,'E Salisbury',NULL,NULL,NULL,NULL),(6342,'E Haan',NULL,NULL,NULL,NULL),(6343,'E Neidermayr',NULL,NULL,NULL,NULL),(6344,'F Macrea',NULL,NULL,NULL,NULL),(6345,'G Farshid',NULL,NULL,NULL,NULL),(6346,'G Lindeman',NULL,NULL,NULL,NULL),(6347,'G Trench',NULL,NULL,NULL,NULL),(6348,'G Mann',NULL,NULL,NULL,NULL),(6349,'G Gill',NULL,NULL,NULL,NULL),(6350,'H Thorne',NULL,NULL,NULL,NULL),(6351,'I Winship',NULL,NULL,NULL,NULL),(6352,'J Flanagan',NULL,NULL,NULL,NULL),(6353,'J Kollias',NULL,NULL,NULL,NULL),(6354,'J Visvader',NULL,NULL,NULL,NULL),(6355,'J Stone',NULL,NULL,NULL,NULL),(6356,'J Burke',NULL,NULL,NULL,NULL),(6357,'J Saunus',NULL,NULL,NULL,NULL),(6358,'J Forbes',NULL,NULL,NULL,NULL),(6359,'J Kirk',NULL,NULL,NULL,NULL),(6360,'K Wu',NULL,NULL,NULL,NULL),(6361,'K Phillips',NULL,NULL,NULL,NULL),(6362,'L Lipton',NULL,NULL,NULL,NULL),(6363,'L Andrews',NULL,NULL,NULL,NULL),(6364,'L Lobb',NULL,NULL,NULL,NULL),(6365,'M Kentwell',NULL,NULL,NULL,NULL),(6366,'M Spurdle',NULL,NULL,NULL,NULL),(6367,'M Cummings',NULL,NULL,NULL,NULL),(6368,'M Gleeson',NULL,NULL,NULL,NULL),(6369,'M Jenkins',NULL,NULL,NULL,NULL),(6370,'M.A Young',NULL,NULL,NULL,NULL),(6371,'M Delatycki',NULL,NULL,NULL,NULL),(6372,'M Wallis',NULL,NULL,NULL,NULL),(6373,'M Burgess',NULL,NULL,NULL,NULL),(6374,'M.C Southey',NULL,NULL,NULL,NULL),(6375,'M Bogwitz',NULL,NULL,NULL,NULL),(6376,'M Field',NULL,NULL,NULL,NULL),(6377,'M Gattas',NULL,NULL,NULL,NULL),(6378,'M Saleh',NULL,NULL,NULL,NULL),(6379,'N Hayward',NULL,NULL,NULL,NULL),(6380,'N Pachter',NULL,NULL,NULL,NULL),(6381,'P Cohen',NULL,NULL,NULL,NULL),(6382,'P Duijf',NULL,NULL,NULL,NULL),(6383,'P.A James',NULL,NULL,NULL,NULL),(6384,'P Simpson',NULL,NULL,NULL,NULL),(6385,'P Fong',NULL,NULL,NULL,NULL),(6386,'R Williams',NULL,NULL,NULL,NULL),(6387,'R Kefford',NULL,NULL,NULL,NULL),(6388,'R.L Milne',NULL,NULL,NULL,NULL),(6389,'R Balleine',NULL,NULL,NULL,NULL),(6390,'S.ΓÇôJ Dawson',NULL,NULL,NULL,NULL),(6391,'S Lok',NULL,NULL,NULL,NULL),(6392,'S OΓÇÖConnell',NULL,NULL,NULL,NULL),(6393,'S Greening',NULL,NULL,NULL,NULL),(6394,'S Nightingale',NULL,NULL,NULL,NULL),(6395,'S.L Edwards',NULL,NULL,NULL,NULL),(6396,'S Fox',NULL,NULL,NULL,NULL),(6397,'S.-A McLachlan',NULL,NULL,NULL,NULL),(6398,'S Lakhani',NULL,NULL,NULL,NULL),(6399,'Y Antill',NULL,NULL,NULL,NULL),(6400,'C Aalfs',NULL,NULL,NULL,NULL),(6401,'H Meijers-Heijboer',NULL,NULL,NULL,NULL),(6402,'K van Engelen',NULL,NULL,NULL,NULL),(6403,'H Gille',NULL,NULL,NULL,NULL),(6404,'I Boere',NULL,NULL,NULL,NULL),(6405,'M Coll├⌐e',NULL,NULL,NULL,NULL),(6406,'C van Deurzen',NULL,NULL,NULL,NULL),(6407,'I.-M Obdeijn',NULL,NULL,NULL,NULL),(6408,'A van den Ouweland',NULL,NULL,NULL,NULL),(6409,'C.M Seynaeve',NULL,NULL,NULL,NULL),(6410,'S Siesling',NULL,NULL,NULL,NULL),(6411,'J Verloop',NULL,NULL,NULL,NULL),(6412,'C.J van Asperen',NULL,NULL,NULL,NULL),(6413,'T van Cronenburg',NULL,NULL,NULL,NULL),(6414,'R Blok',NULL,NULL,NULL,NULL),(6415,'M de Boer',NULL,NULL,NULL,NULL),(6416,'E.G Garcia',NULL,NULL,NULL,NULL),(6417,'M Adank',NULL,NULL,NULL,NULL),(6418,'D Jenner',NULL,NULL,NULL,NULL),(6419,'F van Leeuwen',NULL,NULL,NULL,NULL),(6420,'M Rookus',NULL,NULL,NULL,NULL),(6421,'N Russell',NULL,NULL,NULL,NULL),(6422,'S van den Belt-Dusebout',NULL,NULL,NULL,NULL),(6423,'C Kets',NULL,NULL,NULL,NULL),(6424,'A Mensenkamp',NULL,NULL,NULL,NULL),(6425,'T de Bock',NULL,NULL,NULL,NULL),(6426,'A van der Hout',NULL,NULL,NULL,NULL),(6427,'M Mourits',NULL,NULL,NULL,NULL),(6428,'J Oosterwijk',NULL,NULL,NULL,NULL),(6429,'M Ausems',NULL,NULL,NULL,NULL),(6430,'M Koudijs',NULL,NULL,NULL,NULL),(6431,'R Baxter',NULL,NULL,NULL,NULL),(6432,'D Yip',NULL,NULL,NULL,NULL),(6433,'A Davis',NULL,NULL,NULL,NULL),(6434,'N Pathmanathan',NULL,NULL,NULL,NULL),(6435,'D Graham',NULL,NULL,NULL,NULL),(6436,'M Sachchithananthan',NULL,NULL,NULL,NULL),(6437,'C Isaacs',NULL,NULL,NULL,NULL),(6438,'M Iwasaki',NULL,NULL,NULL,NULL),(6439,'A Jager',NULL,NULL,NULL,NULL),(6440,'M Jakimovska',NULL,NULL,NULL,NULL),(6441,'A Jakubowska',NULL,NULL,NULL,NULL),(6442,'R Janavicius',NULL,NULL,NULL,NULL),(6443,'R.C Jankowitz',NULL,NULL,NULL,NULL),(6444,'E.M John',NULL,NULL,NULL,NULL),(6445,'M.E Jones',NULL,NULL,NULL,NULL),(6446,'A Jukkola-Vuorinen',NULL,NULL,NULL,NULL),(6447,'A Jung',NULL,NULL,NULL,NULL),(6448,'R Kaaks',NULL,NULL,NULL,NULL),(6449,'D Kang',NULL,NULL,NULL,NULL),(6450,'P.M Kapoor',NULL,NULL,NULL,NULL),(6451,'B.Y Karlan',NULL,NULL,NULL,NULL),(6452,'R Keeman',NULL,NULL,NULL,NULL),(6453,'M.J Kerin',NULL,NULL,NULL,NULL),(6454,'E Khusnutdinova',NULL,NULL,NULL,NULL),(6455,'J.I Kiiski',NULL,NULL,NULL,NULL),(6456,'C.M Kitahara',NULL,NULL,NULL,NULL),(6457,'Y.-D Ko',NULL,NULL,NULL,NULL),(6458,'I Konstantopoulou',NULL,NULL,NULL,NULL),(6459,'V.-M Kosma',NULL,NULL,NULL,NULL),(6460,'S Koutros',NULL,NULL,NULL,NULL),(6461,'K Kubelka-Sabit',NULL,NULL,NULL,NULL),(6462,'A Kwong',NULL,NULL,NULL,NULL),(6463,'K Kyriacou',NULL,NULL,NULL,NULL),(6464,'Y Laitman',NULL,NULL,NULL,NULL),(6465,'D Lambrechts',NULL,NULL,NULL,NULL),(6466,'G Leslie',NULL,NULL,NULL,NULL),(6467,'J Lester',NULL,NULL,NULL,NULL),(6468,'A Lindblom',NULL,NULL,NULL,NULL),(6469,'W.-Y Lo',NULL,NULL,NULL,NULL),(6470,'J Long',NULL,NULL,NULL,NULL),(6471,'A Lophatananon',NULL,NULL,NULL,NULL),(6472,'J.T Loud',NULL,NULL,NULL,NULL),(6473,'R.J MacInnis',NULL,NULL,NULL,NULL),(6474,'T Maishman',NULL,NULL,NULL,NULL),(6475,'E Makalic',NULL,NULL,NULL,NULL),(6476,'A Mannermaa',NULL,NULL,NULL,NULL),(6477,'M Manoochehri',NULL,NULL,NULL,NULL),(6478,'S Manoukian',NULL,NULL,NULL,NULL),(6479,'S Margolin',NULL,NULL,NULL,NULL),(6480,'K Matsuo',NULL,NULL,NULL,NULL),(6481,'T Maurer',NULL,NULL,NULL,NULL),(6482,'D Mavroudis',NULL,NULL,NULL,NULL),(6483,'R Mayes',NULL,NULL,NULL,NULL),(6484,'L McGuffog',NULL,NULL,NULL,NULL),(6485,'C McLean',NULL,NULL,NULL,NULL),(6486,'A Meindl',NULL,NULL,NULL,NULL),(6487,'N Miller',NULL,NULL,NULL,NULL),(6488,'M Montagna',NULL,NULL,NULL,NULL),(6489,'F Moreno',NULL,NULL,NULL,NULL),(6490,'K Muir',NULL,NULL,NULL,NULL),(6491,'A.M Mulligan',NULL,NULL,NULL,NULL),(6492,'V.M Mu├▒oz-Garzon',NULL,NULL,NULL,NULL),(6493,'T.A Muranen',NULL,NULL,NULL,NULL),(6494,'S.A Narod',NULL,NULL,NULL,NULL),(6495,'R Nassir',NULL,NULL,NULL,NULL),(6496,'K.L Nathanson',NULL,NULL,NULL,NULL),(6497,'S.L Neuhausen',NULL,NULL,NULL,NULL),(6498,'H Nevanlinna',NULL,NULL,NULL,NULL),(6499,'P Neven',NULL,NULL,NULL,NULL),(6500,'F.C Nielsen',NULL,NULL,NULL,NULL),(6501,'L Nikitina-Zake',NULL,NULL,NULL,NULL),(6502,'A Norman',NULL,NULL,NULL,NULL),(6503,'K Offit',NULL,NULL,NULL,NULL),(6504,'E Olah',NULL,NULL,NULL,NULL),(6505,'O.I Olopade',NULL,NULL,NULL,NULL),(6506,'H Olsson',NULL,NULL,NULL,NULL),(6507,'N Orr',NULL,NULL,NULL,NULL),(6508,'A Osorio',NULL,NULL,NULL,NULL),(6509,'J Papp',NULL,NULL,NULL,NULL),(6510,'T.-W Park-Simon',NULL,NULL,NULL,NULL),(6511,'M.T Parsons',NULL,NULL,NULL,NULL),(6512,'J Paul',NULL,NULL,NULL,NULL),(6513,'I.S Pedersen',NULL,NULL,NULL,NULL),(6514,'B Peissel',NULL,NULL,NULL,NULL),(6515,'B Peshkin',NULL,NULL,NULL,NULL),(6516,'P Peterlongo',NULL,NULL,NULL,NULL),(6517,'J Peto',NULL,NULL,NULL,NULL),(6518,'D Plaseska-Karanfilska',NULL,NULL,NULL,NULL),(6519,'K Prajzendanc',NULL,NULL,NULL,NULL),(6520,'R Prentice',NULL,NULL,NULL,NULL),(6521,'N Presneau',NULL,NULL,NULL,NULL),(6522,'D Prokofyeva',NULL,NULL,NULL,NULL),(6523,'M.A Pujana',NULL,NULL,NULL,NULL),(6524,'K Pylk├ñs',NULL,NULL,NULL,NULL),(6525,'P Radice',NULL,NULL,NULL,NULL),(6526,'S.J Ramus',NULL,NULL,NULL,NULL),(6527,'J Rantala',NULL,NULL,NULL,NULL),(6528,'R Rau-Murthy',NULL,NULL,NULL,NULL),(6529,'G Rennert',NULL,NULL,NULL,NULL),(6530,'H.A Risch',NULL,NULL,NULL,NULL),(6531,'M Robson',NULL,NULL,NULL,NULL),(6532,'A Romero',NULL,NULL,NULL,NULL),(6533,'M Rossing',NULL,NULL,NULL,NULL),(6534,'E Saloustros',NULL,NULL,NULL,NULL),(6535,'E S├ínchez-Herrero',NULL,NULL,NULL,NULL),(6536,'D.P Sandler',NULL,NULL,NULL,NULL),(6537,'M Santamari├▒a',NULL,NULL,NULL,NULL),(6538,'E.J Sawyer',NULL,NULL,NULL,NULL),(6539,'M.T Scheuner',NULL,NULL,NULL,NULL),(6540,'D.F Schmidt',NULL,NULL,NULL,NULL),(6541,'R.K Schmutzler',NULL,NULL,NULL,NULL),(6542,'A Schneeweiss',NULL,NULL,NULL,NULL),(6543,'M.J Schoemaker',NULL,NULL,NULL,NULL),(6544,'B Sch├╢ttker',NULL,NULL,NULL,NULL),(6545,'P Sch├╝rmann',NULL,NULL,NULL,NULL),(6546,'L Senter',NULL,NULL,NULL,NULL),(6547,'M Shah',NULL,NULL,NULL,NULL),(6548,'P Sharma',NULL,NULL,NULL,NULL),(6549,'C.-Y Shen',NULL,NULL,NULL,NULL),(6550,'X.-O Shu',NULL,NULL,NULL,NULL),(6551,'C.F Singer',NULL,NULL,NULL,NULL),(6552,'T.P Slavin',NULL,NULL,NULL,NULL),(6553,'S Smichkoska',NULL,NULL,NULL,NULL),(6554,'J.J Spinelli',NULL,NULL,NULL,NULL),(6555,'A.B Spurdle',NULL,NULL,NULL,NULL),(6556,'C Sutter',NULL,NULL,NULL,NULL),(6557,'A.J Swerdlow',NULL,NULL,NULL,NULL),(6558,'R.M Tamimi',NULL,NULL,NULL,NULL),(6559,'W.J Tapper',NULL,NULL,NULL,NULL),(6560,'J.A Taylor',NULL,NULL,NULL,NULL),(6561,'M.R Teixeira',NULL,NULL,NULL,NULL),(6562,'M Tengstr├╢m',NULL,NULL,NULL,NULL),(6563,'S.H Teo',NULL,NULL,NULL,NULL),(6564,'M.B Terry',NULL,NULL,NULL,NULL),(6565,'A Teul├⌐',NULL,NULL,NULL,NULL),(6566,'M Thomassen',NULL,NULL,NULL,NULL),(6567,'D.L Thull',NULL,NULL,NULL,NULL),(6568,'A.E Toland',NULL,NULL,NULL,NULL),(6569,'R.A.E.M Tollenaar',NULL,NULL,NULL,NULL),(6570,'I Tomlinson',NULL,NULL,NULL,NULL),(6571,'D Torres',NULL,NULL,NULL,NULL),(6572,'G Torres-Mej├¡a',NULL,NULL,NULL,NULL),(6573,'M.A Troester',NULL,NULL,NULL,NULL),(6574,'T Truong',NULL,NULL,NULL,NULL),(6575,'N Tung',NULL,NULL,NULL,NULL),(6576,'M Tzardi',NULL,NULL,NULL,NULL),(6577,'H.-U Ulmer',NULL,NULL,NULL,NULL),(6578,'C.M Vachon',NULL,NULL,NULL,NULL),(6579,'L.E van der Kolk',NULL,NULL,NULL,NULL),(6580,'E.J van Rensburg',NULL,NULL,NULL,NULL),(6581,'A Vega',NULL,NULL,NULL,NULL),(6582,'A Viel',NULL,NULL,NULL,NULL),(6583,'J Vijai',NULL,NULL,NULL,NULL),(6584,'M.J Vogel',NULL,NULL,NULL,NULL),(6585,'Q Wang',NULL,NULL,NULL,NULL),(6586,'B Wappenschmidt',NULL,NULL,NULL,NULL),(6587,'C.R Weinberg',NULL,NULL,NULL,NULL),(6588,'J.N Weitzel',NULL,NULL,NULL,NULL),(6589,'C Wendt',NULL,NULL,NULL,NULL),(6590,'H Wildiers',NULL,NULL,NULL,NULL),(6591,'R Winqvist',NULL,NULL,NULL,NULL),(6592,'A Wolk',NULL,NULL,NULL,NULL),(6593,'A.H Wu',NULL,NULL,NULL,NULL),(6594,'D Yannoukakos',NULL,NULL,NULL,NULL),(6595,'W Zheng',NULL,NULL,NULL,NULL),(6596,'P.D.P Pharoah',NULL,NULL,NULL,NULL),(6597,'J Chang-Claude',NULL,NULL,NULL,NULL),(6598,'M Garc├¡a-Closas',NULL,NULL,NULL,NULL),(6599,'V.N Kristensen',NULL,NULL,NULL,NULL),(6600,'J.D French',NULL,NULL,NULL,NULL),(6601,'A.C Antoniou',NULL,NULL,NULL,NULL),(6602,'G Chenevix-Trench',NULL,NULL,NULL,NULL),(6603,'J Simard',NULL,NULL,NULL,NULL),(6604,'D.F Easton',NULL,NULL,NULL,NULL),(6605,'A.M. Dunning',NULL,NULL,NULL,NULL),(6606,'T.L Jeffries',NULL,NULL,NULL,NULL),(6607,'L Capit├úo',NULL,NULL,NULL,NULL),(6608,'N.I Landr├╕',NULL,NULL,NULL,NULL),(6609,'W.D Hill',NULL,NULL,NULL,NULL),(6610,'R B├╝low',NULL,NULL,NULL,NULL),(6611,'J Klinger-K├╢nig',NULL,NULL,NULL,NULL),(6612,'D J├╝ksel',NULL,NULL,NULL,NULL),(6613,'S Hodson',NULL,NULL,NULL,NULL),(6614,'J Veitch',NULL,NULL,NULL,NULL),(6615,'M Killedar',NULL,NULL,NULL,NULL),(6616,'M Clinical',NULL,NULL,NULL,NULL),(6617,'M Agee',NULL,NULL,NULL,NULL),(6618,'B Alipanahi',NULL,NULL,NULL,NULL),(6619,'A Auton',NULL,NULL,NULL,NULL),(6620,'R.K Bell',NULL,NULL,NULL,NULL),(6621,'K Bryc',NULL,NULL,NULL,NULL),(6622,'S.L Elson',NULL,NULL,NULL,NULL),(6623,'K.E Huber',NULL,NULL,NULL,NULL),(6624,'A Kleinman',NULL,NULL,NULL,NULL),(6625,'N.K Litterman',NULL,NULL,NULL,NULL),(6626,'J.C McCreight',NULL,NULL,NULL,NULL),(6627,'M.H McIntyre',NULL,NULL,NULL,NULL),(6628,'J.L Mountain',NULL,NULL,NULL,NULL),(6629,'E.S Noblin',NULL,NULL,NULL,NULL),(6630,'C.A.M Northover',NULL,NULL,NULL,NULL),(6631,'S.J Pitts',NULL,NULL,NULL,NULL),(6632,'J.F Sathirapongsasuti',NULL,NULL,NULL,NULL),(6633,'O.V Sazonova',NULL,NULL,NULL,NULL),(6634,'J.F Shelton',NULL,NULL,NULL,NULL),(6635,'S Shringarpure',NULL,NULL,NULL,NULL),(6636,'J.Y Tung',NULL,NULL,NULL,NULL),(6637,'V Vacic',NULL,NULL,NULL,NULL),(6638,'B OΓÇÖDea',NULL,NULL,NULL,NULL),(6639,'S.D.X Kong',NULL,NULL,NULL,NULL),(6640,'G Eraslan',NULL,NULL,NULL,NULL),(6641,'C.M Page',NULL,NULL,NULL,NULL),(6642,'E H├ñm├ñl├ñinen',NULL,NULL,NULL,NULL),(6643,'E Kajantie',NULL,NULL,NULL,NULL),(6644,'H Laivuori',NULL,NULL,NULL,NULL),(6645,'P.M Villa',NULL,NULL,NULL,NULL),(6646,'R.M Reynolds',NULL,NULL,NULL,NULL),(6647,'W Nystad',NULL,NULL,NULL,NULL),(6648,'S.E H├Ñberg',NULL,NULL,NULL,NULL),(6649,'S.J London',NULL,NULL,NULL,NULL),(6650,'K.J OΓÇÖDonnell',NULL,NULL,NULL,NULL),(6651,'E Garg',NULL,NULL,NULL,NULL),(6652,'M.J Meaney',NULL,NULL,NULL,NULL),(6653,'S Entringer',NULL,NULL,NULL,NULL),(6654,'P.D Wadhwa',NULL,NULL,NULL,NULL),(6655,'C Buss',NULL,NULL,NULL,NULL),(6656,'J.L MacIsaac',NULL,NULL,NULL,NULL),(6657,'M.S Kobor',NULL,NULL,NULL,NULL),(6658,'N Koen',NULL,NULL,NULL,NULL),(6659,'H.J Zar',NULL,NULL,NULL,NULL),(6660,'S Dalvie',NULL,NULL,NULL,NULL),(6661,'I Kondofersky',NULL,NULL,NULL,NULL),(6662,'N.S M├╝ller',NULL,NULL,NULL,NULL),(6663,'F.J Theis',NULL,NULL,NULL,NULL),(6664,'K R├ñikk├╢nen',NULL,NULL,NULL,NULL),(6665,'C.G.F De Kovel',NULL,NULL,NULL,NULL),(6666,'D Y├╝ksel',NULL,NULL,NULL,NULL),(6667,'H Won',NULL,NULL,NULL,NULL),(6668,'J Pallesen',NULL,NULL,NULL,NULL),(6669,'S Awashti',NULL,NULL,NULL,NULL),(6670,'F Bettella',NULL,NULL,NULL,NULL),(6671,'K Dellenvall',NULL,NULL,NULL,NULL),(6672,'S De Rubeis',NULL,NULL,NULL,NULL),(6673,'M.E Hauberg',NULL,NULL,NULL,NULL),(6674,'S Hope',NULL,NULL,NULL,NULL),(6675,'D.P Howrigan',NULL,NULL,NULL,NULL),(6676,'L Klei',NULL,NULL,NULL,NULL),(6677,'J Maller',NULL,NULL,NULL,NULL),(6678,'J Martin',NULL,NULL,NULL,NULL),(6679,'A.R Martin',NULL,NULL,NULL,NULL),(6680,'M Nyegaard',NULL,NULL,NULL,NULL),(6681,'T N├ªrland',NULL,NULL,NULL,NULL),(6682,'D.S Palmer',NULL,NULL,NULL,NULL),(6683,'A Palotie',NULL,NULL,NULL,NULL),(6684,'T dPoterba',NULL,NULL,NULL,NULL),(6685,'J.B Poulsen',NULL,NULL,NULL,NULL),(6686,'B.S Pourcain',NULL,NULL,NULL,NULL),(6687,'K Rehnstr├╢m',NULL,NULL,NULL,NULL),(6688,'A Reichenberg',NULL,NULL,NULL,NULL),(6689,'J Reichert',NULL,NULL,NULL,NULL),(6690,'E.B Robinson',NULL,NULL,NULL,NULL),(6691,'K Roeder',NULL,NULL,NULL,NULL),(6692,'E Saemundsen',NULL,NULL,NULL,NULL),(6693,'S Sandin',NULL,NULL,NULL,NULL),(6694,'F.K Satterstrom',NULL,NULL,NULL,NULL),(6695,'C.R Stevens',NULL,NULL,NULL,NULL),(6696,'G.B Walters',NULL,NULL,NULL,NULL),(6697,'X Xu',NULL,NULL,NULL,NULL),(6698,'B.S Hromatka',NULL,NULL,NULL,NULL),(6699,'J Clements',NULL,NULL,NULL,NULL),(6700,'L Jazwinska',NULL,NULL,NULL,NULL),(6701,'S Rossell',NULL,NULL,NULL,NULL),(6702,'A Li',NULL,NULL,NULL,NULL),(6703,'F.C Geyer',NULL,NULL,NULL,NULL),(6704,'P Blecua',NULL,NULL,NULL,NULL),(6705,'P Selenica',NULL,NULL,NULL,NULL),(6706,'F Pareja',NULL,NULL,NULL,NULL),(6707,'R Kumar',NULL,NULL,NULL,NULL),(6708,'B Rivera',NULL,NULL,NULL,NULL),(6709,'R Bi',NULL,NULL,NULL,NULL),(6710,'S Piscuoglio',NULL,NULL,NULL,NULL),(6711,'H.Y Wen',NULL,NULL,NULL,NULL),(6712,'J.R Lozada',NULL,NULL,NULL,NULL),(6713,'R Gularte-M├⌐rida',NULL,NULL,NULL,NULL),(6714,'L Cavallone',NULL,NULL,NULL,NULL),(6715,'M Aghmesheh',NULL,NULL,NULL,NULL),(6716,'L Caldon',NULL,NULL,NULL,NULL),(6717,'J Cui',NULL,NULL,NULL,NULL),(6718,'A Dobrovic',NULL,NULL,NULL,NULL),(6719,'T Dudding',NULL,NULL,NULL,NULL),(6720,'L Forrest',NULL,NULL,NULL,NULL),(6721,'D.G Ortega',NULL,NULL,NULL,NULL),(6722,'Z Rezoug',NULL,NULL,NULL,NULL),(6723,'T Nguyen-Dumont',NULL,NULL,NULL,NULL),(6724,'C Tondini',NULL,NULL,NULL,NULL),(6725,'T Terkelsen',NULL,NULL,NULL,NULL),(6726,'K R├╕nlund',NULL,NULL,NULL,NULL),(6727,'S.E Boonen',NULL,NULL,NULL,NULL),(6728,'A Mannerma',NULL,NULL,NULL,NULL),(6729,'M Janatova',NULL,NULL,NULL,NULL),(6730,'P Rajadurai',NULL,NULL,NULL,NULL),(6731,'B Xia',NULL,NULL,NULL,NULL),(6732,'L Norton',NULL,NULL,NULL,NULL),(6733,'P.-S Ng',NULL,NULL,NULL,NULL),(6734,'L.-M Looi',NULL,NULL,NULL,NULL),(6735,'B Weigelt',NULL,NULL,NULL,NULL),(6736,'T Soo-Hwang',NULL,NULL,NULL,NULL),(6737,'J.S. Reis-Filho',NULL,NULL,NULL,NULL),(6738,'J Sim├│n-S├ínchez',NULL,NULL,NULL,NULL),(6739,'L Pihlstr├╕m',NULL,NULL,NULL,NULL),(6740,'A.D Adarmes-G├│mez',NULL,NULL,NULL,NULL),(6741,'A C├ímara',NULL,NULL,NULL,NULL),(6742,'M Carri├│n-Claro',NULL,NULL,NULL,NULL),(6743,'J Clarim├│n',NULL,NULL,NULL,NULL),(6744,'M Fern├índez',NULL,NULL,NULL,NULL),(6745,'R Fern├índez-Santiago',NULL,NULL,NULL,NULL),(6746,'P Garc├¡a-Ruiz',NULL,NULL,NULL,NULL),(6747,'P G├│mez-Garre',NULL,NULL,NULL,NULL),(6748,'S Jes├║s',NULL,NULL,NULL,NULL),(6749,'J Mar├¡n',NULL,NULL,NULL,NULL),(6750,'J.C Mart├¡nez-Castrillo',NULL,NULL,NULL,NULL),(6751,'C M├⌐ndez-del-Barrio',NULL,NULL,NULL,NULL),(6752,'A M├¡nguez',NULL,NULL,NULL,NULL),(6753,'E Mu├▒oz',NULL,NULL,NULL,NULL),(6754,'T Peri├▒├ín-Tocino',NULL,NULL,NULL,NULL),(6755,'P Rizzu',NULL,NULL,NULL,NULL),(6756,'L Robak',NULL,NULL,NULL,NULL),(6757,'A.S Rodriguez',NULL,NULL,NULL,NULL),(6758,'J Ruiz-Mart├¡nez',NULL,NULL,NULL,NULL),(6759,'C Ruz',NULL,NULL,NULL,NULL),(6760,'M Ryten',NULL,NULL,NULL,NULL),(6761,'D Sadykova',NULL,NULL,NULL,NULL),(6762,'S Schreglmann',NULL,NULL,NULL,NULL),(6763,'C Shashkin',NULL,NULL,NULL,NULL),(6764,'M Sierra',NULL,NULL,NULL,NULL),(6765,'E Suarez-Sanmartin',NULL,NULL,NULL,NULL),(6766,'P Taba',NULL,NULL,NULL,NULL),(6767,'C Tabernero',NULL,NULL,NULL,NULL),(6768,'J.P Tartari',NULL,NULL,NULL,NULL),(6769,'C Tejera-Parrado',NULL,NULL,NULL,NULL),(6770,'E Tolosa',NULL,NULL,NULL,NULL),(6771,'D Trabzuni',NULL,NULL,NULL,NULL),(6772,'F Valldeoriola',NULL,NULL,NULL,NULL),(6773,'J.J van Hilten',NULL,NULL,NULL,NULL),(6774,'K Van Keuren-Jensen',NULL,NULL,NULL,NULL),(6775,'L Vargas-Gonz├ílez',NULL,NULL,NULL,NULL),(6776,'L Vela',NULL,NULL,NULL,NULL),(6777,'F Vives',NULL,NULL,NULL,NULL),(6778,'N Williams',NULL,NULL,NULL,NULL),(6779,'N Zharkinbekova',NULL,NULL,NULL,NULL),(6780,'Z Zharmukhanov',NULL,NULL,NULL,NULL),(6781,'E Zholdybayeva',NULL,NULL,NULL,NULL),(6782,'A Zimprich',NULL,NULL,NULL,NULL),(6783,'P Ylikotila',NULL,NULL,NULL,NULL),(6784,'S Reich',NULL,NULL,NULL,NULL),(6785,'J Savitt',NULL,NULL,NULL,NULL),(6786,'B Hicks',NULL,NULL,NULL,NULL),(6787,'E.M Jewett',NULL,NULL,NULL,NULL),(6788,'K.F McManus',NULL,NULL,NULL,NULL),(6789,'G.D Poznik',NULL,NULL,NULL,NULL),(6790,'X Wang',NULL,NULL,NULL,NULL),(6791,'J Sidorenko',NULL,NULL,NULL,NULL),(6792,'A Nicolas',NULL,NULL,NULL,NULL),(6793,'A Tucci',NULL,NULL,NULL,NULL),(6794,'L RΓÇÖBibo',NULL,NULL,NULL,NULL),(6795,'A Giri',NULL,NULL,NULL,NULL),(6796,'L Krohan',NULL,NULL,NULL,NULL),(6797,'M Carcel',NULL,NULL,NULL,NULL),(6798,'A.L de Munain Arregui',NULL,NULL,NULL,NULL),(6799,'J Pagonabarraga',NULL,NULL,NULL,NULL),(6800,'S.A Gagliano Taliun',NULL,NULL,NULL,NULL),(6801,'P Giusti-Rodr├¡guez',NULL,NULL,NULL,NULL),(6802,'A.R Winslow',NULL,NULL,NULL,NULL),(6803,'C Fennema-Notestine',NULL,NULL,NULL,NULL),(6804,'J Vassileva',NULL,NULL,NULL,NULL),(6805,'M.J Lyons',NULL,NULL,NULL,NULL),(6806,'E.C Prom-Wormley',NULL,NULL,NULL,NULL),(6807,'A Arnau-Soler',NULL,NULL,NULL,NULL),(6808,'C Black',NULL,NULL,NULL,NULL),(6809,'M.J.A Diniz',NULL,NULL,NULL,NULL),(6810,'K Matthews',NULL,NULL,NULL,NULL),(6811,'M Ferreira',NULL,NULL,NULL,NULL),(6812,'C OΓÇÖDushlaine',NULL,NULL,NULL,NULL),(6813,'S Raychaudhuri',NULL,NULL,NULL,NULL),(6814,'E Scolnick',NULL,NULL,NULL,NULL),(6815,'B.S Pickard',NULL,NULL,NULL,NULL),(6816,'N Langstrom',NULL,NULL,NULL,NULL),(6817,'J.G Para',NULL,NULL,NULL,NULL),(6818,'J Kammerer-Ciernioch',NULL,NULL,NULL,NULL),(6819,'M Borrmann-Hassenbach',NULL,NULL,NULL,NULL),(6820,'M Schwarz',NULL,NULL,NULL,NULL),(6821,'J Schumacher',NULL,NULL,NULL,NULL),(6822,'E.N Smith',NULL,NULL,NULL,NULL),(6823,'D.L Koller',NULL,NULL,NULL,NULL),(6824,'F.W Lohoff',NULL,NULL,NULL,NULL),(6825,'I Nikolov',NULL,NULL,NULL,NULL),(6826,'A Elkin',NULL,NULL,NULL,NULL),(6827,'R Williamson',NULL,NULL,NULL,NULL),(6828,'V Milanova',NULL,NULL,NULL,NULL),(6829,'N Szeszenia-Dabrowska',NULL,NULL,NULL,NULL),(6830,'E Quinn',NULL,NULL,NULL,NULL),(6831,'V Moskvina',NULL,NULL,NULL,NULL),(6832,'M Lathrop',NULL,NULL,NULL,NULL),(6833,'P.F O`Reilly',NULL,NULL,NULL,NULL),(6834,'J.E Joo',NULL,NULL,NULL,NULL),(6835,'J.G Dowty',NULL,NULL,NULL,NULL),(6836,'E.M Wong',NULL,NULL,NULL,NULL),(6837,'P.-A Dugu├⌐',NULL,NULL,NULL,NULL),(6838,'D English',NULL,NULL,NULL,NULL),(6839,'F Macrae',NULL,NULL,NULL,NULL),(6840,'J Goldblatt',NULL,NULL,NULL,NULL),(6841,'E Lobb',NULL,NULL,NULL,NULL),(6842,'S O\'Connell',NULL,NULL,NULL,NULL),(6843,'S Thomas',NULL,NULL,NULL,NULL),(6844,'R.C Gur',NULL,NULL,NULL,NULL),(6845,'E.G J├╢nsson',NULL,NULL,NULL,NULL),(6846,'C Kn├╢chel',NULL,NULL,NULL,NULL),(6847,'V Oertel-Kn├╢chel',NULL,NULL,NULL,NULL),(6848,'M St├ñblein',NULL,NULL,NULL,NULL),(6849,'S T├╕nnesen',NULL,NULL,NULL,NULL),(6850,'F Yang',NULL,NULL,NULL,NULL),(6851,'N Yao',NULL,NULL,NULL,NULL),(6852,'G Zhang',NULL,NULL,NULL,NULL),(6853,'J Zhao',NULL,NULL,NULL,NULL),(6854,'M.R Munaf├▓',NULL,NULL,NULL,NULL),(6855,'O Piguet',NULL,NULL,NULL,NULL),(6856,'F Kumfor',NULL,NULL,NULL,NULL),(6857,'A Dehghan',NULL,NULL,NULL,NULL),(6858,'M Bakvad-Hansen',NULL,NULL,NULL,NULL),(6859,'H.N Buttenschon',NULL,NULL,NULL,NULL),(6860,'A.D Borglum',NULL,NULL,NULL,NULL),(6861,'J.L Bolton',NULL,NULL,NULL,NULL),(6862,'A Anderson',NULL,NULL,NULL,NULL),(6863,'J Huffman',NULL,NULL,NULL,NULL),(6864,'J.F Wilson',NULL,NULL,NULL,NULL),(6865,'H Campbell',NULL,NULL,NULL,NULL),(6866,'I Rudan',NULL,NULL,NULL,NULL),(6867,'N Hastie',NULL,NULL,NULL,NULL),(6868,'S.H Wild',NULL,NULL,NULL,NULL),(6869,'F.P Velders',NULL,NULL,NULL,NULL),(6870,'E Widen',NULL,NULL,NULL,NULL),(6871,'N.J Timpson',NULL,NULL,NULL,NULL),(6872,'S.M Ring',NULL,NULL,NULL,NULL),(6873,'T Tanaka',NULL,NULL,NULL,NULL),(6874,'S Bandinelli',NULL,NULL,NULL,NULL),(6875,'L Ferrucci',NULL,NULL,NULL,NULL),(6876,'P Van Der Harst',NULL,NULL,NULL,NULL),(6877,'J.G Rosmalen',NULL,NULL,NULL,NULL),(6878,'S.J Bakker',NULL,NULL,NULL,NULL),(6879,'N Verweij',NULL,NULL,NULL,NULL),(6880,'R.P Dullaart',NULL,NULL,NULL,NULL),(6881,'A Mahajan',NULL,NULL,NULL,NULL),(6882,'C.M Lindgren',NULL,NULL,NULL,NULL),(6883,'A Morris',NULL,NULL,NULL,NULL),(6884,'L Lind',NULL,NULL,NULL,NULL),(6885,'E Ingelsson',NULL,NULL,NULL,NULL),(6886,'L.N Anderson',NULL,NULL,NULL,NULL),(6887,'C.E Pennell',NULL,NULL,NULL,NULL),(6888,'S.J Lye',NULL,NULL,NULL,NULL),(6889,'D Mellstrom',NULL,NULL,NULL,NULL),(6890,'C Ohlsson',NULL,NULL,NULL,NULL),(6891,'J.F Price',NULL,NULL,NULL,NULL),(6892,'M.W Strachan',NULL,NULL,NULL,NULL),(6893,'D.A Bennett',NULL,NULL,NULL,NULL),(6894,'J Marchine',NULL,NULL,NULL,NULL),(6895,'H Stephansson',NULL,NULL,NULL,NULL),(6896,'K Stephansson',NULL,NULL,NULL,NULL),(6897,'S W├╝st',NULL,NULL,NULL,NULL),(6898,'T.K.C Ip',NULL,NULL,NULL,NULL),(6899,'N.T.M Chen',NULL,NULL,NULL,NULL),(6900,'P.J.F Clarke',NULL,NULL,NULL,NULL),(6901,'P.F Bartlett',NULL,NULL,NULL,NULL),(6902,'J.C Vickers',NULL,NULL,NULL,NULL),(6903,'P.G Smann',NULL,NULL,NULL,NULL),(6904,'B Krmer',NULL,NULL,NULL,NULL),(6905,'M.E Rentera',NULL,NULL,NULL,NULL),(6906,'R M├ñgi',NULL,NULL,NULL,NULL),(6907,'M Blank',NULL,NULL,NULL,NULL),(6908,'A.D Taylor',NULL,NULL,NULL,NULL),(6909,'M.S Husain',NULL,NULL,NULL,NULL),(6910,'M Bay├⌐s',NULL,NULL,NULL,NULL),(6911,'A.K K├ñhler',NULL,NULL,NULL,NULL),(6912,'E Kenny',NULL,NULL,NULL,NULL),(6913,'L Kent',NULL,NULL,NULL,NULL),(6914,'S.M Klauck',NULL,NULL,NULL,NULL),(6915,'L Krabbendam',NULL,NULL,NULL,NULL),(6916,'R Krasucki',NULL,NULL,NULL,NULL),(6917,'P Kwan',NULL,NULL,NULL,NULL),(6918,'D.H Ledbetter',NULL,NULL,NULL,NULL),(6919,'T Lencz',NULL,NULL,NULL,NULL),(6920,'K.-P Lesch',NULL,NULL,NULL,NULL),(6921,'D.H Linszen',NULL,NULL,NULL,NULL),(6922,'S.K Loo',NULL,NULL,NULL,NULL),(6923,'C Lord',NULL,NULL,NULL,NULL),(6924,'J.K Lowe',NULL,NULL,NULL,NULL),(6925,'E Maestrini',NULL,NULL,NULL,NULL),(6926,'A.K Malhotra',NULL,NULL,NULL,NULL),(6927,'S.M Mane',NULL,NULL,NULL,NULL),(6928,'J.J McGough',NULL,NULL,NULL,NULL),(6929,'R McKinney',NULL,NULL,NULL,NULL),(6930,'W.M McMahon',NULL,NULL,NULL,NULL),(6931,'A Miranda',NULL,NULL,NULL,NULL),(6932,'A.P Monaco',NULL,NULL,NULL,NULL),(6933,'D Moreno-De-Luca',NULL,NULL,NULL,NULL),(6934,'E.M Morrow',NULL,NULL,NULL,NULL),(6935,'M Murtha',NULL,NULL,NULL,NULL),(6936,'I Myin-Germeys',NULL,NULL,NULL,NULL),(6937,'S.F Nelson',NULL,NULL,NULL,NULL),(6938,'C O\'Dushlaine',NULL,NULL,NULL,NULL),(6939,'R.D Oades',NULL,NULL,NULL,NULL),(6940,'A Olincy',NULL,NULL,NULL,NULL),(6941,'G Oliveira',NULL,NULL,NULL,NULL),(6942,'L Olsen',NULL,NULL,NULL,NULL),(6943,'J.R Parr',NULL,NULL,NULL,NULL),(6944,'A.D Paterson',NULL,NULL,NULL,NULL),(6945,'M.A Pericak-Vance',NULL,NULL,NULL,NULL),(6946,'J Pimm',NULL,NULL,NULL,NULL),(6947,'J Piven',NULL,NULL,NULL,NULL),(6948,'F Poustka',NULL,NULL,NULL,NULL),(6949,'P Propping',NULL,NULL,NULL,NULL),(6950,'V Puri',NULL,NULL,NULL,NULL),(6951,'D.J Quested',NULL,NULL,NULL,NULL),(6952,'H.B Rasmussen',NULL,NULL,NULL,NULL),(6953,'H Roeyers',NULL,NULL,NULL,NULL),(6954,'L Rossin',NULL,NULL,NULL,NULL),(6955,'A Rothenberger',NULL,NULL,NULL,NULL),(6956,'A.R Sanders',NULL,NULL,NULL,NULL),(6957,'S.J Sanders',NULL,NULL,NULL,NULL),(6958,'S.L Santangelo',NULL,NULL,NULL,NULL),(6959,'R Schachar',NULL,NULL,NULL,NULL),(6960,'G.D Schellenberg',NULL,NULL,NULL,NULL),(6961,'J.A Sergeant',NULL,NULL,NULL,NULL),(6962,'J.M Silverman',NULL,NULL,NULL,NULL),(6963,'S.L Smalley',NULL,NULL,NULL,NULL),(6964,'E.J.S Sonuga-Barke',NULL,NULL,NULL,NULL),(6965,'M State',NULL,NULL,NULL,NULL),(6966,'H.-C Steinhausen',NULL,NULL,NULL,NULL),(6967,'T Scott Stroup',NULL,NULL,NULL,NULL),(6968,'J Sutcliffe',NULL,NULL,NULL,NULL),(6969,'P Szatmari',NULL,NULL,NULL,NULL),(6970,'A Thapar',NULL,NULL,NULL,NULL),(6971,'S Thirumalai',NULL,NULL,NULL,NULL),(6972,'A.A Todorov',NULL,NULL,NULL,NULL),(6973,'J.-Y Tzeng',NULL,NULL,NULL,NULL),(6974,'J Van Os',NULL,NULL,NULL,NULL),(6975,'A.M Vicente',NULL,NULL,NULL,NULL),(6976,'V.J Vieland',NULL,NULL,NULL,NULL),(6977,'C.A Walsh',NULL,NULL,NULL,NULL),(6978,'T.H Wassink',NULL,NULL,NULL,NULL),(6979,'T.F Wienker',NULL,NULL,NULL,NULL),(6980,'D Wiersma',NULL,NULL,NULL,NULL),(6981,'E.M Wijsman',NULL,NULL,NULL,NULL),(6982,'A Jeremy Willsey',NULL,NULL,NULL,NULL),(6983,'T.W Yu',NULL,NULL,NULL,NULL),(6984,'S Zammit',NULL,NULL,NULL,NULL),(6985,'N.N Parikshak',NULL,NULL,NULL,NULL),(6986,'M.E Goddard',NULL,NULL,NULL,NULL),(6987,'J.S Witte',NULL,NULL,NULL,NULL),(6988,'E.G Jones',NULL,NULL,NULL,NULL),(6989,'W.J Muir',NULL,NULL,NULL,NULL),(6990,'A Agrawal',NULL,NULL,NULL,NULL),(6991,'E Albrecht',NULL,NULL,NULL,NULL),(6992,'B Z Alizadeh',NULL,NULL,NULL,NULL),(6993,'J Allik',NULL,NULL,NULL,NULL),(6994,'N Amin',NULL,NULL,NULL,NULL),(6995,'J.R Attia',NULL,NULL,NULL,NULL),(6996,'J Barnard',NULL,NULL,NULL,NULL),(6997,'F Bastardot',NULL,NULL,NULL,NULL),(6998,'J Beauchamp',NULL,NULL,NULL,NULL),(6999,'K.S Benke',NULL,NULL,NULL,NULL),(7000,'L.F Bielak',NULL,NULL,NULL,NULL),(7001,'J.A Boatman',NULL,NULL,NULL,NULL),(7002,'P.A Boyle',NULL,NULL,NULL,NULL),(7003,'U B├╝ltmann',NULL,NULL,NULL,NULL),(7004,'C.F Chabris',NULL,NULL,NULL,NULL),(7005,'L Cherkas',NULL,NULL,NULL,NULL),(7006,'M.K Chung',NULL,NULL,NULL,NULL),(7007,'D Conley',NULL,NULL,NULL,NULL),(7008,'M De Andrade',NULL,NULL,NULL,NULL),(7009,'J.-E De Neve',NULL,NULL,NULL,NULL),(7010,'G.V Dedoussis',NULL,NULL,NULL,NULL),(7011,'P Deloukas',NULL,NULL,NULL,NULL),(7012,'M Dimitriou',NULL,NULL,NULL,NULL),(7013,'G Eiriksdottir',NULL,NULL,NULL,NULL),(7014,'N Eklund',NULL,NULL,NULL,NULL),(7015,'M.F Elderson',NULL,NULL,NULL,NULL),(7016,'R Fehrmann',NULL,NULL,NULL,NULL),(7017,'K Fischer',NULL,NULL,NULL,NULL),(7018,'M.E Garcia',NULL,NULL,NULL,NULL),(7019,'C Gieger',NULL,NULL,NULL,NULL),(7020,'H.K Gjessing',NULL,NULL,NULL,NULL),(7021,'P.J.F Groenen',NULL,NULL,NULL,NULL),(7022,'H Gr├╢nberg',NULL,NULL,NULL,NULL),(7023,'V Gudnason',NULL,NULL,NULL,NULL),(7024,'S H├ñgg',NULL,NULL,NULL,NULL),(7025,'T.B Harris',NULL,NULL,NULL,NULL),(7026,'W Hoffmann',NULL,NULL,NULL,NULL),(7027,'R Holle',NULL,NULL,NULL,NULL),(7028,'E.G Holliday',NULL,NULL,NULL,NULL),(7029,'C Holzapfel',NULL,NULL,NULL,NULL),(7030,'C.A Ibrahim-Verbaas',NULL,NULL,NULL,NULL),(7031,'T Illig',NULL,NULL,NULL,NULL),(7032,'B Jacobsson',NULL,NULL,NULL,NULL),(7033,'M.A Jhun',NULL,NULL,NULL,NULL),(7034,'P.K Joshi',NULL,NULL,NULL,NULL),(7035,'A Jugessur',NULL,NULL,NULL,NULL),(7036,'M K├ñh├╢nen',NULL,NULL,NULL,NULL),(7037,'S Kanoni',NULL,NULL,NULL,NULL),(7038,'I Kolcic',NULL,NULL,NULL,NULL),(7039,'M Kowgier',NULL,NULL,NULL,NULL),(7040,'K Kristiansson',NULL,NULL,NULL,NULL),(7041,'R.F Krueger',NULL,NULL,NULL,NULL),(7042,'D Laibson',NULL,NULL,NULL,NULL),(7043,'A Latvala',NULL,NULL,NULL,NULL),(7044,'L.J Launer',NULL,NULL,NULL,NULL),(7045,'D.A Lawlor',NULL,NULL,NULL,NULL),(7046,'T Lethim├ñki',NULL,NULL,NULL,NULL),(7047,'P.K Lichtner',NULL,NULL,NULL,NULL),(7048,'D.C Liewald',NULL,NULL,NULL,NULL),(7049,'P Lin',NULL,NULL,NULL,NULL),(7050,'K Lohman',NULL,NULL,NULL,NULL),(7051,'M Loitfelder',NULL,NULL,NULL,NULL),(7052,'T.E M├ñkinen',NULL,NULL,NULL,NULL),(7053,'P.M Vidal',NULL,NULL,NULL,NULL),(7054,'M Masala',NULL,NULL,NULL,NULL),(7055,'O Meirelles',NULL,NULL,NULL,NULL),(7056,'M.N Meyer',NULL,NULL,NULL,NULL),(7057,'A Mielck',NULL,NULL,NULL,NULL),(7058,'S Mukherjee',NULL,NULL,NULL,NULL),(7059,'R Myhre',NULL,NULL,NULL,NULL),(7060,'M.-L Nuotio',NULL,NULL,NULL,NULL),(7061,'C J Oldmeadow',NULL,NULL,NULL,NULL),(7062,'B.A Oostra',NULL,NULL,NULL,NULL),(7063,'L.J Palmer',NULL,NULL,NULL,NULL),(7064,'M Perola',NULL,NULL,NULL,NULL),(7065,'K.E Petrovic',NULL,NULL,NULL,NULL),(7066,'P.A Peyser',NULL,NULL,NULL,NULL),(7067,'O Pola┼íek',NULL,NULL,NULL,NULL),(7068,'A Realo',NULL,NULL,NULL,NULL),(7069,'E Reinmaa',NULL,NULL,NULL,NULL),(7070,'F Rivadeneira',NULL,NULL,NULL,NULL),(7071,'T.S Rizzi',NULL,NULL,NULL,NULL),(7072,'A Rustichini',NULL,NULL,NULL,NULL),(7073,'A.-P Sarin',NULL,NULL,NULL,NULL),(7074,'D Schlessinger',NULL,NULL,NULL,NULL),(7075,'H Schmidt',NULL,NULL,NULL,NULL),(7076,'R Schmidt',NULL,NULL,NULL,NULL),(7077,'K Shakhbazov',NULL,NULL,NULL,NULL),(7078,'J.M Starr',NULL,NULL,NULL,NULL),(7079,'J.H Sul',NULL,NULL,NULL,NULL),(7080,'I Surakka',NULL,NULL,NULL,NULL),(7081,'R Svento',NULL,NULL,NULL,NULL),(7082,'A Terracciano',NULL,NULL,NULL,NULL),(7083,'A.R Thurik',NULL,NULL,NULL,NULL),(7084,'M.J.H.M Van Der Loos',NULL,NULL,NULL,NULL),(7085,'F.J.A Van Rooij',NULL,NULL,NULL,NULL),(7086,'D.R Van Wagoner',NULL,NULL,NULL,NULL),(7087,'E Vartiainen',NULL,NULL,NULL,NULL),(7088,'V Vitart',NULL,NULL,NULL,NULL),(7089,'P.K Vollenweider',NULL,NULL,NULL,NULL),(7090,'J.M Vonk',NULL,NULL,NULL,NULL),(7091,'G Waeber',NULL,NULL,NULL,NULL),(7092,'H.-J Westra',NULL,NULL,NULL,NULL),(7093,'H.-E Wichmann',NULL,NULL,NULL,NULL),(7094,'L Yu',NULL,NULL,NULL,NULL),(7095,'J Van Dongen',NULL,NULL,NULL,NULL),(7096,'V Codd',NULL,NULL,NULL,NULL),(7097,'B Novakovic',NULL,NULL,NULL,NULL),(7098,'R Saffery',NULL,NULL,NULL,NULL),(7099,'S.L Clark',NULL,NULL,NULL,NULL),(7100,'├ÿ Bergmann',NULL,NULL,NULL,NULL),(7101,'G Fern├índez',NULL,NULL,NULL,NULL),(7102,'H.H.H G├╢ring',NULL,NULL,NULL,NULL),(7103,'Jack Jr',NULL,NULL,NULL,NULL),(7104,'C.R',NULL,NULL,NULL,NULL),(7105,'H Lema├«tre',NULL,NULL,NULL,NULL),(7106,'C.D Leonardo',NULL,NULL,NULL,NULL),(7107,'C.-S Li',NULL,NULL,NULL,NULL),(7108,'B Liberg',NULL,NULL,NULL,NULL),(7109,'L.M Lopez',NULL,NULL,NULL,NULL),(7110,'E Loth',NULL,NULL,NULL,NULL),(7111,'A Lourdusamy',NULL,NULL,NULL,NULL),(7112,'M Luciano',NULL,NULL,NULL,NULL),(7113,'F Macciardi',NULL,NULL,NULL,NULL),(7114,'D.S Manoach',NULL,NULL,NULL,NULL),(7115,'J.-L Martinot',NULL,NULL,NULL,NULL),(7116,'M Matarin',NULL,NULL,NULL,NULL),(7117,'A Meyer-Lindenberg',NULL,NULL,NULL,NULL),(7118,'E Meisenzahl',NULL,NULL,NULL,NULL),(7119,'S Mohnke',NULL,NULL,NULL,NULL),(7120,'E.K Moses',NULL,NULL,NULL,NULL),(7121,'S Mu├▒oz Maniega',NULL,NULL,NULL,NULL),(7122,'K Nho',NULL,NULL,NULL,NULL),(7123,'T.E Nichols',NULL,NULL,NULL,NULL),(7124,'L.-G Nilsson',NULL,NULL,NULL,NULL),(7125,'A.C Nugent',NULL,NULL,NULL,NULL),(7126,'R.L Olvera',NULL,NULL,NULL,NULL),(7127,'M Pandolfo',NULL,NULL,NULL,NULL),(7128,'M Papalampropoulou-Tsiridou',NULL,NULL,NULL,NULL),(7129,'C.P Peterson',NULL,NULL,NULL,NULL),(7130,'M Phillips',NULL,NULL,NULL,NULL),(7131,'G.B Pike',NULL,NULL,NULL,NULL),(7132,'J.-B Poline',NULL,NULL,NULL,NULL),(7133,'B P├╝tz',NULL,NULL,NULL,NULL),(7134,'A Ramasamy',NULL,NULL,NULL,NULL),(7135,'J Rasmussen',NULL,NULL,NULL,NULL),(7136,'M Rijpkema',NULL,NULL,NULL,NULL),(7137,'S.L Risacher',NULL,NULL,NULL,NULL),(7138,'R Roiz-Santia├▒ez',NULL,NULL,NULL,NULL),(7139,'N Romanczuk-Seiferth',NULL,NULL,NULL,NULL),(7140,'E.J Rose',NULL,NULL,NULL,NULL),(7141,'N.A Royle',NULL,NULL,NULL,NULL),(7142,'A Salami',NULL,NULL,NULL,NULL),(7143,'C Scanlon',NULL,NULL,NULL,NULL),(7144,'A.J Schork',NULL,NULL,NULL,NULL),(7145,'S.C Schulz',NULL,NULL,NULL,NULL),(7146,'R Sch├╝r',NULL,NULL,NULL,NULL),(7147,'J.M Shoemaker',NULL,NULL,NULL,NULL),(7148,'S.M Sisodiya',NULL,NULL,NULL,NULL),(7149,'C Smith',NULL,NULL,NULL,NULL),(7150,'S.R Sponheim',NULL,NULL,NULL,NULL),(7151,'V.M Steen',NULL,NULL,NULL,NULL),(7152,'S Strakowski',NULL,NULL,NULL,NULL),(7153,'S Trost',NULL,NULL,NULL,NULL),(7154,'M Van den Heuvel',NULL,NULL,NULL,NULL),(7155,'M.C Vald├⌐s Hern├índez',NULL,NULL,NULL,NULL),(7156,'A Versace',NULL,NULL,NULL,NULL),(7157,'J.M Wardlaw',NULL,NULL,NULL,NULL),(7158,'M.E Weale',NULL,NULL,NULL,NULL),(7159,'M.W Weiner',NULL,NULL,NULL,NULL),(7160,'A.M Winkler',NULL,NULL,NULL,NULL),(7161,'G Woldehawariat',NULL,NULL,NULL,NULL),(7162,'C Wolf',NULL,NULL,NULL,NULL),(7163,'D Zilles',NULL,NULL,NULL,NULL),(7164,'M.P Zwiers',NULL,NULL,NULL,NULL),(7165,'N.S Lawrence',NULL,NULL,NULL,NULL),(7166,'W. Drevets',NULL,NULL,NULL,NULL),(7167,'K.M Chittyn',NULL,NULL,NULL,NULL),(7168,'S Dimou',NULL,NULL,NULL,NULL),(7169,'M Biggs',NULL,NULL,NULL,NULL),(7170,'M Tonkin',NULL,NULL,NULL,NULL),(7171,'L.-P Lyytik├ñinen',NULL,NULL,NULL,NULL),(7172,'J H├ñllfors',NULL,NULL,NULL,NULL),(7173,'K Heikkil├ñ',NULL,NULL,NULL,NULL),(7174,'P.D Par├⌐',NULL,NULL,NULL,NULL),(7175,'T Lehtim├ñki',NULL,NULL,NULL,NULL),(7176,'C MMiddeldorp',NULL,NULL,NULL,NULL),(7177,'A Ashley-Koch',NULL,NULL,NULL,NULL),(7178,'C.M Bulik',NULL,NULL,NULL,NULL),(7179,'L.E DeLisi',NULL,NULL,NULL,NULL),(7180,'X Estivill',NULL,NULL,NULL,NULL),(7181,'F Fernandez-Aranda',NULL,NULL,NULL,NULL),(7182,'M Kas',NULL,NULL,NULL,NULL),(7183,'T Reichborn-Kjennerud',NULL,NULL,NULL,NULL),(7184,'J.A.S Vorstman',NULL,NULL,NULL,NULL),(7185,'E. Zeggini',NULL,NULL,NULL,NULL),(7186,'M Y├╝cel',NULL,NULL,NULL,NULL),(7187,'E.M Gregory-Roberts',NULL,NULL,NULL,NULL),(7188,'J Klosterk├╢tter',NULL,NULL,NULL,NULL),(7189,'M.L Hickie',NULL,NULL,NULL,NULL),(7190,'M.I. Bell',NULL,NULL,NULL,NULL),(7191,'J. G├╢tz',NULL,NULL,NULL,NULL),(7192,'S.K Lo',NULL,NULL,NULL,NULL),(7193,'S.-A MaLachlan',NULL,NULL,NULL,NULL),(7194,'I Hickle',NULL,NULL,NULL,NULL),(7195,'A.W Murphy',NULL,NULL,NULL,NULL),(7196,'L. Ciechomski',NULL,NULL,NULL,NULL),(7197,'W Andrews',NULL,NULL,NULL,NULL),(7198,'THE KATHLEEN CUNINGHAM CONSORTIUM FOR RESEARCH INTOFAMILIAL BREAST CANCER PSYCHOSOCIAL GROUP',NULL,NULL,NULL,NULL),(7199,'M.-S Lee',NULL,NULL,NULL,NULL),(7200,'C.-H Chiu',NULL,NULL,NULL,NULL),(7201,'N Sartorius',NULL,NULL,NULL,NULL),(7202,'E Chiu',NULL,NULL,NULL,NULL),(7203,'J Bushnell',NULL,NULL,NULL,NULL),(7204,'P Hirini',NULL,NULL,NULL,NULL),(7205,'S Stevens',NULL,NULL,NULL,NULL),(7206,'T.-W Hu',NULL,NULL,NULL,NULL),(7207,'L.H Chapman',NULL,NULL,NULL,NULL),(7208,'S Bell',NULL,NULL,NULL,NULL),(7209,'N Carr',NULL,NULL,NULL,NULL),(7210,'M D\'Emden',NULL,NULL,NULL,NULL),(7211,'S Elsom',NULL,NULL,NULL,NULL),(7212,'S Henderson',NULL,NULL,NULL,NULL),(7213,'L Hoffman',NULL,NULL,NULL,NULL),(7214,'B Singh',NULL,NULL,NULL,NULL),(7215,'T Welborn',NULL,NULL,NULL,NULL),(7216,'P.W Owen',NULL,NULL,NULL,NULL),(7217,'J Bell',NULL,NULL,NULL,NULL),(7218,'E Bernardi',NULL,NULL,NULL,NULL),(7219,'D Castle',NULL,NULL,NULL,NULL),(7220,'D Chisholm',NULL,NULL,NULL,NULL),(7221,'M Clinton',NULL,NULL,NULL,NULL),(7222,'D Copoloy',NULL,NULL,NULL,NULL),(7223,'L Fellows',NULL,NULL,NULL,NULL),(7224,'T Fowke',NULL,NULL,NULL,NULL),(7225,'T Greenaway',NULL,NULL,NULL,NULL),(7226,'B Happell',NULL,NULL,NULL,NULL),(7227,'D Haupt',NULL,NULL,NULL,NULL),(7228,'J Lammerssma',NULL,NULL,NULL,NULL),(7229,'J Meagher',NULL,NULL,NULL,NULL),(7230,'S Pridmore',NULL,NULL,NULL,NULL),(7231,'R Ramjan',NULL,NULL,NULL,NULL),(7232,'G Riley',NULL,NULL,NULL,NULL),(7233,'L Stewart',NULL,NULL,NULL,NULL),(7234,'J Lim',NULL,NULL,NULL,NULL),(7235,'M Macluran',NULL,NULL,NULL,NULL),(7236,'M Maclurcan',NULL,NULL,NULL,NULL),(7237,'C Apicella',NULL,NULL,NULL,NULL),(7238,'G. Berry',NULL,NULL,NULL,NULL),(7239,'A.H Dinnen',NULL,NULL,NULL,NULL),(7240,'J.D Hundertmark',NULL,NULL,NULL,NULL),(7241,'D.D Beard',NULL,NULL,NULL,NULL),(7242,'R.G Larkins',NULL,NULL,NULL,NULL),(7243,'S.R. Molesworth',NULL,NULL,NULL,NULL),(7244,'N Phillips',NULL,NULL,NULL,NULL),(7245,'M.J Oldmeadow',NULL,NULL,NULL,NULL),(7246,'N Krapivensky',NULL,NULL,NULL,NULL),(7247,'J.B Hickie',NULL,NULL,NULL,NULL),(7248,'N Buchanan',NULL,NULL,NULL,NULL),(7249,'A.S Bansal',NULL,NULL,NULL,NULL),(7250,'H.A Pincus',NULL,NULL,NULL,NULL),(7251,'L.E McQueen',NULL,NULL,NULL,NULL),(7252,'S.E Strauss',NULL,NULL,NULL,NULL),(7253,'C Blatch',NULL,NULL,NULL,NULL),(7254,'T Blatt',NULL,NULL,NULL,NULL),(7255,'E.M Goudsmit',NULL,NULL,NULL,NULL),(7256,'N Anderson',NULL,NULL,NULL,NULL),(7257,'C Tannock',NULL,NULL,NULL,NULL),(7258,'D.C Costa',NULL,NULL,NULL,NULL),(7259,'J Brostoff',NULL,NULL,NULL,NULL),(7260,'D.O ho-Yen',NULL,NULL,NULL,NULL),(7261,'A Grant',NULL,NULL,NULL,NULL),(7262,'M Shanks',NULL,NULL,NULL,NULL),(7263,'N.C Abbot',NULL,NULL,NULL,NULL),(7264,'V.A Spence',NULL,NULL,NULL,NULL),(7265,'R.C Potts',NULL,NULL,NULL,NULL),(7266,'A.H.A Hassan',NULL,NULL,NULL,NULL),(7267,'J.J.F Belch',NULL,NULL,NULL,NULL),(7268,'J.S Beck',NULL,NULL,NULL,NULL),(7269,'C Read',NULL,NULL,NULL,NULL),(7270,'S Howes',NULL,NULL,NULL,NULL),(7271,'K Prince',NULL,NULL,NULL,NULL),(7272,'C Shepherd',NULL,NULL,NULL,NULL),(7273,'C Fleming',NULL,NULL,NULL,NULL),(7274,'V Airs',NULL,NULL,NULL,NULL),(7275,'J Broderick',NULL,NULL,NULL,NULL),(7276,'S. Woodcock',NULL,NULL,NULL,NULL),(7277,'K Withers',NULL,NULL,NULL,NULL),(7278,'G Jacobs',NULL,NULL,NULL,NULL),(7279,'D.S Bell',NULL,NULL,NULL,NULL),(7280,'W Goodrich',NULL,NULL,NULL,NULL),(7281,'B Apfelbaum',NULL,NULL,NULL,NULL),(7282,'K.H Kaplan',NULL,NULL,NULL,NULL),(7283,'M Galvin- Nadeau',NULL,NULL,NULL,NULL),(7284,'B Saltzstein',NULL,NULL,NULL,NULL),(7285,'A Gurwitt',NULL,NULL,NULL,NULL),(7286,'W Webster',NULL,NULL,NULL,NULL),(7287,'S.N Barrett',NULL,NULL,NULL,NULL),(7288,'W.F Sheeley',NULL,NULL,NULL,NULL),(7289,'B.A Fallon',NULL,NULL,NULL,NULL),(7290,'M.R Liebowitz',NULL,NULL,NULL,NULL),(7291,'D.F Klein',NULL,NULL,NULL,NULL),(7292,'S.E. Abbey',NULL,NULL,NULL,NULL),(7293,'D HadziΓÇÉPavlovic',NULL,NULL,NULL,NULL),(7294,'Albert V Smith',NULL,NULL,NULL,NULL),(7295,'Belinda Smith',NULL,NULL,NULL,NULL),(7296,'B.H Smith',NULL,NULL,NULL,NULL),(7297,'K Tran',NULL,NULL,NULL,NULL);
/*!40000 ALTER TABLE `authors` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `keywords`
--

DROP TABLE IF EXISTS `keywords`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `keywords` (
  `keyword_id` int(11) NOT NULL AUTO_INCREMENT,
  `keyword_name` varchar(255) DEFAULT NULL,
  PRIMARY KEY (`keyword_id`),
  UNIQUE KEY `keyword_name` (`keyword_name`)
) ENGINE=InnoDB AUTO_INCREMENT=119 DEFAULT CHARSET=utf8mb4;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `keywords`
--

LOCK TABLES `keywords` WRITE;
/*!40000 ALTER TABLE `keywords` DISABLE KEYS */;
INSERT INTO `keywords` VALUES (66,'Adolescent psychiatry'),(1,'agent based modelling'),(2,'agent based systems'),(73,'aging'),(51,'alcohol-related harm'),(113,'alcohol/substance abuse'),(117,'alcohol/subtance use'),(109,'autism'),(101,'biopolar'),(86,'Bipolar'),(108,'bmc youth model'),(110,'brain imaging'),(35,'care coordination'),(40,'casual loop diagrams'),(58,'causal modeling'),(62,'cessation'),(59,'childhood obesity'),(91,'Chronic Fatigue Syndrome'),(85,'Circadian'),(84,'Clinical Staging'),(105,'cohort profile'),(72,'community-based participatory research'),(4,'complex systems'),(3,'computer simulation'),(8,'decision analysis'),(90,'Depression'),(107,'digital phenotyping'),(39,'dynamics complexity'),(89,'Eating disorder'),(64,'end game'),(44,'epidemiology'),(52,'evidence synthesis'),(83,'Functioning'),(88,'General Practitioners'),(99,'Genetics'),(55,'gestational diabetes mellitus'),(104,'headspace'),(68,'health care reform'),(36,'health systems'),(38,'humanitarian relief operations'),(92,'Immune'),(103,'impact evaluation'),(82,'Innowell'),(34,'internet'),(98,'Intervention'),(33,'medical informatics'),(81,'Medication'),(11,'mental health'),(67,'Mental health policy'),(43,'mental health services'),(69,'mobile phone'),(57,'modeling'),(65,'Mood disorders'),(106,'multidimensional '),(97,'Neurocognitive functioning'),(80,'Novel Intervention'),(114,'omega-3'),(112,'oxytocin'),(96,'Participator Design'),(79,'Participatory Design'),(37,'policy'),(56,'population health'),(78,'Prediction'),(50,'prevention policy'),(94,'Psychosis'),(5,'public health'),(60,'public health policy'),(63,'public policy'),(87,'Quality of life'),(100,'risk factors'),(116,'schizophrenia'),(10,'simulation'),(42,'simulation modeling'),(95,'Social anxiety'),(118,'somatic distress'),(111,'sphere'),(70,'stakeholder participation'),(102,'stepped care'),(7,'strategic planning'),(77,'Suicidality'),(45,'suicide'),(6,'suicide prevention'),(41,'system dynamics'),(61,'system dynamics modelling'),(76,'System modeling'),(9,'systems modelling'),(71,'technology'),(93,'Triage'),(115,'vasopressin');
/*!40000 ALTER TABLE `keywords` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `other_names`
--

DROP TABLE IF EXISTS `other_names`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `other_names` (
  `other_name_id` int(11) NOT NULL AUTO_INCREMENT,
  `other_name` varchar(255) DEFAULT NULL,
  `author_id` int(11) NOT NULL,
  PRIMARY KEY (`other_name_id`),
  KEY `fk_author_id` (`author_id`),
  CONSTRAINT `fk_author_id` FOREIGN KEY (`author_id`) REFERENCES `authors` (`author_id`)
) ENGINE=InnoDB AUTO_INCREMENT=3001 DEFAULT CHARSET=utf8mb4;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `other_names`
--

LOCK TABLES `other_names` WRITE;
/*!40000 ALTER TABLE `other_names` DISABLE KEYS */;
INSERT INTO `other_names` VALUES (1,'Jo-An Atkinson',2),(2,'Ian B. Hickie',20),(3,'Ian B Hickie',20),(7,'Paul Steven Haber',69),(12,'A Skinner',16),(13,'Andrew N Page',58),(14,'Anna Roberts',137),(15,'Anna Elizabeth Roberts',137),(71,'ELIZABETH SCOTT',135),(72,'Elizabeth Scott',135),(73,'EM Scott',135),(74,'E Scott',135),(75,'F Iorfino',15),(76,'G McDonnell',59),(77,'Grace Lee',110),(78,'GY Lee',110),(79,'Graham N Meadows',62),(80,'Hayley Lamonica',136),(81,'Haley LaMonica',136),(82,'IB Hickie',20),(83,'Ian HICKIE',20),(84,'Ian Bernard Hickie',20),(85,'I Hickie',20),(86,'IAN HICKIE',20),(88,'Jan L Scott',77),(89,'J Scott',77),(91,'J Robinson',109),(92,'J Occhipinti',2),(93,'Jo-an Atkinson',2),(94,'Jo-Ann Maree Atkinson',2),(95,'Joanne Mitchell',126),(96,'James E Mitchell',126),(97,'L Freebairn',51),(98,'M Heffernan',60),(99,'Nicolas Ho',108),(100,'Sebastian P Rosenberg',50),(101,'Shelley C Rowe',18),(102,'Tracey A Davenport',17),(103,'T Davenport',17),(104,'TA Davenport',17),(105,'YJC Song',49),(106,'Yun JC Song',49),(107,'Yun Song',49),(108,'YJ Song',49),(109,'Yun Ju C Song',49),(336,'A Abdellaoui',613),(337,'A Alqarni',614),(338,'A Carballedo',617),(339,'A Flego',619),(340,'Adam J Guastella',620),(341,'Adam Guastella',620),(342,'AJ Guastella',620),(343,'A Guastella',620),(344,'A Harris',621),(345,'Amanda Kenyon',624),(346,'A Kenyon',624),(347,'A Krug',625),(348,'Andrew R LLOYD',626),(349,'Andrew Lloyd',626),(350,'AR Lloyd',626),(351,'A Lloyd',626),(352,'A LLOYD',626),(353,'A Lin',627),(354,'A Masi',630),(355,'A Polari',632),(356,'A Riecher-R├â┬╢ssler',633),(357,'Andrew M Scott',634),(358,'AM Scott',634),(359,'A Scott',634),(360,'A Teumer',635),(361,'A Voineskos',637),(362,'AC Huizink',638),(363,'AF Jorm',639),(364,'A Jorm',639),(365,'Aartjan FT Beekman',640),(366,'ATF Beekman',640),(367,'AFT Beekman',640),(368,'Andrew JO Whitehouse',641),(369,'AJO Whitehouse',641),(370,'Albert M Van Hemert',642),(371,'AM Van Hemert',642),(372,'Alison Ruth Yung',643),(373,'Alison R Yung',643),(374,'AR Yung',643),(375,'AS Corvin',644),(376,'Adam J Walker',651),(377,'Adri├â┬ín I Campos',656),(378,'Adrian I Campos',656),(379,'Adrian Campos',656),(381,'A Headey',677),(383,'Alex Fornito',694),(384,'Alex I Stiby',695),(385,'Alexander Hatoum',697),(386,'Alexandra G Parker',704),(387,'AG Parker',704),(388,'A Parker',704),(389,'Alexis C Edwards',708),(390,'AC Edwards',708),(391,'Alice A Gibson',713),(393,'A Norton',715),(397,'Andrew Wilson',723),(398,'Andrew J Wilson',723),(400,'AJ Wilson',723),(401,'A Wilson',723),(402,'A Nichles',724),(403,'Allan F McRae',727),(404,'Alvaro Andres Navarro-Mancilla',733),(405,'Alyssa Clare Milton',735),(406,'Alyssa C Milton',735),(407,'AC Milton',735),(408,'Alyssa H Zhu',736),(409,'A Lampit',743),(410,'Amy Adkins',745),(411,'Andre Aleman',761),(412,'A Block',763),(414,'A Hofman',766),(415,'AJ Forstner',772),(416,'A Metspalu',780),(417,'Andrew McKinnon',784),(419,'Andrew C Heath',789),(420,'AC Heath',789),(421,'A Heath',789),(422,'Andrew J Mackinnon',792),(423,'AJ Mackinnon',792),(424,'A Mackinnon',792),(426,'A Jones',794),(427,'A Tonkin',795),(428,'Andrew M McIntosh',796),(429,'AM McIntosh',796),(430,'AD Thompson',800),(431,'A Thompson',800),(432,'A Zalesky',802),(433,'Angus K Wallace',816),(434,'Anita Van Zwieten',822),(435,'AK Henders',824),(436,'Anna Docherty',830),(437,'A Roos',852),(438,'A Koschera',854),(439,'Annette Hartmann',855),(440,'A Schmiede',856),(441,'Anouk Den Braber',858),(442,'A Komaroff',866),(443,'A Scaffidi',867),(444,'Ashlee B Grierson',887),(445,'AB Grierson',887),(446,'Ashleigh M Tickell',889),(447,'AM Tickell',889),(448,'A Nixon',892),(449,'Ayman Fanous',901),(450,'AH Fanous',901),(451,'B Couvy-Duchesne',904),(452,'B M├â┬╝ller-Myhsok',911),(453,'B Nelson',912),(454,'Brenda W Penninx',913),(455,'Brenda Penninx',913),(456,'Brenda P Penninx',913),(457,'BWJH Penninx',913),(458,'BW Penninx',913),(459,'B Penninx',913),(460,'B Qaiser',915),(461,'B Zurowski',918),(462,'BJ Harrison',919),(463,'BJ Meyer',920),(464,'BP Riley',922),(465,'BT Webb',923),(466,'Bernard Balleine',924),(467,'BW Balleine',924),(468,'Barbara K Bennett',928),(469,'Barbara Bennett',928),(470,'BK Bennett',928),(471,'B Bennett',928),(472,'Barbara CAMERON',929),(473,'B Cameron',929),(474,'Beata Godlewska',934),(475,'BR Godlewska',934),(476,'B Godlewska',934),(477,'Bendik Slagsvold Winsvold',945),(478,'Benjamin M Neale',951),(479,'B Irungu',956),(480,'B McNair',959),(481,'Bernd Kr├â┬ñmer',963),(482,'B Kr├â┬ñmer',963),(483,'Bernhard Baune',965),(484,'Berhard T Baune',965),(485,'BT Baune',965),(486,'B Baune',965),(487,'B Lyndon',971),(488,'Blake A Hamilton',973),(489,'BA Hamilton',973),(490,'Bradley G Whitwell',982),(491,'BG Whitwell',982),(492,'B Whitwell',982),(494,'B O\'Dea',997),(495,'Brion Maher',999),(496,'Brittany L Mitchell',1000),(498,'BA Mueller',1011),(499,'Catherine Brennan',1015),(500,'C Brennan',1015),(501,'C Doughty',1019),(502,'C Fazou',1021),(503,'C Gordon',1023),(504,'C Hayward',1024),(505,'C Healy',1025),(506,'C Hoyos',1026),(507,'C Konrad',1029),(508,'C Ricci',1032),(509,'C RICCI',1032),(510,'CS Weickert',1034),(511,'C Shannon Weickert',1034),(512,'CC Minica',1037),(513,'CM Middeldorp',1043),(514,'Caroline Gao',1044),(515,'CX Gao',1044),(516,'C Gao',1044),(517,'Carlos A Zarate',1057),(518,'Caro Badcock',1064),(519,'C Hickie',1088),(520,'Catherine M McHugh',1089),(521,'C McHugh',1089),(522,'Catherine M Olsen',1090),(523,'Cathryn Lewis',1094),(524,'CM Lewis',1094),(526,'CATHERINE Mason',1096),(527,'C Wijeratne',1100),(528,'C Henry',1102),(530,'Chris J Tanti',1123),(531,'CJ Hopfer',1126),(532,'CY Song',1139),(533,'C Tennant',1143),(534,'Christopher Davey',1144),(535,'CG Davey',1144),(536,'Chris S Haley',1148),(537,'C Pantelis',1149),(540,'C Crainiceanu',1157),(541,'Clem Boughton',1172),(542,'CR Boughton',1172),(543,'C Markulev',1185),(546,'CL Hyde',1197),(547,'Craig L Little',1198),(548,'CL Little',1198),(549,'C S├â┬ínchez-Mora',1207),(550,'D Bartlett',1214),(551,'D Brown',1216),(552,'D Colquhoun',1217),(553,'D Crisp',1219),(554,'D Czamara',1220),(555,'D Goldstein',1222),(556,'D Grotegerd',1223),(557,'D Hadzi-Pavlovic',1224),(558,'D HADZI-PAVLOVIC',1224),(559,'D Hoehn',1225),(560,'D Isaev',1226),(561,'Dagar Koethe',1227),(562,'D Koethe',1227),(563,'D Schoepf',1232),(564,'D Spiliotacopoulos',1234),(565,'D Thompson',1235),(566,'D Velakoulis',1237),(567,'DC Glahn',1239),(568,'DENIS WAKEFIELD',1240),(569,'D Wakefield',1240),(570,'Daniel Francis Hermens',1241),(571,'Daniel F Hermens',1241),(572,'DF Hermens',1241),(573,'Donald J MacIntyre',1242),(574,'DJ MacIntyre',1242),(575,'Dan J Stein',1243),(576,'DJ Stein',1243),(577,'Derrek Hibar',1247),(578,'DP Hibar',1247),(579,'DS Quintana',1249),(580,'DR Nyholt',1254),(581,'Dan I Lubman',1258),(582,'D Bos',1267),(583,'DE Irons',1270),(584,'DH Mathalon',1274),(585,'Daniel Biddle',1277),(586,'DJ Biddle',1277),(587,'D Biddle',1277),(590,'Danielle Dick',1290),(592,'D Cannon',1294),(593,'David A Barton',1302),(594,'D Cotter',1309),(595,'David Craig',1311),(596,'David J Kavanagh',1321),(597,'DJ Porteous',1322),(598,'DL Duffy',1326),(599,'D Hare',1327),(600,'D Clarke',1329),(601,'D Howard',1332),(602,'David M KAYE',1333),(603,'D Mongan',1340),(604,'D Pierce',1341),(605,'David C Whiteman',1347),(606,'Dean Carson',1351),(607,'Debra J Rickwood',1358),(608,'D Rickwood',1358),(609,'DJ Veltman',1378),(610,'D Veltman',1378),(611,'D Mehta',1391),(612,'D White',1393),(613,'Dorien H Nieman',1407),(614,'DH Nieman',1407),(615,'D Nieman',1407),(616,'Dorret Boomsma',1410),(617,'DI Boomsma',1410),(618,'Doug F Levinson',1412),(619,'DF Levinson',1412),(620,'Douglas HR Blackwood',1413),(621,'DRH Blackwood',1413),(622,'DHR Blackwood',1413),(623,'Dubbo Infection Outcomes Study Group',1415),(624,'D Hadzi Pavlovic',1416),(625,'E Agerbo',1418),(626,'Edmond Breen',1420),(627,'E Breen',1420),(628,'Eoin Killackey',1422),(629,'Eoin J Killackey',1422),(630,'E Killackey',1422),(631,'E Loehrer',1423),(632,'E Pozzi',1424),(633,'E Simulionyte',1425),(634,'EC Dunn',1427),(635,'Eco JC De Geus',1429),(636,'Eco J De Geus',1429),(637,'EJC de Geus',1429),(638,'EJC De Geus',1429),(639,'EJW Van Someren',1430),(640,'EW Dickie',1433),(641,'Eric YH Chen',1434),(642,'Eric Chen',1434),(643,'EYH Chen',1434),(644,'E Chen',1434),(645,'EJCG Van den Oord',1439),(646,'Elaine A Barrett',1446),(647,'Elena A Filimonova',1451),(648,'Eleni A Demetriou',1452),(649,'EA Demetriou',1452),(650,'EB Binder',1458),(651,'E Schramm',1460),(652,'Elizabeth M Stewart',1470),(653,'Emily Dennis',1482),(654,'Emma E Thomas',1486),(655,'EE Thomas',1486),(656,'Emma Hawkins',1488),(657,'Enda Byrne',1492),(658,'EM Byrne',1492),(661,'EG J├â┬╢nsson',1508),(662,'Eske Derks',1513),(663,'EM Frey',1522),(664,'E Frey',1522),(665,'E Mihailov',1525),(666,'Evgeniy A Osipov',1526),(667,'E Osipov',1526),(668,'F Giorlando',1528),(669,'F Lamers',1529),(670,'F Markus Leweke',1530),(671,'F Streit',1533),(672,'F Xavier Castellanos',1535),(673,'FM Howells',1539),(674,'FP MacMaster',1540),(675,'F Piras',1544),(676,'Faisal M Rashid',1545),(677,'Farnush Farhadi Hassan Kiadeh',1550),(678,'F Stanley',1560),(679,'Flavio Kapczinski',1564),(680,'FM Boyle',1567),(681,'F Boyle',1567),(682,'Frances P Thorndike',1570),(683,'F Thorndike',1570),(684,'Frank R Wendt',1583),(685,'FA Henskens',1584),(686,'F Degenhardt',1587),(687,'Gunther Paul Amminger',1596),(688,'Gp Paul Amminger',1596),(689,'GP Amminger',1596),(690,'G Paul Amminger',1596),(691,'G Amminger',1596),(692,'G Tofler',1600),(693,'G Van Grootheest',1601),(694,'G Willemsen',1603),(695,'Gail A Alvares',1604),(696,'GA Alvares',1604),(697,'GM MacQueen',1607),(698,'GS Malhi',1609),(699,'Grant Montgomery',1611),(700,'Grant M Montgomery',1611),(701,'GW Montgomery',1611),(702,'Gabri├â┬½lla AM Blokland',1613),(703,'Gabriella Blokland',1613),(705,'Gary Donohoe',1619),(706,'Gavin W LAMBERT',1624),(707,'G Gladstone',1625),(708,'GB Hall',1630),(709,'G Homuth',1632),(710,'G Patton',1638),(711,'Georgina Luscombe',1641),(712,'GM Luscombe',1641),(713,'G Luscombe',1641),(714,'G Breen',1650),(715,'G Pistis',1658),(716,'GH Lubke',1662),(717,'Gordon B Parker',1673),(718,'GORDON Parker',1673),(719,'GORDON PARKER',1673),(720,'G Parker',1673),(721,'Grace Groom',1674),(722,'G Groom',1674),(723,'Graeme O\'Keefe',1676),(724,'G O\'keefe',1676),(725,'Grant Andrew Blashki',1679),(726,'Grant A Blashki',1679),(727,'G Blashki',1679),(728,'Grant BC Sinnamon',1680),(729,'G Murray',1682),(730,'Greig I de Zubicaray',1684),(731,'Greig I De Zubicaray',1684),(732,'Greg de Zubicaray',1684),(733,'GI de Zubicaray',1684),(734,'GI De Zubicaray',1684),(735,'Gregor E Berger',1685),(736,'Gregor Berger',1685),(737,'GE Berger',1685),(738,'G Berger',1685),(739,'G Zhu',1691),(740,'G Morken',1698),(741,'H Brodaty',1706),(742,'H Dobrowolny',1708),(743,'H Li',1715),(744,'H Shou',1717),(745,'H Volzke',1718),(746,'H V├â┬╢lzke',1719),(747,'H Walter',1720),(748,'Hannah F Yee',1723),(749,'H Yee',1723),(750,'Heather C Whalley',1725),(751,'HC Whalley',1725),(752,'H Whalley',1725),(753,'HE Hulshoff Pol',1726),(754,'HK Jayaweera',1727),(755,'HM Koot',1728),(756,'HN  Buttensch├╕n',1729),(757,'HP Yuen',1730),(758,'HR Kranzler',1731),(759,'HS Temmingh',1732),(760,'Hampton L Leonard',1740),(761,'Hans J Grabe',1751),(762,'HJ Grabe',1751),(763,'H Grabe',1751),(764,'H Kugel',1755),(765,'H Sumich',1767),(767,'Helen M Christensen',1768),(768,'Helen Christensen',1768),(769,'H Christensen',1768),(770,'Helen E Herrman',1769),(771,'H Herrman',1769),(772,'H Tiemeier',1777),(773,'Hogni Oskarsson',1792),(775,'H Morgan',1805),(776,'H Gaspar',1814),(777,'I Brack',1815),(778,'I Jones',1816),(779,'IJ Deary',1820),(780,'IP Everall',1821),(781,'Iain MacMillan',1823),(782,'IH Gotlib',1828),(783,'IM Veer',1839),(784,'I Veer',1839),(785,'I Garcia-Martinez',1855),(786,'Iryna Fedko',1857),(787,'I Schweitzer',1859),(788,'I Pokorski',1866),(789,'J Batchelor',1867),(790,'Jane Burns',1870),(791,'JM Burns',1870),(792,'J Burns',1870),(793,'JM Dwyer',1873),(794,'JM DWYER',1873),(795,'J Dwyer',1873),(796,'Jessica A Hartmann',1877),(797,'JA Hartmann',1877),(798,'J Hartmann',1877),(799,'J Menssink',1879),(800,'J Olver',1882),(801,'J Parsons',1884),(802,'Jane E Pirkis',1886),(803,'JE Pirkis',1886),(804,'J Pirkis',1886),(805,'J Shi',1890),(806,'J Tatoulis',1892),(807,'J Tiller',1893),(808,'J Whitfield',1895),(809,'J van der Werf',1896),(810,'JA Knowles',1897),(811,'Jeffrey Colin Richards',1899),(812,'Jeffrey C Richards',1899),(813,'JC Richards',1899),(814,'J Richards',1899),(815,'JG Dobbins',1902),(816,'Janine G Walker',1903),(817,'JG Walker',1903),(818,'JH Smit',1904),(819,'J Ford',1906),(820,'JW Smoller',1910),(821,'JZ Liu',1911),(822,'Jackson G Thorp',1918),(823,'Jacob Crouse',1920),(824,'JJ Crouse',1920),(825,'Jacqueline I Goldstein',1924),(826,'JM Vink',1927),(827,'Jacquelyn L Meyers',1928),(828,'JC Soares',1933),(829,'Jake R Palmer',1934),(830,'James A Dunbar',1937),(831,'James B Potash',1939),(832,'JB Potash',1939),(835,'James M Shine',1946),(836,'J Southan',1948),(837,'Jan Buitelaar',1953),(838,'J Strohmaier',1958),(839,'JL Ebejer',1960),(840,'JPY Tong',1966),(841,'JP Fouche',1986),(842,'Jeanette McClintick',1989),(843,'Jeanne GeHue',1990),(844,'J Leerssen',1991),(845,'Jennifer Evans',2006),(846,'JJ Ware',2007),(847,'J MacKenzie',2010),(848,'J Treutlein',2012),(849,'Jerome C Foo',2015),(850,'Jerome Ip',2017),(853,'Ji He',2031),(854,'Jean Yang',2032),(857,'J Zhang',2037),(858,'J Lagopoulos',2039),(859,'Joanna Biernacka',2049),(860,'Joanne S Carpenter',2054),(861,'Joanne Carpenter',2054),(862,'JS Carpenter',2054),(863,'J Carpenter',2054),(864,'J Gelernter',2059),(865,'John A Hardy',2071),(866,'John A Mendoza',2073),(867,'John B Kwok',2074),(868,'John F Pearson',2080),(869,'John J McGrath',2091),(870,'JP Rice',2094),(871,'JP Khoo',2109),(872,'J Bybjerg-Grauholm',2112),(873,'Jonathan IR Coleman',2120),(874,'JRI Coleman',2120),(875,'J Frank',2134),(876,'JA Ramos-Quiroga',2135),(878,'JD Isen',2147),(879,'Josh Faskowitz',2148),(880,'J Faskowitz',2148),(881,'Jouke Jan Hottenga',2155),(882,'Jouke Hottenga',2155),(883,'JJ Hottenga',2155),(884,'J Bustillo',2162),(885,'J Chan',2170),(886,'J Angst',2175),(888,'J Bryois',2189),(889,'J Tobias-Webb',2192),(893,'JX Chen',2203),(894,'J Wellmann',2205),(895,'K Berger',2206),(896,'Kate Braunstein',2207),(897,'K Braunstein',2207),(898,'K Fields',2208),(899,'K Filia',2209),(900,'K Hegenscheid',2211),(901,'KM Kirk',2213),(902,'K Kirk',2213),(903,'K Lawson',2214),(904,'Katie L Mcmahon',2216),(905,'Katie L McMahon',2216),(906,'KL McMahon',2216),(907,'K McMahon',2216),(909,'K Schnell',2218),(910,'KL Pepper',2220),(911,'Kathleen R Merikangas',2223),(912,'Kathleen Merikangas',2223),(913,'KR Merikangas',2223),(914,'K Hodgson',2234),(915,'Kate Chitty',2251),(916,'KM Chitty',2251),(917,'K Domschke',2255),(918,'K Wittfeld',2257),(919,'Kathryn Alpert',2268),(920,'Kathryn L McCabe',2271),(921,'Kay A Wilhelm',2284),(922,'K Wilhelm',2284),(923,'K Turner',2286),(924,'Kelly A Allott',2291),(925,'Kelsie A Boulton',2297),(926,'Kenneth Krauter',2299),(927,'Ken Krauter',2299),(928,'K Krauter',2299),(929,'KS Kendler',2303),(930,'Kerrie Eyers',2304),(931,'Kerne Eyers',2304),(932,'K Eyers',2304),(933,'Keri L Diamond',2305),(934,'Keri Diamond',2305),(935,'K Diamond',2305),(936,'Kimberly Chambert',2326),(937,'Kimberley D Chambert',2326),(938,'Kitty A Rahilly',2331),(939,'KR Van Eijk',2339),(940,'Kristi Griffiths',2340),(942,'KR Griffiths',2340),(943,'KM Griffiths',2340),(944,'K Griffiths',2340),(945,'L Cui',2356),(946,'Loren Mowszowski',2361),(947,'L Mowszowski',2361),(948,'L Mundy',2362),(949,'L Taylor',2364),(950,'Lieuwe De Haan',2365),(951,'L de Haan',2365),(952,'L De Haan',2365),(953,'L Elliot Hong',2367),(954,'LJ Seidman',2368),(955,'Laura S Van Velzen',2369),(956,'LS van Velzen',2369),(957,'LS Van Velzen',2369),(958,'LT Strike',2371),(959,'LT Westlye',2380),(960,'Laura Hack',2391),(962,'Lauren E Salminen',2402),(963,'Lee M Ritterband',2413),(964,'L Ritterband',2413),(965,'Lei Wang',2416),(966,'L Tozzi',2426),(967,'L Roos',2427),(970,'L Schmaal',2434),(971,'Lillian J Gehue',2440),(972,'Lillian Gehue',2440),(973,'LJ Gehue',2440),(974,'Lindsay A Farrer',2447),(975,'Lisa A Jones',2452),(976,'LA Jones',2452),(977,'Lisa J Phillips',2458),(978,'LJ Phillips',2458),(979,'L Phillips',2458),(980,'Louisa Margaret Norrie',2470),(981,'Louisa M Norrie',2470),(982,'Louisa L Norrie',2470),(983,'LM Norrie',2470),(984,'L Norrie',2470),(985,'Louise A Ellis',2471),(986,'Luc├â┬¡a Colodro-Conde',2483),(987,'Lucia Colodro-Conde',2483),(988,'Luke Bolt',2491),(989,'Lyubomir Aftanas',2493),(990,'Lybomir Aftanas',2493),(991,'L Aftanas',2493),(992,'Lyn Griffiths',2495),(993,'Lyn Littlefield',2496),(994,'L Littlefield',2496),(995,'MA Redoblado-Hodge',2503),(996,'M Antoinette Redoblado-Hodge',2503),(997,'M Bruinenberg',2504),(998,'M B├â┬ªkvad-Hansen',2505),(999,'Miguel Casas',2506),(1000,'M Casas',2506),(1001,'M Fenech',2510),(1002,'M Helena Azevedo',2511),(1003,'M Ising',2513),(1004,'M Kljakovic',2514),(1005,'M Nordentoft',2519),(1006,'M Rietschel',2521),(1007,'M Rivera',2522),(1008,'M Schaefer',2524),(1009,'M Schl├â┬╢gelhofer',2525),(1010,'M Theodoros',2528),(1011,'M Walter',2529),(1012,'M-P Austin',2531),(1013,'MA Ikram',2532),(1014,'MA Porter',2533),(1015,'Michael C Sharpe',2535),(1016,'MC Sharpe',2535),(1017,'ME Renter├â┬¡a',2537),(1018,'MJ Portella',2540),(1019,'Marilena Demayo',2542),(1020,'MM DeMayo',2542),(1021,'MM Noethen',2543),(1022,'Maxwell Bennett',2544),(1023,'Max Bennett',2544),(1024,'MR Bennett',2544),(1025,'MW Vernooij',2545),(1026,'Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium',2560),(1027,'M Bernard',2569),(1028,'M Kaur',2570),(1029,'Manuel B Graeber',2572),(1030,'M Udina',2576),(1031,'Marco Boks',2580),(1032,'MP Boks',2580),(1033,'MR Munaf├â┬▓',2583),(1034,'M Branagan',2585),(1035,'Margie J Wright',2589),(1036,'Margaret Wright',2589),(1038,'Margaret J Wright',2589),(1039,'MJ Wright',2589),(1040,'M J Wright',2589),(1041,'Margaret J Tobin',2596),(1042,'Maria A Di Biase',2601),(1043,'MA Di Biase',2601),(1044,'M Antoinette Redoblado Hodge',2613),(1046,'Marie-Jose van Tol',2617),(1047,'Marie-Jose Van Tol',2617),(1048,'MJ van Tol',2617),(1049,'MJ Van Tol',2617),(1050,'M Van Tol',2617),(1051,'Mariesa A Nicholas',2620),(1052,'Marita McCabe',2633),(1053,'MP McCabe',2633),(1054,'M McCabe',2633),(1055,'Mark Adams',2637),(1056,'MJ Adams',2637),(1057,'Mark Daly',2645),(1058,'Markus P SCHLAICH',2658),(1059,'M Ribas├â┬⌐s',2666),(1060,'Martin A Kennedy',2676),(1061,'M Preisig',2677),(1062,'M Papmeyer',2681),(1063,'M Cannon',2683),(1064,'Matcheri Keshavan',2691),(1067,'MG Harris',2693),(1068,'Matt Paradise',2696),(1070,'Matt B Paradise',2696),(1071,'Matt McGue',2697),(1072,'Matt K McGue',2697),(1073,'MK McGue',2697),(1074,'MD Sacchet',2700),(1075,'M Hickman',2702),(1076,'Matthew Large',2705),(1077,'Matthew B McQueen',2706),(1078,'M Hamilton',2707),(1079,'M Traylor',2711),(1080,'M Nauck',2712),(1081,'M Berger',2720),(1082,'M F├â┬╢cking',2726),(1084,'M Li',2745),(1085,'Meng Zhen Liu',2746),(1086,'Meredith J McHugh',2749),(1087,'MC Stallings',2760),(1088,'M Czisch',2762),(1089,'M Friedlander',2765),(1090,'M Gill',2767),(1091,'MJ Owen',2768),(1092,'Michel G Nivard',2782),(1093,'Michele L Pergadia',2784),(1094,'ML Pergadia',2784),(1095,'ME Renteria',2790),(1096,'Miriam R Schafer',2805),(1097,'Miriam R Sch├â┬ñfer',2806),(1098,'MR Sch├â┬ñfer',2806),(1099,'M Sch├â┬ñfer',2806),(1100,'Mitchell Dowling',2810),(1101,'M Dowling',2810),(1102,'M Sazzad Hussain',2812),(1103,'M Schloegelhofer',2820),(1104,'Nathan A Gillespie',2832),(1105,'NA Gillespie',2832),(1106,'N Gillespie',2832),(1107,'N Jahanshad',2833),(1108,'N Opel',2834),(1109,'Naomi L Rogers',2835),(1110,'NL Rogers',2835),(1111,'N Rogers',2835),(1112,'Nic R Telford',2836),(1113,'N Telford',2836),(1114,'N Wilcken',2837),(1115,'N Zmicerevska',2838),(1116,'Nicole Highet',2841),(1117,'NJ Highet',2841),(1118,'N Highet',2841),(1119,'Nic JA van der Wee',2842),(1120,'Nic JA van Der Wee',2842),(1121,'Nic JA Van der Wee',2842),(1122,'NJ van der Wee',2842),(1123,'NJ Van der Wee',2842),(1124,'N Van der Wee',2842),(1125,'N Van Der Wee',2842),(1126,'NK Hansell',2843),(1127,'Natalie Mills',2845),(1128,'NT Mills',2845),(1129,'N Mills',2845),(1130,'Nancy L Pedersen',2856),(1131,'Nancy L Saccone',2857),(1132,'Naomi R Wray',2859),(1133,'NR Wray',2859),(1134,'N Jaworska',2863),(1135,'Nathan Cross',2868),(1136,'Nathaniel S Thomas',2870),(1137,'N Banaj',2877),(1138,'Nicholas Allen',2883),(1142,'NG Martin',2887),(1143,'N Martin',2887),(1144,'Nicholas Craddock',2891),(1145,'Nick Glozier',2892),(1146,'Nicholas S Glozier',2892),(1147,'Nicholas Glozier',2892),(1148,'N Glozier',2892),(1149,'Nicole Cockayne',2898),(1150,'NL Cockayne',2898),(1151,'Nigel TM Chen',2909),(1152,'Nilu Mossaheb',2915),(1153,'N Mossaheb',2915),(1154,'O Gruber',2929),(1155,'O Mors',2931),(1156,'OA Andreassen',2933),(1157,'Olivia Dean',2941),(1158,'P Cistulli',2947),(1159,'P Cowen',2948),(1160,'P Hazell',2954),(1161,'P Kochunov',2956),(1162,'P McGuffin',2957),(1163,'Pamela AF Madden',2964),(1164,'Pamela A Madden',2964),(1165,'PAF Madden',2964),(1166,'Philip B Mitchell',2965),(1167,'PB Mitchell',2965),(1168,'P Mitchell',2965),(1169,'Phoebe E Carter',2967),(1170,'Phoebe Carter',2967),(1171,'PE Carter',2967),(1172,'Philip Batterham',2970),(1173,'PJ Batterham',2970),(1174,'P Batterham',2970),(1175,'PM Boyce',2972),(1176,'P Boyce',2972),(1177,'Paul Murray Thompson',2974),(1178,'Paul M Thompson',2974),(1179,'PM Thompson',2974),(1180,'PR Jansen',2975),(1181,'PT Michie',2976),(1182,'Patricia Conrod',2993),(1183,'PF Sullivan',2998),(1184,'Patrick J McGrath',3001),(1185,'PJ McGrath',3001),(1186,'Patrick JF Clarke',3002),(1187,'Patrick D Mcgorry',3004),(1188,'Patrick D McGorry',3004),(1189,'Pat McGorry',3004),(1190,'PD McGorry',3004),(1191,'P McGorry',3004),(1192,'Patrik KE Magnusson',3006),(1193,'Patrik K Magnusson',3006),(1194,'Paul B Fitzgerald',3010),(1195,'PB Fitzgerald',3010),(1196,'Paul De Souza',3012),(1197,'PL De Souza',3012),(1198,'Paul Amminger',3018),(1199,'P Amminger',3018),(1200,'Paul Anthony Ryan',3024),(1201,'P Ryan',3024),(1202,'Penelope A Lind',3030),(1203,'P Hoffmann',3035),(1204,'Peter A Holmans',3047),(1205,'Peter McManus',3052),(1206,'Peter A Silburn',3056),(1207,'Phil H Lee',3061),(1208,'Philip Burgess',3067),(1209,'P Burgess',3067),(1210,'Philip Ward',3070),(1211,'Philip B Ward',3070),(1212,'PB Ward',3070),(1213,'PG S├â┬ñmann',3073),(1214,'Philip McGuire',3078),(1215,'PAC Van Lier',3088),(1217,'QS Li',3093),(1218,'R Carney',3097),(1219,'Rico SZ Lee',3101),(1220,'Rico SC Lee',3101),(1221,'Rico Lee',3101),(1222,'Rico Chun Sze Lee',3101),(1225,'RSC Lee',3101),(1226,'RS Lee',3101),(1227,'R Lee',3101),(1228,'R Loblay',3102),(1229,'R Sherva',3106),(1230,'R Wallis',3107),(1231,'R Dale',3109),(1232,'Roseann E Peterson',3111),(1233,'RE Peterson',3111),(1234,'RM Brouwer',3118),(1235,'Rafael A Calvo',3121),(1236,'Randy Gollub',3131),(1239,'R Walters',3142),(1240,'RS Kahn',3153),(1241,'Richard A Grucza',3158),(1242,'Richard B Banati',3160),(1243,'R Banati',3160),(1244,'R Parker',3171),(1245,'R Jansen',3173),(1246,'RA Battisti',3182),(1247,'Robert M Maier',3197),(1248,'Robert A Schoevers',3200),(1249,'R Schoevers',3200),(1250,'Robert RJM Vermeiren',3201),(1251,'RW McCarley',3202),(1252,'R Goya-Maldonado',3203),(1253,'R B├â┬╝low',3205),(1254,'Robin C Corley',3206),(1255,'Ron Ronald Grunstein',3221),(1256,'Ron R Grunstein',3221),(1257,'Ron Grunstein',3221),(1258,'Rosemary Purcell',3230),(1259,'R Purcell',3230),(1260,'RH Perlis',3233),(1262,'RE Gur',3235),(1263,'RC Gur',3235),(1264,'R├â┬⌐becca Robillard',3251),(1265,'Rebecca Robillard',3251),(1266,'R Robillard',3251),(1267,'S Cichon',3254),(1268,'S Cripps',3255),(1272,'SP Cross',3256),(1273,'S Cross',3256),(1274,'S Herms',3261),(1275,'S Huntley',3262),(1276,'S Lavoie',3264),(1277,'Simon JG Lewis',3265),(1278,'Simon J Lewis',3265),(1279,'SJ Lewis',3265),(1280,'S Lewis',3265),(1281,'S Lucae',3266),(1282,'S Macgregor',3267),(1283,'Sarah E Medland',3270),(1284,'SE Medland',3270),(1285,'S Medland',3270),(1286,'S Patel',3273),(1288,'S Rajaratnam',3276),(1289,'S Ripke',3278),(1290,'S Tang',3281),(1291,'Sandra Van der Auwera',3283),(1292,'S Van der Auwera',3283),(1293,'Swapna K Verma',3284),(1294,'S Verma',3284),(1295,'Suzanne VERNON',3285),(1296,'Suzanne D Vernon',3285),(1297,'S Vernon',3285),(1298,'S Wiltink',3286),(1299,'Silviu A Bacanu',3288),(1300,'SA Bacanu',3288),(1301,'SA Brown',3289),(1302,'Stephen E Straus',3293),(1303,'SE Straus',3293),(1304,'SM Cotton',3295),(1305,'S Cotton',3295),(1306,'Sally GALBRAITH',3300),(1307,'Sam Bolitho',3304),(1308,'S Bolitho',3304),(1309,'Samantha J Brooks',3308),(1310,'Samuel Hockey',3311),(1311,'SJ Hockey',3311),(1312,'SE Hetrick',3327),(1313,'S Hetrick',3327),(1314,'Sarah E Piper',3329),(1315,'Sarah Hartz',3336),(1316,'SP Hagenaars',3341),(1317,'Scott D Gordon',3345),(1318,'SD Gordon',3345),(1319,'Sean Hatton',3350),(1320,'SN Hatton',3350),(1322,'Shantel L Duffy',3360),(1323,'Shantel Duffy',3360),(1324,'SL Duffy',3360),(1325,'S Duffy',3360),(1326,'Sharon Linda Naismith',3366),(1327,'Sharon L Naismith',3366),(1328,'SL Naismith',3366),(1329,'S Naismith',3366),(1332,'Sherilyn D Goldstone',3377),(1333,'Shin H Park',3380),(1334,'SH Park',3380),(1337,'S Hong Lee',3381),(1338,'S Choi',3382),(1339,'Shona Francey',3384),(1340,'Simon M Rice',3398),(1341,'S Wessely',3400),(1342,'S Sharmin',3409),(1343,'Stanley Catts',3425),(1344,'Stan Catts',3425),(1345,'SI Shyn',3426),(1346,'S Kloiber',3430),(1347,'Stefan Smesny',3443),(1348,'S Smesny',3443),(1349,'SH Witt',3446),(1350,'S Bunker',3450),(1351,'Stephen J Wood',3453),(1352,'SJ Wood',3453),(1353,'S Wood',3453),(1354,'Stephen Lawrie',3455),(1355,'Steven JA van Der Werff',3468),(1356,'Steven JA Van der Werff',3468),(1357,'Steven J van der Werff',3468),(1358,'Steve Hamilton',3473),(1359,'SP Hamilton',3473),(1360,'SL Einfeld',3476),(1361,'S Stringer',3505),(1362,'Swaran P Singh',3508),(1363,'T Bradshaw',3509),(1364,'T Frodl',3511),(1365,'T Kircher',3513),(1366,'T Paus',3516),(1367,'T Sletten',3517),(1368,'T Usherwood',3519),(1369,'Tim Bigdeli',3520),(1370,'Tim B Bigdeli',3520),(1371,'TB Bigdeli',3520),(1372,'Theo GM van Erp',3521),(1373,'TGM van Erp',3521),(1374,'TGM Van Erp',3521),(1375,'TG Van Erp',3521),(1376,'TL Wall',3524),(1377,'TM Air',3525),(1378,'TP Gurholt',3526),(1379,'Tanya A Jackson',3534),(1380,'Tatiana Foroud',3537),(1381,'T Korhonen',3539),(1382,'TF Blanken',3544),(1383,'T Name',3545),(1384,'TD Satterthwaite',3548),(1385,'Thomas F Hansen',3555),(1386,'TG Schulze',3558),(1387,'Thorgeir E Thorgeirsson',3566),(1389,'Till FM Andlauer',3575),(1390,'TMF Andlauer',3575),(1391,'TFM Andlauer',3575),(1392,'Tim Anderson',3577),(1393,'Tim Shaw',3579),(1394,'T Spector',3581),(1395,'Timothy J Lambert',3585),(1397,'TW Mitchell',3595),(1398,'Toni L Pitcher',3598),(1399,'Tony K Ip',3603),(1400,'Tony Ip',3603),(1401,'TKC Ip',3603),(1402,'TK Ip',3603),(1403,'Trung T Ngo',3617),(1404,'Tonu Esko',3624),(1405,'U Dannlowski',3626),(1406,'Ute Vollmer-Conna',3632),(1407,'Ute S Vollmer-Conna',3632),(1408,'U acute Vollmer-Conna',3632),(1409,'U Vollmer-Conna',3632),(1410,'V Cropley',3634),(1411,'V Richarte',3639),(1412,'V Zipunnikov',3641),(1413,'Vanessa Cheng',3652),(1414,'Vaughan Carr',3655),(1415,'Veronica L Vatiliotis',3662),(1416,'Victoria O├éΓÇÖCallaghan',3670),(1417,'Vince Calhoun',3674),(1418,'Virginia R Winter',3680),(1419,'V Winter',3680),(1420,'V Arolt',3689),(1421,'Wade Berrettini',3696),(1422,'Wayne D Hall',3704),(1423,'William Bunney',3722),(1424,'William C REEVES',3723),(1425,'WC Reeves',3723),(1426,'William Coryell',3726),(1427,'William Byerley',3729),(1428,'Witte Hoogendijk',3737),(1429,'Working Group of the Royal Australasian College of Physicians',3740),(1430,'WJ Peyrot',3741),(1431,'X Chen',3745),(1432,'Y Milaneschi',3755),(1436,'Yu Jiang',3775),(1440,'Zoltan Kutalik',3786),(1441,'Z Kutalik',3786),(1442,'Zoe Terpening',3787),(1443,'Z Terpening',3787),(1444,'AJ Smith',3806),(1445,'Jian-Ping He',3811),(1446,'Daniel Smith',3825),(1447,'Mathew A Harris',3833),(1448,'Emma C Johnson',3843),(1449,'John Beilby',3827),(1450,'Shane P Cross',3834),(1468,'Andrew C McKinnon',792),(1469,'Chloe Wilson',3842),(1470,'Nicholas Martin',3852),(1471,'Raymond K Walters',3854),(1472,'Shane Cross',3834),(1473,'James Scott',3836),(1493,'J.-A Occhipinti',2),(1494,'Y.J.C Song',49),(1495,'G.Y Lee',110),(1496,'S.J Hockey',3311),(1497,'I.B. Hickie',20),(1512,'I.B Hickie',20),(1513,'A.M Hilber',659),(1514,'L. Freebairn',51),(1515,NULL,1950),(1516,'P.M Doraiswamy',2958),(1517,'P Meier',3314),(1518,'L.S van Velzen',2369),(1519,'M.R Dauvermann',2608),(1520,'L.M Villa',2479),(1521,'H.S Savage',1748),(1522,'Y.J Toenders',3761),(1523,'A.H Zhu',736),(1524,'J.K Bright',2052),(1525,'A.I Campos',656),(1526,'L.E Salminen',2402),(1527,'K. Blair',2242),(1528,'C.G Connolly',1181),(1529,'K.R Cullen',2274),(1530,'C.G Davey',1144),(1531,'J.M Fullerton',1968),(1532,'A.S Gonul',712),(1533,'I.H Gotlib',1828),(1534,'B.J Harrison',919),(1535,'T.C Ho',3571),(1536,'E.J Leehr',1459),(1537,'E.T.C Lippard',1472),(1538,'K.A McLaughlin',2276),(1539,'A.B Miller',649),(1540,'P.B Mitchell',1000),(1541,'I Nenadi─ç',1836),(1542,'B.J Overs',1002),(1543,'J.-K Pfarr',2180),(1544,'K.G Ringwald',2224),(1545,'M.A Sheridan',2587),(1546,'J.C Soares',1933),(1547,'G.I Teresi',1652),(1548,'D Tordesillas-Guti├⌐rrez',1376),(1549,'N.J.A van der Wee',2842),(1550,'S.J van der Werff',3468),(1551,'R.R.J.M Vermeiren',3201),(1552,'M.-J Wu',2815),(1553,'T.T Yang',3605),(1554,'P.M Thompson',2974),(1555,'M.E Renter├¡a',2537),(1556,'H.P Blumberg',1788),(1557,'A.-L van Harmelen',850),(1558,'L. Schmaal',2434),(1559,'J.J Crouse',1920),(1560,'S.H Park',3380),(1561,'B.L Mitchell',1000),(1562,'E.M Byrne',1492),(1563,'D.F Hermens',1241),(1564,'S.E Medland',3270),(1565,'N.G Martin',1678),(1566,'N.A Gillespie',2832),(1567,'S Hockey',3311),(1568,'S Park',3380),(1569,'E.M Scott',135),(1570,'H.M LaMonica',136),(1571,'T.A Davenport',17),(1572,'S.C Rowe',18),(1573,'V.W.S Cheng',3706),(1574,'J.S Carpenter',2054),(1575,'S.P.M Cross',3256),(1576,'J Crouse',1920),(1577,'M Brown',1690),(1578,'I. Hickie',20),(1579,NULL,1283),(1580,'K Merikangas',718),(1581,'S.L Naismith',3366),(1582,'A.J Guastella',620),(1583,'D Jamieson',2311),(1584,'D.D Sacks',1297),(1585,'J. Lagopoulos',2039),(1586,'K.D Lawson',2214),(1587,'B Smith',1001),(1588,'C.M Lewis',1094),(1589,'N.R Wray',2859),(1590,'N.G. Martin',1678),(1591,'S.M Cotton',3295),(1592,'M.P Hamilton',2707),(1593,'J.M Menssink',1879),(1594,'S.E Hetrick',3327),(1595,'A.G Parker',704),(1596,'P.D McGorry',3004),(1597,'C.X. Gao',1044),(1598,'A. Milton',735),(1599,'A.L Burton',746),(1600,'H.M La Monica',1714),(1601,'T MacKle',3611),(1602,'E. Byrne',1492),(1603,'B.M Valencia',984),(1604,'A.R. Lloyd',626),(1605,'S.R Susai',3481),(1606,'J.F Byrne',2110),(1607,'M.R Sch├ñfer',2806),(1608,'M Schl├╢gelhofer',2525),(1609,'G.E Berger',1685),(1610,'E.Y.H Chen',1799),(1611,'D.H Nieman',1407),(1612,'A Riecher-R├╢ssler',633),(1613,'A Ruth Yung',3245),(1614,'M F├╢cking',2726),(1615,'D. Cotter',1309),(1616,'Z.A.M Griffin',3802),(1617,'K.A Boulton',2297),(1618,'M.M DeMayo',2542),(1619,'A.J. Guastella',620),(1620,'H.F Yee',1723),(1621,'A Roberts',137),(1622,'S.J Schmidt',3437),(1623,'H.P Yuen',1730),(1624,'S.J Wood',3453),(1625,'W.J Brewer',3702),(1626,'A.R Yung',643),(1627,'J. Hartmann',1877),(1628,'E.E Thomas',1486),(1629,'R.B Banati',3160),(1630,'F.M Leweke',1530),(1631,'R.H Yolken',3189),(1632,'S.L Duffy',3360),(1633,'J.R Palmer',1934),(1634,'A.C. McKinnon',784),(1635,'C.X Gao',1044),(1636,'S.M. Cotton',3295),(1637,'G.P Amminger',1596),(1638,'J.A Hartmann',1877),(1639,'P.D. McGorry',3004),(1640,'D Kong',3373),(1641,'S.L. Naismith',3366),(1642,'E.A Demetriou',1452),(1643,'G.P. Amminger',1596),(1644,'H.M Lamonica',136),(1645,'G Lee',110),(1646,'C Fox',2890),(1647,'H LaMonica',136),(1648,'K.A Allott',2291),(1649,'A.E Roberts',137),(1650,'A.C Milton',735),(1651,'V.W Sze Cheng',3706),(1652,'S.E Piper',3329),(1653,'C.M McHugh',1089),(1654,'C Mchugh',1089),(1655,'K.R. Merikangas',718),(1656,'L.J Gehue',1990),(1657,'R.A Battisti',3182),(1658,'A.K Henders',824),(1659,'S.P Cross',3256),(1660,'S.N Hatton',3350),(1661,'D.F. Hermens',1241),(1662,'K.R Merikangas',718),(1663,'R.R Grunstein',3221),(1664,'R. Robillard',3251),(1665,'A.J Phillips',2458),(1666,'C.E Wilson',1189),(1667,'Y Song',1139),(1668,'E Byrne',1492),(1669,'H.C Dohnt',1778),(1670,'M.J Dowling',2810),(1671,'T.A Jackson',3534),(1672,'M.A Easton',2752),(1673,'K.L Pepper',2220),(1674,'H.-W Moon',1811),(1675,'H.M. LaMonica',136),(1676,'A.M Tickell',889),(1677,'E. Scott',135),(1678,'E.M. Scott',135),(1679,'S.R Clark',3818),(1680,'R.J Blair',3194),(1682,'J.M Biernacka',2049),(1683,'H.-C Chen',1152),(1684,'P.M Czerski',3085),(1692,'J.R DePaulo',1888),(1693,'B ├ëtain',1007),(1694,'A.J Forstner',772),(1695,'M.A Frye',2642),(1696,'J.S Garnham',2185),(1697,'F.S Goes',1558),(1698,'P.-H Kuo',3087),(1699,'J.R Kelsoe',2097),(1700,'M Land├⌐n',2792),(1701,'F.M Mondimore',1575),(1702,'J.B Potash',1939),(1703,'M.J Adams',2637),(1704,'T.M Air',3525),(1705,'T.F.M Andlauer',3575),(1706,'S.-A Bacanu',3288),(1707,'A.T.F Beekman',640),(1708,'T.B Bigdeli',3520),(1709,'E.B Binder',1458),(1710,'D.H.R Blackwood',1413),(1711,'J Christensen',1959),(1712,'T.-K Clarke',3600),(1713,'J.R.I Coleman',2120),(1714,'G.E Crawford',1687),(1715,'I.J Deary',1820),(1716,'E.M Derks',1513),(1717,'C.V Dolan',1186),(1718,'E.C Dunn',1427),(1719,'T.C Eley',3546),(1720,'F.F.H Kiadeh',1550),(1721,'H.K Finucane',1787),(1722,'H.A Gaspar',1814),(1723,'S.D Gordon',3345),(1724,'L.S Hall',3292),(1725,'C.S Hansen',1138),(1726,'T.F Hansen',3555),(1727,'J.-J Hottenga',2155),(1728,'D.M Hougaard',1331),(1729,'J.A Knowles',1897),(1730,'I.S Kohane',1858),(1731,'W.W Kretzschmar',3701),(1732,'P.A Lind',3030),(1733,'D.J MacIntyre',1242),(1734,'D.F MacKinnon',1350),(1735,'R.M Maier',3197),(1736,'C.M Middeldorp',1043),(1737,'G.W Montgomery',1611),(1738,'M.G Nivard',2782),(1739,'D.R Nyholt',1254),(1740,'M.J Owen',2768),(1741,'J.N Painter',2058),(1742,'R.E Peterson',3111),(1743,'W.J Peyrot',3741),(1744,'J.A Quiroz',2127),(1745,'J.P Rice',2094),(1746,'B.P Riley',922),(1747,'S.S Mirza',3297),(1748,'E.C Schulte',1168),(1749,'S.I Shyn',3426),(1750,'G.C.B Sinnamon',1680),(1751,'J.H Smit',1904),(1752,NULL,1283),(1753,'K.E Tansey',2259),(1754,'P.A Thomson',3086),(1755,'T.E Thorgeirsson',3566),(1756,'A.G Uitterlinden',805),(1757,'A.M van Hemert',642),(1758,'P.M Visscher',3051),(1759,'B.T Webb',923),(1760,'S.M Weinsheimer',3361),(1761,'S.H Witt',3446),(1762,'H.S Xi',1800),(1763,'B.T Baune',965),(1764,'D.I Boomsma',1410),(1765,'E.J.C de Geus',1429),(1766,'H.J Grabe',1751),(1767,'S.P Hamilton',2707),(1768,'A.C Heath',789),(1769,'K.S Kendler',2303),(1770,'Q.S Li',3853),(1771,'P.A.F Madden',2964),(1772,'P.K Magnusson',3006),(1773,'A.M McIntosh',796),(1774,'P.B Mortensen',3090),(1775,'B M├╝ller-Myhsok',968),(1778,'M.C OΓÇÖDonovan',2759),(1779,'S.A Paciga',3290),(1780,'N.L Pedersen',2856),(1781,'B.W.J.H Penninx',913),(1782,'R.H Perlis',3233),(1783,'D.J Porteous',1322),(1784,'T.G Schulze',3558),(1785,'J.W Smoller',1910),(1786,'H V├╢lzke',1718),(1787,'M.M Weissman',2830),(1788,'D.F Levinson',1412),(1789,'P.F Sullivan',2998),(1790,'P.R Schofield',3054),(1791,'B.T. Baune',965),(1792,'J.C Foo',2015),(1793,'E.A Stahl',1454),(1794,'C.A de Leeuw',1124),(1795,'J.M.W Pavlides',2009),(1796,'T.H Pers',3619),(1797,'P.A Holmans',3047),(1798,'T.D Als',3552),(1799,'J.A Badner',2166),(1800,'J.D Barchas',1916),(1801,'S.E Bergen',3325),(1802,'M Boks',2580),(1803,'W Bunney',3722),(1804,'W Byerley',3729),(1805,'K Chambert',2326),(1806,'A.W Charney',700),(1807,'W Coryell',3726),(1808,'D.W Craig',1311),(1809,'A.M Dale',759),(1810,'S de Jong',3401),(1811,'A.L Dobbyn',738),(1812,'C.C Fan',1151),(1813,'S.B Fischer',3340),(1814,'T.M Foroud',3537),(1815,'N.B Freimer',2875),(1816,'L Fris├⌐n',5835),(1817,'E.K Green',1449),(1818,'M.J Green',2734),(1819,'T.A Greenwood',3570),(1820,'J.G Parra',2132),(1821,'M.L Hamshere',2610),(1822,'J.S Johnson',2028),(1823,'J.L Kennedy',1945),(1824,'A.C Koller',829),(1825,'W.B Lawson',3721),(1826,'P.H Lee',3061),(1827,'J.Z Li',2034),(1828,'A.N Adolfsson',851),(1829,'S.M Purcell',3371),(1830,'W.A Scheftner',3720),(1831,'C.S Weickert',1034),(1832,'C Slaney',5879),(1833,'D.S Clair',1345),(1834,'T.W Weickert',3527),(1835,'P Zandi',5886),(1836,'W.H Berrettini',3696),(1837,'M.J Daly',2645),(1838,'E.S Gershon',1476),(1839,'F Goes',1558),(1840,'C.M Hultman',1131),(1841,'L.A Jones',2452),(1842,'R.S Kahn',3153),(1843,'R.M Myers',3168),(1844,'B.M Neale',951),(1845,'J.A Ramos-Quiroga',2135),(1846,'H.J Edenberg',1797),(1847,'L.J Scott',2388),(1848,'O.A Andreassen',2933),(1849,'J Kelsoe',2097),(1850,'J.H Christensen',1959),(1851,'D.M Howard',1332),(1852,'M. Rietschel',2521),(1853,'E.R Bemmer',1483),(1854,'C. Gao',1044),(1855,'A.D Harris',621),(1856,'Y.J Song',49),(1857,'P.G Enticott',3044),(1858,'M.K Licari',2735),(1859,'N.C Rogasch',2907),(1860,'A.-M Vallence',828),(1861,'A.J.O Whitehouse',641),(1862,'G.A Alvares',1604),(1863,'J.M Craig',1996),(1864,'N.T Mills',2845),(1865,'N.J Rinehart',2901),(1866,'P.H Donaldson',3045),(1867,'T.C Ford',3528),(1868,'P.B. Fitzgerald',3010),(1869,'S. Cotton',3295),(1870,'B.D.A Gorman',940),(1871,'C.R.K Ching',1147),(1872,'I Brak',1864),(1873,'G.B Filho',1643),(1874,'B.R Godlewska',934),(1875,'N.A Groenewold',2928),(1876,'G.B Hall',1630),(1877,'F.P MacMaster',1540),(1878,'K.L McMahon',2216),(1879,'B.A Mueller',1011),(1880,'M.J Portella',2540),(1881,'P.G.P Rosa',3026),(1882,'M.D Sacchet',2700),(1883,'D.J Stein',1243),(1884,'L.T Strike',2371),(1885,'S.I Thomopoulos',3414),(1886,'M.-J van Tol',2617),(1887,'I.M Veer',1839),(1888,'S.J.A van der Werff',3468),(1889,'N.R Winter',2914),(1890,'M.J Wright',2589),(1891,'G.I de Zubicaray',1684),(1892,'G.B Zunta-Soares',1659),(1893,'T.M Chaim-Avancini',3572),(1894,'F.M Howells',1539),(1895,'T.D Satterthwaite',3548),(1896,'M.H Serpa',2717),(1897,'H.S Temmingh',1732),(1898,'D.J Veltman',1378),(1899,'J.H Cole',1941),(1900,'K.M Filia',2209),(1901,'D.J Rickwood',1358),(1902,'I.H.K Leung',1863),(1903,'K.M Broadhouse',2273),(1904,'S.L. Duffy',3360),(1905,'J.K Hughes',2027),(1906,'N. Glozier',2892),(1907,'M.K Strike',2727),(1908,'K.-L Feilds',2348),(1909,'J De Koninck',2139),(1910,'C.E Beaden',1075),(1911,'K.S Cadenhead',2345),(1912,'T.D Cannon',3622),(1913,'B.A Cornblatt',927),(1914,'H.K Ising',1774),(1915,'D.H Mathalon',1274),(1916,'T.H McGlashan',3560),(1917,'N.G Mifsud',2869),(1918,'D.O Perkins',1373),(1919,'L.J Seidman',2368),(1920,'M.T Tsuang',2799),(1921,'M van der Gaag',2655),(1922,'E.F Walker',1448),(1923,'S.W Woods',3348),(1924,'B. Nelson',912),(1925,'H.C Whalley',1725),(1926,'M.A Harris',3833),(1927,'I.V Brak',1864),(1928,'E.A Filimonova',1451),(1929,'E.A Osipov',1526),(1930,'U. Dannlowski',3626),(1931,'P.G Amminger',3018),(1932,'E.Y Chen',1434),(1933,'D van de Ville',1385),(1934,'S. Eliez',3440),(1935,'M Demayo',2542),(1936,'E Chan',1516),(1937,'M Rees',2644),(1938,'T Shaw',3579),(1939,'K.M Chitty',2251),(1940,'R.S.C Lee',3816),(1941,'A.A Moustafa',667),(1942,'J.M Burns',1870),(1943,'J. Mendoza',2073),(1944,'A.A Navarro-Mancilla',733),(1945,'A.M Rangel',779),(1946,'G.E Rueda-Jaimes',1648),(1947,'T.A. Davenport',17),(1948,'P. McGorry',3004),(1949,'N.R. Wray',2859),(1950,'K.M Kirk',2213),(1951,'J.J McGrath',2091),(1952,'D.J Statham',1392),(1953,'L.I Aftanas',2493),(1954,'K.V Danilenko',2337),(1955,'E.L Hawkins',1488),(1956,'T.A Lett',3616),(1957,'A.S Tomyshev',698),(1958,'M.W Schreiner',2731),(1959,'A.E Whitton',709),(1960,'J.L Shah',1930),(1961,'M.S Keshavan',2691),(1962,'C.M Hoyos',1026),(1963,'S.J.G Lewis',3265),(1964,'J.-A Atkinson',2),(1965,'H.-K Chung',1807),(1966,'H.E Herrman',1769),(1967,'T.W Mitchell',3595),(1968,'B.J Meyer',920),(1969,'B.J. Meyer',920),(1970,'J.G Scott',77),(1971,'J.M Whitehead Pavlides',2009),(1972,'D St Clair',1345),(1973,'F.F Hassan Kiadeh',1550),(1974,'L.M Olde Loohuis',5914),(1975,'P.F O\'Reilly',3015),(1976,'M.C O\'Donovan',2759),(1977,'A Di Florio',5956),(1978,'G. Breen',1650),(1979,'K.L Purves',2330),(1980,'S.W Choi',3382),(1981,'T.C. Eley',3546),(1982,'C.L Clarke',1054),(1983,'A Murray',717),(1984,'M.E Porteous',2723),(1985,'S.S Cross',3256),(1986,'M Harris',3833),(1987,'R.J Scott',3113),(1988,'F Hogervorst',6317),(1989,'M Schmidt',2695),(1990,'F Lesueur',6202),(1991,'M.E Martinez',2607),(1992,'A Miller',649),(1993,'V.S Pankratz',3661),(1994,'S.K Park',3380),(1995,'Y.Y Tan',3756),(1996,'D Hunter',1320),(1997,'M.K Schmidt',2695),(1998,'K.P Glanville',2354),(1999,'K.B Hanscombe',2298),(2000,'P.A Madden',2964),(2001,'A.D. B├╕rglum',5869),(2002,'L.J Phillips',2458),(2003,'S.P Hagenaars',3341),(2004,'J.J Hottenga',2155),(2005,'J.B Whitfield',1895),(2006,'C.M. Lewis',1094),(2007,'S.K Verma',3284),(2008,'K. Gwynne',2352),(2009,'S.R Mallawaarachchi',3486),(2010,'L.K Bolt',2491),(2011,'K.A. Allott',2291),(2012,'N Allen',2883),(2013,'S.P Singh',3508),(2014,'T C. Ho',3571),(2015,'E.J.W Van Someren',1430),(2016,'T.F Blanken',3544),(2017,'K R. Cullen',2274),(2018,'C Davey',1144),(2019,'J Evans',2006),(2020,'B.A Gutman',977),(2021,'D.E.J Linden',1313),(2022,'A M. McIntosh',796),(2023,'D.M.A Mehler',1337),(2024,'P G. S├ñmann',5967),(2025,'N.J.A van Der Wee',2842),(2026,'D.J. Veltman',1378),(2027,'S.V Auwera',3283),(2028,'H.C. Whalley',1725),(2029,'S.J Brooks',3308),(2030,'K.Z Lewinn',2226),(2031,'A.N Simmons',679),(2032,'T.G.M Van Erp',3521),(2033,'N.J.A Van Der Wee',2842),(2034,'M.-J Van Tol',2617),(2035,'D.P Hibar',1247),(2036,'T. Frodl',3511),(2037,'C.L Vallerga',1193),(2038,'A.F McRae',727),(2039,'M.F Nabais',2664),(2040,'G Montgomery',1611),(2041,'Y.-H Chuang',3776),(2042,'J.B Kwok',2074),(2043,'S.R Bentley',3474),(2044,'P.A Silburn',3056),(2045,'T Anderson',3577),(2046,'G.D Mellick',1635),(2047,'J. Gratten',1919),(2048,'R.S Chun Lee',3816),(2049,'M Large',2705),(2050,'C.J Ryan',1146),(2051,'M.M. Large',2705),(2052,'A.B Grierson',887),(2053,'R. Purcell',3230),(2054,'A.M Diaz',872),(2055,'R.S.Z Lee',3816),(2056,'B.A Hamilton',973),(2057,'L Gehue',1990),(2058,'I MacMillan',1823),(2059,'L.-H Chang',2492),(2060,'N.A. Gillespie',2832),(2061,'S. Cross',3256),(2062,'P.B Fitzgerald',3010),(2063,'K.E Hoy',2249),(2064,'J Ip',2017),(2065,'J. Scott',77),(2066,'S.E.R Bogaty',3412),(2067,'E.G Benotsch',1500),(2068,'C.S Ricci',1032),(2069,'L.T McLoughlin',2376),(2070,'K Mcaloney',2309),(2071,'B.P Zietsch',986),(2072,'S.P Rosenberg',50),(2074,'T.C Bates',3582),(2075,'R.M Kirkpatrick',3196),(2076,'E.G. Benotsch',1500),(2077,'M.C Barbu',2809),(2078,'S.R Cox',3397),(2079,'C.S Haley',1148),(2080,'S.M Lawrie',3455),(2081,'N.A Furlotte',2886),(2082,'D.A Hinds',1299),(2083,'C.H Wilson',1189),(2084,'P.J Batterham',2970),(2085,'A.L Calear',719),(2086,'M.E Larsen',2641),(2087,'D J Kavanagh',1321),(2088,'B.F Dear',972),(2089,'P. Gorman',2999),(2090,'G. Paul Amminger',1596),(2091,'E.H.C Chan',1516),(2092,'A.R Lloyd',626),(2093,'U. Vollmer-Conna',3632),(2094,'M.J Jones',6445),(2095,'D.T.S Lin',1293),(2096,'K.C Koenen',2236),(2097,'E.B. Binder',1458),(2098,'A.F Alexander-Bloch',646),(2099,'D.C Glahn',1239),(2100,'B.N Ubani',952),(2101,'S.J.A Van Der Werff',3468),(2102,'C. Francks',1174),(2103,'M de Ridder',2780),(2104,'M Bennett',2544),(2105,'J. Kim',2042),(2106,'L.J Young',2428),(2107,'K.M Griffiths',2340),(2108,'L. Ritterband',2413),(2109,'R.K Walters',3854),(2110,'J.D Buxbaum',2138),(2111,'A.L Dumont',891),(2112,'J.I Goldstein',1924),(2113,'M.V Hollegaard',2551),(2114,'J.L Moran',2093),(2115,'G Davey Smith',1636),(2116,'D.H Geschwind',1273),(2117,'J.A Bourne',1936),(2118,'J.B Mattingley',1975),(2119,'A.J Lawrence',791),(2120,'N Vincent',2897),(2121,'L.J Richards',2443),(2122,'G.F Egan',1621),(2123,'B Fitzgibbon',958),(2124,'D.R Badcock',1342),(2125,'B Balleine',924),(2126,'J.M Bekkers',2090),(2127,'A Bradley',798),(2128,'G de Zubicaray',1684),(2129,'L Griffiths',2495),(2130,'A.J Hannan',865),(2131,'P.T Michie',2976),(2132,'J.M Payne',2115),(2133,'D.H.K Shum',1316),(2134,'G.J Stuart',1681),(2135,'A van Schaik',806),(2136,'S.J Conn',3392),(2137,'M Korgaonkar',2721),(2138,'M.R Azghadi',2825),(2139,'M.B. Thompson',3895),(2140,'J.Y Lee',1944),(2141,'D.N Brown',1216),(2142,'S.S.K Lee',3819),(2143,'S.-J Dawson',6390),(2144,'A De Fazio',6331),(2145,'S Edwards',6395),(2146,'J French',6600),(2147,'G Giles',6292),(2148,'J Hopper',6320),(2149,'P James',6383),(2150,'R Milne',6388),(2151,'J Taylor',6560),(2152,'M.E Robson',6531),(2153,'A.K Merikangas',718),(2154,'N.D Volkow',2921),(2155,'V. Zipunnikov',3641),(2156,'M.A Nalls',2794),(2157,'D.A Kia',1360),(2158,'A.J Noyce',681),(2159,'R von Coelln',3123),(2160,'J.R Gibbs',1887),(2161,'D.G Hernandez',1361),(2162,'S.W Scholz',3411),(2163,'J.A Botia',2158),(2164,'J.-C Corvol',1984),(2165,'L.M Shulman',2456),(2166,'J.M Shulman',2150),(2167,'N.W Wood',2888),(2168,'J.A Hardy',2071),(2169,'H.R Morris',1810),(2170,'R.R Graham',3199),(2171,'A.B Singleton',782),(2172,'R.N Alcalay',3234),(2173,'F.J Barrero',1578),(2174,'J.A Bergareche Yarza',2030),(2175,'J.A Bot├¡a',2158),(2176,'M.T Boungiorno',2687),(2177,'M.R Cookson',2649),(2178,'M.J Gomez Heredia',2605),(2179,'M.M Gonz├ílez',5888),(2180,'K.J Kinghorn',2306),(2181,'M.A Labrador-Espinosa',2789),(2182,'H.L Leonard',1740),(2183,'J.L Lopez-Sendon',2133),(2184,'M.J Marti',2606),(2185,'I Mart├¡nez Torres',1851),(2186,'N.E Mencacci',2882),(2187,'K.Y Mok',2327),(2188,'O.O Ojo',2943),(2189,'N.U Okubadejo',2917),(2190,'A.G Pagola',754),(2191,'F Perez Errazquin',1579),(2192,'E.M Rezola',1456),(2193,'M.X Tan',2575),(2194,'K.-H Lin',2349),(2195,'J Tung',6636),(2196,'S Bentley',3474),(2197,'J Kwok',2074),(2198,'G Mellick',1635),(2199,'F. Zhang',1593),(2200,'R.H Reynolds',6646),(2201,'J Bot├¡a',2158),(2202,'J.A.B Yarza',2030),(2203,'M.J.G Heredia',2605),(2204,'F.P Errazquin',1579),(2205,'I.M Torres',1851),(2206,'M. Ryten',6760),(2207,'S.B Harvey',3310),(2208,'T.A Zaidi',3607),(2209,'R.M Walker',3229),(2210,'S.E Harris',3326),(2211,'A.D Murray',717),(2212,'K.L Evans',2270),(2213,'R.E Marioni',3155),(2214,'P.M. Visscher',3051),(2215,'M.J McHugh',2749),(2216,'M Sch├ñfer',2806),(2217,'D F. Hermens',1241),(2218,'I. B. Hickie',20),(2219,'M.J. Wright',2589),(2220,'T.M.F Andlauer',3575),(2221,'A.F.T Beekman',640),(2222,'D.R.H Blackwood',1413),(2223,'J.I.R Coleman',2120),(2224,'C.A Crowley',1115),(2225,'H.S Dashti',1762),(2226,'N DIrek',2878),(2227,'F.H.F Kiadeh',1550),(2228,'C.S├╕ Hansen',1138),(2229,'C.L Hyde',1197),(2230,'J.M Lane',1926),(2231,'C.B├╕ Pedersen',5864),(2232,'S Saeed Mirza',3297),(2233,'G.B.C Sinnamon',1680),(2234,'C.A Stockmeier',1194),(2235,'S Van Der Auwera',3283),(2236,'A.M Van Hemert',642),(2237,'E.C.J De Geus',1429),(2238,'J.R Depaulo',1888),(2239,'P.F.A Madden',2964),(2240,'P.F. Sullivan',2998),(2241,'C.-A Badcock',1064),(2242,'N.L Rogers',2835),(2243,'S.J Mullin',3364),(2244,'A.C McKinnon',784),(2245,'J.M Shine',1946),(2246,'P.B Ward',3070),(2247,'D.S Quintana',1249),(2248,'J.L Scott',77),(2249,'D.J Biddle',1277),(2250,'M.C Neale',2758),(2251,'M.S Panizzon',2709),(2252,'C.E Franz',1065),(2253,'W.S Kremen',3733),(2254,'D Porteous',1322),(2255,NULL,1001),(2256,'E.J.C De Geus',1429),(2257,'N.E Cross',2868),(2258,'M.L Santoro',2582),(2259,'V.K Ota',3651),(2260,'J Strauss',5931),(2261,'F.G Meng',5909),(2262,'W.E Bunney',3722),(2263,'A.W McLean',117),(2264,'U Osby',5859),(2265,'E Stahl',1454),(2266,'A Dobbyn',738),(2267,'L Oru─ì',5916),(2268,'C.S Bloss',1156),(2269,'J Rice',2094),(2270,'S Z├╢llner',5942),(2271,'D St. Clair',1345),(2272,'D.A Collier',1298),(2273,'I.N Ferrier',1817),(2274,'R Ophoff',5957),(2275,'D Morris',5910),(2276,'A Farmer',846),(2277,'N.J Bass',2884),(2278,'C Hultman',1131),(2279,'L.M Huckins',2386),(2280,'J Nurnberger',5955),(2281,'S.J Newhouse',3452),(2282,'S.I Belangero',3403),(2283,'R.A Bressan',3210),(2284,'J.E Pye',3813),(2285,'C.Y Song',1139),(2286,'P.S Eggins',3038),(2287,'A Spurdle',6555),(2288,'Y. Antill',6399),(2289,'C.A Bousman',1035),(2290,'R.M Brouwer',3118),(2291,'V Calhoun',3674),(2292,'V Carr',3655),(2293,'S Catts',3425),(2294,'J.-X Chen',2203),(2295,'K.K Cho',2333),(2296,'A.S Corvin',644),(2297,'C.M Diaz-Caneja',1042),(2298,'E.W Dickie',1433),(2299,'F.-M Fan',1538),(2300,'J.M Ford',1906),(2301,'J.-P Fouche',1986),(2302,'R Gollub',3131),(2303,'E.D Goudzwaard',1428),(2304,'R.E Gur',3855),(2305,'T.P Gurholt',3526),(2306,'F.A Henskens',1584),(2307,'L.E Hong',2367),(2308,'H.E Hulshoff Pol',1726),(2309,'P.R Jansen',2975),(2310,'L.A Jung',2366),(2311,'S Lawrie',3455),(2312,'R.K Lenroot',3114),(2313,'K.O Lim',2222),(2314,'R.C.W Mandl',3110),(2315,'R.W McCarley',3202),(2316,'R.I Mesholam-Gately',3112),(2317,'D.T Newell',1250),(2318,'P O\'Donnell',2960),(2319,'G.R Pellicano',1608),(2320,'S.G Potkin',3294),(2321,'P.E Rasser',2968),(2322,'D.R Roalf',1248),(2323,'M.L Seal',2541),(2324,'C.D Whelan',1040),(2325,'M.E Shenton',2538),(2326,'J.S Kwon',1908),(2327,'L.T Westlye',2380),(2328,'N.T Doan',2844),(2329,'N.E.M Van Haren',2840),(2330,'C.D Vargas',1039),(2331,'J.Q Voyvodic',1907),(2332,'T.J Whitford',3522),(2333,'J.D Wojcik',1900),(2334,'G. Donohoe',1619),(2335,'C.C Minic─â',1037),(2336,'K.J.H Verweij',2240),(2337,'P.J van der Most',3048),(2338,'K.R van Eijk',2339),(2339,'M.Z Liu',2746),(2340,'D.F Maciejewski',1399),(2341,'S.J.T Branje',3490),(2342,'S.A Brown',3289),(2343,'R.P Corley',3206),(2344,'G.E Davies',3844),(2345,'E.A Ehli',1507),(2346,'I.O Fedko',1857),(2347,'I Garcia-Mart├¡nez',1855),(2348,'C.A Hartman',1082),(2349,'C.J Hopfer',1126),(2350,'H.R Kranzler',1731),(2351,'P.A.C van Lier',3088),(2352,'W.H.J Meeus',3736),(2353,'I.M Nolte',1838),(2354,'A.J Oldehinkel',682),(2355,'R.J Rose',3167),(2356,'M.C Stallings',2760),(2357,'T.L Wall',3524),(2358,'J.J Ware',2007),(2359,'H.M Koot',1728),(2360,'J.K Hewitt',2087),(2361,'M.P Boks',2580),(2362,'J.M Vink',1927),(2363,'E.M. Derks',1513),(2364,'R.C Dale',3109),(2365,'Y.C Song',49),(2366,'N.S. Glozier',2892),(2367,'A.C Abelmann',747),(2368,'M.R Bennett',2544),(2369,'A.A Gibson',713),(2370,'L.A Ellis',2471),(2371,'A. Bechdolf',770),(2372,'A.C Edwards',708),(2373,'A.H Fanous',901),(2374,'P.J McGrath',3001),(2375,'M.L Pergadia',2784),(2376,'K.S. Kendler',2303),(2377,'G.A.M Blokland',1613),(2378,'A.K Wallace',816),(2379,'N.K Hansell',2843),(2380,'M.M.G Koenis',2624),(2381,'K.A Mather',2230),(2382,'H.G Schnack',1806),(2383,'S.C Swagerman',3503),(2384,'J.H Gilmore',2084),(2385,'P.S Sachdev',3037),(2386,'H.E. Hulshoff Pol',1726),(2387,'E.L Dennis',1482),(2388,'G.I De Zubicaray',1684),(2389,'P.M. Thompson',2974),(2390,'M.A Di Biase',2601),(2391,'A.M Scott',634),(2392,'I.P Everall',1821),(2393,'V. Cropley',3634),(2394,'T.G.M van Erp',3521),(2395,'E.M Frey',1522),(2396,'H.J. Grabe',1751),(2397,'E.J Breen',1420),(2398,'J Beilby',2198),(2399,'M.M Demayo',2542),(2400,'C Lewis',1094),(2401,'M.M Nothen',5855),(2402,'P.J Cowen',2948),(2403,'T.M Binz',3587),(2404,'J.G Eriksson',2062),(2405,'M.-R J├ñrvelin',2635),(2406,'D.M Evans',6273),(2407,'B St Pourcain',6686),(2408,'S.G Matthews',3405),(2409,'T.F Andlauer',3575),(2410,'A.T Beekman',640),(2411,'J.R Coleman',2120),(2412,'P De Jager',3066),(2413,'C S├╕holm Hansen',1138),(2414,'D Hougaard',1331),(2415,'G.C Sinnamon',1680),(2416,'P Bo Mortensen',3090),(2417,'B.W Penninx',913),(2418,'M.R Baumgartner',2659),(2419,'B.R Walker',3839),(2420,'A.A Crawford',781),(2421,'J.W Cheung',1909),(2422,'M.A Ikram',2532),(2423,'M.W Vernooij',2545),(2424,'W.J Niessen',3694),(2425,'L.S Van Velzen',2369),(2426,'N.J Van der Wee',2842),(2427,'G.M MacQueen',1607),(2428,'J.E Sussmann',1901),(2429,'N.A Bokhan',2839),(2430,'S.M Rice',3398),(2431,'K Leigh Smith',2343),(2432,'M.K Weinberg',2736),(2433,'L.A. Ellis',2471),(2434,'K.R Griffiths',2340),(2435,'B.W. Balleine',924),(2436,'H.K Jayaweera',1727),(2437,'C.J Yatawara',1041),(2438,'S.L Einfeld',3476),(2439,'R.A Calvo',3121),(2440,'M.S Hussain',2812),(2441,'P. Danckwerts',3042),(2442,'J.L Ebejer',1960),(2443,'D.L Duffy',1326),(2444,'F.J Kay-Lambkin',1568),(2445,'H. Christensen',1768),(2446,'J.A Gosling',2070),(2447,'L.M Ritterband',2413),(2448,'F.P Thorndike',1570),(2449,'A.J. Mackinnon',792),(2450,'R Grunstein',3221),(2451,'N Cross',2868),(2452,'C.A Zarate',1057),(2453,'E.C Long',1465),(2454,'L.R Richards',2443),(2455,'B. Vissel',1010),(2456,'M.J Van Tol',2617),(2457,'F.H Fischer',1537),(2458,'D.P. Hibar',1247),(2459,'J.D Isen',2147),(2460,'J.M Harris',2191),(2461,'A.C Huizink',638),(2462,'D.E Irons',1270),(2463,'G.H Lubke',1662),(2464,'M.K McGue',2697),(2465,'M.B Miller',2753),(2466,'A.I Stiby',695),(2467,'W.G Iacono',3730),(2468,'J.M. Vink',1927),(2469,'X.-N Zuo',3744),(2470,'R.C Craddock',3096),(2471,'P.A Bandettini',3040),(2472,'F.X Castellanos',1535),(2473,'M.P Milham',2775),(2474,'M.A Redoblado Hodge',2503),(2475,'M.A.R Hodge',2503),(2476,'R. Langdon',3207),(2477,'N.L Cockayne',2898),(2478,'H.M Christensen',1768),(2479,'T De Regt',3529),(2480,'R.S Lee',3816),(2481,'P.S Haber',69),(2482,'J GeHue',1990),(2483,'B.G Whitwell',982),(2484,'T Ip',6898),(2485,'K.L Smith',2343),(2486,'B.J Yee',987),(2487,'A.F Jorm',639),(2488,'J.P.Y Tong',1966),(2489,'P.D. Mcgorry',3004),(2490,'L.M Russell',2429),(2491,'S. Sinclair',3301),(2492,'G.M Luscombe',1641),(2493,'K.M Gray',2353),(2494,'B.J Tonge',1005),(2495,'C.M Keating',1069),(2496,'S.L. Einfeld',3476),(2497,'V.A Johnson',3663),(2498,'A.H Kemp',788),(2499,'C.J Lennings',1145),(2500,'L.M Thomas',2403),(2501,'N Cockayne',2898),(2502,'K Chitty',2251),(2503,'S.J Lewis',3265),(2504,'D.L. Duffy',1326),(2505,'E.L Elcombe',1487),(2506,'G.-B Chen',1702),(2507,'W.H Coryell',3726),(2508,'S.H Lee',3819),(2509,'D.E Arking',1257),(2510,'M.H Azevedo',2511),(2511,'A.J Bailey',863),(2512,'M.R Barnes',2776),(2513,'T.B Barrett',3550),(2514,'W Berrettini',3696),(2515,'D.W Black',1401),(2516,'N.G Buccola',2855),(2517,'J.K Buitelaar',1953),(2518,'W.F Byerley',3729),(2519,'R.M Cantor',3177),(2520,'E.H Cook',1438),(2521,'I.W Craig',1833),(2522,'M.L Cuccaro',2770),(2523,'E.J De Geus',1429),(2524,'G.J Donohoe',1619),(2525,'A.E Doyle',734),(2526,'R.P Ebstein',3170),(2527,'A Fanous',901),(2528,'S.V Faraone',3458),(2529,'A.E Farmer',846),(2530,'T Foroud',3537),(2531,'C.M Freitag',1136),(2532,'P.V Gejman',2979),(2533,'D.E Grice',1408),(2534,'J.L Haines',2114),(2535,'A.M Hartmann',855),(2536,'W.J Hoogendijk',3737),(2537,'M.C Keller',2698),(2538,'G.K Kirov',5943),(2539,'M.A Kohli',2670),(2540,'N L├Ñngstr├╢m',6816),(2541,'J.A Lieberman',1995),(2542,'D.-Y Lin',1293),(2543,'P.K.E Magnusson',3006),(2544,'C.L Martin',1199),(2545,'S.A McCarroll',5905),(2546,'K.A McGhee',2219),(2547,'B.J Mowry',909),(2548,'W.A Nolen',3719),(2549,'C.N Pato',5949),(2550,'E.M Quinn',6830),(2551,'G Rouleau',5871),(2552,'D Ruderfer',5923),(2553,'S.W Scherer',3459),(2554,'S.L Slager',3491),(2555,'E.J.C.G van den Oord',1439),(2556,'L.A Weiss',2401),(2557,'F.G Zitman',1585),(2558,'S. Z├╢llner',5942),(2559,'M.H Meier',2549),(2560,'A.W Hewitt',692),(2561,'T.Y Wong',3569),(2562,'D.A. Mackey',1300),(2563,'C OΓÇÖdushlaine',6812),(2564,'S Newhouse',3452),(2565,'C.R Cloninger',1033),(2566,'N L├ñngstr├╢m',6816),(2567,'D.J Macintyre',1242),(2568,'D Moreno-De-luca',6933),(2569,'T.S Stroup',6967),(2570,'J.S Sutcliffe',6968),(2571,'A.J Willsey',6982),(2572,'M.C OΓÇÖdonovan',2759),(2573,'D Mccade',1406),(2574,'M.M Noethen',2543),(2575,'C.A Rietveld',1036),(2576,'D.H Blackwood',1413),(2577,'V.M Castro',3666),(2578,'S.E Churchill',3495),(2579,'V.S Gainer',3682),(2580,'P.J Gallagher',2992),(2581,'W Hoogendijk',3737),(2582,'D.V Iosifescu',1261),(2583,'D Macintyre',1242),(2584,'G.M Montgomery',1611),(2585,'S.N Murphy',3374),(2586,'M O\'Donovan',2759),(2587,'E.J Van Den Oord',1439),(2588,'J.B Weilburg',1993),(2589,'M Daly',6256),(2590,'S E Baumeister',3897),(2591,'D.J Benjamin',1276),(2592,'L.J Bierut',2387),(2593,'P.L De Jager',3066),(2594,'C De Leeuw',1124),(2595,'D.S Evans',6273),(2596,'J.D Faul',2025),(2597,'J.R Harris',2191),(2598,'N.D Hastie',6867),(2599,'S.L.R Kardia',3368),(2600,'P.D Koellinger',3071),(2601,'N.W Martin',2887),(2602,'O.T Raitakari',2942),(2603,'A.V Smith',3806),(2604,'J.A Smith',2001),(2605,'C.M Van Duijn',1190),(2606,'D.R Weir',1343),(2607,'A.F Wright',5885),(2608,'W. Zhao',3710),(2609,'E.M Stewart',1470),(2610,'N Hansell',2843),(2611,'N.J Samani',2912),(2612,'R.A Schoevers',3200),(2613,'A.T.F. Beekman',640),(2614,'M.R. Bennett',2544),(2615,'S.W Rajaratnam',3276),(2616,'J.R Hodges',2096),(2617,'S.J.G. Lewis',3265),(2618,'M.A Redoblado-Hodge',2503),(2619,'M.A Porter',2533),(2620,'J.A Mendoza',2073),(2621,'B.K Bennett',928),(2622,'A.J Mackinnon',792),(2623,'K Kalia Hehir',2229),(2624,'K.L Mcmahon',2216),(2625,'A.W Toga',883),(2626,'M.B Graeber',2572),(2627,'C.J Dunn',1048),(2628,'J.M. Shine',1946),(2629,'T.S Kubarych',3562),(2630,'S.H Aggen',3467),(2631,'M Keshavan',2691),(2632,'S.D Goldstone',3377),(2633,'E.A Papagiannopoulou',1453),(2634,'J.L Stein',1977),(2635,'A.A Vasquez',684),(2636,'M.E Renteria',2537),(2637,'K Alpert',2268),(2638,'N.C Andreasen',2854),(2639,'L.G Apostolova',2433),(2640,'N.J Armstrong',2894),(2641,'M.E Bastin',2640),(2642,'C.E Bearden',1076),(2643,'H.J Bockholt',1780),(2644,'I.J Bowman',1829),(2645,'H.G Brunner',1741),(2646,'D.G Brohawn',1315),(2647,'R.L Buckner',3132),(2648,'J Buitelaar',1953),(2649,'J.R Bustillo',2162),(2650,'V.D Calhoun',3674),(2651,'D.M Cannon',1294),(2652,'M.A Carless',2725),(2653,'G.L Cavalleri',1656),(2654,'M.M Chakravarty',2517),(2655,'K.D Chang',2322),(2656,'V.P Clark',3677),(2657,'P Conrod',2993),(2658,'J.E Curran',2053),(2659,'A den Braber',858),(2660,'G Donohoe',1619),(2661,'T.D Dyer',3553),(2662,'C.J Ekman',1055),(2663,'I Fedko',1857),(2664,'S.E Fisher',3391),(2665,'P.T Fox',3058),(2666,'R.Z Goldstein',3179),(2667,'R.L Gollub',3131),(2668,'U.K Haukvik',3629),(2669,'B.-C Ho',947),(2670,'P.J Hoekstra',3083),(2671,'A.J Holmes',900),(2672,'K.S Hwang',2347),(2673,'J.B.J Kwok',2074),(2674,'B.A Landman',954),(2675,'S Le Hellard',3447),(2676,'M.W.J Machielsen',2631),(2677,'G.D Pearlson',1597),(2678,'J.L Roffman',2149),(2679,'A.J Saykin',793),(2680,'L Seidman',2368),(2681,'L Strike',2371),(2682,'N.J van der Wee',2842),(2683,'K van Eijk',2339),(2684,'N.E.M van Haren',2840),(2685,'D van \'t Ent',1365),(2686,'R Walker',3229),(2687,'J.W Toumbourou',2103),(2688,'S.C Jones',68),(2689,'F.R Walker',1589),(2690,'M.H James',2823),(2691,'A Van Zwieten',822),(2692,'P.R Gehrman',3068),(2693,'T.L Sletten',3517),(2694,'S.M.W Rajaratnam',3276),(2695,'J.-P He',2031),(2696,'B.W Balleine',924),(2697,'P.J Hurley',3000),(2698,'W.J Ryder',3695),(2699,'A van Zwieten',822),(2700,'D.J Hawes',1319),(2701,'M.M McGuinness',2591),(2702,'E.A Woods',1462),(2703,'H.M Disinger',1747),(2704,'H.-K Chan',1734),(2705,'T.F Chen',3584),(2706,'R.B. Banati',3160),(2707,'G.H Tofler',1600),(2708,'D.M Colquhoun',1217),(2709,'S.J Bunker',3450),(2710,'D.M Clarke',1329),(2711,'D.L Hare',1327),(2712,'D.R Thompson',1235),(2713,'M.G. Branagan',2585),(2714,'J Van Der Werf',1896),(2715,'S.E. Medland',3270),(2716,'S.A Mccarroll',5905),(2717,'K.A Mcghee',2219),(2718,'J.J Mcgough',6928),(2719,'P.J Mcgrath',3001),(2720,'P Mcguffin',2957),(2721,'M.G Mcinnis',5906),(2722,'A Mcintosh',796),(2723,'R Mckinney',6929),(2724,'A.W Mclean',117),(2725,'F.J Mcmahon',5887),(2726,'W.M Mcmahon',6930),(2727,'A Mcquillin',797),(2728,'C O\'dushlaine',6938),(2729,'E.J.C.G Van Den Oord',1439),(2730,'M.C O\'donovan',2759),(2731,'I.S McGregor',1824),(2732,'A.H. Kemp',788),(2733,'I.S Mcgregor',1824),(2734,'S.H Stephens',3333),(2735,'S.M Hartz',3336),(2736,'N.R Hoft',2904),(2737,'N.L Saccone',2857),(2738,'R.C Corley',3206),(2739,'N.N Hansel',2848),(2740,'J.R Shaffer',2098),(2741,'S.E Short',3489),(2742,'J.R Thompson',2099),(2743,'B.-Z Yang',926),(2744,'A.J Balmforth',864),(2745,'S.E Baumeister',3897),(2746,'T.H Beaty',3543),(2747,'A.W Bergen',801),(2748,'Y.-C Cheng',3784),(2749,'D Dick',1290),(2750,'A.S Hall',725),(2751,'M.-T Landi',2609),(2752,'S.M Levy',5902),(2753,'R.A Mathias',3134),(2754,'D.W Mcneil',1286),(2755,'K.E North',2237),(2756,'K.C Barnes',2264),(2757,'M.-R Jarvelin',2635),(2758,'M.L Marazita',2684),(2759,'B.D Mitchell',1000),(2760,'A.G Schwartz',826),(2761,'G.E Swan',1620),(2762,'D.S Cannon',1294),(2763,'E.O Johnson',3843),(2764,'V.L Stevens',3668),(2765,'R.B Weiss',3184),(2766,'M.A. Ehringer',2632),(2767,'M.M N├╢ethen',2543),(2768,'J Jan Hottenga',2155),(2769,'B.P Penninx',913),(2770,'G van Grootheest',1601),(2771,'E Binder',1458),(2772,'A. Viktorin',699),(2773,'T.L Watson',3530),(2774,'L.M Norrie',2470),(2775,'P.J Clarke',6900),(2776,'R.-L Kuhnert',3144),(2777,'P.L De Souza',3012),(2778,'N.R.C Wilcken',2837),(2779,'M.M Norberg',2739),(2780,'M.B Paradise',2696),(2781,'N. Solowij',2849),(2782,'P Sullivan',2998),(2783,'R.J.L Anney',3159),(2784,'D Blackwood',1413),(2785,'D Collier',1298),(2786,'R Ebstein',3170),(2787,'M Keller',2698),(2788,'K Klump',2294),(2789,'J McGough',6928),(2790,'M N├╢then',5855),(2791,'M Owen',2768),(2792,'B Riley',922),(2793,'P Schofield',3054),(2794,'A Todorov',6972),(2795,'J.G Walker',1903),(2796,'A.W MacLean',645),(2797,'J.Z Liu',1911),(2798,'B.P McEvoy',921),(2799,'N.L. Rogers',2835),(2800,'P.E Carter',2967),(2801,'A.R Kenyon',624),(2802,'M.-C Chiang',2800),(2803,'A.J MacKinnon',792),(2804,'J. Kulkarni',1981),(2805,'G.S Malhi',1609),(2806,'J.P Khoo',2109),(2807,'D.L Bassett',1296),(2808,'M. Berk',2755),(2809,'N.S Glozier',2892),(2810,'E.L Werry',1431),(2811,'G.J Liu',1605),(2812,'M.D Lovelace',2536),(2813,'L.A Durkin',2400),(2814,'D.S Carson',1351),(2815,'T.J Lambert',3585),(2816,'A.C Andreazza',751),(2817,'A.L. Calear',719),(2818,'M. Stevenson',2652),(2819,'K.M Cullen',2274),(2820,'C.H Stewart',1162),(2821,'B. Whitwell',982),(2822,'G Leigh Carter',1689),(2823,'T. Davenport',17),(2824,'D.I Lubman',1258),(2825,'S.D Vernon',3285),(2826,'W.C Reeves',3723),(2827,'A. Lloyd',626),(2828,'S.M Francey',3384),(2829,'A.R. Yung',643),(2830,'A.N Page',58),(2831,'W.D. Hall',3704),(2832,'K.A Wilhelm',2284),(2833,'A.W Finch',652),(2834,'M. Bennett',2544),(2835,'B.F Piraino',931),(2836,'L.K Littlefield',2496),(2837,'J. Moran',2093),(2839,'N.J. Highet',2841),(2840,'C.L Little',1198),(2841,'G. Parker',1673),(2842,'W.A Longley',3714),(2843,'H.J. Jackson',1781),(2844,'J.A Dunbar',1937),(2845,'P. Reddy',3089),(2846,'A.S Fogarty',768),(2847,'J. Burns',1870),(2848,'N.B Allen',2883),(2849,'J.G Simmons',2181),(2850,'D.A Barton',1302),(2851,'E.A Lambert',1457),(2852,'M.D Esler',2828),(2853,'D.M Kaye',1333),(2854,'M.P Schlaich',2658),(2855,'G.W. Lambert',1624),(2856,'M.A Price',2728),(2857,'J Wilson',6864),(2858,'K.-A Phillips',6361),(2859,'M. Price',2728),(2860,'M.R Stockler',2678),(2861,'A.K Nowak',834),(2862,'N.R Wilcken',2837),(2863,'E.A Abdi',1442),(2864,'P.J Beale',3065),(2865,'R.J. Simes',3098),(2866,'H. Brodaty',1706),(2867,'N.J Highet',2841),(2868,'C. Little',1198),(2869,'G.A. Blashki',1679),(2870,'E. Barrett',1446),(2871,'G.M. Luscombe',1641),(2872,'E.J Killackey',1422),(2873,'H.J Jackson',1781),(2874,'J.E Pirkis',1886),(2875,'G.A Blashki',1679),(2876,'M.G Harris',3833),(2877,'A. Headey',677),(2878,'G.L Groom',1674),(2879,'V.R Winter',3680),(2880,'P.A. Cistulli',2947),(2881,'V.A Rendle',3647),(2882,'W.D Hall',3704),(2883,'W.S Montgomery',3734),(2884,'P.R McManus',3052),(2885,'B.G McNair',959),(2886,'M.-B Lee',7199),(2887,'J.C Richards',1899),(2888,'M.P McCabe',2633),(2889,'P Ellis',3039),(2890,'D.A.R. Smith',1283),(2891,'G. Groom',1674),(2892,'T.J.R Lambert',3585),(2893,'J Newcomer',2102),(2894,'J Thompson',2099),(2895,'K. Wilson',2289),(2896,'S.A McLachlan',6397),(2897,'K.A Phillips',6361),(2898,'P. Cistulli',2947),(2899,'F. Stanley',1560),(2900,'A.J Smith',3806),(2901,'J McCallum',2092),(2902,'K. Pearson',2310),(2903,'P.M Ellis',3039),(2904,'G Berry',7238),(2905,'C. Mason',1096),(2906,'V.M Jelinek',3636),(2907,'B.F Oldenburg',991),(2908,'H.G Peach',1765),(2909,'C.C Tennant',1143),(2910,'A.M. Tonkin',795),(2911,'P. McManus',3052),(2912,'C.S. Ricci',1032),(2913,'G. Andrews',1622),(2914,'H. Morgan',1805),(2915,'M. Tobin',2596),(2916,'W.-O Phoon',3693),(2917,'D.O. Watson',1246),(2918,'K. Wilhelm',2284),(2919,'A. Koschera',854),(2920,'M.-P Austin',2531),(2921,'P. Mitchell',2965),(2922,'G.B. Parker',1673),(2923,'K.A. Wilhelm',2284),(2924,'D. Burke',1304),(2925,'S.E Straus',3293),(2926,'L. Prenter',2410),(2927,'C. Mutch',1072),(2928,'A.J Wilson',723),(2929,'D. Wakefield',1240),(2930,'J.M Wright',1881),(2931,'K. Eyers',2304),(2932,'R.H. Loblay',3102),(2933,'N. Martin',2887),(2934,'D. Whitten',1348),(2935,'K. Turner',2286),(2936,'I.B. Hickle',7194),(2937,'P.K. Peterson',2971),(2938,'D. Hadzi-Pavlovic',1224),(2939,'G Van Der Linden',1602),(2940,'S. Wessely',3400),(2941,'M.J Tobin',2596),(2942,'F.M Yeo',1569),(2943,'L. Chen',2431),(2944,'J.W Lance',1951),(2945,'J.G Colebatch',1942),(2946,'M. Vidailhet',2616),(2947,'S. Naismith',3366),(2948,'U.S Vollmer-Conna',3632),(2949,'C.M Brennan',1015),(2950,'M.P Douglas',2774),(2951,'G.R Hansen',1631),(2952,'A.J Tahmindjis',691),(2953,'T.M Florio',3604),(2954,'C. Ricci',1032),(2955,'A. Urbanc',739),(2956,'X.F Huang',3751),(2957,'K.D Bird',2314),(2958,'R.F. Westbrook',3148),(2959,'R. Schwartz',3141),(2960,'D. Hughes',1317),(2961,'A.W Hooker',890),(2962,'W. Orlay',3716),(2963,'P. Boyce',2972),(2964,'B. Bennett',928),(2965,'M.C Sharpe',2535),(2966,'J.G Dobbins',1902),(2967,'A. Komaroff',866),(2968,'P.M Boyce',2972),(2969,'G.M Allen',1606),(2970,'S.C Gandevia',3291),(2971,'I.R Neering',1822),(2972,'J. Middleton',1880),(2973,'D.K. McKenzie',1244),(2974,'C Boughton',1172),(2975,'J.G Lowe',6924),(2976,'C. Hickie',1088),(2977,'I HICKIE',20),(2978,'C HICKIE',1088),(2979,'J DWYER',1873),(2980,'D. WAKEFIELD',1240),(2981,'D.L Goldenberg',1400),(2982,'G.B Parker',1673),(2983,'E.A Barrett',1446),(2984,'K. Roy',2283),(2985,'C. Tennant',1143),(2986,'J.F.J O\'Dea',2013),(2987,'F. Pedic',1531),(2988,'P. Gordon',2990),(2989,'C. Burke',1133),(2990,'J. Dwyer',1873),(2991,'C.R Boughton',1172),(2992,'D. Silove',1367),(2993,'I.B. Hickie AM',20),(2994,'I.B Hickie AM',20),(2995,'I. Hickie AM',20),(2996,'A.V Smith',7294),(2997,'Alison J Smith',3806),(2998,'Alison J. Smith',3806),(2999,'D.J Smith',3825),(3000,'D Smith',1283);
/*!40000 ALTER TABLE `other_names` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `project_authors`
--

DROP TABLE IF EXISTS `project_authors`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `project_authors` (
  `project_id` int(11) NOT NULL,
  `author_id` int(11) NOT NULL,
  `author_order` int(11) DEFAULT NULL,
  PRIMARY KEY (`project_id`,`author_id`),
  KEY `author_id` (`author_id`),
  CONSTRAINT `project_authors_ibfk_1` FOREIGN KEY (`project_id`) REFERENCES `projects` (`project_id`),
  CONSTRAINT `project_authors_ibfk_2` FOREIGN KEY (`author_id`) REFERENCES `authors` (`author_id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `project_authors`
--

LOCK TABLES `project_authors` WRITE;
/*!40000 ALTER TABLE `project_authors` DISABLE KEYS */;
INSERT INTO `project_authors` VALUES (41,1,5),(41,2,1),(41,15,0),(41,16,2),(41,17,3),(41,18,4),(41,19,6),(41,20,7),(43,4,NULL),(68,1,5),(68,2,0),(68,16,2),(68,20,9),(68,47,1),(68,48,3),(68,49,4),(68,50,6),(68,51,7),(68,52,8),(71,1,0),(71,2,1),(71,3,2),(71,58,3),(71,59,4),(72,1,4),(72,2,0),(72,20,7),(72,58,1),(72,59,3),(72,60,2),(72,61,5),(72,62,6),(73,1,5),(73,2,0),(73,51,13),(73,59,6),(73,63,1),(73,64,2),(73,65,3),(73,66,4),(73,67,7),(73,68,8),(73,69,9),(73,70,10),(73,71,11),(73,72,12),(73,73,14),(73,74,15),(73,75,16),(73,76,17),(74,15,NULL),(74,20,NULL),(74,77,NULL),(74,78,NULL),(107,1,7),(107,2,9),(107,15,6),(107,16,2),(107,20,10),(107,49,8),(107,51,4),(107,52,0),(107,108,1),(107,109,3),(107,110,5),(108,1,7),(108,2,1),(108,3,14),(108,51,0),(108,59,13),(108,111,3),(108,112,5),(108,113,2),(108,114,9),(108,115,8),(108,116,6),(108,117,12),(108,118,4),(108,119,11),(108,120,10),(109,1,5),(109,2,2),(109,51,6),(109,59,4),(109,60,3),(109,64,9),(109,121,1),(109,122,0),(109,123,10),(109,124,8),(109,125,7),(109,126,11),(110,1,10),(110,2,2),(110,16,0),(110,59,9),(110,60,8),(110,127,7),(110,128,6),(110,129,1),(110,130,3),(110,131,12),(110,132,4),(110,133,11),(110,134,5),(116,15,0),(116,17,4),(116,20,11),(116,135,10),(116,620,9),(116,724,7),(116,1241,5),(116,1723,6),(116,1920,3),(116,2054,1),(116,2838,8),(116,3256,2),(118,17,1),(118,20,3),(118,136,0),(118,137,2),(287,20,2),(287,866,5),(287,1902,4),(287,2287,0),(287,2535,3),(287,3293,1),(288,20,133),(288,117,213),(288,644,67),(288,653,15),(288,663,29),(288,734,82),(288,775,282),(288,789,130),(288,796,211),(288,797,216),(288,809,142),(288,818,164),(288,824,131),(288,846,92),(288,855,128),(288,863,23),(288,876,58),(288,901,91),(288,909,6),(288,913,265),(288,932,98),(288,951,2),(288,967,360),(288,968,238),(288,969,163),(288,1004,66),(288,1007,90),(288,1033,62),(288,1043,223),(288,1081,35),(288,1094,180),(288,1117,186),(288,1131,140),(288,1134,99),(288,1136,102),(288,1156,41),(288,1199,200),(288,1220,74),(288,1242,192),(288,1254,251),(288,1257,18),(288,1259,292),(288,1273,109),(288,1291,271),(288,1293,184),(288,1298,63),(288,1311,69),(288,1312,73),(288,1345,318),(288,1368,118),(288,1369,10),(288,1401,39),(288,1408,116),(288,1410,43),(288,1412,179),(288,1413,40),(288,1429,78),(288,1438,64),(288,1439,334),(288,1440,85),(288,1449,114),(288,1458,38),(288,1476,108),(288,1492,53),(288,1499,95),(288,1551,13),(288,1554,331),(288,1563,137),(288,1580,32),(288,1582,84),(288,1585,358),(288,1587,79),(288,1601,335),(288,1603,348),(288,1611,228),(288,1619,81),(288,1642,76),(288,1650,44),(288,1678,201),(288,1698,231),(288,1735,123),(288,1786,65),(288,1797,87),(288,1801,12),(288,1804,120),(288,1816,146),(288,1817,93),(288,1833,70),(288,1841,110),(288,1846,11),(288,1890,309),(288,1897,160),(288,1904,315),(288,1910,367),(288,1916,25),(288,1921,172),(288,1939,272),(288,1945,153),(288,1953,49),(288,1958,323),(288,1995,183),(288,2004,71),(288,2012,332),(288,2034,181),(288,2044,124),(288,2066,222),(288,2093,229),(288,2094,284),(288,2097,361),(288,2114,122),(288,2123,167),(288,2134,97),(288,2135,278),(288,2136,37),(288,2138,51),(288,2144,88),(288,2155,139),(288,2163,83),(288,2166,22),(288,2219,206),(288,2260,113),(288,2303,368),(288,2318,60),(288,2326,59),(288,2365,121),(288,2388,308),(288,2415,224),(288,2419,21),(288,2452,147),(288,2474,105),(288,2502,107),(288,2506,57),(288,2511,20),(288,2513,143),(288,2521,285),(288,2555,117),(288,2566,333),(288,2573,202),(288,2603,134),(288,2610,126),(288,2628,103),(288,2629,174),(288,2645,363),(288,2670,161),(288,2675,129),(288,2698,152),(288,2701,94),(288,2707,125),(288,2754,30),(288,2756,42),(288,2758,242),(288,2759,364),(288,2767,111),(288,2768,259),(288,2770,72),(288,2776,26),(288,2778,320),(288,2784,266),(288,2792,169),(288,2824,204),(288,2830,344),(288,2855,48),(288,2859,369),(288,2875,101),(288,2884,28),(288,2891,365),(288,2933,14),(288,2957,209),(288,2964,193),(288,2979,106),(288,2985,362),(288,2998,366),(288,3001,208),(288,3006,195),(288,3011,47),(288,3020,182),(288,3047,136),(288,3051,340),(288,3061,176),(288,3063,19),(288,3080,235),(288,3120,151),(288,3151,45),(288,3153,150),(288,3159,16),(288,3162,46),(288,3164,77),(288,3168,240),(288,3170,86),(288,3177,56),(288,3188,100),(288,3233,5),(288,3254,61),(288,3261,132),(288,3266,191),(288,3270,218),(288,3278,1),(288,3314,219),(288,3325,33),(288,3345,112),(288,3349,89),(288,3371,4),(288,3386,54),(288,3419,80),(288,3426,311),(288,3446,351),(288,3458,3),(288,3459,302),(288,3480,144),(288,3491,313),(288,3497,135),(288,3501,75),(288,3537,96),(288,3550,27),(288,3551,36),(288,3555,127),(288,3558,304),(288,3564,345),(288,3570,115),(288,3592,24),(288,3650,141),(288,3660,17),(288,3696,34),(288,3712,119),(288,3718,55),(288,3719,247),(288,3720,300),(288,3721,173),(288,3722,50),(288,3726,68),(288,3729,52),(288,3737,138),(288,3738,197),(288,3782,156),(288,3819,0),(288,5835,104),(288,5854,244),(288,5855,248),(288,5859,258),(288,5871,290),(288,5873,298),(288,5876,310),(288,5886,356),(288,5887,214),(288,5904,196),(288,5905,205),(288,5906,210),(288,5908,217),(288,5909,221),(288,5910,232),(288,5911,236),(288,5913,250),(288,5923,291),(288,5925,299),(288,5926,303),(288,5931,322),(288,5932,327),(288,5933,329),(288,5937,343),(288,5939,352),(288,5940,353),(288,5941,357),(288,5942,359),(288,5943,157),(288,5946,220),(288,5947,246),(288,5949,263),(288,5950,264),(288,5951,283),(288,5954,339),(288,5955,249),(288,5957,257),(288,6676,159),(288,6683,260),(288,6687,281),(288,6691,286),(288,6778,349),(288,6810,203),(288,6813,280),(288,6814,307),(288,6815,268),(288,6816,170),(288,6820,306),(288,6821,305),(288,6822,316),(288,6823,162),(288,6824,187),(288,6825,245),(288,6828,225),(288,6830,277),(288,6831,234),(288,6832,171),(288,6910,31),(288,6911,149),(288,6912,154),(288,6913,155),(288,6914,158),(288,6915,165),(288,6916,166),(288,6917,168),(288,6918,175),(288,6919,177),(288,6920,178),(288,6921,185),(288,6922,188),(288,6923,189),(288,6924,190),(288,6925,194),(288,6926,198),(288,6927,199),(288,6928,207),(288,6929,212),(288,6930,215),(288,6931,226),(288,6932,227),(288,6933,230),(288,6934,233),(288,6935,239),(288,6936,241),(288,6937,243),(288,6938,252),(288,6939,253),(288,6940,254),(288,6941,255),(288,6942,256),(288,6943,261),(288,6944,262),(288,6945,267),(288,6946,269),(288,6947,270),(288,6948,273),(288,6949,274),(288,6950,275),(288,6951,276),(288,6952,279),(288,6953,287),(288,6954,288),(288,6955,289),(288,6956,293),(288,6957,294),(288,6958,295),(288,6959,297),(288,6960,301),(288,6961,296),(288,6962,312),(288,6963,314),(288,6964,317),(288,6965,319),(288,6966,321),(288,6967,324),(288,6968,325),(288,6969,326),(288,6970,7),(288,6971,328),(288,6972,330),(288,6973,148),(288,6974,336),(288,6975,337),(288,6976,338),(288,6977,341),(288,6978,342),(288,6979,346),(288,6981,347),(288,6982,350),(288,6983,354),(288,6984,355),(288,6986,8),(288,6987,9),(288,6988,145),(288,6989,237),(289,20,55),(289,613,5),(289,635,136),(289,640,12),(289,642,147),(289,699,148),(289,772,42),(289,780,185),(289,789,174),(289,796,184),(289,805,144),(289,904,25),(289,913,194),(289,922,116),(289,923,151),(289,962,98),(289,965,161),(289,968,188),(289,1024,173),(289,1043,88),(289,1078,58),(289,1094,210),(289,1103,140),(289,1115,28),(289,1138,52),(289,1168,121),(289,1186,35),(289,1194,131),(289,1197,62),(289,1242,78),(289,1254,100),(289,1285,145),(289,1291,111),(289,1299,175),(289,1322,196),(289,1331,60),(289,1350,79),(289,1391,87),(289,1410,163),(289,1412,211),(289,1413,15),(289,1418,7),(289,1427,36),(289,1429,166),(289,1444,51),(289,1458,14),(289,1492,4),(289,1493,125),(289,1494,20),(289,1502,66),(289,1509,108),(289,1513,33),(289,1525,89),(289,1533,132),(289,1550,40),(289,1558,47),(289,1575,93),(289,1587,32),(289,1592,65),(289,1593,159),(289,1603,154),(289,1611,94),(289,1632,57),(289,1650,212),(289,1658,110),(289,1669,178),(289,1678,183),(289,1680,126),(289,1687,27),(289,1718,206),(289,1737,83),(289,1751,171),(289,1762,29),(289,1776,135),(289,1777,204),(289,1787,41),(289,1792,102),(289,1798,129),(289,1800,157),(289,1814,44),(289,1820,31),(289,1858,68),(289,1888,167),(289,1890,123),(289,1897,67),(289,1904,127),(289,1910,202),(289,1926,73),(289,1935,49),(289,1939,197),(289,1958,133),(289,1959,21),(289,2012,142),(289,2022,71),(289,2032,158),(289,2058,104),(289,2094,115),(289,2112,18),(289,2117,82),(289,2118,92),(289,2120,23),(289,2127,113),(289,2134,43),(289,2155,59),(289,2178,69),(289,2189,16),(289,2205,153),(289,2206,162),(289,2239,203),(289,2255,169),(289,2259,134),(289,2303,176),(289,2417,77),(289,2438,91),(289,2449,122),(289,2483,24),(289,2513,63),(289,2519,189),(289,2521,199),(289,2522,117),(289,2546,3),(289,2573,2),(289,2637,6),(289,2677,198),(289,2707,172),(289,2711,141),(289,2712,97),(289,2759,191),(289,2767,45),(289,2768,103),(289,2782,99),(289,2798,61),(289,2830,207),(289,2846,19),(289,2856,193),(289,2859,0),(289,2878,34),(289,2881,96),(289,2885,38),(289,2891,26),(289,2931,186),(289,2957,85),(289,2964,181),(289,2998,214),(289,3001,84),(289,3006,182),(289,3015,101),(289,3030,75),(289,3035,56),(289,3036,114),(289,3051,149),(289,3086,138),(289,3090,187),(289,3111,107),(289,3156,119),(289,3173,64),(289,3197,80),(289,3200,120),(289,3233,195),(289,3237,205),(289,3254,164),(289,3261,54),(289,3266,180),(289,3270,86),(289,3278,1),(289,3283,146),(289,3288,10),(289,3290,192),(289,3292,50),(289,3297,118),(289,3321,95),(289,3345,48),(289,3361,152),(289,3371,112),(289,3424,130),(289,3426,124),(289,3430,177),(289,3446,155),(289,3520,13),(289,3525,8),(289,3546,37),(289,3555,53),(289,3558,201),(289,3564,208),(289,3566,139),(289,3575,9),(289,3600,22),(289,3624,170),(289,3626,165),(289,3645,39),(289,3653,143),(289,3689,160),(289,3701,70),(289,3717,137),(289,3738,81),(289,3741,109),(289,3749,76),(289,3755,90),(289,3764,156),(289,3767,74),(289,3783,150),(289,3786,72),(289,3825,128),(289,3844,30),(289,3853,179),(289,5855,190),(289,5861,11),(289,5862,17),(289,5864,105),(289,5865,106),(289,5866,168),(289,5868,200),(289,5869,213),(289,6801,46),(289,6802,209),(290,20,69),(290,117,50),(290,635,106),(290,699,112),(290,769,105),(290,789,67),(290,796,49),(290,824,68),(290,846,63),(290,913,33),(290,951,6),(290,968,55),(290,1043,51),(290,1094,3),(290,1220,56),(290,1242,48),(290,1254,73),(290,1261,95),(290,1293,4),(290,1410,27),(290,1412,7),(290,1413,47),(290,1429,28),(290,1439,52),(290,1458,54),(290,1492,9),(290,1493,79),(290,1554,46),(290,1563,44),(290,1585,37),(290,1587,16),(290,1601,35),(290,1603,36),(290,1611,72),(290,1650,8),(290,1669,85),(290,1678,71),(290,1718,107),(290,1751,103),(290,1792,78),(290,1798,80),(290,1833,62),(290,1858,96),(290,1890,43),(290,1897,39),(290,1904,34),(290,1910,99),(290,1939,41),(290,1993,100),(290,2012,26),(290,2134,17),(290,2155,29),(290,2239,81),(290,2259,87),(290,2513,58),(290,2521,10),(290,2543,23),(290,2555,18),(290,2566,59),(290,2573,22),(290,2645,1),(290,2670,57),(290,2677,102),(290,2707,12),(290,2712,104),(290,2718,91),(290,2759,86),(290,2776,61),(290,2778,25),(290,2783,84),(290,2784,74),(290,2792,108),(290,2830,13),(290,2856,111),(290,2859,5),(290,2957,64),(290,2964,70),(290,2992,93),(290,2998,0),(290,3001,75),(290,3006,110),(290,3020,109),(290,3080,45),(290,3151,14),(290,3233,98),(290,3237,88),(290,3254,15),(290,3261,19),(290,3266,53),(290,3278,2),(290,3345,66),(290,3357,94),(290,3374,97),(290,3424,82),(290,3426,76),(290,3491,77),(290,3495,90),(290,3497,20),(290,3551,60),(290,3558,24),(290,3566,83),(290,3623,30),(290,3666,89),(290,3682,92),(290,3719,32),(290,3720,42),(290,3721,40),(290,3726,38),(290,3737,11),(290,3738,21),(290,3786,101),(290,7176,31),(291,20,6),(291,620,0),(291,1005,4),(291,2353,2),(291,2901,3),(291,3476,1),(291,3585,5),(292,665,81),(292,693,84),(292,710,132),(292,720,29),(292,728,47),(292,744,79),(292,764,140),(292,778,149),(292,780,137),(292,793,52),(292,797,78),(292,799,48),(292,843,24),(292,860,62),(292,879,141),(292,913,115),(292,925,27),(292,945,96),(292,950,17),(292,968,127),(292,981,93),(292,983,0),(292,985,2),(292,992,77),(292,1046,126),(292,1059,94),(292,1070,105),(292,1127,138),(292,1130,28),(292,1137,42),(292,1169,20),(292,1213,125),(292,1254,147),(292,1273,88),(292,1275,146),(292,1305,61),(292,1362,59),(292,1379,22),(292,1404,14),(292,1410,143),(292,1423,130),(292,1443,122),(292,1445,33),(292,1466,41),(292,1491,26),(292,1496,32),(292,1515,99),(292,1536,40),(292,1611,120),(292,1647,92),(292,1653,60),(292,1661,103),(292,1686,43),(292,1693,8),(292,1701,107),(292,1735,35),(292,1754,66),(292,1758,131),(292,1784,108),(292,1787,3),(292,1912,136),(292,1938,46),(292,1985,25),(292,1992,45),(292,2016,91),(292,2020,145),(292,2035,124),(292,2069,76),(292,2101,44),(292,2106,142),(292,2116,72),(292,2130,5),(292,2140,51),(292,2145,55),(292,2146,80),(292,2155,114),(292,2174,110),(292,2184,111),(292,2225,98),(292,2302,85),(292,2316,70),(292,2372,102),(292,2374,6),(292,2444,58),(292,2447,37),(292,2454,38),(292,2466,53),(292,2478,21),(292,2512,31),(292,2554,63),(292,2600,117),(292,2604,113),(292,2657,71),(292,2660,112),(292,2679,73),(292,2703,30),(292,2713,89),(292,2748,82),(292,2768,67),(292,2781,139),(292,2786,74),(292,2811,121),(292,2822,95),(292,2885,144),(292,2886,100),(292,2890,65),(292,2910,11),(292,2981,9),(292,2995,133),(292,3005,16),(292,3035,75),(292,3053,69),(292,3057,34),(292,3060,64),(292,3061,15),(292,3066,87),(292,3076,23),(292,3091,97),(292,3122,10),(292,3159,148),(292,3183,56),(292,3278,12),(292,3298,118),(292,3345,106),(292,3381,86),(292,3395,68),(292,3433,128),(292,3438,90),(292,3482,83),(292,3542,109),(292,3555,134),(292,3557,39),(292,3564,135),(292,3593,104),(292,3594,101),(292,3645,7),(292,3656,129),(292,3660,1),(292,3661,49),(292,3673,116),(292,3675,18),(292,3684,57),(292,3697,36),(292,3705,50),(292,3770,19),(292,3796,13),(292,3809,54),(292,3831,123),(292,3852,119),(292,3854,4),(293,20,1),(293,643,2),(293,1149,3),(293,1781,4),(293,3004,0),(294,20,59),(294,686,94),(294,696,88),(294,749,34),(294,780,81),(294,789,57),(294,819,30),(294,830,12),(294,847,32),(294,869,27),(294,874,74),(294,945,103),(294,1103,9),(294,1104,49),(294,1107,69),(294,1126,61),(294,1187,35),(294,1188,101),(294,1202,111),(294,1253,121),(294,1271,54),(294,1281,8),(294,1291,87),(294,1299,114),(294,1320,62),(294,1328,4),(294,1343,100),(294,1410,45),(294,1436,52),(294,1502,115),(294,1503,64),(294,1504,90),(294,1547,5),(294,1573,47),(294,1603,36),(294,1616,48),(294,1617,6),(294,1637,26),(294,1672,120),(294,1688,39),(294,1699,31),(294,1705,42),(294,1750,37),(294,1785,97),(294,1795,20),(294,1798,95),(294,1813,11),(294,1895,102),(294,1912,116),(294,1976,43),(294,1994,18),(294,2001,33),(294,2018,117),(294,2025,13),(294,2036,104),(294,2067,14),(294,2079,60),(294,2087,58),(294,2094,89),(294,2111,83),(294,2131,7),(294,2155,19),(294,2235,82),(294,2239,118),(294,2266,56),(294,2299,71),(294,2300,38),(294,2319,96),(294,2342,107),(294,2378,15),(294,2387,106),(294,2490,105),(294,2559,16),(294,2567,68),(294,2583,109),(294,2622,112),(294,2632,50),(294,2656,72),(294,2697,78),(294,2698,67),(294,2706,79),(294,2746,0),(294,2756,44),(294,2760,93),(294,2832,53),(294,2852,25),(294,2857,110),(294,2964,76),(294,2975,22),(294,3030,73),(294,3050,70),(294,3147,24),(294,3167,91),(294,3181,2),(294,3270,80),(294,3345,17),(294,3347,122),(294,3351,113),(294,3356,21),(294,3368,66),(294,3369,75),(294,3524,99),(294,3538,29),(294,3565,98),(294,3566,119),(294,3590,86),(294,3608,55),(294,3624,51),(294,3628,85),(294,3646,28),(294,3648,92),(294,3710,40),(294,3711,41),(294,3730,63),(294,3748,10),(294,3770,65),(294,3775,1),(294,3778,23),(294,3780,84),(294,3807,3),(294,3826,108),(294,3841,46),(294,3852,77),(295,20,21),(295,617,38),(295,763,14),(295,766,8),(295,796,51),(295,904,25),(295,913,59),(295,918,49),(295,934,55),(295,1029,48),(295,1031,46),(295,1225,17),(295,1232,47),(295,1247,61),(295,1378,1),(295,1423,6),(295,1460,45),(295,1522,37),(295,1537,57),(295,1607,36),(295,1630,35),(295,1678,32),(295,1684,29),(295,1718,16),(295,1720,43),(295,1725,53),(295,1751,13),(295,1777,7),(295,1839,42),(295,1901,54),(295,2039,19),(295,2211,15),(295,2216,30),(295,2218,44),(295,2257,12),(295,2369,39),(295,2371,27),(295,2434,0),(295,2523,58),(295,2532,11),(295,2545,10),(295,2589,34),(295,2617,40),(295,2681,52),(295,2762,18),(295,2832,33),(295,2833,5),(295,2842,41),(295,2845,28),(295,2929,24),(295,2948,56),(295,2974,60),(295,3203,22),(295,3270,31),(295,3350,20),(295,3511,4),(295,3515,50),(295,3521,2),(295,3694,9),(295,6903,3),(295,6904,23),(295,6905,26),(296,20,220),(296,660,107),(296,669,53),(296,681,8),(296,707,37),(296,731,110),(296,754,139),(296,782,50),(296,814,9),(296,824,219),(296,878,18),(296,943,131),(296,1054,75),(296,1103,209),(296,1153,92),(296,1155,87),(296,1167,122),(296,1168,14),(296,1175,120),(296,1189,213),(296,1191,1),(296,1193,2),(296,1280,121),(296,1299,44),(296,1311,78),(296,1352,72),(296,1360,7),(296,1361,23),(296,1366,136),(296,1371,5),(296,1394,68),(296,1456,148),(296,1484,11),(296,1542,79),(296,1549,21),(296,1577,84),(296,1578,58),(296,1579,141),(296,1593,233),(296,1594,70),(296,1611,226),(296,1635,225),(296,1666,218),(296,1697,108),(296,1740,20),(296,1773,144),(296,1779,104),(296,1790,19),(296,1810,46),(296,1834,56),(296,1847,60),(296,1851,126),(296,1852,221),(296,1860,97),(296,1887,22),(296,1915,82),(296,1919,47),(296,1932,113),(296,1965,102),(296,1978,217),(296,1984,27),(296,2030,59),(296,2032,38),(296,2063,124),(296,2071,45),(296,2074,223),(296,2078,216),(296,2080,227),(296,2107,105),(296,2130,10),(296,2133,117),(296,2142,29),(296,2150,42),(296,2158,25),(296,2238,33),(296,2243,3),(296,2267,66),(296,2306,111),(296,2325,61),(296,2327,134),(296,2349,196),(296,2381,143),(296,2405,146),(296,2411,231),(296,2456,30),(296,2499,16),(296,2571,15),(296,2575,6),(296,2594,31),(296,2605,94),(296,2606,125),(296,2607,26),(296,2623,128),(296,2627,86),(296,2649,77),(296,2662,62),(296,2663,63),(296,2676,222),(296,2687,65),(296,2694,34),(296,2788,149),(296,2789,114),(296,2794,0),(296,2803,52),(296,2817,80),(296,2859,232),(296,2882,129),(296,2886,190),(296,2888,43),(296,2917,138),(296,2933,35),(296,2943,137),(296,2945,81),(296,2978,133),(296,3003,116),(296,3009,140),(296,3033,32),(296,3046,41),(296,3047,103),(296,3051,48),(296,3056,230),(296,3081,189),(296,3123,12),(296,3133,83),(296,3136,109),(296,3176,99),(296,3199,49),(296,3234,55),(296,3243,118),(296,3265,224),(296,3319,4),(296,3353,98),(296,3363,101),(296,3411,24),(296,3465,90),(296,3469,119),(296,3474,215),(296,3485,112),(296,3504,28),(296,3556,91),(296,3559,40),(296,3577,214),(296,3598,228),(296,3620,36),(296,3642,54),(296,3645,85),(296,3667,57),(296,3679,73),(296,3685,67),(296,3754,147),(296,3762,76),(296,3775,194),(296,3801,39),(296,3894,145),(296,5871,153),(296,5888,96),(296,6617,183),(296,6618,184),(296,6619,185),(296,6620,186),(296,6621,187),(296,6622,188),(296,6623,191),(296,6624,195),(296,6625,197),(296,6626,198),(296,6627,199),(296,6628,201),(296,6629,202),(296,6630,203),(296,6631,204),(296,6632,206),(296,6634,207),(296,6635,208),(296,6636,210),(296,6637,211),(296,6738,13),(296,6739,17),(296,6740,51),(296,6741,69),(296,6742,71),(296,6743,74),(296,6744,88),(296,6745,89),(296,6746,93),(296,6747,95),(296,6748,106),(296,6749,123),(296,6750,127),(296,6751,130),(296,6752,132),(296,6753,135),(296,6754,142),(296,6755,150),(296,6756,151),(296,6757,152),(296,6758,154),(296,6759,155),(296,6760,156),(296,6761,157),(296,6762,158),(296,6763,159),(296,6764,160),(296,6765,161),(296,6766,162),(296,6767,163),(296,6768,165),(296,6769,166),(296,6770,167),(296,6771,168),(296,6772,169),(296,6773,170),(296,6774,171),(296,6775,172),(296,6776,173),(296,6777,174),(296,6778,175),(296,6779,176),(296,6780,177),(296,6781,178),(296,6782,179),(296,6783,180),(296,6784,181),(296,6785,182),(296,6786,192),(296,6787,193),(296,6788,200),(296,6789,205),(296,6790,212),(296,6791,229),(297,20,3),(297,795,10),(297,991,6),(297,1143,9),(297,1217,1),(297,1318,4),(297,1363,8),(297,1765,7),(297,2828,2),(297,3450,0),(297,3636,5),(298,20,4),(298,1006,3),(298,1768,1),(298,2436,0),(298,2892,5),(298,3366,2),(299,20,43),(299,617,45),(299,766,13),(299,796,69),(299,903,54),(299,904,28),(299,913,48),(299,918,59),(299,919,52),(299,934,67),(299,957,53),(299,965,4),(299,1029,60),(299,1031,62),(299,1144,51),(299,1223,20),(299,1225,26),(299,1232,58),(299,1247,1),(299,1267,8),(299,1355,16),(299,1378,80),(299,1460,61),(299,1522,46),(299,1607,66),(299,1630,3),(299,1678,36),(299,1684,33),(299,1718,19),(299,1720,57),(299,1725,71),(299,1751,15),(299,1755,25),(299,1777,12),(299,1815,77),(299,1828,65),(299,1839,56),(299,1901,73),(299,1909,6),(299,1933,55),(299,2014,72),(299,2039,42),(299,2216,34),(299,2218,63),(299,2257,14),(299,2369,47),(299,2371,30),(299,2434,0),(299,2493,76),(299,2526,18),(299,2529,75),(299,2532,9),(299,2537,29),(299,2545,10),(299,2589,31),(299,2617,49),(299,2681,70),(299,2700,64),(299,2745,74),(299,2762,27),(299,2832,37),(299,2833,5),(299,2834,23),(299,2839,78),(299,2842,50),(299,2845,32),(299,2929,39),(299,2974,79),(299,3203,38),(299,3270,35),(299,3350,41),(299,3511,44),(299,3515,68),(299,3521,7),(299,3626,21),(299,3689,22),(299,3692,24),(299,3694,11),(299,5966,40),(299,5967,2),(299,6610,17),(300,17,1),(300,20,0),(300,626,7),(300,929,4),(300,1240,2),(300,3285,5),(300,3632,3),(300,3723,6),(301,20,117),(301,635,251),(301,679,238),(301,684,4),(301,756,285),(301,765,53),(301,771,116),(301,793,228),(301,796,174),(301,858,63),(301,883,252),(301,900,122),(301,913,204),(301,932,9),(301,934,96),(301,946,58),(301,947,118),(301,949,23),(301,954,146),(301,957,188),(301,968,187),(301,1011,184),(301,1040,277),(301,1055,76),(301,1068,133),(301,1076,26),(301,1082,111),(301,1086,32),(301,1101,65),(301,1147,52),(301,1174,88),(301,1182,173),(301,1225,119),(301,1239,95),(301,1247,3),(301,1255,136),(301,1259,222),(301,1264,68),(301,1294,45),(301,1315,39),(301,1365,262),(301,1375,253),(301,1378,265),(301,1410,33),(301,1426,244),(301,1429,62),(301,1458,28),(301,1522,90),(301,1597,203),(301,1607,163),(301,1611,181),(301,1619,72),(301,1630,108),(301,1632,123),(301,1656,49),(301,1660,57),(301,1665,64),(301,1671,144),(301,1678,11),(301,1684,67),(301,1700,8),(301,1718,267),(301,1720,269),(301,1725,276),(301,1726,128),(301,1741,38),(301,1751,99),(301,1780,30),(301,1794,71),(301,1803,93),(301,1806,231),(301,1820,61),(301,1829,35),(301,1846,12),(301,1857,83),(301,1901,249),(301,1910,241),(301,1913,196),(301,1933,242),(301,1953,41),(301,1963,256),(301,1972,36),(301,1977,1),(301,2014,109),(301,2021,81),(301,2039,143),(301,2053,59),(301,2064,112),(301,2071,110),(301,2074,142),(301,2075,29),(301,2089,147),(301,2128,16),(301,2149,217),(301,2155,127),(301,2162,43),(301,2211,115),(301,2216,176),(301,2230,169),(301,2257,280),(301,2268,17),(301,2278,21),(301,2285,42),(301,2322,51),(301,2339,259),(301,2347,129),(301,2365,66),(301,2367,125),(301,2368,235),(301,2371,248),(301,2379,194),(301,2380,275),(301,2384,15),(301,2390,140),(301,2416,270),(301,2433,20),(301,2434,230),(301,2449,236),(301,2472,78),(301,2517,50),(301,2521,214),(301,2537,5),(301,2573,170),(301,2589,10),(301,2617,263),(301,2630,121),(301,2631,162),(301,2640,24),(301,2646,132),(301,2671,13),(301,2681,200),(301,2682,124),(301,2712,189),(301,2725,47),(301,2754,25),(301,2762,60),(301,2792,145),(301,2824,171),(301,2833,7),(301,2840,261),(301,2842,258),(301,2854,18),(301,2875,287),(301,2894,22),(301,2923,126),(301,2929,101),(301,2933,19),(301,2938,100),(301,2956,139),(301,2974,0),(301,2993,56),(301,3037,224),(301,3054,286),(301,3058,87),(301,3061,149),(301,3083,120),(301,3110,165),(301,3118,37),(301,3125,69),(301,3131,98),(301,3132,40),(301,3137,73),(301,3153,135),(301,3177,46),(301,3179,97),(301,3204,6),(301,3229,268),(301,3254,54),(301,3270,2),(301,3294,210),(301,3341,106),(301,3343,14),(301,3346,82),(301,3350,113),(301,3391,85),(301,3402,137),(301,3413,89),(301,3419,70),(301,3428,75),(301,3447,150),(301,3455,148),(301,3483,94),(301,3488,138),(301,3496,79),(301,3511,91),(301,3516,201),(301,3521,260),(301,3537,86),(301,3548,226),(301,3553,74),(301,3554,80),(301,3596,34),(301,3597,107),(301,3606,278),(301,3618,102),(301,3629,114),(301,3674,44),(301,3676,92),(301,3677,55),(301,3709,274),(301,3743,48),(301,3749,156),(301,3755,179),(301,3792,202),(301,3855,103),(301,5860,206),(301,5887,175),(301,5898,31),(301,5899,77),(301,5910,182),(301,5911,186),(301,5946,178),(301,5957,197),(301,5966,141),(301,5967,250),(301,5982,164),(301,5989,227),(301,6760,223),(301,6771,254),(301,6844,104),(301,6845,134),(301,7048,155),(301,7078,245),(301,7100,27),(301,7101,84),(301,7102,105),(301,7103,130),(301,7104,131),(301,7105,151),(301,7106,152),(301,7107,153),(301,7108,154),(301,7109,157),(301,7110,158),(301,7111,159),(301,7112,160),(301,7113,161),(301,7114,166),(301,7115,167),(301,7116,168),(301,7117,172),(301,7118,177),(301,7119,180),(301,7120,183),(301,7121,185),(301,7122,190),(301,7123,191),(301,7124,192),(301,7125,193),(301,7126,195),(301,7127,198),(301,7128,199),(301,7129,205),(301,7130,207),(301,7131,208),(301,7132,209),(301,7133,211),(301,7134,212),(301,7135,213),(301,7136,215),(301,7137,216),(301,7138,218),(301,7139,219),(301,7140,220),(301,7141,221),(301,7142,225),(301,7143,229),(301,7144,232),(301,7145,233),(301,7146,234),(301,7147,237),(301,7148,239),(301,7149,240),(301,7150,243),(301,7151,246),(301,7152,247),(301,7153,255),(301,7154,257),(301,7155,264),(301,7156,266),(301,7157,271),(301,7158,272),(301,7159,273),(301,7160,279),(301,7161,281),(301,7162,282),(301,7163,283),(301,7164,284),(301,7165,288),(301,7166,289),(302,20,1),(302,626,0),(302,1172,2),(302,1240,4),(302,2946,3),(303,20,17),(303,645,9),(303,789,26),(303,824,25),(303,913,3),(303,921,21),(303,1043,13),(303,1094,15),(303,1242,7),(303,1254,5),(303,1392,24),(303,1410,29),(303,1413,2),(303,1429,14),(303,1439,18),(303,1492,22),(303,1603,12),(303,1611,27),(303,1678,28),(303,1904,10),(303,1911,19),(303,2155,11),(303,2219,8),(303,2784,1),(303,2859,0),(303,2957,16),(303,2964,30),(303,2998,31),(303,3267,20),(303,3270,23),(303,3278,6),(303,3345,4),(304,20,0),(304,135,1),(304,928,5),(304,2284,3),(304,2531,4),(304,2965,2),(305,20,51),(305,623,58),(305,629,75),(305,631,98),(305,637,137),(305,644,25),(305,757,102),(305,796,83),(305,802,2),(305,852,106),(305,909,87),(305,946,26),(305,1011,88),(305,1012,5),(305,1013,7),(305,1017,22),(305,1030,74),(305,1034,114),(305,1035,10),(305,1039,134),(305,1040,115),(305,1042,29),(305,1071,70),(305,1149,94),(305,1182,81),(305,1197,56),(305,1226,57),(305,1231,107),(305,1236,135),(305,1237,136),(305,1238,141),(305,1239,40),(305,1243,122),(305,1247,50),(305,1248,104),(305,1250,89),(305,1274,78),(305,1294,16),(305,1375,130),(305,1426,120),(305,1428,42),(305,1433,30),(305,1532,119),(305,1538,32),(305,1539,54),(305,1544,100),(305,1584,49),(305,1597,96),(305,1608,97),(305,1619,157),(305,1654,118),(305,1709,34),(305,1711,43),(305,1721,147),(305,1722,149),(305,1725,143),(305,1726,55),(305,1732,127),(305,1846,4),(305,1869,12),(305,1878,53),(305,1885,99),(305,1894,132),(305,1898,60),(305,1900,146),(305,1906,36),(305,1907,138),(305,1908,117),(305,1963,155),(305,1986,37),(305,2039,69),(305,2148,33),(305,2162,13),(305,2203,19),(305,2215,65),(305,2222,73),(305,2333,23),(305,2357,35),(305,2363,92),(305,2366,62),(305,2367,52),(305,2368,113),(305,2380,128),(305,2515,68),(305,2538,116),(305,2541,112),(305,2688,38),(305,2767,39),(305,2833,1),(305,2840,133),(305,2844,131),(305,2877,8),(305,2932,95),(305,2933,6),(305,2951,28),(305,2955,66),(305,2956,3),(305,2960,90),(305,2961,109),(305,2963,140),(305,2968,103),(305,2974,156),(305,2975,59),(305,2976,86),(305,3104,105),(305,3110,77),(305,3112,85),(305,3113,111),(305,3114,72),(305,3118,11),(305,3131,41),(305,3153,63),(305,3202,79),(305,3250,47),(305,3253,9),(305,3268,80),(305,3269,82),(305,3279,123),(305,3280,125),(305,3281,126),(305,3290,93),(305,3294,101),(305,3350,48),(305,3402,0),(305,3425,18),(305,3428,31),(305,3455,71),(305,3514,84),(305,3521,154),(305,3522,145),(305,3526,46),(305,3527,142),(305,3548,108),(305,3606,144),(305,3625,110),(305,3633,24),(305,3634,27),(305,3635,76),(305,3655,17),(305,3674,15),(305,3718,14),(305,3745,21),(305,3756,124),(305,3785,64),(305,3788,139),(305,3789,148),(305,3855,44),(305,6844,45),(305,6845,61),(305,6846,67),(305,6847,91),(305,6848,121),(305,6849,129),(305,6850,150),(305,6851,151),(305,6852,152),(305,6853,153),(306,20,0),(306,135,4),(306,1673,7),(306,2284,6),(306,2286,3),(306,2965,5),(306,3070,2),(306,3366,1),(307,20,4),(307,1224,9),(307,1673,3),(307,1706,5),(307,2170,6),(307,2284,2),(307,2304,7),(307,2518,8),(307,2531,0),(307,2965,1),(308,20,6),(308,49,4),(308,620,7),(308,743,1),(308,1249,2),(308,1452,0),(308,3366,3),(308,3813,5),(309,20,140),(309,117,217),(309,644,75),(309,653,23),(309,663,37),(309,734,90),(309,775,283),(309,789,137),(309,796,215),(309,797,220),(309,809,148),(309,818,170),(309,824,138),(309,846,100),(309,855,135),(309,863,31),(309,876,65),(309,901,99),(309,909,14),(309,913,267),(309,932,106),(309,951,7),(309,967,360),(309,968,242),(309,969,169),(309,1004,74),(309,1007,98),(309,1033,70),(309,1043,227),(309,1081,43),(309,1094,185),(309,1117,191),(309,1131,146),(309,1134,107),(309,1136,110),(309,1156,49),(309,1199,205),(309,1220,82),(309,1242,197),(309,1254,254),(309,1257,26),(309,1259,292),(309,1273,370),(309,1291,9),(309,1293,189),(309,1298,71),(309,1311,77),(309,1312,81),(309,1345,318),(309,1368,125),(309,1369,18),(309,1401,47),(309,1408,123),(309,1410,51),(309,1412,184),(309,1413,48),(309,1429,86),(309,1438,72),(309,1439,334),(309,1440,93),(309,1449,121),(309,1458,46),(309,1476,116),(309,1492,60),(309,1499,103),(309,1551,21),(309,1554,331),(309,1563,143),(309,1580,40),(309,1582,92),(309,1585,358),(309,1587,87),(309,1601,335),(309,1603,348),(309,1611,232),(309,1619,89),(309,1642,84),(309,1650,374),(309,1678,206),(309,1698,235),(309,1735,130),(309,1786,73),(309,1797,95),(309,1801,20),(309,1804,127),(309,1816,152),(309,1817,101),(309,1833,78),(309,1841,117),(309,1846,19),(309,1890,309),(309,1897,166),(309,1904,315),(309,1910,372),(309,1916,33),(309,1921,178),(309,1939,273),(309,1945,159),(309,1953,56),(309,1958,323),(309,1995,188),(309,2004,79),(309,2012,332),(309,2034,186),(309,2044,131),(309,2066,226),(309,2093,233),(309,2094,285),(309,2097,361),(309,2114,129),(309,2123,173),(309,2134,105),(309,2135,279),(309,2136,45),(309,2138,58),(309,2144,96),(309,2155,145),(309,2163,91),(309,2166,30),(309,2219,210),(309,2260,120),(309,2303,366),(309,2318,67),(309,2326,66),(309,2365,128),(309,2374,3),(309,2388,308),(309,2401,367),(309,2415,228),(309,2419,29),(309,2452,153),(309,2474,113),(309,2502,115),(309,2506,64),(309,2511,28),(309,2513,149),(309,2521,286),(309,2555,124),(309,2566,333),(309,2573,69),(309,2603,141),(309,2610,133),(309,2628,111),(309,2629,180),(309,2645,363),(309,2670,167),(309,2675,136),(309,2698,158),(309,2701,102),(309,2707,132),(309,2754,38),(309,2756,50),(309,2758,246),(309,2759,364),(309,2767,118),(309,2768,261),(309,2770,80),(309,2776,34),(309,2778,320),(309,2784,268),(309,2792,175),(309,2824,208),(309,2830,344),(309,2855,55),(309,2859,368),(309,2875,109),(309,2884,36),(309,2891,365),(309,2933,22),(309,2957,213),(309,2964,198),(309,2979,114),(309,2985,362),(309,2998,371),(309,3001,212),(309,3006,200),(309,3011,54),(309,3020,187),(309,3047,373),(309,3051,340),(309,3061,2),(309,3063,27),(309,3080,239),(309,3120,157),(309,3151,52),(309,3153,156),(309,3159,24),(309,3162,53),(309,3164,85),(309,3168,244),(309,3170,94),(309,3177,63),(309,3188,108),(309,3233,13),(309,3254,68),(309,3261,139),(309,3266,196),(309,3270,222),(309,3278,6),(309,3314,223),(309,3325,41),(309,3345,119),(309,3349,97),(309,3371,8),(309,3386,61),(309,3419,88),(309,3426,311),(309,3446,351),(309,3452,5),(309,3458,12),(309,3459,302),(309,3480,150),(309,3491,313),(309,3497,142),(309,3501,83),(309,3537,104),(309,3550,35),(309,3551,44),(309,3555,134),(309,3558,304),(309,3564,345),(309,3570,122),(309,3592,32),(309,3650,147),(309,3660,25),(309,3696,42),(309,3712,126),(309,3718,62),(309,3719,251),(309,3720,300),(309,3721,179),(309,3722,57),(309,3726,76),(309,3729,59),(309,3737,144),(309,3738,202),(309,3782,162),(309,3799,369),(309,3819,11),(309,5835,112),(309,5854,248),(309,5855,252),(309,5859,260),(309,5871,290),(309,5873,298),(309,5876,310),(309,5886,356),(309,5887,218),(309,5904,201),(309,5905,209),(309,5906,214),(309,5908,221),(309,5909,225),(309,5910,236),(309,5911,240),(309,5913,253),(309,5923,291),(309,5925,299),(309,5926,303),(309,5931,322),(309,5932,327),(309,5933,329),(309,5937,343),(309,5939,352),(309,5940,353),(309,5941,357),(309,5942,359),(309,5943,163),(309,5946,224),(309,5947,250),(309,5949,265),(309,5950,266),(309,5951,284),(309,5954,339),(309,5955,10),(309,5957,259),(309,6676,165),(309,6683,262),(309,6687,282),(309,6691,287),(309,6778,349),(309,6810,207),(309,6812,0),(309,6813,281),(309,6814,307),(309,6815,270),(309,6816,176),(309,6820,306),(309,6821,305),(309,6822,316),(309,6823,168),(309,6824,192),(309,6825,249),(309,6828,229),(309,6830,278),(309,6831,238),(309,6832,177),(309,6910,39),(309,6911,155),(309,6912,160),(309,6913,161),(309,6914,164),(309,6915,171),(309,6916,172),(309,6917,174),(309,6918,181),(309,6919,182),(309,6920,183),(309,6921,190),(309,6922,193),(309,6923,194),(309,6924,195),(309,6925,199),(309,6926,203),(309,6927,204),(309,6928,211),(309,6929,216),(309,6930,219),(309,6931,230),(309,6932,231),(309,6933,234),(309,6934,237),(309,6935,243),(309,6936,245),(309,6937,247),(309,6939,255),(309,6940,256),(309,6941,257),(309,6942,258),(309,6943,263),(309,6944,264),(309,6945,269),(309,6946,271),(309,6947,272),(309,6948,274),(309,6949,275),(309,6950,276),(309,6951,277),(309,6952,280),(309,6953,288),(309,6954,1),(309,6955,289),(309,6956,293),(309,6957,294),(309,6958,295),(309,6959,297),(309,6960,301),(309,6961,296),(309,6962,312),(309,6963,314),(309,6964,317),(309,6965,319),(309,6966,321),(309,6967,324),(309,6968,325),(309,6969,326),(309,6970,15),(309,6971,328),(309,6972,330),(309,6973,154),(309,6974,336),(309,6975,337),(309,6976,338),(309,6977,341),(309,6978,342),(309,6979,346),(309,6981,347),(309,6982,350),(309,6983,354),(309,6984,355),(309,6985,4),(309,6986,16),(309,6987,17),(309,6988,151),(309,6989,241),(310,20,4),(310,767,1),(310,1000,2),(310,3052,5),(310,3647,3),(310,3704,0),(311,20,11),(311,633,6),(311,643,16),(311,770,3),(311,912,1),(311,1588,9),(311,1596,2),(311,1685,5),(311,1799,14),(311,2519,10),(311,2691,15),(311,2755,13),(311,3004,0),(311,3078,12),(311,3384,4),(311,3442,8),(311,7188,7),(312,20,2),(312,639,3),(312,3004,0),(312,3230,1),(313,20,3),(313,620,1),(313,788,4),(313,1249,0),(313,3578,2),(314,20,0),(314,626,1),(314,1240,2),(314,1673,3),(315,20,4),(315,620,5),(315,626,3),(315,630,0),(315,1249,1),(315,2892,2),(316,20,0),(316,2835,1),(317,20,1),(317,620,0),(317,1462,4),(317,1734,6),(317,1747,5),(317,2591,2),(317,2740,3),(317,3160,8),(317,3584,7),(318,20,1),(318,626,2),(318,723,0),(318,1172,4),(318,1224,3),(318,1240,6),(318,1873,5),(319,20,2),(319,620,3),(319,1249,1),(319,1604,0),(320,20,2),(320,1241,1),(320,2039,3),(320,2416,0),(321,17,3),(321,20,2),(321,620,4),(321,1041,0),(321,3476,1),(322,17,1),(322,20,4),(322,1641,3),(322,1870,0),(322,2400,2),(323,20,9),(323,1098,5),(323,1302,0),(323,1333,7),(323,1359,4),(323,1457,2),(323,1562,6),(323,1624,10),(323,2658,8),(323,2828,3),(323,3621,1),(324,20,3),(324,2361,2),(324,2470,1),(324,3366,0),(325,20,3),(325,1123,1),(325,2093,6),(325,2248,4),(325,2496,5),(325,3004,0),(325,3248,2),(326,20,10),(326,643,8),(326,1149,7),(326,2291,4),(326,2691,1),(326,2755,5),(326,3004,0),(326,3018,3),(326,3264,6),(326,3377,2),(326,3453,9),(327,20,5),(327,620,0),(327,1005,4),(327,1069,6),(327,1205,7),(327,1604,3),(327,2353,1),(327,2901,2),(327,3476,8),(328,20,2),(328,866,5),(328,1902,4),(328,2287,0),(328,2535,3),(328,3293,1),(329,20,2),(329,643,3),(329,1149,4),(329,1781,5),(329,3004,0),(329,3230,1),(330,20,4),(330,883,5),(330,1678,3),(330,1684,2),(330,2216,1),(330,2589,6),(330,2800,0),(330,2974,7),(331,20,8),(331,792,9),(331,997,7),(331,1570,5),(331,1768,0),(331,2070,2),(331,2340,4),(331,2413,3),(331,2892,6),(331,2970,1),(332,20,4),(332,1641,1),(332,1673,2),(332,1706,0),(332,2284,3),(332,2531,5),(332,2965,6),(333,20,2),(333,77,0),(333,1324,6),(333,1473,5),(333,1564,4),(333,2629,1),(333,2755,3),(333,3004,7),(334,704,2),(334,1123,3),(334,1358,0),(334,2836,1),(334,3004,4),(335,20,1),(335,1198,3),(335,1673,8),(335,2284,6),(335,2286,2),(335,2965,7),(335,3070,5),(335,3366,0),(335,3680,4),(336,20,8),(336,633,14),(336,643,17),(336,800,16),(336,912,1),(336,1185,2),(336,1407,12),(336,1596,18),(336,1685,9),(336,1730,3),(336,1799,10),(336,2365,11),(336,2519,13),(336,2525,6),(336,2806,4),(336,2915,5),(336,3004,0),(336,3284,15),(336,3443,7),(337,17,1),(337,20,0),(337,135,5),(337,854,3),(337,1224,2),(337,2284,6),(337,3366,4),(338,20,0),(338,135,1),(338,1706,3),(338,2284,2),(339,20,1),(339,626,0),(339,675,2),(339,723,4),(339,1088,3),(339,1240,6),(339,1873,5),(340,17,6),(340,20,8),(340,626,9),(340,929,2),(340,1015,4),(340,1021,1),(340,1240,7),(340,1715,3),(340,2360,5),(340,3632,0),(341,20,2),(341,1446,1),(341,1673,0),(342,20,4),(342,704,2),(342,1358,3),(342,3004,0),(342,3377,1),(343,20,1),(343,626,0),(343,1172,3),(343,1240,2),(343,1873,4),(344,20,2),(344,643,4),(344,704,1),(344,3004,5),(344,3230,3),(344,3327,0),(345,20,3),(345,1224,1),(345,1673,0),(345,1706,4),(345,2284,2),(345,2304,7),(345,2965,6),(345,2972,5),(346,20,1),(346,2972,0),(346,2990,2),(347,20,5),(347,723,9),(347,1217,0),(347,1235,7),(347,1327,4),(347,1329,2),(347,1600,8),(347,1892,6),(347,2585,10),(347,2892,3),(347,3450,1),(348,17,9),(348,20,0),(348,135,1),(348,620,4),(348,836,6),(348,982,7),(348,1149,10),(348,1241,2),(348,2570,5),(348,2892,8),(348,3004,12),(348,3366,3),(348,3453,11),(349,20,5),(349,883,6),(349,1482,0),(349,1678,4),(349,1684,3),(349,2216,2),(349,2589,7),(349,2833,1),(349,2974,8),(350,20,140),(350,117,216),(350,644,71),(350,653,21),(350,663,34),(350,734,88),(350,775,287),(350,789,137),(350,796,214),(350,797,219),(350,809,148),(350,818,169),(350,824,138),(350,846,99),(350,855,135),(350,863,28),(350,876,61),(350,901,97),(350,909,238),(350,913,269),(350,932,105),(350,951,245),(350,967,85),(350,968,241),(350,969,168),(350,1004,69),(350,1007,96),(350,1033,65),(350,1043,226),(350,1081,40),(350,1094,183),(350,1117,189),(350,1131,9),(350,1134,106),(350,1136,109),(350,1156,46),(350,1199,203),(350,1220,78),(350,1242,195),(350,1254,254),(350,1257,23),(350,1259,297),(350,1273,116),(350,1291,276),(350,1293,187),(350,1298,66),(350,1311,73),(350,1312,77),(350,1345,322),(350,1368,125),(350,1369,16),(350,1401,44),(350,1408,123),(350,1410,48),(350,1412,11),(350,1413,45),(350,1429,83),(350,1438,67),(350,1439,341),(350,1440,91),(350,1449,121),(350,1458,43),(350,1476,115),(350,1499,102),(350,1551,19),(350,1554,337),(350,1563,144),(350,1580,37),(350,1582,90),(350,1585,366),(350,1587,84),(350,1601,342),(350,1603,356),(350,1611,231),(350,1619,87),(350,1642,81),(350,1646,1),(350,1650,49),(350,1678,204),(350,1698,234),(350,1702,2),(350,1735,130),(350,1786,68),(350,1797,93),(350,1801,18),(350,1804,127),(350,1816,151),(350,1817,100),(350,1833,74),(350,1841,117),(350,1846,17),(350,1890,7),(350,1897,165),(350,1904,319),(350,1910,13),(350,1916,30),(350,1921,176),(350,1939,5),(350,1945,158),(350,1953,53),(350,1958,327),(350,1995,186),(350,2004,75),(350,2012,338),(350,2034,184),(350,2044,131),(350,2066,225),(350,2093,232),(350,2094,289),(350,2097,157),(350,2114,129),(350,2123,172),(350,2134,104),(350,2135,283),(350,2136,42),(350,2138,55),(350,2144,94),(350,2155,146),(350,2163,89),(350,2166,27),(350,2219,209),(350,2260,120),(350,2303,12),(350,2318,63),(350,2326,62),(350,2365,128),(350,2388,311),(350,2401,351),(350,2415,227),(350,2419,26),(350,2452,152),(350,2474,112),(350,2502,114),(350,2506,60),(350,2511,25),(350,2513,149),(350,2521,290),(350,2555,124),(350,2566,340),(350,2573,205),(350,2603,141),(350,2610,133),(350,2628,110),(350,2629,178),(350,2645,79),(350,2670,166),(350,2675,136),(350,2698,156),(350,2701,101),(350,2707,132),(350,2754,35),(350,2756,47),(350,2759,255),(350,2767,118),(350,2768,263),(350,2770,76),(350,2776,31),(350,2778,324),(350,2784,270),(350,2792,10),(350,2824,207),(350,2830,8),(350,2855,52),(350,2859,14),(350,2875,108),(350,2884,33),(350,2891,72),(350,2933,20),(350,2957,212),(350,2964,196),(350,2979,113),(350,2985,316),(350,2998,329),(350,3001,211),(350,3006,198),(350,3011,70),(350,3020,185),(350,3047,143),(350,3051,347),(350,3061,180),(350,3063,24),(350,3080,239),(350,3120,155),(350,3151,50),(350,3153,154),(350,3159,22),(350,3162,51),(350,3164,82),(350,3168,243),(350,3170,92),(350,3177,59),(350,3188,107),(350,3197,0),(350,3233,272),(350,3254,64),(350,3261,139),(350,3266,194),(350,3270,221),(350,3278,3),(350,3314,222),(350,3325,38),(350,3345,119),(350,3349,95),(350,3371,279),(350,3386,57),(350,3419,86),(350,3426,314),(350,3446,359),(350,3458,98),(350,3459,305),(350,3480,150),(350,3491,317),(350,3497,142),(350,3501,80),(350,3537,103),(350,3550,32),(350,3551,41),(350,3555,134),(350,3558,307),(350,3564,352),(350,3570,122),(350,3592,29),(350,3650,147),(350,3696,39),(350,3712,126),(350,3718,58),(350,3719,250),(350,3720,6),(350,3721,177),(350,3722,54),(350,3726,4),(350,3729,56),(350,3737,145),(350,3738,200),(350,3782,161),(350,3819,15),(350,5835,111),(350,5854,247),(350,5855,251),(350,5859,262),(350,5871,295),(350,5873,302),(350,5876,313),(350,5886,364),(350,5887,217),(350,5904,199),(350,5905,208),(350,5906,213),(350,5908,220),(350,5909,224),(350,5910,235),(350,5911,240),(350,5913,253),(350,5923,296),(350,5925,303),(350,5926,306),(350,5931,326),(350,5932,332),(350,5933,335),(350,5937,350),(350,5939,360),(350,5940,361),(350,5941,365),(350,5942,367),(350,5943,162),(350,5946,223),(350,5947,249),(350,5949,267),(350,5950,268),(350,5951,288),(350,5954,346),(350,5955,252),(350,5957,261),(350,6676,164),(350,6683,264),(350,6687,286),(350,6691,291),(350,6778,357),(350,6810,206),(350,6813,285),(350,6814,310),(350,6815,273),(350,6816,174),(350,6820,309),(350,6821,308),(350,6822,320),(350,6823,167),(350,6824,190),(350,6825,248),(350,6828,228),(350,6830,282),(350,6831,237),(350,6832,175),(350,6910,36),(350,6911,153),(350,6912,159),(350,6913,160),(350,6914,163),(350,6915,170),(350,6916,171),(350,6917,173),(350,6918,179),(350,6919,181),(350,6920,182),(350,6921,188),(350,6922,191),(350,6923,192),(350,6924,193),(350,6925,197),(350,6926,201),(350,6927,202),(350,6928,210),(350,6929,215),(350,6930,218),(350,6931,229),(350,6932,230),(350,6933,233),(350,6934,236),(350,6935,242),(350,6936,244),(350,6937,246),(350,6938,256),(350,6939,257),(350,6940,258),(350,6941,259),(350,6942,260),(350,6943,265),(350,6944,266),(350,6945,271),(350,6946,274),(350,6947,275),(350,6948,277),(350,6949,278),(350,6950,280),(350,6951,281),(350,6952,284),(350,6953,292),(350,6954,293),(350,6955,294),(350,6956,298),(350,6957,299),(350,6958,300),(350,6959,301),(350,6960,304),(350,6961,312),(350,6962,315),(350,6963,318),(350,6964,321),(350,6965,323),(350,6966,325),(350,6967,328),(350,6968,330),(350,6969,331),(350,6970,333),(350,6971,334),(350,6972,336),(350,6973,339),(350,6974,343),(350,6975,344),(350,6976,345),(350,6977,348),(350,6978,349),(350,6979,353),(350,6980,354),(350,6981,355),(350,6982,358),(350,6983,362),(350,6984,363),(351,20,4),(351,639,3),(351,792,2),(351,1219,7),(351,1768,8),(351,1903,0),(351,2510,5),(351,2514,6),(351,2970,1),(352,20,2),(352,939,0),(352,970,1),(353,20,3),(353,1710,2),(353,2947,4),(353,3366,0),(353,3680,1),(354,20,1),(354,620,0),(355,20,3),(355,1241,2),(355,1453,0),(355,2039,4),(355,2251,1),(356,17,3),(356,20,0),(356,135,2),(356,854,4),(356,1224,1),(356,3366,5),(357,20,5),(357,1241,0),(357,2503,2),(357,2570,3),(357,3070,1),(357,3366,4),(358,20,3),(358,135,2),(358,3366,0),(358,3714,1),(359,20,3),(359,1422,0),(359,1781,1),(359,2083,2),(359,3004,4),(360,20,5),(360,703,1),(360,1638,2),(360,2652,9),(360,2653,7),(360,2892,0),(360,3143,3),(360,3208,8),(360,3541,6),(360,3853,4),(361,20,3),(361,718,5),(361,1374,1),(361,1529,2),(361,2031,4),(361,2037,0),(362,20,0),(362,626,5),(362,723,4),(362,890,1),(362,928,3),(362,1224,2),(363,17,3),(363,20,2),(363,959,0),(363,2841,1),(364,20,0),(364,135,1),(364,1673,5),(364,2284,7),(364,2286,4),(364,2965,6),(364,3070,3),(364,3366,2),(365,20,7),(365,1241,0),(365,1667,4),(365,2039,1),(365,2192,2),(365,2453,5),(365,2919,6),(365,3529,3),(366,20,8),(366,77,2),(366,1241,1),(366,2039,5),(366,2340,6),(366,2503,3),(366,2533,7),(366,3366,4),(366,3816,0),(367,20,4),(367,1673,7),(367,1706,0),(367,2241,2),(367,2284,3),(367,2304,8),(367,2498,1),(367,2965,6),(367,2972,5),(368,20,1),(368,1006,4),(368,1768,2),(368,2436,0),(368,2892,6),(368,2898,5),(368,3366,3),(370,20,4),(370,620,5),(370,788,0),(370,1249,1),(370,2340,3),(370,3144,2),(372,20,14),(372,737,8),(372,834,2),(372,1051,13),(372,1222,3),(372,1349,6),(372,1442,7),(372,1761,11),(372,1963,4),(372,2678,0),(372,2769,10),(372,2837,5),(372,3065,9),(372,3098,15),(372,3119,1),(372,3444,12),(373,17,1),(373,20,0),(373,135,2),(373,854,5),(373,1224,3),(373,3366,4),(375,20,4),(375,1674,3),(375,1899,0),(375,2633,2),(375,3024,1),(376,17,3),(376,20,0),(376,1641,4),(376,1674,1),(376,3004,2),(377,613,5),(377,640,12),(377,1413,15),(377,1418,7),(377,1458,14),(377,1492,4),(377,1729,17),(377,2112,18),(377,2189,16),(377,2505,11),(377,2546,3),(377,2573,2),(377,2637,6),(377,2859,0),(377,3278,1),(377,3288,10),(377,3520,13),(377,3525,8),(377,3575,9),(378,20,6),(378,1224,1),(378,1673,0),(378,1706,4),(378,2284,3),(378,2304,7),(378,2965,5),(378,2972,2),(379,20,1),(379,626,15),(379,723,0),(379,783,9),(379,1224,2),(379,1240,3),(379,1335,7),(379,1400,10),(379,1673,4),(379,1704,8),(379,1964,6),(379,2535,14),(379,2639,11),(379,3293,5),(379,3400,13),(379,3601,12),(381,20,6),(381,135,5),(381,1241,4),(381,2835,2),(381,3251,0),(381,3366,1),(381,6898,3),(382,20,0),(382,2213,1),(382,2887,2),(383,17,3),(383,20,5),(383,1870,4),(383,2471,0),(383,3000,2),(383,3074,1),(384,20,5),(384,620,6),(384,788,2),(384,822,3),(384,924,4),(384,1249,1),(384,1604,0),(385,20,12),(385,135,6),(385,626,13),(385,928,1),(385,1222,0),(385,1567,3),(385,2194,10),(385,2252,2),(385,2445,9),(385,2765,11),(385,2837,5),(385,3012,4),(385,3031,8),(385,3244,7),(386,20,4),(386,135,3),(386,2503,1),(386,3265,2),(386,3366,0),(588,20,5),(588,135,0),(588,620,4),(588,1241,1),(588,2892,2),(588,3366,3),(589,20,30),(589,613,17),(589,638,34),(589,682,51),(589,695,60),(589,780,72),(589,789,29),(589,824,28),(589,874,8),(589,915,53),(589,1037,1),(589,1082,27),(589,1126,32),(589,1270,35),(589,1399,9),(589,1410,74),(589,1513,78),(589,1525,10),(589,1611,48),(589,1662,41),(589,1678,76),(589,1728,63),(589,1731,38),(589,1737,3),(589,1756,69),(589,1838,50),(589,1855,24),(589,1912,67),(589,1927,79),(589,1931,5),(589,1983,58),(589,2007,16),(589,2059,73),(589,2087,65),(589,2135,55),(589,2147,7),(589,2155,33),(589,2191,26),(589,2240,2),(589,2299,39),(589,2339,6),(589,2427,13),(589,2494,54),(589,2504,21),(589,2506,22),(589,2569,4),(589,2580,68),(589,2589,62),(589,2697,44),(589,2702,31),(589,2753,47),(589,2760,59),(589,2782,49),(589,2832,77),(589,2964,42),(589,3048,11),(589,3088,40),(589,3106,14),(589,3142,15),(589,3153,36),(589,3167,57),(589,3270,45),(589,3289,20),(589,3345,25),(589,3490,19),(589,3505,0),(589,3516,64),(589,3520,18),(589,3524,61),(589,3539,37),(589,3581,70),(589,3624,23),(589,3639,56),(589,3730,75),(589,3736,46),(589,3792,52),(589,5924,12),(589,5951,66),(589,6854,71),(589,6906,43),(590,17,3),(590,20,4),(590,626,5),(590,928,1),(590,1222,0),(590,2765,2),(591,20,2),(591,2947,3),(591,3366,0),(591,3680,1),(592,20,0),(592,1096,1),(592,1673,2),(592,1706,3),(593,17,3),(593,20,4),(593,2696,0),(593,2892,1),(593,3366,2),(594,20,0),(594,135,3),(594,1241,4),(594,3251,2),(594,3366,1),(595,20,0),(595,1674,1),(596,20,4),(596,1641,1),(596,1673,2),(596,1706,0),(596,2284,3),(596,2531,5),(596,2965,6),(597,20,6),(597,135,3),(597,1241,5),(597,2835,2),(597,3251,0),(597,3366,1),(597,6898,4),(598,20,4),(598,620,0),(598,624,1),(598,1351,3),(598,1604,2),(599,20,6),(599,1217,2),(599,1235,8),(599,1327,5),(599,1329,4),(599,1600,1),(599,1892,7),(599,2585,10),(599,2892,0),(599,3450,3),(599,3823,9),(600,20,2),(600,2010,3),(600,2470,4),(600,2835,1),(600,3265,5),(600,3366,0),(601,20,1),(601,135,4),(601,1198,5),(601,1673,8),(601,2284,7),(601,2286,3),(601,2965,6),(601,3070,2),(601,3366,0),(602,20,1),(602,626,0),(602,1088,2),(602,1240,4),(602,1873,3),(603,20,7),(603,77,0),(603,135,4),(603,1102,2),(603,1682,1),(603,1698,3),(603,2175,5),(603,2223,6),(604,17,3),(604,20,4),(604,626,2),(604,928,0),(604,1222,1),(605,20,0),(605,135,3),(605,835,6),(605,1000,4),(605,1673,8),(605,2284,7),(605,3054,5),(605,3070,2),(605,3366,1),(606,20,1),(606,620,2),(606,1604,0),(607,20,1),(607,626,6),(607,1224,2),(607,1240,4),(607,1873,5),(607,2263,3),(607,3632,0),(608,17,3),(608,20,6),(608,1678,5),(608,2589,1),(608,2843,0),(608,2859,4),(608,3270,2),(609,20,1),(609,626,2),(609,723,0),(609,1240,3),(610,20,8),(610,135,7),(610,1241,1),(610,1393,6),(610,2503,2),(610,2533,4),(610,2570,5),(610,3366,3),(610,3816,0),(611,20,0),(612,20,11),(612,751,3),(612,770,9),(612,1149,6),(612,1564,2),(612,1596,10),(612,1609,7),(612,2755,0),(612,3004,12),(612,3077,1),(612,3354,8),(612,3453,5),(612,7186,4),(613,20,0),(613,626,5),(613,723,1),(613,928,3),(613,1240,4),(613,1881,2),(614,20,4),(614,880,3),(614,1241,5),(614,2570,0),(614,3070,2),(614,3182,1),(615,20,4),(615,639,3),(615,662,5),(615,792,1),(615,1768,7),(615,1903,0),(615,2510,6),(615,2970,2),(616,20,1),(616,1768,0),(617,20,24),(617,617,8),(617,625,30),(617,698,53),(617,736,66),(617,761,3),(617,773,26),(617,796,37),(617,852,45),(617,904,10),(617,913,42),(617,965,6),(617,976,28),(617,1181,9),(617,1223,20),(617,1226,2),(617,1243,51),(617,1378,67),(617,1451,15),(617,1488,23),(617,1526,41),(617,1540,35),(617,1678,36),(617,1720,58),(617,1725,63),(617,1828,18),(617,1836,40),(617,1839,55),(617,1864,7),(617,2039,31),(617,2057,5),(617,2121,44),(617,2218,48),(617,2227,50),(617,2274,11),(617,2337,12),(617,2369,0),(617,2426,54),(617,2434,70),(617,2493,4),(617,2529,59),(617,2540,43),(617,2589,64),(617,2617,52),(617,2700,46),(617,2731,62),(617,2745,34),(617,2833,69),(617,2842,60),(617,2928,19),(617,2956,29),(617,2974,68),(617,3095,38),(617,3101,32),(617,3201,56),(617,3350,22),(617,3402,1),(617,3468,61),(617,3499,39),(617,3511,17),(617,3513,27),(617,3571,25),(617,3605,65),(617,3616,33),(617,3626,13),(617,3658,14),(617,3753,49),(617,3771,57),(617,3833,21),(617,5967,47),(617,6079,16),(618,20,5),(618,626,6),(618,1015,3),(618,3055,0),(618,3232,2),(618,3316,1),(618,3632,4),(619,20,10),(619,77,5),(619,135,9),(619,794,4),(619,1241,1),(619,1393,7),(619,2039,3),(619,2251,6),(619,3251,8),(619,3366,2),(619,3816,0),(620,20,3),(620,135,4),(620,620,9),(620,1205,0),(620,1604,7),(620,2467,6),(620,2503,8),(620,3070,2),(620,3207,1),(620,3366,5),(621,20,2),(621,2039,1),(621,2305,3),(621,2572,4),(621,3265,5),(621,3360,0),(621,3366,6),(622,20,6),(622,1224,1),(622,1673,0),(622,1706,2),(622,2284,5),(622,2304,7),(622,2965,4),(622,2972,3),(623,20,7),(623,792,6),(623,1006,5),(623,1768,1),(623,2436,4),(623,2892,0),(623,2898,3),(623,3366,2),(624,20,3),(624,719,4),(624,1489,1),(624,1768,0),(624,3448,2),(625,20,1),(625,2096,4),(625,2835,6),(625,3265,7),(625,3276,3),(625,3304,5),(625,3366,0),(625,3787,2),(626,20,3),(626,748,1),(626,1089,0),(626,1146,2),(626,2705,4),(627,20,0),(627,135,1),(628,17,4),(628,20,0),(628,1674,3),(628,1679,2),(628,1886,1),(629,17,1),(629,20,4),(629,1279,2),(629,2290,3),(629,3652,0),(630,20,2),(630,718,0),(630,1157,8),(630,1529,7),(630,1717,4),(630,2037,6),(630,2061,1),(630,2356,3),(630,2921,9),(630,3641,10),(631,20,5),(631,1241,3),(631,2503,1),(631,2533,4),(631,3366,2),(631,3816,0),(632,20,6),(632,2305,1),(632,2470,3),(632,2503,4),(632,2967,2),(632,3265,5),(632,3366,0),(633,20,0),(634,20,3),(634,1606,0),(634,1822,2),(634,1880,5),(634,3099,4),(634,3291,1),(635,20,2),(635,1048,0),(635,1946,6),(635,2039,3),(635,3265,4),(635,3360,1),(635,3366,5),(636,20,6),(636,789,4),(636,824,8),(636,1190,7),(636,1254,3),(636,1492,0),(636,1611,9),(636,1678,10),(636,2859,11),(636,2964,5),(636,3068,1),(636,3270,2),(637,20,3),(637,620,4),(637,1249,2),(637,1470,1),(637,3322,0),(638,20,1),(638,1768,0),(639,20,0),(639,626,2),(639,1088,1),(639,1240,4),(639,1367,3),(640,20,79),(640,635,55),(640,666,134),(640,678,100),(640,699,56),(640,762,10),(640,769,112),(640,774,4),(640,776,133),(640,789,29),(640,796,99),(640,813,16),(640,818,91),(640,824,77),(640,846,68),(640,911,42),(640,913,37),(640,951,129),(640,1043,101),(640,1045,17),(640,1094,21),(640,1220,9),(640,1242,95),(640,1254,107),(640,1261,83),(640,1293,41),(640,1381,11),(640,1391,13),(640,1410,27),(640,1412,131),(640,1413,26),(640,1429,66),(640,1439,123),(640,1458,59),(640,1480,18),(640,1492,25),(640,1493,115),(640,1554,121),(640,1563,30),(640,1585,128),(640,1587,67),(640,1601,124),(640,1603,127),(640,1611,103),(640,1640,6),(640,1650,24),(640,1669,94),(640,1670,3),(640,1719,125),(640,1751,45),(640,1792,109),(640,1798,118),(640,1816,85),(640,1833,65),(640,1858,89),(640,1890,43),(640,1897,88),(640,1904,117),(640,1910,50),(640,1939,39),(640,1970,0),(640,1993,126),(640,2012,122),(640,2134,70),(640,2155,82),(640,2239,51),(640,2259,54),(640,2335,5),(640,2415,102),(640,2452,86),(640,2513,84),(640,2521,40),(640,2543,36),(640,2555,75),(640,2566,14),(640,2573,97),(640,2645,130),(640,2670,90),(640,2677,49),(640,2695,7),(640,2712,105),(640,2718,69),(640,2759,108),(640,2776,57),(640,2778,119),(640,2783,76),(640,2784,38),(640,2792,92),(640,2830,23),(640,2856,110),(640,2859,20),(640,2871,8),(640,2891,64),(640,2957,34),(640,2964,32),(640,2992,72),(640,2998,132),(640,3001,98),(640,3006,47),(640,3020,46),(640,3059,2),(640,3080,35),(640,3151,60),(640,3233,48),(640,3237,52),(640,3246,1),(640,3254,28),(640,3261,78),(640,3266,31),(640,3278,19),(640,3345,73),(640,3357,74),(640,3374,104),(640,3424,44),(640,3426,114),(640,3473,22),(640,3491,116),(640,3495,62),(640,3497,80),(640,3551,58),(640,3558,113),(640,3566,120),(640,3610,15),(640,3623,87),(640,3666,61),(640,3682,71),(640,3719,106),(640,3720,111),(640,3721,93),(640,3726,63),(640,3737,81),(640,3738,96),(640,3739,12),(640,3786,53),(640,3852,33),(641,17,3),(641,20,4),(641,626,6),(641,929,2),(641,931,1),(641,1240,5),(641,3632,0),(642,17,2),(642,20,1),(642,1674,0),(643,20,2),(643,854,3),(643,1602,0),(643,2962,4),(643,3400,5),(643,3510,1),(644,20,14),(644,717,21),(644,727,31),(644,796,25),(644,824,4),(644,1148,23),(644,1193,1),(644,1322,22),(644,1405,7),(644,1611,5),(644,1635,18),(644,1666,12),(644,1820,30),(644,1919,27),(644,1978,8),(644,2031,6),(644,2032,26),(644,2074,13),(644,2080,11),(644,2270,24),(644,2676,9),(644,2859,29),(644,3023,20),(644,3051,32),(644,3056,17),(644,3092,0),(644,3155,28),(644,3229,2),(644,3265,15),(644,3326,19),(644,3568,3),(644,3577,16),(644,3598,10),(645,20,5),(645,135,4),(645,1241,0),(645,2503,1),(645,2570,3),(645,3366,2),(646,20,6),(646,767,0),(646,1000,3),(646,3052,5),(646,3647,1),(646,3704,2),(646,3734,4),(647,20,4),(647,1224,7),(647,1673,1),(647,1706,5),(647,2283,8),(647,2284,3),(647,2311,2),(647,2965,0),(647,2972,6),(648,17,2),(648,20,4),(648,1641,1),(648,1870,3),(648,2841,0),(649,20,1),(649,1096,2),(649,1706,0),(649,2410,3),(650,20,3),(650,620,1),(650,788,4),(650,1249,0),(650,1824,2),(651,20,5),(651,135,0),(651,973,3),(651,982,2),(651,1087,4),(651,3366,1),(652,20,3),(652,1641,2),(652,2048,0),(652,3366,1),(654,20,0),(654,77,1),(654,135,3),(654,620,5),(654,1241,2),(654,2892,6),(654,3004,7),(654,3366,4),(655,20,36),(655,697,5),(655,708,111),(655,720,31),(655,745,18),(655,789,72),(655,796,87),(655,830,110),(655,855,118),(655,859,103),(655,874,131),(655,922,91),(655,923,58),(655,953,29),(655,966,90),(655,969,127),(655,999,84),(655,1126,75),(655,1179,122),(655,1262,34),(655,1269,17),(655,1271,15),(655,1290,28),(655,1301,14),(655,1331,37),(655,1390,1),(655,1403,10),(655,1475,89),(655,1503,78),(655,1518,142),(655,1533,146),(655,1553,102),(655,1583,8),(655,1587,109),(655,1611,43),(655,1699,11),(655,1731,81),(655,1737,133),(655,1743,12),(655,1783,83),(655,1841,115),(655,1928,42),(655,1958,147),(655,1974,128),(655,1976,65),(655,1989,40),(655,1997,19),(655,1998,149),(655,2015,113),(655,2029,144),(655,2031,13),(655,2049,105),(655,2080,47),(655,2085,76),(655,2087,74),(655,2094,50),(655,2112,25),(655,2134,114),(655,2137,22),(655,2155,124),(655,2171,54),(655,2265,24),(655,2266,71),(655,2299,38),(655,2303,79),(655,2372,130),(655,2387,64),(655,2391,33),(655,2408,60),(655,2447,67),(655,2468,30),(655,2469,27),(655,2519,46),(655,2589,61),(655,2634,129),(655,2637,63),(655,2676,80),(655,2697,86),(655,2706,41),(655,2716,49),(655,2729,145),(655,2751,126),(655,2760,92),(655,2771,93),(655,2832,69),(655,2857,52),(655,2870,148),(655,2931,44),(655,2964,82),(655,3030,39),(655,3034,123),(655,3081,112),(655,3090,45),(655,3106,53),(655,3111,48),(655,3126,55),(655,3149,4),(655,3158,70),(655,3181,16),(655,3206,26),(655,3261,121),(655,3270,88),(655,3288,20),(655,3289,23),(655,3312,141),(655,3315,6),(655,3323,104),(655,3328,7),(655,3336,35),(655,3345,32),(655,3347,94),(655,3436,120),(655,3449,62),(655,3520,21),(655,3524,57),(655,3537,68),(655,3538,138),(655,3564,59),(655,3565,56),(655,3566,2),(655,3600,9),(655,3648,51),(655,3665,73),(655,3728,66),(655,3730,77),(655,3755,137),(655,3766,108),(655,3843,0),(655,3848,107),(655,3852,85),(655,3854,3),(660,20,6),(660,1165,4),(660,1535,8),(660,1684,5),(660,2216,2),(660,2589,10),(660,2775,9),(660,3040,7),(660,3096,3),(660,3744,1),(660,3797,0),(662,20,1),(662,135,3),(662,1198,4),(662,3070,2),(662,3366,0),(664,20,12),(664,77,4),(664,135,8),(664,620,11),(664,643,9),(664,997,0),(664,1241,6),(664,1495,10),(664,2076,7),(664,2348,5),(664,2892,1),(664,3004,3),(664,3230,2),(667,20,3),(667,626,2),(667,1240,1),(667,2040,4),(667,2314,5),(667,3148,6),(667,3632,0),(669,20,1),(669,1673,2),(669,1706,5),(669,2284,4),(669,2965,3),(669,2972,0),(670,20,1),(670,3256,0),(671,17,3),(671,20,1),(671,626,4),(671,723,2),(671,1224,0),(671,1240,5),(672,20,3),(672,789,2),(672,1678,4),(672,1691,1),(672,2832,0),(673,20,5),(673,135,2),(673,870,3),(673,1241,1),(673,3004,4),(673,3256,0),(674,20,0),(674,3004,1),(675,17,1),(675,20,0),(675,135,3),(675,854,5),(675,1224,4),(675,3366,2),(676,20,3),(676,626,5),(676,929,2),(676,3285,0),(676,3599,1),(676,3723,4),(677,20,0),(677,626,4),(677,854,1),(677,928,3),(677,1224,2),(678,20,7),(678,2305,5),(678,2470,6),(678,2835,1),(678,3265,2),(678,3366,0),(678,3787,3),(678,6898,4),(679,20,5),(679,626,8),(679,929,0),(679,1021,3),(679,1240,4),(679,1923,2),(679,2562,1),(679,3124,7),(679,3228,6),(680,20,118),(680,613,18),(680,635,248),(680,640,37),(680,642,116),(680,644,291),(680,653,27),(680,689,365),(680,699,258),(680,700,57),(680,738,79),(680,759,70),(680,772,4),(680,775,214),(680,780,333),(680,789,310),(680,796,330),(680,797,8),(680,805,255),(680,829,141),(680,851,20),(680,891,81),(680,904,65),(680,913,351),(680,922,217),(680,923,262),(680,951,340),(680,962,188),(680,965,283),(680,968,338),(680,1000,334),(680,1007,298),(680,1024,309),(680,1034,263),(680,1043,176),(680,1078,123),(680,1083,147),(680,1094,386),(680,1117,156),(680,1124,6),(680,1131,312),(680,1134,94),(680,1138,112),(680,1151,86),(680,1160,60),(680,1166,100),(680,1168,228),(680,1186,80),(680,1203,68),(680,1242,159),(680,1254,193),(680,1265,58),(680,1285,256),(680,1291,354),(680,1311,66),(680,1322,353),(680,1331,311),(680,1345,61),(680,1350,160),(680,1377,98),(680,1380,23),(680,1391,174),(680,1397,121),(680,1410,290),(680,1412,385),(680,1413,288),(680,1418,21),(680,1427,82),(680,1429,302),(680,1437,374),(680,1449,105),(680,1454,12),(680,1458,41),(680,1476,301),(680,1492,3),(680,1493,234),(680,1494,53),(680,1502,131),(680,1509,206),(680,1513,76),(680,1518,222),(680,1525,177),(680,1533,243),(680,1550,136),(680,1555,54),(680,1558,101),(680,1575,181),(680,1580,284),(680,1587,73),(680,1593,276),(680,1603,267),(680,1611,182),(680,1632,122),(680,1650,393),(680,1658,209),(680,1669,321),(680,1678,327),(680,1687,67),(680,1698,335),(680,1703,371),(680,1718,376),(680,1737,166),(680,1751,305),(680,1776,247),(680,1777,370),(680,1787,87),(680,1792,199),(680,1797,382),(680,1798,367),(680,1800,270),(680,1801,22),(680,1814,1),(680,1816,313),(680,1820,72),(680,1846,279),(680,1858,140),(680,1888,75),(680,1890,231),(680,1897,138),(680,1904,237),(680,1910,366),(680,1916,34),(680,1921,148),(680,1924,102),(680,1935,108),(680,1939,355),(680,1940,44),(680,1945,135),(680,1958,244),(680,1959,59),(680,1968,300),(680,2009,9),(680,2012,254),(680,2015,90),(680,2022,144),(680,2028,129),(680,2032,272),(680,2034,153),(680,2049,287),(680,2051,308),(680,2058,200),(680,2094,216),(680,2097,384),(680,2112,49),(680,2117,164),(680,2120,0),(680,2127,211),(680,2132,201),(680,2134,93),(680,2135,357),(680,2155,124),(680,2166,32),(680,2178,142),(680,2185,99),(680,2189,2),(680,2196,74),(680,2205,266),(680,2206,285),(680,2239,368),(680,2255,296),(680,2259,246),(680,2260,104),(680,2279,97),(680,2303,316),(680,2326,56),(680,2386,125),(680,2388,389),(680,2419,282),(680,2432,17),(680,2438,179),(680,2449,230),(680,2452,314),(680,2461,92),(680,2483,63),(680,2506,52),(680,2513,126),(680,2519,342),(680,2521,359),(680,2522,219),(680,2546,15),(680,2568,139),(680,2573,7),(680,2580,43),(680,2598,47),(680,2602,306),(680,2603,119),(680,2610,111),(680,2629,320),(680,2637,19),(680,2642,299),(680,2645,293),(680,2671,280),(680,2675,114),(680,2677,356),(680,2701,89),(680,2707,307),(680,2711,253),(680,2712,187),(680,2734,106),(680,2754,36),(680,2756,289),(680,2759,344),(680,2767,303),(680,2768,346),(680,2778,241),(680,2782,191),(680,2792,319),(680,2819,45),(680,2830,377),(680,2846,51),(680,2856,350),(680,2859,392),(680,2875,95),(680,2878,77),(680,2880,24),(680,2881,186),(680,2884,35),(680,2891,292),(680,2931,336),(680,2933,379),(680,2957,169),(680,2964,325),(680,2977,55),(680,2985,390),(680,2998,391),(680,3001,168),(680,3006,326),(680,3015,195),(680,3030,155),(680,3035,120),(680,3036,212),(680,3047,5),(680,3051,259),(680,3054,363),(680,3061,151),(680,3085,69),(680,3086,251),(680,3090,337),(680,3111,205),(680,3120,133),(680,3127,145),(680,3153,315),(680,3161,38),(680,3168,339),(680,3173,128),(680,3195,134),(680,3197,163),(680,3200,226),(680,3214,278),(680,3233,352),(680,3237,372),(680,3254,381),(680,3261,117),(680,3266,324),(680,3270,173),(680,3278,11),(680,3283,29),(680,3288,31),(680,3290,347),(680,3292,110),(680,3297,180),(680,3321,184),(680,3325,39),(680,3335,137),(680,3340,88),(680,3345,103),(680,3361,265),(680,3371,210),(680,3401,130),(680,3419,78),(680,3424,13),(680,3426,233),(680,3430,318),(680,3446,268),(680,3480,127),(680,3507,30),(680,3520,40),(680,3527,264),(680,3537,91),(680,3546,83),(680,3552,25),(680,3555,113),(680,3558,364),(680,3564,378),(680,3566,252),(680,3570,107),(680,3575,26),(680,3600,62),(680,3619,10),(680,3624,297),(680,3626,294),(680,3630,115),(680,3645,85),(680,3653,14),(680,3659,28),(680,3689,281),(680,3696,286),(680,3701,143),(680,3712,109),(680,3717,250),(680,3720,225),(680,3721,149),(680,3722,46),(680,3726,64),(680,3729,50),(680,3738,162),(680,3741,207),(680,3755,178),(680,3764,269),(680,3767,154),(680,3783,16),(680,3786,146),(680,3825,238),(680,3844,71),(680,3853,322),(680,5835,96),(680,5849,165),(680,5851,329),(680,5854,190),(680,5855,343),(680,5859,198),(680,5860,208),(680,5861,33),(680,5862,48),(680,5864,202),(680,5865,203),(680,5866,295),(680,5868,361),(680,5869,380),(680,5871,360),(680,5873,362),(680,5876,232),(680,5879,235),(680,5886,274),(680,5887,331),(680,5898,42),(680,5899,84),(680,5900,132),(680,5901,150),(680,5902,152),(680,5903,158),(680,5904,161),(680,5905,167),(680,5906,170),(680,5907,171),(680,5908,172),(680,5909,175),(680,5910,183),(680,5911,185),(680,5912,189),(680,5913,192),(680,5914,157),(680,5915,196),(680,5916,197),(680,5917,204),(680,5918,213),(680,5919,215),(680,5921,218),(680,5922,220),(680,5923,221),(680,5924,223),(680,5925,224),(680,5926,227),(680,5927,229),(680,5928,236),(680,5929,239),(680,5930,240),(680,5931,242),(680,5932,245),(680,5933,249),(680,5936,260),(680,5937,261),(680,5939,271),(680,5940,273),(680,5941,275),(680,5942,277),(680,5943,317),(680,5944,323),(680,5945,328),(680,5946,332),(680,5947,341),(680,5948,345),(680,5949,348),(680,5950,349),(680,5951,358),(680,5952,369),(680,5953,373),(680,5954,375),(680,5955,387),(680,5956,383),(680,5957,388),(680,6083,194),(680,6084,257),(681,15,3),(681,17,4),(681,20,0),(681,77,15),(681,135,1),(681,620,5),(681,889,13),(681,1092,8),(681,1227,11),(681,1241,10),(681,1530,12),(681,1920,9),(681,2054,7),(681,3256,2),(681,3366,6),(681,3672,14),(682,20,0),(682,1032,2),(682,1224,1),(683,17,2),(683,20,0),(683,768,1),(683,1641,3),(683,1870,4),(684,17,2),(684,20,1),(684,1674,0),(685,20,2),(685,1096,3),(685,1303,1),(685,1706,0),(686,20,3),(686,620,4),(686,924,2),(686,1604,0),(686,6899,1),(687,20,5),(687,748,3),(687,1089,0),(687,1241,2),(687,2705,4),(687,3816,1),(688,20,0),(688,626,1),(689,20,1),(689,1673,2),(689,1706,5),(689,2284,4),(689,2965,3),(689,2972,0),(690,20,0),(690,994,1),(690,1673,2),(691,20,7),(691,1241,5),(691,2305,0),(691,2361,1),(691,2470,3),(691,2696,4),(691,2898,2),(691,3265,6),(691,3366,8),(692,20,15),(692,617,17),(692,763,10),(692,849,20),(692,913,33),(692,918,29),(692,965,30),(692,1029,28),(692,1223,24),(692,1243,5),(692,1247,35),(692,1288,19),(692,1355,1),(692,1378,6),(692,1460,27),(692,1522,16),(692,1708,4),(692,1718,12),(692,1720,22),(692,1751,37),(692,1755,26),(692,1839,21),(692,2039,13),(692,2211,11),(692,2218,23),(692,2257,7),(692,2426,3),(692,2434,2),(692,2617,32),(692,2833,9),(692,2842,31),(692,2974,34),(692,3308,18),(692,3350,14),(692,3511,0),(692,3521,8),(692,3626,36),(692,3689,25),(693,20,1),(693,626,0),(693,675,2),(693,1240,4),(693,1873,3),(694,20,2),(694,135,5),(694,620,0),(694,2503,4),(694,3070,1),(694,3207,6),(694,3322,3),(695,20,3),(695,626,4),(695,928,0),(695,1222,1),(695,2765,2),(696,20,11),(696,634,10),(696,802,1),(696,912,9),(696,965,4),(696,1034,5),(696,1149,16),(696,1534,13),(696,1596,8),(696,1676,2),(696,1821,15),(696,1882,6),(696,2359,3),(696,2530,14),(696,2601,0),(696,3004,7),(696,3160,12),(696,3634,17),(697,20,23),(697,77,0),(697,643,7),(697,1314,1),(697,1422,4),(697,1437,19),(697,1455,11),(697,1571,18),(697,1580,14),(697,1768,5),(697,1823,16),(697,2076,17),(697,2223,22),(697,2519,9),(697,2719,3),(697,2754,20),(697,2892,6),(697,2980,8),(697,3004,2),(697,3077,13),(697,3078,21),(697,3165,15),(697,3390,12),(697,3508,10),(698,17,1),(698,20,0),(698,626,6),(698,1224,5),(698,3227,3),(698,3285,2),(698,3723,4),(699,20,3),(699,2181,2),(699,2883,0),(699,3327,1),(700,17,4),(700,20,7),(700,626,9),(700,929,1),(700,1224,2),(700,1240,8),(700,2341,3),(700,3285,5),(700,3632,0),(700,3723,6),(701,20,4),(701,789,3),(701,1678,5),(701,2213,1),(701,2832,0),(701,6273,2),(702,20,0),(702,135,2),(702,2005,5),(702,2286,6),(702,3070,1),(702,3699,3),(702,3839,4),(703,20,0),(703,626,2),(703,789,3),(703,928,1),(703,2887,4),(704,20,36),(704,763,17),(704,904,3),(704,913,30),(704,918,27),(704,934,28),(704,1029,26),(704,1031,24),(704,1232,25),(704,1247,2),(704,1378,12),(704,1460,23),(704,1678,34),(704,1684,6),(704,1718,19),(704,1720,21),(704,1751,16),(704,1768,35),(704,1839,20),(704,2039,11),(704,2211,18),(704,2216,7),(704,2218,22),(704,2257,15),(704,2371,4),(704,2434,1),(704,2537,0),(704,2589,33),(704,2832,9),(704,2833,31),(704,2842,13),(704,2845,5),(704,2948,29),(704,2974,32),(704,3270,8),(704,3350,10),(704,3521,14),(705,17,2),(705,20,3),(705,959,1),(705,2841,0),(706,20,5),(706,1224,1),(706,1673,0),(706,2284,4),(706,2304,7),(706,2531,2),(706,2965,3),(706,2972,6),(707,20,2),(707,1224,1),(707,1673,0),(707,1706,6),(707,2284,5),(707,2965,4),(707,2972,3),(708,20,34),(708,613,5),(708,635,80),(708,640,7),(708,642,84),(708,708,21),(708,772,23),(708,789,31),(708,796,50),(708,824,32),(708,901,22),(708,904,16),(708,913,62),(708,922,70),(708,923,86),(708,968,57),(708,1024,30),(708,1043,53),(708,1094,92),(708,1242,45),(708,1254,59),(708,1322,66),(708,1391,52),(708,1410,10),(708,1412,91),(708,1413,9),(708,1427,20),(708,1429,18),(708,1492,13),(708,1533,78),(708,1587,19),(708,1601,83),(708,1603,89),(708,1611,55),(708,1632,36),(708,1650,11),(708,1678,47),(708,1718,85),(708,1751,27),(708,1874,94),(708,1890,74),(708,1897,41),(708,1904,76),(708,1910,77),(708,1939,67),(708,1958,79),(708,2012,81),(708,2094,68),(708,2134,24),(708,2155,37),(708,2205,88),(708,2206,8),(708,2303,96),(708,2513,38),(708,2516,42),(708,2521,69),(708,2522,71),(708,2546,3),(708,2707,28),(708,2712,58),(708,2767,25),(708,2768,61),(708,2784,63),(708,2830,87),(708,2859,93),(708,2891,17),(708,2930,29),(708,2931,56),(708,2957,49),(708,2964,46),(708,2998,95),(708,3001,48),(708,3035,35),(708,3111,2),(708,3173,39),(708,3200,72),(708,3233,64),(708,3254,14),(708,3261,33),(708,3266,44),(708,3270,51),(708,3278,1),(708,3283,82),(708,3288,4),(708,3345,26),(708,3426,75),(708,3430,40),(708,3446,90),(708,3520,0),(708,3558,73),(708,3575,6),(708,3600,15),(708,3741,65),(708,3755,54),(708,3853,43),(708,5855,60),(708,5862,12),(709,17,2),(709,20,0),(709,135,4),(709,854,1),(709,3366,3),(710,17,3),(710,20,1),(710,135,2),(710,3366,0),(711,20,2),(711,866,5),(711,1902,4),(711,2287,0),(711,2535,3),(711,3293,1),(712,20,2),(712,1406,1),(712,2305,3),(712,2696,0),(712,3265,4),(712,3366,5),(713,20,0),(713,928,1),(713,2284,3),(713,2965,2),(713,3716,4),(714,20,2),(714,1673,1),(714,1706,4),(714,2284,3),(714,2965,5),(714,2972,0),(715,20,34),(715,625,41),(715,761,9),(715,796,48),(715,857,57),(715,904,14),(715,913,51),(715,919,31),(715,934,22),(715,956,36),(715,965,10),(715,976,40),(715,977,29),(715,1057,73),(715,1144,17),(715,1223,27),(715,1243,60),(715,1313,46),(715,1337,49),(715,1378,77),(715,1424,1),(715,1430,6),(715,1521,35),(715,1540,47),(715,1630,30),(715,1720,66),(715,1725,68),(715,1751,25),(715,1828,23),(715,1836,50),(715,1839,4),(715,1933,59),(715,1991,44),(715,2006,19),(715,2039,43),(715,2206,11),(715,2227,58),(715,2257,69),(715,2274,15),(715,2369,3),(715,2426,61),(715,2434,0),(715,2435,53),(715,2493,8),(715,2529,67),(715,2537,54),(715,2540,52),(715,2581,33),(715,2589,71),(715,2617,63),(715,2700,55),(715,2745,45),(715,2833,75),(715,2834,5),(715,2842,62),(715,2928,26),(715,2929,28),(715,2974,76),(715,3201,64),(715,3203,24),(715,3239,37),(715,3339,70),(715,3350,32),(715,3402,38),(715,3414,74),(715,3511,20),(715,3513,39),(715,3544,12),(715,3571,2),(715,3605,72),(715,3612,18),(715,3626,16),(715,3771,65),(715,5959,7),(715,5964,21),(715,5967,56),(715,6607,13),(715,6608,42),(716,20,6),(716,1326,1),(716,1611,4),(716,1678,7),(716,1896,2),(716,1960,0),(716,2589,3),(716,2832,5),(716,3270,8),(717,20,6),(717,135,4),(717,1241,1),(717,2835,5),(717,3304,3),(717,3366,0),(717,6898,2),(718,20,4),(718,789,2),(718,1678,3),(718,2213,1),(718,2832,0),(719,20,4),(719,1241,1),(719,1393,3),(719,3251,5),(719,3330,0),(719,3366,2),(720,20,76),(720,117,96),(720,613,3),(720,635,52),(720,699,53),(720,766,192),(720,769,108),(720,780,14),(720,789,33),(720,796,95),(720,805,288),(720,818,87),(720,824,74),(720,846,65),(720,913,26),(720,951,125),(720,968,40),(720,1024,189),(720,1036,19),(720,1043,97),(720,1094,27),(720,1124,159),(720,1190,290),(720,1220,63),(720,1242,91),(720,1254,103),(720,1261,79),(720,1276,139),(720,1291,255),(720,1293,39),(720,1306,149),(720,1343,300),(720,1361,190),(720,1410,24),(720,1412,10),(720,1413,31),(720,1429,6),(720,1439,120),(720,1458,56),(720,1492,4),(720,1493,111),(720,1554,117),(720,1563,34),(720,1573,154),(720,1585,124),(720,1587,64),(720,1601,121),(720,1603,22),(720,1611,99),(720,1636,155),(720,1637,238),(720,1650,30),(720,1657,7),(720,1669,90),(720,1678,12),(720,1718,122),(720,1751,42),(720,1756,277),(720,1777,286),(720,1792,105),(720,1798,114),(720,1816,81),(720,1820,161),(720,1833,62),(720,1858,85),(720,1890,21),(720,1897,84),(720,1904,113),(720,1910,47),(720,1912,209),(720,1931,164),(720,1939,17),(720,1974,218),(720,1993,123),(720,2001,276),(720,2012,118),(720,2025,172),(720,2032,307),(720,2034,224),(720,2062,169),(720,2094,261),(720,2129,294),(720,2134,67),(720,2155,8),(720,2172,211),(720,2191,185),(720,2205,301),(720,2206,142),(720,2239,48),(720,2259,51),(720,2387,144),(720,2415,98),(720,2438,15),(720,2452,82),(720,2484,176),(720,2494,256),(720,2513,80),(720,2521,18),(720,2543,16),(720,2555,72),(720,2557,203),(720,2566,119),(720,2573,93),(720,2621,206),(720,2635,201),(720,2670,86),(720,2677,46),(720,2697,237),(720,2707,28),(720,2712,101),(720,2718,66),(720,2753,242),(720,2759,104),(720,2776,54),(720,2778,115),(720,2783,73),(720,2784,38),(720,2792,88),(720,2830,29),(720,2856,106),(720,2859,25),(720,2887,235),(720,2891,61),(720,2942,258),(720,2957,36),(720,2964,35),(720,2992,69),(720,2998,127),(720,3001,94),(720,3006,44),(720,3020,43),(720,3030,228),(720,3051,295),(720,3066,158),(720,3071,213),(720,3080,37),(720,3113,273),(720,3151,57),(720,3196,212),(720,3233,45),(720,3237,49),(720,3254,32),(720,3261,75),(720,3266,11),(720,3270,13),(720,3278,20),(720,3312,263),(720,3345,70),(720,3357,71),(720,3368,210),(720,3374,100),(720,3424,41),(720,3426,110),(720,3430,9),(720,3491,112),(720,3495,59),(720,3497,77),(720,3551,55),(720,3558,109),(720,3566,116),(720,3623,83),(720,3624,5),(720,3656,268),(720,3666,58),(720,3682,68),(720,3710,309),(720,3719,102),(720,3720,107),(720,3721,89),(720,3726,60),(720,3730,196),(720,3737,78),(720,3738,92),(720,3741,0),(720,3755,2),(720,3777,229),(720,3786,50),(720,3790,23),(720,3819,1),(720,3844,156),(720,3897,137),(720,5885,306),(720,6256,126),(720,6273,170),(720,6307,184),(720,6664,257),(720,6683,250),(720,6686,278),(720,6864,305),(720,6865,148),(720,6866,266),(720,6867,188),(720,6870,304),(720,6871,287),(720,6872,262),(720,6873,283),(720,6874,134),(720,6875,174),(720,6885,199),(720,6893,141),(720,6990,128),(720,6991,129),(720,6992,130),(720,6993,131),(720,6994,132),(720,6995,133),(720,6996,135),(720,6997,136),(720,6998,138),(720,6999,140),(720,7000,143),(720,7001,145),(720,7002,146),(720,7003,147),(720,7004,150),(720,7005,151),(720,7006,152),(720,7007,153),(720,7008,157),(720,7009,160),(720,7010,162),(720,7011,163),(720,7012,165),(720,7013,166),(720,7014,167),(720,7015,168),(720,7016,173),(720,7017,175),(720,7018,177),(720,7019,178),(720,7020,179),(720,7021,180),(720,7022,181),(720,7023,182),(720,7024,183),(720,7025,187),(720,7026,191),(720,7027,193),(720,7028,194),(720,7029,195),(720,7030,197),(720,7031,198),(720,7032,200),(720,7033,202),(720,7034,204),(720,7035,205),(720,7036,207),(720,7037,208),(720,7038,214),(720,7039,215),(720,7040,216),(720,7041,217),(720,7042,219),(720,7043,220),(720,7044,221),(720,7045,222),(720,7046,223),(720,7047,225),(720,7048,226),(720,7049,227),(720,7050,230),(720,7051,231),(720,7052,233),(720,7053,234),(720,7054,236),(720,7055,239),(720,7056,240),(720,7057,241),(720,7058,244),(720,7059,245),(720,7060,246),(720,7061,247),(720,7062,248),(720,7063,249),(720,7064,251),(720,7065,252),(720,7066,253),(720,7067,254),(720,7068,259),(720,7069,260),(720,7070,264),(720,7071,265),(720,7072,267),(720,7073,269),(720,7074,270),(720,7075,271),(720,7076,272),(720,7077,274),(720,7078,279),(720,7079,280),(720,7080,281),(720,7081,282),(720,7082,284),(720,7083,285),(720,7084,289),(720,7085,291),(720,7086,292),(720,7087,293),(720,7088,296),(720,7089,297),(720,7090,298),(720,7091,299),(720,7092,302),(720,7093,303),(720,7094,308),(720,7294,275),(721,20,7),(721,135,1),(721,982,5),(721,1241,0),(721,1393,2),(721,2039,4),(721,2665,3),(721,3366,6),(722,20,5),(722,135,4),(722,1304,2),(722,2892,1),(722,2967,3),(722,3366,0),(723,17,1),(723,20,0),(723,1095,2),(723,1622,3),(724,20,10),(724,135,9),(724,982,8),(724,1241,7),(724,1393,4),(724,2343,2),(724,2835,3),(724,3251,0),(724,3366,1),(724,3787,5),(724,6898,6),(725,20,2),(725,1224,1),(725,1531,8),(725,1673,0),(725,1706,5),(725,2284,4),(725,2304,7),(725,2965,3),(725,2972,6),(726,20,11),(726,135,10),(726,887,4),(726,1241,5),(726,2054,1),(726,2348,8),(726,2835,2),(726,2892,9),(726,3251,0),(726,3330,3),(726,3364,7),(726,3366,6),(727,20,2),(727,135,12),(727,620,14),(727,624,15),(727,639,1),(727,643,3),(727,724,17),(727,792,11),(727,867,18),(727,1149,4),(727,1234,19),(727,1241,13),(727,1422,7),(727,1596,5),(727,1966,21),(727,2362,16),(727,2364,20),(727,2458,8),(727,2838,23),(727,2892,6),(727,3004,24),(727,3230,0),(727,3286,22),(727,3453,9),(727,3502,10),(728,20,4),(728,1241,0),(728,1258,1),(728,3070,2),(728,3366,3),(729,20,4),(729,626,5),(729,928,2),(729,1240,3),(729,3632,1),(729,3806,0),(730,17,2),(730,20,5),(730,1870,4),(730,2471,0),(730,3000,3),(730,3074,1),(731,20,4),(731,135,2),(731,973,0),(731,3366,1),(731,3371,3),(732,20,5),(732,1241,2),(732,2039,1),(732,2544,4),(732,3350,0),(732,3366,3),(733,20,2),(733,718,5),(733,1481,4),(733,1529,1),(733,2031,3),(733,2037,0),(734,20,4),(734,135,3),(734,1241,0),(734,2503,2),(734,3366,1),(735,17,1),(735,20,0),(735,1641,2),(735,1768,5),(735,2340,4),(735,2772,3),(736,20,2),(736,626,0),(736,1240,1),(737,20,0),(737,1143,3),(737,1673,1),(737,2284,2),(738,20,2),(738,1133,3),(738,2965,0),(738,3563,1),(739,20,4),(739,620,11),(739,630,0),(739,641,10),(739,831,5),(739,1344,8),(739,1420,1),(739,1604,2),(739,2000,6),(739,2105,9),(739,2198,7),(739,2892,3),(740,20,1),(740,626,9),(740,691,8),(740,928,0),(740,1003,3),(740,1015,4),(740,1240,5),(740,1631,7),(740,2774,6),(740,3632,2),(741,20,4),(741,2835,2),(741,2868,0),(741,3265,5),(741,3360,3),(741,3366,6),(741,3787,1),(742,20,5),(742,1487,0),(742,2039,1),(742,2470,4),(742,3265,3),(742,3360,2),(742,3366,6),(743,20,8),(743,77,0),(743,135,1),(743,620,4),(743,982,6),(743,1241,2),(743,1393,5),(743,2039,7),(743,3366,3),(744,20,1),(744,1100,0),(744,1706,2),(745,17,1),(745,20,0),(745,1032,2),(746,20,5),(746,1673,4),(746,1706,2),(746,2284,6),(746,2699,0),(746,2965,1),(746,2972,3),(747,20,2),(747,626,1),(747,1240,3),(747,3632,0),(748,20,6),(748,1224,1),(748,1673,0),(748,1706,2),(748,2284,5),(748,2531,3),(748,2965,4),(749,20,7),(749,135,6),(749,1241,1),(749,2039,0),(749,2192,3),(749,2340,4),(749,3350,2),(749,3366,5),(750,20,7),(750,135,0),(750,620,3),(750,1241,1),(750,1393,5),(750,2039,6),(750,3366,2),(750,3529,4),(751,20,5),(751,1144,3),(751,1198,4),(751,2039,1),(751,3070,2),(751,3366,0),(752,20,5),(752,135,4),(752,2470,1),(752,2835,3),(752,3265,2),(752,3366,0),(753,17,2),(753,20,0),(753,1641,1),(753,1870,3),(753,2841,4),(754,17,1),(754,20,5),(754,135,4),(754,735,3),(754,1032,2),(754,2395,0),(755,20,2),(755,136,0),(755,713,10),(755,741,1),(755,1097,4),(755,2017,3),(755,2361,7),(755,2892,8),(755,3360,9),(755,3366,11),(755,3423,5),(755,3579,6),(756,20,3),(756,620,4),(756,1249,2),(756,1470,1),(756,3322,0),(757,20,10),(757,135,7),(757,1241,1),(757,1393,5),(757,2039,0),(757,2192,4),(757,2544,9),(757,3182,3),(757,3350,2),(757,3366,6),(757,3695,8),(758,20,4),(758,620,0),(758,624,1),(758,1129,2),(758,1604,3),(759,20,1),(759,50,0),(759,2073,2),(760,20,64),(760,637,138),(760,672,10),(760,673,23),(760,679,124),(760,688,16),(760,698,133),(760,775,112),(760,790,78),(760,793,121),(760,796,98),(760,841,48),(760,849,135),(760,853,37),(760,858,21),(760,861,74),(760,868,6),(760,898,17),(760,900,67),(760,919,59),(760,932,45),(760,936,58),(760,961,95),(760,963,83),(760,964,143),(760,988,96),(760,1056,127),(760,1082,60),(760,1099,72),(760,1135,89),(760,1144,39),(760,1147,34),(760,1182,97),(760,1239,49),(760,1243,128),(760,1251,7),(760,1264,2),(760,1268,22),(760,1294,30),(760,1334,94),(760,1364,101),(760,1365,42),(760,1378,137),(760,1389,62),(760,1410,18),(760,1429,47),(760,1433,40),(760,1435,109),(760,1506,29),(760,1508,76),(760,1535,32),(760,1539,70),(760,1541,38),(760,1614,1),(760,1626,100),(760,1627,113),(760,1644,27),(760,1664,108),(760,1706,24),(760,1719,139),(760,1720,140),(760,1725,147),(760,1726,71),(760,1732,131),(760,1751,51),(760,1828,50),(760,1835,93),(760,1839,136),(760,1846,3),(760,1853,87),(760,1854,126),(760,1910,125),(760,1913,105),(760,1953,26),(760,1986,44),(760,2038,103),(760,2039,85),(760,2043,75),(760,2055,111),(760,2072,77),(760,2077,145),(760,2123,84),(760,2149,114),(760,2151,20),(760,2154,102),(760,2182,134),(760,2216,99),(760,2227,123),(760,2245,79),(760,2257,149),(760,2268,8),(760,2336,82),(760,2365,57),(760,2371,129),(760,2373,0),(760,2379,104),(760,2380,146),(760,2390,81),(760,2416,141),(760,2489,86),(760,2540,110),(760,2619,80),(760,2631,90),(760,2682,68),(760,2700,116),(760,2717,122),(760,2814,4),(760,2833,73),(760,2923,69),(760,2927,13),(760,2929,52),(760,2933,9),(760,2934,63),(760,2988,46),(760,2993,36),(760,2994,53),(760,3022,107),(760,3026,115),(760,3037,117),(760,3061,88),(760,3063,11),(760,3069,130),(760,3083,65),(760,3118,25),(760,3129,15),(760,3140,118),(760,3235,55),(760,3303,119),(760,3334,66),(760,3350,61),(760,3391,43),(760,3414,132),(760,3416,91),(760,3427,19),(760,3428,41),(760,3463,148),(760,3526,56),(760,3548,120),(760,3549,5),(760,3572,33),(760,3592,12),(760,3674,28),(760,3677,35),(760,3709,144),(760,3743,31),(760,3760,106),(760,3852,92),(760,3855,54),(760,3897,14),(760,3900,142),(761,20,16),(761,633,12),(761,643,5),(761,800,6),(761,912,2),(761,1185,0),(761,1596,17),(761,1685,7),(761,1730,3),(761,1799,14),(761,2365,11),(761,2519,13),(761,2524,4),(761,2525,9),(761,2915,8),(761,3004,1),(761,3284,15),(761,3443,10),(762,20,4),(762,135,3),(762,1241,1),(762,2039,0),(762,3366,2),(763,20,4),(763,668,12),(763,971,7),(763,1000,8),(763,1019,15),(763,1144,16),(763,1296,6),(763,1528,14),(763,1609,1),(763,1673,9),(763,1859,3),(763,1893,2),(763,2109,5),(763,2528,17),(763,2576,11),(763,2755,18),(763,3010,10),(763,3354,0),(763,3472,13),(764,20,1),(764,1244,3),(764,1606,0),(764,3291,2),(765,20,15),(765,727,3),(765,824,8),(765,935,13),(765,1193,0),(765,1593,1),(765,1611,10),(765,1635,27),(765,1666,14),(765,1852,7),(765,1919,29),(765,1978,2),(765,2032,22),(765,2074,16),(765,2078,26),(765,2080,17),(765,2411,9),(765,2664,5),(765,2676,19),(765,2859,23),(765,3051,28),(765,3056,21),(765,3092,6),(765,3265,24),(765,3461,12),(765,3474,20),(765,3577,25),(765,3591,4),(765,3598,18),(765,3776,11),(766,20,3),(766,620,1),(766,788,4),(766,1249,0),(766,1824,2),(767,20,6),(767,1224,1),(767,1673,0),(767,1706,2),(767,2284,5),(767,2965,4),(767,2972,3),(768,20,2),(768,49,1),(768,620,3),(768,2542,0),(769,20,3),(769,620,4),(769,630,0),(769,743,1),(769,2892,2),(770,20,3),(770,1241,2),(770,1277,0),(770,2892,4),(770,3251,1),(771,20,2),(771,784,0),(771,1867,3),(771,3221,4),(771,3265,5),(771,3366,6),(771,3787,1),(772,20,1),(772,1678,2),(772,2213,0),(773,20,4),(773,904,0),(773,1326,3),(773,1678,6),(773,1684,7),(773,1960,1),(773,2216,8),(773,2589,10),(773,2832,2),(773,2974,5),(773,3270,9),(774,20,8),(774,135,7),(774,997,1),(774,1149,3),(774,1241,5),(774,1596,4),(774,2892,0),(774,3004,2),(774,3230,6),(775,20,5),(775,883,6),(775,1482,0),(775,1678,4),(775,1684,3),(775,2216,2),(775,2589,7),(775,2833,1),(775,2974,8),(776,20,5),(776,1241,6),(776,2039,1),(776,2570,0),(776,3070,3),(776,3366,4),(776,3816,2),(777,20,0),(778,20,1),(778,626,0),(778,1172,2),(779,20,1),(779,3265,2),(779,3366,0),(780,20,3),(780,1870,0),(780,2400,2),(780,2612,1),(781,20,0),(782,20,1),(782,1283,2),(782,3039,0),(783,20,0),(783,1224,4),(783,1673,2),(783,1706,5),(783,2284,1),(783,2965,6),(783,2972,3),(784,20,1),(784,77,3),(784,887,0),(784,3366,2),(785,20,7),(785,135,6),(785,1241,1),(785,1393,5),(785,2039,0),(785,2192,2),(785,3360,3),(785,3366,4),(786,20,7),(786,1241,8),(786,2305,3),(786,2361,1),(786,2570,5),(786,2696,4),(786,3070,2),(786,3265,6),(786,3366,0),(787,20,4),(787,1241,1),(787,2305,2),(787,2361,0),(787,2470,3),(787,3265,5),(787,3366,6),(788,17,2),(788,20,3),(788,652,1),(788,2284,0),(789,20,1),(789,626,4),(789,723,3),(789,854,0),(789,1224,2),(790,20,9),(790,643,20),(790,893,12),(790,930,8),(790,1206,0),(790,1358,17),(790,1422,11),(790,1596,4),(790,1830,13),(790,2050,1),(790,2313,15),(790,2625,3),(790,2683,6),(790,2685,7),(790,2883,2),(790,3004,21),(790,3230,16),(790,3422,10),(790,3453,19),(790,3462,14),(790,3508,18),(790,3687,5),(791,15,0),(791,17,2),(791,20,6),(791,135,4),(791,2054,3),(791,3256,1),(791,3296,5),(792,17,1),(792,20,5),(792,135,4),(792,733,3),(792,872,2),(792,2395,0),(793,20,6),(793,643,1),(793,1149,9),(793,1241,5),(793,1422,7),(793,1596,2),(793,2892,4),(793,3004,8),(793,3097,0),(793,3230,11),(793,3453,10),(793,3509,3),(794,20,2),(794,1241,1),(794,3256,0),(795,20,2),(795,904,0),(795,1613,1),(795,1678,4),(795,1684,5),(795,2216,6),(795,2589,7),(795,2974,3),(796,20,4),(796,1241,5),(796,2039,2),(796,2570,0),(796,3070,3),(796,3182,1),(797,20,0),(797,1673,1),(798,15,0),(798,20,1),(798,1241,4),(798,2039,3),(798,3816,2),(799,20,1),(799,77,5),(799,135,4),(799,887,0),(799,1241,3),(799,3366,2),(800,17,4),(800,20,5),(800,1485,1),(800,1870,0),(800,1886,3),(800,2471,7),(800,2614,2),(800,2736,6),(801,20,5),(801,1678,7),(801,1684,4),(801,2216,3),(801,2371,2),(801,2537,0),(801,2589,9),(801,2843,1),(801,2974,6),(801,3270,8),(802,20,0),(802,77,1),(802,3004,2),(803,20,1),(803,3160,0),(804,20,0),(804,135,5),(804,1198,3),(804,1673,8),(804,2284,7),(804,2648,4),(804,2965,6),(804,3070,2),(804,3366,1),(805,644,13),(805,766,105),(805,803,118),(805,833,126),(805,855,100),(805,901,76),(805,951,12),(805,960,131),(805,969,122),(805,985,18),(805,999,142),(805,1033,53),(805,1063,137),(805,1125,95),(805,1170,127),(805,1182,149),(805,1254,8),(805,1298,19),(805,1308,54),(805,1321,115),(805,1331,107),(805,1386,64),(805,1390,63),(805,1398,41),(805,1401,34),(805,1418,23),(805,1434,49),(805,1464,32),(805,1478,68),(805,1498,51),(805,1551,26),(805,1582,70),(805,1584,101),(805,1587,61),(805,1619,67),(805,1663,85),(805,1695,40),(805,1696,0),(805,1742,125),(805,1841,87),(805,1844,109),(805,1846,22),(805,1897,121),(805,1910,10),(805,1919,93),(805,1924,90),(805,1925,7),(805,1929,144),(805,1943,58),(805,1944,128),(805,1945,117),(805,1949,14),(805,1956,138),(805,1971,120),(805,1995,135),(805,2033,1),(805,2047,2),(805,2060,103),(805,2062,73),(805,2120,9),(805,2134,78),(805,2141,83),(805,2156,139),(805,2163,69),(805,2165,30),(805,2172,114),(805,2195,62),(805,2225,15),(805,2301,60),(805,2326,46),(805,2350,134),(805,2365,94),(805,2404,75),(805,2476,112),(805,2484,79),(805,2502,86),(805,2548,25),(805,2551,106),(805,2573,146),(805,2599,24),(805,2610,96),(805,2628,82),(805,2643,97),(805,2669,77),(805,2672,28),(805,2690,108),(805,2698,116),(805,2744,84),(805,2745,132),(805,2763,59),(805,2796,140),(805,2824,147),(805,2850,55),(805,2855,36),(805,2861,71),(805,2875,81),(805,2891,57),(805,2918,44),(805,2989,88),(805,3006,141),(805,3011,56),(805,3035,104),(805,3043,72),(805,3047,16),(805,3061,17),(805,3132,37),(805,3138,47),(805,3153,111),(805,3154,6),(805,3157,29),(805,3162,35),(805,3177,42),(805,3188,80),(805,3202,148),(805,3222,48),(805,3261,102),(805,3278,11),(805,3288,27),(805,3320,145),(805,3325,31),(805,3355,113),(805,3381,129),(805,3404,52),(805,3415,130),(805,3419,66),(805,3420,92),(805,3425,45),(805,3445,89),(805,3506,136),(805,3520,33),(805,3536,133),(805,3555,98),(805,3567,5),(805,3583,65),(805,3619,21),(805,3643,99),(805,3644,123),(805,3645,74),(805,3655,43),(805,3657,91),(805,3706,50),(805,3718,39),(805,3729,38),(805,3738,143),(805,3782,119),(805,3798,4),(805,3800,124),(805,3831,20),(805,3899,3),(806,20,5),(806,1184,0),(806,2315,4),(806,2370,2),(806,2865,3),(806,3389,1),(807,17,2),(807,20,0),(807,1622,1),(808,20,0),(809,20,6),(809,1224,1),(809,1625,7),(809,1673,0),(809,1889,2),(809,2284,3),(809,2304,8),(809,2531,5),(809,2965,4),(810,20,219),(810,613,62),(810,635,168),(810,640,69),(810,642,177),(810,699,178),(810,766,20),(810,772,223),(810,780,125),(810,781,229),(810,789,99),(810,796,200),(810,805,21),(810,824,100),(810,904,5),(810,913,204),(810,922,153),(810,923,181),(810,962,133),(810,965,186),(810,968,203),(810,1024,9),(810,1043,126),(810,1078,104),(810,1094,215),(810,1138,98),(810,1150,79),(810,1242,119),(810,1254,135),(810,1285,174),(810,1291,149),(810,1322,148),(810,1331,106),(810,1391,124),(810,1410,188),(810,1412,214),(810,1413,187),(810,1418,64),(810,1427,87),(810,1429,83),(810,1492,74),(810,1493,160),(810,1494,76),(810,1502,110),(810,1507,88),(810,1509,146),(810,1525,127),(810,1533,1),(810,1587,86),(810,1601,176),(810,1603,184),(810,1611,129),(810,1632,103),(810,1636,31),(810,1650,213),(810,1669,117),(810,1678,232),(810,1680,161),(810,1691,2),(810,1718,179),(810,1737,122),(810,1751,194),(810,1777,59),(810,1787,92),(810,1792,138),(810,1795,107),(810,1800,185),(810,1820,85),(810,1874,193),(810,1890,159),(810,1897,112),(810,1904,162),(810,1910,208),(810,1935,95),(810,1939,150),(810,1958,166),(810,1974,22),(810,2012,172),(810,2022,114),(810,2062,27),(810,2091,218),(810,2094,152),(810,2112,73),(810,2120,78),(810,2127,151),(810,2134,4),(810,2155,105),(810,2205,183),(810,2206,71),(810,2259,167),(810,2303,196),(810,2309,3),(810,2438,128),(810,2449,158),(810,2463,0),(810,2483,230),(810,2513,108),(810,2516,116),(810,2519,134),(810,2521,233),(810,2522,154),(810,2546,173),(810,2573,61),(810,2589,221),(810,2621,28),(810,2635,29),(810,2637,63),(810,2659,227),(810,2677,206),(810,2707,195),(810,2712,132),(810,2759,136),(810,2767,93),(810,2768,139),(810,2784,144),(810,2830,182),(810,2832,222),(810,2843,220),(810,2846,75),(810,2856,143),(810,2859,216),(810,2878,10),(810,2881,131),(810,2891,80),(810,2931,201),(810,2957,123),(810,2964,120),(810,2998,217),(810,3006,199),(810,3015,137),(810,3035,102),(810,3066,84),(810,3086,170),(810,3090,202),(810,3111,145),(810,3173,109),(810,3200,157),(810,3233,205),(810,3237,210),(810,3254,191),(810,3261,101),(810,3266,198),(810,3270,231),(810,3278,60),(810,3283,175),(810,3288,67),(810,3290,140),(810,3292,96),(810,3297,156),(810,3321,130),(810,3345,94),(810,3405,52),(810,3424,165),(810,3430,111),(810,3446,6),(810,3520,72),(810,3525,65),(810,3546,89),(810,3555,97),(810,3558,224),(810,3564,211),(810,3566,171),(810,3575,66),(810,3587,7),(810,3600,77),(810,3624,91),(810,3626,81),(810,3645,90),(810,3701,113),(810,3717,169),(810,3741,147),(810,3755,36),(810,3767,118),(810,3783,180),(810,3786,115),(810,3825,163),(810,3839,228),(810,3844,82),(810,3853,197),(810,5855,226),(810,5861,68),(810,5862,190),(810,5864,141),(810,5865,142),(810,5866,192),(810,5868,207),(810,5869,189),(810,5885,16),(810,5923,155),(810,6273,33),(810,6643,24),(810,6646,58),(810,6664,23),(810,6683,26),(810,6686,34),(810,6802,212),(810,6861,8),(810,6862,11),(810,6863,12),(810,6864,13),(810,6865,14),(810,6866,15),(810,6867,17),(810,6868,18),(810,6869,19),(810,6870,25),(810,6871,30),(810,6872,32),(810,6873,35),(810,6874,37),(810,6875,38),(810,6876,39),(810,6877,40),(810,6878,41),(810,6879,42),(810,6880,43),(810,6881,44),(810,6882,45),(810,6883,46),(810,6884,47),(810,6885,48),(810,6886,49),(810,6887,50),(810,6888,51),(810,6889,54),(810,6890,55),(810,6891,56),(810,6892,57),(810,6893,70),(810,6894,121),(810,6895,164),(810,6896,209),(810,6897,225),(811,20,10),(811,756,18),(811,1065,8),(811,1239,2),(811,1247,3),(811,1410,25),(811,1678,12),(811,1684,7),(811,1726,28),(811,1806,15),(811,2084,20),(811,2216,14),(811,2230,13),(811,2371,16),(811,2481,6),(811,2589,24),(811,2624,11),(811,2709,1),(811,2833,5),(811,2843,9),(811,2916,21),(811,2974,27),(811,3037,23),(811,3118,0),(811,3153,22),(811,3503,17),(811,3709,19),(811,3733,26),(811,3752,4),(812,20,4),(812,788,1),(812,1145,3),(812,3191,2),(812,3663,0),(813,20,3),(813,620,4),(813,2403,1),(813,6899,0),(813,6900,2),(814,20,0),(814,135,3),(814,1673,6),(814,2284,5),(814,2965,4),(814,3070,2),(814,3366,1),(815,20,57),(815,617,19),(815,625,20),(815,756,1),(815,761,23),(815,796,12),(815,857,46),(815,913,38),(815,919,32),(815,957,28),(815,965,62),(815,976,35),(815,1011,36),(815,1144,33),(815,1159,4),(815,1223,3),(815,1243,25),(815,1378,40),(815,1424,58),(815,1451,43),(815,1526,44),(815,1540,15),(815,1634,9),(815,1659,27),(815,1718,51),(815,1720,16),(815,1725,13),(815,1751,47),(815,1828,53),(815,1836,21),(815,1839,17),(815,1864,42),(815,1933,26),(815,1969,6),(815,2039,55),(815,2206,10),(815,2227,52),(815,2257,49),(815,2274,34),(815,2393,39),(815,2434,61),(815,2435,45),(815,2493,41),(815,2529,30),(815,2558,7),(815,2581,11),(815,2700,54),(815,2745,31),(815,2815,29),(815,2833,60),(815,2834,0),(815,2923,50),(815,2928,24),(815,2974,59),(815,3130,5),(815,3283,48),(815,3350,56),(815,3511,18),(815,3513,22),(815,3576,8),(815,3626,63),(815,3755,2),(815,3833,14),(815,5967,37),(816,17,2),(816,20,4),(816,735,0),(816,1870,3),(816,2471,1),(817,20,2),(817,135,11),(817,620,22),(817,624,12),(817,639,1),(817,643,3),(817,724,14),(817,792,10),(817,867,15),(817,1149,4),(817,1234,16),(817,1241,21),(817,1422,7),(817,1596,5),(817,1966,18),(817,2362,13),(817,2364,17),(817,2458,8),(817,2838,20),(817,2892,6),(817,3004,23),(817,3230,0),(817,3286,19),(817,3453,9),(818,20,3),(818,2010,2),(818,2835,1),(818,3265,4),(818,3366,0),(819,17,5),(819,20,1),(819,1870,3),(819,1886,0),(819,2428,2),(819,2841,4),(820,17,3),(820,20,4),(820,959,1),(820,2841,0),(820,3895,2),(821,20,0),(822,20,8),(822,626,9),(822,914,10),(822,1020,5),(822,1221,7),(822,1240,14),(822,1246,15),(822,1599,1),(822,1819,13),(822,1868,2),(822,2217,12),(822,2947,3),(822,2949,4),(822,2953,6),(822,3102,0),(822,3640,16),(822,3693,11),(822,3740,17),(823,20,8),(823,617,9),(823,625,29),(823,679,47),(823,849,12),(823,913,53),(823,918,34),(823,965,50),(823,1029,25),(823,1181,39),(823,1223,20),(823,1232,19),(823,1243,3),(823,1247,54),(823,1264,36),(823,1288,11),(823,1295,33),(823,1355,2),(823,1378,56),(823,1460,24),(823,1708,5),(823,1718,16),(823,1720,14),(823,1751,38),(823,1755,23),(823,1836,28),(823,1839,13),(823,1941,37),(823,2039,6),(823,2218,18),(823,2226,42),(823,2257,4),(823,2402,45),(823,2426,0),(823,2434,57),(823,2451,1),(823,2529,46),(823,2617,52),(823,2745,43),(823,2833,49),(823,2834,21),(823,2842,51),(823,2928,44),(823,2974,55),(823,3223,32),(823,3308,10),(823,3350,7),(823,3511,58),(823,3513,26),(823,3521,48),(823,3571,41),(823,3576,30),(823,3605,40),(823,3626,22),(823,5964,35),(823,5969,31),(823,6610,15),(823,6611,17),(823,6612,27),(824,15,11),(824,17,1),(824,20,0),(824,136,12),(824,735,3),(824,1032,6),(824,1870,2),(824,2073,8),(824,2376,7),(824,2395,4),(824,2460,5),(824,3256,9),(824,3329,10),(825,20,6),(825,77,0),(825,643,4),(825,770,7),(825,897,2),(825,1823,3),(825,3169,5),(825,3471,1),(826,20,0),(826,2092,4),(826,2168,3),(826,2310,5),(826,2424,1),(826,3366,2),(827,20,6),(827,620,8),(827,630,1),(827,641,3),(827,1420,7),(827,1604,5),(827,1866,4),(827,3109,2),(827,3273,0),(828,20,1),(828,718,2),(828,1529,0),(829,20,5),(829,690,2),(829,1087,0),(829,1241,3),(829,2503,4),(829,3366,1),(830,20,1),(830,3004,0),(831,20,4),(831,620,6),(831,1486,3),(831,1604,1),(831,3175,0),(831,3380,5),(831,3607,2),(832,20,7),(832,136,4),(832,811,5),(832,1079,3),(832,2868,0),(832,2872,1),(832,3221,8),(832,3265,6),(832,3360,2),(832,3366,9),(833,20,10),(833,633,16),(833,643,19),(833,800,18),(833,912,0),(833,1185,3),(833,1407,14),(833,1596,1),(833,1685,11),(833,1730,2),(833,1799,12),(833,1877,6),(833,2365,13),(833,2519,15),(833,2525,8),(833,2806,5),(833,2915,7),(833,3004,20),(833,3264,4),(833,3284,17),(833,3443,9),(834,20,0),(834,77,5),(834,135,6),(834,620,3),(834,1241,1),(834,2892,4),(834,3366,2),(835,20,4),(835,2470,2),(835,2572,3),(835,2696,0),(835,3366,1),(836,20,5),(836,1006,4),(836,1768,3),(836,2892,1),(836,2898,0),(836,3366,2),(837,126,58),(837,644,109),(837,648,62),(837,653,83),(837,656,2),(837,658,7),(837,671,16),(837,708,4),(837,729,46),(837,772,117),(837,801,22),(837,804,8),(837,838,9),(837,855,131),(837,901,115),(837,965,90),(837,969,145),(837,974,127),(837,978,107),(837,1108,57),(837,1117,55),(837,1128,67),(837,1164,89),(837,1196,45),(837,1215,74),(837,1256,61),(837,1272,6),(837,1311,111),(837,1325,99),(837,1402,51),(837,1458,95),(837,1479,31),(837,1492,102),(837,1494,105),(837,1505,59),(837,1510,21),(837,1517,125),(837,1557,33),(837,1580,91),(837,1587,112),(837,1733,41),(837,1735,39),(837,1744,5),(837,1751,123),(837,1757,25),(837,1797,114),(837,1799,28),(837,1809,11),(837,1816,136),(837,1837,19),(837,1841,122),(837,1846,78),(837,1921,148),(837,1945,49),(837,1967,71),(837,1968,119),(837,2015,116),(837,2049,93),(837,2051,132),(837,2097,140),(837,2113,15),(837,2120,3),(837,2124,1),(837,2126,106),(837,2132,128),(837,2200,120),(837,2206,92),(837,2236,143),(837,2258,40),(837,2294,50),(837,2303,141),(837,2334,53),(837,2377,81),(837,2406,76),(837,2442,138),(837,2452,137),(837,2455,54),(837,2506,104),(837,2511,87),(837,2513,135),(837,2565,34),(837,2568,144),(837,2580,97),(837,2584,68),(837,2602,126),(837,2610,130),(837,2618,146),(837,2629,149),(837,2637,12),(837,2642,118),(837,2671,80),(837,2673,24),(837,2686,85),(837,2724,10),(837,2734,124),(837,2756,96),(837,2766,14),(837,2779,69),(837,2793,147),(837,2799,72),(837,2802,17),(837,2819,101),(837,2881,0),(837,2891,110),(837,2896,63),(837,2933,82),(837,2979,121),(837,2984,48),(837,3035,134),(837,3062,32),(837,3064,37),(837,3082,56),(837,3153,139),(837,3163,100),(837,3168,60),(837,3214,77),(837,3225,98),(837,3254,108),(837,3278,20),(837,3283,86),(837,3342,18),(837,3344,30),(837,3378,52),(837,3408,42),(837,3419,113),(837,3430,142),(837,3432,64),(837,3436,133),(837,3446,73),(837,3451,36),(837,3459,66),(837,3464,29),(837,3466,35),(837,3473,129),(837,3480,43),(837,3494,44),(837,3507,13),(837,3520,94),(837,3525,79),(837,3681,84),(837,3691,65),(837,3696,23),(837,3698,47),(837,3708,27),(837,3718,103),(837,3747,26),(837,3769,38),(837,3794,75),(837,3847,70),(837,3851,88),(838,15,0),(838,17,1),(838,20,6),(838,1241,3),(838,1870,5),(838,2395,2),(838,3256,4),(839,20,4),(839,692,3),(839,1183,9),(839,1300,14),(839,1678,13),(839,1691,12),(839,2091,6),(839,2549,0),(839,2589,11),(839,2832,1),(839,2843,2),(839,3267,7),(839,3270,8),(839,3569,10),(839,3765,5),(840,20,4),(840,1241,0),(840,2039,1),(840,2192,3),(840,3366,2),(841,17,3),(841,20,5),(841,1641,2),(841,2892,1),(841,3763,0),(841,3779,4),(842,17,5),(842,20,6),(842,928,3),(842,970,1),(842,2275,4),(842,2728,2),(842,3079,0),(842,7198,7),(843,20,2),(843,639,1),(843,792,0),(844,20,1),(844,1870,0),(845,20,9),(845,626,10),(845,914,11),(845,1020,6),(845,1221,8),(845,1240,15),(845,1246,16),(845,1599,2),(845,1819,14),(845,1868,3),(845,2217,13),(845,2947,4),(845,2949,5),(845,2953,7),(845,3102,1),(845,3640,0),(845,3693,12),(846,20,2),(846,718,8),(846,1157,6),(846,1228,3),(846,1529,4),(846,1717,0),(846,2037,5),(846,2356,1),(846,3641,7),(847,20,6),(847,49,1),(847,620,9),(847,715,4),(847,1241,7),(847,1452,2),(847,1486,5),(847,2220,3),(847,2892,8),(847,3380,0),(848,20,2),(848,1241,3),(848,2039,1),(848,2251,0),(849,20,4),(849,640,6),(849,642,2),(849,913,5),(849,2169,0),(849,3200,3),(849,3755,1),(850,20,4),(850,58,0),(850,1678,2),(850,3307,3),(850,3338,1),(850,3704,5),(851,17,2),(851,20,0),(851,1674,1),(852,20,0),(852,626,3),(852,1162,2),(852,3160,1),(856,20,3),(856,135,4),(856,1241,2),(856,2039,1),(856,2544,5),(856,3350,0),(857,20,6),(857,701,1),(857,792,4),(857,1768,0),(857,1903,3),(857,2510,5),(857,2970,2),(858,20,3),(858,1224,2),(858,1673,4),(858,2170,5),(858,2304,6),(858,2531,0),(858,2965,1),(860,17,2),(860,20,5),(860,1641,1),(860,2892,4),(860,3763,0),(860,3779,3),(861,15,0),(861,20,8),(861,135,7),(861,724,4),(861,1064,5),(861,1241,1),(861,2152,6),(861,2838,3),(861,3256,2),(862,20,6),(862,1241,1),(862,1867,8),(862,2305,2),(862,2361,0),(862,2470,3),(862,2898,4),(862,3070,5),(862,3265,7),(862,3366,9),(863,20,57),(863,635,25),(863,725,52),(863,789,116),(863,801,37),(863,812,29),(863,826,105),(863,855,55),(863,864,33),(863,913,100),(863,926,31),(863,969,64),(863,1000,98),(863,1111,16),(863,1119,112),(863,1126,6),(863,1174,87),(863,1259,103),(863,1276,36),(863,1286,70),(863,1290,46),(863,1294,113),(863,1306,39),(863,1310,44),(863,1409,115),(863,1410,84),(863,1497,83),(863,1548,51),(863,1572,10),(863,1573,45),(863,1603,81),(863,1611,72),(863,1620,108),(863,1678,120),(863,1718,109),(863,1751,89),(863,1772,48),(863,1786,8),(863,1797,86),(863,1812,90),(863,1841,49),(863,1845,78),(863,1911,19),(863,1912,118),(863,1927,28),(863,2059,88),(863,2087,5),(863,2098,22),(863,2099,26),(863,2117,97),(863,2129,80),(863,2134,13),(863,2155,58),(863,2173,110),(863,2202,24),(863,2203,41),(863,2237,75),(863,2264,82),(863,2303,93),(863,2387,124),(863,2521,102),(863,2557,92),(863,2593,107),(863,2609,65),(863,2621,60),(863,2632,125),(863,2635,91),(863,2647,67),(863,2668,21),(863,2684,96),(863,2712,74),(863,2784,77),(863,2832,50),(863,2848,15),(863,2857,3),(863,2858,7),(863,2873,85),(863,2899,11),(863,2904,2),(863,2906,27),(863,2911,40),(863,2912,104),(863,2922,12),(863,2942,101),(863,2964,119),(863,3006,95),(863,3029,59),(863,3030,18),(863,3050,123),(863,3071,62),(863,3094,111),(863,3134,69),(863,3158,114),(863,3184,122),(863,3206,4),(863,3254,43),(863,3270,71),(863,3317,106),(863,3333,0),(863,3336,1),(863,3383,54),(863,3454,63),(863,3467,32),(863,3489,23),(863,3531,73),(863,3537,47),(863,3539,17),(863,3543,35),(863,3574,66),(863,3627,38),(863,3656,79),(863,3668,121),(863,3735,30),(863,3745,9),(863,3772,14),(863,3784,42),(863,3843,117),(863,3897,34),(863,5855,99),(863,5902,68),(863,7036,61),(863,7171,20),(863,7172,53),(863,7173,56),(863,7174,76),(863,7175,94),(864,20,0),(865,20,2),(865,77,1),(865,3256,0),(866,20,3),(866,77,4),(866,881,6),(866,1149,9),(866,1241,5),(866,1422,8),(866,1596,10),(866,2892,11),(866,3004,2),(866,3230,7),(866,3816,1),(866,6638,0),(867,1037,2),(867,1410,5),(867,1905,3),(867,1927,4),(867,2240,1),(867,2782,0),(869,20,1),(869,1241,3),(869,1727,0),(869,2039,9),(869,2305,5),(869,2361,4),(869,2696,7),(869,3265,8),(869,3360,2),(869,3366,10),(869,3787,6),(871,20,6),(871,135,5),(871,620,4),(871,1241,0),(871,2039,2),(871,3101,3),(871,3366,1),(872,20,2),(872,3251,0),(872,3366,1),(873,20,3),(873,620,2),(873,1406,0),(873,1683,1),(873,3265,4),(873,3366,5),(874,20,6),(874,2305,3),(874,2470,5),(874,2835,1),(874,3265,2),(874,3366,0),(874,3787,4),(875,20,4),(875,1431,0),(875,1605,1),(875,2536,2),(875,2544,5),(875,3103,3),(876,20,2),(876,1096,3),(876,1303,1),(876,1706,0),(878,20,4),(878,135,3),(878,1241,2),(878,2039,1),(878,2544,5),(878,3350,0),(879,20,7),(879,135,6),(879,620,0),(879,822,2),(879,1205,5),(879,1241,1),(879,3366,3),(879,3816,4),(880,20,1),(880,50,0),(881,20,3),(881,823,0),(881,982,4),(881,2926,2),(881,3370,1),(882,20,30),(882,617,8),(882,625,35),(882,646,3),(882,668,57),(882,761,2),(882,796,41),(882,857,53),(882,919,28),(882,934,20),(882,952,59),(882,965,4),(882,1011,44),(882,1144,12),(882,1174,77),(882,1181,9),(882,1223,25),(882,1239,19),(882,1243,58),(882,1264,13),(882,1295,73),(882,1378,75),(882,1425,55),(882,1459,37),(882,1526,46),(882,1540,39),(882,1607,40),(882,1630,18),(882,1643,7),(882,1718,64),(882,1720,65),(882,1725,68),(882,1751,23),(882,1815,5),(882,1828,21),(882,1836,45),(882,1839,62),(882,2039,36),(882,2218,52),(882,2227,54),(882,2254,14),(882,2257,70),(882,2274,10),(882,2434,76),(882,2435,49),(882,2459,56),(882,2493,1),(882,2529,66),(882,2540,48),(882,2681,47),(882,2700,51),(882,2731,67),(882,2745,38),(882,2833,32),(882,2842,60),(882,2914,69),(882,2928,24),(882,2929,26),(882,2974,74),(882,3026,50),(882,3095,42),(882,3203,22),(882,3270,43),(882,3350,29),(882,3468,61),(882,3511,16),(882,3513,33),(882,3571,31),(882,3605,71),(882,3612,15),(882,3626,11),(882,3771,63),(882,3833,27),(882,5964,17),(882,5966,34),(882,6610,6),(882,6665,0),(882,6666,72),(883,15,4),(883,17,0),(883,20,7),(883,136,1),(883,741,3),(883,2460,2),(883,3256,5),(883,6616,6),(884,20,1),(884,1304,0),(884,2757,2),(884,7191,3),(885,20,2),(885,854,3),(885,1100,0),(885,3500,1),(886,17,2),(886,20,0),(886,135,1),(887,20,0),(887,626,6),(887,928,2),(887,1088,1),(887,1240,3),(887,1367,4),(887,2965,5),(888,20,4),(888,1673,2),(888,1706,3),(888,2284,6),(888,2965,5),(888,2972,0),(888,7293,1),(890,20,2),(890,49,3),(890,620,4),(890,2428,1),(890,2542,0),(891,20,6),(891,1678,5),(891,1691,3),(891,2589,2),(891,3276,1),(891,3366,4),(891,3517,0),(892,20,4),(892,2039,1),(892,2868,0),(892,2898,3),(892,3265,5),(892,3360,2),(892,3366,6),(893,20,0),(894,20,6),(894,77,0),(894,135,5),(894,887,2),(894,1241,4),(894,2054,3),(894,3366,1),(895,20,6),(895,69,4),(895,889,3),(895,1241,0),(895,2039,7),(895,2251,1),(895,3366,5),(895,3816,2),(896,20,10),(896,620,4),(896,792,1),(896,997,3),(896,1161,6),(896,1768,0),(896,2199,8),(896,2229,7),(896,2340,5),(896,2351,9),(896,2970,2),(897,20,1),(897,1006,4),(897,1768,2),(897,2436,0),(897,2892,6),(897,2898,5),(897,3366,3),(898,17,2),(898,20,1),(898,1679,0),(899,20,4),(899,1639,1),(899,1673,2),(899,1706,5),(899,2284,3),(899,2965,0),(899,2972,6),(900,20,11),(900,633,17),(900,643,20),(900,800,19),(900,912,4),(900,1185,5),(900,1407,15),(900,1596,1),(900,1685,12),(900,1730,6),(900,1799,13),(900,2081,2),(900,2291,21),(900,2365,14),(900,2491,0),(900,2519,16),(900,2525,9),(900,2806,7),(900,2915,8),(900,3004,3),(900,3284,18),(900,3443,10),(901,20,3),(901,627,8),(901,643,17),(901,800,4),(901,912,18),(901,1185,9),(901,1407,12),(901,1596,16),(901,1730,2),(901,1877,13),(901,2365,5),(901,2519,14),(901,2749,0),(901,2806,15),(901,2820,10),(901,2915,6),(901,3004,1),(901,3443,7),(901,3453,11),(902,20,6),(902,77,2),(902,135,5),(902,997,3),(902,1241,1),(902,2892,4),(902,3816,0),(903,20,4),(903,1241,5),(903,2039,1),(903,2898,2),(903,3265,3),(903,3360,0),(903,3366,6),(904,20,2),(904,2039,5),(904,2696,1),(904,3265,3),(904,3360,0),(904,3366,4),(905,20,3),(905,643,1),(905,1149,2),(905,3004,0),(906,20,0),(906,1096,1),(906,1673,2),(907,20,9),(907,633,15),(907,643,18),(907,800,17),(907,912,1),(907,1185,2),(907,1407,13),(907,1596,0),(907,1685,10),(907,1730,3),(907,1799,11),(907,2365,12),(907,2519,14),(907,2525,7),(907,2720,5),(907,2806,4),(907,2915,6),(907,3004,19),(907,3284,16),(907,3443,8),(909,20,6),(909,135,5),(909,1023,4),(909,1241,2),(909,2054,0),(909,3251,1),(909,3366,3),(910,20,6),(910,135,5),(910,1241,0),(910,2039,3),(910,3366,4),(910,3529,2),(910,3816,1),(911,20,0),(912,20,3),(912,1224,1),(912,1673,2),(912,1706,5),(912,2284,4),(912,2965,0),(912,2972,6),(913,20,2),(913,1241,3),(913,3412,0),(913,3816,1),(914,2,1),(914,20,4),(914,58,0),(914,59,3),(914,60,2),(915,20,8),(915,1241,7),(915,2039,1),(915,2361,5),(915,2868,6),(915,3221,4),(915,3265,3),(915,3360,0),(915,3366,9),(915,3787,2),(916,20,4),(916,987,2),(916,3221,3),(916,3265,1),(916,3366,5),(916,3787,0),(917,17,4),(917,20,6),(917,1870,5),(917,2271,1),(917,2331,2),(917,2471,0),(917,2620,3),(918,17,2),(918,20,0),(918,50,3),(918,1768,7),(918,1870,5),(918,2073,4),(918,2119,6),(918,3004,1),(919,20,1),(919,50,0),(920,20,5),(920,883,2),(920,1482,0),(920,1684,4),(920,2216,3),(920,2589,6),(920,2833,1),(920,2974,7),(921,20,0),(921,135,3),(921,2470,2),(921,3366,1),(926,17,1),(926,20,4),(926,136,5),(926,137,0),(926,1811,3),(926,3569,2),(927,20,7),(927,747,1),(927,1241,4),(927,2039,6),(927,2054,0),(927,2544,5),(927,3251,3),(927,3350,2),(929,20,4),(929,979,1),(929,1465,0),(929,1678,5),(929,2758,2),(929,2832,6),(929,3030,3),(930,20,2),(930,1241,3),(930,2039,1),(930,2251,0),(931,20,4),(931,692,3),(931,1183,8),(931,1300,13),(931,1678,12),(931,1691,11),(931,2549,0),(931,2589,10),(931,2832,1),(931,2843,2),(931,3267,6),(931,3270,7),(931,3569,9),(931,3765,5),(932,20,2),(932,1000,4),(932,1768,0),(932,1981,5),(932,2970,1),(932,3004,3),(934,20,2),(934,2305,1),(934,2470,0),(934,2835,3),(934,3306,4),(934,3366,5),(935,17,3),(935,20,6),(935,626,11),(935,929,0),(935,1240,5),(935,3285,9),(935,3300,1),(935,3599,8),(935,3632,4),(935,3723,10),(935,3727,7),(935,3781,2),(936,17,1),(936,20,0),(936,135,3),(936,723,6),(936,1302,7),(936,1446,8),(936,1467,4),(936,1641,2),(936,1805,5),(937,17,0),(937,20,1),(937,135,4),(937,1224,3),(937,3366,2),(938,20,0),(938,626,1),(938,1240,2),(939,20,12),(939,1392,8),(939,1412,9),(939,1492,0),(939,1678,13),(939,2091,3),(939,2193,10),(939,2213,1),(939,2421,7),(939,2483,4),(939,2859,11),(939,3171,5),(939,3256,6),(939,3270,2),(940,20,5),(940,49,3),(940,620,7),(940,1452,1),(940,1486,4),(940,2220,2),(940,2892,6),(940,3380,0),(941,20,8),(941,633,14),(941,643,17),(941,800,16),(941,912,1),(941,1185,2),(941,1407,12),(941,1596,19),(941,1685,9),(941,1730,3),(941,1799,10),(941,2365,11),(941,2519,13),(941,2525,6),(941,2720,0),(941,2806,4),(941,2915,5),(941,3004,18),(941,3284,15),(941,3443,7),(942,2,1),(942,20,8),(942,58,0),(942,59,6),(942,60,3),(942,657,5),(942,2876,7),(942,3358,4),(942,3724,2),(943,20,6),(943,620,10),(943,715,8),(943,1139,1),(943,1241,5),(943,1393,9),(943,1452,0),(943,1486,7),(943,2220,3),(943,3366,4),(943,3380,2),(944,20,1),(944,643,2),(944,704,8),(944,792,3),(944,1144,5),(944,1241,6),(944,1596,11),(944,2755,4),(944,2806,9),(944,3004,10),(944,3327,7),(944,3398,0),(945,20,8),(945,889,4),(945,1079,6),(945,1241,0),(945,1393,7),(945,2039,9),(945,2251,2),(945,3360,5),(945,3366,1),(945,3816,3),(946,20,7),(946,135,0),(946,982,5),(946,1241,1),(946,1393,2),(946,1990,4),(946,2892,6),(946,3366,3),(947,20,4),(947,1241,1),(947,2570,3),(947,2849,5),(947,2903,0),(947,3182,2),(948,20,8),(948,883,3),(948,1482,2),(948,1678,6),(948,1684,5),(948,2216,4),(948,2547,0),(948,2589,7),(948,2833,1),(948,2974,9),(949,17,2),(949,20,0),(949,50,1),(951,644,8),(951,766,101),(951,796,146),(951,803,114),(951,833,122),(951,855,96),(951,901,72),(951,938,149),(951,951,7),(951,960,127),(951,969,118),(951,985,13),(951,999,138),(951,1033,48),(951,1053,148),(951,1063,133),(951,1120,3),(951,1125,91),(951,1170,123),(951,1182,145),(951,1298,14),(951,1308,49),(951,1312,54),(951,1321,111),(951,1331,103),(951,1386,60),(951,1390,59),(951,1398,36),(951,1401,29),(951,1418,18),(951,1434,44),(951,1464,27),(951,1478,64),(951,1498,46),(951,1551,21),(951,1582,66),(951,1584,97),(951,1587,57),(951,1613,0),(951,1619,63),(951,1663,81),(951,1695,35),(951,1742,121),(951,1841,83),(951,1844,105),(951,1846,17),(951,1897,117),(951,1919,89),(951,1924,86),(951,1929,140),(951,1935,1),(951,1943,53),(951,1945,113),(951,1949,9),(951,1956,134),(951,1971,116),(951,1995,131),(951,2041,124),(951,2060,99),(951,2062,69),(951,2134,74),(951,2141,79),(951,2156,135),(951,2163,65),(951,2165,25),(951,2172,110),(951,2195,58),(951,2225,10),(951,2301,56),(951,2326,41),(951,2350,130),(951,2365,90),(951,2404,71),(951,2476,108),(951,2484,75),(951,2502,82),(951,2548,20),(951,2551,102),(951,2573,142),(951,2599,19),(951,2610,92),(951,2628,78),(951,2643,93),(951,2669,73),(951,2672,23),(951,2690,104),(951,2698,112),(951,2744,80),(951,2745,128),(951,2763,55),(951,2797,136),(951,2824,143),(951,2850,50),(951,2855,31),(951,2861,67),(951,2875,77),(951,2891,52),(951,2918,39),(951,2989,84),(951,3006,137),(951,3011,51),(951,3035,100),(951,3043,68),(951,3047,11),(951,3061,12),(951,3132,32),(951,3138,42),(951,3153,107),(951,3157,24),(951,3162,30),(951,3177,37),(951,3188,76),(951,3190,5),(951,3202,144),(951,3222,43),(951,3261,98),(951,3278,6),(951,3288,22),(951,3314,147),(951,3320,141),(951,3325,26),(951,3355,109),(951,3381,125),(951,3404,47),(951,3415,126),(951,3419,62),(951,3420,88),(951,3425,40),(951,3445,85),(951,3479,4),(951,3506,132),(951,3520,28),(951,3536,129),(951,3555,94),(951,3583,61),(951,3619,16),(951,3643,95),(951,3644,119),(951,3645,70),(951,3655,38),(951,3657,87),(951,3706,45),(951,3718,34),(951,3729,33),(951,3738,139),(951,3782,115),(951,3800,120),(951,3830,2),(951,3831,15),(952,20,85),(952,613,41),(952,640,48),(952,772,74),(952,796,30),(952,877,7),(952,904,60),(952,922,139),(952,962,123),(952,1043,115),(952,1077,130),(952,1078,88),(952,1094,35),(952,1103,29),(952,1138,82),(952,1152,16),(952,1186,68),(952,1242,105),(952,1254,125),(952,1291,135),(952,1331,91),(952,1332,90),(952,1350,106),(952,1391,114),(952,1418,43),(952,1427,32),(952,1454,17),(952,1458,50),(952,1492,40),(952,1493,147),(952,1494,55),(952,1502,96),(952,1509,132),(952,1513,66),(952,1519,143),(952,1525,116),(952,1550,71),(952,1558,78),(952,1575,119),(952,1587,65),(952,1611,120),(952,1632,87),(952,1658,134),(952,1680,148),(952,1687,62),(952,1729,52),(952,1737,110),(952,1786,59),(952,1787,72),(952,1792,127),(952,1799,13),(952,1814,76),(952,1816,94),(952,1820,64),(952,1850,10),(952,1858,98),(952,1890,145),(952,1897,97),(952,1904,149),(952,1935,80),(952,1959,56),(952,2015,73),(952,2024,27),(952,2058,129),(952,2094,138),(952,2112,53),(952,2117,109),(952,2120,8),(952,2127,136),(952,2134,75),(952,2155,89),(952,2178,99),(952,2189,51),(952,2197,104),(952,2244,36),(952,2303,33),(952,2349,1),(952,2388,24),(952,2438,118),(952,2449,144),(952,2452,95),(952,2483,58),(952,2501,81),(952,2505,47),(952,2513,92),(952,2522,140),(952,2546,39),(952,2573,38),(952,2598,25),(952,2611,131),(952,2637,42),(952,2712,122),(952,2724,3),(952,2767,77),(952,2768,128),(952,2782,124),(952,2801,15),(952,2816,14),(952,2827,22),(952,2846,54),(952,2859,37),(952,2878,67),(952,2881,19),(952,2884,9),(952,2891,61),(952,2936,0),(952,2957,112),(952,3001,111),(952,3015,126),(952,3030,103),(952,3035,86),(952,3036,137),(952,3087,4),(952,3111,5),(952,3142,34),(952,3173,93),(952,3193,20),(952,3197,107),(952,3200,142),(952,3219,21),(952,3242,18),(952,3261,84),(952,3270,113),(952,3278,31),(952,3288,46),(952,3297,141),(952,3321,121),(952,3345,79),(952,3421,23),(952,3426,146),(952,3507,6),(952,3520,49),(952,3525,44),(952,3546,69),(952,3555,83),(952,3575,45),(952,3600,57),(952,3645,70),(952,3701,100),(952,3738,108),(952,3741,133),(952,3746,2),(952,3755,117),(952,3768,11),(952,3774,26),(952,3775,28),(952,3786,101),(952,3795,12),(952,3808,102),(952,3844,63),(953,20,7),(953,77,5),(953,135,2),(953,718,6),(953,1189,4),(953,1920,1),(953,2054,0),(953,3366,3),(954,17,1),(954,20,6),(954,136,0),(954,870,3),(954,1199,5),(954,2207,2),(954,3256,7),(954,3329,4),(955,20,1),(955,50,0),(956,20,29),(956,613,14),(956,682,45),(956,789,28),(956,874,60),(956,1037,0),(956,1082,27),(956,1126,31),(956,1399,8),(956,1410,65),(956,1507,22),(956,1513,69),(956,1611,43),(956,1636,20),(956,1678,66),(956,1728,56),(956,1731,36),(956,1737,3),(956,1756,62),(956,1796,55),(956,1838,44),(956,1855,25),(956,1857,24),(956,1912,34),(956,1927,68),(956,1983,50),(956,2007,53),(956,2059,64),(956,2087,58),(956,2135,47),(956,2155,32),(956,2240,1),(956,2299,37),(956,2339,5),(956,2447,23),(956,2506,18),(956,2569,4),(956,2580,61),(956,2589,54),(956,2702,30),(956,2746,7),(956,2758,41),(956,2760,51),(956,2787,12),(956,2832,67),(956,2964,39),(956,3030,6),(956,3048,2),(956,3088,38),(956,3106,11),(956,3153,33),(956,3167,49),(956,3206,19),(956,3270,40),(956,3289,17),(956,3345,26),(956,3490,16),(956,3516,57),(956,3520,15),(956,3524,52),(956,3538,9),(956,3539,35),(956,3639,48),(956,3736,42),(956,3792,46),(956,3844,21),(956,3854,13),(956,5924,10),(956,5951,59),(956,6854,63),(957,20,9),(957,135,7),(957,1241,0),(957,1596,5),(957,2039,8),(957,2570,6),(957,3350,1),(957,3360,4),(957,3366,3),(957,3816,2),(958,20,2),(958,718,6),(958,1057,5),(958,1091,3),(958,1529,0),(958,2356,1),(958,3211,4),(959,20,4),(959,792,0),(959,1867,5),(959,1946,8),(959,2039,1),(959,3221,3),(959,3265,6),(959,3360,7),(959,3366,9),(959,3787,2),(960,20,1),(960,50,0),(960,680,7),(960,1768,5),(960,1870,4),(960,2073,6),(960,2429,8),(960,2488,3),(960,3004,2),(960,3301,9),(961,20,0),(962,20,2),(962,626,3),(962,1511,0),(962,2040,1),(962,3632,4),(963,20,2),(963,1241,3),(963,2039,1),(963,7167,0),(964,20,3),(964,135,7),(964,620,9),(964,822,0),(964,1241,2),(964,1319,4),(964,2066,1),(964,2892,5),(964,3366,6),(964,3816,8),(965,20,6),(965,1673,3),(965,1706,1),(965,2283,2),(965,2284,5),(965,2304,0),(965,2965,7),(965,2972,4),(966,20,1),(966,1224,0),(966,1673,6),(966,1706,2),(966,2284,5),(966,2965,4),(966,2972,3),(967,20,3),(967,1673,6),(967,1706,0),(967,2284,2),(967,2304,7),(967,2498,1),(967,2965,5),(967,2972,4),(968,20,9),(968,49,2),(968,77,8),(968,135,6),(968,718,7),(968,1920,0),(968,2054,1),(968,3221,5),(968,3311,3),(968,3366,4),(969,20,5),(969,656,1),(969,1492,8),(969,1612,3),(969,2487,2),(969,2537,11),(969,2786,4),(969,2859,7),(969,3270,6),(969,3617,9),(969,3731,0),(969,3852,10),(970,17,1),(970,20,8),(970,733,2),(970,779,5),(970,1061,7),(970,1648,6),(970,2395,0),(970,3706,3),(970,6078,4),(971,15,2),(971,20,13),(971,77,11),(971,135,8),(971,620,7),(971,724,5),(971,1241,12),(971,1393,4),(971,1920,0),(971,2054,3),(971,2251,1),(971,2838,6),(971,3366,10),(971,3816,9),(972,20,10),(972,135,9),(972,794,3),(972,982,8),(972,1241,1),(972,1393,5),(972,1948,7),(972,2054,4),(972,3251,0),(972,3366,6),(972,3816,2),(973,20,10),(973,135,0),(973,620,7),(973,982,8),(973,1241,2),(973,1393,6),(973,2343,9),(973,2835,4),(973,3251,1),(973,3366,3),(973,6898,5),(974,20,2),(974,2054,0),(974,3251,1),(975,20,2),(975,1241,3),(975,2039,1),(975,2251,0),(976,20,5),(976,1241,6),(976,2039,1),(976,2570,0),(976,3070,2),(976,3366,4),(976,3530,3),(977,20,2),(977,2926,0),(977,3370,1),(978,17,4),(978,20,5),(978,626,9),(978,905,0),(978,929,1),(978,1240,6),(978,1715,2),(978,3285,7),(978,3632,3),(978,3723,8),(979,17,2),(979,20,0),(979,135,1),(980,20,1),(980,739,2),(980,2596,0),(981,20,1),(981,1224,0),(981,1706,2),(981,2284,5),(981,2965,4),(981,2972,3),(982,20,3),(982,1224,1),(982,1673,0),(982,1706,5),(982,2283,7),(982,2284,4),(982,2965,2),(982,2972,6),(983,20,2),(983,1000,1),(983,2013,0),(984,20,5),(984,109,0),(984,677,6),(984,1886,3),(984,3004,1),(984,3067,4),(984,3833,2),(985,20,1),(985,626,0),(985,2971,2),(986,20,0),(986,626,1),(986,1032,3),(986,1240,2),(987,20,0),(988,20,3),(988,902,2),(988,1706,4),(988,2284,0),(988,2965,1),(988,2972,5),(989,20,11),(989,614,0),(989,633,17),(989,643,20),(989,800,19),(989,912,3),(989,920,22),(989,1185,4),(989,1407,15),(989,1596,21),(989,1685,12),(989,1730,5),(989,1799,13),(989,2365,14),(989,2519,16),(989,2525,9),(989,2720,7),(989,2806,6),(989,2915,8),(989,3004,2),(989,3284,18),(989,3443,10),(989,3595,1),(992,1,4),(992,2,1),(992,3,5),(992,20,6),(992,58,0),(992,59,3),(992,60,2),(993,20,8),(993,741,3),(993,792,5),(993,1768,6),(993,2898,0),(993,3018,4),(993,3226,2),(993,3360,1),(993,3366,7),(995,20,1),(995,626,4),(995,1088,0),(995,1240,3),(995,1367,2),(996,20,3),(996,77,1),(996,1241,2),(996,3256,0),(997,17,9),(997,20,17),(997,77,5),(997,839,6),(997,904,0),(997,986,12),(997,1241,7),(997,1678,16),(997,1870,10),(997,2091,15),(997,2213,4),(997,2589,13),(997,2733,11),(997,2832,18),(997,2845,3),(997,3030,8),(997,3171,2),(997,3270,14),(997,3669,1),(998,20,4),(998,77,2),(998,1241,1),(998,2488,3),(998,3256,0),(999,20,4),(999,816,1),(999,1611,5),(999,1613,0),(999,1678,6),(999,1684,8),(999,2216,7),(999,2589,9),(999,2843,2),(999,2974,3),(1000,20,1),(1000,1727,0),(1000,2039,5),(1000,2361,3),(1000,2470,4),(1000,3360,2),(1000,3366,6),(1001,20,9),(1001,620,1),(1001,792,2),(1001,1161,4),(1001,1768,0),(1001,2199,7),(1001,2228,6),(1001,2340,3),(1001,2351,8),(1001,2970,5),(1002,17,2),(1002,20,1),(1002,1100,0),(1003,20,1),(1003,626,0),(1003,3102,2),(1004,20,7),(1004,1224,3),(1004,1673,0),(1004,1706,6),(1004,2284,5),(1004,2304,8),(1004,2965,4),(1004,2972,2),(1004,3704,1),(1005,15,2),(1005,17,0),(1005,20,7),(1005,135,6),(1005,746,5),(1005,973,3),(1005,1520,4),(1005,3706,1),(1007,20,58),(1007,613,16),(1007,635,129),(1007,640,22),(1007,642,139),(1007,699,140),(1007,772,47),(1007,780,176),(1007,789,166),(1007,796,175),(1007,805,136),(1007,904,34),(1007,913,185),(1007,922,111),(1007,923,143),(1007,962,94),(1007,965,153),(1007,968,179),(1007,1024,165),(1007,1043,85),(1007,1078,61),(1007,1094,200),(1007,1103,227),(1007,1138,55),(1007,1148,8),(1007,1168,115),(1007,1186,41),(1007,1189,230),(1007,1242,75),(1007,1254,96),(1007,1285,137),(1007,1291,107),(1007,1299,213),(1007,1322,187),(1007,1331,63),(1007,1350,76),(1007,1391,84),(1007,1410,155),(1007,1412,201),(1007,1413,25),(1007,1418,17),(1007,1427,42),(1007,1429,158),(1007,1458,24),(1007,1492,15),(1007,1493,119),(1007,1494,30),(1007,1502,66),(1007,1509,104),(1007,1513,39),(1007,1525,86),(1007,1533,125),(1007,1550,45),(1007,1558,51),(1007,1575,89),(1007,1587,38),(1007,1593,151),(1007,1603,146),(1007,1611,90),(1007,1632,60),(1007,1650,202),(1007,1658,106),(1007,1669,169),(1007,1678,174),(1007,1680,120),(1007,1687,36),(1007,1718,197),(1007,1725,231),(1007,1737,80),(1007,1751,163),(1007,1776,128),(1007,1777,195),(1007,1787,46),(1007,1792,98),(1007,1798,123),(1007,1800,149),(1007,1814,49),(1007,1820,10),(1007,1858,68),(1007,1888,159),(1007,1890,117),(1007,1897,67),(1007,1904,121),(1007,1910,193),(1007,1935,53),(1007,1939,188),(1007,1958,126),(1007,1959,31),(1007,2012,134),(1007,2022,71),(1007,2032,150),(1007,2058,100),(1007,2094,110),(1007,2112,28),(1007,2117,79),(1007,2120,32),(1007,2127,108),(1007,2134,48),(1007,2155,62),(1007,2164,5),(1007,2178,69),(1007,2189,26),(1007,2205,145),(1007,2206,154),(1007,2239,194),(1007,2255,161),(1007,2259,127),(1007,2303,167),(1007,2438,88),(1007,2449,116),(1007,2483,33),(1007,2513,64),(1007,2519,180),(1007,2521,190),(1007,2522,112),(1007,2546,14),(1007,2563,7),(1007,2573,13),(1007,2637,6),(1007,2677,189),(1007,2707,164),(1007,2711,133),(1007,2712,93),(1007,2759,182),(1007,2767,50),(1007,2768,99),(1007,2782,95),(1007,2809,0),(1007,2830,198),(1007,2846,29),(1007,2856,184),(1007,2859,11),(1007,2878,40),(1007,2881,92),(1007,2886,212),(1007,2891,35),(1007,2931,177),(1007,2957,82),(1007,2964,172),(1007,2998,204),(1007,3001,81),(1007,3006,173),(1007,3015,97),(1007,3030,74),(1007,3035,59),(1007,3036,109),(1007,3051,141),(1007,3081,211),(1007,3086,131),(1007,3090,178),(1007,3111,103),(1007,3173,65),(1007,3197,77),(1007,3200,114),(1007,3233,186),(1007,3237,196),(1007,3254,156),(1007,3261,57),(1007,3266,171),(1007,3270,83),(1007,3278,12),(1007,3283,138),(1007,3288,20),(1007,3290,183),(1007,3292,54),(1007,3297,113),(1007,3321,91),(1007,3345,52),(1007,3361,144),(1007,3397,3),(1007,3424,124),(1007,3426,118),(1007,3430,168),(1007,3446,147),(1007,3455,9),(1007,3520,23),(1007,3525,18),(1007,3546,43),(1007,3555,56),(1007,3558,192),(1007,3564,199),(1007,3566,132),(1007,3575,19),(1007,3600,4),(1007,3624,162),(1007,3626,157),(1007,3645,44),(1007,3653,135),(1007,3689,152),(1007,3701,70),(1007,3717,130),(1007,3738,78),(1007,3741,105),(1007,3753,2),(1007,3755,87),(1007,3758,1),(1007,3764,148),(1007,3767,73),(1007,3783,142),(1007,3786,72),(1007,3825,122),(1007,3844,37),(1007,3853,170),(1007,5855,181),(1007,5861,21),(1007,5862,27),(1007,5864,101),(1007,5865,102),(1007,5866,160),(1007,5868,191),(1007,5869,203),(1007,6617,205),(1007,6618,206),(1007,6619,207),(1007,6620,208),(1007,6621,209),(1007,6622,210),(1007,6623,214),(1007,6624,215),(1007,6625,216),(1007,6626,217),(1007,6627,218),(1007,6628,219),(1007,6629,220),(1007,6630,221),(1007,6631,222),(1007,6632,223),(1007,6633,224),(1007,6634,225),(1007,6635,226),(1007,6636,228),(1007,6637,229),(1008,20,4),(1008,1277,0),(1008,1768,3),(1008,2340,2),(1008,2892,5),(1008,3366,1),(1009,20,9),(1009,135,8),(1009,982,6),(1009,1201,1),(1009,1241,2),(1009,1393,3),(1009,1948,7),(1009,3107,4),(1009,3251,0),(1009,3366,5),(1010,20,3),(1010,620,4),(1010,1180,2),(1010,6899,0),(1010,6900,1),(1011,17,3),(1011,20,6),(1011,135,5),(1011,626,7),(1011,928,0),(1011,1222,1),(1011,2785,2),(1011,3632,4),(1012,20,1),(1012,77,0),(1012,3004,2),(1013,20,3),(1013,680,0),(1013,845,7),(1013,933,5),(1013,1414,9),(1013,1560,12),(1013,1674,2),(1013,2289,8),(1013,2497,11),(1013,2590,6),(1013,3004,1),(1013,3212,4),(1013,3688,10),(1014,20,1),(1014,1100,0),(1015,20,7),(1015,1224,5),(1015,1625,1),(1015,1673,0),(1015,1889,2),(1015,2284,3),(1015,2531,6),(1015,2965,4),(1016,20,3),(1016,1224,5),(1016,1625,1),(1016,1673,0),(1016,2284,2),(1016,2304,7),(1016,2531,6),(1016,2965,4),(1017,20,6),(1017,902,2),(1017,1224,1),(1017,1673,0),(1017,1706,7),(1017,2284,5),(1017,2965,4),(1017,2972,3),(1018,20,3),(1018,1277,5),(1018,1570,7),(1018,1768,1),(1018,2340,2),(1018,2413,8),(1018,2892,0),(1018,3366,4),(1018,3396,6),(1019,20,3),(1019,1241,2),(1019,2039,4),(1019,3038,0),(1019,3350,1),(1020,20,7),(1020,784,0),(1020,1867,6),(1020,1946,9),(1020,2039,5),(1020,2868,2),(1020,3221,4),(1020,3265,8),(1020,3360,1),(1020,3366,10),(1020,3787,3),(1021,20,2),(1021,1241,3),(1021,2039,1),(1021,2251,0),(1022,17,4),(1022,20,3),(1022,1085,2),(1022,1689,1),(1022,2308,0),(1025,15,2),(1025,20,10),(1025,135,9),(1025,620,6),(1025,667,7),(1025,724,4),(1025,1241,8),(1025,1393,3),(1025,1920,0),(1025,2251,1),(1025,2838,5),(1026,20,9),(1026,135,8),(1026,1241,3),(1026,2039,2),(1026,2054,5),(1026,2249,7),(1026,2570,0),(1026,3010,6),(1026,3366,1),(1026,3816,4),(1027,15,3),(1027,17,2),(1027,20,7),(1027,135,1),(1027,889,0),(1027,1241,8),(1027,2250,5),(1027,2395,4),(1027,2457,6),(1028,20,11),(1028,632,7),(1028,633,17),(1028,643,20),(1028,792,1),(1028,800,19),(1028,912,22),(1028,1185,4),(1028,1407,15),(1028,1596,3),(1028,1685,12),(1028,1730,0),(1028,1799,13),(1028,1877,2),(1028,2365,14),(1028,2519,16),(1028,2525,9),(1028,2806,6),(1028,2915,8),(1028,3004,21),(1028,3264,5),(1028,3284,18),(1028,3443,10),(1029,20,3),(1029,620,4),(1029,1205,0),(1029,3070,2),(1029,3207,1),(1030,20,5),(1030,904,0),(1030,1678,6),(1030,1684,2),(1030,2216,3),(1030,2371,1),(1030,2589,7),(1030,2974,4),(1031,20,4),(1031,77,3),(1031,135,1),(1031,1241,2),(1031,1990,0),(1032,20,8),(1032,135,7),(1032,982,6),(1032,1241,3),(1032,1393,5),(1032,2054,0),(1032,3251,1),(1032,3366,4),(1032,3816,2),(1034,15,1),(1034,20,14),(1034,77,12),(1034,135,13),(1034,620,10),(1034,709,7),(1034,724,3),(1034,1241,11),(1034,1393,8),(1034,1920,5),(1034,1934,6),(1034,2054,0),(1034,2838,4),(1034,3256,2),(1034,3366,9),(1036,20,13),(1036,77,9),(1036,656,1),(1036,904,6),(1036,986,10),(1036,1000,0),(1036,1678,12),(1036,2309,5),(1036,2421,4),(1036,2537,2),(1036,2832,8),(1036,3030,11),(1036,3171,3),(1036,3270,7),(1037,20,7),(1037,49,3),(1037,620,8),(1037,1452,4),(1037,1516,0),(1037,2220,5),(1037,2892,6),(1037,3380,2),(1037,6639,1),(1038,20,5),(1038,77,0),(1038,887,1),(1038,1763,3),(1038,1823,4),(1038,1990,2),(1039,20,8),(1039,77,6),(1039,135,7),(1039,620,4),(1039,1241,1),(1039,2570,3),(1039,2892,5),(1039,3366,2),(1039,3816,0),(1040,20,56),(1040,117,238),(1040,613,12),(1040,635,127),(1040,640,19),(1040,642,137),(1040,644,234),(1040,653,235),(1040,699,138),(1040,738,249),(1040,760,2),(1040,772,46),(1040,775,337),(1040,780,174),(1040,789,164),(1040,796,173),(1040,797,351),(1040,805,134),(1040,846,345),(1040,851,330),(1040,885,3),(1040,904,32),(1040,913,183),(1040,922,110),(1040,923,141),(1040,962,94),(1040,965,151),(1040,968,177),(1040,1000,277),(1040,1007,251),(1040,1024,163),(1040,1043,85),(1040,1078,59),(1040,1094,198),(1040,1105,364),(1040,1117,288),(1040,1131,353),(1040,1134,308),(1040,1138,53),(1040,1156,284),(1040,1168,114),(1040,1186,40),(1040,1203,322),(1040,1204,6),(1040,1242,75),(1040,1254,96),(1040,1285,135),(1040,1291,106),(1040,1298,314),(1040,1311,362),(1040,1322,185),(1040,1331,61),(1040,1345,305),(1040,1350,76),(1040,1368,310),(1040,1369,218),(1040,1391,84),(1040,1410,153),(1040,1412,199),(1040,1413,22),(1040,1418,14),(1040,1427,41),(1040,1429,156),(1040,1449,309),(1040,1454,248),(1040,1458,21),(1040,1476,287),(1040,1492,11),(1040,1493,117),(1040,1494,27),(1040,1502,66),(1040,1509,103),(1040,1513,38),(1040,1525,86),(1040,1533,123),(1040,1550,44),(1040,1558,50),(1040,1575,89),(1040,1580,252),(1040,1587,37),(1040,1593,149),(1040,1603,144),(1040,1611,90),(1040,1632,58),(1040,1650,371),(1040,1658,105),(1040,1669,167),(1040,1678,172),(1040,1680,118),(1040,1687,34),(1040,1698,233),(1040,1703,324),(1040,1718,195),(1040,1737,80),(1040,1738,366),(1040,1751,161),(1040,1776,126),(1040,1777,193),(1040,1787,45),(1040,1792,97),(1040,1797,285),(1040,1798,121),(1040,1800,147),(1040,1801,226),(1040,1804,350),(1040,1814,48),(1040,1816,64),(1040,1817,318),(1040,1820,36),(1040,1858,68),(1040,1888,157),(1040,1890,363),(1040,1897,67),(1040,1904,119),(1040,1910,191),(1040,1916,223),(1040,1921,237),(1040,1935,52),(1040,1939,186),(1040,1945,346),(1040,1958,124),(1040,1959,28),(1040,1968,258),(1040,2012,132),(1040,2022,71),(1040,2032,148),(1040,2034,216),(1040,2049,333),(1040,2051,339),(1040,2058,99),(1040,2093,229),(1040,2094,109),(1040,2097,279),(1040,2112,25),(1040,2117,79),(1040,2120,30),(1040,2127,107),(1040,2134,47),(1040,2155,60),(1040,2166,289),(1040,2178,69),(1040,2189,23),(1040,2196,331),(1040,2205,143),(1040,2206,152),(1040,2219,341),(1040,2239,192),(1040,2255,159),(1040,2259,125),(1040,2260,307),(1040,2303,165),(1040,2326,228),(1040,2386,355),(1040,2388,213),(1040,2419,245),(1040,2438,88),(1040,2449,115),(1040,2452,65),(1040,2483,31),(1040,2513,62),(1040,2519,178),(1040,2521,188),(1040,2522,111),(1040,2546,10),(1040,2568,270),(1040,2573,9),(1040,2582,4),(1040,2598,215),(1040,2602,327),(1040,2603,293),(1040,2610,311),(1040,2629,356),(1040,2637,13),(1040,2642,334),(1040,2671,320),(1040,2675,278),(1040,2677,187),(1040,2701,214),(1040,2707,162),(1040,2711,131),(1040,2712,93),(1040,2754,275),(1040,2756,227),(1040,2759,180),(1040,2767,49),(1040,2768,98),(1040,2778,359),(1040,2782,95),(1040,2792,242),(1040,2824,348),(1040,2830,196),(1040,2846,26),(1040,2856,182),(1040,2859,7),(1040,2878,39),(1040,2881,92),(1040,2884,349),(1040,2891,33),(1040,2931,175),(1040,2933,347),(1040,2957,82),(1040,2964,170),(1040,2977,321),(1040,2985,212),(1040,2998,201),(1040,3001,81),(1040,3006,171),(1040,3020,354),(1040,3030,74),(1040,3035,57),(1040,3036,108),(1040,3047,344),(1040,3051,139),(1040,3054,272),(1040,3085,263),(1040,3086,129),(1040,3090,176),(1040,3111,102),(1040,3120,236),(1040,3151,352),(1040,3168,225),(1040,3173,63),(1040,3197,77),(1040,3200,113),(1040,3210,370),(1040,3214,329),(1040,3233,184),(1040,3237,194),(1040,3254,154),(1040,3261,55),(1040,3266,169),(1040,3270,83),(1040,3278,8),(1040,3283,136),(1040,3288,17),(1040,3290,181),(1040,3292,367),(1040,3297,112),(1040,3314,202),(1040,3321,91),(1040,3325,240),(1040,3335,257),(1040,3340,255),(1040,3345,51),(1040,3361,142),(1040,3371,209),(1040,3386,306),(1040,3401,0),(1040,3403,369),(1040,3419,231),(1040,3424,122),(1040,3426,116),(1040,3430,166),(1040,3446,145),(1040,3452,365),(1040,3480,250),(1040,3520,20),(1040,3525,15),(1040,3537,360),(1040,3546,42),(1040,3555,54),(1040,3558,190),(1040,3564,197),(1040,3566,130),(1040,3570,280),(1040,3575,16),(1040,3600,29),(1040,3624,160),(1040,3626,155),(1040,3645,43),(1040,3651,5),(1040,3653,133),(1040,3689,150),(1040,3696,361),(1040,3701,70),(1040,3712,217),(1040,3717,128),(1040,3720,290),(1040,3721,291),(1040,3722,222),(1040,3726,294),(1040,3729,296),(1040,3738,78),(1040,3741,104),(1040,3755,87),(1040,3764,146),(1040,3767,73),(1040,3783,140),(1040,3786,72),(1040,3825,120),(1040,3844,35),(1040,3853,168),(1040,5835,246),(1040,5854,281),(1040,5855,179),(1040,5859,244),(1040,5860,267),(1040,5861,18),(1040,5862,24),(1040,5864,100),(1040,5865,101),(1040,5866,158),(1040,5868,189),(1040,5869,200),(1040,5871,323),(1040,5873,243),(1040,5876,282),(1040,5885,276),(1040,5886,299),(1040,5887,297),(1040,5901,253),(1040,5903,254),(1040,5904,300),(1040,5906,301),(1040,5907,269),(1040,5909,220),(1040,5910,335),(1040,5911,273),(1040,5913,292),(1040,5916,259),(1040,5919,256),(1040,5921,262),(1040,5923,211),(1040,5925,221),(1040,5926,336),(1040,5931,203),(1040,5932,304),(1040,5933,219),(1040,5937,224),(1040,5939,204),(1040,5940,317),(1040,5941,303),(1040,5942,302),(1040,5943,312),(1040,5944,338),(1040,5945,261),(1040,5946,232),(1040,5947,241),(1040,5949,332),(1040,5954,205),(1040,5955,358),(1040,5957,328),(1040,6084,265),(1040,6247,268),(1040,6802,326),(1040,6809,1),(1040,6810,206),(1040,6811,207),(1040,6812,208),(1040,6813,210),(1040,6814,230),(1040,6815,239),(1040,6816,247),(1040,6817,260),(1040,6818,264),(1040,6819,266),(1040,6820,271),(1040,6821,274),(1040,6822,283),(1040,6823,286),(1040,6824,298),(1040,6825,313),(1040,6826,315),(1040,6827,316),(1040,6828,319),(1040,6829,340),(1040,6830,342),(1040,6831,343),(1040,6832,357),(1040,6833,368),(1041,20,10),(1041,135,9),(1041,982,7),(1041,1214,6),(1041,1241,3),(1041,1393,4),(1041,1948,8),(1041,2054,1),(1041,2348,2),(1041,3251,0),(1041,3366,5),(1042,20,4),(1042,620,5),(1042,630,0),(1042,743,1),(1042,2542,2),(1042,2892,3),(1043,20,4),(1043,1568,3),(1043,1768,5),(1043,2091,1),(1043,2970,0),(1043,3004,2),(1044,20,7),(1044,135,6),(1044,1241,2),(1044,1393,3),(1044,2039,1),(1044,3251,5),(1044,3360,4),(1044,3366,0),(1045,20,3),(1045,1241,4),(1045,2039,2),(1045,2251,0),(1045,2570,1),(1046,20,41),(1046,685,57),(1046,711,58),(1046,727,69),(1046,744,64),(1046,794,56),(1046,824,11),(1046,832,51),(1046,1008,22),(1046,1193,3),(1046,1208,62),(1046,1396,32),(1046,1441,15),(1046,1444,66),(1046,1561,24),(1046,1590,33),(1046,1593,48),(1046,1611,44),(1046,1618,30),(1046,1635,8),(1046,1666,40),(1046,1789,17),(1046,1820,55),(1046,1831,5),(1046,1865,21),(1046,1919,39),(1046,1955,65),(1046,1973,16),(1046,1979,38),(1046,2032,50),(1046,2074,6),(1046,2078,37),(1046,2080,45),(1046,2118,67),(1046,2230,7),(1046,2233,63),(1046,2277,14),(1046,2295,34),(1046,2411,10),(1046,2425,60),(1046,2554,18),(1046,2664,0),(1046,2676,42),(1046,2750,28),(1046,2859,68),(1046,2894,4),(1046,2982,27),(1046,2983,61),(1046,3007,19),(1046,3019,13),(1046,3037,9),(1046,3051,49),(1046,3056,47),(1046,3128,12),(1046,3155,53),(1046,3186,25),(1046,3187,52),(1046,3213,31),(1046,3265,43),(1046,3326,54),(1046,3331,23),(1046,3385,29),(1046,3393,20),(1046,3394,1),(1046,3474,36),(1046,3492,26),(1046,3568,2),(1046,3577,35),(1046,3598,46),(1046,3742,59),(1048,20,91),(1048,613,55),(1048,635,153),(1048,640,60),(1048,642,162),(1048,699,163),(1048,772,18),(1048,780,189),(1048,789,183),(1048,796,32),(1048,805,160),(1048,904,68),(1048,913,38),(1048,922,138),(1048,923,166),(1048,962,121),(1048,965,9),(1048,968,36),(1048,1024,182),(1048,1043,114),(1048,1078,94),(1048,1094,203),(1048,1138,88),(1048,1168,142),(1048,1186,75),(1048,1242,105),(1048,1254,123),(1048,1285,161),(1048,1291,134),(1048,1322,196),(1048,1331,96),(1048,1332,97),(1048,1350,106),(1048,1391,113),(1048,1410,12),(1048,1412,26),(1048,1413,11),(1048,1418,57),(1048,1427,17),(1048,1429,19),(1048,1458,10),(1048,1492,54),(1048,1493,144),(1048,1494,65),(1048,1502,100),(1048,1509,131),(1048,1513,74),(1048,1525,115),(1048,1533,45),(1048,1550,78),(1048,1558,84),(1048,1575,117),(1048,1587,73),(1048,1593,174),(1048,1603,169),(1048,1611,118),(1048,1632,93),(1048,1650,6),(1048,1658,133),(1048,1669,27),(1048,1678,188),(1048,1680,145),(1048,1687,70),(1048,1718,201),(1048,1737,110),(1048,1751,20),(1048,1776,152),(1048,1777,47),(1048,1787,79),(1048,1792,125),(1048,1798,148),(1048,1800,172),(1048,1814,82),(1048,1816,22),(1048,1820,72),(1048,1858,101),(1048,1888,178),(1048,1890,42),(1048,1897,24),(1048,1904,146),(1048,1910,44),(1048,1917,3),(1048,1935,86),(1048,1939,39),(1048,1958,150),(1048,1959,66),(1048,2012,158),(1048,2015,80),(1048,2032,173),(1048,2058,127),(1048,2094,137),(1048,2112,63),(1048,2117,109),(1048,2120,1),(1048,2127,135),(1048,2134,81),(1048,2155,95),(1048,2178,102),(1048,2189,62),(1048,2205,168),(1048,2206,176),(1048,2239,200),(1048,2255,180),(1048,2259,151),(1048,2298,2),(1048,2303,184),(1048,2330,5),(1048,2354,0),(1048,2438,116),(1048,2449,143),(1048,2452,23),(1048,2483,14),(1048,2513,98),(1048,2519,191),(1048,2521,197),(1048,2522,139),(1048,2546,53),(1048,2573,52),(1048,2637,56),(1048,2677,40),(1048,2707,21),(1048,2711,157),(1048,2712,120),(1048,2759,193),(1048,2767,83),(1048,2768,126),(1048,2782,122),(1048,2830,50),(1048,2846,64),(1048,2856,37),(1048,2859,51),(1048,2878,16),(1048,2881,119),(1048,2891,69),(1048,2931,34),(1048,2957,31),(1048,2964,187),(1048,2998,46),(1048,3001,111),(1048,3006,30),(1048,3015,124),(1048,3030,28),(1048,3035,92),(1048,3036,136),(1048,3051,164),(1048,3086,155),(1048,3090,190),(1048,3111,130),(1048,3173,99),(1048,3197,107),(1048,3200,141),(1048,3233,195),(1048,3237,48),(1048,3254,177),(1048,3261,90),(1048,3266,29),(1048,3270,112),(1048,3278,41),(1048,3283,49),(1048,3288,58),(1048,3290,194),(1048,3292,87),(1048,3297,140),(1048,3321,35),(1048,3345,85),(1048,3361,167),(1048,3382,4),(1048,3424,149),(1048,3426,43),(1048,3430,185),(1048,3446,170),(1048,3520,61),(1048,3525,7),(1048,3546,76),(1048,3555,89),(1048,3558,199),(1048,3564,202),(1048,3566,156),(1048,3575,8),(1048,3600,67),(1048,3624,181),(1048,3626,15),(1048,3645,77),(1048,3653,159),(1048,3689,175),(1048,3701,103),(1048,3717,154),(1048,3738,108),(1048,3741,132),(1048,3755,33),(1048,3764,171),(1048,3767,104),(1048,3783,165),(1048,3786,25),(1048,3825,147),(1048,3844,71),(1048,3853,186),(1048,5855,192),(1048,5861,59),(1048,5862,13),(1048,5864,128),(1048,5865,129),(1048,5866,179),(1048,5868,198),(1048,5869,204),(1049,20,1),(1049,136,0),(1049,741,5),(1049,1097,3),(1049,2017,2),(1049,2361,4),(1049,2892,6),(1049,3366,7),(1050,20,2),(1050,889,0),(1050,1241,3),(1050,3816,1),(1055,20,1),(1055,77,2),(1055,784,0),(1055,1867,8),(1055,1946,10),(1055,2039,7),(1055,2470,4),(1055,3221,6),(1055,3265,9),(1055,3360,3),(1055,3366,11),(1055,3787,5),(1058,2,0),(1058,15,2),(1058,16,1),(1058,17,6),(1058,19,4),(1058,20,8),(1058,1266,7),(1058,2214,3),(1058,3700,5),(1063,20,6),(1063,1241,4),(1063,1727,0),(1063,2039,1),(1063,2470,5),(1063,3265,3),(1063,3360,2),(1063,3366,7),(1064,17,1),(1064,1641,2),(1064,7194,0),(1065,20,100),(1065,613,56),(1065,640,62),(1065,656,7),(1065,689,42),(1065,772,89),(1065,842,9),(1065,904,74),(1065,955,22),(1065,962,137),(1065,965,35),(1065,1024,14),(1065,1043,128),(1065,1077,144),(1065,1078,103),(1065,1106,27),(1065,1116,13),(1065,1138,97),(1065,1186,82),(1065,1242,119),(1065,1254,139),(1065,1259,52),(1065,1278,20),(1065,1284,11),(1065,1291,149),(1065,1322,25),(1065,1331,105),(1065,1332,106),(1065,1350,120),(1065,1380,49),(1065,1391,127),(1065,1418,57),(1065,1427,83),(1065,1450,30),(1065,1458,64),(1065,1492,6),(1065,1494,69),(1065,1501,18),(1065,1502,111),(1065,1513,80),(1065,1525,129),(1065,1550,86),(1065,1558,93),(1065,1575,132),(1065,1587,79),(1065,1611,133),(1065,1632,102),(1065,1655,50),(1065,1658,148),(1065,1669,19),(1065,1687,76),(1065,1692,37),(1065,1703,44),(1065,1729,66),(1065,1737,123),(1065,1787,87),(1065,1792,141),(1065,1814,91),(1065,1816,109),(1065,1820,78),(1065,1858,113),(1065,1897,112),(1065,1935,95),(1065,1945,17),(1065,1959,70),(1065,2015,88),(1065,2049,36),(1065,2051,16),(1065,2058,143),(1065,2112,67),(1065,2117,122),(1065,2120,72),(1065,2134,90),(1065,2143,47),(1065,2155,104),(1065,2178,114),(1065,2189,65),(1065,2190,53),(1065,2234,1),(1065,2255,38),(1065,2261,33),(1065,2438,131),(1065,2452,110),(1065,2483,73),(1065,2501,96),(1065,2505,61),(1065,2513,107),(1065,2521,28),(1065,2537,26),(1065,2546,55),(1065,2573,54),(1065,2611,145),(1065,2637,5),(1065,2689,39),(1065,2712,136),(1065,2767,92),(1065,2768,142),(1065,2782,138),(1065,2813,12),(1065,2846,68),(1065,2847,24),(1065,2859,32),(1065,2878,81),(1065,2879,15),(1065,2881,135),(1065,2891,75),(1065,2931,23),(1065,2939,0),(1065,2957,125),(1065,2986,51),(1065,3001,124),(1065,3017,140),(1065,3030,118),(1065,3035,101),(1065,3093,40),(1065,3111,146),(1065,3172,45),(1065,3173,108),(1065,3197,121),(1065,3237,29),(1065,3261,99),(1065,3270,126),(1065,3278,3),(1065,3288,60),(1065,3321,134),(1065,3345,94),(1065,3379,43),(1065,3387,46),(1065,3478,48),(1065,3520,63),(1065,3525,58),(1065,3532,8),(1065,3546,84),(1065,3552,10),(1065,3555,98),(1065,3575,59),(1065,3600,71),(1065,3645,85),(1065,3653,2),(1065,3671,4),(1065,3689,34),(1065,3701,115),(1065,3738,31),(1065,3741,147),(1065,3755,130),(1065,3777,41),(1065,3786,116),(1065,3808,117),(1065,3844,77),(1065,3852,21),(1066,20,24),(1066,617,8),(1066,625,27),(1066,796,32),(1066,934,16),(1066,957,35),(1066,965,6),(1066,1147,9),(1066,1223,19),(1066,1378,49),(1066,1383,48),(1066,1424,2),(1066,1425,43),(1066,1430,52),(1066,1451,13),(1066,1488,23),(1066,1526,37),(1066,1540,31),(1066,1725,47),(1066,1746,29),(1066,1815,7),(1066,1828,18),(1066,1836,36),(1066,1933,44),(1066,1969,17),(1066,1991,0),(1066,2039,28),(1066,2121,40),(1066,2254,11),(1066,2434,51),(1066,2493,4),(1066,2529,45),(1066,2540,38),(1066,2700,41),(1066,2833,3),(1066,2863,25),(1066,2925,46),(1066,2929,20),(1066,2933,5),(1066,2974,50),(1066,3073,42),(1066,3095,33),(1066,3223,39),(1066,3350,22),(1066,3439,14),(1066,3499,34),(1066,3511,15),(1066,3513,26),(1066,3544,1),(1066,3626,10),(1066,3658,12),(1066,3815,30),(1066,3833,21),(1067,20,0),(1068,17,2),(1068,20,5),(1068,735,0),(1068,948,1),(1068,1870,4),(1068,2810,3),(1071,20,4),(1071,1241,3),(1071,1954,2),(1071,2739,0),(1071,3182,1),(1072,20,1),(1072,135,2),(1072,620,3),(1072,6900,0),(1073,20,0),(1074,20,0),(1075,17,5),(1075,20,0),(1075,135,1),(1075,1416,6),(1075,1767,3),(1075,1805,2),(1075,1875,7),(1075,3271,8),(1075,3366,4),(1076,17,1),(1076,20,0),(1077,20,3),(1077,1673,6),(1077,1706,4),(1077,2284,0),(1077,2531,5),(1077,2965,1),(1077,2972,2),(1079,2,0),(1079,16,1),(1079,20,4),(1079,50,3),(1079,2214,2),(1080,15,2),(1080,20,13),(1080,77,11),(1080,135,10),(1080,724,5),(1080,889,7),(1080,1241,12),(1080,1393,4),(1080,1920,0),(1080,2054,3),(1080,2251,1),(1080,2838,6),(1080,3366,9),(1080,3816,8),(1081,20,7),(1081,632,13),(1081,633,14),(1081,643,21),(1081,800,18),(1081,912,23),(1081,1185,9),(1081,1407,11),(1081,1596,22),(1081,1685,4),(1081,1730,20),(1081,1799,5),(1081,1877,0),(1081,2365,6),(1081,2519,12),(1081,2525,16),(1081,2720,3),(1081,2806,15),(1081,2915,10),(1081,3004,2),(1081,3264,8),(1081,3284,19),(1081,3437,1),(1081,3443,17),(1082,20,4),(1082,789,7),(1082,979,6),(1082,1392,9),(1082,1678,5),(1082,1895,1),(1082,2492,0),(1082,2746,2),(1082,2832,10),(1082,2964,8),(1082,3270,3),(1083,17,1),(1083,20,4),(1083,904,0),(1083,1678,2),(1083,2589,3),(1084,20,5),(1084,1487,0),(1084,2039,1),(1084,2305,3),(1084,2361,2),(1084,2696,4),(1084,3265,6),(1084,3366,7),(1085,20,2),(1085,2926,1),(1085,3370,0),(1086,20,1),(1086,50,0),(1087,20,0),(1087,982,1),(1088,17,2),(1088,20,0),(1088,1641,3),(1088,1768,1),(1089,20,0),(1090,20,0),(1090,1072,3),(1090,1304,1),(1090,2596,2),(1091,20,1),(1091,1673,0),(1092,20,5),(1092,620,6),(1092,942,3),(1092,1483,0),(1092,1486,2),(1092,2297,1),(1092,3487,4),(1093,2,0),(1093,16,1),(1093,20,8),(1093,49,7),(1093,1461,6),(1093,1769,4),(1093,2890,3),(1093,2958,2),(1093,3375,5),(1094,17,1),(1094,20,5),(1094,126,4),(1094,1279,2),(1094,2290,3),(1094,3706,0),(1095,20,4),(1095,620,6),(1095,1452,1),(1095,1486,5),(1095,2220,0),(1095,2297,3),(1095,3380,2),(1096,20,3),(1096,1163,4),(1096,1471,0),(1096,1862,1),(1096,2892,6),(1096,3121,2),(1096,3310,5),(1097,20,1),(1097,50,0),(1098,15,1),(1098,17,3),(1098,20,13),(1098,77,11),(1098,135,12),(1098,620,9),(1098,1092,5),(1098,1227,8),(1098,1241,4),(1098,1530,7),(1098,1920,6),(1098,2054,0),(1098,3366,10),(1098,3834,2),(1099,1001,1),(1099,1216,3),(1099,1826,7),(1099,2086,6),(1099,2588,4),(1099,2732,2),(1099,3014,5),(1099,3713,0),(1100,17,1),(1100,20,2),(1100,2892,0),(1101,20,0),(1101,3004,1),(1102,20,3),(1102,823,2),(1102,2926,1),(1102,3370,0),(1103,20,2),(1103,643,3),(1103,785,4),(1103,2093,5),(1103,2954,1),(1103,3004,0),(1103,3166,6),(1104,20,0),(1104,1341,1),(1104,1679,5),(1104,1767,7),(1104,1805,3),(1104,1899,2),(1104,2633,6),(1104,3024,4),(1105,20,2),(1105,723,3),(1105,1304,1),(1105,1317,0),(1105,2596,4),(1106,20,0),(1107,17,3),(1107,20,0),(1107,854,2),(1107,3150,1),(1108,20,7),(1108,704,5),(1108,1044,3),(1108,1358,1),(1108,1769,8),(1108,1879,2),(1108,2209,0),(1108,2707,6),(1108,2836,9),(1108,3004,11),(1108,3295,12),(1108,3327,4),(1108,3409,10),(1109,20,1),(1109,3672,0),(1110,17,3),(1110,20,4),(1110,870,2),(1110,3329,1),(1110,3706,0),(1111,15,0),(1111,17,4),(1111,20,11),(1111,108,1),(1111,135,10),(1111,620,9),(1111,724,7),(1111,1241,5),(1111,1723,6),(1111,2054,2),(1111,2838,8),(1111,3256,3),(1112,1,4),(1112,2,0),(1112,15,5),(1112,16,3),(1112,20,11),(1112,47,7),(1112,49,1),(1112,51,6),(1112,108,8),(1112,718,2),(1112,1920,9),(1112,3641,10),(1113,20,6),(1113,704,9),(1113,1044,1),(1113,1067,5),(1113,1358,8),(1113,1769,7),(1113,1879,4),(1113,2209,3),(1113,2291,0),(1113,3004,10),(1113,3295,11),(1113,3327,2),(1114,20,2),(1114,979,4),(1114,1500,8),(1114,1678,7),(1114,2303,6),(1114,2832,0),(1114,3196,5),(1114,3270,3),(1114,3582,1),(1115,1,4),(1115,2,0),(1115,16,2),(1115,20,5),(1115,58,1),(1115,60,3),(1116,20,7),(1116,135,5),(1116,620,4),(1116,1241,0),(1116,1393,2),(1116,2039,8),(1116,3350,1),(1116,3366,6),(1116,3816,3),(1117,20,3),(1117,620,4),(1117,1205,0),(1117,1249,1),(1117,1604,2),(1118,20,3),(1118,136,0),(1118,1277,1),(1118,2892,5),(1118,3021,4),(1118,3366,2),(1119,17,1),(1119,20,9),(1119,77,0),(1119,1241,3),(1119,1678,7),(1119,2589,6),(1119,2832,8),(1119,3030,4),(1119,3171,2),(1119,3270,5),(1120,20,14),(1120,717,21),(1120,727,31),(1120,796,25),(1120,824,4),(1120,1148,23),(1120,1193,1),(1120,1322,22),(1120,1405,7),(1120,1611,5),(1120,1635,18),(1120,1666,12),(1120,1820,30),(1120,1919,27),(1120,1978,8),(1120,2031,6),(1120,2032,26),(1120,2074,13),(1120,2080,11),(1120,2270,24),(1120,2676,9),(1120,2859,29),(1120,3023,20),(1120,3051,32),(1120,3056,17),(1120,3092,0),(1120,3155,28),(1120,3229,2),(1120,3265,15),(1120,3326,19),(1120,3568,3),(1120,3577,16),(1120,3598,10),(1121,20,9),(1121,135,8),(1121,1241,4),(1121,1393,7),(1121,2032,2),(1121,2054,3),(1121,2851,0),(1121,3251,1),(1121,3366,5),(1121,3787,6),(1122,17,4),(1122,20,6),(1122,2034,1),(1122,2395,3),(1122,2471,2),(1122,2812,0),(1122,3121,5),(1123,20,6),(1123,824,4),(1123,1326,8),(1123,1678,7),(1123,1896,2),(1123,1960,0),(1123,2589,3),(1123,2832,5),(1123,3270,1),(1124,20,3),(1124,2103,0),(1124,2355,1),(1124,3313,2),(1125,20,12),(1125,633,13),(1125,643,2),(1125,770,9),(1125,912,0),(1125,1434,14),(1125,1588,7),(1125,2045,6),(1125,2519,15),(1125,2691,11),(1125,2755,5),(1125,3004,1),(1125,3018,3),(1125,3078,10),(1125,3238,8),(1125,3384,4),(1126,17,4),(1126,20,2),(1126,1679,0),(1126,1767,3),(1126,1805,1),(1127,17,4),(1127,20,3),(1127,1679,0),(1127,1805,2),(1127,1884,1),(1128,20,5),(1128,1224,3),(1128,1673,0),(1128,1706,6),(1128,2284,4),(1128,2965,2),(1128,2972,1),(1129,20,27),(1129,625,30),(1129,656,0),(1129,796,36),(1129,857,47),(1129,919,24),(1129,965,7),(1129,1057,60),(1129,1144,13),(1129,1181,11),(1129,1212,18),(1129,1223,22),(1129,1264,15),(1129,1378,2),(1129,1424,3),(1129,1432,63),(1129,1540,34),(1129,1591,50),(1129,1684,14),(1129,1719,54),(1129,1725,56),(1129,1746,32),(1129,1751,21),(1129,1828,19),(1129,1836,40),(1129,2006,17),(1129,2039,31),(1129,2121,44),(1129,2206,8),(1129,2216,33),(1129,2227,48),(1129,2253,9),(1129,2257,57),(1129,2371,51),(1129,2398,4),(1129,2420,55),(1129,2434,61),(1129,2435,43),(1129,2537,62),(1129,2581,26),(1129,2589,58),(1129,2637,6),(1129,2700,45),(1129,2833,5),(1129,2834,41),(1129,2842,52),(1129,2974,1),(1129,3203,20),(1129,3205,10),(1129,3223,42),(1129,3270,37),(1129,3350,25),(1129,3399,46),(1129,3468,53),(1129,3499,38),(1129,3513,29),(1129,3571,28),(1129,3588,39),(1129,3605,59),(1129,3612,16),(1129,3626,12),(1129,3833,23),(1129,3837,49),(1129,3852,35),(1130,20,7),(1130,633,14),(1130,643,21),(1130,800,18),(1130,912,22),(1130,1185,9),(1130,1407,12),(1130,1596,2),(1130,1685,3),(1130,1730,20),(1130,1799,4),(1130,1877,6),(1130,2365,5),(1130,2458,1),(1130,2519,13),(1130,2525,16),(1130,2806,15),(1130,2915,11),(1130,3004,10),(1130,3264,8),(1130,3284,19),(1130,3287,0),(1130,3443,17),(1131,20,11),(1131,1392,7),(1131,1412,8),(1131,1492,0),(1131,2091,3),(1131,2193,9),(1131,2213,1),(1131,2421,6),(1131,2859,10),(1131,3171,4),(1131,3256,5),(1131,3270,2),(1131,3852,12),(1132,20,3),(1132,1641,2),(1132,2048,0),(1132,3366,1),(1133,20,2),(1133,620,3),(1133,624,0),(1133,1604,1),(1134,20,0),(1134,135,2),(1134,1088,1),(1134,2284,3),(1135,20,6),(1135,1639,1),(1135,1673,2),(1135,1706,4),(1135,2284,3),(1135,2965,0),(1135,2972,5),(1136,2,0),(1136,16,1),(1136,20,7),(1136,1914,3),(1136,2214,4),(1136,2262,5),(1136,3209,6),(1136,3305,2),(1137,20,3),(1137,77,1),(1137,135,9),(1137,643,10),(1137,887,0),(1137,1149,7),(1137,1422,5),(1137,2458,8),(1137,2892,2),(1137,3004,6),(1137,3018,4),(1137,3230,11),(1138,15,0),(1138,17,3),(1138,20,12),(1138,135,11),(1138,620,5),(1138,1092,6),(1138,1227,9),(1138,1241,4),(1138,1530,8),(1138,1920,7),(1138,2054,1),(1138,3366,10),(1138,3834,2),(1139,20,4),(1139,667,3),(1139,1241,5),(1139,1393,2),(1139,1920,0),(1139,3816,1),(1140,20,0),(1141,17,2),(1141,20,6),(1141,1870,3),(1141,2271,1),(1141,2331,4),(1141,2471,0),(1141,2620,5),(1142,20,4),(1142,1184,0),(1142,2370,2),(1142,2865,3),(1142,3389,1),(1143,20,0),(1143,1674,1),(1144,17,5),(1144,20,3),(1144,135,4),(1144,1679,0),(1144,1767,2),(1144,1805,1),(1145,20,0),(1145,2965,1),(1146,20,8),(1146,704,6),(1146,1044,2),(1146,1358,3),(1146,1769,7),(1146,1879,1),(1146,2209,0),(1146,2707,4),(1146,3004,10),(1146,3295,11),(1146,3327,5),(1146,3409,9),(1147,15,5),(1147,17,1),(1147,18,3),(1147,20,9),(1147,136,0),(1147,870,2),(1147,2011,8),(1147,2752,7),(1147,3256,4),(1147,3534,6),(1148,20,5),(1148,77,0),(1148,904,3),(1148,1678,1),(1148,3171,2),(1148,3270,4),(1149,20,7),(1149,719,1),(1149,972,9),(1149,1321,4),(1149,2056,11),(1149,2179,10),(1149,2392,12),(1149,2586,8),(1149,2641,3),(1149,2893,5),(1149,2970,0),(1149,2999,13),(1149,3410,6),(1149,6638,2),(1150,15,2),(1150,20,10),(1150,135,0),(1150,620,9),(1150,1189,6),(1150,1241,4),(1150,1393,7),(1150,1990,5),(1150,2054,1),(1150,3256,3),(1150,3366,8),(1151,20,38),(1151,655,1),(1151,674,25),(1151,676,37),(1151,694,32),(1151,714,67),(1151,730,62),(1151,791,6),(1151,798,24),(1151,806,60),(1151,844,27),(1151,865,35),(1151,924,21),(1151,958,18),(1151,1010,61),(1151,1211,7),(1151,1316,55),(1151,1342,20),(1151,1354,63),(1151,1621,11),(1151,1629,45),(1151,1666,14),(1151,1681,58),(1151,1684,30),(1151,1861,19),(1151,1936,2),(1151,1975,5),(1151,1987,0),(1151,2003,29),(1151,2023,48),(1151,2090,22),(1151,2095,49),(1151,2115,50),(1151,2122,59),(1151,2167,34),(1151,2193,43),(1151,2323,13),(1151,2396,15),(1151,2443,10),(1151,2495,33),(1151,2500,8),(1151,2651,57),(1151,2704,40),(1151,2721,66),(1151,2755,23),(1151,2757,12),(1151,2825,68),(1151,2874,4),(1151,2897,9),(1151,2908,44),(1151,2937,69),(1151,2940,26),(1151,2976,47),(1151,2987,52),(1151,3044,31),(1151,3054,54),(1151,3174,42),(1151,3270,46),(1151,3324,64),(1151,3362,16),(1151,3392,65),(1151,3429,36),(1151,3580,56),(1151,3589,17),(1151,3614,41),(1151,3704,3),(1151,3803,53),(1151,3806,70),(1151,3895,71),(1151,6699,28),(1151,6700,39),(1151,6701,51),(1152,20,9),(1152,135,8),(1152,1241,2),(1152,1393,5),(1152,2039,1),(1152,2054,6),(1152,2570,7),(1152,2835,4),(1152,3251,0),(1152,3366,3),(1153,20,0),(1154,20,4),(1154,1570,5),(1154,1768,1),(1154,2340,2),(1154,2413,6),(1154,2892,7),(1154,2898,0),(1154,3366,3),(1155,20,3),(1155,1241,4),(1155,2039,2),(1155,2251,0),(1155,2570,1),(1156,20,0),(1156,1679,1),(1157,17,2),(1157,20,0),(1157,135,1),(1158,20,0),(1158,135,5),(1158,626,1),(1158,1240,7),(1158,1356,4),(1158,1623,2),(1158,1666,3),(1158,2965,6),(1159,20,2),(1159,626,1),(1159,1240,0),(1160,20,8),(1160,656,3),(1160,1000,0),(1160,1090,7),(1160,1254,4),(1160,1347,6),(1160,1492,12),(1160,1918,1),(1160,2859,11),(1160,3270,10),(1160,3345,5),(1160,3764,2),(1160,3852,9),(1161,20,9),(1161,620,10),(1161,1486,3),(1161,1843,8),(1161,1866,1),(1161,2297,5),(1161,2542,4),(1161,3175,0),(1161,3273,7),(1161,3405,6),(1161,3791,2),(1162,17,5),(1162,20,6),(1162,704,3),(1162,1358,4),(1162,1769,7),(1162,3004,8),(1162,3275,0),(1162,3295,2),(1162,3327,1),(1163,20,3),(1163,643,8),(1163,912,9),(1163,1596,2),(1163,1713,0),(1163,2458,5),(1163,3004,4),(1163,3230,6),(1163,3453,7),(1163,3518,1),(1164,15,2),(1164,20,22),(1164,77,13),(1164,135,0),(1164,620,8),(1164,724,17),(1164,889,16),(1164,973,14),(1164,1227,11),(1164,1241,4),(1164,1393,5),(1164,1530,10),(1164,1920,15),(1164,1990,19),(1164,2039,12),(1164,2054,1),(1164,2251,21),(1164,2570,20),(1164,2838,18),(1164,2892,9),(1164,3256,3),(1164,3366,7),(1164,3816,6),(1165,20,2),(1165,626,4),(1165,1240,3),(1165,1511,0),(1165,1715,1),(1165,3632,5),(1166,20,4),(1166,1339,2),(1166,2332,3),(1166,2812,1),(1166,3042,5),(1166,3121,0),(1167,20,5),(1167,1178,4),(1167,2597,0),(1167,3281,1),(1167,3602,2),(1167,3686,3),(1168,20,3),(1168,1241,4),(1168,2039,1),(1168,2251,0),(1168,2570,2),(1169,20,7),(1169,1112,3),(1169,1241,1),(1169,2039,8),(1169,2251,2),(1169,2399,0),(1169,2570,4),(1169,3070,5),(1169,3115,6),(1170,20,3),(1170,135,4),(1170,1241,2),(1170,2039,1),(1170,2544,5),(1170,3350,0),(1171,20,3),(1171,68,2),(1171,2103,0),(1171,2355,1),(1172,20,7),(1172,708,4),(1172,1678,6),(1172,2303,1),(1172,2758,8),(1172,2832,9),(1172,3249,3),(1172,3467,2),(1172,3562,0),(1172,7099,5),(1173,20,0),(1174,20,3),(1174,1641,2),(1174,2048,0),(1174,3366,1),(1175,20,7),(1175,883,2),(1175,1482,0),(1175,1678,6),(1175,1684,5),(1175,2216,4),(1175,2338,3),(1175,2589,8),(1175,2833,1),(1175,2974,9),(1176,20,0),(1177,20,0),(1178,17,7),(1178,20,1),(1178,135,3),(1178,1674,5),(1178,1679,0),(1178,1886,4),(1178,1899,6),(1178,2496,2),(1179,17,4),(1179,20,2),(1179,1348,5),(1179,1767,1),(1179,1805,0),(1179,3366,3),(1180,17,4),(1180,20,0),(1180,135,1),(1180,1032,2),(1180,1224,3),(1180,3366,5),(1181,20,1),(1181,1569,2),(1181,2431,3),(1181,2596,0),(1182,20,1),(1182,1096,2),(1182,1224,3),(1182,1673,0),(1183,20,0),(1183,723,1),(1184,20,0),(1184,626,1),(1184,1240,2),(1185,20,0),(1185,1367,1),(1186,2,1),(1186,16,3),(1186,20,8),(1186,49,2),(1186,51,0),(1186,110,5),(1186,2214,4),(1186,3262,7),(1186,3311,6),(1187,20,4),(1187,704,7),(1187,1044,10),(1187,1358,3),(1187,1769,8),(1187,1879,1),(1187,2209,2),(1187,2707,5),(1187,3004,9),(1187,3295,0),(1187,3327,6),(1188,20,12),(1188,633,18),(1188,643,21),(1188,721,0),(1188,800,20),(1188,912,5),(1188,1185,6),(1188,1407,16),(1188,1596,22),(1188,1685,13),(1188,1730,7),(1188,1799,14),(1188,2291,1),(1188,2365,15),(1188,2519,17),(1188,2525,10),(1188,2720,2),(1188,2806,8),(1188,2915,9),(1188,3004,4),(1188,3180,3),(1188,3284,19),(1188,3443,11),(1189,17,9),(1189,18,3),(1189,20,8),(1189,136,0),(1189,735,1),(1189,870,4),(1189,886,7),(1189,2207,2),(1189,2752,6),(1189,3534,5),(1190,20,1),(1190,135,0),(1190,2272,2),(1191,15,3),(1191,17,2),(1191,20,8),(1191,135,1),(1191,889,0),(1191,1241,9),(1191,1393,5),(1191,2250,6),(1191,2395,4),(1191,2457,7),(1192,15,2),(1192,20,0),(1192,135,3),(1192,1241,5),(1192,2054,1),(1192,3256,4),(1193,17,5),(1193,20,7),(1193,126,0),(1193,848,8),(1193,989,9),(1193,990,10),(1193,1279,2),(1193,1870,6),(1193,2290,1),(1193,2902,3),(1193,3652,4),(1194,20,3),(1194,924,4),(1194,1241,2),(1194,2039,1),(1194,2340,0),(1195,20,16),(1195,643,5),(1195,800,6),(1195,820,12),(1195,912,2),(1195,1185,1),(1195,1434,14),(1195,1596,17),(1195,1685,7),(1195,1730,3),(1195,2365,11),(1195,2519,13),(1195,2524,4),(1195,2820,9),(1195,2915,8),(1195,3004,0),(1195,3284,15),(1195,3443,10),(1196,20,0),(1196,2835,1),(1197,20,0),(1198,20,0),(1198,3004,1),(1199,20,5),(1199,626,6),(1199,786,2),(1199,928,4),(1199,1764,3),(1199,3632,1),(1199,3806,0),(1200,20,1),(1200,1240,2),(1200,1576,4),(1200,1942,3),(1200,1951,0),(1200,2616,5),(1201,20,3),(1201,1673,1),(1201,2284,5),(1201,2531,2),(1201,2965,4),(1201,3604,0),(1202,20,6),(1202,1673,2),(1202,1706,1),(1202,2284,5),(1202,2304,0),(1202,2965,4),(1202,2972,3),(1203,20,8),(1203,651,5),(1203,656,1),(1203,1000,0),(1203,1090,3),(1203,1347,2),(1203,1492,12),(1203,2755,7),(1203,2859,10),(1203,2941,6),(1203,3270,9),(1203,3345,4),(1203,3852,11),(1204,15,4),(1204,17,1),(1204,20,9),(1204,110,7),(1204,135,8),(1204,136,2),(1204,870,3),(1204,3256,6),(1204,3329,0),(1204,3706,5),(1205,17,3),(1205,20,4),(1205,110,2),(1205,136,0),(1205,137,1),(1206,20,9),(1206,620,2),(1206,641,10),(1206,828,7),(1206,1043,5),(1206,1113,11),(1206,1604,12),(1206,1736,13),(1206,1770,14),(1206,1996,15),(1206,2231,1),(1206,2232,21),(1206,2297,8),(1206,2735,3),(1206,2737,16),(1206,2845,17),(1206,2862,22),(1206,2901,18),(1206,2907,4),(1206,3010,24),(1206,3044,0),(1206,3045,19),(1206,3418,23),(1206,3528,20),(1206,3818,6),(1207,20,6),(1207,1556,4),(1207,1934,0),(1207,2577,5),(1207,3360,1),(1207,3366,7),(1207,3498,2),(1207,3813,3),(1208,20,6),(1208,49,4),(1208,620,7),(1208,1452,0),(1208,1486,5),(1208,2220,2),(1208,3366,3),(1208,3380,1),(1209,2,0),(1209,16,1),(1209,20,7),(1209,49,3),(1209,51,2),(1209,108,4),(1209,110,6),(1209,2214,5),(1210,20,3),(1210,77,0),(1210,1492,1),(1210,3270,2),(1211,20,3),(1211,1410,9),(1211,1603,6),(1211,1870,4),(1211,2183,0),(1211,2280,2),(1211,2372,5),(1211,2483,1),(1211,3586,7),(1211,3852,8),(1212,20,7),(1212,49,4),(1212,108,2),(1212,620,8),(1212,1452,0),(1212,1486,6),(1212,2220,3),(1212,3366,5),(1212,3380,1),(1213,20,2),(1213,50,0),(1213,2073,3),(1213,2488,1),(1214,20,0),(1214,1088,1),(1215,20,3),(1215,1241,5),(1215,2039,2),(1215,2251,1),(1215,2570,0),(1215,3360,4),(1216,15,3),(1216,17,5),(1216,20,12),(1216,135,11),(1216,620,7),(1216,1092,0),(1216,1227,9),(1216,1241,6),(1216,1530,8),(1216,1920,1),(1216,2054,2),(1216,3366,10),(1216,3834,4),(1217,20,2),(1217,1206,0),(1217,3004,1),(1218,20,5),(1218,626,8),(1218,906,0),(1218,929,1),(1218,1240,6),(1218,1715,2),(1218,1891,4),(1218,3259,3),(1218,3632,7),(1219,17,5),(1219,20,6),(1219,2034,3),(1219,2395,4),(1219,2471,2),(1219,3121,1),(1219,6909,0),(1220,17,1),(1220,20,0),(1220,135,2),(1221,20,0),(1222,17,1),(1222,20,0),(1222,135,2),(1222,1805,3),(1223,17,2),(1223,20,0),(1223,135,1),(1224,17,4),(1224,20,0),(1224,135,1),(1224,854,6),(1224,1032,2),(1224,1224,3),(1224,3366,5),(1225,20,1),(1225,1100,0),(1225,3141,2),(1226,15,2),(1226,20,10),(1226,77,1),(1226,108,4),(1226,135,9),(1226,620,8),(1226,1241,5),(1226,1920,3),(1226,2054,0),(1226,3256,6),(1226,3366,7),(1227,20,8),(1227,656,0),(1227,1000,2),(1227,1492,1),(1227,2193,5),(1227,2537,9),(1227,2859,3),(1227,3030,4),(1227,3270,6),(1227,3852,7),(1228,20,4),(1228,1090,6),(1228,1347,5),(1228,1492,11),(1228,1925,0),(1228,1988,2),(1228,2019,3),(1228,2483,7),(1228,2859,10),(1228,3270,8),(1228,3309,1),(1228,3852,9),(1230,20,8),(1230,656,0),(1230,875,1),(1230,1492,4),(1230,1918,2),(1230,2537,9),(1230,2859,3),(1230,3030,5),(1230,3270,6),(1230,3852,7),(1231,20,5),(1231,882,16),(1231,986,8),(1231,1000,10),(1231,1290,12),(1231,1410,15),(1231,1429,14),(1231,1513,3),(1231,1553,7),(1231,1927,17),(1231,2157,1),(1231,2240,2),(1231,2714,9),(1231,2832,13),(1231,2870,6),(1231,3117,0),(1231,3345,4),(1231,3852,11),(1232,20,9),(1232,1000,5),(1232,1049,0),(1232,1410,15),(1232,1870,8),(1232,2153,1),(1232,2155,11),(1232,2309,6),(1232,2483,3),(1232,2782,14),(1232,2786,4),(1232,3152,10),(1232,3171,7),(1232,3270,13),(1232,3460,2),(1232,3852,12),(1233,20,12),(1233,77,0),(1233,108,2),(1233,718,10),(1233,904,8),(1233,1000,9),(1233,1492,7),(1233,1920,1),(1233,2054,3),(1233,2832,11),(1233,2887,4),(1233,3171,6),(1233,3270,5),(1234,17,0),(1234,18,2),(1234,19,3),(1234,20,7),(1234,110,5),(1234,135,4),(1234,136,1),(1234,3706,6),(1235,15,3),(1235,20,9),(1235,77,0),(1235,108,2),(1235,1920,1),(1235,2091,6),(1235,2832,7),(1235,2887,4),(1235,3171,5),(1235,3270,8),(1236,17,4),(1236,20,5),(1236,137,3),(1236,735,0),(1236,886,1),(1236,2810,2),(1237,15,1),(1237,20,10),(1237,108,6),(1237,135,9),(1237,724,4),(1237,889,3),(1237,1089,0),(1237,1241,8),(1237,1920,2),(1237,2838,5),(1237,3101,7),(1238,20,4),(1238,49,1),(1238,135,7),(1238,620,8),(1238,1241,6),(1238,1452,2),(1238,2220,3),(1238,2892,5),(1238,3380,0),(1239,20,11),(1239,614,0),(1239,633,17),(1239,643,20),(1239,800,19),(1239,912,3),(1239,920,21),(1239,1185,4),(1239,1407,15),(1239,1596,22),(1239,1685,12),(1239,1730,5),(1239,1799,13),(1239,2365,14),(1239,2519,16),(1239,2525,9),(1239,2720,7),(1239,2806,6),(1239,2915,8),(1239,3004,2),(1239,3284,18),(1239,3443,10),(1239,3595,1),(1240,20,3),(1240,77,5),(1240,135,6),(1240,643,1),(1240,687,14),(1240,785,0),(1240,893,11),(1240,1282,13),(1240,1307,4),(1240,1422,2),(1240,2088,10),(1240,2414,9),(1240,2450,8),(1240,2519,12),(1240,3004,15),(1240,3013,7),(1241,17,4),(1241,20,8),(1241,619,6),(1241,735,0),(1241,1714,1),(1241,1723,3),(1241,1870,7),(1241,2207,5),(1241,2810,2),(1242,20,12),(1242,633,18),(1242,643,21),(1242,800,20),(1242,912,4),(1242,1185,7),(1242,1407,16),(1242,1596,1),(1242,1685,13),(1242,1730,5),(1242,1799,14),(1242,2081,2),(1242,2291,22),(1242,2365,15),(1242,2491,3),(1242,2519,17),(1242,2525,10),(1242,2806,8),(1242,2915,9),(1242,3004,6),(1242,3284,19),(1242,3443,11),(1242,3486,0),(1243,20,0),(1244,20,0),(1245,20,4),(1245,904,1),(1245,1678,6),(1245,2492,0),(1245,2832,3),(1245,3171,5),(1245,3270,2),(1246,20,8),(1246,633,14),(1246,643,17),(1246,800,16),(1246,912,2),(1246,1185,3),(1246,1407,12),(1246,1434,10),(1246,1596,18),(1246,1685,9),(1246,1730,4),(1246,2365,11),(1246,2519,13),(1246,2525,0),(1246,2806,5),(1246,2915,6),(1246,3004,1),(1246,3284,15),(1246,3443,7),(1247,20,5),(1247,620,4),(1247,924,6),(1247,1241,2),(1247,2039,1),(1247,2340,0),(1247,3816,3),(1248,20,1),(1248,626,2),(1248,723,0),(1248,1224,3),(1248,1240,4),(1249,20,49),(1249,613,5),(1249,640,12),(1249,772,38),(1249,904,24),(1249,962,87),(1249,1043,78),(1249,1077,94),(1249,1078,52),(1249,1138,46),(1249,1186,31),(1249,1242,68),(1249,1254,89),(1249,1291,99),(1249,1331,54),(1249,1332,55),(1249,1350,69),(1249,1391,77),(1249,1418,7),(1249,1427,32),(1249,1458,14),(1249,1492,4),(1249,1494,19),(1249,1502,60),(1249,1513,29),(1249,1525,79),(1249,1550,35),(1249,1558,42),(1249,1575,82),(1249,1587,28),(1249,1611,83),(1249,1632,51),(1249,1658,98),(1249,1687,26),(1249,1729,16),(1249,1737,73),(1249,1787,36),(1249,1792,91),(1249,1814,40),(1249,1816,58),(1249,1858,62),(1249,1897,61),(1249,1935,44),(1249,1959,20),(1249,2015,37),(1249,2058,93),(1249,2112,17),(1249,2117,72),(1249,2120,22),(1249,2134,39),(1249,2155,53),(1249,2178,63),(1249,2189,15),(1249,2438,81),(1249,2452,59),(1249,2483,23),(1249,2501,45),(1249,2505,11),(1249,2513,56),(1249,2546,3),(1249,2573,2),(1249,2611,95),(1249,2637,6),(1249,2712,86),(1249,2767,41),(1249,2768,92),(1249,2782,88),(1249,2846,18),(1249,2859,0),(1249,2878,30),(1249,2881,85),(1249,2891,25),(1249,2957,75),(1249,3001,74),(1249,3015,90),(1249,3030,67),(1249,3035,50),(1249,3111,96),(1249,3173,57),(1249,3197,70),(1249,3261,48),(1249,3270,76),(1249,3278,1),(1249,3288,10),(1249,3321,84),(1249,3345,43),(1249,3520,13),(1249,3525,8),(1249,3546,33),(1249,3555,47),(1249,3575,9),(1249,3600,21),(1249,3645,34),(1249,3701,64),(1249,3738,71),(1249,3741,97),(1249,3755,80),(1249,3786,65),(1249,3808,66),(1249,3844,27),(1251,20,7),(1251,632,13),(1251,633,14),(1251,643,21),(1251,750,18),(1251,800,19),(1251,912,0),(1251,1185,9),(1251,1407,11),(1251,1596,2),(1251,1685,3),(1251,1730,1),(1251,1799,4),(1251,1877,6),(1251,2365,5),(1251,2519,12),(1251,2525,16),(1251,2806,15),(1251,2915,10),(1251,3004,22),(1251,3264,8),(1251,3284,20),(1251,3443,17),(1254,17,2),(1254,20,11),(1254,49,6),(1254,110,3),(1254,135,5),(1254,136,10),(1254,973,7),(1254,1092,9),(1254,1778,0),(1254,2810,1),(1254,3256,4),(1254,3311,8),(1255,20,8),(1255,49,2),(1255,620,9),(1255,621,1),(1255,1486,7),(1255,1866,3),(1255,2542,0),(1255,3175,4),(1255,3273,5),(1255,3791,6),(1256,17,2),(1256,20,3),(1256,136,0),(1256,137,1),(1257,15,2),(1257,20,11),(1257,108,4),(1257,135,9),(1257,824,6),(1257,1241,8),(1257,1492,5),(1257,1920,0),(1257,2054,1),(1257,2411,7),(1257,2859,10),(1257,3568,3),(1259,17,4),(1259,20,15),(1259,1000,0),(1259,1241,5),(1259,1768,12),(1259,1870,14),(1259,2054,9),(1259,2091,7),(1259,2213,1),(1259,2309,2),(1259,2589,3),(1259,2832,8),(1259,3270,11),(1259,3670,10),(1259,3836,6),(1259,3852,13),(1261,15,4),(1261,17,3),(1261,20,16),(1261,49,1),(1261,135,15),(1261,620,12),(1261,724,7),(1261,889,9),(1261,973,5),(1261,1092,0),(1261,1189,10),(1261,1227,13),(1261,1530,14),(1261,1920,2),(1261,2054,8),(1261,2838,6),(1261,3256,11),(1262,20,8),(1262,633,15),(1262,643,22),(1262,800,19),(1262,912,23),(1262,1185,10),(1262,1407,13),(1262,1596,3),(1262,1685,4),(1262,1712,0),(1262,1724,1),(1262,1730,21),(1262,1799,5),(1262,1877,7),(1262,2365,6),(1262,2458,2),(1262,2519,14),(1262,2525,17),(1262,2806,16),(1262,2915,12),(1262,3004,11),(1262,3264,9),(1262,3284,20),(1262,3443,18),(1263,20,1),(1263,50,0),(1265,15,3),(1265,17,1),(1265,20,5),(1265,135,2),(1265,3672,4),(1265,3834,0),(1266,20,0),(1267,20,2),(1267,1189,0),(1267,2054,1),(1268,20,0),(1268,928,2),(1268,1088,1),(1269,20,5),(1269,2032,2),(1269,2039,4),(1269,2042,7),(1269,2247,1),(1269,2544,6),(1269,2780,0),(1269,3032,3),(1270,20,2),(1270,1241,3),(1270,1920,1),(1270,3412,0),(1272,15,3),(1272,17,6),(1272,20,13),(1272,135,12),(1272,620,8),(1272,889,4),(1272,1092,1),(1272,1227,10),(1272,1241,7),(1272,1530,9),(1272,1920,0),(1272,2054,2),(1272,3366,11),(1272,3834,5),(1273,20,8),(1273,633,14),(1273,643,18),(1273,800,17),(1273,912,1),(1273,1185,3),(1273,1407,12),(1273,1434,10),(1273,1596,0),(1273,1685,9),(1273,1730,2),(1273,2365,11),(1273,2519,13),(1273,2525,5),(1273,2720,16),(1273,2806,4),(1273,2915,6),(1273,3004,19),(1273,3284,15),(1273,3443,7),(1274,20,7),(1274,1482,0),(1274,1545,1),(1274,1678,6),(1274,1684,5),(1274,2148,2),(1274,2216,4),(1274,2589,8),(1274,2833,9),(1274,2974,10),(1274,3757,3),(1275,20,6),(1275,135,4),(1275,1241,1),(1275,2835,5),(1275,3304,3),(1275,3366,0),(1275,3603,2),(1276,20,6),(1276,723,9),(1276,1217,2),(1276,1235,8),(1276,1327,5),(1276,1329,4),(1276,1600,1),(1276,1892,7),(1276,2585,10),(1276,2892,0),(1276,3450,3),(1277,20,5),(1277,135,4),(1277,1241,2),(1277,2503,1),(1277,2967,3),(1277,3366,0),(1278,20,3),(1278,896,0),(1278,1304,1),(1278,3025,2),(1279,20,0),(1279,2544,1),(1280,20,4),(1280,1674,3),(1280,1899,0),(1280,2633,2),(1280,3024,1),(1281,20,0),(1281,1032,2),(1281,1224,1),(1282,20,0),(1282,626,3),(1282,723,1),(1282,1088,2),(1283,20,1),(1283,626,0),(1283,723,2),(1283,1240,3),(1284,20,1),(1284,2972,0),(1285,20,1),(1285,2965,0),(1285,3563,2),(1286,20,1),(1286,626,0),(1286,1240,2),(1288,20,9),(1288,49,2),(1288,620,10),(1288,1395,6),(1288,1486,8),(1288,1842,7),(1288,1866,1),(1288,2542,0),(1288,3175,3),(1288,3273,4),(1288,3791,5),(1293,20,4),(1293,656,0),(1293,1492,5),(1293,2790,7),(1293,2859,3),(1293,3270,2),(1293,3617,1),(1293,3852,6),(1295,20,13),(1295,627,16),(1295,633,25),(1295,643,38),(1295,800,30),(1295,912,40),(1295,927,8),(1295,1075,5),(1295,1185,17),(1295,1274,18),(1295,1373,24),(1295,1407,22),(1295,1448,34),(1295,1596,4),(1295,1685,9),(1295,1730,37),(1295,1774,14),(1295,1775,1),(1295,1793,2),(1295,1799,10),(1295,1877,12),(1295,1982,3),(1295,2345,6),(1295,2365,11),(1295,2368,28),(1295,2519,23),(1295,2525,27),(1295,2655,32),(1295,2799,31),(1295,2806,26),(1295,2869,20),(1295,2915,21),(1295,3004,39),(1295,3264,15),(1295,3284,33),(1295,3348,36),(1295,3443,29),(1295,3453,35),(1295,3560,19),(1295,3622,7),(1295,5997,0),(1296,20,3),(1296,626,8),(1296,984,0),(1296,1110,7),(1296,1240,4),(1296,1511,1),(1296,1715,5),(1296,3632,2),(1296,3678,6),(1297,15,0),(1297,17,4),(1297,20,6),(1297,135,5),(1297,1723,3),(1297,3256,2),(1297,3706,1),(1299,20,0),(1301,20,5),(1301,49,3),(1301,620,7),(1301,1452,1),(1301,1486,4),(1301,2220,2),(1301,2892,6),(1301,3380,0),(1302,20,2),(1302,135,1),(1302,889,0),(1302,1241,3),(1303,20,23),(1303,616,15),(1303,796,44),(1303,910,32),(1303,913,35),(1303,965,11),(1303,1024,22),(1303,1094,47),(1303,1220,17),(1303,1322,37),(1303,1332,5),(1303,1410,14),(1303,1413,13),(1303,1429,20),(1303,1458,12),(1303,1650,46),(1303,1658,36),(1303,1678,30),(1303,1814,3),(1303,1816,26),(1303,1820,45),(1303,1895,42),(1303,2120,1),(1303,2155,24),(1303,2234,6),(1303,2255,19),(1303,2452,27),(1303,2507,16),(1303,2513,25),(1303,2637,4),(1303,2677,38),(1303,2707,21),(1303,2711,7),(1303,2768,33),(1303,2859,43),(1303,2998,41),(1303,3266,29),(1303,3272,34),(1303,3278,39),(1303,3341,0),(1303,3382,2),(1303,3426,40),(1303,3525,8),(1303,3575,9),(1303,3626,18),(1303,3689,10),(1303,3755,31),(1303,3786,28),(1304,20,9),(1304,633,15),(1304,643,18),(1304,800,17),(1304,912,2),(1304,1185,3),(1304,1407,13),(1304,1434,11),(1304,1596,19),(1304,1685,10),(1304,1730,4),(1304,2365,12),(1304,2519,14),(1304,2524,5),(1304,2720,0),(1304,2821,7),(1304,2915,6),(1304,3004,1),(1304,3284,16),(1304,3443,8),(1305,20,10),(1305,633,16),(1305,643,19),(1305,800,18),(1305,912,3),(1305,1185,4),(1305,1407,14),(1305,1434,12),(1305,1596,20),(1305,1685,11),(1305,1730,5),(1305,2291,0),(1305,2365,13),(1305,2491,2),(1305,2519,15),(1305,2524,6),(1305,2525,8),(1305,2915,7),(1305,3004,1),(1305,3284,17),(1305,3443,9),(1306,20,2),(1306,1323,0),(1306,1802,3),(1306,2892,1),(1306,3255,4),(1307,20,6),(1307,620,10),(1307,715,8),(1307,1139,1),(1307,1241,5),(1307,1393,9),(1307,1452,0),(1307,1486,7),(1307,2220,3),(1307,3366,4),(1307,3380,2),(1308,20,6),(1308,77,1),(1308,135,5),(1308,887,0),(1308,1393,3),(1308,2054,2),(1308,3366,4),(1309,20,0),(1309,135,1),(1309,2223,2),(1310,20,16),(1310,633,12),(1310,643,5),(1310,800,6),(1310,912,2),(1310,1185,0),(1310,1434,14),(1310,1685,7),(1310,1730,3),(1310,2365,11),(1310,2519,13),(1310,2524,4),(1310,2525,9),(1310,2915,8),(1310,3004,1),(1310,3018,17),(1310,3284,15),(1310,3443,10),(1311,20,1),(1311,3892,0),(1312,20,3),(1312,1641,2),(1312,2048,0),(1312,3366,1),(1313,20,2),(1313,620,0),(1313,1604,1),(1313,1734,3),(1313,3160,5),(1313,3584,4),(1314,20,4),(1314,982,2),(1314,2835,5),(1314,3251,0),(1314,3585,1),(1314,3603,3),(1315,20,5),(1315,883,6),(1315,1684,2),(1315,2216,1),(1315,2589,4),(1315,2800,0),(1315,2974,7),(1315,3852,3),(1316,20,1),(1316,626,0),(1316,1240,2),(1317,20,0),(1318,20,1),(1318,1283,2),(1318,3039,0),(1319,17,2),(1319,20,1),(1319,1622,0),(1320,17,3),(1320,20,2),(1320,1072,0),(1320,1304,4),(1320,2596,1),(1321,20,5),(1321,626,0),(1321,1240,6),(1321,1623,1),(1321,3070,3),(1321,3425,4),(1321,3751,2),(1322,20,1),(1322,626,0),(1322,1240,2),(1323,20,11),(1323,626,12),(1323,723,13),(1323,1240,14),(1323,1400,4),(1323,7279,0),(1323,7280,1),(1323,7281,2),(1323,7282,3),(1323,7283,5),(1323,7284,6),(1323,7285,7),(1323,7286,8),(1323,7287,9),(1323,7288,10),(1323,7289,15),(1323,7290,16),(1323,7291,17),(1323,7292,18),(1324,2,2),(1324,16,5),(1324,20,1),(1324,49,3),(1324,51,9),(1324,110,0),(1324,659,8),(1324,2214,6),(1324,3302,4),(1324,3311,7),(1325,20,0),(1327,20,3),(1327,50,0),(1327,62,2),(1327,2488,1),(1328,2,2),(1328,16,5),(1328,20,1),(1328,49,3),(1328,51,8),(1328,110,0),(1328,2214,6),(1328,3262,4),(1328,3311,7),(1330,20,5),(1330,620,6),(1330,940,0),(1330,1452,4),(1330,1556,1),(1330,2542,3),(1330,2944,2),(1332,20,6),(1332,49,4),(1332,620,8),(1332,1452,0),(1332,1486,7),(1332,2220,1),(1332,2462,3),(1332,3366,5),(1332,3380,2),(1333,20,13),(1333,633,19),(1333,643,22),(1333,800,21),(1333,825,3),(1333,912,5),(1333,1185,8),(1333,1192,0),(1333,1385,24),(1333,1407,17),(1333,1434,15),(1333,1685,14),(1333,1730,7),(1333,2365,16),(1333,2519,18),(1333,2525,11),(1333,2715,2),(1333,2915,10),(1333,3004,23),(1333,3018,6),(1333,3284,20),(1333,3440,25),(1333,3443,12),(1333,5998,1),(1333,5999,4),(1333,6000,9),(1334,2,1),(1334,16,0),(1334,20,3),(1334,49,2),(1335,17,6),(1335,20,4),(1335,626,8),(1335,941,2),(1335,1240,5),(1335,1511,1),(1335,1715,0),(1335,1952,7),(1335,3632,3),(1336,20,4),(1336,647,1),(1336,1372,0),(1336,2027,2),(1336,2892,5),(1336,3220,3),(1339,20,9),(1339,77,2),(1339,108,1),(1339,904,4),(1339,1241,5),(1339,1678,3),(1339,1920,0),(1339,2832,7),(1339,3171,6),(1339,3270,8),(1340,17,3),(1340,20,4),(1340,735,0),(1340,1470,1),(1340,2395,2),(1341,15,0),(1341,20,4),(1341,718,5),(1341,1158,1),(1341,1241,3),(1341,2356,2),(1342,15,3),(1342,20,8),(1342,135,7),(1342,1241,9),(1342,1297,0),(1342,1920,5),(1342,2039,1),(1342,2054,4),(1342,3350,2),(1342,3366,6),(1343,20,20),(1343,796,7),(1343,884,1),(1343,913,12),(1343,965,9),(1343,1094,5),(1343,1171,3),(1343,1410,11),(1343,1412,10),(1343,1429,26),(1343,1492,19),(1343,1603,27),(1343,1650,13),(1343,1690,28),(1343,1816,18),(1343,1890,22),(1343,1939,21),(1343,1945,29),(1343,2448,0),(1343,2452,17),(1343,2560,30),(1343,2637,8),(1343,2830,23),(1343,3278,16),(1343,3426,25),(1343,3473,14),(1343,3507,15),(1343,3649,2),(1343,3671,4),(1343,3755,24),(1343,3852,6),(1344,20,12),(1344,1492,9),(1344,1717,4),(1344,1870,10),(1344,1920,6),(1344,2054,3),(1344,2216,8),(1344,2223,13),(1344,2309,7),(1344,2371,5),(1344,2589,14),(1344,2843,1),(1344,3670,0),(1344,3707,2),(1344,3852,11),(1347,20,8),(1347,77,6),(1347,667,4),(1347,1241,7),(1347,1393,2),(1347,1920,0),(1347,2251,1),(1347,3366,5),(1347,3816,3),(1348,15,2),(1348,17,1),(1348,20,5),(1348,619,3),(1348,735,0),(1348,1870,4),(1349,20,4),(1349,664,2),(1349,817,0),(1349,1807,1),(1349,1950,3),(1350,20,8),(1350,633,14),(1350,643,19),(1350,800,18),(1350,912,1),(1350,920,17),(1350,1185,2),(1350,1407,12),(1350,1434,10),(1350,1596,21),(1350,1685,9),(1350,1730,3),(1350,2365,11),(1350,2519,13),(1350,2525,6),(1350,2720,0),(1350,2806,4),(1350,2915,5),(1350,3004,20),(1350,3284,15),(1350,3443,7),(1350,3595,16),(1352,17,1),(1352,20,8),(1352,732,2),(1352,779,5),(1352,808,4),(1352,1060,7),(1352,1649,6),(1352,2394,0),(1352,3652,3),(1353,20,6),(1353,787,1),(1353,796,13),(1353,980,2),(1353,1094,11),(1353,1477,10),(1353,1492,5),(1353,1513,12),(1353,1918,3),(1353,2637,0),(1353,2782,4),(1353,2859,9),(1353,2887,7),(1353,3270,8),(1354,20,11),(1354,632,7),(1354,633,17),(1354,643,20),(1354,792,1),(1354,800,19),(1354,912,22),(1354,1185,4),(1354,1407,15),(1354,1434,13),(1354,1685,12),(1354,1730,0),(1354,1877,2),(1354,2437,14),(1354,2519,16),(1354,2805,6),(1354,2821,9),(1354,2915,8),(1354,3004,21),(1354,3018,3),(1354,3264,5),(1354,3284,18),(1354,3443,10),(1355,20,6),(1355,892,0),(1355,1016,5),(1355,1277,4),(1355,1871,7),(1355,2208,2),(1355,2892,1),(1355,3107,3),(1355,3251,8),(1356,20,2),(1356,643,10),(1356,800,3),(1356,912,11),(1356,1407,8),(1356,2365,4),(1356,2519,9),(1356,2749,0),(1356,2915,5),(1356,3004,1),(1356,3434,6),(1356,3453,7),(1357,20,3),(1357,77,4),(1357,643,7),(1357,998,0),(1357,1241,8),(1357,1422,6),(1357,2892,9),(1357,3004,2),(1357,3101,1),(1357,3230,5),(1358,20,4),(1358,2039,1),(1358,3221,5),(1358,3265,3),(1358,3360,0),(1358,3366,6),(1358,3787,2),(1359,20,15),(1359,634,8),(1359,694,7),(1359,802,1),(1359,965,5),(1359,1132,9),(1359,1149,17),(1359,1209,12),(1359,1676,3),(1359,1760,11),(1359,1821,14),(1359,1882,4),(1359,2412,13),(1359,2601,0),(1359,3004,6),(1359,3160,16),(1359,3475,10),(1359,3634,2),(1360,20,6),(1360,135,5),(1360,1052,4),(1360,2570,0),(1360,3010,2),(1360,3101,1),(1360,3360,3),(1361,20,11),(1361,615,3),(1361,618,1),(1361,634,4),(1361,636,0),(1361,856,2),(1361,908,5),(1361,917,6),(1361,1018,7),(1361,1218,8),(1361,1230,9),(1361,1598,10),(1361,1876,12),(1361,3263,13),(1361,3519,14),(1361,3523,15),(1361,3638,16),(1362,20,1),(1362,3251,0),(1363,20,21),(1363,617,38),(1363,763,14),(1363,766,8),(1363,796,51),(1363,904,25),(1363,913,59),(1363,918,49),(1363,934,55),(1363,963,23),(1363,1029,48),(1363,1031,46),(1363,1225,17),(1363,1232,47),(1363,1247,61),(1363,1378,1),(1363,1423,6),(1363,1460,45),(1363,1522,37),(1363,1537,57),(1363,1607,36),(1363,1630,35),(1363,1684,29),(1363,1719,16),(1363,1720,43),(1363,1725,53),(1363,1751,13),(1363,1777,7),(1363,1839,42),(1363,1901,54),(1363,2039,19),(1363,2211,15),(1363,2216,30),(1363,2218,44),(1363,2257,12),(1363,2369,39),(1363,2371,27),(1363,2434,0),(1363,2523,58),(1363,2532,11),(1363,2545,10),(1363,2589,34),(1363,2617,40),(1363,2681,52),(1363,2762,18),(1363,2790,26),(1363,2832,33),(1363,2833,5),(1363,2842,41),(1363,2845,28),(1363,2887,32),(1363,2929,24),(1363,2948,56),(1363,2974,60),(1363,3073,3),(1363,3203,22),(1363,3270,31),(1363,3350,20),(1363,3511,4),(1363,3515,50),(1363,3521,2),(1363,3694,9),(1364,20,11),(1364,634,6),(1364,694,5),(1364,965,4),(1364,1034,8),(1364,1132,7),(1364,1149,0),(1364,1821,9),(1364,1882,3),(1364,2601,12),(1364,3004,10),(1364,3018,2),(1364,3160,14),(1364,3475,13),(1364,3634,1),(1365,20,2),(1365,1589,0),(1365,2823,1),(1365,3004,3),(1366,20,3),(1366,1241,1),(1366,1469,2),(1366,3834,0),(1367,20,2),(1367,1241,1),(1367,3834,0),(1368,20,5),(1368,723,9),(1368,1217,0),(1368,1235,7),(1368,1327,4),(1368,1329,2),(1368,1600,8),(1368,1892,6),(1368,2585,10),(1368,2892,3),(1368,3450,1),(1369,20,6),(1369,135,5),(1369,1241,4),(1369,2835,2),(1369,3251,0),(1369,3366,1),(1369,3603,3),(1370,20,6),(1370,135,7),(1370,626,9),(1370,928,0),(1370,1222,1),(1370,1567,2),(1370,2765,5),(1370,2835,8),(1370,2837,4),(1370,3012,3),(1371,20,3),(1371,620,0),(1371,624,1),(1371,1351,2),(1371,1604,4),(1372,20,3),(1372,1641,1),(1372,2926,0),(1372,3370,2),(1373,20,8),(1373,135,7),(1373,628,9),(1373,928,1),(1373,929,2),(1373,1222,0),(1373,1567,3),(1373,2765,6),(1373,2837,5),(1373,2952,4),(1374,2883,0),(1375,20,2),(1375,795,1),(1375,1217,3),(1375,1937,5),(1375,3260,4),(1375,3450,0),(1376,17,0),(1376,20,3),(1376,1679,4),(1376,1805,1),(1376,1884,2),(1377,20,0),(1378,20,0),(1378,1870,1),(1379,3208,1),(1379,3456,0),(1380,20,0),(1381,20,0),(1382,20,3),(1382,1244,0),(1382,1606,1),(1382,3291,2),(1383,20,1),(1383,626,0),(1383,1240,2),(1383,1873,3),(1384,20,2),(1384,626,1),(1384,1172,4),(1384,1240,3),(1384,1873,0),(1385,20,0),(1385,626,2),(1385,1240,3),(1385,1673,1),(1386,20,0),(1387,1,2),(1387,2,8),(1387,15,0),(1387,17,4),(1387,20,9),(1387,110,5),(1387,135,7),(1387,136,3),(1387,3329,1),(1387,3725,6),(1388,2,2),(1388,20,9),(1388,49,1),(1388,51,0),(1388,110,6),(1388,1628,8),(1388,2187,5),(1388,2991,4),(1388,3262,3),(1388,3311,7),(1389,20,13),(1389,633,19),(1389,800,22),(1389,912,24),(1389,1025,2),(1389,1185,7),(1389,1309,28),(1389,1340,1),(1389,1407,17),(1389,1596,27),(1389,1645,4),(1389,1685,14),(1389,1799,15),(1389,2110,6),(1389,2321,5),(1389,2365,16),(1389,2519,18),(1389,2525,11),(1389,2683,3),(1389,2720,9),(1389,2726,26),(1389,2806,8),(1389,2915,10),(1389,3004,25),(1389,3145,21),(1389,3245,23),(1389,3284,20),(1389,3443,12),(1389,3481,0),(1390,20,5),(1390,77,0),(1390,135,4),(1390,887,2),(1390,1007,1),(1390,3366,3),(1391,20,6),(1391,620,8),(1391,726,2),(1391,1452,4),(1391,1468,7),(1391,1471,0),(1391,2297,5),(1391,2892,1),(1391,3664,3),(1392,2,2),(1392,16,4),(1392,20,1),(1392,49,3),(1392,51,8),(1392,110,0),(1392,659,7),(1392,2214,6),(1392,3302,5),(1393,15,0),(1393,20,2),(1393,135,1),(1394,20,7),(1394,620,8),(1394,1486,5),(1394,1866,6),(1394,2297,1),(1394,2542,3),(1394,3175,2),(1394,3791,4),(1394,3802,0),(1395,2,4),(1395,15,1),(1395,17,5),(1395,18,10),(1395,20,18),(1395,110,2),(1395,135,17),(1395,136,0),(1395,735,7),(1395,870,13),(1395,1470,12),(1395,1870,16),(1395,2395,8),(1395,2460,9),(1395,2810,11),(1395,3256,6),(1395,3311,14),(1395,3329,3),(1395,3706,15),(1396,20,4),(1396,136,2),(1396,784,7),(1396,1934,5),(1396,2361,3),(1396,2900,0),(1396,3360,1),(1396,3366,6),(1397,20,8),(1397,77,0),(1397,718,7),(1397,1007,1),(1397,1283,6),(1397,1338,2),(1397,1920,3),(1397,2054,4),(1397,3471,5),(1398,15,7),(1398,16,8),(1398,20,10),(1398,49,1),(1398,108,6),(1398,135,9),(1398,724,4),(1398,1089,0),(1398,1189,5),(1398,1920,3),(1398,2838,2),(1400,20,12),(1400,633,18),(1400,643,21),(1400,800,20),(1400,912,4),(1400,1185,5),(1400,1407,16),(1400,1685,13),(1400,1730,2),(1400,1799,14),(1400,1877,24),(1400,2291,0),(1400,2365,15),(1400,2519,17),(1400,2525,10),(1400,2806,8),(1400,2915,9),(1400,3004,23),(1400,3018,22),(1400,3264,6),(1400,3284,19),(1400,3437,1),(1400,3443,11),(1400,3453,3),(1400,3702,7),(1401,20,7),(1401,650,6),(1401,810,4),(1401,815,1),(1401,1690,3),(1401,2246,2),(1401,2297,5),(1401,3672,0),(1403,20,2),(1403,135,1),(1403,2539,0),(1404,20,6),(1404,670,4),(1404,1092,1),(1404,1530,2),(1404,2924,3),(1404,3160,0),(1404,3189,5),(1405,20,11),(1405,633,17),(1405,643,20),(1405,800,19),(1405,912,4),(1405,1025,2),(1405,1185,5),(1405,1309,23),(1405,1340,1),(1405,1407,15),(1405,1596,24),(1405,1685,12),(1405,1799,13),(1405,2365,14),(1405,2519,16),(1405,2525,9),(1405,2683,3),(1405,2720,7),(1405,2726,22),(1405,2806,6),(1405,2915,8),(1405,3004,21),(1405,3284,18),(1405,3443,10),(1405,3481,0),(1406,20,1),(1406,817,0),(1407,20,5),(1407,77,0),(1407,2395,2),(1407,2625,4),(1407,2958,3),(1407,3311,1),(1408,20,6),(1408,49,5),(1408,108,2),(1408,135,7),(1408,889,0),(1408,1089,3),(1408,1092,1),(1408,1677,4),(1409,20,4),(1409,136,2),(1409,792,6),(1409,1934,5),(1409,2361,3),(1409,2900,0),(1409,3360,1),(1409,3366,7),(1410,20,6),(1410,704,9),(1410,1044,1),(1410,1358,4),(1410,1769,5),(1410,1879,3),(1410,2209,2),(1410,2836,8),(1410,3004,7),(1410,3295,10),(1410,3327,0),(1411,17,3),(1411,20,6),(1411,137,2),(1411,619,4),(1411,735,0),(1411,886,1),(1411,1870,5),(1412,20,8),(1412,651,5),(1412,656,1),(1412,1000,0),(1412,1090,3),(1412,1347,2),(1412,1492,12),(1412,2755,7),(1412,2859,9),(1412,2941,6),(1412,3270,10),(1412,3345,4),(1412,3852,11),(1413,20,10),(1413,633,16),(1413,800,18),(1413,912,3),(1413,1025,1),(1413,1185,4),(1413,1309,22),(1413,1340,0),(1413,1407,14),(1413,1434,12),(1413,1685,11),(1413,2365,13),(1413,2519,15),(1413,2525,8),(1413,2683,2),(1413,2720,6),(1413,2726,21),(1413,2806,5),(1413,2915,7),(1413,3004,20),(1413,3018,23),(1413,3245,19),(1413,3284,17),(1413,3443,9),(1414,656,1),(1414,1000,0),(1414,1025,6),(1414,1340,5),(1414,1347,2),(1414,1492,3),(1414,1596,7),(1414,3481,4),(1415,20,9),(1415,620,10),(1415,726,0),(1415,1452,2),(1415,1468,4),(1415,1471,1),(1415,2297,3),(1415,2892,5),(1415,2905,7),(1415,3075,8),(1415,3664,6),(1416,20,9),(1416,49,2),(1416,77,8),(1416,135,6),(1416,1920,0),(1416,2054,1),(1416,2223,7),(1416,3221,5),(1416,3311,3),(1416,3366,4),(1417,20,3),(1417,2054,4),(1417,2320,5),(1417,2397,2),(1417,2723,0),(1417,3251,6),(1417,3477,1),(1418,20,5),(1418,136,3),(1418,1863,0),(1418,1934,4),(1418,2273,1),(1418,2361,2),(1418,3360,7),(1418,3366,6),(1419,20,4),(1419,108,3),(1419,1139,2),(1419,1189,0),(1419,2054,1),(1420,20,57),(1420,617,19),(1420,625,20),(1420,756,1),(1420,761,23),(1420,796,12),(1420,857,46),(1420,913,38),(1420,919,32),(1420,957,28),(1420,965,62),(1420,976,35),(1420,1011,36),(1420,1144,33),(1420,1159,4),(1420,1223,3),(1420,1243,25),(1420,1378,40),(1420,1424,58),(1420,1451,43),(1420,1526,44),(1420,1540,15),(1420,1634,9),(1420,1659,27),(1420,1718,51),(1420,1720,16),(1420,1725,13),(1420,1751,47),(1420,1828,53),(1420,1836,21),(1420,1839,17),(1420,1864,42),(1420,1933,26),(1420,1969,6),(1420,2039,55),(1420,2206,10),(1420,2227,52),(1420,2257,49),(1420,2274,34),(1420,2393,39),(1420,2434,61),(1420,2435,45),(1420,2493,41),(1420,2529,30),(1420,2558,7),(1420,2581,11),(1420,2700,54),(1420,2815,29),(1420,2833,60),(1420,2834,0),(1420,2923,50),(1420,2928,24),(1420,2974,59),(1420,3072,37),(1420,3130,5),(1420,3283,48),(1420,3350,56),(1420,3511,18),(1420,3513,22),(1420,3576,8),(1420,3626,63),(1420,3755,2),(1420,3815,31),(1420,3833,14),(1421,20,9),(1421,727,3),(1421,789,6),(1421,1109,0),(1421,1254,11),(1421,1391,12),(1421,1475,7),(1421,1766,1),(1421,2375,4),(1421,2495,5),(1421,2589,8),(1421,3171,2),(1421,3852,10),(1422,1,1),(1422,2,3),(1422,15,0),(1422,17,6),(1422,20,8),(1422,135,7),(1422,136,5),(1422,856,4),(1422,3329,2),(1423,20,9),(1423,49,4),(1423,135,8),(1423,724,1),(1423,973,6),(1423,1089,5),(1423,1189,0),(1423,2054,3),(1423,2838,2),(1423,3311,7),(1424,15,16),(1424,20,20),(1424,49,2),(1424,77,12),(1424,108,9),(1424,135,19),(1424,620,18),(1424,718,13),(1424,724,0),(1424,973,5),(1424,1089,4),(1424,1092,7),(1424,1189,3),(1424,1227,15),(1424,1241,10),(1424,1530,14),(1424,1920,6),(1424,2054,8),(1424,2838,1),(1424,2859,11),(1424,3366,17),(1425,20,5),(1425,892,0),(1425,2139,6),(1425,2348,2),(1425,2727,1),(1425,2892,3),(1425,3251,7),(1425,3406,4),(1426,20,7),(1426,136,3),(1426,888,0),(1426,1026,1),(1426,1097,6),(1426,2039,4),(1426,2361,2),(1426,2542,5),(1426,3360,9),(1426,3366,8),(1427,20,6),(1427,1463,3),(1427,1492,11),(1427,1925,0),(1427,1988,2),(1427,2019,5),(1427,2483,7),(1427,2859,10),(1427,3270,8),(1427,3309,1),(1427,3611,4),(1427,3852,9),(1428,17,1),(1428,20,5),(1428,136,2),(1428,870,3),(1428,886,0),(1428,2864,4),(1429,17,2),(1429,20,5),(1429,136,1),(1429,870,0),(1429,2207,3),(1429,2864,4),(1430,20,6),(1430,135,5),(1430,1920,1),(1430,1990,0),(1430,2054,4),(1430,2654,3),(1430,3182,2),(1431,1,1),(1431,2,3),(1431,15,0),(1431,17,6),(1431,20,8),(1431,135,7),(1431,136,5),(1431,856,4),(1431,3329,2),(1432,17,15),(1432,20,17),(1432,136,14),(1432,137,16),(1432,807,0),(1432,837,19),(1432,1140,26),(1432,1141,22),(1432,1357,8),(1432,1523,25),(1432,1586,6),(1432,1651,21),(1432,1745,3),(1432,1808,5),(1432,2346,1),(1432,2385,2),(1432,2464,4),(1432,2578,13),(1432,2636,7),(1432,2710,10),(1432,3337,18),(1432,3431,23),(1432,3441,20),(1432,3457,12),(1432,3573,11),(1432,3615,24),(1432,3819,9),(1434,20,3),(1434,1090,4),(1434,1260,2),(1434,1347,5),(1434,2483,0),(1434,2887,6),(1434,3030,1),(1434,3270,7),(1435,20,10),(1435,656,14),(1435,1118,4),(1435,1492,5),(1435,2441,0),(1435,2465,6),(1435,2483,2),(1435,2485,3),(1435,2537,12),(1435,2786,11),(1435,2859,8),(1435,3030,7),(1435,3270,9),(1435,3318,1),(1435,3852,13),(1437,20,3),(1437,1920,1),(1437,2054,2),(1437,3842,0),(1438,15,37),(1438,20,35),(1438,649,47),(1438,656,8),(1438,706,69),(1438,712,29),(1438,736,6),(1438,740,51),(1438,773,38),(1438,850,76),(1438,894,65),(1438,904,22),(1438,919,33),(1438,946,23),(1438,957,49),(1438,976,41),(1438,1000,48),(1438,1002,52),(1438,1144,26),(1438,1181,20),(1438,1223,31),(1438,1376,64),(1438,1459,43),(1438,1472,44),(1438,1490,21),(1438,1543,39),(1438,1544,54),(1438,1591,62),(1438,1633,57),(1438,1652,63),(1438,1654,61),(1438,1668,56),(1438,1748,4),(1438,1788,75),(1438,1828,30),(1438,1836,50),(1438,1933,60),(1438,1968,28),(1438,2052,7),(1438,2057,14),(1438,2180,53),(1438,2224,55),(1438,2242,15),(1438,2253,17),(1438,2254,27),(1438,2274,24),(1438,2276,45),(1438,2369,0),(1438,2402,9),(1438,2418,2),(1438,2434,77),(1438,2479,3),(1438,2537,73),(1438,2587,59),(1438,2608,1),(1438,2661,58),(1438,2738,42),(1438,2747,34),(1438,2815,70),(1438,2833,74),(1438,2842,66),(1438,2877,12),(1438,2974,72),(1438,3194,16),(1438,3201,68),(1438,3215,19),(1438,3224,11),(1438,3407,10),(1438,3468,67),(1438,3499,46),(1438,3513,40),(1438,3571,36),(1438,3576,32),(1438,3605,71),(1438,3626,25),(1438,3761,5),(1438,3784,18),(1438,3793,13),(1439,20,7),(1439,1044,1),(1439,1093,8),(1439,1358,9),(1439,1769,6),(1439,1879,3),(1439,2209,2),(1439,2707,0),(1439,2836,5),(1439,3004,10),(1439,3295,11),(1439,3409,4),(1440,15,16),(1440,20,20),(1440,49,2),(1440,77,12),(1440,108,9),(1440,135,19),(1440,620,18),(1440,724,0),(1440,973,5),(1440,1089,4),(1440,1092,7),(1440,1227,15),(1440,1241,10),(1440,1530,14),(1440,1920,6),(1440,2054,8),(1440,2223,13),(1440,2838,1),(1440,2859,11),(1440,3366,17),(1440,3842,3),(1442,20,7),(1442,49,3),(1442,135,8),(1442,702,2),(1442,889,0),(1442,1092,1),(1442,2054,4),(1442,2250,5),(1442,2457,6),(1443,20,7),(1443,49,3),(1443,135,8),(1443,702,2),(1443,889,0),(1443,1092,1),(1443,2054,4),(1443,2250,5),(1443,2457,6),(1444,20,6),(1444,975,4),(1444,1336,2),(1444,1447,5),(1444,1565,3),(1444,2352,8),(1444,2592,7),(1444,3218,0),(1444,6606,1),(1445,20,6),(1445,975,4),(1445,1336,2),(1445,1447,5),(1445,1565,3),(1445,2352,8),(1445,2592,7),(1445,3218,0),(1445,3561,1),(1446,20,5),(1446,656,0),(1446,1492,8),(1446,1612,3),(1446,2486,2),(1446,2537,11),(1446,2786,4),(1446,2859,7),(1446,3270,6),(1446,3617,9),(1446,3731,1),(1446,3852,10),(1447,20,8),(1447,643,19),(1447,800,18),(1447,820,14),(1447,912,1),(1447,920,17),(1447,1185,2),(1447,1407,12),(1447,1434,10),(1447,1596,21),(1447,1685,9),(1447,1730,3),(1447,2365,11),(1447,2519,13),(1447,2720,0),(1447,2805,4),(1447,2820,6),(1447,2915,5),(1447,3004,20),(1447,3284,15),(1447,3443,7),(1447,3595,16),(1448,15,3),(1448,20,0),(1448,135,1),(1448,2054,2),(1449,20,5),(1449,656,1),(1449,1492,8),(1449,1612,3),(1449,2487,2),(1449,2537,11),(1449,2786,4),(1449,2859,7),(1449,3270,6),(1449,3617,9),(1449,3731,0),(1449,3852,10),(1450,20,9),(1450,633,15),(1450,643,18),(1450,800,17),(1450,912,2),(1450,1185,4),(1450,1407,13),(1450,1434,11),(1450,1596,19),(1450,1685,10),(1450,1730,5),(1450,2365,12),(1450,2519,14),(1450,2525,0),(1450,2720,3),(1450,2806,6),(1450,2915,7),(1450,3004,1),(1450,3284,16),(1450,3443,8),(1451,20,5),(1451,643,8),(1451,937,6),(1451,1142,3),(1451,1411,7),(1451,1771,4),(1451,1930,0),(1451,2883,1),(1451,3376,2),(1452,20,2),(1452,824,1),(1452,1043,3),(1452,1492,0),(1452,2859,4),(1453,20,0),(1454,15,1),(1454,20,14),(1454,77,12),(1454,135,13),(1454,620,10),(1454,709,7),(1454,724,3),(1454,1241,11),(1454,1393,8),(1454,1920,5),(1454,1934,6),(1454,2054,0),(1454,2838,4),(1454,3366,9),(1454,3834,2),(1455,1,3),(1455,2,4),(1455,15,0),(1455,20,6),(1455,108,1),(1455,3217,2),(1455,3255,5),(1456,15,4),(1456,17,3),(1456,20,16),(1456,49,1),(1456,135,15),(1456,620,12),(1456,724,7),(1456,889,9),(1456,973,5),(1456,1092,0),(1456,1227,13),(1456,1530,14),(1456,1920,2),(1456,2054,8),(1456,2838,6),(1456,3834,11),(1456,3842,10),(1457,20,3),(1457,2108,2),(1457,2680,0),(1457,2741,1),(1458,20,5),(1458,1023,1),(1458,1026,0),(1458,2470,3),(1458,3265,4),(1458,3366,6),(1458,3787,2),(1459,20,1),(1459,2054,0),(1460,20,2),(1460,2480,4),(1460,2887,1),(1460,3171,3),(1460,3270,0),(1461,20,2),(1461,1685,0),(1461,3004,1),(1462,20,0),(1463,20,9),(1463,77,6),(1463,135,0),(1463,621,7),(1463,1027,2),(1463,1216,4),(1463,1530,1),(1463,3109,3),(1463,3252,5),(1463,3255,8),(1464,15,2),(1464,20,4),(1464,77,1),(1464,135,3),(1464,2054,0),(1465,20,13),(1465,625,17),(1465,796,21),(1465,934,8),(1465,956,14),(1465,965,5),(1465,1223,10),(1465,1378,30),(1465,1424,2),(1465,1425,26),(1465,1430,33),(1465,1526,22),(1465,1540,20),(1465,1725,29),(1465,1828,9),(1465,1933,27),(1465,1991,0),(1465,2039,18),(1465,2434,32),(1465,2493,4),(1465,2529,28),(1465,2540,23),(1465,2700,24),(1465,2745,19),(1465,2833,3),(1465,2863,15),(1465,2929,11),(1465,2969,25),(1465,2974,31),(1465,3350,12),(1465,3511,7),(1465,3513,16),(1465,3544,1),(1465,3626,6),(1466,17,6),(1466,20,11),(1466,136,5),(1466,716,16),(1466,755,4),(1466,870,8),(1466,1073,0),(1466,1080,2),(1466,1195,24),(1466,1199,10),(1466,1252,13),(1466,1546,21),(1466,2002,23),(1466,2207,7),(1466,2328,17),(1466,2407,3),(1466,2552,1),(1466,2556,26),(1466,2667,27),(1466,2743,22),(1466,2761,14),(1466,2804,15),(1466,2860,18),(1466,2996,25),(1466,3121,20),(1466,3329,9),(1466,3366,19),(1466,3834,12),(1467,20,9),(1467,614,0),(1467,643,17),(1467,800,16),(1467,912,3),(1467,920,19),(1467,1185,4),(1467,1407,13),(1467,1434,11),(1467,1596,18),(1467,1685,10),(1467,1730,5),(1467,2365,12),(1467,2519,14),(1467,2720,6),(1467,2915,7),(1467,3004,2),(1467,3284,15),(1467,3443,8),(1467,3595,1),(1468,20,9),(1468,614,0),(1468,643,17),(1468,800,16),(1468,912,3),(1468,920,18),(1468,1185,4),(1468,1407,13),(1468,1434,11),(1468,1596,19),(1468,1685,10),(1468,1730,5),(1468,2365,12),(1468,2519,14),(1468,2720,6),(1468,2915,7),(1468,3004,2),(1468,3284,15),(1468,3443,8),(1468,3595,1),(1469,20,1),(1469,979,3),(1469,1500,7),(1469,2303,5),(1469,3196,4),(1469,3270,2),(1469,3582,0),(1469,3852,6),(1470,20,2),(1470,1492,0),(1470,2859,4),(1470,3270,1),(1470,3852,3),(1471,15,2),(1471,20,4),(1471,656,0),(1471,1094,5),(1471,1116,3),(1471,1492,1),(1471,1678,9),(1471,2537,8),(1471,2859,6),(1471,3270,7),(1472,15,4),(1472,20,0),(1472,77,1),(1472,135,2),(1472,620,7),(1472,1241,6),(1472,2054,3),(1472,2213,8),(1472,2887,11),(1472,3171,10),(1472,3256,5),(1472,3270,9),(1473,20,10),(1473,135,9),(1473,982,7),(1473,1214,6),(1473,1241,3),(1473,1393,4),(1473,1948,8),(1473,2054,1),(1473,2208,2),(1473,3251,0),(1473,3366,5),(1474,20,1),(1474,50,0),(1475,20,8),(1475,643,18),(1475,800,17),(1475,821,14),(1475,912,1),(1475,1185,2),(1475,1407,12),(1475,1434,10),(1475,1596,0),(1475,1685,9),(1475,1730,3),(1475,2365,11),(1475,2519,13),(1475,2720,16),(1475,2805,4),(1475,2821,6),(1475,2915,5),(1475,3004,19),(1475,3284,15),(1475,3443,7),(1476,20,3),(1476,892,1),(1476,2054,2),(1476,2212,0),(1476,3251,4),(1477,20,6),(1477,136,2),(1477,1292,0),(1477,2361,3),(1477,3221,7),(1477,3265,5),(1477,3360,8),(1477,3366,1),(1477,3813,4),(1478,20,2),(1478,77,1),(1478,3256,0),(1479,20,7),(1479,135,6),(1479,1241,1),(1479,2039,3),(1479,2570,0),(1479,3010,5),(1479,3101,2),(1479,3366,4),(1480,20,2),(1480,1089,0),(1480,2892,1),(1486,20,4),(1486,661,0),(1486,1492,2),(1486,1612,1),(1486,2537,7),(1486,2859,5),(1486,3270,3),(1486,3617,8),(1486,3852,6),(1487,15,2),(1487,20,0),(1487,77,5),(1487,135,1),(1487,1241,3),(1487,3256,4),(1488,15,0),(1488,17,1),(1488,20,6),(1488,1241,3),(1488,1870,5),(1488,2395,2),(1488,3834,4),(1489,20,1),(1489,77,2),(1489,784,0),(1490,20,30),(1490,613,17),(1490,638,34),(1490,682,51),(1490,695,60),(1490,780,72),(1490,789,29),(1490,824,28),(1490,874,8),(1490,915,53),(1490,1037,1),(1490,1082,27),(1490,1126,32),(1490,1207,12),(1490,1270,35),(1490,1399,9),(1490,1410,74),(1490,1513,78),(1490,1525,10),(1490,1611,48),(1490,1662,41),(1490,1728,63),(1490,1731,38),(1490,1737,3),(1490,1756,69),(1490,1838,50),(1490,1855,24),(1490,1912,67),(1490,1927,79),(1490,1931,5),(1490,1983,58),(1490,2007,16),(1490,2059,73),(1490,2087,65),(1490,2135,55),(1490,2147,7),(1490,2155,33),(1490,2191,26),(1490,2240,2),(1490,2299,39),(1490,2339,6),(1490,2427,13),(1490,2494,54),(1490,2504,21),(1490,2506,22),(1490,2569,4),(1490,2580,68),(1490,2583,71),(1490,2589,62),(1490,2666,66),(1490,2697,44),(1490,2702,31),(1490,2753,47),(1490,2760,59),(1490,2782,49),(1490,2832,77),(1490,2964,42),(1490,3048,11),(1490,3088,40),(1490,3106,14),(1490,3147,43),(1490,3153,36),(1490,3167,57),(1490,3270,45),(1490,3289,20),(1490,3345,25),(1490,3490,19),(1490,3505,0),(1490,3516,64),(1490,3520,18),(1490,3524,61),(1490,3539,37),(1490,3581,70),(1490,3624,23),(1490,3639,56),(1490,3730,75),(1490,3736,46),(1490,3792,52),(1490,3852,76),(1490,3854,15),(1491,20,8),(1491,633,14),(1491,643,17),(1491,800,16),(1491,912,1),(1491,1185,2),(1491,1407,12),(1491,1434,10),(1491,1596,0),(1491,1685,9),(1491,1730,3),(1491,2365,11),(1491,2519,13),(1491,2524,4),(1491,2820,6),(1491,2915,5),(1491,3004,18),(1491,3284,15),(1491,3443,7),(1492,20,7),(1492,135,6),(1492,1241,1),(1492,2039,3),(1492,2570,0),(1492,3010,5),(1492,3101,2),(1492,3366,4),(1495,20,7),(1495,77,0),(1495,135,4),(1495,718,6),(1495,1102,2),(1495,1682,1),(1495,1698,3),(1495,2175,5),(1505,20,9),(1505,633,15),(1505,643,21),(1505,800,19),(1505,912,22),(1505,1185,5),(1505,1407,13),(1505,1596,3),(1505,1685,6),(1505,1730,4),(1505,1799,7),(1505,1877,0),(1505,2365,8),(1505,2519,14),(1505,2525,17),(1505,2749,11),(1505,2806,16),(1505,2915,12),(1505,3004,1),(1505,3264,10),(1505,3284,20),(1505,3437,2),(1505,3443,18),(1508,17,2),(1508,20,4),(1508,626,6),(1508,929,0),(1508,1014,1),(1508,1240,5),(1508,3632,3),(1551,20,0),(1551,1685,1),(1557,20,2),(1557,3849,0),(1557,3852,1),(1558,20,6),(1558,136,3),(1558,2039,1),(1558,2361,4),(1558,2868,2),(1558,3265,5),(1558,3359,0),(1558,3366,7),(1559,20,9),(1559,772,13),(1559,781,19),(1559,904,5),(1559,995,18),(1559,1533,0),(1559,1691,2),(1559,2091,8),(1559,2134,4),(1559,2309,3),(1559,2463,1),(1559,2480,20),(1559,2521,23),(1559,2589,11),(1559,2657,16),(1559,2659,17),(1559,2832,12),(1559,2843,10),(1559,3270,21),(1559,3435,15),(1559,3446,6),(1559,3558,14),(1559,3587,7),(1559,3852,22),(1560,20,3),(1560,1089,0),(1560,1241,2),(1560,3101,1),(1561,20,0),(1561,135,1),(1561,1241,2),(1562,20,2),(1562,135,0),(1562,3834,1),(1563,17,1),(1563,20,3),(1563,1870,2),(1563,2395,0),(1564,20,4),(1564,1277,0),(1564,1768,3),(1564,2340,2),(1564,2892,5),(1564,3366,1),(1565,20,0),(1565,135,1),(1566,20,3),(1566,1570,5),(1566,1768,1),(1566,2340,2),(1566,2413,6),(1566,2892,0),(1566,3366,4),(1567,20,18),(1567,763,12),(1567,796,41),(1567,904,22),(1567,907,20),(1567,913,46),(1567,918,40),(1567,934,44),(1567,1029,39),(1567,1031,37),(1567,1225,14),(1567,1232,38),(1567,1247,48),(1567,1378,1),(1567,1423,6),(1567,1460,36),(1567,1537,45),(1567,1630,30),(1567,1684,26),(1567,1720,35),(1567,1725,42),(1567,1751,11),(1567,1839,34),(1567,1901,43),(1567,2039,16),(1567,2211,13),(1567,2216,27),(1567,2257,10),(1567,2369,31),(1567,2371,24),(1567,2434,0),(1567,2532,9),(1567,2545,7),(1567,2589,25),(1567,2617,32),(1567,2762,15),(1567,2790,23),(1567,2832,29),(1567,2833,5),(1567,2842,33),(1567,2929,21),(1567,2969,3),(1567,2974,47),(1567,3203,19),(1567,3270,28),(1567,3350,17),(1567,3511,4),(1567,3521,2),(1567,3694,8),(1568,20,18),(1568,763,12),(1568,796,41),(1568,904,22),(1568,907,20),(1568,913,46),(1568,918,40),(1568,934,44),(1568,1029,39),(1568,1031,37),(1568,1225,14),(1568,1232,38),(1568,1247,48),(1568,1378,1),(1568,1423,6),(1568,1460,36),(1568,1537,45),(1568,1630,30),(1568,1684,26),(1568,1720,35),(1568,1725,42),(1568,1751,11),(1568,1839,34),(1568,1901,43),(1568,2039,16),(1568,2211,13),(1568,2216,27),(1568,2257,10),(1568,2369,31),(1568,2371,24),(1568,2434,0),(1568,2532,9),(1568,2545,7),(1568,2589,25),(1568,2617,32),(1568,2762,15),(1568,2790,23),(1568,2832,29),(1568,2833,5),(1568,2842,33),(1568,2929,21),(1568,2969,3),(1568,2974,47),(1568,3203,19),(1568,3270,28),(1568,3350,17),(1568,3511,4),(1568,3521,2),(1568,3694,8),(1569,15,0),(1569,20,1),(1569,1241,4),(1569,2039,3),(1569,3101,2),(1572,20,4),(1572,784,0),(1572,1867,5),(1572,1946,8),(1572,2039,1),(1572,3221,3),(1572,3265,6),(1572,3360,7),(1572,3366,9),(1572,3787,2),(1573,20,5),(1573,77,2),(1573,997,4),(1573,1241,1),(1573,2892,3),(1573,3101,0),(1574,20,0),(1574,135,5),(1574,1241,4),(1574,1870,3),(1574,3004,1),(1574,3834,2),(1575,17,1),(1575,20,2),(1575,2892,0),(1576,20,4),(1576,1431,0),(1576,1605,1),(1576,2536,2),(1576,2544,5),(1576,3103,3),(1577,20,0),(1578,17,9),(1578,20,0),(1578,135,1),(1578,620,4),(1578,836,6),(1578,982,7),(1578,1149,10),(1578,1241,2),(1578,2570,5),(1578,2892,8),(1578,3004,12),(1578,3366,3),(1578,3453,11),(1579,20,4),(1579,668,12),(1579,971,7),(1579,1019,15),(1579,1144,16),(1579,1245,6),(1579,1528,14),(1579,1609,1),(1579,1673,9),(1579,1859,3),(1579,1893,2),(1579,2109,5),(1579,2528,17),(1579,2576,11),(1579,2755,18),(1579,2965,8),(1579,3010,10),(1579,3354,0),(1579,3472,13),(1580,20,9),(1580,714,1),(1580,862,3),(1580,944,13),(1580,1074,5),(1580,1122,6),(1580,1749,12),(1580,1840,14),(1580,1962,4),(1580,2312,15),(1580,2324,11),(1580,2895,0),(1580,2926,8),(1580,3185,10),(1580,3216,2),(1580,3370,7),(1581,20,3),(1581,3276,1),(1581,3366,2),(1581,3517,0),(1582,1832,0),(1582,2430,1),(1583,20,1),(1583,50,0),(1584,20,1),(1584,50,0),(1584,2073,2),(1585,20,0),(1586,20,4),(1586,639,3),(1586,792,2),(1586,1219,6),(1586,1768,7),(1586,1903,0),(1586,2510,5),(1586,2970,1),(1587,20,0),(1588,20,2),(1588,620,3),(1588,624,1),(1588,1604,0),(1589,20,0),(1590,777,3),(1590,1176,4),(1590,1200,8),(1590,2188,7),(1590,2595,0),(1590,2808,1),(1590,2829,6),(1590,2866,5),(1590,3547,2),(1591,20,9),(1591,620,1),(1591,792,2),(1591,1161,4),(1591,1768,0),(1591,2199,7),(1591,2228,6),(1591,2351,8),(1591,2970,5),(1591,3832,3),(1592,20,2),(1592,1241,0),(1592,2570,1),(1593,20,3),(1593,982,2),(1593,1229,0),(1593,1241,1),(1593,2835,5),(1593,3603,4),(1594,20,2),(1594,135,5),(1594,982,1),(1594,1241,4),(1594,2835,6),(1594,3366,3),(1594,3603,0),(1595,20,2),(1595,1241,0),(1595,2570,1),(1596,20,5),(1596,703,1),(1596,1638,2),(1596,2652,9),(1596,2653,7),(1596,2892,0),(1596,3143,3),(1596,3208,8),(1596,3541,6),(1596,3853,4),(1597,20,1),(1597,1768,0),(1598,20,2),(1598,982,1),(1598,1241,3),(1598,2835,0),(1599,20,2),(1599,982,1),(1599,1241,3),(1599,2835,0),(1600,20,1),(1600,982,5),(1600,1241,2),(1600,2835,6),(1600,3292,0),(1600,3366,3),(1600,3603,4),(1601,20,4),(1601,639,3),(1601,792,2),(1601,1219,7),(1601,1768,8),(1601,1903,0),(1601,2510,5),(1601,2514,6),(1601,2970,1),(1602,20,7),(1602,1022,1),(1602,2100,6),(1602,2210,0),(1602,2358,3),(1602,2508,5),(1602,2950,2),(1602,2959,4),(1603,20,2),(1603,2835,4),(1603,3251,0),(1603,3274,3),(1603,3366,1),(1604,20,2),(1604,982,1),(1604,1241,3),(1604,2835,0),(1605,20,2),(1605,1241,1),(1605,2570,0),(1606,20,2),(1606,982,4),(1606,1229,0),(1606,2835,5),(1606,3366,1),(1606,3603,3),(1607,20,3),(1607,2221,0),(1607,2520,4),(1607,2835,5),(1607,3265,2),(1607,3366,1),(1608,20,2),(1608,1241,0),(1608,2570,1),(1609,20,1),(1609,982,5),(1609,1241,2),(1609,2835,6),(1609,3292,0),(1609,3366,3),(1609,3603,4),(1610,20,4),(1610,2305,2),(1610,2470,3),(1610,2835,1),(1610,3366,5),(1610,3787,0),(1611,20,2),(1611,135,5),(1611,982,1),(1611,1241,4),(1611,2835,6),(1611,3366,3),(1611,3603,0),(1612,20,4),(1612,135,3),(1612,982,1),(1612,1241,2),(1612,1883,0),(1612,2835,5),(1613,17,2),(1613,20,1),(1613,1224,3),(1613,2589,6),(1613,2843,0),(1613,2859,4),(1613,3852,5),(1614,20,5),(1614,2305,1),(1614,2470,2),(1614,2967,4),(1614,3366,0),(1614,3662,3),(1615,20,0),(1615,626,11),(1615,643,6),(1615,1149,5),(1615,1162,10),(1615,1237,7),(1615,1241,12),(1615,1258,13),(1615,1346,19),(1615,1527,3),(1615,1981,16),(1615,2091,2),(1615,2102,18),(1615,2544,8),(1615,3004,1),(1615,3070,14),(1615,3160,9),(1615,3366,15),(1615,3453,4),(1615,3898,17),(1616,20,8),(1616,823,5),(1616,840,11),(1616,873,18),(1616,982,9),(1616,1189,3),(1616,1581,2),(1616,1827,19),(1616,1922,13),(1616,2068,20),(1616,2409,22),(1616,2475,15),(1616,2638,17),(1616,2920,21),(1616,2926,7),(1616,3116,12),(1616,3146,16),(1616,3299,10),(1616,3370,6),(1616,3484,0),(1616,3533,1),(1616,3683,14),(1616,3773,4),(1617,20,3),(1617,2470,2),(1617,2835,4),(1617,3265,1),(1617,3366,0),(1618,20,5),(1618,2305,1),(1618,2470,2),(1618,2967,4),(1618,3366,0),(1618,3662,3),(1619,20,3),(1619,2997,1),(1619,3049,2),(1619,3231,0),(1620,20,2),(1620,643,1),(1620,785,3),(1620,1258,4),(1620,3004,0),(1621,20,3),(1621,916,6),(1621,1233,8),(1621,1419,0),(1621,1560,9),(1621,1716,5),(1621,1906,1),(1621,3277,7),(1621,3512,2),(1621,3812,4),(1622,20,1),(1622,135,3),(1622,982,0),(1622,2010,2),(1622,2835,5),(1622,3258,4),(1623,20,0),(1623,135,1),(1623,2835,3),(1623,3366,2),(1624,17,17),(1624,20,18),(1624,62,30),(1624,652,16),(1624,742,3),(1624,996,5),(1624,1084,35),(1624,1154,41),(1624,1329,11),(1624,1353,36),(1624,1387,24),(1624,1552,6),(1624,1559,32),(1624,1566,44),(1624,1615,20),(1624,1673,27),(1624,1675,13),(1624,1679,8),(1624,1759,0),(1624,1768,1),(1624,1769,26),(1624,1886,10),(1624,1961,19),(1624,2186,43),(1624,2198,37),(1624,2201,4),(1624,2269,28),(1624,2282,12),(1624,2284,15),(1624,2296,23),(1624,2307,42),(1624,2423,14),(1624,2482,7),(1624,2561,34),(1624,2650,45),(1624,2708,29),(1624,2730,22),(1624,2795,25),(1624,2853,39),(1624,3008,21),(1624,3067,9),(1624,3150,33),(1624,3654,31),(1624,3715,40),(1624,3829,38),(1624,3832,2),(1625,20,6),(1625,135,7),(1625,626,8),(1625,928,0),(1625,1222,1),(1625,1567,3),(1625,2765,2),(1625,2889,5),(1625,3012,4),(1626,20,3),(1626,639,1),(1626,3004,0),(1626,3230,2),(1627,20,0),(1627,1673,2),(1627,3100,1),(1628,20,1),(1628,1937,0),(1628,2104,2),(1628,3089,3),(1629,626,4),(1629,929,1),(1629,2966,0),(1629,3285,2),(1629,3300,5),(1629,3723,3),(1630,20,4),(1630,1333,2),(1630,1624,5),(1630,2658,3),(1630,2674,0),(1630,3631,1),(1632,20,1),(1632,2082,0),(1632,3519,2),(1633,20,5),(1633,626,8),(1633,929,0),(1633,1021,3),(1633,1240,4),(1633,1923,2),(1633,2562,1),(1633,3124,7),(1633,3228,6),(1634,17,5),(1634,20,6),(1634,622,1),(1634,626,8),(1634,929,3),(1634,1240,7),(1634,1421,0),(1634,1707,2),(1634,3632,4),(1672,17,2),(1672,20,0),(1672,1641,3),(1672,1768,1),(1673,20,0),(1674,17,3),(1674,20,0),(1674,639,5),(1674,767,10),(1674,792,26),(1674,959,2),(1674,1009,23),(1674,1289,18),(1674,1674,9),(1674,1679,8),(1674,1768,20),(1674,1870,16),(1674,1886,7),(1674,2008,19),(1674,2288,6),(1674,2292,24),(1674,2841,1),(1674,2965,13),(1674,3052,15),(1674,3139,17),(1674,3241,22),(1674,3535,4),(1674,3647,11),(1674,3704,12),(1674,3734,14),(1674,3832,21),(1674,3895,25),(1675,20,2),(1675,1638,1),(1675,1870,0),(1675,2509,4),(1675,2954,3),(1676,20,4),(1676,1341,1),(1676,1679,2),(1676,1805,0),(1676,1899,3),(1676,2633,5),(1676,3024,6),(1676,3105,7),(1677,20,6),(1677,1341,3),(1677,1674,5),(1677,1679,4),(1677,1899,1),(1677,2633,2),(1677,3024,0),(1678,17,4),(1678,20,5),(1678,1679,1),(1678,1805,0),(1678,1884,3),(1678,3257,2),(1679,20,0),(1682,17,2),(1682,20,1),(1682,2841,0),(1683,17,3),(1683,20,2),(1683,959,0),(1683,1818,4),(1683,2841,1),(1684,20,1),(1684,1100,0),(1684,1706,2),(1685,17,0),(1685,20,3),(1685,1679,1),(1685,1767,2),(1685,1805,4),(1686,1210,6),(1686,1574,11),(1686,1739,2),(1686,1782,10),(1686,1825,5),(1686,1957,8),(1686,2177,3),(1686,2329,1),(1686,2344,9),(1686,2477,4),(1686,2644,0),(1686,2768,13),(1686,3192,14),(1686,3240,15),(1686,3365,7),(1686,3613,12),(1687,20,1),(1687,1678,0),(1687,1886,3),(1687,3108,2),(1688,20,1),(1688,135,4),(1688,1198,2),(1688,3070,3),(1688,3366,0),(1689,20,4),(1689,626,5),(1689,928,2),(1689,1240,3),(1689,3632,1),(1689,3806,0),(1690,17,1),(1690,20,2),(1690,626,4),(1690,1240,3),(1690,3632,0),(1691,20,4),(1691,626,5),(1691,928,1),(1691,1240,3),(1691,3632,2),(1691,3806,0),(1692,20,2),(1692,1678,3),(1692,1886,1),(1692,3703,0),(1693,20,0),(1693,1674,1),(1694,20,2),(1694,959,0),(1694,2841,1),(1695,20,3),(1695,1595,4),(1695,1899,0),(1695,2633,1),(1695,3024,2),(1696,17,1),(1696,20,0),(1696,135,2),(1696,3366,3),(1748,20,11),(1748,704,8),(1748,1044,13),(1748,1093,5),(1748,1358,6),(1748,1769,9),(1748,1879,3),(1748,2209,2),(1748,2707,1),(1748,2836,10),(1748,3004,12),(1748,3295,0),(1748,3327,7),(1748,3903,4),(1749,20,35),(1749,617,12),(1749,625,43),(1749,761,7),(1749,773,38),(1749,796,48),(1749,849,135),(1749,857,63),(1749,904,14),(1749,913,142),(1749,919,32),(1749,934,25),(1749,957,53),(1749,965,8),(1749,976,41),(1749,1000,113),(1749,1002,116),(1749,1011,52),(1749,1102,103),(1749,1144,17),(1749,1147,3),(1749,1181,13),(1749,1182,112),(1749,1223,29),(1749,1243,67),(1749,1264,18),(1749,1294,93),(1749,1378,141),(1749,1424,56),(1749,1425,64),(1749,1435,118),(1749,1437,136),(1749,1451,21),(1749,1526,54),(1749,1539,105),(1749,1540,46),(1749,1607,47),(1749,1630,31),(1749,1643,11),(1749,1659,86),(1749,1668,121),(1749,1684,85),(1749,1718,82),(1749,1720,74),(1749,1725,77),(1749,1732,133),(1749,1751,27),(1749,1828,26),(1749,1839,72),(1749,1864,10),(1749,1933,65),(1749,1941,144),(1749,1968,99),(1749,2039,44),(1749,2055,119),(1749,2121,58),(1749,2206,9),(1749,2216,50),(1749,2218,62),(1749,2227,130),(1749,2257,79),(1749,2274,15),(1749,2371,69),(1749,2434,145),(1749,2435,57),(1749,2493,5),(1749,2540,55),(1749,2581,34),(1749,2589,80),(1749,2617,71),(1749,2671,88),(1749,2700,60),(1749,2717,129),(1749,2792,109),(1749,2814,6),(1749,2815,81),(1749,2833,139),(1749,2842,75),(1749,2914,78),(1749,2923,37),(1749,2928,28),(1749,2929,30),(1749,2933,89),(1749,2974,140),(1749,3026,59),(1749,3054,128),(1749,3095,49),(1749,3130,45),(1749,3140,123),(1749,3201,73),(1749,3211,110),(1749,3270,51),(1749,3350,33),(1749,3414,70),(1749,3468,76),(1749,3511,23),(1749,3513,40),(1749,3548,125),(1749,3571,36),(1749,3572,95),(1749,3576,2),(1749,3597,102),(1749,3605,83),(1749,3626,16),(1749,3658,20),(1749,3743,94),(1749,5898,90),(1749,5899,96),(1749,5959,0),(1749,5960,1),(1749,5961,4),(1749,5962,19),(1749,5963,22),(1749,5964,24),(1749,5965,39),(1749,5966,42),(1749,5967,61),(1749,5968,66),(1749,5969,68),(1749,5970,84),(1749,5971,87),(1749,5972,91),(1749,5973,92),(1749,5974,97),(1749,5975,98),(1749,5976,100),(1749,5977,101),(1749,5978,104),(1749,5979,106),(1749,5980,107),(1749,5981,108),(1749,5982,111),(1749,5983,114),(1749,5984,115),(1749,5985,117),(1749,5986,120),(1749,5987,122),(1749,5988,124),(1749,5989,126),(1749,5990,127),(1749,5991,131),(1749,5992,132),(1749,5993,134),(1749,5994,137),(1749,5995,138),(1749,5996,143),(1750,20,1),(1750,7197,0),(1751,20,1),(1751,7240,0),(1751,7241,2),(1751,7242,3),(1751,7243,4),(1752,7194,2),(1752,7250,0),(1752,7251,1),(1753,20,0),(1753,626,4),(1753,1088,2),(1753,1240,3),(1753,1367,1),(1754,20,6),(1754,1463,3),(1754,1492,11),(1754,1925,0),(1754,1988,2),(1754,2019,5),(1754,2483,7),(1754,2859,10),(1754,2887,9),(1754,3270,8),(1754,3309,1),(1754,3611,4),(1755,20,4),(1755,1241,3),(1755,2039,1),(1755,2898,2),(1755,3360,0),(1755,3366,5),(1756,20,12),(1756,928,3),(1756,970,7),(1756,1143,10),(1756,2275,8),(1756,2728,2),(1756,3079,4),(1756,6361,6),(1756,6397,5),(1756,7234,0),(1756,7235,1),(1756,7236,9),(1756,7237,11),(1756,7238,13),(1757,17,1),(1757,20,0),(1757,135,3),(1757,3366,2),(1758,20,0),(1759,20,0),(1759,626,1),(1759,1240,2),(1760,20,1),(1760,50,0),(1761,20,4),(1761,626,5),(1761,984,2),(1761,1511,1),(1761,1715,3),(1761,3907,0),(1762,20,36),(1762,615,21),(1762,1516,24),(1762,2035,11),(1762,2644,62),(1762,3579,68),(1762,6001,0),(1762,6002,1),(1762,6003,2),(1762,6004,3),(1762,6005,4),(1762,6006,5),(1762,6007,6),(1762,6008,7),(1762,6009,8),(1762,6010,9),(1762,6011,10),(1762,6012,12),(1762,6013,13),(1762,6014,14),(1762,6015,15),(1762,6016,16),(1762,6017,17),(1762,6018,18),(1762,6019,19),(1762,6020,20),(1762,6021,22),(1762,6022,23),(1762,6023,25),(1762,6024,26),(1762,6025,27),(1762,6026,28),(1762,6027,29),(1762,6028,30),(1762,6029,31),(1762,6030,32),(1762,6031,33),(1762,6032,34),(1762,6033,35),(1762,6034,37),(1762,6035,38),(1762,6036,39),(1762,6037,40),(1762,6038,41),(1762,6039,42),(1762,6040,43),(1762,6041,44),(1762,6042,45),(1762,6043,46),(1762,6044,47),(1762,6045,48),(1762,6046,49),(1762,6047,50),(1762,6048,51),(1762,6049,52),(1762,6050,53),(1762,6051,54),(1762,6052,55),(1762,6053,56),(1762,6054,57),(1762,6055,58),(1762,6056,59),(1762,6057,60),(1762,6058,61),(1762,6059,63),(1762,6060,64),(1762,6061,65),(1762,6062,66),(1762,6063,67),(1762,6064,69),(1762,6065,70),(1762,6066,71),(1762,6067,72),(1762,6068,73),(1762,6069,74),(1762,6070,75),(1762,6071,76),(1762,6072,77),(1762,6073,78),(1762,6074,79),(1762,6075,80),(1762,6076,81),(1762,6077,82),(1763,17,1),(1763,20,6),(1763,136,0),(1763,1870,2),(1763,3256,3),(1763,6613,4),(1763,6614,5),(1764,20,1),(1764,3004,0),(1765,20,108),(1765,613,69),(1765,635,173),(1765,640,74),(1765,642,183),(1765,699,184),(1765,772,99),(1765,780,220),(1765,789,210),(1765,796,219),(1765,805,180),(1765,891,25),(1765,904,85),(1765,913,226),(1765,922,157),(1765,923,187),(1765,951,273),(1765,962,143),(1765,965,197),(1765,967,23),(1765,968,221),(1765,1024,209),(1765,1043,134),(1765,1078,111),(1765,1094,239),(1765,1131,33),(1765,1138,27),(1765,1160,19),(1765,1168,161),(1765,1186,93),(1765,1189,265),(1765,1242,124),(1765,1254,145),(1765,1273,267),(1765,1285,181),(1765,1291,154),(1765,1322,228),(1765,1331,269),(1765,1350,125),(1765,1390,21),(1765,1391,133),(1765,1410,199),(1765,1412,240),(1765,1413,77),(1765,1418,7),(1765,1427,94),(1765,1429,202),(1765,1458,76),(1765,1492,68),(1765,1493,165),(1765,1494,81),(1765,1502,115),(1765,1509,151),(1765,1513,91),(1765,1525,135),(1765,1533,169),(1765,1550,97),(1765,1555,16),(1765,1558,103),(1765,1575,138),(1765,1587,90),(1765,1593,195),(1765,1603,190),(1765,1611,139),(1765,1632,110),(1765,1636,58),(1765,1650,241),(1765,1658,153),(1765,1669,213),(1765,1678,218),(1765,1680,166),(1765,1687,87),(1765,1718,237),(1765,1737,129),(1765,1751,207),(1765,1776,172),(1765,1777,235),(1765,1787,98),(1765,1792,147),(1765,1795,32),(1765,1798,59),(1765,1800,193),(1765,1814,101),(1765,1820,89),(1765,1858,117),(1765,1888,203),(1765,1890,163),(1765,1897,116),(1765,1904,167),(1765,1910,234),(1765,1924,26),(1765,1935,0),(1765,1939,229),(1765,1958,170),(1765,1959,18),(1765,2012,178),(1765,2022,120),(1765,2032,194),(1765,2058,149),(1765,2093,38),(1765,2094,156),(1765,2112,14),(1765,2117,128),(1765,2120,83),(1765,2127,155),(1765,2134,100),(1765,2138,13),(1765,2155,112),(1765,2178,118),(1765,2189,78),(1765,2205,189),(1765,2206,198),(1765,2239,266),(1765,2255,205),(1765,2259,171),(1765,2303,211),(1765,2326,17),(1765,2438,137),(1765,2449,162),(1765,2483,84),(1765,2513,113),(1765,2519,268),(1765,2521,231),(1765,2522,158),(1765,2546,67),(1765,2551,29),(1765,2573,3),(1765,2637,70),(1765,2645,274),(1765,2677,230),(1765,2707,208),(1765,2711,177),(1765,2712,142),(1765,2759,223),(1765,2767,102),(1765,2768,148),(1765,2782,144),(1765,2830,238),(1765,2846,80),(1765,2856,225),(1765,2859,66),(1765,2878,92),(1765,2881,141),(1765,2886,249),(1765,2891,86),(1765,2931,271),(1765,2933,8),(1765,2957,131),(1765,2964,216),(1765,2998,62),(1765,3001,130),(1765,3005,63),(1765,3006,217),(1765,3030,123),(1765,3035,109),(1765,3036,48),(1765,3051,185),(1765,3081,248),(1765,3086,175),(1765,3090,272),(1765,3111,150),(1765,3159,9),(1765,3161,11),(1765,3173,114),(1765,3197,126),(1765,3200,160),(1765,3233,227),(1765,3237,236),(1765,3254,200),(1765,3261,107),(1765,3266,215),(1765,3270,132),(1765,3278,1),(1765,3283,182),(1765,3288,73),(1765,3290,224),(1765,3292,105),(1765,3297,159),(1765,3321,140),(1765,3345,104),(1765,3361,188),(1765,3419,24),(1765,3424,60),(1765,3426,164),(1765,3430,212),(1765,3446,191),(1765,3520,75),(1765,3525,71),(1765,3546,95),(1765,3552,2),(1765,3555,106),(1765,3558,233),(1765,3564,270),(1765,3566,176),(1765,3575,72),(1765,3600,82),(1765,3624,206),(1765,3626,201),(1765,3645,96),(1765,3653,179),(1765,3689,196),(1765,3701,119),(1765,3717,174),(1765,3738,127),(1765,3741,152),(1765,3755,136),(1765,3764,192),(1765,3767,122),(1765,3783,186),(1765,3786,121),(1765,3825,168),(1765,3844,88),(1765,3853,214),(1765,3854,4),(1765,5855,222),(1765,5861,15),(1765,5862,79),(1765,5863,146),(1765,5864,43),(1765,5865,44),(1765,5866,204),(1765,5868,232),(1765,5869,275),(1765,5922,54),(1765,6617,242),(1765,6618,243),(1765,6619,244),(1765,6620,245),(1765,6621,246),(1765,6622,247),(1765,6623,251),(1765,6624,252),(1765,6625,253),(1765,6627,254),(1765,6628,255),(1765,6629,256),(1765,6630,257),(1765,6631,258),(1765,6632,259),(1765,6633,260),(1765,6634,261),(1765,6635,262),(1765,6636,263),(1765,6637,264),(1765,6667,5),(1765,6668,6),(1765,6669,10),(1765,6670,12),(1765,6671,20),(1765,6672,22),(1765,6673,28),(1765,6674,30),(1765,6675,31),(1765,6676,34),(1765,6677,35),(1765,6678,36),(1765,6679,37),(1765,6680,39),(1765,6681,40),(1765,6682,41),(1765,6683,42),(1765,6684,45),(1765,6685,46),(1765,6686,47),(1765,6687,49),(1765,6688,50),(1765,6689,51),(1765,6690,52),(1765,6691,53),(1765,6692,55),(1765,6693,56),(1765,6694,57),(1765,6695,61),(1765,6696,64),(1765,6697,65),(1765,6698,250),(1766,15,0),(1766,20,8),(1766,135,7),(1766,620,6),(1766,724,4),(1766,1241,1),(1766,2152,5),(1766,2838,3),(1766,3256,2),(1767,15,2),(1767,17,1),(1767,20,6),(1767,135,5),(1767,889,3),(1767,2395,0),(1767,3256,4),(1768,20,10),(1768,694,8),(1768,844,6),(1768,865,9),(1768,1010,16),(1768,1316,13),(1768,1342,2),(1768,1621,7),(1768,1681,14),(1768,1936,5),(1768,1975,11),(1768,2090,4),(1768,2443,0),(1768,2976,1),(1768,3054,12),(1768,6901,3),(1768,6902,15),(1769,20,15),(1769,135,14),(1769,620,8),(1769,982,11),(1769,1241,1),(1769,1393,3),(1769,1604,7),(1769,1948,12),(1769,2343,9),(1769,2835,4),(1769,2892,13),(1769,3251,0),(1769,3364,6),(1769,3366,2),(1769,3763,10),(1769,6898,5),(1770,20,3),(1770,1241,4),(1770,2039,1),(1770,2251,0),(1770,3816,2),(1771,20,8),(1771,77,7),(1771,135,0),(1771,620,3),(1771,982,5),(1771,1241,1),(1771,1393,4),(1771,2039,6),(1771,3366,2),(1772,17,2),(1772,20,5),(1772,1641,1),(1772,2892,4),(1772,3763,0),(1772,3779,3),(1773,20,1),(1773,7201,0),(1774,20,1),(1774,7202,0),(1775,20,1),(1775,1283,5),(1775,3039,0),(1775,7203,2),(1775,7204,3),(1775,7205,4),(1776,20,12),(1776,928,3),(1776,970,0),(1776,1143,10),(1776,2275,5),(1776,2728,2),(1776,3079,1),(1776,6361,7),(1776,6397,6),(1776,7234,8),(1776,7236,9),(1776,7237,11),(1776,7238,4),(1777,20,3),(1777,795,10),(1777,991,6),(1777,1143,9),(1777,1217,1),(1777,1318,4),(1777,1363,8),(1777,1765,7),(1777,2828,2),(1777,3450,0),(1777,3636,5),(1778,17,2),(1778,20,1),(1778,2841,0),(1779,20,0),(1779,626,3),(1779,1678,4),(1779,2213,2),(1779,7249,1),(1780,20,0),(1780,1224,1),(1780,1240,4),(1780,1673,2),(1780,2314,3),(1781,20,3),(1781,626,4),(1781,723,2),(1781,1172,6),(1781,1224,5),(1781,1240,8),(1781,1873,7),(1781,6924,19),(1781,7253,0),(1781,7254,1),(1781,7255,9),(1781,7256,10),(1781,7257,11),(1781,7258,12),(1781,7259,13),(1781,7260,14),(1781,7261,15),(1781,7262,16),(1781,7263,17),(1781,7264,18),(1781,7265,20),(1781,7266,21),(1781,7267,22),(1781,7268,23),(1781,7269,24),(1781,7270,25),(1781,7271,26),(1781,7272,27),(1781,7273,28),(1781,7274,29),(1781,7275,30),(1781,7276,31),(1782,20,3),(1782,1673,4),(1782,1706,0),(1782,2241,1),(1782,2284,6),(1782,2965,5),(1782,2972,2),(1847,1,9),(1847,2,0),(1847,16,2),(1847,20,10),(1847,49,3),(1847,50,5),(1847,2076,1),(1847,2958,7),(1847,3314,8),(1847,3901,6),(1847,7297,4),(1848,20,12),(1848,77,2),(1848,108,1),(1848,904,5),(1848,1000,6),(1848,1241,8),(1848,1492,7),(1848,1678,10),(1848,1920,0),(1848,2832,11),(1848,3171,3),(1848,3270,9),(1848,3380,4),(1849,20,5),(1849,135,4),(1849,1089,3),(1849,1189,0),(1849,2054,1),(1849,3380,2),(1850,2,1),(1850,16,3),(1850,20,7),(1850,49,4),(1850,51,2),(1850,110,5),(1850,2214,0),(1850,3262,6),(1851,2,3),(1851,16,6),(1851,20,7),(1851,49,0),(1851,50,1),(1851,51,5),(1851,1001,2),(1851,2073,4),(1852,20,5),(1852,735,6),(1852,1372,0),(1852,2892,1),(1852,3904,2),(1852,3905,3),(1852,3906,4),(1853,15,2),(1853,20,5),(1853,135,4),(1853,746,0),(1853,973,1),(1853,1714,3),(1854,17,5),(1854,20,6),(1854,137,4),(1854,735,1),(1854,1470,0),(1854,1723,2),(1854,3908,3),(1855,20,5),(1855,1112,1),(1855,1934,0),(1855,2577,3),(1855,3366,7),(1855,3373,2),(1855,3813,4),(1855,3910,6),(1856,20,6),(1856,2361,4),(1856,2458,1),(1856,3360,5),(1856,3366,7),(1856,3813,0),(1856,3911,2),(1856,3912,3),(1857,20,131),(1857,613,90),(1857,635,200),(1857,640,97),(1857,642,210),(1857,699,211),(1857,772,38),(1857,775,84),(1857,780,245),(1857,789,235),(1857,796,244),(1857,805,207),(1857,904,110),(1857,913,253),(1857,922,182),(1857,923,214),(1857,962,165),(1857,965,224),(1857,968,248),(1857,1000,292),(1857,1007,35),(1857,1024,234),(1857,1043,157),(1857,1078,133),(1857,1083,64),(1857,1094,267),(1857,1138,129),(1857,1152,26),(1857,1168,186),(1857,1186,117),(1857,1203,29),(1857,1242,147),(1857,1254,167),(1857,1285,208),(1857,1291,178),(1857,1322,255),(1857,1331,135),(1857,1350,148),(1857,1391,156),(1857,1410,226),(1857,1412,268),(1857,1413,100),(1857,1418,92),(1857,1427,118),(1857,1429,228),(1857,1437,288),(1857,1458,99),(1857,1492,89),(1857,1493,190),(1857,1494,105),(1857,1502,138),(1857,1509,175),(1857,1513,115),(1857,1525,158),(1857,1533,196),(1857,1550,121),(1857,1558,44),(1857,1571,72),(1857,1575,74),(1857,1580,19),(1857,1587,7),(1857,1593,222),(1857,1603,217),(1857,1611,161),(1857,1632,132),(1857,1650,269),(1857,1658,177),(1857,1669,238),(1857,1671,62),(1857,1678,243),(1857,1680,191),(1857,1687,112),(1857,1703,287),(1857,1718,264),(1857,1737,152),(1857,1751,232),(1857,1776,199),(1857,1777,262),(1857,1787,122),(1857,1792,169),(1857,1798,194),(1857,1800,220),(1857,1814,124),(1857,1820,114),(1857,1858,140),(1857,1888,34),(1857,1890,188),(1857,1897,139),(1857,1904,192),(1857,1910,260),(1857,1935,127),(1857,1939,83),(1857,1958,197),(1857,1959,106),(1857,1968,41),(1857,2012,205),(1857,2022,143),(1857,2032,221),(1857,2049,22),(1857,2051,48),(1857,2058,171),(1857,2094,181),(1857,2097,57),(1857,2112,103),(1857,2117,151),(1857,2120,108),(1857,2127,179),(1857,2134,123),(1857,2155,134),(1857,2178,141),(1857,2185,43),(1857,2189,101),(1857,2205,216),(1857,2206,225),(1857,2239,261),(1857,2255,230),(1857,2259,198),(1857,2303,236),(1857,2419,17),(1857,2438,160),(1857,2449,187),(1857,2483,109),(1857,2507,5),(1857,2513,136),(1857,2519,249),(1857,2521,257),(1857,2522,183),(1857,2546,88),(1857,2573,87),(1857,2602,45),(1857,2629,65),(1857,2637,91),(1857,2642,40),(1857,2671,294),(1857,2677,256),(1857,2707,233),(1857,2711,204),(1857,2712,164),(1857,2754,293),(1857,2759,250),(1857,2767,125),(1857,2768,170),(1857,2782,166),(1857,2792,63),(1857,2830,265),(1857,2846,104),(1857,2856,252),(1857,2859,85),(1857,2878,116),(1857,2881,163),(1857,2891,111),(1857,2931,246),(1857,2957,154),(1857,2964,241),(1857,2977,25),(1857,2998,271),(1857,3001,153),(1857,3006,242),(1857,3030,146),(1857,3035,50),(1857,3036,180),(1857,3051,212),(1857,3054,276),(1857,3085,30),(1857,3086,202),(1857,3087,55),(1857,3090,247),(1857,3111,174),(1857,3173,137),(1857,3197,149),(1857,3200,185),(1857,3233,254),(1857,3237,263),(1857,3250,47),(1857,3254,28),(1857,3261,49),(1857,3266,240),(1857,3270,155),(1857,3278,86),(1857,3283,209),(1857,3288,95),(1857,3290,251),(1857,3292,128),(1857,3297,184),(1857,3321,162),(1857,3335,58),(1857,3345,126),(1857,3361,215),(1857,3424,195),(1857,3426,189),(1857,3430,237),(1857,3446,218),(1857,3480,36),(1857,3520,98),(1857,3525,93),(1857,3546,119),(1857,3555,130),(1857,3558,259),(1857,3564,266),(1857,3566,203),(1857,3575,94),(1857,3600,107),(1857,3624,231),(1857,3626,227),(1857,3630,6),(1857,3645,120),(1857,3653,206),(1857,3689,223),(1857,3701,142),(1857,3717,201),(1857,3738,150),(1857,3741,176),(1857,3755,159),(1857,3764,219),(1857,3767,145),(1857,3783,213),(1857,3786,144),(1857,3818,3),(1857,3825,193),(1857,3844,113),(1857,3853,239),(1857,3914,1),(1857,3915,2),(1857,3916,4),(1857,3917,8),(1857,3918,9),(1857,3919,10),(1857,3920,11),(1857,3921,12),(1857,3922,13),(1857,3923,14),(1857,3924,15),(1857,3925,16),(1857,3926,18),(1857,3927,20),(1857,3928,21),(1857,3929,23),(1857,3930,24),(1857,3931,27),(1857,3932,31),(1857,5831,0),(1857,5832,32),(1857,5833,33),(1857,5834,37),(1857,5835,39),(1857,5836,42),(1857,5837,46),(1857,5838,51),(1857,5839,52),(1857,5840,53),(1857,5841,54),(1857,5842,56),(1857,5843,59),(1857,5844,60),(1857,5845,61),(1857,5846,66),(1857,5847,67),(1857,5848,68),(1857,5849,69),(1857,5850,70),(1857,5851,71),(1857,5852,73),(1857,5853,75),(1857,5854,76),(1857,5855,77),(1857,5856,78),(1857,5857,79),(1857,5858,80),(1857,5859,81),(1857,5860,82),(1857,5861,96),(1857,5862,102),(1857,5863,168),(1857,5864,172),(1857,5865,173),(1857,5866,229),(1857,5868,258),(1857,5869,270),(1857,5870,272),(1857,5871,273),(1857,5872,274),(1857,5873,275),(1857,5874,277),(1857,5875,278),(1857,5876,279),(1857,5877,280),(1857,5878,281),(1857,5879,282),(1857,5880,283),(1857,5881,284),(1857,5882,285),(1857,5883,286),(1857,5884,289),(1857,5885,290),(1857,5886,291),(1857,5887,295),(1858,20,317),(1858,613,290),(1858,635,367),(1858,640,294),(1858,642,375),(1858,644,214),(1858,653,46),(1858,689,269),(1858,699,376),(1858,700,69),(1858,738,82),(1858,759,77),(1858,772,26),(1858,775,165),(1858,780,244),(1858,789,395),(1858,796,241),(1858,797,27),(1858,805,372),(1858,829,122),(1858,851,152),(1858,891,83),(1858,904,303),(1858,913,402),(1858,922,355),(1858,923,378),(1858,951,251),(1858,962,343),(1858,965,207),(1858,968,249),(1858,1000,245),(1858,1007,219),(1858,1024,394),(1858,1034,178),(1858,1043,337),(1858,1078,319),(1858,1083,124),(1858,1094,235),(1858,1117,131),(1858,1124,34),(1858,1131,228),(1858,1134,91),(1858,1138,185),(1858,1151,86),(1858,1160,71),(1858,1166,97),(1858,1168,358),(1858,1186,309),(1858,1203,75),(1858,1242,134),(1858,1254,345),(1858,1265,70),(1858,1285,373),(1858,1291,261),(1858,1311,74),(1858,1322,403),(1858,1331,227),(1858,1332,321),(1858,1345,187),(1858,1350,331),(1858,1377,95),(1858,1380,43),(1858,1391,336),(1858,1397,112),(1858,1410,388),(1858,1412,410),(1858,1413,211),(1858,1418,41),(1858,1427,310),(1858,1429,389),(1858,1437,277),(1858,1449,102),(1858,1454,24),(1858,1458,296),(1858,1476,222),(1858,1492,289),(1858,1493,181),(1858,1494,300),(1858,1502,324),(1858,1509,350),(1858,1513,307),(1858,1518,173),(1858,1525,338),(1858,1533,2),(1858,1550,312),(1858,1555,66),(1858,1558,224),(1858,1575,340),(1858,1580,208),(1858,1587,14),(1858,1593,385),(1858,1603,381),(1858,1611,146),(1858,1632,318),(1858,1650,25),(1858,1658,352),(1858,1669,398),(1858,1678,238),(1858,1680,362),(1858,1687,304),(1858,1698,246),(1858,1703,275),(1858,1718,408),(1858,1737,334),(1858,1751,392),(1858,1776,366),(1858,1777,406),(1858,1787,313),(1858,1792,347),(1858,1797,283),(1858,1798,271),(1858,1800,383),(1858,1801,42),(1858,1814,33),(1858,1816,229),(1858,1820,306),(1858,1846,204),(1858,1858,325),(1858,1888,80),(1858,1890,360),(1858,1897,121),(1858,1904,363),(1858,1910,270),(1858,1916,51),(1858,1921,125),(1858,1924,99),(1858,1935,105),(1858,1939,162),(1858,1940,59),(1858,1945,119),(1858,1958,3),(1858,1959,301),(1858,1968,221),(1858,2009,36),(1858,2012,20),(1858,2015,19),(1858,2028,115),(1858,2032,384),(1858,2034,130),(1858,2049,210),(1858,2051,226),(1858,2058,348),(1858,2094,167),(1858,2097,287),(1858,2112,63),(1858,2117,333),(1858,2120,32),(1858,2127,353),(1858,2132,1),(1858,2134,18),(1858,2135,262),(1858,2155,320),(1858,2166,49),(1858,2185,96),(1858,2189,297),(1858,2196,79),(1858,2205,380),(1858,2206,387),(1858,2239,272),(1858,2255,391),(1858,2259,365),(1858,2260,101),(1858,2279,94),(1858,2303,396),(1858,2326,68),(1858,2386,113),(1858,2388,285),(1858,2419,206),(1858,2432,40),(1858,2438,145),(1858,2449,359),(1858,2452,230),(1858,2461,90),(1858,2483,302),(1858,2506,65),(1858,2513,322),(1858,2519,253),(1858,2521,264),(1858,2522,170),(1858,2546,37),(1858,2568,23),(1858,2573,30),(1858,2580,58),(1858,2598,62),(1858,2602,225),(1858,2603,111),(1858,2610,108),(1858,2629,234),(1858,2637,291),(1858,2642,220),(1858,2645,216),(1858,2671,205),(1858,2675,109),(1858,2677,404),(1858,2701,88),(1858,2707,393),(1858,2711,371),(1858,2712,342),(1858,2734,103),(1858,2754,53),(1858,2756,212),(1858,2759,255),(1858,2767,223),(1858,2768,257),(1858,2778,188),(1858,2782,344),(1858,2792,233),(1858,2819,60),(1858,2830,409),(1858,2846,299),(1858,2856,401),(1858,2859,281),(1858,2875,92),(1858,2878,308),(1858,2880,44),(1858,2881,149),(1858,2884,52),(1858,2891,215),(1858,2931,247),(1858,2933,286),(1858,2957,139),(1858,2964,399),(1858,2977,67),(1858,2985,288),(1858,2998,274),(1858,3001,335),(1858,3006,400),(1858,3030,330),(1858,3035,17),(1858,3036,354),(1858,3047,39),(1858,3051,377),(1858,3054,267),(1858,3061,128),(1858,3085,76),(1858,3086,369),(1858,3090,248),(1858,3111,349),(1858,3120,117),(1858,3127,123),(1858,3153,231),(1858,3161,54),(1858,3168,250),(1858,3173,323),(1858,3195,118),(1858,3197,332),(1858,3200,357),(1858,3214,203),(1858,3233,159),(1858,3237,407),(1858,3254,22),(1858,3261,16),(1858,3266,132),(1858,3270,143),(1858,3278,28),(1858,3283,374),(1858,3288,293),(1858,3290,258),(1858,3292,315),(1858,3297,356),(1858,3321,341),(1858,3325,55),(1858,3335,120),(1858,3340,87),(1858,3345,100),(1858,3361,379),(1858,3371,163),(1858,3401,78),(1858,3419,81),(1858,3424,35),(1858,3426,361),(1858,3430,397),(1858,3436,15),(1858,3446,21),(1858,3480,114),(1858,3507,48),(1858,3520,295),(1858,3525,292),(1858,3527,196),(1858,3537,89),(1858,3546,311),(1858,3552,45),(1858,3555,316),(1858,3558,268),(1858,3564,279),(1858,3566,370),(1858,3570,104),(1858,3575,0),(1858,3600,72),(1858,3619,38),(1858,3624,218),(1858,3626,217),(1858,3630,110),(1858,3645,85),(1858,3653,29),(1858,3659,47),(1858,3689,386),(1858,3696,209),(1858,3701,327),(1858,3712,106),(1858,3717,368),(1858,3720,176),(1858,3721,126),(1858,3722,61),(1858,3726,73),(1858,3729,64),(1858,3738,136),(1858,3741,351),(1858,3755,339),(1858,3764,382),(1858,3767,329),(1858,3783,31),(1858,3786,328),(1858,3825,364),(1858,3844,305),(1858,3853,236),(1858,5835,93),(1858,5849,137),(1858,5851,240),(1858,5854,151),(1858,5855,254),(1858,5857,154),(1858,5859,158),(1858,5860,161),(1858,5861,50),(1858,5862,298),(1858,5863,346),(1858,5864,56),(1858,5865,98),(1858,5866,390),(1858,5868,405),(1858,5869,213),(1858,5871,265),(1858,5873,266),(1858,5876,180),(1858,5879,182),(1858,5886,200),(1858,5887,242),(1858,5888,4),(1858,5889,5),(1858,5890,6),(1858,5891,7),(1858,5892,8),(1858,5893,9),(1858,5894,10),(1858,5895,11),(1858,5896,12),(1858,5897,13),(1858,5898,57),(1858,5899,84),(1858,5900,116),(1858,5901,127),(1858,5902,129),(1858,5903,133),(1858,5904,135),(1858,5905,138),(1858,5906,140),(1858,5907,141),(1858,5908,142),(1858,5909,144),(1858,5910,147),(1858,5911,148),(1858,5912,150),(1858,5913,153),(1858,5914,155),(1858,5915,156),(1858,5916,157),(1858,5917,160),(1858,5918,164),(1858,5919,166),(1858,5920,168),(1858,5921,169),(1858,5922,171),(1858,5923,172),(1858,5924,174),(1858,5925,175),(1858,5926,177),(1858,5927,179),(1858,5928,183),(1858,5929,184),(1858,5930,186),(1858,5931,189),(1858,5932,190),(1858,5933,191),(1858,5934,192),(1858,5935,193),(1858,5936,194),(1858,5937,195),(1858,5938,197),(1858,5939,198),(1858,5940,199),(1858,5941,201),(1858,5942,202),(1858,5943,232),(1858,5944,237),(1858,5945,239),(1858,5946,243),(1858,5947,252),(1858,5948,256),(1858,5949,259),(1858,5950,260),(1858,5951,263),(1858,5952,273),(1858,5953,276),(1858,5954,278),(1858,5955,280),(1858,5956,282),(1858,5957,284),(1858,5958,326),(1859,20,60),(1859,613,18),(1859,635,132),(1859,640,24),(1859,642,141),(1859,699,142),(1859,772,50),(1859,780,178),(1859,789,168),(1859,796,177),(1859,805,139),(1859,904,35),(1859,913,187),(1859,922,114),(1859,923,145),(1859,962,98),(1859,965,155),(1859,968,181),(1859,1024,167),(1859,1043,89),(1859,1078,63),(1859,1094,202),(1859,1138,57),(1859,1168,118),(1859,1186,43),(1859,1242,79),(1859,1254,100),(1859,1285,140),(1859,1291,110),(1859,1322,189),(1859,1331,65),(1859,1332,66),(1859,1350,80),(1859,1391,88),(1859,1410,157),(1859,1412,203),(1859,1418,19),(1859,1427,44),(1859,1429,160),(1859,1458,26),(1859,1492,17),(1859,1493,122),(1859,1494,31),(1859,1502,71),(1859,1509,108),(1859,1513,41),(1859,1525,90),(1859,1533,128),(1859,1550,47),(1859,1558,53),(1859,1575,93),(1859,1587,40),(1859,1593,153),(1859,1603,148),(1859,1611,94),(1859,1632,62),(1859,1650,204),(1859,1658,109),(1859,1669,171),(1859,1678,176),(1859,1680,123),(1859,1687,37),(1859,1718,199),(1859,1737,84),(1859,1751,165),(1859,1776,131),(1859,1777,197),(1859,1787,48),(1859,1792,102),(1859,1798,126),(1859,1800,151),(1859,1814,7),(1859,1816,69),(1859,1820,39),(1859,1858,73),(1859,1888,161),(1859,1890,120),(1859,1897,72),(1859,1904,124),(1859,1910,195),(1859,1935,55),(1859,1939,190),(1859,1958,129),(1859,1959,32),(1859,2012,137),(1859,2015,49),(1859,2032,152),(1859,2058,104),(1859,2094,113),(1859,2112,29),(1859,2117,83),(1859,2120,0),(1859,2127,111),(1859,2134,51),(1859,2155,64),(1859,2178,74),(1859,2189,27),(1859,2205,147),(1859,2206,156),(1859,2239,196),(1859,2255,163),(1859,2259,130),(1859,2303,169),(1859,2330,2),(1859,2438,92),(1859,2449,119),(1859,2452,70),(1859,2483,34),(1859,2513,67),(1859,2519,182),(1859,2521,192),(1859,2522,115),(1859,2546,16),(1859,2573,15),(1859,2637,10),(1859,2677,191),(1859,2707,166),(1859,2711,136),(1859,2712,97),(1859,2759,184),(1859,2767,52),(1859,2768,103),(1859,2782,99),(1859,2830,200),(1859,2846,30),(1859,2856,186),(1859,2859,13),(1859,2878,42),(1859,2881,96),(1859,2891,36),(1859,2931,179),(1859,2957,86),(1859,2964,174),(1859,2998,206),(1859,3001,85),(1859,3006,175),(1859,3030,78),(1859,3035,61),(1859,3036,112),(1859,3051,143),(1859,3086,134),(1859,3090,180),(1859,3111,107),(1859,3173,68),(1859,3197,81),(1859,3200,117),(1859,3233,188),(1859,3237,198),(1859,3254,158),(1859,3261,59),(1859,3266,173),(1859,3270,87),(1859,3278,14),(1859,3283,9),(1859,3288,22),(1859,3290,185),(1859,3292,56),(1859,3297,116),(1859,3321,95),(1859,3345,54),(1859,3361,146),(1859,3382,5),(1859,3424,127),(1859,3426,121),(1859,3430,170),(1859,3446,149),(1859,3520,25),(1859,3525,20),(1859,3546,45),(1859,3555,58),(1859,3558,194),(1859,3564,201),(1859,3566,135),(1859,3575,21),(1859,3600,33),(1859,3624,164),(1859,3626,159),(1859,3645,46),(1859,3653,138),(1859,3689,154),(1859,3701,75),(1859,3717,133),(1859,3738,82),(1859,3741,1),(1859,3755,91),(1859,3764,150),(1859,3767,77),(1859,3783,144),(1859,3786,76),(1859,3825,125),(1859,3844,38),(1859,3853,172),(1859,5855,183),(1859,5861,23),(1859,5862,28),(1859,5863,101),(1859,5864,105),(1859,5865,106),(1859,5866,162),(1859,5868,193),(1859,5869,205),(1859,6085,3),(1859,6086,4),(1859,6087,6),(1859,6088,8),(1859,6089,11),(1859,6090,12),(1859,6091,207),(1859,6092,208),(1859,6093,209),(1859,6094,210),(1860,20,265),(1860,649,417),(1860,717,136),(1860,970,246),(1860,1054,67),(1860,1187,9),(1860,1320,531),(1860,1474,392),(1860,1690,292),(1860,1956,401),(1860,2054,357),(1860,2275,275),(1860,2523,87),(1860,2607,409),(1860,2695,345),(1860,2723,154),(1860,2728,291),(1860,2765,296),(1860,2807,179),(1860,2865,370),(1860,3079,306),(1860,3113,309),(1860,3256,164),(1860,3380,442),(1860,3661,440),(1860,3756,492),(1860,3781,529),(1860,3833,285),(1860,6095,0),(1860,6096,1),(1860,6097,2),(1860,6098,3),(1860,6099,4),(1860,6100,5),(1860,6101,6),(1860,6102,7),(1860,6103,8),(1860,6104,10),(1860,6105,11),(1860,6106,12),(1860,6107,13),(1860,6108,14),(1860,6109,15),(1860,6110,16),(1860,6111,17),(1860,6112,18),(1860,6113,19),(1860,6114,20),(1860,6115,21),(1860,6116,22),(1860,6117,23),(1860,6118,24),(1860,6119,25),(1860,6120,26),(1860,6121,27),(1860,6122,28),(1860,6123,29),(1860,6124,30),(1860,6125,31),(1860,6126,32),(1860,6127,33),(1860,6128,34),(1860,6129,35),(1860,6130,36),(1860,6131,37),(1860,6132,38),(1860,6133,39),(1860,6134,40),(1860,6135,41),(1860,6136,42),(1860,6137,43),(1860,6138,44),(1860,6139,45),(1860,6140,46),(1860,6141,47),(1860,6142,48),(1860,6143,49),(1860,6144,50),(1860,6145,51),(1860,6146,52),(1860,6147,53),(1860,6148,54),(1860,6149,55),(1860,6150,56),(1860,6151,57),(1860,6152,58),(1860,6153,59),(1860,6154,60),(1860,6155,61),(1860,6156,62),(1860,6157,63),(1860,6158,64),(1860,6159,65),(1860,6160,66),(1860,6161,68),(1860,6162,69),(1860,6163,70),(1860,6164,71),(1860,6165,72),(1860,6166,73),(1860,6167,74),(1860,6168,75),(1860,6169,76),(1860,6170,77),(1860,6171,78),(1860,6172,79),(1860,6173,80),(1860,6174,81),(1860,6175,82),(1860,6176,83),(1860,6177,84),(1860,6178,85),(1860,6179,86),(1860,6180,88),(1860,6181,89),(1860,6182,90),(1860,6183,91),(1860,6184,92),(1860,6185,93),(1860,6186,94),(1860,6187,95),(1860,6188,96),(1860,6189,97),(1860,6190,98),(1860,6191,99),(1860,6192,100),(1860,6193,101),(1860,6194,102),(1860,6195,103),(1860,6196,104),(1860,6197,105),(1860,6198,106),(1860,6199,107),(1860,6200,108),(1860,6201,109),(1860,6202,110),(1860,6203,111),(1860,6204,112),(1860,6205,113),(1860,6206,114),(1860,6207,115),(1860,6208,116),(1860,6209,117),(1860,6210,118),(1860,6211,119),(1860,6212,120),(1860,6213,121),(1860,6214,122),(1860,6215,123),(1860,6216,124),(1860,6217,125),(1860,6218,126),(1860,6219,127),(1860,6220,128),(1860,6221,129),(1860,6222,130),(1860,6223,131),(1860,6224,132),(1860,6225,133),(1860,6226,134),(1860,6227,135),(1860,6228,137),(1860,6229,138),(1860,6230,139),(1860,6231,140),(1860,6232,141),(1860,6233,142),(1860,6234,143),(1860,6235,144),(1860,6236,145),(1860,6237,146),(1860,6238,147),(1860,6239,148),(1860,6240,149),(1860,6241,150),(1860,6242,151),(1860,6243,152),(1860,6244,153),(1860,6245,155),(1860,6246,156),(1860,6247,157),(1860,6248,158),(1860,6249,159),(1860,6250,160),(1860,6251,161),(1860,6252,162),(1860,6253,163),(1860,6254,165),(1860,6255,166),(1860,6256,167),(1860,6257,168),(1860,6258,169),(1860,6259,170),(1860,6260,171),(1860,6261,172),(1860,6262,173),(1860,6263,174),(1860,6264,175),(1860,6265,176),(1860,6266,177),(1860,6267,178),(1860,6268,180),(1860,6269,181),(1860,6270,182),(1860,6271,183),(1860,6272,184),(1860,6273,185),(1860,6274,186),(1860,6275,187),(1860,6276,188),(1860,6277,189),(1860,6278,190),(1860,6279,191),(1860,6280,192),(1860,6281,193),(1860,6282,194),(1860,6283,195),(1860,6284,196),(1860,6285,197),(1860,6286,198),(1860,6287,199),(1860,6288,200),(1860,6289,201),(1860,6290,202),(1860,6291,203),(1860,6292,204),(1860,6293,205),(1860,6294,206),(1860,6295,207),(1860,6296,208),(1860,6297,209),(1860,6298,210),(1860,6299,211),(1860,6300,212),(1860,6301,213),(1860,6302,214),(1860,6303,215),(1860,6304,216),(1860,6305,217),(1860,6306,218),(1860,6307,219),(1860,6308,220),(1860,6309,221),(1860,6310,222),(1860,6311,223),(1860,6312,224),(1860,6313,225),(1860,6314,226),(1860,6315,227),(1860,6316,228),(1860,6317,229),(1860,6318,230),(1860,6319,231),(1860,6320,232),(1860,6321,233),(1860,6322,234),(1860,6323,235),(1860,6324,236),(1860,6325,237),(1860,6326,238),(1860,6327,239),(1860,6328,240),(1860,6329,241),(1860,6330,242),(1860,6331,243),(1860,6332,244),(1860,6333,245),(1860,6334,247),(1860,6335,249),(1860,6336,250),(1860,6337,251),(1860,6338,252),(1860,6339,253),(1860,6340,254),(1860,6341,255),(1860,6342,256),(1860,6343,257),(1860,6344,258),(1860,6345,259),(1860,6346,260),(1860,6347,261),(1860,6348,262),(1860,6349,263),(1860,6350,264),(1860,6351,266),(1860,6352,267),(1860,6353,268),(1860,6354,269),(1860,6355,270),(1860,6356,271),(1860,6357,272),(1860,6358,273),(1860,6359,274),(1860,6360,276),(1860,6361,277),(1860,6362,278),(1860,6363,279),(1860,6364,280),(1860,6365,281),(1860,6366,282),(1860,6367,283),(1860,6368,284),(1860,6369,286),(1860,6370,287),(1860,6371,288),(1860,6372,289),(1860,6373,290),(1860,6374,293),(1860,6375,294),(1860,6376,295),(1860,6377,297),(1860,6378,298),(1860,6379,299),(1860,6380,300),(1860,6381,301),(1860,6382,302),(1860,6383,303),(1860,6384,304),(1860,6385,305),(1860,6386,307),(1860,6387,308),(1860,6388,310),(1860,6389,311),(1860,6390,312),(1860,6391,313),(1860,6392,314),(1860,6393,315),(1860,6394,316),(1860,6395,317),(1860,6396,318),(1860,6397,319),(1860,6398,320),(1860,6399,321),(1860,6400,322),(1860,6401,323),(1860,6402,324),(1860,6403,325),(1860,6404,326),(1860,6405,327),(1860,6406,328),(1860,6407,329),(1860,6408,330),(1860,6409,331),(1860,6410,332),(1860,6411,333),(1860,6412,334),(1860,6413,335),(1860,6414,336),(1860,6415,337),(1860,6416,338),(1860,6417,339),(1860,6418,341),(1860,6419,342),(1860,6420,343),(1860,6421,344),(1860,6422,346),(1860,6423,347),(1860,6424,348),(1860,6425,349),(1860,6426,350),(1860,6427,351),(1860,6428,352),(1860,6429,353),(1860,6430,354),(1860,6431,355),(1860,6432,356),(1860,6433,358),(1860,6434,359),(1860,6435,360),(1860,6436,361),(1860,6437,362),(1860,6438,363),(1860,6439,364),(1860,6440,365),(1860,6441,366),(1860,6442,367),(1860,6443,368),(1860,6444,369),(1860,6445,371),(1860,6446,372),(1860,6447,373),(1860,6448,374),(1860,6449,375),(1860,6450,376),(1860,6451,377),(1860,6452,378),(1860,6453,379),(1860,6454,380),(1860,6455,381),(1860,6456,382),(1860,6457,383),(1860,6458,384),(1860,6459,385),(1860,6460,386),(1860,6461,387),(1860,6462,388),(1860,6463,389),(1860,6464,390),(1860,6465,391),(1860,6466,393),(1860,6467,394),(1860,6468,396),(1860,6469,397),(1860,6470,398),(1860,6471,399),(1860,6472,400),(1860,6473,402),(1860,6474,403),(1860,6475,404),(1860,6476,405),(1860,6477,406),(1860,6478,407),(1860,6479,408),(1860,6480,410),(1860,6481,411),(1860,6482,412),(1860,6483,413),(1860,6484,414),(1860,6485,415),(1860,6486,416),(1860,6487,418),(1860,6488,419),(1860,6489,420),(1860,6490,421),(1860,6491,422),(1860,6492,423),(1860,6493,424),(1860,6494,425),(1860,6495,426),(1860,6496,427),(1860,6497,428),(1860,6498,429),(1860,6499,430),(1860,6500,431),(1860,6501,432),(1860,6502,433),(1860,6503,434),(1860,6504,435),(1860,6505,436),(1860,6506,437),(1860,6507,438),(1860,6508,439),(1860,6509,441),(1860,6510,443),(1860,6511,444),(1860,6512,445),(1860,6513,446),(1860,6514,447),(1860,6515,448),(1860,6516,449),(1860,6517,450),(1860,6518,451),(1860,6519,452),(1860,6520,453),(1860,6521,454),(1860,6522,455),(1860,6523,456),(1860,6524,457),(1860,6525,458),(1860,6526,459),(1860,6527,460),(1860,6528,461),(1860,6529,462),(1860,6530,463),(1860,6531,464),(1860,6532,465),(1860,6533,466),(1860,6534,467),(1860,6535,468),(1860,6536,469),(1860,6537,470),(1860,6538,471),(1860,6539,472),(1860,6540,473),(1860,6541,474),(1860,6542,475),(1860,6543,476),(1860,6544,477),(1860,6545,478),(1860,6546,479),(1860,6547,480),(1860,6548,481),(1860,6549,482),(1860,6550,483),(1860,6551,484),(1860,6552,485),(1860,6553,486),(1860,6554,487),(1860,6555,488),(1860,6556,489),(1860,6557,490),(1860,6558,491),(1860,6559,493),(1860,6560,494),(1860,6561,495),(1860,6562,496),(1860,6563,497),(1860,6564,498),(1860,6565,499),(1860,6566,500),(1860,6567,501),(1860,6568,502),(1860,6569,503),(1860,6570,504),(1860,6571,505),(1860,6572,506),(1860,6573,507),(1860,6574,508),(1860,6575,509),(1860,6576,510),(1860,6577,511),(1860,6578,512),(1860,6579,513),(1860,6580,514),(1860,6581,515),(1860,6582,516),(1860,6583,517),(1860,6584,518),(1860,6585,519),(1860,6586,520),(1860,6587,521),(1860,6588,522),(1860,6589,523),(1860,6590,524),(1860,6591,525),(1860,6592,526),(1860,6593,527),(1860,6594,528),(1860,6595,530),(1860,6596,532),(1860,6597,533),(1860,6598,534),(1860,6599,536),(1860,6600,537),(1860,6601,538),(1860,6602,539),(1860,6603,540),(1860,6604,541),(1860,6605,542),(1861,20,54),(1861,613,12),(1861,635,126),(1861,640,18),(1861,642,136),(1861,699,137),(1861,772,43),(1861,780,172),(1861,789,163),(1861,796,5),(1861,805,133),(1861,904,29),(1861,913,181),(1861,922,108),(1861,923,140),(1861,962,91),(1861,965,150),(1861,968,175),(1861,1024,162),(1861,1043,82),(1861,1078,57),(1861,1094,196),(1861,1138,51),(1861,1168,112),(1861,1186,36),(1861,1242,72),(1861,1254,93),(1861,1285,134),(1861,1291,104),(1861,1322,183),(1861,1331,59),(1861,1332,1),(1861,1350,73),(1861,1391,81),(1861,1410,152),(1861,1412,197),(1861,1418,13),(1861,1427,37),(1861,1429,155),(1861,1458,20),(1861,1492,11),(1861,1493,116),(1861,1494,25),(1861,1502,64),(1861,1509,101),(1861,1513,34),(1861,1525,83),(1861,1533,122),(1861,1550,40),(1861,1558,47),(1861,1575,86),(1861,1587,33),(1861,1593,148),(1861,1603,143),(1861,1611,87),(1861,1632,56),(1861,1650,198),(1861,1658,103),(1861,1669,166),(1861,1678,171),(1861,1680,117),(1861,1687,31),(1861,1718,193),(1861,1725,201),(1861,1737,77),(1861,1751,160),(1861,1776,125),(1861,1777,191),(1861,1787,41),(1861,1792,95),(1861,1798,120),(1861,1800,146),(1861,1814,45),(1861,1816,62),(1861,1820,6),(1861,1858,66),(1861,1888,156),(1861,1890,114),(1861,1897,65),(1861,1904,118),(1861,1910,189),(1861,1935,49),(1861,1939,184),(1861,1958,123),(1861,1959,26),(1861,2012,131),(1861,2015,42),(1861,2032,147),(1861,2058,97),(1861,2094,107),(1861,2112,23),(1861,2117,76),(1861,2120,27),(1861,2127,105),(1861,2134,44),(1861,2155,58),(1861,2178,67),(1861,2189,21),(1861,2205,142),(1861,2206,151),(1861,2239,190),(1861,2255,158),(1861,2259,124),(1861,2303,164),(1861,2438,85),(1861,2449,113),(1861,2452,63),(1861,2483,28),(1861,2513,60),(1861,2519,176),(1861,2521,186),(1861,2522,109),(1861,2546,10),(1861,2573,9),(1861,2637,2),(1861,2677,185),(1861,2707,161),(1861,2711,130),(1861,2712,90),(1861,2759,178),(1861,2767,46),(1861,2768,96),(1861,2782,92),(1861,2830,194),(1861,2846,24),(1861,2856,180),(1861,2859,7),(1861,2878,35),(1861,2881,89),(1861,2891,30),(1861,2931,173),(1861,2957,79),(1861,2964,169),(1861,2998,200),(1861,3001,78),(1861,3006,170),(1861,3030,71),(1861,3035,55),(1861,3036,106),(1861,3051,138),(1861,3086,128),(1861,3090,174),(1861,3111,100),(1861,3173,61),(1861,3197,74),(1861,3200,111),(1861,3233,182),(1861,3237,192),(1861,3254,153),(1861,3261,53),(1861,3266,168),(1861,3270,80),(1861,3278,8),(1861,3283,135),(1861,3288,16),(1861,3290,179),(1861,3292,50),(1861,3297,110),(1861,3321,88),(1861,3345,48),(1861,3361,141),(1861,3424,121),(1861,3426,115),(1861,3430,165),(1861,3446,144),(1861,3520,19),(1861,3525,14),(1861,3546,38),(1861,3555,52),(1861,3558,188),(1861,3564,195),(1861,3566,129),(1861,3575,15),(1861,3600,4),(1861,3624,159),(1861,3626,154),(1861,3645,39),(1861,3653,132),(1861,3689,149),(1861,3701,68),(1861,3717,127),(1861,3738,75),(1861,3741,102),(1861,3753,0),(1861,3755,84),(1861,3764,145),(1861,3767,70),(1861,3783,139),(1861,3786,69),(1861,3825,119),(1861,3844,32),(1861,3853,167),(1861,5855,177),(1861,5861,17),(1861,5862,22),(1861,5863,94),(1861,5864,98),(1861,5865,99),(1861,5866,157),(1861,5868,187),(1861,5869,199),(1861,6609,3),(1862,20,1),(1862,3004,0),(1862,3256,2),(1863,20,1),(1863,50,0),(1864,20,80),(1864,613,36),(1864,635,151),(1864,640,43),(1864,642,161),(1864,699,162),(1864,772,69),(1864,780,198),(1864,789,188),(1864,796,197),(1864,805,158),(1864,904,55),(1864,913,207),(1864,922,133),(1864,923,165),(1864,962,116),(1864,965,175),(1864,968,201),(1864,1024,187),(1864,1043,107),(1864,1078,83),(1864,1094,222),(1864,1138,77),(1864,1168,137),(1864,1186,63),(1864,1220,0),(1864,1242,97),(1864,1243,27),(1864,1254,118),(1864,1285,159),(1864,1291,129),(1864,1293,20),(1864,1322,209),(1864,1331,85),(1864,1350,98),(1864,1391,106),(1864,1410,177),(1864,1412,223),(1864,1413,45),(1864,1418,38),(1864,1427,64),(1864,1429,180),(1864,1458,228),(1864,1492,35),(1864,1493,141),(1864,1494,50),(1864,1502,88),(1864,1509,126),(1864,1513,61),(1864,1525,108),(1864,1533,147),(1864,1550,67),(1864,1558,73),(1864,1575,111),(1864,1587,60),(1864,1593,173),(1864,1603,168),(1864,1611,112),(1864,1632,82),(1864,1650,224),(1864,1658,128),(1864,1669,191),(1864,1678,196),(1864,1680,142),(1864,1687,57),(1864,1718,219),(1864,1737,102),(1864,1751,185),(1864,1776,150),(1864,1777,217),(1864,1787,68),(1864,1792,120),(1864,1798,145),(1864,1800,171),(1864,1814,71),(1864,1820,59),(1864,1858,90),(1864,1888,181),(1864,1890,139),(1864,1897,89),(1864,1904,143),(1864,1910,215),(1864,1935,75),(1864,1939,210),(1864,1958,148),(1864,1959,51),(1864,1974,3),(1864,2012,156),(1864,2022,93),(1864,2032,172),(1864,2058,122),(1864,2094,132),(1864,2112,48),(1864,2117,101),(1864,2120,53),(1864,2127,130),(1864,2134,70),(1864,2155,84),(1864,2178,91),(1864,2189,46),(1864,2205,167),(1864,2206,176),(1864,2236,25),(1864,2239,216),(1864,2255,183),(1864,2259,149),(1864,2303,189),(1864,2438,110),(1864,2449,138),(1864,2483,54),(1864,2513,86),(1864,2519,202),(1864,2521,212),(1864,2522,134),(1864,2546,34),(1864,2573,33),(1864,2634,4),(1864,2637,37),(1864,2677,211),(1864,2707,186),(1864,2711,155),(1864,2712,115),(1864,2759,204),(1864,2767,72),(1864,2768,121),(1864,2782,117),(1864,2830,220),(1864,2846,49),(1864,2856,206),(1864,2859,31),(1864,2878,62),(1864,2881,114),(1864,2891,56),(1864,2931,199),(1864,2957,104),(1864,2964,194),(1864,2998,226),(1864,3001,103),(1864,3006,195),(1864,3030,96),(1864,3035,81),(1864,3036,131),(1864,3051,163),(1864,3086,153),(1864,3090,200),(1864,3111,125),(1864,3173,87),(1864,3197,99),(1864,3200,136),(1864,3233,208),(1864,3237,218),(1864,3254,178),(1864,3261,79),(1864,3266,193),(1864,3270,105),(1864,3278,32),(1864,3283,160),(1864,3288,41),(1864,3290,205),(1864,3292,76),(1864,3297,135),(1864,3321,113),(1864,3345,74),(1864,3361,166),(1864,3424,146),(1864,3426,140),(1864,3430,190),(1864,3446,169),(1864,3520,44),(1864,3525,39),(1864,3546,65),(1864,3555,78),(1864,3558,214),(1864,3564,221),(1864,3566,154),(1864,3575,40),(1864,3600,52),(1864,3624,184),(1864,3626,179),(1864,3645,66),(1864,3653,157),(1864,3689,174),(1864,3701,92),(1864,3717,152),(1864,3738,100),(1864,3741,127),(1864,3755,109),(1864,3764,170),(1864,3767,95),(1864,3783,164),(1864,3786,94),(1864,3825,144),(1864,3844,58),(1864,3853,192),(1864,5855,203),(1864,5861,42),(1864,5862,47),(1864,5863,119),(1864,5864,123),(1864,5865,124),(1864,5866,182),(1864,5868,213),(1864,5869,225),(1864,6445,19),(1864,6640,1),(1864,6641,2),(1864,6642,5),(1864,6643,6),(1864,6644,7),(1864,6645,8),(1864,6646,9),(1864,6647,10),(1864,6648,11),(1864,6649,12),(1864,6650,13),(1864,6651,14),(1864,6652,15),(1864,6653,16),(1864,6654,17),(1864,6655,18),(1864,6656,21),(1864,6657,22),(1864,6658,23),(1864,6659,24),(1864,6660,26),(1864,6661,28),(1864,6662,29),(1864,6663,30),(1864,6664,227),(1865,20,63),(1865,970,81),(1865,1054,31),(1865,1216,5),(1865,1690,24),(1865,1944,3),(1865,2275,104),(1865,2765,53),(1865,3079,27),(1865,3113,93),(1865,3819,7),(1865,3833,61),(1865,6097,21),(1865,6152,29),(1865,6240,106),(1865,6243,131),(1865,6279,132),(1865,6292,56),(1865,6320,64),(1865,6325,94),(1865,6326,30),(1865,6327,102),(1865,6328,97),(1865,6329,45),(1865,6330,95),(1865,6331,37),(1865,6332,22),(1865,6333,33),(1865,6334,86),(1865,6335,90),(1865,6336,65),(1865,6337,92),(1865,6338,17),(1865,6339,79),(1865,6340,42),(1865,6341,89),(1865,6342,60),(1865,6344,77),(1865,6345,44),(1865,6346,73),(1865,6347,103),(1865,6348,78),(1865,6349,57),(1865,6350,101),(1865,6351,109),(1865,6352,47),(1865,6353,71),(1865,6354,105),(1865,6355,99),(1865,6356,26),(1865,6357,91),(1865,6358,49),(1865,6359,70),(1865,6360,110),(1865,6361,87),(1865,6362,74),(1865,6363,18),(1865,6364,75),(1865,6365,69),(1865,6366,98),(1865,6367,35),(1865,6368,58),(1865,6369,67),(1865,6370,111),(1865,6371,38),(1865,6372,107),(1865,6373,25),(1865,6374,128),(1865,6375,23),(1865,6376,46),(1865,6377,55),(1865,6378,88),(1865,6379,62),(1865,6380,85),(1865,6381,32),(1865,6382,41),(1865,6383,66),(1865,6384,96),(1865,6385,48),(1865,6386,108),(1865,6387,68),(1865,6388,82),(1865,6389,20),(1865,6390,36),(1865,6391,76),(1865,6392,84),(1865,6393,59),(1865,6394,83),(1865,6395,43),(1865,6396,51),(1865,6397,80),(1865,6398,72),(1865,6399,19),(1865,6516,114),(1865,6531,125),(1865,6560,100),(1865,6591,120),(1865,6600,52),(1865,6702,0),(1865,6703,1),(1865,6704,2),(1865,6705,4),(1865,6706,6),(1865,6707,8),(1865,6708,9),(1865,6709,10),(1865,6710,11),(1865,6711,12),(1865,6712,13),(1865,6713,14),(1865,6714,15),(1865,6715,16),(1865,6716,28),(1865,6717,34),(1865,6718,39),(1865,6719,40),(1865,6720,50),(1865,6721,54),(1865,6722,112),(1865,6723,113),(1865,6724,115),(1865,6725,116),(1865,6726,117),(1865,6727,118),(1865,6728,119),(1865,6729,121),(1865,6730,122),(1865,6731,123),(1865,6732,124),(1865,6733,126),(1865,6734,127),(1865,6735,129),(1865,6736,130),(1865,6737,133),(1866,20,159),(1866,660,125),(1866,681,3),(1866,707,38),(1866,754,93),(1866,782,9),(1866,814,150),(1866,824,145),(1866,878,136),(1866,943,29),(1866,1153,88),(1866,1168,44),(1866,1175,56),(1866,1191,12),(1866,1193,151),(1866,1280,73),(1866,1352,96),(1866,1360,17),(1866,1361,8),(1866,1394,66),(1866,1456,91),(1866,1542,39),(1866,1549,13),(1866,1577,110),(1866,1578,90),(1866,1579,123),(1866,1593,149),(1866,1594,67),(1866,1611,147),(1866,1635,143),(1866,1666,158),(1866,1740,11),(1866,1773,19),(1866,1779,18),(1866,1810,28),(1866,1834,80),(1866,1847,64),(1866,1851,128),(1866,1852,146),(1866,1860,104),(1866,1887,7),(1866,1915,97),(1866,1919,156),(1866,1932,102),(1866,1965,124),(1866,1978,142),(1866,1984,41),(1866,2030,92),(1866,2032,154),(1866,2063,62),(1866,2071,164),(1866,2074,160),(1866,2078,144),(1866,2080,163),(1866,2107,100),(1866,2130,14),(1866,2133,127),(1866,2150,51),(1866,2158,1),(1866,2238,135),(1866,2267,45),(1866,2306,33),(1866,2325,31),(1866,2327,20),(1866,2381,132),(1866,2411,152),(1866,2571,50),(1866,2575,27),(1866,2605,122),(1866,2606,115),(1866,2607,42),(1866,2627,114),(1866,2649,5),(1866,2662,87),(1866,2663,65),(1866,2676,162),(1866,2687,81),(1866,2788,24),(1866,2789,72),(1866,2794,2),(1866,2803,79),(1866,2817,78),(1866,2859,153),(1866,2882,54),(1866,2888,21),(1866,2917,137),(1866,2943,138),(1866,2945,99),(1866,2978,69),(1866,3003,34),(1866,3009,83),(1866,3046,47),(1866,3047,32),(1866,3051,155),(1866,3056,157),(1866,3133,107),(1866,3176,15),(1866,3243,22),(1866,3265,161),(1866,3319,6),(1866,3411,57),(1866,3465,55),(1866,3469,53),(1866,3474,141),(1866,3485,133),(1866,3504,40),(1866,3556,37),(1866,3559,48),(1866,3577,140),(1866,3598,139),(1866,3645,35),(1866,3667,85),(1866,3679,25),(1866,3754,10),(1866,3762,113),(1866,3801,58),(1866,3894,30),(1866,5871,59),(1866,5888,86),(1866,6646,0),(1866,6738,46),(1866,6740,63),(1866,6741,112),(1866,6742,68),(1866,6743,98),(1866,6744,116),(1866,6745,118),(1866,6746,121),(1866,6747,70),(1866,6748,71),(1866,6749,101),(1866,6750,126),(1866,6751,75),(1866,6752,111),(1866,6753,117),(1866,6754,76),(1866,6755,49),(1866,6756,52),(1866,6757,105),(1866,6758,95),(1866,6759,108),(1866,6760,166),(1866,6764,106),(1866,6765,89),(1866,6766,134),(1866,6767,129),(1866,6768,84),(1866,6769,77),(1866,6770,119),(1866,6771,26),(1866,6772,120),(1866,6773,61),(1866,6775,74),(1866,6776,130),(1866,6777,109),(1866,6778,36),(1866,6782,131),(1866,6791,148),(1866,6792,4),(1866,6793,16),(1866,6794,23),(1866,6795,43),(1866,6796,60),(1866,6797,82),(1866,6798,94),(1866,6799,103),(1866,6800,165),(1867,20,3),(1867,667,1),(1867,1241,4),(1867,1920,0),(1867,3412,2),(1868,17,1),(1868,20,5),(1868,126,4),(1868,1279,2),(1868,2290,3),(1868,3706,0),(1869,20,0),(1869,135,2),(1869,2054,1),(1870,20,11),(1870,1065,17),(1870,1678,16),(1870,1684,10),(1870,2091,12),(1870,2216,8),(1870,2371,13),(1870,2537,14),(1870,2589,19),(1870,2709,15),(1870,2758,1),(1870,2832,0),(1870,2974,9),(1870,3582,2),(1870,3733,18),(1870,5961,3),(1870,6803,4),(1870,6804,5),(1870,6805,6),(1870,6806,7),(1871,20,59),(1871,613,15),(1871,616,5),(1871,635,130),(1871,640,21),(1871,642,139),(1871,699,140),(1871,772,48),(1871,780,174),(1871,789,165),(1871,796,9),(1871,805,136),(1871,904,34),(1871,913,183),(1871,922,112),(1871,923,143),(1871,962,95),(1871,965,153),(1871,968,177),(1871,1024,2),(1871,1043,86),(1871,1078,62),(1871,1094,198),(1871,1138,56),(1871,1168,116),(1871,1186,42),(1871,1242,76),(1871,1254,97),(1871,1285,137),(1871,1291,108),(1871,1322,4),(1871,1331,64),(1871,1350,77),(1871,1391,85),(1871,1410,155),(1871,1412,199),(1871,1413,24),(1871,1418,16),(1871,1427,43),(1871,1429,158),(1871,1458,23),(1871,1492,14),(1871,1493,120),(1871,1494,29),(1871,1502,67),(1871,1509,105),(1871,1513,40),(1871,1525,87),(1871,1533,126),(1871,1550,46),(1871,1558,52),(1871,1575,90),(1871,1587,39),(1871,1593,151),(1871,1603,146),(1871,1611,91),(1871,1632,61),(1871,1650,200),(1871,1658,107),(1871,1669,168),(1871,1678,173),(1871,1680,121),(1871,1687,36),(1871,1718,195),(1871,1737,81),(1871,1751,163),(1871,1776,129),(1871,1777,193),(1871,1787,47),(1871,1792,99),(1871,1798,124),(1871,1800,149),(1871,1814,50),(1871,1820,38),(1871,1858,69),(1871,1888,159),(1871,1890,118),(1871,1897,68),(1871,1904,122),(1871,1910,191),(1871,1935,54),(1871,1939,186),(1871,1958,127),(1871,1959,30),(1871,2012,134),(1871,2022,72),(1871,2032,150),(1871,2058,101),(1871,2094,111),(1871,2112,27),(1871,2117,80),(1871,2120,32),(1871,2127,109),(1871,2134,49),(1871,2155,63),(1871,2178,70),(1871,2189,25),(1871,2205,145),(1871,2206,154),(1871,2239,192),(1871,2255,161),(1871,2259,128),(1871,2303,166),(1871,2438,89),(1871,2449,117),(1871,2483,33),(1871,2513,65),(1871,2519,178),(1871,2521,188),(1871,2522,113),(1871,2546,13),(1871,2573,12),(1871,2637,1),(1871,2677,187),(1871,2707,164),(1871,2711,133),(1871,2712,94),(1871,2759,180),(1871,2767,51),(1871,2768,100),(1871,2782,96),(1871,2830,196),(1871,2846,28),(1871,2856,182),(1871,2859,10),(1871,2878,41),(1871,2881,93),(1871,2891,35),(1871,2931,175),(1871,2957,83),(1871,2964,171),(1871,2998,202),(1871,3001,82),(1871,3006,172),(1871,3015,98),(1871,3030,75),(1871,3035,60),(1871,3036,110),(1871,3051,141),(1871,3086,3),(1871,3090,176),(1871,3111,104),(1871,3173,66),(1871,3197,78),(1871,3200,115),(1871,3233,184),(1871,3237,194),(1871,3254,156),(1871,3261,58),(1871,3266,170),(1871,3270,84),(1871,3272,8),(1871,3278,11),(1871,3283,138),(1871,3288,19),(1871,3290,181),(1871,3292,55),(1871,3297,114),(1871,3321,92),(1871,3345,53),(1871,3361,144),(1871,3424,125),(1871,3426,119),(1871,3430,167),(1871,3446,147),(1871,3520,22),(1871,3525,17),(1871,3546,44),(1871,3555,57),(1871,3558,190),(1871,3564,197),(1871,3566,132),(1871,3575,18),(1871,3600,31),(1871,3624,162),(1871,3626,157),(1871,3645,45),(1871,3653,135),(1871,3689,152),(1871,3701,71),(1871,3717,131),(1871,3738,79),(1871,3741,106),(1871,3755,88),(1871,3764,148),(1871,3767,74),(1871,3783,142),(1871,3786,73),(1871,3825,123),(1871,3844,37),(1871,3853,169),(1871,5855,179),(1871,5861,20),(1871,5862,26),(1871,5864,102),(1871,5865,103),(1871,5866,160),(1871,5868,189),(1871,5869,201),(1871,6807,0),(1871,6808,7),(1871,7296,6),(1872,20,39),(1872,970,19),(1872,1054,21),(1872,1690,71),(1872,2275,53),(1872,2728,70),(1872,2765,74),(1872,3079,84),(1872,3113,87),(1872,3833,64),(1872,6097,50),(1872,6152,38),(1872,6240,59),(1872,6292,8),(1872,6296,7),(1872,6320,6),(1872,6325,10),(1872,6326,11),(1872,6327,12),(1872,6328,13),(1872,6329,14),(1872,6330,15),(1872,6331,16),(1872,6332,17),(1872,6333,18),(1872,6334,20),(1872,6335,22),(1872,6336,23),(1872,6337,24),(1872,6338,25),(1872,6339,26),(1872,6340,27),(1872,6341,28),(1872,6342,29),(1872,6343,30),(1872,6345,32),(1872,6346,33),(1872,6348,35),(1872,6349,36),(1872,6350,37),(1872,6351,40),(1872,6352,42),(1872,6353,43),(1872,6354,44),(1872,6355,45),(1872,6356,47),(1872,6357,48),(1872,6358,49),(1872,6359,51),(1872,6360,54),(1872,6361,55),(1872,6362,56),(1872,6363,57),(1872,6365,60),(1872,6367,62),(1872,6368,63),(1872,6369,65),(1872,6370,66),(1872,6371,67),(1872,6372,68),(1872,6373,69),(1872,6374,9),(1872,6375,72),(1872,6376,73),(1872,6377,75),(1872,6378,76),(1872,6379,77),(1872,6380,78),(1872,6381,79),(1872,6382,80),(1872,6383,81),(1872,6384,82),(1872,6385,83),(1872,6386,85),(1872,6387,86),(1872,6388,2),(1872,6389,88),(1872,6390,89),(1872,6391,90),(1872,6393,92),(1872,6394,93),(1872,6395,94),(1872,6396,95),(1872,6397,96),(1872,6398,97),(1872,6399,99),(1872,6555,61),(1872,6560,46),(1872,6600,52),(1872,6602,34),(1872,6834,0),(1872,6835,1),(1872,6836,3),(1872,6837,4),(1872,6838,5),(1872,6839,31),(1872,6840,41),(1872,6841,58),(1872,6842,91),(1872,6843,98),(1873,20,4),(1873,49,3),(1873,620,10),(1873,1205,5),(1873,1452,1),(1873,1486,9),(1873,2220,0),(1873,3207,6),(1873,3380,2),(1873,6855,7),(1873,6856,8),(1874,20,72),(1874,613,28),(1874,635,19),(1874,640,35),(1874,642,142),(1874,699,143),(1874,772,6),(1874,780,176),(1874,789,166),(1874,796,175),(1874,805,140),(1874,904,48),(1874,913,23),(1874,922,119),(1874,923,146),(1874,962,104),(1874,965,3),(1874,968,179),(1874,1024,165),(1874,1043,98),(1874,1078,74),(1874,1094,10),(1874,1138,69),(1874,1168,122),(1874,1186,56),(1874,1242,88),(1874,1254,106),(1874,1285,141),(1874,1291,115),(1874,1322,186),(1874,1331,76),(1874,1350,89),(1874,1391,97),(1874,1410,22),(1874,1412,197),(1874,1413,38),(1874,1418,30),(1874,1427,57),(1874,1429,159),(1874,1458,37),(1874,1492,27),(1874,1493,126),(1874,1494,43),(1874,1502,79),(1874,1509,114),(1874,1513,54),(1874,1525,99),(1874,1529,1),(1874,1533,17),(1874,1550,60),(1874,1558,65),(1874,1575,101),(1874,1587,53),(1874,1593,154),(1874,1603,149),(1874,1611,102),(1874,1632,8),(1874,1650,4),(1874,1658,13),(1874,1669,169),(1874,1678,174),(1874,1680,127),(1874,1687,50),(1874,1718,194),(1874,1737,93),(1874,1751,7),(1874,1776,133),(1874,1777,192),(1874,1787,61),(1874,1792,108),(1874,1798,130),(1874,1800,152),(1874,1814,63),(1874,1820,52),(1874,1858,81),(1874,1888,160),(1874,1890,124),(1874,1897,80),(1874,1904,128),(1874,1910,190),(1874,1935,67),(1874,1939,187),(1874,1958,18),(1874,1959,44),(1874,2012,138),(1874,2022,84),(1874,2032,153),(1874,2058,110),(1874,2094,118),(1874,2112,41),(1874,2117,92),(1874,2120,46),(1874,2127,116),(1874,2134,62),(1874,2155,75),(1874,2178,82),(1874,2189,39),(1874,2205,148),(1874,2206,156),(1874,2239,191),(1874,2255,162),(1874,2259,132),(1874,2303,167),(1874,2438,100),(1874,2449,123),(1874,2483,47),(1874,2513,77),(1874,2519,180),(1874,2521,16),(1874,2522,15),(1874,2546,26),(1874,2573,25),(1874,2637,29),(1874,2677,14),(1874,2707,164),(1874,2711,137),(1874,2712,12),(1874,2759,182),(1874,2767,64),(1874,2768,109),(1874,2782,105),(1874,2830,195),(1874,2846,42),(1874,2856,184),(1874,2859,21),(1874,2878,55),(1874,2881,11),(1874,2891,49),(1874,2931,177),(1874,2957,95),(1874,2964,172),(1874,2998,199),(1874,3001,94),(1874,3006,173),(1874,3015,107),(1874,3030,87),(1874,3035,73),(1874,3036,117),(1874,3051,144),(1874,3086,135),(1874,3090,178),(1874,3111,113),(1874,3173,78),(1874,3197,90),(1874,3200,121),(1874,3233,185),(1874,3237,193),(1874,3254,157),(1874,3261,71),(1874,3266,171),(1874,3270,96),(1874,3278,24),(1874,3283,20),(1874,3288,33),(1874,3290,183),(1874,3292,68),(1874,3297,120),(1874,3321,103),(1874,3345,66),(1874,3361,147),(1874,3424,131),(1874,3426,125),(1874,3430,168),(1874,3446,150),(1874,3520,36),(1874,3525,31),(1874,3546,58),(1874,3555,70),(1874,3558,189),(1874,3564,196),(1874,3566,136),(1874,3575,32),(1874,3600,45),(1874,3624,163),(1874,3626,158),(1874,3645,59),(1874,3653,139),(1874,3689,155),(1874,3701,83),(1874,3717,134),(1874,3738,91),(1874,3741,2),(1874,3755,0),(1874,3764,151),(1874,3767,86),(1874,3783,145),(1874,3786,85),(1874,3825,129),(1874,3844,51),(1874,3853,170),(1874,5855,181),(1874,5864,111),(1874,5865,112),(1874,5866,161),(1874,5868,188),(1874,6088,9),(1874,6857,5),(1874,6858,34),(1874,6859,40),(1874,6860,198),(1875,20,2),(1875,1241,3),(1875,2039,1),(1875,2251,0),(1876,20,7),(1876,889,6),(1876,1241,8),(1876,1667,1),(1876,2039,5),(1876,2453,2),(1876,3366,4),(1876,3529,3),(1876,3816,0),(1877,20,4),(1877,718,5),(1877,1529,2),(1877,2037,1),(1877,6907,0),(1877,6908,3),(1878,20,2),(1878,1358,1),(1878,3004,0),(1879,20,2),(1879,620,3),(1879,1249,0),(1879,1604,1),(1880,20,15),(1880,824,11),(1880,1254,3),(1880,1410,18),(1880,1533,10),(1880,1603,2),(1880,1611,12),(1880,1678,20),(1880,1691,4),(1880,1958,0),(1880,1996,16),(1880,2463,9),(1880,2521,19),(1880,2589,8),(1880,2832,14),(1880,2843,7),(1880,2912,13),(1880,7095,1),(1880,7096,5),(1880,7097,6),(1880,7098,17),(1881,20,4),(1881,789,1),(1881,1492,0),(1881,1611,5),(1881,1678,6),(1881,2784,3),(1881,2859,7),(1881,2964,2),(1882,20,3),(1882,1613,0),(1882,1678,4),(1882,1684,5),(1882,2216,1),(1882,2589,6),(1882,2974,2),(1883,17,2),(1883,20,6),(1883,824,1),(1883,1241,3),(1883,1678,5),(1883,2589,4),(1883,2832,0),(1884,20,1),(1884,50,0),(1885,20,3),(1885,2039,4),(1885,7168,0),(1885,7169,1),(1885,7170,2),(1886,20,7),(1886,135,0),(1886,620,5),(1886,982,4),(1886,1241,1),(1886,1393,3),(1886,2892,6),(1886,3366,2),(1887,20,1),(1887,50,0),(1888,17,2),(1888,20,3),(1888,2696,0),(1888,2892,4),(1888,3366,1),(1889,20,28),(1889,623,30),(1889,644,12),(1889,846,19),(1889,909,51),(1889,913,63),(1889,922,72),(1889,932,23),(1889,951,54),(1889,966,65),(1889,968,53),(1889,1094,42),(1889,1259,75),(1889,1291,66),(1889,1298,11),(1889,1410,6),(1889,1412,41),(1889,1413,5),(1889,1439,89),(1889,1554,87),(1889,1650,7),(1889,1678,45),(1889,1751,26),(1889,1797,16),(1889,1798,84),(1889,1874,21),(1889,1897,40),(1889,1910,83),(1889,1912,32),(1889,1939,67),(1889,1953,8),(1889,2059,24),(1889,2091,48),(1889,2094,70),(1889,2097,35),(1889,2239,85),(1889,2294,39),(1889,2303,36),(1889,2476,31),(1889,2521,71),(1889,2676,37),(1889,2677,68),(1889,2698,34),(1889,2707,27),(1889,2759,58),(1889,2767,25),(1889,2768,60),(1889,2830,92),(1889,2859,94),(1889,2891,13),(1889,2933,1),(1889,2957,49),(1889,2965,50),(1889,2985,82),(1889,2998,0),(1889,3020,43),(1889,3054,80),(1889,3063,3),(1889,3080,52),(1889,3159,2),(1889,3170,15),(1889,3233,64),(1889,3254,10),(1889,3266,44),(1889,3278,73),(1889,3458,18),(1889,3459,79),(1889,3537,22),(1889,3558,81),(1889,3564,93),(1889,3737,29),(1889,5855,55),(1889,5905,46),(1889,5949,61),(1889,5950,62),(1889,5955,56),(1889,5957,59),(1889,6072,91),(1889,6913,38),(1889,6928,47),(1889,6939,57),(1889,6955,74),(1889,6958,76),(1889,6959,77),(1889,6960,78),(1889,6972,86),(1889,6973,88),(1889,7177,4),(1889,7178,9),(1889,7179,14),(1889,7180,17),(1889,7181,20),(1889,7182,33),(1889,7183,69),(1889,7184,90),(1889,7185,95),(1890,20,0),(1891,20,0),(1892,20,3),(1892,2274,2),(1892,3366,1),(1892,7187,0),(1893,20,1),(1893,1937,0),(1893,2104,2),(1893,3089,3),(1894,20,4),(1894,928,6),(1894,970,7),(1894,1143,10),(1894,2275,8),(1894,2728,0),(1894,3079,1),(1894,6361,5),(1894,6864,3),(1894,7192,2),(1894,7193,9),(1895,20,3),(1895,1679,1),(1895,1886,0),(1895,7195,2),(1895,7196,4),(1896,20,1),(1896,7199,0),(1897,20,3),(1897,1032,0),(1897,7199,1),(1897,7200,2),(1898,20,8),(1898,623,31),(1898,680,11),(1898,933,30),(1898,1674,6),(1898,1679,17),(1898,1981,32),(1898,2099,40),(1898,2102,35),(1898,2289,41),(1898,3425,20),(1898,3585,0),(1898,3655,18),(1898,3833,27),(1898,7207,1),(1898,7208,2),(1898,7209,3),(1898,7210,4),(1898,7211,5),(1898,7212,7),(1898,7213,9),(1898,7214,12),(1898,7215,13),(1898,7216,14),(1898,7217,15),(1898,7218,16),(1898,7219,19),(1898,7220,21),(1898,7221,22),(1898,7222,23),(1898,7223,24),(1898,7224,25),(1898,7225,26),(1898,7226,28),(1898,7227,29),(1898,7228,33),(1898,7229,34),(1898,7230,36),(1898,7231,37),(1898,7232,38),(1898,7233,39),(1899,20,6),(1899,1341,4),(1899,1674,5),(1899,1679,3),(1899,1899,1),(1899,2633,2),(1899,3024,0),(1900,20,3),(1900,626,4),(1900,928,2),(1900,3632,1),(1900,3806,0),(1901,20,2),(1901,1100,0),(1901,1706,1),(1902,20,1),(1902,7247,0),(1903,20,1),(1903,1673,2),(1903,7248,0),(1904,20,1),(1904,2596,0),(1905,20,0),(1905,1317,1),(1906,20,0),(1907,20,0),(1907,626,3),(1907,723,1),(1907,1088,2),(1908,20,3),(1908,2965,0),(1908,7277,1),(1908,7278,2),(1909,20,0),(1909,1088,1),(1910,20,0),(1910,1088,1),(1911,15,4),(1911,20,8),(1911,135,7),(1911,620,6),(1911,1241,0),(1911,1297,3),(1911,1920,5),(1911,2039,9),(1911,2311,1),(1911,3902,2),(1912,20,6),(1912,620,7),(1912,1486,3),(1912,2297,1),(1912,2542,4),(1912,3175,2),(1912,3791,0),(1912,3909,5),(1913,20,13),(1913,77,1),(1913,135,9),(1913,643,8),(1913,912,5),(1913,1102,12),(1913,1930,0),(1913,2691,4),(1913,3004,2),(1913,3077,11),(1913,3256,3),(1913,3453,6),(1913,3471,7),(1913,6080,10),(1914,20,5),(1914,1023,1),(1914,1026,0),(1914,2470,3),(1914,3265,4),(1914,3366,6),(1914,3787,2),(1915,17,1),(1915,18,0),(1915,20,7),(1915,870,5),(1915,2011,4),(1915,2752,2),(1915,3534,3),(1915,6081,6),(1916,20,5),(1916,49,1),(1916,620,6),(1916,1452,2),(1916,1486,4),(1916,2220,3),(1916,3380,0),(1917,15,0),(1917,20,12),(1917,77,10),(1917,135,1),(1917,620,9),(1917,724,6),(1917,1241,4),(1917,1393,8),(1917,2054,2),(1917,2838,7),(1917,3004,11),(1917,3256,3),(1917,6615,5),(1918,20,6),(1918,904,1),(1918,979,4),(1918,1500,5),(1918,1678,7),(1918,2492,0),(1918,2746,2),(1918,2832,8),(1918,3270,3),(1919,17,1),(1919,20,0),(1919,1641,2),(1919,3763,3),(1919,7189,4),(1919,7190,5),(1920,20,1),(1920,7206,0),(1922,20,23),(1922,77,0),(1922,643,7),(1922,718,22),(1922,1314,1),(1922,1422,4),(1922,1437,19),(1922,1455,11),(1922,1571,18),(1922,1580,14),(1922,1768,5),(1922,1823,16),(1922,2076,17),(1922,2519,9),(1922,2719,3),(1922,2754,20),(1922,2892,6),(1922,2980,8),(1922,3004,2),(1922,3077,13),(1922,3078,21),(1922,3165,15),(1922,3390,12),(1922,3508,10),(1923,20,2),(1923,3251,0),(1923,3366,1),(1924,20,6),(1924,723,9),(1924,1217,2),(1924,1235,8),(1924,1327,5),(1924,1329,4),(1924,1600,1),(1924,1892,7),(1924,2585,10),(1924,2892,0),(1924,3450,3),(1925,17,4),(1925,20,3),(1925,135,5),(1925,3366,6),(1925,7244,0),(1925,7245,1),(1925,7246,2),(1926,17,3),(1926,20,2),(1926,1622,1),(1926,7239,0),(1927,20,2),(1927,866,5),(1927,1902,4),(1927,2287,0),(1927,2535,3),(1927,7252,1),(1928,20,2),(1928,1673,5),(1928,1706,3),(1928,2284,0),(1928,2531,4),(1928,2965,1),(1928,2972,6);
/*!40000 ALTER TABLE `project_authors` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `project_keywords`
--

DROP TABLE IF EXISTS `project_keywords`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `project_keywords` (
  `project_id` int(11) NOT NULL,
  `keyword_id` int(11) NOT NULL,
  PRIMARY KEY (`project_id`,`keyword_id`),
  KEY `keyword_id` (`keyword_id`),
  CONSTRAINT `project_keywords_ibfk_1` FOREIGN KEY (`project_id`) REFERENCES `projects` (`project_id`),
  CONSTRAINT `project_keywords_ibfk_2` FOREIGN KEY (`keyword_id`) REFERENCES `keywords` (`keyword_id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `project_keywords`
--

LOCK TABLES `project_keywords` WRITE;
/*!40000 ALTER TABLE `project_keywords` DISABLE KEYS */;
INSERT INTO `project_keywords` VALUES (41,4),(41,10),(41,11),(41,33),(41,34),(41,35),(41,36),(41,37),(41,44),(43,4),(43,38),(43,39),(43,40),(43,41),(43,42),(68,6),(68,7),(68,8),(68,9),(68,10),(68,11),(68,76),(72,41),(72,43),(72,44),(72,45),(73,1),(73,50),(73,51),(73,52),(107,8),(107,9),(107,11),(108,55),(108,56),(108,57),(108,58),(109,50),(109,52),(109,59),(109,60),(109,61),(110,62),(110,63),(110,64),(116,65),(116,66),(116,67),(116,83),(118,11),(118,68),(118,69),(118,70),(118,71),(118,72),(118,73),(118,79),(289,99),(289,100),(291,112),(293,84),(304,90),(306,90),(314,91),(316,90),(317,112),(321,112),(324,90),(325,104),(329,84),(333,84),(335,99),(338,90),(348,84),(354,112),(358,90),(363,90),(364,99),(365,113),(366,86),(373,105),(375,90),(378,84),(381,85),(382,99),(386,98),(592,78),(594,85),(597,85),(598,115),(600,85),(602,90),(605,90),(606,79),(610,85),(611,90),(617,90),(619,86),(620,112),(625,85),(626,77),(631,98),(632,90),(636,99),(639,92),(645,78),(646,81),(648,90),(649,98),(654,84),(662,90),(664,105),(670,93),(673,84),(675,105),(678,85),(681,108),(687,77),(694,112),(698,91),(701,99),(702,110),(703,99),(705,90),(709,113),(710,98),(713,91),(717,85),(718,118),(719,85),(721,105),(723,105),(724,85),(725,90),(726,85),(731,105),(733,85),(735,98),(737,100),(743,83),(745,90),(749,86),(750,86),(751,90),(752,85),(753,90),(758,115),(762,84),(770,85),(779,85),(780,98),(781,90),(782,100),(784,84),(785,86),(786,78),(788,98),(789,105),(791,82),(792,79),(796,100),(797,100),(799,85),(802,84),(804,90),(814,90),(818,85),(821,90),(826,90),(829,100),(838,77),(843,90),(846,86),(847,109),(848,113),(852,116),(861,83),(864,90),(865,78),(866,105),(869,100),(874,85),(879,100),(881,105),(887,90),(891,99),(892,85),(894,85),(895,90),(898,117),(901,94),(902,83),(909,85),(910,113),(911,90),(911,113),(914,77),(916,85),(921,90),(927,78),(930,110),(939,99),(942,76),(944,90),(946,105),(953,85),(961,86),(963,113),(968,85),(970,79),(972,78),(973,85),(976,78),(982,90),(983,90),(992,77),(993,114),(997,100),(998,84),(1008,85),(1009,85),(1012,84),(1015,90),(1017,90),(1021,100),(1021,110),(1025,83),(1026,85),(1030,99),(1032,85),(1034,105),(1038,107),(1039,83),(1041,90),(1044,85),(1045,98),(1049,85),(1050,84),(1055,110),(1058,76),(1072,84),(1076,85),(1080,105),(1082,105),(1083,111),(1093,76),(1101,90),(1102,104),(1109,84),(1110,96),(1119,90),(1136,76),(1137,100),(1139,85),(1148,83),(1150,105),(1152,90),(1153,77),(1155,113),(1156,85),(1162,104),(1164,106),(1170,94),(1177,90),(1179,90),(1181,94),(1184,91),(1186,76),(1188,94),(1189,103),(1192,84),(1198,116),(1200,90),(1204,76),(1209,76),(1210,100),(1213,102),(1215,86),(1217,84),(1226,86),(1233,86),(1234,93),(1235,86),(1236,79),(1236,95),(1237,97),(1238,95),(1243,84),(1245,99),(1257,84),(1263,77),(1267,85),(1297,84),(1324,76),(1334,76),(1339,83),(1340,98),(1341,99),(1342,84),(1347,76),(1347,101),(1348,77),(1362,85),(1377,90),(1378,77),(1388,80),(1392,79),(1393,83),(1395,82),(1397,85),(1398,78),(1401,84),(1404,92),(1406,100),(1411,89),(1417,85),(1419,85),(1423,98),(1430,83),(1438,77),(1452,99),(1471,77),(1495,86),(1748,87),(1753,92),(1754,90),(1758,91),(1759,91),(1761,91),(1763,79),(1764,84),(1766,78),(1767,84),(1769,85),(1770,110),(1772,90),(1773,90),(1774,105),(1778,90),(1779,91),(1780,91),(1847,76),(1848,78),(1849,81),(1850,84),(1852,88),(1853,89),(1856,85),(1862,84),(1867,78),(1868,79),(1869,90),(1875,78),(1875,113),(1876,83),(1877,85),(1881,99),(1886,77),(1890,90),(1893,98),(1896,90),(1897,90),(1902,98),(1913,84),(1914,85),(1917,84),(1919,90),(1922,83),(1923,85),(1928,90);
/*!40000 ALTER TABLE `project_keywords` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `projects`
--

DROP TABLE IF EXISTS `projects`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `projects` (
  `project_id` int(11) NOT NULL AUTO_INCREMENT,
  `project_name` varchar(255) NOT NULL,
  `url` varchar(2048) DEFAULT NULL,
  `doi` varchar(255) DEFAULT NULL,
  `statement` text DEFAULT NULL,
  `full_text` mediumtext NOT NULL,
  `year` year(4) DEFAULT NULL,
  `start_date` date DEFAULT NULL,
  `end_date` date DEFAULT NULL,
  `release_date` date DEFAULT NULL,
  `country` varchar(255) DEFAULT NULL,
  `funding_org` varchar(255) DEFAULT NULL,
  `funding_amount` int(11) DEFAULT NULL,
  `type_id` int(11) DEFAULT NULL,
  `cited_by` varchar(255) DEFAULT NULL,
  `journal` varchar(255) DEFAULT NULL,
  `volume` varchar(255) DEFAULT NULL,
  `issue` varchar(255) DEFAULT NULL,
  `pages` varchar(255) DEFAULT NULL,
  `publisher` varchar(255) DEFAULT NULL,
  `project_lead` varchar(255) DEFAULT NULL,
  `primary_tag` varchar(255) DEFAULT NULL,
  `secondary_tag` varchar(255) DEFAULT NULL,
  PRIMARY KEY (`project_id`),
  UNIQUE KEY `project_name` (`project_name`),
  KEY `type_id` (`type_id`),
  CONSTRAINT `projects_ibfk_1` FOREIGN KEY (`type_id`) REFERENCES `types` (`type_id`)
) ENGINE=InnoDB AUTO_INCREMENT=1931 DEFAULT CHARSET=utf8mb4;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `projects`
--

LOCK TABLES `projects` WRITE;
/*!40000 ALTER TABLE `projects` DISABLE KEYS */;
INSERT INTO `projects` VALUES (41,'The impact of technology-enabled care coordination in a complex mental health system:a local system dynamics model','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85109180213&doi=10.2196%2f25331&partnerID=40&md5=b62013ee239c97b83b77b308ce07ba49','10.2196/25331','           Background           Prior to the COVID-19 pandemic, major shortcomings in the way mental health care systems were organized were impairing the delivery of effective care. The mental health impacts of the pandemic, the recession, and the resulting social dislocation will depend on the extent to which care systems will become overwhelmed and on the strategic investments made across the system to effectively respond.                             Objective           This study aimed to explore the impact of strengthening the mental health system through technology-enabled care coordination on mental health and suicide outcomes.                             Methods           A system dynamics model for the regional population catchment of North Coast New South Wales, Australia, was developed that incorporated defined pathways from social determinants of mental health to psychological distress, mental health care, and suicidal behavior. The model reproduced historic time series data across a range of outcomes and was used to evaluate the relative impact of a set of scenarios on attempted suicide (ie, self-harm hospitalizations), suicide deaths, mental health├éΓÇôrelated emergency department (ED) presentations, and psychological distress over the period from 2021 to 2030. These scenarios include (1) business as usual, (2) increase in service capacity growth rate by 20%, (3) standard telehealth, and (4) technology-enabled care coordination. Each scenario was tested using both pre├éΓÇô and post├éΓÇôCOVID-19 social and economic conditions.                             Results           Technology-enabled care coordination was forecast to deliver a reduction in self-harm├é┬á├éΓÇª\n','',2021,NULL,NULL,'2021-06-30',NULL,NULL,NULL,NULL,'14','Journal of Medical Internet Research','23','6','e25331','JMIR Publications Inc., Toronto, Canada','YMH team','Digital health','Models of care'),(43,'System Dynamics Modeling of Humanitarian Relief Operations','https://papers.ssrn.com/sol3/papers.cfm?abstract_id=1139817#',NULL,NULL,'',0000,NULL,NULL,'2008-06-02',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(68,'Sound Decision Making in Uncertain Times: Can Systems Modelling be Useful for Informing Policy and Planning for Suicide Prevention?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85123367034&doi=10.3390%2fijerph19031468&partnerID=40&md5=f2dca803152a3a0e60c8b4c74da9a85d','10.3390/ijerph19031468','The COVID-19 pandemic demonstrated the significant value of systems modelling in supporting proactive and effective public health decision making despite the complexities and uncertainties that characterise an evolving crisis. The same approach is possible in the field of mental health. However, a commonly levelled (but misguided) criticism prevents systems modelling from being more routinely adopted, namely, that the presence of uncertainty around key model input parameters renders a model useless. This study explored whether radically different simulated trajectories of suicide would result in different advice to decision makers regarding the optimal strategy to mitigate the impacts of the pandemic on mental health. Using an existing system dynamics model developed in August 2020 for a regional catchment of Western Australia, four scenarios were simulated to model the possible effect of the COVID-19 pandemic on levels of psychological distress. The scenarios produced a range of projected impacts on suicide deaths, ranging from a relatively small to a dramatic increase. Discordance in the sets of best-performing intervention scenarios across the divergent COVID-mental health trajectories was assessed by comparing differences in projected numbers of suicides between the baseline scenario and each of 286 possible intervention scenarios calculated for two time horizons; 2026 and 2041. The best performing intervention combinations over the period 2021ΓÇô2041 (i.e., post-suicide attempt assertive aftercare, community support programs to increase community connectedness, and technology enabled care coordination) were highly├é┬á├éΓÇª','',2022,NULL,NULL,'2022-01-27',NULL,NULL,NULL,NULL,'1','International Journal of Environmental Research and Public Health','19','3','1468','MDPI','YMH team','Mental Health System',''),(71,'Systems modelling tools to support policy and planning','https://doi.org/10.1016/S0140-6736(18)30302-7',NULL,NULL,'',2018,NULL,NULL,'2018-03-24',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(72,'The impact of strengthening mental health services to prevent suicidal behaviour','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060217163&doi=10.1177%2f0004867418817381&partnerID=40&md5=9f75d0a3ac0bb8b36a62a1b68809fa94','10.1177/0004867418817381','\nObjective:\nSuccessive suicide prevention frameworks and action plans in Australia and internationally have called for improvements to mental health services and enhancement of workforce capacity. However, there is debate regarding the priorities for resource allocation and the optimal combination of mental health services to best prevent suicidal behaviour. This study investigates the potential impacts of service capacity improvements on the incidence of suicidal behaviour in the Australian context.\nMethods:\nA system dynamics model was developed to investigate the optimal combination of (1) secondary (acute) mental health service capacity, (2) non-secondary (non-acute) mental health service capacity and (3) resources to re-engage those lost to services on the incidence of suicidal behaviour over the period 2018ΓÇô2028 for the Greater Western Sydney (Australia) population catchment. The model captured├é┬á├éΓÇª\n','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'23','Australian and New Zealand Journal of Psychiatry','53','7','642-650','Sage Publications','YMH team','Mental Health System','Illness specific areas'),(73,'Harnessing advances in computer simulation to inform policy and planning to reduce alcohol-related harms','https://doi.org/10.1007/s00038-017-1041-y',NULL,'Objectives\r\nAlcohol misuse is a complex systemic problem. The aim of this study was to explore the feasibility of using a transparent and participatory agent-based modelling approach to develop a robust decision support tool to test alcohol policy scenarios before they are implemented in the real world.\r\n\r\nMethods\r\nA consortium of AustraliaΓÇÖs leading alcohol experts was engaged to collaboratively develop an agent-based model of alcohol consumption behaviour and related harms. As a case study, four policy scenarios were examined.\r\n\r\nResults\r\nA 19.5 ┬▒ 2.5% reduction in acute alcohol-related harms was estimated with the implementation of a 3 a.m. licensed venue closing time plus 1 a.m. lockout; and a 9 ┬▒ 2.6% reduction in incidence was estimated with expansion of treatment services to reach 20% of heavy drinkers. Combining the two scenarios produced a 33.3 ┬▒ 2.7% reduction in the incidence of acute alcohol-related harms, suggesting a synergistic effect.\r\n\r\nConclusions\r\nThis study demonstrates the feasibility of participatory development of a contextually relevant computer simulation model of alcohol-related harms and highlights the value of the approach in identifying potential policy responses that best leverage limited resources.','',2017,NULL,NULL,'2017-10-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(74,'Youth Mania Model',NULL,NULL,NULL,'',0000,'2021-03-01',NULL,NULL,'Australia','MRFF',3100000,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(107,'Optimizing Strategies for Improving Mental Health in Victoria, Australia during the COVID-19 Era: A System Dynamics Modelling Study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85130867457&doi=10.3390%2fijerph19116470&partnerID=40&md5=277bf00d8c2a348d946c3d4314d480a3','10.3390/ijerph19116470','The ongoing COVID-19 pandemic has impacted the mental health of populations and highlighted the limitations of mental health care systems. As the trajectory of the pandemic and the economic recovery are still uncertain, decision tools are needed to help evaluate the best interventions to improve mental health outcomes. We developed a system dynamics model that captures causal relationships among population, demographics, post-secondary education, health services, COVID-19 impact, and mental health outcomes. The study was conducted in the Australian state of Victoria. The model was calibrated using historical data and was stratified by age group and by geographic remoteness. Findings demonstrate that the most effective intervention combination includes economic, social, and health sector initiatives. Assertive post-suicide attempt care is the most impactful health sector intervention, but delaying implementation reduces the potency of its impact. Some evidence-based interventions, such as population-wide community awareness campaigns, are projected to worsen mental health outcomes when implemented on their own. Systems modelling offers a powerful decision-support tool to test alternative strategies for improving mental health outcomes in the Victorian context.','',2022,NULL,NULL,'2022-05-26',NULL,NULL,NULL,1,NULL,'International Journal of Environmental Research and Public Health',NULL,NULL,NULL,NULL,'YMH team','Mental Health System','Mental Health System'),(108,'\'Turning the tide\' on hyperglycemia in pregnancy: insights from multiscale dynamic simulation modeling','https://doi.org/10.1136/bmjdrc-2019-000975',NULL,'Introduction Hyperglycemia in pregnancy (HIP, including gestational diabetes and pre-existing type 1 and type 2 diabetes) is increasing, with associated risks to the health of women and their babies. Strategies to manage and prevent this condition are contested. Dynamic simulation models (DSM) can test policy and program scenarios before implementation in the real world. This paper reports the development and use of an advanced DSM exploring the impact of maternal weight status interventions on incidence of HIP.\r\n\r\nMethods A consortium of experts collaboratively developed a hybrid DSM of HIP, comprising system dynamics, agent-based and discrete event model components. The structure and parameterization drew on a range of evidence and data sources. Scenarios comparing population-level and targeted prevention interventions were simulated from 2018 to identify the intervention combination that would deliver the greatest impact.\r\n\r\nResults Population interventions promoting weight loss in early adulthood were found to be effective, reducing the population incidence of HIP by 17.3% by 2030 (baseline (ΓÇÿbusiness as usualΓÇÖ scenario)=16.1%, 95%ΓÇëCI 15.8 to 16.4; population intervention=13.3%, 95%ΓÇëCI 13.0 to 13.6), more than targeted prepregnancy (5.2% reduction; incidence=15.3%, 95%ΓÇëCI 15.0 to 15.6) and interpregnancy (4.2% reduction; incidence=15.5%, 95%ΓÇëCI 15.2 to 15.8) interventions. Combining targeted interventions for high-risk groups with population interventions promoting healthy weight was most effective in reducing HIP incidence (28.8% reduction by 2030; incidence=11.5, 95%ΓÇëCI 11.2 to 11.8). Scenarios exploring the effect of childhood weight status on entry to adulthood demonstrated significant impact in the selected outcome measure for glycemic regulation, insulin sensitivity in the short term and HIP in the long term.\r\n\r\nDiscussion Population-level weight reduction interventions will be necessary to ΓÇÿturn the tideΓÇÖ on HIP. Weight reduction interventions targeting high-risk individuals, while beneficial for those individuals, did not significantly impact forecasted HIP incidence rates. The importance of maintaining interventions promoting healthy weight in childhood was demonstrated.','',2020,NULL,NULL,'2020-05-31',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(109,'Can the Target Set for Reducing Childhood Overweight and Obesity Be Met? A System Dynamics Modelling Study in New South Wales, Australia','https://doi.org/10.1002/sres.2555',NULL,'The persistent prevalence of childhood overweight and obesity raises significant concerns about the impact on health, society and the economy. Responding to a target announced in September 2015 by the New South Wales (Australia) Premier to reduce childhood overweight and obesity by five percentage points by 2025, a system dynamics model was developed to support Government and stakeholders responsible for meeting the target. A participatory model building process, drawing cross-sectorial expertise, was undertaken to estimate the individual and combined impact of interventions on meeting the target. The model demonstrated that it is theoretically possible to meet the target by implementing a comprehensive combination of policies and programmes. When limited to existing and enhanced population health interventions, the modelled result did not reach the target. The project provides an example of how participatory simulation modelling can combine a broad range of interventions together into likely scenarios and usefully inform government decision-making. ┬⌐ 2018 The authors. Systems Research and Behavioral Science published by International Federation for Systems Research and John Wiley & Sons Ltd','',2018,NULL,NULL,'2018-09-21',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(110,'Policy options for endgame planning in tobacco control: A simulation modelling study','http://dx.doi.org/10.1136/tobaccocontrol-2019-055126',NULL,NULL,'',2019,NULL,NULL,'2019-12-19',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(116,'Social and occupational outcomes for young people who attend early intervention mental health services: a longitudinal study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85117196248&doi=10.5694%2fmja2.51308&partnerID=40&md5=62446af669657a8415c3ca6046767f05','10.5694/mja2.51308','  Objective To identify trajectories of social and occupational functioning in young people during the two years after presenting for early intervention mental health care; to identify demographic and clinical factors that influence these trajectories.   Design Longitudinal, observational study of young people presenting for mental health care.   Setting Two primary care-based early intervention mental health services at the Brain and Mind Centre (University of Sydney), 1 June 2008 ├éΓÇô 31 July 2018.   Participants 1510 people aged 12-25 years who had presented with anxiety, mood, or psychotic disorders, for whom two years├éΓÇÖ follow-up data were available for analysis.   Main outcome measures Latent class trajectories of social and occupational functioning based on growth mixture modelling of Social and Occupational Assessment Scale (SOFAS) scores.   Results We identified four trajectories of functioning during the first├é┬á├éΓÇª\n','',2022,NULL,NULL,'2022-02-07',NULL,NULL,NULL,1,'5','Medical Journal of Australia','216','2','87-93','','YMH team','Outcome Research',''),(118,'Understanding technology preferences and requirements for health information technologies designed to improve and maintain the mental health and well-being of older adults: Participatory design study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099472539&doi=10.2196%2f21461&partnerID=40&md5=8a9bf24bdfc12486d92794b98a7b19b8','10.2196/21461','Background:\r\nWorldwide, the population is aging rapidly; therefore, there is a growing interest in strategies to support and maintain health and well-being in later life. Although familiarity with technology and digital literacy are increasing among this group, some older adults still lack confidence in their ability to use web-based technologies. In addition, age-related changes in cognition, vision, hearing, and perception may be barriers to adoption and highlight the need for digital tools developed specifically to meet the unique needs of older adults.\r\n\r\nObjective:\r\nThe aim of this study is to understand the use of technology by older adults in general and identify the potential barriers to and facilitators of the adoption of health information technologies (HITs) to support the health and well-being of older adults to facilitate implementation and promote user uptake. In addition, this study aims to co-design and configure the InnoWell Platform, a digital tool designed to facilitate better outcomes for people seeking mental health services, to meet the needs of adults 50 years and older and their supportive others (eg, family members, caregivers) to ensure the accessibility, engagement, and appropriateness of the technology.\r\n\r\nMethods:\r\nParticipants were adults 50 years and older and those who self-identified as a supportive other (eg, family member, caregiver). Participants were invited to participate in a 3-hour participatory design workshop using a variety of methods, including prompted discussion, creation of descriptive artifacts, and group-based development of user journeys.\r\n\r\nResults:\r\nFour participatory design workshops were conducted, including a total of 21 participants, each attending a single workshop. Technology use was prevalent, with a preference indicated for smartphones and computers. Factors facilitating the adoption of HITs included personalization of content and functionality to meet and be responsive to a consumerΓÇÖs needs, access to up-to-date information from reputable sources, and integration with standard care practices to support the relationship with health professionals. Concerns regarding data privacy and security were the primary barriers to the use of technology to support mental health and well-being.\r\n\r\nConclusions:\r\nAlthough HITs have the potential to improve access to cost-effective and low-intensity interventions at scale for improving and maintaining mental health and well-being, several strategies may improve the uptake and efficacy of technologies by the older adult community, including the use of co-design methodologies to ensure usability, acceptability, and appropriateness of the technology; support in using and understanding the clinical applications of the technology by a digital navigator; and ready availability of education and training materials.','',2021,NULL,NULL,'2021-06-01',NULL,NULL,NULL,1,NULL,'JMIR Aging',NULL,NULL,NULL,NULL,'YMH team','Digital health',''),(287,'The chronic fatigue syndrome: A comprehensive approach to its definition and study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027973857&doi=10.7326%2f0003-4819-121-12-199412150-00009&partnerID=40&md5=9178643862b36b346b0eaaac77a39f09','10.7326/0003-4819-121-12-199412150-00009','\nThe complexities of the chronic fatigue syndrome and the methodologic problems associated with its study indicate the need for a comprehensive, systematic, and integrated approach to the evaluation, classification, and study of persons with this condition and other fatiguing illnesses. We propose a conceptual framework and a set of guidelines that provide such an approach. Our guidelines include recommendations for the clinical evaluation of fatigued persons, a revised case definition of the chronic fatigue syndrome, and a strategy for subgrouping fatigued persons in formal investigations.             *For a listing of members of the Study Group, see Appendix.\n','',1994,NULL,NULL,'1994-12-15',NULL,NULL,NULL,NULL,'6253','Annals of Internal Medicine','121','12','953-959','American College of Physicians','Other','',''),(288,'Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84883465830&doi=10.1038%2fng.2711&partnerID=40&md5=78983a70239a11ab920cd4bb5c03ed7c','10.1038/ng.2711','Naomi Wray and colleagues report an analysis of genome-wide association data sets from the Psychiatric Genomics Consortium for five psychiatric disorders. They find that common variation explains 17ΓÇô29% of the variance in liability and provide further support for a shared genetic etiology for these related psychiatric disorders.','',2013,NULL,NULL,'2013-08-11',NULL,NULL,NULL,NULL,'2135','Nature Genetics','45','9','984-994','Nature Publishing Group US','Other','',''),(289,'Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046022254&doi=10.1038%2fs41588-018-0090-3&partnerID=40&md5=cea270dcdedd41cf00a77dfbe82fe473','10.1038/s41588-018-0090-3','Major depressive disorder (MDD) is a common illness accompanied by considerable morbidity, mortality, costs, and heightened risk of suicide. We conducted a genome-wide association meta-analysis based in 135,458 cases and 344,901 controls and identified 44 independent and significant loci. The genetic findings were associated with clinical features of major depression and implicated brain regions exhibiting anatomical differences in cases. Targets of antidepressant medications and genes involved in gene splicing were enriched for smaller association signal. We found important relationships of genetic risk for major depression with educational attainment, body mass, and schizophrenia: lower educational attainment and higher body mass were putatively causal, whereas major depression and schizophrenia reflected a partly shared biological etiology. All humans carry lesser or greater numbers of genetic├é┬á├éΓÇª','',2018,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'1824','Nature Genetics','50','5','668-681','Nature Publishing Group','YMH team','Neurobiology','illness specific areas'),(290,'A mega-Analysis of genome-wide association studies for major depressive disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84879892380&doi=10.1038%2fmp.2012.21&partnerID=40&md5=eecc0fbdddf485e0954b25d8605d65c2','10.1038/mp.2012.21','Prior genome-wide association studies (GWAS) of major depressive disorder (MDD) have met with limited success. We sought to increase statistical power to detect disease loci by conducting a GWAS mega-analysis for MDD. In the MDD discovery phase, we analyzed more than 1.2 million autosomal and X chromosome single-nucleotide polymorphisms (SNPs) in 18 759 independent and unrelated subjects of recent European ancestry (9240 MDD cases and 9519 controls). In the MDD replication phase, we evaluated 554 SNPs in independent samples (6783 MDD cases and 50 695 controls). We also conducted a cross-disorder meta-analysis using 819 autosomal SNPs with P< 0.0001 for either MDD or the Psychiatric GWAS Consortium bipolar disorder (BIP) mega-analysis (9238 MDD cases/8039 controls and 6998 BIP cases/7775 controls). No SNPs achieved genome-wide significance in the MDD discovery├é┬á├éΓÇª','',2013,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'1165','Molecular Psychiatry','18','4','','NIH Public Access','Other','',''),(291,'Intranasal Oxytocin Improves Emotion Recognition for Youth with Autism Spectrum Disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-77949486670&doi=10.1016%2fj.biopsych.2009.09.020&partnerID=40&md5=2e26091a73e08f86af544a2a67f6c040','10.1016/j.biopsych.2009.09.020','\n\nBackground\nA diagnostic hallmark of autism spectrum disorders is a qualitative impairment in social communication and interaction. Deficits in the ability to recognize the emotions of others are believed to contribute to this. There is currently no effective treatment for these problems.\n\n\nMethods\nIn a double-blind, randomized, placebo-controlled, crossover design, we administered oxytocin nasal spray (18 or 24 IU) or a placebo to 16 male youth aged 12 to 19 who were diagnosed with Autistic or Asperger\'s Disorder. Participants then completed the Reading the Mind in the Eyes Task, a widely used and reliable test of emotion recognition.\n\n\nResults\nIn comparison with placebo, oxytocin administration improved performance on the Reading the Mind in the Eyes Task. This effect was also shown when analysis was restricted to the younger participants aged 12 to 15 who received the lower dose.\n\n\nConclusions\nThis study provides\n\n','',2010,NULL,NULL,'2010-04-01',NULL,NULL,NULL,NULL,'1098','Biological Psychiatry','67','7','692-694','Elsevier','Other','Neurobiology',''),(292,'Analysis of shared heritability in common disorders of the brain','https://www.science.org/doi/abs/10.1126/science.aap8757',NULL,'Disorders of the brain can exhibit considerable epidemiological comorbidity and often share symptoms, provoking debate about their etiologic overlap. We quantified the genetic sharing of 25 brain disorders from genome-wide association studies of 265,218 patients and 784,643 control participants and assessed their relationship to 17 phenotypes from 1,191,588 individuals. Psychiatric disorders share common variant risk, whereas neurological disorders appear more distinct from one another and from the psychiatric disorders. We also identified significant sharing between disorders and a number of brain phenotypes, including cognitive measures. Further, we conducted simulations to explore how statistical power, diagnostic misclassification, and phenotypic heterogeneity affect genetic correlations. These results highlight the importance of common genetic variation as a risk factor for brain disorders and the├é┬á├éΓÇª','',2018,NULL,NULL,'2018-06-22',NULL,NULL,NULL,NULL,'1065','','360','6395','eaap8757','American Association for the Advancement of Science',NULL,NULL,NULL),(293,'Clinical staging of psychiatric disorders: A heuristic framework for choosing earlier, safer and more effective interventions','https://www.scopus.com/inward/record.uri?eid=2-s2.0-33745632817&doi=10.1111%2fj.1440-1614.2006.01860.x&partnerID=40&md5=0d51d4216e82379528a2974011bb2cc8','10.1111/j.1440-1614.2006.01860.x','Diagnosis in psychiatry increasingly struggles to fulfil its key purposes, namely, to guide treatment and to predict outcome. The clinical staging model, widely used in clinical medicine yet virtually ignored in psychiatry, is proposed as a more refined form of diagnosis which could restore the utility of diagnosis, promote early intervention and also make more sense of the confusing array of biological research findings in psychiatry by organizing data into a coherent clinicopathological framework. A selective review of key papers in clinical medicine and psychiatry which describe clinical and clinicopathological staging, and a range of related issues. Clinical staging has immediate potential to improve the logic and timing of interventions in psychiatry just as it does in many complex and potentially serious medical disorders. Interventions could be evaluated in terms of their ability to prevent or delay progression from earlier','',2006,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'968','Australian and New Zealand Journal of Psychiatry','40','8','616-622','Sage Publications','YMH team','Models of care',''),(294,'Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use','https://www.nature.com/articles/s41588-018-0307-5',NULL,'Tobacco and alcohol use are leading causes of mortality that influence risk for many complex diseases and disorders. They are heritable, and etiologically related, behaviors that have been resistant to gene discovery efforts├éΓÇô. In sample sizes up to 1.2 million individuals, we discovered 566 genetic variants in 406 loci associated with multiple stages of tobacco use (initiation, cessation, and heaviness) as well as alcohol use, with 150 loci evidencing pleiotropic association. Smoking phenotypes were positively genetically correlated with many health conditions, whereas alcohol use was negatively correlated with these conditions, such that increased genetic risk for alcohol use is associated with lower disease risk. We report evidence for the involvement of many systems in tobacco and alcohol use, including genes involved in nicotinic, dopaminergic, and glutamatergic neurotransmission. The results provide a solid├é┬á├éΓÇª','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'938','Nature genetics','51','2','237-244','Nature Publishing Group',NULL,NULL,NULL),(295,'Subcortical brain alterations in major depressive disorder: Findings from the ENIGMA Major Depressive Disorder working group','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84933575497&doi=10.1038%2fmp.2015.69&partnerID=40&md5=419f5f12702c6deb643805a74dc083ea','10.1038/mp.2015.69','The pattern of structural brain alterations associated with major depressive disorder (MDD) remains unresolved. This is in part due to small sample sizes of neuroimaging studies resulting in limited statistical power, disease heterogeneity and the complex interactions between clinical characteristics and brain morphology. To address this, we meta-analyzed three-dimensional brain magnetic resonance imaging data from 1728 MDD patients and 7199 controls from 15 research samples worldwide, to identify subcortical brain volumes that robustly discriminate MDD patients from healthy controls. Relative to controls, patients had significantly lower hippocampal volumes (Cohen├éΓÇÖs d=- 0.14,% difference=- 1.24). This effect was driven by patients with recurrent MDD (Cohen├éΓÇÖs d=- 0.17,% difference=- 1.44), and we detected no differences between first episode patients and controls. Age of onset 21 was associated with├é┬á├éΓÇª','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'871','Molecular Psychiatry','21','6','806-812','Nature Publishing Group','Other','',''),(296,'Identification of novel risk loci, causal insights, and heritable risk for Parkinson\'s disease: a meta-analysis of genome-wide association studies','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074322282&doi=10.1016%2fS1474-4422%2819%2930320-5&partnerID=40&md5=f7f425e1b2e5ca185fcadb32b43ebb61','10.1016/S1474-4422(19)30320-5','\n\nBackground\nGenome-wide association studies (GWAS) in Parkinson\'s disease have increased the scope of biological knowledge about the disease over the past decade. We aimed to use the largest aggregate of GWAS data to identify novel risk loci and gain further insight into the causes of Parkinson\'s disease.\n\n\nMethods\nWe did a meta-analysis of 17 datasets from Parkinson\'s disease GWAS available from European ancestry samples to nominate novel loci for disease risk. These datasets incorporated all available data. We then used these data to estimate heritable risk and develop predictive models of this heritability. We also used large gene expression and methylation resources to examine possible functional consequences as well as tissue, cell type, and biological pathway enrichments for the identified risk factors. Additionally, we examined shared genetic risk between Parkinson\'s disease and other├é┬á├éΓÇª\n\n','',2019,NULL,NULL,'2019-12-01',NULL,NULL,NULL,NULL,'863','The Lancet Neurology','18','12','1091-1102','Elsevier','Other','',''),(297,'├éΓÇ£Stress├éΓÇ¥ and coronary heart disease: psychosocial risk factors','https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.2003.tb05193.x',NULL,' An Expert Working Group of the National Heart Foundation of Australia undertook a review of systematic reviews of the evidence relating to major psychosocial risk factors to assess whether there are independent associations between any of the factors and the development and progression of coronary heart disease (CHD), or the occurrence of acute cardiac events. The expert group concluded that (i) there is strong and consistent evidence of an independent causal association between depression, social isolation and lack of quality social support and the causes and prognosis of CHD; and (ii) there is no strong or consistent evidence for a causal association between chronic life events, work-related stressors (job control, demands and strain), Type A behaviour patterns, hostility, anxiety disorders or panic disorders and CHD. The increased risk contributed by these psychosocial factors is of similar order to the├é┬á├éΓÇª\n\n','',2003,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'827','','178','6','272-276','',NULL,NULL,NULL),(298,'A systematic review of the impact of adherence on the effectiveness of e-therapies','https://www.scopus.com/inward/record.uri?eid=2-s2.0-80053539483&doi=10.2196%2fjmir.1772&partnerID=40&md5=763f8686e54d073c1e6403bcbe64cc62','10.2196/jmir.1772','\nBackground: As the popularity of e-therapies grows, so too has the body of literature supporting their effectiveness. However, these interventions are often plagued by high attrition rates and varying levels of user adherence. Understanding the role of adherence may be crucial to understanding how program usage influences the effectiveness of e-therapy interventions.\nObjective: The aim of this study was to systematically review the e-therapy literature to (1) describe the methods used to assess adherence and (2) evaluate the association of adherence with outcome of these interventions.\nMethods: A systematic review of e-therapy interventions was conducted across disease states and behavioral targets. Data were collected on adherence measures, outcomes, and analyses exploring the relationship between adherence measures and outcomes.\nResults: Of 69 studies that reported an adherence measure, only 33 (48%) examined the relationship between adherence and outcomes. The number of logins was the most commonly reported measure of adherence, followed by the number of modules completed. The heterogeneity of adherence and outcome measures limited analysis. However, logins appeared to be the measure of adherence most consistently related to outcomes in physical health interventions, while module completion was found to be most related to outcomes in psychological health interventions.\nConclusions: There is large variation in the reporting of adherence and the association of adherence with outcomes. A lack of agreement about how best to measure adherence is likely to contribute to the variation in findings. Physical and├é┬á├éΓÇª\n','',2011,NULL,NULL,'2011-08-05',NULL,NULL,NULL,NULL,'735','Journal of Medical Internet Research','13','3','e1772','JMIR Publications Inc., Toronto, Canada','Other','',''),(299,'Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84965019188&doi=10.1038%2fmp.2016.60&partnerID=40&md5=730a4b2247942468203ea52291ac69d9','10.1038/mp.2016.60','','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Molecular Psychiatry','','','','Nature Publishing Group','Other','',''),(300,'Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-33748925038&doi=10.1136%2fbmj.38933.585764.AE&partnerID=40&md5=7284c71379a051c9b3e24717e72dada2','10.1136/bmj.38933.585764.AE',' \nObjective To delineate the risk factors, symptom patterns, and longitudinal course of prolonged illnesses after a variety of acute infections.\n\nDesign Prospective cohort study following patients from the time of acute infection with Epstein-Barr virus (glandular fever), Coxiella burnetii (Q fever), or Ross River virus (epidemic polyarthritis).\n\nSetting The region surrounding the township of Dubbo in rural Australia, encompassing a 200 km geographical radius and 104 400 residents.\n\nParticipants 253 patients enrolled and followed at regular intervals over 12 months by self report, structured interview, and clinical assessment.\n\nOutcome measures Detailed medical, psychiatric, and laboratory evaluations at six months to apply diagnostic criteria for chronic fatigue syndrome. Premorbid and intercurrent illness characteristics recorded to define risk factors for chronic fatigue syndrome. Self reported illness phenotypes compared\n','',2006,NULL,NULL,'2006-09-14',NULL,NULL,NULL,NULL,'720','British Medical Journal','333','7568','575','British Medical Journal Publishing Group','Other','',''),(301,'The ENIGMA Consortium: Large-scale collaborative analyses of neuroimaging and genetic data','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84899930958&doi=10.1007%2fs11682-013-9269-5&partnerID=40&md5=8c7d4248abe026d967be0643777a4fa3','10.1007/s11682-013-9269-5','               The Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) Consortium is a collaborative network of researchers working together on a range of large-scale studies that integrate data from 70 institutions worldwide. Organized into Working Groups that tackle questions in neuroscience, genetics, and medicine, ENIGMA studies have analyzed neuroimaging data from over 12,826 subjects. In addition, data from 12,171 individuals were provided by the CHARGE consortium for replication of findings, in a total of 24,997 subjects. By meta-analyzing results from many sites, ENIGMA has detected factors that affect the brain that no individual site could detect on its own, and that require larger numbers of subjects than any individual neuroimaging study has currently collected. ENIGMA├éΓÇÖs first project was a genome-wide association study identifying common variants in the genome associated with├é┬á├éΓÇª\n','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'571','Brain Imaging and Behavior','8','2','153-182','Springer US','Other','',''),(302,'Prevalence of chronic fatigue syndrome in an Australian population','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025084004&doi=10.5694%2fj.1326-5377.1990.tb126191.x&partnerID=40&md5=0ab7b77808d68969a807e806c3099f62','10.5694/j.1326-5377.1990.tb126191.x','An epidemiological study was undertaken to provide the first reported estimate of the point prevalence of chronic fatigue syndrome in an Australian community. After a pilot study in a separate location, the population of the Richmond Valley, New South Wales, was sampled using a structured case-finding technique, which included notification from local medical practitioners, the use of a screening questionnaire and standardised interviews conducted by a physician and psychiatrist. In addition, investigations were performed to exclude alternative diagnoses and to assess cell-mediated immunity. Forty-two patients with chronic fatigue syndrome, with a female:male ratio of 1.3:1.0, were detected in a population of 114 000. The mean age at onset of symptoms was 28.6 years (SD, 12.3 years), and the median duration of symptoms from onset to sampling date was 30 months. The social status of the patients was','',1990,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'538','Medical Journal of Australia','153','9','522-528','','Other','',''),(303,'Genome-wide association study of major depressive disorder: New results, meta-analysis, and lessons learned','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84855360075&doi=10.1038%2fmp.2010.109&partnerID=40&md5=9d5e8f07e170b9ac9b54f52ef2089bf7','10.1038/mp.2010.109','Major depressive disorder (MDD) is a common complex disorder with a partly genetic etiology. We conducted a genome-wide association study of the MDD2000+ sample (2431 cases, 3673 screened controls and> 1 M imputed single-nucleotide polymorphisms (SNPs)). No SNPs achieved genome-wide significance either in the MDD2000+ study, or in meta-analysis with two other studies totaling 5763 cases and 6901 controls. These results imply that common variants of intermediate or large effect do not have main effects in the genetic architecture of MDD. Suggestive but notable results were (a) gene-based tests suggesting roles for adenylate cyclase 3 (ADCY3, 2p23. 3) and galanin (GAL, 11q13. 3); published functional evidence relates both of these to MDD and serotonergic signaling;(b) support for the bipolar disorder risk variant SNP rs1006737 in CACNA1C (P= 0.020, odds ratio= 1.10); and (c) lack of support├é┬á├éΓÇª','',2012,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'529','Molecular Psychiatry','17','1','36-48','Nature Publishing Group','Other','',''),(304,'Subcortical hyperintensities on magnetic resonance imaging: Clinical correlates and prognostic significance in patients with severe depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028832032&doi=10.1016%2f0006-3223%2894%2900174-2&partnerID=40&md5=906cc3161532a8301fda7044b2289bf4','10.1016/0006-3223(94)00174-2','In 39 hospital inpatients with severe primary depressive disorders, we evaluated the relationships between subcortical hyperintensities on magnetic resonance imaging (MRI) and clinical features, neuropsychological impairment and response to standard therapies. Both white matter and gray nuclei lesions were associated with older age and the absence of a family history of affective disorder. White matter hyperintensities were also associated with onset of first affective episode after the age of 50 years and impaired psychomotor speed. Most importantly, the severity of white matter hyperintensities predicted a poorer response to treatment (r = -0.44, p < .01). Negative correlations of the same order were detected in those (n = 20) who received electroconvulsive therapy (r = -0.42, p = .06) and those (n = 19) who received pharmacotherapy alone (r = -.49, p < .05). This study provides preliminary evidence supporting','',1995,NULL,NULL,'1995-02-01',NULL,NULL,NULL,NULL,'487','Biological Psychiatry','37','3','151-160','Elsevier','YMH team','Neurobiology','illness specific areas'),(305,'Widespread white matter microstructural differences in schizophrenia across 4322 individuals: Results from the ENIGMA Schizophrenia DTI Working Group','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85035110805&doi=10.1038%2fmp.2017.170&partnerID=40&md5=2a0526eca2514b0eb887425af80c1967','10.1038/mp.2017.170','The regional distribution of white matter (WM) abnormalities in schizophrenia remains poorly understood, and reported disease effects on the brain vary widely between studies. In an effort to identify commonalities across studies, we perform what we believe is the first ever large-scale coordinated study of WM microstructural differences in schizophrenia. Our analysis consisted of 2359 healthy controls and 1963 schizophrenia patients from 29 independent international studies; we harmonized the processing and statistical analyses of diffusion tensor imaging (DTI) data across sites and meta-analyzed effects across studies. Significant reductions in fractional anisotropy (FA) in schizophrenia patients were widespread, and detected in 20 of 25 regions of interest within a WM skeleton representing all major WM fasciculi. Effect sizes varied by region, peaking at (d= 0.42) for the entire WM skeleton, driven more by├é┬á├éΓÇª','',2018,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'465','Molecular Psychiatry','23','5','1261-1269','Nature Publishing Group','Other','',''),(306,'Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-14844322379&doi=10.1192%2fbjp.186.3.197&partnerID=40&md5=4e39b087aeaac97b15a65ac621eed24a','10.1192/bjp.186.3.197','Background Hippocampal volume reduction has been reported inconsistently in people with major depression. Aims To evaluate the interrelationships between hippocampal volumes, memory and key clinical, vascular and genetic risk factors. Method Totals of 66 people with depression and 20 control participants underwent magnetic resonance imaging and clinical assessment. Measures of depression severity, psychomotor retardation, verbal and visual memory and vascular and specific genetic risk factors were collected. Results Reduced hippocampal volumes occurred in older people with depression, those with both early-onset and late-onset disorders and those with the melancholic subtype. Reduced hippocampal volumes were associated with deficits in visual and verbal memory performance. Conclusions Although reduced hippocampal volumes are most pronounced in late-onset depression, older people','',2005,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'465','British Journal of Psychiatry','186','3','197-202','Cambridge University Press','YMH team','Neurobiology','illness specific areas'),(307,'Cognitive function in depression: A distinct pattern of frontal impairment in melancholia?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032897159&doi=10.1017%2fS0033291798007788&partnerID=40&md5=68d88520949d94f1498c6fe24ff0d976','10.1017/S0033291798007788','\nBackground.\n\n Although depressed patients demonstrate impaired performance on a range of neuropsychological tests, there is little research that examines either frontal cognitive deficits or possible differences in test performance between melancholic and non-melancholic subtypes.\nMethods.\n\n Depressed subjects were administered a broad neuropsychological battery. In an overall analysis, 77 depressed subjects were compared with 28 controls. In a second set of analyses, the depressed sample was divided into melancholic and non-melancholic subsets according to DSM-III-R, the CORE system and the Newcastle scale. These depressed subsets were contrasted to controls and with each other using ANCOVA controlling for age, IQ, simple reaction time and Hamilton Depression scores where appropriate.\nResults.\n\n The total depressed sample was impaired on most mnemonic tasks, simple reaction time and Trails B\n','',1999,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'461','Psychological Medicine','29','1','73-85','Cambridge University Press','Other','',''),(308,'Autism spectrum disorders: A meta-analysis of executive function','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042348130&doi=10.1038%2fmp.2017.75&partnerID=40&md5=8999e2f74b2afa58a8551ee51a4d0232','10.1038/mp.2017.75','Evidence of executive dysfunction in autism spectrum disorders (ASD) across development remains mixed and establishing its role is critical for guiding diagnosis and intervention. The primary objectives of this meta-analysis is to analyse executive function (EF) performance in ASD, the fractionation across EF subdomains, the clinical utility of EF measures and the influence of multiple moderators (for example, age, gender, diagnosis, measure characteristics). The Embase, Medline and PsychINFO databases were searched to identify peer-reviewed studies published since the inclusion of Autism in DSM-III (1980) up to end of June 2016 that compared EF in ASD with neurotypical controls. A random-effects model was used and moderators were tested using subgroup analysis. The primary outcome measure was HedgesΓÇÖg effect size for EF and moderator factors. Clinical sensitivity was determined by the overlap├é┬á├éΓÇª','',2018,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'454','Molecular Psychiatry','23','5','1198-1204','Nature Publishing Group','Other','',''),(309,'Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84923077204&doi=10.1038%2fnn.3922&partnerID=40&md5=a2ebe9b06ea27fae8c01045a89f57d02','10.1038/nn.3922','Better analytical methods are needed to extract biological meaning from genome-wide association studies (GWAS) of psychiatric disorders. Here the authors take GWAS data from over 60,000 subjects, including patients with schizophrenia, bipolar disorder and major depression, and identify common etiological pathways shared amongst them.','',2015,NULL,NULL,'2015-01-19',NULL,NULL,NULL,NULL,'454','Nature Neuroscience','18','2','199-209','Nature Publishing Group US','Other','',''),(310,'Association between antidepressant prescribing and suicide in Australia, 1991-2000: Trend analysis','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0038137620&partnerID=40&md5=9de4804e24b5cb0ae26d3ac1b1cff420','',' \nObjective: To examine the association between trends in antidepressant prescribing and suicide rates in Australia for 1991-2000.\n\nDesign: Analysis of databases of suicide and rates of antidepressant prescribing according to age and sex.\n\nSetting: Australian Bureau of Statistics data, sales data from the Australian pharmaceutical industry, prescribing data in general practice.\n\nSubjects: Men and women aged 15 years and over in 10 year age groups.\n\nMain outcome measures: Trends in suicide rates and trends in antidepressant prescribing. Association measured by Spearman9s rank correlations.\n\nResults: While overall national rates of suicide did not fall significantly, incidence decreased in older men and women and increased in younger adults. In both men (rs=-0.91; P<0.01) and women (rs=-0.76; P<0.05) the higher the exposure to antidepressants the larger the decline in rate of suicide.\n\nConclusions: Changes in\n','',2003,NULL,NULL,'2003-05-10',NULL,NULL,NULL,NULL,'432','British Medical Journal','326','7397','1008','British Medical Journal Publishing Group','Other','',''),(311,'Intervention in individuals at ultra-high risk for psychosis: A review and future directions','https://www.scopus.com/inward/record.uri?eid=2-s2.0-70350441313&doi=10.4088%2fJCP.08r04472&partnerID=40&md5=84c296a20da8674d9f5d431f99e28574','10.4088/JCP.08r04472','\nObjective: Over the last 15 years, a focus on early intervention in psychotic disorders has emerged. Initially, the early psychosis movement focused on timely recognition and phase-specific treatment of first-episode psychosis. However, early psychosis researchers suspected that pushing the point of intervention even further back to the prodromal phase of psychotic disorders may result in even better outcomes. This article reviews intervention research in the ultra-high-risk phase of psychotic disorders.\nData sources: A literature search of intervention trials with ultra-high-risk cohorts published after 1980 was conducted on PubMed with the search terms prodrome and intervention.\nStudy selection: All published intervention trials with ultra-high-risk cohorts.\nData synthesis: The first generation of intervention trials indicated that both pharmacologic and psychological intervention strategies may be of value in terms of├é┬á├éΓÇª\n','',2009,NULL,NULL,'2009-06-30',NULL,NULL,NULL,NULL,'402','Journal of Clinical Psychiatry','70','9','9320','Physicians Postgraduate Press, Inc.','Other','',''),(312,'Investing in youth mental health is a best buy','https://www.mja.com.au/system/files/issues/187_07_011007/mcg10312_fm.pdf',NULL,'EDITORIAL mental health. We contend it represents the best value for money for new investment in the mental health arena. Services for young people affected by mental health and related substance use disorders tend to be threadbare and split across multiple levels of government, multiple program areas, and myriad cash-strapped service providers. In addition, spending in the area remains poor, and service access and tenure are actively withheld in most specialist mental health and substance misuse service systems until high levels of risk or danger are reached, or severe illness, sustained disability and chronicity are entrenched. While primary care services encounter many young people with mental disorders, the detection and treatment rates are extremely low and poorly supported by specialist services. 23, 24 The consequences of this structural weakness in both primary care and specialist services, as well as the under-resourcing and poor coordination, are enormous. Just when mental health services are most needed by young people and their families, they are often inaccessible or unacceptable in design, style and quality. Numerous young people with distressing and disabling mental health difficulties struggle to find age-appropriate assistance (see Rickwood et al, page S35 and Hickie et al, page S47). Young people with moderately severe non-psychotic disorders (eg, depression, anxiety disorders and personality disorders), and those with comorbid substance use and mental health issues, are particularly vulnerable. Without access to appropriate treatment, many young people present in repeated crisis to overstretched hospital','',2007,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'398','Medical Journal of Australia','187','S7','S5-S7','',NULL,NULL,NULL),(313,'Heart rate variability is associated with emotion recognition: Direct evidence for a relationship between the autonomic nervous system and social cognition','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84869083567&doi=10.1016%2fj.ijpsycho.2012.08.012&partnerID=40&md5=1046b89ed09b12119514ad728522c6dd','10.1016/j.ijpsycho.2012.08.012','It is well established that heart rate variability (HRV) plays an important role in social communication. Polyvagal theory suggests that HRV may provide a sensitive marker of one\'s ability to respond and recognize social cues. The aim of the present study was to directly test this hypothesis. Resting-state HRV was collected and performance on the Reading the Mind in the Eyes Test was assessed in 65 volunteers. HRV was positively associated with performance on this emotion recognition task confirming our hypothesis and these findings were retained after controlling for a variety of confounding variables known to influence HRV ΓÇö sex, BMI, smoking habits, physical activity levels, depression, anxiety, and stress. Our data suggests that increased HRV may provide a novel marker of one\'s ability to recognize emotions in humans. Implications for understanding the biological basis of emotion recognition, and social├é┬á├éΓÇª','',2012,NULL,NULL,'2012-11-01',NULL,NULL,NULL,NULL,'397','International Journal of Psychophysiology','86','2','168-172','Elsevier','Other','',''),(314,'The psychiatric status of patients with the chronic fatigue syndrome','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025228732&doi=10.1192%2fbjp.156.4.534&partnerID=40&md5=f4335dde156f1c81f8c46c69df750c34','10.1192/bjp.156.4.534','The prevalence of psychiatric disorder in 48 patients with chronic fatigue syndrome (CFS) was determined. Twenty-two had had a major depressive (non-endogenous) episode during the course of their illness, while seven had a current major (non-endogenous) depression. The pre-morbid prevalence of major depression (12.5%) and of total psychiatric disorder (24.5%) was no higher than general community estimates. The pattern of psychiatric symptoms in the CFS patients was significantly different to that of 48 patients with non-endogenous depression, but was comparable with that observed in other medical disorders. Patients with CFS were not excessively hypochrondriacal. We conclude that psychological disturbance is likely to be a consequence of, rather than an antecedent risk factor to the syndrome.','',1990,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'382','British Journal of Psychiatry','156','4','534-540','Cambridge University Press','Other','Illness specific areas',''),(315,'Cytokine aberrations in autism spectrum disorder: A systematic review and meta-analysis','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84926168759&doi=10.1038%2fmp.2014.59&partnerID=40&md5=0746cf7a7eb98243f10479f6988db065','10.1038/mp.2014.59','The role of non-diagnostic features in the pathophysiology of autism spectrum disorders (ASDs) is unclear. Increasing evidence suggests immune system alterations in ASD may be implicated in the severity of behavioral impairment and other developmental outcomes. The primary objective of this meta-analysis was to investigate if there is a characteristic abnormal cytokine profile in ASD compared with healthy controls (HCs). We identified relevant studies following a search of MEDLINE, EMBASE, PsycINFO, Web of Knowledge and Scopus. A meta-analysis was performed on studies comparing plasma and serum concentrations of cytokines in unmedicated participants with ASD and HCs. Results were reported according to PRISMA statement. Seventeen studies with a total sample size of 743 participants with ASD and 592 HC were included in the analysis. Nineteen cytokines were assessed. Concentrations of','',2015,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'380','Molecular Psychiatry','20','4','440-446','Nature Publishing Group','Other','',''),(316,'Novel melatonin-based therapies: Potential advances in the treatment of major depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-80051796810&doi=10.1016%2fS0140-6736%2811%2960095-0&partnerID=40&md5=bd75fd3579b4d967274630729cfcd2f4','10.1016/S0140-6736(11)60095-0','Major depression is one of the leading causes of premature death and disability. Although available drugs are effective, they also have substantial limitations. Recent advances in our understanding of the fundamental links between chronobiology and major mood disorders, as well as the development of new drugs that target the circadian system, have led to a renewed focus on this area. In this review, we summarise the associations between disrupted chronobiology and major depression and outline new antidepressant treatment strategies that target the circadian system. In particular, we highlight agomelatine, a melatonin-receptor agonist and selective serotonergic receptor subtype (ie, 5-HT2C) antagonist that has chronobiotic, antidepressant, and anxiolytic effects. In the short-term, agomelatine has similar antidepressant efficacy to venlafaxine, fluoxetine, and sertraline and, in the longer term, fewer patients on','',2011,NULL,NULL,'2011-08-13',NULL,NULL,NULL,NULL,'370','The Lancet','378','9791','621-631','Elsevier','YMH team','Models of care','illness specific areas'),(317,'Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84876087515&doi=10.1016%2fj.psyneuen.2012.11.019&partnerID=40&md5=1a1470bc59646f5417cc364e67da4a39','10.1016/j.psyneuen.2012.11.019','A series of studies have reported on the salubrious effects of oxytocin nasal spray on social cognition and behavior in humans, across physiology (e.g., eye gaze, heart rate variability), social cognition (e.g., attention, memory, and appraisal), and behavior (e.g., trust, generosity). Findings suggest the potential of oxytocin nasal spray as a treatment for various psychopathologies, including autism and schizophrenia. There are, however, increasing reports of variability of response to oxytocin nasal spray between experiments and individuals. In this review, we provide a summary of factors that influence transmucosal nasal drug delivery, deposition, and their impact on bioavailability. These include variations in anatomy and resultant airflow dynamic, vascularisation, status of blood vessels, mode of spray application, gallenic formulation (including presence of uptake enhancers, control release formulation), and amount','',2013,NULL,NULL,'2013-05-01',NULL,NULL,NULL,NULL,'348','Psychoneuroendocrinology','38','5','612-625','Pergamon','Other','Illness specific areas',''),(318,'Longitudinal study of outcome of chronic fatigue syndrome','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028351409&doi=10.1136%2fbmj.308.6931.756&partnerID=40&md5=e6b783e7cfdc16b7014362bbe90a1aeb','10.1136/bmj.308.6931.756',' \nObjective : To examine the predictors of long term outcome for patients with the chronic fatigue syndrome.\n\nDesign : Cohort study.\n\nSubjects : 139 subjects previously enrolled in two treatment trials; 103 (74%) were reassessed a mean of 3.2 years after start of the trials.\n\nSetting : University hospital referral centre.\n\nMain outcome measures : Age at onset, duration of illness, psychological and immunological status at initial assessment. Ongoing symptom severity, levels of disability, and immunological function at follow up. Results - 65 subjects had improved but only six reported no current symptoms. An alternative medical diagnosis had been made in two and psychiatric illness diagnosed in 20. The assignment of a primary psychiatric diagnosis at follow up and the strength of the belief that a physical disease process explained all symptoms at entry to the trials both predicted poor outcome. Age at onset of illness, duration of\n','',1994,NULL,NULL,'1994-03-19',NULL,NULL,NULL,NULL,'348','BMJ','308','6931','756-759','British Medical Journal Publishing Group','Other','Outcome Research',''),(319,'Autonomic nervous system dysfunction in psychiatric disorders and the impact of psychotropic medications: A systematic review and meta-analysis','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84975769750&doi=10.1503%2fjpn.140217&partnerID=40&md5=708b953293924adb33e7089a7350027d','10.1503/jpn.140217','\nBackground: Autonomic nervous system (ANS) dysfunction is a putative underlying mechanism for increased cardiovascular disease risk in individuals with psychiatric disorders. Previous studies suggest that this risk may be related to psychotropic medication use. In the present study we systematically reviewed and analyzed published studies of heart rate variability (HRV), measuring ANS output, to determine the effect of psychiatric illness and medication use.\nMethods: We searched for studies comparing HRV in physically healthy adults with a diagnosed psychiatric disorder to controls and comparing HRV pre- and post-treatment with a psychotropic medication.\nResults: In total, 140 caseΓÇôcontrol (mood, anxiety, psychosis, dependent disorders, k = 151) and 30 treatment (antidepressants, antipsychotics; k = 43) studies were included. We found that HRV was reduced in all patient groups compared to controls├é┬á├éΓÇª\n','',2016,NULL,NULL,'2016-03-01',NULL,NULL,NULL,NULL,'346','Journal of Psychiatry and Neuroscience','41','2','89-104','Journal of Psychiatry and Neuroscience','YMH team','Neurobiology',''),(320,'A systematic review of resting-state functional-MRI studies in major depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84868106375&doi=10.1016%2fj.jad.2012.04.013&partnerID=40&md5=39a6df9eb4f6ee16d9cdff2e8b7b20ef','10.1016/j.jad.2012.04.013','\n\nBackground\nTo evaluate the literature pertaining to the use of resting-state functional magnetic resonance imaging (fMRI) in Major Depression (MD).\n\n\nMethods\nA search for papers published in English was conducted using MedLine, Embase, PsycINFO, OvidSP, and ScienceDirect with the following words: resting state, depression, MRI, affective, and default-mode.\n\n\nResults\nThe findings from 16 resting-state fMRI studies on MD are tabulated. Some common findings are discussed in further detail.\n\n\nConclusion\nThe use of resting-state fMRI in MD research has yielded a number of significant findings that provide the basis for understanding the pathophysiology of depressive symptoms. Of particular note and deserving of further research are the roles of the cortico-limbic mood regulating circuit (MRC) and the interaction between task-positive and task-negative networks in MD. There is increasing interest in the use of resting\n\n','',2012,NULL,NULL,'2012-12-15',NULL,NULL,NULL,NULL,'331','Journal of Affective Disorders','142','1-Mar','6-Dec','Elsevier','Other','',''),(321,'The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: A randomized clinical crossover trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84945558237&doi=10.1038%2fmp.2015.162&partnerID=40&md5=9d696a9e2e8d7ad52c12a1b570da3e82','10.1038/mp.2015.162','Interventions for autism are limited. The synthetic hormone oxytocin may provide a potential treatment to improve core social and behavioral difficulties in autism, but its efficacy has yet to be evaluated in young children who potentially may benefit to a greater extent. We investigated the efficacy, tolerability and safety of oxytocin treatment in young children with autism using a double-blind, randomized, placebo-controlled, crossover, clinical trial. Thirty-one children with autism received 12 International Units (IU) of oxytocin and placebo nasal spray morning and night (24 IU per day) for 5 weeks, with a 4-week washout period between each treatment. Compared with placebo, oxytocin led to significant improvements on the primary outcome of caregiver-rated social responsiveness. Overall, nasal spray was well tolerated, and the most common reported adverse events were thirst, urination and constipation. This study is','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'317','Molecular Psychiatry','21','9','1225-1231','Nature Publishing Group','Other','Outcome Research','Models of care'),(322,'The internet as a setting for mental health service utilisation by young people','https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955866794&doi=10.5694%2fj.1326-5377.2010.tb03688.x&partnerID=40&md5=54ec00c4c2c55c537351312439da9bcc','10.5694/j.1326-5377.2010.tb03688.x',' \nObjective: To explore patterns of internet use by young people in Australia and assess the usefulness of online resources for mental health problems, exploring functionality that may be relevant in the development of online mental health services. \nDesign and participants: Cross-sectional survey of a nationally representative sample of young people (2000 randomly selected participants aged 12ΓÇô25 years), via telephone interview, conducted in January├éΓÇôMarch 2008. \nMain outcome measures: Patterns of internet use including type of use, social networking, sources of information about mental health, alcohol or other substance use problems and levels of satisfaction with the information, and type of information accessed via websites. \nResults: Young people reported using the internet to connect with other young people (76.9%; 1464/1905) and to seek information about a mental health problem, regardless of whether├é┬á├éΓÇª\n','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'315','Medical Journal of Australia','192','','S22-S26','','YMH team','Digital health',''),(323,'Sympathetic activity in major depressive disorder: Identifying those at increased cardiac risk?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-34748907880&doi=10.1097%2fHJH.0b013e32829baae7&partnerID=40&md5=e3010d12d5b742300d40f32ab4d94282','10.1097/HJH.0b013e32829baae7','\nBackground\nEvidence exists linking major depressive disorder (MDD) with clinical cardiovascular events. The importance of the sympathetic nervous system in the generation of cardiac risk in other contexts is established.\nObjective\nTo examine the importance of the sympathetic nervous system in the generation of cardiac risk in patients with major depressive disorder (MDD).\nMethods\nStudies were performed in 39 patients meeting the Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV) criteria for MDD and in 76 healthy subjects. Treatment for patients consisted of selective serotonin reuptake inhibition (SSRI) for 12 weeks. Whole body and cardiac sympathetic activity were examined using noradrenaline isotope dilution methodology and sympathetic nerve recording techniques. Measurement of the extraction of infused tritiated noradrenaline by the heart, and estimation of cardiac dihydroxyphenylglycol├é┬á├éΓÇª\n','',2007,NULL,NULL,'2007-10-01',NULL,NULL,NULL,NULL,'308','Journal of Hypertension','25','10','2117-2124','LWW','Other','',''),(324,'The neurobiology of depression in later-life: Clinical, neuropsychological, neuroimaging and pathophysiological features','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84861746014&doi=10.1016%2fj.pneurobio.2012.05.009&partnerID=40&md5=f392003a6ef32017bd3e4f4078faddb8','10.1016/j.pneurobio.2012.05.009','As the population ages, the economic and societal impacts of neurodegenerative and neuropsychiatric disorders are expected to rise sharply. Like dementia, late-life depressive disorders are common and are linked to increased disability, high healthcare utilisation, cognitive decline and premature mortality. Considerable heterogeneity in the clinical presentation of major depression across the life cycle may reflect unique pathophysiological pathways to illness; differentiating those with earlier onset who have grown older (early-onset depression), from those with illness onset after the age of 50 or 60 years (late-onset depression). The last two decades have witnessed significant advances in our understanding of the neurobiology of early- and late-onset depression, and has shown that disturbances of fronto-subcortical functioning are implicated. New biomedical models extend well beyond perturbations of traditional','',2012,NULL,NULL,'2012-07-01',NULL,NULL,NULL,NULL,'304','Progress in Neurobiology','98','1','99-143','Pergamon','YMH team','Neurobiology','illness specific areas'),(325,'headspace: Australia\'s National Youth Mental Health Foundation--where young minds come first.','https://www.scopus.com/inward/record.uri?eid=2-s2.0-38449113112&partnerID=40&md5=c74a1fb53da1cd4f6333651d44a4b467','','\nheadspace, Australia\'s national youth mental health initiative, was created in 2006 in response to the recognition that the existing health system needed to be much more accessible and effective for young people with mental and substance use disorders. With funding of more than $54 million from the Australian Government, a carefully constructed and selected system of 30 ├éΓÇ£communities of youth services├éΓÇ¥, or integrated service hubs and networks, across the nation is being established, supported by programs for community awareness, workforce training and evidence-based resource material. \nheadspace aims to improve access, and service cohesion and quality, and ultimately health and social outcomes, for young people aged 12├éΓÇô25 years experiencing mental illness and related substance use problems. Within the Council of Australian Governments framework, this will require synergistic planning with, and├é┬á├éΓÇª\n','',2007,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'294','The Medical journal of Australia','187','S7','S68-S70','','YMH team','Mental Health System','Models of care'),(326,'Biomarkers and clinical staging in psychiatry','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908115819&doi=10.1002%2fwps.20144&partnerID=40&md5=935b1cc71ab1e0ea28b775ca5c1b253f','10.1002/wps.20144','Personalized medicine is rapidly becoming a reality in today\'s physical medicine. However, as yet this is largely an aspirational goal in psychiatry, despite significant advances in our understanding of the biochemical, genetic and neurobiological processes underlying major mental disorders. Preventive medicine relies on the availability of predictive tools; in psychiatry we still largely lack these. Furthermore, our current diagnostic systems, with their focus on well-established, largely chronic illness, do not support a pre-emptive, let alone a preventive, approach, since it is during the early stages of a disorder that interventions have the potential to offer the greatest benefit. Here, we present a clinical staging model for severe mental disorders and discuss examples of biological markers that have already undergone some systematic evaluation and that could be integrated into such a framework. The advantage of this├é┬á├éΓÇª','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'293','World Psychiatry','13','3','211-223','','Other','',''),(327,'The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: A randomized controlled trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84924901787&doi=10.1111%2fjcpp.12305&partnerID=40&md5=ff8e07c73bb8a47c6977948eea05754b','10.1111/jcpp.12305',' Background There is increasing interest in oxytocin as a therapeutic to treat social deficits in autism spectrum disorders (ASD). The aim of this study was to investigate the efficacy of a course of oxytocin nasal spray to improve social behavior in youth with ASD.   Methods In a double-blind, placebo-controlled trial across two Australian university sites between February 2009 and January 2012, 50 male participants aged between 12 and 18┬áyears, with Autistic or Asperger\'s Disorder, were randomized to receive either oxytocin (n├é┬á=├é┬á26) or placebo (n├é┬á=├é┬á24) nasal sprays (either 18 or 24 International Units), administered twice-daily for 8├é┬áweeks. Participants were assessed at baseline, after 4- and 8-weeks of treatment, and at 3-month follow-up. Primary outcomes were change in total scores on the caregiver-completed Social Responsiveness Scale and clinician-ratings on the Clinical Global Impressions-Improvement├é┬á├éΓÇª\n','',2015,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'290','Journal of Child Psychology and Psychiatry and Allied Disciplines','56','4','444-452','','Other','',''),(328,'International Chronic Fatigue Syndrome Study Group: The chronic fatigue syndrome: a comprehensive approach to its definition and study','https://scholar.google.com/scholar?cluster=15972073245404635311&hl=en&oi=scholarr',NULL,'','',1994,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'288','Ann Intern Med','121','12','953-959','',NULL,NULL,NULL),(329,'Clinical staging: a heuristic model for psychiatry and youth mental health.','https://www.scopus.com/inward/record.uri?eid=2-s2.0-38449083072&doi=10.5694%2fj.1326-5377.2007.tb01335.x&partnerID=40&md5=2ceec8e8c24f1df8c14820776fca4d8a','10.5694/j.1326-5377.2007.tb01335.x','Diagnosis in psychiatry continues to struggle to fulfil its key purposes, namely to guide treatment and to predict outcome. A clinical staging model, widely used in clinical medicine, could improve the utility of diagnosis in psychiatry, especially in young people with emerging disorders. Clinical staging has immediate potential to improve the logic and timing of interventions in psychiatry, as it does in many complex and potentially serious medical disorders. Interventions could be evaluated in terms of their ability to prevent or delay progression from earlier to later stages of a disorder, and selected by consumers and clinicians on the basis of clear-cut riskΓÇôbenefit criteria. This would ensure that, as treatments are offered earlier, they remain safe, acceptable and affordable, and potentially more effective. Biological variables and a range of candidate risk and protective factors could be studied within and across stages, and├é┬á├éΓÇª\n','',2007,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'279','The Medical journal of Australia','187','S7','S40-S42','','YMH team','Models of care',''),(330,'Genetics of white matter development: A DTI study of 705 twins and their siblings aged 12 to 29','https://www.scopus.com/inward/record.uri?eid=2-s2.0-78650209451&doi=10.1016%2fj.neuroimage.2010.10.015&partnerID=40&md5=366328213091a0101daa0197ea8f96ec','10.1016/j.neuroimage.2010.10.015','White matter microstructure is under strong genetic control, yet it is largely unknown how genetic influences change from childhood into adulthood. In one of the largest brain mapping studies ever performed, we determined whether the genetic control over white matter architecture depends on age, sex, socioeconomic status (SES), and intelligence quotient (IQ). We assessed white matter integrity voxelwise using diffusion tensor imaging at high magnetic field (4-Tesla), in 705 twins and their siblings (age range 12ΓÇô29; 290├é┬áM/415├é┬áF). White matter integrity was quantified using a widely accepted measure, fractional anisotropy (FA). We fitted gene-environment interaction models pointwise, to visualize brain regions where age, sex, SES and IQ modulate heritability of fiber integrity. We hypothesized that environmental factors would start to outweigh genetic factors during late childhood and adolescence. Genetic├é┬á├éΓÇª','',2011,NULL,NULL,'2011-02-01',NULL,NULL,NULL,NULL,'277','NeuroImage','54','3','2308-2317','Academic Press','Other','',''),(331,'Effectiveness of an online insomnia program (SHUTi) for prevention of depressive episodes (the GoodNight Study): A randomised controlled trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84962106591&doi=10.1016%2fS2215-0366%2815%2900536-2&partnerID=40&md5=45641b00824f33106214778e003cb722','10.1016/S2215-0366(15)00536-2','\n\nBackground\nIn view of the high co-occurrence of depression and insomnia, a novel way to reduce the risk of escalating depression might be to offer an insomnia intervention. We aimed to assess whether an online self-help insomnia program could reduce depression symptoms.\n\n\nMethods\nWe did this randomised controlled trial at the Australian National University in Canberra, Australia. Internet users (aged 18ΓÇô64 years) with insomnia and depression symptoms, but who did not meet criteria for major depressive disorder, were randomly assigned (1:1), via computer-generated randomisation, to receive SHUTi, a 6 week, modular, online insomnia program based on cognitive behavioural therapy for insomnia, or HealthWatch, an interactive, attention-matched, internet-based placebo control program. Randomisation was stratified by age and sex. Telephone-based interviewers, statisticians, and chief investigators were├é┬á├éΓÇª\n\n','',2016,NULL,NULL,'2016-04-01',NULL,NULL,NULL,NULL,'272','The Lancet Psychiatry','3','4','333-341','Elsevier','Other','',''),(332,'Early and late onset depression in old age: Different aetiologies, same phenomenology','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034813196&doi=10.1016%2fS0165-0327%2800%2900317-7&partnerID=40&md5=cbcb9f7fd66ed44e4494bbd2130df351','10.1016/S0165-0327(00)00317-7','\nBackground: Phenomenological differences between older patients with early onset (EO; onset of first major depressive episode before 60 years) and late onset (LO) depression have been inconsistent but, if real, may reflect differences in aetiology. We aimed to compare aetiological factors, phenomenology and cognitive function in older patients with depression by age of onset. Methods: Subjects were all patients =60 years old (n=73) from 407 consecutive attenders to a Mood Disorders Unit, diagnosed with DSM-III-R Major Depressive Episode, at or close to the nadir of their episode. Putative risk factors were assessed by structured interview. Psychological morbidity and depressive symptoms were assessed by the 21-item Hamilton Rating Scale for Depression, CORE rating of psychomotor disturbance, Newcastle Endogeneity Scale, Zung Depression Scale and General Health Questionnaire. Cognition was','',2001,NULL,NULL,'2001-10-01',NULL,NULL,NULL,NULL,'267','Journal of Affective Disorders','66','2-Mar','225-236','Elsevier','YMH team','Illness specific areas','Outcome Research'),(333,'Clinical staging in psychiatry: A cross-cutting model of diagnosis with heuristic and practical value','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84876175841&doi=10.1192%2fbjp.bp.112.110858&partnerID=40&md5=1a7557363ebb9343da47a18707b1cf62','10.1192/bjp.bp.112.110858','Staging models are used routinely in general medicine for potentially serious or chronic physical disorders such as diabetes, arthritis and cancers, describing the links between biomarkers, clinical phenotypes and disease extension, and promoting a personalised or stratified medicine approach to treatment planning. Clinical staging involves a detailed description of where an individual exists on a continuum of disorder progression from stage 0 (an at-risk or latency stage) through to stage IV (late or end-stage disease). The approach is popular owing to its clinical utility and is increasingly being applied in psychiatry. The concept offers an informed approach to research and the active promotion of indicated prevention and early intervention strategies. We suggest that for young persons with emerging bipolar disorder, such transdiagnostic staging models could provide a framework that better reflects the','',2013,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'265','British Journal of Psychiatry','202','4','243-245','Cambridge University Press','YMH team','Models of care',''),(334,'headspace├éΓÇöAustralia\'s innovation in youth mental health: who are the clients and why are they presenting?','https://onlinelibrary.wiley.com/doi/abs/10.5694/mja13.11235',NULL,' \nObjectives: To provide the first national profile of the characteristics of young people (aged 12├éΓÇô25├é┬áyears) accessing headspace centre services ├éΓÇö the Australian Government\'s innovation in youth mental health service delivery ├éΓÇö and investigate whether headspace is providing early service access for adolescents and young adults with emerging mental health problems. \nDesign and participants: Census of all young people accessing a headspace centre across the national network of 55├é┬ácentres comprising a total of 21├é┬á274├é┬áheadspace clients between 1├é┬áJanuary and 30├é┬áJune 2013. \nMain outcome measures: Reason for presentation, Kessler Psychological Distress Scale, stage of illness, diagnosis, functioning. \nResults: Young people were most likely to present with mood and anxiety symptoms and disorders, self-reporting their reason for attendance as problems with how they felt. Client demographic characteristics├é┬á├éΓÇª\n','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'246','Medical Journal of Australia','200','2','108-111','',NULL,NULL,NULL),(335,'Neuropsychological Performance in Patients with Depression is Associated with Clinical, Etiological and Genetic Risk Factors','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0242352330&doi=10.1076%2fjcen.25.6.866.16472&partnerID=40&md5=14bd43e4d2f06efac148f5af22d8ba14','10.1076/jcen.25.6.866.16472','The present study explores neuropsychological functioning in patients with depression with reference to key clinical, etiological and genetic features. In comparison to healthy volunteers, patients with severe depression demonstrated poorer performance on all neuropsychological tests except for WAIS-R Vocabulary and a 64-item computerized version of the Wisconsin Card Sorting Test. On average, patients exhibited significant impairments (greater than ΓÇô2 standard deviation units) on tests of simple reaction time, Part B of the Trail Making Test and Raven├éΓÇÖs Colored Progressive Matrices. When performance decrements were analyzed with reference to key clinical features, patients with melancholia performed more poorly on WAIS-R Vocabulary, semantic fluency and choice reaction time than those with nonmelancholic depression. After controlling for age, those patients with late-onset depression (i.e., age of onset├é┬á├éΓÇª','',2003,NULL,NULL,'2003-09-01',NULL,NULL,NULL,NULL,'246','Journal of Clinical and Experimental Neuropsychology','25','6','866-877','Taylor & Francis Group','YMH team','Neurobiology','illness specific areas'),(336,'Effect of ╧ë-3 polyunsaturated fatty acids in young people at ultrahigh risk for psychotic disorders: The NEURAPRO randomized clinical trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85011416514&doi=10.1001%2fjamapsychiatry.2016.2902&partnerID=40&md5=89cc71d6fc5ac370b091675d217ff525','10.1001/jamapsychiatry.2016.2902','\nImportance\nA promising treatment to prevent onset and improve outcomes in patients at ultrahigh risk for psychosis is dietary supplementation with long-chain -3 polyunsaturated fatty acids (PUFAs).\nObjective\nTo determine whether treatment with -3 PUFAs in combination with a high-quality psychosocial intervention (cognitive behavioral case management [CBCM]) is more effective than placebo plus CBCM.\nDesign, Setting, and Participants\nNEURAPRO, a double-blind, placebo-controlled, randomized clinical trial, was conducted from March 1, 2010, to September 30, 2014, in 10 specialized early psychosis treatment services in Australia, Asia, and Europe. The primary analysis used the intention-to-treat approach.\nInterventions\nA daily dose of 1.4 g of -3 PUFAs or placebo (paraffin oil), plus 20 or fewer sessions of CBCM over the 6-month study period.\nMain Outcomes and Measures\nThe primary outcome was├é┬á├éΓÇª\n','',2017,NULL,NULL,'2017-01-01',NULL,NULL,NULL,NULL,'243','JAMA Psychiatry','74','1','19-27','American Medical Association','Other','',''),(337,'Development of a simple screening tool for common mental disorders in general practice','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035898383&doi=10.5694%2fj.1326-5377.2001.tb143784.x&partnerID=40&md5=b3f994edcd8d1fcd6b884e092449c7be','10.5694/j.1326-5377.2001.tb143784.x','\n\nObjective: To develop and validate a self-report screening tool for common mental disorders. \nDesign and setting: Sequential development and validation studies in three cohorts of patients in general practice and one cohort of patients in a specialist psychiatry clinic. \nParticipants: 1585 patients in general practice examined cross-sectionally and longitudinally; 46515 patients attending 386 general practitioners nationwide; 364 patients participating in a longitudinal study of psychiatric disorders in general practice; and 522 patients attending a specialist psychiatry clinic. \nMain outcome measures: Performance of the 12 items from the 34-item SPHERE questionnaire against DSM-lll-R and DSM-IV diagnoses of psychiatric disorder, self-reported Brief Disability Questionnaire findings, GPs\' ratings of patients\' needs for psychological care and degree of risk resulting from mental disorder, and patients\' and GPs\' reports of\n','',2001,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'240','Medical Journal of Australia','175','','S10-S17','','YMH team','Models of care',''),(338,'Subcortical hyperintensities on magnetic resonance imaging in patients with severe depression - A longitudinal evaluation','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030820379&doi=10.1016%2fS0006-3223%2896%2900363-0&partnerID=40&md5=9bafbbe9ba55d82fa4134aadee4f43be','10.1016/S0006-3223(96)00363-0','In a longitudinal evaluation of 37 patients with severe depression who had undergone brain magnetic resonance imaging (MRI) 6 months├éΓÇö2 years (mean 14.1 months) previously, the degree of residual dysfunction was predicted by the extent of subcortical white matter hyperintensities (WMHS, p < .01), longer time elapsed since the MRI scan (p < .05), older age (p < .05), and older age at onset of affective disorder (p < .05). Ten (27%) patients developed ├éΓÇ£probable├éΓÇ¥ dementia syndromes of the vascular type, with such syndromes being predicted by WMHS (p < .01) and older age of onset of affective disorder (p < .05). Institutionalization of patients was predicted largely by the combination of chronic depression, progressive cognitive decline, and advanced age. The study supports the notion that a subgroup of patients with late-onset depressive disorders, without a family history of depression, and with risk factors to├é┬á├éΓÇª','',1997,NULL,NULL,'1997-09-01',NULL,NULL,NULL,NULL,'240','Biological Psychiatry','42','5','367-374','Elsevier','YMH team','Neurobiology','illness specific areas'),(339,'Immunologic and psychologic therapy for patients with chronic fatigue syndrome: A double-blind, placebo-controlled trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027447369&doi=10.1016%2f0002-9343%2893%2990183-P&partnerID=40&md5=9222bd3f43b4f2a059d6fe1bd8c68f55','10.1016/0002-9343(93)90183-P','Purpose: To evaluate the potential benefit of immunologic therapy with dialyzable leukocyte extract and psychologic treatment in the form of cognitive-behavioral therapy (CBT) in patients with chronic fatigue syndrome (CFS). Patients and methods: Immunologic and psychologic treatments were administered to 90 adult patients who fulfilled diagnostic criteria for CFS in a double-blind, randomized, and placebo-controlled study. A four-cell trial design allowed the assessment of benefit from immunologic and psychologic treatment individually or in combination. Outcome was evaluated by measurement of global well-being (visual analogue scales), physical capacity (standardized diaries of daily activities), functional status (Karnofsky performance scale), and psychologic morbidity (Profile of Mood States questionnaire), and cell-mediated immunity was evaluated by peripheral blood T-cell subset analysis and delayed','',1993,NULL,NULL,'1993-02-01',NULL,NULL,NULL,NULL,'238','The American Journal of Medicine','94','2','197-203','Elsevier','Other','',''),(340,'Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans','https://www.scopus.com/inward/record.uri?eid=2-s2.0-8744242039&doi=10.1017%2fS0033291704001953&partnerID=40&md5=e7ac4a7901140a9aebb4e0ea1558f821','10.1017/S0033291704001953','\nBackground.\n\n Elaboration of the concept of cytokine-induced sickness behaviour in recent years has opened new avenues for understanding brain involvement in sickness and recovery processes. Additionally, this has led to much speculation about the role of the immune system in neuropsychiatric syndromes, including depression and chronic fatigue. However, few studies have examined this phenomenon as it naturally occurs in sick humans, and none has attempted to document the quantitative relationships between cytokine levels and non-specific symptoms. The aim of this research was to examine human sickness behaviour and its immunological correlates in documented EpsteinΓÇôBarr virus (EBV), Q fever or Ross River virus (RRV) infections.\nMethod.\n\n We studied two separate samples. The first consisted of 21 patients with acute Q fever. The second included 48 patients with acute RRV or EBV infection├é┬á├éΓÇª\n','',2004,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'236','Psychological Medicine','34','7','1289-1297','Cambridge University Press','Other','',''),(341,'From nurture to network: Examining links between perceptions of parenting received in childhood and social bonds in adulthood','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026695293&doi=10.1176%2fajp.149.7.877&partnerID=40&md5=648e198d5424679dc65e897fa4247a65','10.1176/ajp.149.7.877','Considered the extent to which key characteristics of parents influence children\'s later socialization in terms of social networks and intimate relationships, and examined whether there is evidence of such continuity. A literature review revealed links (more evident in women) between perceptions of having received uncaring parenting and deficiencies in diffuse social bonds, which could reflect a causal process, a general response bias, or methodological limitations. By contrast, studies using the Parental Bonding Instrument and a specific measure of adult intimate bonds failed to find links between perceptions of parenting received in childhood and the quality of current intimate relationships unless there was extreme deprivation of parental care; in that case, the current intimate relationship was more likely to be rated as uncaring.(PsycINFO Database Record (c) 2016 APA, all rights reserved)','',1992,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'233','American Journal of Psychiatry','','','','American Psychiatric Assn','Other','',''),(342,'Cultures for mental health care of young people: An Australian blueprint for reform','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84919426638&doi=10.1016%2fS2215-0366%2814%2900082-0&partnerID=40&md5=3a98f0e3a674e142cc201f00481b9403','10.1016/S2215-0366(14)00082-0','Mental ill health is now the most important health issue facing young people worldwide. It is the leading cause of disability in people aged 10ΓÇô24 years, contributing 45% of the overall burden of disease in this age group. Despite their manifest need, young people have the lowest rates of access to mental health care, largely as a result of poor awareness and help-seeking, structural and cultural flaws within the existing care systems, and the failure of society to recognise the importance of this issue and invest in youth mental health. We outline the case for a specific youth mental health stream and describe the innovative service reforms in youth mental health in Australia, using them as an example of the processes that can guide the development and implementation of such a service stream. Early intervention with focus on the developmental period of greatest need and capacity to benefit, emerging adulthood, has├é┬á├éΓÇª','',2014,NULL,NULL,'2014-12-01',NULL,NULL,NULL,NULL,'223','The Lancet Psychiatry','1','7','559-568','Elsevier','Other','',''),(343,'A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025091617&doi=10.1016%2f0002-9343%2890%2990173-B&partnerID=40&md5=bb65a9b13040a2218d540638b2834ebd','10.1016/0002-9343(90)90173-B','Abstract purpose: The chronic fatigue syndrome (CFS) is characterized by profound fatigue, neuropsychiatric dysfunction, and frequent abnormalities in cell-mediated immunity. No effective therapy is known. patients and methods: Forty-nine patients (40 with abnormal cell-mediated immunity) participated in a randomized, double-blind, placebo-controlled trial to determine the effectiveness of high-dose intravenously administered immunoglobulin G. The patients received three intravenous infusions of a placebo solution or immunoglobulin at a dose of 2 g/kg/month. Assessment of the severity of symptoms and associated disability, both before and after treatment, was completed at detailed interviews by a physician and psychiatrist, who were unaware of the treatment status. In addition, any change in physical symptoms and functional capacity was recorded using visual analogue scales, while changes in psychologic','',1990,NULL,NULL,'1990-11-01',NULL,NULL,NULL,NULL,'214','The American Journal of Medicine','89','5','561-568','Elsevier','Other','',''),(344,'Early identification and intervention in depressive disorders: Towards a clinical staging model','https://www.scopus.com/inward/record.uri?eid=2-s2.0-45149091856&doi=10.1159%2f000140085&partnerID=40&md5=bbf732063840255c3d3f38b3f5d199f4','10.1159/000140085','\nBackground:\n\n Depressive disorders are common and associated risks include the onset of secondary disorders, substance use disorders, impairment in social and occupational functioning, and an increase in suicidality. As the onset often occurs in youth, there is a clear imperative for early identification and intervention to ameliorate, if not prevent, associated distress. \nMethods:\n\n An extensive search of relevant databases and an ancestry search was undertaken. \nResults:\n\n There is a limited but growing body of literature on this topic that is discussed in relation to a clinical staging model, which may prove to be a useful framework for identifying where an individual lies along the continuum of the course of a depressive illness thus allowing interventions to be matched for that stage. The identification of a subsyndromal and prodromal stage of depressive disorders provides early intervention opportunities. \nConclusions:\n\n It is\n','',2008,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'213','Psychotherapy and Psychosomatics','77','5','263-270','Karger Publishers','Other','',''),(345,'Defining melancholia: Properties of a refined sign-based measure','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028268385&doi=10.1192%2fbjp.164.3.316&partnerID=40&md5=67b0d5eb40f8d6baa6b5502d2faea8d3','10.1192/bjp.164.3.316','We hypothesised that psychomotor disturbance is specific to the melancholic subtype of depression and capable of defining melancholia more precisely than symptom-based criteria sets. We studied 413 depressed patients, and examined the utility of a refined, operationally driven set of clinician-rated signs, principally against a set of historically accepted symptoms of endogeneity. We specified items defining psychomotor disturbance generally as well as those weighted either to agitation or to retardation. We demonstrated the system\'s capacity to differentiate ΓÇÿmelancholic├éΓÇÖ and ├éΓÇÿnon-melancholic├éΓÇÖ depression (and the comparable success of DSM├éΓÇôIII├éΓÇôR and Newcastle criteria systems) by reference to several patient, illness and treatment response variables, to an independent measure of psychomotor disturbance (reaction time) and to a biological marker (the dexamethasone suppression test).','',1994,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'210','British Journal of Psychiatry','164','3','316-326','Cambridge University Press','Other','',''),(346,'Parents, partners or personality? Risk factors for post-natal depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025755523&doi=10.1016%2f0165-0327%2891%2990004-C&partnerID=40&md5=c79da90df4e472dbeb623db43150c5fa','10.1016/0165-0327(91)90004-C','The relevance of three different interpersonal risk factors to post-natal depression was examined. One hundred and forty-nine non-depressed women completed the Parental Bonding Instrument (PBI), the Intimate Bond Measure (IBM) and the Interpersonal Sensitivity Measure (IPSM) antenatally. Post-natal depression was identified using the Edinburgh Post-natal Depression Scale (EPDS) at 1, 3 and 6 months post partum. Significantly increased risks for post-natal depression were found for the women whose spouses provided low care or were overcontrolling and for women with high interpersonal sensitivity. Low maternal care and paternal overprotection were additional predictors when multiple regression analyses were used. Importantly, the different risk factors had their impact at different times post partum. The implication of these findings is discussed.','',1991,NULL,NULL,'1991-04-01',NULL,NULL,NULL,NULL,'208','Journal of Affective Disorders','21','4','245-255','Elsevier','YMH team','Illness specific areas',''),(347,'Screening, referral and treatment for depression in patients with coronary heart disease: A consensus statement from the national heart foundation of Australia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84940233059&doi=10.5694%2fmja13.10153&partnerID=40&md5=4c376b7a70ea253dbadec2e9ec3d390c','10.5694/mja13.10153',' In 2003, the National Heart Foundation of Australia position statement on ├éΓÇ£stress├éΓÇ¥ and heart disease found that depression was an important risk factor for coronary heart disease (CHD). This 2013 statement updates the evidence on depression (mild, moderate and severe) in patients with CHD, and provides guidance for health professionals on screening and treatment for depression in patients with CHD. The prevalence of depression is high in patients with CHD and it has a significant impact on the patient\'s quality of life and adherence to therapy, and an independent effect on prognosis. Rates of major depressive disorder of around 15% have been reported in patients after myocardial infarction or coronary artery bypass grafting. To provide the best possible care, it is important to recognise depression in patients with CHD. Routine screening for depression in all patients with CHD is indicated at first presentation├é┬á├éΓÇª\n\n','',2013,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'207','Medical Journal of Australia','198','9','483-484','','Other','',''),(348,'Applying clinical staging to young people who present for mental health care','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84873306388&doi=10.1111%2fj.1751-7893.2012.00366.x&partnerID=40&md5=99ebcc0dd89388d8dbbf1f3ffab69b93','10.1111/j.1751-7893.2012.00366.x',' \nAim: The study aims to apply clinical staging to young people who present for mental health care; to describe the demographic features, patterns of psychological symptoms, disability correlates and clinical stages of those young people; and to report longitudinal estimates of progression from less to more severe stages. \nMethods: The study uses cross-sectional and longitudinal assessments of young people managed in specialized youth clinics. On the basis of clinical records, subjects were assigned to a specific clinical ├éΓÇÿstage├éΓÇÖ (i.e. ├éΓÇÿhelp-seeking├éΓÇÖ, ├éΓÇÿattenuated syndrome├éΓÇÖ, ├éΓÇÿdiscrete disorder├éΓÇÖ or ├éΓÇÿpersistent or recurrent illness├éΓÇÖ). \nResults: Young people (n = 209, mean age = 19.9 years (range = 12├éΓÇô30 years), 48% female) were selected from a broader cohort of n = 1483 subjects. Ten percent were assigned to the earliest ├éΓÇÿhelp-seeking├éΓÇÖ stage, 54% to the ├éΓÇÿattenuated syndrome├éΓÇÖ stage, 25% to the ├éΓÇÿdiscrete├é┬á├éΓÇª\n','',2013,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'206','Early Intervention in Psychiatry','7','1','31-43','Blackwell Publishing Asia','YMH team','Models of care',''),(349,'Development of brain structural connectivity between ages 12 and 30: A 4-Tesla diffusion imaging study in 439 adolescents and adults','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014638421&doi=10.1016%2fj.neuroimage.2012.09.004&partnerID=40&md5=f955b4502fbfe761e930733b2e84312b','10.1016/j.neuroimage.2012.09.004','Understanding how the brain matures in healthy individuals is critical for evaluating deviations from normal development in psychiatric and neurodevelopmental disorders. The brain\'s anatomical networks are profoundly re-modeled between childhood and adulthood, and diffusion tractography offers unprecedented power to reconstruct these networks and neural pathways in vivo. Here we tracked changes in structural connectivity and network efficiency in 439 right-handed individuals aged 12 to 30 (211 female/126 male adults, mean age┬á=├é┬á23.6, SD├é┬á=├é┬á2.19; 31 female/24 male 12├é┬áyear olds, mean age├é┬á=├é┬á12.3, SD├é┬á=├é┬á0.18; and 25 female/22 male 16├é┬áyear olds, mean age├é┬á=├é┬á16.2, SD├é┬á=├é┬á0.37). All participants were scanned with high angular resolution diffusion imaging (HARDI) at 4├é┬áT. After we performed whole brain tractography, 70 cortical gyral-based regions of interest were extracted from each participant\'s co-registered├é┬á├éΓÇª','',2013,NULL,NULL,'2013-01-01',NULL,NULL,NULL,NULL,'200','NeuroImage','64','','671-684','Academic Press','Other','',''),(350,'Joint analysis of psychiatric disorders increases accuracy of risk prediction for schizophrenia, bipolar disorder, and major depressive disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84925130699&doi=10.1016%2fj.ajhg.2014.12.006&partnerID=40&md5=4274d2d146e12046f49e5a5381c6316e','10.1016/j.ajhg.2014.12.006','Genetic risk prediction has several potential applications in medical research and clinical practice and could be used, for example, to├é┬ástratify a heterogeneous population of patients by their predicted genetic risk. However, for polygenic traits, such as psychiatric disorders, the accuracy of risk prediction is low. Here we use a multivariate linear mixed model and apply multi-trait genomic best linear unbiased prediction for genetic risk prediction. This method exploits correlations between disorders and simultaneously evaluates individual risk for each disorder. We show that the multivariate approach significantly increases the prediction accuracy for schizophrenia, bipolar disorder, and major depressive disorder in the discovery as well as in independent validation datasets. By grouping SNPs based on genome annotation and fitting multiple random effects, we show that the prediction accuracy could be further improved├é┬á├éΓÇª','',2015,NULL,NULL,'2015-02-05',NULL,NULL,NULL,NULL,'198','American Journal of Human Genetics','96','2','283-294','Cell Press','Other','',''),(351,'Oral folic acid and vitamin B-12 supplementation to prevent cognitive decline in community-dwelling older adults with depressive symptoms - The Beyond Ageing Project: A randomized controlled trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84455188736&doi=10.3945%2fajcn.110.007799&partnerID=40&md5=3dc999d4ef71fa19cb30dcd9b1ce3dac','10.3945/ajcn.110.007799','                    Background: Evidence remains unclear as to whether folic acid (FA) and vitamin B-12 supplementation is effective in reducing depressive symptoms.                    Objectives: The objective was to determine whether oral FA + vitamin B-12 supplementation prevented cognitive decline in a cohort of community-dwelling older adults with elevated psychological distress.                    Design: A randomized controlled trial (RCT) with a completely crossed 2 ├âΓÇö 2 ├âΓÇö 2 factorial design comprising daily oral 400 ├é┬╡g FA + 100 ├é┬╡g vitamin B-12 supplementation (compared with placebo), physical activity promotion, and depression literacy with comparator control interventions for reducing depressive symptoms was conducted in 900 adults aged 60├éΓÇô74 y with elevated psychological distress (Kessler Distress 10├éΓÇôScale; scores >15). The 2-y intervention was delivered in 10 modules via mail with concurrent telephone tracking├é┬á├éΓÇª\n','',2012,NULL,NULL,'2012-01-01',NULL,NULL,NULL,NULL,'195','American Journal of Clinical Nutrition','95','1','194-203','Oxford University Press','Other','',''),(352,'Psychometric properties of the impact of event scale amongst women at increased risk for hereditary breast cancer','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035188006&doi=10.1002%2fpon.533&partnerID=40&md5=c01455ee4d664cd42d3e1784b9893a64','10.1002/pon.533','The Impact of Event Scale (IES; Horowitz MJ, Wilner N, Alvarez W. 1979. Psychosom Med41: 209ΓÇô218) has been widely used in the psycho-oncology literature as a measure of cancer-related anxiety. More recently, the IES has been applied to the assessment of breast cancer-related anxiety amongst women who are at increased risk of developing hereditary breast cancer. Despite its widespread use, no studies to date have described the validity of the IES amongst these women. The present study is a replication of reliability analyses and exploration of the factor structure and validity of the IES amongst a sample of 480 female hereditary breast cancer clinic patients. Results suggest good internal consistency (Cronbach\'s a= 0.84├éΓÇô0.91), and satisfactory test-retest reliability (IES-Total r= 0.80). The IES was found to have good face validity and be an acceptable instrument to women at increased risk of breast cancer├é┬á├éΓÇª','',2001,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'194','Psycho-Oncology','10','6','459-468','John Wiley & Sons, Ltd.','Other','',''),(353,'Neurobehavioral Functioning in Obstructive Sleep Apnea: Differential Effects of Sleep Quality, Hypoxemia and Subjective Sleepiness','https://www.scopus.com/inward/record.uri?eid=2-s2.0-1642462875&doi=10.1076%2fjcen.26.1.43.23929&partnerID=40&md5=1a39b221a48971cab5c075472ce9020e','10.1076/jcen.26.1.43.23929','This study evaluated the relationship between neuropsychological and affective functioning, subjective sleepiness and sleep-disordered breathing in 100 patients with obstructive sleep apnea (OSA). Using principal components analysis, three indices of sleep-disordered breathing were identified from polysomnography: sleep disturbance, extent of nocturnal hypoxemia, and sleep quality. Poorer sleep quality was related to slower processing speed, somatic symptomatology and tension-anxiety levels. Nocturnal hypoxemia was related to visuconstructional abilities, processing speed and mental flexibility. Patients who had high levels of subjective sleepiness had poorer performances on a complex task of executive functioning and higher levels of tension-anxiety. These results imply a differential effect of sleep-disordered breathing on domains of neuropsychological functioning. Additionally, they suggest that a','',2004,NULL,NULL,'2004-01-01',NULL,NULL,NULL,NULL,'193','Journal of Clinical and Experimental Neuropsychology','26','1','43-54','Taylor & Francis Group','Other','',''),(354,'Oxytocin Treatment, Circuitry, and Autism: A Critical Review of the Literature Placing Oxytocin into the Autism Context','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84955563865&doi=10.1016%2fj.biopsych.2015.06.028&partnerID=40&md5=f04966b5506bd09a636d15bd585b9b9e','10.1016/j.biopsych.2015.06.028','Observed impairment in reciprocal social interaction is a diagnostic hallmark of autism spectrum disorders. There is no effective medical treatment for these problems. Psychological treatments remain costly, time intensive, and developmentally sensitive for efficacy. In this review, we explore the potential of oxytocin-based therapies for social impairments in autism. Evidence shows that acute oxytocin administration improves numerous markers critical to the social circuitry underlying social deficits in autism. Oxytocin may optimize these circuits and enhance reward, motivation, and learning to improve therapeutic outcomes. Despite this, the current evidence of therapeutic benefit from extended oxytocin treatment remains very limited. We highlight complexity in crossing from the laboratory to the autism clinical setting in evaluation of this therapeutic. We discuss a clinical trial approach that provides optimal opportunity','',2016,NULL,NULL,'2016-02-01',NULL,NULL,NULL,NULL,'192','Biological Psychiatry','79','3','234-242','Elsevier','YMH team','Illness specific areas',''),(355,'A systematic review and meta-analysis of eye-tracking studies in children with autism spectrum disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907416819&doi=10.1080%2f17470919.2014.934966&partnerID=40&md5=4c7ac21343d6e956e665220b7d1313c3','10.1080/17470919.2014.934966','Aberrant eye gaze mechanisms have been implicated in autism spectrum disorders (ASD). Studies of eye movements in children with ASD reveal diminished eye gaze duration and lack of specific eye gaze fixation to the eyes and/or mouth compared with controls. However, findings to date have been contradictory. We examined eye-tracking studies on face processing in children with ASD and conducted meta-analyses to examine whether these children demonstrate atypical fixation on primary facial regions. Twenty eye-tracking studies in children with ASD were reviewed, of which the results from 14 studies were incorporated in the meta-analyses that evaluated fixation duration on (i) eyes (eight studies) and (ii) mouth (six studies). The results reveal that children with ASD have significantly reduced gaze fixation to the eye region of faces. The results of the meta-analyses indicate that ASD patients have significant','',2014,NULL,NULL,'2014-11-02',NULL,NULL,NULL,NULL,'192','Social Neuroscience','9','6','610-632','Routledge','Other','',''),(356,'Sphere: A national depression project','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031740693&doi=10.3109%2f10398569809084854&partnerID=40&md5=43068fd09970d2d1a9687054cd484635','10.3109/10398569809084854','SPHERE: A National Depression Project ΓÇö Macquarie University Skip to main navigation Skip \nto search Skip to main content Macquarie University Logo Help & FAQ Home Profiles Research \nUnits Projects Research Outputs Prizes Activities Press / Media Impacts Search by expertise, \nname or affiliation SPHERE: A National Depression Project IB Hickie * , TA Davenport, SL \nNaismith, EM Scott * Corresponding author for this work Research output: Contribution to \njournal ├éΓÇ║ Editorial ├éΓÇ║ peer-review 56 Citations (Scopus) Overview Original language English \nPages (from-to) 248-250 Number of pages 3 Journal Medical Journal of Australia Volume 175 \nIssue number SUPPL. Publication status Published - 16 Jul 2001 Access to Document Link to \npublication in Scopus Cite this APA Author BIBTEX Harvard Standard RIS Vancouver Powered \nby Pure, Scopus & Elsevier Fingerprint Engine├éΓäó ├é┬⌐ 2021 Elsevier BV We use cookies ├éΓÇª','',1998,NULL,NULL,'2001-07-16',NULL,NULL,NULL,NULL,'191*','Australasian Psychiatry','175','SUPPL.','248-250','Wiley-Blackwell, Wiley','YMH team','Models of care',''),(357,'Impaired MMN/P3a complex in first-episode psychosis: Cognitive and psychosocial associations','https://www.scopus.com/inward/record.uri?eid=2-s2.0-81755187049&doi=10.1016%2fj.pnpbp.2010.03.019&partnerID=40&md5=bc80caf3a62c311ce0667235a64baa6e','10.1016/j.pnpbp.2010.03.019','Mismatch negativity (MMN) is a neurophysiological indicator of the brain\'s ability to extract relevant information from an irrelevant background. The P3a orienting response often accompanies MMN in deviance detection paradigms. Both MMN and P3a have been described as reliable biomarkers of schizophrenia. MMN/P3a impairments are associated with deficits in verbal memory and attentional switching, reflecting dysfunctions in the temporal and frontal systems, respectively. It remains unresolved whether MMN/P3a are robust biomarkers of psychosis in first-episode patients. Thirty-four young people (18 to 30┬áyears) were assessed in this study; 17 first-episode psychosis (FEP) patients were compared to 17 healthy controls. To elicit MMN/P3a, a two-tone passive auditory oddball paradigm with 8% duration deviants was used; event-related potentials were recorded at frontal, central and temporal (mastoid) sites├é┬á├éΓÇª','',2010,NULL,NULL,'2010-08-16',NULL,NULL,NULL,NULL,'189','Progress in Neuro-Psychopharmacology and Biological Psychiatry','34','6','822-829','Elsevier','YMH team','Outcome Research',''),(358,'Disability in major depression related to self-rated and objectively-measured cognitive deficits: A preliminary study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548463097&doi=10.1186%2f1471-244X-7-32&partnerID=40&md5=64f5b41dd998dcf82d8f25c26d294b27','10.1186/1471-244X-7-32','Although major depression (MD) is associated with high levels of disability, the relationships between cognitive dysfunction and self-rated disability are poorly understood. This study examined the relationships between self-rated disability in persons with MD and both self-rated and objectively-measured cognitive functioning. Twenty-one persons with MD and 21 control participants underwent neuropsychological assessment and z-scores representing deviations from control performance were calculated and averaged across the domains of psychomotor speed, initial learning, memory retention and executive function. Self-ratings of cognitive deficits (SRCDs) were reported on a 6-point scale for overall rating of cognitive change, speed of thinking, concentration, and short-term memory. Disability scores for self-rated physical, mental-health and functional (ie. days out of role) disability were computed from the Brief-Disability Questionnaire and the SF-12 \'mental component\' subscale. Persons with MD had a mean age of 53.9 years (SD = 11.0, 76% female) and had moderate to high depression severity (mean HDRS 21.7, sd = 4.4). As expected, depression severity was a strong predictor of physical (r = 0.7, p < 0.01), mental-health (r = 0.7, p < 0.01) and functional (r = 0.8, p < 0.001) disability on the Brief Disability Questionnaire. Additionally, for physical disability, both overall SRCDs and objectively-measured psychomotor speed continued to be independent significant predictors after controlling for depression severity, uniquely accounting for 13% and 16% of variance respectively. For functional disability scores, objectively-measured memory','',2007,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'189','BMC Psychiatry','7','1','1-Jul','BioMed Central','YMH team','Illness specific areas',''),(359,'Exciting career opportunity beckons! Early intervention and vocational rehabilitation in first-episode psychosis: Employing cautious optimism','https://www.scopus.com/inward/record.uri?eid=2-s2.0-33750039655&doi=10.1111%2fj.1440-1614.2006.01918.x&partnerID=40&md5=0851f5abe6714ac4c14f35ad9f258916','10.1111/j.1440-1614.2006.01918.x','\nObjective: While there are now effective interventions for the symptoms of psychosis and schizopshrenia, treatment for the functional domains of these illnesses has received less attention. A key area affected by psychotic illness is vocational functioning. This area is currently of interest to clinicians, policy-makers, politicians and patients. This paper reviews several forms of vocational intervention practised over the years and highlights the issues around adopting an early intervention approach towards vocational rehabilitation. The paper has four aims: first, to consider some of the consequences of unemployment for those with psychotic illnesses; second, to review methods that have been used to address unemployment among the mentally ill; third, to highlight the importance of vocational development at a developmentally appropriate life stage; and finally, to consider the application of evidence-based vocational','',2006,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'188','Australian and New Zealand Journal of Psychiatry','40','11-Dec','951-962','Sage Publications','Other','',''),(360,'Short sleep duration in prevalent and persistent psychological distress in young adults: The DRIVE study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-77956368276&doi=10.1093%2fsleep%2f33.9.1139&partnerID=40&md5=63f4779a88106798e6a3bc1ceaf1f52c','10.1093/sleep/33.9.1139','                    Objectives:           Young people are sleeping less. Short sleep duration has a range of negative consequences including a hypothesized link with psychological distress, which has yet to be studied                             Design:           Prospective cohort study                             Setting:           Community-based sample from Australia                             Participants:           Twenty thousand (20,822) young adults (aged 17ΓÇô24) identified through the state vehicle licensing authority. A random sample (n = 5000) was approached for follow-up 12├éΓÇô18 months later, with 2937 providing full data.                             Main Outcome Measure:           Psychological distress, determined by a Kessler 10 score > 21, at baseline; and as both onset and persistence of distress at follow-up.                             Results:           Shorter sleep duration was linearly associated with prevalent psychological distress: relative risk (RR) 1.14 (95%CI 1.12 to 1├é┬á├éΓÇª\n','',2010,NULL,NULL,'2010-09-01',NULL,NULL,NULL,NULL,'187','Sleep','33','9','1139-1145','Oxford University Press','Other','',''),(361,'Sleep Patterns and Mental Health Correlates in US Adolescents','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85007518161&doi=10.1016%2fj.jpeds.2016.11.007&partnerID=40&md5=73b497c4dd433972c392199078b7fe2e','10.1016/j.jpeds.2016.11.007','\n\nObjective\nTo investigate systematically the associations of sleep patterns with a range of mental disorders and other outcomes among a nationally representative sample of US adolescents.\n\n\nStudy design\nUsing the National Comorbidity Survey Adolescent Supplement, a nationally representative cross-sectional survey of 10 123 US adolescents 13-18 years of age, we assessed associations between adolescent-reported sleep patterns (tertiles of weeknight bedtime, weeknight sleep duration, weekend bedtime delay, and weekend oversleep) and past-year mental disorders based on the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, smoking, injury, suicidality, and perceived mental and physical health, assessed via direct diagnostic interview.\n\n\nResults\nThe average weeknight bedtime was at 22:37 and sleep duration was 7.72 hours. Average weekend bedtime delay was 1.81 hours and average\n\n','',2017,NULL,NULL,'2017-03-01',NULL,NULL,NULL,NULL,'154','Journal of Pediatrics','182','','137-143','Mosby','Other','',''),(362,'Fatigue in selected primary care settings: Sociodemographic and psychiatric correlates','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030594512&doi=10.5694%2fj.1326-5377.1996.tb122199.x&partnerID=40&md5=449005fe0b419f32c46a0bb310fa81dd','10.5694/j.1326-5377.1996.tb122199.x',' Objectives To determine the prevalence and sociodemographic and psychiatric correlates of prolonged fatigue syndromes among patients in primary care.   Design Prospective questionnaire survey.   Patients and setting Adults over 18 years attending three general practices in metropolitan Sydney and one on the Central Coast, north of Sydney.   Results Of 1593 patients, 25% had prolonged fatigue, while 37% had psychological disorder. Of the patients with fatigue, 70% had both fatigue and psychological disorder, while 30% had fatigue only. The factors associated with prolonged fatigue were concurrent psychological disorder, female gender, lower socioeconomic status and fewer total years of education. Patients with fatigue were more likely to have a current depressive disorder.   Conclusions Prolonged fatigue/neurasthenia syndromes are common in Australian primary care settings, and are commonly\n','',1996,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'181','Medical Journal of Australia','164','10','585-588','','YMH team','Outcome Research',''),(363,'Exploring the perspectives of people whose lives have been affected by depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037141122&doi=10.5694%2fj.1326-5377.2002.tb04507.x&partnerID=40&md5=385a5c7d8e835ba0daa529d60666f929','10.5694/j.1326-5377.2002.tb04507.x',' \nObjectives: To describe the experiences of people whose lives have been affected by depression. \nDesign, setting and participants: Thematic review of data collected from 21 community meetings (1529 people, providing 911 evaluation forms) and nine focus groups (69 individuals) held nationally, and written feedback and website-based interactions with beyondblue: the national depression initiative between April and December 2001. \nMain outcome measures: Barriers to social participation experienced by people whose lives have been affected by depression, and their interactions with the healthcare system. \nResults: The key theme was the experience of stigma, which was evident in healthcare settings and in barriers to social participation, particularly regarding employment. Inadequacies of primary care and specialist treatment systems were highlighted. Particular emphasis was placed on limited access to high\n','',2002,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'179','Medical Journal of Australia','176','10','S69-S69','','YMH team','Illness specific areas',''),(364,'Late-onset depression: Genetic, vascular and clinical contributions','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034760643&doi=10.1017%2fs0033291701004731&partnerID=40&md5=86ebe2b557afc075022ce7926ef676dc','10.1017/s0033291701004731','\nBackground.\n\n Neuropsychiatric research needs to examine the relationships between aetiological, genotypic and clinical risk factors and behavioural phenotypes. These relationships can now be examined in older patients with depressive disorders.\nMethods.\n\n Key behavioural features, clinical and vascular risk factors and putative genotypes for late-onset neurodegenerative disorders and/or vascular disease were recorded in 78 older patients with depression (mean age = 54┬╖9 years, S.D. = 14├é┬╖1) and 22 healthy control subjects (mean age = 55├é┬╖5 years, S.D. = 9├é┬╖6).\nResults.\n\n Two or more vascular risks were more common in older patients (65% v. 26% of control subjects, P < 0├é┬╖01), and in patients with late-onset disorders (82% v. 57% in patients with early-onset disorders, P < 0├é┬╖05). Patients with late-onset depression had a higher prevalence of the homozygous or heterozygous forms of the C677T mutation of the├é┬á├éΓÇª\n','',2001,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'179','Psychological Medicine','31','8','1403-1412','Cambridge University Press','YMH team','Illness specific areas','Neurobiology'),(365,'Pathways to alcohol-induced brain impairment in young people: A review','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872156429&doi=10.1016%2fj.cortex.2012.05.021&partnerID=40&md5=ddab463ccdc39e59cd9b67669b83b110','10.1016/j.cortex.2012.05.021','Classically, disorders associated with ΓÇÿalcohol-related brain damage├éΓÇÖ (ARBD) occur as a result of chronic excessive alcohol misuse and confer significant physical and psychological disability to the individual as well as to the community. These phenotypes are often difficult to detect at early stages and therefore early intervention and treatment is limited. It remains unresolved as to whether there are neurobiological markers of the early stages of such brain damage in young ├éΓÇÿat-risk├éΓÇÖ drinkers, who probably experience ├éΓÇÿalcohol-induced brain impairment├éΓÇÖ prior to the onset of ARBD, per se. This review focuses on neurobiological (in particular, neuropsychological and neuroimaging) markers that are associated with alcohol misuse in young people (13├éΓÇô24 years of age). The findings from this review suggest that a clearer understanding of alcohol misuse (particularly with regards to binge drinking) is needed. Despite this├é┬á├éΓÇª','',2013,NULL,NULL,'2013-01-01',NULL,NULL,NULL,NULL,'171','Cortex','49','1','Mar-17','Elsevier','YMH team','Outcome Research',''),(366,'A meta-analysis of neuropsychological functioning in first-episode bipolar disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84905572124&doi=10.1016%2fj.jpsychires.2014.06.019&partnerID=40&md5=a2ba7ae3708ea4e6677c563adfda258c','10.1016/j.jpsychires.2014.06.019','Broad neuropsychological deficits have been consistently demonstrated in well-established bipolar disorder. The aim of the current study was to systematically review neuropsychological studies in first-episode bipolar disorders to determine the breadth, extent and predictors of cognitive dysfunction at this early stage of illness through meta-analytic procedures. Electronic databases were searched for studies published between January 1980 and December 2013. Twelve studies met eligibility criteria (N┬á=├é┬á341, mean age├é┬á=├é┬á28.2 years), and pooled effect sizes (ES) were calculated across eight cognitive domains. Moderator analyses were conducted to identify predictors of between-study heterogeneity. Controlling for known confounds, medium to large deficits (ES├é┬á=├é┬á0.5) in psychomotor speed, attention and working memory, and cognitive flexibility were identified, whereas smaller deficits (ES 0.20├éΓÇô0.49) were found├é┬á├éΓÇª','',2014,NULL,NULL,'2014-10-01',NULL,NULL,NULL,NULL,'165','Journal of Psychiatric Research','57','','1-Nov','Pergamon','YMH team','Illness specific areas',''),(367,'Prognosis of depression in the elderly. A comparison with younger patients','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027435298&doi=10.1192%2fbjp.163.5.589&partnerID=40&md5=828aa390277d343a9c59afe292f1f1da','10.1192/bjp.163.5.589','The prognosis of depression in the elderly was investigated in a mixed-age sample of 242 consecutive referrals, with DSM-III defined unipolar major depressive episode, to a specialist unit for mood disorders. Subjects were followed up at about 1 and 3.8 years. There was no significant difference in outcome between younger (under 40 years), middle aged (40ΓÇô59 years) and older (60 years or more) depressed patients. For the 61 elderly subjects with depression, prognosis improved with time, with 25% having a lasting recovery at the first and 41% at the second follow-up. Early onset, recurrence, and poor premorbid personality were associated with a worse prognosis. Three (5%) elderly depressives had committed suicide and seven (11%) had died from natural causes by the second follow-up. Despite some methodological limitations, our findings suggest a more optimistic outlook and the need for longer, more├é┬á├éΓÇª','',1993,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'175','British Journal of Psychiatry','163','5','589-596','Cambridge University Press','Other','',''),(368,'Rethinking the dose-response relationship between usage and outcome in an online intervention for depression: Randomized controlled trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84887926410&doi=10.2196%2fjmir.2771&partnerID=40&md5=4f58a3f45c1732936fd07037f9cba8a7','10.2196/jmir.2771','                     Background                     There is now substantial evidence that Web-based interventions can be effective at changing behavior and successfully treating psychological disorders. However, interest in the impact of usage on intervention outcomes has only been developed recently. To date, persistence with or completion of the intervention has been the most commonly reported metric of use, but this does not adequately describe user behavior online. Analysis of alternative measures of usage and their relationship to outcome may help to understand how much of the intervention users may need to obtain a clinically significant benefit from the program.                                                       Objective                     The objective of this study was to determine which usage metrics, if any, are associated with outcome in an online depression treatment trial.                                                       Methods                     Cardiovascular Risk E-couch Depression Outcome (CREDO) is a randomized controlled trial evaluating an unguided Web-based program (E-couch) based on cognitive behavioral therapy and interpersonal therapy for people with depression and cardiovascular disease. In all, 280 participants in the active arm of the trial commenced the program, delivered in 12 modules containing pages of text and activities. Usage data (eg, number of log-ins, modules completed, time spent online, and activities completed) were captured automatically by the program interface. We estimated the association of these and composite metrics with the outcome of a clinically significant improvement in depression score on the Patient Health Questionnaire (PHQ-9) of =5├é┬á├éΓÇª\n','',2013,NULL,NULL,'2013-10-17',NULL,NULL,NULL,NULL,'168','Journal of Medical Internet Research','15','10','e2771','JMIR Publications Inc., Toronto, Canada','Other','',''),(370,'Oxytocin Increases Heart Rate Variability in Humans at Rest: Implications for Social Approach-Related Motivation and Capacity for Social Engagement','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84865505968&doi=10.1371%2fjournal.pone.0044014&partnerID=40&md5=a40969016d411fd3060cedc628d199fd','10.1371/journal.pone.0044014','Context Oxytocin (OT) plays a key regulatory role in human social behaviour. While prior studies have examined the effects of OT on observable social behaviours, studies have seldom examined the effects of OT on psychophysiological markers such as heart rate variability (HRV), which provides an index of individualΓÇÖs motivation for social behaviour. Furthermore, no studies have examined the impact of OT on HRV under resting conditions, which provides an index of maximal capacity for social engagement.   Objective To examine the effects of OT on HRV measures in healthy male participants while at rest. OT was hypothesised to increase HRV, compared to placebo, and that the effects would be greatest for a non-linear measure of HRV (the detrended fluctuation scaling exponent).   Methods Twenty-one male participants were recruited for this study. Participants were non-smokers, not on any medications and reported no history of psychiatric illness, neurological disorder, or any other serious medical condition (e.g. diabetes, cardiovascular disease). The study employed a randomised, placebo-controlled, within-subject, crossover, experimental design.   Main Outcome Measures HRV was calculated from electrocardiography under a standardized, 10-minute, resting state condition.   Results As hypothesised, OT increased HRV and these effects were largest using the detrended fluctuation scaling exponent, a non-linear measure. These changes were observed in the absence of any change in state mood, as measured by the profile of mood states. Importantly, participants were unable to correctly guess which treatment they had been assigned├é┬á├éΓÇª','',2012,NULL,NULL,'2012-08-28',NULL,NULL,NULL,NULL,'171','PLoS ONE','7','8','e44014','Public Library of Science','Other','',''),(372,'Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-34347270539&doi=10.1016%2fS1470-2045%2807%2970148-1&partnerID=40&md5=e4a6661b31b9da16f492ac11710c4c2b','10.1016/S1470-2045(07)70148-1','\n\nBackground\nDepression, anxiety, fatigue, and impaired wellbeing are common, important, and closely related in advanced cancer. We aimed to identify the effects of an established antidepressant on these symptoms and survival in patients with advanced cancer who did not have major depression as assessed by clinicians.\n\n\nMethods\nBetween July, 2001, and February, 2006, 189 patients with advanced cancer were randomly assigned sertraline 50 mg (n=95), or placebo (n=94), once per day. The primary outcome was depression as assessed by the Centre for Epidemiologic Studies Depression scale (CES-D); the main secondary outcomes were: anxiety as assessed by Hospital Anxiety and Depression Scales (HADS-A); overall quality of life and fatigue as assessed by Functional Assessment of Cancer Therapy General and Fatigue scales (FACT-G and FACT-F, respectively); and clinicians\' ratings of quality of life by├é┬á├éΓÇª\n\n','',2007,NULL,NULL,'2007-07-01',NULL,NULL,NULL,NULL,'166','Lancet Oncology','8','7','603-612','Elsevier','Other','',''),(373,'Unmet need for recognition of common mental disorders in Australian general practice','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035898319&doi=10.5694%2fj.1326-5377.2001.tb143785.x&partnerID=40&md5=598066cd4ea2ef2778cf27ce1335bcff','10.5694/j.1326-5377.2001.tb143785.x','\n\nObjective: To determine the rate and predictors of unmet need for recognition of common mental disorders in Australian general practice. \nDesign and setting: Cross-sectional national audit of general practices throughout Australia in 1998ΓÇô1999. \nParticipants: 46515 ambulatory care patients attending 386 GPs. \nScreening tools: Prevalence of common mental disorders ├éΓÇö 12 items from the 34-item SPHERE self-report questionnaire and associated classification system; prevalence of recognition of mental disorders by GPs ├éΓÇö GPs reporting whether patients had depression, anxiety, mixed depression/anxiety, somatoform, or other psychological disorder; predictors of unmet need for recognition of mental disorders ├éΓÇö self-report questions about demography for patients and GPs, and about practice organisation for GPs. \nMain outcome measures: Reported recognition of psychological disorders by GPs; actual prevalence├é┬á├éΓÇª\n','',2001,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'165','Medical Journal of Australia','175','','S18-S24','','YMH team','Mental Health System',''),(375,'Barriers to the effective management of depression in general practice','https://www.scopus.com/inward/record.uri?eid=2-s2.0-6444241884&doi=10.1111%2fj.1440-1614.2004.01464.x&partnerID=40&md5=a5530635cefe621b7360aea3611f0c31','10.1111/j.1440-1614.2004.01464.x','\n\nObjective: The aim of this study was to investigate the effects of prior general practice training in mental health and practice location on general practitioner (GP) attitudes toward depression, self-confidence in assessing and treating depressed patients, identification of doctor, patient and practice barriers to the effective care of depressed patients in general medical practice and GP-reported current clinical practice.\n\nMethod: Fifty-two (out of 123) Divisions of General Practice that responded to an invitation to participate in the study distributed 608 anonymous surveys to a representative sample of GPs; 420 (69%) were returned. The questionnaire focused on current clinical practice, perceived barriers to care of depressed patients and doctors\' self-efficacy for assessing and treating depressed patients. It also consisted of two scales, based upon previous research, designed to assess doctors\' attitudes towards depression\n','',2004,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'158','Australian and New Zealand Journal of Psychiatry','38','10','795-803','Sage Publications','YMH team','Illness specific areas',''),(376,'Australian mental health reform: Time for real outcomes','https://www.scopus.com/inward/record.uri?eid=2-s2.0-17644385556&doi=10.5694%2fj.1326-5377.2005.tb06759.x&partnerID=40&md5=366f149b110458e090863c8a368fdc68','10.5694/j.1326-5377.2005.tb06759.x','ΓÇó After 12 years of national mental health reform, major service gaps and poor experiences of care are common.├éΓÇó The mental health community reports little progress in implementing its key priorities, such as expanded earlyintervention programs, comanagement of people with mental health problems and related alcohol or substance misuse, and widening of the spectrum of acute care settings.├éΓÇó We propose new national targets for reducing the social and economic costs of poor mental health; these include increased access to effective care, reduced suicide rates and improved rates of return to full social and economic participation.','',2005,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'158','Medical Journal of Australia','182','8','401-406','','YMH team','Mental Health System',''),(377,'Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium.(2018). Genome-wide association analyses identify 44 risk variants and refine the genetic├é┬á├éΓÇª','https://scholar.google.com/scholar?cluster=11887643881694042413&hl=en&oi=scholarr',NULL,'','',2007,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'156','Nature genetics','50','5','668-681','',NULL,NULL,NULL),(378,'Classifying depression by mental stage signs','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025353750&doi=10.1192%2fbjp.157.1.55&partnerID=40&md5=edf0c03184161b7b6e53362629029ac6','10.1192/bjp.157.1.55','The possibility that separation of a categorical depressive disease (ΓÇÿmelancholia├éΓÇÖ) from remaining depressive disorders can be improved by assessment of mental state signs was examined in patients treated by representative Sydney psychiatrists and patients referred to a specialised mood disorders unit. A set of signs, principally assessing retardation, was derived within the two samples by principal-components and latent-class analyses. Scores were significantly correlated with clinical, DSM├éΓÇôIII, and RDC diagnoses, and appeared independent of severity, suggesting that melancholia can be defined phenomenologically. Scores were also associated with several ├éΓÇÿvalidating├éΓÇÖfactors. Comparative analyses of a refined list of melancholia symptoms suggested that ratings of defined signs are likely to have greater capacity than symptom ratings to differentiate melancholia from residual depressive disorders.','',1990,NULL,NULL,'1990-07-01',NULL,NULL,NULL,NULL,'156','British Journal of Psychiatry','157','1','55-65','Cambridge University Press','YMH team','Models of care','illness specific areas'),(379,'What is chronic fatigue syndrome? Heterogeneity within an international multicenter study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034858156&doi=10.1046%2fj.1440-1614.2001.00888.x&partnerID=40&md5=2cd1172676de4b60ab3881fe8573818e','10.1046/j.1440-1614.2001.00888.x','\n Objective: We sought to compare the characteristics of patients presenting with chronic fatigue (CF) and related syndromes in eight international centres and to subclassify these subjects based on symptom profiles. The validity of the subclasses was then tested against clinical data.  Method: Subjects with a clinical diagnosis of CF completed a 119-item self-report questionnaire to provide clinical symptom data and other information such as illness course and functional impairment. Subclasses were generated using a principal components-like analysis followed by latent profile analysis (LPA).  Results: 744 subjects returned complete data sets (mean age 40.8 years, mean length of illness 7.9 years, female to male ratio 3:1). Overall, the subjects had a high rate of reporting typical CF symptoms (fatigue, neuropsychological dysfunction, sleep disturbance). Using LPA, two subclasses were generated. Class one (68├é┬á├éΓÇª\n','',2001,NULL,NULL,'2001-08-20',NULL,NULL,NULL,NULL,'154','Australian and New Zealand Journal of Psychiatry','35','4','520-527','Blackwell Science Pty','Other','',''),(381,'Delayed sleep phase in young people with unipolar or bipolar affective disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872867152&doi=10.1016%2fj.jad.2012.06.006&partnerID=40&md5=f5eef073c1a2ee812f3af9daa790c9e2','10.1016/j.jad.2012.06.006','\n\nBackground\nCircadian disturbances may play a key role in the pathogenesis of some forms of mood disorders. Despite marked changes in circadian rhythms during the normal course of adolescence and young adulthood, less is known about changes in the 24-h sleep├éΓÇôwake cycle in young persons with mood disorders.\n\n\nMethods\nSeventy-five young participants with mood disorders (unipolar: n=46, 20.1├é┬▒4.7 years old; bipolar I or II: n=29, 23.2├é┬▒4.3) and 20 healthy participants (24.8├é┬▒2.5 years old) underwent actigraphy monitoring during a depressive phase over seven consecutive days and nights. Sleep phase delay was defined as mean sleep onset =1:30├é┬áam and/or sleep offset =10:00├é┬áam.\n\n\nResults\nA delayed sleep phase was found in 62% of participants with bipolar disorders when depressed, compared with 30% of those with unipolar depression (2=6.0, p=0.014) and 10% of control participants (2=11.2, p<0.001├é┬á├éΓÇª\n\n','',2013,NULL,NULL,'2013-02-20',NULL,NULL,NULL,NULL,'153','Journal of Affective Disorders','145','2','260-263','Elsevier','YMH team','Illness specific areas',''),(382,'Unique genetic and environmental determinants of prolonged fatigue: A twin study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032991742&doi=10.1017%2fS0033291798007934&partnerID=40&md5=d20eb1ee0d8c6f30e0bfc00d4d09d1bb','10.1017/S0033291798007934','\nBackground.\n\n Prolonged fatigue syndromes have been proposed as prevalent and disabling forms of distress that occur independently of conventional notions of anxiety and depression.\nMethods.\n\n To investigate the genetic and environmental antecedents of common forms of psychological and somatic distress, we measured fatigue, anxiety, depression and psychological distress in 1004 normal adult twin pairs (533 monozygotic (MZ), 471 dizygotic (DZ)) over 50 years of age.\nResults.\n\n Familial aggregation of psychological distress, anxiety and fatigue appeared to be due largely to additive genetic factors (MZ[ratio ]DZ ratios of 2┬╖12├éΓÇô2├é┬╖69). The phenotypic correlations between the psychological measures (distress, anxiety and depression) were moderate (0├é┬╖67├éΓÇô0├é┬╖79) and higher than that between fatigue and psychological distress (0├é┬╖38). Multivariate genetic modelling revealed a common genetic factor contributing to the├é┬á├éΓÇª\n','',1999,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'153','Psychological Medicine','29','2','259-268','Cambridge University Press','YMH team','Neurobiology',''),(383,'Young men\'s attitudes and behaviour in relation to mental health and technology: Implications for the development of online mental health services','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84876968893&doi=10.1186%2f1471-244X-13-119&partnerID=40&md5=70943d2b184f7ce5fd77f93e373ad169','10.1186/1471-244X-13-119','This mixed-methods study was designed to explore young Australian men├éΓÇÖs attitudes and behaviour in relation to mental health and technology use to inform the development of online mental health services for young men. National online survey of 486 males (aged 16 to 24) and 17 focus groups involving 118 males (aged 16 to 24). Young men are heavy users of technology, particularly when it comes to entertainment and connecting with friends, but they are also using technology for finding information and support. The focus group data suggested that young men would be less likely to seek professional help for themselves, citing a preference for self-help and action-oriented strategies instead. Most survey participants reported that they have sought help for a problem online and were satisfied with the help they received. Focus group participants identified potential strategies for how technology could be used to overcome the barriers to help-seeking for young men. The key challenge for online mental health services is to design interventions specifically for young men that are action-based, focus on shifting behaviour and stigma, and are not simply about increasing mental health knowledge. Furthermore, such interventions should be user-driven, informed by young men├éΓÇÖs views and everyday technology practices, and leverage the influence of peers.','',2013,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'151','BMC Psychiatry','13','1','1-Oct','BioMed Central','YMH team','Digital health',''),(384,'Reduced Heart Rate Variability in Social Anxiety Disorder: Associations with Gender and Symptom Severity','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84880784327&doi=10.1371%2fjournal.pone.0070468&partnerID=40&md5=484d87338d6b8b87cd7baaaa1eb90023','10.1371/journal.pone.0070468','Background Polyvagal theory emphasizes that autonomic nervous system functioning plays a key role in social behavior and emotion. The theory predicts that psychiatric disorders of social dysfunction are associated with reduced heart rate variability, an index of autonomic control, as well as social inhibition and avoidance. The purpose of this study was to examine whether heart rate variability was reduced in treatment-seeking patients diagnosed with social anxiety disorder, a disorder characterized by social fear and avoidance.  Methods Social anxiety patients (n = 53) were recruited prior to receiving psychological therapy. Healthy volunteers were recruited through the University of Sydney and the general community and were matched by gender and age (n = 53). Heart rate variability was assessed during a five-minute recording at rest, with participants completing a range of self-report clinical symptom measures.  Results Compared to controls, participants with social anxiety exhibited significant reductions across a number of heart rate variability measures. Reductions in heart rate variability were observed in females with social anxiety, compared to female controls, and in patients taking psychotropic medication compared to non-medicated patients. Finally, within the clinical group, we observed significant associations between reduced heart rate variability and increased social interaction anxiety, psychological distress, and harmful alcohol use.  Conclusions The results of this study confirm that social anxiety disorder is associated with reduced heart rate variability. Resting state heart rate variability may therefore be considered a marker for','',2013,NULL,NULL,'2013-07-30',NULL,NULL,NULL,NULL,'150','PLoS ONE','8','7','e70468','Public Library of Science','YMH team','Illness specific areas',''),(385,'Cancer-related fatigue in women with breast cancer: Outcomes of a 5-year prospective cohort study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863974865&doi=10.1200%2fJCO.2011.34.6148&partnerID=40&md5=621e38788f4bbf5eb6604abd7b5b3ca9','10.1200/JCO.2011.34.6148','\nPurpose\nProlonged and disabling fatigue is prevalent after cancer treatment, but the early natural history of cancer-related fatigue (CRF) has not been systematically examined to document consistent presence of symptoms. Hence, relationships to cancer, surgery, and adjuvant therapy are unclear.\n','',2012,NULL,NULL,'2012-05-20',NULL,NULL,NULL,NULL,'149','Journal of Clinical Oncology','30','15','1805-1812','American Society of Clinical Oncology','Other','',''),(386,'Cognitive training in affective disorders improves memory: A preliminary study using the NEAR approach','https://www.scopus.com/inward/record.uri?eid=2-s2.0-74449084365&doi=10.1016%2fj.jad.2009.06.028&partnerID=40&md5=448b58986380e6c5962d655ecdddc6db','10.1016/j.jad.2009.06.028','\n\nBackground\nNeuropsychological deficits in depression include difficulties with psychomotor speed, executive functions and memory. Some of these changes persist despite antidepressant treatment. While research in other areas of psychiatry has shown cognitive training techniques to be effective, only one study has evaluated this approach in depression.\n\n\nMethods\nSixteen patients (mean age┬á=├é┬á33.5├é┬áyears) with a lifetime diagnosis of major depressive disorder were administered a standardised battery of neuropsychological tests and allocated to treatment (n├é┬á=├é┬á8) or waitlist control (n├é┬á=├é┬á8) conditions. The treatment consisted of 10-weeks of twice weekly cognitive training using the Neuropsychological Educational Approach to Remediation. All participants were re-assessed after 10-weeks by interviewers blinded to group allocation.\n\n\nResults\nParticipants in the treatment condition demonstrated greater improvements on├é┬á├éΓÇª\n\n','',2010,NULL,NULL,'2010-03-01',NULL,NULL,NULL,NULL,'148','Journal of Affective Disorders','121','3','258-262','Elsevier','YMH team','Models of care',''),(588,'Targeted primary care-based mental health services for young Australians','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84857812953&doi=10.5694%2fmja11.10481&partnerID=40&md5=c1eb6f46a0b5ec51a6efe3ceff9b4885','10.5694/mja11.10481',' \nObjective: To assess the extent to which youth-specific, mental health care centres engage young people (12ΓÇô25 years of age) in treatment, and to report the degree of psychological distress, and the diagnostic type, stage of illness, and psychosocial and vocational impairment evident in these young people. \nDesign and setting: Standardised clinical and self-report assessments of consecutive presentations at two youth-specific centres from October 2007 to December 2009. Both sites are operated by the Brain and Mind Research Institute in Sydney, Australia, as part of headspace: the National Youth Mental Health Foundation mental health care service. \nResults: Of 1260 young people assessed, 53% were male, and the mean (SD) age was 18.1 (3.9) years. Over 40% of the young people were self-referred, or their assessment was arranged by family or friends, or by other social agencies; 30% of young people├é┬á├éΓÇª\n','',2012,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'148','Medical Journal of Australia','196','2','136-140','','YMH team','Mental Health System','Models of care'),(589,'Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32330 subjects from the international cannabis consortium','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85011976876&doi=10.1038%2ftp.2016.36&partnerID=40&md5=a2c462366dcff541a928e9baeb65e461','10.1038/tp.2016.36','Cannabis is the most widely produced and consumed illicit psychoactive substance worldwide. Occasional cannabis use can progress to frequent use, abuse and dependence with all known adverse physical, psychological and social consequences. Individual differences in cannabis initiation are heritable (40├éΓÇô48%). The International Cannabis Consortium was established with the aim to identify genetic risk variants of cannabis use. We conducted a meta-analysis of genome-wide association data of 13 cohorts (N= 32 330) and four replication samples (N= 5627). In addition, we performed a gene-based test of association, estimated single-nucleotide polymorphism (SNP)-based heritability and explored the genetic correlation between lifetime cannabis use and cigarette use using LD score regression. No individual SNPs reached genome-wide significance. Nonetheless, gene-based tests identified four genes├é┬á├éΓÇª','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'147','Translational Psychiatry','6','3','e769-e769','Nature Publishing Group','Other','',''),(590,'Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: A longitudinal study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-33750349720&doi=10.1186%2f1471-2407-6-240&partnerID=40&md5=20c670421d6000bc9f10fc18639a168f','10.1186/1471-2407-6-240','Persistent fatigue is recognised as one of the most common, ongoing symptoms reported by patients following cancer treatment and may have profound effects on the quality of life. However, recent cross-sectional studies also highlight the close relationship between cancer related fatigue (CRF) and diagnoses of depression or anxiety disorder. There is currently limited information about the relationships between these conditions over time. We sought to examine the longitudinal relationships between fatigue and mood disorder in women treated with adjuvant therapy for early stage breast cancer. Women who had recently completed adjuvant therapy for Stage I or II breast cancer (n = 212) were sent a questionnaire with established case thresholds for clinically-significant fatigue and psychological disorder, as well as a questionnaire assessing disability. Potentially relevant variables linked to fatigue states, including age, treatment modality, menopausal status, and hematological indices were recorded. The illness outcomes were assessed over 48 months of follow-up. The 176 women who responded to the questionnaire (84%) had a mean age of 55 (range 24ΓÇô83) years and had completed adjuvant treatment on average 10 (range 4.7 ├éΓÇô 16.3) months previously. Radiotherapy had been administered, either alone (50% of women) or in combination with chemotherapy (36%). Responses from 87 women (48%) indicated a significant fatigue state (termed here post-cancer fatigue; PCF), and from 59 women (33%) responses indicated significant psychological distress. Thirty-four women (19%) were cases of fatigue alone (i.e. unaccompanied by├é┬á├éΓÇª','',2006,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'146','BMC Cancer','6','1','1-Aug','BioMed Central','Other','',''),(591,'Effect of oral appliance therapy on neurobehavioral functioning in obstructive sleep apnea: a randomized controlled trial.','https://www.scopus.com/inward/record.uri?eid=2-s2.0-28244488152&doi=10.5664%2fjcsm.26365&partnerID=40&md5=40211e7699184a1da01e5101ccbd7128','10.5664/jcsm.26365','\nStudy Objectives: This study aimed to assess the efficacy of a custommade mandibular advancement splint for the treatment of obstructive sleep apnea with respect to neuropsychological functioning and mood state.\nMethods: A randomized controlled crossover design was used in which 73 participants (mean age= 48.4, SD= 11.0,% men= 80.8) with at least 2 symptoms of obstructive sleep apnea and an apnea hypopnea index= 10 per hour underwent treatment with both mandibular advancement splint and an inactive oral device. Polysomnographic, neuropsychological and self-report measures were conducted at baseline and repeated after each of the two 4-week treatment phases. Results: MAS treatment was associated with improvements on the somatic component of the Beck Depression Inventory and the Vigor-Activity and Fatigue-Inertia scales of the Profile of Mood States. While there were no improvements\n','',2005,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'145','Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine','1','4','374-380','','Other','',''),(592,'Prediction of ECT response: Validation of a refined sign-based (CORE) system for defining melancholia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029742513&doi=10.1192%2fbjp.169.1.68&partnerID=40&md5=d987abc44bcdfdbf5d9ba973ed9640e5','10.1192/bjp.169.1.68','Background The clinical validity of melancholia has been argued on the basis of its capacity to predict response to electroconvulsive therapy (ECT). We have argued that a sign-based (CORE) rating system of psychomotor disturbance can identify patients with melancholia. Therefore, the clinical validity of the CORE system was tested here in terms of its capacity to predict response to ECT. Method The response of 81 patients with primary affective disorders to an individualised course of ECT was investigated. CORE scores and other clinical predictors were evaluated in terms of their capacity to predict effect size changes in symptoms and disability. Results CORE scores predicted ECT response, as did the presence of psychotic features. The combination of marked psychomotor change (high CORE scores) and psychotic features predicted the best response to ECT. Conclusion This study supports the clinical validity','',1996,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'144','British Journal of Psychiatry','169','1','68-74','Cambridge University Press','YMH team','Outcome Research',''),(593,'Subjective memory complaints, vascular risk factors and psychological distress in the middle-aged: A cross-sectional study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-79959764728&doi=10.1186%2f1471-244X-11-108&partnerID=40&md5=f477d6f4dc860e5f5579de37f91c0e8d','10.1186/1471-244X-11-108','Subjective memory complaints (SMC) are common but their significance is still unclear. It has been suggested they are a precursor of mild cognitive impairment (MCI) or dementia and an early indicator of cognitive decline. Vascular risk factors have an important role in the development of dementia and possibly MCI. We therefore aimed to test the hypothesis that vascular risk factors were associated with SMC, independent of psychological distress, in a middle-aged community-dwelling population. A cross-sectional analysis of baseline data from the 45 and Up Study was performed. This is a cohort study of people living in New South Wales (Australia), and we explored the sample of 45, 532 participants aged between 45 and 64 years. SMC were defined as \'fair\' or \'poor\' on a self-reported five-point Likert scale of memory function. Vascular risk factors of obesity, diabetes, hypertension, hypercholesterolemia and smoking were identified by self-report. Psychological distress was measured by the Kessler Psychological Distress Scale. We tested the model generated from a randomly selected exploratory sample (n = 22, 766) with a confirmatory sample of equal size. 5, 479/45, 532 (12%) of respondents reported SMC. Using multivariate logistic regression, only two vascular risk factors: smoking (OR 1.18; 95% CI = 1.03 - 1.35) and hypercholesterolaemia (OR 1.19; 95% CI = 1.04 - 1.36) showed a small independent association with SMC. In contrast psychological distress was strongly associated with SMC. Those with the highest levels of psychological distress were 7.00 (95% CI = 5.41 - 9.07) times more likely to have SMC than the non-distressed. The','',2011,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'144','BMC Psychiatry','11','1','1-Jul','BioMed Central','Other','',''),(594,'Manipulating the sleep-wake cycle and circadian rhythms to improve clinical management of major depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84875155027&doi=10.1186%2f1741-7015-11-79&partnerID=40&md5=23417124665207a1c8816ab3e9bae743','10.1186/1741-7015-11-79','Clinical psychiatry has always been limited by the lack of objective tests to substantiate diagnoses and a lack of specific treatments that target underlying pathophysiology. One area in which these twin failures has been most frustrating is major depression. Due to very considerable progress in the basic and clinical neurosciences of sleep-wake cycles and underlying circadian systems this situation is now rapidly changing. The development of specific behavioral or pharmacological strategies that target these basic regulatory systems is driving renewed clinical interest. Here, we explore the extent to which objective tests of sleep-wake cycles and circadian function - namely, those that measure timing or synchrony of circadian-dependent physiology as well as daytime activity and nighttime sleep patterns - can be used to identify a sub-class of patients with major depression who have disturbed circadian profiles. Once├é┬á├éΓÇª','',2013,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'143','BMC Medicine','11','1','Jan-27','BioMed Central','YMH team','Outcome Research','illness specific areas'),(595,'Primary care-led mental health service reform: An outline of the Better Outcomes in Mental Health Care initiative','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036910525&doi=10.1046%2fj.1440-1665.2002.00498.x&partnerID=40&md5=f438c96521fa5de74682d0734d588f08','10.1046/j.1440-1665.2002.00498.x','\n\nObjective: To describe the key features of the ΓÇÿBetter Outcomes in Mental Health Care├éΓÇÖ initiative (2001-2005) and to detail some of the conceptual, community, professional and epidemiological forces that shaped its content.\n\nConclusions: The ├éΓÇÿBetter Outcomes in Mental Health Care├éΓÇÖ initiative represents a major development in mental health care in Australia. It recognises the central role of primary care, promotes integrated medical and psychological care, rewards treatments that occur over an episode of illness, promotes active purchasing of non-pharmacological interventions earlier in the course of illness, and attempts to better link general practitioners, non-medical mental health specialists and psychiatrists to meet population-based mental health needs. Central to its development has been a commitment by general practitioners to develop progressively better mental health skills and measure both individual├é┬á├éΓÇª\n','',2002,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'138','Australasian Psychiatry','10','4','376-382','SAGE Publications','YMH team','Mental Health System','Models of care'),(596,'Increased rate of psychosis and psychomotor change in depression with age','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030829018&doi=10.1017%2fS0033291797005436&partnerID=40&md5=000bbaed4523d5ec8cae7770f112a13c','10.1017/S0033291797005436','Background. We examined the phenomenology of depression in younger (<60 years old) versus older ([ges ]60 years) subjects and, more specifically, the interaction between age and psychomotor disturbance associated with depression.Method. Two hundred and eighty-five patients with a DSM-III-R diagnosis of unipolar major depression referred to a mood disorders unit were assessed using the CORE rating scale, a sign-based system for defining melancholia. Subjects were also assessed using the Hamilton Rating Scale for Depression, Zung Depression Scale, Newcastle Endogenous Depression Inventory and the General Health Questionnaire.Results. The total CORE score (and each of its subscales) was found to interact with age. Rates of psychotic and melancholic depression increased with age. Elderly depressives suffered more severe depression (higher HRSD scores), appetite loss and weight loss','',1997,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'136','Psychological Medicine','27','5','1205-1213','Cambridge University Press','YMH team','Illness specific areas','Outcome Research'),(597,'Sleep-Wake cycle and melatonin rhythms in adolescents and young adults with mood disorders: Comparison of unipolar and bipolar phenotypes','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84883561146&doi=10.1016%2fj.eurpsy.2013.04.001&partnerID=40&md5=e718c38de386d4b21a76f27ff0b745df','10.1016/j.eurpsy.2013.04.001','This study evaluated the potential of circadian measures as early markers of mood disorders subtypes. Patients with bipolar disorders had significantly lower levels and later onset of melatonin secretion than those with unipolar depression. Furthermore, abnormal phase angles between sleep, melatonin and temperature were found in several patients.','',2013,NULL,NULL,'2013-09-01',NULL,NULL,NULL,NULL,'135','European Psychiatry','28','7','412-416','No longer published by Elsevier','YMH team','Illness specific areas',''),(598,'Intranasal Arginine Vasopressin Enhances the Encoding of Happy and Angry Faces in Humans','https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953126435&doi=10.1016%2fj.biopsych.2010.03.014&partnerID=40&md5=5e42473fe62c64e9a516b223022544b0','10.1016/j.biopsych.2010.03.014','\n\nBackground\nArginine vasopressin (AVP) has a complex but crucial role in social behavior. In nonhuman mammals it facilitates social recognition and bonding while also promoting defensive, aggressive, and territorial behaviors. There has been little research in humans exploring its effect on social cognition, including the encoding of social memories.\n\n\nMethods\nIn a double-blind, randomized, placebo-controlled, between-subject design, we administered AVP (20 IU) or a placebo intranasally to 48 healthy human male volunteers and then presented 54 happy, angry, or neutral human faces. Participants returned the following day to make ΓÇ£remember├éΓÇ¥, ├éΓÇ£know├éΓÇ¥, or ├éΓÇ£new├éΓÇ¥ judgments for a mix of 108 new and previously seen faces.\n\n\nResults\nParticipants who were administered AVP were more likely to make know judgments for previously seen happy and angry faces in comparison with neutral human faces. Arginine├é┬á├éΓÇª\n\n','',2010,NULL,NULL,'2010-06-15',NULL,NULL,NULL,NULL,'134','Biological Psychiatry','67','12','1220-1222','Elsevier','Other','Neurobiology',''),(599,'Psychosocial risk factors for coronary heart disease','https://onlinelibrary.wiley.com/doi/abs/10.5694/mja13.10440',NULL,' In 2003, the National Heart Foundation of Australia published a position statement on psychosocial risk factors and coronary heart disease (CHD). This consensus statement provides an updated review of the literature on psychosocial stressors, including chronic stressors (in particular, work stress), acute individual stressors and acute population stressors, to guide health professionals based on current evidence. It complements a separate updated statement on depression and CHD. Perceived chronic job strain and shift work are associated with a small absolute increased risk of developing CHD, but there is limited evidence regarding their effect on the prognosis of CHD. Evidence regarding a relationship between CHD and job (in)security, job satisfaction, working hours, effort├éΓÇôreward imbalance and job loss is inconclusive. Expert consensus is that workplace programs aimed at weight loss, exercise and other├é┬á├éΓÇª\n\n','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'133','','199','3','179-180','',NULL,NULL,NULL),(600,'Sleep well, think well: Sleep-wake disturbance in mild cognitive impairment','https://www.scopus.com/inward/record.uri?eid=2-s2.0-77951973059&doi=10.1177%2f0891988710363710&partnerID=40&md5=c802d61e8bfce64d96ec6addbf0c5a05','10.1177/0891988710363710','While literature suggests that sleep is important for cognition and mood, and that sleep disturbance is a prominent feature of neurodegenerative and neuropsychiatric disorders, these relationships have not yet been examined in older people ├æΓÇÿat risk\"\" of dementia. In this study, 15 older people with the nonamnestic subtype of mild cognitive impairment ([MCI] mean age = 66.7 years, SD = 8.7) underwent psychiatric and neuropsychological assessment. Participants completed sleep diaries, questionnaires, and 2 weeks of actigraphy. Key outcome data during the rest interval were time spent ├æΓÇÿawake\"\" or wake after sleep onset (WASO) and the number of arousals/wake bouts. Results showed that even after controlling for age, greater WASO was associated with reduced attention and executive functioning and increased arousals were related to poorer nonverbal learning and problem solving. This preliminary data','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'133','Journal of Geriatric Psychiatry and Neurology','23','2','123-130','Sage Publications','YMH team','Outcome Research','Neurobiology'),(601,'Caudate nucleus volumes and genetic determinants of homocysteine metabolism in the prediction of psychomotor speed in older persons with depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036895715&doi=10.1176%2fappi.ajp.159.12.2096&partnerID=40&md5=88252650be70f5434912c56ee98b6089','10.1176/appi.ajp.159.12.2096','\nOBJECTIVE:\n\n The authors sought to determine whether caudate nucleus volumes or specific genotypes predict psychomotor slowing in older persons with depression. \nMETHOD:\n\n Forty-seven persons with depression (mean age= 51.8 years, SD= 12.4) and 20 healthy volunteers (mean age= 56.1 years, SD= 9.8) underwent clinical assessments, a neuropsychological test of psychomotor speed (part A of the Trail Making Test), high-resolution magnetic resonance imaging scans, and genotyping for the apolipoprotein E e4 allele and a mutation of the methylenetetrahydrofolate reductase enzyme. \nRESULTS:\n\n Multivariate analyses revealed that psychomotor speed was uniquely predicted by age, a diagnosis of depression, right caudate nucleus volume, and mutation of the methylenetetrahydrofolate reductase enzyme. \nCONCLUSIONS:\n\n Psychomotor slowing, a key clinical and cognitive phenomenon in older persons with\n','',2002,NULL,NULL,'2002-12-01',NULL,NULL,NULL,NULL,'133','American Journal of Psychiatry','159','12','2096-2098','American Psychiatric Publishing','Other','',''),(602,'CellΓÇÉmediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026565692&doi=10.1111%2fj.1365-2249.1992.tb06416.x&partnerID=40&md5=fb0770c5c179f281ef2bdc74ed8e1861','10.1111/j.1365-2249.1992.tb06416.x','         The chronic fatigue syndrome (CFS) is characterized by severe persistent fatigue and neuropsychiatric symptoms. It has been proposed that the abnormalities in cell-mediated immunity which have been documented in patients with CFS may be attributable to a clinical depression, prevalent in patients with this disorder. Cell-mediated immune status was evaluated in patients with carefully defined CFS and compared with that of matched subjects with major depression (non-melancholic, non-psychotic) as well as healthy control subjects. Patients with CFS demonstrated impaired lymphocyte responses to phytohaemagglutinin (PHA) stimulation, and reduced or absent delayed-type hypersensitivity (DTH) skin responses when compared either with subjects with major depression or with healthy control subjects (P < 0┬╖05 for each analysis). Although depression is common in patients with CFS, the disturbances of├é┬á├éΓÇª\n','',1992,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'133','Clinical &amp; Experimental Immunology','87','1','76-79','Oxford University Press','YMH team','Illness specific areas','Neurobiology'),(603,'Activation in bipolar disorders: a systematic review','https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2592473',NULL,'Importance\r\nIncreased activity and energy alongside mood change are identified in theDSM-5as cardinal symptoms of mania and hypomania. A wide range of existing research suggests that this revision may be valid, but systematic integration of the evidence has not been reported. The termactivationis understood as emerging from underlying physiological change and having objective (observable motor activity) and related subjective (energy) levels.\r\nObjectives\r\nTo systematically review studies of the clinical phenomenon of activation in bipolar disorder, to determine whether activation is statistically abnormal in bipolar disorder and demonstrably distinct from mood, and to identify any significant between- and within-individual differences in the dynamics of activation.\r\nEvidence Review\r\nThis systematic review of MEDLINE, PsycINFO, EMBASE, CINAHL, and PubMed databases from January 1, 1970, until September 30','',2017,NULL,NULL,'2017-02-01',NULL,NULL,NULL,NULL,'130',NULL,'74','2','189-196','American Medical Association',NULL,NULL,NULL),(604,'Fatigue and psychological distress - Exploring the relationship in women treated for breast cancer','https://www.scopus.com/inward/record.uri?eid=2-s2.0-3142568650&doi=10.1016%2fj.ejca.2004.03.021&partnerID=40&md5=8515271d60240fdb422613a3f9fd9686','10.1016/j.ejca.2004.03.021','Disabling fatigue and psychological symptoms of depression or anxiety are commonly reported by women with treated breast cancer. However, most instruments designed to assess fatigue do not assess concurrent psychological symptoms. This study compared the characteristics of two conceptually different, self-report instruments assessing fatigue to determine the extent to which common psychological symptoms co-exist with the symptom of fatigue in women treated for breast cancer. Women attending an oncology day-care facility for adjuvant treatment of breast cancer or ongoing surveillance post-treatment, completed two self-report questionnaires. The Somatic and Psychological Health REport-34 items (SPHERE) and the Functional Assessment of Cancer Therapy-Fatigue (FACT-F subscale-13 items).One hundred and nine women (mean age 52.8 years) completed both questionnaires and total scores on├é┬á├éΓÇª','',2004,NULL,NULL,'2004-07-01',NULL,NULL,NULL,NULL,'129','European Journal of Cancer','40','11','1689-1695','Pergamon','Other','',''),(605,'Serotonin transporter gene status predicts caudate nucleus but not amygdala or hippocampal volumes in older persons with major depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-33846011123&doi=10.1016%2fj.jad.2006.07.010&partnerID=40&md5=0b8805d457df2239b9e7353ef8580307','10.1016/j.jad.2006.07.010','\n\nBackground\nAlthough the short allele of the serotonin transporter promoter polymorphism (5-HTT) has been linked to increased risk of major depression in early adult life, its relationships with late-life depression and to changes in subcortical nuclei remain unclear.\n\n\nMethods\n5-HTT genotypes (SS, SL, LL) were determined for 45 older persons with major depression (mean age┬á=├é┬á52.0, sd├é┬á=├é┬á12.8) and 16 healthy controls (mean age├é┬á=├é┬á55.8, sd├é┬á=├é┬á10.3). MRI-derived volumes of the amygdala, hippocampus, caudate and putamen were determined by reliable tracing techniques.\n\n\nResults\nIn those with depression, the short allele of 5-HTT was associated with smaller caudate nucleus volumes. Although hippocampal and amygdala volumes were smaller in those with depression as compared with control subjects, 5-HTT gene status did not predict this reduction in size.\n\n\nLimitations\nThe findings are limited by the number of clinical├é┬á├éΓÇª\n\n','',2007,NULL,NULL,'2007-02-01',NULL,NULL,NULL,NULL,'129','Journal of Affective Disorders','98','1-Feb','137-142','Elsevier','YMH team','Neurobiology','illness specific areas'),(606,'Acute effects of intranasal oxytocin on subjective and behavioral responses to social rejection','https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955839969&doi=10.1037%2fa0019719&partnerID=40&md5=7487d593b242614bfcfff1888f9b47e7','10.1037/a0019719','The hormone and neuropeptide oxytocin is believed to buffer against social stress and reduce social-threat perception. We employed a widely used ostracism paradigm, Cyberball, to investigate whether oxytocin ameliorated the acute behavioral and affective consequences of social rejection. In a double-blind, randomized, between-subjects design, 74 healthy male and female participants were administered intranasal oxytocin or placebo and subsequently ostracized or included during this virtual ball-tossing game. Ostracized participants reported negative affective and attachment-related reactions, as well as a significant motivational change in increased desire to be involved in the game; these effects were not influenced by oxytocin. Intranasal oxytocin did, however, increase included participants\' desire to play again with the same participants, suggesting oxytocin enhanced desire for future social engagement','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'129','Experimental and Clinical Psychopharmacology','18','4','316','American Psychological Association','Other','',''),(607,'Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030873395&doi=10.1016%2fS0002-9343%2897%2990045-0&partnerID=40&md5=cb2687188c4c4350c64810cd88b6680a','10.1016/S0002-9343(97)90045-0','\nPURPOSE: To determine whether the reported therapeutic benefit of intravenous immunoglobulin in patients with chronic fatigue syndrome (CFS) is dose dependent.\nPATIENTS AND METHODS: Ninety-nine adult patients, who fulfilled diagnostic criteria for CFS, participated in this double-blind, randomized, and placebo-controlled trial. Patients received intravenous infusions with either a placebo solution (1% albumin) or one of three doses of immunoglobulin (0.5, 1, or 2 g/kg) on a monthly basis for 3 months, followed by a treatment-free follow-up period of 3 months. Outcome was assessed by changes in a series of self-report measures (quality-of-life visual analog scales, standardized diaries of daily activities, the profile of mood states questionnaire) and the Karnofsky performance scale. Cell-mediated immunity was evaluated by T-cell subset analysis and delayed-type hypersensitivity (DTH) skin testing.\nRESULTS\n','',1997,NULL,NULL,'1997-07-01',NULL,NULL,NULL,NULL,'129','American Journal of Medicine','103','1','38-43','Elsevier','Other','',''),(608,'Genetic co-morbidity between neuroticism, anxiety/depression and somatic distress in a population sample of adolescent and young adult twins','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84860723180&doi=10.1017%2fS0033291711002431&partnerID=40&md5=3d15cf62ef293f2f3bb9e2556b36c3e7','10.1017/S0033291711002431','BackgroundGenetic studies in adults indicate that genes influencing the personality trait of neuroticism account for substantial genetic variance in anxiety and depression and in somatic health. Here, we examine for the first time the factors underlying the relationship between neuroticism and anxiety/depressive and somatic symptoms during adolescence.MethodThe Somatic and Psychological Health Report (SPHERE) assessed symptoms of anxiety/depression (PSYCH-14) and somatic distress (SOMA-10) in 2459 adolescent and young adult twins [1168 complete pairs (35.4% monozygotic, 53% female)] aged 12ΓÇô25 years (mean=15.5├é┬▒2.9). Differences between boys and girls across adolescence were explored for neuroticism, SPHERE-34, and the subscales PSYCH-14 and SOMA-10. Trivariate analyses partitioned sources of covariance in neuroticism, PSYCH-14 and SOMA-10.ResultsGirls scored higher than├é┬á├éΓÇª','',2012,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'126','Psychological Medicine','42','6','1249-1260','Cambridge University Press','Other','',''),(609,'The treatment of chronic fatigue syndrome: Science and speculation','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028233922&doi=10.1016%2f0002-9343%2894%2990095-7&partnerID=40&md5=8b4793e9f2088e1639932db11260c004','10.1016/0002-9343(94)90095-7','The chronic fatigue syndrome (CFS) is a heterogeneous disorder characterized by fatigue, neuropsychiatric symptoms, and various other somatic complaints. Treatment studies to date reflect both the diversity of medical disciplines involved in the management of patients with CFS and the multiple pathophysiologic mechanisms proposed. There have been few attempts to study integrated treatment programs, and although several controlled studies have been reported, no treatment has been shown clearly to result in long-term benefit in the majority of patients. Good clinical care integrating medical and psychologic concepts, together with symptomatic management, may prevent significant secondary impairment in the majority of patients. Future treatment studies should examine differential response rates for possible subtypes of the disorder (eg, documented viral onset, concurrent clinical depression), evaluate the','',1994,NULL,NULL,'1994-06-01',NULL,NULL,NULL,NULL,'124','The American Journal of Medicine','96','6','544-550','Elsevier','Other','',''),(610,'Neuropsychological and Socio-Occupational Functioning in Young Psychiatric Outpatients: A Longitudinal Investigation','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84874577713&doi=10.1371%2fjournal.pone.0058176&partnerID=40&md5=beb3aa0c4a742eb74290ab620abee695','10.1371/journal.pone.0058176','Background Clinical symptoms and neuropsychological deficits are longitudinally associated with functional outcome in chronic psychiatric cohorts. The current study extended these findings to young and early-course psychiatric outpatients, with the aim of identifying cognitive markers that predict later socio-occupational functioning.   Methods At baseline, 183 young psychiatric outpatients were assessed. Ninety-three returned for follow-up (M = 21.6 years old; SD = 4.5) with an average re-assessment interval of 21.6 months (SD = 7.0), and primary diagnoses of major depressive disorder (n = 34), bipolar disorder (n = 29), or psychosis (n = 30). The primary outcome measure was cross-validated with various other functional measures and structural equation modelling was used to map out the interrelationships between predictors and later functional outcome.   Results Good socio-occupational functioning at follow-up was associated with better quality of life, less disability, current employment and being in a romantic relationship. The final structural equation model explained 47.5% of the variability in functional outcome at follow-up, with baseline neuropsychological functioning (a composite of memory, working memory and attentional switching) the best independent predictor of later functional outcome. Notably, depressive and negative symptoms were only associated with functioning cross-sectionally. Diagnosis at follow-up was not associated with functional outcome.   Conclusions Neuropsychological functioning was the single best predictor of later socio-occupational outcome among young psychiatric outpatients. Therefore, framing','',2013,NULL,NULL,'2013-03-01',NULL,NULL,NULL,NULL,'123','PLoS ONE','8','3','e58176','Public Library of Science','YMH team','Outcome Research',''),(611,'Can we reduce the burden of depression? The Australian experience with beyondblue: The national depression initiative','https://www.scopus.com/inward/record.uri?eid=2-s2.0-5644292382&doi=10.1111%2fj.1039-8562.2004.02098.x-i1&partnerID=40&md5=6272fd4bf0fe0283651d18443fa7f19d','10.1111/j.1039-8562.2004.02098.x-i1','\n Objective:           Throughout the Asia Pacific region, there is an urgent need to reduce the burden of depression by increasing depression awareness, reducing stigma and dismantling those social barriers that prevent full participation by people with depression. This paper describes the development and early achievements of the Australian depression initiative, beyondblue.\n  Methods:           A review of the key priorities of beyondblue and their impacts during the first three years of operation (2001-03).\n  Results:           Key achievements include: the degree of national recognition of beyondblue; size and scope of media impact; growth in website utilisation; increased reporting of the community\'s recognition of people with depression; genuine reforms in life insurance and income protection; development of a new national consumer and carer organisation; establishment of major population-based preventative and\n','',2004,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'123','Australasian Psychiatry','12','','S38-S46','Blackwell Science Pty','YMH team','Illness specific areas',''),(612,'From neuroprogression to neuroprotection: Implications for clinical care','https://www.scopus.com/inward/record.uri?eid=2-s2.0-77956996479&partnerID=40&md5=9dd883e9dd4d126cf3cd02bf3954cbf4','','├éΓÇó Bipolar disorder follows a staged trajectory in which persistence of illness is associated with a number of clinical features such as progressive shortening of the inter-episode interval and decreased probability of treatment response.','',2010,NULL,NULL,'2010-08-16',NULL,NULL,NULL,NULL,'120','Medical Journal of Australia','193','4 Suppl','S36-40','','Other','',''),(613,'A randomized, double-blind, placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033808227&doi=10.4088%2fJCP.v61n0909&partnerID=40&md5=1f252bd736bdc878c1e00ae8119e5b8c','10.4088/JCP.v61n0909','Background: Chronic fatigue syndrome is characterized by prolonged and disabling fatigue and a range of neuropsychiatric symptoms including depressed and/or irritable mood. To date, no medical or psychotropic therapies have provided clear symptomatic benefit. Method: Ninety patients with chronic fatigue syndrome, diagnosed with our system that approximates CDC criteria, participated in a randomized, placebo-controlled, double-blind trial of 450 to 600 mg/day of moclobemide, a novel reversible inhibitor of monoamine oxidase-A. Results: Fifty-one percent (24/47) of patients receiving moclobemide improved compared with 33%(14/43) of patients receiving placebo (odds ratio= 2.16, 95% confidence interval [CI]= 0.9 to 5.1). Drug response was best characterized symptomatically by an increase in the subjective sense of vigor and energy rather than a reduction in depressed mood. The effect of moclobemide','',2000,NULL,NULL,'2000-09-01',NULL,NULL,NULL,NULL,'120','Journal of Clinical Psychiatry','61','9','643-648','[Memphis, Tenn., Physicians Postgraduate Press]','Other','',''),(614,'MMN/P3a deficits in first episode psychosis: Comparing schizophrenia-spectrum and affective-spectrum subgroups','https://www.scopus.com/inward/record.uri?eid=2-s2.0-79960306796&doi=10.1016%2fj.schres.2011.03.025&partnerID=40&md5=ed460f7a52d56b55517d29df01a28c0a','10.1016/j.schres.2011.03.025','\n\nBackground\nReduced mismatch negativity (MMN) and P3a amplitudes are neurophysiological biomarkers for schizophrenia that index deviance detection and the orienting response, respectively. First-episode psychosis (FEP) patients show reduced amplitudes of the ΓÇÿMMN/P3a complex├éΓÇÖ, but it is unclear whether this occurs across the FEP spectrum.\n\n\nMethods\nFifty-three young people (17├éΓÇô36├é┬áyears) were assessed: 17 FEP affective-spectrum (bipolar disorder with psychotic features and major depressive disorder with psychotic features), 18 FEP schizophrenia-spectrum (schizophrenia, schizoaffective disorder, and schizophreniform disorder), and 18 healthy controls. MMN/P3a was acquired during a two-tone, auditory paradigm with 8% duration deviants. Clinical, psychosocial and neuropsychological assessments were also undertaken.\n\n\nResults\nFEP schizophrenia- and FEP affective-spectrum showed significantly├é┬á├éΓÇª\n\n','',2011,NULL,NULL,'2011-08-01',NULL,NULL,NULL,NULL,'119','Schizophrenia Research','130','1-Mar','203-209','Elsevier','YMH team','Neurobiology',''),(615,'Mental health literacy, folic acid and vitamin B12, and physical activity for the prevention of depression in older adults: Randomised controlled trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-77954600956&doi=10.1192%2fbjp.bp.109.075291&partnerID=40&md5=dd5436c694b9336bf4fbf64e209eb216','10.1192/bjp.bp.109.075291','Background Few randomised controlled trials (RCTs) have examined potential preventive agents in high-risk community populations. Aims To determine whether a mental health literacy intervention, the promotion of physical activity, or folic acid plus vitamin B12 reduce depression symptoms in community-dwelling older adults with elevated psychological distress. Method An RCT with a completely crossed 2 ├ù 2 ├âΓÇö 2 factorial design: (400 mcg/d folic acid + 100 mcg/d vitamin B12 v. placebo)├âΓÇö(physical activity v. nutrition promotion control) ├âΓÇö (mental health literacy v. pain information control). The initial target sample size was 2000; however, only 909 adults (60├éΓÇô74 years) met the study criteria. Interventions were delivered by mail with telephone calls. The main outcome was depressive symptoms on the Patient Health Questionnaire (PHQ├éΓÇô9) at 6 weeks, 6, 12 and 24 months. The Clinicaltrials.gov registration number is├é┬á├éΓÇª','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'119','British Journal of Psychiatry','197','1','45-54','Cambridge University Press','Other','',''),(616,'Using e-health applications to deliver new mental health services','https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955895445&doi=10.5694%2fj.1326-5377.2010.tb03695.x&partnerID=40&md5=733247cffc29c909dad619ba3d6909ba','10.5694/j.1326-5377.2010.tb03695.x','ΓÇó Traditional clinic-based service delivery systems remain inaccessible to many Australians with mental health problems.','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'118','Medical Journal of Australia','192','','S53-S56','','Other','',''),(617,'White matter disturbances in major depressive disorder: a coordinated analysis across 20 international cohorts in the ENIGMA MDD working group','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072031087&doi=10.1038%2fs41380-019-0477-2&partnerID=40&md5=886d9e2f4b0d7a92e4a5c1bc2e0a589b','10.1038/s41380-019-0477-2','Alterations in white matter (WM) microstructure have been implicated in the pathophysiology of major depressive disorder (MDD). However, previous findings have been inconsistent, partially due to low statistical power and the heterogeneity of depression. In the largest multi-site study to date, we examined WM anisotropy and diffusivity in 1305 MDD patients and 1602 healthy controls (age range 12├éΓÇô88 years) from 20 samples worldwide, which included both adults and adolescents, within the MDD Working Group of the Enhancing Neuroimaging Genetics through Meta-Analysis (ENIGMA) consortium. Processing of diffusion tensor imaging (DTI) data and statistical analyses were harmonized across sites and effects were meta-analyzed across studies. We observed subtle, but widespread, lower fractional anisotropy (FA) in adult MDD patients compared with controls in 16 out of 25 WM tracts of interest (Cohen├éΓÇÖs d├é┬á├éΓÇª','',2020,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'118','Molecular Psychiatry','25','7','1511-1525','Nature Publishing Group','YMH team','Neurobiology','illness specific areas'),(618,'Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0038721272&doi=10.1002%2fjmv.10439&partnerID=40&md5=27e5f051f1ab956b04ebd31c9da6eec0','10.1002/jmv.10439','  Current serological methods for the diagnosis of Epstein-Barr virus (EBV) infection still differentiate poorly between primary infection and reactivation. This is particularly true when IgG and IgM antibodies are present simultaneously and only a single serum sample is provided for analysis. The demonstration of the IgG avidity state has the potential to distinguish recent from past or reactivated infection. An analysis of the kinetics of avidity maturation of anti-VCA antibodies in primary EBV infection was undertaken with longitudinally collected sets of sera from 28 well-characterised EBV cases and in sera from 35 cases with previous EBV infection and recent primary infection due to HIV, CMV, or hepatitis A. Antibodies directed against the viral capsid antigen (VCA) and Epstein-Barr nuclear antigen (EBNA-1) were sought, using a commercial enzyme immunoassay (EIA). In parallel with standard IgG anti-VCA├é┬á├éΓÇª\n','',2003,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'117','Journal of Medical Virology','70','4','617-623','Wiley Subscription Services, Inc., A Wiley Company','Other','',''),(619,'Neuropsychological and functional outcomes in recent-onset major depression, bipolar disorder and schizophrenia-spectrum disorders: A longitudinal cohort study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84989288156&doi=10.1038%2ftp.2015.50&partnerID=40&md5=3355cee576ede2939774b7b61f20834e','10.1038/tp.2015.50','Functional disability is the lead contributor to burden of mental illness. Cognitive deficits frequently limit functional recovery, although whether changes in cognition and disability are longitudinally associated in recent-onset individuals remains unclear. Using a prospective, cohort design, 311 patients were recruited and assessed at baseline. One hundred and sixty-seven patients met eligibility criteria (M= 21.5 years old, sd= 4.8) and returned for follow-up (M= 20.6 months later, sd= 7.8). Two-hundred and thirty participants were included in the final analysis, comprising clinically stable patients with major depression (n= 71), bipolar disorder (BD; n= 61), schizophrenia-spectrum disorders (n= 35) and 63 healthy controls. Neuropsychological functioning and self-rated functional disability were examined using mixed-design, repeated-measures analysis, across diagnoses and cognitive clusters, covarying for relevant├é┬á├éΓÇª','',2015,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'115','Translational Psychiatry','5','4','e555-e555','Nature Publishing Group','YMH team','Illness specific areas','Outcome Research'),(620,'A Double-Blind Randomized Controlled Trial of Oxytocin Nasal Spray and Social Cognition Training for Young People with Early Psychosis','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84940825450&doi=10.1093%2fschbul%2fsbu094&partnerID=40&md5=e5486ace5cfb65e2d1b8ebed96c32fe5','10.1093/schbul/sbu094','         Social-cognitive deficits contribute to poor functional outcomes in early psychosis; however, no effective pharmacological treatments exist for these problems. This study was the first to investigate the efficacy of an extended treatment of oxytocin nasal spray combined with social cognition training (SCT) to improve social cognition, clinical symptoms, and social functioning in early psychosis. In a double-blind, randomized, placebo-controlled, between-subjects trial, 52 individuals (aged 16ΓÇô35 years) diagnosed with an early psychosis schizophrenia-spectrum illness were recruited. Participants received oxytocin (24 International Units) or placebo nasal spray twice-daily for 6 weeks, combined with group SCT (2 ├âΓÇö 1 hour weekly sessions for 6 weeks). An additional dose of oxytocin was administered before each weekly session. Assessments were conducted at baseline, post-treatment, and at 3-month follow-up├é┬á├éΓÇª\n','',2015,NULL,NULL,'2015-03-01',NULL,NULL,NULL,NULL,'115','Schizophrenia Bulletin','41','2','483-493','Oxford University Press','YMH team','Illness specific areas',''),(621,'Glutathione relates to neuropsychological functioning in mild cognitive impairment','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84891144344&doi=10.1016%2fj.jalz.2013.01.005&partnerID=40&md5=51a073448d4d82c4f571565a1b10df61','10.1016/j.jalz.2013.01.005','\n\nBackground\nMild cognitive impairment (MCI) represents an at-risk state for Alzheimer\'s disease in which underlying pathophysiological mechanisms could be delineated. Oxidative stress has been implicated in Alzheimer\'s disease and can be measured by levels of the antioxidant glutathione. This study aims to assess in┬ávivo levels of glutathione via proton magnetic resonance spectroscopy in patients with MCI and to determine how glutathione relates to cognitive decline.\n\n\nMethods\nFifty-four patients with MCI and 41 healthy control subjects underwent proton magnetic resonance spectroscopy in conjunction with medical, psychiatric, and neuropsychological assessments. The concentration of glutathione was measured in the anterior and posterior cingulate, and ratios of glutathione were calculated relative to creatine. Neuropsychological performance was assessed across the domains of processing speed, learning├é┬á├éΓÇª\n\n','',2014,NULL,NULL,'2014-01-01',NULL,NULL,NULL,NULL,'115','Alzheimer\'s and Dementia','10','1','67-75','No longer published by Elsevier','Other','',''),(622,'Psychomotor disturbance in depression: defining the constructs','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027510578&doi=10.1016%2f0165-0327%2893%2990049-P&partnerID=40&md5=abfd28f1824f801afecce820ef52db22','10.1016/0165-0327(93)90049-P','Four hundred and thirteen depressed patients were rated on eighteen signs of psychomotor disturbance, and the data examined by factor analyses. A three-factor solution was favoured. In addition to ΓÇÿretardation├éΓÇÖ and ├éΓÇÿagitation├éΓÇÖ dimensions (whose derived factor scores suggested independence of those two dimensions), a third ├éΓÇÿnon-interactive├éΓÇÖ dimension was evident - with derived factor scores correlating significantly with both the retardation and agitation dimensions. Thus, a ├éΓÇÿtrunk and branch├éΓÇÖ analogy was suggested for construing psychomotor disturbance, with a truncal ├éΓÇÿpsychic├éΓÇÖ component arborising into retardation and agitation ├éΓÇÿmotoric├éΓÇÖ expressions. Higher scores on all three factors were significantly linked with features weighted more to the melancholic ├éΓÇÿtype├éΓÇÖ of depression.','',1993,NULL,NULL,'1993-04-01',NULL,NULL,NULL,NULL,'114','Journal of Affective Disorders','27','4','255-265','Elsevier','Other','',''),(623,'Internet-Delivered Cognitive Behavioural Therapy for Adults with Mild to Moderate Depression and High Cardiovascular Disease Risks: A Randomised Attention-Controlled Trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84875457932&doi=10.1371%2fjournal.pone.0059139&partnerID=40&md5=1a4698c47cee291db1ae1b674bc8a7c5','10.1371/journal.pone.0059139','Background and Aim Mild to moderate depression is common in those with cardiovascular disease and undertreated. We aimed to evaluate the effectiveness of internet-delivered Cognitive Behaviour Therapy (iCBT) on depressive symptom severity and adherence to medical advice and lifestyle interventions in adults with mild to moderate depression and high cardiovascular disease (CVD) risks.   Methods Randomised double-blind, 12 week attention-controlled trial comparing an iCBT programme (E-couch) with an internet-delivered attention control health information package (HealthWatch, n = 282). The primary outcome was depression symptom level on the nine-item Patient Health Questionnaire (PHQ-9) (trial registration: ACTRN12610000085077).   Results 487/562 (88%) participants completed the endpoint assessment. 383/562 (70%) were currently treated for cardiovascular disease and 314/562 (56%) had at least one other comorbid condition. In ITT analysis of 562 participants iCBT produced a greater decline in the mean PHQ-9 score compared to the attention control of 1.06 (95% CI: 0.23ΓÇô1.89) points, with differences between the two arms increasing over the intervention period (time by treatment effect interaction p = .012). There were also larger improvements in adherence (2.16 points; 95% CI: 0.33├éΓÇô3.99), reductions in anxiety (0.96 points; 95% CI: 0.19├éΓÇô1.73), and a greater proportion engaging in beneficial physical activity (Odds Ratio 1.91, 95%CI: 1.01├éΓÇô3.61) in the iCBT participants but no effect upon disability, or walking time/day. There were no withdrawals due to study related adverse events.   Conclusions In people with mild to├é┬á├éΓÇª','',2013,NULL,NULL,'2013-03-26',NULL,NULL,NULL,NULL,'114','PLoS ONE','8','3','e59139','Public Library of Science','Other','',''),(624,'Community-based prevention programs for anxiety and depression in youth: A systematic review','https://www.scopus.com/inward/record.uri?eid=2-s2.0-77956048288&doi=10.1007%2fs10935-010-0214-8&partnerID=40&md5=89529e8e040b944acb5c49b43af1123a','10.1007/s10935-010-0214-8','               Little is known about the effectiveness of prevention and early intervention programs for young people and adolescents once they leave or dropout from school. The effectiveness of 18 anxiety and 26 depression studies addressing prevention in community programs were identified using systematic review methodology. Anxiety and depression symptoms were reduced in ~60% of the programs. Cognitive behavioral therapy programs were more common than other interventions and were consistently found to lower symptoms or prevent depression or anxiety. Automated or computerized interventions showed promise, with 60% of anxiety programs and 83% of depression programs yielding successful outcomes on at least one measure. Further research is needed to determine the active components of successful programs, to explore cost-effectiveness and scalability factors, to investigate individual predictors\n','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'114','Journal of Primary Prevention','31','3','139-170','Springer US','Other','',''),(625,'Circadian misalignment and sleep disruption in mild cognitive impairment','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84890495142&doi=10.3233%2fJAD-131217&partnerID=40&md5=24729c77fbbce2609676a9095899ae0d','10.3233/JAD-131217','Background: While it is evident that AlzheimerΓÇÖs disease is associated with disturbed sleep and circadian rhythms, the extent to which such changes are evident in older people ├éΓÇÿat risk├éΓÇÖof developing dementia is unknown. Objective: In this study, we aimed to determine whether patients with mild cognitive impairment (MCI) demonstrated significant alterations in the timing of melatonin secretion onset and amount, as well as sleep architecture. Methods: Thirty patients with MCI and 28 age-matched controls underwent psychiatric, medical, and neuropsychological assessment, followed by overnight polysomnography and dim light melatonin onset assessment. Participants also performed an episodic memory task while in the laboratory. Dim light melatonin onset was computed using a standardized algorithm, and area under the curve was computed for melatonin secretion. Sleep architecture measures including wake├é┬á├éΓÇª','',2014,NULL,NULL,'2014-01-01',NULL,NULL,NULL,NULL,'113','Journal of Alzheimer\'s Disease','38','4','857-866','IOS Press','YMH team','Illness specific areas','Neurobiology'),(626,'Association between suicidal ideation and suicide: Meta-analyses of odds ratios, sensitivity, specificity and positive predictive value','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061003060&doi=10.1192%2fbjo.2018.88&partnerID=40&md5=d5a08ad6c6810b18328a7be1eb63d973','10.1192/bjo.2018.88','BackgroundThe expression of suicidal ideation is considered to be an important warning sign for suicide. However, the predictive properties of suicidal ideation as a test of later suicide are unclear.AimsTo assess the strength of the association between suicidal ideation and later suicide measured by odds ratio (OR), sensitivity, specificity and positive predictive value (PPV).MethodWe located English-language studies indexed in PubMed that reported the expression or non-expression of suicidal ideation among people who later died by suicide or did not. A random effects meta-analysis was used to assess the pooled OR, sensitivity, specificity and PPV of suicidal ideation for later suicide among groups of people from psychiatric and non-psychiatric settings.ResultsThere was a moderately strong but highly heterogeneous association between suicidal ideation and later suicide (n┬á=├é┬á71, OR├é┬á=├é┬á3.41, 95% CI 2.59├éΓÇô4.49├é┬á├éΓÇª','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'113','BJPsych Open','5','2','','Cambridge University Press','YMH team','Illness specific areas',''),(627,'Late-onset depressive disorders: A preventable variant of cerebrovascular disease?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031692033&doi=10.1017%2fS0033291797006090&partnerID=40&md5=c3758fbd834606c42f942f5ec6b58904','10.1017/S0033291797006090','The severe depressive disorders of late life are associated with high rates of medical morbidity and mortality, cognitive impairment, suicide, disability, complex treatment regimens, institutionalization and high costs to the community (Murphy, 1983; Murphy et al. 1988; Bruce & Leaf, 1989; NIH Consensus Development Panel, 1992; Alexopoulos et al. 1993a, b; Brodaty et al. 1993; Bruce et al. 1994; Forsell et al. 1994; Hickie et al. 1995; Blazer, 1996). Those disorders that are accompanied by cognitive impairment and/or concurrent medical morbidity have a particularly poor outcome (Bruce & Leaf, 1989; Alexopoulos et al. 1993b; Hickie et al. 1995, 1997a). Although psychosocial models of late-life depression place considerable importance on age-related psychological and social risk factors, those who survive into later life may actually be characterized by psychological resilience (Henderson, 1994; Blazer, 1997','',1998,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'113','Psychological Medicine','28','5','1007-1013','Cambridge University Press','YMH team','Neurobiology',''),(628,'General practitioners\' response to depression and anxiety in the Australian community: A preliminary analysis','https://www.scopus.com/inward/record.uri?eid=2-s2.0-5044241105&doi=10.5694%2fj.1326-5377.2004.tb06349.x&partnerID=40&md5=c3f1c1f4dd6f6c2971b32f2352e9bfca','10.5694/j.1326-5377.2004.tb06349.x',' \nObjectives: To examine the uptake by general practitioners (GPs) of the five key components of the Better Outcomes in Mental Health Care (BOiMHC) initiative: education and training for GPs; the three-step mental health process; focussed psychological strategies; access to allied health services; and access to psychiatrist support. \nSetting: All Australian states and territories during the first 15├é┬ámonths of the initiative (1├é┬áJuly 2002├é┬á├éΓÇô 30├é┬áSeptember 2003). \nDesign: Retrospective survey of de-identified registration data held by the General Practice Mental Health Standards Collaboration (training uptake), de-identified Health Insurance Commission (HIC) billing data (provision of the three-step mental health process, focussed psychological strategies and case conferences with psychiatrists), and reports from ├éΓÇ£access to allied health services├éΓÇ¥ projects to the Australian Department of Health and Ageing (project participation├é┬á├éΓÇª\n','',2004,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'113','Medical Journal of Australia','181','','S15-S20','','YMH team','Mental Health System',''),(629,'Gamification in apps and technologies for improving mental health and well-being: systematic review','https://mental.jmir.org/2019/6/e13717',NULL,'\nBackground: There is little research on the application of gamification to mental health and well-being. Furthermore, usage of gamification-related terminology is inconsistent. Current applications of gamification for health and well-being have also been critiqued for adopting a behaviorist approach that relies on positive reinforcement and extrinsic motivators.\nObjective: This study aimed to analyze current applications of gamification for mental health and well-being by answering 3 research questions (RQs). RQ1: which gamification elements are most commonly applied to apps and technologies for improving mental health and well-being? RQ2: which mental health and well-being domains are most commonly targeted by these gamified apps and technologies? RQ3: what reasons do researchers give for applying gamification to these apps and technologies? A systematic review of the literature was conducted to answer these questions.\nMethods: We searched ACM Digital Library, CINAHL, Cochrane Library, EMBASE, IEEE Explore, JMIR, MEDLINE, PsycINFO, PubMed, ScienceDirect, Scopus, and Web of Science for qualifying papers published between the years 2013 and 2018. To answer RQ1 and RQ2, papers were coded for gamification elements and mental health and well-being domains according to existing taxonomies in the game studies and medical literature. During the coding process, it was necessary to adapt our coding frame and revise these taxonomies. Thematic analysis was conducted to answer RQ3.\nResults: The search and screening process identified 70 qualifying papers that collectively reported on 50 apps and technologies\n','',2000,NULL,NULL,'2019-06-26',NULL,NULL,NULL,NULL,'112','','6','6','e13717','JMIR Publications Inc., Toronto, Canada',NULL,NULL,NULL),(630,'Real-time Mobile Monitoring of the Dynamic Associations among Motor Activity, Energy, Mood, and Sleep in Adults with Bipolar Disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058540810&doi=10.1001%2fjamapsychiatry.2018.3546&partnerID=40&md5=88481129e56efe4a044ccccef656052b','10.1001/jamapsychiatry.2018.3546','\nImportance\nBiologic systems involved in the regulation of motor activity are intricately linked with other homeostatic systems such as sleep, feeding behavior, energy, and mood. Mobile monitoring technology (eg, actigraphy and ecological momentary assessment devices) allows the assessment of these multiple systems in real time. However, most clinical studies of mental disorders that use mobile devices have not focused on the dynamic associations between these systems.\nObjectives\nTo examine the directional associations among motor activity, energy, mood, and sleep using mobile monitoring in a community-identified sample, and to evaluate whether these within-day associations differ between people with a history of bipolar or other mood disorders and controls without mood disorders.\nDesign, Setting, and Participants\nThis study used a nested case-control design of 242 adults, a subsample of a community├é┬á├éΓÇª\n','',2019,NULL,NULL,'2019-02-01',NULL,NULL,NULL,NULL,'109','JAMA Psychiatry','76','2','190-198','American Medical Association','Other','',''),(631,'Cognitive remediation improves memory and psychosocial functioning in first-episode psychiatric out-patients','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84877763980&doi=10.1017%2fS0033291712002127&partnerID=40&md5=d9ddf3672da59817fa489928feb839c8','10.1017/S0033291712002127','BackgroundCognitive remediation (CR) is an effective treatment for several psychiatric disorders. To date, there have been no published studies examining solely first-episode psychiatric cohorts, despite the merits demonstrated by early intervention CR studies. The current study aimed to assess the effectiveness of CR in patients with a first-episode of either major depression or psychosis.MethodFifty-five patients (mean age┬á=├é┬á22.8 years, s.d.├é┬á=├é┬á4.3) were randomly assigned to either CR (n├é┬á=├é┬á28) or treatment as usual (TAU; n├é┬á=├é┬á27). CR involved once-weekly 2-h sessions for a total of 10 weeks. Patients were comprehensively assessed before and after treatment. Thirty-six patients completed the study, and analyses were conducted using an intent-to-treat (ITT) approach with all available data.ResultsIn comparison to TAU, CR was associated with improved immediate learning and memory controlling for diagnosis and├é┬á├éΓÇª','',2013,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'109','Psychological Medicine','43','6','1161-1173','Cambridge University Press','YMH team','Models of care',''),(632,'Enhancing memory in late-life depression: The effects of a combined psychoeducation and cognitive training program','https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952105383&doi=10.1097%2fJGP.0b013e3181dba587&partnerID=40&md5=8c10b20e7ed13fa68c0fd3769c2480c2','10.1097/JGP.0b013e3181dba587','\n\nObjective\nTo evaluate the efficacy of a multifactorial cognitive training (CT) program for older people with a lifetime history of depressive disorder.\n\n\nMethods\nThis was a single-blinded waitlist control design. The study was conducted in the Healthy Brain Ageing Clinic, a specialist outpatient clinic at the Brain & Mind Research Institute, Sydney, Australia. Forty-one participants (mean age = 64.8 years, sd = 8.5) with a lifetime history of major depression were included. They were stabilized on medication and had depressive symptoms in the normal to mild range. The intervention encompassed both psychoeducation and CT. Each component was 1-hour in duration and was delivered in a group format over a 10-week period. Psychoeducation was multifactorial, was delivered by health professionals and targeted cognitive strategies, as well depression, anxiety, sleep, vascular risk factors, diet and exercise. CT was computer\n\n','',2011,NULL,NULL,'2011-03-01',NULL,NULL,NULL,NULL,'108*','American Journal of Geriatric Psychiatry','19','3','240-248','Elsevier','YMH team','Illness specific areas','Models of care'),(633,'Primary care psychiatry is not specialist psychiatry in general practice','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033558134&doi=10.5694%2fj.1326-5377.1999.tb127716.x&partnerID=40&md5=8e82e068f665f894f491156a329785f1','10.5694/j.1326-5377.1999.tb127716.x','Current psychiatric diagnostic systems are not useful for general practice','',1999,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'108','Medical Journal of Australia','170','4','171-173','','YMH team','Mental Health System','Models of care'),(634,'Muscle performance, voluntary activation and perceived effort in normal subjects and patients with prior poliomyelitis','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028132770&doi=10.1093%2fbrain%2f117.4.661&partnerID=40&md5=7b4f64a7e9f0cf38e13ba1e7d660c33b','10.1093/brain/117.4.661','         Many people previously affected by polio complain of increased fatigue, weakness and pain many years after the initial illness. Although electromyographic abnormalities have been found in these patients, the cause of their increased weakness is not well understood. Previous studies have shown decreased strength and impaired exercise performance in those with prior polio, but the level of voluntary drive to the muscle has not been investigated. The present study investigated maximal voluntary activation without fatigue and both peripheral and central components of muscle fatigue during exercise in 21 subjects with poliomyelitis 20ΓÇô40 years previously, and 20 healthy, age-matched control subjects. Voluntary activation and strength of the elbow flexors were quantified using twitch interpolation during maximal isometric voluntary contractions both at rest, and during fatigue induced by 45 min of repeated├é┬á├éΓÇª\n','',1994,NULL,NULL,'1994-08-01',NULL,NULL,NULL,NULL,'106','Brain','117','4','661-670','Oxford University Press','Other','',''),(635,'Deficits in episodic memory retrieval reveal impaired default mode network connectivity in amnestic mild cognitive impairment','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896525478&doi=10.1016%2fj.nicl.2014.02.010&partnerID=40&md5=e3acea16e58113eaca8ff32018776f19','10.1016/j.nicl.2014.02.010','Amnestic mild cognitive impairment (aMCI) is believed to represent a transitional stage between normal healthy ageing and the development of dementia. In particular, aMCI patients have been shown to have higher annual transition rates to┬áAlzheimer\'s Disease (AD) than individuals without cognitive impairment. Despite intensifying interest investigating the neuroanatomical basis of this transition, there remain a number of questions regarding the pathophysiological process underlying aMCI itself. A number of recent studies in aMCI have shown specific impairments in connectivity within the├é┬ádefault mode network (DMN), which is a group of regions strongly related to episodic memory capacities. However to date, no study has investigated the integrity of the DMN between patients with aMCI and those with a non-amnestic├é┬ápattern of MCI (naMCI), who have cognitive impairment, but intact memory storage systems. In├é┬á├éΓÇª','',2014,NULL,NULL,'2014-01-01',NULL,NULL,NULL,NULL,'105','NeuroImage: Clinical','4','','473-480','Elsevier','Other','',''),(636,'A genome-wide association study of sleep habits and insomnia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84879339384&doi=10.1002%2fajmg.b.32168&partnerID=40&md5=0f2580e8c52c7287ec005723f527f5c0','10.1002/ajmg.b.32168','  Several aspects of sleep behavior such as timing, duration and quality have been demonstrated to be heritable. To identify common variants that influence sleep traits in the population, we conducted a genome-wide association study of six sleep phenotypes assessed by questionnaire in a sample of 2,323 individuals from the Australian Twin Registry. Genotyping was performed on the Illumina 317, 370, and 610K arrays and the SNPs in common between platforms were used to impute non-genotyped SNPs. We tested for association with more than 2,000,000 common polymorphisms across the genome. While no SNPs reached the genome-wide significance threshold, we identified a number of associations in plausible candidate genes. Most notably, a group of SNPs in the third intron of the CACNA1C gene ranked as most significant in the analysis of sleep latency (P = 1.3 ├âΓÇö 10-6). We attempted to replicate├é┬á├éΓÇª\n','',2013,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'105','American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics','162','5','439-451','','YMH team','Illness specific areas','Neurobiology'),(637,'Heart rate variability during adolescent and adult social interactions: A meta-analysis','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84920971224&doi=10.1016%2fj.biopsycho.2014.12.012&partnerID=40&md5=6fb23ba097ab3e3e1b9f211c230eac51','10.1016/j.biopsycho.2014.12.012','Social interaction skill is important for psychological wellbeing, stress regulation, protection from disability and overall life satisfaction. Increase in activity of the vagus nerve, measured by heart rate variability (HRV), is associated with social interaction skill and decreased stress. In this meta-analysis we collated statistics from thirteen studies consisting of 787 participants who were participating in social interactions while HRV was simultaneously collected. Results revealed that while dyadic social interactions do not increase HRV generally from a baseline state, negative dyadic social interactions decrease HRV in a manner similar to the Trier Social Stress Task. Further, participants with psychopathology do not show cardiac autonomic flexibility during social interactions as indicated by reductions under stress and increases with subsequently positive social interactions. The role of age, gender and HRV index were','',2015,NULL,NULL,'2015-02-01',NULL,NULL,NULL,NULL,'104','Biological Psychology','105','','43-50','Elsevier','Other','',''),(638,'E-mental health: A new era in delivery of mental health services','https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955876022&doi=10.5694%2fj.1326-5377.2010.tb03684.x&partnerID=40&md5=745a19ff1691a7e20d5b09120267b3ff','10.5694/j.1326-5377.2010.tb03684.x','E-mental health: a new era in delivery of mental health services Page 1 S2 MJA ΓÇó Volume 192 \nNumber 11 ├éΓÇó 7 June 2010 SUPPLEMENT The Medical Journal of Australia ISSN: 0025729X 7 \nJune 2010 192 11 S2-S3 ├é┬⌐The Medical Journal of Australia 2010 www.mja.com.au Delivering \ntimely interventions: the impact of the internet on mental health range of factors have come \ntogether rapidly over the past decade to create a health services environment in which \nweb-based technologies now offer one of the most promising opportunities for earlier and better \nmanagement of common mental health problems. These factors include international recognition \nof the health burden attributable to anxiety, depression and substance misuse;1 epidemiological \nevidence that mental disorders largely commence before the age of 25 years;2,3 the \ndevelopment of highly interactive web-based technologies, and their widespread use in ├éΓÇª','',2010,NULL,NULL,'2010-06-07',NULL,NULL,NULL,NULL,'104','Medical Journal of Australia','192','11','S2','','Other','',''),(639,'Impaired in vivo immune responses in patients with melancholia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027289304&doi=10.1192%2fbjp.162.5.651&partnerID=40&md5=59f5466578ff509a7d15813746f842c3','10.1192/bjp.162.5.651','Previous attempts to establish a relationship between impaired cell-mediated immunity (CMI) and major mood disorders have been limited by a failure to explore the relevance of depressive subcategories or to assess CMI by in vivo methods. In this case-control study CMI was assessed in 57 patients with major depression (31 with melancholic, 26 with non-melancholic disorders), and in age- and sex-matched controls by both in vitro and in vivo immunological techniques. Compared with control subjects and patients with non-melancholic depression, patients with melancholia demonstrated reduced in vivo CMI as assessed by delayed-type hypersensitivity (DTH) skin responses. Although increasing age, severity of depression, hospital admission for treatment, and reported weight loss are correlates of melancholia, none of these factors alone, or in combination, accounted for the differences in DTH responses','',1993,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'97','British Journal of Psychiatry','162','5','651-657','Cambridge University Press','YMH team','Neurobiology',''),(640,'Genetic differences in the immediate transcriptome response to stress predict risk-related brain function and psychiatric disorders','https://www.sciencedirect.com/science/article/pii/S0896627315004730',NULL,'Depression risk is exacerbated by genetic factors and stress exposure; however, the biological mechanisms through which these factors interact to confer depression risk are poorly understood. One putative biological mechanism implicates variability in the ability of cortisol, released in response to stress, to trigger a cascade of adaptive genomic and non-genomic processes through glucocorticoid receptor (GR) activation. Here, we demonstrate that common genetic variants in long-range enhancer elements modulate the immediate transcriptional response to GR activation in human blood cells. These functional genetic variants increase risk for depression and co-heritable psychiatric disorders. Moreover, these risk variants are associated with inappropriate amygdala reactivity, a transdiagnostic psychiatric endophenotype and an important stress hormone response trigger. Network modeling and animal experiments├é┬á├éΓÇª','',2014,NULL,NULL,'2015-06-03',NULL,NULL,NULL,NULL,'103','Neuron','86','5','1189-1202','Cell Press',NULL,NULL,NULL),(641,'Cytokine polymorphisms have a synergistic effect on severity of the acute sickness response to infection','https://www.scopus.com/inward/record.uri?eid=2-s2.0-55849087296&doi=10.1086%2f592967&partnerID=40&md5=2ab68c04a8d37b17b78915e4e1411972','10.1086/592967','                                 Background           . Functional polymorphisms in immune response genes are increasingly recognized as important contributors to the marked individual differences in susceptibility to and outcomes of infectious disease. The acute sickness response is a stereotypical set of illness manifestations mediated by the proinflammatory cytokines induced by many different pathogens. The genetic determinants of severity of the acute sickness response have not previously been explored.                                 Methods           . We examined the impact of functional polymorphisms in cytokine genes with critical roles in the early immune response (tumor necrosis factor├éΓÇôa, interleukin-6, interleukin-10, and interferon-) on the severity and duration of illness following acute infection with Epstein-Barr virus, Coxiella burnetii (the causative agent of Q fever), or Ross River virus.                                 Results           . We found├é┬á├éΓÇª\n','',2008,NULL,NULL,'2008-12-01',NULL,NULL,NULL,NULL,'99','Clinical Infectious Diseases','47','11','1418-1425','The University of Chicago Press','Other','',''),(642,'\'Out of Hospital, Out of Mind!\': A Report Detailing Mental Health Services in Australia in 2002 and Community Priorities for National Mental Health Policy for 2003-2008','https://scholar.google.com/scholar?cluster=11986139565561813281&hl=en&oi=scholarr',NULL,'','',2003,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'97','','','','','Mental Health Council of Australia',NULL,NULL,NULL),(643,'Fatigue and psychiatric disorder: Different or the same?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032807872&doi=10.1017%2fS0033291799008697&partnerID=40&md5=e218506f02537a867549509239a8095d','10.1017/S0033291799008697','Background. Fatigue and psychiatric symptoms are common in the community, but their association and outcome are sparsely studied.Method. A total of 1177 patients were recruited from UK primary care on attending their general practitioner. Fatigue and psychiatric disorder was measured at three time points with the 12-item General Health Questionnaire and the 11-item Fatigue Questionnaire.Results. Total scores for fatigue and psychiatric disorder did not differ between the three time points and were closely correlated (r around 0┬╖6). The association between non-co-morbid (├éΓÇÿpure├éΓÇÖ) fatigue and developing psychiatric disorder 6 months later was the same as that for being well and subsequent psychiatric disorder. Similarly, having non-co-morbid psychiatric disorder did not predict having fatigue any more than being well 6 months previously. Between 13 and 15% suffered from non-co-morbid fatigue at each time├é┬á├éΓÇª','',1999,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'93','Psychological Medicine','29','4','863-868','Cambridge University Press','Other','',''),(644,'Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071444839&doi=10.1186%2fs13073-019-0667-1&partnerID=40&md5=42680ee9705b8fdb50f605e193df3362','10.1186/s13073-019-0667-1','DNA methylation changes with age. Chronological age predictors built from DNA methylation are termed ├éΓÇÿepigenetic clocks├éΓÇÖ. The deviation of predicted age from the actual age (├éΓÇÿage acceleration residual├éΓÇÖ, AAR) has been reported to be associated with death. However, it is currently unclear how a better prediction of chronological age affects such association. In this study, we build multiple predictors based on training DNA methylation samples selected from 13,661 samples (13,402 from blood and 259 from saliva). We use the Lothian Birth Cohorts of 1921 (LBC1921) and 1936 (LBC1936) to examine whether the association between AAR (from these predictors) and death is affected by (1) improving prediction accuracy of an age predictor as its training sample size increases (from 335 to 12,710) and (2) additionally correcting for confounders (i.e., cellular compositions). In addition, we investigated the performance├é┬á├éΓÇª','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'102','Genome Medicine','11','1','1-Nov','BioMed Central','Other','',''),(645,'Neuropsychological clustering highlights cognitive differences in young people presenting with depressive symptoms','https://www.scopus.com/inward/record.uri?eid=2-s2.0-79959494627&doi=10.1017%2fS1355617710001566&partnerID=40&md5=04f5caf58a502ad6a284c984d1669704','10.1017/S1355617710001566','Early stages of affective or psychotic disorders may be accompanied by neuropsychological changes that help to predict risk of developing more severe disorders. A comprehensive set of neuropsychological measures was collected in 109 help-seeking young people (16 to 30 years; 54 females), recently diagnosed with an affective or psychotic disorder and presenting with current depression. Hierarchical cluster analysis determined three clusters: one deemed to have a ΓÇ£poor memory├éΓÇ¥ profile (n = 40); another with a ├éΓÇ£poor mental flexibility├éΓÇ¥ profile (n = 38) and a third with widespread difficulties plus ├éΓÇ£impaired attention and memory├éΓÇ¥ (n = 31). In general, the three clusters were comparable in demographic, functional and clinical factors suggesting some unique role for neurocognitive impairments. A discriminant function analysis confirmed that the clusters were best characterized by performance in ├éΓÇ£attentional├éΓÇ¥ versus├é┬á├éΓÇª','',2011,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'101','Journal of the International Neuropsychological Society','17','2','267-276','Cambridge University Press','YMH team','Outcome Research',''),(646,'Making new choices about antidepressants in Australia: The long view 1975-2002','https://www.scopus.com/inward/record.uri?eid=2-s2.0-5044247749&doi=10.5694%2fj.1326-5377.2004.tb06350.x&partnerID=40&md5=712abec170e4fea44250b89058dd4d2f','10.5694/j.1326-5377.2004.tb06350.x',' \nObjective: To examine trends in types of antidepressant medications prescribed in Australia between 1975├é┬áand 2002. \nDesign: Sales data from the Australian pharmaceutical industry were used to examine trends in overall antidepressant prescribing and changes in the types of antidepressants prescribed between 1975├é┬áand 2002. \nMain outcome measures: Antidepressant sales were expressed as defined daily doses (DDDs) per 1000├é┬ápeople per day, using the estimated Australian population for each year obtained from the Australian Bureau of Statistics. \nResults: Average annual growth in the sales of antidepressants was 1.1% per year from 1975├é┬áto 1990, after which growth rose steeply to reach 29% in 1995. By 2002├é┬áthe rate of growth had slowed to 6.6%. Eighty per cent of total sales were accounted for by four drugs in 1975, 1980├é┬áand 1985; five in 1990; seven drugs in 1995├é┬áand 2000; and six drugs in 2001├é┬áand├é┬á├éΓÇª\n','',2004,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'94','Medical Journal of Australia','181','','S21-S24','','YMH team','Models of care',''),(647,'Are there any differences between bipolar and unipolar melancholia?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026772502&doi=10.1016%2f0165-0327%2892%2990072-E&partnerID=40&md5=1584dc364bb7a6e7245c982fe147b75c','10.1016/0165-0327(92)90072-E','Although it is now more than 30 years since Leonhard originally proposed the distinction between bipolar and monopolar (unipolar) forms of affective disorder, there have been relatively few studies which have investigated clinical features which may differentiate the depressed phase of bipolar disorder from unipolar depression. In this study we examined the value of a new scale for rating depressive mental state signs (the ΓÇÿcore├éΓÇÖ score system), and a large series of symptoms and risk factors, in distinguishing between 27 age and sex-matched pairs of bipolar and unipolar patients diagnosed as melancholic on several diagnostic criteria. In general, we found a marked similarity between the groups on clinical features of the depressive episode when allowance was made for multiple tests. Bipolar patients, however, had shorter episodes of depression and were less likely to demonstrate ├éΓÇÿslowed movements├éΓÇÖ than├é┬á├éΓÇª','',1992,NULL,NULL,'1992-06-01',NULL,NULL,NULL,NULL,'96','Journal of Affective Disorders','25','2','97-105','Elsevier','Other','',''),(648,'Positive relationships between public awareness activity and recognition of the impacts of depression in Australia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-33644769239&doi=10.1111%2fj.1440-1614.2006.01742.x&partnerID=40&md5=65f108c200b3a3653f0b8b747408f119','10.1111/j.1440-1614.2006.01742.x','\n\nObjective: This report records the level of exposure to depression-related information across the Australian community and explores associations with recognition of depression and relevant sociodemographic factors.\n\nMethod: A cross-sectional telephone survey was conducted with a representative community sample. Participants consisted of 3200 respondents (400 respondents across each Australian State/Territory).\n\nResults: Sixty-five point four per cent (n=2089/3193) of respondents indicated that they or someone close to them had experienced depression, of whom 18.7% (n=391/2089) reported a personal experience of this illness. Various measures of recent exposure to depression-related information were high with 69.0% (n=2207/3200) reporting that they had seen, read or heard something in the media in the last 12 months. Recognition of beyondblue: the national depression initiativewas also surprisingly\n','',2006,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'93','Australian and New Zealand Journal of Psychiatry','40','1','55-58','Sage Publications','YMH team','Illness specific areas','Mental Health System'),(649,'A prospective follow-up study of ECT outcome in older depressed patients','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033864672&doi=10.1016%2fS0165-0327%2899%2900169-X&partnerID=40&md5=8420a4d95851d8ba44f5d762818812bd','10.1016/S0165-0327(99)00169-X','\nBackground: This study examined the relationship between age and outcome of electroconvulsive therapy (ECT). Method: This was a naturalistic, prospective follow-up of 81 consecutive in-patients with primary major depression. ECT outcome was compared for three age groups ΓÇö under 65, 65├éΓÇô74 and 75 years and over ├éΓÇö on the Hamilton Rating Scale for Depression (HRSD), Global Assessment of Functioning scale (GAF) and clinical outcome rating scale. Assessments were performed pre-ECT, immediately post-ECT, 1├éΓÇô3 years later and, for patients suspected of having dementia, 5 years later. Results: At post-ECT and follow-up, improvement on HRSD and clinical outcome ratings were comparable for patients in the three age groups. Improvements on GAF were also comparable post-ECT, but not between post-ECT and follow-up. At follow-up, 35.7% of the oldest group had dementia. Importantly, patients who├é┬á├éΓÇª','',2000,NULL,NULL,'2000-11-01',NULL,NULL,NULL,NULL,'92','Journal of Affective Disorders','60','2','101-111','Elsevier','YMH team','Outcome Research','Models of care'),(650,'Heart rate variability predicts alcohol craving in alcohol dependent outpatients: Further evidence for HRV as a psychophysiological marker of self-regulation','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84881666011&doi=10.1016%2fj.drugalcdep.2013.02.025&partnerID=40&md5=a66224aee9d304c99f3c70c1d7dfa454','10.1016/j.drugalcdep.2013.02.025','\n\nBackground\nPast research has highlighted an important role of the autonomic nervous system in alcohol dependence and capacity for self-regulation. While previous studies have examined alcohol dependent inpatients, it remains unclear whether resting-state HRV, a potential psychophysiological marker of ones capacity for self-regulation, is related to craving in patients who currently consume alcohol. Thus, the aim of the present study was to determine whether HRV predicts alcohol craving in dependent individuals in the community.\n\n\nMethods\nResting-state HRV and alcohol craving, as indexed by the obsessive compulsive drinking scale, were assessed in 26 alcohol dependent outpatients.\n\n\nResults\nResults supported hypotheses indicating that HRV accounts for an additional 12.1% of the variance in craving after controlling for age, anxiety and levels of alcohol consumption. Here we show for the first time that resting\n\n','',2013,NULL,NULL,'2013-09-01',NULL,NULL,NULL,NULL,'94','Drug and Alcohol Dependence','132','1-Feb','395-398','Elsevier','Other','',''),(651,'Delivering youth-specific mental health services: The advantages of a collaborative, multi-disciplinary system','https://www.scopus.com/inward/record.uri?eid=2-s2.0-67650296295&doi=10.1080%2f10398560802657322&partnerID=40&md5=d9e685a9ca432ab41948f0c9d5853cd1','10.1080/10398560802657322','\n\nObjective: Evidence suggests that quality mental health care is based on well-integrated multi-disciplinary care provided by a range of mental health, substance use, and general healthcare clinicians. There is a growing focus in Australia on providing this type of mental health care to young people, particularly those in the early stages of a major disorder. The development of such services has proceeded on the basis of limited service-based data and has also been impeded by current healthcare funding structures.\n\nMethods: This report outlines the service characteristics of three models: a traditional ΓÇÿfee for service├éΓÇÖ model, a specialized youth mental health clinic, and a new headspace multi-disciplinary site in South Western Sydney.\n\nResults: Naturalistic data from these three services collected during their developmental phase indicate that each model is associated with differential demographic, illness and service├é┬á├éΓÇª\n','',2009,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'96','Australasian Psychiatry','17','3','189-194','SAGE Publications','YMH team','Mental Health System','Models of care'),(652,'Psychological distress and quality of life in older persons: Relative contributions of fixed and modifiable risk factors','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84884990462&doi=10.1186%2f1471-244X-13-249&partnerID=40&md5=d271a67757062140ee53d932f13f3f29','10.1186/1471-244X-13-249','With a rapidly ageing population and increasing life expectancy, programs directed at improving the mental health and quality of life (QOL) of older persons are extremely important. This issue may be particularly relevant in the aged-care residential sector, where very high rates of depression and poor QOL are evident. This study aims to investigate the fixed and modifiable risk factors of psychological distress and QOL in a cohort of Australians aged 60 and over living in residential and community settings. The study examined the relationship between demographic, health and lifestyle factors and the outcome variables of self-reported QOL and psychological distress (K10 scores) based on data from 626 Australians aged 60 and over from the 45 and Up Study dataset. Univariate and multivariate regression analyses (performed on a subset of 496) examined risk factors related to psychological distress and QOL','',2013,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'99','BMC Psychiatry','13','1','1-Oct','BioMed Central','Other','',''),(654,'Clinical classification in mental health at the cross-roads: Which direction next?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84877629661&doi=10.1186%2f1741-7015-11-125&partnerID=40&md5=ac1e7ccabc012617357677ff6e6ea437','10.1186/1741-7015-11-125','After 30 years of consensus-derived diagnostic categories in mental health, it is time to head in new directions. Those categories placed great emphasis on enhanced reliability and the capacity to identify them via standardized checklists. Although this enhanced epidemiology and health services planning, it failed to link broad diagnostic groupings to underlying pathophysiology or specific treatment response. It is time to adopt new goals that prioritize the validation of clinical entities and foster alternative strategies to support those goals. The value of new dimensions (notably clinical staging), that are both clinically relevant and directly related to emerging developmental and neurobiological research, is proposed. A strong emphasis on ΓÇÿreverse translation├éΓÇÖ (that is, working back from the clinic to the laboratory) underpins these novel approaches. However, it relies on using diagnostic groupings that already have├é┬á├éΓÇª','',2013,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'98','BMC Medicine','11','1','Jan-14','BioMed Central','YMH team','Models of care','Mental Health System'),(655,'A large-scale genome-wide association study meta-analysis of cannabis use disorder','https://www.sciencedirect.com/science/article/pii/S2215036620303394',NULL,'\n\nBackground\nVariation in liability to cannabis use disorder has a strong genetic component (estimated twin and family heritability about 50├éΓÇô70%) and is associated with negative outcomes, including increased risk of psychopathology. The aim of the study was to conduct a large genome-wide association study (GWAS) to identify novel genetic variants associated with cannabis use disorder.\n\n\nMethods\nTo conduct this GWAS meta-analysis of cannabis use disorder and identify associations with genetic loci, we used samples from the Psychiatric Genomics Consortium Substance Use Disorders working group, iPSYCH, and deCODE (20916 case samples, 363116 control samples in total), contrasting cannabis use disorder cases with controls. To examine the genetic overlap between cannabis use disorder and 22 traits of interest (chosen because of previously published phenotypic correlations [eg, psychiatric disorders├é┬á├éΓÇª\n\n','',2020,NULL,NULL,'2020-12-01',NULL,NULL,NULL,NULL,'97','The Lancet Psychiatry','7','12','1032-1045','Elsevier',NULL,NULL,NULL),(660,'Genetic and Environmental Contributions to Functional Connectivity Architecture of the Human Brain','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84965097479&doi=10.1093%2fcercor%2fbhw027&partnerID=40&md5=06dc671728323692cb37e5d93bbc2772','10.1093/cercor/bhw027','         One of the grand challenges faced by neuroscience is to delineate the determinants of interindividual variation in the comprehensive structural and functional connection matrices that comprise the human connectome. At present, this endeavor appears most tractable at the macroanatomic scale, where intrinsic brain activity exhibits robust patterns of synchrony that recapitulate core functional circuits at the individual level. Here, we use a classical twin study design to examine the heritability of intrinsic functional network properties in 101 twin pairs, including network activity (i.e., variance of a network\'s specific temporal fluctuations) and internetwork coherence (i.e., correlation between networks\' specific temporal fluctuations). Five of 7 networks exhibited significantly heritable (23.3├éΓÇô65.2%) network activity, 6 of the 21 internetwork coherences were significantly heritable (25.6├éΓÇô42.0%), and 11 of the 21├é┬á├éΓÇª\n','',2016,NULL,NULL,'2016-05-01',NULL,NULL,NULL,NULL,'94','Cerebral Cortex','26','5','2341-2352','Oxford University Press','Other','',''),(662,'Impaired implicit sequence learning in depression: A probe for frontostriatal dysfunction?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-33646709878&doi=10.1017%2fS0033291705006835&partnerID=40&md5=6307795c715127071b0926055f0401af','10.1017/S0033291705006835','\nBackground.\n\n Implicit learning through motor sequencing tasks is sensitive to basal ganglia dysfunction. Consequently, it is ideally suited for testing elements of the frontostriatal model of major depression and performance can be related to key clinical, neuropsychological, vascular and biochemical data.\nMethod.\n\n Twenty-one subjects with moderate to severe unipolar depression and 21 age-, sex- and education-matched controls were recruited. Clinical, vascular and biochemical data were recorded. Subjects were administered a battery of neuropsychological tests that assessed speed of processing, working memory, learning, memory, language, perceptual organization and executive functioning. Additionally, subjects were administered a motor sequencing implicit learning task. Implicit learning is assumed when reaction times improve during the sequenced condition as compared to the pseudo-random baseline\n','',2006,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'94','Psychological Medicine','36','3','313-323','Cambridge University Press','YMH team','Illness specific areas','Neurobiology'),(664,'A cross-sectional exploration of the clinical characteristics of disengaged (NEET) young people in primary mental healthcare','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84920545923&doi=10.1136%2fbmjopen-2014-006378&partnerID=40&md5=8bf49d23c72aac9a2c93914ca1cbb07d','10.1136/bmjopen-2014-006378','\nObjective Youth with mental health problems often have difficulties engaging in education and employment. In Australia, youth mental health services have been widely established with a key aim of improving role functioning; however, there is little knowledge of those who are not engaged in employment, education or training (NEET) and the factors which may influence this. This study aimed to examine NEET status and its correlates in a sample of such youth.\nDesign Cross-sectional data from a longitudinal cohort study.\nSetting Between January 2011 and August 2012, young people presenting to one of the four primary mental health centres in Sydney or Melbourne were invited to participate.\nParticipants Young adults (N=696) aged between 15 and 25 years (M=19.0, SD=2.8), 68% female, 58% (n=404) attended headspace in Sydney.\nMeasures Individuals ├éΓÇÿNot in any type of Education, Employment or Training├éΓÇÖ in├é┬á├éΓÇª\n','',2014,NULL,NULL,'2014-12-01',NULL,NULL,NULL,NULL,'93','BMJ Open','4','12','e006378','British Medical Journal Publishing Group','YMH team','Outcome Research',''),(667,'Cognitive deficits in patients suffering from chronic fatigue syndrome, acute infective illness or depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030921163&doi=10.1192%2fbjp.171.4.377&partnerID=40&md5=2b4e1088b686f69d7ad4b5e412a1c514','10.1192/bjp.171.4.377','Background Patients with chronic fatigue syndrome (CFS) report neuropsychological symptoms as a characteristic feature. We sought to assess cognitive performance in patients with CFS, and compare cognitive performance and subjective workload experience of these patients with that of two disease comparison groups (non-melanchonic depression and acute infection) and healthy controls. Method A computerised performance battery employed to assess cognitive functioning included tests of continuous attention, response speed, performance accuracy and memory. Severity of mood disturbance and subjective fatigue were assessed by questionnaire. Results All patient groups demonstrated increased errors and slower reaction times, and gave higher workload ratings than healthy controls. Patients with CFS and non-melancholic depression had more severe deficits than patients with acute infection. All patient','',1997,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'93','British Journal of Psychiatry','171','4','377-381','Cambridge University Press','Other','',''),(669,'Specificity of interpersonal sensitivity to non-melancholic depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027413464&doi=10.1016%2f0165-0327%2893%2990082-U&partnerID=40&md5=5b617f63315ac673f637d5098cf21bf3','10.1016/0165-0327(93)90082-U','Scores of 69 remitted depressed patients were compared to control subjects on the Interpersonal Sensitivity Measure (IPSM). The patients were categorised into melancholic and non-melancholic sub-groups according to DSM-III criteria. Differences between the depressives and controls were detected but were principally the result of high IPSM scores being returned by the non-melancholic depressives. Melancholic depressives did not differ from the controls in their IPSM scores, supporting the proposition that this depressive sub-type is not associated with a vulnerable personality style.','',1993,NULL,NULL,'1993-02-01',NULL,NULL,NULL,NULL,'92','Journal of Affective Disorders','27','2','101-105','Elsevier','YMH team','Illness specific areas',''),(670,'Transdiagnostic stepped care in mental health','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019469746&doi=10.17061%2fphrp2721712&partnerID=40&md5=207d1556d72958706ece05098dc14cad','10.17061/phrp2721712','\nA component of AustraliaΓÇÖs recent national reform agenda for mental health services is the directive to the Primary Health Networks to develop and implement stepped-care models of service delivery. The current guidance proposes that interventions are aligned to mild, moderate and severe illness categories. Other models in operation are tied to single disorders, such as depression. Both approaches have a number of limitations when applied to real-world, complex clinical practice, especially in primary care.\nThis article outlines some limitations of these models and argues for the development of a transdiagnostic model, based on developments in our work in primary care youth services, which can be generalised to adult populations. Such models aim to ensure that consumers receive the right intensity of care at the right time. The adjunct use of technology within services could also improve service accessibility and outcomes monitoring, and help to improve the efficiency of resource allocation based on consumer need.\n','',2017,NULL,NULL,'2017-04-27',NULL,NULL,NULL,NULL,'90','Public Health Research and Practice','27','2','1','','YMH team','Mental Health System',''),(671,'Screening for prolonged fatigue syndromes: Validation of the SOFA scale','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033756699&doi=10.1007%2fs001270050266&partnerID=40&md5=2d112b477a159a59cacec1445f4d42a9','10.1007/s001270050266','                                         Background: The identification of syndromes characterised by persistent and disabling mental and/or physical fatigue is of renewed interest in psychiatric epidemiology. This report details the development of two specific instruments: the SOFA/CFS for identification of patients with chronic fatigue syndrome (CFS) in specialist clinics and the SOFA/GP for identification of prolonged fatigue syndromes (PFS) in community and primary care settings. Methods: Patients with clinical diagnoses of CFS (n=770) and consecutive attenders at primary care (n=1593) completed various self-report questionnaires to assess severity of current fatigue-related symptoms and other common somatic and psychological symptoms. Quality receiver operating characteristic curves were used to derive appropriate cut-off scores for each of the instruments. Comparisons with other self-report measures of anxiety\n','',2000,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'90','Social Psychiatry and Psychiatric Epidemiology','35','10','471-479','Steinkopff Verlag','Other','',''),(672,'The genetic aetiology of somatic distress','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033829951&doi=10.1017%2fS0033291799002640&partnerID=40&md5=de22c7a71f2fefa396a048566d34b509','10.1017/S0033291799002640','\nBackground.\n\n Somatoform disorders such as neurasthenia and chronic fatigue syndrome are characterized by a combination of prolonged mental and physical fatigue. This study aimed to investigate the heritability of somatic distress and determine whether this dimension is aetiologically distinct from measures of depression and anxiety.\nMethod.\n\n Measures of anxiety, depression, phobic anxiety, somatic distress and sleep difficulty were administered in a self-report questionnaire to a community-based sample of 3469 Australian twin individuals aged 18 to 28 years. Factor analysis using a Promax rotation, produced four factors: depression, phobic anxiety, somatic distress and sleep disturbance. Multivariate and univariate genetic analyses of the raw categorical data scores for depression, phobic anxiety and depression were then analysed in Mx1.47.\nResults.\n\n Univariate genetic analysis revealed that an additive\n','',2000,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'90','Psychological Medicine','30','5','1051-1061','Cambridge University Press','Other','',''),(673,'A clinical staging model for early intervention youth mental health services','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84903753358&doi=10.1176%2fappi.ps.201300221&partnerID=40&md5=8c77b7ab74fb1d32839004605573252b','10.1176/appi.ps.201300221','Transformational reforms in mental health services are providing more young Australians who experience mental health problems with access to high-quality care. However, the current diagnostic approach has low utility in the early stages of illness, causing uncertainty among clinicians in regard to matching clientsΓÇÖ needs with safe and effective interventions. The authors propose a clinical staging model that has the potential to better match illness stage to intervention. The model allows clinicians to provide more personalized and responsive care, especially to young people with attenuated syndromes (subthreshold disorders) who have a clear need for mental health care but who may not otherwise receive it. This approach can also assist clinicians in considering the potential trajectory of illness. Recent research using this framework has demonstrated the model├éΓÇÖs prospective utility. The authors describe├é┬á├éΓÇª','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'89','Psychiatric Services','65','7','939-943','American Psychiatric Association','YMH team','Models of care',''),(674,'Increased access to evidence-based primary mental health care: Will the implementation match the rhetoric?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-34547486397&doi=10.5694%2fj.1326-5377.2007.tb01150.x&partnerID=40&md5=31e5eda3fa6017081eb2d7ed335ca305','10.5694/j.1326-5377.2007.tb01150.x','ΓÇó There is clear evidence that coordinated systems of medical and psychological care (├éΓÇ£collaborative care├éΓÇ¥) are superior to single-provider-based treatment regimens.├éΓÇó Although other general practice-based mental health schemes promoted collaborative care, the new Medicare Benefits Schedule payments revert largely to individualprovider service systems and fee-for-service rebates. Such systems have previously resulted in high out-of-pocket expenses, poor geographical and socioeconomic distribution of specialist services, and proliferation of individual-providerbased treatments rather than collaborative care.├éΓÇó The new arrangements for broad access to psychological therapies should provide the financial basis for major structural reform. Unless this reform is closely monitored for equity of access, degree of out-of-pocket expenses, extent of development of evidence-based collaborative care structures, and impact on young people in the early phases of mental illness, we may waste this opportunity.├éΓÇó The responsibility for achieving the best outcome does not lie only with governments. To date, the professions have not placed enough emphasis on systematically adopting','',2007,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'89','Medical Journal of Australia','187','2','100-103','','YMH team','Models of care','Mental Health System'),(675,'Treatment of common mental disorders in Australian general practice','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035898361&doi=10.5694%2fj.1326-5377.2001.tb143786.x&partnerID=40&md5=af30d20b7a2c31c3cacbf8309dbdc7d1','10.5694/j.1326-5377.2001.tb143786.x','\n\nObjective: To determine the rates and predictors of treatments for patients with common mental disorders in Australian general practice. \nDesign and setting: Cross-sectional national audit of general practices throughout Australia in 1998ΓÇô1999. \nParticipants: 46515 ambulatory care patients attending 386 GPs. \nScreening tools: Prevalence of common mental disorders ├éΓÇö 12 items from the 34-item SPHERE self-report questionnaire and associated classification system; pharmacological and non-pharmacological treatment provided, as reported by the GPs ├éΓÇö questions relating to treatments provided; predictors of treatments ├éΓÇö self-report questions about demography for patients and GPs, and about practice organisation for GPs. \nMain outcome measures: GPs\' reported provision of pharmacological and non-pharmacological treatments; and patient, GP and practice characteristics predicting treatment provision. \nResults├é┬á├éΓÇª\n','',2001,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'89','Medical Journal of Australia','175','','S25-S30','','YMH team','Mental Health System',''),(676,'Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus','https://www.scopus.com/inward/record.uri?eid=2-s2.0-32944464646&doi=10.1186%2f1471-2334-6-15&partnerID=40&md5=7506d738b651384d073ec23f9595f3cc','10.1186/1471-2334-6-15','Acute infectious diseases are typically accompanied by non-specific symptoms including fever, malaise, irritability and somnolence that usually resolve on recovery. However, in some individuals these symptoms persist in what is commonly termed post-infective fatigue. The objective of this pilot study was to determine the gene expression correlates of post-infective fatigue following acute Epstein Barr virus (EBV) infection. We followed 5 people with acute mononucleosis who developed post-infective fatigue of more than 6 months duration and 5 HLA-matched control subjects who recovered within 3 months. Subjects had peripheral blood mononuclear cell (PBMC) samples collected at varying time points including at diagnosis, then every 2 weeks for 3 months, then every 3 months for a year. Total RNA was extracted from the PBMC samples and hybridized to microarrays spotted with 3,800 oligonucleotides. Those who developed post-infective fatigue had gene expression profiles indicative of an altered host response during acute mononucleosis compared to those who recovered uneventfully. Several genes including ISG20 (interferon stimulated gene), DNAJB2 (DnaJ [Hsp40] homolog and CD99), CDK8 (cyclin-dependent kinase 8), E2F2 (E2F transcription factor 2), CDK8 (cyclin-dependent kinase 8), and ACTN2 (actinin, alpha 2), known to be regulated during EBV infection, were differentially expressed in post-infective fatigue cases. Several of the differentially expressed genes affect mitochondrial functions including fatty acid metabolism and the cell cycle. These preliminary data provide insights into alterations in gene transcripts associated','',2006,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'88','BMC Infectious Diseases','6','1','1-Jul','BioMed Central','Other','',''),(677,'The temporal stability and co-morbidity of prolonged fatigue: A longitudinal study in primary care','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032798561&doi=10.1017%2fS0033291799008582&partnerID=40&md5=20ecd1dc9436a840f9cc17471d8ec201','10.1017/S0033291799008582','\nBackground.\n\n Depression, anxiety and fatigue are among the most common symptoms presented in primary care. Whether such symptoms indicate discrete psychological syndromes or whether they result from a common vulnerability is not clear. This study examined longitudinally the patterns of co-morbidity between prolonged fatigue and other forms of psychological distress in patients attending general practitioners.\nMethods.\n\n Adults attending primary care completed questionnaires designed to detect cases of prolonged fatigue and psychological distress at presentation and 12 months later.\nResults.\n\n Of 652 patients, the prevalence rates of ΓÇÿprolonged fatigue├éΓÇÖ alone, ├éΓÇÿpsychological distress├éΓÇÖ alone, ├éΓÇÿprolonged fatigue+psychological distress├éΓÇÖ and ├éΓÇÿno disorder├éΓÇÖ were 7%, 19%, 15% and 59% respectively at initial assessment. Of those patients with any prolonged fatigue syndrome initially, 58% still reported fatigue 12├é┬á├éΓÇª\n','',1999,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'87','Psychological Medicine','29','4','855-861','Cambridge University Press','YMH team','Illness specific areas',''),(678,'Sleep disturbance relates to neuropsychological functioning in late-life depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-79958093021&doi=10.1016%2fj.jad.2011.02.027&partnerID=40&md5=1f8bc8295966f0ab85d708419228f952','10.1016/j.jad.2011.02.027','\n\nBackground\nSleep├éΓÇôwake disturbance in older people is a risk factor for depression onset and recurrence. The aim of this study was to determine if objective sleep├éΓÇôwake disturbance in late-life depression relates to neuropsychological functioning.\n\n\nMethods\nForty-four older patients with a lifetime history of major depression and 22 control participants underwent psychiatric, medical and neuropsychological assessments. Participants completed self-report sleep measures, sleep diaries and wore wrist actigraphy for two weeks. Outcome measures included sleep latency, the number and duration of nocturnal awakenings and the overall sleep efficiency.\n\n\nResults\nPatients with depression had a greater duration of nocturnal awakenings and poorer sleep efficiency, in comparison to control participants. Sleep disturbance in patients was associated with greater depression severity and later ages of depression onset. It also├é┬á├éΓÇª\n\n','',2011,NULL,NULL,'2011-07-01',NULL,NULL,NULL,NULL,'86','Journal of Affective Disorders','132','1-Feb','139-145','Elsevier','YMH team','Illness specific areas',''),(679,'Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load','https://www.scopus.com/inward/record.uri?eid=2-s2.0-33144463730&doi=10.1086%2f500248&partnerID=40&md5=33d25e0640c8321c2e35df6170f452c0','10.1086/500248','                    BackgroundPrimary Epstein-Barr virus (EBV) infection causes a spectrum of characteristics that range from asymptomatic seroconversion to severe infectious mononucleosis (IM), sometimes with prolonged symptoms and disability. We examined the relationships between clinical course, number of viral copies, and immunological parameters in a prospective cohort of subjects with recent IM                    MethodsEight case patients with at least 6 months of disabling symptoms and 31 matched control subjects who had recovered promptly were included. Symptom scores were recorded at regular intervals over the course of 12 months. Cellular EBV load, EBV-specific antibody responses, lymphocyte subsets, and EBV-specific interferon (IFN)ΓÇô induction were measured                    ResultsIn case patients with prolonged illness, the severity of acute-phase symptoms was greater, the development of anti├éΓÇôEBV├é┬á├éΓÇª\n','',2006,NULL,NULL,'2006-03-01',NULL,NULL,NULL,NULL,'86','Journal of Infectious Diseases','193','5','664-671','The University of Chicago Press','Other','',''),(680,'The Genetics of the Mood Disorder Spectrum: Genome-wide Association Analyses of More Than 185,000 Cases and 439,000 Controls','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078024661&doi=10.1016%2fj.biopsych.2019.10.015&partnerID=40&md5=f68aa8f8f9eac9e81bae6dab45c06474','10.1016/j.biopsych.2019.10.015','Background\r\nMood disorders (including major depressive disorder and bipolar disorder) affect 10% to 20% of the population. They range from brief, mild episodes to severe, incapacitating conditions that markedly impact lives. Multiple approaches have shown considerable sharing of risk factors across mood disorders despite their diagnostic distinction.\r\n\r\n\r\nMethods\r\nTo clarify the shared molecular genetic basis of major depressive disorder and bipolar disorder and to highlight disorder-specific associations, we meta-analyzed data from the latest Psychiatric Genomics Consortium genome-wide association studies of major depression (including data from 23andMe) and bipolar disorder, and an additional major depressive disorder cohort from UK Biobank (total: 185,285 cases, 439,741 controls; nonoverlapping N├é┬á= 609,424).\r\n\r\n\r\nResults\r\nSeventy-three loci reached genome-wide significance in the meta-analysis, including 15├é┬á├éΓÇª','',2020,NULL,NULL,'2020-07-15',NULL,NULL,NULL,NULL,'85','Biological Psychiatry','88','2','169-184','Elsevier','Other','',''),(681,'Right care, first time: a highly personalised and measurement-based care model to manage youth mental health','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074273890&doi=10.5694%2fmja2.50383&partnerID=40&md5=ea166ae881bea5f75a6fe1ead060ec92','10.5694/mja2.50383','   Mood and psychotic syndromes most often emerge during adolescence and young adulthood, a period characterised by major physical and social change. Consequently, the effects of adolescent-onset mood and psychotic syndromes can have long term consequences.  A key clinical challenge for youth mental health is to develop and test new systems that align with current evidence for comorbid presentations and underlying neurobiology, and are useful for predicting outcomes and guiding decisions regarding the provision of appropriate and effective care.  Our highly personalised and measurement-based care model includes three core concepts: \n A multidimensional assessment and outcomes framework that includes: social and occupational function; self-harm, suicidal thoughts and behaviour; alcohol or other substance misuse; physical health; and illness trajectory.\n \n Clinical stage.\n \n Three common├é┬á├éΓÇª\n\n\n\n','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'85','Medical Journal of Australia','211','','S3-S46','','YMH team','Models of care',''),(682,'Reviving the diagnosis of neurasthenia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030829015&doi=10.1017%2fS0033291797004893&partnerID=40&md5=62d15f6bdb138abca14d937cb21b52f1','10.1017/S0033291797004893','Reviews prevalence and symptom data from community and primary care studies to advocate the validity of neurasthenia as its own diagnostic category. Current statistical, longitudinal, neurobiological and treatment response data suggest that neurasthenia/chronic fatigue may be at least as robust a diagnostic category as the common anxiety and depressive disorders and require specifically designed pharmacological and non-pharacological treatment interventions. While critics of the neurasthenia entity emphasize the degree of overlap with other non-psychological disorders, the authors assert that this criticism is equally applicable to the more commonly accepted disorders (eg major depression, generalized anxiety and panic disorder) that show large degrees of over-lap cross-sectionally, longitudinally, and within family history data.(PsycINFO Database Record (c) 2016 APA, all rights reserved)','',1997,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'85','Psychological Medicine','','','','Cambridge University Press','YMH team','Models of care',''),(683,'Responding to experiences of young people with common mental health problems attending Australian general practice.','https://www.scopus.com/inward/record.uri?eid=2-s2.0-38449084625&doi=10.5694%2fj.1326-5377.2007.tb01337.x&partnerID=40&md5=164bca55da3a34109137fbc8af339cc0','10.5694/j.1326-5377.2007.tb01337.x','The development of evidence-based (ΓÇ£collaborative care├éΓÇ¥) mental health services in primary care for young people with anxiety, depression and alcohol or other substance misuse is a major challenge. Data from two clinical audits of selected Australian general practices (1998├éΓÇô1999and 2000├éΓÇô2002) were analysed to explore actual experiences of care among people aged 16├éΓÇô25years. Syndromal (1998├éΓÇô1999: 31.0% [n=1849/5957]; 2000├éΓÇô2002: 37.8% [n=148/392]) and subsyndromal (1998├éΓÇô1999: 27.4% [n=1635/5957]; 2000├éΓÇô2002: 29.1% [114/392]) mental disorders are very common among young people presenting to general practitioners. However, a mental health diagnosis (1998├éΓÇô1999: 42.6% [n=740/1736]; 2000├éΓÇô2002: 52.0% [n=77/148]) or provision of formal treatment (1998├éΓÇô1999: 36.1% [n=600/1661]; 2000├éΓÇô2002: 51.7% [n=74/143]) occurs in only about half of the patients with├é┬á├éΓÇª\n','',2007,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'84','The Medical journal of Australia','187','S7','S47-S52','','YMH team','Mental Health System',''),(684,'Out of hospital, out of mind','https://mhaustralia.org/sites/default/files/imported/component/rsfiles/publications/Out_of_Hospital_Out_of_Mind.pdf',NULL,'\nThe Australian National Survey of Mental Health and Wellbeing indicates that approximately 20% of the population experiences a mental health problem each year. Such mental health problems include affective, anxiety and substance abuse disorders (3). The prevalence of mental health problems in children and adolescents in Australia is 14% of the population (16). Three percent of Australian adults experience serious mental illness such as a psychotic disorder (17).\nThe stigma associated with mental illness is especially pervasive in the community, and society often deals with such fear and distress by alienating and segregating those with mental illness. The impact of stigma, discrimination and misunderstanding is often profoundΓÇôbecoming a part of the problem and affecting the life of the individual.\n','',2003,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'84','','','','','Mental Health Council of Australia',NULL,NULL,NULL),(685,'\'Side effects\' of ECT are mainly depressive phenomena and are independent of age','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034812491&doi=10.1016%2fS0165-0327%2800%2900314-1&partnerID=40&md5=a5691ac5f10ce39832d373a3a942e628','10.1016/S0165-0327(00)00314-1','\nBackground: The aetiology of reported side effects of electroconvulsive therapy (ECT) is unclear. We examined the interaction of depression and age on adverse neuropsychological and putative side effects of ECT. Method: Inpatients (N=81; median age 70 years) with major depression were assessed prospectively pre-ECT, immediately post-ECT and 1├éΓÇô3 years later. Patients were administered the Hamilton Rating Scale for Depression (HRSD), the Global Assessment of Functioning scale (GAF) and neuropsychological tests from the Wechsler Memory Scale. Side effects and total burden scores were rated pre- and post-treatment. Results: HRSD and GAF scores improved with treatment after ECT, but the prevalence and total burden of side effects were unchanged. Side effect burden was related to depression level before and after ECT. Improvement in depression correlated with reduction in side effect burden├é┬á├éΓÇª','',2001,NULL,NULL,'2001-10-01',NULL,NULL,NULL,NULL,'84','Journal of Affective Disorders','66','2-Mar','237-245','Elsevier','Other','',''),(686,'Oxytocin selectively moderates negative cognitive appraisals in high trait anxious males','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84869884031&doi=10.1016%2fj.psyneuen.2012.04.018&partnerID=40&md5=f30b4136525f26faa51860a3ef647fd7','10.1016/j.psyneuen.2012.04.018','The mammalian neuropeptide oxytocin has well-characterized effects in facilitating prosocial and affiliative behavior. Additionally, oxytocin decreases physiological and behavioral responses to social stress. In the present study we investigated the effects of oxytocin on cognitive appraisals after a naturalistic social stress task in healthy male students. In a randomized, double-blind, placebo-controlled trial, 48 participants self-administered either an oxytocin or placebo nasal spray and, following a wait period, completed an impromptu speech task. Eye gaze to a pre-recorded video of an audience displayed during the task was simultaneously collected. After the speech, participants completed questionnaires assessing negative cognitive beliefs about speech performance. Whilst there was no overall effect of oxytocin compared to placebo on either eye gaze or questionnaire measures, there were significant positive','',2012,NULL,NULL,'2012-12-01',NULL,NULL,NULL,NULL,'82','Psychoneuroendocrinology','37','12','2022-2031','Pergamon','Other','',''),(687,'Impulsivity in the self-harm and suicidal behavior of young people: A systematic review and meta-analysis','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066944848&doi=10.1016%2fj.jpsychires.2019.05.012&partnerID=40&md5=8a6c5fa1918b81f21fd5f834e62b8328','10.1016/j.jpsychires.2019.05.012','\n\nBackground\nImpulsivity is considered a possible phenotype underlying the expression of self-harm and suicidal behaviors. Yet impulsivity is a not a unitary construct and there is evidence that different facets of impulsivity follow different neurodevelopmental trajectories and that some facets may be more strongly associated with such behaviors than others. Moreover, it is unclear whether impulsivity is a useful predictor of self-harm or suicidal behavior in young people, a population already considered to display heightened impulsive behavior.\n\n\nMethods\nA systematic review and meta-analysis of studies published in Medline, PubMed, PsychInfo or Embase between 1970 and 2017 that used a neurocognitive measure to assess the independent variable of impulsivity and the dependent variable of self-harm and/or suicidal behavior among young people (mean age<30 years old).\n\n\nResults\n6183 titles were identified, 141\n\n','',2019,NULL,NULL,'2019-09-01',NULL,NULL,NULL,NULL,'81','Journal of Psychiatric Research','116','','51-60','Pergamon','YMH team','Illness specific areas',''),(688,'Are cytokines associated with neuropsychiatric syndromes in humans?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028846560&doi=10.1016%2f0192-0561%2895%2900054-6&partnerID=40&md5=e67ea288493d7994d4388ab8a6680ced','10.1016/0192-0561(95)00054-6','Traditional aetiological models in neuropsychiatry have placed little emphasis on the abnormal behavioural responses (decreased psychomotor activity, anorexia, weight loss, decreased social exploration and sexual behaviour, impaired cognitive function and increased somnolence) that are common to both psychiatric syndromes, notably depression, and the illness behaviour of sick animals. In recent years, the possible role of cytokines, as mediators of not only the immunological and metabolic responses to infection and inflammation but also a co-ordinated behavioural response, has been described. Further, a range of possible mechanisms for these effects has been postulated, notably involving corticotropin releasing factor (CRF) and prostaglandins of the E series (PgE) with the central nervous system (CNS). Here we outline a series of human clinical conditions where neuropsychiatric syndromes co-occur','',1995,NULL,NULL,'1995-08-01',NULL,NULL,NULL,NULL,'81','International Journal of Immunopharmacology','17','8','677-683','Pergamon','Other','',''),(689,'Interpersonal sensitivity and the one-year outcome of a depressive episode','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026710299&doi=10.3109%2f00048679209072022&partnerID=40&md5=6897a0789727630a834220ee01eae2e0','10.3109/00048679209072022','Previous studies have demonstrated that abnormalities of personality can contribute to a poor prognosis following a depressive episode. In this study the relevance of a specific personality trait, interpersonal sensitivity, to poor outcome was examined. One hundred and eleven depressives completed the Interpersonal Sensitivity Measure (IPSM) twenty weeks after a baseline assessment. High scores on the IPSM were associated with a poor outcome at one year following the baseline assessment, judged according to whether they had remitted clinically or not and by the degree of change in depression severity measured using the Hamilton and Zung Depression Rating Scales. The relevance of this personality trait to the course and treatment of depression is discussed.','',1992,NULL,NULL,'1992-01-01',NULL,NULL,NULL,NULL,'81','Australian and New Zealand Journal of Psychiatry','26','2','156-161','Taylor & Francis','Other','',''),(690,'Prediction of response to electroconvulsive therapy. Preliminary validation of a sign-based typology of depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025309557&doi=10.1192%2fbjp.157.1.65&partnerID=40&md5=e84822add107d86e98fe7abd5d09d432','10.1192/bjp.157.1.65','In an open study of 35 depressed patients, psychomotor disturbance, assessed by the CORE rating system, significantly predicted response to ECT in patients with a ΓÇÿretarded├éΓÇÖ but not those with an ├éΓÇÿagitated├éΓÇÖ type of illness. In multivariate analyses, psychomotor disturbance was the sole predictor of response. This preliminary study suggests that the CORE system, which has been shown to differentiate endogenous and non-endogenous depressive disorders, has predictive validity in relation to ECT response.','',1990,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'81','British Journal of Psychiatry','157','1','65-71','Cambridge University Press','YMH team','Models of care','illness specific areas'),(691,'Randomized controlled trial of a healthy brain ageing cognitive training program: effects on memory, mood, and sleep','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84939570984&doi=10.3233%2fJAD-142061&partnerID=40&md5=e1686206b6d7756d9cbdbb356454f2f4','10.3233/JAD-142061','\nBackground:\nWith the rise in the ageing population and absence of a cure for dementia, cost-effective prevention strategies for those ΓÇÿat risk├éΓÇÖof dementia including those with depression and/or mild cognitive impairment are urgently required.\nObjective:\nThis study evaluated the efficacy of a multifaceted Healthy Brain Ageing Cognitive Training (HBA-CT) program for older adults ├éΓÇÿat risk├éΓÇÖof dementia.\nMethods:\nUsing a single-blinded design, 64 participants (mean age= 66.5 years, SD= 8.6) were randomized to an immediate treatment (HBA-CT) or treatment-as-usual control arm. The HBA-CT intervention was conducted twice-weekly for seven weeks and comprised group-based psychoeducation about cognitive strategies and modifiable lifestyle factors pertaining to healthy brain ageing, and computerized cognitive training.\nResults:\nIn comparison to the treatment-as-usual control arm, the HBA-CT program was associated├é┬á├éΓÇª\n','',2015,NULL,NULL,'2015-01-01',NULL,NULL,NULL,NULL,'80','Journal of Alzheimer\'s disease : JAD','44','4','1181-1191','IOS Press','Other','',''),(692,'Childhood adversity impacts on brain subcortical structures relevant to depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85001130110&doi=10.1016%2fj.jpsychires.2016.11.010&partnerID=40&md5=45a7962fe70a09e6510520cfcea5b270','10.1016/j.jpsychires.2016.11.010','','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Journal of Psychiatric Research','','','','Pergamon','Other','',''),(693,'Cytokine levels in serum and cerebrospinal fluid in patients with chronic fatigue syndrome and control subjects [2]','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026060423&doi=10.1093%2finfdis%2f164.5.1023&partnerID=40&md5=d6fe8a145e46e244fe0241b561652ef9','10.1093/infdis/164.5.1023','\nColleagues-Chronic and excessive production of cytokines after viral infection or other antigenic challenge has been proposed as the pathophysiologic basis ofchronic fatigue syndrome (CFS)[1]. The most significant, although circumstantial, evidence for the role ofcytokines in the pathogenesis ofCFS is the observation that a syndrome resembling CFS results from the administration of recombinant interferon-a (IFN-a) for therapeutic purposes [2].\nThe central nervous system (CNS) is the most likely site ofthe pathophysiology ofthe symptom complex ofCFS: Neuropsychiatric symptoms are prevalent [3], and\" fatigue,\" the cardinal symptom, likely arises from a CNS disturbance, because muscle strength, endurance, and recovery have been shown to be normal [4]. Disordered cellular immunity in patients with CFS has also been documented [5]. Evidence for an immunologic process occurring within the CNS that could\n','',1991,NULL,NULL,'1991-11-01',NULL,NULL,NULL,NULL,'79','Journal of Infectious Diseases','164','5','1023-1024','The University of Chicago Press','Other','',''),(694,'A single dose of oxytocin nasal spray improves higher-order social cognition in schizophrenia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84946482620&doi=10.1016%2fj.schres.2015.06.005&partnerID=40&md5=6451f6092806098a28e6d0203a681c59','10.1016/j.schres.2015.06.005','Schizophrenia is associated with significant impairments in both higher and lower order social cognitive performance and these impairments contribute to poor social functioning. People with schizophrenia report poor social functioning to be one of their greatest unmet treatment needs. Recent studies have suggested the potential of oxytocin as such a treatment, but mixed results render it uncertain what aspects of social cognition are improved by oxytocin and, subsequently, how oxytocin might best be applied as a therapeutic. The aim of this study was to determine whether a single dose of oxytocin improved higher-order and lower-order social cognition performance for patients with schizophrenia across a well-established battery of social cognition tests. Twenty-one male patients received both a single dose of oxytocin nasal spray (24┬áIU) and a placebo, two weeks apart in a randomized within-subjects placebo├é┬á├éΓÇª','',2015,NULL,NULL,'2015-11-01',NULL,NULL,NULL,NULL,'78','Schizophrenia Research','168','3','628-633','Elsevier','YMH team','Outcome Research',''),(695,'The Experience of Cancer-Related Fatigue and Chronic Fatigue Syndrome: A Qualitative and Comparative Study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-34547096009&doi=10.1016%2fj.jpainsymman.2006.10.014&partnerID=40&md5=086cc9acefde15adad306b6856b78a12','10.1016/j.jpainsymman.2006.10.014','Cancer-related fatigue (CRF) is a common and disabling symptom complex reported by survivors. This study aimed to better understand the manifestations of CRF in women treated for breast cancer, and to compare them with those of women diagnosed with chronic fatigue syndrome (CFS). Women with CRF persisting 6 months after treatment for early stage breast cancer, and women with CFS participated in separate, audiotaped focus groups. Transcripts of the sessions were analyzed using the NUD*IST software, and interpreted using grounded theory. Twenty-eight women participated, 16 with CRF and 12 with CFS. Analysis of transcripts from both groups revealed a similar core set of symptoms, featuring fatigue, neurocognitive difficulties, and mood disturbances. Women with CFS reported additional symptoms including musculoskeletal pain and influenza-like manifestations. Both groups suffered disabling','',2007,NULL,NULL,'2007-08-01',NULL,NULL,NULL,NULL,'78','Journal of Pain and Symptom Management','34','2','126-135','Elsevier','Other','',''),(696,'PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85034629149&doi=10.1038%2ftp.2017.193&partnerID=40&md5=5f54bb200b6e5e786ffa9681d34bea6e','10.1038/tp.2017.193','','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Translational Psychiatry','','','','Nature Publishing Group','Other','',''),(697,'Adolescents and young adults who are not in employment, education, or training','https://www.bmj.com/content/347/bmj.f5270',NULL,'\nThe term NEET (not in employment, education, or training) refers to economically inactive adolescents and young adults. 1 2 During economic crises, youth unemployment rises faster and recovers more slowly than general unemployment. 1 In 2012, there were 7.5 million 15-24 year old (13% of the age group) and 6.5 million 25-29 year old (20%) economically inactive young people in the European Union. Together, they cost├éΓé¼ 153bn (├é┬ú 131bn; $204 bn) in welfare benefits and lost productivity├éΓÇö1.2% of EU gross domestic product. 2 International publications confirm global rates of 10-20% youth unemployment and highlight that the optimal solution is to increase retention in education and training. 1 2 3 4 5\nProlonged economic inactivity has profound effects on mental health: the risks of depression (odds ratio 2.7), alcohol or substance misuse (3.4), and suicidal attempts (3.6) are significantly increased in├é┬á├éΓÇª\n','',2013,NULL,NULL,'2013-09-18',NULL,NULL,NULL,NULL,'77','','347','','','British Medical Journal Publishing Group',NULL,NULL,NULL),(698,'Are chronic fatigue and chronic fatigue syndrome valid clinical entities across countries and healthcare settings?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-58049102313&doi=10.1080%2f00048670802534432&partnerID=40&md5=a30280483af45217020f9707c8f4b98f','10.1080/00048670802534432','\n\nObjective: The validity of the diagnosis of chronic fatigue syndrome and related chronic fatigue states remains controversial, particularly in psychiatry. This project utilized international epidemiological and clinical research data to test construct validity across diagnostic categories, health-care settings and countries. Relevant demographic, symptom and diagnostic data were obtained from 33 studies in 21 countries. The subjects had fatigue lasting 1ΓÇô6 months (prolonged fatigue), or >6 months (chronic fatigue), or met diagnostic criteria for chronic fatigue syndrome.\n\nMethod: Common symptom domains were derived by factor analytic techniques. Mean scores on each symptom factor were compared across diagnostic categories, health-care settings and countries.\n\nResults: Data were obtained on 37 724 subjects (n = 20 845 female, 57%), including from population-based studies (n = 15 749, 42%), studies in primary├é┬á├éΓÇª\n','',2009,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'77','Australian and New Zealand Journal of Psychiatry','43','1','25-35','Sage Publications','Other','Illness specific areas',''),(699,'Early intervention for depressive disorders in young people: the opportunity and the (lack of) evidence.','https://www.scopus.com/inward/record.uri?eid=2-s2.0-38449113754&doi=10.5694%2fj.1326-5377.2007.tb01329.x&partnerID=40&md5=ee6e8b9f610c213f536a308f31db459e','10.5694/j.1326-5377.2007.tb01329.x','ΓÇó Young people experiencing their first onset of depression are a group at risk of relapse and recurrence to whom early intervention and prevention efforts should be targeted.','',2007,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'77','The Medical journal of Australia','187','S7','S15-S17','','Other','',''),(700,'Postinfective fatigue syndrome is not associated with altered cytokine production','https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548475752&doi=10.1086%2f520990&partnerID=40&md5=35ed9eb995e887ece41efeaab746c7c4','10.1086/520990','         Peripheral blood specimens and clinical data were obtained over a 12-month period from subjects in the Dubbo Infection Outcomes Study to examine cytokine production in postinfective fatigue syndrome. Ex vivo production of 8 cytokines was examined in 22 case patients and in 42 control subjects who recovered promptly. No significant differences were found. Ongoing production of the cytokines examined does not play a role in postinfective fatigue syndrome.\n','',2007,NULL,NULL,'2007-09-15',NULL,NULL,NULL,NULL,'77','Clinical Infectious Diseases','45','6','732-735','The University Chicago Press','Other','',''),(701,'Do the Genetic or Environmental Determinants of Anxiety and Depression Change with Age? A Longitudinal Study of Australian Twins','https://www.scopus.com/inward/record.uri?eid=2-s2.0-1542514854&doi=10.1375%2f13690520460741435&partnerID=40&md5=a03ced96af0c19b54bf8733b8e074702','10.1375/13690520460741435','Because the determinants of anxiety and depression in late adolescence and early adulthood may differ from those in later life, we investigated the temporal stability and magnitude of genetic and environmental correlates of symptoms of anxiety and depression across the life span. Data were collected from a population-based Australian sample of 4364 complete twin pairs and 777 singletons aged 20 to 96 years who were followed-up over three studies between 1980 and 1996. Each study contained the 14-item self-report DSSI/sAD scale which was used to measure recently experienced symptoms of anxiety and depression. Symptom scores were then divided and assigned to age intervals according to each subject\'s age at time of participation. We fitted genetic simplex models to take into account the longitudinal nature of the data. For male anxiety and depression, the best fitting simplex models comprised a','',2004,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'77','Twin Research','7','1','39-53','Cambridge University Press','YMH team','Outcome Research','Neurobiology'),(702,'Neo-striatal rCBF correlates of psychomotor slowing in patients with major depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033406186&doi=10.1016%2fS0925-4927%2899%2900038-4&partnerID=40&md5=97be2ddc61c8b02b30a576f0ace196f4','10.1016/S0925-4927(99)00038-4','Psychomotor slowing is a fundamental clinical feature of severe depression and is thought to reflect dysfunction within prefrontal-subcortical circuits. This study utilised a split-dose single photon emission computerised tomography (SPECT) scanning technique in association with a two-stage test of psychomotor speed. Twenty-five patients with primary depressive disorders were injected with technetium-99m hexamethylpropylene amine oxime (99mTc-HMPAO) whilst performing each component of a two-stage psychomotor task. The first stage, ΓÇÿsimple reaction time├éΓÇÖ (RT) and the second stage, ├éΓÇÿchoice reaction time├éΓÇÖ (CRT), were each followed by 30-min SPECT scans. Regions of interest (ROIs) corresponding to the left and right neo-striatum (caudate-putamen) were drawn, and regional cerebral blood flow (rCBF) values were calculated. Importantly, the change in rCBF measure in the left neo-striatum was inversely├é┬á├éΓÇª','',1999,NULL,NULL,'1999-12-20',NULL,NULL,NULL,NULL,'77','Psychiatry Research - Neuroimaging','92','2-Mar','75-81','Elsevier','YMH team','Neurobiology',''),(703,'Complex genetic and environmental relationships between psychological distress, fatigue and immune functioning: A twin study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033039520&doi=10.1017%2fS0033291798007922&partnerID=40&md5=7d360a836eeb118b2859795bde0859b1','10.1017/S0033291798007922','\nBackground.\n\n Although there is considerable support for adverse relationships between states of psychological and somatic distress and immune response, there is little evidence in humans of the relative contribution of genetic and environmental factors.\nMethods.\n\n This study utilized a twin methodology to examine the interplay between psychological distress, fatigue and immune function. We recorded a number of measures of distress, including conventional depression and anxiety as well as the somatic symptom of prolonged fatigue, and immune responsiveness (by delayed-type hypersensitivity skin response) in 124 normal adult twin pairs (79 monozygotic, 45 dizygotic).\nResults.\n\n While there were strong genetic influences on the psychological distress and fatigue factors (only some of which are common to both), familial aggregation of immune responsiveness arose mainly from environmental factors shared by\n','',1999,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'76','Psychological Medicine','29','2','269-277','Cambridge University Press','YMH team','Neurobiology',''),(704,'Subcortical brain structure and suicidal behaviour in major depressive disorder: A meta-analysis from the ENIGMA-MDD working group','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85038814444&doi=10.1038%2ftp.2017.84&partnerID=40&md5=3c538fd13044a242486d172b4eb9eb5e','10.1038/tp.2017.84','','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Translational Psychiatry','','','','Nature Publishing Group','Other','',''),(705,'\"How much more can we lose?\": Carer and family perspectives on living with a person with depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-5044240833&doi=10.5694%2fj.1326-5377.2004.tb06347.x&partnerID=40&md5=28aad18ec4a728d4449f476f6e2bfdf6','10.5694/j.1326-5377.2004.tb06347.x',' \nObjective: To explore the experiences of carers and families of people with depression. \nDesign and setting: Structured focus groups conducted in six Australian capital cities between February 2002├é┬áand July 2002. Thematic analyses were conducted using the QSR NUD*IST software package for qualitative data. \nParticipants: Thirty-seven carers or family members. \nResults: Thematic analyses highlighted five key themes. Most notably, the carer\'s role is made more difficult by the lack of community awareness about depression, and, in some instances, an unwillingness of other family and friends to provide ongoing support. Carers experience a resulting sense of isolation, often exacerbated by adverse experiences with healthcare providers. Carers and family members are frequently excluded when key decisions are made, and report that emergency services are relatively unresponsive to their concerns. By contrast├é┬á├éΓÇª\n','',2004,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'75','Medical Journal of Australia','181','','S6-S9','','YMH team','Illness specific areas',''),(706,'Sub-typing depression, I. Is psychomotor disturbance necessary and sufficient to the definition of melancholia?','https://www.cambridge.org/core/journals/psychological-medicine/article/subtyping-depression-i-is-psychomotor-disturbance-necessary-and-sufficient-to-the-definition-of-melancholia/2B28D25F23BA20E66756D1BD39C63181',NULL,'Melancholia is most commonly distinguished from non-melancholic depression by the presence of psychomotor disturbance (PMD) and a set of ΓÇÿendogeneity├éΓÇÖ symptoms. We examine the capacity of an operationalized clinician-rated measure of PMD (the CORE system) to predict diagnostic assignment to ├éΓÇÿmelancholic/endogenous├éΓÇÖ classes by the DSM-III-R and Newcastle systems. Examining a pre-established CORE cut-off score (= 8) against independent diagnostic assignment, PMD was present in 51% of those assigned as melancholic by DSM-III-R, and 85% of those assigned as endogenous by the Newcastle system, quantifying the extent to which it is ├éΓÇÿnecessary├éΓÇÖ to the two definitions of ├éΓÇÿmelancholia├éΓÇÖ. Additionally, multivariate analyses established that the addition of a refined set of historically suggested endogeneity symptoms added only slightly to overall discrimination of melancholic and non-melancholic├é┬á├éΓÇª','',1995,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'75','Psychological Medicine','25','4','815-823','Cambridge University Press',NULL,NULL,NULL),(707,'Distinguishing psychotic and non-psychotic melancholia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025864667&doi=10.1016%2f0165-0327%2891%2990047-V&partnerID=40&md5=63461b4174dc103661a3119faf9a0757','10.1016/0165-0327(91)90047-V','To examine the necessary and sufficient status of delusions and hallucinations as clinical features of psychotic (delusional) depression, we studied a consecutive sample of 137 patients meeting DSM-III, RDC and our clinical criteria for endogenous depression/melancholia, of whom 35 had delusions and/or hallucinations, and represented our putative ΓÇÿpsychotic depressives├éΓÇÖ (PDs). The PDs were contrasted with the remaining ├éΓÇÿendogenous depressives├éΓÇÖ (the EDs), and an age- and sex-matched subsample of the latter, the MEDs. Univariate and multivariate analyses of clinical features established that, in addition to the presence of delusions and/or hallucinations, the PDs could be distinguished in particular by severe psychomotor disturbance, as well as by sustained and unvarying depressive content, the absence of any diurnal mood variation and by constipation. Latent class analyses suggested that overt psychotic├é┬á├éΓÇª','',1991,NULL,NULL,'1991-07-01',NULL,NULL,NULL,NULL,'75','Journal of Affective Disorders','22','3','135-148','Elsevier','YMH team','Illness specific areas',''),(708,'Genetic effects influencing risk for major depressive disorder in China and Europe','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020498216&doi=10.1038%2ftp.2016.292&partnerID=40&md5=38197c8eaf491a231a05697ca9056721','10.1038/tp.2016.292','','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Translational Psychiatry','','','','Nature Publishing Group','Other','',''),(709,'Comorbidity of common mental disorders and alcohol or other substance misuse in Australian general practice','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035898524&doi=10.5694%2fj.1326-5377.2001.tb143787.x&partnerID=40&md5=3b9cb21b079bb1e7c76d5aee3b6bb311','10.5694/j.1326-5377.2001.tb143787.x','\n\nObjective: To determine in patients attending general practice 1) the extent of comorbidity of mental disorders and alcohol or other substance misuse, and consequent disability; and 2) GPs\' diagnosis and management of patients with comorbidity. \nDesign and setting: Cross-sectional national audit of general practices throughout Australia in 1998ΓÇô1999. \nParticipants: 46515 ambulatory care patients attending 386 GPs. \nScreening tools: Prevalence of common mental disorders ├éΓÇö 12 items from the 34-item SPHERE self-report questionnaire and associated classification system; prevalence of alcohol or other substance misuse ├éΓÇö two self-report screening questions, defining ├éΓÇ£probable├éΓÇ¥ misuse (a positive response to both questions) and ├éΓÇ£possible├éΓÇ¥ misuse (a positive response to one of the questions); disability ├éΓÇö four items from the Brief Disability Questionnaire, and self-reported ├éΓÇ£days out of role├éΓÇ¥ and ├éΓÇ£days in bed├éΓÇ¥ in├é┬á├éΓÇª\n','',2001,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'74','Medical Journal of Australia','175','','S31-S36','','YMH team','Illness specific areas','Outcome Research'),(710,'Effects of mental health training and clinical audit on general practitioners\' management of common mental disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035898502&doi=10.5694%2fj.1326-5377.2001.tb143789.x&partnerID=40&md5=08d1f9526f2b5a2578e0bea006e669a6','10.5694/j.1326-5377.2001.tb143789.x','\n\nObjective: To evaluate the effects of a seminar-based training program and clinical practice audit on general practitioners\' (GPs\') knowledge and management of common mental disorders. \nDesign: Survey of GPs\' knowledge before and after training, and clinical practice audit and re-audit after feedback. \nParticipants and setting: GP volunteers from around Australia in 1998ΓÇô1999: 1008 completed the pre-training test, 190 the post-training test, 386 the first audit (33 235 patients), and 157 of these the re-audit (13 280 patients), with 57 undertaking both audit and training. \nInterventions: Four-seminar, 12-hour training program focused on improving GPs\' capacity to identify and manage patients with depression and anxiety; practice audit with patient- and practice-based feedback on diagnosis and treatment of common mental disorders. \nMain outcome measures: Scores on pre- and post-training knowledge tests; self├é┬á├éΓÇª\n','',2001,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'74','Medical Journal of Australia','175','','S42-S47','','YMH team','Models of care','Mental Health System'),(711,'Th e chronic fatigue syndrome: a comprehensive approach to its definition an d study. International Chronic Fatigue Syndrome Study Group','https://scholar.google.com/scholar?cluster=3175432235664470393&hl=en&oi=scholarr',NULL,'','',1994,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'74','Ann Intern Me d','121','','953-959','',NULL,NULL,NULL),(712,'Caregiver burden in mild cognitive impairment','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84911417781&doi=10.1080%2f13607863.2014.915922&partnerID=40&md5=204662a33556d9968b539843683efba5','10.1080/13607863.2014.915922','\n\nObjectives: We aimed to compare the rates of burden amongst caregivers of participants with mild cognitive impairment (MCI), compared to a control group. We also aimed to identify factors in both the caregiver and patient that are associated with significant levels of burden.\n\nMethod: This was a cross-sectional study. Sixty-four participants with MCI, 36 control-participants and their respective caregivers/informants were recruited to a university research clinic. The proportion of those who showed clinically significant levels of burden was determined by a Zarit Burden Interview score of >21. The associations of burden in MCI-caregivers were calculated in the following categories; participant characteristics (including depressive symptoms, cognition and informant ratings of cognitive and behavioural change); caregiver characteristics; and the caregiving context. Multivariate analyses were performed to examine the\n','',2015,NULL,NULL,'2015-01-02',NULL,NULL,NULL,NULL,'73','Aging and Mental Health','19','1','72-78','Routledge','Other','',''),(713,'Clinical and subclinical hypothyroidism in patients with chronic and treatment-resistant depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030012402&doi=10.3109%2f00048679609076101&partnerID=40&md5=249243a014bd66b0bd0c023f2cde0e6b','10.3109/00048679609076101','\nObjective: To investigate the relationship between hypothyroidism and treatment-resistant depression (TRD).\nMethod: A retrospective case audit of 93 inpatients of a specialist Mood Disorders Unit. Patients referred with TRD were sub-classified into ΓÇÿadequate├éΓÇÖ or ├éΓÇÿinadequate├éΓÇÖ prior treatment groups on the basis of pre-established criteria, and compared with a ├éΓÇÿnon-TRD├éΓÇÖ control sample. Grades I (clinical) and II (subclinical) hypothyroidism were determined by review of relevant thyroid indices.\nResults: Patients had chronic depressive disorders (sub-group means of 57.5-82.2 weeks of illness). Of those patients referred with TRD, 22% (10/46) had evidence of clinical or subclinical hypothyroidism compared with 2% (1/47) of the non-TRD patients (p < 0.01). A gradient in the rates of grade I hypothyroidism was observed with the adequately-treated TRD patients having the highest rate (13%), the inadequately-treated TRD├é┬á├éΓÇª\n','',1996,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'73','Australian and New Zealand Journal of Psychiatry','30','2','246-252','Sage Publications','Other','Illness specific areas',''),(714,'Personality differences between patients with remitted melancholic and nonmelancholic depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025038441&doi=10.1176%2fajp.147.11.1476&partnerID=40&md5=797f19f386b0fc8f86f6dd81ada59600','10.1176/ajp.147.11.1476','Categorized 75 adult patients with remitted depression as having melancholic-endogenous (ME) or nonmelancholic (NM) and nonendogenous (NE) depression according to Diagnostic and Statistical Manual of Mental Disorders (DSM-III) criteria, Research Diagnostic Criteria, and an endogeneity scale. Ss\' scores on 4 personality scales (the Eysenck Personality Inventory, the Interpersonal Dependency Inventory, a locus of control scale, and an interpersonal sensitivity measure) were compared. Ss with NM/NE depression were generally rated as having more vulnerable personality styles than were ME Ss, but differences were dependent on the diagnostic system used. Three underlying personality constructs were isolated: dependency, introversion, and timidity. Ss with NM/NE depression scored as significantly more dependent.(PsycINFO Database Record (c) 2016 APA, all rights reserved)','',1990,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'73','American Journal of Psychiatry','','','','American Psychiatric Assn','Other','',''),(715,'ENIGMA MDD: seven years of global neuroimaging studies of major depression through worldwide data sharing','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085688346&doi=10.1038%2fs41398-020-0842-6&partnerID=40&md5=110822ec4c106e566359f91b39a881cc','10.1038/s41398-020-0842-6','A key objective in the field of translational psychiatry over the past few decades has been to identify the brain correlates of major depressive disorder (MDD). Identifying measurable indicators of brain processes associated with MDD could facilitate the detection of individuals at risk, and the development of novel treatments, the monitoring of treatment effects, and predicting who might benefit most from treatments that target specific brain mechanisms. However, despite intensive neuroimaging research towards this effort, underpowered studies and a lack of reproducible findings have hindered progress. Here, we discuss the work of the ENIGMA Major Depressive Disorder (MDD) Consortium, which was established to address issues of poor replication, unreliable results, and overestimation of effect sizes in previous studies. The ENIGMA MDD Consortium currently includes data from 45 MDD study cohorts from 14├é┬á├éΓÇª','',2020,NULL,NULL,'2020-05-29',NULL,NULL,NULL,NULL,'72','Translational Psychiatry','10','1','Jan-19','Nature Publishing Group','Other','',''),(716,'Genome-wide association study of inattention and hyperactivity-impulsivity measured as quantitative traits','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84875983395&doi=10.1017%2fthg.2013.12&partnerID=40&md5=53a3101dda9e3ff11ef3df76a194f200','10.1017/thg.2013.12','Genome-wide association studies (GWAS) of attention-deficit/hyperactivity disorder (ADHD) offer the benefit of a hypothesis-free approach to measuring the quantitative effect of genetic variants on affection status. Generally the findings of GWAS relying on ADHD status have been non-significant, but the one study using quantitative measures of symptoms found SLC9A9 and SLC6A1 were associated with inattention and hyperactivity├éΓÇôimpulsivity. Accordingly, we performed a GWAS using quantitative measures of each ADHD subtype measured with the Strengths and Weaknesses of ADHD and Normal Behaviour (SWAN) scale in two community-based samples. This scale captures the full range of attention and kinetic behavior; from high levels of attention and appropriate activity to the inattention and hyperactivity├éΓÇôimpulsivity associated with ADHD within two community-based samples. Our discovery sample├é┬á├éΓÇª','',2013,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'72','Twin Research and Human Genetics','16','2','560-574','Cambridge University Press','Other','',''),(717,'Circadian profiles in young people during the early stages of affective disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84861694280&doi=10.1038%2ftp.2012.47&partnerID=40&md5=0672b15239891c6ab29c3f87af0700a8','10.1038/tp.2012.47','Although disturbances of the circadian system are strongly linked to affective disorders, no known studies have examined melatonin profiles in young people in early stages of illness. In this study, 44 patients with an affective disorder underwent clinical and neuropsychological assessments. They were then rated by a psychiatrist according to a clinical staging model and were categorized as having an ΓÇÿattenuated syndrome├éΓÇÖor an ├éΓÇÿestablished disorder├éΓÇÖ. During the evening, salivary melatonin was sampled under dim light conditions over an 8-h interval and for each patient, the time of melatonin onset, total area under the curve and phase angle (difference between time of melatonin onset and time of habitual sleep onset) were computed. Results showed that there was no difference in the timing of melatonin onset across illness stages. However, area under the curve analyses showed that those patients with├é┬á├éΓÇª','',2012,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'72','Translational Psychiatry','2','5','e123-e123','Nature Publishing Group','YMH team','Illness specific areas',''),(718,'Somatic distress as a distinct psychological dimension','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032819512&doi=10.1007%2fs001270050219&partnerID=40&md5=83760df8078670bbed4bea12a18c7ba2','10.1007/s001270050219','                                         Background: Somatoform disorders such as neurasthenia and chronic fatigue are characterized by a combination of prolonged fatigue and disabling neuropsychological and neuromuscular symptoms. However, the debate concerning the theoretical underpinnings of somatic disorders resembles the perennial dispute over the taxonomy of anxiety and depression. The objective of this study is to analyse the dimensional structure of items measuring anxiety, depression, phobic anxiety, somatic distress, and insomnia. It is anticipated that somatic distress should emerge as empirically distinct from measures of anxiety and depression, thereby lending support to proponents of the construct as independent of both anxiety and depression symptomatology. Methods: A 33-item self-report symptom inventory derived from the SCL-90 and DSSI/sAD scales was used to measure recently experienced\n','',1999,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'72','Social Psychiatry and Psychiatric Epidemiology','34','9','451-458','Steinkopff Verlag','YMH team','Illness specific areas',''),(719,'Clinical correlates of chronotypes in young persons with mental disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84948095399&doi=10.3109%2f07420528.2015.1078346&partnerID=40&md5=e5529c51667bdf9be8e1be17ac658519','10.3109/07420528.2015.1078346','While important changes in circadian rhythms take place during adolescence and young adulthood, it is unclear how circadian profiles during this period relate to emerging mental disorders. This study aimed to: (i) characterise morningness├éΓÇôeveningness preference in young people with primary anxiety, depression, bipolar or psychotic disorders as compared to healthy controls, and (ii) to investigate associations between morningness├éΓÇôeveningness preference and the severity of psychiatric symptoms. Four hundred and ninety-six males and females aged between 12 and 30 years were divided into five groups according to primary diagnosis. The Hamilton Depression Rating Scale and the Brief Psychiatric Rating Scale were administered by a research psychologist and participants completed the Kessler Psychological Distress Scale and the Horne├éΓÇô├âΓÇôstberg Morningness├éΓÇôEveningness Questionnaire (ME). ME├é┬á├éΓÇª','',2015,NULL,NULL,'2015-10-21',NULL,NULL,NULL,NULL,'71','Chronobiology International','32','9','1183-1191','Informa Healthcare','YMH team','Illness specific areas',''),(720,'The association between lower educational attainment and depression owing to shared genetic effects? Results in Γê╝25 000 subjects','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930226539&doi=10.1038%2fmp.2015.50&partnerID=40&md5=bed8d90b7cc3c0eb272ed007ab561f64','10.1038/mp.2015.50','An association between lower educational attainment (EA) and an increased risk for depression has been confirmed in various western countries. This study examines whether pleiotropic genetic effects contribute to this association. Therefore, data were analyzed from a total of 9662 major depressive disorder (MDD) cases and 14 949 controls (with no lifetime MDD diagnosis) from the Psychiatric Genomics Consortium with additional Dutch and Estonian data. The association of EA and MDD was assessed with logistic regression in 15 138 individuals indicating a significantly negative association in our sample with an odds ratio for MDD 0.78 (0.75├éΓÇô0.82) per standard deviation increase in EA. With data of 884 105 autosomal common single-nucleotide polymorphisms (SNPs), three methods were applied to test for pleiotropy between MDD and EA:(i) genetic profile risk scores (GPRS) derived from training data for EA├é┬á├éΓÇª','',2015,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'70','Molecular Psychiatry','20','6','735-743','Nature Publishing Group','Other','',''),(721,'Frequent alcohol, nicotine or cannabis use is common in young persons presenting for mental healthcare: A cross-sectional study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84875047878&doi=10.1136%2fbmjopen-2012-002229&partnerID=40&md5=fcf36cf35c330e55a155b2dbca712da3','10.1136/bmjopen-2012-002229','\nObjectives To determine the prevalence of recent alcohol, nicotine or cannabis use in young persons presenting for mental healthcare.\nDesign A cross-sectional study of young people seeking mental healthcare completed self-report questionnaires regarding their use of alcohol, nicotine or cannabis.\nSetting Data were collected from two sites as part of the national headspace services programme.\nParticipants 2122 young people aged 12ΓÇô30 years provided information as part of a patient register; a subset of N=522 participants also provided more detailed information about their patterns of alcohol use.\nOutcome measures Prevalence levels of recent alcohol, nicotine or cannabis use within relevant age bands (12├éΓÇô17, 18├éΓÇô19 and 20├éΓÇô30) or primary diagnostic categories.\nResults The rates for use at least weekly of alcohol for the three age bands were 12%, 39% and 45%, and for cannabis 7%, 14% and 18├é┬á├éΓÇª\n','',2013,NULL,NULL,'2013-01-01',NULL,NULL,NULL,NULL,'70','BMJ Open','3','2','e002229','British Medical Journal Publishing Group','YMH team','Outcome Research',''),(722,'Early intervention for cognitive decline: Is there a role for multiple medical or behavioural interventions?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-64949139099&doi=10.1111%2fj.1751-7893.2008.00102.x&partnerID=40&md5=4cf08aca7df2d5116a2ea4bfba8a1b6f','10.1111/j.1751-7893.2008.00102.x',' \nAim: Early medical or behavioural intervention to slow cognitive decline might be a viable strategy for reducing disability and rates of institutional care in older persons. This paper details the published work supporting cross-sectional and longitudinal associations between vascular risk factors, depressive symptoms and progressive cognitive decline. Evidence for the beneficial effects of providing relevant interventions is assessed. \nMethods: Relevant published work from the areas of dementia research, ΓÇÿvascular depression├éΓÇÖ and the cognitive benefits that might result from treating vascular risk factors, managing depression or promoting nutrition, cognitive or physical exercise was ascertained from electronic database searches and recent reviews of key areas. \nResults: The existing published work does not provide many examples of early intervention strategies that target vascular strategies or active treatment of├é┬á├éΓÇª\n','',2009,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'70','Early Intervention in Psychiatry','3','1','19-27','Blackwell Publishing Asia','Other','',''),(723,'Neurasthenia: Prevalence, disability and health care characteristics in the Australian community','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036298402&doi=10.1192%2fbjp.181.1.56&partnerID=40&md5=105c4228fcc7963965c61c731073211b','10.1192/bjp.181.1.56','Background Neurasthenia imposes a high burden on primary medical health care systems in all societies. Aims To determine the prevalence of ICD-10 neurasthenia and associated comorbidity, disability and health care utilisation. Method Utilisation of a national sample of Australian households previously surveyed using the Composite International Diagnostic Interview and other measures. Results Prolonged and excessive fatigue was reported by 1465 people (13.29% of the sample). Of these, one in nine people meet current ICD-10 criteria for neurasthenia. Comorbidity was associated with affective, anxiety and physical disorders. People with neurasthenia alone (< 0.5% of the population) were less disabled and used less services than those with comorbid disorders. Conclusions Fatigue is frequent in the Australian community and is common in people attending general practice. Neurasthenia is disabling and','',2002,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'70','British Journal of Psychiatry','181','1','56-61','Cambridge University Press','YMH team','Outcome Research',''),(724,'Sleep-wake cycle in young and older persons with a lifetime history of mood disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84897750913&doi=10.1371%2fjournal.pone.0087763&partnerID=40&md5=eaf8fb5be5f1fd3e57650a93a2710caa','10.1371/journal.pone.0087763','Considering the marked changes in sleep and circadian rhythms across the lifespan, age may contribute to the heterogeneity in sleep-wake profiles linked to mood disorders. This study aimed to investigate the contributions of age and depression severity to sleep-wake disturbances. The Hamilton Depression Rating Scale (HDRS) was administered to assess current symptoms severity in 238 persons with a history of a mood disorder between 12 and 90 years of age (y.o.). Actigraphy was recorded over five to 22 days. Regression analyses and analyses of variance [age (12├éΓÇô19 y.o., 20├éΓÇô39 y.o., 40├éΓÇô59 y.o., and =60 y.o.) by depression severity (HDRS< and =8)] were conducted. The 12├éΓÇô19 y.o. and 20├éΓÇô39 y.o. groups had a delayed sleep schedule and acrophase compared to all other groups. The =60 y.o. group had a lower rhythmicity and amplitude (p=.006) than the 12├éΓÇô19 y.o. group (p=.046). Participants with a HDRS=8 spent longer time in bed, had later sleep offset times and had lower circadian rhythmicity than those with a HDRS<8 (p=.036). Younger age and higher HDRS score correlated with later sleep onset and offset times, longer time in bed, higher WASO, lower sleep efficiency and later acrophase (p=.023). Age was a significant predictor of delayed sleep and activity schedules (p=.001). The profile of sleep-wake cycle disturbances associated with mood disorders changes with age, with prominent sleep phase delay during youth and reduced circadian strength in older persons. Conversely, disruptions in sleep consolidation seem more stable across age.','',2014,NULL,NULL,'2014-02-25',NULL,NULL,NULL,NULL,'69','PLoS ONE','9','2','e87763','Public Library of Science','YMH team','Illness specific areas',''),(725,'Psychotic depression: A review and clinical experience','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025912526&doi=10.1080%2f00048679109077732&partnerID=40&md5=4149c38ed792e470b4ca689e50df5777','10.1080/00048679109077732','We review research literature on psychotic (delusional) depression, including demographic, illness pattern, clinical, biological marker and treatment issues. Secondly, we report a study of a consecutive sample of 137 patients meeting criteria for DSM-III melancholia, RDC definite endogenous depression and our ΓÇ£clinical├éΓÇ¥ criteria for endogenous depression, of whom there were 35 ├éΓÇ£psychotic depressives├éΓÇ¥ (PDs).The PDs were contrasted with the remaining 76 depressives (EDs) and with an age and sex-matched subset (MEDs). The PDs were distinctly older than the EDs at assessment and at initial onset of any affective disorder. Compared to the MEDs, they tended to have longer illnesses, were more likely to be hospitalised (and to have longer stays), to receive (in the past and for the current episode) combination antipsychotic/antidepressant medication and/or ECT, and to have a poorer course over the following├é┬á├éΓÇª','',1991,NULL,NULL,'1991-01-01',NULL,NULL,NULL,NULL,'69','Australian and New Zealand Journal of Psychiatry','25','2','169-180','Taylor & Francis','YMH team','Illness specific areas',''),(726,'Circadian rhythms and psychiatric profiles in young adults with unipolar depressive disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054588099&doi=10.1038%2fs41398-018-0255-y&partnerID=40&md5=a8349ecd0cf9f468292ed73e4f19576e','10.1038/s41398-018-0255-y','Abnormalities in circadian rhythms have been reported in people with mood disorders, but these abnormalities are marked by considerable inter-individual variability. This study aimed to identify pathophysiological subgroups on the basis of circadian markers and evaluate how these subgroups relate to psychiatric profiles. Thirty-five young adults (18├éΓÇô31 years old) receiving clinical care for unipolar depressive disorders and 15 healthy controls took part to this study. The Hamilton Rating Scale for Depression and the Young Mania rating scale were used to evaluate the severity of mood symptoms in participants with depressive disorders. All participant underwent ambulatory sleep monitoring with actigraphy for about 12 days before attending a laboratory-based chronobiological assessment which included repeated salivary samples to determine dim light melatonin onset (DLMO) and continuous core body├é┬á├éΓÇª','',2018,NULL,NULL,'2018-10-09',NULL,NULL,NULL,NULL,'68','Translational Psychiatry','8','1','1-Aug','Nature Publishing Group','YMH team','Illness specific areas','Outcome Research'),(727,'Demographic and clinical characteristics of young people seeking help at youth mental health services: Baseline findings of the Transitions Study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84945199584&doi=10.1111%2feip.12133&partnerID=40&md5=c84900084b43bf038cac765efb6280a9','10.1111/eip.12133','  Aim The Transitions Study was designed to establish a cohort of young people (12├éΓÇô25 years) seeking help for mental health problems, in order to longitudinally explore and refine a clinical staging model of the development and progression of mental disorders. This paper presents the baseline demographic and clinical characteristics of the cohort, particularly the nature and severity of psychopathology.   Method All eligible young people attending one of four headspace clinical services were invited to participate, and completed a battery of self-report and interviewer-administered measures of psychopathology and functional impairment at baseline, which will be repeated at the annual follow up.   Results Of 1615 eligible clients, 802 young people (66% women; mean age = 18.3 years) consented to participate and completed baseline assessments (participation rate = 50%). The severity of mental health├é┬á├éΓÇª\n','',2015,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'68','Early Intervention in Psychiatry','9','6','487-497','','YMH team','Outcome Research',''),(728,'Amphetamine psychosis: A model for studying the onset and course of psychosis','https://www.scopus.com/inward/record.uri?eid=2-s2.0-61849088303&doi=10.5694%2fj.1326-5377.2009.tb02370.x&partnerID=40&md5=354431e90184aa5d495f4ff55a1c7e1f','10.5694/j.1326-5377.2009.tb02370.x','ΓÇó The aetiology of schizophrenia remains complex, although proposed models have identified genetic markers and environmental pathogens as important risk factors.','',2009,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'68','Medical Journal of Australia','190','S4','S22-S25','','YMH team','Digital health','Outcome Research'),(729,'The relationship between distress and the development of a primary immune response to a novel antigen','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0345256388&doi=10.1016%2fS0889-1591%2803%2900107-7&partnerID=40&md5=e7c2f1ca0a7a6eb170144bb4bb814666','10.1016/S0889-1591(03)00107-7','Forty-five medical students were recruited to examine the effects of distress on the development of an immune response to the novel antigen, keyhole limpet hemocyanin (KLH). The subjectsΓÇÖ level of distress was manipulated by immunizing them either at the time of an important viva voce examination (n=22) or during examination-free term time (n=23). This manipulation increased variance amongst the subjects, but the emphasis in this research was on individual distress as a predictor of immune function. In the group as a whole, the likelihood of developing DTH skin responses to KLH was reduced in the more distressed subjects (r=-.45; p=.002), independently of a number of behavioral (e.g., sleep disturbance) and demographic (e.g., sex) variables. Proliferation of T cells against KLH in vitro and the development of anti-KLH IgG antibodies were not related to levels of distress. Thus, cellular, rather than humoral├é┬á├éΓÇª','',2004,NULL,NULL,'2004-01-01',NULL,NULL,NULL,NULL,'68','Brain, Behavior, and Immunity','18','1','65-75','Academic Press','Other','',''),(730,'Young men, mental health, and technology: Implications for service design and delivery in the digital age','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872447466&doi=10.2196%2fjmir.2291&partnerID=40&md5=e4d06c362ef4214a8ae7906557d0307c','10.2196/jmir.2291','                     Background                     Young men are particularly vulnerable to suicide, drug, and alcohol problems and yet fail to seek appropriate help. An alternative or adjunct to face-to-face services has emerged with widespread uptake of the Internet and related communication technologies, yet very little evidence exists that examines the capacity of the Internet to engage young men and promote help seeking.                                                       Objective                     To explore young peopleΓÇÖs attitudes and behaviors in relation to mental health and technology use. The aim was to identify key gender differences to inform the development of online mental health interventions for young men.                                                       Methods                     A cross-sectional online survey of 1038 young people (aged 16 to 24 years) was used.                                                       Results                     Young men are more likely than young women to play computer games, access online video/music content, and visit online forums. More than half of young men and women reported that they sought help for a problem online, and the majority were satisfied with the help they received. Significant gender differences were identified in relation to how young people would respond to a friend in need, with young men being less likely than young women to confront the issue directly.                                                       Conclusions                     Online interventions for young men need to be action-oriented, informed by young men├éΓÇÖs views and everyday technology practices, and leverage the important role that peers play in the help-seeking process.                 ','',2012,NULL,NULL,'2012-11-22',NULL,NULL,NULL,NULL,'67','Journal of Medical Internet Research','14','6','e2291','JMIR Publications Inc., Toronto, Canada','YMH team','Digital health','Mental Health System'),(731,'Disability is already pronounced in young people with early stages of affective disorders: Data from an early intervention service','https://www.scopus.com/inward/record.uri?eid=2-s2.0-79955916983&doi=10.1016%2fj.jad.2010.10.052&partnerID=40&md5=8f10297129f66a55d9cba5e9b0e7090b','10.1016/j.jad.2010.10.052','\n\nBackground\nAlthough there is growing recognition that disability emerges early in the course of psychotic disorders, it is unclear whether young people with early stages of anxiety or affective disorders are similarly affected. This study examined patient self-reported disability in young people attending a designated early intervention service.\n\n\nMethods\nCross-sectional study comparing new headspace patients on self-reported measures of disability and distress (Kessler-10, Work and Social Adjustment Scale, and Brief Disability Questionnaire) with clinician-rated diagnosis and clinical stage.\n\n\nResults\nData from 330 participants with an average age of 16.8┬áyears (50.0% male) was analysed and demonstrated high levels of psychological distress and disability in the overall group. Higher levels of self-reported psychological distress and disability were associated with affective disorder diagnosis and increased with├é┬á├éΓÇª\n\n','',2011,NULL,NULL,'2011-06-01',NULL,NULL,NULL,NULL,'67','Journal of Affective Disorders','131','1-Mar','84-91','Elsevier','YMH team','Models of care',''),(732,'Correlating anterior insula gray matter volume changes in young people with clinical and neurocognitive outcomes: an MRI study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84861130524&doi=10.1186%2f1471-244X-12-45&partnerID=40&md5=5b28a83a3f8d95c85d6085e09ea9c158','10.1186/1471-244X-12-45','The anterior insula cortex is considered to be both the structural and functional link between experience, affect, and behaviour. Magnetic resonance imaging (MRI) studies have shown changes in anterior insula gray matter volume (GMV) in psychosis, bipolar, depression and anxiety disorders in older patients, but few studies have investigated insula GMV changes in young people. This study examined the relationship between anterior insula GMV, clinical symptom severity and neuropsychological performance in a heterogeneous cohort of young people presenting for mental health care. Participants with a primary diagnosis of depression (n = 43), bipolar disorder (n = 38), psychosis (n = 32), anxiety disorder (n = 12) or healthy controls (n = 39) underwent structural MRI scanning, and volumetric segmentation of the bilateral anterior insula cortex was performed using the FreeSurfer application. Statistical analysis examined the linear and quadratic correlations between anterior insula GMV and participantsΓÇÖ performance in a battery of clinical and neuropsychological assessments. Compared to healthy participants, patients had significantly reduced GMV in the left anterior insula (t = 2.05, p = .042) which correlated with reduced performance on a neuropsychological task of attentional set-shifting ( = .32, p = .016). Changes in right anterior insula GMV was correlated with increased symptom severity (r = .29, p = .006) and more positive symptoms (r = .32, p = .002). By using the novel approach of examining a heterogeneous cohort of young depression, anxiety, bipolar and psychosis patients together, this study has├é┬á├éΓÇª','',2012,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'66','BMC Psychiatry','12','1','1-Oct','BioMed Central','YMH team','Outcome Research','Neurobiology'),(733,'Differentiating nonrestorative sleep from nocturnal insomnia symptoms: Demographic, clinical, inflammatory, and functional correlates','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84877103180&doi=10.5665%2fsleep.2624&partnerID=40&md5=6dadfb14db838d9f0636f79c9faee15e','10.5665/sleep.2624','                    Study Objectives:           Recent studies have suggested that nonrestorative sleep (NRS) symptoms may be distinct from nocturnal insomnia symptoms (NIS). However, there is limited information on the demographic, medical, and biologic correlates of NRS independent from NIS in the general population. This report presents the sociodemographic correlates, patterns of comorbidity with other sleep and physical disorders, C-reactive protein (CRP) levels, and general productivity associated with NIS and NRS in a nationally representative sample of US adults.                             Design:           National Health and Nutrition Examination Survey (NHANES).                             Setting:           The 2005-2008 surveys of the general population in the United States.                             Participants:           There were 10,908 individuals (20 years or older)                             Interventions:           N/A\n','',2013,NULL,NULL,'2013-05-01',NULL,NULL,NULL,NULL,'65','Sleep','36','5','671-679','Oxford University Press','YMH team','Illness specific areas',''),(734,'Impaired verbal memory in young adults with unipolar and bipolar depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955730456&doi=10.1111%2fj.1751-7893.2010.00194.x&partnerID=40&md5=628a9112efe962331773496dc3c4e4f3','10.1111/j.1751-7893.2010.00194.x',' \nAim: Early stages of severe mood disorders may be accompanied by neurocognitive changes. Specifically, deficits in verbal memory have been linked to depression in young people. This study examined whether young adults with unipolar compared with bipolar depression showed similar neurocognitive deficits. \nMethods: A total of 57 young adults (16ΓÇô32 years) were assessed in this study. Twenty with unipolar and 20 with bipolar depression, all currently depressed, were compared with 17 healthy controls. Neuropsychological assessment included psychomotor speed, attention for routine mental operations, attentional switching, executive control and verbal learning and memory. \nResults: Both unipolar and bipolar subjects showed significant impairments in verbal memory and attentional switching compared with controls. Both mood disorder groups showed no impairments in psychomotor speed, attention for├é┬á├éΓÇª\n','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'65','Early Intervention in Psychiatry','4','3','227-233','Blackwell Publishing Asia','YMH team','Illness specific areas',''),(735,'Practitioner-supported delivery of internet-based cognitive behaviour therapy: Evaluation of the feasibility of conducting a cluster randomised trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955906942&doi=10.5694%2fj.1326-5377.2010.tb03690.x&partnerID=40&md5=95e358097248d2778f06985b53b107f5','10.5694/j.1326-5377.2010.tb03690.x',' \nObjective: To determine the feasibility of conducting a cluster randomised trial in Australia of the effectiveness of general practitioner-supported delivery of internet-based cognitive behaviour therapy (CBT) and enhanced psychological care. \nDesign, setting and participants: Cluster randomised trial involving patients attending general practices in Australia. Participating practices were randomly allocated to interventions. The study was conducted between January 2004 and January 2007. \nInterventions: Enhanced GP care was delivered by doctors who had completed specific mental health training; the experimental condition consisted of enhanced GP care plus MoodGYM, an internet-based CBT intervention. \nMain outcome measures: Demographic and behavioural characteristics of patients, and demographic and practice characteristics of GPs; time to resolution of psychological symptoms for patients involved in\n','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'65','Medical Journal of Australia','192','','S31-S35','','YMH team','Digital health','Models of care'),(736,'Immunity and the pathophysiology of chronic fatigue syndrome.','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027352877&partnerID=40&md5=696220488eaa25e10446b57d8882ae84','',' The pathophysiology of chronic fatigue syndrome (CFS) remains unknown. The syndrome often follows a recognized or presumed infection and the disorder may therefore result from a disordered immune response to a precipitating infection or antigenic challenge. Abnormalities of both humoral and cellular immunity have been demonstrated in a substantial proportion of patients with CFS. The most consistent findings are of impaired lymphocyte responses to mitogen and reduced natural killer cell cytotoxicity. Cutaneous anergy and immunoglobulin G subclass deficiencies have also been found. Further studies are needed examining cytokine levels in serum and cerebrospinal fluid, and cytokine production in vitro in patients with CFS. Interpretation of the findings of published studies of immunity is limited by probable heterogeneity in the patient groups studied, and by the lack of standardization and reproducibility\n','',1993,NULL,NULL,'2007-09-28',NULL,NULL,NULL,NULL,'65','Ciba Foundation symposium','','','176-192','John Wiley & Sons, Ltd.','Other','',''),(737,'Perceived interpersonal risk factors of non-endogenous depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025845883&doi=10.1017%2fS0033291700020511&partnerID=40&md5=e3ea40e700a070dc3e244b2d6d5337ae','10.1017/S0033291700020511','In a case-control study, two potential interpersonal risk factors of non-endogenous depression, namely a patient\'s perception of their current intimate partner as dysfunctional and a patient\'s recall of exposure to previous deprivational parenting, were quantified. The interpersonal characteristics of the partner were assessed principally by a brief self-report questionnaire, the Intimate Bond Measure (IBM). By cross-sectional and longitudinal comparison of this instrument with other interview-derived and self-report measures, the convergent, discriminant and predictive validity of the IBM in depressed patients was established. Further, little evidence of any distorting effect of depressed mood or neuroticism was detected. The perception of the current intimate partner as dysfunctional imparted a risk to non-endogenous depression of at least five times, while reported exposure to parental ΓÇÿaffectionless control├éΓÇÖ was quantified├é┬á├éΓÇª','',1991,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'65','Psychological Medicine','21','2','399-412','Cambridge University Press','YMH team','Illness specific areas',''),(738,'Propofol as an anaesthetic agent for ect: Effect on outcome and length of course','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907036204&doi=10.3109%2f00048679109077742&partnerID=40&md5=d7cfcc4e3f93ce2e8d5ddc988ef923b1','10.3109/00048679109077742','Recent reports of reduced seizure duration with ECT under propofol anaesthesia have led to concerns that propofol may diminish the efficacy of this treatment. To investigate the effect of propofol on the response to ECT, we reviewed records of 66 patients with primary depression treated with ECT, 37 of whom had been assessed prospectively with pre- and post-ECT Hamilton and Zung depression severity ratings. Despite demonstrating that the individual seizure duration was significantly reduced with propofol compared to thiopentone we found no evidence of reduced ECT efficacy with propofol. Courses under propofol anaesthesia were on an average two treatments longer than with thiopentone. Although this difference was not statistically significant this may have been due to a type II error. These results suggest that it is premature to abandon the use of this new anaesthetic agent in ECT without controlled','',1991,NULL,NULL,'1991-01-01',NULL,NULL,NULL,NULL,'65','Australasian Psychiatry','25','2','255-261','Taylor & Francis','Other','',''),(739,'Cytokine levels and associations with symptom severity in male and female children with autism spectrum disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85036653948&doi=10.1186%2fs13229-017-0176-2&partnerID=40&md5=ae394a8bbec9641124cd2d476eccdb04','10.1186/s13229-017-0176-2','','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Molecular Autism','','','','BioMed Central','Other','',''),(740,'The relationship between fatigue, psychological and immunological variables in acute infectious illness','https://www.scopus.com/inward/record.uri?eid=2-s2.0-7144222748&doi=10.3109%2f00048679809062727&partnerID=40&md5=d7339a46ae702cc0cbed4b2aac1e7211','10.3109/00048679809062727','\nObjective The aim of this paper is to explore the longitudinal relationships between physical and psychological symptoms and immunological factors following acute infective illnesses.  Method Preliminary data from a prospective investigation of patients with serologically proven acute infectious illnesses due to Epstein-Barr virus (EBV), Ross River virus (RRV) or Q fever are reported. Patients were assessed within 4 weeks of onset of symptoms and then reviewed 2 and 4 weeks later. Physical illness data were collected at interview. Psychological and somatic symptom profiles were assessed by standardised self-report questionnaires. Cell-mediated immune (CMI) function was assessed by measurement of delayed-type hypersensitivity (DTH) skin responses.  Results Thirty patients who had been assessed and followed over the 4ΓÇôweek period (including 17 patients with EBV, five with RRV and eight with Q fever├é┬á├éΓÇª\n','',1998,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'64','Australian and New Zealand Journal of Psychiatry','32','2','180-186','Sage Publications','Other','',''),(741,'Napping in older people \'at risk\' of dementia: Relationships with depression, cognition, medical burden and sleep quality','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84942199418&doi=10.1111%2fjsr.12313&partnerID=40&md5=092700159eafba12775fd0a8b33d811c','10.1111/jsr.12313',' Sleep disturbance is prevalent in older adults, particularly so in those at a greater risk of dementia. However, so far the clinical, medical and neuropsychological correlates of daytime sleep have not been examined. The aims of this study were to investigate the characteristics and effects of napping using actigraphy in older people, particularly in those ├éΓÇÿat risk├éΓÇÖ of dementia. The study used actigraphy and sleep diaries to measure napping habits in 133 older adults ├éΓÇÿat risk├éΓÇÖ of dementia (mean age├é┬á=├é┬á65.5├é┬áyears, SD├é┬á=├é┬á8.4├é┬áyears), who also underwent comprehensive medical, psychiatric and neuropsychological assessment. When defined by actigraphy, napping was present in 83.5% (111/133) of participants; however, duration and timing varied significantly among subjects. Nappers had significantly greater medical burden and body mass index, and higher rates of mild cognitive impairment. Longer and more frequent├é┬á├éΓÇª\n','',2015,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'63','Journal of Sleep Research','24','5','494-502','','Other','',''),(742,'Hippocampal volume in older adults at risk of cognitive decline: the role of sleep, vascular risk, and depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84946559093&doi=10.3233%2fJAD-142016&partnerID=40&md5=948e9be08dc12361e1291c269658a044','10.3233/JAD-142016','\nMethods:\nTwo hundred and eighteen participants (mean age= 67.3 years, MMSE= 28.6) with mood and/or memory complaints underwent clinical and neuropsychological assessment, and magnetic resonance imaging. Measures of depression, global cognitive functioning, exercise, vascular health, cognitive reserve, sleep, and memory were collected. Hippocampal volumes were derived using image segmentation as implemented by FMRIB Software Library.\nResults:\nSmaller hippocampal volumes were strongly associated with poorer verbal learning and memory as well as diagnoses of either multiple or amnestic mild cognitive impairment. Based on univariate correlations, multivariable regressions were performed (controlling for age and total intracranial volume) to determine which modifiable risk factors were associated with hippocampal volume. For the left hippocampus, poor sleep efficiency and greater than five\n','',2015,NULL,NULL,'2015-01-01',NULL,NULL,NULL,NULL,'63','Journal of Alzheimer\'s disease : JAD','44','4','1279-1290','IOS Press','Other','',''),(743,'Functional impairment in adolescents and young adults with emerging mood disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84909993417&doi=10.1192%2fbjp.bp.113.134262&partnerID=40&md5=3f70d63aec77dfccd08825ba6639e70f','10.1192/bjp.bp.113.134262','Background Between 30 and 60% of adults with unipolar or bipolar disorders exhibit impairments across multiple domains. However, little is known about impaired functioning in youth with mood disorders. Aims To examine the prevalence of objective, subjective and observer-rated disability in a large, representative sample of young people with a primary mood disorder. Method Individuals aged 16ΓÇô25 years presenting to youth mental health services for the first time with a primary mood disorder participated in a systematic diagnostic and clinical assessment. Impairment was assessed using objective (unemployment or disability payments), observer- (Social and Occupational Functioning Assessment Scale; SOFAS) and self-rated measures (role functioning according to the Brief Disability Questionnaire). Results Of 1241 participants (83% unipolar; 56% female), at least 30% were functionally impaired on the├é┬á├éΓÇª','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'63','British Journal of Psychiatry','205','5','362-368','Cambridge University Press','YMH team','Illness specific areas','Outcome Research'),(744,'The characteristics of fatigue in an older primary care sample','https://www.scopus.com/inward/record.uri?eid=2-s2.0-33846542439&doi=10.1016%2fj.jpsychores.2006.09.011&partnerID=40&md5=6c055be8d601cd88550924f309ab7415','10.1016/j.jpsychores.2006.09.011','\n\nBackground\nPrimary care studies of younger adults have reported fatigue to be common and etiologically heterogeneous with both physical and psychological associations. This has led to considerable debate about whether fatigue may present independently of psychological disorder. Somatic symptoms in older people have been assumed to be almost entirely physical in origin.\n\n\nAims\nTo determine the characteristics of fatigue and its relationship with psychological disorder in older primary care attenders.\n\n\nMethod\nAmbulatory primary care patients aged 60 years and over completed self-report questionnaires and psychiatric interview at baseline and at 12 months.\n\n\nResults\nThe overall prevalence of fatigue was 27.4% with most, but not all, cases being comorbid with psychological disorder. Psychological disorder (OR, 8.43; 95% CI, 2.98ΓÇô23.88) was a greater predictor of fatigue than physical illness (OR, 4.74; 95% CI, 1├é┬á├éΓÇª\n\n','',2007,NULL,NULL,'2007-02-01',NULL,NULL,NULL,NULL,'63','Journal of Psychosomatic Research','62','2','153-158','Elsevier','Other','',''),(745,'Screening for depression in general practice and related medical settings','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037038193&doi=10.5694%2fj.1326-5377.2002.tb04869.x&partnerID=40&md5=cd5ba4723e05d8296196c97e1511d76c','10.5694/j.1326-5377.2002.tb04869.x',' \nObjective: To determine if screening in general practice and related medical settings improves management and clinical outcomes in people with depression. \nData sources: The Medline (1966ΓÇô2002), EMBASE (1980├éΓÇô2002) and PsycINFO (1966├éΓÇô2002) databases were searched. These were supplemented by searching the Cochrane databases (to 2002); performing additional specific searches on Medline, EMBASE and PsycINFO; scrutinising reference lists of selected articles; and querying experts. \nStudy selection: Inclusion criteria were: review of prospective studies with a primary focus of depression screening in general practice settings; review of studies of healthy populations or people with known depression; publication in a peer-reviewed journal; and written in English. Eleven reviews that satisfied these criteria were assessed for quality using the Oxman and Guyatt Index. Four reviews met the criterion of a├é┬á├éΓÇª\n','',2002,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'63','Medical Journal of Australia','177','','S111-S116','','YMH team','Illness specific areas','Models of care'),(746,'Carbamazepine for treatment-resistant melancholia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025838234&partnerID=40&md5=34f2681e0dab1009d853344347e23e82','','Identified 16 patients receiving carbamazepine (CBZ) for treatment-resistant depression: 9 Ss were treated with CBZ alone, while for 7, CBZ was added to preexisting treatments such as lithium, antidepressants, or antipsychotics. 7 Ss did not respond to CBZ at all; 2 Ss demonstrated a minimal response; 4 Ss demonstrated a moderate response; and 3 Ss demonstrated a marked response. Of 9 Ss who improved, 5 Ss had no concurrent medications, 2 Ss were already taking antipsychotics, 1 S was taking a tricyclic antidepressant, and 1 S was taking lithium and a monoamine oxidase (MAO) inhibitor. The rate of complications for CBZ was high: CBZ had to be discontinued in 7 Ss, 5 of whom had demonstrated a moderate or marked therapeutic response to this treatment; 2 Ss had developed a rash; 2 Ss hyponatremia; and 3 Ss gastrointestinal problems.(PsycINFO Database Record (c) 2016 APA, all rights reserved)','',1991,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'63','Journal of Clinical Psychiatry','','','','Physicians Postgraduate Press','Other','',''),(747,'Chronic fatigue syndrome: An immunological perspective','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031873147&doi=10.3109%2f00048679809068326&partnerID=40&md5=62e9146836208f9bbb744f359a27edc6','10.3109/00048679809068326','\n\nObjective: The aim of this study is to review research examining an immunological basis for chronic fatigue syndrome (CFS) and to discuss how a disturbance in immunity could produce central nervous system (CNS)-mediated symptoms. Method: Data relevant to the hypothesis that abnormal cytokine release plays a role in the pathogenesis of CFS are reviewed as well as recent evidence relating to potential mechanisms by which immune products may enter the brain and produce a disturbance in CNS processes.\n\nResults: Examinations of cytokine levels in patients with CFS have produced inconclusive results. Recent evidence suggests that abnormal release of cytokines within the CNS may cause neural dysfunction by a variety of complex mechanisms.\n\nConclusion: Neuropsychiatric symptoms in patients with CFS may be more closely related to disordered cytokine production by glial cells within the CNS than to├é┬á├éΓÇª\n','',1998,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'62','Australian and New Zealand Journal of Psychiatry','32','4','523-527','Sage Publications','Other','',''),(748,'Sub-typing depression, II. Clinical distinction of psychotic depression and non-psychotic melancholia','https://www.cambridge.org/core/journals/psychological-medicine/article/subtyping-depression-ii-clinical-distinction-of-psychotic-depression-and-nonpsychotic-melancholia/469365C4613BB428525528925C8D36D2',NULL,'We have attempted to clarify clinical differentiating features of psychotic depression. Forty-six depressed subjects meeting DSM-III-R criteria for major depression with psychotic features were compared with (i) DSM-defined melancholic, (ii) Newcastle-defined endogenous, and (iii) a residual DSM-defined major depressive episode group. Additionally, a ΓÇÿbottom up├éΓÇÖ latent class analysis (LCA) suggested a larger sample of 82 ├éΓÇÿpsychotic depressive├éΓÇÖ subjects, and multivariate analyses contrasted these subjects with both LCA-identified melancholic and all residual depressed subjects. Analyses suggested that, in addition to two features with absolute specificity (delusions and hallucinations), both the DSM-defined and LCA-defined ├éΓÇÿpsychotic depressive├éΓÇÖ subjects were significantly more likely to demonstrate marked psychomotor disturbance, to report two morbid cognitions (feeling sinful and guilty; feeling deserving of├é┬á├éΓÇª','',1995,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'62','Psychological Medicine','25','4','825-832','Cambridge University Press',NULL,NULL,NULL),(749,'Microstructural White Matter Changes in the Corpus Callosum of Young People with Bipolar Disorder: A Diffusion Tensor Imaging Study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84875102092&doi=10.1371%2fjournal.pone.0059108&partnerID=40&md5=04fba6fa8bf575a9c60ed641a7f1b1f6','10.1371/journal.pone.0059108','To date, most studies of white matter changes in Bipolar Disorder (BD) have been conducted in older subjects and with well-established disorders. Studies of young people who are closer to their illness onset may help to identify core neurobiological characteristics and separate these from consequences of repeated illness episodes or prolonged treatment. Diffusion tensor imaging (DTI) was used to examine white matter microstructural changes in 58 young patients with BD (mean age 23 years; range 16ΓÇô30 years) and 40 controls. Whole brain voxelwise measures of fractional anisotropy (FA), parallel diffusivity (//) and radial diffusivity () were calculated for all subjects. White matter microstructure differences (decreased FA corrected p<.05) were found between the patients with BD and controls in the genu, body and splenium of the corpus callosum as well as the superior and anterior corona radiata. In addition, significantly increased radial diffusivity (p<.01) was found in the BD group. Neuroimaging studies of young patients with BD may help to clarify neurodevelopmental aspects of the illness and for identifying biomarkers of disease onset and progression. Our findings provide evidence of microstructural white matter changes early in the course of illness within the corpus callosum and the nature of these changes suggest they are associated with abnormalities in the myelination of axons.','',2013,NULL,NULL,'2013-03-19',NULL,NULL,NULL,NULL,'61','PLoS ONE','8','3','e59108','Public Library of Science','YMH team','Neurobiology','illness specific areas'),(750,'Distinguishing young people with emerging bipolar disorders from those with unipolar depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84870561375&doi=10.1016%2fj.jad.2012.06.031&partnerID=40&md5=16f7fd39aaafb705111403217022e713','10.1016/j.jad.2012.06.031','\n\nBackground\nTo facilitate early intervention, there is a need to distinguish unipolar versus bipolar illness trajectories in adolescents and young adults with adult-type mood disorders.\n\n\nMethods\nDetailed clinical and neuropsychological evaluation of 308 young persons (aged 12 to 30 years) with moderately severe unipolar and bipolar affective disorders.\n\n\nResults\nAlmost 30% (90/308) of young people (mean age=19.4┬▒4.4├é┬áyr) presenting for care with affective disorders met criteria for a bipolar-type syndrome (26% with bipolar I). Subjects with bipolar- and unipolar-type syndromes were of similar age (19.8 vs. 19.2├é┬áyr) and reported comparable ages of onset (14.5 vs. 14.3├é┬áyr). Clinically, those subjects with unipolar and bipolar-type disorders reported similar levels of psychological distress, depressive symptoms, current role impairment, neuropsychological dysfunction and alcohol or other substance misuse. Subjects with├é┬á├éΓÇª\n\n','',2013,NULL,NULL,'2013-01-25',NULL,NULL,NULL,NULL,'61','Journal of Affective Disorders','144','3','208-215','Elsevier','YMH team','Illness specific areas',''),(751,'Fronto-striatal correlates of impaired implicit sequence learning in major depression: An fMRI study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955554651&doi=10.1016%2fj.jad.2010.02.114&partnerID=40&md5=5b2e3ca4ec04d712d9ca3d90d181d454','10.1016/j.jad.2010.02.114','\n\nBackground\nNeural network models of major depression (MD) suggest that the striatum is involved in the pathophysiology and is linked to key cognitive and clinical features. However, functional imaging studies have largely assessed the prefrontal cortex and have utilised emotional paradigms. This study sought to probe the integrity of fronto-striatal circuits using functional magnetic resonance imaging (fMRI) in conjunction with a theoretically-driven motor sequencing implicit learning (IL) task.\n\n\nMethods\nNineteen patients with MD (mean age┬á=├é┬á56.1├é┬áyears, sd├é┬á=├é┬á9.8) and 20 control participants (mean age├é┬á=├é┬á50.6├é┬áyears, sd├é┬á=├é┬á11.9) participated. A blocked fMRI paradigm was used in association with a motor sequencing task which included an IL and random sequence (baseline) condition. Although the study was hypothesis driven, within and between groups whole-brain analysis was used to examine fMRI patterns in the IL├é┬á├éΓÇª\n\n','',2010,NULL,NULL,'2010-09-01',NULL,NULL,NULL,NULL,'61','Journal of Affective Disorders','125','1-Mar','256-261','Elsevier','YMH team','Neurobiology','illness specific areas'),(752,'Does sleep disturbance mediate neuropsychological functioning in older people with depression?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-67349182865&doi=10.1016%2fj.jad.2008.11.017&partnerID=40&md5=cff2f2e0dfddc55c3e6f3a4953d555e6','10.1016/j.jad.2008.11.017','\n\nBackground\nDepression in older adults is associated with neuropsychological dysfunction, fronto-subcortical brain changes and sleep disturbance. Research suggests that adequate sleep is critical for many aspects of cognition including processing speed, verbal skills and memory. However, the association between sleep disturbance and neuropsychological functioning in depression has not been well evaluated. The current study therefore aimed to investigate these relationships.\n\n\nMethods\nForty-eight people (mean age┬á=├é┬á59.6, sd├é┬á=├é┬á8.2) meeting DSM-IV criteria for unipolar major depression were included for analysis. Neuropsychological assessment included assessment of processing speed, learning and memory, verbal fluency and executive functions. Early and late insomnia were defined by scores on the Hamilton Depression Rating Scale.\n\n\nResults\nWhile early insomnia was related to depression severity and├é┬á├éΓÇª\n\n','',2009,NULL,NULL,'2009-07-01',NULL,NULL,NULL,NULL,'61','Journal of Affective Disorders','116','1-Feb','139-143','Elsevier','YMH team','Outcome Research',''),(753,'Perspectives of young people on depression: awareness, experiences, attitudes and treatment preferences.','https://www.scopus.com/inward/record.uri?eid=2-s2.0-70349646588&doi=10.1111%2fj.1751-7893.2007.00042.x&partnerID=40&md5=cdf65370f84dd79ac1ed13c238fb9801','10.1111/j.1751-7893.2007.00042.x',' \nAim: Ascertaining current knowledge and attitudes towards depression among young people is vital for developing campaigns promoting community awareness and early intervention. \nMethods: Cross-sectional computer-assisted telephone interviews of persons aged 18ΓÇô90 years were conducted by beyondblue in Australia in 2002 and 2004/05. Items assessed consideration of depression as a major general health or mental health problem, knowledge about prevalence of depression, usual age of onset for depression or anxiety and treatment preferences. \nResults: The surveys included 2003 and 3200 persons, respectively, with 285 and 400 aged between 18 and 25 years. Depression was not recognized by young persons as a major general health problem (1├éΓÇô2% of responses), but was the most frequently named mental health problem (37├éΓÇô42%). Younger persons were more likely than older persons to see├é┬á├éΓÇª\n','',2007,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'61','Early intervention in psychiatry','1','4','333-339','Blackwell Publishing Asia','YMH team','Illness specific areas',''),(754,'Developing a mental health eclinic to improve access to and quality of mental health care for young people: Using participatory design as research methodologies','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064853055&doi=10.2196%2fJMIR.9716&partnerID=40&md5=0f69cb4b4ab2576844d59bb91cf236b7','10.2196/JMIR.9716','         Background         Each year, many young Australians aged between 16 and 25 years experience a mental health disorder, yet only a small proportion access services and even fewer receive timely and evidence-based treatments. Today, with ever-increasing access to the Internet and use of technology, the potential to provide all young people with access (24 hours a day, 7 days a week) to the support they require to improve their mental health and well-being is promising.                       Objective         The aim of this study was to use participatory design (PD) as research methodologies with end users (young people aged between 16 and 25 years and youth health professionals) and our research team to develop the Mental Health eClinic (a Web-based mental health clinic) to improve timely access to, and better quality, mental health care for young people across Australia.                       Methods         A research and development (R&D) cycle for the codesign and build of the Mental Health eClinic included several iterative PD phases: PD workshops; translation of knowledge and ideas generated during workshops to produce mockups of webpages either as hand-drawn sketches or as wireframes (simple layout of a webpage before visual design and content is added); rapid prototyping; and one-on-one consultations with end users to assess the usability of the alpha build of the Mental Health eClinic.                       Results         Four PD workshops were held with 28 end users (young people n=18, youth health professionals n=10) and our research team (n=8). Each PD workshop was followed by a knowledge translation session. At the conclusion of├é┬á├éΓÇª\n','',2018,NULL,NULL,'2018-05-28',NULL,NULL,NULL,NULL,'60','Journal of Medical Internet Research','20','5','e9716','JMIR Publications Inc., Toronto, Canada','YMH team','Digital health','Models of care'),(755,'Examining internet and ehealth practices and preferences: Survey study of australian older adults with subjective memory complaints, mild cognitive impairment, or dementia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042432862&doi=10.2196%2fJMIR.7981&partnerID=40&md5=d03c3e13e5fdf65ed624821f12783d7c','10.2196/JMIR.7981','','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Journal of Medical Internet Research','','','','Centre for Global Health Innovation','YMH team','Digital health',''),(756,'Heart rate variability during social interactions in children with and without psychopathology: A meta-analysis','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84905841376&doi=10.1111%2fjcpp.12226&partnerID=40&md5=ab4e987b1d86fac1d74266173701d5c4','10.1111/jcpp.12226',' Background The inability to regulate autonomic activity during social interactions is believed to contribute to social and emotional dysregulation in children. Research has employed heart rate variability (HRV) during both socially engaging and socially disengaging dyadic tasks between children and adults to assess this.   Methods We conducted a meta-analysis including evidence from 18 studies comprising 1,544 children who were categorized as either healthy or at risk/diagnosed with psychopathology. Within these groups, we assessed the impact of social engagement and disengagement tasks on HRV.   Results Results showed that social engagement tasks left HRV unaltered to a baseline. Social disengagement, however, was associated with decreases in HRV. In a task that included disengagement and then engagement, HRV was reduced during disengagement but was then restored during the reunion\n','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'59','Journal of Child Psychology and Psychiatry and Allied Disciplines','55','9','981-989','','Other','',''),(757,'Microstructural white matter changes are correlated with the stage of psychiatric illness','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878664196&doi=10.1038%2ftp.2013.25&partnerID=40&md5=37749a7bb5282e90cf97a0ccf357b42d','10.1038/tp.2013.25','Microstructural white matter changes have been reported in the brains of patients across a range of psychiatric disorders. Evidence now demonstrates significant overlap in these regions in patients with affective and psychotic disorders, thus raising the possibility that these conditions share common neurobiological processes. If affective and psychotic disorders share these disruptions, it is unclear whether they occur early in the course or develop gradually with persistence or recurrence of illness. Utilisation of a clinical staging model, as an adjunct to traditional diagnostic practice, is a viable mechanism for measuring illness progression. It is particularly relevant in young people presenting early in their illness course. It also provides a suitable framework for determining the timing of emergent brain alterations, including disruptions of white matter tracts. Using diffusion tensor imaging, we investigated the integrity of├é┬á├éΓÇª','',2013,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'59','Translational Psychiatry','3','4','e248-e248','Nature Publishing Group','YMH team','Neurobiology','illness specific areas'),(758,'Arginine Vasopressin selectively enhances recognition of sexual cues in male humans','https://www.scopus.com/inward/record.uri?eid=2-s2.0-79551474312&doi=10.1016%2fj.psyneuen.2010.07.023&partnerID=40&md5=27a04340aa3adca83c9934a1e5a447ec','10.1016/j.psyneuen.2010.07.023','Arginine Vasopressin modulates complex social and sexual behavior by enhancing social recognition, pair bonding, and aggression in non-human mammals. The influence of Arginine Vasopressin in human social and sexual behavior is, however, yet to be fully understood. We evaluated whether Arginine Vasopressin nasal spray facilitated recognition of positive and negative social and sexual stimuli over non-social stimuli. We used a recognition task that has already been shown to be sensitive to the influence of Oxytocin nasal spray (Unkelbach et al., 2008). In a double-blind, randomized, placebo-controlled, between-subjects design, 41 healthy male volunteers were administered Arginine Vasopressin (20┬áIU) or a placebo nasal spray after a 45├é┬ámin wait period and then completed the recognition task. Results showed that the participants administered Arginine Vasopressin nasal spray were faster to detect├é┬á├éΓÇª','',2011,NULL,NULL,'2011-02-01',NULL,NULL,NULL,NULL,'59','Psychoneuroendocrinology','36','2','294-297','Pergamon','Other','Neurobiology',''),(759,'National mental health reform: Less talk, more action','https://www.scopus.com/inward/record.uri?eid=2-s2.0-61849143180&doi=10.5694%2fj.1326-5377.2009.tb02346.x&partnerID=40&md5=7295376c415a9040eeeb6b575b724280','10.5694/j.1326-5377.2009.tb02346.x','ΓÇó The Council of Australian Governments revitalised national mental health reform in 2006. Unfortunately, evidence-based models of collaborative care have not yet been supported.','',2009,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'59','Medical Journal of Australia','190','4','193-195','','YMH team','Mental Health System',''),(760,'Greater male than female variability in regional brain structure across the lifespan','https://onlinelibrary.wiley.com/doi/abs/10.1002/hbm.25204',NULL,' For many traits, males show greater variability than females, with possible implications for understanding sex differences in health and disease. Here, the ENIGMA (Enhancing Neuro Imaging Genetics through Meta-Analysis) Consortium presents the largest-ever mega-analysis of sex differences in variability of brain structure, based on international data spanning nine decades of life. Subcortical volumes, cortical surface area and cortical thickness were assessed in MRI data of 16,683 healthy individuals 1-90years old (47% females). We observed significant patterns of greater male than female between-subject variance for all subcortical volumetric measures, all cortical surface area measures, and 60% of cortical thickness measures. This pattern was stable across the lifespan for 50% of the subcortical structures, 70% of the regional area measures, and nearly all regions for thickness. Our findings that these├é┬á├éΓÇª\n','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'39','Human brain mapping','43','1','470-499','John Wiley & Sons, Inc.',NULL,NULL,NULL),(761,'NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84940211300&doi=10.1111%2feip.12260&partnerID=40&md5=feb8679ce4a704c4c2fde0d69845af1f','10.1111/eip.12260','','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Early Intervention in Psychiatry','','','','Blackwell Publishers','Other','',''),(762,'Frontal lobe changes occur early in the course of affective disorders in young people','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878650510&doi=10.1186%2f1471-244X-42-4&partnerID=40&md5=b5fdb42949ceb352c55ad145f6d24452','10.1186/1471-244X-42-4','More severe and persistent forms of affective disorders are accompanied by grey matter loss in key frontal and temporal structures. It is unclear whether such changes precede the onset of illness, occur early in the course or develop gradually with persistence or recurrence of illness. A total of 47 young people presenting with admixtures of depressive and psychotic symptoms were recruited from specialist early intervention services along with 33 age matched healthy control subjects. All participants underwent magnetic resonance imaging and patients were rated clinically as to current stage of illness. Twenty-three patients were identified as being at an early \'attenuated syndrome\' stage, while the remaining were rated as having already reached the \'discrete disorder\' or \'persistent or recurrent illness\' stage. Contrasts were carried out between controls subjects and patients cohorts with attenuated syndromes and','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'58','BMC Psychiatry','12','1','1-Jul','BioMed Central','YMH team','Neurobiology','Models of care'),(763,'A consensus statement for safety monitoring guidelines of treatments for major depressive disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-80052509442&doi=10.3109%2f00048674.2011.595686&partnerID=40&md5=4137a656b5d3f016934728ed5b9ce823','10.3109/00048674.2011.595686','\n\nObjective: This paper aims to present an overview of screening and                     safety considerations for the treatment of clinical depressive disorders and                     make recommendations for safety monitoring.\n\nMethod: Data were sourced by a literature search using MEDLINE and a                     manual search of scientific journals to identify relevant articles. Draft                     guidelines were prepared and serially revised in an iterative manner until all                     co-authors gave final approval of content.\n\nResults: Screening and monitoring can detect medical causes of                     depression. Specific adverse effects associated with antidepressant treatments                     may be reduced or identified earlier by baseline screening and agent-specific                     monitoring after commencing treatment.\n\nConclusion: The adoption of safety monitoring guidelines when                     treating clinical depression is likely to improve├é┬á├éΓÇª\n','',2011,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'58','Australian and New Zealand Journal of Psychiatry','45','9','712-725','Sage Publications','Other','',''),(764,'Impaired voluntary drive to breathe: A possible link between depression and unexplained ventilatory failure in asthmatic patients','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028017841&doi=10.1136%2fthx.49.9.881&partnerID=40&md5=4db654ef475e70d30db2666e6dfb85bc','10.1136/thx.49.9.881','\nBACKGROUND--\nAlthough psychological distress predicts mortality in asthma, an underlying physiological link has not been shown. This study examined relations between impaired voluntary drive to breathe and measures of mood states. METHODS--\nThe level of maximal voluntary activation of the diaphragm and elbow flexors was measured in a previous study using a sensitive modification of the twitch interpolation technique in 11 asthmatic and 10 control subjects. In this study psychological distress was assessed using the Profile of Mood States questionnaire and measures of distress were compared with the muscle voluntary activation results. RESULTS--\nFor the asthmatic subjects, depressed mood increased the risk of impaired maximal voluntary activation of the diaphragm by 3.5 times (95% CI 1.09 to 11.3). No such association was observed in control subjects. CONCLUSIONS--\nThese results suggest that','',1994,NULL,NULL,'1994-09-01',NULL,NULL,NULL,NULL,'58','Thorax','49','9','881-884','BMJ Publishing Group Ltd','Other','',''),(765,'Analysis of DNA methylation associates the cystineΓÇôglutamate antiporter SLC7A11 with risk of ParkinsonΓÇÖs disease','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081528467&doi=10.1038%2fs41467-020-15065-7&partnerID=40&md5=164dc77afc7b173c0c5a0f09b02bf1c7','10.1038/s41467-020-15065-7','An improved understanding of etiological mechanisms in Parkinson├éΓÇÖs disease (PD) is urgently needed because the number of affected individuals is projected to increase rapidly as populations age. We present results from a blood-based methylome-wide association study of PD involving meta-analysis of 229 K CpG probes in 1,132 cases and 999 controls from two independent cohorts. We identify two previously unreported epigenome-wide significant associations with PD, including cg06690548 on chromosome 4. We demonstrate that cg06690548 hypermethylation in PD is associated with down-regulation of the SLC7A11 gene and show this is consistent with an environmental exposure, as opposed to medications or genetic factors with effects on DNA methylation or gene expression. These findings are notable because SLC7A11 codes for a cysteine-glutamate anti-porter regulating levels of the antioxidant├é┬á├éΓÇª','',2020,NULL,NULL,'2020-03-06',NULL,NULL,NULL,NULL,'57','Nature Communications','11','1','1-Oct','Nature Publishing Group','Other','',''),(766,'Moderate alcohol intake is related to increased heart rate variability in young adults: Implications for health and well-being','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84887411557&doi=10.1111%2fpsyp.12134&partnerID=40&md5=4936f7bf52893af54454058168822142','10.1111/psyp.12134',' Epidemiological literature indicates that the relationship between alcohol consumption and health outcomes reflects a J-shaped curve such that moderate alcohol consumption confers a protective effect in comparison to abstinence, while heavy consumption is associated with poorer health. While heart rate variability (HRV) may underpin the relationship between drinking and poor health in heavy drinkers, it is unclear whether HRV is increased in moderate, habitual drinkers relative to nonhabitual drinkers. HRV and drinking habits were assessed in 47 volunteers. Results supported hypotheses suggesting that moderate, habitual drinking increases HRV. Although not supported by a significant interaction between drinking group and sex, planned follow-up analysis also revealed that these findings may be specific to males. Regardless, results highlight HRV as a candidate mechanism for the findings reported in the\n','',2013,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'57','Psychophysiology','50','12','1202-1208','','Other','',''),(767,'Predicting the course of melancholic and nonmelancholic depression: A naturalistic comparison study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026731220&doi=10.1097%2f00005053-199211000-00003&partnerID=40&md5=9613bd70df4dc5c8e04927fa81f2f833','10.1097/00005053-199211000-00003','Assessed improvement patterns and predictors of outcome over a 1-yr period for 309 patients with a primary depressive disorder receiving treatment from a mood disorders unit. The 138 Ss with composite melancholia (CM) had differential improvement pattern from the 171 nonmelancholic (NM) Ss in the first 20 wks, but case rates and severity levels were comparable at 20 wks and 1 yr. Only 3 variables (older age at 1st episode, less severe depression, and extraversion) were predictors of improvement in both groups. Improvement was predicted by less psychomotor disturbance, absence of personality disorder, and higher social functioning in Ss with CM. Absence of timidity and shyness in childhood, briefer duration of depression, and receipt of individual psychotherapy predicted better outcome in NM Ss. The suggested differential relevance for most isolated predictors argues for outcome studies that examine','',1992,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'57','Journal of Nervous and Mental Disease','','','','Lippincott Williams & Wilkins','Other','',''),(768,'A Review of the Safety, Efficacy and Mechanisms of Delivery of Nasal Oxytocin in Children: Therapeutic Potential for Autism and Prader-Willi Syndrome, and Recommendations for Future Research','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85024474476&doi=10.1007%2fs40272-017-0248-y&partnerID=40&md5=da41ab465039cba710e5a6fe83395c32','10.1007/s40272-017-0248-y','In this article, we conduct a comprehensive review of┬áexisting evidence for the├é┬ásafety and therapeutic potential of intranasal oxytocin in pediatric populations. Unique considerations for dosing and delivery of oxytocin to the nasal passageway in pediatric populations and methods to promote adherence are reviewed. Intranasal oxytocin has been administered to 261 children in three open-label studies and eight randomized controlled trials. To date, the only published results in pediatric populations have focused on autism spectrum disorder (ASD) and Prader-Willi syndrome (PWS). Results regarding efficacy for improving social impairment in ASD are equivocal, partially due to mixed methodological designs, dosing regimens, and outcome measures. At present, there is no randomized controlled evidence that oxytocin provides benefit to individuals with PWS. There is no clear evidence of a link between oxytocin├é┬á├éΓÇª','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'56','Pediatric Drugs','19','5','391-410','Springer International Publishing','Other','',''),(769,'Predictors of placebo response in pharmacological and dietary supplement treatment trials in pediatric autism spectru disorder: A meta-analysis','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84977762971&doi=10.1038%2ftp.2015.143&partnerID=40&md5=70cfaf1184eca437d123c6cca04a6819','10.1038/tp.2015.143','Large placebo responses in many clinical trials limit our capacity to identify effective therapeutics. Although it is often assumed that core behaviors in children with autism spectrum disorders (ASDs) rarely remit spontaneously, there has been limited investigation of the size of the placebo response in relevant clinical trials. These trials also rely on caregiver and clinical observer reports as outcome measures. The objectives of this meta-analysis are to identify the pooled placebo response and the predictors of placebo response in pharmacological and dietary supplement treatment trials for participants with a diagnosis of ASD. Randomized controlled trials (RCTs) in pediatric ASD, conducted between 1980 and August 2014, were identified through a search of Medline, EMBASE, Web of Science, Cochrane Database of Systematic Reviews and clinicaltrials. gov. RCTs of at least 14 days duration, comparing the','',2015,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'56','Translational Psychiatry','5','9','e640-e640','Nature Publishing Group','Other','',''),(770,'Accuracy of self-reported sleep parameters compared with actigraphy in young people with mental ill-health','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84940899259&doi=10.1016%2fj.sleh.2015.07.006&partnerID=40&md5=f1caa95f321426fb44a13c60708732f6','10.1016/j.sleh.2015.07.006','\n\nObjectives\nValidation of self-report assessment of habitual sleep duration and onset time in young people with mental ill-health.\n\n\nDesign\nValidation sample.\n\n\nSetting\nSpecialized early intervention centers for young people in Sydney, Australia.\n\n\nParticipants\nOne hundred and forty-six young people with mental ill-health.\n\n\nIntervention\nN/A.\n\n\nMeasurements\nSelf-reported habitual sleep duration and onset time were compared against at least 7 days of actigraphy monitoring. Average bias in and calibration of subjective measures were assessed, along with correlation of subjective and objective measures. Differences by age, sex, mental-disorder type, and reported insomnia were also explored.\n\n\nResults\nOn average, subjective estimates of sleep were unbiased. Overall, each additional hour of objective habitual sleep duration predicted 41 minutes more subjective habitual sleep duration, and each hour later objective habitual sleep├é┬á├éΓÇª\n\n','',2015,NULL,NULL,'2015-09-01',NULL,NULL,NULL,NULL,'56','Sleep Health','1','3','214-220','Elsevier','YMH team','Illness specific areas',''),(771,'Prevalence and predictors of poor sleep quality in mild cognitive impairment','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907210871&doi=10.1177%2f0891988714527516&partnerID=40&md5=4499258e862276085eb40bb58c18651b','10.1177/0891988714527516','\nAims:\nTo investigate the prevalence of and contributors to poor sleep quality in patients with mild cognitive impairment (MCI).\nMethods:\nData were collected for 158 patients meeting the criteria for MCI. Measures included the Pittsburgh Sleep Quality Index, Geriatric Depression Scale, and Mini-Mental State Examination. Demographic, lifestyle, medication, and substance use data were also collected.\nResults:\nA total of 63% of patients with MCI demonstrated sleep disturbance, a significantly higher rate than that of the controls (44%; chi-square = 8.77; P = .003). Depressive symptoms, cognition, antidepressant usage, alcohol consumption, age, and education were identified as significant predictors of self-reported sleep quality in patients with MCI (R2 = .327, F6,145 = 11.729, P < .0001).\nConclusions:\nSleep disturbance occurs in around two-thirds of patients with MCI. Interventions addressing depression, cognition, and\n','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'56','Journal of Geriatric Psychiatry and Neurology','27','3','204-211','Sage Publications','Other','',''),(772,'Fatigue as related to anxiety and depression in a community-based sample of twins aged over 50','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032929993&doi=10.1007%2fs001270050116&partnerID=40&md5=d449beb6aac8be9f82f83dae35014052','10.1007/s001270050116','                Measures of fatigue, anxiety and depression were administered in self-report questionnaire format to a community-based sample of 2703 Australian twins aged over 50. Factor analysis indicated that a two-factor solution was appropriate and demonstrated a clear separation between fatigue-related items and questionnaire items relating to anxiety and depression. Highly congruent factor structures were derived for male and female subjects.\n','',1999,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'56','Social Psychiatry and Psychiatric Epidemiology','34','2','85-90','Steinkopff Verlag','YMH team','Outcome Research',''),(773,'Head motion and Inattention/Hyperactivity share common genetic influences: Implications for fMRI studies of ADHD','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84954349589&doi=10.1371%2fjournal.pone.0146271&partnerID=40&md5=173cd948155114f6a67a1d069a8e040e','10.1371/journal.pone.0146271','Head motion (HM) is a well known confound in analyses of functional MRI (fMRI) data. Neuroimaging researchers therefore typically treat HM as a nuisance covariate in their analyses. Even so, it is possible that HM shares a common genetic influence with the trait of interest. Here we investigate the extent to which this relationship is due to shared genetic factors, using HM extracted from resting-state fMRI and maternal and self report measures of Inattention and Hyperactivity-Impulsivity from the Strengths and Weaknesses of ADHD Symptoms and Normal Behaviour (SWAN) scales. Our sample consisted of healthy young adult twins (N = 627 (63% females) including 95 MZ and 144 DZ twin pairs, mean age 22, who had mother-reported SWAN; N = 725 (58% females) including 101 MZ and 156 DZ pairs, mean age 25, with self reported SWAN). This design enabled us to distinguish genetic from environmental factors in the association between head movement and ADHD scales. HM was moderately correlated with maternal reports of Inattention (r = 0.17, p-value = 7.4E-5) and Hyperactivity-Impulsivity (r = 0.16, p-value = 2.9E-4), and these associations were mainly due to pleiotropic genetic factors with genetic correlations [95% CIs] of rg = 0.24 [0.02, 0.43] and rg = 0.23 [0.07, 0.39]. Correlations between self-reports and HM were not significant, due largely to increased measurement error. These results indicate that treating HM as a nuisance covariate in neuroimaging studies of ADHD will likely reduce power to detect between-group effects, as the implicit assumption of independence between HM and Inattention or Hyperactivity-Impulsivity is not├é┬á├éΓÇª','',2016,NULL,NULL,'2016-01-08',NULL,NULL,NULL,NULL,'55','PLoS ONE','11','1','e0146271','Public Library of Science','Other','',''),(774,'Delayed sleep onset in depressed young people','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896738687&doi=10.1186%2f1471-244X-14-33&partnerID=40&md5=c9aad6ad838d76df9d5585d67a176f03','10.1186/1471-244X-14-33','The circadian abnormality of delayed sleep phase has been suggested to characterise a subgroup of depressed young adults with different risk factors and course of illness. We aim to assess the prevalence and factors, particularly substance use, associated with such delay in a large help-seeking cohort of young people with mental health problems. From a consecutively recruited sample of 802 help-seeking young people, 305 (38%) had at least moderate depressive symptoms (QIDS-C16 >10), sleep data and did not have a chronic severe mental illness. Demographic and clinical characteristics were evaluated through self report and clinical interview. Delayed sleep phase was defined as a sleep onset between the hours of 02:00 a.m. ├éΓÇô 06:00 a.m. and the characteristics of this group were compared to normal phase sleepers. Delayed sleep onset was reported amongst 18% (n = 56/305) of the depressed group├é┬á├éΓÇª','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'55','BMC Psychiatry','14','1','1-Sep','BioMed Central','Other','',''),(775,'Development of insula connectivity between ages 12 and 30 revealed by high angular resolution diffusion imaging','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896391499&doi=10.1002%2fhbm.22292&partnerID=40&md5=5538d28431a0a9869f706761ba794573','10.1002/hbm.22292','The insula, hidden deep within the Sylvian fissures, has proven difficult to study from a connectivity perspective. Most of our current information on the anatomical connectivity of the insula comes from studies of nonhuman primates and post mortem human dissections. To date, only two neuroimaging studies have successfully examined the connectivity of the insula. Here we examine how the connectivity of the insula develops between ages 12 and 30, in 307 young adolescent and adult subjects scanned with 4-Tesla high angular resolution diffusion imaging (HARDI). The density of fiber connections between the insula and the frontal and parietal cortex decreased with age, but the connection density between the insula and the temporal cortex generally increased with age. This trajectory is in line with well-known patterns of cortical development in these regions. In addition, males and females showed different','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'55','Human Brain Mapping','35','4','1790-1800','','Other','',''),(776,'Longitudinal associations between mismatch negativity and disability in early schizophrenia- and affective-spectrum disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84882773568&doi=10.1016%2fj.pnpbp.2013.07.002&partnerID=40&md5=79b890dd8ab35fb824b5d9bafb13f333','10.1016/j.pnpbp.2013.07.002','\n\nBackground\nImpaired mismatch negativity (MMN) is a robust finding in schizophrenia and, more recently, similar impairments have been reported in other psychotic- and affective-disorders (including at early stages of illness). Although cross-sectional studies have been numerous, there are few longitudinal studies that have explored the predictive value of this event-related potential in relation to clinical/functional outcomes. This study assessed changes in MMN (and the concomitant P3a) amplitude over time and aimed to determine the longitudinal relationship between MMN/P3a and functional outcomes in patients recruited during the early stage of a schizophrenia- or affective-spectrum disorder.\n\n\nMethods\nSixty young patients with schizophrenia- and affective-spectrum disorders and 30 healthy controls underwent clinical, neuropsychological and neurophysiological assessment at baseline. Thirty-one patients\n\n','',2013,NULL,NULL,'2013-10-01',NULL,NULL,NULL,NULL,'55','Progress in Neuro-Psychopharmacology and Biological Psychiatry','46','','161-169','Elsevier','YMH team','Outcome Research',''),(777,'Youth mental health: We know where we are and we can now say where we need to go next','https://www.scopus.com/inward/record.uri?eid=2-s2.0-78650862202&doi=10.1111%2fj.1751-7893.2010.00243.x&partnerID=40&md5=853495c4fa2208fc7b353873e4cee627','10.1111/j.1751-7893.2010.00243.x',' \nAim: To provide an overview of the state of knowledge relevant to the development of youth-specific mental health initiatives. \nMethods: A selective review of data, particularly from Australian community and health service studies, that are relevant to the decisions faced by those who fund and organize health services internationally. \nResults: It is possible to reach consensus on key issues such as the current state of evidence, myths that need to be challenged, areas of genuine uncertainty, priorities for future reform, and five and ten year goals and targets. \nConclusions: There is considerable convergence of evidence from epidemiology, clinical and basic neuroscience, population health and health service evaluation that supports an urgent new investment in development and evaluation of youth mental health initiatives.\n','',2011,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'55','Early Intervention in Psychiatry','5','','63-69','Blackwell Publishing Asia','YMH team','Mental Health System','Models of care'),(778,'Spencer 0, Wakefield D. Prevalence of chronic fatigue syndrome in an Australian population','https://scholar.google.com/scholar?cluster=5476502188107972747&hl=en&oi=scholarr',NULL,'','',1990,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'55','Med J Aust','153','','522-528','',NULL,NULL,NULL),(779,'The role of mild depression in sleep disturbance and quality of life in Parkinson\'s disease','https://www.scopus.com/inward/record.uri?eid=2-s2.0-78149340435&doi=10.1176%2fjnp.2010.22.4.384&partnerID=40&md5=7eb60418fc3423b23c2ab1eaff174323','10.1176/jnp.2010.22.4.384','This study examined depressive symptoms, sleep disturbance, and quality of life in 35 patients with Parkinson├éΓÇÖs disease. Results showed that nocturnal sleep disturbance, depressive symptoms, and motor disease severity accounted for over two-thirds of the variance in quality of life scores. Depression was the largest predictor of quality of life, uniquely explaining 21% of the variance. Nocturnal sleep disturbance was associated with depressive symptoms as well as with daytime sleepiness. Overall, these data highlight the need to screen patients for even mild levels of depression because its relationship with sleep and quality of life are evident early in the disease course.','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'54','Journal of Neuropsychiatry and Clinical Neurosciences','22','4','384-389','American Psychiatric Publishing, Inc.','YMH team','Illness specific areas','Outcome Research'),(780,'Reach out central: A serious game designed to engage young men to improve mental health and wellbeing','https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955889821&doi=10.5694%2fj.1326-5377.2010.tb03689.x&partnerID=40&md5=cfe54f2bf0d57ad065b5b03b695c4abd','10.5694/j.1326-5377.2010.tb03689.x',' Reach Out Central (ROC) is a serious game drawing on the principles of cognitive behaviour theory that has been designed to improve the mental health and wellbeing of young people, particularly men. ROC was developed over a 3-year period from 2003 to 2006, in consultation with young people aged 16ΓÇô25 years who use the Reach Out mental health website (http://www.reachout.com). ROC was launched online in September 2007. A traditional and viral awareness campaign was designed to engage young men, particularly ├éΓÇ£gamers├éΓÇ¥. In the first month after launch, ROC had 76 045 unique website visits, with 10 542 new members (52% male) joining Reach Out. An independent online evaluation involving 266 young people aged 18├éΓÇô25 years was conducted between August 2007 and February 2008 to examine psychological wellbeing, stigma and help seeking in ROC players. Overall results indicated that├é┬á├éΓÇª\n\n','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'54','Medical Journal of Australia','192','','S27-S30','','YMH team','Digital health','Models of care'),(781,'Is depression overdiagnosed? No.','https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548444248&doi=10.1136%2fbmj.39268.497350.AD&partnerID=40&md5=7cebaa99bb1081dfaad84835c1b87ce3','10.1136/bmj.39268.497350.AD','Rates of diagnosis of depression have risen steeply in recent years. Gordon Parker believes this is because current criteria are medicalising sadness, but Ian Hickie argues that many people are still missing out on lifesaving treatment ','',2007,NULL,NULL,'2007-08-16',NULL,NULL,NULL,NULL,'54','BMJ (Clinical research ed.)','335','7615','329-329','British Medical Journal Publishing Group','YMH team','Illness specific areas',''),(782,'Summary of guideline for the treatment of depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0038216730&doi=10.1046%2fj.1440-1665.2003.00530.x&partnerID=40&md5=1a91f2c32923ec8982264c9d2103e1a1','10.1046/j.1440-1665.2003.00530.x','Depression is common, serious and treatable. The Australian and New Zealand Clinical Practice Guideline for the Treatment of Depression by Specialist Services provides evidence-based treatment guidance across the spectrum of depressive disorders and delineates where specialist treatment and primary care management is indicated. The present summary version covers the key contents of the guideline. It includes assessment, treatment and general management issues by category type and severity of depressive disorder. Algorithms of first-line and subsequent treatment choices are provided for: (i) mild depression without complications; (ii) moderately severe depression (including with comorbid anxiety) and dysthymia; (iii) uncomplicated, melancholic or atypical depression; (iv) moderately severe depression with comorbid substance abuse; (v) moderate to severe depression with physical disorders; (vi','',2003,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'54','Australasian Psychiatry','11','1','34-38','SAGE Publications','YMH team','Models of care',''),(783,'Perceived dysfunctional intimate relationships: a specific association with the non-melancholic depressive subtype','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025283810&doi=10.1016%2f0165-0327%2890%2990014-Y&partnerID=40&md5=743c2c9578a852be4ee666898f82307e','10.1016/0165-0327(90)90014-Y','Associations between perceptions of dysfunctional current intimate relationships and subtypes of depressive disorders were quantified in a sample of 136 patients, using the Intimate Bond Measure (IBM). Deficient care was two to three times more likely to be reported by patients with non-melancholic disorders than by matched subjects, but was no more likely to be reported by patients with melancholic disorders, suggesting a risk factor selective for depressive type. Patients who reported markedly deficient care in childhood were more likely to report very poor current intimate relationships. For the remaining patients, however, no evidence of continuity between a dysfunctional parental relationship and a current dysfunctional intimate relationship was found.','',1990,NULL,NULL,'1990-06-01',NULL,NULL,NULL,NULL,'54','Journal of Affective Disorders','19','2','99-107','Elsevier','Other','',''),(784,'The role of rumination in illness trajectories in youth: Linking trans-diagnostic processes with clinical staging models','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84976556303&doi=10.1017%2fS0033291716001392&partnerID=40&md5=7a4954f6640aa80313c70d3894b4b6c9','10.1017/S0033291716001392','Research in developmental psychopathology and clinical staging models has increasingly sought to identify trans-diagnostic biomarkers or neurocognitive deficits that may play a role in the onset and trajectory of mental disorders and could represent modifiable treatment targets. Less attention has been directed at the potential role of cognitive-emotional regulation processes such as ruminative response style. Maladaptive rumination (toxic brooding) is a known mediator of the association between gender and internalizing disorders in adolescents and is increased in individuals with a history of early adversity. Furthermore, rumination shows moderate levels of genetic heritability and is linked to abnormalities in neural networks associated with emotional regulation and executive functioning. This review explores the potential role of rumination in exacerbating the symptoms of alcohol and substance misuse, and','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'53','Psychological Medicine','46','12','2467-2484','Cambridge University Press','YMH team','Models of care',''),(785,'In vivo glutathione levels in young persons with bipolar disorder: A magnetic resonance spectroscopy study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84873524925&doi=10.1016%2fj.jpsychires.2012.12.006&partnerID=40&md5=ced10a14b09d0a7f65e219e2d51d80c0','10.1016/j.jpsychires.2012.12.006','Oxidative stress has recently been reported to assume a significant role in the pathophysiology of bipolar disorder. Several studies have demonstrated the replenishment of glutathione (GSH) diminishes oxidative cellular damage and ameliorates depressive symptoms in this disorder. Whilst the mechanism by which GSH exerts any clinical effect is unknown it has been proposed that it involves the bolstering of antioxidant defences by increasing the bioavailability of GSH, which in turn reverses clinical symptoms of depression. Such a proposal is predicated on the implicit assumption that GSH is diminished in these patients prior to GSH supplementation. However hitherto no study has reported in┬ávivo measures of GSH in patients with bipolar disorder. Using magnetic resonance spectroscopy we obtained in├é┬ávivo measures of GSH in young people with bipolar disorder and contrasted these with matched healthy├é┬á├éΓÇª','',2013,NULL,NULL,'2013-03-01',NULL,NULL,NULL,NULL,'53','Journal of Psychiatric Research','47','3','412-417','Pergamon','YMH team','Illness specific areas','Neurobiology'),(786,'Reduced temporal mismatch negativity in late-life depression: An event-related potential index of cognitive deficit and functional disability?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84858286518&doi=10.1016%2fj.jad.2011.12.028&partnerID=40&md5=ce469af3894aa31c854b8447ee12f95d','10.1016/j.jad.2011.12.028','\n\nBackground\nDepression in older people has been consistently linked with a variety of neurobiological brain changes. One measure of preattentive auditory processing, the mismatch negativity (MMN), has not been previously examined in late-life depression. This study examined MMN elicited by duration deviant stimuli in older people with lifetime depression, and explored its relationship with neuropsychological functioning and disability.\n\n\nMethods\nTwenty-two older health-seeking patients (mean age┬á=├é┬á65.2├é┬áyears) with lifetime major depressive disorder and twelve age and sex-matched control participants (mean age├é┬á=├é┬á64.6├é┬áyears) completed detailed clinical and neuropsychological assessments and the WHO-DAS as a measure of disability. MMN amplitudes were elicited using a two-tone passive auditory oddball paradigm and measured at frontal (Fz), central (Cz) and temporal (left and right mastoid: M1 and M2├é┬á├éΓÇª\n\n','',2012,NULL,NULL,'2012-04-01',NULL,NULL,NULL,NULL,'53','Journal of Affective Disorders','138','1-Feb','71-78','Elsevier','YMH team','Illness specific areas',''),(787,'Reduced mismatch negativity in mild cognitive impairment: Associations with neuropsychological performance','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84861519620&doi=10.3233%2fJAD-2012-111868&partnerID=40&md5=9f10e27cae880ca9f603882f284d67c6','10.3233/JAD-2012-111868','Mild cognitive impairment (MCI) refers to a transitory state between healthy aging and dementia. Biomarkers are needed to facilitate early identification of MCI and predict progression to dementia. One potential neurophysiological biomarker, mismatch negativity (MMN), is an event-related potential reflecting fundamental, pre-attentive cognitive processes. MMN is reduced in normal aging and dementia and in neuropsychiatric samples and is associated with verbal memory deficits and poor executive functioning. This study aimed to investigate auditory MMN and its relationship to neuropsychological performance in MCI. Twenty-eight MCI participants and fourteen controls, aged= 50 years, underwent neurophysiological and neuropsychological assessment, and completed questionnaires pertaining to disability. Relative to controls, the MCI group demonstrated reduced temporal MMN amplitude (p< 0.01). Reduced','',2012,NULL,NULL,'2012-01-01',NULL,NULL,NULL,NULL,'53','Journal of Alzheimer\'s Disease','30','1','209-219','IOS Press','Other','',''),(788,'What can alert the general practitioner to people whose common mental health problems are unrecognised?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-48549091168&doi=10.5694%2fj.1326-5377.2008.tb01873.x&partnerID=40&md5=a7ce89e0d4402d7efd427f23ca8cc3e3','10.5694/j.1326-5377.2008.tb01873.x','\n\nObjectives: To assess the characteristics of people with common mental health problems who are recognised by their general practitioner, and those who are not. \nDesign: Two different case-finding techniques (brief self-report and structured diagnostic interview) were compared with GPsΓÇÖ independent assessments of patients├éΓÇÖ presentations as psychological and/or medical. \nSetting and participants: 371 patients in general practices in metropolitan Sydney and rural New South Wales, with follow-up telephone interview as soon as possible after the GP visit. The study was conducted from 2001 to 2003. \nMain outcome measures: Overall rates of disorder, measured by the 12-item Somatic and Psychological HEalth REport (SPHERE-12), and anxiety, depression and somatisation diagnostic categories of the Composite International Diagnostic Interview ├éΓÇô Auto; rates of disability, assessed by the 12-item Short-Form├é┬á├éΓÇª\n','',2008,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'53','The Medical journal of Australia','188','','S114-S118','','YMH team','Models of care',''),(789,'Prolonged fatigue, anxiety and depression: Exploring relationships in a primary care sample','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032764626&doi=10.1046%2fj.1440-1614.1999.00593.x&partnerID=40&md5=b76ae5cf97bb87278641335ffbb9ad2c','10.1046/j.1440-1614.1999.00593.x','\n\nObjective: While prolonged fatigue states are frequently comorbid with other forms of distress, they are now the subject of independent aetiological and treatment research. The objective of this study was to use principal component analysis to clarify the relationships between proposed measures of prolonged fatigue and anxiety and depression in data obtained from patients attending primary care.\n\nMethod: Self-report measures of prolonged fatigue and psychological distress (anxiety and depression) were administered to consecutive ambulatory care patients attending primary care.\n\nResults: Data from 1593 subjects were obtained. A two-factor principal component solution (varimax rotation) demonstrated a clear separation between fatigue-related items (Cronbach\'s a = 0.81) as compared with those items describing anxiety and/or depression (Cronbach\'s a = 0.95). A four-factor solution produced similar results with\n','',1999,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'53','Australian and New Zealand Journal of Psychiatry','33','4','545-552','Sage Publications','YMH team','Outcome Research',''),(790,'Global research priorities for youth mental health','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078255903&doi=10.1111%2feip.12878&partnerID=40&md5=3374c7c767ce314146d709aa03e55c9b','10.1111/eip.12878','  Aim Over the past two decades, the youth mental health field has expanded and advanced considerably. Yet, mental disorders continue to disproportionately affect adolescents and young adults. Their prevalence and associated morbidity and mortality in young people have not substantially reduced, with high levels of unmet need and poor access to evidence-based treatments even in high-income countries. Despite the potential return on investment, youth mental disorders receive insufficient funding. Motivated by these continual disparities, we propose a strategic agenda for youth mental health research.   Method Youth mental health experts and funders convened to develop youth mental health research priorities, via thematic roundtable discussions, that address critical evidence-based gaps.   Results Twenty-one global youth mental health research priorities were developed, including population health├é┬á├éΓÇª\n','',2020,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'35','Early Intervention in Psychiatry','14','1','Mar-13','Wiley Publishing Asia Pty Ltd','Other','',''),(791,'A Digital Platform Designed for Youth Mental Health Services to Deliver Personalized and Measurement-Based Care','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072224571&doi=10.3389%2ffpsyt.2019.00595&partnerID=40&md5=858457c3381002207529cb7d5c159a68','10.3389/fpsyt.2019.00595','Those mental disorders that commonly emerge during adolescence and young adulthood are associated with substantial immediate burden and risks, as well as potentially imparting lifetime morbidity and premature mortality. While the development of health services that are youth-focused and prioritize early intervention has been a critical step forward, an ongoing challenge is the heterogeneous nature of symptom profiles and illness trajectories. Consequently, it is often difficult to provide quality mental health care, at scale, that addresses the broad range of health, social and functional needs of young people. Here, we describe a new digital platform designed to deliver personalized and measurement-based care. It provides health services and clinicians with the tools to directly address the multidimensional needs of young people. The term ΓÇÿpersonalized├éΓÇÖ describes the notion that the assessment of, and the sequence of interventions for, mental disorders are tailored to the young person - and their changing needs over time. While, ├éΓÇÿmeasurement-based├éΓÇÖ describes the use of systematic and continuing assessment of a young person├éΓÇÖs outcomes over the entire course of clinical care. Together, these concepts support a framework for care that transcends a narrow focus on symptom reduction or risk reduction. Instead it prioritizes a broader focus on enhancing social, health and physical outcomes for young people, and a commitment to tracking these outcomes throughout this key developmental period. Now, with twenty-first century technologies, it is possible to provide health services with the tools needed to deliver quality mental health care.','',2019,NULL,NULL,'2019-08-23',NULL,NULL,NULL,NULL,'52','Frontiers in Psychiatry','10','','595','Frontiers Media SA','YMH team','Digital health',''),(792,'Using participatory design methodologies to co-design and culturally adapt the Spanish version of the mental health eClinic: Qualitative study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071178540&doi=10.2196%2f14127&partnerID=40&md5=79bb6608b576e2c2129d7c4aa901d133','10.2196/14127','           Background           The  Mental Health eClinic (MHeC) aims to deliver best-practice clinical services to young people experiencing mental health problems by making clinical care accessible, affordable, and available to young people whenever and wherever they need it most. The original MHeC consists of home page with a visible triage system for those requiring urgent help; a online physical and mental health self-report assessment; a results dashboard; a booking and videoconferencing system; and the generation of a personalized well-being plan. Populations who do not speak English and reside in English-speaking countries are less likely to receive mental health care. In Australia, international students have been identified as disadvantaged compared with their peers; have weaker social support networks; and have higher rates of psychological distress. This scenario is acquiring significant relevance as Spanish-speaking migration is rapidly growing in Australia, and the mental health services for culturally and linguistically diverse populations are limited. Having a Spanish version (MHeC-S) of the Mental Health eClinic would greatly benefit these students.                             Objective           We used participatory design methodologies with users (young people aged 16-30 years, supportive others, and health professionals) to (1) conduct workshops with users to co-design and culturally adapt the MHeC; (2) inform the development of the MHeC-S alpha prototype; (3) test the usability of the MHeC-S alpha prototype; (4) translate, culturally adapt, and face-validate the MHeC-S self-report assessment; and (5) collect information to inform its├é┬á├éΓÇª\n','',2019,NULL,NULL,'2019-08-02',NULL,NULL,NULL,NULL,'52','Journal of Medical Internet Research','21','8','e14127','JMIR Publications Inc., Toronto, Canada','YMH team','Digital health',''),(793,'Substance use in youth at risk for psychosis','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85015609293&doi=10.1016%2fj.schres.2016.08.026&partnerID=40&md5=cec46cc99173aeb4263f6314ce521826','10.1016/j.schres.2016.08.026','','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Schizophrenia Research','','','','Elsevier','Other','',''),(794,'Treatment patterns and short-term outcomes in an early intervention youth mental health service','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84953911785&doi=10.1111%2feip.12191&partnerID=40&md5=9a801e5bb4fad59fc48d5ef379f87d7a','10.1111/eip.12191','  Aim Early intervention mental health services tailored for young people are being developed across the world, yet reports on service use patterns and short-term clinical outcomes for the clinically diverse group accessing these services are very limited. The current study employed the clinical staging model to examine whether young people within the two clinical stages that precede full-threshold disorder (stage 1a and stage 1b) differed in terms of treatments received and short-term symptomatic and functional outcomes.   Methods Eight hundred ninety young people aged 12ΓÇô25 years seeking mental healthcare within a 12-month period were analysed in this study.   Results Attenuated syndrome (stage 1b) patients used significantly more services than help-seeking (stage 1a) patients, including significantly higher rates of psychotropic medication prescription (9.3% vs. 43.6%). Stage 1a patients started with├é┬á├éΓÇª\n','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'52','Early Intervention in Psychiatry','10','1','88-97','','YMH team','Outcome Research',''),(795,'Heritability of head motion during resting state functional MRI in 462 healthy twins','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84906505424&doi=10.1016%2fj.neuroimage.2014.08.010&partnerID=40&md5=0e0e7f82f1ced5a7c65408ac78f33da1','10.1016/j.neuroimage.2014.08.010','Head motion (HM) is a critical confounding factor in functional MRI. Here we investigate whether HM during resting state functional MRI (RS-fMRI) is influenced by genetic factors in a sample of 462 twins (65% female; 101 MZ (monozygotic) and 130 DZ (dizygotic) twin pairs; mean age: 21 (SD= 3.16), range 16├éΓÇô29). Heritability estimates for three HM components├éΓÇömean translation (MT), maximum translation (MAXT) and mean rotation (MR)├éΓÇöranged from 37 to 51%. We detected a significant common genetic influence on HM variability, with about two-thirds (genetic correlations range 0.76├éΓÇô1.00) of the variance shared between MR, MT and MAXT. A composite metric (HM-PC1), which aggregated these three, was also moderately heritable (h 2= 42%). Using a sub-sample (N= 35) of the twins we confirmed that mean and maximum translational and rotational motions were consistent ├éΓÇ£traits├éΓÇ¥ over repeated scans (r= 0.53├é┬á├éΓÇª','',2014,NULL,NULL,'2014-11-15',NULL,NULL,NULL,NULL,'52','NeuroImage','102','','424-434','Academic Press','Other','',''),(796,'Neurophysiological biomarkers support bipolar-spectrum disorders within psychosis cluster','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84865846943&doi=10.1503%2fjpn.110081&partnerID=40&md5=8b77c5bbbaeedb6af3a07276ee7f95b5','10.1503/jpn.110081','\nBackground: Mismatch negativity (MMN) and P3a are event-related potentials that index deviance detection and the orienting response, respectively. We have previously shown that the MMN/P3a complex is impaired in patients with schizophrenia and affective spectrum psychoses, which suggests that it may index a common pathophysiology and argues against the purported specificity in schizophrenia. Further research is warranted to determine whether patients with bipolar-spectrum disorders show similar impairments in these biomarkers.\nMethods: We assessed patients aged 15ΓÇô30 years with early schizophrenia-spectrum disorders (schizophrenia, schizoaffective disorder, schizophreniform disorder), early bipolar-spectrum disorders (bipolar I or II, with and without psychotic features) and healthy, matched controls. We acquired MMN/P3a amplitudes during a 2-tone, auditory paradigm with 8% duration deviants├é┬á├éΓÇª\n','',2012,NULL,NULL,'2012-09-01',NULL,NULL,NULL,NULL,'52','Journal of Psychiatry and Neuroscience','37','5','313-321','Journal of Psychiatry and Neuroscience','YMH team','Neurobiology','illness specific areas'),(797,'The impact of an uncaring partner on improvement in non-melancholic depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026643457&doi=10.1016%2f0165-0327%2892%2990077-J&partnerID=40&md5=a7d8051229828e51162e9483b5cef358','10.1016/0165-0327(92)90077-J','Interpersonal characteristics of the intimate partners of patients with non-melancholic depressive disorders were evaluated as potential predictors of outcome in an eighteen-month, longitudinal study. The short-term reduction in depressive symptoms was predicted most significantly by the patient\'s perception of the partner\'s care (as measured by the Intimate Bond Measure). The longer-term reduction in depressive symptoms was predicted by two components of the intimate relationship (the perceived care of the intimate and a briefer relationship) and was more likely in younger patients. Those who separated from an uncaring partner reported a distinct improvement in depressive symptoms. The patterns of improvement for patients who separated from uncaring partners and for patients who remained in caring relationships were similar, and distinctly superior to the pattern for those who remained with a partner who','',1992,NULL,NULL,'1992-06-01',NULL,NULL,NULL,NULL,'52','Journal of Affective Disorders','25','2','147-160','Elsevier','YMH team','Illness specific areas',''),(798,'The underlying neurobiology of key functional domains in young people with mood and anxiety disorders: A systematic review','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84969206854&doi=10.1186%2fs12888-016-0852-3&partnerID=40&md5=0602100e8d3b1c6f95114ce3211f45f4','10.1186/s12888-016-0852-3','Mood and anxiety disorders are leading causes of disability and mortality, due largely to their onset during adolescence and young adulthood and broader impact on functioning. Key factors that are associated with disability and these disorders in young people are social and economic participation (e.g. education, employment), physical health, suicide and self-harm behaviours, and alcohol and substance use. A better understanding of the objective markers (i.e. neurobiological parameters) associated with these factors is important for the development of effective early interventions that reduce the impact of disability and illness persistence. We systematically reviewed the literature for neurobiological parameters (i.e. neuropsychology, neuroimaging, sleep-wake and circadian biology, neurophysiology and metabolic measures) associated with functional domains in young people (12 to 30 years) with mood and/or anxiety disorders. Of the one hundred and thirty-four studies selected, 7.6┬á% investigated social and economic participation, 2.1├é┬á% physical health, 15.3├é┬á% suicide and self-harm behaviours, 6.9├é┬á% alcohol and substance use, whereas the majority (68.1├é┬á%) focussed on clinical syndrome. Despite the predominance of studies that solely examine the clinical syndrome of young people the literature also provides evidence of distinct associations among objective measures (indexing various aspects of brain circuitry) and other functional domains. We suggest that a shift in focus towards characterising the mechanisms that underlie and/or mediate multiple functional domains will optimise personalised interventions and improve illness trajectories.','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'51','BMC Psychiatry','16','1','Jan-38','BioMed Central','YMH team','Neurobiology',''),(799,'Circadian rhythmicity in emerging mood disorders: state or trait marker?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84961258286&doi=10.1186%2fs40345-015-0043-z&partnerID=40&md5=33465b272d1bc78b3742396672242416','10.1186/s40345-015-0043-z','Circadian rhythm disturbances overlap with the symptoms of mood episodes and may trigger or prolong mood symptoms. There is limited research on the role of circadian disturbances in mood disorders in young people and/or first episode cases of unipolar and bipolar disorders. Actigraphy was undertaken for about 14┬ádays in 63 post-pubertal individuals aged 13├éΓÇô25├é┬áyears with a recent onset of a mood disorder meeting recognised diagnostic criteria. We examined associations between three easily interpretable markers of circadian rhythm activity (amplitude, acrophase and rhythmicity index) and demography and clinical characteristics. Then, circadian markers were compared between diagnostic groups, controlling for potential confounders. Longer duration of illness was correlated with reduced circadian rhythmicity and lower levels of activity over 24├é┬áh. A delay in the timing of maximum activity was associated with the level of manic but not depressive symptoms. The circadian rhythmicity index differentiated  unipolar from bipolar cases, and in bipolar but not unipolar disorder, the rhythmicity was less robust in those with more severe manic or depressive symptoms. Less robust circadian rhythmicity, especially associated with increasing symptom severity, may represent a more specific or a trait marker of young people with mood disorders who are at higher risk of a bipolar course of illness.','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'51','International Journal of Bipolar Disorders','4','1','1-Jul','SpringerOpen','YMH team','Illness specific areas',''),(800,'The role of technology in Australian youth mental health reform','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84991670450&doi=10.1071%2fAH15115&partnerID=40&md5=c7341c0b85b34226b05be0f2226ff0ec','10.1071/AH15115','This paper describes the extent and nature of Internet use by young people, with specific reference to psychological distress and help-seeking behaviour. It draws on data from an Australian cross-sectional study of 1400 young people aged 16 to 25 years. Nearly all of these young people used the Internet, both as a source of trusted information and as a means of connecting with their peers and discussing problems. A new model of e-mental health care is introduced that is directly informed by these findings. The model creates a system of mental health service delivery spanning the spectrum from general health and wellbeing (including mental health) promotion and prevention to recovery. It is designed to promote health and wellbeing and to complement face-to-face services to enhance clinical care. The model has the potential to improve reach and access to quality mental health care for young people, so that','',2016,NULL,NULL,'2016-03-03',NULL,NULL,NULL,NULL,'51','Australian Health Review','40','5','584-590','CSIRO PUBLISHING','YMH team','Digital health','Mental Health System'),(801,'Genetic architecture of subcortical brain regions: Common and region-specific genetic contributions','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84911806019&doi=10.1111%2fgbb.12177&partnerID=40&md5=213314699b6534b61d3307c9c9ba6473','10.1111/gbb.12177','Understanding the aetiology of patterns of variation within and covariation across brain regions is key to advancing our understanding of the functional, anatomical and developmental networks of the brain. Here we applied multivariate twin modelling and principal component analysis (PCA) to investigate the genetic architecture of the size of seven subcortical regions (caudate nucleus, thalamus, putamen, pallidum, hippocampus, amygdala and nucleus accumbens) in a genetically informative sample of adolescents and young adults (N = 1038; mean age = 21.6 ├é┬▒ 3.2 years; including 148 monozygotic and 202 dizygotic twin pairs) from the Queensland Twin IMaging (QTIM) study. Our multivariate twin modelling identified a common genetic factor that accounts for all the heritability of intracranial volume (0.88) and a substantial proportion of the heritability of all subcortical structures, particularly those of the├é┬á├éΓÇª','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'51','Genes, Brain and Behavior','13','8','821-830','Blackwell Publishing Ltd','Other','',''),(802,'Clinical staging for mental disorders: A new development in diagnostic practice in mental health: Matching the timing and intensity of interventions to the specific needs of patients','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878133738&doi=10.5694%2fmja13.10431&partnerID=40&md5=12f62c4fa45ef36beae8afbfb8898b87','10.5694/mja13.10431','\nT he release of the fifth edition of the Diagnostic and statistical manual of mental disorders (DSM-5) 1 classification system, scheduled for May 2013, will create controversy due to the expanded range of problems now classed as mental disorders. However, in our view, it is unlikely to improve clinical care. The ultimate test for any system of diagnosis is its clinical utility. That is, does it assist clinicians to improve their selection or sequencing of treatments and enable them to make more accurate prognostic statements in keeping with newer concepts and knowledge? We propose that a refinement to traditional diagnostic practiceΓÇöclinical staging├éΓÇöis more likely to improve clinical care and inform future research into the causes of mental disorders. 2-5 Further, clinical staging draws the practice of clinical psychiatry closer to general medicine, especially with regard to chronic disease management.\nIn the past century, a├é┬á├éΓÇª\n','',2013,NULL,NULL,'2013-05-20',NULL,NULL,NULL,NULL,'51','Medical Journal of Australia','198','9','461-462','','YMH team','Models of care',''),(803,'Therapeutic signposts: Using biomarkers to guide better treatment of schizophrenia and other psychotic disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-61849179511&doi=10.5694%2fj.1326-5377.2009.tb02371.x&partnerID=40&md5=ac32c2ef0c7a7c43fe9a35c38b8287b4','10.5694/j.1326-5377.2009.tb02371.x','ΓÇó We propose that various measures of brain structure or function, gene expression and proteomic technologies can be used to guide better treatment of schizophrenia and other psychotic disorders.','',2009,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'51','Medical Journal of Australia','190','S4','S26-S32','','YMH team','Neurobiology','Illness specific areas'),(804,'Psychomotor slowing in older patients with major depression: Relationships with blood flow in the caudate nucleus and white matter lesions','https://www.scopus.com/inward/record.uri?eid=2-s2.0-34447291619&doi=10.1016%2fj.pscychresns.2007.01.006&partnerID=40&md5=6a99e55fe364b585e348cc6001e9b67a','10.1016/j.pscychresns.2007.01.006','\nObjectives\nSelected structural and functional neuroimaging correlates of psychomotor slowing were examine in older persons with depression. Clinical, neuropsychological, magnetic resonance imaging (MRI) and single photon emission computerized tomography (SPECT) data were obtained for 32 persons with depression (mean age┬á=├é┬á55.5) and 17 controls (mean age = 55.4). Psychomotor slowing was measured by simple (SRT) and choice (CRT) reaction times. White matter lesions (WMLs) were visually rated and caudate nucleus regional cerebral blood flow (rCBF) was obtained through the co-registration of MRI and SPECT data. Two SPECT scans were performed (corresponding to the SRT and CRT tasks) and a percentage change score in rCBF (%rCBF) due to the increasing complexity of the second task was calculated. Persons with depression and controls did not differ with respect to %rCBF or frequency├é┬á├éΓÇª\n','',2007,NULL,NULL,'2007-08-15',NULL,NULL,NULL,NULL,'51','Psychiatry Research - Neuroimaging','155','3','211-220','Elsevier','YMH team','Neurobiology','illness specific areas'),(805,'A comparison of ten polygenic score methods for psychiatric disorders applied across multiple cohorts','https://www.sciencedirect.com/science/article/pii/S0006322321012634',NULL,'\n\nBackground\nPolygenic scores (PGSs), which assess the genetic risk of individuals for a disease, are calculated as a weighted count of risk alleles identified in genome-wide association studies. PGS methods differ in which DNA variants are included and the weights assigned to them; some require an independent tuning sample to help inform these choices. PGSs are evaluated in independent target cohorts with known disease status. Variability between target cohorts is observed in applications to real data sets, which could reflect a number of factors, e.g., phenotype definition or technical factors.\n\n\nMethods\nThe Psychiatric Genomics Consortium Working Groups for schizophrenia and major depressive disorder bring together many independently collected case-control cohorts. We used these resources (31,328 schizophrenia cases, 41,191 controls; 248,750 major depressive disorder cases, 563,184 controls) in├é┬á├éΓÇª\n\n','',2021,NULL,NULL,'2021-11-01',NULL,NULL,NULL,NULL,'50','Biological psychiatry','90','9','611-620','Elsevier',NULL,NULL,NULL),(806,'More us than them: Positive depictions of mental illness on Australian television news','https://www.scopus.com/inward/record.uri?eid=2-s2.0-68049111586&doi=10.1080%2f00048670902873623&partnerID=40&md5=04524e29662b157ec2df059b63883bcb','10.1080/00048670902873623','\n\nObjective: The aim of the present study was to review television news coverage of mental illness including self-depictions from people with mental illness, and views expressed by mental health experts and politicians in all 538 news and current affairs items related to mental illness broadcast on free-to-air Sydney television, May 2005ΓÇôOctober 2007.\n\nMethods: Content and frame analysis was done of news actors (those with mental illnesses, experts and politicians) of whether depictions were positive ├éΓÇÿone of us├éΓÇÖ, or negative ├éΓÇÿone of them├éΓÇÖ.\n\nResults: Only 6% of all items with a main focus on a specific health condition, focused on mental health. Individuals with mental illness were present in 264 (49%) of 538 items, with most (174, 66%) of these self-depictions categorized as either neutral or positive. Experts and politicians overwhelmingly represented and described people with mental illnesses in neutral or positive ways├é┬á├éΓÇª\n','',2009,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'50','Australian and New Zealand Journal of Psychiatry','43','6','554-560','Sage Publications','Other','',''),(807,'Measuring outcomes in patients with depression or anxiety: An essential part of clinical practice','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037135829&doi=10.5694%2fj.1326-5377.2002.tb04734.x&partnerID=40&md5=b0fe0734f7af6ee084c93efdfd2da20d','10.5694/j.1326-5377.2002.tb04734.x','To encourage widespread application in general medical settings, measures need to have a number of key characteristics. These include brevity, low cost (preferably being in the public domain), self-report rather than clinician-administered format, results that are readily communicated to the patient, and demonstrated responsiveness to change in clinical status. Further, symptom-based instruments should be focused on the common symptoms of depression, anxiety or related somatic constructs. 9 Such instruments also lend themselves to automation and electronic record keeping. While illness-specific measures are commonly used in specialist practice (eg, for major depression, panic disorder, social anxiety or obsessive compulsive disorder only), they are far less attractive in general medical settings. Given these considerations, we recommend a small series of instruments for use in general medical settings. For the assessment of common symptoms of depression and anxiety, we recommend the Kessler Psychological Distress Scale (K10), 16 the Somatic and Psychological HEalth REport (SPHERE), 8 or the Hospital Anxiety and Depression Scale (HADS). 17 The K10 is a 10-item instrument that was developed internationally and has been used in the Australian National Survey of Mental Health and Wellbeing. Scores range from 10 to 50, with scores above 30 being highly predictive of a depressive or anxiety disorder. The sensitivity and specificity of the K10 (ie, its ability to predict diagnosis) is superior to that of the 30-item General Health Questionnaire (GHQ). 18 In the national mental health survey, it correlated 0.5 with the GHQ,ΓÇô0.6 with├é┬á├éΓÇª','',2002,NULL,NULL,'2002-08-19',NULL,NULL,NULL,NULL,'50','Medical Journal of Australia','177','4','205-207','Sydney, Australia: Australian Medical Association, 1914-','YMH team','Models of care','Outcome Research'),(808,'An approach to managing depression in general practice','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034679741&doi=10.5694%2fj.1326-5377.2000.tb139255.x&partnerID=40&md5=18cdcb8b9621978149f58e7b7574f282','10.5694/j.1326-5377.2000.tb139255.x','Detection of depression in primary care can be enhanced by use of self-report assessment forms. With the new classes of antidepressants, there is the opportunity to choose specific drug classes for different types of depressive disorders. Depression is frequently a relapsing illness. Treatment goals should include long term reduction of vulnerability factors. An active therapeutic partnership can be facilitated by providing accurate detailed information early in the course of the illness. Behavioural therapies, which focus on modification of the sleep-wake cycle, activity planning and reduction of substance abuse, are essential. Structured problem solving is the most accessible form of cognitive intervention that general practitioners can readily provide. More complex cognitive therapies are usually provided by mental health professionals or general practitioners with extensive training.','',2000,NULL,NULL,'2000-07-01',NULL,NULL,NULL,NULL,'50','Medical Journal of Australia','173','2','106-110','','YMH team','Mental Health System',''),(809,'Non-melancholic depression: The contribution of personality, anxiety and life events to subclassification','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031720290&doi=10.1017%2fS0033291798007107&partnerID=40&md5=2c20038b76d7297523e4d63fdc46b955','10.1017/S0033291798007107','\nBackground.\n\n We sought to develop a clinically useful subtyping system for the non-melancholic depressive disorders, and here we assess one weighted to central aetiological factors.\nMethods.\n\n We studied 185 patients meeting DSM-III-R and/or clinical criteria for non-melancholic depression. Data were obtained by self-report, interview of patients and from corroborative witnesses. We developed a set of variables for class definition, assessing: (i) ΓÇÿP├éΓÇÖ, disordered personality as a vulnerability factor; (ii) ├éΓÇÿA├éΓÇÖ, meeting criteria for a lifetime anxiety disorder or positive on probe questions about trait anxiety characteristics, so assessing anxiety as a vulnerability factor; and (iii) ├éΓÇÿL├éΓÇÖ, psychiatrist and consensually-rated life event stress prior to depression onset.\nResults.\n\n A latent class analysis generated a four-class solution for the P├éΓÇôA├éΓÇôL variables. Life event stressors had similar item probabilities across all four classes, and did not├é┬á├éΓÇª\n','',1998,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'50','Psychological Medicine','28','5','1209-1219','Cambridge University Press','Other','',''),(810,'Hair Cortisol in Twins: Heritability and Genetic Overlap with Psychological Variables and Stress-System Genes','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85033567547&doi=10.1038%2fs41598-017-11852-3&partnerID=40&md5=f9f18bf914dde26d21071f3502aa73bf','10.1038/s41598-017-11852-3',NULL,'',2017,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'','Scientific Reports','','','','Nature Publishing Group','Other','',''),(811,'Genetic influences on individual differences in longitudinal changes in global and subcortical brain volumes: Results of the ENIGMA plasticity working group','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020183556&doi=10.1002%2fhbm.23672&partnerID=40&md5=d445273ee5ab7149ef89ce08a7f8c34d','10.1002/hbm.23672',' Structural brain changes that occur during development and ageing are related to mental health and general cognitive functioning. Individuals differ in the extent to which their brain volumes change over time, but whether these differences can be attributed to differences in their genotypes has not been widely studied. Here we estimate heritability (h2) of changes in global and subcortical brain volumes in five longitudinal twin cohorts from across the world and in different stages of the lifespan (N = 861). Heritability estimates of brain changes were significant and ranged from 16% (caudate) to 42% (cerebellar gray matter) for all global and most subcortical volumes (with the exception of thalamus and pallidum). Heritability estimates of change rates were generally higher in adults than in children suggesting an increasing influence of genetic factors explaining individual differences in brain structural changes with age├é┬á├éΓÇª\n','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'49','Human Brain Mapping','38','9','4444-4458','','Other','',''),(812,'Childhood-versus adolescent-onset antisocial youth with conduct disorder: Psychiatric illness, neuropsychological and psychosocial function','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84926660311&doi=10.1371%2fjournal.pone.0121627&partnerID=40&md5=07aa32957b0946747a6d00846275e75a','10.1371/journal.pone.0121627','Objective The present study investigates whether youths with childhood-onset antisocial behavior have higher rates of psychiatric illness, neuropsychological and psychosocial dysfunction than youths who engage in antisocial behavior for the first time in adolescence. Prior studies have generally focused on single domains of function in heterogeneous samples. The present study also examined the extent to which adolescent-onset antisocial behavior can be considered normative, an assumption of MoffittΓÇÖs dual taxonomy model.   Method Forty-three subjects (34 males, 9 females, mean age = 15.31, age range 12├éΓÇô21) with a diagnosis of conduct disorder (CD) were recruited through Headspace Services and the Juvenile Justice Community Centre. We compared childhood-onset antisocial youths (n = 23) with adolescent-onset antisocial youths (n = 20) with a conduct disorder, across a battery of psychiatric, neuropsychological and psychosocial measures. Neuropsychological function of both groups was also compared with normative scores from control samples.   Results The childhood-onset group displayed deficits in verbal learning and memory, higher rates of psychosis, childhood maltreatment and more serious violent behavior, all effects associated with a large effect size. Both groups had impaired executive function, falling within the extremely low range (severely impaired).   Conclusions Childhood-onset CD displayed greater cognitive impairment, more psychiatric symptoms and committed more serious violent offences. The finding of severe executive impairment in both childhood- and adolescent-onset groupings challenges the├é┬á├éΓÇª','',2015,NULL,NULL,'2015-04-02',NULL,NULL,NULL,NULL,'49','PLoS ONE','10','4','e0121627','Public Library of Science','Other','Illness specific areas','Outcome Research'),(813,'Hyperscanning and avoidance in social anxiety disorder: The visual scanpath during public speaking','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922838499&doi=10.1016%2fj.psychres.2014.11.025&partnerID=40&md5=cc07f9b18b6b6e5d9b893873657d9d0f','10.1016/j.psychres.2014.11.025','Social anxiety disorder (SAD) is a debilitating mental illness which is thought to be maintained in part by the aberrant attentional processing of socially relevant information. Critically however, research has not assessed whether such aberrant attentional processing occurs during social-evaluative contexts characteristically feared in SAD. The current study presents a novel approach for the assessment of the visuocognitive biases operating in SAD during a social-evaluative stressor. For this task, clinically socially anxious participants and controls were required to give a brief impromptu speech in front of a pre-recorded audience who intermittently displayed socially positive or threatening gestures. Participant gaze at the audience display was recorded throughout the speech. Socially anxious participants exhibited a significantly longer visual scanpath, relative to controls. In addition, socially anxious participants spent','',2015,NULL,NULL,'2015-02-28',NULL,NULL,NULL,NULL,'49','Psychiatry Research','225','3','667-672','Elsevier','Other','',''),(814,'Vascular risk and low serum B12 predict white matter lesions in patients with major depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-15244345592&doi=10.1016%2fj.jad.2004.11.003&partnerID=40&md5=85908ff076abd3ee196e85c2669953c0','10.1016/j.jad.2004.11.003','\n\nBackground\nWhile patients with depression have been shown to have a greater incidence of vascular risk factors and structural brain changes, any association with dietary co-factors is unclear.\n\n\nMethods\nForty-seven patients with major depression (mean age=52.8 years, SD=12.6) and 21 healthy volunteers (mean age=54.7 years, SD=9.1) underwent high-resolution magnetic resonance imaging scanning. T2-weighted films were scored for deep white matter (DWM), periventricular (PV), and subcortical (SC) hyperintensities.\n\n\nResults\nThere was no difference in lesion severity between patients and control subjects. After controlling for age, vitamin B12 levels were predictive of DWM lesions in patients. DWM and SC lesions were associated with histories of hypertension and diabetes.\n\n\nLimitations\nA relatively small sample of patients were recruited from specialist services and the findings may not represent those observed in\n\n','',2005,NULL,NULL,'2005-04-01',NULL,NULL,NULL,NULL,'49','Journal of Affective Disorders','85','3','327-332','Elsevier','YMH team','Neurobiology','illness specific areas'),(815,'Brain structural abnormalities in obesity: relation to age, genetic risk, and common psychiatric disorders: Evidence through univariate and multivariate mega-analysis including 6420 participants from the ENIGMA MDD working group','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85083229293&doi=10.1038%2fs41380-020-0774-9&partnerID=40&md5=a8b17769bc6b105cf8e226197b1cfe49','10.1038/s41380-020-0774-9','Emerging evidence suggests that obesity impacts brain physiology at multiple levels. Here we aimed to clarify the relationship between obesity and brain structure using structural MRI (n = 6420) and genetic data (n = 3907) from the ENIGMA Major Depressive Disorder (MDD) working group. Obesity (BMI > 30) was significantly associated with cortical and subcortical abnormalities in both mass-univariate and multivariate pattern recognition analyses independent of MDD diagnosis. The most pronounced effects were found for associations between obesity and lower temporo-frontal cortical thickness (maximum Cohen├é┬┤s d (left fusiform gyrus) = -0.33). The observed regional distribution and effect size of cortical thickness reductions in obesity revealed considerable similarities with corresponding patterns of lower cortical thickness in previously published studies of neuropsychiatric disorders. A higher├é┬á├éΓÇª','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'48','Molecular Psychiatry','26','9','4839-4852','Nature Publishing Group','Other','',''),(816,'Comparison of self-reported telephone interviewing and web-based survey responses: Findings from the second australian young and well national survey','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052193051&doi=10.2196%2fmental.8222&partnerID=40&md5=6059442d1682f3340f3565957c8cce38','10.2196/mental.8222','','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','JMIR Mental Health','','','','JMIR Publications, Inc.','YMH team','Models of care','Digital health'),(817,'Transitions Study of Predictors of illness progression in young people with mental ill Health: Study methodology','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84921263296&doi=10.1111%2feip.12079&partnerID=40&md5=4a5651aae1cb7c18ac19163e2e1ca2dd','10.1111/eip.12079','  Aim An estimated 75% of mental disorders begin before the age of 24 and approximately 25% of 13├éΓÇô24-year-olds are affected by mental disorders at any one time. To better understand and ideally prevent the onset of post-pubertal mental disorders, a clinical staging model has been proposed that provides a longitudinal perspective of illness development. This heuristic model takes account of the differential effects of both genetic and environmental risk factors, as well as markers relevant to the stage of illness, course or prognosis. The aim of the Transitions Study is to test empirically the assumptions that underpin the clinical staging model. Additionally, it will permit investigation of a range of psychological, social and genetic markers in terms of their capacity to define current clinical stage or predict transition from less severe or enduring to more severe and persistent stages of mental disorder.   Method This paper├é┬á├éΓÇª\n','',2015,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'38','Early Intervention in Psychiatry','9','1','38-47','','YMH team','Outcome Research',''),(818,'The relationship between actigraphically defined sleep disturbance and REM sleep behaviour disorder in Parkinson\'s Disease','https://www.scopus.com/inward/record.uri?eid=2-s2.0-77951835435&doi=10.1016%2fj.clineuro.2010.02.011&partnerID=40&md5=e1210864e2f070763bb50a9ae1be343d','10.1016/j.clineuro.2010.02.011','\n\nAim\nIn this study, we sought to evaluate the utility of actigraphy for examining symptoms of rapid eye movement sleep behaviour disorder (RSBD).\n\n\nMethods\nTwenty-two patients with idiopathic Parkinson\'s Disease (mean age┬á=├é┬á63.4 years, SD├é┬á=├é┬á7.5) underwent neurological assessment and completed sleep diaries, self-report sleep questionnaires and 2-weeks of actigraphy. They also completed the rapid eye movement sleep behavior disorder questionnaire and were classified as screening negative (RSBD-, n├é┬á=├é┬á9) or positive (RSBD+, n├é┬á=├é┬á13) for RSBD according to published criteria. Key outcome data were the number of wake bouts and duration of arousals during the sleep interval as determined by actigraphy.\n\n\nResults\nPatients classified as RSBD+ demonstrated a higher number of wake bouts than those who were RSBD- (p├é┬á=├é┬á0.011).\n\n\nConclusions\nThese results suggest that actigraphy may be a viable tool to assist in├é┬á├éΓÇª\n\n','',2010,NULL,NULL,'2010-06-01',NULL,NULL,NULL,NULL,'48','Clinical Neurology and Neurosurgery','112','5','420-423','Elsevier','YMH team','Illness specific areas',''),(819,'An evaluation of beyondblue, Australia\'s national depression initiative','https://www.tandfonline.com/doi/abs/10.1080/14623730.2005.9721865',NULL,'beyondblue is a five-year Australian initiative which takes a populationhealth approach to combating depression. This paper\'s aim is to describe the findings of an evaluation of beyondblue, conducted four years into its existence.The achievements of beyondblue were examined in the light of its objectives, using synthesised data from 15 secondary sources. Many of beyondblue\'s lower-level objectives have been completely achieved, with a plethora of key initiatives in place that have led to greater availability of information about depression, improvements in consumer networks, better support for mental health care delivery in primary care settings and increases in targeted research. Most of its intermediate-level and high-level objectives have been partly achieved, with headway made in terms of the community\'s ΓÇÿdepression literacy├éΓÇÖ, acknowledgement of the consumer/carer perspective, the degree to which the├é┬á├éΓÇª','',2005,NULL,NULL,'2005-05-01',NULL,NULL,NULL,NULL,'48','International Journal of Mental Health Promotion','7','2','35-53','Taylor & Francis Group',NULL,NULL,NULL),(820,'Experience with treatment services for people with bipolar disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-5044250015&doi=10.5694%2fj.1326-5377.2004.tb06353.x&partnerID=40&md5=2de2ed4b12ad2cd83fd786e4b042c875','10.5694/j.1326-5377.2004.tb06353.x',' \nObjective: To describe the experiences of people with bipolar disorder with primary care and specialist mental health services. \nDesign and setting: Focus groups and indepth interviews were conducted in seven Australian capital cities between July 2002┬áand April 2003. Thematic analyses were conducted using the QSR NUD*IST software package for qualitative data. \nParticipants: Forty-nine people with bipolar disorder participated in the focus groups and four participated in the interviews. \nResults: Thematic analyses highlighted eight key themes. Most notably, respondents identified a lack of awareness and understanding about bipolar disorder within the Australian community, which contributed to apparent delays in seeking medical assessment. The burden of illness was exacerbated by difficulties experienced with obtaining an accurate diagnosis and optimal treatment. The healthcare system responses were├é┬á├éΓÇª\n','',2004,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'48','Medical Journal of Australia','181','','S47-S51','','YMH team','Illness specific areas','Mental Health System'),(821,'Responding to the Australian experience of depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037141066&doi=10.5694%2fj.1326-5377.2002.tb04505.x&partnerID=40&md5=a4db460b97386f4751d0faac8522e0c2','10.5694/j.1326-5377.2002.tb04505.x','Depression is a major public health issue in Australia. 1 Although more than 800 000 Australians experience depression each year, less than 40% of affected individuals present for care and fewer than one in six receive an evidence-based treatment. 1 Most people with depression experience significant disability (reduced productivity on\" seven of the past 28 days\" 2) and those who present for care are likely to have relapsing or chronic disorders. 3 The current health burden of depression, and the projected future impact on our society, prompted the Federal and Victorian governments to develop beyondblue: the national depression initiative. 4 The initiative has bipartisan political support and has grown to include active participation by other States and Territories and the development of partnerships with a range of non-government and community-based organisations. 5','',2002,NULL,NULL,'2002-05-20',NULL,NULL,NULL,NULL,'48','Medical Journal of Australia','176','10','61','','YMH team','Illness specific areas',''),(822,'Chronic fatigue syndrome: Clinical practice guidelines','https://scholar.google.com/scholar?cluster=3422650085279047016&hl=en&oi=scholarr',NULL,'\nThank you for the opportunity to comment on Draft Two of the Guidelines. I have not followed the methodology of response suggested by the email forwarding the Guidelines because I do not believe that our organisation, representing consumers around Australia, can support the current version.\nIt is my hope that the members of the working party will meet in a face to face situation to fully debate the contents of Draft Two in light of all of the responses and suggested references put before you. Surely CFS patients are entitled to the very best outcome possible from a guidelines document. General Practitioners, the significant target audience for this document should be able to find it useful, relevant and accurate.\n','',2002,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'48','Med J Aust','176','Suppl','S23-S56','',NULL,NULL,NULL),(823,'Interactive impact of childhood maltreatment, depression, and age on cortical brain structure: Mega-analytic findings from a large multi-site cohort','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065738289&doi=10.1017%2fS003329171900093X&partnerID=40&md5=e701d4f5393dd4794180c70123d85544','10.1017/S003329171900093X','Background       Childhood maltreatment (CM) plays an important role in the development of major depressive disorder (MDD). The aim of this study was to examine whether CM severity and type are associated with MDD-related brain alterations, and how they interact with sex and age. Methods       Within the ENIGMA-MDD network, severity and subtypes of CM using the Childhood Trauma Questionnaire were assessed and structural magnetic resonance imaging data from patients with MDD and healthy controls were analyzed in a mega-analysis comprising a total of 3872 participants aged between 13 and 89 years. Cortical thickness and surface area were extracted at each site using FreeSurfer. Results       CM severity was associated with reduced cortical thickness in the banks of the superior temporal sulcus and supramarginal gyrus as well as with reduced surface area of the middle temporal lobe. Participants├é┬á├éΓÇª','',2020,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'47','Psychological Medicine','50','6','1020-1031','Cambridge University Press','Other','',''),(824,'Project Synergy: co-designing technology-enabled solutions for Australian mental health services reform','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072926780&doi=10.5694%2fmja2.50349&partnerID=40&md5=9ebf450f140b41552734b987c3f90a76','10.5694/mja2.50349','  Project Synergy aims to test the potential of new and emerging technologies to enhance the quality of mental health care provided by traditional face-to-face services. Specifically, it seeks to ensure that consumers get the right care, first time (delivery of effective mental health care early in the course of illness).  Using co-design with affected individuals, Project Synergy has built, implemented and evaluated an online platform to assist the assessment, feedback, management and monitoring of people with mental disorders. It also promotes the maintenance of wellbeing by collating health and social information from consumers, their supportive others and health professionals. This information is reported back openly to consumers and their service providers to promote genuine collaborative care.  The online platform does not provide stand-alone medical or health advice, risk assessment, clinical diagnosis or├é┬á├éΓÇª\n\n','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'47','Medical Journal of Australia','211','','S3-S39','','YMH team','Models of care','Digital health'),(825,'Bipolar At-Risk Criteria: An Examination of Which Clinical Features Have Optimal Utility for Identifying Youth at Risk of Early Transition from Depression to Bipolar Disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021783796&doi=10.1093%2fschbul%2fsbw154&partnerID=40&md5=ab0c32e994e05f133e83c1dc39ff04ba','10.1093/schbul/sbw154','','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Schizophrenia Bulletin','','','','Oxford University Press','YMH team','Illness specific areas',''),(826,'Vascular risk to late-life depression: Evidence from a longitudinal community study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0346034586&doi=10.1046%2fj.1440-1614.2003.01105.x&partnerID=40&md5=fdb8b791d381ade545105ad843705155','10.1046/j.1440-1614.2003.01105.x','\n\nObjective: To determine prospectively relationships between minor cerebrovascular episodes and depressive symptoms in a community cohort of older persons.\n\nMethod: In 1988ΓÇô1989, baseline measurements of vascular risk factors and depressive symptoms were obtained in older community residents (mean age = 67). At 10-year followup, three subgroups of subjects still residing in the community were re-assessed: those who had suffered a transient ischaemic attack (TIA) (n = 16) in the intervening period; those with hypertension but no TIAs (n = 38); and, those with neither TIAs nor hypertension (n = 40).\n\nResults: Of the 16 persons with depressive symptoms at 10-year follow-up, only three had reported depressive symptoms initially. Subjects who had experienced TIAs during the longitudinal phase had higher rates of depressive symptoms than the subjects from the other two groups (38% vs 13%, p < 0.05├é┬á├éΓÇª\n','',2003,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'47','Australian and New Zealand Journal of Psychiatry','37','1','62-65','Sage Publications','YMH team','Illness specific areas','Outcome Research'),(827,'Social impairments in autism spectrum disorder are related to maternal immune history profile','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053824781&doi=10.1038%2fmp.2017.201&partnerID=40&md5=ef7328e624f0be0830103271fde4f0b3','10.1038/mp.2017.201','Maternal immune activation has been highlighted as a factor that might increase the risk and severity of autism spectrum disorder (ASD) in children. Preclinical animal evidence shows that immune activation in mothers during pregnancy causes ASD-like behavioural traits in offspring. To this point, there has been no investigation of whether immune system activation in human mothers during pregnancy is associated with more severe symptoms in children with ASD. In this study, data from an existing ASD cohort (N=220) were analysed to investigate whether immune conditions in the mother were associated with greater severity of autism-related symptoms. Results showed that children whose mothers reported a history of immune activation (allergies and asthma) had significantly higher scores on the Social Responsiveness Scale (SRS; P=0.016), suggesting more severe social impairment symptoms in these','',2018,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'46','Molecular Psychiatry','23','8','1794-1797','Nature Publishing Group','Other','',''),(828,'Prevalence and correlates of prolonged fatigue in a U.S. sample of adolescents','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84879444232&doi=10.1176%2fappi.ajp.2012.12040454&partnerID=40&md5=439245d812c8735159f1fc00c6534c05','10.1176/appi.ajp.2012.12040454','\nObjective\nProlonged fatigue in adolescents has a major impact on social functioning and school attendance. In adults, prolonged fatigue substantially overlaps with mood and anxiety disorders. Extending the data to adolescents, the authors studied the prevalence and correlates of fatigue in a representative U.S. sample.\nMethod\nThe participants were 10,123 adolescents ages 13ΓÇô18 years from the National Comorbidity Survey Adolescent Supplement. They were interviewed about prolonged fatigue, defined as extreme fatigue with at least one associated symptom (pains, dizziness, headache, sleep disturbance, inability to relax, irritability) that does not resolve by resting or relaxing and lasting at least 3 months.\nResults\nThe prevalence of prolonged fatigue was 3.0% (SE=0.3), with 1.4% (SE=0.2) for prolonged fatigue only and 1.6% (SE=0.2) for prolonged fatigue concomitant with a depressive or anxiety disorder. Nearly├é┬á├éΓÇª\n','',2013,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'46','American Journal of Psychiatry','170','5','502-510','American Psychiatric Association','Other','',''),(829,'How does social functioning in the early stages of psychosis relate to depression and social anxiety?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-79960834638&doi=10.1111%2fj.1751-7893.2011.00280.x&partnerID=40&md5=e38026f1af351d27bb68a74c8534c612','10.1111/j.1751-7893.2011.00280.x',' \nAims: The study aims to compare social functioning in young people considered to be at risk of psychosis with those meeting criteria for first episode psychosis (FEP) and controls, and to determine the association between social functioning and positive and negative symptoms, depressive symptoms, and social anxiety. \nMethods: This study examined social functioning in 20 individuals at risk of psychosis, 20 FEP patients and 20 healthy controls. Social functioning was measured using the Social Functioning Scale and World Health Organization Disability Assessment Scale. Psychiatric variables were also measured using the Comprehensive Assessment of At-Risk Mental States, the Brief Psychiatric Rating Scale, the Brief Social Phobia Scale, and the Depression Anxiety and Stress Scale. \nResults: At-risk individuals had comparable social deficits to the FEP group, and both patient groups had significantly poorer\n','',2011,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'46','Early Intervention in Psychiatry','5','3','224-232','Blackwell Publishing Asia','YMH team','Outcome Research',''),(830,'Clinical staging in psychiatry','https://books.google.com/books?hl=en&lr=&id=gjGdDwAAQBAJ&oi=fnd&pg=PR7&dq=info:hgjMchWIuvkJ:scholar.google.com&ots=1xKhnl6Xnr&sig=bnm14fnrfIBvTsJDcRJfQ6mWlRo',NULL,'Psychiatric diagnosis is experiencing a crisis of confidence. Current approaches are outmoded, with reform desperately needed. Clinical staging is a solution to this crisis. Clinical staging addresses the limitations of current diagnostic systems by recognising the full continuum or trajectory of mental illness from asymptomatic to chronic illness. It acknowledges the overlap between mental health symptoms during early stages and directly links each stage to treatment and underlying cognitive, neurological and biological changes. This approach enhances chances of early identification, promotes the implementation of safer treatments, and increases opportunities to alter the negative trajectory of mental disorders. This book comprehensively describes the conceptual basis of clinical staging in psychiatry, details current progress in identifying biomarkers for each stage, and explores the implications of staging on treatment and health systems. This book provides a foundation for transformational reform in psychiatric diagnosis.','',2019,NULL,NULL,'2019-08-29',NULL,NULL,NULL,NULL,'45','','','','','Cambridge University Press',NULL,NULL,NULL),(831,'Reduced heart rate variability in adults with autism spectrum disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066796618&doi=10.1002%2faur.2104&partnerID=40&md5=a745e63e6b5324680a8eb0c9d961f3a8','10.1002/aur.2104',' A growing body of research has suggested heart rate variability (HRV) may be reduced in autism spectrum disorder (ASD) in comparison to neurotypical cohorts. While there have been several studies investigating HRV in children diagnosed with ASD, few studies have been conducted in adults. The objective of the current study was to investigate autonomic nervous system activity as assessed by HRV in adults diagnosed with ASD. We hypothesized that adults with ASD would show a reduction in HRV compared to neurotypical participants. Participants diagnosed with ASD (n=55) were recruited from the Autism Clinic for Translational Research at the Brain and Mind Centre (University of Sydney) between 2013 and 2017. Neurotypical participants were recruited from advertisements and online media. Resting state heart rate was measured for 5min while participants sat in an upright position. Results showed\n','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'36','Autism Research','12','6','922-930','John Wiley & Sons, Inc.','Other','',''),(832,'Structural brain correlates of obstructive sleep apnoea in older adults at risk for dementia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049650216&doi=10.1183%2f13993003.00740-2018&partnerID=40&md5=6a308255174418291cbce3ad7bffa085','10.1183/13993003.00740-2018','\nThis study aimed to investigate associations between obstructive sleep apnoea (OSA) and cortical thickness in older adults with subjective and objective cognitive difficulties, who are considered ΓÇ£at-risk├éΓÇ¥ for dementia.\n83 middle-aged to older adults (51├éΓÇô88 years) underwent neuropsychological testing, polysomnography assessment of OSA and a structural magnetic resonance imaging brain scan. A principal components analysis was performed on OSA measures. Cortical thickness and subcortical volumes were compared to extracted components of ├éΓÇ£oxygen desaturation├éΓÇ¥ and ├éΓÇ£sleep disturbance├éΓÇ¥.\nOxygen desaturation was significantly related to reduced cortical thickness in the bilateral temporal lobes (left: r=-0.44, p<0.001; right: r=-0.39, p=0.003). Conversely, sleep disturbance was associated with increased thickness in the right postcentral gyrus (r=0.48, p<0.001), pericalcarine (r=0.50, p=0.005) and pars├é┬á├éΓÇª\n','',2018,NULL,NULL,'2018-07-01',NULL,NULL,NULL,NULL,'40','European Respiratory Journal','52','1','','European Respiratory Society','Other','',''),(833,'NEURAPRO: A multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders - Medium-term follow-up and clinical course','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052688321&doi=10.1038%2fs41537-018-0052-x&partnerID=40&md5=2153299321792bde8e8f66aac38ab0be','10.1038/s41537-018-0052-x','This study reports a medium-term follow-up of a randomised, double-blind, placebo-controlled trial of omega-3 polyunsaturated fatty acids (PUFA) in ultra-high risk for psychosis (UHR) patients. Primary outcomes of interest were transition to psychosis and symptomatic and functional outcome. A secondary aim was to investigate clinical predictors of medium-term outcome. Three hundred four UHR participants were recruited across 10 specialised early psychosis services in Australia, Asia, and Europe. The intervention consisted of 1.4 g/daily of omega-3 PUFA or placebo, plus up to 20 sessions of cognitive-behavioural case management (CBCM), over the 6-month study period, with participants receiving further CBCM sessions on basis of need between months 6├éΓÇô12. Mean time to follow-up was 3.4 (median = 3.3; SD = 0.9) years. There was a modest increase in transitions between 12-month and medium-term├é┬á├éΓÇª','',2018,NULL,NULL,'2018-06-25',NULL,NULL,NULL,NULL,'45','npj Schizophrenia','4','1','1-Aug','Nature Publishing Group','Other','',''),(834,'Evaluating differential developmental trajectories to adolescent-onset mood and psychotic disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84887271290&doi=10.1186%2f1471-244X-13-303&partnerID=40&md5=a7d1fa7d06db1e4685530b5278b1f08f','10.1186/1471-244X-13-303','It is an open question as to whether differential developmental trajectories, potentially representing underlying pathophysiological processes, can form the basis of a more useful typology in young persons who present for mental health care. A cohort of 605 young people was recruited from youth mental health services that target the early phases of anxiety, mood or psychotic disorders. Participants were assigned to one of three clinical sub-types (anxious-depression; mania-fatigue; developmental-psychotic) according to putative developmental trajectories. The distribution of subtypes was: 51% anxiety-depression, 25% mania-fatigue and 24% developmental-psychotic, with key differences in demographic, clinical, family history and neuropsychological characteristics. When analyses were limited to 286 cases with ΓÇÿattenuated├éΓÇÖ or sub-threshold syndromes, the pattern of differences was similar. Multinomial logistic├é┬á├éΓÇª','',2013,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'45','BMC Psychiatry','13','1','1-Nov','BioMed Central','YMH team','Outcome Research',''),(835,'The role of glia in late-life depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84868252034&doi=10.1017%2fS1041610212000828&partnerID=40&md5=cd5b7e39b5151199c6363dab5a189dd1','10.1017/S1041610212000828','Late-life depression (LLD) has a complex and multifactoral etiology. There is growing interest in elucidating how glia, acting alone or as part of a glialΓÇôneuronal network, may contribute to the pathophysiology of depression. In this paper, we explore results from neuroimaging studies showing gray-matter volume loss in key frontal and subcortical structures implicated in LLD, and present the few histological studies that have examined neuronal and glial densities in these regions. Compared to results in younger people with depression, there appear to be age-dependent differences in neuronal pathology but the changes in glial pathology may be more subtle, perhaps reflecting a longer-term compensatory gliosis to earlier damage. We then consider the mechanisms by which both astrocytes and microglia may mediate and modulate neuronal dysfunction and possible degeneration in depression. These include a├é┬á├éΓÇª','',2012,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'45','International Psychogeriatrics','24','12','1878-1890','Cambridge University Press','Other','',''),(836,'Internet-based treatment for older adults with depression and co-morbid cardiovascular disease: Protocol for a randomised, double-blind, placebo controlled trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-78651359823&doi=10.1186%2f1471-244X-11-10&partnerID=40&md5=5cb3c966bc2e9ff23cc9a734db7a4fbb','10.1186/1471-244X-11-10','Depression, cardiovascular disease (CVD) risk factors and cognitive impairment are important causes of disability and poor health outcomes. In combination they lead to an even worse prognosis. Internet or web-based interventions have been shown to deliver efficacious psychological intervention programs for depression on a large scale, yet no published studies have evaluated their impact among patients with co-existing physical conditions. The aims of this randomised controlled trial are to determine the effects of an evidence-based internet intervention program for depression on depressive mood symptoms, cognitive function and treatment adherence in patients at risk of CVD. This study is an internet-based, double-blind, parallel group randomised controlled trial. The trial will compare the effectiveness of online cognitive behavioural therapy with an online attention control placebo. The trial will consist of a 12','',2011,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'45','BMC Psychiatry','11','1','1-Oct','BioMed Central','YMH team','Digital health',''),(837,'Dissecting the shared genetic architecture of suicide attempt, psychiatric disorders, and known risk factors','https://www.sciencedirect.com/science/article/pii/S0006322321015705',NULL,'\n\nBackground\nSuicide is a leading cause of death worldwide, and nonfatal suicide attempts, which occur far more frequently, are a major source of disability and social and economic burden. Both have substantial genetic etiology, which is partially shared and partially distinct from that of related psychiatric disorders.\n\n\nMethods\nWe conducted a genome-wide association study (GWAS) of 29,782 suicide attempt (SA) cases and 519,961 controls in the International Suicide Genetics Consortium (ISGC). The GWAS of SA was conditioned on psychiatric disorders using GWAS summary statistics via multitrait-based conditional and joint analysis, to remove genetic effects on SA mediated by psychiatric disorders. We investigated the shared and divergent genetic architectures of SA, psychiatric disorders, and other known risk factors.\n\n\nResults\nTwo loci reached genome-wide significance for SA: the major histocompatibility complex├é┬á├éΓÇª\n\n','',2016,NULL,NULL,'2022-02-01',NULL,NULL,NULL,NULL,'19','Biological psychiatry','91','3','313-327','Elsevier',NULL,NULL,NULL),(838,'Using new and emerging technologies to identify and respond to suicidality among help-seeking young people: A cross-sectional study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85026442110&doi=10.2196%2fjmir.7897&partnerID=40&md5=0e54e0ca8356e8bca6a51f03c076f8f9','10.2196/jmir.7897','         Background         Suicidal thoughts are common among young people presenting to face-to-face and online mental health services. The early detection and rapid response to these suicidal thoughts and other suicidal behaviors is a priority for suicide prevention and early intervention efforts internationally. Establishing how best to use new and emerging technologies to facilitate person-centered systematic assessment and early intervention for suicidality is crucial to these efforts.                       Objective         The aim of this study was to examine the use of a suicidality escalation protocol to respond to suicidality among help-seeking young people.                       Methods         A total of 232 young people in the age range of 16-25 years were recruited from either a primary mental health care service or online in the community. Each young person used the Synergy Online System and completed an initial clinical assessment online before their face-to-face or online clinical appointment. A suicidality escalation protocol was used to identify and respond to current and previous suicidal thoughts and behaviors.                       Results         A total of 153 young people (66%, 153/232) reported some degree of suicidality and were provided with a real-time alert online. Further levels of escalation (email or phone contact and clinical review) were initiated for the 35 young people (15%, 35/232) reporting high suicidality. Higher levels of psychological distress (P<.001) and a current alcohol or substance use problem (P=.02) predicted any level of suicidality compared with no suicidality. Furthermore, predictors of high suicidality compared with low suicidality were├é┬á├éΓÇª\n','',2017,NULL,NULL,'2017-07-12',NULL,NULL,NULL,NULL,'44','Journal of Medical Internet Research','19','7','e7897','JMIR Publications Inc., Toronto, Canada','YMH team','Digital health','illness specific areas'),(839,'Retinal microvessels reflect familial vulnerability to psychotic symptoms: A comparison of twins discordant for psychotic symptoms and controls','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929282263&doi=10.1016%2fj.schres.2015.01.045&partnerID=40&md5=117e50fa1056b5365b382a4314f9c0c6','10.1016/j.schres.2015.01.045','Mounting evidence suggests that individuals with schizophrenia have an underlying vulnerability to cardiovascular disease, and a recent study suggested that this vulnerability might be reflected in the retinal microvasculature. The purpose of this study was to test the hypothesis that the retinal microvessels reflect familial vulnerability to psychotic symptoms. Participants were 531 adolescent and young adult twins who took part in the Brisbane Longitudinal Twin Study and the Twins Eye Study in Tasmania. The twins had photographs taken of their retina when they were adolescents or young adults (M age├é┬á=├é┬á20.6├é┬áyears), and retinal vessel diameter was assessed using computer software. The twins completed an assessment of psychosis symptoms approximately six years later. We compared retinal venular diameters of individuals with one or more symptoms of psychosis (n├é┬á=├é┬á45), their unaffected co-twins (n├é┬á=├é┬á24), and├é┬á├éΓÇª','',2015,NULL,NULL,'2015-05-01',NULL,NULL,NULL,NULL,'44','Schizophrenia Research','164','1-Mar','47-52','Elsevier','Other','',''),(840,'Distinct neurometabolic profiles are evident in the anterior cingulate of young people with major psychiatric disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84861179603&doi=10.1038%2ftp.2012.35&partnerID=40&md5=0799be43a5517cf96e6f80e08c38f0ce','10.1038/tp.2012.35','Currently, there are no validated neurobiological methods for distinguishing different pathophysiological pathways in young patients presenting in the early phases of major psychiatric disorders. Hence, treatments are delivered simply on the basis of their possible effects on nonspecific symptom constructs such as depression, cognitive change or psychotic symptoms. In this study, the ratios (relative to creatine) of key metabolites (N-acetyl aspartate, myoinositol, glutamate and glutathione) were measured with proton magnetic resonance spectroscopy (1 H-MRS) within the anterior cingulate cortex of 88 young persons presenting with major mood or psychotic symptoms. We derived empirically (using a cluster analytical technique) three subgroups of subjects on the basis of their patterns of in vivo brain biochemistry. The three subgroups were distinguished (from each other) by all the four metabolites, in particular','',2012,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'44','Translational Psychiatry','2','5','e110-e110','Nature Publishing Group','YMH team','Neurobiology',''),(841,'Improving Knowledge and Attitudes towards Depression: A controlled trial among Chinese medical students','https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952335084&doi=10.1186%2f1471-244X-11-36&partnerID=40&md5=be4fad0ee44f8343d912e54609b339c8','10.1186/1471-244X-11-36','Establishing an evidence-based method of improving knowledge and attitudes concerning depression has been identified as a priority in Chinese medical education. The purpose of this study was to determine whether a self-directed learning strategy as a part of student-centred education improved knowledge of and attitudes towards depression among Chinese medical students. A controlled trial in which 205 medical students were allocated to one of two groups: didactic teaching (DT) group or a combined didactic teaching and self-directed learning (DT/SDL) group. The DT/SDL group continued having a series of learning activities after both groups had a lecture on depression together. Student\'s knowledge and attitudes were assessed immediately after the activities, one month and six months later. The intervention (DT/SDL) group showed substantially greater improvements in recognition of depression as a','',2011,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'44','BMC Psychiatry','11','1','1-Oct','BioMed Central','Other','',''),(842,'Psychological morbidity in women at increased risk of developing breast cancer: A controlled study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-20144363678&doi=10.1002%2fpon.835&partnerID=40&md5=e196bdd1ce1379bbe656b6b59c8e94b6','10.1002/pon.835','  There has been an ongoing debate in the literature on the extent to which women with a family history of breast cancer are at risk of psychological morbidity. This study compares psychological morbidity in 557 women participating in a large Australian registry of high-risk breast cancer families (kConFab) with 2 age and education matched samples, 1494 general practitioner attendees and 158 members of a twin registry. Participants completed the Somatic and Psychological Health Report (SPHERE). There were no significant differences between the three groups on psychological distress (F2, 670=1.77, p=0.17). Unsurprisingly, GP attendees reported more symptoms of somatic distress than the kConFab group (t411=2.89, p=0.004); there were no differences between the twins and the kConFab group on somatic distress (t174=0.40, p=0.687). Clinically significant anxiety/depression, a combination of\n','',2005,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'44','Psycho-Oncology','14','3','196-203','John Wiley & Sons, Ltd.','Other','',''),(843,'A National Depression Index for Australia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-5044242784&doi=10.5694%2fj.1326-5377.2004.tb06354.x&partnerID=40&md5=2d1b17a3f879d671d4e3dd43bfa67deb','10.5694/j.1326-5377.2004.tb06354.x',' \nObjective: To develop a National Depression Index for measuring the depression status of the Australian population. \nDesign: Cross-sectional data were analysed from two random samples of the Australian adult population ΓÇö the National Survey of Mental Health and Wellbeing (2000) and the National Health Survey (2001). \nParticipants: The National Survey of Mental Health and Wellbeing (2000) ├éΓÇö 10├é┬á641├é┬áparticipants; and the National Health Survey (2001) ├éΓÇö 17├é┬á918├é┬áparticipants. \nMain outcome measures: Selected items from the Kessler Psychological Distress Scale (K10); and diagnoses of a major depressive episode according to DSM-IV criteria using a computerised interview. \nResults: Six items from the K10├é┬áthat were most closely related to the DSM-IV diagnosis of ├éΓÇ£major depressive episode├éΓÇ¥ were identified. Scores on an index calculated from these items were rescaled to form an index reflecting relative risk├é┬á├éΓÇª\n','',2004,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'44','Medical Journal of Australia','181','','S52-S56','','YMH team','Illness specific areas','Models of care'),(844,'Depression in young people: A national school-based initiative for prevention, early intervention and pathways for care','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036310183&doi=10.1046%2fj.1440-1665.2002.00421.x&partnerID=40&md5=74554b745e1df25b0c8660771d368806','10.1046/j.1440-1665.2002.00421.x','\n\nObjective: To describe the national school-based initiative of ΓÇÿbeyondblue├éΓÇÖ.\n\nConclusions: The goals of the initiative are: to reduce levels of depressive symptoms in young people, to promote emotional well-being in adolescence and to increase the capacity of organisations to design, implement and evaluate interventions relevant to the prevention of depression. The theoretical framework underpinning the program will build on expertise and evidence-based research from both the education and health sectors while the proposed initiative will draw on the existing capacity of school systems. The program will target not only the specific needs of individual students but will combine this targeted approach with a whole-school approach that addresses the quality of the social climate in which the individual is situated. The intervention strategy in partnership with the education sector will seek to make changes in the schools\'├é┬á├éΓÇª\n','',2002,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'44','Australasian Psychiatry','10','2','134-138','SAGE Publications','YMH team','Models of care','Illness specific areas'),(845,'Chronic fatigue syndrome: Clinical practice guidelines - 2002','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037029960&partnerID=40&md5=bc6f35d3c9291b9f22106c7d7c00bb9e','','','',2002,NULL,NULL,'2002-05-06',NULL,NULL,NULL,NULL,'44','Medical Journal of Australia','176','S9','S17-S55','','Other','',''),(846,'Dysregulation of objectively assessed 24-hour motor activity patterns as a potential marker for bipolar I disorder: results of a community-based family study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85038616629&doi=10.1038%2fTP.2017.136&partnerID=40&md5=b6282cceccdc9e529b707af280c35e85','10.1038/TP.2017.136','','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Translational Psychiatry','','','','Nature Publishing Group','YMH team','Illness specific areas',''),(847,'Disability, functioning, and quality of life among treatment-seeking young autistic adults and its relation to depression, anxiety, and stress','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060661126&doi=10.1177%2f1362361318823925&partnerID=40&md5=20cf52d7b2aa4671c0ccaf28b4f042fd','10.1177/1362361318823925','In this study, we consecutively recruited treatment-seeking young autistic adults without intellectual impairment aged 16ΓÇô30years who presented to a mental health service and evaluated general health (distress, quality of life, and disability), functioning (work loss days and social functioning), and mood symptoms (depression, anxiety, and stress) in those diagnosed with autism spectrum disorder (n=96). This group was compared to young adults presenting to the same service with primary mental health disorders (depression, n=343; bipolar, n=132; psychosis, n=166; and anxiety, n=303). This study also investigated the influence of mood symptoms on general health and functioning in the autism spectrum disorder group. Young autistic adults reported significant general health and functioning impairments that were of similar degree to those presenting with primary mental health disorders├é┬á├éΓÇª','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'31','Autism','23','7','1675-1686','Sage Publications','YMH team','Outcome Research',''),(848,'The impact of alcohol and tobacco use on invivo glutathione in youth with bipolar disorder: An exploratory study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901477610&doi=10.1016%2fj.jpsychires.2014.03.024&partnerID=40&md5=4fd996ad4f3d1df47d3ad61b022ba474','10.1016/j.jpsychires.2014.03.024','Risky alcohol consumption and tobacco smoking is highly prevalent in bipolar disorder (BD) and is associated with increased formation of neural reactive oxygen species. Proton magnetic resonance spectroscopy (1H-MRS) is an in┬ávivo imaging modality that allows quantification of glutathione (GSH) concentration, the brains primary antioxidant. Sixty-four patients with BD and 49 controls (18├éΓÇô30 years) completed self-report questionnaires regarding alcohol and tobacco use and underwent 1H-MRS. Levels of GSH in the hippocampus and anterior cingulate cortex (ACC) were determined. Within-group Pearson\'s correlations were used to explore the relationship between alcohol use and GSH concentration for BD and controls, covarying for age, gender, family history of alcohol dependence and smoking status. Relationships between GSH and presence/severity of alcohol-induced blackouts were determined using├é┬á├éΓÇª','',2014,NULL,NULL,'2014-08-01',NULL,NULL,NULL,NULL,'42','Journal of Psychiatric Research','55','','59-67','Pergamon','YMH team','Neurobiology','Illness specific areas'),(849,'Clinical staging of major depressive disorder: An empirical exploration','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84943530366&doi=10.4088%2fJCP.14m09272&partnerID=40&md5=46b028e6428ba07f27e7a5994245dbbf','10.4088/JCP.14m09272','\nObjective: Clinical staging has been proposed to supplement psychiatric diagnoses. We examined the construct and predictive validity of a clinical staging model for major depressive disorder (MDD) that distinguishes 8 consecutive stages (0, 1A, 1B, 2, 3A, 3B, 3C, 4) based on symptom severity (Inventory of Depressive Symptomatology [IDS]) and duration (Life Chart Interview) and number of episodes (Composite International Diagnostic Interview [CIDI] based on DSM-IV criteria).\nMethod: This study is a secondary data analysis based on baseline data (collected 2004-2007) and 2-year follow-up assessment (collected 2006-2009) from the Netherlands Study of Depression and Anxiety. 2,333 baseline participants were assigned to the 8 stages of the clinical staging model for MDD, and 2,012 participants were followed up after 2 years. For construct validity, differences between stages in clinical characteristics (eg\n','',2015,NULL,NULL,'2015-09-23',NULL,NULL,NULL,NULL,'38','Journal of Clinical Psychiatry','76','9','2953','Physicians Postgraduate Press, Inc.','Other','',''),(850,'Sociodemographic correlates of antidepressant utilisation in Australia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-67649205894&doi=10.5694%2fj.1326-5377.2009.tb02522.x&partnerID=40&md5=45a7420ec93802c46a5b6362c6fdf94f','10.5694/j.1326-5377.2009.tb02522.x','\n\nObjective: To investigate sociodemographic variation in antidepressant utilisation. \nDesign and setting: Cross-sectional analysis of antidepressant prescription under the Pharmaceutical Benefits Scheme in Australia, 2003ΓÇô2005. \nMain outcome measures: Antidepressant utilisation (defined daily dose/1000/day) by sex, age, socioeconomic status (SES) and geographichal area. \nResults: Total antidepressant utilisation increased with age. Among those aged = 15 years, female utilisation was about double that of males. About half of antidepressant utilisation was accounted for by sertraline, venlafaxine, citalopram, and paroxetine. SES differentials in antidepressant utilisation changed across age groups for males and females: among those aged = 19 years, total antidepressant utilisation was significantly less in lower SES groups (P < 0.001); there was no relationship to SES among 20├éΓÇô29-year-olds; and among├é┬á├éΓÇª\n','',2009,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'41','Medical Journal of Australia','190','9','479-483','','Other','',''),(851,'Investing in Australia\'s future: the personal, social and economic benefits of good mental health','https://scholar.google.com/scholar?cluster=355228751029984817&hl=en&oi=scholarr',NULL,'','',1995,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'41','','','','','Mental Health Council of Australia',NULL,NULL,NULL),(852,'Are common childhood or adolescent infections risk factors for schizophrenia and other psychotic disorders?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-61849156712&doi=10.5694%2fj.1326-5377.2009.tb02369.x&partnerID=40&md5=f7d3cf5f1155bffceba7dd627cad6573','10.5694/j.1326-5377.2009.tb02369.x','ΓÇó Postnatal infection may represent a preventable risk factor for onset of psychotic disorders in adolescence and early adulthood.','',2009,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'41','Medical Journal of Australia','190','S4','S17-S21','','YMH team','Illness specific areas',''),(854,'','https://scholar.google.com.au/citations?view_op=view_citation&hl=en&user=5cRsn2AAAAAJ&cstart=900&pagesize=100&citation_for_view=5cRsn2AAAAAJ:SrsqWtBqNIQC',NULL,'','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','','','','',NULL,NULL,NULL),(856,'White matter tractography in early psychosis: Clinical and neurocognitive associations','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908296036&doi=10.1503%2fjpn.130280&partnerID=40&md5=ba61844c44ecd68ca6a4ae38e77fab96','10.1503/jpn.130280','\nBackground: While many diffusion tensor imaging (DTI) investigations have noted disruptions to white matter integrity in individuals with chronic psychotic disorders, fewer studies have been conducted in young people at the early stages of disease onset. Using whole tract reconstruction techniques, the aim of this study was to identify the white matter pathology associated with the common clinical symptoms and executive function impairments observed in young people with psychosis.\nMethods: We obtained MRI scans from young people with psychosis and healthy controls. Eighteen major white matter tracts were reconstructed to determine group differences in fractional anisotropy (FA), axial diffusivity (AD) and radial diffusivity (RD) and then were subsequently correlated with symptomatology and neurocognitive performance.\nResults: Our study included 42 young people with psychosis (mean age 23 yr) and 45\n','',2014,NULL,NULL,'2014-11-01',NULL,NULL,NULL,NULL,'40','Journal of Psychiatry and Neuroscience','39','6','417-427','Journal of Psychiatry and Neuroscience','YMH team','Neurobiology',''),(857,'No clear potentiation of antidepressant medication effects by folic acid + vitamin B12 in a large community sample','https://www.scopus.com/inward/record.uri?eid=2-s2.0-79953181959&doi=10.1016%2fj.jad.2010.07.029&partnerID=40&md5=d347d3c8636fd8fa7a8b66a1a16391bd','10.1016/j.jad.2010.07.029','\n\nBackground\nObservational studies link low folate levels to depressive symptoms and to poor antidepressant medication response. Evidence supports a role for folate in potentiating the effect of antidepressant medications.\n\n\nAim\nThis prospective study examines the effects of folic acid┬á+├é┬ávitamin B12 supplementation and antidepressant medication in a community-based study of older adults with depressive symptoms.\n\n\nMethod\nA randomised controlled trial investigated the effectiveness of a medicinal and two behavioural preventive interventions over a two year period. The medicinal intervention compared dietary supplementation of 400├é┬ámcg/d folic acid├é┬á+├é┬á100├é┬ámcg/d vitamin B12 to placebo. Self reported use of antidepressant medication over two years was recorded. Participants were screened for psychological distress using the Kessler Distress 10-Scale (K-10; >├é┬á15 eligible) and the main outcome measure was change in├é┬á├éΓÇª\n\n','',2011,NULL,NULL,'2011-04-01',NULL,NULL,NULL,NULL,'40','Journal of Affective Disorders','130','1-Feb','37-45','Elsevier','Other','',''),(858,'Effect of apomorphine on motor and cognitive function in melancholic patients: A preliminary report','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034722930&doi=10.1016%2fS0165-1781%2800%2900222-5&partnerID=40&md5=da77a0a79cda0bfea3495310fcef768f','10.1016/S0165-1781(00)00222-5','Given the many clinical parallels between melancholia and disorders associated with impaired dopaminergic function such as Parkinson\'s Disease (PD), it has been hypothesised that major depressive disorder, and in particular the psychomotor features of melancholic depression, may also be associated with a hypodopaminergic state. If this is the case, then the use of a dopamine agonist might lead to reversal of both the cognitive and motor impairments seen in these patients. A double-blind, placebo-controlled cross-over design was used to test the effect of apomorphine on motor and cognitive function in seven melancholic subjects (as defined by the CORE instrument) and five control subjects. The testing battery included the following items: finger tapping, rapid alternating movements, verbal fluency, Rey Auditory Verbal Learning Task, digit symbol substitution task and simple and complex reaction times. The','',2000,NULL,NULL,'2000-12-27',NULL,NULL,NULL,NULL,'39','Psychiatry Research','97','2-Mar','207-215','Elsevier','Other','',''),(860,'Recognition and treatment of depression','https://link.springer.com/article/10.1007/s00127-008-0471-5',NULL,'                                Background                 Depression is a major public health problem in both China and Australia. To improve services, we need to ensure health professionals have an appropriate understanding of depression and its treatments. This study compares the level of awareness of depression between Chinese and Australian medical students.                                               Methods                 The International Depression Literacy Survey assessing the public health impact, recognition and treatment of depression was completed by pre-psychiatric training medical students in China (n┬á=├é┬á220) and Australia (n├é┬á=├é┬á177).                                               Results                 Chinese students were far less likely to consider mental health conditions and depression as major public health problems (P├é┬á<├é┬á0.001). Depression symptom recognition was similar with four of the top five symptoms of depression the same in both groups of├é┬á├éΓÇª\n','',2018,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'39','Social Psychiatry and Psychiatric Epidemiology','44','8','636-642','Steinkopff-Verlag',NULL,NULL,NULL),(861,'Delineating the trajectories of social and occupational functioning of young people attending early intervention mental health services in Australia: A longitudinal study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048764022&doi=10.1136%2fbmjopen-2017-020678&partnerID=40&md5=0a7343b08e107fe5eeefe323df563e98','10.1136/bmjopen-2017-020678','','',2018,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','BMJ Open','','','','BMJ Publishing Group','YMH team','Outcome Research',''),(862,'Cognitive training enhances pre-attentive neurophysiological responses in older adults \'at risk\' of dementia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84923645010&doi=10.3233%2fJAD-131985&partnerID=40&md5=ef1d9caa8e0f4715b60809aa881e7636','10.3233/JAD-131985','\nBackground:\nWith predicted increases in dementia incidence, interventions targeting neuroplasticity and neuroprotection are required. Cognitive Training (CT) is an intervention which has been shown to improve aspects of cognition, but the pathophysiological mechanisms contributing to its efficacy are unknown.\nObjective:\nWe aimed to explore the neurobiological correlates of CT using Mismatch Negativity (MMN), a neurophysiological marker of pre-attentive information processing, which in turn, is postulated to underpin higher-order cognitive processes.\nMethods:\nAs part of a larger randomized controlled trial, forty ├éΓÇÿat risk├éΓÇÖ(ie, mild cognitive impairment or late-life depression) participants aged 51├éΓÇô79 years underwent neurophysiological, neuropsychological, and psychiatric assessments before and after a multi-faceted seven-week CT program or a ├éΓÇÿtreatment-as-usual├éΓÇÖseven-week waitlist period.\nResults:\nThe treatment├é┬á├éΓÇª\n','',2014,NULL,NULL,'2014-01-01',NULL,NULL,NULL,NULL,'39','Journal of Alzheimer\'s Disease','41','4','1095-1108','IOS Press','Other','',''),(863,'Distinct loci in the CHRNA5/CHRNA3/CHRNB4 gene cluster are associated with onset of regular smoking','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84887606484&doi=10.1002%2fgepi.21760&partnerID=40&md5=0d0684c5b7130365ac1b4690ab64b255','10.1002/gepi.21760',' Neuronal nicotinic acetylcholine receptor (nAChR) genes (CHRNA5/CHRNA3/CHRNB4) have been reproducibly associated with nicotine dependence, smoking behaviors, and lung cancer risk. Of the few reports that have focused on early smoking behaviors, association results have been mixed. This meta-analysis examines early smoking phenotypes and SNPs in the gene cluster to determine: (1) whether the most robust association signal in this region (rs16969968) for other smoking behaviors is also associated with early behaviors, and/or (2) if additional statistically independent signals are important in early smoking. We focused on two phenotypes: age of tobacco initiation (AOI) and age of first regular tobacco use (AOS). This study included 56,034 subjects (41 groups) spanning nine countries and evaluated five SNPs including rs1948, rs16969968, rs578776, rs588765, and rs684513. Each dataset was├é┬á├éΓÇª\n','',2013,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'39','Genetic Epidemiology','37','8','846-859','','Other','',''),(864,'Reducing the burden of depression: Are we making progress in Australia?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-5044252442&doi=10.5694%2fj.1326-5377.2004.tb06346.x&partnerID=40&md5=531636436dcaad50cd62d326d82c9b61','10.5694/j.1326-5377.2004.tb06346.x','\nD epression is now AustraliaΓÇÖs most debilitating illness, accounting for 8% of all years lived with disability and over $3 billion annually in direct and indirect costs. 1 Other mood disorders, such as bipolar disorder, add significant additional costs. 2 Unfortunately, mood and anxiety disorders, which typically first become evident in adolescence, often go untreated or only come to attention later in adult life. Thus, people who present for care have recurrent or persistent disorders. 3 Moreover, depressive disorders are frequently complicated by alcohol or other substance misuse, 4 as well as physical health problems. 5 Mental disorders in total now account for 60% of all disability costs in those aged 15├éΓÇô34 years. 1 In a caring society, such statistics should demand an urgent, national and coordinated response.\nOne aspect of our national response was the establishment in 2000 of beyondblue: the national depression├é┬á├éΓÇª\n','',2004,NULL,NULL,'2004-10-04',NULL,NULL,NULL,NULL,'39','Medical Journal of Australia','181','7','S4','','YMH team','Illness specific areas','Mental Health System'),(865,'Predicting early transition from sub-syndromal presentations to major mental disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85051657385&doi=10.1192%2fbjpo.bp.117.004721&partnerID=40&md5=3b9ae0a338205c2f3beea8a79e711b88','10.1192/bjpo.bp.117.004721','Background Transition from at-risk state to full syndromal mental disorders is underexplored for unipolar and bipolar disorders compared with psychosis. Aims Prospective, trans-diagnostic study of rates and predictors of early transition from sub-threshold to full syndromal mental disorder. Method One-year outcome of 243 consenting youth aged 15ΓÇô25 years with a sub-syndromal presentation of a potentially severe mental disorder. Survival analysis and odds ratio (OR) for predictors of transition identified from baseline clinical and demographic ratings. Results About 17% (n=36) experienced transition to a major mental disorder. Independent of syndromal diagnosis, transition was significantly more likely in individuals who were NEET (not in education, employment or training), in females and in those with more negative psychological symptoms (e.g. social withdrawal). Conclusions NEET status and negative├é┬á├éΓÇª','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'39','BJPsych Open','3','5','223-227','Cambridge University Press','YMH team','Outcome Research',''),(866,'A prospective cohort study of depression course, functional disability, and NEET status in help-seeking young adults','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84982893637&doi=10.1007%2fs00127-016-1272-x&partnerID=40&md5=9aa7c6c66c7c7852ef9c9d5d8a769863','10.1007/s00127-016-1272-x','                                Purpose                 To examine the associations between depression course, functional disability, and Not in Education or Training (NEET) status in a clinical sample of young adults with mental health problems.                                               Methods                 Young adults aged 15├éΓÇô25├é┬áyears seeking help from four primary mental health services were invited to participate in a prospective cohort study evaluating the course of psychiatric disorders in youth. Demographic and clinical characteristics, including depressive symptomatology and functioning, were evaluated through clinical interview and self-report at baseline and 12├é┬ámonth follow-up.                                               Results                 A total of 448 young adults participated (70├é┬á% female; M: 20.05├é┬áyears, SD├é┬á=├é┬á2.85). A significant interaction effect for time and depression course was found, such that those who became depressed reported an increase in├é┬á├éΓÇª\n','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'39','Social Psychiatry and Psychiatric Epidemiology','51','10','1395-1404','Springer Berlin Heidelberg','YMH team','Outcome Research',''),(867,'Erratum: Connecting the dots, genome-wide association studies in substance use','https://www.nature.com/articles/mp201693',NULL,'Following publication of this paper, the journal was alerted that the published International Cannabis Consortium member list was incomplete. The complete list and affiliations are presented below. Molecular Psychiatry regrets the error.','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'38','Molecular Psychiatry','21','8','1155-1156','Nature Publishing Group',NULL,NULL,NULL),(869,'Mild Cognitive Impairment Subtypes in Older People with Depressive Symptoms: Relationship with Clinical Variables and Hippocampal Change','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929592661&doi=10.1177%2f0891988715573535&partnerID=40&md5=85624fe8c44221e3897684a692b077d0','10.1177/0891988715573535','\nAims:\nTo examine the rates and clinical characteristics of mild cognitive impairment (MCI) in older people with depressive symptoms and to determine the relative contribution of hippocampal volume and MCI to memory change.\nMethod:\nOne hundred and fifty-two participants with lifetime Major Depression and remitted or mild symptoms and 28 healthy controls underwent psychiatric and neuropsychological assessments. Magnetic resonance imaging was also conducted in a subset of the patients (n = 81) and healthy controls (n = 18).\nResults:\nMCI was diagnosed in 75.7% of the patients and was associated with increasing age, medical burden, vascular risk factors, later age of depression onset and smaller hippocampi. Multiple regression showed that both hippocampal volume and MCI diagnosis mediate memory performance in depression.\nConclusions:\nMCI occurs in older adults with a history of depression and is not├é┬á├éΓÇª\n','',2015,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'38','Journal of Geriatric Psychiatry and Neurology','28','3','174-183','SAGE Publications','YMH team','Neurobiology','Outcome Research'),(871,'Neuropsychological profile according to the clinical stage of young persons presenting for mental health care','https://link.springer.com/article/10.1186/2050-7283-1-8',NULL,'Clinical staging of mental disorders proposes that individuals can be assessed at various sub-syndromal and later developed phases of illness. As an adjunctive rating, it may complement traditional diagnostic silo-based approaches. In this study, we sought to determine the relationships between clinical stage and neuropsychological profile in young persons presenting to youth-focused mental health services. Neuropsychological testing of 194 help-seeking young people (mean age 22.6 years, 52% female) and 50 healthy controls. Clinical staging rated 94 persons as having an ΓÇÿattenuated syndrome├éΓÇÖ (stage 1b) and 100 with a discrete or persistent disorder (stage 2/3). The discrete disorder group (stage 2/3) showed the most impaired neuropsychological profile, with the earlier stage (1b) group showing an intermediate profile, compared to controls. Greatest impairments were seen in verbal memory and executive├é┬á├éΓÇª','',2018,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'37','BMC psychology','1','1','1-Sep','BioMed Central',NULL,NULL,NULL),(872,'Recent advances in sleep-wake cycle and biological rhythms in bipolar disorder','https://link.springer.com/article/10.1007/s11920-013-0402-3',NULL,'               The cyclical nature of periodic switches in energy, motor activation and sleep-wake cycles in bipolar disorder suggests a strong underlying relationship with disturbances in chronobiology. Current research is refining our understanding of the various patterns of sleep-wake and biological rhythms alterations at early and later stages of this illness, as well as across its depressive/fatigue, manic/hypomanic and euthymic phases. This research focuses on early detection and subsequent monitoring to predict and better manage recurrent episodes. Sleep-wake cycle and biological rhythms disturbances are also well known to affect other key aspects of physical health (notably metabolic functions), cognitive performance and elevated risks for suicide. Increasing evidence now supports the integration of behavioural or pharmacological therapeutic strategies that target the sleep-wake and circadian systems in the├é┬á├éΓÇª\n','',2013,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'37','','15','10','1-Oct','Springer US',NULL,NULL,NULL),(873,'Emotion recognition in mild cognitive impairment: Relationship to psychosocial disability and caregiver burden','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84883187105&doi=10.1177%2f0891988713491832&partnerID=40&md5=84316e47b3644332efe60d2ae7ce1761','10.1177/0891988713491832','\nBackground:\nImpaired emotion recognition in dementia is associated with increased patient agitation, behavior management difficulties, and caregiver burden. Emerging evidence supports the presence of very early emotion recognition difficulties in mild cognitive impairment (MCI); however, the relationship between these impairments and psychosocial measures is not yet explored.\nMethods:\nEmotion recognition abilities of 27 patients with nonamnestic MCI (naMCI), 29 patients with amnestic MCI (aMCI), and 22 control participants were assessed. Self-report measures assessed patient functional disability, while informants rated the degree of burden they experienced.\nResults:\nDifficulties in recognizing anger was evident in the amnestic subtype. Although both the patient groups reported greater social functioning disability, compared with the controls, a relationship between social dysfunction and anger recognition\n','',2013,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'37','Journal of Geriatric Psychiatry and Neurology','26','3','165-173','SAGE Publications','Other','',''),(874,'Sleep disturbance in mild cognitive impairment: Differential effects of current and remitted depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-79960563294&doi=10.1111%2fj.1601-5215.2011.00555.x&partnerID=40&md5=2aeaaf9780a367bb91d1f1dfab898cbf','10.1111/j.1601-5215.2011.00555.x','\nNaismith SL, Rogers NL, Lewis SJG, Diamond K, Terpening Z, Norrie L, Hickie IB. Sleep disturbance in mild cognitive impairment: differential effects of current and remitted depression.\nObjective:\n\n Although patients with mild cognitive impairment (MCI) commonly report sleep disturbance, the extent to which depressive symptoms contribute to this relationship is unclear. This study sought to delineate the contribution of current and remitted major depression (MD) to sleep disturbance in MCI.\nMethods:\n\n Seventy-seven patients meeting criteria for MCI (mean age = 66.6 ├é┬▒ 8.8 years) were grouped according to those with no history of depression (MCI, n = 33), those meeting criteria for current MD [mild cognitive impairment and meeting criteria for current major depression (DEP-C), n = 14] and those with remitted MD [mild cognitive impairment and remitted major depression (DEP-R), n = 30]. Additionally, 17 healthy controls├é┬á├éΓÇª\n','',2011,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'37','Acta Neuropsychiatrica','23','4','167-172','Cambridge University Press','YMH team','Illness specific areas',''),(875,'Lipopolysaccharide-stimulated interleukin-10 release from neonatal spinal cord microglia is potentiated by glutamate','https://www.scopus.com/inward/record.uri?eid=2-s2.0-78951484585&doi=10.1016%2fj.neuroscience.2010.10.080&partnerID=40&md5=40dee13ad90b3f36ab389ba444afa3f7','10.1016/j.neuroscience.2010.10.080','Interleukin-10 (IL-10) is a cytokine with important endogenous and therapeutic anti-inflammatory effects. Given this, it is of interest to investigate factors that modulate IL-10 levels in the central nervous system. IL-10 is released after lipopolysaccharide (LPS) stimulation of microglia. Microglia also express functional glutamate receptors and in inflammatory conditions are exposed to increased levels of glutamate. The aim of this research, then, is to investigate whether glutamate can modulate lipopolysaccharide stimulation of IL-10 release from neonatal rat spinal cord microglia. Enzyme-linked immunosorbent assays (ELISAs) were used to quantify IL-10 release from cultured neonatal spinal cord microglia and reverse transcriptase-polymerase chain reaction (RT-PCR) was used to measure IL-10 mRNA expression. Glutamate (1 mM) significantly increased LPS (1 ┬╡g/ml)-stimulated IL-10 release from microglia by 172├é┬á├éΓÇª','',2011,NULL,NULL,'2011-02-17',NULL,NULL,NULL,NULL,'36','Neuroscience','175','','93-103','Pergamon','Other','',''),(876,'Perceptions of outcome from electroconvulsive therapy by depressed patients and psychiatrists','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037986660&doi=10.1046%2fj.1440-1614.2003.01129.x&partnerID=40&md5=21caa8be85272ffcb08556734141218f','10.1046/j.1440-1614.2003.01129.x','\n\nObjective: To determine (i) patients\' expectations before and attitudes after a course of electroconvulsive therapy (ECT); (ii) the concordance between the perceptions of patients and their psychiatrists; and (iii) whether patients and psychiatrists are accurate in predicting a positive outcome with ECT.\n\nMethod: Eighty-one inpatients (mean 67.2 years, median 70 years) with major depression were assessed before and after receiving a course of ECT. On both occasions, patients were administered the Hamilton Rating Scale for Depression (HRSD) and the Global Assessment of Functioning Scale (GAF). Patients and two research psychiatrists rated their expectancy of treatment outcome before ECT and their impression of outcome after ECT was completed.\n\nResults: Both HRSD and GAF scores improved with treatment. Before treatment, 39.7% of patients believed ECT would improve their condition. Following treatment\n','',2003,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'36','Australian and New Zealand Journal of Psychiatry','37','2','196-199','Sage Publications','Other','',''),(878,'Cortical thinning in young psychosis and bipolar patients correlate with common neurocognitive deficits','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908268863&doi=10.1186%2f2194-7511-1-3&partnerID=40&md5=2926e09e3350382ec971b4eed97b7760','10.1186/2194-7511-1-3','People in midlife with established psychosis or bipolar disorder exhibit patterns of cortical thinning across several brain regions. It is unclear whether these patterns are indicative of a continuously active pathological process, residual effects of an earlier illness phase or pre-illness onset developmental risk factors. Here, we investigated whether cortical thinning is evident in younger patients in the early phase of psychosis or bipolar disorder and the relationship between cortical thinning and neurocognitive performance in young people. Magnetic resonance imaging was obtained from a sample of young patients with psychosis (n = 40; mean age 23.5 years), bipolar disorder (n = 73; mean age 21.9 years) or controls (n = 49; mean age 24.2 years). Group differences in cortical thickness were assessed using statistical difference maps, and regions of cortical thinning were correlated with medication dosage and performance on neurocognitive tasks. As initial comparisons using multiple corrections found no differences between the groups, follow-up analysis with a significance threshold of p < 0.001 was performed. As distinct from reported findings in older subjects, young patients with psychosis have less extensive thinning in parietal-temporal areas and do not demonstrate significant thinning in the insula or dorsal lateral prefrontal cortex. Young patients with bipolar disorder exhibit cortical thinning in regions more consistent with those previously reported in paediatric bipolar patients. Although there were some differences in the regions of cortical thinning between the two groups, the shared regions of cortical thinning were correlated with','',2013,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'36','International Journal of Bipolar Disorders','1','1','Jan-13','SpringerOpen','YMH team','Neurobiology','illness specific areas'),(879,'Social cognitive performance as a marker of positive psychotic symptoms in young people seeking help for mental health problems','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84881218242&doi=10.1016%2fj.schres.2013.06.006&partnerID=40&md5=635df1fe7a2d7fbc690f8ac46be5dab5','10.1016/j.schres.2013.06.006','Previous research has suggested that psychotic symptoms are associated with impairments in social cognition. However, there is limited research evaluating this association in the context of younger patients with a broad range of mental health problems. In the present study, we evaluated social cognitive performance in 115 treatment-seeking participants who presented to a youth mental health service with affective or psychotic disturbances. Participants completed symptom severity measures, a social cognition task (the Reading the Mind in the Eyes Test (RMET)), and a standardised battery of neuropsychological tests. Analyses based on diagnostic groups showed that patients with psychotic illnesses (n┬á=├é┬á23) showed impaired performance on the RMET compared to patients with primarily bipolar (n├é┬á=├é┬á40) and depressive illnesses (n├é┬á=├é┬á52). Performance on the RMET was negatively correlated with positive and├é┬á├éΓÇª','',2013,NULL,NULL,'2013-09-01',NULL,NULL,NULL,NULL,'36','Schizophrenia Research','149','1-Mar','77-82','Elsevier','YMH team','Outcome Research',''),(880,'How to tackle a giant: Creating a genuine evaluation of the Better Access Program','https://www.scopus.com/inward/record.uri?eid=2-s2.0-78649858743&doi=10.3109%2f10398562.2010.525642&partnerID=40&md5=4ff8a26241b078662fce192c49d4f22c','10.3109/10398562.2010.525642','\n\nObjective: This paper proposes a framework for a systematic evaluation of the Better Access Program, the largest single component of mental health reform announced under the Council of Australian Governments National Action Plan on Mental Health 2006ΓÇô11.\n\nMethod: The article explores the genesis of the Program and considers extant data sets and information available with which to establish the impact of the Program on consumers and service providers.\n\nResults: There are useful data available in Australia from which to derive pre- and post-implementation analysis about the impact of the Better Access Program. There is doubt as to whether these data form part of the Federal Government\'s current approach to evaluation of the Program.\n\nConclusions: Anything less than a genuine and comprehensive evaluation will leave Australia unable to assess the real impact of the Better Access Program. The merit of├é┬á├éΓÇª\n','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'36','Australasian Psychiatry','18','6','496-502','SAGE Publications','YMH team','Models of care','Mental Health System'),(881,'Young people\'s experiences of mental health care: Implications for the headspace National Youth Mental Health Foundation','https://www.scopus.com/inward/record.uri?eid=2-s2.0-70349649809&partnerID=40&md5=96f0fa2db4e9a1f6a2ca2dc5a2460f5e','','Fifteen in-depth interviews were conducted to explore young people\'s experiences of mental health care in Australia with the aim of informing the headspace National Youth Mental Health Foundation. The interviews revealed that significant numbers of respondents had been aware of their mental health problems for several years before seeking help and that barriers to help-seeking included a range of social, cultural and demographic factors. Additionally, perceptions of experience of care centred upon the interpersonal aspects of young people\'s relationships with mental health care providers. These finding are discussed in relation to the shaping of the headspace initiative.','',2009,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'36','Youth Studies Australia','28','1','13-20','','YMH team','Mental Health System',''),(882,'No alterations of brain structural asymmetry in major depressive disorder: An ENIGMA consortium analysis','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075265195&doi=10.1176%2fappi.ajp.2019.18101144&partnerID=40&md5=917c28e7a45841ada230c7abda26ffce','10.1176/appi.ajp.2019.18101144','\nObjective:\nAsymmetry is a subtle but pervasive aspect of the human brain, and it may be altered in several psychiatric conditions. MRI studies have shown subtle differences of brain anatomy between people with major depressive disorder and healthy control subjects, but few studies have specifically examined brain anatomical asymmetry in relation to this disorder, and results from those studies have remained inconclusive. At the functional level, some electroencephalography studies have indicated left fronto-cortical hypoactivity and right parietal hypoactivity in depressive disorders, so aspects of lateralized anatomy may also be affected. The authors used pooled individual-level data from data sets collected around the world to investigate differences in laterality in measures of cortical thickness, cortical surface area, and subcortical volume between individuals with major depression and healthy control subjects├é┬á├éΓÇª\n','',2019,NULL,NULL,'2019-12-01',NULL,NULL,NULL,NULL,'35','American Journal of Psychiatry','176','12','1039-1049','American Psychiatric Association','Other','',''),(883,'Validation of the innowell platform: Protocol for a clinical trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85067407623&doi=10.2196%2f13955&partnerID=40&md5=17e99cc2d442578d457c5421ac544bfd','10.2196/13955','\nBackground: New electronic health technologies are being rapidly developed to improve the delivery of mental health care for both health professionals and consumers and better support self-management of care. We developed a Web-based platform (the InnoWell Platform) that supports the prevention, early intervention, treatment, and continuous monitoring of mental health and maintenance of well-being in people aged 2 years and older. The platform is a customizable digital tool kit that operates through existing service providers who utilize the system to provide their consumers with access to evidence-based assessments and feedback, intervention options, and outcome monitoring. It does this by collecting, storing, and reporting personal and health information back to consumers and their health professionals to promote collaborative care partnerships that aim to improve the management of mental ill health and maintenance of well-being\nObjective: The aim of this study was to describe the research protocol for a naturalistic prospective clinical trial wherein all consumers presenting for care to a traditional face-to-face or Web-based mental health service in which the InnoWell Platform is being offered as part of standard clinical care will be given the opportunity to use the platform.\nMethods: The Web-based platform is a configurable and customizable digital tool that assists in the assessment, monitoring and management of mental ill health, and maintenance of well-being. It does this by collecting, storing, and reporting health information back to the person and his or her clinician to enable transformation to person-centered care. The clinical trial\n','',2019,NULL,NULL,'2019-05-31',NULL,NULL,NULL,NULL,'35','JMIR Research Protocols','8','5','e13955','JMIR Publications Inc., Toronto, Canada','YMH team','Digital health',''),(884,'Possibilities for the prevention and treatment of cognitive impairment and dementia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-34248220068&doi=10.1192%2fbjp.bp.106.033407&partnerID=40&md5=b1387356f694ec08f9b5e1daad5e1764','10.1192/bjp.bp.106.033407','The human brain has a remarkable capacity for plasticity, but does it have the capacity for repair and/or regeneration? On the basis of controversial new evidence we speculate that the answer may be ├éΓÇÿyes\', and suggest that clinicians should therefore approach cognitive impairment and dementia with a new, cautious optimism.','',2007,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'35','British Journal of Psychiatry','190','5','371-372','Cambridge University Press','Other','',''),(885,'An age-based comparison of chronic pain clinic patients','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035009830&doi=10.1002%2fgps.366&partnerID=40&md5=aa7926d383267d981f7cfb529f10dadf','10.1002/gps.366','   Objective The aim of this study was to compare demographic, illness and personality characteristics, and formal rates of mental disorder between younger (<65 years) and older (=65 years) patients attending a chronic pain clinic.   Method Patients with non-malignant pain of >6 months\' duration attending a specialist outpatient clinic were given a structured medical and psychiatric interview, and completed self-report questionnaires assessing disability, personality style and attitudes to illness.   Results Fifty patients (26 of whom were older) participated in the study. None of the older patients had experienced the onset of chronic pain before the age of 50 years. Although current and lifetime major depression were common in both groups, there was no specific association between age and depression. The younger group was more likely to have been injured prior to the onset of pain and to be seeking financial\n','',2001,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'35','International Journal of Geriatric Psychiatry','16','5','477-483','John Wiley & Sons, Ltd.','Other','',''),(886,'Somatic distress: Developing more integrated concepts','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031951724&doi=10.1097%2f00001504-199803000-00007&partnerID=40&md5=51846ff48a5c43a37137db7dee459f84','10.1097/00001504-199803000-00007','Epidemiological, longitudinal and treatment studies have emphasized the significance of the common somatic presentations of distress (eg chronic fatigue, musculoskeletal pain, gastrointestinal symptoms). Aetiological models for these syndromes now emphasize unique genetic, cognitive and neurobiological factors. Treatment paradigms emphasize the central role of cognitive-behavioural approaches but their implementation, particularly in primary care, remains problematic.','',1998,NULL,NULL,'1998-03-01',NULL,NULL,NULL,NULL,'35','Current Opinion in Psychiatry','11','2','153-158','LWW','YMH team','Neurobiology',''),(887,'Biochemical correlates of in vivo cell-mediated immune dysfunction in patients with depression: A preliminary report','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028856264&doi=10.1016%2f0192-0561%2895%2900055-7&partnerID=40&md5=3cba087be36ebac9f0df195dc10f6751','10.1016/0192-0561(95)00055-7','We have previously demonstrated that at least 50% of patients with melancholia have impaired cell-mediated immunity (CMI) as assessed by delayed-type hypersensitivity (DTH) skin responses to a standardized battery of antigens. Hypercortisolaemia and increased circulating catecholamines both occur in patients with severe depressive disorders and each has been proposed as a possible mediator of observed immune abnormalities in patients with mood disorders. As part of a larger study, we collected 24 h urine samples from 28 patients with major depression and measured concentrations of urinary free cortisol (UFC), the noradrenaline metabolite dihydroxyphenylglycol (DHPG), adrenaline, and the dopamine metabolite DOPAC. CMI multitest skin testing revealed a reduced or absent response in 54% of subjects. Those with reduced DTH skin responses demonstrated increased urinary adrenaline (P<0.02','',1995,NULL,NULL,'1995-08-01',NULL,NULL,NULL,NULL,'35','International Journal of Immunopharmacology','17','8','685-690','Pergamon','YMH team','Neurobiology','illness specific areas'),(888,'Depressive type and state effects on personality measures','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025363088&doi=10.1111%2fj.1600-0447.1990.tb06478.x&partnerID=40&md5=f73b33df8796f30c8eb2084f66780fc9','10.1111/j.1600-0447.1990.tb06478.x','We examine the hypothesis that the effect of mood state on personality questionnaire scores is more a function of diagnosis than of depression severity. Sixteen endogenous and 83 neurotic depressives completed a battery of personality questionnaires at a baseline assessment and again 20 weeks later. Scores on the personality measures changed significantly. Endogenous depressives were found to have more pronounced changes on measures of dependence and timidity, but when change in mood state was partialled out only one of the dependence measures and timidity remained significant. Thus the hypothesis only received partial support - change in mood state appears to be the major factor in elevating personality questionnaire scores.','',1990,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'35','Acta Psychiatrica Scandinavica','81','2','197-200','Blackwell Publishing Ltd','Other','',''),(890,'Circuits for social learning: A unified model and application to Autism Spectrum Disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072758025&doi=10.1016%2fj.neubiorev.2019.09.034&partnerID=40&md5=3af46681d5ba40a9b12f62243b293ccc','10.1016/j.neubiorev.2019.09.034','Early life social experiences shape neural pathways in infants to develop lifelong social skills. This review presents the first unified circuit-based model of social learning that can be applied to early life social development, drawing together unique human developmental milestones, sensitive learning periods, and behavioral and neural scaffolds. Circuit domains for social learning are identified governing Activation, Integration, Discrimination, Response and Reward (AIDRR) to sculpt and drive human social learning. This unified model can be used to identify social delays earlier in development. We propose social impairments observed in Autism Spectrum Disorder are underpinned by early mistimed sensitive periods in brain development and alterations in amygdala development to disrupt the AIDRR circuits. This model directs how interventions can target neural circuits for social development and be applied early','',2019,NULL,NULL,'2019-12-01',NULL,NULL,NULL,NULL,'35','Neuroscience and Biobehavioral Reviews','107','','388-398','Pergamon','Other','',''),(891,'Genetic and environmental contributions to sleep-wake behavior in 12-year-old twins','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84887089279&doi=10.5665%2fsleep.3136&partnerID=40&md5=de86e406bbd15e61b3dbb665fa15e4be','10.5665/sleep.3136','                    Study Objectives:           To examine the role of genetic and environmental factors on sleep behavior in 12-year-old twins matched for family environment.                             Design:           Population-based twin cohort.                             Setting:           Participants were assessed in their home environment.                             Patients or Participants:           One hundred thirty-two adolescent twins comprising 25 monozygotic (MZ) and 41 dizygotic (DZ) twin pairs; aged 12.2 ┬▒ 0.1 y (mean ├é┬▒ standard deviation).                             Interventions:           N/A.                             Measurements and Results:           For 2 weeks in their home environment, participants wore a wrist activity monitor and completed a daily sleep diary. Sleep diaries included reports of bedtime, wake time, and estimated sleep onset time. Mean timing, duration, and quality of sleep during the 2 weeks were calculated for each individual and compared within├é┬á├éΓÇª\n','',2013,NULL,NULL,'2013-11-01',NULL,NULL,NULL,NULL,'34','Sleep','36','11','1715-1722','Oxford University Press','YMH team','Illness specific areas','Neurobiology'),(892,'Sleep quality in healthy older people: Relationship with 1H magnetic resonance spectroscopy markers of glial and neuronal integrity','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84887552479&doi=10.1037%2fa0034154&partnerID=40&md5=afde70537edf477af2c923d161866287','10.1037/a0034154','The hippocampus and thalamus assume a significant role in the overnight consolidation of memories, a process that is negatively impacted by sleep disruption. Emerging evidence suggests that disturbances of sleep in older people may co-occur with underlying neurobiological changes. This study sought to assess glial and neuronal integrity in these regions in relation to subjective sleep disturbance in a healthy older sample. Forty-three healthy older people (mean age= 70, SD= 5.0) were assessed clinically and medically and screened for cognitive and depressive symptoms, as well as sleep disturbance. Single voxel hippocampal and thalamus metabolite ratios of N-acetyl aspartate (NAA) and myo-inositol (mI) with total creatine (Cr+ PCr) were measured using magnetic resonance spectroscopy at 3-Tesla. Higher hippocampal mI/Cr+ PCr ratios were significantly correlated with poorer self-reported sleep quality├é┬á├éΓÇª','',2013,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'34','Behavioral Neuroscience','127','5','803','American Psychological Association','Other','',''),(893,'Validity of the CORE: II. Neuropsychological tests','https://books.google.com/books?hl=en&lr=&id=aQYJbOT4PCUC&oi=fnd&pg=PA149&dq=info:w8ePfJtmS64J:scholar.google.com&ots=SmMIv1MiTA&sig=XkcRP7MtMqKrDa2J4g0M2ahrGAs',NULL,'\nAlthough extensively researched (see Watts 1992; Austin et al. 1992b), neuropsychological testing in patients with depressive disorders contin-ues to reveal disparate findings, though clear evidence of impairment across a range of functions has been documented in those patients with more severe and/or psychotic disorders, those hospitalized for treatment and/or those receiving psychotropic medication (Robbins, Joyce and Sahakian 1992). The deficits described have primarily involved the do-mains of attention, concentration and motor speed (the so-called\" sub-corticalΓÇ¥ tasks). Various aspects of memory and planning have also been noted to be affected, though the nature of such impairments has often been described in non-uniform terms, reflecting the specific cog-nitive paradigm under investigation. In the interpretation of memory impairment, emphasis continues to be placed on the possible roles of effort, motivation and attention to the task, all of which are impaired in depressed patients. However, memory deficits that do not reflect such factors are probably a feature of most depressive disorders (Austin et al. 1992b). Aphasias and apraxias (cortical tasks), have not generally been associated with depressive disorders and, when present, have typ-ically been considered as positive evidence of an underlying dementing disorder.\nDifferential patterns of neurocognitive impairment may be evident in less severe forms of depression (ie, greatest impairment in subcortical rather than cortical tasks). It has been suggested that the most severe forms of depression are also associated with more significant memory and frontal deficits (Austin et al. 1992b├é┬á├éΓÇª\n','',2018,NULL,NULL,'1996-03-29',NULL,NULL,NULL,NULL,'34','Melancholia: a disorder of movement and mood','','','149-59','Cambridge University Press',NULL,NULL,NULL),(894,'SleepΓÇôwake cycle phenotypes in young people with familial and non-familial mood disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85008472834&doi=10.1111%2fbdi.12450&partnerID=40&md5=d2c6eca0c77ac5e6bca3c5494bcb37e1','10.1111/bdi.12450',' Objectives Converging evidence identifies that the offspring of parents with bipolar disorder (BD), individuals at clinical high risk of BD, and young people with recent onset BD may differ from other clinical cases or healthy controls in terms of sleep├éΓÇôwake profiles. However, it is possible that these differences may reflect current mental state, subtype of mood disorder, or familial traits. This study aimed to determine objective and subjective sleep├éΓÇôwake profiles in individuals aged 15├éΓÇô25├é┬áyears with a current major depressive episode, in relation to familial traits.   Methods Frequency matching was employed to ensure that each individual with a confirmed family history of BD (FH+) could be compared to four controls who did not have a familial mood disorder (FH├éΓÇô). Pre-selected objective actigraphy and subjective Pittsburgh Sleep Quality Index (PSQI) ratings were compared using one-way analysis of variance (ANOVA├é┬á├éΓÇª\n','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'34','Bipolar Disorders','18','8','642-649','','YMH team','Illness specific areas',''),(895,'Hippocampal glutamate is increased and associated with risky drinking in young adults with major depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84938250446&doi=10.1016%2fj.jad.2015.07.009&partnerID=40&md5=57bbdfca924f5217e7a53ddf09d83598','10.1016/j.jad.2015.07.009','\n\nBackground\nRisky drinking in young people is harmful, highly prevalent and often complicated by comorbid mental health problems that compound alcohol-induced impairment. The hippocampus and the glutamate system have been implicated in the pathophysiology of alcoholism and depression. This study aimed to determine whether risky drinking is associated with glutamate levels recorded within the hippocampus of young adults with major depression.\n\n\nMethods\nSixty-three young persons with major depression (22.1┬▒3.1 years; 65% female) and 38 healthy controls were recruited. Participants completed the alcohol use disorder identification test and underwent proton magnetic resonance spectroscopy to measure in vivo glutamate levels within the hippocampus following a period of at least 48├é┬áh of abstinence.\n\n\nResults\nYoung adults with depression had significantly increased hippocampal glutamate levels and a├é┬á├éΓÇª\n\n','',2015,NULL,NULL,'2015-11-01',NULL,NULL,NULL,NULL,'34','Journal of Affective Disorders','186','','95-98','Elsevier','YMH team','Neurobiology',''),(896,'The effectiveness of an online e-health application compared to attention placebo or Sertraline in the treatment of Generalised Anxiety Disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84920138070&doi=10.1016%2fj.invent.2014.08.002&partnerID=40&md5=41d2dd9dfce6b309d9721ae7f9aa31a1','10.1016/j.invent.2014.08.002','\n\nBackground\nGeneralised Anxiety Disorder (GAD) is a high prevalence, chronic disorder that can be treated effectively through a number of web-based programs. However, online web programs for GAD have not been compared to standard pharmacological treatment. The present study compares an Internet Intervention (Active Website) for GAD and a selective serotonin re-uptake inhibitor (SSRI) (Sertraline), with an online attention placebo condition (Control Website).\n\n\nObjective\nTo evaluate the effectiveness of a web-based intervention for GAD in comparison to standard antidepressant medication and an online attention placebo condition over a 10├é┬áweek period, and with a follow-up at 6 and at 12├é┬ámonths.\n\n\nMethods\nThe study was part of a larger scale prevention program. 152 people aged 18├éΓÇô30├é┬áyears who met the criteria for GAD on the MINI received referrals to the treatment sub-study. The primary outcome was├é┬á├éΓÇª\n\n','',2014,NULL,NULL,'2014-10-01',NULL,NULL,NULL,NULL,'34','Internet Interventions','1','4','169-174','Elsevier','Other','',''),(897,'Sampling bias in an internet treatment trial for depression.','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84875440458&doi=10.1038%2ftp.2012.100&partnerID=40&md5=98f5673838896e2bd4121d2d70cbf868','10.1038/tp.2012.100','Internet psychological interventions are efficacious and may reduce traditional access barriers. No studies have evaluated whether any sampling bias exists in these trials that may limit the translation of the results of these trials into real-world application. We identified 7999 potentially eligible trial participants from a community-based health cohort study and invited them to participate in a randomized controlled trial of an online cognitive behavioural therapy programme for people with depression. We compared those who consented to being assessed for trial inclusion with nonconsenters on demographic, clinical and behavioural indicators captured in the health study. Any potentially biasing factors were then assessed for their association with depression outcome among trial participants to evaluate the existence of sampling bias. Of the 35 health survey variables explored, only 4 were independently associated','',2012,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'34','Translational psychiatry','2','10','e174-e174','Nature Publishing Group','Other','',''),(898,'Providing psychological treatments in general practice: How will it work?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0042873022&doi=10.5694%2fj.1326-5377.2003.tb05411.x&partnerID=40&md5=1d2d6c5f3126434368d5797b1ebdd264','10.5694/j.1326-5377.2003.tb05411.x','┬ª Provision of ├éΓÇ£Focussed Psychological Strategies├éΓÇ¥ by general practitioners is one component of the recent Better','',2003,NULL,NULL,'2003-07-07',NULL,NULL,NULL,NULL,'33','Medical Journal of Australia','179','1','23-25','AUSTRALASIAN MEDICAL PUBLISHING COMPANY LTD','YMH team','Models of care','Mental Health System'),(899,'Hormonal responses to fenfluramine in depressive subtypes','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025132251&doi=10.1192%2fbjp.157.4.551&partnerID=40&md5=04020e8488d3d0c34b3e2435dcd9f4eb','10.1192/bjp.157.4.551','In order to study putative differences in central neurotransmitter function in depressive subtypes, serum Cortisol and prolactin responses to the putative serotonin agonist fenfluramine were examined in 30 subjects with major depression. Patients with endogenous depression (melancholia) as defined by each of ICDΓÇô9, DSM├éΓÇôIII, RDC and Newcastle scale demonstrated a reduced prolactin response to 60 mg oral fenfluramine when compared with non-endogenous subjects. This was independent of either prolactin or Cortisol baseline levels, and indicates that there are differences in brain neurotransmitter function in the endogenous and non-endogenous subtypes of depression. Basal prolactin levels were reduced in bipolar compared with unipolar subjects, and delusional compared with non-delusional patients, although there were no differences in the prolactin responses to fenfluramine between these subgroups├é┬á├éΓÇª','',1990,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'33','British Journal of Psychiatry','157','4','551-557','Cambridge University Press','Other','',''),(900,'Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058398700&doi=10.1016%2fj.schres.2018.12.013&partnerID=40&md5=f89029b161c80aa5f0f9ac3a888ceb6b','10.1016/j.schres.2018.12.013','\n\nBackground\nNeurocognitive impairments experienced by individuals at ultra-high risk (UHR) for psychosis are potential predictors of outcome within this population, however there is inconsistency regarding the specific neurocognitive domains implicated. This study aimed to examine whether baseline neurocognition predicted transition to psychosis, or functional outcomes, at medium-term (mean=3.4years) follow-up, while controlling for other clinical/treatment variables associated with transition to psychosis.\n\n\nMethod\nAnalysis of data collected as part of a multi-centre RCT of omega-3 fatty acids and cognitive-behavioural case management (NEURAPRO) for UHR individuals was conducted on the 294 participants (134 males, 160 females) who completed neurocognitive assessment (Brief Assessment of Cognition for Schizophrenia) at baseline. Transition to psychosis was determined using the Comprehensive├é┬á├éΓÇª\n\n','',2019,NULL,NULL,'2019-04-01',NULL,NULL,NULL,NULL,'33','Schizophrenia Research','206','','67-74','Elsevier','Other','',''),(901,'The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85031741582&doi=10.1016%2fj.schres.2017.09.003&partnerID=40&md5=35c07afcc2763548a422b7363331c11c','10.1016/j.schres.2017.09.003','','',2018,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Schizophrenia Research','','','','Elsevier','YMH team','Illness specific areas',''),(902,'A transdiagnostic study of education, employment, and training outcomes in young people with mental illness','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017450852&doi=10.1017%2fS0033291717000484&partnerID=40&md5=5252666c635024d82c8ff51776a676bd','10.1017/S0033291717000484','','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Psychological Medicine','','','','Cambridge University Press','YMH team','Models of care','Outcome Research'),(903,'The effect of 12-wk ╧ë-3 fatty acid supplementation on in vivo thalamus glutathione concentration in patients \"at risk\" for major depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84942237270&doi=10.1016%2fj.nut.2015.04.019&partnerID=40&md5=f811702b14b15c042719579004e1fffb','10.1016/j.nut.2015.04.019','\n\nObjectives\nAs life expectancy increases, the need to prevent major health disorders is clear. Depressive symptoms are common in older adults and are associated with cognitive decline and greater risk for transitioning to major depression. Oxidative stress may be implicated in the pathophysiology of major depression and can be measured in├é┬ávivo using proton magnetic resonance spectroscopy via the neurometabolite glutathione (GSH). Evidence suggests -3 fatty acid (FA) supplementation may prevent depression and directly affect GSH concentration. The aim of this study was to examine the effect of -3 FA supplementation on in├é┬ávivo GSH concentration in older adults at risk for depression.\n\n\nMethods\nFifty-one older adults at risk for depression were randomized to receive either four 1000-mg -3 FA supplements daily (containing eicosapentaenoic acid 1200├é┬ámg plus docosahexaenoic acid 800├é┬ámg) or placebo (four├é┬á├éΓÇª\n\n','',2015,NULL,NULL,'2015-10-01',NULL,NULL,NULL,NULL,'32','Nutrition','31','10','1247-1254','Elsevier','Other','',''),(904,'Cognitive impairment with and without depression history: An analysis of white matter microstructure','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84895479334&doi=10.1503%2fjpn.130079&partnerID=40&md5=7db7b7bfc3258ee76a4ab455ec3abec4','10.1503/jpn.130079','\nBackground: Mild cognitive impairment (MCI) and late-life depression are clinical syndromes that often co-occur and may represent an early manifestation of neurodegenerative disease. The present study examined white matter microstructure in patients with MCI with and without a history of major depression compared with healthy controls.\nMethods: Older adults with MCI and no history of major depression (MCI), adults with MCI and euthymic major depression (MCI-MD) and healthy controls underwent comprehensive medical, psychiatric and neuropsychological assessments. Participants also underwent diffusion tensor imaging, which was analyzed using tract-based spatial statistics. White matter hyperintensity (WMH) burden and medical burden were also quantified.\nResults: We enrolled 30 participants in the MCI group, 36 in the MCI-MD group and 22 in the control group. Compared with controls, participants in\n','',2014,NULL,NULL,'2014-03-01',NULL,NULL,NULL,NULL,'32','Journal of Psychiatry and Neuroscience','39','2','135-143','Journal of Psychiatry and Neuroscience','Other','',''),(905,'A clinical trials agenda for testing interventions in earlier stages of psychotic disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-61849144203&doi=10.5694%2fj.1326-5377.2009.tb02372.x&partnerID=40&md5=575b98ff7f67c941dcef9316f128d5e0','10.5694/j.1326-5377.2009.tb02372.x','A fundamental shift in the design of clinical trials for psychotic disorders is desirable and feasible. Priority should be placed on evaluation of the efficacy of interventions targeting different phases of illness. A range of traditional therapeutic approaches needs to be augmented by an increased emphasis on the potential benefits of informational, e-health, behavioural and neuroprotective strategies. A new national clinical trials platform, based on headspace, the National Youth Mental Health Foundation, is outlined. It provides the opportunity for conducting large multisite clinical trials in young people with emerging major mental disorders. ','',2009,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'29','Medical Journal of Australia','190','S4','S33-S36','','Other','',''),(906,'Comparative validity of two measures of psychomotor function in patients with severe depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029965475&doi=10.1016%2f0165-0327%2895%2900087-9&partnerID=40&md5=b9b12b543d500661dc3328c0a02baf1f','10.1016/0165-0327(95)00087-9','Psychomotor function is a key construct in depressed patients and two measures have been developed for systematic rating. Parker and colleagues utilise an observer-rated scale (CORE) while the scale (DRRS) developed by Widl├╢cher assesses motor and ideational aspects. Associations between the scales and their relative capacity to predict ECT response were investigated in a sample of 81 depressed patients. Both predicted ECT response. While the CORE scale rates a wider variety of phenomena (including non-interactiveness and agitation) and does not rely on the subject\'s capacity to report aspects of their cognitive function, the study supports the predictive and comparitive validity of both scales.','',1996,NULL,NULL,'1996-04-12',NULL,NULL,NULL,NULL,'29','Journal of Affective Disorders','37','2-Mar','143-149','Elsevier','YMH team','Outcome Research',''),(907,'The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074514668&doi=10.1016%2fj.biopsych.2019.08.030&partnerID=40&md5=7ccf4fb559d43558fdaa719a9b39be32','10.1016/j.biopsych.2019.08.030','\n\nBackground\nNEURAPRO was a multicenter, placebo-controlled trial of long-chain omega-3 polyunsaturated fatty acids (n-3 PUFAs) (fish oil) in 304 individuals at ultra-high risk for psychotic disorders. The study failed to show benefits of n-3 PUFAs over placebo. Although the randomized controlled trial design is placed at the top of the evidence hierarchy, this methodology has limitations in fish oil randomized controlled trials, as not only is the test agent present in the intervention group, but also n-3 fats are present in the diet and the body tissue of all participants.\n\n\nMethods\nAnalysis of biomarker data (eicosapentaenoic acid [EPA], docosahexaenoic acid [DHA], n-3 index, EPA+DHA) collected as part of NEURAPRO was conducted on 218 participants with longitudinal biomarker data to determine if n-3 PUFAs measured in erythrocytes at baseline and month 6 predicted clinical outcomes.\n\n\nResults\nIncreases of the n-3 index├é┬á├éΓÇª\n\n','',2020,NULL,NULL,'2020-02-01',NULL,NULL,NULL,NULL,'31','Biological Psychiatry','87','3','243-252','Elsevier','Other','',''),(909,'Sleep-wake profiles and circadian rhythms of core temperature and melatonin in young people with affective disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85023604426&doi=10.1016%2fj.jpsychires.2017.07.007&partnerID=40&md5=64ece31ad3d68444c960075032577e45','10.1016/j.jpsychires.2017.07.007','While disturbances of the sleep-wake cycle are common in people with affective disorders, the characteristics of these disturbances differ greatly between individuals. This heterogeneity is likely to reflect multiple underlying pathophysiologies, with different perturbations in circadian systems contributing to the variation in sleep-wake cycle disturbances. Such disturbances may be particularly relevant in adolescents and young adults with affective disorders as circadian rhythms undergo considerable change during this key developmental period. This study aimed to identify profiles of sleep-wake disturbance in young people with affective disorders and investigate associations with biological circadian rhythms. Fifty young people with affective disorders and 19 control participants (aged 16├éΓÇô31 years) underwent actigraphy monitoring for approximately two weeks to derive sleep-wake cycle parameters, and completed├é┬á├éΓÇª','',2017,NULL,NULL,'2017-11-01',NULL,NULL,NULL,NULL,'31','Journal of Psychiatric Research','94','','131-138','Pergamon','YMH team','Illness specific areas',''),(910,'Neuropsychological functioning is compromised in binge drinking young adults with depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84885857113&doi=10.1016%2fj.psychres.2013.05.001&partnerID=40&md5=74a9809c11b7244e0c00a2850aca21c7','10.1016/j.psychres.2013.05.001','For many young people, binge drinking is the most common form of alcohol misuse, particularly in those with a depressive disorder. Nonetheless, relatively little is known about the effects that the combination of depression and binge drinking has on neuropsychological outcomes. This study aimed to determine whether binge drinkers with depression show more pronounced neuropsychological dysfunction compared to their peers with depression alone or binge drinking alone. Neuropsychological testing was conducted on help-seeking young people (18ΓÇô30 years) recently diagnosed with a depressive disorder and classified as either ├éΓÇÿbinge drinkers├éΓÇÖ (n=43) or ├éΓÇÿnon-bingers├éΓÇÖ (n=48). Two healthy control groups (i.e. binge drinkers, n=24 and non-bingers, n=21) were additionally recruited and also underwent the same testing. Qualitatively, binge-drinking patients with depression performed consistently below controls├é┬á├éΓÇª','',2013,NULL,NULL,'2013-11-30',NULL,NULL,NULL,NULL,'31','Psychiatry Research','210','1','256-262','Elsevier','YMH team','Neurobiology','Outcome Research'),(911,'Preventing depression: A challenge for the Australian community','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037038199&doi=10.5694%2fj.1326-5377.2002.tb04862.x&partnerID=40&md5=53e5f51d7eb8238789a863e78eecbb9c','10.5694/j.1326-5377.2002.tb04862.x','Each year, more than 800 000 adults 1 and 95 000 children and adolescents 2 are affected by depression. Depression is already a leading cause of both disability and premature mortality, 3 and is likely to be second only to cardiovascular disease within 20 years. 4 Even if effective treatments were provided to all those affected, the overall burden of depression may still only be reduced by 50%. 5 By international standards, Australia spends a small proportion of its healthcare budget on mental health services (less than 7%), compared with more than 10%ΓÇô12% in the United Kingdom, Canada and New Zealand. 6 Before we spend more, however, we need to determine what priority should be given to the search for preventive strategies, new treatments, or new ways of delivering existing treatments. 7 There is a clear need to move from simple advocacy for more services to a wider population health-based research├é┬á├éΓÇª','',2002,NULL,NULL,'2002-10-07',NULL,NULL,NULL,NULL,'31','Medical Journal of Australia','177','7','S85','','YMH team','Illness specific areas',''),(912,'Depressive psychomotor disturbance, cortisol, and dexamethasone','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030588955&doi=10.1016%2f0006-3223%2895%2900635-4&partnerID=40&md5=10777a27b2e29f8005e2b14a79de6a04','10.1016/0006-3223(95)00635-4','We examine the dexamethasone suppression test as a biological correlate of melancholia as defined by the CORE system, a scale for rating objective signs of psychomotor disturbance. Postdexamethasone cortisol concentrations and rates of nonsuppression were higher in CORE, Newcastle, and DSM-III-R defined melancholic groups. These differences, however, were no longer significant after partialling out the combined effects of age, dexamethasone, and basal cortisol concentrations. There was a significant correlation between the CORE (but not the Newcastle) scale and 8:00 am postdexamethasone cortisol levels, which persisted after partialling out those same three covariates. Dexamethasone concentrations themselves were lower in CORE- and Newcastle-defined melancholics, though these were no longer significant after covarying for cortisol concentrations. Dexamethasone levels were also','',1996,NULL,NULL,'1996-11-15',NULL,NULL,NULL,NULL,'26','Biological Psychiatry','40','10','941-950','Elsevier','Other','',''),(913,'Meta-analysis of neurocognition in young psychosis patients with current cannabis use','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041472056&doi=10.1016%2fj.jpsychires.2018.01.010&partnerID=40&md5=d0d72e6b57fa63269bb573b3ed863dce','10.1016/j.jpsychires.2018.01.010','\n\nObjective\nAdult psychosis patients (i.e. over the age of 25 years) who are also lifetime cannabis users (CANN┬▒) appear to exhibit superior cognition compared to never-using patients (CANN-). The objective of this meta-analysis was to evaluate the cognitive differences between CANN- and patients who currently use cannabis (CANN+) (i.e. during the CANN├é┬▒ patients\' cannabis-using stage). Specifically, focusing on young patients under the age of 25 years, the typical stage of both psychosis- and cannabis-onset.\n\n\nMethod\nOf the 308 studies identified through database searches and secondary referencing, 14 compared neurocognition of CANN+ and CANN- in young people with psychotic disorders (mean age between 15 and 45 years). Effect sizes were extracted using neurocognitive test performance between CANN+ and CANN- and random effects modelling was conducted on pooled ES and moderator analyses├é┬á├éΓÇª\n\n','',2018,NULL,NULL,'2018-04-01',NULL,NULL,NULL,NULL,'30','Journal of Psychiatric Research','99','','22-32','Pergamon','YMH team','Illness specific areas',''),(914,'A decision-support tool to inform Australian strategies for preventing suicide and suicidal behaviour','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019406135&doi=10.17061%2fphrp2721717&partnerID=40&md5=5dfa3a2c8735eeae436a24f2b07b8f2e','10.17061/phrp2721717','','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Public Health Research and Practice','','','','The Sax Institute','YMH team','Digital health','illness specific areas'),(915,'Association of anterior cingulate glutathione with sleep apnea in older adults at-risk for dementia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84962468900&doi=10.5665%2fsleep.5650&partnerID=40&md5=a36fd08e0572f6b4b267bbd95ae835dd','10.5665/sleep.5650','','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Sleep','','','','The American Academy of Sleep Medicine','Other','',''),(916,'Association between sleep-disordered breathing and neuropsychological performance in older adults with mild cognitive impairment','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929310079&doi=10.3233%2fJAD-141860&partnerID=40&md5=77f8448b9aa057ccb7aaeb283a32108a','10.3233/JAD-141860','Sleep-disordered breathing in middle-age and older adults has been shown to be linked to a range of neuropsychological deficits, but the extent to which these relationships are evident in older people ΓÇÿat risk├éΓÇÖof developing dementia in unknown. In this study, we aimed to determine whether changes in sleep-disordered breathing and sleep fragmentation during nocturnal sleep were related to neuropsychological dysfunction in patients with mild cognitive impairment. Forty-six patients with MCI (mean age= 66.1 y, sd= 8.4) and 40 age-matched healthy controls (mean age= 63.5 y, sd= 8.9) underwent psychiatric, medical, and neuropsychological assessment, in addition to overnight polysomnography and self-report questionnaires. Measures of hypoxemia, sleep fragmentation, and sleep quality were derived including the apnoea-hypopnea index, oxygen desaturation index, percentage of total sleep time spent below├é┬á├éΓÇª','',2015,NULL,NULL,'2015-01-01',NULL,NULL,NULL,NULL,'29','Journal of Alzheimer\'s Disease','46','1','157-165','IOS Press','YMH team','Illness specific areas',''),(917,'Encouraging young men\'s participation in mental health research and treatment: perspectives in our technological age','https://www.researchgate.net/profile/Louise-Ellis-3/publication/276145392_Encouraging_young_men\'s_participation_in_mental_health_research_and_treatment_perspectives_in_our_technological_age/links/5553e6df08aeaaff3bf19f05/Encouraging-young-mens-participation-in-mental-health-research-and-treatment-perspectives-in-our-technological-age.pdf',NULL,'Young men have traditionally been under-represented in mental health research, which has had significant implications for the validity of reported findings and for the delivery of effective mental health services to this group. Innovative strategies are needed to recruit young men to mental health research and treatment. The internet, and in particular social media, offer a promising new way to engage with young men around their mental health. Youth participation approaches also offer the potential to enhance young men├éΓÇÖs engagement with research and mental health services. In this article we draw on our experience with these approaches, we discuss their potential strengths and limitations and describe opportunities for technology-based engagement with young men on issues of mental health.','',2013,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'30','Clin Investig','4','10','881-888','',NULL,NULL,NULL),(918,'Getting mental health reform back on track: A leadership challenge for the new australian government','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84903289470&doi=10.5694%2fmja13.11207&partnerID=40&md5=758cd484b40ca05995787ba035a7c2be','10.5694/mja13.11207','From the late 1950s, specialist mental health services started rapidly moving out of asylums. In the 1970s, this was accelerated by the human and civil rights movements. In 1983, the Richmond Report of mental health services in New South Wales provided the first coherent policy framework in Australia to underpin the process. In 1993, as Australia finalised its first National Mental Health Strategy, the Burdekin Report on the human rights of people with mental illness highlighted systemic failures in both community and institutional care.','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'27','Medical Journal of Australia','200','8','445-448','','YMH team','Mental Health System',''),(919,'Managing madness: mental health and complexity in public policy','https://search.informit.org/doi/abs/10.3316/informit.252700374830160',NULL,'This paper explores the concept of collaborative care, particularly in relation to a range of new models of organisation and service that are emerging in response to one of the most problematic areas of public policy - mental health. These emerging models of coordinated mental health care are testing the limits of the evidence supporting coordinated care, and require critical evaluation. Myriad concepts of collaborative or coordinated care in health, including mental health, have created multiple definitions. Once definitional issues have been surmounted, however, the evidence for coordination of health care is reasonably strong. There is considerable research about which treatments and programs are best for people with a mental illness. There are few areas seemingly as complex as mental health, given that responsibility for policy and service lies across all three tiers of Australian government and across multiple','',2013,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'29','Evidence Base: A Journal of Evidence Reviews in Key Policy Areas','','3','Jan-19','',NULL,NULL,NULL),(920,'Development of the \'rich club\' in brain connectivity networks from 438 adolescents &amp; adults aged 12 to 30','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84881652753&doi=10.1109%2fISBI.2013.6556552&partnerID=40&md5=818e821a26c516343e3e02958b9c63f3','10.1109/ISBI.2013.6556552','The `rich club\' coefficient describes a phenomenon where a network\'s hubs (high-degree nodes) are on average more intensely interconnected than lower-degree nodes. Networks with rich clubs often have an efficient, higher-order organization, but we do not yet know how the rich club emerges in the living brain, or how it changes as our brain networks develop. Here we chart the developmental trajectory of the rich club in anatomical brain networks from 438 subjects aged 12-30. Cortical networks were constructed from 68x68 connectivity matrices of fiber density, using whole-brain tractography in 4-Tesla 105-gradient high angular resolution diffusion images (HARDI). The adult and younger cohorts had rich clubs that included different nodes; the rich club effect intensified with age. Rich-club organization is a sign of a network\'s efficiency and robustness. These concepts and findings may be advantageous for├é┬á├éΓÇª','',2013,NULL,NULL,'2013-04-07',NULL,NULL,NULL,NULL,'29','Proceedings - International Symposium on Biomedical Imaging','','','624-627','IEEE','Other','',''),(921,'Managing depression across the life cycle: New strategies for clinicians and their patients','https://www.scopus.com/inward/record.uri?eid=2-s2.0-71049138079&doi=10.1111%2fj.1445-5994.2009.02016.x&partnerID=40&md5=102abbce637274f8e0421ccb06b8f11f','10.1111/j.1445-5994.2009.02016.x',' Depression is the leading cause of non-fatal disease burden in Australia. Recently, increasing public recognition, together with the development of more integrated medical and psychological healthcare services has resulted in significant improvements. New pathophysiological models incorporate structural brain changes with established changes in neurotransmitter function. Further, recognition of predisposing factors and the salience of differential ages of onset have led to more pragmatic diagnostic systems. There is an ongoing need to promote early recognition, better information to inform treatment choices and more comprehensive treatment programmes that incorporate behavioural and lifestyle factors in addition to the wide range of pharmacological therapies that are now available.\n','',2009,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'29','Internal Medicine Journal','39','11','720-727','Blackwell Publishing Asia','YMH team','Illness specific areas','Models of care'),(926,'Evaluating the quality and safety of health-related apps and e-tools: Adapting the Mobile App Rating Scale and developing a quality assurance protocol','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102640736&doi=10.1016%2fj.invent.2021.100379&partnerID=40&md5=08bc6a1aa276960531b25e416764e651','10.1016/j.invent.2021.100379','\n\nBackground\nWhilst apps and e-tools have tremendous potential as low-cost, scalable mental health intervention and prevention tools, it is essential that consumers and health professionals have a means by which to evaluate their quality and safety.\n\n\nObjective\nThis study aimed to: 1) adapt the original Mobile App Rating Scale (MARS) in order to be appropriate for the evaluation of both mobile phone applications as well as e-tools; 2) test the reliability of the revised scale; and 3) develop a quality assurance protocol for identifying and rating new apps and e-tools to determine appropriateness for use in clinical practice.\n\n\nMethods\nThe MARS was adapted to include items specific to health-related apps and e-tools, such as the availability of resources, strategies for self-management, and quality information. The 41 apps and e-tools in the standard youth configuration of the InnoWell Platform, a digital tool designed to support\n\n','',2021,NULL,NULL,'2021-04-01',NULL,NULL,NULL,NULL,'28','Internet Interventions','24','','100379','Elsevier','YMH team','Digital health',''),(927,'Pineal volume and evening melatonin in young people with affective disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84994226514&doi=10.1007%2fs11682-016-9650-2&partnerID=40&md5=e8fdeb3182c63d1523c3ef66acf53b35','10.1007/s11682-016-9650-2','','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Brain Imaging and Behavior','','','','Springer New York LLC','YMH team','Neurobiology',''),(929,'The Genetic and Environmental Contributions to Internet Use and Associations with Psychopathology: A Twin Study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84955719188&doi=10.1017%2fthg.2015.91&partnerID=40&md5=9df3a3ae14d70d1d0ace5c585874ead4','10.1017/thg.2015.91','Excessive internet use has been linked to psychopathology. Therefore, understanding the genetic and environmental risks underpinning internet use and their relation to psychopathology is important. This study aims to explore the genetic and environmental etiology of internet use measures and their associations with internalizing disorders and substance use disorders. The sample included 2,059 monozygotic (MZ) and dizygotic (DZ) young adult twins from the Brisbane Longitudinal Twin Study (BLTS). Younger participants reported more frequent internet use, while women were more likely to use the internet for interpersonal communication. Familial aggregation in ΓÇÿfrequency of internet use├éΓÇÖ was entirely explained by additive genetic factors accounting for 41% of the variance. Familial aggregation in ├éΓÇÿfrequency of use after 11 pm├éΓÇÖ, ├éΓÇÿusing the internet to contact peers├éΓÇÖ, and ├éΓÇÿusing the internet primarily to access social├é┬á├éΓÇª','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'28','Twin Research and Human Genetics','19','1','1-Sep','Cambridge University Press','Other','',''),(930,'Hippocampal glutamatergic/NMDA receptor functioning in bipolar disorder: A study combining mismatch negativity and proton magnetic resonance spectroscopy','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937694923&doi=10.1016%2fj.pscychresns.2015.05.002&partnerID=40&md5=5c25d6e84f0e15651555d27ff9e2d39e','10.1016/j.pscychresns.2015.05.002','Disturbances in the hippocampal glutamate (Glu)/N-methyl-d-aspartate (NMDA) system have been implicated in the pathophysiology of bipolar disorder (BD). Here we aim to provide a targeted integration of two measures of glutamatergic functioning in BD; the association between mismatch negativity (MMN) and in vivo hippocampal-Glu measured via proton magnetic resonance spectroscopy (1H MRS). Participants comprised of 33 patients with BD and 23 matched controls who underwent a two-tone passive, duration deviant MMN paradigm and 1H MRS. Levels of Glu/creatine (Cr) in the hippocampus were determined. Pearsons correlations were used to determine associations between MMN and Glu/Cr. In controls, MMN amplitude was positively associated with Glu/Cr at the left temporal site. We did not find any significant associations with Glu/Cr and frontocentral MMN nor did we find any significant','',2015,NULL,NULL,'2015-08-30',NULL,NULL,NULL,NULL,'28','Psychiatry Research - Neuroimaging','233','2','88-94','Elsevier','YMH team','Neurobiology','Illness specific areas'),(931,'Associations between depression and anxiety symptoms and retinal vessel caliber in adolescents and young adults','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84926086489&doi=10.1097%2fPSY.0000000000000117&partnerID=40&md5=1dea1e4775b0fd383a7e846810d22e5a','10.1097/PSY.0000000000000117','\nObjective\nPrevious longitudinal studies suggest that depression and anxiety are associated with risk for cardiovascular disease. The aim of the present study was to test whether an association between depression and anxiety symptoms and retinal vessel caliber, an indicator of subclinical cardiovascular risk, is apparent as early as adolescence and young adulthood.\nMethods\nParticipants were 865 adolescents and young adults who participated in the Brisbane Longitudinal Twin Study and the Twin Eye Study in Tasmania. Participants completed the Somatic and Psychological Health Report (SPHERE), including assessments of depression/anxiety and somatic symptom subscales, when they were M= 16.5 years, and they underwent retinal imaging M= 2.5 years later (range= 2 years before to 7 years after the depression/anxiety assessment). Retinal vessel caliber was assessed using computer software.\nResults├é┬á├éΓÇª\n','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'28','Psychosomatic Medicine','76','9','732','NIH Public Access','Other','',''),(932,'Funding for mental health research: The gap remains','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84857097812&doi=10.5694%2fmja10.11415&partnerID=40&md5=f61fa1d4abdfa69b79f0a35b4746f9f4','10.5694/mja10.11415',' \nObjectives: To examine the levels and growth rates of absolute funding to mental health research from 2001 to 2010, compared with other National Health Priority Areas (NHPAs), and the relative rate of mental health funding compared with other NHPAs, by taking disease burden into account. The quality of Australian research in mental health was also examined using objective indicators of research strength. \nDesign and setting: Retrospective analysis of levels of funding overall and as a function of mental health domains using data from the National Health and Medical Research Council, with and without adjustment for burden of disease. A keyword analysis was used to assess the success rate of mental health project grant applications. Objective indicators of the quality of Australian mental health research were sought from citation indicators. \nMain outcome measures: Funding for mental health research relative\n','',2011,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'28','Medical Journal of Australia','195','11-Dec','681-684','','Other','',''),(934,'Can older at risk adults benefit from psychoeducation targeting healthy brain aging?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-79960598717&doi=10.1017%2fS1041610210001109&partnerID=40&md5=6f507a322d3255da830a8f11f2df17a5','10.1017/S1041610210001109','\nBackground:\n\n Multifactorial strategies that prevent or delay the onset or progress of cognitive decline and dementia are needed, and should include education regarding recognized risk factors. The current study sought to investigate whether older adults ├éΓÇ£at risk├éΓÇ¥ of cognitive decline benefit from psychoeducation targeting healthy brain aging.\nMethods:\n\n 65 participants (mean age 64.8 years, SD 9.6) with a lifetime history of major depression; vascular risk as evidenced by at least one vascular risk factor; and/or subjective or objective memory impairment were allocated to weekly psychoeducation sessions or a waitlist control group. The small group sessions were conducted over ten weeks by a team of medical and allied health professionals with expertise in late-life depression and cognition. Sessions focused on modifiable risk factors for cognitive decline including vascular risk, diet, exercise, depression, anxiety and├é┬á├éΓÇª\n','',2011,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'27','International Psychogeriatrics','23','3','413-424','Cambridge University Press','Other','',''),(935,'Gene expression correlates of postinfective fatigue syndrome after infectious mononucleosis','https://www.scopus.com/inward/record.uri?eid=2-s2.0-34250841948&doi=10.1086%2f518614&partnerID=40&md5=46c92ac8e80fb8d1dcaf7109a5902529','10.1086/518614','                                 Background.            Infectious mononucleosis (IM) commonly triggers a protracted postinfective fatigue syndrome (PIFS) of unknown pathogenesis.                                 Methods.            Seven subjects with PIFS with 6 or more months of disabling symptoms and 8 matched control subjects who had recovered promptly from documented IM were studied. The expression of 30,000 genes was examined in the peripheral blood by microarray analysis in 65 longitudinally collected samples. Gene expression patterns associated with PIFS were sought by correlation with symptom factor scores.                                 Results.            Differential expression of 733 genes was identified when samples collected early during the illness and at the late (recovered) time point were compared. Of these genes, 234 were found to be significantly correlated with the reported severity of the fatigue symptom factor, and 180 were├é┬á├éΓÇª\n','',2007,NULL,NULL,'2007-07-01',NULL,NULL,NULL,NULL,'27','Journal of Infectious Diseases','196','1','56-66','The University of Chicago Press','Other','',''),(936,'Is real reform of the Medicare Benefits Schedule for psychiatrists in Australia economically, socially or professionally desirable?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-33645148303&doi=10.1111%2fj.1440-1665.2006.02245.x&partnerID=40&md5=96f2f3fe92ea77860ae887c55b7ca517','10.1111/j.1440-1665.2006.02245.x','\n\nObjective: To propose alternative Medicare Benefits Schedule-based funding models for outpatient psychiatric services in Australia.\n\nMethod: Development of alternative funding schedules for a variety of under-serviced populations.\n\nConclusions: Consideration of alternative systems is necessary to address the restrictive work practices, inequity and poor distribution of the psychiatric workforce.\n','',2006,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'27','Australasian Psychiatry','14','1','Aug-14','SAGE Publications','YMH team','Mental Health System',''),(937,'Variability and predictors of mental disorder rates and medical practitioner responses across Australian general practices','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035898497&doi=10.5694%2fj.1326-5377.2001.tb143788.x&partnerID=40&md5=507d69ac250bc8099afda2a9cac391a1','10.5694/j.1326-5377.2001.tb143788.x','\n\nObjective: To determine the variation in prevalence of common mental disorders and general practitioner (GP) responses across Australian general practices, and to identify practice characteristics that predict these rates. \nDesign: Cross-sectional national audit of general practices throughout Australia in 1998ΓÇô1999. \nParticipants: 46 515 ambulatory care patients attending 386 GPs. \nMain outcome measures: Practice-based prevalence of mental disorders (based on patient-reported symptoms) and GP-reported rates of psychological diagnoses and treatment (median and range, excluding the upper and lower 10% of practices); practice characteristics (patient, doctor and organisational) that predict prevalences and rates, determined by multiple regression analysis. \nResults: Even after omitting the upper and lower 10% of practices, there were large variations between practices in prevalence of common mental├é┬á├éΓÇª\n','',2001,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'27','Medical Journal of Australia','175','','S37-S41','','YMH team','Mental Health System',''),(938,'Immunological and psychological dysfunction in patients receiving immunotherapy for chronic fatigue syndrome','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026769063&doi=10.3109%2f00048679209072034&partnerID=40&md5=c27735255807e5d475156737551c7d6a','10.3109/00048679209072034','Associations between immunological and psychological dysfunction in 33 patients with Chronic Fatigue Syndrome (CFS) were examined before and in response to treatment in a double blind, placebo-controlled trial of high dose intravenous immunoglobulin. Only those patients who received active immunotherapy demonstrated a consistent pattern of correlations between improvement in depressive symptoms and markers of cell-mediated immunity (CMI). This finding lends some support to the hypothesis that depressive symptoms in patients with CFS occur secondary to, or share a common pathophysiology with, immunological dysfunction. This pattern and the lack of strong associations between depression and immunological disturbance prior to treatment are less supportive of the view that CFS is primarily a form of depressive disorder or that immunological dysfunction in patients with CFS is secondary to','',1992,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'27','Australian and New Zealand Journal of Psychiatry','26','2','249-256','SAGE Publications','Other','',''),(939,'Cohort profile: The Australian genetics of depression study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085588783&doi=10.1136%2fbmjopen-2019-032580&partnerID=40&md5=ba5f8770fee489da2c424947d94f5379','10.1136/bmjopen-2019-032580','\nPurpose Depression is the most common psychiatric disorder and the largest contributor to global disability. The Australian Genetics of Depression study was established to recruit a large cohort of individuals who have been diagnosed with depression at some point in their lifetime. The purpose of establishing this cohort is to investigate genetic and environmental risk factors for depression and response to commonly prescribed antidepressants.\nParticipants A total of 20 689 participants were recruited through the Australian Department of Human Services and a media campaign, 75% of whom were female. The average age of participants was 43 years├é┬▒15 years. Participants completed an online questionnaire that consisted of a compulsory module that assessed self-reported psychiatric history, clinical depression using the Composite Interview Diagnostic Interview Short Form and experiences of using commonly├é┬á├éΓÇª\n','',2020,NULL,NULL,'2020-05-01',NULL,NULL,NULL,NULL,'21','BMJ Open','10','5','e032580','British Medical Journal Publishing Group','YMH team','Illness specific areas','Neurobiology'),(940,'Validation of the 36-item and 12-item self-report World Health Organization Disability Assessment Schedule II (WHODAS-II) in individuals with autism spectrum disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065192278&doi=10.1002%2faur.2115&partnerID=40&md5=a79f17c3f1393bde408c9e234e1b41ec','10.1002/aur.2115',' The World Health Organization Disability Assessment Schedule II (WHODAS-II) is one of the most widely used generic assessments for measuring disability levels in both clinical and nonclinical populations, with sound psychometrics that is also aligned with the International Classification of Functioning framework. However, its psychometric properties have not been explored extensively in individuals with autism spectrum disorder (ASD). This study examined the psychometric properties of the 36-item and 12-item Self-Report WHODAS-II from 109 individuals diagnosed with ASD and without intellectual disability (IQ = 70). Participants were consecutively recruited from the Brain and Mind Centre in New South Wales, Australia. The WHODAS-II showed adequate internal consistency for all domain scores (a = 0.78ΓÇô0.97 for 36-item) and for the summary scale (a = 0.95 for 36-item; 0.86 for 12-item). All items├é┬á├éΓÇª\n','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'26','Autism Research','12','7','1101-1111','John Wiley & Sons, Inc.','Other','',''),(941,'Relationship between polyunsaturated fatty acids and psychopathology in the NEURAPRO clinical trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85069464635&doi=10.3389%2ffpsyt.2019.00393&partnerID=40&md5=849133c9b5ce0e4a754f3c55a3fe88c6','10.3389/fpsyt.2019.00393','Background Deficiencies in membrane polyunsaturated fatty acids (PUFA) such as omega-3 (n-3) fatty acids are thought to contribute to the pathophysiological processes underlying psychotic disorders. Emerging evidence suggests that the levels of PUFA are related to clinical symptoms but significant heterogeneity exists between studies. Here, we investigated associations of membrane PUFA with clinical symptoms and functioning in a large sample of individuals at ultra-high risk (UHR) for psychosis. Methods A total of 285 participants of the NEURAPRO clinical trial were investigated for erythrocyte PUFA levels, including the n-3 index, n-6/n-3 PUFA ratio, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). Severity of general psychopathology (BPRS), psychotic symptoms (BPRS psychosis subscale), negative symptoms (SANS), manic symptoms (YMRS), depressive symptoms (MADRS) and functioning (SOFAS, GF-R, GF-S) were assessed concurrently. Partial correlation taking into account the effects of gender, age and smoking were used to examine the relationship between PUFAs and symptoms severity. Results The n-3 index negatively correlated with the severity of general psychopathology, psychotic symptoms, depressive symptoms and manic symptoms. The n-6/n-3 PUFA ratio positively correlated with severity of psychotic and depressive symptoms. The n-3 PUFA DHA negatively correlated with the severity of general psychopathology, positive, manic and depressive symptoms. EPA negatively correlated with manic symptoms. Nervonic acid, an n-9 monounsaturated fatty acid, positively correlated with general├é┬á├éΓÇª','',2019,NULL,NULL,'2019-06-06',NULL,NULL,NULL,NULL,'26','Frontiers in Psychiatry','10','','393','Frontiers Media SA','Other','',''),(942,'A decision support tool to inform local suicide prevention activity in Greater Western Sydney (Australia)','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053782315&doi=10.1177%2f0004867418767315&partnerID=40&md5=8c2218d42b1e9a9ebe60fbb2baf1be13','10.1177/0004867418767315','\nObjectives:\nThis study describes the development of a decision support tool to identify the combination of suicide prevention activities and service priorities likely to deliver the greatest reductions in suicidal behaviour in Western Sydney (Australia) over the period 2018ΓÇô2028.\nMethods:\nA dynamic simulation model for the WentWest ├éΓÇô Western Sydney Primary Health Network population-catchment was developed in partnership with primary health network stakeholders based on defined pathways to mental health care and suicidal behaviour, and which represented the current incidence of suicide and attempted suicide in Western Sydney. A series of scenarios relating to potential suicide prevention activities and service priorities identified by primary health network stakeholders were investigated to identify the combination of interventions associated with the largest reductions in the forecast number of attempted suicide├é┬á├éΓÇª\n','',2018,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'26','Australian and New Zealand Journal of Psychiatry','52','10','983-993','SAGE Publications','YMH team','Digital health',''),(943,'Autism, Early Psychosis, and Social Anxiety Disorder: a transdiagnostic examination of executive function cognitive circuitry and contribution to disability','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053935090&doi=10.1038%2fs41398-018-0193-8&partnerID=40&md5=b456db53d074f24912164f0e960d345d','10.1038/s41398-018-0193-8','The disability burden in clinical cohorts with social impairment is significant, leading to poor functional outcomes. Some of this impairment has been linked to executive dysfunction. In this study, a transdiagnostic approach was taken to identify executive function (EF) processes in young adults that may underpin social impairment and to evaluate their contribution to disability. Comparisons were made between three prominent disorders that are characterized by social impairments, Autism Spectrum Disorder (ASD), Early Psychosis (EP) and Social Anxiety Disorder (SAD), as well as a neurotypically developing group (TYP). We examined whether overall disability could be predicted by neuropsychological and self-report assessments of EF. Our study showed that ASD participants demonstrated impaired performance on most domains of EF compared to the TYP group (mental flexibility, sustained attention and fluency├é┬á├éΓÇª','',2018,NULL,NULL,'2018-09-24',NULL,NULL,NULL,NULL,'23','Translational Psychiatry','8','1','1-Oct','Nature Publishing Group','Other','',''),(944,'Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85028262000&doi=10.1111%2feip.12166&partnerID=40&md5=7d398a36563a84f9afe3bcf2f07ac2fd','10.1111/eip.12166','','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Early Intervention in Psychiatry','','','','Blackwell Publishers','YMH team','Models of care','illness specific areas'),(945,'Cluster analysis reveals abnormal hippocampal neurometabolic profiles in young people with mood disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930277708&doi=10.1016%2fj.euroneuro.2015.02.009&partnerID=40&md5=551a93cfbdb903541d2865a246e0c32f','10.1016/j.euroneuro.2015.02.009','While numerous studies have employed magnetic resonance spectroscopy (MRS) to determine in vivo neurometabolite levels associated with mood disorders the findings in both unipolar depression and bipolar disorder have been mixed. Data-driven studies may shed new light on this literature by identifying distinct subgroups of patients who may benefit from different treatment strategies. The objective of the present study was to utilize hierarchical cluster analysis in order to generate new hypotheses with respect to neurometabolic profiling of mood disorder. Participants were 165 young persons (18ΓÇô30├é┬á yrs) with a mood disorder and 40 healthy controls. Neurometabolite levels were recorded via proton-MRS (1H MRS). The ratios (relative to creatine) of glutamate (GLU), N-acetyl aspartate (NAA) and myo-inositol (MI) measured within the hippocampus. Self-reported and clinician rated symptoms as well as├é┬á├éΓÇª','',2015,NULL,NULL,'2015-06-01',NULL,NULL,NULL,NULL,'26','European Neuropsychopharmacology','25','6','836-845','Elsevier','YMH team','Neurobiology',''),(946,'Body mass, cardiovascular risk and metabolic characteristics of young persons presenting for mental healthcare in Sydney, Australia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84926675435&doi=10.1136%2fbmjopen-2014-007066&partnerID=40&md5=ea6ab8e9ab2a86e81058ee81b81fa2eb','10.1136/bmjopen-2014-007066','\nObjectives To determine the body mass, cardiovascular and metabolic characteristics of young people presenting for mental healthcare.\nDesign Cross-sectional assessments of body mass, cardiovascular and metabolic risk factors.\nSetting Two primary-care based sites in Sydney, Australia for young people in the early stages of mental disorders.\nParticipants A clinical sample of young people (12ΓÇô30 years) with mental health problems.\nOutcome measures Daily smoking rates, body mass index (BMI), blood glucose and lipids, blood pressure (BP) and pulse rate.\nResults Of 1005 young people who had their BMI determined (62% female; 19.0├é┬▒3.5 years), three quarters (739/1005) also had BP recordings and one-third (298/1005) had blood sampling. Clinically, 775 were assigned to one of three diagnostic categories (anxious-depression: n=541; mania-fatigue, n=104; developmental-psychotic n=130). The profile of├é┬á├éΓÇª\n','',2015,NULL,NULL,'2015-03-01',NULL,NULL,NULL,NULL,'26','BMJ Open','5','3','e007066','British Medical Journal Publishing Group','YMH team','Outcome Research',''),(947,'Delayed preattentional functioning in early psychosis patients with cannabis use','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84864442091&doi=10.1007%2fs00213-012-2676-2&partnerID=40&md5=cdde0e4bebd4d1e27ce5e0252f602046','10.1007/s00213-012-2676-2','                                Rationale                 Cannabis use is prevalent among the early psychosis (EP) population. The event-related potentials, mismatch negativity (MMN) and P3a are reduced in EP. Cannabinoids have been shown to modulate N-methyl-D-aspartate receptors which are involved in MMN generation.                                               Objectives                 This study is the first to investigate the effects of cannabis use on MMN/P3a in EP.                                               Methods                 EP was defined as a history of psychosis or psychotic symptoms with no progression to date to chronic schizophrenia. Twenty-two EP patients with cannabis use (EP + CANN), 22 non-cannabis-using EP patients (EP-CANN) and 21 healthy controls participated in this study. MMN/P3a was elicited using a two-tone, auditory paradigm with 8% duration deviants.                                               Results                 As expected, EP-CANN showed\n','',2012,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'26','Psychopharmacology','222','3','507-518','Springer-Verlag','Other','',''),(948,'Left versus right hemisphere differences in brain connectivity: 4-Tesla HARDI tractography in 569 twins','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84864861512&doi=10.1109%2fISBI.2012.6235601&partnerID=40&md5=191460ca7ff2aaf823760ee5ab54ccef','10.1109/ISBI.2012.6235601','Diffusion imaging can map anatomical connectivity in the living brain, offering new insights into fundamental questions such as how the left and right brain hemispheres differ. Anatomical brain asymmetries are related to speech and language abilities, but less is known about left/right hemisphere differences in brain wiring. To assess this, we scanned 457 young adults (age 23.4┬▒2.0 SD years) and 112 adolescents (age 12-16) with 4-Tesla 105-gradient high-angular resolution diffusion imaging. We extracted fiber tracts throughout the brain with a Hough transform method. A 70├âΓÇö70 connectivity matrix was created, for each subject, based on the proportion of fibers intersecting 70 cortical regions. We identified significant differences in the proportions of fibers intersecting left and right hemisphere cortical regions. The degree of asymmetry in the connectivity matrices varied with age, as did the asymmetry in network├é┬á├éΓÇª','',2012,NULL,NULL,'2012-05-02',NULL,NULL,NULL,NULL,'26','Proceedings - International Symposium on Biomedical Imaging','','','526-529','IEEE','Other','',''),(949,'Australia\'s Better Access initiative: Still awaiting serious evaluation?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-80053961572&doi=10.3109%2f00048674.2011.610744&partnerID=40&md5=281c37d48582470a82e379c1c8c389f9','10.3109/00048674.2011.610744','There are few more heated issues in Australian mental health than determining the value of the Better Access to Psychiatrists, Psychologists and General Practitioners through the Medicare Benefits Schedule (Better Access) initiative. In our view, the need for genuine, well-designed and ongoing evaluation of its impacts has never been seriously addressed [1]. Sadly, the publication of aspects of the extremely limited government-purchased ΓÇÿpatient outcomes├éΓÇÖ evaluation [2] adds very little to our knowledge base.','',2011,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'26','Australian and New Zealand Journal of Psychiatry','45','10','814-823','Sage Publications','YMH team','Mental Health System',''),(951,'Sex-dependent shared and nonshared genetic architecture across mood and psychotic disorders','https://www.sciencedirect.com/science/article/pii/S0006322321011392',NULL,'\n\nBackground\nSex differences in incidence and/or presentation of schizophrenia (SCZ), major depressive disorder (MDD), and bipolar disorder (BIP) are pervasive. Previous evidence for shared genetic risk and sex differences in brain abnormalities across disorders suggest possible shared sex-dependent genetic risk.\n\n\nMethods\nWe conducted the largest to date genome-wide genotype-by-sex (G├âΓÇöS) interaction of risk for these disorders using 85,735 cases (33,403 SCZ, 19,924 BIP, and 32,408 MDD) and 109,946 controls from the PGC (Psychiatric Genomics Consortium) and iPSYCH.\n\n\nResults\nAcross disorders, genome-wide significant single nucleotide polymorphism├éΓÇôby-sex interaction was detected for a locus encompassing NKAIN2 (rs117780815, p├é┬á= 3.2├é┬á├âΓÇö 10-8), which interacts with sodium/potassium-transporting ATPase (adenosine triphosphatase) enzymes, implicating neuronal excitability. Three additional loci├é┬á├éΓÇª\n\n','',2021,NULL,NULL,'2022-01-01',NULL,NULL,NULL,NULL,'18','Biological psychiatry','91','1','102-117','Elsevier',NULL,NULL,NULL),(952,'The genetic architecture of depression in individuals of East Asian ancestry: a genome-wide association study','https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2784695',NULL,'\nImportance\nMost previous genome-wide association studies (GWAS) of depression have used data from individuals of European descent. This limits the understanding of the underlying biology of depression and raises questions about the transferability of findings between populations.\nObjective\nTo investigate the genetics of depression among individuals of East Asian and European descent living in different geographic locations, and with different outcome definitions for depression.\nDesign, Setting, and Participants\nGenome-wide association analyses followed by meta-analysis, which included data from 9 cohort and case-control data sets comprising individuals with depression and control individuals of East Asian descent. This study was conducted between January 2019 and May 2021.\nExposures\nAssociations of genetic variants with depression risk were assessed using generalized linear mixed models and├é┬á├éΓÇª\n','',2021,NULL,NULL,'2021-11-01',NULL,NULL,NULL,NULL,'25','JAMA psychiatry','78','11','1258-1269','American Medical Association',NULL,NULL,NULL),(953,'Circadian depression: A mood disorder phenotype','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103421818&doi=10.1016%2fj.neubiorev.2021.02.045&partnerID=40&md5=696b111cd67b782798c2a02e62564c03','10.1016/j.neubiorev.2021.02.045','Major mood syndromes are among the most common and disabling mental disorders. However, a lack of clear delineation of their underlying pathophysiological mechanisms is a major barrier to prevention and optimised treatments. Dysfunction of the 24-h circadian system is a candidate mechanism that has genetic, behavioural, and neurobiological links to mood syndromes. Here, we outline evidence for a new clinical phenotype, which we have called ΓÇÿcircadian depression├éΓÇÖ. We propose that key clinical characteristics of circadian depression include disrupted 24-h sleep-wake cycles, reduced motor activity, low subjective energy, and weight gain. The illness course includes early age-of-onset, phenomena suggestive of bipolarity (defined by bidirectional associations between objective motor and subjective energy/mood states), poor response to conventional antidepressant medications, and concurrent├é┬á├éΓÇª','',2021,NULL,NULL,'2021-07-01',NULL,NULL,NULL,NULL,'19','Neuroscience and Biobehavioral Reviews','126','','79-101','Pergamon','YMH team','Illness specific areas',''),(954,'Technology-enabled person-centered mental health services reform: Strategy for implementation science','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85097129062&doi=10.2196%2f14719&partnerID=40&md5=2b41c40982edf0f73b23c96f258749e0','10.2196/14719','\nBackground: Health information technologies are being rapidly developed to improve the delivery of mental health care; however, a range of facilitators, barriers, and contextual conditions can impact the adoption and sustainment of these solutions. An implementation science protocol supports researchers to achieve primary effectiveness goals in relation to mental health services reform and aids in the optimization of implementation processes to promote quality health care, prolonging sustainability.\nObjective: The aim of this paper is to describe our implementation science protocol, which serves as a foundation by which to systematically guide the implementation of technology-enabled solutions in traditional face-to-face and Web-based mental health services, allowing for revisions over time on the basis of retrospective review and constructive feedback from the services in which the technology-enabled solutions are implemented.\nMethods: Our implementation science protocol comprises four phases. The primary objective of the scoping and feasibility phase (Phase 1) is to determine the alignment between the service partner and the quality improvement goals supported by the technology-enabled solution. This is followed by Phase 2, the local co-design and preimplementation phase, which aims to utilize co-design methodologies, including service pathway modelling, participatory design, and user (acceptance) testing, to determine how the solutions could be used to enhance the service. In Phase 3, implementation, the accepted solution is embedded in the mental health service to achieve better outcomes for consumers and their families as\n','',2019,NULL,NULL,'2019-09-19',NULL,NULL,NULL,NULL,'25','JMIR Mental Health','6','9','e14719','JMIR Publications Inc., Toronto, Canada','YMH team','Digital health','Models of care'),(955,'The runaway giant: ten years of the Better Access program','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85063696170&doi=10.5694%2fmja2.50068&partnerID=40&md5=b205af66e56f0a4faa103e1b4afc3248','10.5694/mja2.50068','It is now more than 15 years since the Howard government first provided Commonwealth funding support for psychological interventions. First, in 2001, the Better Outcomes in Mental Health Care program responded specifically to the imbalance in care between medication-based and psychological treatment options for common forms of anxiety or depression. The program had very attractive design features focusing on regional implementation, practitioner education, improved multidisciplinary care and funding for completed episodes of care. However, program funding was both capped and very limited (around $30 million per year).','',2019,NULL,NULL,'2019-04-01',NULL,NULL,NULL,NULL,'25','Medical Journal of Australia','210','7','299-301. e1','','YMH team','Models of care','Mental Health System'),(956,'Genome-wide association meta-analysis of age at first cannabis use','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052393915&doi=10.1111%2fadd.14368&partnerID=40&md5=d3680bf3ac1508aafbbb229c41face75','10.1111/add.14368','  Background and aims Cannabis is one of the most commonly used substances among adolescents and young adults. Earlier age at cannabis initiation is linked to adverse life outcomes, including multi-substance use and dependence. This study estimated the heritability of age at first cannabis use and identified associations with genetic variants.   Methods A twin-based heritability analysis using 8055 twins from three cohorts was performed. We then carried out a genome-wide association meta-analysis of age at first cannabis use in a discovery sample of 24 953 individuals from nine European, North American and Australian cohorts, and a replication sample of 3735 individuals.   Results The twin-based heritability for age at first cannabis use was 38% [95% confidence interval (CI)├é┬á=├é┬á19├éΓÇô60%]. Shared and unique environmental factors explained 39% (95% CI├é┬á=├é┬á20├éΓÇô56%) and 22% (95% CI├é┬á=├é┬á16├éΓÇô29%). The├é┬á├éΓÇª\n','',2018,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'25','Addiction','113','11','2073-2086','','Other','',''),(957,'In vivo imaging of oxidative stress and fronto-limbic white matter integrity in young adults with mood disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85016414638&doi=10.1007%2fs00406-017-0788-8&partnerID=40&md5=5c5ba6339d0c9377dd4c28d122d87294','10.1007/s00406-017-0788-8','               Fronto-limbic connectivity is compromised in mood disorders, as reflected by impairments in white matter (WM) integrity revealed by diffusion tensor imaging. Although the underlying mechanisms remain unclear, disruption to normal myelination due to oxidative stress is thought to play a key role. We aimed to determine whether fronto-limbic WM integrity is compromised, and associated with in vivo antioxidant levels (indexed by glutathione; GSH), in young adults with unipolar depression (DEP) and bipolar (BD) disorders. Ninety-four patients with DEP, 76 with BD and 59 healthy controls (18ΓÇô30 years) underwent diffusion tensor and proton magnetic resonance spectroscopy imaging. Fractional anisotropy (FA) was calculated from the cingulum bundle (cingulate, hippocampus), fornix, stria terminalis (ST) and uncinate fasciculus tracts. GSH concentration was measured in anterior cingulate cortex (ACC) and├é┬á├éΓÇª\n','',2018,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'25','European Archives of Psychiatry and Clinical Neuroscience','268','2','145-156','Springer Berlin Heidelberg','YMH team','Neurobiology','illness specific areas'),(958,'Familial aggregation and heritability of the melancholic and atypical subtypes of depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84979644216&doi=10.1016%2fj.jad.2016.06.040&partnerID=40&md5=3f22e93ebabe5c76cd0fdb8f759349ef','10.1016/j.jad.2016.06.040','\n\nBackground\nThe heterogeneity of mood disorders has been a challenge to our understanding of their underlying biologic and genetic pathways. This report examines the specificity of the familial aggregation of atypical and melancholic subtypes of depression and their clinical correlates in a large community based family study of affective spectrum disorders.\n\n\nMethods\nThe sample includes 457 probands and their directly interviewed adult first degree relatives from the National Institute of Mental Health (NIMH) Family Study of Affective Spectrum Disorder. Depression subtypes were based on best estimate diagnoses using information from semi-structured diagnostic interviews by experienced clinical interviews and multiple family history reports.\n\n\nResults\nAtypical depression in probands was significantly associated with the atypical subtype of depression in relatives (OR 1.75 [95%CI 1.02ΓÇô3.02], p=0.04), independent of├é┬á├éΓÇª\n\n','',2016,NULL,NULL,'2016-11-01',NULL,NULL,NULL,NULL,'25','Journal of Affective Disorders','204','','241-246','Elsevier','Other','',''),(959,'Sleep disturbance in mild cognitive impairment is associated with alterations in the brain├éΓÇÖs default mode network.','https://psycnet.apa.org/record/2016-11915-001',NULL,'This study aimed to identify default mode network (DMN) functional connectivity deficits in patients with mild cognitive impairment (MCI) and sleep disturbance, relative to those with MCI and no sleep disturbance. A control group was included to aid in identifying DMN changes specific to MCI. A cross-sectional, single-center study was performed at the Brain and Mind Research Centre in Sydney, Australia. Participants (95 adults over the age of 65: 38 controls and 57 meeting criteria for MCI) underwent resting-state functional MRI along with comprehensive neuropsychological, medical, and psychiatric assessment. Self-report data were collected including sleep quality assessment via the Pittsburgh Sleep Quality Index. A total score of greater than 5 on the Pittsburgh Sleep Quality Index was used to signify the presence of significant sleep disturbance, as per commonly used methodology. Using this criterion, 53%(n├é┬á├éΓÇª','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'25','Behavioral Neuroscience','130','3','305','American Psychological Association',NULL,NULL,NULL),(960,'Using accountability for mental health to drive reform summary','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84945174144&doi=10.5694%2fmja15.00447&partnerID=40&md5=3b075483166e6939bf0a7419ec51d9ea','10.5694/mja15.00447','Greatly enhanced accountability can drive mental health reform. As extant approaches are ineffective, we propose a new approach.','',2015,NULL,NULL,'2015-10-19',NULL,NULL,NULL,NULL,'25','Medical Journal of Australia','203','8','328-330','','YMH team','Mental Health System',''),(961,'Evidence for separate inheritance of mania and depression challenges current concepts of bipolar mood disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84893654077&doi=10.1038%2fmp.2013.173&partnerID=40&md5=6724ab9844831c56db4d096b4ede782c','10.1038/mp.2013.173','\nDespite the vast investments in epidemiological, clinical and neurobiological research, the boundaries between the key psychiatric disorders remain indistinct. The pathophysiological paths that underpin the common affective disorders, including bipolar disorder, have not been clearly delineated. 3 Consequently, choice of clinical treatments still occurs largely on the basis of reducing target symptoms (psychosis, depression, mania/hypomania and anxiety), resulting often in the use of multiple medical or psychological therapies.\nThese fundamental challenges are not simply advanced by the release of DSM-5 (http://www. dsm5. org/) or other new systems for use in research (for example, Research Domain Criteria of National Institute of Mental Health-http://www. nimh. nih. gov/researchpriorities/rdoc/index. shtml). Indeed, recent evidence from family, twin and molecular genetic studies highlight common genetic factors\n','',2014,NULL,NULL,'2014-02-01',NULL,NULL,NULL,NULL,'25','Molecular Psychiatry','19','2','153','Nature Publishing Group','YMH team','Illness specific areas',''),(962,'Neurocognitive disturbances associated with acute infectious mononucleosis, Ross River fever and Q fever: A preliminary investigation of inflammatory and genetic correlates','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84891837206&doi=10.1016%2fj.bbi.2013.11.002&partnerID=40&md5=aa6165fe23601901473654a336297d1c','10.1016/j.bbi.2013.11.002','\nDisturbances in neurocognitive performance are a core feature of the acute sickness response to infection; however the underlying mechanisms remain unclear. The current study used a computerised battery to assess neurocognitive functioning in subjects enrolled in the Dubbo Infection Outcomes Study (n├é┬á=├é┬á107) ├éΓÇô a prospective cohort of subjects followed from documented acute infection with Epstein Barr virus, Ross River virus, or Coxiella burnetii until recovery. Subjects were assessed when ill, and a subset again after complete recovery. Associations between sickness-related cognitive disturbances and single nucleotide polymorphisms (SNPs) in cytokine (interleukin [IL]-6, IL-10, tumor necrosis factor-a and interferon-) and neurobehavioral genes (serotonin transporter and catechol-O-methyltransferase) were explored.\nDuring acute infection, subjects exhibited slower matching-to-sample responses (p├é┬á=├é┬á0.03├é┬á├éΓÇª\n','',2014,NULL,NULL,'2014-02-01',NULL,NULL,NULL,NULL,'25','Brain, Behavior, and Immunity','36','','207-214','Academic Press','Other','',''),(963,'Risky alcohol use in young persons with emerging bipolar disorder is associated with increased oxidative stress','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84888391527&doi=10.1016%2fj.jad.2013.06.003&partnerID=40&md5=09e6be3079718b735626fa56841bcd8d','10.1016/j.jad.2013.06.003','\n\nBackground\nAlcohol misuse is highly prevalent in bipolar disorder (BD) and has been associated with increased formation of reactive oxygen species in the CNS. Proton magnetic resonance spectroscopy (1H-MRS) is an in vivo tissue-based imaging modality that allows the investigation of changes in the brains primary antioxidant, glutathione (GSH), as a result of alcohol use in this population.\n\n\nMethods\nThirty-three patients with BD and 17 controls aged 18ΓÇô30 years were recruited. Participants completed the Alcohol Use Disorders Identification Test (AUDIT) and underwent 1H-MRS. Levels of GSH in the anterior cingulate cortex (ACC) were determined. ANOVA was conducted to determine differences between high and low risk drinking bipolar participants and controls.\n\n\nResults\nANOVA with all groups revealed a significant difference in GSH between bipolar high and low risk drinkers, with those in the high-risk group├é┬á├éΓÇª\n\n','',2013,NULL,NULL,'2013-09-25',NULL,NULL,NULL,NULL,'25','Journal of Affective Disorders','150','3','1238-1241','Elsevier','YMH team','Neurobiology',''),(964,'Social Cognition Deficits and Psychopathic Traits in Young People Seeking Mental Health Treatment','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84879828809&doi=10.1371%2fjournal.pone.0067753&partnerID=40&md5=0cd6f95c1fbdb032f401dfbbb6b895ce','10.1371/journal.pone.0067753','Antisocial behaviours and psychopathic traits place an individual at risk for criminality, mental illness, substance dependence, and psychosocial dysfunction. Social cognition deficits appear to be associated with psychopathic traits and are believed to contribute to interpersonal dysfunction. Most research investigating the relationship of these traits with social cognition has been conducted either in children or adult forensic settings. We investigated whether psychopathic traits were associated with social cognition in 91 young people presenting for mental healthcare (aged between 15 and 25 years). Participants completed symptom severity measures, neuropsychological tests, the Reading the Mind in the Eyes Test of social cognition (RMET), and the Antisocial Process Screening Device (APSD) to assess psychopathic personality traits. Correlation analyses showed poorer social cognition was associated with greater psychopathic traits (r = -.36, p = .01). Interestingly, social cognition performance predicted unique variance in concurrent psychopathic personality traits above gender, IQ sustained attention, and working memory performance. These findings suggest that social cognitive impairments are associated with psychopathic tendencies in young people presenting for community mental healthcare. Research is needed to establish the directionality of this relationship and to determine whether social cognition training is an effective treatment amongst young people with psychopathic tendencies.','',2013,NULL,NULL,'2013-07-04',NULL,NULL,NULL,NULL,'25','PLoS ONE','8','7','e67753','Public Library of Science','YMH team','Outcome Research',''),(965,'Patient satisfaction with a mood disorders unit: Elements and components','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907034445&doi=10.3109%2f00048679409075640&partnerID=40&md5=d27b1684bbdb0ed141b2906797a6631f','10.3109/00048679409075640','Patient satisfaction is an indicator of effective service provision and may influence compliance with treatment. Of 265 patients attending a specialised mood disorders unit and surveyed at least two years after their initial contact, 221 (83%) replied. Characteristics of responders and non-responders were compared on demographic and clinical information from index assessment and follow-up. Sixty-four percent of responders were very satisfied and 21% partly satisfied with their management. Components of satisfaction included perceived competence of clinical management; the unit\'s administrative and after-treatment accessibility; and the support of staff and other patients. Those with a more adequate personality and melancholic depression at baseline assessment were more satisfied. A low current mood state at time of survey was associated with lower satisfaction in non-melancholies only. There were','',1994,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'25','Australasian Psychiatry','28','2','279-287','Sage Publications','Other','',''),(966,'Inter-rater reliability of a refined index of melancholia: the CORE system','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027513728&doi=10.1016%2f0165-0327%2893%2990003-3&partnerID=40&md5=0940bd2f3cf85be3299717e488bc06ed','10.1016/0165-0327(93)90003-3','We report an inter-rater reliability study of the modified 18-item, sign-based CORE index of melancholia, undertaken on 205 ratings of 35 patients by five clinical research psychiatrists. Inter-rater agreement about the presence or absence of indicidual items was slight to moderate when examined by the kappa coefficient, but moderate to high when examined by the intraclass correlation statistic. For total CORE scores, perhaps the most important application of the index of melancholia, high levels of intraclass correlation coefficients (ranging 0.79 to 0.90 across the varying rater dyads) were established. When a single cut-off score (of 7/8) was used to allocate patients to either a ΓÇÿmelancholic├éΓÇÖ or ├éΓÇÿnon-melancholic├éΓÇÖ class, only moderate agreement was established between raters in such ├éΓÇÿclass├éΓÇÖ assignments - a limitation which can be redressed by imposing a ├éΓÇÿprobable/possible melancholia├éΓÇÖ band of scores.','',1993,NULL,NULL,'1993-03-01',NULL,NULL,NULL,NULL,'25','Journal of Affective Disorders','27','3','155-162','Elsevier','YMH team','Models of care',''),(967,'Lessons from a mood disorders unit','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027270864&doi=10.1080%2f00048679309075774&partnerID=40&md5=75d13a4cc90fa395417b30492a2f6679','10.1080/00048679309075774','Specialist treatment centres, such as the Mood Disorders Unit (MDU) at Prince Henry Hospital, Sydney, have developed in response to the high prevalence of mood disorders and their frequent persistence and treatment resistance. The MDU\'s assessment and treatment of patients from state-wide catchment area and its teaching and research effectiveness are reviewed. Of 479 patients assessed between 1985 and 1989, there were 304 with primary depressive disorders, of whom 154 were followed up by clinical assessment at 52 weeks and 231 by telephone interview at 3 1/2 years. At intake, 59% were tertiary referral patients and 88% were from outside the local area. Two-thirds were recovered 3 1/2 years later, despite the disorders having been generally severe and protracted. Treatment modality was associated primarily with diagnosis, but also with age and somewhat with the patient\'s personality and','',1993,NULL,NULL,'1993-01-01',NULL,NULL,NULL,NULL,'25','Australian and New Zealand Journal of Psychiatry','27','2','254-263','Taylor & Francis','Other','',''),(968,'Circadian rhythm sleepΓÇôwake disturbances and depression in young people: implications for prevention and early intervention','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85113141325&doi=10.1016%2fS2215-0366%2821%2900034-1&partnerID=40&md5=9195e9cb8801b212ce8451e2ce2659bf','10.1016/S2215-0366(21)00034-1','A rate-limiting step in the prevention and early intervention of depressive disorders in young people is our insufficient understanding of causal mechanisms. One plausible pathophysiological pathway is disturbance in the 24 h sleep├éΓÇôwake cycle and the underlying circadian system. Abnormalities in circadian rhythms are well documented in adults with various depressive disorders and have been linked to core clinical features, including unstable mood, daytime fatigue, non-restorative sleep, reduced motor activity, somatic symptoms, and appetite and weight change. In this Review, we summarise four areas of research: basic circadian biology and animal models of circadian disturbances; developmental changes in circadian rhythms during adolescence and implications for the emergence of adolescent-onset depressive syndromes; community and clinical studies linking 24 h sleep├éΓÇôwake cycle disturbances and├é┬á├éΓÇª','',2021,NULL,NULL,'2021-09-01',NULL,NULL,NULL,NULL,'24','The Lancet Psychiatry','8','9','813-823','Elsevier','YMH team','Illness specific areas','Outcome Research'),(969,'Comorbid chronic pain and depression: Shared risk factors and differential antidepressant effectiveness','https://www.frontiersin.org/articles/10.3389/fpsyt.2021.643609/full',NULL,'The bidirectional relationship between depression and chronic pain is well recognized, but their clinical management remains challenging. Here we characterize the shared risk factors and outcomes for their comorbidity in the Australian Genetics of Depression cohort study (N=13,839). Participants completed online questionnaires about chronic pain, psychiatric symptoms, comorbidities, treatment response and general health. Logistic regression models were used to examine the relationship between chronic pain and clinical and demographic factors. Cumulative linked logistic regressions assessed the effect of chronic pain on treatment response for ten different antidepressants. Chronic pain was associated with an increased risk of depression (OR=1.86 [1.37├éΓÇô2.54]), recent suicide attempt (OR=1.88[1.14├éΓÇô3.09]), higher use of alcohol, tobacco and misuse of painkillers. Participants with comorbid chronic pain and depression reported fewer functional benefits from antidepressant use and lower benefits from sertraline (OR=0.75[0.68├éΓÇô0.83]), escitalopram (OR=0.75[0.67├éΓÇô0.85]) and venlafaxine (OR=0.78[0.68├éΓÇô0.88]) when compared to participants without chronic pain. Furthermore, participants taking sertraline (OR=0.45[0.30├éΓÇô0.67]), escitalopram (OR=0.45[0.27├éΓÇô0.74]) and citalopram (OR=0.32[0.15├éΓÇô0.67]) specifically for chronic pain (among other indications) reported lower benefits compared to other participants taking these same medications but not for chronic pain. These findings reveal novel insights into the complex relationship between chronic pain and depression. Treatment response analyses indicate differential effectiveness between├é┬á├éΓÇª','',2021,NULL,NULL,'2021-04-12',NULL,NULL,NULL,NULL,'24','Frontiers in psychiatry','12','','643609','Frontiers Media SA',NULL,NULL,NULL),(970,'Involving end users in adapting a Spanish version of a web-based mental health clinic for young people in Colombia: Exploratory study using participatory design methodologies','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85097854469&doi=10.2196%2f15914&partnerID=40&md5=d3e6b3fea5d3c2b7bba527d2069a1294','10.2196/15914','           Background           Health information technologies (HITs) hold enormous promise for improving access to and providing better quality of mental health care. However, despite the spread of such technologies in high-income countries, these technologies have not yet been commonly adopted in low- and middle-income countries. People living in these parts of the world are at risk of experiencing physical, technological, and social health inequalities. A possible solution is to utilize the currently available HITs developed in other counties.                             Objective           Using participatory design methodologies with Colombian end users (young people, their supportive others, and health professionals), this study aimed to conduct co-design workshops to culturally adapt a Web-based Mental Health eClinic (MHeC) for young people, perform one-on-one user-testing sessions to evaluate an alpha prototype of a Spanish version of the MHeC and adapt it to the Colombian context, and inform the development of a skeletal framework and alpha prototype for a Colombian version of the MHeC (MHeC-C).                             Methods           This study involved the utilization of a research and development (R&D) cycle including 4 iterative phases: co-design workshops; knowledge translation; tailoring to language, culture, and place (or context); and one-on-one user-testing sessions.                             Results           A total of 2 co-design workshops were held with 18 users├éΓÇöyoung people (n=7) and health professionals (n=11). Moreover, 10 users participated in one-on-one user-testing sessions├éΓÇöyoung people (n=5), supportive others (n=2), and health├é┬á├éΓÇª\n','',2020,NULL,NULL,'2020-02-06',NULL,NULL,NULL,NULL,'18','JMIR Mental Health','7','2','e15914','JMIR Publications Inc., Toronto, Canada','YMH team','Digital health',''),(971,'Modelling associations between neurocognition and functional course in young people with emerging mental disorders: a longitudinal cohort study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079587949&doi=10.1038%2fs41398-020-0726-9&partnerID=40&md5=e6df9082b65e9aabd3c9ff604764578b','10.1038/s41398-020-0726-9','Neurocognitive impairment is commonly associated with functional disability in established depressive, bipolar and psychotic disorders. However, little is known about the longer-term functional implications of these impairments in early phase transdiagnostic cohorts. We aimed to examine associations between neurocognition and functioning at baseline and over time. We used mixed effects models to investigate associations between neurocognitive test scores and longitudinal social and occupational functioning (├éΓÇ£Social and Occupational Functioning Assessment Scale├éΓÇ¥) at 1├éΓÇô7 timepoints over five-years in 767 individuals accessing youth mental health services. Analyses were adjusted for age, sex, premorbid IQ, and symptom severity. Lower baseline functioning was associated with male sex (coefficient -3.78, 95% CI -5.22 to -2.34 p < 0.001), poorer verbal memory (coefficient 0.90, 95% CI 0.42 to 1.38, p <├é┬á├éΓÇª','',2020,NULL,NULL,'2020-01-21',NULL,NULL,NULL,NULL,'24','Translational Psychiatry','10','1','1-Sep','Nature Publishing Group','YMH team','Digital health','Outcome Research'),(972,'SleepΓÇôwake profiles predict longitudinal changes in manic symptoms and memory in young people with mood disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84973866668&doi=10.1111%2fjsr.12413&partnerID=40&md5=b986e9ad8f9646ac900c3f1263ec0a46','10.1111/jsr.12413',' Mood disorders are characterized by disabling symptoms and cognitive difficulties which may vary in intensity throughout the course of the illness. Sleep├éΓÇôwake cycles and circadian rhythms influence emotional regulation and cognitive functions. However, the relationships between the sleep├éΓÇôwake disturbances experienced commonly by people with mood disorders and the longitudinal changes in their clinical and cognitive profile are not well characterized. This study investigated associations between initial sleep├éΓÇôwake patterns and longitudinal changes in mood symptoms and cognitive functions in 50 young people (aged 13├éΓÇô33├é┬áyears) with depression or bipolar disorder. Data were based on actigraphy monitoring conducted over approximately 2 weeks and clinical and neuropsychological assessment. As part of a longitudinal cohort study, these assessments were repeated after a mean follow-up interval of 18.9├é┬á├éΓÇª\n','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'24','Journal of Sleep Research','25','5','549-555','','YMH team','Illness specific areas','Outcome Research'),(973,'Dysregulated sleep-wake cycles in young people are associated with emerging stages of major mental disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84954027445&doi=10.1111%2feip.12143&partnerID=40&md5=fa22fa21db962dcf5cb6c4df2f7663db','10.1111/eip.12143','  Aim To determine if disturbed sleep├éΓÇôwake cycle patterns in young people with evolving mental disorder are associated with stages of illness.   Methods The sleep├éΓÇôwake cycle was monitored using actigraphy across 4 to 22 days. Participants (21 healthy controls and 154 persons seeking help for mental health problems) were aged between 12 and 30 years. Those persons seeking mental health care were categorized as having mild symptoms (stage 1a), an ├éΓÇÿattenuated syndrome├éΓÇÖ (stage 1b) or an ├éΓÇÿestablished mental disorder├éΓÇÖ (stage 2+).   Results The proportions of individuals with a delayed weekdays sleep schedule increased progressively across illness stages: 9.5% of controls, 11.1% of stage 1a, 25.6% of stage 1b, and 50.0% of stage 2+ (2 (3 d.f.) = 18.4, P < 0.001). A similar pattern was found for weekends (2 (3 d.f.) = 7.6, P = 0.048). Compared with controls, stage 1b participants had later sleep├é┬á├éΓÇª\n','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'24','Early Intervention in Psychiatry','10','1','63-70','','YMH team','Illness specific areas','Models of care'),(974,'Variations in the sleep├éΓÇôwake cycle from childhood to adulthood: chronobiological perspectives','https://lancegoyke.com/wp-content/uploads/2018/05/CPT-41765-variation-in-the-sleep-wake-cycle-from-childhood-to-adulthoo_072115.pdf',NULL,'Changes in the sleep├éΓÇôwake cycle across development from childhood to adulthood, typically involve a steady shortening of the sleep period and a delay of sleep phase, with a period of more rapid change across adolescence. Accompanying these changes is the maturation of neuroendocrine rhythms such as melatonin, cortisol, and pubertal hormones. These endogenous rhythms are closely associated with behavioral changes in rest and activity rhythms, although environmental factors such as light exposure and academic and social demands likely play an interactive role. Other behavioral aspects, such as physical activity and eating behaviors, are also associated with changes in sleep├éΓÇôwake rhythms, and may be mediational factors in the development of physical illnesses. The sleep├éΓÇôwake cycle and related factors are implicated in the development of mental illnesses. There are several potential avenues of future research that may be valuable in terms of improving interventions and treatments for both mental and physical illnesses.','',1998,NULL,NULL,'2015-07-21',NULL,NULL,NULL,NULL,'23','ChronoPhysiology and Therapy','5','','37-49','Dove Press',NULL,NULL,NULL),(975,'A longitudinal proton magnetic resonance spectroscopy study investigating oxidative stress as a result of alcohol and tobacco use in youth with bipolar disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922553435&doi=10.1016%2fj.jad.2015.01.021&partnerID=40&md5=e2c6288cf792a481ee9e24f593d6f727','10.1016/j.jad.2015.01.021','\nAlcohol and tobacco have been suggested to be ΓÇ£aggravating factors├éΓÇ¥ for neuroprogression in bipolar disorder (BD), however the impact of these substances on the underlying neurobiology is limited. Oxidative stress is a key target for research into neuroprogression in BD and in accordance with this model, our previous cross-sectional studies have found that risky alcohol and tobacco use in BD is associated with increased oxidative stress, investigated via in vivo glutathione (GSH) measured by proton magnetic resonance spectroscopy (1H-MRS) in the anterior cingulate cortex (ACC). What remains unknown is whether the negative impact on GSH levels can be modified as a result of limiting alcohol and tobacco use.\nThirty BD patients were included in the study. 1H-MRS and tobacco and alcohol measures were conducted at baseline and follow-up assessments (15.5├é┬▒4.6 months apart). Pearsons correlations were├é┬á├éΓÇª\n','',2015,NULL,NULL,'2015-04-01',NULL,NULL,NULL,NULL,'24','Journal of Affective Disorders','175','','481-487','Elsevier','YMH team','Neurobiology',''),(976,'Mismatch Negativity/P3a Complex in Young People with Psychiatric Disorders: A Cluster Analysis','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84871333391&doi=10.1371%2fjournal.pone.0051871&partnerID=40&md5=cab78c3e19578e200e47fd58b14b33c3','10.1371/journal.pone.0051871','Background We have recently shown that the event-related potential biomarkers, mismatch negativity (MMN) and P3a, are similarly impaired in young patients with schizophrenia- and affective-spectrum psychoses as well as those with bipolar disorder. A data driven approach may help to further elucidate novel patterns of MMN/P3a amplitudes that characterise distinct subgroups in patients with emerging psychiatric disorders.   Methods Eighty seven outpatients (16 to 30 years) were assessed: 19 diagnosed with a depressive disorder; 26 with a bipolar disorder; and 42 with a psychotic disorder. The MMN/P3a complex was elicited using a two-tone passive auditory oddball paradigm with duration deviant tones. Hierarchical cluster analysis utilising frontal, central and temporal neurophysiological variables was conducted.   Results Three clusters were determined: the ΓÇÿglobally impaired├éΓÇÖ cluster (n = 53) displayed reduced frontal and temporal MMN as well as reduced central P3a amplitudes; the ├éΓÇÿlargest frontal MMN├éΓÇÖ cluster (n = 17) were distinguished by increased frontal MMN amplitudes and the ├éΓÇÿlargest temporal MMN├éΓÇÖ cluster (n = 17) was characterised by increases in temporal MMN only. Notably, 55% of those in the globally impaired cluster were diagnosed with schizophrenia-spectrum disorder, whereas the three patient subgroups were equally represented in the remaining two clusters. The three cluster-groups did not differ in their current symptomatology; however, the globally impaired cluster was the most neuropsychologically impaired, compared with controls.   Conclusions These findings suggest that in emerging psychiatric disorders there├é┬á├éΓÇª','',2012,NULL,NULL,'2012-12-14',NULL,NULL,NULL,NULL,'24','PLoS ONE','7','12','e51871','Public Library of Science','YMH team','Neurobiology',''),(977,'Distress and depression among Australian law students: incidence, attitudes and the role of universities','https://heinonline.org/hol-cgi-bin/get_pdf.cgi?handle=hein.journals/sydney32&section=8',NULL,'Levels of psychological distress and depression as well as attitudes and behaviours concerning depression and treatment were investigated in final-year law students attending 13 Australian universities. These law students showed elevated levels of distress compared to the general Australian population and medical students, and had personal experiences of depression and low expectations regarding treatment outcomes. Despite these expectations. surprisingly large numbers of the students who had experienced depression had sought treatment. Issues concerning the role of educational institutions in preventing and relieving student distress are discussed.','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'24','Sydney L. Rev.','32','','113','',NULL,NULL,NULL),(978,'Polymorphisms in Toll-like receptors-2 and -4 are not associated with disease manifestations in acute Q fever','https://www.scopus.com/inward/record.uri?eid=2-s2.0-36949006088&doi=10.1038%2fsj.gene.6364428&partnerID=40&md5=13d9e113b26e46c3b8eeccd7d41ed5bd','10.1038/sj.gene.6364428','Coxiella burnetii is a macrophage-tropic, Gram-negative organism, which causes acute Q fever infection in humans. This zoonotic infection causes illness ranging from asymptomatic seroconversion to severe and protracted disease featuring hepatitis and pneumonia. Interactions between C. burnetii lipopolysaccharide (LPS) and host Toll-like receptors (TLR)-2 and-4 have been implicated in pathogen recognition, phagocytosis and signaling responses. Nonconservative single nucleotide polymorphisms in the coding regions of TLR-2 (Arg677Trp and Arg753Gln) and TLR-4 (Asp299Gly) have been found to correlate with mycobacterial infections and Gram-negative sepsis respectively. Associations between the TLR-2 and-4 polymorphisms, illness characteristics and immune response parameters were examined in subjects with acute Q fever (n= 85) and comparison subjects with viral infections (n= 162). No','',2007,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'24','Genes and Immunity','8','8','699-702','Nature Publishing Group','Other','',''),(979,'Are antidepressants all the same? Surveying the opinions of Australian psychiatrists','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032832382&doi=10.1046%2fj.1440-1614.1999.00632.x&partnerID=40&md5=3d64b9d5e1ca87bb86c35d566e558825','10.1046/j.1440-1614.1999.00632.x','\n\nObjective: Controlled trials do not suggest differences in efficacy between antidepressant compounds. Psychiatrists, however, frequently express the view that real differences do exist and are relevant to clinical practice. Since multiple comparative trials are not feasible, an alternative method for expanding the evidence base is to survey regularly the opinions of practising psychiatrists.\n\nMethod: Two surveys of psychiatrists\' opinions were conducted. Participants in the first survey were drawn from contact with ΓÇÿSPHERE: A National Depression Project├éΓÇÖ, while those in the second survey responded to a brief questionnaire distributed with Australasian Psychiatry.\n\nResults: Reported volumes of scripts written, ratings of efficacy and tolerability, and preferences in specific clinical situations indicate that clinical psychiatrists now strongly prefer the newer antidepressant agents. They rate serotonin and noradren-alin re-uptake├é┬á├éΓÇª\n','',1999,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'24','Australian and New Zealand Journal of Psychiatry','33','5','642-649','Sage Publications','YMH team','Mental Health System',''),(980,'Increasing general practitioner skills with patients with serious mental illness.','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030629004&doi=10.1071%2fAH970055a&partnerID=40&md5=5647ac4285538b3172135315915736aa','10.1071/AH970055a','This report describes a clinical training program designed to increase generalpractitioner involvement with a public mental health service. The program involvedone half-day clinical session per week and one two-hour formal training seminar permonth, over a six-month period. Prior to training, participants demonstrated major clinical and theoretical skill deficits when assessing patients with serious mental illnesses. While specific knowledge of psychiatry increased by the end of the training program, little change in clinical interview skills was evident. Current initiatives toenhance general practitioner involvement in mental health care may be hampered if these skill deficits are not directly addressed in relevant shared care programs.','',1997,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'24','Australian health review : a publication of the Australian Hospital Association','20','3','55-67','CSIRO PUBLISHING','YMH team','Models of care','Mental Health System'),(981,'Sub-Typing Depression, III. Development of a Clinical Algorithm for Melancholia and Comparison with other Diagnostic Measures','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029127836&doi=10.1017%2fS003329170003508X&partnerID=40&md5=f97ad55e52e3688321eb437f85bbd3d0','10.1017/S003329170003508X','We describe the development of a clinical algorithm to differentiate melancholic from non-melancholic depression, using refined sets of ΓÇÿendogeneity├éΓÇÖ symptoms together with clinician-rated CORE scores assessing psychomotor disturbance. Assignment by the empirically developed algorithm is contrasted with assignment by DSM-III-R and with several other melancholia subtyping indices. Both the numbers of ├éΓÇÿmelancholies├éΓÇÖ assigned by the several systems and their capacity to distinguish ├éΓÇÿmelancholics├éΓÇÖ on clinical, demographic and a biological index test (the DST) varied across the systems with the algorithm being as ├éΓÇÿsuccessful├éΓÇÖ as several systems that include inter-episode and treatment response variables. Analyses provide information on the criteria set developed for DSM-IV definition of ├éΓÇÿmelancholia├éΓÇÖ.','',1995,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'24','Psychological Medicine','25','4','833-840','Cambridge University Press','YMH team','Models of care',''),(982,'Psychosocial risk factors distinguishing melancholic and nonmelancholic depression: A comparison of six systems','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026354231&doi=10.1016%2f0165-1781%2891%2990089-8&partnerID=40&md5=914a3142bdd1f19f2e7235a92484668f','10.1016/0165-1781(91)90089-8','We examined six systems or scales designed to distinguish melancholia from residual nonmelancholic depressive disorders in a sample of 305 patients. A count of the number of significant psychosocial risk factors showed that a clinical diagnosis was the most differentiating (19 significant risk factors), followed by the Newcastle index (13), DSM-III (10), and the CORE system (10)ΓÇöthe last essentially assessing psychomotor change; Research Diagnostic Criteria (RDC) (7) and an endogeneity symptom scale (2) were the least differentiating. A subsample of ├éΓÇ£composite melancholics├éΓÇ¥ was derived, comprising 138 who met ├éΓÇ£melancholia├éΓÇ¥ criteria for DSM-III, RDC, and CORE, and they were contrasted with residual depressives. The composite melancholics were older, had had a briefer depressive episode, and differed significantly on 12 risk factors, essentially being less likely to report deprivational experiences such as├é┬á├éΓÇª','',1991,NULL,NULL,'1991-12-01',NULL,NULL,NULL,NULL,'24','Psychiatry Research','39','3','211-226','Elsevier','YMH team','Illness specific areas',''),(983,'Unilateral or bilateral electroconvulsive therapy for depression? A survey of practice and attitudes in Australia and New Zealand','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025760274&doi=10.5694%2fj.1326-5377.1991.tb116367.x&partnerID=40&md5=4f1cd11cae264d2997e786d90e9297c9','10.5694/j.1326-5377.1991.tb116367.x','\n\nObjective: We report the findings of the first survey of the practice of electroconvulsive therapy (ECT) for the treatment of depression in Australia and New Zealand. The major aim was to examine the frequency of use of unilateral and bilateral electrode placement, as bilateral ECT has been recently recommended as the treatment of choice by the Royal College of Psychiatrists (UK). \nDesign: A questionnaire about details of ECT given in the second half of 1989 was forwarded to the medical superintendents of 130 psychiatric hospitals and units in Australia and New Zealand. \nResults: Reports were received from 96 psychiatric institutions representing a response rate of 74%. In these units, 915 patients were treated with ECT during the study period. In contrast to depressed patients in the United Kingdom or the United States, a majority of Australian and New Zealand patients given ECT were found to receive unilateral\n','',1991,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'24','Medical Journal of Australia','155','1','9-Nov','','YMH team','Models of care','illness specific areas'),(984,'Australia\'s National Suicide Prevention Strategy: the next chapter.','https://www.scopus.com/inward/record.uri?eid=2-s2.0-33748454498&doi=10.1071%2fAH060271&partnerID=40&md5=774d97522d4a9ab44ce8d1f79c7e6498','10.1071/AH060271','Australia\'s National Suicide Prevention Strategy (NSPS) is about to move into a new funding phase. In this context this paper considers the emphasis of the NSPS since its inception in 1999. Certain high risk groups (particularly people with mental illness and people who have self-harmed) have been relatively neglected, and some promising approaches (particularly selective and indicated interventions) have been under-emphasised. This balance should be redressed and the opportunity should be taken to build the evidence-base regarding suicide prevention. Such steps have the potential to maximise the impact of suicide prevention activities in Australia.  (author abstract)','',2006,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Australian health review : a publication of the Australian Hospital Association','30','3','','','Other','',''),(985,'Chronic fatigue syndrome: Current concepts of pathogenesis and treatment','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032601776&partnerID=40&md5=d2b6c47740d909eb84549705e43ee95f','','','',1999,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'23','Current Clinical Topics in Infectious Diseases','19','','135-159','','Other','',''),(986,'Is there a postinfection fatigue syndrome?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030340002&partnerID=40&md5=60ecefe191941652cf43829c44cdb7d8','','Prolonged fatigue syndromes are common in general practice. Most of these syndromes are secondary to other common medical or psychological disorders. It appears, however, that some specific infectious illnesses are associated with prolonged recovery. Theories as to the mechanisms for such post infection fatigue syndromes include a range of immunological, psychological and neurobiological processes. Current evidence suggests disruption of fundamental central nervous system mechanisms, such as the sleep-wake cycle and the hypothalamic-pituitary-adrenal axis, may underpin the clinical features of this disorder. Treatment should focus on the provision of continuous medical care, physical rehabilitation and adjunctive psychological therapies.','',1996,NULL,NULL,'1996-12-01',NULL,NULL,NULL,NULL,'23','Australian family physician','25','12','1847-1852','','Other','',''),(987,'III. Utilising Behavioural Constructs','https://books.google.com/books?hl=en&lr=&id=aQYJbOT4PCUC&oi=fnd&pg=PA38&dq=info:wvN0w8fU8T0J:scholar.google.com&ots=SmMIz3NjSC&sig=8iYToQaZeCS1HFkncjioAAiL2v4',NULL,'Much of the work described in this book represents a specific attempt to identify a key behavioural construct, namely psychomotor change, which appears to underpin an important clinical entity, namely melancholia. Conceptually, this represents a different approach to much current clini-cal research which utilizes broad, non-specific diagnostic categories. The logical developments of this departureΓÇôidentification of key constructs, and the systematic investigation of the patterns of association between these key constructs-are described. Such patterns of association are hypothesised to be sensitive indicators of underlying neurobiological processes and, hence, the basis of more focussed neurobiological research. Even if major discoveries occur outside the clinical realm (as is likely in the realms of molecular biology, genetics and neurochemistry), the examination of the relationships between such fundamental processes and refined behavioural constructs will be more useful than studying the relationships between such processes and broader clinical syndromes. The application of this approach to current neurobiological research in melancholia will now be detailed.','',2018,NULL,NULL,'1996-03-29',NULL,NULL,NULL,NULL,'23','Melancholia: A Disorder of Movement and Mood: A Phenomenological and Neurobiological Review','','','38','Cambridge University Press',NULL,NULL,NULL),(988,'Treatment resistant depression in an Australian context II: Outcome of a series of patients','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028360499&doi=10.3109%2f00048679409075842&partnerID=40&md5=a00dc5cde058a43f9586b37bedad466e','10.3109/00048679409075842','The clinical characteristics and treatment outcome of a series of 107 patients referred to a mood disorders unit with an episode of ΓÇ£treatment resistant├éΓÇ¥ Major Depression are reviewed. Subjects were categorised by diagnosis (into melancholic and non-melancholic subtypes) and by adequacy of previous treatment. At subsequent review (mean period of 37.5 months) these patients were re-assessed both in terms of outcome and which treatments had been considered to be most effective. Forty one percent of the patient group were fully recovered and a further 43% were partially improved. Different treatments were considered effective for melancholic and non-melancholic sub-types.','',1994,NULL,NULL,'1994-01-01',NULL,NULL,NULL,NULL,'23','Australian and New Zealand Journal of Psychiatry','28','1','23-33','Taylor & Francis','Other','',''),(989,'Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068526205&doi=10.1016%2fj.schres.2019.06.020&partnerID=40&md5=a004fe3d61588bdb5fa0a9f86b5c4041','10.1016/j.schres.2019.06.020','People classified as ultra-high risk (UHR) of developing psychosis have reduced cellular membrane omega-3 and omega-6 polyunsaturated fatty acids (PUFA). We aimed to compare omega-3 index, fatty acids and molecular phospholipid species from erythrocytes of people with UHR (n├é┬á=├é┬á285) with age-matched healthy controls (n├é┬á=├é┬á120) assessed by mass spectrometry. Lower proportions of PUFA were observed in the UHR group compared to healthy controls; specifically, eicosapentaenoic acid (EPA) was 29.3% lower, docosahexaenoic acid (DHA) was 27.2% lower, arachidonic acid (AA) was 15.8% lower and the omega-3 index was 26.9% lower. The AA to EPA ratio was higher in the UHR group compared to the healthy group. Smoking status had no significant effect on PUFA levels in healthy or the UHR groups. BMI was associated with PUFA levels in the UHR group only and the statistical model only├é┬á├éΓÇª','',2020,NULL,NULL,'2020-12-01',NULL,NULL,NULL,NULL,'23','Schizophrenia Research','226','','44-51','Elsevier','Other','',''),(992,'Static metrics of impact for a dynamic problem: The need for smarter tools to guide suicide prevention planning and investment','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85043379232&doi=10.1177%2f0004867417752866&partnerID=40&md5=53773d71c45e5f0c5739f72656dac133','10.1177/0004867417752866','\nObjectives:\nThis study investigates two approaches to estimate the potential impact of a population-level intervention on Australian suicide, to highlight the importance of selecting appropriate analytic approaches for informing evidence-based strategies for suicide prevention.\nMethods:\nThe potential impact of a psychosocial therapy intervention on the incidence of suicide in Australia over the next 10 years was used as a case study to compare the potential impact on suicides averted using: (1) a traditional epidemiological measure of population attributable risk and (2) a dynamic measure of population impact based on a systems science model of suicide that incorporates changes over time.\nResults:\nBased on the population preventive fraction, findings suggest that the psychosocial therapy intervention if implemented among all eligible individuals in the Australian population would prevent 5.4% of suicides (or 1936\n','',2018,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'23','Australian and New Zealand Journal of Psychiatry','52','7','660-667','SAGE Publications','YMH team','Illness specific areas','Mental Health System'),(993,'The beyond ageing project phase 2 - a double-blind, selective prevention, randomised, placebo-controlled trial of omega-3 fatty acids and sertraline in an older age cohort at risk for depression: Study protocol for a randomized controlled trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84934971920&doi=10.1186%2fs13063-015-0762-6&partnerID=40&md5=d784727ce0cc5f2bb3b6f5d5e423e504','10.1186/s13063-015-0762-6','Late-life depression is associated with high rates of morbidity, premature mortality, disability, functional decline, caregiver burden and increased health care costs. While clinical and public health approaches are focused on prevention or early intervention strategies, the ideal method of intervention remains unclear. No study has set out to evaluate the role of neurobiological agents in preventing depressive symptoms in older populations at risk of depression. Subjects with previously reported sub-threshold depressive symptoms, aged 60 to 74 years, will be screened to participate in a single-centre, double-blind, randomised controlled trial with three parallel groups involving omega-3 fatty acid supplementation or sertraline hydrochloride, compared with matching placebo. Subjects will be excluded if they have current depression or suicide ideation; are taking antidepressants or any supplement containing omega-3 fatty acid; or have a prior history of stroke or other serious cerebrovascular or cardiovascular disease, neurological disease, significant psychiatric disease (other than depression) or neurodegenerative disease. The trial will consist of a 12 month treatment phase with follow-up at three months and 12 months to assess outcome events. At three months, subjects will undergo structural neuroimaging to assess whether treatment effects on depressive symptoms correlate with brain changes. Additionally, proton spectroscopy techniques will be used to capture brain-imaging markers of the biological effects of the interventions. The trial will be conducted in urban New South Wales, Australia, and will recruit a community-based sample of 450','',2015,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'17','Trials','16','1','Jan-16','BioMed Central','YMH team','Neurobiology',''),(995,'Delayed-type hypersensitivity skin testing: Normal values in the Australian population','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028825049&doi=10.1016%2f0192-0561%2895%2900048-7&partnerID=40&md5=b10d2602532966936f33a895e64ffa55','10.1016/0192-0561(95)00048-7','In our human psychoimmunological studies we have utilized a standardized assessment kit, the cell-mediated immunity (CMI) Multitest system, for determining delayed-type hypersensitivity (DTH) skin responses to a panel of ubiquitous antigens. Although the kit had been assessed in large populations of healthy controls in the U.S.A. and Europe, few data were available with regard to normative values in the Australian population. There are cogent reasons to suspect that results for the test will vary depending on geographical location, age cohort, compliance with specific immunization schedules and rates of natural exposure to certain diseases in differing populations. Most of our patient cohorts have a preponderance of female subjects and most standardization had been conducted in males. We tested medically and psychologically healthy males (n = 66) and females (n = 53). The percentage of positive','',1995,NULL,NULL,'1995-08-01',NULL,NULL,NULL,NULL,'22','International Journal of Immunopharmacology','17','8','629-634','Pergamon','Other','',''),(996,'Variability in clinical outcomes for youths treated for subthreshold severe mental disorders at an early intervention service','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046342929&doi=10.1176%2fappi.ps.201700046&partnerID=40&md5=139470ea4f7c73585f074bbbd808dc05','10.1176/appi.ps.201700046','\nObjective:\nThe study assessed the longitudinal clinical and functional outcomes of young people receiving early intervention services for subthreshold manifestations of severe mental disorders at a youth mental health service in Sydney, Australia.\nMethods:\nThe six-month, prospective, longitudinal study collected data on clinical outcomes of 243 young people treated for subsyndromal presentations of putative major mental disorders. Reliable change index scores and effect sizes were calculated to compare results at baseline, three months, and six months for measures of symptoms (Brief Psychiatric Rating Scale [BPRS]), psychological distress (Kessler 10 [K10]), and social functioning (Social and Occupational Functioning Assessment Scale [SOFAS]).\nResults:\nThere was variability in outcomes across each of the outcome measures, with 25%, 33%, and 23% of patients showing reliable improvement and 9%, 13\n','',2018,NULL,NULL,'2018-05-01',NULL,NULL,NULL,NULL,'22','Psychiatric Services','69','5','555-561','American Psychiatric Association','YMH team','Outcome Research','Models of care'),(997,'Nineteen and Up study (19Up): Understanding pathways to mental health disorders in young Australian twins','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044243782&doi=10.1136%2fbmjopen-2017-018959&partnerID=40&md5=7bdad2e3cb546809090de9c00953af30','10.1136/bmjopen-2017-018959',NULL,'',2018,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'','BMJ Open','','','','BMJ Publishing Group','YMH team','Outcome Research',''),(998,'Differential impact of current diagnosis and clinical stage on attendance at a youth mental health service','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84958062514&doi=10.1111%2feip.12319&partnerID=40&md5=009c37a88ac551ddefff75fe8732d033','10.1111/eip.12319','  Aim To examine whether clinical stage of illness and current diagnosis influence appointment behaviour in a specialized primary-level youth mental health service.   Methods Factors associated with attendance at 8697 appointments made by 828 young people (females = 497) aged 12ΓÇô25 years over a 1-year period were analysed.   Results The number of appointments made did not correlate with the rates of attendance. However, those with more severe psychiatric morbidity made significantly more appointments and missed significantly more appointments than those with less severe presentations. Impaired social functioning was the best predictor of female attendance rates, whereas age and clinical stage of illness best predicted male attendance rates. Current diagnosis rather than functional impairment appeared to influence the level of input offered by clinicians.   Conclusions Age, gender, severity of├é┬á├éΓÇª\n','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'22','Early Intervention in Psychiatry','11','3','255-262','','YMH team','Models of care',''),(999,'Genome-wide association study of working memory brain activation','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84992188053&doi=10.1016%2fj.ijpsycho.2016.09.010&partnerID=40&md5=b5a1297d57045153dff533611a96fdcd','10.1016/j.ijpsycho.2016.09.010','','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','International Journal of Psychophysiology','','','','Elsevier','Other','',''),(1000,'Episodic memory in depression: The unique contribution of the anterior caudate and hippocampus','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84965064461&doi=10.1017%2fS0033291716000787&partnerID=40&md5=6ae658e15910052ee19f844ff9f7d555','10.1017/S0033291716000787','Background Learning and memory impairments in older adults with depression are linked to hippocampal atrophy. However, other subcortical regions may also be contributing to these deficits. We aimed to examine whether anterior caudate nucleus volume is significantly reduced in older adults with depression compared to controls; whether anterior caudate volume is associated with performance on tasks of episodic learning and memory, and if so, whether this association is independent of the effects of the hippocampus. Method Eighty-four health-seeking participants meeting criteria for lifetime major depressive disorder (mean age = 64.2, s.d. = 9.1 years) and 27 never-depressed control participants (mean age = 63.9, s.d. = 8.0 years) underwent neuropsychological assessment including verbal episodic memory tests [Rey Auditory Verbal Learning Test and Logical Memory (WMS-III)]. Magnetic resonance','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'22','Psychological Medicine','46','10','2189-2199','Cambridge University Press','YMH team','Neurobiology',''),(1001,'Protocol for a randomised controlled trial investigating the effectiveness of an online e-health application compared to attention placebo or sertraline in the treatment of generalised anxiety disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953939868&doi=10.1186%2f1745-6215-11-48&partnerID=40&md5=10dcfa02176e772d8c6b234d90aa7375','10.1186/1745-6215-11-48','Generalised anxiety disorder (GAD) is a high prevalence, chronic psychiatric disorder which commonly presents early in the lifespan. Internet e-health applications have been found to be successful in reducing symptoms of anxiety and stress for post traumatic stress disorder (PTSD), panic disorder, social phobia and depression. However, to date, there is little evidence for the effectiveness of e-health applications in adult GAD. There are no studies which have directly compared e-health applications with recognised evidence-based medication. This study aims to determine the effectiveness of a web-based program for treating GAD relative to sertraline and attention placebo. 120 community-dwelling participants, aged 18-30 years with a clinical diagnosis of GAD will be recruited from the Australian Electoral Roll. They will be randomly allocated to one of three conditions: (i) an online treatment program for GAD, E','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'22','Trials','11','1','1-Aug','BioMed Central','Other','',''),(1002,'Is there an independent somatic symptom dimension in older people?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-33746339218&doi=10.1016%2fj.jpsychores.2006.01.012&partnerID=40&md5=afad484b6a587b624be4c5293be5495a','10.1016/j.jpsychores.2006.01.012','\n\nObjective\nIn explaining the dimensions underlying nonpsychotic symptom reporting, traditional psychiatric paradigm has advocated a hierarchical model in which somatic symptoms are subsumed within two correlated psychological dimensions. A more recent alternate view is that somatic symptoms may be clearly separated from typical anxiety and depression symptoms if somatic symptoms are adequately recorded. The main aim of this study is to determine whether discrete somatic dimension(s) could be derived in older people.\n\n\nMethod\nExploratory factor analysis was used to determine the factor structure underlying the responses of 10┬á662 ambulatory primary care patients, aged 60 years and over, who completed the 34-item SPHERE (Somatic and Psychological HEalth REport) questionnaire of somatic and psychological symptoms. In addition, weighted factor scores were compared according to whether there├é┬á├éΓÇª\n\n','',2006,NULL,NULL,'2006-08-01',NULL,NULL,NULL,NULL,'22','Journal of Psychosomatic Research','61','2','197-204','Elsevier','Other','',''),(1003,'Illness or disease? The case of chronic fatigue syndrome','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034657271&doi=10.5694%2fj.1326-5377.2000.tb124069.x&partnerID=40&md5=b03367472180d8666528c474a7e7ebc5','10.5694/j.1326-5377.2000.tb124069.x','Not every illness can be defined as a disease before care and treatment should commence','',2000,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'22','Medical Journal of Australia','172','10','471-472','','Other','',''),(1004,'Depression sub-typing: Unitary, binary or arbitrary?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907034769&doi=10.3109%2f00048679109077720&partnerID=40&md5=6cf114e5338be80575426c2755c4a80b','10.3109/00048679109077720','The strongest statistical support for the binary view of depression has been provided by factor (principal components) analytic studies which delineate a bipolar factor with features interpreted as reflecting ΓÇ£endogenous depression├éΓÇ¥ and ├éΓÇ£neurotic depression├éΓÇ¥ at opposing poles. We review the seminal studies to suggest instead that the bipolar factor has generally polarised depression and anxiety, and that no such entity or symptom complex of ├éΓÇ£neurotic depression├éΓÇ¥ has been isolated. Instead, ├éΓÇ£neurotic depression├éΓÇ¥ has been defined principally by features of anxiety and personality style. We argue that the suggested entity is, in fact, a pseudo-entity, being no more than a residual group of non-depressive features without any significant intrinsic depressive characteristics. We support our interpretation by showing comparable solutions in published studies of depressives alone, contrasted with separate analyses of├é┬á├éΓÇª','',1991,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'22','Australian and New Zealand Journal of Psychiatry','25','1','63-76','Sage Publications','Other','',''),(1005,'Flip the clinic: A digital health approach to youth mental health service delivery during the COVID-19 pandemic and beyond','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85098563806&doi=10.2196%2f24578&partnerID=40&md5=8508d94301dfb3cb00caaf665e1070c8','10.2196/24578','The demand for mental health services is projected to rapidly increase as a direct and indirect result of the COVID-19 pandemic. Given that young people are disproportionately disadvantaged by mental illness and will face further challenges related to the COVID-19 pandemic, it is crucial to deliver appropriate mental health care to young people as early as possible. Integrating digital health solutions into mental health service delivery pathways has the potential to greatly increase efficiencies, enabling the provision of ΓÇ£right care, first time.├éΓÇ¥ We propose an innovative digital health solution for demand management intended for use by primary youth mental health services, comprised of (1) a youth mental health model of care (ie, the Brain and Mind Centre Youth Model) and (2) a health information technology specifically designed to deliver this model of care (eg, the InnoWell Platform). We also propose an operational protocol of how this solution could be applied to primary youth mental health service delivery processes. By ├éΓÇ£flipping├éΓÇ¥ the conventional service delivery models of majority in-clinic and minority web-delivered care to a model where web-delivered care is the default, this digital health solution offers a scalable way of delivering quality youth mental health care both in response to public health crises (such as the COVID-19 pandemic) and on an ongoing basis in the future.','',2020,NULL,NULL,'2020-12-15',NULL,NULL,NULL,NULL,'21','JMIR Mental Health','7','12','e24578','JMIR Publications Inc., Toronto, Canada','YMH team','Digital health','Models of care'),(1007,'Association of Whole-Genome and NETRIN1 Signaling PathwayΓÇôDerived Polygenic Risk Scores for Major Depressive Disorder and White Matter Microstructure in the UK Biobank','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052912914&doi=10.1016%2fj.bpsc.2018.07.006&partnerID=40&md5=c45edc8067ecca4006cfb4fe080f0a6a','10.1016/j.bpsc.2018.07.006','Background\r\nMajor depressive disorder is a clinically heterogeneous psychiatric disorder with a polygenic architecture. Genome-wide association studies have identified a number of risk-associated variants across the genome and have reported growing evidence of NETRIN1 pathway involvement. Stratifying disease risk by genetic variation within the NETRIN1 pathway may provide important routes for identification of disease mechanisms by focusing on a specific process, excluding heterogeneous risk-associated variation in other pathways. Here, we sought to investigate whether major depressive disorder polygenic risk scores derived from the NETRIN1 signaling pathway (NETRIN1-PRSs) and the whole genome, excluding NETRIN1 pathway genes (genomic-PRSs), were associated with white matter microstructure.\r\n\r\n\r\nMethods\r\nWe used two diffusion tensor imaging measures, fractional anisotropy (FA) and mean├é┬á├éΓÇª','',2019,NULL,NULL,'2019-01-01',NULL,NULL,NULL,NULL,'21','Biological Psychiatry: Cognitive Neuroscience and Neuroimaging','4','1','91-100','Elsevier','Other','',''),(1008,'Associations of objective and subjective sleep disturbance with cognitive function in older men with comorbid depression and insomnia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017335319&doi=10.1016%2fj.sleh.2017.03.007&partnerID=40&md5=38e0221be7dcdb8a51d1e9d9dad526d2','10.1016/j.sleh.2017.03.007','\n\nObjectives\nTo examine whether poor objective and subjective sleep quality are differentially associated with cognitive function.\n\n\nDesign\nCross-sectional.\n\n\nSetting\nParticipants were recruited from primary and secondary care, and directly from the community, in Sydney, Australia.\n\n\nParticipants\nThe sample consisted of 74 men 50┬áyears and older (mean [SD], 58.4 [6.2] years), with comorbid depression and above-threshold insomnia symptoms, participating in a trial of online cognitive behavioral therapy for insomnia.\n\n\nMeasurements\nInsomnia severity and depression severity were assessed via self-report. Objective sleep efficiency and duration were measured using actigraphy. Objective cognitive function was measured using 3 subtests of a computerized neuropsychological battery.\n\n\nResults\nPoor objective sleep efficiency was associated with slower reaction time (r├é┬á=├é┬á-0.249, P├é┬á=├é┬á.033) and poorer executive functioning (odds ratio├é┬á├éΓÇª\n\n','',2017,NULL,NULL,'2017-06-01',NULL,NULL,NULL,NULL,'21','Sleep Health','3','3','178-183','Elsevier','YMH team','Illness specific areas',''),(1009,'The relative contributions of psychiatric symptoms and psychotropic medications on the sleep-wake profile of young persons with anxiety, depression and bipolar disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84978664151&doi=10.1016%2fj.psychres.2016.06.025&partnerID=40&md5=90b690e443c15b776d0aae34ca7ffa1f','10.1016/j.psychres.2016.06.025','This study investigated the relative contribution of psychiatric symptoms and psychotropic medications on the sleep-wake cycle. Actigraphy and clinical assessments (Brief Psychiatric Rating Scale) were conducted in 146 youths with anxiety, depression or bipolar disorders. Independently of medications, mania symptoms were predictive of lower circadian amplitude and rhythmicity. Independently of diagnosis and symptoms severity: i) antipsychotics were related to longer sleep period and duration, ii) serotonin-norepinephrine reuptake inhibitors to longer sleep period, and iii) agomelatine to earlier sleep onset. Manic symptoms and different subclasses of medications may have independent influences on the sleep-wake cycle of young people with mental disorders.','',2016,NULL,NULL,'2016-09-30',NULL,NULL,NULL,NULL,'21','Psychiatry Research','243','','403-406','Elsevier','YMH team','Illness specific areas',''),(1010,'Aberrant Gaze Patterns in Social Anxiety Disorder: An Eye Movement Assessment during Public Speaking','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019832312&doi=10.5127%2fjep.040313&partnerID=40&md5=4bf5a575d53191c650e6d85d67dbb2bf','10.5127/jep.040313','Social anxiety disorder is maintained by biased attentional processing, which may encompass biases in the component engagement, disengagement, and avoidance attentional processes. However, few studies have directly examined whether such biases occur during social-evaluative conditions characteristically feared in social anxiety. The current study presents a novel approach for the assessment of attentional bias. Clinically socially anxious (n = 27) and control (n = 29) participants were required to give a speech in front of a pre-recorded audience displaying emotional social gestures while eye movement was recorded. Socially anxious individuals avoided attending to positive and threatening stimuli. At the onset of an emotional gesture, control participants were additionally faster to orient towards positive, relative to threatening gestures, while this bias was absent in socially anxious participants. The findings','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'21','Journal of Experimental Psychopathology','7','1','Jan-17','SAGE Publications','Other','',''),(1011,'Characterization of fatigue states in medicine and psychiatry by structured interview','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84903270414&doi=10.1097%2fPSY.0000000000000061&partnerID=40&md5=54b291a4c4d8f9fa3410ccb16638d7ce','10.1097/PSY.0000000000000061','\nObjective\nPatients with fatigue-related illnesses were investigated by questionnaire and a novel semistructured interview to identify discriminatory features.\nMethods\nCross-sectional samples of women from specialist practices with chronic fatigue syndrome (n= 20), postcancer fatigue (PCF; n= 20), or major depression (n= 16) were recruited. Additionally, two longitudinal samples were studied: women with fatigue associated with acute infection who subsequently developed postinfective fatigue syndrome (n= 20) or recovered uneventfully (n= 21), and women undergoing adjuvant therapy for breast cancer experiencing treatment-related fatigue who subsequently developed PCF (n= 16) or recovered uneventfully (n= 16). Patients completed self-report questionnaires, and trained interviewers applied the Semi-structured Clinical Interview for Neurasthenia. The receiver operating characteristics curves of the interview\n','',2014,NULL,NULL,'2014-06-01',NULL,NULL,NULL,NULL,'21','Psychosomatic Medicine','76','5','379-388','LWW','Other','',''),(1012,'Pre-emptive psychiatric treatments: Pipe dream or a realistic outcome of clinical staging models?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84876509695&doi=10.2217%2fnpy.12.32&partnerID=40&md5=a8a26b53b11fe26c5c78cc2e05fc4d90','10.2217/npy.12.32','EDITORIAL Scott, Hickie & McGorry largely independent of illness severity or duration. Clinical staging is therefore a more refined concept than cross-sectional diagnosis (which is largely blind to concepts such as age at onset or illness progression). For clinical psychiatry, it actively promotes greater attention to indicated prevention strategies (eg, interventions for individuals at ultra-high risk of developing psychosis)[Scott J, Leboyer M, Hickie I et al.','',2012,NULL,NULL,'2012-08-01',NULL,NULL,NULL,NULL,'21','Neuropsychiatry','2','4','263-266','Future Medicine Ltd.','YMH team','Models of care',''),(1013,'Australia needs a mental health commission','https://www.scopus.com/inward/record.uri?eid=2-s2.0-4744370991&doi=10.1111%2fj.1039-8562.2004.02116.x&partnerID=40&md5=3f6f4607a87c8bc3d0cecde29385da72','10.1111/j.1039-8562.2004.02116.x','\n\nObjectives: The present paper aims to: (i) describe how the Mental Health Commission in New Zealand works and has contributed to the * substantial enhancement of mental health resources and services; (ii) determine whether mental health reform policies will ever be implemented properly without an independent monitor with official influence at the highest levels of government; and (iii) demonstrate how variants on this model work in other Western countries and how it can be adapted to the Federated system in Australia.\n\nConclusions: It is recommended that the Australian National Mental Health Plan 2003├éΓÇô2008 should be complemented by a long-standing national mental health commission (or similarly constituted body), which is also able to report independently from and to the government, with direct access to the Prime Minister, Premiers and Australian Health Ministers. Its aims would be to monitor service├é┬á├éΓÇª\n','',2004,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'21','Australasian Psychiatry','12','3','213-219','SAGE Publications','Other','',''),(1014,'Somatic distress syndromes in later life: The need for paradigm change','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035022604&doi=10.1017%2fS003329170100383X&partnerID=40&md5=f7704343c9e09d5926467527c0388e23','10.1017/S003329170100383X','Somatic distress syndromes, which include somatoform disorders and syndromes of chronic fatigue such as neurasthenia but not somatic presentations of anxiety and depression, are one of the common expressions of distress in primary care (Ormel et al. 1994) and general hospital settings (Hemert et al. 1993). They are of considerable importance cross-culturally (Ono et al. 1999), and often lie at the interface of psychiatry and medicine (Hickie, 1999). They are associated with significant disability (Ormel et al. 1994; Andrews, 2000) and health-care utilization (Escobar et al. 1991).','',2001,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'20','Psychological Medicine','31','4','571-576','Cambridge University Press','Other','',''),(1015,'Qualitative and quantitative analyses of a \'lock and key\' hypothesis of depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031744672&doi=10.1017%2fS0033291798007387&partnerID=40&md5=121713030b26781e71e776167652a93d','10.1017/S0033291798007387','\nBackground.\n\n We examine a ├éΓÇÿlock and key├éΓÇÖ (├éΓÇÿL├éΓÇôK├éΓÇÖ) hypothesis to depression which posits that early adverse experiences establish locks that are activated by keys mirroring the earlier adverse experience to induce depression.\nMethods.\n\n Two-hundred and seventy clinically depressed patients were examined with open-ended and pre-coded interview questions to ascertain both early adverse experiences and precipitating life events. Qualitative and quantitative data analyses examined for any associations between developmental ├éΓÇÿlocks├éΓÇÖ and precipitating ├éΓÇÿkeys├éΓÇÖ.\nResults.\n\n Qualitative assessment suggested ├éΓÇÿL├éΓÇôK├éΓÇÖ links in almost one-third of the sample, and examples are provided. While quantitative analyses indicated significant associations between several identical ├éΓÇÿlock├éΓÇÖ and ├éΓÇÿkey├éΓÇÖ constructs, evidence of specificity was rare. When individual ├éΓÇÿlocks├éΓÇÖ and ├éΓÇÿkeys├éΓÇÖ were consolidated into three higher-order constructs, variable├é┬á├éΓÇª\n','',1998,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'20','Psychological Medicine','28','6','1263-1273','Cambridge University Press','YMH team','Illness specific areas','Models of care'),(1016,'An aetiological model of non-melancholic depression: Study design and validity of the measures','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031967950&doi=10.1046%2fj.1440-1614.1998.00384.x&partnerID=40&md5=2cb161cd7819157ef075e9076930d89f','10.1046/j.1440-1614.1998.00384.x','\nObjective: The aim of this paper is to describe an approach to sub-typing non-melancholic depression and to determine which raters from a variety of backgrounds provided the most valid information on study variables.\nMethod: A sample of non-melancholic depressed patients is described. Multiple raters (i.e. patients, psychiatrists, referrers and corroborative witnesses) completed measures of the patient\'s trait anxiety levels, severity of recent life event stressors and personality functioning.\nResults: The study and representative data are reported. Congruence between several measures employed indicated that psychiatrist rating of disordered personality was superior to corroborative witness report. Assessment of anxiety traits indicated reasonable agreement between referrers and corroborative witnesses but poor agreement between those ratings and interview-elicited ratings. There were also discrepancies in\n','',1998,NULL,NULL,'1998-01-01',NULL,NULL,NULL,NULL,'20','Australian and New Zealand Journal of Psychiatry','32','1','104-111','Taylor & Francis','Other','',''),(1017,'A brief self-report depression measure assessing mood state and social impairment','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028115932&doi=10.1016%2f0165-0327%2894%2990041-8&partnerID=40&md5=03dab6d92a270e9f56306514b5688c66','10.1016/0165-0327(94)90041-8','Many measures of depression severity appear confounded by including depressive sub-typing features. We report the design of a brief (11 item) self-report scale of depression severity (the AUSSI), assessing both mood state and social impairment domains, and designed to be independent of sub-typing features. Mood severity and functional impairment scores demonstrated some independence in a sample of 360 patients. Patients with a ΓÇÿmelancholic├éΓÇÖ depressive type (categorised by four differing systems) differed from residual ├éΓÇÿnon-melancholic├éΓÇÖ depressed patients by having higher impairment scores, but the assigned groups did not differ, in the main, by mood severity scores. Advantages of the measure are summarised.','',1994,NULL,NULL,'1994-02-01',NULL,NULL,NULL,NULL,'20','Journal of Affective Disorders','30','2','133-142','Elsevier','YMH team','Illness specific areas',''),(1018,'Adjunctive Internet-delivered cognitive behavioural therapy for insomnia in men with depression: A randomised controlled trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060144704&doi=10.1177%2f0004867418797432&partnerID=40&md5=ccb21f43a7fe1eb18f5d9ea9e8404a34','10.1177/0004867418797432','\nObjective:\nInternet-delivered cognitive behavioural therapy for insomnia is efficacious for insomnia, and post hoc analyses suggest mood improvements. We undertook the first clinical trial evaluating the efficacy of Internet-delivered cognitive behavioural therapy for insomnia on depressive symptoms as an adjunct to guideline-based treatment of depressive disorders.\nMethods:\nOlder men undergoing psychiatrist-coordinated treatment for major depressive disorder or dysthymia and who had significant insomnia symptoms were randomised to either adjunctive Internet-delivered cognitive behavioural therapy for insomnia (Sleep Healthy Using The Internet) or online sleep psychoeducation. The primary outcome was change in depressive symptoms (Centre for Epidemiological Studies Depression scale) from baseline to week 12 (post intervention). Secondary outcomes were insomnia and anxiety symptoms.\nResults:\nIn\n','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'20','Australian and New Zealand Journal of Psychiatry','53','4','350-360','Sage Publications','Other','',''),(1019,'Subcortical volumetric differences between clinical stages of young people with affective and psychotic disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85036573574&doi=10.1016%2fj.pscychresns.2017.11.015&partnerID=40&md5=1a4caa0ec49ddd917f0390ca11232639','10.1016/j.pscychresns.2017.11.015','The aim of this study was to investigate differences in subcortical and hippocampal volumes between healthy controls, young people at an early stage of affective and psychotic disorders and those in more advanced stages, to identify markers associated with functional outcomes and illness severity. Young people presenting to youth mental health services with admixtures of depressive, manic and psychotic symptoms (n = 141), and healthy counterparts (n = 49), aged 18ΓÇô25 were recruited. Participants underwent magnetic resonance imaging, clinical assessments and were rated as to their current clinical stage. Eighty-four patients were classified at the attenuated syndrome stage (Stage 1b) and 57 were classified as having discrete and persistent disorders (Stage 2+). Automated segmentation was performed using NeuroQuant├é┬« to determine volumes of subcortical and hippocampus structures which were├é┬á├éΓÇª','',2018,NULL,NULL,'2018-01-30',NULL,NULL,NULL,NULL,'20','Psychiatry Research - Neuroimaging','271','','Aug-16','Elsevier','Other','',''),(1020,'Functional Connectivity in the Default Mode Network is Reduced in Association with Nocturnal Awakening in Mild Cognitive Impairment','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85013447154&doi=10.3233%2fJAD-160922&partnerID=40&md5=21c3c132719b33277c90eda1cd80b15d','10.3233/JAD-160922','','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Journal of Alzheimer\'s Disease','','','','IOS Press','Other','',''),(1021,'Investigating the role of glutathione in mismatch negativity: An insight into NMDA receptor disturbances in bipolar disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84928754046&doi=10.1016%2fj.clinph.2014.09.025&partnerID=40&md5=48c70432a02c655e6f817915cda6129a','10.1016/j.clinph.2014.09.025','\n\nObjective\nWe aim to provide a targeted integration to investigate neuronal mechanisms underlying mismatch negativity (MMN) in bipolar disorder (BD), by looking at the association between temporal MMN and in vivo hippocampal glutathione (GSH) measured via proton magnetic resonance spectroscopy (1H-MRS).\n\n\nMethods\nTwenty-eight people with BD and 22 matched controls underwent a two-tone passive, duration deviant MMN paradigm as well as 1H-MRS. GSH concentration in the left hippocampus was determined and PearsonΓÇÖs correlations were used to identify associations between MMN amplitude and in vivo GSH concentration.\n\n\nResults\nIn controls MMN amplitude was negatively associated with GSH at the left temporal site (r├é┬á=├é┬á-0.542, 95% C.I.: -0.810, -0.060), and a similar trend at the right (r├é┬á=├é┬á-0.374, 95% C.I.: -0.678, 0.007). There were no significant associations in BD.\n\n\nConclusions\nThe results provide├é┬á├éΓÇª\n\n','',2015,NULL,NULL,'2015-06-01',NULL,NULL,NULL,NULL,'19','Clinical Neurophysiology','126','6','1178-1184','Elsevier','YMH team','Neurobiology','Illness specific areas'),(1022,'Concurrent validity of the PSYCH-6, a very short scale for detecting anxiety and depression, among oncology outpatients','https://www.scopus.com/inward/record.uri?eid=2-s2.0-68049107378&doi=10.1080%2f00048670902970809&partnerID=40&md5=6837e399922f04a4983068c07c28e805','10.1080/00048670902970809','\n\nObjective: To improve the acceptability of screening for depression and anxiety among patients with cancer there is a need for scales that are both very short and accurate. To date no very short questionnaire has been found to provide optimal performance for screening in oncology populations and other candidates must be examined. This study examined the concurrent validity of a relatively new, very short scale, the six item PSYCH-6 subscale of the Somatic and Psychological Health Report (SPHERE-12), in an oncology outpatient population.\n\nMethods: Cross-sectional survey of 340 oncology outpatients attending a regional hospital in Newcastle, Australia. The performance of the PSYCH-6 against the Hospital Anxiety and Depression Scale (HADS) was evaluated using correlation, Cohen\'s kappa, positive agreement and negative agreement.\n\nResults: The PSYCH-6 subscale of the SPHERE-12, at a cut-off point of\n','',2009,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'19','Australian and New Zealand Journal of Psychiatry','43','7','682-688','Sage Publications','YMH team','Outcome Research',''),(1025,'Exploring associations between early substance use and longitudinal socio-occupational functioning in young people engaged in a mental health service','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060162734&doi=10.1371%2fjournal.pone.0210877&partnerID=40&md5=e7bceec0d2d4ec87f54ccf1e7ecfe24d','10.1371/journal.pone.0210877','Neuropsychiatric disorders (including substance misuse) are associated with the greatest burden of functional disability in young people, and contributory factors remain poorly understood. Early-onset substance use is one candidate risk factor which may inform functional prognosis and facilitate direction of interventions aiming to curtail impairment. Accordingly, we modelled associations between early-onset use of alcohol, tobacco, cannabis and amphetamine-type stimulants (ATSs) and longitudinal socio-occupational functioning (indexed by the Social and Occupational Functioning Assessment Scale) in an observational cohort presenting to early intervention mental health services. A clinical proforma collated demographic, clinical, and socio-occupational information for up to 60-months from presentation to services in young people aged 17├éΓÇô30. Of the wider cohort (n = 2398), 446 participants were selected with complete alcohol and substance use data. Latent class analysis was used to derive an ├éΓÇÿearly-onset├éΓÇÖ (n = 243) and ├éΓÇÿlater-onset├éΓÇÖ class (n = 203) based on age of first use of alcohol, tobacco, cannabis and ATSs. Maximum-likelihood multilevel analyses modelled functioning over time in care and tested associations with substance use latent class, age, gender and diagnosis. Membership in the ├éΓÇÿearly-onset├éΓÇÖ class (B = -1.64, p = 0.05), male gender (B = -3.27, p<0.001) and psychotic disorder diagnosis (B = -7.62, p<0.001) were associated with poorer functioning at presentation and at least one other time-point. To our knowledge, this is the first study to explore associations of early-onset substance use and longitudinal functioning in a cohort├é┬á├éΓÇª','',2019,NULL,NULL,'2019-01-17',NULL,NULL,NULL,NULL,'17','PLoS ONE','14','1','e0210877','Public Library of Science','YMH team','Outcome Research',''),(1026,'Sleep-wake, cognitive and clinical correlates of treatment outcome with repetitive transcranial magnetic stimulation for young adults with depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85057779415&doi=10.1016%2fj.psychres.2018.12.002&partnerID=40&md5=ebe7676c9c36967ee3496f6b2ac4979a','10.1016/j.psychres.2018.12.002','The utility of key phenotypes of depression in predicting response to repetitive transcranial magnetic stimulation (rTMS), namely sleep-wake behaviour, cognition and illness chronicity, has been understudied and not been extended to young samples. This study aimed to determine whether sleep-wake disturbance, cognition or depression chronicity are associated with rTMS outcome in young depressed adults. Sixteen depressed young adults diagnosed with mood disorders (aged 18ΓÇô29├é┬áyears) completed this open-label study. Neuronavigationally targeted high-frequency rTMS was administered at 110% of motor threshold on the left dorsolateral prefrontal cortex for 20 sessions over 4├é┬áweeks. Clinical, sleep-wake and cognitive assessments were undertaken pre- and post-treatment. Repeated-measures and correlational analyses determined pre- and post-treatment changes and predictors of treatment outcome├é┬á├éΓÇª','',2019,NULL,NULL,'2019-01-01',NULL,NULL,NULL,NULL,'17','Psychiatry Research','271','','335-342','Elsevier','YMH team','Outcome Research',''),(1027,'Neurocognitive clusters: A pilot study of young people with affective disorders in an inpatient facility','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052438269&doi=10.1016%2fj.jad.2018.08.045&partnerID=40&md5=2648f05668cbff66c752380904535505','10.1016/j.jad.2018.08.045','\n\nBackground\nThere is growing evidence to support the need for personalised intervention in the early stages of a major psychiatric illness, as well as the clear delineation of subgroups in psychiatric disorders based on cognitive impairment. Affective disorders are often accompanied by neurocognitive deficits; however a lack of research among young adult inpatients highlights the need to assess the utility of cognitive testing in this population.\n\n\nMethods\nA computerised cognitive battery was administered to 50 current inpatient young adults (16ΓÇô30 years; 75% female) with an affective disorder. Patients also completed a computerised self-report questionnaire (to measure demographics and clinical features) that included items evaluating subjective impressions of their cognition.\n\n\nResults\nHierarchical cluster analysis determined two neurocognitive subgroups: cluster 1 (n=16) showed more severe impairments in├é┬á├éΓÇª\n\n','',2019,NULL,NULL,'2019-01-01',NULL,NULL,NULL,NULL,'17','Journal of Affective Disorders','242','','80-86','Elsevier','YMH team','Outcome Research',''),(1028,'Dynamic prediction of transition to psychosis using joint modelling','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049464398&doi=10.1016%2fj.schres.2018.07.002&partnerID=40&md5=6aea23e7866d21b99c3f4a555e93aa18','10.1016/j.schres.2018.07.002','Considerable research has been conducted seeking risk factors and constructing prediction models for transition to psychosis in individuals at ultra-high risk (UHR). Nearly all such research has only employed baseline predictors, i.e. data collected at the baseline time point, even though longitudinal data on relevant measures such as psychopathology have often been collected at various time points. Dynamic prediction, which is the updating of prediction at a post-baseline assessment using baseline and longitudinal data accumulated up to that assessment, has not been utilized in the UHR context. This study explored the use of dynamic prediction and determined if it could enhance the prediction of frank psychosis onset in UHR individuals. An emerging statistical methodology called joint modelling was used to implement the dynamic prediction. Data from the NEURAPRO study (n=304 UHR individuals), an├é┬á├éΓÇª','',2018,NULL,NULL,'2018-12-01',NULL,NULL,NULL,NULL,'16','Schizophrenia Research','202','','333-340','Elsevier','Other','',''),(1029,'Clinical symptoms predict concurrent social and global functioning in an early psychosis sample','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044391542&doi=10.1111%2feip.12295&partnerID=40&md5=056764fd22519078f38bd735bd45a982','10.1111/eip.12295','  Aim Although well established in chronic schizophrenia, the key determinants of functioning remain unknown during the early phase of a psychotic disorder. The aim of this study was to comprehensively examine the social cognitive, basic neurocognitive and clinical predictors of concurrent social functioning and global functioning in an early psychosis sample.   Methods This study examined the relationship between social cognition, basic neurocognition and clinical symptoms with concurrent functioning in 51 early psychosis individuals. Assessments included a range of self-report, observational and clinician-rated measures of cognitive, symptom severity and functioning domains.   Results Results revealed a significant association between self-reported social function and lower levels of both social interaction anxiety and negative psychotic symptoms. A significant association was also observed between lower\n','',2018,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'17','Early Intervention in Psychiatry','12','2','177-184','','YMH team','Outcome Research','Illness specific areas'),(1030,'Lingual gyrus surface area is associated with anxiety-depression severity in young adults: A genetic clustering approach','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85040990196&doi=10.1523%2fENEURO.0153-17.2017&partnerID=40&md5=ef969df731a5681c40903d31c80a73c8','10.1523/ENEURO.0153-17.2017','Here we aimed to identify cortical endophenotypes for anxiety-depression. Our data-driven approach used vertex-wise genetic correlations (estimated from a twin sample: 157 monozygotic and 194 dizygotic twin pairs) to parcellate cortical thickness (CT) and surface area (SA) into genetically homogeneous regions (Chen et al., 2013). In an overlapping twin and sibling sample (n= 834; aged 15ΓÇô29, 66% female), in those with anxiety-depression Somatic and Psychological Health Report (SPHERE) scores (Hickie et al., 2001) above median, we found a reduction of SA in an occipito-temporal cluster, which comprised part of the right lingual, fusiform and parahippocampal gyrii. A similar reduction was observed in the Human Connectome Project (HCP) sample (n= 890, age 22├éΓÇô37, 56.5% female) in those with Adult Self Report (ASR) DSM-oriented scores (Achenbach et al., 2005) in the 25├éΓÇô95% quantiles. A post hoc├é┬á├éΓÇª','',2018,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'19','eNeuro','5','1','','Society for Neuroscience','YMH team','Neurobiology',''),(1031,'Youth Early-intervention Study (YES) - group interventions targeting social participation and physical well-being as an adjunct to treatment as usual: study protocol for a randomized controlled trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84938601013&doi=10.1186%2fs13063-015-0834-7&partnerID=40&md5=3067bce4a8793319ac26eca6a1520db9','10.1186/s13063-015-0834-7','It is increasingly acknowledged that clinical interventions for young persons with mental disorders need to optimize social, vocational and physical functioning, and take into account developmental needs, rather than focusing only on the traditional target of psychiatric symptom change. However, few interventions for youth presenting to mental health services offer a coherent rationale for multi-faceted approaches that efficiently address all these targets. This trial uses two facilitated group therapy modules (social and physical activity) as a vehicle for promoting clinical, cognitive, social and vocational change. The modules are an adjunct to usual treatments offered to youth attending mental health services in Sydney, Australia. The design is a 2-arm, parallel group cross-over, randomized clinical trial (RCT) that examines the efficacy of this adjunctive youth early intervention program (called ├éΓÇ£YES├éΓÇ¥) for improving social, vocational, mental and physical health functioning in a trans-diagnostic sample of 120 young persons aged 14├éΓÇô25 years who are currently receiving a range of ├éΓÇ£usual treatments├éΓÇ¥ for clinically diagnosed anxiety, affective and/or psychotic disorders. Individuals who provide written informed consent are offered 2 group therapy modules (each comprising 4 hours per week for 8 weeks) with a 3-week ├éΓÇ£pause├éΓÇ¥ between modules. Randomization determines whether individuals commence with module A or module B. The sample will be assessed pre-randomization, and at week 1 and week 8 (after completion of the first module), and at week 11 (commencement of second module) and week 19 (completion of second module). Final follow├éΓÇôup is├é┬á├éΓÇª','',2015,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'16','Trials','16','1','1-Sep','BioMed Central','YMH team','Models of care',''),(1032,'The relationship between sleep-wake cycle and cognitive functioning in young people with affective disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929484551&doi=10.1371%2fjournal.pone.0124710&partnerID=40&md5=0f8e4be00581b64774fa96b78b03c36c','10.1371/journal.pone.0124710','Although early-stage affective disorders are associated with both cognitive dysfunction and sleep-wake disruptions, relationships between these factors have not been specifically examined in young adults. Sleep and circadian rhythm disturbances in those with affective disorders are considerably heterogeneous, and may not relate to cognitive dysfunction in a simple linear fashion. This study aimed to characterise profiles of sleep and circadian disturbance in young people with affective disorders and examine associations between these profiles and cognitive performance. Actigraphy monitoring was completed in 152 young people (16ΓÇô30 years; 66% female) with primary diagnoses of affective disorders, and 69 healthy controls (18├éΓÇô30 years; 57% female). Patients also underwent detailed neuropsychological assessment. Actigraphy data were processed to estimate both sleep and circadian parameters. Overall neuropsychological performance in patients was poor on tasks relating to mental flexibility and visual memory. Two hierarchical cluster analyses identified three distinct patient groups based on sleep variables and three based on circadian variables. Sleep clusters included a ├éΓÇÿlong sleep├éΓÇÖ cluster, a ├éΓÇÿdisrupted sleep├éΓÇÖ cluster, and a ├éΓÇÿdelayed and disrupted sleep├éΓÇÖ cluster. Circadian clusters included a ├éΓÇÿstrong circadian├éΓÇÖ cluster, a ├éΓÇÿweak circadian├éΓÇÖ cluster, and a ├éΓÇÿdelayed circadian├éΓÇÖ cluster. Medication use differed between clusters. The ├éΓÇÿlong sleep├éΓÇÖ cluster displayed significantly worse visual memory performance compared to the ├éΓÇÿdisrupted sleep├éΓÇÖ cluster. No other cognitive functions differed between clusters. These results highlight the├é┬á├éΓÇª','',2015,NULL,NULL,'2015-04-21',NULL,NULL,NULL,NULL,'19','PLoS ONE','10','4','e0124710','Public Library of Science','YMH team','Illness specific areas',''),(1034,'Cohort profile: The Brain and Mind Centre Optymise cohort: Tracking multidimensional outcomes in young people presenting for mental healthcare','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082790787&doi=10.1136%2fbmjopen-2019-030985&partnerID=40&md5=774cc897537429aac4f1bec6c42967c3','10.1136/bmjopen-2019-030985','\nPurpose The Brain and Mind Centre (BMC) Optymise cohort assesses multiple clinical and functional domains longitudinally in young people presenting for mental health care and treatment. Longitudinal tracking of this cohort will allow investigation of the relationships between multiple outcome domains across the course of care. Subsets of Optymise have completed detailed neuropsychological and neurobiological assessments, permitting investigation of associations between these measures and longitudinal course.\nParticipants Young people (aged 12├éΓÇô30) presenting to clinics coordinated by the BMC were recruited to a research register (n=6743) progressively between June 2008 and July 2018. To date, 2767 individuals have been included in Optymise based on the availability of at least one detailed clinical assessment.\nMeasures Trained researchers use a clinical research proforma to extract key data from├é┬á├éΓÇª\n','',2020,NULL,NULL,'2020-03-01',NULL,NULL,NULL,NULL,'17','BMJ Open','10','3','e030985','British Medical Journal Publishing Group','YMH team','Outcome Research',''),(1036,'Twenty-Five and Up (25Up) Study: A New Wave of the Brisbane Longitudinal Twin Study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85067349203&doi=10.1017%2fthg.2019.27&partnerID=40&md5=f34f3e5fee7c927ac8812ea58d7c61e8','10.1017/thg.2019.27','The aim of the 25 and Up (25Up) study was to assess a wide range of psychological and behavioral risk factors behind mental illness in a large cohort of Australian twins and their non-twin siblings. Participants had already been studied longitudinally from the age of 12 and most recently in the 19Up study (mean age = 26.1 years, SD = 4.1, range = 20├éΓÇô39). This subsequent wave follows up these twins several years later in life (mean age = 29.7 years, SD├é┬á=├é┬á2.2, range├é┬á= 22├éΓÇô44). The resulting data set enables additional detailed investigations of genetic pathways underlying psychiatric illnesses in the Brisbane Longitudinal Twin Study (BLTS). Data were collected between 2016 and 2018 from 2540 twins and their non-twin siblings (59% female, including 341 monozygotic complete twin-pairs, 415 dizygotic complete pairs and 1028 non-twin siblings and singletons). Participants were from South-East Queensland├é┬á├éΓÇª','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'18','Twin Research and Human Genetics','22','3','154-163','Cambridge University Press','YMH team','Outcome Research','Neurobiology'),(1037,'Validation of the social functioning scale: Comparison and evaluation in early psychosis, autism spectrum disorder and social anxiety disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064326473&doi=10.1016%2fj.psychres.2019.03.037&partnerID=40&md5=66aa75a2207cf2dda88f4a378c68fd0d','10.1016/j.psychres.2019.03.037','Social functioning is an important component of mental disorders for assessment and treatment. There is no recognised self-report instrument to measure social functioning across disorders where social impairment is significant. The Social Functioning Scale (SFS) has, however, been used to assess social functioning in psychotic disorders, including Schizophrenia and Early Psychosis. The current study investigated the reliability, validity and sensitivity of the SFS in Early Psychosis, Autism Spectrum Disorder (ASD), Social Anxiety Disorder (SAD) and neurotypical control populations. As expected, all clinical groups showed significant impairment on the total and sub-scale scores of the SFS. The SFS showed good internal consistency and concurrent validity for people diagnosed with SAD and Early Psychosis and a similar factors structure was found for these groups. Participants with ASD reported a relatively low','',2019,NULL,NULL,'2019-06-01',NULL,NULL,NULL,NULL,'18','Psychiatry Research','276','','45-55','Elsevier','Other','',''),(1038,'Can consumer grade activity devices replace research grade actiwatches in youth mental health settings?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85063617869&doi=10.1007%2fs41105-018-00204-x&partnerID=40&md5=7e879f59a096153b5e242cdf1a1be2f1','10.1007/s41105-018-00204-x','               Mental health services increasingly recognize the benefits of monitoring sleep and activity patterns in youth. Objective, ecological monitoring via research grade actiwatches is valid, but an emerging literature suggests using cheaper, consumer grade activity tracking devices. This study aimed to compare the cross-validity of these devices, and their feasibility and usability in youth mental health settings. A convenience sample of 13 individuals recruited from youth mental health settings wore a consumer grade and research grade activity device for seven consecutive days. The five most frequently reported sleep and activity variables extracted directly from each device were compared using paired t tests, mean average percentage errors, and magnitude and direction of biases. Ten individuals provided usable recordings of sleep and activity parameters. Compared to the actiwatch recordings (criterion values\n','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'18','Sleep and Biological Rhythms','17','2','223-232','Springer Japan','YMH team','Digital health',''),(1039,'Clinical, neurocognitive and demographic factors associated with functional impairment in the Australian Brain and Mind Youth Cohort Study (2008-2016)','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058899818&doi=10.1136%2fbmjopen-2018-022659&partnerID=40&md5=f99dd2f130a3085867807486983d34a1','10.1136/bmjopen-2018-022659','\nObjectives We sought to determine the unique and shared contributions of clinical, neurocognitive and demographic factors to functional impairment in a large, transdiagnostic, clinical cohort of adolescents and young adults.\nDesign Cross-sectional baseline data from a prospective, cohort study.\nSetting Help-seeking youth referred from outpatient services were recruited to the Brain and Mind Youth Cohort (2008├éΓÇô2016) in Sydney, Australia.\nParticipants In total, 1003 outpatients were recruited, aged between 12 and 36years (mean= 20.4years, 54% female), with baseline diagnoses of affective, psychotic, developmental or behavioural disorders.\nInterventions Treatment as usual.\nPrimary outcome measures Social and occupational functioning was used to index level of functional impairment. Structural equation modelling was used to examine associations between neurocognition, core clinical symptoms and alcohol├é┬á├éΓÇª\n','',2018,NULL,NULL,'2018-12-01',NULL,NULL,NULL,NULL,'16','BMJ Open','8','12','e022659','British Medical Journal Publishing Group','YMH team','Outcome Research',''),(1040,'Applying polygenic risk scoring for psychiatric disorders to a large family with bipolar disorder and major depressive disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061101811&doi=10.1038%2fs42003-018-0155-y&partnerID=40&md5=6b4b253b76abb5b2a15509e004dbe299','10.1038/s42003-018-0155-y','Psychiatric disorders are thought to have a complex genetic pathology consisting of interplay of common and rare variation. Traditionally, pedigrees are used to shed light on the latter only, while here we discuss the application of polygenic risk scores to also highlight patterns of common genetic risk. We analyze polygenic risk scores for psychiatric disorders in a large pedigree (n~260) in which 30% of family members suffer from major depressive disorder or bipolar disorder. Studying patterns of assortative mating and anticipation, it appears increased polygenic risk is contributed by affected individuals who married into the family, resulting in an increasing genetic risk over generations. This may explain the observation of anticipation in mood disorders, whereby onset is earlier and the severity increases over the generations of a family. Joint analyses of rare and common variation may be a powerful way to├é┬á├éΓÇª','',2018,NULL,NULL,'2018-10-08',NULL,NULL,NULL,NULL,'15','Communications Biology','1','1','1-Oct','Nature Publishing Group','Other','',''),(1041,'Parallel Changes in Mood and Melatonin Rhythm Following an Adjunctive Multimodal Chronobiological Intervention With Agomelatine in People With Depression: A Proof of Concept Open Label Study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074465100&doi=10.3389%2ffpsyt.2018.00624&partnerID=40&md5=b3aee36cc6107030d1bf0d4e428ac184','10.3389/fpsyt.2018.00624','Background Agomelatine is a melatonin agonist and 5HT antagonist developed for the treatment of major depressive disorder which also has some effects on the circadian system. Since circadian dysfunctions are thought to play a role in the pathophysiology of depression, some of the mechanism of action of this drug may relate to improvements in circadian rhythms. Objective This proof of concept open-label study sought to determine if improvements in depressive symptoms following an adjunctive multimodal intervention including agomelatine intake are associated with the magnitude of circadian realignment. This was investigated in young people with depression, a subgroup known to have high rates of delayed circadian rhythms. Methods Young people with depression received a psychoeducation session about sleep and circadian rhythms, were asked to progressively phase advance their wake up time, and completed an 8-week course of agomelatine (25-50 mg). Participants underwent semi-structured psychological assessments, ambulatory sleep-wake monitoring and measurement of melatonin circadian phase before and after the intervention. Results Twenty-four young adults with depression (17-28 years old; 58% females) completed the study. After the intervention, depressive symptoms were significantly reduced (t(23) = 6.9, p < .001) and, on average, the timing of dim light melatonin onset (DLMO) shifted 3.6 hours earlier (t(18) = 4.4, p < .001). On average, sleep onset was phase shifted 28 minutes earlier (t(19) = 2.1, p = .047) and total sleep time increased by 24 minutes (t(19) = -2.6, p = 0.018). There was no significant change in├é┬á├éΓÇª','',2018,NULL,NULL,'2018-12-11',NULL,NULL,NULL,NULL,'18','Frontiers in Psychiatry','9','','624','Frontiers Media SA','YMH team','Models of care','illness specific areas'),(1042,'A comprehensive systematic review and meta-analysis of pharmacological and dietary supplement interventions in paediatric autism: Moderators of treatment response and recommendations for future research','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85009818555&doi=10.1017%2fS0033291716003457&partnerID=40&md5=31bbb473c1d8073f02da6aaf45fd8f21','10.1017/S0033291716003457','Background Autism spectrum disorders (ASDs) are pervasive and multifactorial neurodevelopmental conditions, characterized by impairments in social communication and interaction, and restricted, repetitive patterns of behaviour, interests or activities. Treatment options to ameliorate symptoms of ASDs are limited. Heterogeneity complicates the quest for personalized medicine in this population. Our aim was to investigate if there are baseline characteristics of patients that moderate response or trial design features that impede the identification of efficacious interventions for ASDs. Method Literature searches of EMBASE, MEDLINE and PsycINFO identified 43 studies for qualitative assessment of baseline characterization of participants and 37 studies for quantitative analysis of moderators of treatment response. Criteria included blinded randomized controlled trials (RCTs) in paediatric ASD, with at least 10','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'16','Psychological Medicine','47','7','1323-1334','Cambridge University Press','Other','',''),(1043,'NHMRC funding of mental health research','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84991662013&doi=10.5694%2fmja16.00179&partnerID=40&md5=4f85c90ea46d4671a739623fb0aad2c5','10.5694/mja16.00179','\nMental health research has long been the poor cousin in medical research, despite mental illness being both an independent and comorbid risk factor for every major medical disease, and a significant contributor to morbidity and mortality. Of the five major non-communicable disease areas, mental illness has the largest impact on the world economy by reducing gross domestic product. 1 Yet, 11 times more money is donated from the private and corporate sectors to cancer research than to mental health research. In addition, cancer research receives twice the funding from governments. 2\nThis pattern is reflected in the funding distribution from the National Health and Medical Research Council (NHMRC) in Australia, where mental health research has received a lower proportion of NHMRC health funding compared with other National Health Priority Areas such as cancer, diabetes and cardiovascular disease\n','',2016,NULL,NULL,'2016-10-17',NULL,NULL,NULL,NULL,'18','Medical Journal of Australia','205','8','350-351','','Other','',''),(1044,'Delayed circadian phase is linked to glutamatergic functions in young people with affective disorders: A proton magnetic resonance spectroscopy study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84924112013&doi=10.1186%2fs12888-014-0345-1&partnerID=40&md5=a179774c5ed1ae8fd0a787164afbb6b6','10.1186/s12888-014-0345-1','While the association between affective disorders and sleep and circadian disturbance is well established, little is known about the neurobiology underpinning these relationships. In this study, we sought to determine the relationship between a marker of circadian rhythm and neuronal integrity (N-Acetyl Aspartate, NAA), oxidative stress (glutathione, GSH) and neuronal-glial dysfunction (Glutamate+Glutamine, Glx). Fifty-three young adults (age range 15ΓÇô33 years, mean=21.8, sd=4.3) with emerging affective disorders were recruited from a specialized tertiary referral service. Participants underwent clinical assessment and actigraphy monitoring, from which sleep midpoint was calculated as a marker of circadian rhythm. Proton magnetic resonance spectroscopy was performed in the anterior cingulate cortex (ACC). The metabolites NAA, GSH and Glx were obtained, and expressed as a ratio to Creatine. Neither NAA or GSH were associated with sleep midpoint. However, higher levels of ACC Glx were associated with later sleep midpoints (rho=0.35, p=0.013). This relationship appeared to be independent of age and depression severity. This study is the first to demonstrate that delayed circadian phase is related to altered glutamatergic processes. It is aligned with animal research linking circadian rhythms with glutamatergic neurotransmission as well as clinical studies showing changes in glutamate with sleep interventions. Further studies may seek to examine the role of glutamate modulators for circadian misalignment.','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'15','BMC Psychiatry','14','1','1-Jul','BioMed Central','YMH team','Illness specific areas','Neurobiology'),(1045,'Risky alcohol use predicts temporal mismatch negativity impairments in young people with bipolar disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896501244&doi=10.1016%2fj.biopsycho.2014.02.013&partnerID=40&md5=729ac48511685a5c221fed885edfb457','10.1016/j.biopsycho.2014.02.013','Alcohol misuse in bipolar disorder (BD) has a negative impact on illness progression. The NMDA/glutamatergic system is implicated in BD pathophysiology and is critically involved in the effects of alcohol on the brain. Mismatch negativity (MMN) is purported to reflect NMDA receptor output, providing a measure for investigating this association. Forty-two patients and 34 controls (16ΓÇô30 years) were split into low and high-risk drinkers (based on the Alcohol Use Disorders Identification Test) and underwent a two-tone passive auditory oddball, duration deviant MMN paradigm. Multiple regression models revealed risky drinking and BD diagnosis were predictors of impaired temporal MMN. Potentially reflecting an additive effect of alcohol on a perturbed NMDA/glutamatergic system in BD, these findings highlight alcohol as both a modifiable risk factor of neurobiological impairments and as a potential confounder in├é┬á├éΓÇª','',2014,NULL,NULL,'2014-05-01',NULL,NULL,NULL,NULL,'17','Biological Psychology','99','','60-68','Elsevier','YMH team','Neurobiology','Illness specific areas'),(1046,'Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders','https://genomebiology.biomedcentral.com/articles/10.1186/s13059-021-02275-5',NULL,'People with neurodegenerative disorders show diverse clinical syndromes, genetic heterogeneity, and distinct brain pathological changes, but studies report overlap between these features. DNA methylation (DNAm) provides a way to explore this overlap and heterogeneity as it is determined by the combined effects of genetic variation and the environment. In this study, we aim to identify shared blood DNAm differences between controls and people with Alzheimer├éΓÇÖs disease, amyotrophic lateral sclerosis, and Parkinson├éΓÇÖs disease. We use a mixed-linear model method (MOMENT) that accounts for the effect of (un)known confounders, to test for the association of each DNAm site with each disorder. While only three probes are found to be genome-wide significant in each MOMENT association analysis of amyotrophic lateral sclerosis and Parkinson├éΓÇÖs disease (and none with Alzheimer├éΓÇÖs disease), a fixed-effects meta-analysis of the three disorders results in 12 genome-wide significant differentially methylated positions. Predicted immune cell-type proportions are disrupted across all neurodegenerative disorders. Protein inflammatory markers are correlated with profile sum-scores derived from disease-associated immune cell-type proportions in a healthy aging cohort. In contrast, they are not correlated with MOMENT DNAm-derived profile sum-scores, calculated using effect sizes of the 12 differentially methylated positions as weights. We identify shared differentially methylated positions in whole blood between neurodegenerative disorders that point to shared pathogenic mechanisms. These shared differentially methylated positions may reflect├é┬á├éΓÇª','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'17','Genome biology','22','1','Jan-30','BioMed Central',NULL,NULL,NULL),(1048,'Classical Human Leukocyte Antigen Alleles and C4 Haplotypes Are Not Significantly Associated With Depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072749953&doi=10.1016%2fj.biopsych.2019.06.031&partnerID=40&md5=80a3fc7f5b2fb6a6ebb24d02426a63da','10.1016/j.biopsych.2019.06.031','Background\r\nThe prevalence of depression is higher in individuals with autoimmune diseases, but the mechanisms underlying the observed comorbidities are unknown. Shared genetic etiology is a plausible explanation for the overlap, and in this study we tested whether genetic variation in the major histocompatibility complex (MHC), which is associated with risk for autoimmune diseases, is also associated with risk for depression.\r\n\r\n\r\nMethods\r\nWe fine-mapped the classical MHC (chr6: 29.6├éΓÇô33.1 Mb), imputing 216 human leukocyte antigen (HLA) alleles and 4 complement component 4 (C4) haplotypes in studies from the Psychiatric Genomics Consortium Major Depressive Disorder Working Group and the UK Biobank. The total sample size was 45,149 depression cases and 86,698 controls. We tested for association between depression status and imputed MHC variants, applying both a region-wide significance├é┬á├éΓÇª','',2020,NULL,NULL,'2020-03-01',NULL,NULL,NULL,NULL,'17','Biological Psychiatry','87','5','419-430','Elsevier','Other','',''),(1049,'Disability in older adults across the continuum of cognitive decline: Unique contributions of depression, sleep disturbance, cognitive deficits and medical burden','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061106544&doi=10.1017%2fS1041610218002144&partnerID=40&md5=8d51c397d9fb6adfb64466c2ea2f40a2','10.1017/S1041610218002144','\nObjectives:\n\nDisability in older adults is associated with a need for support in work, education, and community activities, reduced independence, and poorer quality of life. This study examines potential determinants of disability in a clinical sample of older adults across the continuum of cognitive decline, including sociodemographic, medical, psychiatric, and cognitive factors.\nDesign:\n\nThis is a cross-sectional study.\nSetting:\n\nParticipants were recruited from a specialty clinic for adults ΓÇ£at risk├éΓÇ¥ of or with early dementia (including subjective cognitive complaints, mild cognitive impairment, and early dementia).\nParticipants:\n\nFour hundred forty-two older adults (mean age = 67.11, SD = 9.33) underwent comprehensive medical, neuropsychological, and mood assessments.\nMeasurements:\n\nDisability was assessed via the self-report World Health Organization Disability Assessment Schedule 2.0. A stepwise (forward) linear├é┬á├éΓÇª\n','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'17','International Psychogeriatrics','31','11','1611-1625','Cambridge University Press','YMH team','Outcome Research',''),(1050,'The course of neuropsychological functioning in young people with attenuated vs discrete mental disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85033461170&doi=10.1111%2feip.12499&partnerID=40&md5=173e73c943929f3fd605d4c1072a1f35','10.1111/eip.12499',' Aim Clinical staging of mental disorders is designed to facilitate the selection of stage-appropriate interventions, early in the course of illness. Neuropsychological performance, particularly at early stages of mental disorder, is a strong predictor of medium-term functional outcomes. Despite this, the longitudinal examination of neuropsychological profiles in early stages of illness is poorly researched. Thus, we examined baseline and longitudinal neuropsychological profiles of young patients with attenuated syndromes vs those with discrete disorders.   Methods Neuropsychological testing of 497 help-seeking young people (21.2┬▒3years; 56% female). Clinical staging, assigned separately from testing, rated 262 individuals as ├éΓÇ£attenuated syndrome├éΓÇ¥ (stage 1b) and 235 as ├éΓÇ£discrete├éΓÇ¥ or ├éΓÇ£persistent├éΓÇ¥ disorder (stage 2+). Follow-up testing was undertaken in 170 individuals (54% at stage 1b) after 19.8├é┬▒9 months├é┬á├éΓÇª\n','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'17','Early Intervention in Psychiatry','13','3','425-433','Wiley Publishing Asia Pty Ltd','YMH team','Models of care','Outcome Research'),(1055,'Current sleep disturbance in older people with a lifetime history of depression is associated with increased connectivity in the Default Mode Network','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85040012395&doi=10.1016%2fj.jad.2017.12.052&partnerID=40&md5=7758699adee61b9c0f14621aff8a1092','10.1016/j.jad.2017.12.052','\n\nBackground\nThe present study investigated Default Mode Network (DMN) functional connectivity in subjects with a lifetime history of major depression, comparing those with and without current sleep disturbance. Controls were included to assess DMN abnormalities specific to depression.\n\n\nMethods\nA total of 93 adults aged 50 years and over were recruited from the Healthy Brain Ageing Clinic at the Brain and Mind Centre, Sydney, Australia. The sample comprised two groups, including 22 controls and 71 participants with a lifetime history of DSM-IV major depression (with depressive episode current or remitted). 52 of those with a lifetime history of depression also met criteria for Mild Cognitive Impairment (MCI). Participants underwent resting-state fMRI along with comprehensive psychiatric, neuropsychological, and medical assessment. Subjective sleep quality was assessed via the Pittsburgh Sleep Quality Index├é┬á├éΓÇª\n\n','',2018,NULL,NULL,'2018-03-15',NULL,NULL,NULL,NULL,'17','Journal of Affective Disorders','229','','85-94','Elsevier','YMH team','Illness specific areas','Neurobiology'),(1058,'Reducing youth suicide: systems modelling and simulation to guide targeted investments across the determinants','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102477395&doi=10.1186%2fs12916-021-01935-4&partnerID=40&md5=a2abc683147c239cf27e246729bc0689','10.1186/s12916-021-01935-4','Reducing suicidal behaviour (SB) is a critical public health issue globally. The complex interplay of social determinants, service system factors, population demographics, and behavioural dynamics makes it extraordinarily difficult for decision makers to determine the nature and balance of investments required to have the greatest impacts on SB. Real-world experimentation to establish the optimal targeting, timing, scale, frequency, and intensity of investments required across the determinants is unfeasible. Therefore, this study harnesses systems modelling and simulation to guide population-level decision making that represent best strategic allocation of limited resources. Using a participatory approach, and informed by a range of national, state, and local datasets, a system dynamics model was developed, tested, and validated for a regional population catchment. The model incorporated defined pathways from social determinants of mental health to psychological distress, mental health care, and SB. Intervention scenarios were investigated to forecast their impact on SB over a 20-year period. A combination of social connectedness programs, technology-enabled coordinated care, post-attempt assertive aftercare, reductions in childhood adversity, and increasing youth employment projected the greatest impacts on SB, particularly in a youth population, reducing self-harm hospitalisations (suicide attempts) by 28.5% (95% interval 26.3ΓÇô30.8%) and suicide deaths by 29.3% (95% interval 27.1├éΓÇô31.5%). Introducing additional interventions beyond the best performing suite of interventions produced only marginal improvement in population level├é┬á├éΓÇª','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'16','BMC Medicine','19','1','Jan-13','BioMed Central','YMH team','Mental Health System','Mental Health System'),(1063,'Spectroscopic markers of memory impairment, symptom severity and age of onset in older people with lifetime depression: Discrete roles of N-acetyl aspartate and glutamate','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929574545&doi=10.1016%2fj.jad.2015.04.023&partnerID=40&md5=a79135c8670d854eabb3fce9cf63a30a','10.1016/j.jad.2015.04.023','\n\nBackground\nGlutamate (Glu) and N-acetyl aspartate (NAA) are markers of excitatory processes and neuronal compromise respectively. Increased Glu and decreased NAA concentrations have been implicated in the pathophysiology of depression and cognitive impairment respectively.\n\n\nObjective\nTo determine the relationship between NAA, Glu, memory and key clinical features in older people with lifetime depression compared to comparison subjects.\n\n\nMethod\nThirty-five health-seeking older adults (mean age=63.57 years), with a lifetime depression diagnosis, and 21 age-matched healthy comparison subjects (mean age=65.48 years) underwent neuropsychological testing, psychiatric assessment and proton magnetic resonance spectroscopy from which Glu and NAA were measured (reported as a ratio to creatine).\n\n\nResults\nCompared to comparison subjects, the depressed subjects showed poorer verbal learning and\n\n','',2015,NULL,NULL,'2015-09-01',NULL,NULL,NULL,NULL,'16','Journal of Affective Disorders','183','','31-38','Elsevier','Other','',''),(1064,'Mental health expenditure in Australia: Time for affirmative action','https://www.scopus.com/inward/record.uri?eid=2-s2.0-33646269956&doi=10.1111%2fj.1467-842X.2006.tb00102.x&partnerID=40&md5=7b7e2a194290d010ee8b99d539b2e3fa','10.1111/j.1467-842X.2006.tb00102.x',' In Australia, there is a clear relationship (r=-0.56) between the ratio of health expenditure to burden and the ratio of mortality to disability across illness groups. Those illnesses with high mortality relative to disability (e. g. cancer and cardiovascular) are associated with lower health expenditure, relative to the burden they impose. Conversely, illnesses with low mortality but high disability (e. g. musculoskeletal disorders) demonstrate higher expenditure. The notable exception is mental health, which has low mortality, high disability and very low health expenditure. Indeed, the relationship between the mortality/disability and health expenditure/burden ratios is stronger (r=-0.72) when mental health is excluded. As this disparity cannot be explained by a lack of cost-effective treatments for mental disorders, we propose a process of affirmative action for mental health. Urgent investments in cost-effective modes of care\n','',2006,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'16','Australian and New Zealand Journal of Public Health','30','2','119-122','Blackwell Publishing Ltd','YMH team','Mental Health System',''),(1065,'Identifying the common genetic basis of antidepressant response','https://www.sciencedirect.com/science/article/pii/S2667174321000859',NULL,'\n\nBackground\nAntidepressants are a first-line treatment for depression. However, only a third of individuals experience remission after the first treatment. Common genetic variation, in part, likely regulates antidepressant response, yet the success of previous genome-wide association studies has been limited by sample size. This study performs the largest genetic analysis of prospectively assessed antidepressant response in major depressive disorder to gain insight into the underlying biology and enable out-of-sample prediction.\n\n\nMethods\nGenome-wide analysis of remission (nremit├é┬á= 1852, nnonremit├é┬á= 3299) and percentage improvement (n├é┬á= 5218) was performed. Single nucleotide polymorphism├éΓÇôbased heritability was estimated using genome-wide complex trait analysis. Genetic covariance with eight mental health phenotypes was estimated using polygenic scores/AVENGEME. Out-of-sample prediction of├é┬á├éΓÇª\n\n','',2022,NULL,NULL,'2022-04-01',NULL,NULL,NULL,NULL,'15','Biological Psychiatry Global Open Science','2','2','115-126','Elsevier',NULL,NULL,NULL),(1066,'Brain structural correlates of insomnia severity in 1053 individuals with major depressive disorder: results from the ENIGMA MDD Working Group','https://www.nature.com/articles/s41398-020-01109-5',NULL,'It has been difficult to find robust brain structural correlates of the overall severity of major depressive disorder (MDD). We hypothesized that specific symptoms may better reveal correlates and investigated this for the severity of insomnia, both a key symptom and a modifiable major risk factor of MDD. Cortical thickness, surface area and subcortical volumes were assessed from T1-weighted brain magnetic resonance imaging (MRI) scans of 1053 MDD patients (age range 13-79 years) from 15 cohorts within the ENIGMA MDD Working Group. Insomnia severity was measured by summing the insomnia items of the Hamilton Depression Rating Scale (HDRS). Symptom specificity was evaluated with correlates of overall depression severity. Disease specificity was evaluated in two independent samples comprising 2108 healthy controls, and in 260 clinical controls with bipolar disorder. Results showed that MDD patients├é┬á├éΓÇª','',2020,NULL,NULL,'2020-12-08',NULL,NULL,NULL,NULL,'15','Translational psychiatry','10','1','1-Nov','Nature Publishing Group',NULL,NULL,NULL),(1067,'The role of new technologies in monitoring the evolution of┬ápsychopathology and providing measurement-based care in young┬ápeople','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077706226&doi=10.1002%2fwps.20697&partnerID=40&md5=7d7fc70c44d4e4a7bee71fcaaa284e55','10.1002/wps.20697','\nTwo of the most important innovations in clinical psychiatry over the last decade have been the deployment of youth-focused early intervention services and the development of a clinical staging framework for clinical care and pathophysiological research1, 2. Together, they engage young people in active clinical care, promote secondary prevention strategies and provide the platform for more detailed clinical research. These developments respond directly to the epidemiology, namely, that most mood and psychotic syndromes have their onset in adolescence and are associated with social and educational impairment and other at-risk behaviors (notably suicidal thoughts and behaviors, and alcohol and other substance misuse) 3.\nCritics of these proactive innovations highlight possible adverse effects, including premature assignment of specific diagnoses, unwarranted exposure to medicines and inappropriate\n','',2020,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'15','World Psychiatry','19','1','38','World Psychiatric Association','YMH team','Models of care','Digital health'),(1068,'Sexting, web-based risks, and safety in two representative national samples of young Australians: Prevalence, perspectives, and predictors','https://mental.jmir.org/2019/6/e13338/',NULL,'           Background           The rapid uptake of information and communication technology (ICT) over the past decadeΓÇöparticularly the smartphone├éΓÇöhas coincided with large increases in sexting. All previous Australian studies examining the prevalence of sexting activities in young people have relied on convenience or self-selected samples. Concurrently, there have been recent calls to undertake more in-depth research on the relationship between mental health problems, suicidal thoughts and behaviors, and sexting. How sexters (including those who receive, send, and two-way sext) and nonsexters apply ICT safety skills warrants further research.                             Objective           This study aimed to extend the Australian sexting literature by measuring (1) changes in the frequency of young people├éΓÇÖs sexting activities from 2012 to 2014; (2) young people├éΓÇÖs beliefs about sexting; (3) association of demographics, mental health and well-being items, and internet use with sexting; and (4) the relationship between sexting and ICT safety skills.                             Methods           Computer-assisted telephone interviewing using random digit dialing was used in two Young and Well National Surveys conducted in 2012 and 2014. The participants included representative and random samples of 1400 young people aged 16 to 25 years.                             Results           From 2012 to 2014, two-way sexting (2012: 521/1369, 38.06%; 2014: 591/1400, 42.21%; P=.03) and receiving sexts (2012: 375/1369, 27.39%; 2014: 433/1400, 30.93%; P<.001) increased significantly, not sexting (2012: 438/1369, 31.99%; 2014: 356/1400, 25.43%; P<.001) reduced significantly├é┬á├éΓÇª\n','',2019,NULL,NULL,'2019-06-17',NULL,NULL,NULL,NULL,'15','JMIR mental health','6','6','e13338','JMIR Publications Inc., Toronto, Canada',NULL,NULL,NULL),(1071,'Two Sides of the Same Coin: Cannabis Dependence and Mental Health Problems in Help-Seeking Adolescent and Young Adult Outpatients','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84871248488&doi=10.1007%2fs11469-012-9378-1&partnerID=40&md5=6fa5c43eaa6ecfe17aee03e35666b59b','10.1007/s11469-012-9378-1','               The aim of the current study was to delineate the psychiatric profile of cannabis dependent young people (14ΓÇô29├é┬áyears old) with mental health problems (N=36) seeking treatment via a research study. To do so, the Structured Clinical Interview for DSM-IV-TR Axis I Disorders and the Structured Clinical Interview for DSM-IV Childhood Diagnoses were used to obtain DSM-IV diagnoses, while a modified Timeline Followback interview and self-reports were used to measure cannabis use, cannabis-related problems, and impairment. Most individuals had at least two Axis I disorders in addition to cannabis dependence. Anxiety disorders were common, with posttraumatic stress disorder, social phobia, and generalised anxiety disorder accounting for the majority of these diagnoses. On average, young people reported a moderate degree of dependence and functional impairment, and a substantial number of├é┬á├éΓÇª\n','',2012,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'15','International Journal of Mental Health and Addiction','10','6','818-828','Springer-Verlag','Other','',''),(1072,'Clinical staging model applied to young people presenting with social anxiety','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84864322406&doi=10.1111%2fj.1751-7893.2012.00364.x&partnerID=40&md5=42f60b5898dd31f88fc12049f771b9ac','10.1111/j.1751-7893.2012.00364.x',' \nAim: Although the use of illness-staging models in clinical medicine has proved particularly useful, the concept has not been widely applied in mental health. Here, we apply a clinical staging framework to a population of help-seeking young people presenting with social anxiety. The goal was to provide a detailed description of common clinical stage of those presenting for treatment of social anxiety, and to delineate the associations between symptom type, severity and clinical stage. \nMethods: The results of a structured clinical interview along with background clinical information formed the basis for consensus-derived decisions regarding clinical stage. Subjects also completed self-report measures to assess anxiety and depressive symptoms. Comparisons were conducted largely between those subjects who were considered to have reached a critical clinical threshold for discrete or progressive disorders (i.e\n','',2012,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'15','Early Intervention in Psychiatry','6','3','256-264','Blackwell Publishing Asia','YMH team','Models of care','illness specific areas'),(1073,'Antidepressants in elderly people','https://www.bmj.com/content/343/bmj.d4660.long',NULL,'\nBecause older people with clinical depression have high rates of concurrent medical illness, particularly cerebrovascular disease, they are at high risk of adverse events from most antidepressants. 1 However, given the likelihood of poor functional outcomes and the increased risk of premature death by suicide, vascular disease, accident, or injury, safe and effective interventions are needed. 1 2 3 In the linked cohort study (doi: 10.1136/bmj. d4551), Coupland and colleagues assess the association between antidepressant treatment and risk of adverse outcomes in older people with depression in primary care. 4\nBefore the 1990s, enthusiasm for drug treatment of depression was tempered by the risks associated with tricyclic antidepressants or monoamine oxidase inhibitors. With the arrival of selective serotonin reuptake inhibitors (SSRIs), which were reported to have far fewer major side effects treatment increased\n','',2011,NULL,NULL,'2011-08-02',NULL,NULL,NULL,NULL,'15','','343','','','British Medical Journal Publishing Group',NULL,NULL,NULL),(1074,'\"Beyondblue: The national depression initiative\"','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034935050&doi=10.1046%2fj.1440-1665.2001.00321.x&partnerID=40&md5=1c1d069addb510f8a5804353943a116f','10.1046/j.1440-1665.2001.00321.x','\nObjective: To describe the initial phases of ΓÇ£beyondblue: the national depression initiative├éΓÇ¥. In doing so, this paper aims to highlight those issues that are likely to be most relevant to clinical, academic and administrative psychiatrists.\nConclusions: beyondblue potentially represents a very significant development in mental health for the Australian community. Its success will depend on its capacity to engage the wider community in the issues that impact on persons suffering from depression and related disorders. There is the potential for psychiatrists to take leading roles in promoting a public health approach, working closely with primary care and allied health colleagues and devising national research projects of international significance.\n','',2001,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'15','Australasian Psychiatry','9','2','147-150','SAGE Publications','YMH team','Mental Health System',''),(1075,'A depression management program: incorporating cognitive behavioural strategies','https://scholar.google.com/scholar?cluster=3782842814923796226&hl=en&oi=scholarr',NULL,'','',2000,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'15','Melbourne: Educational Health Solutions','11','','','',NULL,NULL,NULL),(1076,'A behavioral approach based on reconstructing the sleep-wake cycle','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0000523954&doi=10.1016%2fS1077-7229%2899%2980065-0&partnerID=40&md5=9e80e0a2c1dbd796784d80187140b70d','10.1016/S1077-7229(99)80065-0','Patients who present with chronic fatigue syndrome require careful medical, psychiatric, and behavioral review. Therapeutic approaches based on the assessment of the degree and type of sleep-wake cycle disturbance, and active treatment of concurrent psychological distress, appear to offer considerable benefits. For patients to accept this type of intervention, a detailed explanation of the biomedical and behavioral rationale is required. Adequate patient information and self-monitoring schedules will assist the process. Further detailed evaluation of the long-term benefits of this treatment approach are required.','',1999,NULL,NULL,'1999-09-01',NULL,NULL,NULL,NULL,'15','Cognitive and Behavioral Practice','6','4','442-450','Elsevier','YMH team','Illness specific areas',''),(1077,'Treatment resistant depression in an australian context l: The utility of the term and approaches to management','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907037255&doi=10.3109%2f00048679409075841&partnerID=40&md5=a52a2a5b9fc31c5bf2deef38613a0979','10.3109/00048679409075841','The concept of ΓÇ£treatment resistant depression├éΓÇ¥ (TRD) has generally been defined in terms of failure to respond to a standard course of somatic therapy with little reference to diagnostic sub-types or relevant psychosocial factors. In this paper we examine problems with the use of the term ├éΓÇ£treatment resistant depression├éΓÇ¥ and then outline an approach to TRD employed in an Australian mood disorders unit. After discussing the need for a biopsychosocial assessment, multimodal management strategies for melancholic and non-melancholic TRD patients are described.','',1994,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'15','Australasian Psychiatry','28','1','14-22','Sage Publications','Other','',''),(1079,'Bringing new tools, a regional focus, resource-sensitivity, local engagement and necessary discipline to mental health policy and planning','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086008686&doi=10.1186%2fs12889-020-08948-3&partnerID=40&md5=c8e2326f6e00e5ebc376f8b9e420b858','10.1186/s12889-020-08948-3','While reducing the burden of mental and substance use disorders is a global challenge, it is played out locally. Mental disorders have early ages of onset, syndromal complexity and high individual variability in course and response to treatment. As most locally-delivered health systems do not account for this complexity in their design, implementation, scale or evaluation they often result in disappointing impacts. In this viewpoint, we contend that the absence of an appropriate predictive planning framework is one critical reason that countries fail to make substantial progress in mental health outcomes. Addressing this missing infrastructure is vital to guide and coordinate national and regional (local) investments, to ensure limited mental health resources are put to best use, and to strengthen health systems to achieve the mental health targets of the 2015 Sustainable Development Goals. Most broad national policies over-emphasize provision of single elements of care (e.g. medicines, individual psychological therapies) and assess their population-level impact through static, linear and program logic-based evaluation. More sophisticated decision analytic approaches that can account for complexity have long been successfully used in non-health sectors and are now emerging in mental health research and practice. We argue that utilization of advanced decision support tools such as systems modelling and simulation, is now required to bring a necessary discipline to new national and local investments in transforming mental health systems. Systems modelling and simulation delivers an interactive decision analytic tool to test mental health reform','',2020,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'14','BMC Public Health','20','1','1-Sep','BioMed Central','YMH team','Mental Health System',''),(1080,'Transdiagnostic neurocognitive subgroups and functional course in young people with emerging mental disorders: a cohort study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85090269756&doi=10.1192%2fbjo.2020.12&partnerID=40&md5=8b36e209133b5f0c853f0ac2f59b6045','10.1192/bjo.2020.12','BackgroundNeurocognitive impairments robustly predict functional outcome. However, heterogeneity in neurocognition is common within diagnostic groups, and data-driven analyses reveal homogeneous neurocognitive subgroups cutting across diagnostic boundaries.AimsTo determine whether data-driven neurocognitive subgroups of young people with emerging mental disorders are associated with 3-year functional course.MethodModel-based cluster analysis was applied to neurocognitive test scores across nine domains from 629 young people accessing mental health clinics. Cluster groups were compared on demographic, clinical and substance-use measures. Mixed-effects models explored associations between cluster-group membership and socio-occupational functioning (using the Social and Occupational Functioning Assessment Scale) over 3 years, adjusted for gender, premorbid IQ, level of├é┬á├éΓÇª','',2020,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'14','BJPsych Open','6','2','','Cambridge University Press','YMH team','Outcome Research',''),(1081,'Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075575815&doi=10.1016%2fj.brat.2019.103527&partnerID=40&md5=68b985517d86e52982b6cff578ba8c5d','10.1016/j.brat.2019.103527','\nThe Ultra-High Risk (UHR) for psychosis group is known to be heterogeneous with diverse outcomes. This study aimed to: 1. Identify subclasses of UHR individuals based on trajectories of symptomatic and functional change over time, 2. Identify predictors of these trajectories.\nA sample of 304 UHR individuals participating in the Neurapro trial were followed over an average of 40 months. All participants received cognitive-behavioural case management (CBCM). Symptomatic and functional profiles were investigated using latent class growth analysis. Multinomial regression was employed to investigate predictors of classes.\nIdentified trajectories showed mostly parallel slopes (i.e. improving symptoms/functioning over time), which were primarily distinct regarding the severity of symptomatology/level of functioning at baseline (i.e. the intercept). Higher symptomatic/lower functioning classes were predicted by higher├é┬á├éΓÇª\n','',2020,NULL,NULL,'2020-01-01',NULL,NULL,NULL,NULL,'14','Behaviour Research and Therapy','124','','103527','Pergamon','Other','',''),(1082,'Associations between polygenic risk for tobacco and alcohol use and liability to tobacco and alcohol use, and psychiatric disorders in an independent sample of 13,999 Australian adults','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074755313&doi=10.1016%2fj.drugalcdep.2019.107704&partnerID=40&md5=83cca8a686f0297ace9c06be60d6c1a6','10.1016/j.drugalcdep.2019.107704','\n\nBackground\nSubstance use, substance use disorders (SUDs), and psychiatric disorders commonly co-occur. Genetic risk common to these complex traits is an important explanation; however, little is known about how polygenic risk for tobacco or alcohol use overlaps the genetic risk for the comorbid SUDs and psychiatric disorders.\n\n\nMethods\nWe constructed polygenic risk scores (PRSs) using GWAS meta-analysis summary statistics from a large discovery sample, GWAS & Sequencing Consortium of Alcohol and Nicotine use (GSCAN), for smoking initiation (SI; N=631,564), age of initiating regular smoking (AI; N=258,251), cigarettes per day (CPD; N=258,999), smoking cessation (SC; N=312,273), and drinks per week (DPW; N=527,402). We then estimated the fixed effect of these PRSs on the liability to 15 phenotypes related to tobacco and alcohol use, substance use disorders, and psychiatric├é┬á├éΓÇª\n\n','',2019,NULL,NULL,'2019-12-01',NULL,NULL,NULL,NULL,'14','Drug and Alcohol Dependence','205','','107704','Elsevier','YMH team','Outcome Research',''),(1083,'Validation and psychometric properties of the Somatic and Psychological HEalth REport (SPHERE) in a young Australian-based population sample using non-parametric item response theory','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85026503168&doi=10.1186%2fs12888-017-1420-1&partnerID=40&md5=5f6163c207861ff660a5d00a19d8b7da','10.1186/s12888-017-1420-1','','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','BMC Psychiatry','','','','BioMed Central Ltd.','YMH team','Outcome Research',''),(1084,'Clinical and cognitive correlates of structural hippocampal change in \"at-risk\" older adults','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84900536681&doi=10.1177%2f0891988713509137&partnerID=40&md5=c0e79ec9f2565fb5b08323e3bc3ffa17','10.1177/0891988713509137','With estimates of dementia expected to rise over the coming decades, there is interest in understanding the factors associated with promoting neuroprotection and limiting neurodegeneration. In this study, we examined the change in the volume of the hippocampus over a 2-month period in 34 older people ├éΓÇ£at risk├éΓÇ¥ of cognitive decline (mean age = 66.8 years, 38% male). Factors that were examined included cognitive reserve, neuropsychological functioning, depression as well as a lifestyle (cognitive training) intervention. The results showed that over a 2-month period, increases in hippocampal size were associated with having higher premorbid intellect, greater occupational attainment, superior memory, and higher levels of functioning. Conversely, depression and disability were associated with decreases in hippocampal volume. Cognitive training was not associated with changes in hippocampal volume. These├é┬á├éΓÇª','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'14','Journal of Geriatric Psychiatry and Neurology','27','2','67-76','SAGE Publications','Other','',''),(1085,'Depression and the law: experiences of Australian barristers and solicitors.','https://search.informit.org/doi/abs/10.3316/agispt.20120262',NULL,'Research findings indicate high levels of depression and psychological distress in solicitors, barristers and law students - discrimination against people with depression in the workplace - lawyers have low levels of confidence in assistance from mental health professionals - role for professional bodies in raising awareness and providing support and treatment.','',2011,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'14','Sydney Law Review','33','4','771-799','',NULL,NULL,NULL),(1086,'Were the budgetary reforms to the better access to mental health care initiative appropriate? - No','https://www.scopus.com/inward/record.uri?eid=2-s2.0-79958812345&doi=10.5694%2fj.1326-5377.2011.tb03112.x&partnerID=40&md5=47d4147ed5bc77783a390a9071b167c8','10.5694/j.1326-5377.2011.tb03112.x','NO The Australian Government had little option but to reform the Better Access to Mental Health Care initiative in the federal Budget. The surprise is their timidity. The changes reduce some of the bureaucracy and waste while promoting more targeted services for those in greatest need.','',2011,NULL,NULL,'2011-06-06',NULL,NULL,NULL,NULL,'14','Medical Journal of Australia','194','11','595','','YMH team','Mental Health System',''),(1087,'Alcohol and the teenage brain: safest to keep them apart','https://drinkwise.org.au/wp-content/uploads/Alcohol_and_the_Teenage_Brain-Safest_to_keep_them_apart-Drinkwise.pdf',NULL,'\nTraditionally, the major components of brain development were believed to occur before birth and in early childhood. Consequently, there has always been a strong view that exposure to alcohol and other substances that are toxic to brain cells should be minimized during these periods. The most recent National Health and Medical Research Council guidelines (2009) have recently significantly reinforced this perspective.\nWith the onset of puberty, most cultures have recognized that individuals move rapidly towards sexual maturity and associated adult responsibilities. Consistent with that major change in social roles, and its associated rites of passage, consumption of alcohol and other substances is encouraged or at least widely tolerated.\n','',2009,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'14','','','','','Brain & Mind Research Institute, University of Sydney',NULL,NULL,NULL),(1088,'Can we track the impact of Australian mental health research?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-27744536716&doi=10.1111%2fj.1440-1614.2005.01631.x&partnerID=40&md5=78ff803d0e2d0f64c032b04f87afdfff','10.1111/j.1440-1614.2005.01631.x','\n Objective: Arguments are being made to increase research and development funding for mental health research in Australia. Consequently, the methods used to measure the results of increased investment require review. This study aimed to describe the status of Australian mental health research and to propose potential methods for tracking changes in research output. Specifically, we describe the research output of nations, Australian states, Australian and New Zealand institutions and Australian and New Zealand researchers using citation rates.  Method: Information on research output was sourced from two international databases (Institute for scientific information [ISI] Essential Science Indicators and ISI Web of Science) and the ISI list of Highly Cited Researchers.  Results: In an international setting, Australia does not perform as well as other comparable countries such as New Zealand or Canada in terms\n','',2005,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'14','Australian and New Zealand Journal of Psychiatry','39','7','591-599','Blackwell Science Pty','YMH team','Mental Health System',''),(1089,'Choosing antidepressant drugs in general practice.','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035408918&partnerID=40&md5=7f3653882e960c68ba7b4e50de55f1c3','','\nBackground:\n  General practitioners provide most of the mental health care to patients with common forms of anxiety or depression. There is a range of mental health therapies available, both pharmacological and nonpharmacological. In order to individualise treatment, practitioners need to consider the range of choices now available.  Objective:\n  To outline reasons for choosing between different antidepressant compounds in different clinical settings. Discussion:\n  Newer antidepressant drugs, especially the selective serotonin reuptake inhibitors, now account for most of the antidepressant prescriptions written. Practitioners may find it useful to differentiate the severity and types of depressive disorders that patients commonly present with. Such differentiation may assist in the selection of appropriate second line choices or alternative first line choices in some situations.  (author abstract)','',2001,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'14','Australian family physician','30','7','663-667','','YMH team','Models of care',''),(1090,'The impact of the organisation of mental health services on the quality of assessment provided to older patients with depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033809114&doi=10.1046%2fj.1440-1614.2000.00805.x&partnerID=40&md5=dd18437d80accb945deedd45948f066b','10.1046/j.1440-1614.2000.00805.x','\n\nObjective: The objective of this study was to examine the impact of the organisation of mental health services on the quality of medical and psychiatric assessment provided to patients with depression over 50 years of age.\n\nMethod: A retrospective clinical audit of 99 patients with primary depressive disorders who were over 50 years of age was used. These patients were assessed initially by specialised psychogeriatric outpatient and community services (44%), community-based adult mental health services (35%) or an inpatient service (21%). At 2ΓÇô3 years follow up, clinical outcomes were rated by treating physicians and included current depression status, cognitive and medical status, course of illness since initial assessment and current living circumstances.\n\nResults: Patients who were assessed by the community-based adult mental health service received the least comprehensive assessment. Although these├é┬á├éΓÇª\n','',2000,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'14','Australian and New Zealand Journal of Psychiatry','34','5','748-754','Sage Publications','YMH team','Mental Health System',''),(1091,'Psychotic Depression: Clinical Definition, Status and the Relevance of Psychomotor','https://books.google.com/books?hl=en&lr=&id=aQYJbOT4PCUC&oi=fnd&pg=PA179&dq=info:QIp02R_vFZUJ:scholar.google.com&ots=SmMIz3PnWC&sig=BbLr1cChoLMEBDA5KMsKUtYoAlQ',NULL,'We will first provide evidence of quite contrasting views about the sub-typing of psychotic (delusional) depression. Next we will report two studies that consider whether it has any specific or over-represented clinical features (examining psychomotor disturbance in particular), and then we will consider its status as a separate entity or a sub-type of some other broader depressive condition. Our two studies were undertaken as components of the CORE I and CORE II studies (reported in Chapter 6); methodological issues are only summarised here.','',1996,NULL,NULL,'1996-03-29',NULL,NULL,NULL,NULL,'14','Melancholia: a disorder of movement and mood: a phenomenological and neurobiological review','','','179','Cambridge University Press',NULL,NULL,NULL),(1092,'Modified CBT for social anxiety and social functioning in young adults with autism spectrum disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101099284&doi=10.1186%2fs13229-021-00418-w&partnerID=40&md5=1089e8bab4da4d8fe93e3cfcf3507ff5','10.1186/s13229-021-00418-w','There is a strong research imperative to investigate effective treatment options for adolescents and adults with autism spectrum disorder (ASD). Elevated social anxiety, difficulties with social functioning and poor mental health have all been identified as core treatment targets for this group. While theoretical models posit a strong bidirectionality between social anxiety and ASD social functioning deficits, few interventions have targeted both domains concurrently. Of the two group interventions previously conducted with adolescents and adults with ASD, significant results have only been observed in either social anxiety or social functioning, and have not generalised to changes in overall mood. The aim of this study was to evaluate the┬ápotential benefit, tolerability and acceptability  of a group cognitive-behaviour therapy (CBT)├é┬áintervention in young adults with ASD. Primary treatment outcomes were social anxiety symptoms and social functioning difficulties; secondary outcomes were self-reported mood and overall distress. Ten groups of participants completed an eight-week, modified  group├é┬áCBT intervention targeting both social anxiety and social functioning, that included social skills training, exposure tasks and behavioural experiment components. Seventy-eight adolescents and young adults with ASD, without intellectual impairment, aged between 16 and 38 (M=22.77; SD=5.31), were recruited from the community, Headspace centres and the Autism Clinic for Translational Research at the Brain and Mind Centre, University of Sydney. Outcomes (social anxiety, social functioning and mood) were measured pre- and post-intervention via├é┬á├éΓÇª','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'13','Molecular Autism','12','1','Jan-15','BioMed Central','Other','',''),(1093,'Mental health: build predictive models to steer policy','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85117025242&doi=10.1038%2fd41586-021-02581-9&partnerID=40&md5=e7f1296336fb98149556f2014f9560a1','10.1038/d41586-021-02581-9','Combine economic, social and medical data to forecast need and design services to address the growing crisis.','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'13','Nature','597','7878','633-636','Nature Publishing Group','YMH team','Mental Health System','Models of care'),(1094,'Naturalistic evaluation of a sport-themed mental health and wellbeing app aimed at men (MindMax), that incorporates applied video games and gamification','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081207920&doi=10.1016%2fj.invent.2020.100306&partnerID=40&md5=8b9342bedf01e532c95eef71fb406447','10.1016/j.invent.2020.100306','\n\nIntroduction\nWhile men display lower help-seeking rates than women, there is a lack of mental health interventions targeting men. To address this issue, we developed a smartphone app named MindMax, an Australian Football League (AFL)-themed app containing psychoeducational modules teaching strategies derived from positive psychology and acceptance and commitment therapy. MindMax also incorporates gamification, casual video games, and social connection and is intended to appeal to male Australians interested in AFL. This study reports results from a naturalistic trial intended to investigate whether using MindMax was associated with improved wellbeing, resilience, and help-seeking intentions.\n\n\nMethods\nWe conducted a naturalistic trial from July 2017 to May 2018, where participants were given access to MindMax to use as they wished, and asked to answer wellbeing surveys at multiple time points\n\n','',2020,NULL,NULL,'2020-04-01',NULL,NULL,NULL,NULL,'13','Internet Interventions','20','','100306','Elsevier','YMH team','Digital health',''),(1095,'Self-reported empathy in adults with autism, early psychosis, and social anxiety disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073148068&doi=10.1016%2fj.psychres.2019.112604&partnerID=40&md5=ff2f253fc718fa199f77cdd5bb2ba6d5','10.1016/j.psychres.2019.112604','The Empathy Quotient (EQ) self-report questionnaire is used to measure empathy in individuals with clinical conditions that have been associated with social impairments. In this study, older teens and adults with autism spectrum disorder (ASD; N=60), early psychosis (EP; N=51) and social anxiety disorder (SAD; N=71) and neurotypical controls (NT; N=26) were compared on the cognitive empathy, emotional reactivity and social skills sub-scales of the Empathy Quotient (EQ) measure. All three clinical groups reported lower cognitive empathy than NT controls, and the ASD group reported lower cognitive empathy than EP and SAD groups. The ASD group reported lower emotional reactivity than the SAD group. All three clinical groups reported lower social skills that NT controls. The poor self-rated empathy for the ASD and EP groups generally reflects previous research that found individuals with these','',2019,NULL,NULL,'2019-11-01',NULL,NULL,NULL,NULL,'13','Psychiatry Research','281','','112604','Elsevier','Other','',''),(1096,'Web-based decision aid tool for disclosure of a mental health condition in the workplace: A randomised controlled trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071013399&doi=10.1136%2foemed-2019-105726&partnerID=40&md5=3fde56f3241fd3b939f55079092e9c73','10.1136/oemed-2019-105726','\nObjectives Making decisions about disclosing a mental illness in the workplace is complicated. Decision aid tools are designed to help an individual make a specific choice. We developed a web-based decision aid to help inform decisions about disclosure for employees. This study aimed to examine the efficacy of this tool.\nMethod We conducted a randomised controlled trial with recruitment, randomisation and data collection all online. Participants had access to the intervention for 2weeks. Assessments occurred at baseline, postintervention and 6weeks├éΓÇÖ follow-up. The primary outcome was decisional conflict. Secondary outcomes were stage and satisfaction of decision-making and mental health symptoms.\nResults 107 adult employees were randomised to READY (n=53) or the control (n=54). The sample was predominantly female (83.2%). Participants using READY showed greater reduction in decisional├é┬á├éΓÇª\n','',2019,NULL,NULL,'2019-09-01',NULL,NULL,NULL,NULL,'13','Occupational and Environmental Medicine','76','9','595-602','BMJ Publishing Group Ltd','Other','',''),(1097,'No gold medals: Assessing AustraliaΓÇÖs international mental health performance','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059609924&doi=10.1177%2f1039856218804335&partnerID=40&md5=48bddcb9912227e474258ae1d6137f54','10.1177/1039856218804335','\nObjective:\nThe objective of this study was to present an assessment of Australia├éΓÇÖs mental health system performance, within its social context, by comparison with other countries.\nMethod:\nA review of existing literature and databases from both Australia and overseas was undertaken. Systems permitting international comparison of mental health and its social context are few. The review is limited in scope.\nResults:\nAlthough Australia was one of the first nations to develop and adopt a national mental health policy (in 1992), the data that are available suggest that we are not World leaders across the identified domains.\nConclusions:\nWhile international benchmarking can play an important role in fostering quality improvement, there are only limited mental health or social system performance data sources to utilise. It would be desirable for a more systematic international process to be established to review existing├é┬á├éΓÇª\n','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'13','Australasian Psychiatry','27','1','36-40','SAGE Publications','YMH team','Mental Health System',''),(1098,'Combining clinical stage and pathophysiological mechanisms to understand illness trajectories in young people with emerging mood and psychotic syndromes','https://research.usc.edu.au/esploro/outputs/journalArticle/Combining-clinical-stage-and-pathophysiological-mechanisms/99450975002621',NULL,'Traditional diagnostic classification systems for mental disorders map poorly onto the early stages of illness experienced by young people, and purport categorical distinctions that are not readily supported by research into genetic, environmental and neurobiological risk factors. Consequently, a key clinical challenge in youth mental health is to develop and test new classification systems that align with current evidence on comorbid presentations, are consistent with current understanding of underlying neurobiology, and provide utility for predicting outcomes and guiding decisions regarding the provision of appropriate and effective care. This chapter outlines a transdiagnostic framework for classifying common adolescent-onset mood and psychotic syndromes, combining two independent but complementary dimensions: clinical staging, and three proposed pathophysiological mechanisms. Clinical staging reflects the progression of mental disorders and is in line with the concept used in general medicine, where more advanced stages are associated with a poorer prognosis and a need for more intensive interventions with a higher risk-to-benefit ratio. The three proposed pathophysiological mechanisms are neurodevelopmental abnormalities, hyperarousal and circadian dysfunction, which, over time, have illness trajectories (or pathways) to psychosis, anxious depression and bipolar spectrum disorders, respectively. The transdiagnostic framework has been evaluated in young people presenting to youth mental health clinics of the University of Sydney\'s Brain and Mind Centre, alongside a range of clinical and objective measures. Our research to├é┬á├éΓÇª','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'13','Medical Journal of Australia','211','Supplement 9','S12-S22','Wiley-Blackwell Publishing Asia',NULL,NULL,NULL),(1099,'Streamlining ethics review for multisite quality and safety initiatives: national bariatric surgery registry experience','https://www.mja.com.au/system/files/issues/205_05/10.5694mja16.00027.pdf',NULL,'\nRigorous methods for assessing and improving the quality of health care have proven difficult to develop by traditional research approaches. 1 Clinical quality registries (CQRs) systematically collect an agreed minimum dataset of data across multiple sites on clinically relevant outcome measures. Data are analysed, comparing procedures, providers and institutions. 2 Feedback to practitioners has been shown to drive performance improvement, especially if the data are perceived to be high quality. 3\nBecause CQRs collect and store health information, protocols require human research ethics committee (HREC) approval to ensure that they comply with the Australian Privacy Act 1988 (Cwlth). Principle 6 of this Act states that stored personal information must not be used or disclosed for a secondary purpose unless patient consent is obtained or there is a permitted health situation. Section 16B of the Act defines the permitted health situations, which include research relevant to public health or public safety. The use or disclosure of personal information must be conducted under guidelines approved under section 95A of the Act. Current National Health and Medical Research Council guidelines state that ethical review is required at each contributing site for CQRs except where multi-institutional approval is in operation. 4\n','',2016,NULL,NULL,'2016-09-05',NULL,NULL,NULL,NULL,'13','Med J Aust','205','5','200-1','',NULL,NULL,NULL),(1100,'Identification and management of depression in Australian primary care and access to specialistmental health care','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878738069&doi=10.1176%2fappi.ps.201200017&partnerID=40&md5=d450549137d7022c486600510fde6038','10.1176/appi.ps.201200017','\nObjective\nThe authors evaluated management of illness, including access to specialist mental health care, among people identified by general practitioners as clinically depressed.\nMethods\nAustralian primary care practitioners recruited in 2009 completed case reports and collected self-report assessments from five to seven consecutively presenting patients whom they identified as having clinical depression.\nResults\nAmong 735 patients with clinical depression, 55% met criteria for major depressive syndrome, 86% reported clinically significant sleep disturbance, and 47% had been depressed for more than 12 months. Most (77%) were prescribed antidepressants, and 30% were prescribed anxiolytics or hypnotics. Patients under shared care with specialist mental health care providers (42%) had more severe, chronic, and recurrent conditions but no demographic advantages.\nConclusions\nDepressed patients of general\n','',2012,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'13','Psychiatric Services','63','12','1247-1251','American Psychiatric Association','Other','',''),(1101,'Guidelines for youth depression: Time to incorporate new perspectives','https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955727894&doi=10.5694%2fj.1326-5377.2010.tb03828.x&partnerID=40&md5=59799477c1927b4957d0a51fd9ec5312','10.5694/j.1326-5377.2010.tb03828.x','Guidelines for youth depression: time to incorporate new perspectives Page 1 MJA ΓÇó Volume \n193 Number 3 ├éΓÇó 2 August 2010 133 EDITORIALS The Medical Journal of Australia ISSN: \n0025729X 2 August 2010 193 3 133-134 ├é┬⌐The Medical Journal of Australia 2010 \nwww.mja.com.au Editorials here are few mental health issues of greater concern to the wider \ncommunity than the management of young people with depressive disorders. Consequently, the \nnew draft clinical practice guidelines from beyondblue: the national depression initiative1 are \ntimely. The previous National Health and Medical Research Council Clinical practice guidelines: \ndepression in young people were produced in 1997 and rescinded in 2004, and a variety of \nother international perspectives are now available.Internationally, the limitations of the clinical \ntrial database, such as small and non-representative or restricted trial samples, and exclusion ├éΓÇª','',2010,NULL,NULL,'2010-08-02',NULL,NULL,NULL,NULL,'13','Medical Journal of Australia','193','9','557','','YMH team','Illness specific areas',''),(1102,'Facilitating early intervention: Experiences of young people and implications for the shaping of headspace services','https://www.scopus.com/inward/record.uri?eid=2-s2.0-77954870380&doi=10.3109%2f10398560903468777&partnerID=40&md5=8e1f8212c5e28a2a4431f79afe0528fe','10.3109/10398560903468777','\n\nObjective: The aim of this study was to gain an understanding of the factors that facilitate entry of young people into the Australian mental health care system with a view to developing headspace service delivery in youth-friendly directions.\n\nMethod: Fifteen semi-structured interviews were conducted with experienced mental health help-seekers in early adulthood.\n\nResults: Social factors involving families, friends and professionals dominated discussions about the initiation and voluntary continuation of mental health care.\n\nConclusions: A range of social interactions combine to facilitate the entry of young people into care. The actions of families and friends are very important for the initiation of care while the cliniciansΓÇÖ modes of communicating with young people are critical in making the experience of care comfortable and worth the perseverance. If genuine service delivery reform is to be achieved, taking account of the├é┬á├éΓÇª\n','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'13','Australasian Psychiatry','18','4','335-339','SAGE Publications','YMH team','Models of care','Mental Health System'),(1103,'The ├éΓÇÿyouth model├éΓÇÖin mental health services','https://journals.sagepub.com/doi/abs/10.1080/10398560801888563',NULL,'','',2008,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'13','','16','2','136-137','SAGE Publications',NULL,NULL,NULL),(1104,'Cognitive behavioural strategies for general practice','https://search.informit.org/doi/abs/10.3316/INFORMIT.375554203513176',NULL,'This is the fourth article in the ?Psychological treatments in general practice? series describing a practical approach to cognitive behavioral strategies (CBS) using patient handouts and worksheets. The CBS approach can be integrated with other behavioural and structured problem solving approaches as part of the overall management of common general practice presentations such as depression, anxiety and somatisation.  (editor abstract)','',2003,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Australian Family Physician','32','11','','',NULL,NULL,NULL),(1105,'Advanced Training in Adult Psychiatry','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036196209&doi=10.1046%2fj.1440-1665.2002.00384.x&partnerID=40&md5=aee7eb56c1afc2d1c644d8d49261c640','10.1046/j.1440-1665.2002.00384.x','\n\nObjectives: To discuss the current and future challenges facing Adult Psychiatry, explore innovative Advanced Training in Adult Psychiatry as a solution to some of these challenges, and promote discussion among interested parties as a precursor to developing a bi-national program of Advanced Training in Adult Psychiatry.\n\nConclusions: Adult Psychiatry is an exciting and rewarding subspecialty with a sound and substantial academic and research base.\n','',2002,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'13','Australasian Psychiatry','10','1','6-Oct','SAGE Publications','YMH team','Mental Health System',''),(1106,'Building a \'National Coalition for People with Depression\'','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033868306&doi=10.1046%2fj.1440-1665.2000.00251.x&partnerID=40&md5=81b5573cb9684700989914c0964b85ba','10.1046/j.1440-1665.2000.00251.x','\n\nObjective: To describe how the current complex and discontinuous mental health systems in Australia fail to provide high quality care for patients with severe affective disorders. To outline how the development of a ├éΓÇÿNational Coalition for People with Depression├éΓÇÖ could result in the delineation of the essential aspects of high quality, long-term and continuous mental health care for these consumers of health services. To highlight the key role of educated and responsible consumers, and eventually the wider community, in determining the future shape of mental health service systems and clinical and health services research.\n\nConclusions: Although in its early stages, the process of developing a ├éΓÇÿNational Coalition for People with Depression├éΓÇÖ has already led to fundamental shifts in attitudes in some mental health services. By focusing on the consumers\' needs for high quality and continuous services, traditional├é┬á├éΓÇª\n','',2000,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'13','Australasian Psychiatry','8','2','125-131','SAGE Publications','YMH team','Mental Health System',''),(1107,'Why are somatoform disorders so poorly recognized and treated','https://books.google.com/books?hl=en&lr=&id=mYM9JvgXxq0C&oi=fnd&pg=PA309&dq=info:zhU-4BK8r9YJ:scholar.google.com&ots=o0lJfzTIdo&sig=fQD_WpXQFvbp_gQszkLV6W4sBRE',NULL,'Although somatic forms of distress are of considerable epidemiological signiWcance, impact adversely on health care utilization, and result in considerable economic, social, and personal burden, they occupy a rather minor place in much clinical psychiatry research and teaching (Hickie, Scott & Davenport, 1998). There is ongoing debate about appropriate nomenclature, the role of genetic, psychosocial, cultural and neurobiological factors in etiology, and the eYcacy of speciWc pharmacological and behavioral interventions (Bass, 1990; Escobar, 1997; Hickie, Hadzi-Pavlovic & Ricci, 1997; Hickie et al., 1998; Kleinman, 1987; Mayou, 1993; Pilowsky, 1991). Despite these diYculties, the most striking feature of many of these disorders in medical settings is their impact on patterns of health care utilization and doctorΓÇôpatient interactions (Clements, Sharpe, Simkin, Borrill & Hawton, 1997; Gureje, Simon, Ustun & Goldberg, 1997; Kroenke et al., 1997). As long as doctors remain ill-informed about the signiWcance of somatoform disorders and appropriate forms of intervention, they will continue to result in high levels of disability. In this chapter the nature of somatization will be explored, the epidemiology described, and research and clinical issues outlined.','',2000,NULL,NULL,'2000-02-13',NULL,NULL,NULL,NULL,'13','Unmet Need in Psychiatry: Problems, Resources, Responses, Andrews G, Henderson S (eds). Cambridge University Press: Cambridge','','','309-323','',NULL,NULL,NULL),(1108,'Clinical and functional characteristics of a subsample of young people presenting for primary mental healthcare at headspace services across Australia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100118363&doi=10.1007%2fs00127-020-02020-6&partnerID=40&md5=5ca20a366afb62bf77129060aed6661d','10.1007/s00127-020-02020-6','                                Purpose                 \nHeadspace services provide treatment options to young people seeking mental healthcare. To obtain a better understanding of needs and characteristics of this population, and effectively evaluate services, we require novel youth-specific outcome measures. As part of our broad research program to establish such measures, a sample of young people were recruited and assessed. The study describes (i) methodology used to obtain clinical, functioning, and substance use characteristics of young people presenting to headspace services; and (ii) an overview of these characteristics.                                               Methods                 Young people presenting to headspace centres were recruited. Multidimensional information was obtained relating to clinical and functional outcomes, demographic information, and lifestyle factors.                                               Results                 1107 young help├é┬á├éΓÇª\n','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'12','Social Psychiatry and Psychiatric Epidemiology','56','7','1311-1323','Springer Berlin Heidelberg','Other','',''),(1109,'Using Staged Care to Provide \"Right Care First Time\" to People With Common Affective Disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85122440766&doi=10.1176%2fappi.ps.721205&partnerID=40&md5=40bd781883abf7ec85ffaa5befb29158','10.1176/appi.ps.721205','An ongoing need exists for innovation in service delivery to ensure that mental health services deliver high-quality treatment and prevention in the population. This Special Article proposes the adoption of ├éΓÇ£staged care├éΓÇ¥ as a population health├éΓÇôoriented service delivery model for packages of specialized services delivered largely in ambulatory care settings for individuals with common affective disorders. Staged care integrates measures of clinical need alongside clinical stage and personal choice to select hierarchically arranged service packages for individuals. Packages then vary according to the intensity, duration, and mix of treatment options. This Special Article describes five levels of care in staged care: self- or family-directed monitoring and management, low-intensity services, moderate-intensity services, high-intensity services, and acute and specialist community mental health services. The care environment├é┬á├éΓÇª','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'12','Psychiatric services (Washington, D.C.)','72','6','691-703','American Psychiatric Association','YMH team','Models of care',''),(1110,'Recommendations for designing health information technologies for mental health drawn from self-determination theory and co-design with culturally diverse populations: Template analysis','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101035577&doi=10.2196%2f23502&partnerID=40&md5=32e31f2ece9a6ae6e6164ffab497f112','10.2196/23502','           Background           Culturally diverse populations (including Aboriginal and Torres Strait Islander people, people of diverse genders and sexualities, and culturally and linguistically diverse people) in nonurban areas face compounded barriers to accessing mental health care. Health information technologies (HITs) show promising potential to overcome these barriers.                             Objective           This study aims to identify how best to improve a mental health and well-being HIT for culturally diverse Australians in nonurban areas.                             Methods           We conducted 10 co-design workshops (N=105 participants) in primary youth mental health services across predominantly nonurban areas of Australia and conducted template analysis on the workshop outputs. Owing to local (including service) demographics, the workshop participants naturalistically reflected culturally diverse groups.                             Results           We identified 4 main themes: control, usability, affirmation, and health service delivery factors. The first 3 themes overlap with the 3 basic needs postulated by self-determination theory (autonomy, competence, and relatedness) and describe participant recommendations on how to design an HIT. The final theme includes barriers to adopting HITs for mental health care and how HITs can be used to support care coordination and delivery. Hence, it describes participant recommendations on how to use an HIT.                             Conclusions           Although culturally diverse groups have specific concerns, their expressed needs fall broadly within the relatively universal design principles identified in this study. The findings of this\n','',2021,NULL,NULL,'2021-02-10',NULL,NULL,NULL,NULL,'12','Journal of Medical Internet Research','23','2','e23502','JMIR Publications Inc., Toronto, Canada','YMH team','Digital health',''),(1111,'Predicting self-harm within six months after initial presentation to youth mental health services: A machine learning study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85098969463&doi=10.1371%2fjournal.pone.0243467&partnerID=40&md5=a8e35955118773e426ba9dec18bbe39e','10.1371/journal.pone.0243467','Background A priority for health services is to reduce self-harm in young people. Predicting self-harm is challenging due to their rarity and complexity, however this does not preclude the utility of prediction models to improve decision-making regarding a service response in terms of more detailed assessments and/or intervention. The aim of this study was to predict self-harm within six-months after initial presentation.   Method The study included 1962 young people (12├éΓÇô30 years) presenting to youth mental health services in Australia. Six machine learning algorithms were trained and tested with ten repeats of ten-fold cross-validation. The net benefit of these models were evaluated using decision curve analysis.   Results Out of 1962 young people, 320 (16%) engaged in self-harm in the six months after first assessment and 1642 (84%) did not. The top 25% of young people as ranked by mean predicted probability accounted for 51.6% - 56.2% of all who engaged in self-harm. By the top 50%, this increased to 82.1%-84.4%. Models demonstrated fair overall prediction (AUROCs; 0.744├éΓÇô0.755) and calibration which indicates that predicted probabilities were close to the true probabilities (brier scores; 0.185├éΓÇô0.196). The net benefit of these models were positive and superior to the ├éΓÇÿtreat everyone├éΓÇÖ strategy. The strongest predictors were (in ranked order); a history of self-harm, age, social and occupational functioning, sex, bipolar disorder, psychosis-like experiences, treatment with antipsychotics, and a history of suicide ideation.   Conclusion Prediction models for self-harm may have utility to identify a large sub population who would benefit from├é┬á├éΓÇª','',2020,NULL,NULL,'2020-12-31',NULL,NULL,NULL,NULL,'12','PLoS ONE','15','12','e0243467','Public Library of Science','YMH team','Digital health','Outcome Research'),(1112,'The Science of Complex Systems Is Needed to Ameliorate the Impacts of COVID-19 on Mental Health','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85097442973&doi=10.3389%2ffpsyt.2020.606035&partnerID=40&md5=d7d716193a8a0f7b16a7063d4fbb22b2','10.3389/fpsyt.2020.606035','To assist with proactive and effective responses to the global COVID-19 crisis, the scientific community has been rapidly deploying our most advanced analytic tools to model the dynamics of disease transmission based on existing (albeit imperfect) knowledge, data, and available human and material resources. The multifactorial, multilevel influences on transmission dynamics and the disease├éΓÇÖs pervasive impact at the individual, community, and global levels have required the use of the analytic techniques of complex systems science, namely, systems modeling and simulation, to forecast the trajectory of the disease under different conditions, to quantify uncertainty, and to inform effective responses (1├éΓÇô3). These methods have been deployed by infectious disease epidemiologists for over a century (4), maturing into a robust interdisciplinary field intersecting mathematics, computational epidemiology, ecology, evolutionary biology, immunology, behavioral science, and public health (5). As a result, there have been numerous advances that have informed policies to control infectious diseases, facilitate epidemic and bioterrorism preparedness, and provide governments with critical tools for managing complexity and weighing alternative responses in the midst of the confusion of an evolving crisis (6├éΓÇô14). The field├éΓÇÖs commitment to achieving rapid response capability in the face of changing conditions has led to advances in rapid assessment of the impact of the pandemic, and data assimilation methods that combine theory with empirical observations in a continuous knowledge feedback process facilitating continuous hypothesis development, testing├é┬á├éΓÇª','',2020,NULL,NULL,'2020-11-25',NULL,NULL,NULL,NULL,'12','Frontiers in Psychiatry','11','','606035','Frontiers Media SA','YMH team','Mental Health System',''),(1113,'Subjective cognitive functioning in relation to changes in levels of depression and anxiety in youth over 3 months of treatment','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85107557862&doi=10.1192%2fbjo.2020.68&partnerID=40&md5=6067e7fb9181014b42fcf2c4959b05e4','10.1192/bjo.2020.68','BackgroundSubjective cognitive difficulties are common in mental illness and have a negative impact on role functioning. Little is understood about subjective cognition and the longitudinal relationship with depression and anxiety symptoms in young people.AimsTo examine the relationship between changes in levels of depression and anxiety and changes in subjective cognitive functioning over 3 months in help-seeking youth.MethodThis was a cohort study of 656 youth aged 12├éΓÇô25 years attending Australian headspace primary mental health services. Subjective changes in cognitive functioning (rated as better, same, worse) reported after 3 months of treatment was assessed using the Neuropsychological Symptom Self-Report. Multivariate multinomial logistic regression analysis was conducted to evaluate the impact of baseline levels of and changes in depression (nine-item Patient Health Questionnaire; PHQ9├é┬á├éΓÇª','',2020,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'12','BJPsych Open','6','5','','Cambridge University Press','Other','',''),(1114,'Genetic and environmental risk factors in the non-medical use of over-the-counter or prescribed analgesics, and their relationship to major classes of licit and illicit substance use and misuse in a population-based sample of young adult twins','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070824638&doi=10.1111%2fadd.14750&partnerID=40&md5=bfa2ab1832af05ea7f26c7a566d91daf','10.1111/add.14750','  Background and Aims The non-medical use of over-the-counter or prescribed analgesics (NMUA) is a significant public health problem. Little is known about the genetic and environmental etiology of NMUA and how these risks relate to other classes of substance use and misuse. Our aims were to estimate the heritability NMUA and sources of genetic and environmental covariance with cannabis and nicotine use, cannabis and alcohol use disorders and nicotine dependence in Australian twins.   Design Biometrical genetic analyses or twin methods using structural equation univariate and multivariate modeling.   Setting Australia.   Participants A total of 2007 young adult twins [66% female; ┬╡age├é┬á=├é┬á25.9, standard deviation (SD)├é┬á=├é┬á3.6, range├é┬á=├é┬á18├éΓÇô38] from the Brisbane Longitudinal Twin Study retrospectively assessed between 2009 and 2016.   Measurements Self-reported NMUA (non-opioid or opioid-based), life├é┬á├éΓÇª\n','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'12','Addiction','114','12','2229-2240','','Other','',''),(1115,'The impact of reducing psychiatric beds on suicide rates','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85069753681&doi=10.3389%2ffpsyt.2019.00448&partnerID=40&md5=8066837caf720ad36217578ba412156d','10.3389/fpsyt.2019.00448','There has been ongoing debate regarding the impact of reductions in psychiatric beds on suicide rates, and the potential effect of reallocation of acute hospital funding to community-based mental health programs and services. Computer simulation offers significant value in advancing such debate by providing a robust platform for exploring strategic resource allocation scenarios before they are implemented in the real world. We report an application that demonstrates a threshold effect of cuts to psychiatric beds on suicide rates and the role of context specific variations in population, behavioral, and service use dynamics in determining where that threshold lies. Findings have important implications for regional decision-making regarding resource allocation for suicide prevention.','',2019,NULL,NULL,'2019-07-02',NULL,NULL,NULL,NULL,'12','Frontiers in Psychiatry','10','','448','Frontiers Media SA','YMH team','Mental Health System','Illness specific areas'),(1116,'A data-driven transdiagnostic analysis of white matter integrity in young adults with major psychiatric disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053033381&doi=10.1016%2fj.pnpbp.2018.08.032&partnerID=40&md5=23fe98db3cad1b12e87ce005bd85a71c','10.1016/j.pnpbp.2018.08.032','Diffusion tensor imaging (DTI) has been utilized to index white matter (WM) integrity in the major psychiatric disorders. However, the findings within and across such disorders have been mixed. Given this, transdiagnostic sampling with data-driven statistical approaches may lead to new and better insights about the clinical and functional factors associated with WM abnormalities. Thus, we undertook a cross-sectional DTI study of 401 young adult (18ΓÇô30years old) outpatients with a major psychiatric (depressive, bipolar, psychotic, or anxiety) disorder and 61 healthy controls. Participants also completed self-report questionnaires and underwent neuropsychological assessment. Fractional anisotropy (FA) as well as axial (AD) and radial (RD) diffusivity was determined via a whole brain voxel-wise approach (tract-based spatial statistics). Hierarchical cluster analysis was performed on FA scores in patients only├é┬á├éΓÇª','',2019,NULL,NULL,'2019-03-08',NULL,NULL,NULL,NULL,'12','Progress in Neuro-Psychopharmacology and Biological Psychiatry','89','','73-83','Elsevier','YMH team','Neurobiology',''),(1117,'Reduced heart rate variability in a treatment-seeking early psychosis sample','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052474544&doi=10.1016%2fj.psychres.2018.08.068&partnerID=40&md5=62984e777b2edb3ae5e4388a4827733e','10.1016/j.psychres.2018.08.068','Reduced cardiac autonomic function is associated with increased risk of cardiovascular disease (CVD), with heart rate variability (HRV) providing an accessible index of cardiac autonomic function. HRV may provide a candidate physiological mechanism linking reduced cardiac autonomic function to increased risk for CVD in schizophrenia illness. This study examines whether HRV is also reduced in a community sample of treatment-seeking participants experiencing early psychosis (n=48) compared to healthy volunteers (n=48) and social anxiety control groups (n=48) matched by gender and age. HRV was assessed during a five-minute interbeat interval recording at rest. Participants also completed self-report psychiatric symptom measures. Early psychosis participants showed significant reductions in HRV compared to social anxiety and healthy control groups. Reductions in HRV were also observed','',2018,NULL,NULL,'2018-11-01',NULL,NULL,NULL,NULL,'12','Psychiatry Research','269','','293-300','Elsevier','YMH team','Neurobiology',''),(1118,'The relationship between depression and cognitive function in adults with cardiovascular risk: Evidence from a randomised attention-controlled trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052862382&doi=10.1371%2fjournal.pone.0203343&partnerID=40&md5=7672bceda15ca37736b5fb9dd69f5d93','10.1371/journal.pone.0203343','Background and aim This study assessed the association between depressive symptom severity and cognition in middle-to-older aged adults with mild-to-moderate depression and cardiovascular risk factors using an online test battery (CogState) and whether changes in depressive symptoms over 3 months were associated with changes in cognition.   Methods Participants (mean age = 57.8) with cardiovascular risk and mildΓÇôto-moderate depressive symptoms completed measures of psychomotor speed, learning, and executive function prior to (n = 445)_and after (n = 334) online depression or attention control interventions. The symptom severity-cognition relationship was examined both cross-sectionally and prospectively.   Results Participants exhibited significantly reduced psychomotor speed and variable impairments on measures of learning and executive functioning relative to normative data. However, there was no association of depression severity with cognition at baseline or of change in depressive symptoms with change in cognitive performance.   Limitations Participants were well-educated, which may have protected against cognitive decline. Attrition may limit generalisability, though is unlikely to explain the lack of association between depression symptoms and cognition.   Conclusions Adults with comorbid mild-to-moderate depressive symptoms and cardiovascular risks performed less well than age-matched normative data on three online cognitive tests; however, we were unable to show any symptom-cognition association cross-sectionally or longitudinally, despite significant improvements in depressive symptoms. This├é┬á├éΓÇª','',2018,NULL,NULL,'2018-09-05',NULL,NULL,NULL,NULL,'12','PLoS ONE','13','9','e0203343','Public Library of Science','YMH team','Outcome Research',''),(1119,'Pathways to depression by age 16 years: Examining trajectories for self-reported psychological and somatic phenotypes across adolescence','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041595924&doi=10.1016%2fj.jad.2017.12.007&partnerID=40&md5=4ec949d3ec716fa5bb053693044d2a0a','10.1016/j.jad.2017.12.007','\n\nBackground\nSex differences in rates of depression emerge during adolescence. However, it is unclear whether symptom patterns and trajectories differ significantly according to gender in youth. Barriers to research include the fact that most self-report tools are weighted towards psychological rather than somatic symptoms.\n\n\nMethods\nData were collected on symptoms of depression in about 1800 individuals at ages 12, 14 and 16 years. Odds ratios and 95% confidence intervals were used to examine the trajectory of psychological and somatic phenotypes and self-reported depression caseness over time.\n\n\nResults\nAt age 12, 24% of participants met criteria for self-reported depression caseness. Although there was only a small incremental increase in the prevalence over time (about 5%), 57% of participants met criteria for self-reported depression caseness at least once. Generic symptoms at age 12 were associated with\n\n','',2018,NULL,NULL,'2018-04-01',NULL,NULL,NULL,NULL,'12','Journal of Affective Disorders','230','','1-Jun','Elsevier','YMH team','Illness specific areas','Outcome Research'),(1120,'Improved prediction of chronological age from DNA methylation limits it as a biomarker of ageing','https://www.biorxiv.org/content/10.1101/327890.abstract',NULL,' DNA methylation is associated with age. The deviation of age predicted from DNA methylation from actual age has been proposed as a biomarker for ageing. However, a better prediction of chronological age implies less opportunity for biological age. Here we used 13,661 samples (from blood and saliva) in the age range of 2 to 104 years from 14 cohorts measured on Illumina HumanMethylation450/EPIC arrays to perform prediction analyses. We show that increasing the sample size achieves a smaller prediction error and higher correlations in test datasets. We demonstrate that smaller prediction errors provide a limit to how much variation in biological ageing can be captured by methylation and provide evidence that age predictors from small samples are prone to confounding by cell composition. Our predictor shows a similar or better performance in non-blood tissues including saliva, endometrium, breast, liver, adipose and muscle, compared with Horvath├éΓÇÖs across-tissue age predictor.\n','',2018,NULL,NULL,'2018-01-01',NULL,NULL,NULL,NULL,'12','bioRxiv','','','327890','Cold Spring Harbor Laboratory',NULL,NULL,NULL),(1121,'Quantifying the effect of body mass index, age, and depression severity on 24-h activity patterns in persons with a lifetime history of affective disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84986593126&doi=10.1186%2fs12888-016-1023-2&partnerID=40&md5=983f4b2732c0428c720437073965d4ce','10.1186/s12888-016-1023-2','Patients with affective disorders of different ages have been found to present weight changes and different circadian activity patterns. This study assessed the effects of age, Body Mass Index (BMI) and depression severity on the activity-rest cycle in persons with affective disorders using a novel multifactorial 24-h analysis method. Two hundred and thirty-six participants aged between 14 and 85├é┬áyears underwent 5 to 22├é┬ádays of actigraphy monitoring (mean duration=14├é┬ádays). BMI was also recorded and symptom severity was assessed with the Hamilton Depression Rating Scale (HDRS). Participants were divided into two groups: healthy controls (n=68) and participants with a lifetime diagnosis of affective disorders (n=168). First, the multiple regression method was employed to formulate the circadian activity pattern in term of the factors age, BMI and HDRS. For each group, the functional linear analysis├é┬á├éΓÇª','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'12','BMC Psychiatry','16','1','1-Nov','BioMed Central','YMH team','Outcome Research',''),(1122,'Moderator Assistant: A Natural Language Generation-Based Intervention to Support Mental Health via Social Media','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84949988418&doi=10.1080%2f15228835.2015.1105768&partnerID=40&md5=0d086e64bf61e2b43c8c104c0d5d73ed','10.1080/15228835.2015.1105768','As online mental health support groups become increasingly popular, they require more support from volunteers and trained moderators who help their users through ΓÇ£interventions├éΓÇ¥ (i.e., responding to questions and providing support). We present a system that supports such human interventions using Natural Language Generation (NLG) techniques. The system generates draft responses aimed at reducing moderators├éΓÇÖ workload, and improving their efficacy. NLG and human interventions were compared through the ratings of 35 psychology interns. The NLG-based system was capable of generating messages that are grammatically correct with clear language. The system needs improvement, however, moderators can already use it as draft responses.','',2015,NULL,NULL,'2015-10-02',NULL,NULL,NULL,NULL,'12','Journal of Technology in Human Services','33','4','304-329','Routledge','YMH team','Digital health',''),(1123,'Contrast Effects and Sex Influence Maternal and Self-Report Dimensional Measures of Attention-Deficit Hyperactivity Disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84920757448&doi=10.1007%2fs10519-014-9670-x&partnerID=40&md5=7e3e6277a8c0c78a785605b05451c054','10.1007/s10519-014-9670-x','               The heritability of attention-deficit/hyperactivity disorder (ADHD) is higher for children than adults. This may be due to increasing importance of environment in symptom variation, measurement inaccuracy when two raters report behavior of a twin-pair, a contrast effect resulting from parental comparison of siblings and/or dimensionality of measures. We examine rater contrast and sex effects in ADHD subtypes using a dimensional scale and compare the aetiology of self, versus maternal-report. Data were collected using the Strengths and Weaknesses of ADHD and Normal Behaviour Scale (SWAN): maternal-report for 3,223 twins and siblings (mean age 21.2, SD┬á=├é┬á6.3) and self-report for 1,617 twins and siblings (mean age 25.5, SD├é┬á=├é┬á3.2). Contrast effects and magnitude of genetic and environmental contributions to variance of ADHD phenotypes (inattention, hyperactivity-impulsivity, combined behaviours├é┬á├éΓÇª\n','',2015,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'12','Behavior Genetics','45','1','35-50','Springer US','Other','',''),(1124,'Should the legal age for alcohol purchase be raised to 21?','http://www.mja.com.au/journal/2014/200/10/should-legal-age-alcohol-purchase-be-raised-21',NULL,'Harmful alcohol consumption is a prevention priority in Australia. Frequent or episodic binge drinking (consuming five or more standard drinks on a single occasion) is of specific concern among youth because of their neurobiological vulnerability to the effects of alcohol. There is increasing evidence that key aspects of brain and related neurocognitive development continue into early adulthood. Available evidence associates short-and longer-term cognitive impairment during the postpubertal and early adult years with an earlier age-of-onset of harmful alcohol consumption. 1 Although ethical limitations preclude human experimental trials, there is emerging neuropsychological and brain-imaging evidence associating binge drinking or persistent high levels of alcohol use with adverse impacts on brain development (notably of the frontal lobe and frontalΓÇôstriatal circuits) in young people. 1 The ways in which such├é┬á├éΓÇª','',2014,NULL,NULL,'2014-06-02',NULL,NULL,NULL,NULL,'12','The Medical Journal of Australia','200','10','568-570','',NULL,NULL,NULL),(1125,'The NEURAPRO (North America, Europe, Australia Prodrome) Study: a multicenter RCT of treatment strategies for symptomatic patients at ultra-high risk for progression to├é┬á├éΓÇª','https://www.infona.pl/resource/bwmeta1.element.elsevier-cd2004a1-98bc-36e5-8093-ee21dfcc57da',NULL,'THE NEURAPRO (NORTH AMERICA, EUROPE, AUSTRALIA PRODROME) STUDY: A \nMULTICENTER RCT OF TREATMENT STRATEGIES FOR SYMPTOMATIC PATIENTS AT \nULTRA-HIGH RISK FOR PROGRESSION TO SCHIZOPHRENIA AND RELATED \nDISORDERS. DESIGN AND STUDY PLAN ├âΓÇö Close The Infona portal uses cookies, ie \nstrings of text saved by a browser on the user\'s device. The portal can access those files \nand use them to remember the user\'s data, such as their chosen settings (screen view, \ninterface language, etc.), or their login data. By using the Infona portal the user accepts \nautomatic saving and using this information for portal operation purposes. More information \non the subject can be found in the Privacy Policy and Terms of Service. By closing this \nwindow the user confirms that they have read the information on cookie usage, and they \naccept the privacy policy and the way cookies are ├éΓÇª','',2008,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'12','Schizophrenia Research','1','102','155','',NULL,NULL,NULL),(1126,'Structured problem solving in general practice. 3.','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0642365076&partnerID=40&md5=60ae1fd753e83e3c4f681776847a72f4','','','',2003,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'12','Australian family physician','32','10','836-842','','YMH team','Models of care','Mental Health System'),(1127,'Providing psychological treatments in general practice. Rationale and practicalities.','https://www.scopus.com/inward/record.uri?eid=2-s2.0-1542541447&partnerID=40&md5=15577c46e8d5ab2edec868ad7549693d','','Providing psychological treatments in general practice. Rationale and practicalities. - \nAbstract - Europe PMC Sign in or create an account https://orcid.org Europe PMC Menu \nAbout Tools Developers Help Contact us Helpdesk Feedback Twitter Blog Tech blog \nDeveloper Forum Europe PMC plus Search worldwide, life-sciences literature Search \nAdvanced Search Recent history Saved searches Abstract Citations & impact Providing \npsychological treatments in general practice. Rationale and practicalities. Blashki G, \nParsons J, Morgan H, Hickie IB, Davenport TA Author information Affiliations All authors 1. \nDepartment of General Practice, Monash University, Victoria. Grant.Blashki@med.monash.edu.au \nAustralian Family Physician, 01 Aug 2003, 32(8):625-630 PMID: 12973871 Review Share \nthis article Share with emailShare with twitterShare with linkedinΓÇª','',2003,NULL,NULL,'2003-08-01',NULL,NULL,NULL,NULL,'12','Australian family physician','32','8','625-630','','YMH team','Models of care',''),(1128,'Comparison of clinician rated and family corroborative witness data for depressed patients','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026517743&doi=10.1016%2f0165-0327%2892%2990057-D&partnerID=40&md5=4f6803915153859ae259288c143a576c','10.1016/0165-0327(92)90057-D','There appear to be few published studies that have examined the levels of agreement between ratings of features of depression as assessed by clinicians and by corroborative witnesses. We therefore report a study of 141 depressed patients assessed by a clinical psychiatrist at a semi-structured interview, reviewing family and historical data as well as depressive symptoms, and rated on a series of designated mental state signs. A family member completed questionnaire data assessing the same features. Moderate agreement was obtained only for several historical items (e.g., previous depressive episode, response to ECT). Agreement was minimal or non-existent on numerous clinical symptoms and signs of depression. A number of sources of disagreement are considered, and it is suggested that discordance may have emerged principally from the contrasting domains and training experiences of the clinicians','',1992,NULL,NULL,'1992-01-01',NULL,NULL,NULL,NULL,'12','Journal of Affective Disorders','24','1','25-34','Elsevier','Other','',''),(1129,'Brain correlates of suicide attempt in 18,925 participants across 18 international cohorts','https://www.sciencedirect.com/science/article/pii/S0006322321011744',NULL,'\n\nBackground\nNeuroimaging studies of suicidal behavior have so far been conducted in small samples, prone to biases and false-positive associations, yielding inconsistent results. The ENIGMA-MDD Working Group aims to address the issues of poor replicability and comparability by coordinating harmonized analyses across neuroimaging studies of major depressive disorder and related phenotypes, including suicidal behavior.\n\n\nMethods\nHere, we pooled data from 18 international cohorts with neuroimaging and clinical measurements in 18,925 participants (12,477 healthy control subjects and 6448 people with depression, of whom 694 had attempted suicide). We compared regional cortical thickness and surface area and measures of subcortical, lateral ventricular, and intracranial volumes between suicide attempters, clinical control subjects (nonattempters with depression), and healthy control subjects.\n\n\nResults\nWe├é┬á├éΓÇª\n\n','',2021,NULL,NULL,'2021-08-15',NULL,NULL,NULL,NULL,'11','Biological psychiatry','90','4','243-252','Elsevier',NULL,NULL,NULL),(1130,'Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomes','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076863599&doi=10.1016%2fj.schres.2019.11.047&partnerID=40&md5=9c614111e0ddfce6ef28963847186d91','10.1016/j.schres.2019.11.047','There has been limited research into the predictive value of basic symptoms and their relationship with other psychopathology in patients identified using the ├éΓÇÿultra high risk├éΓÇÖ (UHR) for psychosis approach. The current study investigated whether basic symptoms, specifically cognitive disturbances (COGDIS), were associated with a greater risk of transition to psychotic disorder and persistent attenuated psychotic symptoms (APS) at medium term follow-up (mean├é┬á=├é┬á3.4├é┬áyears) in UHR patients, as well as with general psychopathology at baseline. The sample included 304 UHR participants (mean age├é┬á=├é┬á19.12├é┬áyears) involved in an international multicenter trial of omega-3 fatty acids. UHR individuals who also met the COGDIS criteria (basic symptoms risk criteria) did not have a greater risk of transition than those who met the UHR criteria alone. However, meeting COGDIS risk criteria was associated with a greater├é┬á├éΓÇª','',2020,NULL,NULL,'2020-02-01',NULL,NULL,NULL,NULL,'11','Schizophrenia Research','216','','255-261','Elsevier','Other','',''),(1131,'The Australian genetics of depression study: Study description and sample characteristics','https://www.biorxiv.org/content/10.1101/626762.abstract',NULL,' Objectives Depression is the most common psychiatric disorder and the largest contributor to global disability. The Australian Genetics of Depression study was established to recruit a large cohort of individuals who have been diagnosed with depression, and to investigate genetic and environmental risk factors for depression and response to commonly prescribed antidepressants. This paper describes the recruitment and characteristics of the sample.\nMethods Participants completed an online questionnaire that consisted of a compulsory module that assessed self-reported psychiatric history, clinical depression using the Composite Interview Diagnostic Interview Short Form, and experiences of using commonly prescribed antidepressants. Further voluntary modules assessed a wide range of traits of relevance to psychopathology. Participants who reported they were willing to provide a DNA sample were sent a saliva kit in the mail.\nResults A total of 20,689 participants, 75% of whom were female, enrolled in the study. The average age of participants was 43 years ├é┬▒ 15 years. 15,807 participants (76% of the participant group) returned saliva kits. The overwhelming majority of participants reported being given a diagnosis of depression by a medical practitioner and 88% met the criteria for a depressive episode. Rates of comorbidity with other psychiatric disorders were high. Two-thirds of the sample reported having taken more than one type of antidepressant during treatment for their depression.\nConclusions This study was effective in recruiting a large community sample of people with a history of clinical depression, highlighting the willingness of├é┬á├éΓÇª\n','',2019,NULL,NULL,'2019-01-01',NULL,NULL,NULL,NULL,'11','bioRxiv','','','626762','Cold Spring Harbor Laboratory',NULL,NULL,NULL),(1132,'Elderly care recipientsΓÇÖ perceptions of treatment helpfulness for depression and the relationship with help-seeking','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84921718892&doi=10.2147%2fCIA.S70086&partnerID=40&md5=d844cad99e14f88e7f7b7264d1f55b50','10.2147/CIA.S70086','\nObjective\nThis study aims to examine perceptions of the helpfulness of treatments/interventions for depression held by elderly care recipients, to examine whether these beliefs are related to help-seeking and whether the experience of depression affects beliefs about treatment seeking, and to identify the characteristics of help-seekers.\nMethod\nOne hundred eighteen aged care recipients were surveyed on their beliefs about the helpfulness of a variety of treatments/interventions for depression, on their actual help-seeking behaviors, and on their experience of depression (current and past).\nResults\nFrom the sample, 32.4% of the participants screened positive for depression on the Geriatric Depression Scale, and of these, 24.2% reported receiving treatment. Respondents believed the most helpful treatments for depression were increasing physical activity, counseling, and antidepressant medication. Help-seeking from├é┬á├éΓÇª\n','',2015,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'11','Clinical Interventions in Aging','10','','287','Dove Press','Other','',''),(1133,'The effects of acute arginine vasopressin administration on social cognition in healthy males','https://downloads.hindawi.com/archive/2013/386306.pdf',NULL,'The structurally similar neuropeptides and hormones oxytocin (OT) and arginine vasopressin (AVP) play significant and complex roles in modulating a range of social behaviours, including social recognition and bond formation. Although OT has well-known roles in facilitating prosocial behaviors and enhancing emotion recognition, AVP has received increasing interest for diverging effects on social cognition behaviour most notably in males. The current study aimed to determine whether AVP also modulates the ability to understand emotion. Using a randomised double blind procedure, 45 healthy young males received either an AVP or placebo nasal spray and completed the Reading the Mind in the Eyes Test (RMET). In contrast to previous findings, there were no significant differences observed in performance on the RMET between AVP and placebo groups, even after examining items separated by task difficulty, emotional valence, and gender. This study provides diverging evidence from previous findings and adds to the growing body of research exploring the influence of neuropeptide hormones in social behaviour. It demonstrates that in this sample of participants, AVP does not enhance the ability to understand higher order emotion from others. Implications and suggestions for future AVP administration studies are discussed.','',2013,NULL,NULL,'2013-05-19',NULL,NULL,NULL,NULL,'11','Journal of Hormones','2013','','','Hindawi',NULL,NULL,NULL),(1134,'Magnetic resonance imaging in primary and secondary depression','https://scholar.google.com/scholar?cluster=3781416732563359238&hl=en&oi=scholarr',NULL,'','',1996,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'11','Melancholia: a disorder of movement and mood','','','252-266','Cambridge University Press New York',NULL,NULL,NULL),(1135,'Growth hormone and other hormonal responses to clonidine in melancholic and nonmelancholic depressed subjects and controls','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025884420&doi=10.1016%2f0165-1781%2891%2990074-Y&partnerID=40&md5=a78a705dad75ffbbdadf5cfacc5d685c','10.1016/0165-1781(91)90074-Y','To study putative differences in central neurotransmitter function in depressive subtypes, growth hormone, adrenocorticotropic hormone (ACTH), cortisol, and prolactin responses to the a2-noradrenergic receptor agonist clonidine (1.3 ┬╡/kg i.v.) were examined in 26 subjects with major depression, 13 of whom had melancholia. The responses of 10 of these endogenous/melancholic subjects were compared with those of 10 controls who were matched to the patients on age, sex, and menopausal status. In 15 of the depressed subjects, prolactin and cortisol responses to the putative serotonergic agonist fenfluramine were also examined to test for associations between these challenges. There were no significant differences in any of the responses between melancholic and nonmelancholic depressive subgroups after controlling for age and sex. With the exception of a greater reduction in ACTH in the endogenous├é┬á├éΓÇª','',1991,NULL,NULL,'1991-05-01',NULL,NULL,NULL,NULL,'11','Psychiatry Research','37','2','179-193','Elsevier','Other','',''),(1136,'Federal and state cooperation necessary but not sufficient for effective regional mental health systems: insights from systems modelling and simulation','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85107007921&doi=10.1038%2fs41598-021-90762-x&partnerID=40&md5=8090c42867f891194d1947e6aa96fdb2','10.1038/s41598-021-90762-x','For more than a decade, suicide rates in Australia have shown no improvement despite significant investment in reforms to support regionally driven initiatives. Further recommended reforms by the Productivity Commission call for Federal and State and Territory Government funding for mental health to be pooled and new Regional Commissioning Authorities established to take responsibility for efficient and effective allocation of ΓÇÿtaxpayer money.├éΓÇÖ This study explores the sufficiency of this recommendation in preventing ongoing policy resistance. A system dynamics model of pathways between psychological distress, the mental health care system, suicidal behaviour and their drivers was developed, tested, and validated for a large, geographically diverse region of New South Wales; the Hunter New England and Central Coast Primary Health Network (PHN). Multi-objective optimisation was used to explore potential├é┬á├éΓÇª','',2021,NULL,NULL,'2021-05-27',NULL,NULL,NULL,NULL,'10','Scientific Reports','11','1','1-Dec','Nature Publishing Group','YMH team','Mental Health System','Mental Health System'),(1137,'Can youth at high risk of illness progression be identified by measures of rumination and sleep-wake disturbance','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85057817387&doi=10.1111%2feip.12757&partnerID=40&md5=d2b49bfe039d3261611c486cfc7371cd','10.1111/eip.12757',' Aim Clinical staging models offer a useful framework for understanding illness trajectories, where individuals are located on a continuum of illness progression from stage 0 (at-risk but asymptomatic) to stage 4 (end-stage disease). Importantly, clinical staging allows investigation of risk factors for illness progression with the potential to target trans-diagnostic mechanisms at an early stage, especially in help-seeking youth who often present with sub-threshold syndromes. While depressive symptoms, rumination and sleep-wake disturbances may worsen syndrome outcomes, the role of these related phenomena has yet to be examined as risk factors for trans-diagnostic illness progression in at-risk youth.   Methods This study is a prospective follow-up of 248 individuals aged 12 to 25 years presenting to headspace services with sub-threshold syndromes (stage 1) classified under the clinical staging model to├é┬á├éΓÇª\n','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'10','Early Intervention in Psychiatry','13','5','1214-1219','Wiley Publishing Asia Pty Ltd','YMH team','Outcome Research','illness specific areas'),(1138,'Multidimensional outcomes in youth mental health care: what matters and why?','https://research.usc.edu.au/esploro/outputs/journalArticle/Multidimensional-outcomes-in-youth-mental-health/99450976402621',NULL,'Mood and psychotic syndromes present one of the most serious public health challenges that we face in the 21st century. Factors including prevalence, age of onset, and chronicity contribute to substantial burden and secondary risks such as alcohol or other substance misuse. Mood and psychotic syndromes most often emerge during adolescence and young adulthood, a period characterised by major physical and social change; thus, effects can have long term consequences. We propose five key domains which make up a multidimensional outcomes framework that aims to address the specific needs of young people presenting to health services with emerging mental illness. These include social and occupational function; self-harm, suicidal thoughts and behaviours; alcohol or other substance misuse; physical health; and illness type, stage and trajectory. Impairment and concurrent morbidity are well established in young people by the time they present for mental health care. Despite this, services and health professionals tend to focus on only one aspect of the presentation-illness type, stage and trajectory-and are often at odds with the preferences of young people and their families. There is a need to address the disconnect between mental health, physical health and social services and interventions, to ensure that youth mental health care focuses on the outcomes that matter to young people.','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'10','Medical Journal of Australia','211','Supplement 9','S4-S11','Wiley-Blackwell Publishing Asia',NULL,NULL,NULL),(1139,'Distress and sleep quality in young amphetamine-type stimulant users with an affective or psychotic illness','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042177055&doi=10.1016%2fj.psychres.2018.02.033&partnerID=40&md5=62a20c434b13a8197900ac2c99ad5526','10.1016/j.psychres.2018.02.033','Misuse of amphetamine-type stimulant (ATS) drugs may disrupt key neurodevelopmental processes in young people and confer protracted neurocognitive and psychopathological harm. ATS users with a co-occurring psychiatric illness are typically excluded from research, reducing generalisability of findings. Accordingly, we conducted a cross-sectional examination of key clinical, sleep, socio-occupational and neurocognitive measures in current, past and never users of ATS drugs who were accessing a youth mental health service (headspace) for affective- or psychotic-spectrum illnesses. Contrary to hypotheses, groups did not differ in psychotic symptomology, socio-occupational functioning or neurocognitive performance. Current ATS users were however significantly more distressed and reported poorer subjective sleep quality and greater subjective sleep disturbances than never users, with a trend toward','',2018,NULL,NULL,'2018-04-01',NULL,NULL,NULL,NULL,'10','Psychiatry Research','262','','254-261','Elsevier','YMH team','Illness specific areas',''),(1140,'Time to implement national mental health reform','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930161102&doi=10.5694%2fmja15.00490&partnerID=40&md5=944a91ee4dccd990f7a63d59a931af8c','10.5694/mja15.00490','\nAt the halfway point of its first term, the Abbott Government has finally released the 700-page report of the National Review of Mental Health Programmes and Services, Contributing lives, thriving communities. 1 Fulfilling a 2013 election commitment, Health Minister Dutton had requested the National Mental Health Commission (NMHC) to recommend specific actions that the federal government could take to directly improve the lives of those affected by mental health problems, as well as to enhance programs for preventing suicide. The terms of reference of the review were restricted to considering how existing resources could be better deployed rather than making requests for new funding.\nThe NMHC recruited experts to inform its recommendations, and received more than 2000 submissions. It recognised that the Commonwealth already spends $9.6 billion on mental health each year, largely through five direct health or welfare programs (most notably, the disability support pension), but found that our ΓÇ£patchwork of services, programmes and systems├éΓÇª are not maximising the best outcomes from either a social or economic perspective├éΓÇ¥(page 13). 1\n','',2015,NULL,NULL,'2015-06-01',NULL,NULL,NULL,NULL,'10','Medical Journal of Australia','202','10','515-517','','YMH team','Mental Health System',''),(1141,'Development and evaluation of an Internet-based program to improve the mental health and wellbeing of young men','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84938225693&doi=10.1108%2fITSE-05-2014-0009&partnerID=40&md5=3f2aac21e38e6e792a0f9f36fc520752','10.1108/ITSE-05-2014-0009','               Purpose                ΓÇô This paper aims to describe the development of WorkOut, an Internet-based program designed to help young men overcome the barriers towards help-seeking and to build the skills they need to understand and manage their own mental health. Information and communication technologies (ICT) hold great potential to significantly improve mental health outcomes for hard-to-reach and traditionally underserved groups. Internet-based programs and mobile phone applications may be particularly appealing to young men due to their convenience, accessibility and privacy and they also address the strong desire for independence and autonomy held by most men.                                        Design/methodology/approach                ├éΓÇô In this paper, we describe the design process itself, and the strategies used for multi-disciplinary collaboration. The initial evaluation process and results are also├é┬á├éΓÇª\n','',2015,NULL,NULL,'2015-04-20',NULL,NULL,NULL,NULL,'10','Interactive Technology and Smart Education','12','1','Feb-13','Emerald Group Publishing Limited','YMH team','Digital health',''),(1142,'Room for improvement: Mixed portrayal of young people with mental illness on Australian television news','https://www.scopus.com/inward/record.uri?eid=2-s2.0-77649112151&doi=10.3109%2f00048670903487183&partnerID=40&md5=5b56ad176890e60ccdda007baf2711c5','10.3109/00048670903487183','\n\nObjective: The aim of the present study was to review television news depiction of mental illness in children and adolescents to test the hypothesis that positive portrayals of adults with mental illness also apply to young people.\n\nMethods: Content and frame analysis of first-person depictions and overall news angle was carried out to determine whether depictions were positive, neutral or negative.\n\nResults: The media portrayal of young people with mental illnesses was mixed. Overall, 10 items (29%) of news angles were positive, 13 items (37%) neutral and nine items (26%) negative. Positive themes were significantly less frequent for young people compared to adults (10 items, 29% compared to 151 items, 66%), and negative themes were more frequent (nine items, 26% vs 21 items, 9%). First-person depictions, however, were similar for young people and adults (24 items, 69% vs 150 items, 66%). An anti-medication\n','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'10','Australian and New Zealand Journal of Psychiatry','44','3','267-272','Sage Publications','Other','',''),(1143,'Surveying perceptions of the progress of national mental health reform','https://www.scopus.com/inward/record.uri?eid=2-s2.0-4043135995&doi=10.1111%2fj.1039-8562.2004.02082.x&partnerID=40&md5=8d5f5ef3c61d5e51aad01088542eddd0','10.1111/j.1039-8562.2004.02082.x','\n\nObjective: To provide comment on the latest Australian government commitment to a 5 year plan under the National Mental Health Strategy.\n\nConclusions: In the absence of a credible system of accountability for the implementation of mental health reform, the Mental Health Council of Australia, in association with the Brain and Mind Research Institute, has taken up the task of auditing. A national, government-supported system needs to be developed in order to monitor progress of genuine mental health reform in Australia.\n','',2004,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'10','Australasian Psychiatry','12','2','123-125','SAGE Publications','YMH team','Mental Health System',''),(1144,'Behavioural modification strategies for general practice.','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0142150070&partnerID=40&md5=b8dada3f36a50be9ac39c1d1286c4307','','This second article in the \'Psychological treatments in general practice\'  series describes a number of behavioural modification strategies and provides patient handouts for use in general practice. (editor abstract)','',2003,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'10','Australian family physician','32','9','','','YMH team','Models of care','Mental Health System'),(1145,'Anorexia nervosa presenting in a prepubertal boy','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024562480&doi=10.5694%2fj.1326-5377.1989.tb136399.x&partnerID=40&md5=5887e900f58e06fb24803ad222c1a582','10.5694/j.1326-5377.1989.tb136399.x','A case of anorexia nervosa that presented in a prepubertal boy is reported. It seemed that particular maternal attitudes towards dieting, paternal criticism of the boy\'s body shape and size, and severe family disruption were the major factors in the aetiology of this disorder. If such attitudes to food intake and body size and shape and major family disruptions become more prevalent in the community, then one might expect to see an increase in the prevalence of this serious disorder in younger children, which results in serious physical and psychological sequelae.','',1989,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'10','Medical Journal of Australia','150','3','155-158','','YMH team','Illness specific areas',''),(1146,'Social inclusion, intersectionality, and profiles of vulnerable groups of young people seeking mental health support','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85107461352&doi=10.1007%2fs00127-021-02123-8&partnerID=40&md5=68bfb76b91145298e94e9459b9d0c522','10.1007/s00127-021-02123-8','                            Background               \nheadspace centres provide enhanced primary mental healthcare for young people. A priority is to provide services for all young people irrespective of a range of social disadvantages or social exclusion. The aims of this study were to: (i) delineate extent of social inclusion across domains of housing, studying/employment, functioning, alcohol, and other drug use; and (ii) map profiles of young people deemed vulnerable to experiencing additional barriers to accessing services based on their social inclusion domains (e.g., those living in unstable housing, not in employment/education, and/or experiencing intersecting or multiple forms of disadvantage or difficulties), including detailing their clinical characteristics.                                         Methods               Young people were recruited from five headspace centres. Data relevant to social inclusion were examined. Multivariate logistic├é┬á├éΓÇª\n','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'2','Social Psychiatry and Psychiatric Epidemiology','57','2','245-254','Springer Berlin Heidelberg','Other','',''),(1147,'Optimising the integration of technology-enabled solutions to enhance primary mental health care: a service mapping study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099474765&doi=10.1186%2fs12913-021-06069-0&partnerID=40&md5=2fa97d559f06fa896de54483fca4fb5f','10.1186/s12913-021-06069-0','Despite the widely acknowledged potential for health information technologies to improve the accessibility, quality and clinical safety of mental health care, implementation of such technologies in services is frequently unsuccessful due to varying consumer, health professional, and service-level factors. The objective of this co-design study was to use process mapping (i.e. service mapping) to illustrate the current consumer journey through primary mental health services, identify barriers to and facilitators of quality mental health care, and highlight potential points at which to integrate the technology-enabled solution to optimise the provision of care based on key service performance indicators. Interactive, discussion-based workshops of up to six hours were conducted with representative stakeholders from each participating service, including health professionals, service managers and administrators from Open','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'9','BMC Health Services Research','21','1','1-Dec','BioMed Central','YMH team','Digital health',''),(1148,'Prevalence of self-reported subthreshold phenotypes of major mental disorders and their association with functional impairment, treatment and full-threshold syndromes in a community-residing cohort of young adults','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079367729&doi=10.1111%2feip.12942&partnerID=40&md5=657d13c688b98393b6e3c181b3a03420','10.1111/eip.12942','  Aim Subthreshold syndromes (STS) frequently precede the onset of full-threshold syndromes (FTS) of the corresponding mental disorder (homotypic continuity). This study examines whether subthreshold conditions are comorbid and whether there is heterotypic continuity also between STS and FTS.   Methods Data were extracted from the Brisbane ΓÇ£19Up├éΓÇ¥ cohort study of twins and siblings (N = 1838; 56% female) on individuals who (i) completed self-report ratings of depression-like (DLE), hypomanic-like (HMLE) and psychotic-like experiences (PLE) and (ii) were assessed for mood and psychotic FTS using the Composite International Diagnostic Interview (CIDI). Associations between STS and FTS were estimated using adjusted prevalence ratios (APR) and 95% confidence intervals (CI).   Results STS are prevalent, with 22% reporting DLE, 14% HMLE and 5% PLE; 7% reported >1 STS, with PLE most likely to├é┬á├éΓÇª\n','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'9','Early Intervention in Psychiatry','15','2','306-313','Wiley Publishing Asia Pty Ltd','YMH team','Outcome Research',''),(1149,'Stakeholder perspectives on evidence for digital mental health interventions: Implications for accreditation systems','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073251343&doi=10.1177%2f2055207619878069&partnerID=40&md5=e6d09abd3ee2495af0aacd361b431d77','10.1177/2055207619878069','\nBackground\nDigital mental health interventions can be effective for treating mental health problems, but uptake by consumers and clinicians is not optimal. The lack of an accreditation pathway for digital mental health interventions is a barrier to their uptake among clinicians and consumers. However, there are a number of factors that may contribute to whether a digital intervention is suitable for recommendation to the public. The aim of this study was to identify the types of evidence that would support the accreditation of digital interventions.\nMethod\nAn expert workshop was convened, including researcher, clinician, consumer (people with lived experience of a mental health condition) and policymaker representatives.\nResults\nExisting methods for assessing the evidence for digital mental health interventions were discussed by the stakeholders present at the workshop. Empirical evidence from randomised controlled├é┬á├éΓÇª\n','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'9','Digital Health','5','','2.06E+15','Sage Publications','Other','',''),(1150,'What is the prevalence, and what are the clinical correlates, of insulin resistance in young people presenting for mental health care? A cross-sectional study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066628218&doi=10.1136%2fbmjopen-2018-025674&partnerID=40&md5=9d29a338f3459e7a8c469c4dc88fc359','10.1136/bmjopen-2018-025674','\nObjectives To report the distribution and predictors of insulin resistance (IR) in young people presenting to primary care-based mental health services.\nDesign Cross-sectional.\nSetting Headspace-linked clinics operated by the Brain and Mind Centre of the University of Sydney.\nParticipants 768 young people (66% female, mean age 19.7├é┬▒3.5, range 12├éΓÇô30 years).\nMain outcome measures IR was estimated using the updated homeostatic model assessment (HOMA2-IR). Height and weight were collected from direct measurement or self-report for body mass index (BMI).\nResults For BMI, 20.6% of the cohort were overweight and 10.2% were obese. However, <1% had an abnormally high fasting blood glucose (>6.9mmol/L). By contrast, 9.9% had a HOMA2-IR score >2.0 (suggesting development of IR) and 11.7% (n=90) had a score between 1.5 and 2. Further, there was a positive correlation between BMI and HOMA2├é┬á├éΓÇª\n','',2019,NULL,NULL,'2019-05-01',NULL,NULL,NULL,NULL,'9','BMJ Open','9','5','e025674','British Medical Journal Publishing Group','YMH team','Outcome Research',''),(1151,'A Neuroethics Framework for the Australian Brain Initiative','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060517082&doi=10.1016%2fj.neuron.2019.01.004&partnerID=40&md5=e18302063231eeb573b6e42b9d2952ab','10.1016/j.neuron.2019.01.004','Neuroethics is central to the Australian Brain Initiative├éΓÇÖs aim to sustain a thriving and responsible neurotechnology industry. Diverse and inclusive community and stakeholder engagement and a trans-disciplinary approach to neuroethics will be key to the success of the Australian Brain Initiative.','',2019,NULL,NULL,'2019-02-06',NULL,NULL,NULL,NULL,'9','Neuron','101','3','365-369','Cell Press','Other','',''),(1152,'Lower in vivo myo-inositol in the anterior cingulate cortex correlates with delayed melatonin rhythms in young persons with depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021195202&doi=10.3389%2ffnins.2017.00336&partnerID=40&md5=0dde51337d640e187eaedf4e1955a80f','10.3389/fnins.2017.00336','','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Frontiers in Neuroscience','','','','Frontiers Research Foundation','YMH team','Neurobiology','illness specific areas'),(1153,'Putting mental health services and suicide prevention reform into practice','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019465974&doi=10.17061%2fphrp2721710&partnerID=40&md5=62400d76205df2914232016b204ad7aa','10.17061/phrp2721710','\nAs recently highlighted by Nutbeam and Milat4, the process of public policy development and, more specifically, the move from theory to action involve a complex interplay between what is scientifically plausible, politically acceptable and practical to implement. The recommendations of the NMHC were developed after considering all three of these factors. The NMHC review has become the template for action led by the Australian Government, emphasising the key concepts of personalised care options, regionalisation of mental health services and suicide prevention, adoption of new technologies and systematic evaluation to drive future investments. 2\nThe NMHC review made bold and specific recommendations, including shifting the expenditure curve from acute, hospital-based and late-intervention health and disability services to initiatives focused on prevention, early intervention and recovery. Sadly, the most controversial element├ûΓÇ£Reallocate a minimum of $1 billion in Commonwealth acute hospital funding in the forward estimates over the 5 years from 2017ΓÇô18 into more community-based psychosocial, primary and community health services├éΓÇ¥(recommendation 7)├éΓÇôwas rejected immediately by former health minister Sussan Ley just before a national health ministers├éΓÇÖ meeting with key state and territory├éΓÇôbased colleagues. Despite this political setback, the need to invest more in noninstitutional settings remains high on the national reform agenda.\n','',2017,NULL,NULL,'2017-04-27',NULL,NULL,NULL,NULL,'9','Public Health Research and Practice','27','2','e2721710','','YMH team','Mental Health System',''),(1154,'The Sleep Or Mood Novel Adjunctive therapy (SOMNA) trial: A study protocol for a randomised controlled trial evaluating an internet-delivered cognitive behavioural therapy program for insomnia on outcomes of standard treatment for depression in men','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84924159315&doi=10.1186%2fs12888-015-0397-x&partnerID=40&md5=27047da1a2c9e4e3f0f2eaf4ea016b43','10.1186/s12888-015-0397-x','Insomnia is a significant risk factor for depression onset, can result in more disabling depressive illness, and is a common residual symptom following treatment cessation that can increase the risk of relapse. Internet-based cognitive behavioural therapy for insomnia has demonstrated efficacy and acceptability to men who are less likely than women to seek help in standard care. We aim to evaluate whether internet delivered cognitive behavioural therapy for insomnia as an adjunct to a standard depression therapeutic plan can lead to improved mood outcomes. Male participants aged 50┬áyears or more, meeting Diagnostic and Statistical Manual of Mental Disorders criteria for current Major Depressive Episode and/or Dysthymia and self-reported insomnia symptoms, will be screened to participate in a single-centre double-blind randomised controlled trial with two parallel groups involving adjunctive internet-delivered cognitive behavioural therapy for insomnia and an internet-based control program. The trial will consist of a nine-week insomnia intervention period with a six-month follow-up period. During the insomnia intervention period participants will have their depression management coordinated by a psychiatrist using standard guideline-based depression treatments. The study will be conducted in urban New South Wales, Australia, where 80 participants from primary and secondary care and direct from the local community will be recruited. The primary outcome is change in the severity of depressive symptoms from baseline to week 12. This study will provide evidence on whether a widely accessible, evidence-based, internet-delivered├é┬á├éΓÇª','',2015,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'9','BMC Psychiatry','15','1','1-Dec','BioMed Central','Other','',''),(1155,'Alcohol use and mismatch negativity in young patients with psychotic disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-80855144230&doi=10.1097%2fWNR.0b013e32834cdc3f&partnerID=40&md5=16fca7aaa200f7dc0078777dc48995be','10.1097/WNR.0b013e32834cdc3f','Mismatch negativity (MMN) is a neurophysiological indicator of the brainΓÇÖs ability to extract relevant information from an irrelevant background. MMN has been described as a reliable biomarker of schizophrenia and more recently it has found to be impaired in the early stages of psychosis. In addition, drugs (including alcohol) that block glutamate├éΓÇÖs N-methyl-D-aspartate receptor have been shown to reduce MMN. This study aims to determine whether risky alcohol consumption in young patients with psychotic disorder further impacts or changes their MMN response. Patients with high-alcohol use were found to show reduced temporal MMN amplitudes compared with patients with low-alcohol use and controls. In contrast, early psychosis patients with low-alcohol use showed reduced fronto-central MMN amplitudes compared with controls; whereas patients with high-alcohol use showed an intermediate response at├é┬á├éΓÇª','',2011,NULL,NULL,'2011-12-07',NULL,NULL,NULL,NULL,'9','NeuroReport','22','17','918-922','LWW','YMH team','Illness specific areas',''),(1156,'Evidence into practice: The mental health hurdle is high','https://www.scopus.com/inward/record.uri?eid=2-s2.0-33745448528&doi=10.5694%2fj.1326-5377.2006.tb00375.x&partnerID=40&md5=b25f62b10128004f8a04d8fd44357e30','10.5694/j.1326-5377.2006.tb00375.x','A comment on this article appears in\" Evidence into practice: the mental health hurdle is high.\" Med J Aust. 2006 Sep 4; 185 (5): 295. A comment on this article appears in\" Evidence into practice: the mental health hurdle is high.\" Med J Aust. 2006 Sep 4; 185 (5): 295. This is a comment on\" The management of bipolar disorder in general practice.\" Med J Aust. 2006 Jun 5; 184 (11): 566-70.','',2006,NULL,NULL,'2006-06-01',NULL,NULL,NULL,NULL,'9','Medical Journal of Australia','184','11','542-543','','YMH team','Mental Health System','Models of care'),(1157,'Enhancing the evidence base for clinical psychiatry: Are practice surveys a useful tool?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033588850&doi=10.5694%2fj.1326-5377.1999.tb123667.x&partnerID=40&md5=c6b2efabe2732d58a7ba9f5c04ad27c3','10.5694/j.1326-5377.1999.tb123667.x','Clinical practice guidelines for psychiatry are now being developed, but important deficits in the evidence base are apparent. For many of the new treatments, clinical decisions can be idiosyncratic or based on limited knowledge. There is a need not only to perform properly constructed trials, but also to make immediate use of less rigorous forms of evidence, such as clinical practice surveys. An example is a recent survey of psychiatrists\' use of antidepressant drugs. Such surveys are now part of a wider movement towards a more coordinated system of practice-based outcome assessment.','',1999,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'9','Medical Journal of Australia','171','6','315-318','','YMH team','Models of care',''),(1158,'Utilising molecular biological and histopathological techniques to study the dopaminergic system in patients with melancholia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030946150&doi=10.3109%2f00048679709073796&partnerID=40&md5=5a28c10de23662853845f75a62da81e4','10.3109/00048679709073796','\nObjective: To describe the rationale for investigating the dopaminergic system in patients with melancholia by applying molecular biological (notably, in situ hybridisation) and histopathological techniques in postmortem brain tissue.\nMethod: Relevant advances in the functional neuroanatomy of frontostriatal circuits, as well as insights from clinical neuroimaging studies in primary and secondary depressive disorders, are presented. These are integrated with developments in the pharmacological and molecular characteristics of dopamine receptor subtypes and recognition of their selective anatomical distribution.\nResults: Converging data from the basic and clinical neurosciences suggest that the pathophysiology of depressive disorders characterised by psychomotor phenomena, such as melancholia, may involve dysregulation of dopaminergic mechanisms within complex frontostriatal circuits.\nConclusions: The key\n','',1997,NULL,NULL,'1997-01-01',NULL,NULL,NULL,NULL,'9','Australian and New Zealand Journal of Psychiatry','31','1','27-35','Taylor & Francis','Other','Neurobiology',''),(1159,'Chronic fatigue syndrome','https://scholar.google.com/scholar?cluster=11198797582200782993&hl=en&oi=scholarr',NULL,'','',1993,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'9','','','','','Pathology Education Committee',NULL,NULL,NULL),(1160,'Polygenic risk scores derived from varying definitions of depression and risk of depression','https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2783096',NULL,'\nImportance\nGenetic studies with broad definitions of depression may not capture genetic risk specific to major depressive disorder (MDD), raising questions about how depression should be operationalized in future genetic studies.\nObjective\nTo use a large, well-phenotyped single study of MDD to investigate how different definitions of depression used in genetic studies are associated with estimation of MDD and phenotypes of MDD, using polygenic risk scores (PRSs).\nDesign, Setting, and Participants\nIn this case-control polygenic risk score analysis, patients meeting diagnostic criteria for a diagnosis of MDD were drawn from the Australian Genetics of Depression Study, a cross-sectional, population-based study of depression, and controls and patients with self-reported depression were drawn from QSkin, a population-based cohort study. Data analyzed herein were collected before September 2018, and data├é┬á├éΓÇª\n','',2020,NULL,NULL,'2021-10-01',NULL,NULL,NULL,NULL,'3','JAMA psychiatry','78','10','1152-1160','American Medical Association',NULL,NULL,NULL),(1161,'Heart Rate Variability in Children With Autism Spectrum Disorder and Associations With Medication and Symptom Severity','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85096746180&doi=10.1002%2faur.2437&partnerID=40&md5=b0cc44c32311814dcebe7a48d71737e1','10.1002/aur.2437',' Abstract Decreased heart rate variability (HRV) is considered a common marker of autonomic dysfunction that contributes to poor health outcomes. While some studies have suggested that children with autism spectrum disorder (ASD) show reduced HRV, research is yet to consider whether this may be associated with medication use and symptom severity. This study examined the relationship between resting state HRV, medication use and symptom severity in children diagnosed with ASD. Children with ASD (N = 86), aged between 3 and 12years (M = 8.09), were compared to 44 neurotypical children of similar age (M = 7.15). Laboratory assessment of HRV involved 5min of non-invasive baseline electrocardiogram assessments while participants viewed an age-appropriate non-verbal animated video. Time-domain and frequency-domain HRV measures were analyzed. ASD symptom severity was assessed├é┬á├éΓÇª\n','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'8','Autism Research','14','1','75-85','John Wiley & Sons, Inc.','Other','',''),(1162,'Awareness of headspace youth mental health service centres across Australian communities between 2008 and 2015','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068208676&doi=10.1080%2f09638237.2019.1630718&partnerID=40&md5=163ac70ed970d8a7958a20100fc94081','10.1080/09638237.2019.1630718','\n\nBackground: Two common barriers to help-seeking are lack of awareness of appropriate services, and low mental health literacy. The headspace awareness campaigns are designed to address these factors.\n\nAims: To examine whether distance from a headspace centre affects community awareness of headspace, and whether general awareness of headspace changed between 2008 and 2015.\n\nMethod: Responses from 4707 participants aged 12ΓÇô25years, collected in 2008 and 2015, were analysed. The effect of headspace centre location on awareness of services was assessed by comparing awareness between those living in headspace areas (within 20km of a centre) and those who were not. Change in awareness between 2008 and 2015 was assessed.\n\nResults: Awareness of headspace and its services was significantly greater among those living in headspace areas than among those living further away├é┬á├éΓÇª\n','',2020,NULL,NULL,'2020-07-03',NULL,NULL,NULL,NULL,'8','Journal of Mental Health','29','4','410-417','Routledge','YMH team','Mental Health System',''),(1163,'The prognostic significance of attenuated psychotic symptoms in help-seeking youth','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073211768&doi=10.1016%2fj.schres.2019.10.016&partnerID=40&md5=c6ba06ca84be4a7425ca6b6c21eb16c0','10.1016/j.schres.2019.10.016','\n\nBackground\nRecent findings suggest that attenuated psychotic symptoms (APS) might serve as a risk factor for general mental health impairment in help-seeking youth. The current study was designed to test this possibility by examining the prognostic significance of APS in a large cohort of help-seeking youth not selected for psychosis risk.\n\n\nMethod\n465 youth aged 12ΓÇô25 referred to general youth mental health services were grouped as either APS├é┬á+├é┬áor APS- based on whether or not they met ├éΓÇÿultra high risk├éΓÇÖ for psychosis APS risk criteria as assessed using the Comprehensive Assessment of At Risk Mental States (CAARMS). They completed clinical assessments at baseline and at 12-month follow-up, measuring a range of psychopathology (depression, anxiety, eating disorders, general psychological distress, substance abuse) and psychosocial functioning.\n\n\nResults\nAPS├é┬á+├é┬áhad significantly poorer outcomes at 12├é┬á├éΓÇª\n\n','',2020,NULL,NULL,'2020-01-01',NULL,NULL,NULL,NULL,'8','Schizophrenia Research','215','','277-283','Elsevier','Other','',''),(1164,'Early intervention, prevention, and prediction in mood disorders: Tracking multidimensional outcomes in young people presenting for mental health care','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074524996&doi=10.1016%2fB978-0-12-813176-3.00005-5&partnerID=40&md5=4fcb7be532bc891766d7a928e6487f88','10.1016/B978-0-12-813176-3.00005-5','Personalized Psychiatry presents the first book to explore this novel field of biological psychiatry that covers both basic science research and its translational applications. The book conceptualizes personalized psychiatry and provides state-of-the-art knowledge on biological and neuroscience methodologies, all while integrating clinical phenomenology relevant to personalized psychiatry and discussing important principles and potential models. It is essential reading for advanced students and neuroscience and psychiatry researchers who are investigating the prevention and treatment of mental disorders.[Book Synopsis]','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'4','Personalized Psychiatry','','','39-62','Academic Press','YMH team','Outcome Research','Models of care'),(1165,'Contribution of individual psychological and psychosocial factors to symptom severity and time-to-recovery after naturally-occurring acute infective illness: The Dubbo Infection Outcomes Study (DIOS)','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070058182&doi=10.1016%2fj.bbi.2019.07.034&partnerID=40&md5=20c4633ec8157d5f1d15b9bd391689c5','10.1016/j.bbi.2019.07.034','\n\nBackground\nSubstantial heterogeneity exists in both the severity of symptoms experienced as part of the sickness response to naturally-occurring infections, and the time taken for individuals to recover from these symptoms. Although contributing immunological and genetic factors have been previously been explored, less is known about the role of individual psychological and psychosocial factors, which may modulate the host immune response, or contribute independently, to symptom severity and duration.\n\n\nMethods\nLongitudinally-collected data from 484 Caucasian participants (mean age: 33.5years; 51% women) experiencing a naturally-occurring acute infective illness enrolled in the prospective Dubbo Infection Outcome Study (DIOS) were analysed. At intake and subsequent follow-up assessments, self-report questionnaires were used to ascertain individual psychological and psychosocial characteristics and├é┬á├éΓÇª\n\n','',2019,NULL,NULL,'2019-11-01',NULL,NULL,NULL,NULL,'8','Brain, Behavior, and Immunity','82','','76-83','Academic Press','Other','',''),(1166,'Augmenting online mental health support services','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018613262&doi=10.4018%2f978-1-5225-0778-9.ch013&partnerID=40&md5=33425c306e6bc6d67a3cfd9c25c96b88','10.4018/978-1-5225-0778-9.ch013','The Internet allows mental health organisations to provide services to more people via new models of care. Amongst these, online support groups are becoming increasingly popular. This model of mental health service provision includes moderators who read posts, recognise those that need attention and provide support via online responses. However, as these groups become more popular they risk becoming more difficult to manage due to the sheer volume of posts. This challenge can be addressed through computational linguistics techniques. This chapter reports on work with a mental health organisation on three components to help scale up the number of people they can support. The design aims to go beyond helping end-users and explores how design can support the wellbeing of the moderators themselves. The design of the three components is discussed: 1) A triage component automatically detects','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'8','Gaming and Technology Addiction: Breakthroughs in Research and Practice','','','264-285','IGI Global','Other','Digital health',''),(1167,'Being well in the law: A guide for lawyers','https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2861586',NULL,'Being Well in the Law is a toolkit for lawyers. It has been well informed by the input of experts from the Australian National University and Sydney University, as well as a range of other experts. It draws heavily on multidisciplinary knowledge embracing mindfulness and meditation, and evokes ideas to help us switch off from other thoughts and focus only on the moment, helping to alleviate anxiety.','',2016,NULL,NULL,'2016-11-03',NULL,NULL,NULL,NULL,'8','Being Well in the Law (2016) The Law Society of New South Wales','','','','',NULL,NULL,NULL),(1168,'The N-methyl-d-aspartate receptor as a neurobiological intersection between bipolar disorder and alcohol use: A longitudinal mismatch negativity study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937694634&doi=10.1093%2fijnp%2fpyu113&partnerID=40&md5=22c38ae229579c2974f9e93274728e9c','10.1093/ijnp/pyu113','                    Background:           Comorbid risky alcohol use in bipolar disorder (BD) is recognized for its high prevalence and clinical relevance, though understanding of its neurobiological underpinning is limited. The N-methyl-D-aspartate (NMDA) receptor has recognized alterations in BD and is a major site of ethanolΓÇÖs effects in the brain. The present study aimed to examine the NMDA receptor system in adolescents and young adults with BD by evaluating the longitudinal changes in a robust marker of NMDA function, mismatch negativity (MMN), in relation to changes in alcohol use patterns.                             Methods:           Forty-six BD patients (aged 16├éΓÇô30) were recruited at baseline and 59% (n = 27) returned for follow-up 17.9 +/- 7.3 months later. At both time-points a two-tone, passive, duration-deviant MMN paradigm was conducted and alcohol measures were collected. Pearson├éΓÇÖs correlations were performed├é┬á├éΓÇª\n','',2015,NULL,NULL,'2015-04-01',NULL,NULL,NULL,NULL,'8','International Journal of Neuropsychopharmacology','18','6','','Oxford University Press','Other','Neurobiology',''),(1169,'Emotional processing, P50 sensory gating, and social functioning in bipolar disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84927794850&doi=10.1177%2f1550059414523417&partnerID=40&md5=a02fcef8591af36983feefffd55c9553','10.1177/1550059414523417','Emotional processing has been reported to effect sensory gating as measured by the event-related potential known as P50. Because both P50 and emotional processing are dysfunctional in bipolar disorder (BD), we sought to investigate the impact that concurrent emotional processing has on sensory gating in this psychiatric population. P50 was recorded using a paired-click paradigm. Peak-to-peak amplitudes for stimulus 1 (S1) and stimulus 2 (S2) were acquired during the presentation of disgust and neutral faces to young adults with BD (n = 19) and controls (n = 20). Social functioning and quality-of-life self-reported measures were also obtained. The BD group had significantly larger P50 amplitudes elicited by the S2-disgust response compared with controls, but no significant difference in overall P50 sensory gating was found between the groups. There were also no differences between groups in S1-disgust','',2015,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'8','Clinical EEG and Neuroscience','46','2','81-87','SAGE Publications','Other','',''),(1170,'Short association fibres of the insula-temporoparietal junction in early psychosis: A diffusion tensor imaging study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84911934884&doi=10.1371%2fjournal.pone.0112842&partnerID=40&md5=88839a617f00e369b6c2d16cbccb978e','10.1371/journal.pone.0112842','Evidence shows that there are reductions in gray matter volume (GMV) and changes in long association white matter fibres within the left insula-temporoparietal junction (TPJ) during the early stages of psychotic disorders but less is known about short association fibres (sAFs). In this study we sought to characterise the changes in sAFs and associated volumetric changes of the left insula-TPJ during the early stages of psychosis. Magnetic resonance imaging was obtained from a sample of young people with psychosis (n = 42) and healthy controls (n = 45), and cortical parcellations of the left insula-TPJ were used as seeding masks to reconstruct 13 sAFs. Compared to healthy counterparts, the psychosis group showed significant reductions in fractional anisotropy (FA) in the sAFs connecting the superior (STG) and middle temporal gyri (MTG) and as well as reduced GMV within the inferior temporal gyrus and increased white matter volume (WMV) within Heschl\'s gyrus (HG). Furthermore, adolescent-onset psychosis subjects (onset 18 year or earlier) showed FA reductions in the STG-HG sAF when compared to adult-onset subjects, but this was not associated with changes in GMV nor WMV of the STG or HG. These findings suggest that during the early stages of psychosis, changes in sAFs and associated cortical GMV and WMV appear to occur independently, however age of onset of a psychotic syndrome/disorder influences the pattern of neuroanatomical abnormalities.','',2014,NULL,NULL,'2014-11-18',NULL,NULL,NULL,NULL,'8','PLoS ONE','9','11','e112842','Public Library of Science','YMH team','Neurobiology','illness specific areas'),(1171,'Should the legal age for buying alcohol be raised to 21 years?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84904470266&doi=10.5694%2fmja13.10465&partnerID=40&md5=4c61b538dbcb351905047542468296ba','10.5694/mja13.10465','Harmful alcohol consumption is a prevention priority in Australia. Frequent or episodic binge drinking (consuming five or more standard drinks on a single occasion) is of specific concern among youth because of their neurobiological vulnerability to the effects of alcohol. There is increasing evidence that key aspects of brain and related neurocognitive development continue into early adulthood. Available evidence associates short-and longer-term cognitive impairment during the postpubertal and early adult years with an earlier age-of-onset of harmful alcohol consumption. 1 Although ethical limitations preclude human experimental trials, there is emerging neuropsychological and brain-imaging evidence associating binge drinking or persistent high levels of alcohol use with adverse impacts on brain development (notably of the frontal lobe and frontalΓÇôstriatal circuits) in young people. 1 The ways in which such harms may accumulate are increasingly considered within a developmental framework that seeks to identify pathways to alcohol-induced brain impairment. 1 This pathway-based approach emphasises the potential benefits that may result from earlier modification of patterns of excessive alcohol use. A delay in the age of exposure to the toxic effects of alcohol may be of particular benefit to those who are vulnerable due to neurodevelopmental delays. 1 The need to introduce effective alcohol control policies targeting the youth population is indicated by recent increases in alcohol-attributable hospitalisations and emergency department attendances. The need for change is further evident in the normalisation of harmful alcohol behaviour in├é┬á├éΓÇª','',2014,NULL,NULL,'2014-11-17',NULL,NULL,NULL,NULL,'8','Medical Journal of Australia','200','','568-570','','Other','',''),(1172,'Comparing factor, class, and mixture models of cannabis initiation and DSM cannabis use disorder criteria, including craving, in the Brisbane longitudinal twin study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896920047&doi=10.1017%2fthg.2014.9&partnerID=40&md5=06dd65c962c92ff4747b77eecb8eae6c','10.1017/thg.2014.9','Accumulating evidence suggests that the Diagnostic and Statistical Manual of Mental Disorders (DSM) diagnostic criteria for cannabis abuse and dependence are best represented by a single underlying factor. However, it remains possible that models with additional factors, or latent class models or hybrid models, may better explain the data. Using structured interviews, 626 adult male and female twins provided complete data on symptoms of cannabis abuse and dependence, plus a craving criterion. We compared latent factor analysis, latent class analysis, and factor mixture modeling using normal theory marginal maximum likelihood for ordinal data. Our aim was to derive a parsimonious, best-fitting cannabis use disorder (CUD) phenotype based on DSM-IV criteria and determine whether DSM-5 craving loads onto a general factor. When compared with latent class and mixture models, factor models provided a','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'8','Twin Research and Human Genetics','17','2','89-98','Cambridge University Press','Other','',''),(1173,'Reducing off-label prescribing in psychiatry','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84893276199&doi=10.5694%2fmja14.00050&partnerID=40&md5=4bc5f43b11ff761c310b2b1c999bf46e','10.5694/mja14.00050','T here are few more controversial topics in mental health than what constitutes evidence-based prescribing. Medications not indicated for common conditions like anxiety or depression, or particular age groups such as the young or old, are often prescribed for these conditions or age groups. Consequently, strident calls for clamping down on such ΓÇ£off-label├éΓÇ¥ prescribing are common. Three drivers are behind these public and professional concerns.','',2014,NULL,NULL,'2014-02-03',NULL,NULL,NULL,NULL,'8','Medical Journal of Australia','200','2','65-66','','YMH team','Mental Health System','Models of care'),(1174,'A preliminary study of aged care facility staff indicates limitations in awareness of the link between depression and physical morbidity','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84875907003&doi=10.1186%2f1471-2318-13-30&partnerID=40&md5=eb4e162e4c4713f25e9d33750e8b8130','10.1186/1471-2318-13-30','It is important to understand the complex inter-relationship between depression and physical illness in order to plan and provide quality health care services for older persons and reduce suffering and early mortality. This study assessed the awareness and knowledge of age-care staff of the link between physical morbidity and depression. One hundred and nineteen staff from both residential (high and low care) and community aged care facilities were surveyed on their awareness and knowledge of the relationship between physical morbidity and symptoms of depression. Predictors of levels of knowledge were assessed using multiple regression analysis. Awareness of the link between physical morbidity and symptoms of depression was generally high. However, while nearly eighty percent of respondents said they had had training in mental health, they were only able to answer an average of six out of ten of the knowledge questions correctly. Predictors of knowledge were: higher age, higher educational status and working in a high care facility. Responses to the survey questions demonstrated gaps in knowledge about the relationship between depression and physical health. The need for regular ongoing training to improve knowledge and awareness of this relationship is indicated. Treatment of physical health issues which is essential in reducing the risk for depression in older persons in aged care environments could be optimized by improved staff training.','',2013,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'8','BMC Geriatrics','13','1','1-Sep','BioMed Central','Other','',''),(1175,'Changes in anatomical brain connectivity between ages 12 and 30: A HARDI study of 467 adolescents and adults','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84864832316&doi=10.1109%2fISBI.2012.6235695&partnerID=40&md5=3c18b5e48ef10bce3679dae22b50556c','10.1109/ISBI.2012.6235695','Graph theory can be applied to matrices that represent the brain\'s anatomical connections, to better understand global properties of anatomical networks, such as their clustering, efficiency and ΓÇ£small-world├éΓÇ¥ topology. Network analysis is popular in adult studies of connectivity, but only one study ├éΓÇö in just 30 subjects ├éΓÇö has examined how network measures change as the brain develops over this period. Here we assessed the developmental trajectory of graph theory metrics of structural brain connectivity in a cross-sectional study of 467 subjects, aged 12 to 30. We computed network measures from 70├âΓÇö70 connectivity matrices of fiber density generated using whole-brain tractography in 4-Tesla 105-gradient high angular resolution diffusion images (HARDI). We assessed global efficiency and modularity, and both age and age 2  effects were identified. HARDI-based connectivity maps are sensitive to the remodeling├é┬á├éΓÇª','',2012,NULL,NULL,'2012-05-02',NULL,NULL,NULL,NULL,'8','Proceedings - International Symposium on Biomedical Imaging','','','904-907','IEEE','Other','',''),(1176,'A new model for delivering selected mental health services in Australia','https://scholar.google.com/scholar?cluster=1284513107988659461&hl=en&oi=scholarr',NULL,'','',2008,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'8','Brain and Mind Institute University of Sydney','','','','',NULL,NULL,NULL),(1177,'Treatment guidelines for depression in the Asia Pacific region: A review of current developments','https://www.scopus.com/inward/record.uri?eid=2-s2.0-5644292383&doi=10.1111%2fj.1039-8562.2004.02100.x-i1&partnerID=40&md5=235a9211536c498db1c6b4245d3032ec','10.1111/j.1039-8562.2004.02100.x-i1','\n\nObjective: This paper examines the development of treatment guidelines, medication algorithms and clinical pathway guides for depression in countries participating in the SEBoD Initiative.\n\nMethods: A systematic review of the extent of development of treatment guidelines, medication algorithms or clinical pathway guides for depression in participating countries.\n\nResults: Most countries in the Asia Pacific region have commenced the development of treatment guidelines, medication algorithms or clinical pathway guides. The promoters of such efforts have included a range of professional and government bodies. Most efforts have borrowed heavily on existing international guidelines. There is a significant emphasis on medication practices in most countries, with less emphasis on the role of psychological or other non-pharmacological approaches. There has been insufficient emphasis on integrating local classification\n','',2004,NULL,NULL,'2004-01-01',NULL,NULL,NULL,NULL,'8','Australasian Psychiatry','12','sup1','s33-s37','Taylor & Francis','YMH team','Illness specific areas','Models of care'),(1178,'Referral of patients with depression to specialist psychological care from general practice.','https://www.scopus.com/inward/record.uri?eid=2-s2.0-1442284592&partnerID=40&md5=fb54b62e045c967acdffe06a818d6bfb','','This fifth and final article in the \'Psychological treatments in general practice\' series provides a practical four step approach to assist general practitioners to refer patients with depression from general practice to specialist psychological care. Referral represents one important step within a broader shared care framework. The four step approach provides information and resources to help GPs with assessment, patient education, choice of mental health specialist(s) and long term monitoring.   (editor abstract)','',2003,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Australian family physician','32','12','998-1002','','YMH team','Models of care',''),(1179,'A cognitive-behavioural therapy training program for general practitioners to manage depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033400490&doi=10.1046%2fj.1440-1665.1999.00223.x&partnerID=40&md5=8313109fe0e89c4365de1fb528c2850c','10.1046/j.1440-1665.1999.00223.x','INTRODUCTION The recent National Survey of Mental Health and Wellbeing [1] has emphasised the gap between the prevalence of common mental disorders such as anxiety and depression and the provision of medical assessment. The provision of effective pharmacological and non-pharmacological treatments to those in need represents a major challenge to both government and mental health professionals. General practitioners (GPs) have signaled their willingness to take an active role in the provision of such services [2]. Such involvement, however, will depend on the extent to which they are provided with relevant forms of education, training and practice support. In 1998,├éΓÇÿSPHERE: A National Depression Project├éΓÇÖ[3] was launched by an independent group of mental health professionals and GPs to address these issues. This brief report describes the development of the second phase of the Project, namely├é┬á├éΓÇª','',1999,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'8','Australasian Psychiatry','7','6','326-328','SAGE Publications','YMH team','Models of care','illness specific areas'),(1180,'A depression management program for patients and their general practitioners','https://scholar.google.com/scholar?cluster=6972079228984482501&hl=en&oi=scholarr',NULL,'','',1998,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'8*','','','','','Sydney: Educational Health Solutions',NULL,NULL,NULL),(1181,'Discussing the impact of first onset psychosis programs on public sector health services','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031696228&doi=10.3109%2f10398569809084834&partnerID=40&md5=55ca461942ceaf61ddaec33503c5b653','10.3109/10398569809084834','Following the recognition of patients with first onset psychosis as a special needs group, there has been a significant growth in clinical and research interest in this area [1]. Identified issues have included: the earliest possible detection of the illness [2]; the interaction between developmental needs of adolescents and the trauma of the illness [3]; evaluating the evidence concerning the relative effectiveness of early interventions [4]; and determining the impact on long term health outcomes for young persons who are treated assertively in the early stages of psychosis [3].','',1998,NULL,NULL,'1998-01-01',NULL,NULL,NULL,NULL,'8','Australasian Psychiatry','6','4','181-183','Taylor & Francis','YMH team','Mental Health System','illness specific areas'),(1182,'Validity of the CORE measure: III. Outcome and treatment prediction','https://books.google.com/books?hl=en&lr=&id=aQYJbOT4PCUC&oi=fnd&pg=PA160&dq=info:0aR_tRXtI14J:scholar.google.com&ots=SmMIA3MqVD&sig=DngCTucgUZa1tgOw8wpgtbkxSdw',NULL,'\nAs noted in Chapter 2, suggested defining characteristics of melancholia have included selective response to physical treatments (ie, antidepressant drugs and electroconvulsive therapy) in addition to clinical features. Again in that chapter, we noted support for the view of N├¡ Brolch├â┬íin (1979) that classification should be restricted ├éΓÇ£in the first instance, to mental state items,\" before subsequently examining how aetiological and other factors (including treatment) relate to the clinically defined classes. In Chapter 6 we noted the reasons leading to revision of DSM-III melan-cholia criteria, with Zimmerman, Black and Coryell (1989) pointing out that the DSM-III criteria differentiated patients along a severity dimension, and that those criteria ├éΓÇ£did not predict treatment response.├éΓÇ¥ If melancholia and non-melancholic depression have differential naturalistic and/or treatment outcome patterns, and if the CORE measure is a valid measure of melancholia, then CORE scores should show predictive validity in outcome studies. Before reviewing several of our studies, we first note some evidence supporting differential outcomes for melancholic and non-melancholic depression.\nThe literature on naturalistic outcome is necessarily restricted by (i) the variable validity of criterion measures of melancholia or endogenous depression;(ii) intrinsic difficulties in measuring course of illness;(iii) co-morbidity issues├éΓÇônotably the presence or absence of anxiety, per-sonality disorder and medical illness;(iv) non-illness variables-such as service access and sophistication; and by (v) varying definitions of the term ├éΓÇ£naturalistic.├éΓÇ¥ As most long-term studies have involved depressed├é┬á├éΓÇª\n','',1996,NULL,NULL,'1996-03-29',NULL,NULL,NULL,NULL,'8','Melancholia: A disorder of movement and mood','','','160-171','Cambridge University Press',NULL,NULL,NULL),(1183,'A catecholamine model of fatigue','https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/catecholamine-model-of-fatigue/533826D7BE6B111BE27316E9BB98FE80',NULL,'//static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS0007125000132660/resource/name/firstPage-S0007125000132660a.jpg','',1994,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'8','The British Journal of Psychiatry','165','2','275-276','Cambridge University Press',NULL,NULL,NULL),(1184,'Chronic fatigue syndrome and depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025905028&doi=10.1016%2f0140-6736%2891%2990260-V&partnerID=40&md5=db91ce9bf97f800ba9631d726c9ae9ea','10.1016/0140-6736(91)90260-V','','',1991,NULL,NULL,'1991-04-13',NULL,NULL,NULL,NULL,'8','The Lancet','337','8746','922-923','Elsevier','Other','Illness specific areas',''),(1185,'A family panics','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024418481&doi=10.3109%2f00048678909068300&partnerID=40&md5=e86c9d05fa85fddc7cf0c5c4e297b487','10.3109/00048678909068300','We report the treatment of a family in which both spouses developed panic disorder, and their son school phobia, soon after the death of a close relative. The interactional style observed within this family suggested that interpersonal factors were important in the generation of anxiety in each member. Detailed case histories such as the one we report underscore the importance of a systemic perspective when assessing individuals who present with anxiety disorders.','',1989,NULL,NULL,'1989-01-01',NULL,NULL,NULL,NULL,'8','Australian and New Zealand Journal of Psychiatry','23','3','418-421','Taylor & Francis','Other','',''),(1186,'Participatory Methods for Systems Modeling of Youth Mental Health: Implementation Protocol','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85124984579&doi=10.2196%2f32988&partnerID=40&md5=6e000f1b0668ac3f172cdbaf5f5d733e','10.2196/32988','\nBackground: Despite significant investment, mental health issues remain a leading cause of death among young people globally. Sophisticated decision analysis methods are needed to better understand the dynamic and multisector drivers of youth mental health. System modeling can help explore complex issues such as youth mental health and inform strategies to effectively respond to local needs and achieve lasting improvements. The advantages of engaging stakeholders in model development processes have long been recognized; however, the methods for doing so are often not well-described.\nObjective: This paper aims to describe the participatory procedures that will be used to support systems modeling for national multisite implementation. The Right Care, First Time, Where You Live research program will focus on regional youth mental health applications of systems modeling in 8 different sites across Australia.\nMethods: The participatory model development approach involves an iterative process of engaging with a range of participants, including people with lived experience of mental health issues. Their knowledge of the local systems, pathways, and drivers is combined with the academic literature and data to populate the models and validate their structure. The process centers around 3 workshops where participants interact and actively engage in group model-building activities to define, refine, and validate the systems models. This paper provides a detailed blueprint for the implementation of this process for mental health applications.\nResults: The participatory modeling methods described in this paper will be implemented at 2├é┬á├éΓÇª\n','',2022,NULL,NULL,'2022-02-07',NULL,NULL,NULL,NULL,'7','JMIR Research Protocols','11','2','e32988','JMIR Publications Inc., Toronto, Canada','YMH team','Mental Health System',''),(1187,'The psychometric characteristics of the Kessler Psychological Distress Scale (K6) in help-seeking youth: What do you miss when using it as an outcome measure?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85113612387&doi=10.1016%2fj.psychres.2021.114182&partnerID=40&md5=206fc1a36581cce28f896250ddc1457e','10.1016/j.psychres.2021.114182','This is the first study to describe psychometric properties of the Kessler Psychological Distress Scale (K6) in a large cohort of help-seeking young people presenting to primary mental health care services. The aim was to determine whether the K6 was appropriate for monitoring outcomes in such settings. 1067 young people were recruited from Australian headspace services. We examined dimensionality of the K6, measurement invariance, and how the K6 correlated with the the Patient Health Questionnaire├éΓÇô9 (PHQ-9)and the Generalised Anxiety Disorder├éΓÇô7 Scale (GAD-7). Standardised Response Mean (SRM) and Cohen\'s d effect size (ES) were used to examine 3-month stability of the K6. The best-fitting model was a two-factor model: (i) nervous and restlessness; and (ii) hopeless, worthless, depressed and effort. Measurement non-invariance was observed for sex and age groups. K6 strongly correlated with├é┬á├éΓÇª','',2021,NULL,NULL,'2021-11-01',NULL,NULL,NULL,NULL,'2','Psychiatry Research','305','','114182','Elsevier','Other','',''),(1188,'Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosis','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85090248853&doi=10.1111%2feip.13025&partnerID=40&md5=4fdafb73db9bd77d5858620ee4888981','10.1111/eip.13025','  Background Neurocognitive impairments are core early features of psychosis and are observed in those at ultra-high risk (UHR) for psychosis. The aim of the present study was to explore whether neurocognition is associated with polyunsaturated fatty acids (PUFAs), as has been observed in other clinical populations.   Method Erythrocyte levels of total omega-3-and omega-6 PUFAs the omega-3/omega-6 ratio, were measured in 265 UHR individuals. Six domains of neurocognition as well a Composite Score, were assessed using the Brief Assessment of Cognition in Schizophrenia. Pearson\'s correlations were used to assess the relationship between PUFAs and neurocognition. All analyses were controlled for tobacco smoking.   Results Verbal Fluency correlated positively with eicosapentaenoic acid (P = .024) and alpha-linolenic acid (P = .01), and negatively with docosahexanoic acid (P = .007) and├é┬á├éΓÇª\n','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'7','Early Intervention in Psychiatry','15','4','874-881','Wiley Publishing Asia Pty Ltd','YMH team','Illness specific areas','Models of care'),(1189,'Technology-enabled solutions for australian mental health services reform: Impact evaluation','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85096831450&doi=10.2196%2f18759&partnerID=40&md5=17beae4ab016e4172ec46fee10d71475','10.2196/18759','           Background           Health information technologies (HITs) are becoming increasingly recognized for their potential to provide innovative solutions to improve the delivery of mental health services and drive system reforms for better outcomes.                             Objective           This paper describes the baseline results of a study designed to systematically monitor and evaluate the impact of implementing an HIT, namely the InnoWell Platform, into Australian mental health services to facilitate the iterative refinement of the HIT and the service model in which it is embedded to meet the needs of consumers and their supportive others as well as health professionals and service providers.                             Methods           Data were collected via web-based surveys, semistructured interviews, and a workshop with staff from the mental health services implementing the InnoWell Platform to systematically monitor and evaluate its impact. Descriptive statistics, Fisher exact tests, and a reliability analysis were used to characterize the findings from the web-based surveys, including variability in the results between the services. Semistructured interviews were coded using a thematic analysis, and workshop data were coded using a basic content analysis.                             Results           Baseline data were collected from the staff of 3 primary youth mental health services (n=18), a counseling service for veterans and their families (n=23), and a helpline for consumers affected by eating disorders and negative body image issues (n=6). As reported via web-based surveys, staff members across the services consistently agreed or strongly agreed that there was benefit\n','',2020,NULL,NULL,'2020-11-19',NULL,NULL,NULL,NULL,'7','JMIR Formative Research','4','11','e18759','JMIR Publications Inc., Toronto, Canada','YMH team','Digital health','Mental Health System'),(1190,'Autoimmune disease in patients hospitalised with depressive disorders','https://www.taylorfrancis.com/chapters/edit/10.1201/9780429279164-7/autoimmune-disease-patients-hospitalised-depressive-disorders-elizabeth-scott-ian-hickie-kathryn-lovric',NULL,'Autoimmune processes have been proposed as aetiological mechanisms in a range of neuropsychiatric disorders. The available literature contains inconsistent results with regard to the prevalence of systemic autoimmune diseases in depression, though it appears that autoimmune thyroid disease may be over-represented in at least some patient subgroups. It is possible that autoimmune factors are only relevant in specific subpopulations of depressives. The majority of available studies of autoimmune processes in depressive disorders have produced conflicting results. Clinical evidence of autoimmune disease was most evident in the patients attending the tertiary-referral Mood Disorders Unit at Prince Henry Hospital, with 50% of those patients having at least one autoimmune disorder. A study of the long term outcome of patients with depression treated in a London teaching hospital reported a trend towards','',2019,NULL,NULL,'2019-06-04',NULL,NULL,NULL,NULL,'7','','','','79-86','CRC Press',NULL,NULL,NULL),(1191,'Developing neurocognitive standard clinical care: A study of young adult inpatients','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065783450&doi=10.1016%2fj.psychres.2019.05.003&partnerID=40&md5=b0dc7dc52a052a33207152b88154da5d','10.1016/j.psychres.2019.05.003','Neuropsychological assessments have provided the field of psychiatry with important information about patients. As an assessment tool, a neuropsychological battery can be useful in a clinical setting; however, implementation as standard clinical care in an inpatient unit has not been extensively evaluated. A computerized┬ácognitive battery was administered to 103 current young adult inpatients (19.2├é┬á├é┬▒├é┬á3.1 years; 72% female) with affective disorder. Neurocognitive tasks included Verbal Recognition Memory (VRM), Attention Switching (AST), Paired Association Learning (PAL), and Rapid Visual Processing (RVP). Patients also completed a computerized self-report questionnaire evaluating subjective impressions of their cognition. Hierarchical cluster analysis determined three neurocognitive subgroups: cluster 1 (n├é┬á=├é┬á17) showed a more impaired neurocognitive profile on three of the four variables compared to├é┬á├éΓÇª','',2019,NULL,NULL,'2019-06-01',NULL,NULL,NULL,NULL,'7','Psychiatry Research','276','','232-238','Elsevier','YMH team','Models of care',''),(1192,'The Utility of Clinical Staging in Youth Mental Health Settings: Neurobiological and Longitudinal Data from Sydney-Based Studies of Transdiagnostic Cohorts','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074486211&doi=10.1017%2f9781139839518.005&partnerID=40&md5=83e4fd431a7d9567355fb088ccc15c52','10.1017/9781139839518.005','Psychiatric diagnosis is experiencing a crisis of confidence. Current approaches are outmoded with reform desperately needed. Clinical staging is a solution to this crisis. Clinical staging addresses the limitations of current diagnostic systems by recognising the full continuum or trajectory of mental illness from asymptomatic to chronic illness. It acknowledges the overlap between mental health symptoms during early stages and directly links each stage to treatment and underlying cognitive, neurological and biological changes. This approach enhances chances of early identification, promotes the implementation of safer treatments, and increases opportunities to alter the negative trajectory of mental disorders. This book comprehensively describes the conceptual basis of clinical staging in psychiatry, details current progress in identifying biomarkers for each stage, and explores the implications of staging on treatment and health systems. This book provides a foundation for transformational reform in psychiatric diagnosis.[Book Synopsis]','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'7','Clinical Staging in Psychiatry: Making Diagnosis Work for Research and Treatment','','','81-102','Cambridge University Press','YMH team','Models of care',''),(1193,'MindMax: Using videogames and sport to engage young men and improve wellbeing','https://eprints.qut.edu.au/118415/',NULL,'While there is growing interest in men├éΓÇÖs mental health, engagement with this population remains a challenge, suggesting the need for non-traditional approaches. In addition, the increased use of new and emerging technology (especially by young people) denotes its suitability for delivering such services. In 2015, the Australian Football League Players Association was the successful recipient of a Movember foundation grant to improve the mental health of Australian males aged between 16-35 years. The project proposed was a strategy incorporating wellbeing science, delivered via mobile technology, and leveraging interest in elite sport and videogames. This has resulted in MindMax, a new and innovative mobile application that delivers psychoeducation within an integrated digital sporting community, driven by real-world challenges and events. This paper describes the supporting iterative research and development cycle including participatory design and user (acceptance) testing, the technology build, and proposed evaluation of the final product.','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'7','Proceedings of the 2nd Symposium Computing and Mental Health, 2017','','','1-May','MIT Media Laboratory',NULL,NULL,NULL),(1194,'Right external globus pallidus changes are associated with altered causal awareness in youth with depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84943244109&doi=10.1038%2ftp.2015.148&partnerID=40&md5=8f0d43fabdc5ef0e9718d2a617685796','10.1038/tp.2015.148','Cognitive impairment is a functionally disabling feature of depression contributing to maladaptive decision-making, a loss of behavioral control and an increased disease burden. The ability to calculate the causal efficacy of ones actions in achieving specific goals is critical to normal decision-making and, in this study, we combined voxel-based morphometry (VBM), shape analysis and diffusion tensor tractography to investigate the relationship between corticalΓÇôbasal ganglia structural integrity and such causal awareness in 43 young subjects with depression and 21 demographically similar healthy controls. Volumetric analysis determined a relationship between right pallidal size and sensitivity to the causal status of specific actions. More specifically, shape analysis identified dorsolateral surface vertices where an inward location was correlated with reduced levels of causal awareness. Probabilistic tractography├é┬á├éΓÇª','',2015,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'7','Translational Psychiatry','5','10','e653-e653','Nature Publishing Group','Other','',''),(1195,'The neurapro-E study: a multicenter rct of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic├é┬á├éΓÇª','https://scholar.google.com/scholar?cluster=13740009206544519249&hl=en&oi=scholarr',NULL,'','',2015,NULL,NULL,'2015-03-01',NULL,NULL,NULL,NULL,'7','','','','S322-S323','OXFORD UNIV PRESS',NULL,NULL,NULL),(1196,'Novel melatonin-based treatments for major depression├éΓÇôAuthors\' reply','https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)60099-3/fulltext',NULL,'2 European Medicines Agency. CHMP assessment report for Valdoxan. http://www. ema. europa. eu/docs/en_GB/document_library/EPAR_-_ Public_assessment_report/human/000915/WC500046226. pdf (accessed Dec 16, 2011). 3 Simon G, Revicki D, Heiligenstein M, et al. Recovery from depression, work productivity and health care costs among primary care patients. Gen Hosp Psychiatry 2000; 22: 153├éΓÇô62. 4 Hickie I. Nefazodone for patients with chronic fatigue syndrome. Aust NZJ Psychiatry 1999;','',2012,NULL,NULL,'2012-01-21',NULL,NULL,NULL,NULL,'7','The Lancet','379','9812','217-219','Elsevier',NULL,NULL,NULL),(1197,'National health reform: It\'s time for a decision','https://www.scopus.com/inward/record.uri?eid=2-s2.0-77952307733&doi=10.5694%2fj.1326-5377.2009.tb02844.x&partnerID=40&md5=951a001563f4022a2e9e027f7a4e2efe','10.5694/j.1326-5377.2009.tb02844.x','The Medical Journal of Australia Page 1 382 MJA ├éΓÇó Volume 191 Number 7 ├éΓÇó 5 October 2009 \nHEALTH CARE REFORM The Medical Journal of Australia ISSN: 0025729X 5 October 2009 \n191 7 382-383 ├é┬⌐The Medical Journal of Australia 2009 www.mja.com.au Health care reform \nfter 18 months of summits, taskforces, and work by the National Health and Hospitals Reform \nCommission (NHHRC),1 it is still unclear whether Australia├éΓÇÖs health system stands on the \nthreshold of major change. Despite Prime Minister Kevin Rudd├éΓÇÖs bold statements during the \n2007 election campaign, we do not know the real shape, scope or timetable for health reform. \nWhy the delay? First, the government was elected without a detailed health reform plan. \nSecond, substantive change requires a national leadership group with the confidence and \ntechnical expertise to confront the vested professional, business and political interests that will ├éΓÇª','',2009,NULL,NULL,'2009-10-05',NULL,NULL,NULL,NULL,'7','Medical Journal of Australia','191','7','382-383','','YMH team','Mental Health System',''),(1198,'Characterising novel pathways to schizophrenia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-61849105882&doi=10.5694%2fj.1326-5377.2009.tb02365.x&partnerID=40&md5=5f1e8f92b791c9a18e1c9075d4095c70','10.5694/j.1326-5377.2009.tb02365.x','SUPPLEMENT sis on the need for biomarkers of earlier stages. We need to have some confidence that we can predict progression before we engage in more assertive interventions. This process has been aided in other neurological disorders by tracking reactive features such as microglial response to illness onset. Preliminary evidence suggests such an approach may be viable in patients with schizophreniaΓÇöparticularly if such data are combined with other neurophysiological, neuropsychological or inflammatory markers (Banati and','',2009,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'7','Medical Journal of Australia','190','S4','S5-S6','','YMH team','Illness specific areas',''),(1199,'Does genotype mask the relationship between psychological factors and immune function?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-12344330552&doi=10.1016%2fj.bbi.2004.06.005&partnerID=40&md5=6058c514f610a338557219001d724235','10.1016/j.bbi.2004.06.005','This paper examined the interaction between genetic influences of the polymorphic human leukocyte antigens (DRB1 and DQB1) and psychological distress on the development of cellular immunity to the novel antigen, keyhole limpet hemocyanin (KLH). Participants (n┬á=├é┬á227) were immunized with KLH and the development of cutaneous delayed-type hypersensitivity (DTH) against KLH was examined 3 weeks later. Distress was assessed using the Profile of Mood States. DNA was typed for the serologically defined DRB1 and DQB1 antigens. There was a significant correlation between distress at immunization and the development of DTH skin test responses to KLH (n├é┬á=├é┬á214, r├é┬á=├é┬á.24, p├é┬á=├é┬á.003). HLA DQ2 was weakly associated with a decreased likelihood of developing a cutaneous delayed-type hypersensitivity response against KLH (odds ratio [OR]├é┬á=├é┬á1.6; confidence interval [CI] 0.9├éΓÇô2.7). HLA DQ5 was weakly├é┬á├éΓÇª','',2005,NULL,NULL,'2005-03-01',NULL,NULL,NULL,NULL,'7','Brain, Behavior, and Immunity','19','2','147-152','Academic Press','Other','',''),(1200,'An akinetic-rigid syndrome, depression, and stereotypies in a young man','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031655820&doi=10.1002%2fmds.870130515&partnerID=40&md5=5b35d82f479dccd8a629c76abfdd027e','10.1002/mds.870130515','  A young man is presented who developed an akinetic-rigid syndrome shortly after a minor illness. Rituals and stereoptypies were prominent. At its most severe he was unable to feed himself. There was no response to L-dopa/cardopa treatment. A course of ECT was followed by a marked improvement in his condition. Attempts to stop ECT for more than a week have led to recurrence of his bradykinesia.\n','',1998,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'7','Movement Disorders','13','5','835-844','Wiley Subscription Services, Inc., A Wiley Company','YMH team','Illness specific areas',''),(1201,'Neural network subtyping of depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031737122&doi=10.3109%2f00048679809113124&partnerID=40&md5=a27f643472fb004987942a2fb9dca742','10.3109/00048679809113124','\nObjective: To examine the applicability of a neural network classification strategy to examine the independent contribution of psychomotor disturbance (PMD) and endogeneity symptoms to the DSM-III-R definition of melancholia.\nMethod: We studied 407 depressed patients with the clinical dataset comprising 17 endogeneity symptoms and the 18-item CORE measure of behaviourally rated PMD. A multilayer perceptron neural network was used to fit non-linear models of varying complexity. A linear discriminant function analysis was also used to generate a model for comparison with the non-linear models.\nResults: Models (linear and non-linear) using PMD items only and endogeneity symptoms only had similar rates of successful classification, while non-linear models combining both PMD and symptom scores achieved the best classifications.\nConclusions: Our current non-linear model was superior to a linear\n','',1998,NULL,NULL,'1998-01-01',NULL,NULL,NULL,NULL,'7','Australian and New Zealand Journal of Psychiatry','32','5','687-694','Taylor & Francis','Other','',''),(1202,'If the referral fits: Bridging the gap between patient and referrer requirements in a tertiary referral unit','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030035517&doi=10.3109%2f00048679609064995&partnerID=40&md5=e87fbc79de636654967e176a6c68351d','10.3109/00048679609064995','\nObjective:\n We examined the reasons for which doctors refer and patients request referral to our tertiary Mood Disorders Unit (MDU), focussing on congruence and ΓÇÿfit├éΓÇÖ, and the potential for more efficient use of referral resources. Method:\n A postal survey of patients (n=265 or 83% responders) and referrers (n=156 or 94% responders) sought views regarding referral and service components. Ratings from 156 matched referrer-patient dyads were compared. Results:\n Overall, referrers and patients were satisfied with the MDU. There was disparity between what referrers sought and what patients thought were the reasons for referral, and different perceptions of the value of interventions and the amount of improvement. Congruent matched referrer-patient judgements of patient outcome were more likely to correspond with objective clinician ratings than discordant ratings. Satisfaction with MDU contact or intervention was├é┬á├éΓÇª','',1996,NULL,NULL,'1996-01-01',NULL,NULL,NULL,NULL,'7','Australian and New Zealand Journal of Psychiatry','30','3','332-336','Taylor & Francis','YMH team','Mental Health System',''),(1203,'The Australian Genetics of Depression Study: new risk loci and dissecting heterogeneity between subtypes','https://www.sciencedirect.com/science/article/pii/S0006322321017157',NULL,'\n\nBackground\nMajor depressive disorder (MDD) is a common and highly heterogeneous psychiatric disorder, but little is known about the genetic characterization of this heterogeneity. Understanding the genetic etiology of MDD can be challenging because large sample sizes are needed for gene discovery├éΓÇöoften achieved with a trade-off in the depth of phenotyping.\n\n\nMethods\nThe Australian Genetics of Depression Study is the largest stand-alone depression cohort with both genetic data and in-depth phenotyping and comprises a total of 15,792 participants of European ancestry, 92% of whom met diagnostic criteria for MDD. We leveraged the unique nature of this cohort to conduct a meta-analysis with the largest publicly available depression genome-wide association study to date and subsequently used polygenic scores to investigate genetic heterogeneity across various clinical subtypes of MDD.\n\n\nResults\nWe├é┬á├éΓÇª\n\n','',2020,NULL,NULL,'2022-08-01',NULL,NULL,NULL,NULL,'3','Biological Psychiatry','92','3','227-235','Elsevier',NULL,NULL,NULL),(1204,'Implementing a digital health model of care in Australian youth mental health services: protocol for impact evaluation','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85105709023&doi=10.1186%2fs12913-021-06394-4&partnerID=40&md5=e6cb538b6ac047c33bc66cd2bc4757e9','10.1186/s12913-021-06394-4','The World Economic Forum has recently highlighted substantial problems in mental health service provision and called for the rapid deployment of smarter, digitally-enhanced health services as a means to facilitate effective care coordination and address issues of demand. In mental health, the biggest enabler of digital solutions is the implementation of an effective model of care that is facilitated by integrated health information technologies (HITs); the latter ensuring the solution is easily accessible, scalable and sustainable. The University of SydneyΓÇÖs Brain and Mind Centre (BMC) has developed an innovative digital health solution ├éΓÇô delivered through the Youth Mental Health and Technology Program ├éΓÇô which incorporates two components: 1) a highly personalised and measurement-based (data-driven) model of youth mental health care; and 2) an industrial grade HIT registered on the Australian Register of Therapeutic Goods. This paper describes a research protocol to evaluate the impact of implementing the BMC├éΓÇÖs digital health solution into youth mental health services (i.e. headspace - a highly accessible, youth-friendly integrated service that responds to the mental health, physical health, alcohol or other substance use, and vocational concerns of young people aged 12 to 25 years) within urban and regional areas of Australia. The digital health solution will be implemented into participating headspace centres using a naturalistic research design. Quantitative and qualitative data will be collected from headspace health professionals, service managers and administrators, as well as from lead agency and local Primary Health Network├é┬á├éΓÇª','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'6','BMC Health Services Research','21','1','1-Sep','BioMed Central','YMH team','Digital health','Models of care'),(1205,'Privacy practices of health information technologies: Privacy policy risk assessment study and proposed guidelines','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85115646655&doi=10.2196%2f26317&partnerID=40&md5=dae622cdc007e9260601e063e0c9476a','10.2196/26317','           Background           Along with the proliferation of health information technologies (HITs), there is a growing need to understand the potential privacy risks associated with using such tools. Although privacy policies are designed to inform consumers, such policies have consistently been found to be confusing and lack transparency.                             Objective           This study aims to present consumer preferences for accessing privacy information; develop and apply a privacy policy risk assessment tool to assess whether existing HITs meet the recommended privacy policy standards; and propose guidelines to assist health professionals and service providers with understanding the privacy risks associated with HITs, so that they can confidently promote their safe use as a part of care.                             Methods           In phase 1, participatory design workshops were conducted with young people who were attending a participating headspace center, their supportive others, and health professionals and service providers from the centers. The findings were knowledge translated to determine participant preferences for the presentation and availability of privacy information and the functionality required to support its delivery. Phase 2 included the development of the 23-item privacy policy risk assessment tool, which incorporated material from international privacy literature and standards. This tool was then used to assess the privacy policies of 34 apps and e-tools. In phase 3, privacy guidelines, which were derived from learnings from a collaborative consultation process with key stakeholders, were developed to assist health professionals and service\n','',2021,NULL,NULL,'2021-09-16',NULL,NULL,NULL,NULL,'5','Journal of Medical Internet Research','23','9','e26317','JMIR Publications Inc., Toronto, Canada','YMH team','Digital health','Mental Health System'),(1206,'Repetitive transcranial magnetic stimulation (rTMS) in autism spectrum disorder: Protocol for a multicentre randomised controlled clinical trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85109528008&doi=10.1136%2fbmjopen-2020-046830&partnerID=40&md5=fce33801c2f6fbb9bcedf931a7a414e9','10.1136/bmjopen-2020-046830','\nIntroduction There are no well-established biomedical treatments for the core symptoms of autism spectrum disorder (ASD). A small number of studies suggest that repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, may improve clinical and cognitive outcomes in ASD. We describe here the protocol for a funded multicentre randomised controlled clinical trial to investigate whether a course of rTMS to the right temporoparietal junction (rTPJ), which has demonstrated abnormal brain activation in ASD, can improve social communication in adolescents and young adults with ASD.\nMethods and analysis This study will evaluate the safety and efficacy of a 4-week course of intermittent theta burst stimulation (iTBS, a variant of rTMS) in ASD. Participants meeting criteria for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition ASD (n=150, aged 14├éΓÇô40 years) will├é┬á├éΓÇª\n','',2021,NULL,NULL,'2021-07-01',NULL,NULL,NULL,NULL,'3','BMJ Open','11','7','e046830','British Medical Journal Publishing Group','Other','',''),(1207,'RestΓÇôactivity functioning is related to white matter microarchitecture and modifiable risk factors in older adults at-risk for dementia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85112022827&doi=10.1093%2fsleep%2fzsab007&partnerID=40&md5=44e214ed8d67d74e3e08563a90e08dfd','10.1093/sleep/zsab007','                    Study Objectives           Growing evidence demonstrates pronounced alterations in rest├éΓÇôactivity functioning in older adults at-risk for dementia. White matter degeneration, poor cardiometabolic functioning, and depression have also been linked to a greater risk of decline; however, limited studies have examined the white matter in relation to rest├éΓÇôactivity functioning in at-risk older adults.                             Methods           We investigated associations between nonparametric actigraphy measures and white matter microarchitecture using whole-brain fixel-based analysis of diffusion-weighted imaging in older adults (aged 50 years or older) at-risk for cognitive decline and dementia. The fixel-based metrics assessed were fiber density, fiber cross-section, and combined fiber-density, and cross-section. Interactions between rest├éΓÇôactivity functioning and known clinical risk factors, specifically body mass index (BMI├é┬á├éΓÇª\n','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'6','Sleep','44','7','zsab007','Oxford University Press','Other','',''),(1208,'A transdiagnostic examination of anxiety and stress on executive function outcomes in disorders with social impairment','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85098198088&doi=10.1016%2fj.jad.2020.11.089&partnerID=40&md5=4a17c55796943d8455231906eb50662c','10.1016/j.jad.2020.11.089','\n\nBackground\nExecutive function (EF) difficulties characterise a number of psychiatric conditions and EF impairment may be a predisposing factor and/or consequence of anxiety and stress. The aim of the study was to examine EF factors in a mixed clinical cohort (Autism Spectrum Disorder and Social Anxiety Disorder) characterised by social impairment and investigate the influence of trait anxiety and state-based depression, anxiety and stress.\n\n\nMethods\nIn Study 1, a factor analysis identified EF and non-EF latent factor structures (N=205). In Study 2, (N=137) multiple regression analyses investigated the association between trait anxiety and state based depression, anxiety and stress, on EF and non-EF cognitive domains and on the two composite indices of the Behavioural Rating Inventory of Executive Function (BRIEF).\n\n\nResults\nTrait anxiety was associated with better performance on neuropsychological measures of\n\n','',2021,NULL,NULL,'2021-02-15',NULL,NULL,NULL,NULL,'6','Journal of Affective Disorders','281','','695-707','Elsevier','Other','',''),(1209,'Which Social, Economic, and Health Sector Strategies Will Deliver the Greatest Impacts for Youth Mental Health and Suicide Prevention? Protocol for an Advanced, Systems Modelling Approach','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118359586&doi=10.3389%2ffpsyt.2021.759343&partnerID=40&md5=b7bdf04addace0718d32612f2ac27724','10.3389/fpsyt.2021.759343','\nBackground:\n\n Current global challenges are generating extensive social disruption and uncertainty that have the potential to undermine the mental health, wellbeing, and futures of young people. The scale and complexity of challenges call for engagement with systems science-based decision analytic tools that can capture interrelationships between physical, social, economic, and health systems, and support effective national and regional responses. At the outset of the pandemic mental health-related systems models were developed for the Australian context, however, the extent to which findings are generalizable across diverse regions remains unknown. This study aims to explore the context dependency of systems modelling insights. \nMethods:\n\n This study will employ a comparative case study design, applying participatory system dynamics modelling across eight diverse regions of Australia to answer three primary research questions: (1) Will current regional differences in key youth mental health outcomes be exacerbated in forward projections due to the social and economic impacts of COVID-19?; (ii) What combination of social policies and health system strengthening initiatives will deliver the greatest impacts within each region?; (iii) To what extent are optimal strategic responses consistent across the diverse regions? We provide a detailed technical blueprint as a potential springboard for more timely construction and deployment of systems models in international contexts to facilitate a broader examination of the question of generalizability and inform investments in the mental health and wellbeing of young people in the post COVID-19\n','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'6','Frontiers in Psychiatry','','','1760','Frontiers','YMH team','Mental Health System','Mental Health System'),(1210,'Short communication: Self-reported sleep-wake disturbances preceding onset of full-threshold mood and/or psychotic syndromes in community residing adolescents and young adults','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85090248448&doi=10.1016%2fj.jad.2020.08.083&partnerID=40&md5=b4fa741bb11470ca591b74be7badd92a','10.1016/j.jad.2020.08.083','\n\nBackground\nInsomnia may predict onset of mental disorders in adults. However, it is unclear whether the same directional relationship exists during the peak age range for the onset of major mental disorders and/or whether other types of sleep-wake disturbance, such as hypersomnia, show similar associations.\n\n\nMethods\nLongitudinal follow-up of >1800 community residing twins and non-twin siblings (mean age ~26; 57% female). Adjusted relative risk ratios and 95% confidence intervals (Adj RR and 95% CI) were estimated for onset of depression, hypomania and psychosis in individuals with prior self-reported exposure to Insomnia and/or Hypersomnia or proxies for insomnia disorder (Insomnia and Daytime Impairment) and atypical symptom profile (Hypersomnia and Anergia).\n\n\nResults\nRisk of onset differed somewhat according to type of syndrome and the nature of sleep-wake disturbance (e.g. Insomnia alone\n\n','',2020,NULL,NULL,'2020-12-01',NULL,NULL,NULL,NULL,'6','Journal of Affective Disorders','277','','592-595','Elsevier','YMH team','Illness specific areas','Outcome Research'),(1211,'Genetic and environmental causes of individual differences in borderline personality disorder features and loneliness are partially shared','https://www.cambridge.org/core/journals/twin-research-and-human-genetics/article/genetic-and-environmental-causes-of-individual-differences-in-borderline-personality-disorder-features-and-loneliness-are-partially-shared/32D418BC4A37E585BBBDC10C1AE1A488',NULL,'Loneliness is related to mental and somatic health outcomes, including borderline personality disorder. Here, we analyze the sources of variation that are responsible for the relationship between borderline personality features (including four dimensions, affective instability, identity disturbance, negative relationships, self-harm and a total score) and loneliness. Using genetically informative data from two large nonclinical samples of adult twin pairs from Australia and the Netherlands (N = 11,329), we estimate the phenotypic, genetic and environmental correlations between self-reported borderline personality features and loneliness. Individual differences in borderline personality and loneliness were best explained by additive genetic factors with heritability estimates h2 = 41% for the borderline personality total score and h2 = 36% for loneliness, with the remaining variation explained by environmental influences├é┬á├éΓÇª','',2018,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'3','Twin Research and Human Genetics','23','4','214-220','Cambridge University Press',NULL,NULL,NULL),(1212,'Machine Learning for Differential Diagnosis Between Clinical Conditions With Social Difficulty: Autism Spectrum Disorder, Early Psychosis, and Social Anxiety Disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087438118&doi=10.3389%2ffpsyt.2020.00545&partnerID=40&md5=d1cf2b12008222a4dfce7dfee4556139','10.3389/fpsyt.2020.00545','Differential diagnosis in adult cohorts with social difficulty is confounded by comorbid mental health conditions, common aetiologies and shared phenotypes. Identifying shared and discriminating profiles can facilitate intervention and remediation strategies. The objective of the study was to identify salient features of a composite test battery of cognitive and mood measures using a machine learning paradigm in clinical cohorts with social interaction difficulties. We recruited clinical participants who met standardised diagnostic criteria for Autism Spectrum Disorder (ASD: N=62), Early Psychosis (EP: N=48) or Social Anxiety Disorder (SAD: N=83) and compared them with a neurotypical comparison group (TYP: N=43). Using five machine-learning algorithms and repeated cross-validation, we trained and tested classification models using measures of cognitive and executive function, lower and higher order social cognition and mood severity. Performance metrics were the Area Under the Curve (AUC) and Brier Scores. Sixteen features successfully differentiated between the groups. The control versus social impairment cohorts (ASD, EP, SAD) were differentiated by social cognition visuospatial memory and mood measures. Importantly, a distinct profile cluster drawn from social cognition, visual learning, executive function and mood, distinguished the neurodevelopmental cohort (EP and ASD) from the SAD group. The mean AUC range was between 0.892 and 0.915 for social impairment versus control cohorts and, 0.731 to 0.777 for SAD vs neurodevelopmental cohorts. This is the first study that compares an extensive battery of neuropsychological','',2020,NULL,NULL,'2020-06-19',NULL,NULL,NULL,NULL,'4','Frontiers in Psychiatry','11','','545','Frontiers Media SA','Other','',''),(1213,'Stepped mental health care model leading Australia astray','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085699441&doi=10.1177%2f1039856220928858&partnerID=40&md5=a2b9df487aa6bab7b1e8e31dc8cc3e1c','10.1177/1039856220928858','\nThe Australian Government chose the ├éΓÇÿstepped care├éΓÇÖframework to guide mental health planning, promising people ├éΓÇÿvarying levels of primary care treatment and support depending on their level of need as determined by a health professional, whether that be ├éΓÇÿat risk├éΓÇÖ, mild, moderate or severe/complex├éΓÇÖ[https://bit. ly/2OW9NrX].\nThere is evidence this framework may not be appropriate, even for common disorders. 2 Stepped care is typically applied to specific therapies, like the UK├éΓÇÖs Improving Access to Psycho logical Therapies (IAPT). There, the model was implemented with coordi nated tiers of care, from guided self help, to low, then higher intensity and professional facetoface care. 3 Patient progress was systematically monitored.\n','',2020,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'3','Australasian Psychiatry','','','','Sage Publications Inc','YMH team','Models of care',''),(1214,'Immune dysfunction in depressive disorders','https://www.taylorfrancis.com/chapters/edit/10.1201/9780429260445-22/immune-dysfunction-depressive-disorders-ian-hickie-catherine-hickie',NULL,'There is a public belief that strong scientific evidence exists to support the proposition that depressed mood is associated with immune impairment. Eighty-seven per cent reported that depression resulted in medically significant immune dysfunction, although only 21 % were able to offer a plausible pathophysiology as to how this might occur. Although a number of research reports have suggested an association between depressive disorders and impaired cell-mediated immunity (CMI), especially in older more severely depressed patients, the results have been inconsistent. Non-melancholic patients were not impaired at baseline and, on the whole, did not receive pharmacotherapy. They have also experienced less change in their depressive symptoms over the course of the study. It would appear that effective pharmacotherapy for melancholic depressive disorders results in normalization of CMI as assessed by','',2019,NULL,NULL,'2019-06-04',NULL,NULL,NULL,NULL,'6','','','','211-214','CRC Press',NULL,NULL,NULL),(1215,'Elucidating the glutamatergic processes underlying mismatch negativity deficits in early stage bipolar disorder and schizophrenia: A combined 1 H-MRS and EEG study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85063577829&doi=10.1016%2fj.jpsychires.2019.03.018&partnerID=40&md5=c29107075374f6c7ff7ae8b7862f289a','10.1016/j.jpsychires.2019.03.018','Impairments in mismatch negativity (MMN) in schizophrenia are well-established; these findings have been extended to show impairments at early illness stages and in bipolar disorder. A substantial literature supports MMN as an index of NMDA receptor output, however, few studies have conducted in vivo assessments to elucidate the neurochemical underpinnings of MMN. Sixty young (16ΓÇô33 years) participants with bipolar disorder (n├é┬á=├é┬á47) or schizophrenia (n├é┬á=├é┬á13) underwent 1H-MRS and MMN assessment. Glutamate over creatine (Glu/Cr) levels in the anterior cingulate cortex (ACC) and hippocampus were determined and MMN was measured frontally and temporally. Correlational analyses assessed the relationship between MMN amplitudes and Glu/Cr. Any significant relationships were assessed for specificity with a follow up correlation analysis of MMN and n-acetyleaspartate (NAA/Cr). No├é┬á├éΓÇª','',2019,NULL,NULL,'2019-06-01',NULL,NULL,NULL,NULL,'6','Journal of Psychiatric Research','113','','83-89','Pergamon','YMH team','Neurobiology','illness specific areas'),(1216,'Personalising care options in youth mental health: using multidimensional assessment, clinical stage, pathophysiological mechanisms, and individual illness trajectories to├é┬á├éΓÇª','https://research.usc.edu.au/esploro/outputs/journalArticle/Personalising-care-options-in-youth-mental/99450835902621',NULL,'New models of mental health care for young people require that interventions be matched to illness type, clinical stage, underlying pathophysiological mechanisms and individual illness trajectories. Narrow syndrome-focused classifications often direct clinical attention away from other key factors such as functional impairment, self-harm and suicidality, alcohol or other substance misuse, and poor physical health. By contrast, we outline a treatment selection guide for early intervention for adolescent-onset mood and psychotic syndromes (ie, active treatments and indicated and more specific secondary prevention strategies). This guide is based on experiences with the Brain and Mind Centre\'s highly personalised and measurement-based care model to manage youth mental health. The model incorporates three complementary core concepts: A multidimensional assessment and outcomes framework including: social and occupational function; self-harm, suicidal thoughts and behaviours; alcohol or other substance misuse; physical health; and illness trajectory. Clinical stage. Three common illness subtypes (psychosis, anxious depression, bipolar spectrum) based on three underlying pathophysiological mechanisms (neurodevelopmental, hyperarousal, circadian). These core concepts are not mutually exclusive and together may facilitate improved outcomes through a clinical stage-appropriate and transdiagnostic framework that helps guide decisions regarding the provision of appropriate and effective care options. Given its emphasis on adolescent-onset mood and psychotic syndromes, the Brain and Mind Centre\'s model of care also respects a├é┬á├éΓÇª','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'6','Medical Journal of Australia','211','Supplement 9','S32-S41','Wiley-Blackwell Publishing Asia',NULL,NULL,NULL),(1217,'Clinical Staging and Its Potential to Enhance Mental Health Care','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85123892639&doi=10.1017%2f9781139839518.002&partnerID=40&md5=2c2aa9a13994cd1860267cfe2a2c834f','10.1017/9781139839518.002','Over the last two decades, application of the clinical staging model in mental health has been advanced to improve diagnosis, intervention, prediction of illness trajectory and, ultimately, outcomes. While clinical diagnosis remains the cornerstone for selecting appropriately targeted interventions and predicting long-term outcomes, diagnosis in mental health care has historically been very limited in its focus, utilising concepts largely based on characteristics of chronic or persistent phases of illness. Critically, this can lead to inappropriate treatment choices for individuals with earlier-stage presentations who do not meet full diagnostic criteria or sufficient severity (eg use of medications when simpler psychological or behavioural options are sufficient)(McGorry, 2013). The clinical staging model offers a substantive advance for mental health care as it goes beyond traditional fixed categories to incorporate a stepwise','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'6','Clinical Staging in Psychiatry: Making Diagnosis Work for Research and Treatment','','','Dec-33','','YMH team','Models of care',''),(1218,'The natural history of acute Q fever: A prospective Australian cohort','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84996841829&doi=10.1093%2fqjmed%2fhcw041&partnerID=40&md5=fdaab29676d82fac1d00141e984eb35c','10.1093/qjmed/hcw041','\n           Background: A detailed description of the natural history of acute Q fever, caused by infection with Coxiella burnetii,                    Aim           : To significantly increase understanding of the illness.                    Design: Subjects with provisional acute Q fever (n = 115) were recruited from primary care in rural Australia, and followed prospectively by interview and blood collection including for serological confirmation. A nested series of subjects with prolonged illness (cases), and those without (controls), were investigated in detail.                    Methods: Total phase I and phase II anti-C. burnetii antibodies were detected by complement fixation test; and IgG, IgM and IgA phase I and phase II titres by immunofluorescence. Flow cytometric analysis was conducted to enumerate circulating T cells subsets, B cells, monocytes and natural killer cells.                    Results: Serological testing confirmed acute Q fever in 73 subjects\n','',2016,NULL,NULL,'2016-10-01',NULL,NULL,NULL,NULL,'6','QJM','109','10','661-668','Oxford University Press','Other','',''),(1219,'NLG-based moderator response generator to support mental health','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84954232071&doi=10.1145%2f2702613.2732758&partnerID=40&md5=475908a087f85fd490bde7ed3bdf8c04','10.1145/2702613.2732758','The global need to effectively address mental health problems and wellbeing is well recognised. Today, online systems are increasingly being viewed as an effective solution for their ability to reach broad populations. As online support groups become popular the workload for human moderators increases. Maintaining quality feedback becomes increasingly challenging as the community grows. Tools that can automatically detect mental health problems from social media posts and then generate smart feedback can greatly reduce human overload. In this paper, we present a system for the automation of interventions using Natural Language Generation (NLG) techniques. In particular, we focus on\'depression\'and\'anxiety\'related interventions. Psychologists evaluated the quality of the systems\' interventions and results were compared against human (ie moderator) interventions. Results indicate our intervention','',2015,NULL,NULL,'2015-04-18',NULL,NULL,NULL,NULL,'6','Conference on Human Factors in Computing Systems - Proceedings','','','1385-1390','','YMH team','Digital health',''),(1220,'Depression: out of the shadows','https://scholar.google.com/scholar?cluster=14949982176515407049&hl=en&oi=scholarr',NULL,'','',2006,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'6','','','','','Media 21 Publishing',NULL,NULL,NULL),(1221,'Commentary on ├éΓÇÿEvaluating treatments for the mood disorders: time for the evidence to get real├éΓÇÖ','https://journals.sagepub.com/doi/abs/10.1080/j.1440-1614.2004.01387.x',NULL,'Clinical academics in Australasia take great pride in the ground-breaking efforts of Gavin Andrews and colleagues, who in association with the Royal Australian and New Zealand College of Psychiatrists, first argued the merits of an evidence-based approach to clinical psychiatry in the early 1980s [1, 2]. In this, and a series of other closely related articles [3, 4], Parker now asserts that there are major limitations to such research methods and that the evidence base for current recommendations for antidepressant treatments [5, 6] is severely flawed. At first glance, health professionals, administrators, consumers and their families might rightly be distressed by this view, especially when it is expressed by such an eminent clinician. Additionally, wide media reporting [7] of such views reinforces negative beliefs about the lack of seriousness of depressive disorders [8], and the dangers of presenting for treatment [9]. It is in├é┬á├éΓÇª','',2004,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'6','Australian & New Zealand Journal of Psychiatry','38','6','415-418','SAGE Publications',NULL,NULL,NULL),(1222,'E-health responses to common mental disorders in primary care: Experiences with \'beyondblue\' and \'SPHERE\'','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036750181&doi=10.1046%2fj.1440-1665.2002.00458.x&partnerID=40&md5=9ef2d451414784104862c6a7e88d31a4','10.1046/j.1440-1665.2002.00458.x','\n  Objective:  To highlight opportunities for enhancing mental health services in primary care through utilisation of e-health systems. Specifically, an information-based website (provided by \'beyondblue: the national depression initiative\') and a web-based support system for general practitioners (provided by \'SPHERE: a national depression project\') are described. \n  Conclusions:  Recommendations regarding potential roles for e-health systems in association with Australian primary care are outlined. \n','',2002,NULL,NULL,'2002-01-01',NULL,NULL,NULL,NULL,'6','Australasian Psychiatry','10','3','1-Apr','Taylor & Francis','YMH team','Digital health',''),(1223,'An agenda for psychiatric education in primary care','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032806697&doi=10.1046%2fj.1440-1665.1999.00190.x&partnerID=40&md5=3611fe9e43847154397d9a5f1b33a9a5','10.1046/j.1440-1665.1999.00190.x','Psychiatric epidemiology now highlights the need to improve markedly the delivery of psychological treatments in primary care. There have, however, been significant deficits in the training of practitioners for this role and a lack of ongoing support from specialist mental health services. This paper describes the educational and training agenda for ΓÇÿSPHERE: A National Depression Project├éΓÇÖ. Primarily, the SPHERE Project provides an opportunity for better organising ongoing education and training initiatives for treating common mental disorders in primary care. By having a broad base of interested practitioners the psychological care delivered within any target community may be rapidly expanded. The ongoing involvement of Divisions of General Practice, access to improved technologies and continuous modification of the Project to meet individual practitioners\' needs lie at the heart of the Project.','',1999,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'6','Australasian Psychiatry','7','3','133-136','SAGE Publications','YMH team','Mental Health System',''),(1224,'Treating depression and anxiety in general practice: training manual','https://scholar.google.com/scholar?cluster=16597437137636828391&hl=en&oi=scholarr',NULL,'','',1998,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'6','Sydney: Educational Health Solutions','','','','',NULL,NULL,NULL),(1225,'Erotomania associated with temporal lobe abnormalities following radiotherapy','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030704288&doi=10.3109%2f00048679709062693&partnerID=40&md5=11278094dcb967a683873306520ef655','10.3109/00048679709062693','\nObjective: The aetiology of primary erotomania is usually discussed in terms of psychological disturbance in the patient. A case associated with demonstrable left temporal lobe abnormalities is described.\nClinical picture: An elderly female patient presented with the delusion of being loved by a physician who had treated her previously. She had received radiotherapy to her left periorbital area in childhood. Structural and functional neuroimaging revealed medial temporal lobe damage.\nTreatment and outcome: She was treated with haloperidol with moderate improvement in her distress.\nConclusions: This case illustrates the contribution of both cerebral injury and psychosocial factors in the eventual development of this unusual psychiatric syndrome. Key words: erotomania, pathology, temporal lobe.\n','',1997,NULL,NULL,'1997-01-01',NULL,NULL,NULL,NULL,'6','Australian and New Zealand Journal of Psychiatry','31','5','765-768','Taylor & Francis','Other','',''),(1226,'Predicting the emergence of full-threshold bipolar I, bipolar II and psychotic disorders in young people presenting to early intervention mental health services','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85095457410&doi=10.1017%2fS0033291720003840&partnerID=40&md5=f7d2edde4b712350eea9728a34e5d1f3','10.1017/S0033291720003840','BackgroundPredictors of new-onset bipolar disorder (BD) or psychotic disorder (PD) have been proposed on the basis of retrospective or prospective studies of ├éΓÇÿat-risk├éΓÇÖ cohorts. Few studies have compared concurrently or longitudinally factors associated with the onset of BD or PDs in youth presenting to early intervention services. We aimed to identify clinical predictors of the onset of full-threshold (FT) BD or PD in this population.MethodMulti-state Markov modelling was used to assess the relationships between baseline characteristics and the likelihood of the onset of FT BD or PD in youth (aged 12├éΓÇô30) presenting to mental health services.ResultsOf 2330 individuals assessed longitudinally, 4.3% (n = 100) met criteria for new-onset FT BD and 2.2% (n = 51) met criteria for a new-onset FT PD. The emergence of FT BD was associated with older age, lower social and occupational functioning, mania-like experiences├é┬á├éΓÇª','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'5','Psychological Medicine','52','10','1990-2000','Cambridge University Press','YMH team','Outcome Research',''),(1227,'Impact of CYP2C19 metaboliser status on SSRI response: a retrospective study of 9500 participants of the Australian Genetics of Depression Study','https://www.nature.com/articles/s41397-022-00267-7',NULL,'\nBackground\nVariation within the CYP2C19 gene has been linked to differential metabolism of selective serotonin reuptake inhibitors (SSRIs). Pharmacogenetic recommendations based on the effect of CYP2C19 variants have been made available and are used increasingly by clinical practitioners. Nonetheless, the underlying assumption linking differential metabolism to efficacy or adverse side effects remains understudied. Here, we aim to fill this gap by studying CYP2C19 polymorphisms and inferred metabolism and patient-reported antidepressant response in a sample of 9531 Australian adults who have taken SSRIs.\nMethods\nMetaboliser status was inferred for participants based on CYP2C19 alleles. Primary analysis consisted of assessing differences in treatment efficacy and tolerability between normal (reference) and: ultrarapid, rapid, intermediate and poor metabolisers.\nResults\nAcross medications, poor├é┬á├éΓÇª\n','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'3','The pharmacogenomics journal','22','2','130-135','Nature Publishing Group',NULL,NULL,NULL),(1228,'Perinatal depression is associated with a higher polygenic risk for major depressive disorder than non-perinatal depression','https://onlinelibrary.wiley.com/doi/abs/10.1002/da.23232',NULL,'  Background Distinctions between major depressive disorder (MDD) and perinatal depression (PND) reflect varying views of PND, from a unique etiological subtype of MDD to an MDD episode that happens to coincide with childbirth. This case├éΓÇôcontrol study investigated genetic differences between PND and MDD outside the perinatal period (non-perinatal depression or NPD).   Methods We conducted a genome-wide association study├é┬áusing PND cases (Edinburgh Postnatal Depression Scale score = 13) from the Australian Genetics of Depression Study├é┬á2018 data (n = 3804) and screened controls (n = 6134). Results of gene-set enrichment analysis were compared with those of women with non-PND. For six psychiatric disorders/traits, genetic correlations with PND were evaluated, and logistic regression analysis reported polygenic score (PGS) association with both PND and NPD.   Results Genes├é┬á├éΓÇª\n','',2008,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'1','Depression and anxiety','39','3','182-191','',NULL,NULL,NULL),(1230,'Understanding genetic risk factors for common side effects of antidepressant medications','https://www.nature.com/articles/s43856-021-00046-8',NULL,'\nBackground\nMajor depression is one of the most disabling health conditions internationally. In recent years, new generation antidepressant medicines have become very widely prescribed. While these medicines are efficacious, side effects are common and frequently result in discontinuation of treatment. Compared with specific pharmacological properties of the different medications, the relevance of individual vulnerability is understudied.\nMethods\nWe used data from the Australian Genetics of Depression Study to gain insights into the aetiology and genetic risk factors to antidepressant side effects. To this end, we employed structural equation modelling, polygenic risk scoring and regressions.\nResults\nHere we show that participants reporting a specific side effect for one antidepressant are more likely to report the same side effect for other antidepressants, suggesting the presence of shared individual or├é┬á├éΓÇª\n','',2018,NULL,NULL,'2021-11-09',NULL,NULL,NULL,NULL,'2','Communications medicine','1','1','1-Oct','Nature Publishing Group',NULL,NULL,NULL),(1231,'Associations between the CADM2 gene, substance use, risky sexual behavior, and self-control: A phenome-wide association study','https://onlinelibrary.wiley.com/doi/abs/10.1111/adb.13015',NULL,' Risky behaviors, such as substance use and unprotected sex, are associated with various physical and mental health problems. Recent genome-wide association studies indicated that variation in the cell adhesion molecule 2 (CADM2) gene plays a role in risky behaviors and self-control. In this phenome-wide scan for risky behavior, it was tested if underlying common vulnerability could be (partly) explained by pleiotropic effects of this gene and how large the effects were. Single nucleotide polymorphism (SNP)-level and gene-level association tests within four samples (25 and Up, Spit for Science, Netherlands Twin Register, and UK Biobank and meta-analyses over all samples (combined sample of 362,018 participants) were conducted to test associations between CADM2, substance- and sex-related risk behaviors, and various measures related to self-control. We found significant associations between the├é┬á├éΓÇª\n','',2009,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'5','Addiction biology','26','6','e13015','',NULL,NULL,NULL),(1232,'Continuity of genetic risk for aggressive behavior across the life-course','https://link.springer.com/article/10.1007/s10519-021-10076-6',NULL,'We test whether genetic influences that explain individual differences in aggression in early life also explain individual differences across the life-course. In two cohorts from The Netherlands (N = 13,471) and Australia (N = 5628), polygenic scores (PGSs) were computed based on a genome-wide meta-analysis of childhood/adolescence aggression. In a novel analytic approach, we ran a mixed effects model for each age (Netherlands: 12├éΓÇô70├é┬áyears, Australia: 16├éΓÇô73├é┬áyears), with observations at the focus age weighted as 1, and decaying weights for ages further away. We call this approach a ├éΓÇÿrolling weights├éΓÇÖ model. In The Netherlands, the estimated effect of the PGS was relatively similar from age 12 to age 41, and decreased from age 41├éΓÇô70. In Australia, there was a peak in the effect of the PGS around age 40├é┬áyears. These results are a first indication from a molecular genetics perspective that genetic influences├é┬á├éΓÇª','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'3','Behavior genetics','51','5','592-606','Springer US',NULL,NULL,NULL),(1233,'Can network analysis of self-reported psychopathology shed light on the core phenomenology of bipolar disorders in adolescents and young adults?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102179468&doi=10.1111%2fbdi.13067&partnerID=40&md5=e50a5482f6d0bc35dde7bec5c785d4b1','10.1111/bdi.13067','  Objectives Network analysis is increasingly applied to psychopathology research. We used it to examine the core phenomenology of emerging bipolar disorder (BD I and II) and ├éΓÇÿat risk├éΓÇÖ presentations (major depression with a family history of BD).   Methodology The study sample comprised a community cohort of 1867 twin and nontwin siblings (57% female; mean age ~26) who had completed self-report ratings of (i) depression-like, hypomanic-like and psychotic-like experiences; (ii) family history of BD; and (iii) were assessed for mood and psychotic syndromes using the Composite International Diagnostic Interview (CIDI). Symptom networks were compared for recent onset BD versus other cohort members and then for individuals at risk of BD (depression with/without a family history of BD).   Results The four key symptoms that differentiated recent onset BD from other cohort members were: anergia, psychomotor├é┬á├éΓÇª\n','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'3','Bipolar Disorders','23','6','584-594','','YMH team','Illness specific areas',''),(1234,'Innovative preclinic triage system to guide Australians to the right mental health care first time','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85108859915&doi=10.1071%2fAH20233&partnerID=40&md5=8f1be7094b3c714ef914b5965da9a861','10.1071/AH20233','This paper presents a case study of an innovative direct-to-consumer preclinic triage system designed to reduce predicted peak demand for Australian mental health services as a result of COVID-19 and its associated socioeconomic consequences by guiding Australians to the right mental health care first time. Our innovative, digital health solution comprises two components: (1) a highly personalised and measurement-based model of care (Brain and Mind Centre model of care) that considers both the heterogeneity of mental disorders and other underlying comorbidities, as well as clinical staging; and (2) a health information technology (i.e. the InnoWell Platform). This digital health solution has been embedded as part of standard service delivery into a community-based intake service, thus resulting in a redesigned service model. The service model is currently being implemented as part of a pilot feasibility study','',2021,NULL,NULL,'2021-06-24',NULL,NULL,NULL,NULL,'2','Australian Health Review','45','5','578-583','CSIRO PUBLISHING','YMH team','Mental Health System',''),(1235,'Early expressions of psychopathology and risk associated with trans-diagnostic transition to mood and psychotic disorders in adolescents and young adults','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85107348981&doi=10.1371%2fjournal.pone.0252550&partnerID=40&md5=5d2a2cbf7f63a6eda186d84fedaf4d63','10.1371/journal.pone.0252550','Objectives The heterogeneity and comorbidity of major mental disorders presenting in adolescents and young adults has fostered calls for trans-diagnostic research. This study examines early expressions of psychopathology and risk and trans-diagnostic caseness in a community cohort of twins and non-twin siblings.   Methods Using data from the Brisbane Longitudinal Twin Study, we estimated median number of self-rated psychiatric symptoms, prevalence of subthreshold syndromes, family history of mood and/or psychotic disorders, and likelihood of subsequent trans-diagnostic caseness (individuals meeting diagnostic criteria for mood and/or psychotic syndromes). Next, we used cross-validated Chi-Square Automatic Interaction Detector (CHAID) analyses to identify the nature and relative importance of individual self-rated symptoms that predicted trans-diagnostic caseness. We examined the positive and negative predictive values (PPV; NPV) and accuracy of all classifications (Area under the Curve and 95% confidence intervals: AUC; 95% CI).   Results Of 1815 participants (Female 1050, 58%; mean age 26.40), more than one in four met caseness criteria for a mood and/or psychotic disorder. Examination of individual factors indicated that the AUC was highest for subthreshold syndromes, followed by family history then self-rated psychiatric symptoms, and that NPV always exceeded PPV for caseness. In contrast, the CHAID analysis (adjusted for age, sex, twin status) generated a classification tree comprising six trans-diagnostic symptoms. Whilst the contribution of two symptoms (need for sleep; physical activity) to the model was more','',2021,NULL,NULL,'2021-06-04',NULL,NULL,NULL,NULL,'2','PLoS ONE','16','6','e0252550','Public Library of Science','YMH team','Outcome Research',''),(1236,'Technology-enabled reform in a nontraditional mental health service for eating disorders: Participatory design study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101395785&doi=10.2196%2f19532&partnerID=40&md5=79b88416bff5454546c6e937cfda6f00','10.2196/19532','           Background           The recent Australian National Agenda for Eating Disorders highlights the role technology can play in improving accessibility and service development through web-based prevention, early access pathways, self-help, and recovery assistance. However, engagement with the eating disorders community to co-design, build, and evaluate these much-needed technology solutions through participatory design processes has been lacking and, until recently, underresourced.                             Objective           This study aims to customize and configure a technology solution for a nontraditional (web-based, phone, email) mental health service that provides support for eating disorders and body image issues through the use of participatory design processes.                             Methods           Participants were recruited chiefly through the Butterfly National Helpline 1800 ED HOPE (ButterflyΓÇÖs National Helpline), an Australian-wide helpline supporting anyone concerned by an eating disorder or body image issue. Participants included individuals with lived experience of eating disorders and body image issues, their supportive others (such as family, health professionals, support workers), and staff of the Butterfly Foundation. Participants took part in participatory design workshops, running up to four hours, which were held nationally in urban and regional locations. The workshop agenda followed an established process of discovery, evaluation, and prototyping. Workshop activities included open and prompted discussion, reviewing working prototypes, creating descriptive artifacts, and developing user journeys. Workshop artifacts were├é┬á├éΓÇª\n','',2021,NULL,NULL,'2021-02-16',NULL,NULL,NULL,NULL,'5','Journal of Medical Internet Research','23','2','e19532','JMIR Publications Inc., Toronto, Canada','YMH team','Digital health','illness specific areas'),(1237,'Neurocognitive functioning predicts suicidal behaviour in young people with affective disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85097676811&doi=10.1016%2fj.jad.2020.11.077&partnerID=40&md5=227d78097cfd01dd125c850dba80e645','10.1016/j.jad.2020.11.077','\n\nBackground\nNeurocognitive impairment is recognised as a risk factor for suicidal behaviour in adults. The current study aims to determine whether neurocognitive deficits also predict ongoing or emergent suicidal behaviour in young people with affective disorders.\n\n\nMethods\nParticipants were aged 12-30 years and presented to early intervention youth mental health clinics between 2008 and 2018. In addition to clinical assessment a standardised neurocognitive assessment was conducted at baseline. Clinical data was extracted from subsequent visits using a standardised proforma.\n\n\nResults\nOf the 635 participants who met inclusion criteria (mean age 19.6 years, 59% female, average follow up 476 days) 104 (16%) reported suicidal behaviour during care. In 5 of the 10 neurocognitive domains tested (cognitive flexibility, processing speed, working memory, verbal memory and visuospatial memory) those with suicidal├é┬á├éΓÇª\n\n','',2021,NULL,NULL,'2021-02-15',NULL,NULL,NULL,NULL,'5','Journal of Affective Disorders','281','','289-296','Elsevier','YMH team','Illness specific areas',''),(1238,'Distress, quality of life and disability in treatment-seeking young adults with social anxiety disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078615844&doi=10.1111%2feip.12910&partnerID=40&md5=8907b658e29d5da25d1464dfc7e33468','10.1111/eip.12910','  Aim This study aimed to: (a) examine whether treatment-seeking young adults with social anxiety disorder (SAD) demonstrate similar degrees of distress, quality of life (QoL) and disability to those with other mental disorders; and (b) investigate the impact of comorbidity, specific comorbid conditions and antidepressants use on distress, QoL and disability in treatment-seeking young adults with SAD.   Methods A cohort of treatment-seeking young adults (aged 16-45) diagnosed with SAD (N = 298) or other mental health disorders (N = 842; including depression, N = 349; bipolar, N = 141; psychosis, N = 173) completed self-report assessments of distress, QoL and disability.   Results Young adults with SAD showed distress and disability of similar degree to those with most other mental disorders. Specifically, young adults with SAD reported significantly lower QoL than those with major depressive disorder or\n','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'5','Early Intervention in Psychiatry','15','1','57-67','Wiley Publishing Asia Pty Ltd','YMH team','Outcome Research',''),(1239,'Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073056873&doi=10.1016%2fj.schres.2019.08.033&partnerID=40&md5=f1923a1a246ceab393153be01b9550c7','10.1016/j.schres.2019.08.033','Omega-3 long chain polyunsaturated fatty acids (n-3 LCPUFA) are necessary for optimum mental health, with recent studies showing low n-3 LCPUFA in people at ultra-high risk (UHR) of developing psychosis. Furthermore, people at UHR of psychosis had increased erythrocyte sphingomyelin (SM) and reduced phosphatidylethanolamine (PE) concentrations as well as 27 erythrocyte phospholipid species that differed when compared to erythrocytes from age matched people not at UHR of psychosis. The aim of this analysis was to evaluate the effect of n-3 supplementation on the different erythrocyte lipid species (including SM and PE concentrations) in people at UHR of psychosis. Participants were randomly assigned to fish oil (containing 840├é┬ámg EPA and 560├é┬ámg DHA per day) or placebo (paraffin oil) for 6├é┬ámonths. Fasted blood samples were taken at baseline and post intervention. Mass spectrometry was├é┬á├éΓÇª','',2020,NULL,NULL,'2020-12-01',NULL,NULL,NULL,NULL,'5','Schizophrenia Research','226','','52-60','Elsevier','Other','',''),(1240,'The value of early intervention in creating the new mental health system: Response to Allison et al','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085687752&doi=10.1177%2f0004867420925169&partnerID=40&md5=84d483597387c49c4ebc3a27f6ac480a','10.1177/0004867420925169','Australian & New Zealand Journal of Psychiatry, 54 (7) evident that substantial investment is urgently needed in adult mental health and this has been the goal of sustained advocacy led by some of us. The failures of the adult mental health system have largely driven the decision to hold the Royal Commission. Yet, the authors offer neither reflection upon these failures nor solutions. We, including our leading international coauthors, advocate for a united call for increased funding, system redesign and culture change for mental health services across the lifespan.','',2020,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'5','Australian and New Zealand Journal of Psychiatry','54','7','667-669','Sage Publications','Other','',''),(1241,'Gambling and the Role of Resilience in an International Online Sample of Current and Ex-serving Military Personnel as Compared to the General Population','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074580122&doi=10.1007%2fs10899-019-09900-w&partnerID=40&md5=dc4582f5372e937fb4eba8fed354f03f','10.1007/s10899-019-09900-w',' Compared to the general population, military personnel are particularly vulnerable to developing gambling problems. The present study examined the presentation of gamblingΓÇöincluding gambling frequency, personal thoughts on reducing gambling and recommendations from others to reduce gambling├éΓÇöacross these populations. Additionally, the study measured the association between gambling and various psychosocial risk and protective factors├éΓÇöincluding psychological distress, suicidal ideation, external encouragement to reduce substance use, days out of role, personal wellbeing, resilience, social support and intimate bonds. Data was extracted from the Global Health & Wellbeing Survey, an online self-report survey conducted in Australia, Canada, New Zealand, the United Kingdom and the United States. Of the 10,765 eligible respondents, 394 were military veterans and 337 were active military├é┬á├éΓÇª\n','',2020,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'4','Journal of Gambling Studies','36','2','477-498','Springer US','YMH team','Outcome Research',''),(1242,'Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081537228&doi=10.1016%2fj.schres.2020.03.008&partnerID=40&md5=03ed584aab6eb43e6385952490b4f845','10.1016/j.schres.2020.03.008','Neurocognitive impairments are well established in both ultra-high risk (UHR) for psychosis and major depressive disorder (MDD). Despite this understanding, investigation of neurocognitive deficits in UHR individuals with MDD and its association with MDD within this population, has been scarce. Hence, this study aimed to examine any differences in neurocognition at baseline between those with MDD at baseline and those with no history of MDD, as well as determine whether neurocognitive variables are significantly associated with meeting criteria for MDD at follow-up, while controlling for relevant clinical variables, within a UHR cohort. Data analysis was conducted on 207 participants whose baseline neurocognition was assessed using Brief Assessment of Cognition for Schizophrenia, as part of a trial of omega-3 fatty acids (NEURAPRO) for UHR individuals. While baseline MDD was the strongest predictor├é┬á├éΓÇª','',2020,NULL,NULL,'2020-04-01',NULL,NULL,NULL,NULL,'5','Schizophrenia Research','218','','48-54','Elsevier','Other','',''),(1243,'Moving beyond stepped care to staged care using a novel, technology-enabled care model for youth mental health','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074296578&doi=10.5694%2fmja2.50379&partnerID=40&md5=304f7eade87a4ebe85249ce9806df0a8','10.5694/mja2.50379','\nAustralia can rightly claim to lead the world in mental health awareness, especially for the mental health and wellbeing of young people. 1 However, despite the development of designated primary care-style services (eg, headspace), 1 we still do not deliver effective care, early in the course of illness, to most young people with anxiety, depression, or alcohol or other substance misuse. 2 Even when we do deliver care, the longer term functional outcomes are often disappointing. 3 The consequences of this failure remain largeΓÇöpersonally, socially and economically. 4\nWhile the Morrison Government is committed to expanding youth services and reducing youth suicide, 5 practical questions remain to be answered. Specifically, do we have: a viable clinical model; the necessary multidisciplinary workforce and team-based funding structures; health system capability and integration of key acute and ongoing service settings; regional planning, governance and service commissioning capability; and health information technology infrastructure to enable personal and system-level data tracking and integration?\n','',2019,NULL,NULL,'2019-11-03',NULL,NULL,NULL,NULL,'5','Medical Journal of Australia','211','9','404-405','','YMH team','Models of care','Digital health'),(1244,'Time for structural reform in mental health: Who is up for the challenge?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078890862&doi=10.1071%2fAHv43n4_ED&partnerID=40&md5=97569f0ec63b6c076e0584f2ea2337ca','10.1071/AHv43n4_ED','\nMental health reform is again in the newsΓÇôfor both the right and wrong reasons. On the upside, following his recent election victory, Prime Minister Scott Morrison has put youth suicide prevention, and more general mental health services initiatives, at the top of his personal priorities. This follows on from the Turnbull Government├éΓÇÖs commitment to invest in growing the ├éΓÇÿmental wealth├éΓÇÖof Australians. 1 Across the Tasman, Prime Minister Jacinda Ardern has surprised many by framing a 21st century national budget focused not simply on economic outcomes but rather national ├éΓÇÿwellbeing├éΓÇÖ, with a very strong emphasis on major new investments in mental health services. In California, new digital technology-based initiatives are being used to underpin a new state-wide effort to transform mental health and wellbeing.\nOn the downside, overwhelming numbers are presenting with mental ill-health or suicidal behaviour to├é┬á├éΓÇª\n','',2019,NULL,NULL,'2019-08-02',NULL,NULL,NULL,NULL,'5','Australian Health Review','43','4','361-362','CSIRO PUBLISHING','YMH team','Mental Health System','Models of care'),(1245,'The genetic relationship between psychological distress, somatic distress, affective disorders, and substance use in young australian adults: A multivariate twin study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049998934&doi=10.1017%2fthg.2018.33&partnerID=40&md5=f68f551708e4f0774b697334c3d039e9','10.1017/thg.2018.33','Psychological distress (PSYCH), somatic distress (SOMA), affective disorders (AD), and substance use (SU) frequently co-occur. The genetic relationship between PSYCH and SOMA, however, remains understudied. We examined the genetic and environmental influences on these two disorders and their comorbid AD and SU using structural equation modeling. Self-reported PSYCH and SOMA were measured in 1,548 twins using the two subscales of a 12-item questionnaire, the Somatic and Psychological Health Report. Its reliability and psychometric properties were examined. Six ADs, involvement of licit and illicit substance, and two SU disorders were obtained from 1,663ΓÇô2,132 twins using the World Mental Health Composite International Diagnostic Interview and/or from an online adaption of the same. SU phenotypes (heritability: 49├éΓÇô79%) were found to be more heritable than the affective disorder├é┬á├éΓÇª','',2018,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'5','Twin Research and Human Genetics','21','5','347-360','Cambridge University Press','YMH team','Neurobiology',''),(1246,'T49. The Neurapro study: adherence to study medication','https://academic.oup.com/schizophreniabulletin/article-abstract/44/suppl_1/S132/4957390',NULL,'                    Background           Adherence to a medication is generally defined as the extent to which patients take medications as prescribed by their health care providers. Poor adherence to study medication is not uncommon posing a major challenge to treatment trails. However, poor adherence may not be randomly distributed but rather be associated with demographic or illness factors. The aim of the present study was to identify factors associated with adherence to study medication in young people at ultrahigh risk of psychosis who participated in the NEURAPRO study.                             Methods           Secondary analysis of data collected in a multi-centre, double-blind, placebo-controlled, randomized clinical trial to prevent or delay the onset of psychosis in participants at ultrahigh risk of psychosis testing omega-3 polyunsaturated fatty acids (omega-3 PUFAs) vs. placebo, in combination with cognitive├é┬á├éΓÇª\n','',2018,NULL,NULL,'2018-04-01',NULL,NULL,NULL,NULL,'5','Schizophrenia Bulletin','44','suppl_1','S132-S133','Oxford University Press',NULL,NULL,NULL),(1247,'Impaired causal awareness and associated corticalΓÇôbasal ganglia structural changes in youth psychiatric disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84981239934&doi=10.1016%2fj.nicl.2016.06.017&partnerID=40&md5=b6adc94dabda64855a5130ffdb536aa0','10.1016/j.nicl.2016.06.017','\n\nBackground\nCognitive impairments contribute significantly to disease burden in young individuals presenting with major psychiatric disorders. The capacity to encode the consequences of one\'s actions may be of particular importance for real-world functioning due to its fundamental role in goal-directed behavior.\n\n\nMethods\nHere, we investigated a dimensional measure of causal awareness during a probabilistic learning task in 92 young individuals with an admixture of major mood and psychotic illnesses, at early and more established stages. Using automated gray matter segmentation of T1-weighted images, we estimated the volume and shapes of major subcortical structures and investigated their association with causal awareness.\n\n\nResults\nThe low causal awareness (LCA) group (n├é┬á=├é┬á35) reported increased social disability (p├é┬á=├é┬á.004) and reduced right pallidal size, specifically within the dorsolateral surfaces (p├é┬á=├é┬á.02├é┬á├éΓÇª\n\n','',2016,NULL,NULL,'2016-02-01',NULL,NULL,NULL,NULL,'5','NeuroImage: Clinical','12','','285-292','Elsevier','YMH team','Neurobiology',''),(1248,'Cell-mediated immune function and the outcome of chronic fatigue syndrome','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028863140&doi=10.1016%2f0192-0561%2895%2900056-8&partnerID=40&md5=5edbd79e0e01f9b11819ac4b3a3cf03f','10.1016/0192-0561(95)00056-8','This study examined the importance of cell-mediated immunity in determining the long-term outcome of patients diagnosed with chronic fatigue syndrome (CSF). A total of 103 patients (74%) of 139 previously enrolled in one of two treatment trials conducted within a university hospital referral centre was reviewed a mean of 3.2 yr after trial entry. Ongoing symptom severity, levels of disability and immunological function were assessed at follow-up. The relationship between immunological function at trial entry and measures of outcome was also evaluated. Sixty-five patients (63%) had improved, while only 6 (6%) reported no current symptoms. Thirty-one subjects (30%) were unable to perform any form of work and 26 (25%) were on a disability benefit directly attributable to CFS. Cell-mediated immune function, as measured at trial entry or follow-up, did not appear to affect outcome. Whilst improvement occurred in the','',1995,NULL,NULL,'1995-08-01',NULL,NULL,NULL,NULL,'5','International Journal of Immunopharmacology','17','8','691-694','Pergamon','Other','Outcome Research',''),(1249,'Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium','https://orca.cardiff.ac.uk/152050/1/Data_Sheet_2.pdf',NULL,'Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium Naomi R \nWray* 1, 2 Stephan Ripke* 3, 4, 5 Manuel Page 1 Major Depressive Disorder Working Group \nof the Psychiatric Genomics Consortium Naomi R Wray* 1, 2 Stephan Ripke* 3, 4, 5 Manuel \nMattheisen* 6, 7, 8 Maciej Trzaskowski 1 Enda M Byrne 1 Abdel Abdellaoui 9 Mark J Adams \n10 Esben Agerbo 11, 12, 13 Tracy M Air 14 Till FM Andlauer 15, 16 Silviu-Alin Bacanu 17 \nMarie B├â┬ªkvad-Hansen 13, 18 Aartjan TF Beekman 19 Tim B Bigdeli 17, 20 Elisabeth B Binder \n15, 21 Julien Bryois 22 Henriette N Buttensch├â┬╕n 13, 23, 24 Jonas Bybjerg-Grauholm 13, 18 \nNa Cai 25, 26 Enrique Castelao 27 Jane Hvarregaard Christensen 8, 13, 24 Toni-Kim Clarke \n10 Jonathan RI Coleman 28 Luc├â┬¡a Colodro-Conde 29 Baptiste Couvy-Duchesne 2, 30 Nick \nCraddock 31 Gregory E Crawford 32, 33 Gail Davies 34 Franziska Degenhardt 35 Eske M ├éΓÇª','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'5','Genome-wide association analyses identify','44','','','',NULL,NULL,NULL),(1251,'Distress Related to Attenuated Psychotic Symptoms: Static and Dynamic Association With Transition to Psychosis, Nonremission, and Transdiagnostic Symptomatology in Clinical High-Risk Patients in an International Intervention Trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85097788740&doi=10.1093%2fschizbullopen%2fsgaa006&partnerID=40&md5=72e2fb3d0cd66d7c53bbb14ee658e704','10.1093/schizbullopen/sgaa006','         This study examined whether distress in relation to attenuated psychotic symptoms (DAPS) is associated with clinical outcomes in an ultra-high risk (UHR) for psychosis sample. We also investigated whether DAPS is associated with cognitive style (attributional style and cognitive biases) and whether amount of psychosocial treatment provided is associated with reduction in DAPS. The study was a secondary analysis of the ├éΓÇ£Neurapro├éΓÇ¥ clinical trial of omega-3 fatty acids. Three hundred and four UHR patients were recruited across 10 early intervention services. Data from baseline assessment, regular assessments over 12 months, and medium term follow-up (mean = 3.4 years) were used for analysis. Findings indicated: a positive association between DAPS assessed over time and transition to psychosis; a significant positive association between baseline and longitudinal DAPS and transdiagnostic clinical and├é┬á├éΓÇª\n','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'5','Schizophrenia Bulletin Open','3','1','sgaa006','Oxford University Press','Other','',''),(1254,'Supporting clinicians to use technology to deliver highly personalized and measurement-based mental health care to young people: Protocol for an evaluation study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85108513312&doi=10.2196%2f24697&partnerID=40&md5=480d620d8eb1b17c6762dedd66180ef6','10.2196/24697','\nBackground: Australia├éΓÇÖs mental health care system has long been fragmented and under-resourced, with services falling well short of demand. In response, the World Economic Forum has recently called for the rapid deployment of smarter, digitally enhanced health services to facilitate effective care coordination and address issues of demand. The University of Sydney├éΓÇÖs Brain and Mind Centre (BMC) has developed an innovative digital health solution that incorporates 2 components: a highly personalized and measurement-based (data-driven) model of youth mental health care and a health information technology (HIT) registered on the Australian Register of Therapeutic Goods. Importantly, research into implementation of such solutions considers education and training of clinicians to be essential to adoption and optimization of use in standard clinical practice. The BMC├éΓÇÖs Youth Mental Health and Technology Program has subsequently developed a comprehensive education and training program to accompany implementation of the digital health solution.\nObjective: This paper describes the protocol for an evaluation study to assess the effectiveness of the education and training program on the adoption and optimization of use of the digital health solution in service delivery. It also describes the proposed tools to assess the impact of training on knowledge and skills of mental health clinicians.\nMethods: The evaluation study will use the Kirkpatrick Evaluation Model as a framework with 4 levels of analysis: Reaction (to education and training), Learning (knowledge acquired), Behavior (practice change), and Results (client outcomes). Quantitative├é┬á├éΓÇª\n','',2021,NULL,NULL,'2021-06-14',NULL,NULL,NULL,NULL,'5','JMIR Research Protocols','10','6','e24697','JMIR Publications Inc., Toronto, Canada','YMH team','Digital health',''),(1255,'Age-related parietal GABA alterations in children with autism spectrum disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101635432&doi=10.1002%2faur.2487&partnerID=40&md5=7f811e2172289b28e927a801a1e6eba0','10.1002/aur.2487','  GABA is the primary inhibitory neurotransmitter in the brain, and is essential to the balance of cortical excitation and inhibition. Reductions in GABA are proposed to result in an overly excitatory cortex that may cause, or contribute to, symptoms of autism spectrum disorder (ASD). This study employed a cross-sectional design to explore GABA+ differences in ASD and the impact of age, comparing 4ΓÇô12 year olds with ASD (N├é┬á=├é┬á24) to typically developing children (N├é┬á=├é┬á35). GABA+ concentration was measured using edited magnetic resonance spectroscopy in the left parietal lobe. This study used a mixed model to investigate group differences between children with ASD and typically developing children. There was a significant difference in GABA+ levels between the groups, a significant effect of age and interaction between age and diagnostic group. The ASD group showed an association between GABA+ and age├é┬á├éΓÇª\n','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'5','Autism Research','14','5','859-872','John Wiley & Sons, Inc.','Other','',''),(1256,'Evaluation of the usability and acceptability of the InnoWell platform as rated by older adults: Survey study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85104883670&doi=10.2196%2f25928&partnerID=40&md5=c5d044329b4d681bb069218e43509b52','10.2196/25928','           Background           As the global population ages, there is increased interest in developing strategies to promote health and well-being in later life, thus enabling continued productivity, social engagement, and independence. As older adults use technologies with greater frequency, proficiency, and confidence, health information technologies (HITs) now hold considerable potential as a means to enable broader access to tools and services for the purposes of screening, treatment, monitoring, and ongoing maintenance of health for this group. The InnoWell Platform is a digital tool co-designed with lived experience to facilitate better outcomes by enabling access to a comprehensive multidimensional assessment, the results of which are provided in real time to enable consumers to make informed decisions about clinical and nonclinical care options independently or in collaboration with a health professional.                             Objective           This study aims to evaluate the usability and acceptability of a prototype of the InnoWell Platform, co-designed and configured with and for older adults, using self-report surveys.                             Methods           Participants were adults 50 years and older who were invited to engage with the InnoWell Platform naturalistically (ie, at their own discretion) for a period of 90 days. In addition, they completed short web-based surveys at baseline regarding their background, health, and mental well-being. After 90 days, participants were asked to complete the System Usability Scale to evaluate the usability and acceptability of the prototyped InnoWell Platform, with the aim of informing the iterative redesign and\n','',2021,NULL,NULL,'2021-04-21',NULL,NULL,NULL,NULL,'5','JMIR Aging','4','2','e25928','JMIR Publications Inc., Toronto, Canada','YMH team','Digital health',''),(1257,'Schizophrenia polygenic risk scores in youth mental health: Preliminary associations with diagnosis, clinical stage and functioning','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85108224241&doi=10.1192%2fbjo.2021.14&partnerID=40&md5=7a4f6a8bbc839859ff5c7be68ead1218','10.1192/bjo.2021.14','Background     The schizophrenia polygenic risk score (SCZ-PRS) is an emerging tool in psychiatry. Aims     We aimed to evaluate the utility of SCZ-PRS in a young, transdiagnostic, clinical cohort. Method     SCZ-PRSs were calculated for young people who presented to early-intervention youth mental health clinics, including 158 patients of European ancestry, 113 of whom had longitudinal outcome data. We examined associations between SCZ-PRS and diagnosis, clinical stage and functioning at initial assessment, and new-onset psychotic disorder, clinical stage transition and functional course over time in contact with services. Results     Compared with a control group, patients had elevated PRSs for schizophrenia, bipolar disorder and depression, but not for any non-psychiatric phenotype (for example cardiovascular disease). Higher SCZ-PRSs were elevated in participants with psychotic, bipolar, depressive├é┬á├éΓÇª','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'5','BJPsych Open','7','2','','Cambridge University Press','YMH team','Illness specific areas',''),(1259,'16up: outline of a study investigating wellbeing and information and communication technology use in adolescent twins','https://www.cambridge.org/core/journals/twin-research-and-human-genetics/article/16up-outline-of-a-study-investigating-wellbeing-and-information-and-communication-technology-use-in-adolescent-twins/CF69CD2B0CA1D98CE6307B6C718024E9',NULL,'The ├éΓÇÿ16Up├éΓÇÖ study conducted at the QIMR Berghofer Medical Research Institute from January 2014 to December 2018 aimed to examine the physical and mental health of young Australian twins aged 16-18 years (N = 876; 371 twin pairs and 18 triplet sets). Measurements included online questionnaires covering physical and mental health as well as information and communication technology (ICT) use, actigraphy, sleep diaries and hair samples to determine cortisol concentrations. Study participants generally rated themselves as being in good physical (79%) and mental (73%) health and reported lower rates of psychological distress and exposure to alcohol, tobacco products or other substances than previously reported for this age group in the Australian population. Daily or near-daily online activity was almost universal among study participants, with no differences noted between males and females in terms of├é┬á├éΓÇª','',1996,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'5','Twin Research and Human Genetics','23','6','345-357','Cambridge University Press',NULL,NULL,NULL),(1261,'Youth Mental Health Tracker: protocol to establish a longitudinal cohort and research database for young people attending Australian mental health services','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086354519&doi=10.1136%2fbmjopen-2019-035379&partnerID=40&md5=bff00511f50e26ee92e6a9286a016b4d','10.1136/bmjopen-2019-035379','\nIntroduction Mental disorders are a leading cause of long-term disability worldwide. Much of the burden of mental ill-health is mediated by early onset, comorbidities with physical health conditions and chronicity of the illnesses. This study aims to track the early period of mental disorders among young people presenting to Australian mental health services to facilitate more streamlined transdiagnostic processes, highly personalised and measurement-based care, secondary prevention and enhanced long-term outcomes.\nMethods and analysis Recruitment to this large-scale, multisite, prospective, transdiagnostic, longitudinal clinical cohort study (├éΓÇÿYouth Mental Health Tracker├éΓÇÖ) will be offered to all young people between the ages of 12 and 30 years presenting to participating services with proficiency in English and no history of intellectual disability. Young people will be tracked over 3 years with standardised├é┬á├éΓÇª\n','',2020,NULL,NULL,'2020-06-01',NULL,NULL,NULL,NULL,'4','BMJ open','10','6','e035379','British Medical Journal Publishing Group','YMH team','Outcome Research',''),(1262,'Do schizotypal or borderline personality disorders predict onset of psychotic disorder or persistent attenuated psychotic symptoms in patients at high clinical risk?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086404744&doi=10.1016%2fj.schres.2020.03.065&partnerID=40&md5=876954c0d1e607c796a8a6920e5b5beb','10.1016/j.schres.2020.03.065','Do schizotypal or borderline personality disorders predict onset of psychotic disorder or \npersistent attenuated psychotic symptoms in patients at high clinical risk? - Zurich Open \nRepository and Archive Header Quicknavigation Home Navigation Content Contact Search \nNavigation Toggle navigation University of Zurich ZORA University of Zurich ZORA Homepage \nAbout ZORA OA-Team Statistics Login DE EN ZORA DE EN oai@hbz.uzh.ch Contact Open \nAccess Team via Email Visit the Facebook page of Main Library at UZH Visit the YouTube \nchannel of Main Library at UZH Visit the Twitter channel of Main Library at UZH Browse by: Year \nCreators & Editors Communities & Collections DDC Scopus Subject Areas Statistics DE EN \nAdvanced Search Help UZH-Logo Maintenance Infos Do schizotypal or borderline personality \ndisorders predict onset of psychotic disorder or persistent attenuated psychotic symptoms in ├éΓÇª','',2020,NULL,NULL,'2020-06-01',NULL,NULL,NULL,NULL,'4','Schizophrenia Research','220','','275-277','Elsevier','Other','',''),(1263,'W(h)ither psychiatry? Contemporary challenges in Australian mental health workforce design','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081532925&doi=10.1177%2f1039856220905300&partnerID=40&md5=cdee89c26358fd113f18941f9f859b9c','10.1177/1039856220905300','\nObjective:\nTo consider the changing profile of AustraliaΓÇÖs mental health workforce and the implications, particularly for specialist psychiatry services.\nMethod:\nWe analyse data from a national collection that describes changes in the workforce over a decade, to 2017├éΓÇô2018.\nResults:\nWhile single practitioner-based psychological services flourish, other areas of more complex and team-based care are struggling to remain relevant. Psychiatry and mental health nursing, two areas that previously led Australia├éΓÇÖs response to complex mental illness, are under enormous pressure.\nConclusion:\nThe shifting balance of specialised mental health workforces is affecting the mental healthcare available in each region of Australia. Questions arise regarding the desired or optimal mix of professionals we wish to deploy. What roles should each professional group play and how should they work together? What does this mean for how├é┬á├éΓÇª\n','',2020,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'4','Australasian Psychiatry','28','3','297-299','SAGE Publications','YMH team','Mental Health System',''),(1265,'A service delivery model to support highly personalised and measurement-based care in youth mental health','https://www.researchgate.net/profile/Shane-Cross/publication/346754101_A_service_delivery_model_to_support_highly_personalised_and_measurement-based_care_in_youth_mental_health/links/5fd02a94299bf188d403fc69/A-service-delivery-model-to-support-highly-personalised-and-measurement-based-care-in-youth-mental-health.pdf',NULL,'\nShane P Cross 1, Tracey A Davenport1, Elizabeth M Scott1, 2, Frank Iorfino1, Vilas Sawrikar1, 3, Ian B Hickie1 Mental health services in Australia are characterised by service fragmentation, late intervention, a lack of focus on an individualΓÇÖs needs, and inequitable distribution of scarce resources. 1 These factors perpetuate poor experiences of care and suboptimal outcomes for individuals. 1 For young people, additional challenges include: presentations of subthreshold disorders; 2├éΓÇô4 high rates of deterioration5, 6 and illness progression; 7, 8 high rates of self-harm and suicidality; impacts on social, educational or vocational participation; comorbid physical health problems; and alcohol or other substance misuse. 9├éΓÇô11 Consequently, there is a need to create person-centred and transdiagnostic youth mental health models of care that respond directly to these challenges. 11├éΓÇô19\nCurrent Australian health policy promotes a stepped-care service approach, designed to make the best use of available workforces and new technologies. 20, 21 Stepped-care models hierarchically arrange service provision based on proposed treatment intensity. 22, 23 Typically, individuals are stratified by current symptoms (or syndromes), functional impairment and risk assessment. However, such approaches tend to be generic and therefore result in broad, non-specific categories such as mild, moderate or severe. 20, 21 Typically, this categorisation does not detect the types of issues which can be identified by a highly personalised approach to care, which incorporates transdiagnostic youth models, multidimensional needs, likely underlying pathophysiological├é┬á├éΓÇª\n','',2021,NULL,NULL,'2019-11-01',NULL,NULL,NULL,NULL,'4','Med J Aust','211','9','S42-S46','',NULL,NULL,NULL),(1266,'The ΓÇ£uberisationΓÇ¥ of mental health care: a welcome global phenomenon?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072909743&doi=10.5694%2fmja2.50342&partnerID=40&md5=0397c80d9174ece225189bf34736cc46','10.5694/mja2.50342','\nThe World Economic Forum has highlighted the capacity for health information technologies to transform health care. 1 Four key care themes emerge: smart care (emphasising precision medicine); care anywhere (promoting access closer to home); empowered care (engaging people in their own care); and intelligent health enterprises (using data to drive new solutions). 1 More recently, the World Economic Forum has focused on the digital transformation of mental health care, 2 highlighting the need to address ethical issues such as privacy, trust and clinical governance.\nGiven the rapid spread of health information technologies and the unmet demand for mental health services, extensive deployment of digitally enhanced care is now inevitable. This will be driven by economic imperatives and more educated users. People expect access to digital tools that support greater choice, convenience, lower cost and higher quality care. However, given the broader socio-political concerns about the impacts of health information technologies, those engaged in this deployment will need to answer substantive ethical, legal and funding questions (Box).\n','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'4','Medical Journal of Australia','211','7','315-316','','YMH team','Mental Health System','Digital health'),(1267,'The Role of the Sleep-Wake Cycle in Adolescent Mental Illness','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078815082&doi=10.1007%2fs40675-019-00145-y&partnerID=40&md5=206e2f531294c5b5282b4ec8f3990e63','10.1007/s40675-019-00145-y','                                Purpose of Review                 Considerable sleep-wake cycle changes occur throughout adolescence and young adulthood, typically involving reductions of sleep duration and sleep-wake phase delays. The purpose of this review is to synthesize current evidence regarding sleep-wake cycle and circadian rhythm disturbance in adolescence, particularly in the context of emerging mental disorders.                                               Recent Findings                 The clinical presentation of sleep-wake disturbances in adolescents with emerging mood or psychotic disorders is heterogeneous and multifaceted both between individuals and across studies. Whilst the available evidence suggests that sleep-wake cycle disturbances are common in adolescents with emerging psychopathologies, there are limited studies conducted on this age group. The pathophysiological mechanisms underlying these relationships\n','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'4','Current Sleep Medicine Reports','5','3','118-127','Springer International Publishing','YMH team','Illness specific areas',''),(1268,'Does immune dysfunction in depression cause medical illness? Evaluation of the epidemiological evidence','https://www.taylorfrancis.com/chapters/edit/10.1201/9780429279164-6/immune-dysfunction-depression-cause-medical-illness-evaluation-epidemiological-evidence-ian-hickie-catherine-hickie-barbara-bennett',NULL,'The field of psychoimmunology attracts research workers from many disciplines largely as a result of its potential to elucidate the fundamental mechanisms by which the central nervous system interacts with peripheral immune, endocrine and neural mechanisms. If the immune dysfunction which occurs in depressive disorders results in new episodes of medical illness then one would expect to find: increased medical morbidity and/or mortality in depressed patients over time; and increased rates of specific disorders, such as malignancies and infection, which are associated with a compromised immune response. Increased morbidity or mortality and immune dysfunction may both be due to the pathophysiological consequences of a specific behavioural state, but the medical morbidity may not be due to concurrent immune changes. Depressive symptoms are commonly reported by patients in the period immediately','',2020,NULL,NULL,'2019-06-04',NULL,NULL,NULL,NULL,'4','','','','65-78','CRC Press',NULL,NULL,NULL),(1269,'An Uncertainty Visual Analytics Framework for fMRI Functional Connectivity','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052216385&doi=10.1007%2fs12021-018-9395-8&partnerID=40&md5=7a332b964b4b006ceca881b01dbb4b5e','10.1007/s12021-018-9395-8','               Analysis and interpretation of functional magnetic resonance imaging (fMRI) has been used to characterise many neuronal diseases, such as schizophrenia, bipolar disorder and AlzheimerΓÇÖs disease. Functional connectivity networks (FCNs) are widely used because they greatly reduce the amount of data that needs to be interpreted and they provide a common network structure that can be directly compared. However, FCNs contain a range of data uncertainties stemming from inherent limitations, e.g. during acquisition, as well as the loss of voxel-level data, and the use of thresholding in data abstraction. Additionally, human uncertainties arise during interpretation due to the complexity in understanding the data. While existing FCN visual analytics tools have begun to mitigate the human ambiguities, reducing the impact of data limitations is an open problem. In this paper, we propose a novel visual├é┬á├éΓÇª\n','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'4','Neuroinformatics','17','2','211-223','Springer US','Other','',''),(1270,'The neuropsychological profiles of young psychosis patients with and without current cannabis use','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059955510&doi=10.1080%2f13546805.2018.1562887&partnerID=40&md5=15cafaa186cb4ca0c0287bffd4ce8852','10.1080/13546805.2018.1562887','\n\nIntroduction: Evidence suggests that patients with psychosis who have a history of cannabis use, but currently abstain, demonstrate superior cognitive performance than patients who have never used cannabis. The present study aimed to determine the neurocognitive profiles of patients who are in adolescence or early adulthood, when both illness- and drug-onset typically occur.\n\nMethods: Subjects were 24 cannabis-using and 79 cannabis-na├»ve psychosis patients between 16 and 25 years of age. Patients and controls were administered a neurocognitive battery, indexing estimated pre-morbid intelligence, psychomotor speed, mental flexibility, verbal learning and memory, verbal fluency, sustained attention, motor and mental response, and visuospatial learning and memory.\n\nResults: While healthy controls outperformed both patient groups across most cognitive measures, no significant differences between├é┬á├éΓÇª\n','',2019,NULL,NULL,'2019-01-02',NULL,NULL,NULL,NULL,'4','Cognitive Neuropsychiatry','24','1','40-53','Routledge','YMH team','Illness specific areas',''),(1272,'A comprehensive assessment framework for youth mental health: guiding highly personalised and measurement-based care using multidimensional and objective measures','https://research.usc.edu.au/esploro/outputs/journalArticle/A-comprehensive-assessment-framework-for-youth/99450835402621',NULL,'There is an urgent need for improved care for young people with mental health problems, in particular those with subthreshold mental disorders that are not sufficiently severe to meet traditional diagnostic criteria. New comprehensive assessment frameworks are needed to capture the biopsychosocial profile of a young person to drive highly personalised and measurement-based mental health care. We present a range of multidimensional measures involving five key domains: social and occupational function; self-harm, suicidal thoughts and behaviours; alcohol or other substance misuse; physical health; and illness type, stage and trajectory. Objective measures include: neuropsychological function; sleep-wake behaviours and circadian rhythms; metabolic and immune markers; and brain structure and function. The recommended multidimensional measures facilitate the development of a comprehensive clinical picture. The objective measures help to further develop informative and novel insights into underlying pathophysiological mechanisms and illness trajectories to guide personalised care plans. A panel of specific multidimensional and objective measures are recommended as standard clinical practice, while others are recommended secondarily to provide deeper insights with the aim of revealing alternative clinical paths for targeted interventions and treatments matched to the clinical stage and proposed pathophysiological mechanisms of the young person.','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'4','Medical Journal of Australia','211','Supplement 9','S23-S31','Wiley-Blackwell Publishing Asia',NULL,NULL,NULL),(1273,'F25. NEURAPRO REVISITED: INCREASES IN LONG-CHAIN OMEGA-3 FATTY ACIDS IMPROVE FUNCTIONAL AND SYMPTOMATIC OUTCOMES IN ULTRAHIGH RISK PATIENTS','https://academic.oup.com/schizophreniabulletin/article-abstract/44/suppl_1/S228/4957622',NULL,'                    Background           The NEURAPRO multicentre randomised controlled trial (RCT) of long-chain polyunsaturated omega-3 fatty acids (-3 PUFAs) (├éΓÇÿfish oil├éΓÇÖ) in combination with high-quality psychosocial intervention (cognitive behavioural case management [CBCM]) vs. placebo in combination with CBCM in young people at ultrahigh risk (UHR) of psychosis showed that the group allocated to fish oil had no clinical benefits over the placebo group. However, a limitation of the trial was that adherence with the study medication was relatively low. Furthermore, although RCTs are placed at the top of the evidence hierarchy, this methodology has limitations in fish oil RCTs, since the test agent is not only present in the intervention group, but -3 fats are present in the diet and in the tissues of all participants. A biomarker analysis of -3 changes during the trial can ultimately determine the efficacy of -3├é┬á├éΓÇª\n','',2018,NULL,NULL,'2018-04-01',NULL,NULL,NULL,NULL,'','Schizophrenia Bulletin','44','suppl_1','S228-S228','Oxford University Press',NULL,NULL,NULL),(1274,'Mapping age effects along fiber tracts in young adults','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85023197388&doi=10.1109%2fISBI.2017.7950478&partnerID=40&md5=40d12bac78371c60b3316f3bab15587d','10.1109/ISBI.2017.7950478','','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Proceedings - International Symposium on Biomedical Imaging','','','','(IEEE) Institute of Electrical and Electronics Engineers','Other','',''),(1275,'Erratum: Circadian profiles in young people during the early stages of affective disorder','https://www.nature.com/articles/tp2012127',NULL,'ΓÇÿIBH has led projects for health professionals and the community supported by governmental, community agency and drug industry partners (Wyeth, Eli Lilly, Servier, Pfizer, AstraZeneca) for the identification and management of depression and anxiety. He has served on advisory boards convened by the drug industry in relation to specific antidepressants, including nefazodone, duloxetine and desvenlafaxine, and has participated in a multicenter clinical trial of agomelatine effects on sleep architecture in depression. He has participated in Servier-sponsored educational programs related to circadian-based therapies. ES has participated in educational and professional training programs that were supported by several pharmaceutical companies, including Pfizer, AstraZeneca, Servier and Eli Lilly. She has also participated in clinical research funded by Pfizer (focused on experiences of care) and Servier (focused on├é┬á├éΓÇª','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'4','Translational Psychiatry','3','1','e217-e217','Nature Publishing Group',NULL,NULL,NULL),(1276,'The National Heart Foundation of Australia consensus statement on psychosocial risk factors for coronary heart disease','https://www.heartlungcirc.org/article/S1443-9506(13)00973-6/abstract',NULL,'\nObjective: Text message-based interventions show great potential to effectively support lifestyle change for the secondary prevention of CVD. We aimed to assess acceptability and usability of text messages targeting lifestyle change.\nMaterials and Methods: We conducted two focus groups with CVD survivors who had participated in a six-month programme that involved receiving four mobile phone text messages per week. Standard focus group methodology was used including the use of a moderator, scribe and audio-taping. A set of seven questions and probes were used to facilitate discussion. Results: Thirteen patients participated in focus group discussion; mean age 60├é┬▒6 years, the majority (69%) were male and 62% used text messages daily. Participants felt receiving information and advice via text messages had a range of benefits including a feeling of being linked to the hospital and receiving personalised├é┬á├éΓÇª\n','',2013,NULL,NULL,'2013-01-01',NULL,NULL,NULL,NULL,'4','Heart, lung and circulation','22','','S258','Elsevier',NULL,NULL,NULL),(1277,'Cognitive training improves cognitive and psychosocial functioning in a mixed psychiatric outpatient sample','https://research.usc.edu.au/esploro/outputs/journalArticle/Cognitive-training-improves-cognitive-and-psychosocial/99450618502621',NULL,'','',2012,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'4','Journal of Cognitive Rehabilitation','28','','4-Oct','NeuroScience Publishers',NULL,NULL,NULL),(1278,'Cognitive impairment in the elderly homeless in the inner-city of Sydney: a preliminary report on a study in progress','https://search.informit.org/doi/abs/10.3316/INFORMIT.742754167632862',NULL,'The demography of the elderly homeless population in NSW and Sydney is discussed. It is mentioned that there is a significant unmet need for old age psychiatry services amongst the elderly homeless population in the inner-city of Sydney as evidenced by their high rates of mental health problems and mental illness, but most strikingly by their very high rates of significant cognitive impairment.','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'4','Parity','21','7','22-23','',NULL,NULL,NULL),(1279,'The Brain and Mind Research Institute: A unique campus for the integration of clinical and basic neurosciences in Australia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-45949110093&doi=10.1080%2f10398560802005100&partnerID=40&md5=aae1bec70b3d5da82ae8679c69f681b9','10.1080/10398560802005100','\n\nObjective: The aim of this paper is to describe the conceptual and practical development of the Brain and Mind Research Institute (BMRI) at the University of Sydney.\n\nMethod: The key conceptual framework of the BMRI is reviewed and contrasted with other biomedical institutes. The major timelines for appointment of key personnel, development of infrastructure and implementation of clinical capacities are presented.\n\nResults: The BMRI has developed over 15000 square metres of designated basic research and clinical space. This is thanks to major investments by the University of Sydney, the Australian and NSW governments and the wider community.\n\nConclusion: Amelioration of the burden of disease due to disorders of the brain and mind may result from a conceptual and practical move away from the traditional emphasis on single disorders or narrow research platforms.\n','',2008,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'4','Australasian Psychiatry','16','3','169-172','SAGE Publications','YMH team','Mental Health System',''),(1280,'The influence of mental health education on GPs\' management of depression','https://scholar.google.com/scholar?cluster=602098032812898090&hl=en&oi=scholarr',NULL,'','',2004,NULL,NULL,'2003-01-01',NULL,NULL,NULL,NULL,'4','','','','207-207','Australian Psychological Society',NULL,NULL,NULL),(1281,'EDITORIAL Reviving the diagnosis of neurasthenia','https://www.cambridge.org/core/journals/psychological-medicine/article/editorial-reviving-the-diagnosis-of-neurasthenia/3B010C8DC3FCA8F54D810325202DBF1E',NULL,'ΓÇÿWhether or not it is worthwhile to distinguish between ├éΓÇ£neurasthenia├éΓÇ¥ and ├éΓÇ£dysthymic disorders├éΓÇ¥ must depend either on the demonstration that such syndromes have different social covariates, or pursue a different course, or have particular responses to treatment. Until such studies are forthcoming, the distinction seems especially insubstantial.├éΓÇÖ (Goldberg & Bridges, 1991)Epidemiological studies now indicate that fatigue is one of the most common symptoms of ill-health in the community, primary care and other medical settings, and that syndromal diagnoses based on fatigue (including chronic fatigue and neurasthenia) are prevalent and major sources of health care utilization. Such syndromes are characterized by a combination of persistent and disabling fatigue and neuropsychological and neuromuscular symptoms (Lloyd et al. 1990; Angst & Koch, 1991; Sharpe et al. 1991; Fukuda et al. 1994). Essentially, the├é┬á├éΓÇª','',1997,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'4','Psychological Medicine','27','5','989-994','Cambridge University Press',NULL,NULL,NULL),(1282,'Reply-Cognitive Behavior Therapy for Chronic Fatigue Syndrome','https://scholar.google.com/scholar?cluster=3547476471474163986&hl=en&oi=scholarr',NULL,'','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'3','American Journal of Medicine','98','4','419-419','New York: Technical Pub. Co., 1946-',NULL,NULL,NULL),(1283,'Immune Function in Chronic Fatigue Syndrome and Depression: Implications for Understanding these Disorders and for Therapy','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0008232381&doi=10.1007%2fBF03259258&partnerID=40&md5=b2ebab27132ea82c38dad9e37156fb9f','10.1007/BF03259258','Considerable data now support the concept that patients with chronic fatigue syndrome and those with the melancholic subtype of major depression frequently have alterations in measures of immune function in vitro and in vivo. Although chronic fatigue syndrome and major depression have significant clinical similarity, the patterns of immunological and neuroendocrine alterations seen in the 2 disorders are dissimilar. The immunological changes provide tantalising clues to the pathophysiology of these disorders but, as yet, do not have clear implications for therapy.','',1994,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'3','Clinical Immunotherapeutics','2','2','84-88','Springer International Publishing','YMH team','Illness specific areas',''),(1284,'A brave new world in managing depression--or is it?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028412503&partnerID=40&md5=c59b82149ed881ca2fc36a1e7f7b2cb6','','In recent years new pharmacological agents have become available for the treatment of depression encouraging many to opt for the biochemical theory as the cause of depression. This article looks at the pros and cons and whether there is still a place for non pharmacological interventions in the treatment of depression.','',1994,NULL,NULL,'1994-04-01',NULL,NULL,NULL,NULL,'3','Australian family physician','23','4','627-632','','YMH team','Illness specific areas','Models of care'),(1285,'Propofol and ECT','https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/propofol-and-ect/1300456F6ECD9B7AE5C489527157B3EC',NULL,'//static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS0007125000131174/resource/name/firstPage-S0007125000131174a.jpg','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'3','The British Journal of Psychiatry','161','6','861-862','Cambridge University Press',NULL,NULL,NULL),(1286,'Immunological abnormalities in the chronic fatigue syndrome (Reply)','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025181537&doi=10.5694%2fj.1326-5377.1990.tb124438.x&partnerID=40&md5=7a89b454cc2e6a7c8f3ba46104a984e0','10.5694/j.1326-5377.1990.tb124438.x','','',1990,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'3','Medical Journal of Australia','152','1','51-52','','Other','',''),(1288,'The Feasibility of Magnetic Resonance Imaging in a Non-Selective Comprehensive Clinical Trial in Pediatric Autism Spectrum Disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85104935150&doi=10.1007%2fs10803-021-05028-2&partnerID=40&md5=bc8f07eece6d1d09e8bc91b319ed0445','10.1007/s10803-021-05028-2','There is an increasing interest in using magnetic resonance imaging (MRI) as a tool for precision medicine in autism spectrum disorder (ASD). This study investigated the feasibility of MRI scanning in a large comprehensive, inclusive and test heavy clinical trial for children (aged 3├éΓÇô12├é┬áyears) with ASD, without functioning constraints for participation. Of the 71 participants enrolled who consented to the MRI, 24 participants (38%) successfully completed an MRI scan at baseline along with other assessments. This scanning followed a familiarization procedure at two preceding visits. At post-treatment, 21 participants successfully completed the MRI scan. This study highlights the challenge of completing MRI assessments in ASD populations when conducted as one of a number of tests in a clinical trial.','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'3','Journal of Autism and Developmental Disorders','52','3','1211-1222','Springer US','Other','',''),(1293,'Genetic risk for chronic pain is associated with lower antidepressant effectiveness: Converging evidence for a depression subtype','https://journals.sagepub.com/doi/pdf/10.1177/00048674211031491',NULL,'\nIntroduction:\nChronic pain and depression are highly comorbid and difficult-to-treat disorders. We previously showed this comorbidity is associated with higher depression severity, lower antidepressant treatment effectiveness and poorer prognosis in the Australian Genetics of Depression Study.\nObjective:\nThe current study aimed to assess whether a genetic liability to chronic pain is associated with antidepressant effectiveness over and above the effect of genetic factors for depression in a sample of 12,863 Australian Genetics of Depression Study participants.\nMethods:\nPolygenic risk scores were calculated using summary statistics from genome-wide association studies of multisite chronic pain and major depression. Cumulative linked regressions were employed to assess the association between polygenic risk scores and antidepressant treatment effectiveness across 10 different medications.\nResults:\nMixed-effects├é┬á├éΓÇª\n','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'3','Australian & New Zealand Journal of Psychiatry','56','9','1177-1186','Sage Publications',NULL,NULL,NULL),(1295,'The association between migrant status and transition in an ultra-high risk for psychosis population','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099180219&doi=10.1007%2fs00127-020-02012-6&partnerID=40&md5=cc164dffac69048873bab5dfc9ad0bf4','10.1007/s00127-020-02012-6','                                Purpose                 Migrant status is one of the most replicated and robust risk factors for developing a psychotic disorder. This study aimed to determine whether migrant status in people identified as Ultra-High Risk for Psychosis (UHR) was associated with risk of transitioning to a full-threshold psychotic disorder.                                               Methods                 Hazard ratios for the risk of transition were calculated from five large UHR cohorts (n = 2166) and were used to conduct a meta-analysis using the generic inverse-variance method using a random-effects model.                                               Results                 2166 UHR young people, with a mean age of 19.1├é┬áyears (SD ├é┬▒ 4.5) were included, of whom 221 (10.7%) were first-generation migrants. A total of 357 young people transitioned to psychosis over a median follow-up time of 417├é┬ádays (I.Q.R.147├éΓÇô756├é┬ádays), representing 17.0% of the cohort. The├é┬á├éΓÇª\n','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'3','Social Psychiatry and Psychiatric Epidemiology','56','6','943-952','Springer Berlin Heidelberg','Other','',''),(1296,'The severity of the pathogen-induced acute sickness response is affected by polymorphisms in genes of the NLRP3 inflammasome pathway','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099719283&doi=10.1016%2fj.bbi.2021.01.005&partnerID=40&md5=8d19e72aff80de01af2b06127583800a','10.1016/j.bbi.2021.01.005','The acute sickness response (ASR) is a stereotyped set of symptoms including fatigue, pain, and disturbed mood, which are present in most acute infections. The immunological mechanisms of the ASR are conserved, with variations in severity determined partly by the pathogen, but also by polymorphisms in host genes. The ASR was characterised in three different serologically-confirmed acute infections in Caucasians (n┬á=├é┬á484) across four symptom domains or endophenotypes (termed ├éΓÇÿFatigue├éΓÇÖ, ├éΓÇÿMusculoskeletal pain├éΓÇÖ, ├éΓÇÿMood disturbance├éΓÇÖ, and ├éΓÇÿAcute sickness├éΓÇÖ). Correlations were sought with functional single nucleotide polymorphisms in the NLRP3 inflammasone pathway and severity of the endophenotypes. Individuals with severe Fatigue, Musculoskeletal pain, or Mood endophenotypes were more likely to have prior episodes of significant fatigue (11.4 vs. 3.8%, p├é┬á=├é┬á0.07), pain (14.3 vs. 1.2%, p├é┬á=├é┬á0.001), or Mood├é┬á├éΓÇª','',2021,NULL,NULL,'2021-03-01',NULL,NULL,NULL,NULL,'3','Brain, Behavior, and Immunity','93','','186-193','Academic Press','Other','',''),(1297,'Right Care, First Time: Developing a Theory-Based Automated Protocol to Help Clinically Stage Young People Based on Severity and Persistence of Mental Illness','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85114893392&doi=10.3389%2ffpubh.2021.621862&partnerID=40&md5=8f734f51d799ea8e4259975bf32e7380','10.3389/fpubh.2021.621862','Most mental disorders emerge before the age of 25 years and, if left untreated, have the potential to lead to considerable lifetime burden of disease. Many services struggle to manage high demand and have difficulty matching individuals to timely interventions due to the heterogeneity of disorders. The technological implementation of clinical staging for youth mental health may assist the early detection and treatment of mental disorders. We describe the development of a theory-based automated protocol to facilitate the initial clinical staging process, its intended use, and strategies for protocol validation and refinement. The automated clinical staging protocol leverages the clinical validation and evidence base of the staging model to improve its standardization, scalability, and utility by deploying it using Health Information Technologies (HIT). Its use has the potential to enhance clinical decision-making and','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'3','Frontiers in Public Health','9','','','Frontiers Media SA','YMH team','Digital health',''),(1299,'Building the social, economic, legal, and health-care foundations for ΓÇ£Contributing Lives and Thriving CommunitiesΓÇ¥','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078042531&doi=10.1016%2fS2215-0366%2819%2930378-5&partnerID=40&md5=4a2655ec54cc2eddc16edd699e10e051','10.1016/S2215-0366(19)30378-5','Although it is entirely possible for international organisations to provide a balanced approach to enhanced mental health care, 1 it is not inevitable. Recent statements2, 3 by the UN Special Rapporteur on Mental Health are a good example of how such balance is easily lost. These reports advance an ill-conceived and historically inaccurate4 proposition, namely that the','',2020,NULL,NULL,'2020-02-01',NULL,NULL,NULL,NULL,'3','The Lancet Psychiatry','7','2','119-121','Elsevier','YMH team','Models of care',''),(1301,'Replication of the psychometric properties of the WHODAS-II in individuals with autism spectrum disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073993693&doi=10.1002%2faur.2216&partnerID=40&md5=01300f2cadff77fbc23d5dd880ef1a84','10.1002/aur.2216','Replication of the psychometric properties of the WHODAS-II in individuals with autism \nspectrum disorder Replication of the psychometric properties of the WHODAS-II in individuals \nwith autism spectrum disorder Autism Res. 2019 Dec;12(12):1726-1727. doi: 10.1002/aur.2216. \nEpub 2019 Oct 8. Authors Shin H Park 1 , Eleni A Demetriou 1 , Karen L Pepper 1 , Yun JC \nSong 1 , Emma E Thomas 1 , Ian B Hickie 2 , Nick Glozier 2 , Adam J Guastella 1 Affiliations 1 \nBrain and Mind Centre, Children\'s Hospital Westmead Clinical School, Faculty of Medicine and \nHealth, University of Sydney, Sydney, New South Wales, Australia. 2 Brain and Mind Centre, \nCentral Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New \nSouth Wales, Australia. PMID: 31593369 DOI: 10.1002/aur.2216 No abstract available \nPublication types Letter Comment MeSH terms Autism Spectrum Disorder* Disability Evaluation ΓÇª','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'3','Autism Research','12','12','1726-1727','','Other','',''),(1302,'A case study of feedback and cognitive assessment of a young adult inpatient with major depressive disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061825456&doi=10.1177%2f1039856219828125&partnerID=40&md5=480e11b70cedd3b66f280565d8e310f8','10.1177/1039856219828125','\nObjectives:\nNeurocognitive assessment and feedback to a young adult inpatient.\nMethods:\nComputerised neurocognitive assessment and feedback.\nResults:\nA collaborative process of personalised intervention.\nConclusions:\nPersonalised feedback in this setting can be employed as a management tool to identify and prioritise care.\n','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'3','Australasian Psychiatry','27','3','302-306','SAGE Publications','YMH team','Models of care',''),(1303,'Genetic comorbidity between major depression and cardio-metabolic traits, stratified by age at onset of major depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088038263&doi=10.1002%2fajmg.b.32807&partnerID=40&md5=a060101560f4a0699db5b40da3ad27ce','10.1002/ajmg.b.32807',' Introduction It├éΓÇÖs imperative to understand the specific and shared aetiologies of major depression and cardio-metabolic disease, as both traits are frequently comorbid and each represents a major burden to society. This study examined whether there is a genetic association between major depression and cardio-metabolic traits and if this association is stratified by age at onset for major depression.\nMethods Polygenic risk scores analysis and linkage disequilibrium score regression was performed to examine whether differences in shared genetic aetiology exist between depression case control status (N cases = 40,940, N controls = 67,532), earlier (N = 15,844), and later onset depression (N = 15,800) with body mass index, coronary artery disease, stroke, and type 2 diabetes in eleven data sets from the Psychiatric Genomics Consortium, Generation Scotland, and UK Biobank.\nResults All cardio-metabolic polygenic risk scores were associated with depression status. Significant genetic correlations were found between depression and body mass index, coronary artery disease, and type 2 diabetes. Higher polygenic risk for body mass index, coronary artery disease and type 2 diabetes was associated with both early and later onset depression, while higher polygenic risk for stroke was associated with later onset depression only. Significant genetic correlations were found between body mass index and later onset depression, and between coronary artery disease and both early and late onset depression.\nConclusions The phenotypic associations between major depression and cardio-metabolic traits may partly reflect their overlapping genetic├é┬á├éΓÇª\n','',2020,NULL,NULL,'2019-01-01',NULL,NULL,NULL,NULL,'3','American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics','','','645077','Cold Spring Harbor Laboratory','Other','',''),(1304,'T9. CROSS-SECTIONAL ASSOCIATION OF MEMBRANE FATTY ACID COMPOSITION AND PSYCHOPATHOLOGY IN THE NEURAPRO-E STUDY','https://pdfs.semanticscholar.org/c44d/7500ba886902f01c91c85c5e76b8061ab8b0.pdf',NULL,'Background: Converging evidence suggests that people at ultra-high risk (UHR) for psychosis have depleted levels of several fatty acids (FAs), and that changes in omega-3 (n-3) FA levels may indicate a higher risk for transition to psychosis. However, limited information is available on how FA deficiencies relate to psychopathology in individuals with UHR phenotypes. Here, we report the relationship between membrane FA levels and symptom severity in a study of individuals at UHR for psychosis. Methods: Data from 280 of 304 (92%) of participants of the NEURAPRO study, a multi-centre randomized-controlled trial of omega-3 fatty acids versus placebo, were used for the present analysis. All participants were aged between 13 and 40 years and met criteria for UHR for psychosis. Blood samples were collected at study baseline and month 6 (end-of-intervention). Membrane fatty acids were analysed using mass spectrometry as percentage of total fatty acids in erythrocytes. Pearson correlation coefficients were calculated between baseline erythrocyte fatty acid levels and scores on the Scale for the Assessment of Negative Symptoms (SANS) and Brief Psychiatric Rating Scale (BPRS). Results: Negative symptoms were positively correlated with one saturated FA (Tetracosanoic acid [24: 0], R= 0.272, p< 0.0001), one n-3 FA (Eicosapentaenoic acid [20: 5], R= 0.142, p= 0.017) and one n-9 FA (Nervonic acid [24: 1], R= 0.274, p< 0.0001), and negatively correlated with one saturated FA (Palmitic acid [16: 0], R=-0.224, p< 0.0001), two n-6 FAs (Dihomo-y-linolenc acid [20: 3], R=-0.201, p< 0.001 and Linolelaidic acid [18: 2], R=-0.333, p< 0.0001), and├é┬á├éΓÇª','',2008,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'3','Schizophrenia Bulletin','44','Suppl 1','S116','Oxford University Press',NULL,NULL,NULL),(1305,'O8. 8. NEUROCOGNITION IN ULTRA-HIGHRISK INDIVIDUALS AND RELATIONSHIP TO TRANSITION TO PSYCHOSIS, DEPRESSIVE DISORDER, AND FUNCTIONING: FINDINGS FROM THE NEURAPRO TRIAL','https://academic.oup.com/schizophreniabulletin/article-abstract/44/suppl_1/S99/4957309',NULL,'                    Background           Neurocognitive impairments are a core feature of psychosis and major depressive disorder (MDD) and are associated with poorer functioning outcomes in these illnesses. Individuals at ultra-high risk (UHR) for psychosis have been shown to experience mild but significant cognitive impairments relative to healthy controls. Evidence suggests neurocognitive deficits are useful predictors of transition to psychotic disorder, although there is inconsistency regarding the specific domains implicated. Furthermore, depression is common in the UHR population, but the relationship between neurocognitive impairment and depression in UHR has not been investigated. The aim of this study was to examine neurocognitive functioning in UHR participants at baseline and whether neurocognitive performance is associated with i) transition to psychosis; ii) depressive disorder; and iii) functioning at├é┬á├éΓÇª\n','',2003,NULL,NULL,'2018-04-01',NULL,NULL,NULL,NULL,'3','Schizophrenia Bulletin','44','suppl_1','S99-S99','Oxford University Press',NULL,NULL,NULL),(1306,'Irreproducibility; Nothing is More Predictable','https://arxiv.org/abs/1803.04481',NULL,'The increasing ease of data capture and storage has led to a corresponding increase in the choice of data, the type of analysis performed on that data, and the complexity of the analysis performed. The main contribution of this paper is to show that the subjective choice of data and analysis methodology substantially impacts the identification of factors and outcomes of observational studies. This subjective variability of inference is at the heart of recent discussions around irreproducibility in scientific research. To demonstrate this subjective variability, data is taken from an existing study, where interest centres on understanding the factors associated with a young adult\'s propensity to fall into the category of `not in employment, education or training\' (NEET). A fully probabilistic analysis is performed, set in a Bayesian framework and implemented using Reversible Jump Markov chain Monte Carlo (RJMCMC). The results show that different techniques lead to different inference but that models consisting of different factors often have the same predictive performance, whether the analysis is frequentist or Bayesian, making inference problematic. We demonstrate how the use of prior distributions in Bayesian techniques can be used to as a tool for assessing a factor\'s importance.','',1997,NULL,NULL,'2018-03-12',NULL,NULL,NULL,NULL,'3','arXiv preprint arXiv:1803.04481','','','','',NULL,NULL,NULL),(1307,'Autism, first-episode psychosis, and social anxiety disorder: A transdiagnostic examination of executive function cognitive circuitry and contribution to disability','https://research.usc.edu.au/esploro/outputs/journalArticle/Autism-First-Episode-Psychosis-and-Social-Anxiety/99450443602621',NULL,'Non-syndromal X-linked intellectual disability (NS-XLID) represents a broad group of clinical disorders in which ID is the only clinically consistent manifestation. Although in many cases either chromosomal linkage data or knowledge of the> 100 existing XLID genes has assisted mutation discovery, the underlying cause of disease remains unresolved in many families. We report the resolution of a large family (K8010) with NSXLID, with variable macrocephaly and macro-orchidism. Although a previous linkage study had mapped the locus to Xq12-q21, this region contained too many candidate genes to be analyzed using conventional approaches. However, X-chromosome exome sequencing, bioinformatics analysis and segregation analysis revealed a novel missense mutation (c. 1012C> T; p. R338W) in ARHGEF9. This gene encodes collybistin (CB), a neuronal GDP-GTP exchange factor previously implicated in several cases of XLID, as well as clustering of gephyrin and GABAA receptors at inhibitory synapses. Molecular modeling of the CB R338W substitution revealed that this change results in the substitution of a long electropositive side-chain with a large non-charged hydrophobic side-chain. The R338W change is predicted to result in clashes with adjacent amino acids (K363 and N335) and disruption of electrostatic potential and local folding of the PH domain, which is known to bind phosphatidylinositol-3-phosphate (PI3P/PtdIns-3-P). Consistent with this finding, functional assays revealed that recombinant CB CB2 R338W SH3 was deficient in PI3P binding and was not able to translocate EGFP-- gephyrin to submembrane├é┬á├éΓÇª','',1995,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'3','Translational Psychiatry','8','','','Nature Publishing Group',NULL,NULL,NULL),(1308,'A pilot study of a brief intervention program (RECHARGE) to reduce sleep-wake and circadian rhythm disturbances in youth being treated for depression','https://scholar.google.com/scholar?cluster=12191762040130188767&hl=en&oi=scholarr',NULL,'\nAim: Sleep-wake and circadian rhythm disturbances are linked to the emergence and persistence of depression in youth. However, few youth-specific interventions have been developed to address these problems in clinical settings. We aimed to test the efficacy of a novel program targeted at sleep-wake and circadian rhythm problems in youth with depression.\nMethods: Adolescents and young adults with depression and sleep-wake disturbances were invited to join the 8-week RECHARGE program. Outcomes of interest were pre-to postintervention changes in self-reported sleep-wake patterns and circadian preference, actigraphy recordings of circadian sleep rhythms, and depressive symptoms.\nResults: 10 individuals completed the RECHARGE program showed modest improvements in self-reported sleep-wake patterns and circadian rhythmicity as measured by actigraphy; however these did not explain a significant portion of the variance in post-intervention\n','',1995,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'3','Int J Neurosci Res','1','102','10.31829','',NULL,NULL,NULL),(1309,'Use of mobile technologies to monitor activity, sleep, and mood states to identify targets of prevention of mood disorders','https://scholar.google.com/scholar?cluster=8477433990874698692&hl=en&oi=scholarr',NULL,'','',1994,NULL,NULL,'2015-12-01',NULL,NULL,NULL,NULL,'3','','40','','S507-S508','NATURE PUBLISHING GROUP',NULL,NULL,NULL),(1310,'The NEURAPRO-E study protocol: A multicentre RCT of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other├é┬á├éΓÇª','https://scholar.google.com/scholar?cluster=5481270703705900650&hl=en&oi=scholarr',NULL,'','',1994,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'3','Early Interv Psychiatry','','','','',NULL,NULL,NULL),(1311,'eHealth integrated interventions for MH','https://dspace.library.uu.nl/bitstream/handle/1874/305905/1881-7766-1-PB.pdf?sequence=2',NULL,'\nAustralia is an innovator in the development of e health interventions for mental health conditions, such as anxiety, depression, PTSD, suicide risk, and comorbidity with drug and alcohol problems.\nE mental health is cost effecitve, able to be delivered into a range of settings, including health, education and community contexts, works for mild to moderate as well as more severe mental health conditions. Importantly, e health solutions are likely to cost less than face to face conditions, yet are relatively under-used. There are a variety of ΓÇÿmodels├éΓÇÖ for e health delivery. However, a major problem has been the difficulty in integrating e health into health systems.\n','',1992,NULL,NULL,'2014-12-08',NULL,NULL,NULL,NULL,'3','International Journal of Integrated Care','14','9','','Igitur',NULL,NULL,NULL),(1312,'More age-care staff report helping care recipients following a brief depression awareness raising intervention','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84875839289&doi=10.1186%2f1472-6955-12-10&partnerID=40&md5=a4da2fc77c95c2677abf578a23268e6d','10.1186/1472-6955-12-10','Those working with elderly care recipients require a good working knowledge of depression and appropriate help giving responses. While it is important for age-care staff to recognize depression in care recipients it is also critical that they know the appropriate course of action to assist a care recipient who may be depressed. This study aims to determine the knowledge of age-care staff of appropriate help giving responses, their confidence in knowing what kind of assistance to provide and their actual likelihood of providing help to potentially depressed care recipients and to examine if these measures improve following an intervention training program. One hundred and two age-care staff were surveyed on their confidence in helping age-care recipients and on their knowledge of appropriate ways to provide assistance. Staff then participated in a two hour depression awareness raising intervention. The survey was','',2013,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'3','BMC Nursing','12','1','1-Jul','BioMed Central','Other','',''),(1313,'Unitary hormonal models, peripheral markers, and evaluation of response to drug: A response to Weisman and Feldman','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84876081927&doi=10.1016%2fj.psyneuen.2013.03.005&partnerID=40&md5=70a776bd0d14d7916c82c1f039445972','10.1016/j.psyneuen.2013.03.005','\nThere is growing recognition of the complexity in studying cognitive, behavioral, and neural effects of oxytocin (OT) administration in humans. We recently emphasized the importance of standardization of experimental methodologies assessing social cognition (Guastella and MacLeod, 2012) and delivery of peptide nasal spray (Guastella et al., in press) in such investigations. This is partly in response to a growing number of reported and inconsistent individual differences and contextual factors believed to moderate response, combined with a lack of consideration for factors associated with experimental designs.\nWeisman and Feldman (2013) have thoughtfully placed debate about unitary hormonal explanations and argued for the study of interplay between hormonal and neurochemical systems (eg Bos et al., 2012; Goodson, 2013). In addition to what occurs subsequent to OTrelease, animal studies reveal a remarkable lack of receptor selectivity amongst OTand vasopressin agonists and antagonists, as well as interspecies differences in selectivity (Manning et al., 2012). Receptor selectivity may be further lost when higher doses of drug are employed (Manning et al., 2012). As Insel (2010) noted, the efficacy of peptide administration is also likely to be moderated by genetic variants in receptor expression. Elevations or suppression of hormones may, therefore, not only be triggeredbyincreasesinOTlevels (exogenousorendogenous), but also via receptor cross-reactivity of agonists/antagonists and individual differences in receptor expression. To assess interplay between hormonal systems, Weisman and Feldman, 2013 argued for the use of\n','',2013,NULL,NULL,'2013-05-01',NULL,NULL,NULL,NULL,'2','Psychoneuroendocrinology','38','5','627-628','Elsevier','Other','',''),(1314,'MM-115 SLEEP-WAKE PATTERNS AND MOOD DISTURBANCES IN PATIENTS WITH PSYCHOTIC DISORDERS: A CONTROLLED STUDY','https://www.infona.pl/resource/bwmeta1.element.elsevier-6071f4d3-2229-3bad-aed6-55d2b3b5cd38',NULL,'MM-115 SLEEP-WAKE PATTERNS AND MOOD DISTURBANCES IN PATIENTS WITH \nPSYCHOTIC DISORDERS: A CONTROLLED STUDY ├âΓÇö Close The Infona portal uses cookies, \nie strings of text saved by a browser on the user\'s device. The portal can access those files and \nuse them to remember the user\'s data, such as their chosen settings (screen view, interface \nlanguage, etc.), or their login data. By using the Infona portal the user accepts automatic \nsaving and using this information for portal operation purposes. More information on the \nsubject can be found in the Privacy Policy and Terms of Service. By closing this window the \nuser confirms that they have read the information on cookie usage, and they accept the privacy \npolicy and the way cookies are used by the portal. You can change the cookie settings in your \nbrowser. I accept Polski English Login or register account remember me Password recovery ├éΓÇª','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'2','Sleep Medicine','','12','S53','',NULL,NULL,NULL),(1315,'Environmental factors surpass genetic influences in determining fiber microstructure as the brain develops: a diffusion tensor imaging study of 705 twins','https://scholar.google.com/scholar?cluster=3998397004322971233&hl=en&oi=scholarr',NULL,'Methods (1,213 characters): We acquired 30-gradient DTI at 4 Tesla from 705 twins and their non-twin siblings, including 531 healthy adults (aged 20 or older) and 174 adolescents (aged 12 and 16), from 358 different families. High angular resolution diffusion-weighted scans (b= 1145.7 s/mm2). were acquired using single-shot echo planar imaging with a twice-refocused spin echo sequence, to reduce eddy-current distortions. Total scan time was 3.05 minutes. We used FSL software (http://www. fmrib. ox. ac. uk/fsl/) to pre-processing and linearly align the diffusion images. FA maps computed from the linearly-registered DT data were fluidly registered to a mean FA template. We assessed age-related differences in heritability of white matter integrity between adolescence (age< 20 years) and adulthood (age= 20 years) by modeling age as a moderator that linearly interacts with additive genetic and unique','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'2','San Diego, Calif, USA','','','','',NULL,NULL,NULL),(1316,'Chronic Fatigue and Postinfective Fatigue Syndromes','https://onlinelibrary.wiley.com/doi/abs/10.1128/9781555815981.ch17',NULL,'                                                         Chronic fatigue syndrome and postinfective fatigue syndrome have been the focus of considerable research interest, including epidemiological studies; investigations of microbiological, immunologic, neuroendocrine, metabolic, and psychological hypotheses of etiology; and treatment interventions. The most widely known predecessor to the current label of chronic fatigue syndrome is the disorder termed ΓÇ£neurasthenia,├éΓÇ¥. The fatigue state was present from the time of onset of symptoms of the acute infection and was stable in character over time, suggesting that the genesis of the postinfective fatigue syndrome is intrinsically linked to the host-pathogen interactions in the acute infection phase. The fatigue syndrome was most prevalent in those with mononucleosis documented to be due to Epstein-Barr virus (EBV) infection and was shown to be essentially independent of psychiatric├é┬á├éΓÇª\n','',2021,NULL,NULL,'2009-02-27',NULL,NULL,NULL,NULL,'2','Clinical Virology','','','371-383','ASM Press',NULL,NULL,NULL),(1317,'Specific Mental Health Disorders: Depressive and Anxiety Disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85043342162&doi=10.1016%2fB978-0-12-803678-5.00425-2&partnerID=40&md5=026559fa0d1d2ead3aea11b396a6df07','10.1016/B978-0-12-803678-5.00425-2','The degree of disability associated with common forms of anxiety and depression is due largely to the combination of early age of onset, a natural history of recurrence or persistence of symptoms, frequent comorbidity with harmful use of alcohol or other substances, and increased risk of common medical conditions, notably cardiovascular disease. As most people do not have affordable access to evidence-based medical or psychological care, do not present to clinical services, or do not continue with effective treatments, opportunities to reduce illness burden are often missed. Major public health initiatives, e-health technologies, and reform of clinical services to emphasize collaborative care are now developing internationally. Together, these developments can offer hope of real improvements.','',2016,NULL,NULL,'2008-01-01',NULL,NULL,NULL,NULL,'2','International Encyclopedia of Public Health','','','154-169','Academic Press','YMH team','Models of care',''),(1318,'Evidence-based guidelines: response to Professor Gordon Parker\'s critique','https://journals.sagepub.com/doi/abs/10.1080/j.1440-1614.2004.01506.x',NULL,'\n\nObjective: To clarify the development of the ΓÇÿAustralian and New Zealand clinical practice guidelines for the treatment of depression├éΓÇÖ and to discuss the critique of these guidelines.\n\nMethod: Consideration of international practice in evidence-based medicine and rebuttal of criticisms.\n\nResults: We agree with Professor Gordon Parker on fundamental issues in the treatment of depression. His main criticisms reflect his concerns about the classification of depression. We consider that many of his detailed criticisms reflect a difference of opinion on how data should be evaluated or interpreted.\n\nConclusions: The guideline for the treatment of depression makes sound recommendations, in agreement with comparable guidelines from the US and the UK.\n','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'2','Australian & New Zealand Journal of Psychiatry','38','11-Dec','891-895','Sage Publications',NULL,NULL,NULL),(1319,'In reply: Measuring outcomes in patients with depression and anxiety: an essential part of clinical practice','https://www.mja.com.au/journal/2003/178/1/reply-measuring-outcomes-patients-depression-and-anxiety-essential-part-clinical',NULL,'In reply: It is pleasing to note that a senior psychiatrist is looking at the practicality of general practitioners (GPs) measuring the clinical outcome of patients with mental disorders. However, Dinnen\'s concerns may be groundless. For example, the Kessler Psychological Distress scale (K10) consists of 10 simple questions that patients can complete in two minutes in the waiting room and doctors can then score by summing 10 numbers between one and five. 1 This takes less time than writing a progress note.','',2021,NULL,NULL,'2003-01-06',NULL,NULL,NULL,NULL,'2','The Medical Journal of Australia','178','1','48','',NULL,NULL,NULL),(1320,'Improving community-based services for older patients with depression: The benefits of an educational and service initiative','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034843278&doi=10.1046%2fj.1440-1614.2001.00921.x&partnerID=40&md5=e224a6b1b8a34b58125d5191907f330e','10.1046/j.1440-1614.2001.00921.x','\n\nObjective: The objective of this study was to report a quality improvement project for older patients with depression. The initiative focused on both clinical practice changes (improvement of medical, neurocognitive and behavioural assessment) and service development (greater continuity of care).\n\nMethod: After initial identification of key deficits, implementation of a service and educational initiative took place within a district mental health service. The service consisted of an inpatient unit, a specialized psychogeriatric service and two adult community mental health services. Mental health staff received education regarding the specific needs of older patients with depression and were provided with assessment materials, patient education and treatment aids. General practitioners participated in shared long-term management.\n\nResults: Following graded implementation, the management of 44 subjects (mean age = 65.4\n','',2001,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'2','Australian and New Zealand Journal of Psychiatry','35','4','449-454','Sage Publications','Other','',''),(1321,'Molecular biology and the major psychoses','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031010196&doi=10.3109%2f00048679709073794&partnerID=40&md5=a7975882c6b111a832ebf00e2ac686d8','10.3109/00048679709073794','\nObjective: To highlight the potential role of molecular biological studies in examining the expression of genes of interest in brain tissue to elucidate the pathophysiological basis of the major psychoses.\nMethod: To review the principles underlying the available techniques for expression studies.\nResults: Detection of messenger RNA by in situ hybridisation and quantitation by Northern analysis are powerful tools to detect abnormalities in gene expression in brain tissue.\nConclusion: The availability of simple techniques to examine the expression of RNA and protein products of individual genes, including examination at the level of individual cells, offers a clear opportunity to define the molecular basis of the major psychoses.\n','',1997,NULL,NULL,'1997-01-01',NULL,NULL,NULL,NULL,'2','Australian and New Zealand Journal of Psychiatry','31','1','Dec-16','Taylor & Francis','Other','',''),(1322,'Studies of the pathophysiology of chronic fatigue syndrome in Australia','https://scholar.google.com/scholar?cluster=10579748783500398020&hl=en&oi=scholarr',NULL,'','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'2','INFECTIOUS DISEASE AND THERAPY SERIES','14','','353-353','MARCEL DEKKER AG',NULL,NULL,NULL),(1323,'Taking chronic fatigue syndrome seriously [6]','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026490241&partnerID=40&md5=29ca229e15791ea2f88423842b85695e','','\nI. The authors omitted recent medical research into the etiology of chronic fatigue syndrome. This includes polymer chain reaction techniques that show a possible association be-tween chronic fatigue syndrome and a retrovirus(I) and immune system abnormalities and activation markers (2). 2. The authors failed to examine the research on neuropsy-chological abnormalities. MRI scans have revealed abnormalities (3), as have single photon emission computed tomography (SPECT) and brain electrical activity mapping scans (4). Reduced ability to acquire new information, as well as drop in IQ, have been seen (unpublished 1989 paper by S. Bastien).\n3. The authors concluded that a majority ofchronic fatigue syndrome patients will have an identifiable psychiatric disor-der. Patients may develop psychiatric difficulties once they acquire chronic fatigue syndrome, but a recent study has shown that the incidence of prc\n','',1992,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'2','American Journal of Psychiatry','149','12','1755-b-1756','American Psychiatric Publishing','Other','',''),(1324,'Participatory Systems Modelling for Youth Mental Health: An Evaluation Study Applying a Comprehensive Multi-Scale Framework','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85127070510&doi=10.3390%2fijerph19074015&partnerID=40&md5=7bbc75119020ece0490ac4c90cc6f512','10.3390/ijerph19074015','The youth mental health sector is persistently challenged by issues such as service fragmentation and inefficient resource allocation. Systems modelling and simulation, particularly utilizing participatory approaches, is offering promise in supporting evidence-informed decision making with limited resources by testing alternative strategies in safe virtual environments before implementing them in the real world. However, improved evaluation efforts are needed to understand the critical elements involved in and to improve methods for implementing participatory modelling for youth mental health system and service delivery. An evaluation protocol is described to evaluate the feasibility, value, impact, and sustainability of participatory systems modelling in delivering advanced decision support capabilities for youth mental health. This study applies a comprehensive multi-scale evaluation framework, drawing on participatory action research principles as well as formative, summative, process, and outcome evaluation techniques. Novel data collection procedures are presented, including online surveys that incorporate gamification to enable social network analysis and patient journey mapping. The evaluation approach also explores the experiences of diverse stakeholders, including young people with lived (or living) experience of mental illness. Social and technical opportunities will be uncovered, as well as challenges implementing these interdisciplinary methods in complex settings to improve youth mental health policy, planning, and outcomes. This study protocol can also be adapted for broader international applications, disciplines, and contexts.','',2022,NULL,NULL,'2022-03-28',NULL,NULL,NULL,NULL,'2','International Journal of Environmental Research and Public Health','19','7','4015','MDPI','YMH team','Mental Health System',''),(1325,'Implementing 21st century ΓÇ£end-to-endΓÇ¥ and technology-enhanced care for young people','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85122727550&doi=10.1002%2fwps.20928&partnerID=40&md5=6e0ad0c01f742a305b4758125b4748fa','10.1002/wps.20928','80 World Psychiatry 21: 1-February 2022 goal of clinical care to provide high-quality and more personalized interventions. If the more substantive aim is to halt or even reverse illness course and, thereby, prevent premature death or long-term functional impairment, then it is timely to ask: are the new youth services optimally designed to deliver these outcomes? To date, national health systems have never seriously moved to implement an integrated ├éΓÇ£supply-chain├éΓÇ¥ of clinical services, operating across the spectrum from indicated prevention to continuing specialist care. By contrast, the traditional response to the ever-increasing demand is to add new stand-alone service ├éΓÇ£blocks├éΓÇ¥ to the existing disconnected structures. New service ├éΓÇ£blocks├éΓÇ¥ are often based on historic concepts of primary, secondary and specialist care. Typically, access to specialist services remains severely restricted, being reserved largely for those├é┬á├éΓÇª','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'2','World Psychiatry','21','1','79','World Psychiatric Association','YMH team','Digital health','Models of care'),(1327,'Fit for PurposeΓÇöRe-Designing AustraliaΓÇÖs Mental Health Information System','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85128203541&doi=10.3390%2fijerph19084808&partnerID=40&md5=47e5916174e679c27b1988fbe92de5b9','10.3390/ijerph19084808','\nBackground:\n Monitoring and reporting mental health is complex. Australia├éΓÇÖs first National Mental Health Strategy in 1992 included a new national commitment to accountability and data collection in mental health. This article provides a narrative review of thirty years of experience. Materials and Methods:\n This review considers key documents, policies, plans and strategies in relation to the evolution of mental health data and reporting. Documents produced by the Federal and the eight state and territory governments are considered, as well as publications produced by key information agencies, statutory authorities and others. A review of this literature demonstrates both its abundance and limitations. Results:\n Australia├éΓÇÖs approach to mental health reporting is characterised by duplication and a lack of clarity. The data available fail to do justice to the mental health services provided in Australia. Mental health data collection and reporting processes are centrally driven, top├éΓÇôdown and activity-focused, largely eschewing actual health outcomes, the social determinants of mental health. There is little, if any, link to clearly identifiable service user or carer priorities. Consequently, it is difficult to link this process longitudinally to clinical or systemic quality improvement. Initial links between the focus of national reform efforts and mental health data collection were evident, but these links have weakened over time. Changes to governance and reporting, including under COVID, have made the task of delivering accountability for mental health more difficult. Conclusion:\n Australia├éΓÇÖs current approach is not fit for purpose. It is at a pivotal point in mental health reform├é┬á├éΓÇª','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'2','International Journal of Environmental Research and Public Health','19','8','4808','Multidisciplinary Digital Publishing Institute','YMH team','Mental Health System',''),(1328,'Prototyping, developing, and iterating a gamified survey to evaluate participatory systems modelling for youth mental health: Quality assurance pilot','https://scholar.google.com/scholar?cluster=5153508338121867598&hl=en&oi=scholarr',NULL,'Gamification is rapidly gaining popularity in research, including in participatory modelling programs. To facilitate stakeholder engagement and learning, gamification is utilised to communicate complex systems challenges at all stages of participatory modelling. However, this has excluded evaluation processes. We argue that evaluation of participatory modelling is important for refining and improving participatory processes and describe the potential for gamification to provide a more appealing platform for participants to engage in evaluation activities, eliciting richer data. This paper describes a quality assurance pilot to prototype, develop, and iterate online surveysΓÇôspecifically its gamified activities├éΓÇôin the context of evaluating a national youth mental health participatory systems modelling program. Usability testing of the gamified surveys will be undertaken with diverse participants, which includes a rigorous├é┬á├éΓÇª','',2018,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'2','Proceedings of the 24th International Congress on Modelling and Simulation','','','','',NULL,NULL,NULL),(1330,'Investigating white matter structure in social anxiety disorder using fixel-based analysis','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85113290861&doi=10.1016%2fj.jpsychires.2021.08.028&partnerID=40&md5=ffd8fbd7f4d4a26623ade70a39838ea2','10.1016/j.jpsychires.2021.08.028','Social anxiety disorder (SAD) is one of the most common mental health disorders in youth, defined by a persistent and intense fear of negative evaluation by others. Recent research has examined its neurological underpinnings, including structural connectivity changes in the brain. This has been examined through measurement of the white matter (WM) structure of fibre pathways. Previous studies have shown inconsistent results. This study attempts to resolve these inconsistencies by utilising a recently proposed, advanced method for diffusion MRI analysis, known as fixel based analysis (FBA). This technique enables examination of WM macro- and micro-structure with measures of fibre density (FD), fibre bundle cross-section (FC) and fibre density-cross-section (FDC). This study evidenced increased FDC in a region of the right superior longitudinal fasciculus (SLF) from a whole brain FBA, along with increased','',2021,NULL,NULL,'2021-11-01',NULL,NULL,NULL,NULL,'2','Journal of Psychiatric Research','143','','30-37','Pergamon','Other','',''),(1332,'Autism spectrum disorder: An examination of sex differences in neuropsychological and self-report measures of executive and non-executive cognitive function','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85108850998&doi=10.1177%2f13623613211014991&partnerID=40&md5=7dc45faaacb81130c366b57de948a21a','10.1177/13623613211014991','\nSex differences in autism may in part be understood by an atypical sex profile of executive function and non-executive function. In this study, we compared females and males with autism against non-autistic individuals on neuropsychological and self-report measures to examine whether any sex differences in executive function and non-executive function might be unique to autism. Our study showed a significant overall female advantage for measures of psychomotor speed, cognitive flexibility, verbal learning and memory and semantic fluency. There was no significant interaction effect between diagnosis and sex. No sex differences were observed on the self-report measure of executive function. Our results suggest that while females show different cognitive performance to males, these sex differences were not specific to the autistic cohort.\nLay abstract\nResearch comparing females and males with a diagnosis of\n','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'2','Autism','25','8','2223-2237','SAGE Publications','Other','',''),(1333,'Characterization and prediction of clinical pathways of vulnerability to psychosis through graph signal processing','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85116856872&doi=10.7554%2feLife.59811&partnerID=40&md5=215429d6ed9f0a56afb48a687c43da8e','10.7554/eLife.59811','Causal interactions between specific psychiatric symptoms could contribute to the heterogenous clinical trajectories observed in early psychopathology. Current diagnostic approaches merge clinical manifestations that co-occur across subjects and could significantly hinder our understanding of clinical pathways connecting individual symptoms. Network analysis techniques have emerged as alternative approaches that could help shed light on the complex dynamics of early psychopathology. The present study attempts to address the two main limitations that have in our opinion hindered the application of network approaches in the clinical setting. Firstly, we show that a multi-layer network analysis approach, can move beyond a static','',2021,NULL,NULL,'2021-09-27',NULL,NULL,NULL,NULL,'2','eLife','10','','e59811','eLife Sciences Publications Limited','Other','',''),(1334,'Regional suicide prevention planning: A dynamic simulation modelling analysis','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85123350631&doi=10.1192%2fbjo.2021.989&partnerID=40&md5=edae44cc9865baa9ce286057b2a037ed','10.1192/bjo.2021.989','Background     Regional planning may help to ensure that the specific measures implemented as part of a national suicide prevention strategy are aligned with the varying needs of local services and communities; however, there are concerns that the reliability of local programme development may be limited in practice. Aims     The potential impacts of independent regional planning on the effectiveness of suicide prevention programmes in the Australian state of New South Wales were quantified using a system dynamics model of mental health services provision and suicidal behaviour in each of the state\'s ten Primary Health Network (PHN) catchments. Method     Reductions in projected suicide mortality over the period 2021ΓÇô2031 were calculated for scenarios in which combinations of four and five suicide prevention and mental health services interventions (selected from 13 possible interventions) are├é┬á├éΓÇª','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'2','BJPsych Open','7','5','','Cambridge University Press','YMH team','Mental Health System','illness specific areas');
INSERT INTO `projects` VALUES (1335,'Regulation of the Acute Sickness Response by the P2RX7 Receptor','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102758617&doi=10.1093%2finfdis%2fjiab027&partnerID=40&md5=c700401542cf898f1df4449dd821ecab','10.1093/infdis/jiab027','                    Background           The acute sickness response to infection is a stereotyped set of illness manifestations initiated by proinflammatory signals in the periphery but mediated centrally. P2RX7 is a highly polymorphic gene encoding an ATP-gated cationic pore, widely expressed on immune cells and the brain, and regulating the NLRP3 inflammasome, as well as diverse neural functions.                             Methods           Associations between P2RX7 genotype, pore activity, and illness manifestations were examined in a cohort with acute viral and bacterial infections (n = 484). Genotyping of 12 P2RX7 function-modifying single-nucleotide polymorphisms (SNPs) was used to identify haplotypes and diplotypes. Leucocyte pore activity was measured by uptake of the fluorescent dye, YO-PRO-1, and by ATP-induced interleukin-1├ƒ (IL-1├â┼╕) release. Associations were sought with scores describing the symptom├é┬á├éΓÇª\n','',2021,NULL,NULL,'2021-09-01',NULL,NULL,NULL,NULL,'2','Journal of Infectious Diseases','224','5','914-920','Oxford University Press','Other','',''),(1336,'Effect of interventions for the well-being, satisfaction and flourishing of general practitioners - A systematic review','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85113503021&doi=10.1136%2fbmjopen-2020-046599&partnerID=40&md5=ef3c4d80a02a82dc641aea35c9ba7a54','10.1136/bmjopen-2020-046599','\nObjectives Clinician well-being has been recognised as an important pillar of healthcare. However, research mainly addresses mitigating the negative aspects of stress or burnout, rather than enabling positive aspects. With the added strain of a pandemic, identifying how best to maintain and support the well-being, satisfaction and flourishing of general practitioners (GPs) is now more important than ever.\nDesign Systematic review.\nData sources We searched MEDLINE, PsycINFO, Embase, CINAHL and Scopus from 2000 to 2020.\nStudy selection Intervention studies with more than 50% GPs in the sample evaluating self-reported well-being, satisfaction and related positive outcomes were included. The Cochrane Risk of Bias 2 tool was applied.\nResults We retrieved 14 792 records, 94 studies underwent full-text review. We included 19 studies in total. Six randomised controlled trials, three non-randomised, controlled├é┬á├éΓÇª\n','',2021,NULL,NULL,'2021-08-01',NULL,NULL,NULL,NULL,'2','BMJ Open','11','8','e046599','British Medical Journal Publishing Group','Other','',''),(1339,'Days out of role and somatic, anxious-depressive, hypo-manic, and psychotic-like symptom dimensions in a community sample of young adults','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85105799866&doi=10.1038%2fs41398-021-01390-y&partnerID=40&md5=123cf24e380cb30367d2ee7acf8a0e33','10.1038/s41398-021-01390-y','Improving our understanding of the causes of functional impairment in young people is a major global challenge. Here, we investigated the relationships between self-reported days out of role and the total quantity and different patterns of self-reported somatic, anxious-depressive, psychotic-like, and hypomanic symptoms in a community-based cohort of young adults. We examined self-ratings of 23 symptoms ranging across the four dimensions and days out of role in >1900 young adult twins and non-twin siblings participating in the ΓÇ£19Up├éΓÇ¥ wave of the Brisbane Longitudinal Twin Study. Adjusted prevalence ratios (APR) and 95% confidence intervals (95% CI) quantified associations between impairment and different symptom patterns. Three individual symptoms showed significant associations with days out of role, with the largest association for impaired concentration. When impairment was assessed according to├é┬á├éΓÇª','',2021,NULL,NULL,'2021-05-13',NULL,NULL,NULL,NULL,'2','Translational Psychiatry','11','1','1-Oct','Nature Publishing Group','YMH team','Outcome Research',''),(1340,'Participatory design of an activities-based collective mentoring program in after-school care settings: Connect, promote, and protect program','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85104112699&doi=10.2196%2f22822&partnerID=40&md5=01a73bfed224c5881627b7264cfd1d08','10.2196/22822','           Background           Out of school hours care (OSHC) services provide a unique opportunity to deliver early intervention programs to enhance primary schoolΓÇôaged children├éΓÇÖs social, emotional, physical, and cognitive well-being; however, such programs are currently lacking.                             Objective           This study aims to address the lack of well-being programs for children accessing OSHC services in the research literature by using participatory design (PD) to collaboratively develop and test an OSHC well-being program├éΓÇöthe connect, promote, and protect program (CP3).                             Methods           The study employed methods of PD, user (acceptance) testing, and iterative knowledge translation to develop a novel well-being program framework├éΓÇöCP3├éΓÇöwith key stakeholders (eg, children, OSHC staff, volunteers, families, clinicians, educators, and researchers). Thematic techniques were used to interpret and translate the qualitative information obtained during the research and design cycles.                             Results           The co-design process generated the CP3 model, which comprises a group-based mentoring approach to facilitate enhanced activities in OSHC settings. Activities are underpinned by 4 key principles of program delivery: build well-being and resilience, broaden horizons, inspire and engage, and connect communities.                             Conclusions           To our knowledge, the CP3 program is the first co-designed well-being program developed specifically for OSHC services. This co-design process is key to ensuring local community needs├éΓÇöparticularly those of young people accessing OSHC├éΓÇöare met and that these├é┬á├éΓÇª\n','',2021,NULL,NULL,'2021-04-12',NULL,NULL,NULL,NULL,'2','JMIR Pediatrics and Parenting','4','2','e22822','JMIR Publications Inc., Toronto, Canada','YMH team','Models of care',''),(1341,'Familial aggregation of anxiety disorder subtypes and anxious temperament in the NIMH Family Study of Affective Spectrum Disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85097087299&doi=10.1016%2fj.jad.2020.11.070&partnerID=40&md5=9617d5d5698769126635013bf577dcbf','10.1016/j.jad.2020.11.070','\n\nBackground\nEvidence from family and twin studies suggests that mood and anxiety disorders, and related temperamental factors may share common etiologic factors. We examine the familial aggregation and coaggregation of anxiety disorder subtypes and anxiety-related temperamental traits, and their association with mood disorders.\n\n\nMethods\nA total of 477 probands and 549 first-degree adult relatives from a large community based family study of affective spectrum disorders completed semi-structured diagnostic interviews and self-reported assessments of temperamental traits including: negative affectivity on the ΓÇÿPositive and Negative Affect Schedule├éΓÇÖ (PANAS), neuroticism anxiety on the ├éΓÇÿZuckerman-Kuhlman Personality Questionnaire├éΓÇÖ (ZKPQ), and anxiety sensitivity on the ├éΓÇÿAnxiety Sensitivity Index├éΓÇÖ (ASI).\n\n\nResults\nThe anxiety-related temperamental traits of negative affectivity, neuroticism anxiety and anxiety├é┬á├éΓÇª\n\n','',2021,NULL,NULL,'2021-02-15',NULL,NULL,NULL,NULL,'2','Journal of Affective Disorders','281','','751-758','Elsevier','YMH team','Illness specific areas',''),(1342,'White Matter Integrity According to the Stage of Mental Disorder in Youth','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85095599408&doi=10.1016%2fj.pscychresns.2020.111218&partnerID=40&md5=f6c4ad3fc3550948c5b07f9d4857c635','10.1016/j.pscychresns.2020.111218','The present study investigated differences in white matter (WM) integrity between 96 young people with affective and/or psychotic symptoms classified at an early stage of mental disorder (i.e. ΓÇÿattenuated syndrome├éΓÇÖ; stage 1b), 85 young people classified at a more advanced stage of mental disorder (i.e. ├éΓÇÿdiscrete disorder├éΓÇÖ; stage 2), and 81 demographically matched healthy controls using diffusion tensor imaging. The relationship between WM integrity (indexed by fractional anisotropy; FA) across the tracts and neuropsychological functioning was also investigated. A significant reduction in FA was identified in those with more advanced disorder in the body of the corpus callosum. Clinical stage groups were associated with significant neuropsychological impairment, which was significantly greater in those with discrete disorders. Compared to those in the earlier stage of disorder, participants at the later clinical stage├é┬á├éΓÇª','',2021,NULL,NULL,'2021-01-30',NULL,NULL,NULL,NULL,'2','Psychiatry Research - Neuroimaging','307','','111218','Elsevier','YMH team','Models of care','Neurobiology'),(1343,'Potential genetic overlap between insomnia and sleep symptoms in major depressive disorder: a polygenic risk score analysis','https://www.frontiersin.org/articles/10.3389/fpsyt.2021.734077/full',NULL,'\n\nBackground: The prevalence of insomnia and hypersomnia in depressed individuals is substantially higher than that found in the general population. Unfortunately, these concurrent sleep problems can have profound effects on the disease course. Although the full biology of sleep remains to be elucidated, a recent genome-wide association (GWAS) of insomnia, and other sleep traits in over 1 million individuals was recently published and provides many promising hits for genetics of insomnia in a population-based sample. \nMethods: Using data from the largest available GWAS of insomnia and other sleep traits, we sought to test if sleep variable PRS scores derived from population-based studies predicted sleep variables in samples of depressed cases [Psychiatric Genomics Consortium - Major Depressive Disorder subjects (PGC MDD)]. A leave-one-out analysis was performed to determine the effects that each individual study had on our results. \nResults: The only significant finding was for insomnia, where p-value threshold, p = 0.05 was associated with insomnia in our PGC MDD sample (R2 = 1.75-3, p = 0.006). \nConclusion: Our results reveal that <1% of variance is explained by the variants that cover the two significant p-value thresholds, which is in line with the fact that depression and insomnia are both polygenic disorders. To the best of our knowledge, this is the first study to investigate genetic overlap between the general population and a depression sample for insomnia, which has important treatment implications, such as leading to novel drug targets in future research efforts.\n','',2004,NULL,NULL,'2021-12-03',NULL,NULL,NULL,NULL,'2','Frontiers in psychiatry','12','','734077','Frontiers Media SA',NULL,NULL,NULL),(1344,'Genetic and environmental influences on sleep-wake behaviors in adolescence','https://academic.oup.com/sleepadvances/article-abstract/2/1/zpab018/6408541',NULL,'                    Study Objectives           To investigate the influence of genetic and environmental factors on sleep-wake behaviors across adolescence.                             Methods           Four hundred and ninety-five participants (aged 9├éΓÇô17; 55% females), including 93 monozygotic and 117 dizygotic twin pairs, and 75 unmatched twins, wore an accelerometry device and completed a sleep diary for 2 weeks.                             Results           Individual differences in sleep onset, wake time, and sleep midpoint were influenced by both additive genetic (44%├éΓÇô50% of total variance) and shared environmental (31%├éΓÇô42%) factors, with a predominant genetic influence for sleep duration (62%) and restorative sleep (43%). When stratified into younger (aged 9├éΓÇô14) and older (aged 16├éΓÇô17) subsamples, genetic sources were more prominent in older adolescents. The moderate correlation between sleep duration and midpoint (rP = -.43, rG├é┬á├éΓÇª\n','',2003,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'2','Sleep Advances','2','1','zpab018','Oxford University Press',NULL,NULL,NULL),(1347,'Modelling change in neurocognition, symptoms and functioning in young people with emerging mental disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85090275030&doi=10.1016%2fj.jpsychires.2020.08.028&partnerID=40&md5=b80ece800bd7965c79951613d57855fa','10.1016/j.jpsychires.2020.08.028','Mental disorders and their functional impacts evolve dynamically over time. Neurocognition and clinical symptoms are commonly modelled as predictors of functioning, however, studies tend to rely on static variables and adult samples with chronic disorders, with limited research investigating change in these variables in young people with emerging mental disorders. These relationships were explored in a longitudinal clinical cohort of young people accessing early intervention mental health services in Australia, around three-quarters of whom presented with a mood disorder (N┬á=├é┬á176, aged 12├éΓÇô30├é┬áat baseline). Bivariate latent change score models quantified associations between neurocognition (a latent variable of working memory, verbal memory, visuospatial memory, and cognitive flexibility), global clinical symptoms, and functioning (self- and clinician-rated) and their relative change over follow-up (median├é┬á├éΓÇª','',2020,NULL,NULL,'2020-12-01',NULL,NULL,NULL,NULL,'2','Journal of Psychiatric Research','131','','22-30','Pergamon','YMH team','Digital health','Outcome Research'),(1348,'Suicidal thoughts and behaviors and their associations with transitional life events in men and women: Findings from an international web-based sample','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85097853700&doi=10.2196%2f18383&partnerID=40&md5=0226fb5899890a646e6e3b2238cda837','10.2196/18383','\nBackground: Although numerous studies have demonstrated sex differences in the prevalence of suicidal thoughts and behaviors (STB), there is a clear lack of research examining the similarities and differences between men and women in terms of the relationship between STB, transitional life events, and the coping strategies employed after experiencing such events when they are perceived as stressful.\nObjective: This study aims to examine the differences between menΓÇÖs and women├éΓÇÖs experiences of STB, sociodemographic predictors of STB, and how coping responses after experiencing a stressful transitional life event predict STB.\nMethods: A web-based self-report survey was used to assess the health and well-being of a voluntary community-based sample of men and women aged 16 years and older, living in Australia, Canada, New Zealand, the United Kingdom, and the United States, who were recruited using web-based social media promotion and snowballing.\nResults: In total, 10,765 eligible web-based respondents participated. Compared with men, a significantly greater proportion of women reported STB (P<. 001) and endorsed experiencing a transitional life event as stressful (P<. 001). However, there were no gender differences in reporting that the transitional life event or events was stressful for those who also reported STB. Significant sociodemographic adjusted risk factors of STB included younger age; identifying as a sexual minority; lower subjective social connectedness; lower subjective intimate bonds; experiencing a stressful transitional life event in the past 12 months; living alone (women only); not being in employment├é┬á├éΓÇª\n','',2020,NULL,NULL,'2020-09-11',NULL,NULL,NULL,NULL,'2','JMIR Mental Health','7','9','e18383','JMIR Publications Inc., Toronto, Canada','YMH team','Illness specific areas',''),(1349,'Economic rationality in youth with emerging mood disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088476582&doi=10.1037%2fnpe0000129&partnerID=40&md5=c1a119b40240eb277578e0e0443efdb7','10.1037/npe0000129','Cognitive difficulties are common in persons experiencing anxiety or mood disorders. In this article, we explore the economic concept of rational decision-making in young people with emerging mood disorders by using incentive-compatible experiments involving choices over consumer products. At 2 time points, separated by 6├éΓÇô8 weeks, we measured irrational decision-making (defined as violations of the Generalized Axiom of Revealed Preference) concurrently with levels of anxiety and depression levels using the 10-item Kessler Psychological Distress Scale (K10); the 17-item Quick Inventory of Depressive Symptomology, Adolescent Version (QIDS-A17); and the 12-item Somatic and Psychological Health Report (SPHERE-12) in 30 participants (mean age 19.22 years, 19 male) attending a youth mental health clinic. In total, 15 (50%) participants rated high on all three psychological questionnaires combined├é┬á├éΓÇª','',2020,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'2','Journal of Neuroscience, Psychology, and Economics','13','3','164','Educational Publishing Foundation','YMH team','Mental Health System',''),(1350,'Corrigendum: Relationship between polyunsaturated fatty acids and psychopathology in the NEURAPRO clinical trial','https://www.frontiersin.org/articles/10.3389/fpsyt.2020.00514/full',NULL,'MB and GA designed the study. MB analyzed the data and wrote the manuscript. BN, CM, HY, MRS, NM, MS, SS, IH, GB, EC, LH, DN, MN, AR-R, SV, AY, PM, and GA contributed to the primary study that provided data for this analysis, including acquisition of funding, recruitment of participants, and/or collection of data. TM and BM analyzed erythrocyte fatty acids. All authors contributed to the interpretation of results and to the manuscript.','',2020,NULL,NULL,'2020-06-10',NULL,NULL,NULL,NULL,'2','Frontiers in psychiatry','11',NULL,'514','Frontiers Media SA',NULL,NULL,NULL),(1352,'Involving end users in adapting the Spanish version of the Mental Health eClinic for young people in Colombia: A pilot study using participatory design methodologies','https://repository.javeriana.edu.co/handle/10554/48255',NULL,'\nBackground:\n Health information technologies (HIT) hold enormous promise for improving access to, and better quality, mental health care. However, despite rapid spread of such technologies in high-income countries, they have not yet been commonly adopted in low and middle-income countries. People living in these parts of the world are at risk of experiencing not only physical but also technological and social health inequalities. One possible solution is to utilise already available (and successfully implemented) HITs developed in other counties. Objective:\n Using participatory design methodologies with Colombian end users (young people, their supportive others, health professionals), this study aimed to: conduct co-design workshops to culturally adapt an online mental health clinic (MHeC) for young people; perform one-on-one user testing sessions to evaluate an alpha prototype of a Spanish version of the MHeC, and adapt it to the Colombian context; and, inform the development of a skeletal framework and alpha prototype for a Colombian version of the MHeC (MHeC-C). Methods:\n Utilisation of a research and development (R&D) cycle including four iterative phases: co-design workshops; knowledge translation; tailoring to language, culture and place (or context); rapid prototyping; and then, one-on-one user testing sessions. Results:\n Two co-design workshops were held with 18 users (young people n= 7, health professionals n= 11). A total of 10 participated in one-on-one user-testing sessions (young people n= 5, supportive others n= 2, health professionals n= 3). 203 source documents were collected and 605 annotations were coded. A├é┬á├éΓÇª','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'1','','','','','',NULL,NULL,NULL),(1353,'Genomic structural equation models of major depression symptoms','https://espace.library.uq.edu.au/view/UQ:da59c7c',NULL,'','',2022,NULL,NULL,'2019-01-01',NULL,NULL,NULL,NULL,'1','European Neuropsychopharmacology','29','','S135-S135','Elsevier',NULL,NULL,NULL),(1354,'S136. A NOVEL APPROACH FOR DEVELOPING PREDICTION MODEL OF TRANSITION TO PSYCHOSIS: DYNAMIC PREDICTION USING JOINT MODELLING','https://academic.oup.com/schizophreniabulletin/article-abstract/44/suppl_1/S378/4958035',NULL,'                    Background           Ever since the establishment of strategies for identifying people at ultra-high risk (UHR) of developing psychosis about twenty years ago, much research has been conducted in seeking risk factors and in developing prediction models for predicting which UHR individuals will actually make a transition to psychosis. The goal is to provide specific interventions to those of high susceptibility. Such research almost invariably uses fixed predictor variables, typically variables assessed at baseline, i.e. service entry. Interest has now emerged to investigate whether the dynamic nature of psychopathology can be used to improve prediction of the onset of psychosis. As studies on UHR individuals usually require follow-up of participants over time, the longitudinal nature of these studies provides the opportunity to capture the dynamic characteristics of psychopathology by conducting multiple├é┬á├éΓÇª\n','',2022,NULL,NULL,'2018-04-01',NULL,NULL,NULL,NULL,'1','Schizophrenia Bulletin','44','suppl_1','S378-S379','Oxford University Press',NULL,NULL,NULL),(1355,'1098 Improvements in subjective sleep and depression along the course of adjunctive phototherapy','https://academic.oup.com/sleep/article-abstract/40/suppl_1/A409/3781145',NULL,'                    Introduction:           Depression is often associated with disrupted sleep. Sleep onset difficulties and sleep quality have been suspected to play an important role in the pathogenesis of depression. Phototherapy has the potential to restore sleep dysfunctions, which in turn may alleviate mood. This study examined the relationship between changes in sleep and depressive symptoms alongside adjunctive phototherapy.                             Methods:           Twenty-two young individuals with depression (21.3 ┬▒ 5.2├é┬áyears old; 76% female) were recruited from early-intervention mental health services in Sydney and Ottawa. Phototherapy was self-administered with green-blue light-emitting glasses for 60 minutes upon awakening for two weeks as an adjunct to standard clinical care. Prior to starting phototherapy (baseline), participants completed the Leeds Sleep Evaluation Questionnaire (LSEQ) and the Beck├é┬á├éΓÇª\n','',2022,NULL,NULL,'2017-04-28',NULL,NULL,NULL,NULL,'1','Journal of Sleep and Sleep Disorders Research','40','suppl_1','A409-A409','Oxford University Press',NULL,NULL,NULL),(1356,'Defining trait and state risk for psychosis: evidence to maintain the status quo','https://scholar.google.com/scholar?cluster=4530224510718318809&hl=en&oi=scholarr',NULL,'','',2022,NULL,NULL,'2016-10-01',NULL,NULL,NULL,NULL,'1','','10','','75-75','WILEY-BLACKWELL',NULL,NULL,NULL),(1357,'Depression course, functional disability, and NEET status in young adults with mental health problems','https://www.cambridge.org/core/journals/european-psychiatry/article/depression-course-functional-disability-and-neet-status-in-young-adults-with-mental-health-problems/BD71ED5A65329C4B8D856F56EF9ABCBE',NULL,'IntroductionRole functioning is key to optimal health and inoculates against life-long inequality. Depression is a leading cause of functional disability. In most cases, improved symptomatology corresponds with improved functioning; however, functioning does not always return to ├éΓÇ£normal├éΓÇ¥, despite symptom remission. Furthermore, the relationship between symptom remission and the likelihood of being Not in Employment, Education or Training (NEET) is unknown.Objectives and aimTo examine the temporal associations between depression course, functioning, and NEET status in young adults with mental health problems.MethodsA prospective and multisite clinical cohort study of young people aged 15├éΓÇô25 years seeking help from a primary mental health service (n = 448). Participants completed a clinical interview (incl. QIDS-C16) and self-report battery (incl. WHODAS 2.0, employment, education) at baseline├é┬á├éΓÇª','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'1','European Psychiatry','33','S1','S176-S177','Cambridge University Press',NULL,NULL,NULL),(1358,'P4-215: In vivo glutathione relates to sleep apnoea severity and oxygen desaturation in older adults ├éΓÇÿat risk├éΓÇÖ of developing dementia','https://alz-journals.onlinelibrary.wiley.com/doi/abs/10.1016/j.jalz.2015.08.043',NULL,'\nBackground\nSleep-disordered breathing (SDB) occurs in around 60% of older adults and is aetiologically linked to cognitive decline with up to 30% of elderly patients with obstructive sleep apnoea (OSA) meeting criteria for mild cognitive impairment. This possible dementia risk factor has received increased attention in the literature, with several studies now showing that patients with OSA are up to 6-times more likely (depending on age and gender) to develop dementia within 5-years. Increasing evidence suggests that prolonged hypoxia resulting from SDB is associated with increased reactive oxygen species and oxidative stress. However, studies to-date have examined animal models or measured plasma markers in blood. This pilot study aimed to examine the relationship between hypoxia and oxidative stress in-vivo (via the neurometabolite glutathione) using proton magnetic resonance spectroscopy (1 H├é┬á├éΓÇª\n','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'1','Alzheimer\'s & Dementia','11','7S_Part_18','P863-P863','',NULL,NULL,NULL),(1359,'Microglial Activation: A PET Study in Schizophrenia','https://scholar.google.com/scholar?cluster=8240070747807724387&hl=en&oi=scholarr',NULL,'','',2022,NULL,NULL,'2015-05-01',NULL,NULL,NULL,NULL,'1','','77','9','','ELSEVIER SCIENCE INC',NULL,NULL,NULL),(1360,'The relationship between treatment parameters and efficacy with repetitive transcranial magnetic stimulation in depression: a meta-analytic study','https://www.brainstimjrnl.com/article/S1935-861X(15)00775-5/abstract',NULL,'\nBackground\nThere is great variability in effect sizes across clinical trials of repetitive transcranial magnetic stimulation (rTMS) in depression. The several treatment parameters have also varied considerably between studies and reflect the lack of consensus for optimal parameters for depression. Whilst few reports have linked patterns of rTMS response to some treatment parameters, the relationship between treatment parameters and efficacy remains to be elucidated. Furthermore, unlike several trials and meta-analyses, this analysis will exclude older depressed samples with potentially different neuropathologies that may confound findings.\nMethods\nPubMed was used to search for peer-reviewed studies published between August 1975 and October 2014 on the efficacy of high-frequency, left prefrontal cortex rTMS treatment in mood disorder cohorts under 65 years-old. Twenty-two studies met eligibility criteria (N\n','',2022,NULL,NULL,'2015-03-01',NULL,NULL,NULL,NULL,'1','Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation','8','2','423-424','Elsevier',NULL,NULL,NULL),(1361,'Investing in healthier lives: Pathways to healthcare financing reform in Australia','https://opus.lib.uts.edu.au/bitstream/10453/135495/1/investing_in_healthier_lives_roundtable_report_12_august_2015.pdf',NULL,'The fee-for-service model, with its strong historical roots, has been increasingly implicated as an important contributor to the system-wide problems of fragmented and inappropriate care resulting in unnecessary costs. By financially rewarding activity without considering effectiveness and quality, it has been argued that fee-for-service payments promote suboptimal care. Strong public debate over the past 18 months around patient co-payments in Australia have in large part been driven by fundamental concerns about these economic incentives and unnecessary costs created by fee-for-service payments, balanced against underlying concerns about equity of access to care.','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'1','','','','','The George Institute for Global Health',NULL,NULL,NULL),(1362,'Sleep and Biological Rhythms in Mania','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84944406827&doi=10.1016%2fB978-0-12-417188-6.00014-1&partnerID=40&md5=4cc38d52b214c05b7dc0c97246995451','10.1016/B978-0-12-417188-6.00014-1','Over the past few years, a growing number of researchers have begun investigating the potential roles of sleep and biological rhythm disturbances in affective disorders. Although particular attention has been given to depressive syndromes, the sleep and circadian literature also links sleep disturbances to mania and the course of bipolar disorder. These links are especially relevant in an era when efforts to advance knowledge about the biological mechanisms underlying affective illnesses coincide with the emergence of increasing evidence that mania is a phenomenon distinct and independent from depression. This chapter reviews sleep and biological rhythms characteristic of mania and related disorders, their possible role in the onset and recurrence of manic states, and relevant therapeutic applications.','',2015,NULL,NULL,'2015-01-01',NULL,NULL,NULL,NULL,'1','Sleep and Affect: Assessment, Theory, and Clinical Implications','','','293-319','Academic Press','YMH team','Illness specific areas',''),(1363,'P. 2. b. 017 Structural brain alterations in major depression: findings from the ENIGMA Major Depressive Disorder Working Group','https://www.infona.pl/resource/bwmeta1.element.elsevier-7ffadda2-785f-3fcc-9da3-86df0ef21d6d',NULL,'P.2.b.017 Structural brain alterations in major depression: findings from the ENIGMA Major \nDepressive Disorder Working Group ├âΓÇö Close The Infona portal uses cookies, ie strings of text \nsaved by a browser on the user\'s device. The portal can access those files and use them to \nremember the user\'s data, such as their chosen settings (screen view, interface language, \netc.), or their login data. By using the Infona portal the user accepts automatic saving and using \nthis information for portal operation purposes. More information on the subject can be found \nin the Privacy Policy and Terms of Service. By closing this window the user confirms that they \nhave read the information on cookie usage, and they accept the privacy policy and the way \ncookies are used by the portal. You can change the cookie settings in your browser. I accept \nPolski English Login or register account remember me Password recovery INFONA - science ├éΓÇª','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'1','European Neuropsychopharmacology','','25','S394-S395','',NULL,NULL,NULL),(1364,'Using [11C]-(R)-PK11195 PET to investigate neuroinflammation in psychosis','https://scholar.google.com/scholar?cluster=10413304154142655402&hl=en&oi=scholarr',NULL,'','',2022,NULL,NULL,'2014-05-01',NULL,NULL,NULL,NULL,'1','','75','9','28S-29S','ELSEVIER SCIENCE INC',NULL,NULL,NULL),(1365,'Clinical staging: A necessary step in the development of improved animal models of mood disturbance?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84897891089&doi=10.1017%2fS1461145713001107&partnerID=40&md5=30f441374e70f88dba8588727bad72b1','10.1017/S1461145713001107','         Recently, it has been suggested that the clinical staging approach be considered a serious alternative framework for conceptualising mood related psychopathology. The fundamental difference between clinical staging and the now dominant categorical diagnostic framework is that the entire illness trajectory becomes relevant, as opposed to simply the end-stage. The concept of disease trajectory has significant implications for animal models of psychopathology, and particularly for animal models of depression. This article will introduce and discuss the implications of the clinical staging approach for those undertaking research using animal models of mood disturbance.\n','',2014,NULL,NULL,'2014-03-01',NULL,NULL,NULL,NULL,'1','International Journal of Neuropsychopharmacology','17','3','491-495','Cambridge University Press','Other','',''),(1366,'Clinical staging in an early intervention youth mental health service: preliminary date examining psychotic-like experiences','https://www.researchgate.net/profile/Shane-Cross/publication/281049859_Clinical_staging_in_an_early_intervention_youth_mental_health_service_preliminary_data_examining_psychotic-like_experiences/links/55d2b22208ae0a34172221c9/Clinical-staging-in-an-early-intervention-youth-mental-health-service-preliminary-data-examining-psychotic-like-experiences.pdf',NULL,'\nΓÇó Evidence is accumulating that clinical staging is a useful adjunct to the traditional diagnostic system in guiding safe and effective patient management decisions for young people with emerging serious mental disorders[1].\n├éΓÇó Patients at earlier stages of illness (├éΓÇÿhelp seeking mild symptoms-stage 1a) experience faster symptomatic and functional recovery using less clinical resources than do patients with attenuated or emerging serious mental disorders (stage 1b)[2], highlighting a need to provide more intensive treatment to these patients over a longer time period[3].\n','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'1','Poster presented at the 9th International Conference on Early Psychosis','','','','',NULL,NULL,NULL),(1367,'Clinical staging in an early intervention youth mental health service: patient characteristics, treatment patterns and clinical outcomes','https://research.usc.edu.au/esploro/outputs/abstract/Clinical-staging-in-an-early-intervention/99451487702621',NULL,'','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'1','Early Intervention in Psychiatry','8','Supplement 1','90','Wiley-Blackwell Publishing Asia',NULL,NULL,NULL),(1368,'National Heart Foundation of Australia Consensus Statement on Depression in Patients with Coronary Heart Disease: Recommendations for Screening, Referral and Treatment','https://www.heartlungcirc.org/article/S1443-9506(13)00970-0/abstract',NULL,'\nObjective: To present the National Heart Foundation of Australia consensus statement on depression and coronary heart disease (CHD), to guide health professionals in acute and primary care, based on current evidence (Med J Aust 2013; 198 (9): 483-484).\nMethods: An expert working group reviewed new evidence in this area. Literature searches used key search phrases, including stress, depression, anxiety, treatment of depression, acute coronary syndromes, adherence and depression, and screening for depression. Recommendations were made for screening, referral and treatment based on this evidence. CSANZ has endorsed the content.\nResults: The prevalence of depression is high in patients with CHD and it has a significant impact on the patient\'s quality of life, adherence to therapy and an independent effect on prognosis.\n','',2021,NULL,NULL,'2013-01-01',NULL,NULL,NULL,NULL,'1','Heart, Lung and Circulation','22','','S256-S257','Elsevier',NULL,NULL,NULL),(1369,'Delayed circadian rhythms in young persons with unipolar or bipolar affective disorders','https://research.usc.edu.au/esploro/outputs/abstract/Delayed-circadian-rhythms-in-young-persons/99450609102621',NULL,'','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'1','Sleep and Biological Rhythms','10','Supplement 1','39','Springer UK',NULL,NULL,NULL),(1370,'What part does sleep disturbance play in post-cancer fatigue? Findings from a prospective cohort study.','https://ascopubs.org/doi/abs/10.1200/jco.2010.28.15_suppl.605',NULL,'\n         605              \nBackground: Daytime fatigue and poor quality sleep are more common in patients with cancer than healthy populations. Self-reported sleep disturbance is significantly associated with fatigue severity in post-cancer fatigue (PCF). In women treated for breast cancer, early menopause-associated vasomotor symptoms may trigger sleep disturbance. The \"domino theory\" of sleep disruption leading to insomnia followed by fatigue and depression has been proposed. Following alleviation of the vasomotor symptoms insomnia may persist, driving ongoing fatigue.       \nMethods: Women treated for early-stage breast cancer participated in a prospective cohort study exploring the aetiology of PCF. Clinical assessment and blood sampling were performed post-surgery (baseline) and repeated at end-adjuvant treatment and 1, 3, and 6 months later. Physical and psychological health was monitored using\n','',2021,NULL,NULL,'2010-05-20',NULL,NULL,NULL,NULL,'1','Journal of Clinical Oncology','28','15_suppl','605-605','American Society of Clinical Oncology',NULL,NULL,NULL),(1371,'Arginine Vasopressin Influences on the Recognition of Social Words','https://scholar.google.com/scholar?cluster=5607406343439296528&hl=en&oi=scholarr',NULL,'','',2021,NULL,NULL,'2010-05-01',NULL,NULL,NULL,NULL,'1','','67','9','174S-174S','ELSEVIER SCIENCE INC',NULL,NULL,NULL),(1372,'Courting the Blues','https://www.anulss.com/wp-content/uploads/2016/05/Courting-the-Blues.pdf',NULL,'\nOver the last decade in Australia we have seen great progress in our communityΓÇÖs response to those whose lives are affected by suicide, depression, anxiety or related substance misuse. This progress has been a consequence of the active engagement of people from all walks of life. Most important has been the willingness of those who have experienced these problems directly to tell their personal or family stories.\nAcross the board, we have also seen true leadership from politicians, celebrities, sportspersons, health professionals, the Media, community organizations and business and other commercial entities. A reduction in tragedies associated with mental health problems depends on expanding and enriching this broad-based community response. Our educational institutions and our professions have particularly important roles to play in this process.\n','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'1','','','','','',NULL,NULL,NULL),(1373,'A prospective cohort study of fatigue after adjuvant therapy for breast cancer: Association with hematologic, endocrine, and immune parameters','https://ascopubs.org/doi/abs/10.1200/jco.2008.26.15_suppl.9596',NULL,'\n         9596              \nBackground: Persisting fatigue states after cancer therapy remain a major survivorship issue, with up to 40% of individuals reported to experience disabling post cancer fatigue (PCF). An immunologic mechanism has been proposed. Methods: Women with early stage breast cancer from six metropolitan teaching hospitals in Sydney, were enrolled post surgery. Clinical assessment and blood sampling was conducted at baseline (post surgery), end of adjuvant treatment, and then at 1, 3, 6, 9 and 12 months. Structured interviews and self-report questionnaires were used to record physical and psychological health and disability. Provisional PCF cases were assessed at 6 months to exclude alternative medical and psychiatric causes of fatigue. Nested case-control series were selected for hematologic (full blood count), endocrine (thyroid stimulating hormone, follicle stimulating hormone) and immune\n','',2021,NULL,NULL,'2008-05-20',NULL,NULL,NULL,NULL,'1','Journal of Clinical Oncology','26','15_suppl','9596-9596','American Society of Clinical Oncology',NULL,NULL,NULL),(1374,'What├éΓÇÖs the evidence? Early intervention in youth mental health','https://scholar.google.com/scholar?cluster=2951682593711743808&hl=en&oi=scholarr',NULL,'Early intervention for depressive disorders in young people: the opportunity and the (lack of) evidence','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'1','','','','','',NULL,NULL,NULL),(1375,'Epidemiologists and researchers continue to overlook the obvious','https://scholar.google.com/scholar?cluster=12759598201988645267&hl=en&oi=scholarr',NULL,'','',2021,NULL,NULL,'2005-01-01',NULL,NULL,NULL,NULL,'1','British Medical Journal','331','','869-869','BMJ Publishing Group',NULL,NULL,NULL),(1376,'Providing psychological treatments in general practice: Rationale and practicalities','https://search.informit.org/doi/abs/10.3316/INFORMIT.376821245558733',NULL,'This is the first article in a series on psychological treatments. Over the next four issues of AFP, we will discuss behavioural strategies, structured problem solving, cognitive behavioural therapy and referring for psychological treatments.  (editor abstract)','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'1','','32','8','','',NULL,NULL,NULL),(1377,'Case-finding instruments may help identify depression in primary care: Commentary','https://www.scopus.com/inward/record.uri?eid=2-s2.0-73549112986&doi=10.1136%2febmh.6.2.63&partnerID=40&md5=de28f58d6772bdc8da9edee7873d18f9','10.1136/ebmh.6.2.63','Case-finding instruments may help identify depression in primary care. - Abstract - Europe PMC \nSign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help \nContact us Helpdesk Feedback Twitter Blog Tech blog Developer Forum Europe PMC plus \nSearch life-sciences literature (Over 39 million articles, preprints and more) Search Advanced \nsearch This website requires cookies, and the limited processing of your personal data in order \nto function. By using the site you are agreeing to this as outlined in our privacy notice and \ncookie policy. Abstract Full text Unpaywall Citations & impact Case-finding instruments may \nhelp identify depression in primary care. Hickie IB 1 Author information Affiliations 1 author \n1. Professor of Community Psychiatry, School of Psychiatry, University of NSW, Australia. \nEvidence-based Mental Health, 01 May 2003, 6(2):63 DOI: 10.1136/ebmh.6.2.63 PMID: ΓÇª','',2003,NULL,NULL,'2003-05-01',NULL,NULL,NULL,NULL,'1','Evidence-Based Mental Health','6','2','63-63','','YMH team','Illness specific areas',''),(1378,'Rising to the challenge of youth suicide.','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035316683&partnerID=40&md5=6a446fd04f57923ad660671bb88f10c6','','SafetyLit: Rising to the challenge of youth suicide HOME SEARCH SOURCES AUTHORS \nWEEKLY UPDATES ABOUT US MY SAFETYLIT Aa Aa Aa SAFETYLIT WEEKLY UPDATE We \ncompile citations and summaries of about 400 new articles every week. Email Signup | RSS \nFeed HELP: Tutorials | FAQ CONTACT US: Contact info SafetyLit is a service of: Journal Article \nRising to the challenge of youth suicide Citation Hickie I, Burns J. Aust. Fam. Physician 2001; \n30(4): 389-390. Copyright (Copyright ┬⌐ 2001, Royal Australian College of General Practitioners) \nDOI unavailable PMID 11355230 Abstract [Abstract unavailable] Language: en BACK TO \nRESULTS NEW SEARCH Download this record to: RIS | BibTeX | EndNote All SafetyLit \nrecords are available for automatic download to Zotero & Mendeley Print Email Find full text \nat... DOI: unavailable - Publisher website - Google Scholar - Inter-Library Document Request ├éΓÇª','',2001,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'1','Australian family physician','30','4','389-390','Royal Australian College of General Practitioners','YMH team','Mental Health System',''),(1379,'Combating the new epidemics of chronic diseases and injuries in the Asia-Pacific region','https://onlinelibrary.wiley.com/doi/abs/10.5694/j.1326-5377.2000.tb124120.x',NULL,'Australia is well placed to take a larger role','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'1','','172','12','574-575','',NULL,NULL,NULL),(1380,'Beyoind camelot: The future of academic psychiatry','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031740528&doi=10.3109%2f10398569809084852&partnerID=40&md5=e24c21e553b62e2b57da6ebe33a46d8a','10.3109/10398569809084852','Currently, there is a worldwide concern about the ongoing viability of traditional academic medical centres. The nostalgic view is that the best times have passed. Key institutions, like Camelot, will now dissolve as external economic and political forces combine to demand less expensive and more pragmatic forms of medical care. Like all great myths, however, this romanticised view may distract from the opportunities which are presently on offer. In reality, the future for academic psychiatry in Australasia should be bright. There is a clear need now, to develop more accountable systems which not only support high quality research but also bring a wider group of clinicians and consumers into the process.','',1998,NULL,NULL,'1998-01-01',NULL,NULL,NULL,NULL,'1','Australasian Psychiatry','6','5','241-243','Taylor & Francis','Other','',''),(1381,'Handbook of Affective Disorders, 2nd edn. Edited by E. S. Paykel. (Pp. 712; illustrated; ├é┬ú95.00.) Churchill Livingstone: Edinburgh. 1992.','https://www.cambridge.org/core/journals/psychological-medicine/article/handbook-of-affective-disorders-2nd-edn-edited-by-paykel-e-s-pp-712-illustrated-9500-churchill-livingstone-edinburgh-1992/FD16317B367CF10266ED336BA6123023',NULL,'//static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS0033291700029135/resource/name/firstPage-S0033291700029135a.jpg','',2018,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'1','Psychological Medicine','24','4','1047-1048','Cambridge University Press',NULL,NULL,NULL),(1382,'IMPAIRED VOLUNTARY DRIVE TO BREATHE-A POSSIBLE RISK FACTOR FOR DEATH FROM ASTHMA','https://scholar.google.com/scholar?cluster=15083726017954768300&hl=en&oi=scholarr',NULL,'','',2017,NULL,NULL,'1993-04-01',NULL,NULL,NULL,NULL,'1','','147','4','A701-A701','AMER LUNG ASSOC',NULL,NULL,NULL),(1383,'IMMUNOGLOBULIN TREATMENT FOR CHRONIC FATIGUE SYNDROME-REPLY','https://scholar.google.com/scholar?cluster=16124811853812069791&hl=en&oi=scholarr',NULL,'','',2017,NULL,NULL,'1991-10-01',NULL,NULL,NULL,NULL,'1','AMERICAN JOURNAL OF MEDICINE','91','4','443-444','EXCERPTA MEDICA INC',NULL,NULL,NULL),(1384,'The response of patients with chronic fatigue syndrome to intravenously administered gammaglobulin','https://scholar.google.com/scholar?cluster=877715671706218506&hl=en&oi=scholarr',NULL,'status. A quality of life (QAL) visual analog scale (modified to include ten aspects of physical and neuropsychiatrie symptomatology typical of CFS) was completed by the patients on entry, and at monthly intervals throughout the trial (10). T he patients who had been interviewed by the psychiatrist before treatment completed self-report measures of depression (Zung scale) at entry and at monthly intervals throughout the trial. Cell-mediated immunity was assessed by analysis of peripheral blood T-cell subsets, delayed-type hypersensitivity (DTH) skin 380 JM Dwyeret al. testing, and T-cell stimulation with phytohemagglutinen (PHA). IgG subclass levels were assayed at entry by radial immunodiffusion. Adverse effects were monitored both during and after infusions by a combination of investigator recordings and patient reports of local and constitutional symptoms during and after the infusions. For the purpose of','',2016,NULL,NULL,'1991-01-01',NULL,NULL,NULL,NULL,'1','','','','377-386','Academic Press',NULL,NULL,NULL),(1385,'CHRONIC FATIGUE SYNDROME-REPLY','https://scholar.google.com/scholar?cluster=10076337009815763257&hl=en&oi=scholarr',NULL,'','',2016,NULL,NULL,'1990-09-01',NULL,NULL,NULL,NULL,'1','BRITISH JOURNAL OF PSYCHIATRY','157','','449-450','ROYAL COLLEGE OF PSYCHIATRISTS',NULL,NULL,NULL),(1386,'Interpersonal relationships and depressive disorders','https://scholar.archive.org/work/tu3wwr7h2bg6fpvzgajg4fphs4/access/wayback/https://repository.unsworks.unsw.edu.au/server/api/core/bitstreams/1607eebe-a8e0-4ac9-8202-b92177c70294/content',NULL,'An interpersonal perspective of depressive disorders suggests the key relevance of a patient\'s most intimate relationship as a potential risk factor to onset, and determinant of longitudinal course. This perspective is supported by influential theoretical models in developmental psychiatry, particularly attachment theory. Although previous empirical data highlight an association between dysfunctional intimate relationships and depressive disorders, the quantification and direction of causality of the association, and the contribution to outcome, remain to be clarified.','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'1','','','','','University of New South Wales',NULL,NULL,NULL),(1387,'Using digital technologies to facilitate care coordination between youth mental health services: A guide for implementation','https://www.frontiersin.org/articles/10.3389/frhs.2021.745456/full',NULL,'Enhanced care coordination is essential to improving access to and navigation between youth mental health services. By facilitating better communication and coordination within and between youth mental health services, the goal is to guide young people quickly to the level of care they need and reduce instances of those receiving inappropriate care (too much or too little), or no care at all. Yet, it is often unclear how this goal can be achieved in a scalable way in local regions. We recommend using technology-enabled care coordination to facilitate streamlined transitions for young people across primary, secondary, more specialised or hospital-based care. First, we describe how technology-enabled care coordination could be achieved through two fundamental shifts in current service provisions; a model of care which puts the person at the centre of their care; and a technology infrastructure that facilitates this model. Second, we detail how dynamic simulation modelling can be used to rapidly test the operational features of implementation and the likely impacts of technology-enabled care coordination in a local service environment. Combined with traditional implementation research, dynamic simulation modelling can facilitate the transformation of real-world services. This work demonstrates the benefits of creating a smart health service infrastructure with embedded dynamic simulation modelling to improve operational efficiency and clinical outcomes through participatory and data driven health service planning.','',2016,NULL,NULL,'2021-11-18',NULL,NULL,NULL,NULL,'1','Frontiers in Health Services','1','','745456','Frontiers Media SA',NULL,NULL,NULL),(1388,'Applying systems approaches to stakeholder and community engagement and knowledge mobilisation in youth mental health system modelling','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85128872068&doi=10.1186%2fs13033-022-00530-1&partnerID=40&md5=94327a83ac3e8502505bb7ef9005b179','10.1186/s13033-022-00530-1','There is a significant push to change the trajectory of youth mental ill-health and suicide globally. Ensuring that young people have access to services that meet their individual needs and are easily accessible is a priority. Genuine stakeholder engagement in mental health system design is critical to ensure that system strengthening is likely to be successful within these complex environments. There is limited literature describing engagement processes undertaken by research teams in mental health program implementation and planning. This protocol describes the methods that will be used to engage local communities using systems science methods to mobilize knowledge and action to strengthen youth mental health services. Using participatory action research principles, the research team will actively engage with local communities to ensure genuine user-led participatory systems modelling processes and enhance knowledge mobilisation within research sites. Ensuring that culturally diverse and Aboriginal and Torres Strait Islander community voices are included will support this process. A rigorous site selection process will be undertaken to ensure that the community is committed and has capacity to actively engage in the research activities. Stakeholder engagement commences from the site selection process with the aim to build trust between researchers and key stakeholders. The research team will establish a variety of engagement resources and make opportunities available to each site depending on their local context, needs and audiences they wish to target during the process. This protocol describes the inclusive community','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'1','International Journal of Mental Health Systems','16','1','Jan-18','BioMed Central','YMH team','Mental Health System',''),(1389,'Machine learning based prediction and the influence of complement ΓÇô Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85128186404&doi=10.1016%2fj.bbi.2022.03.013&partnerID=40&md5=3ece051c4b8df33d781b93d1a0245013','10.1016/j.bbi.2022.03.013','\n\nBackground\nFunctional outcomes are important measures in the overall clinical course of psychosis and individuals at clinical high-risk (CHR), however, prediction of functional outcome remains difficult based on clinical information alone. In the first part of this study, we evaluated whether a combination of biological and clinical variables could predict future functional outcome in CHR individuals. The complement and coagulation pathways have previously been identified as being of relevance to the pathophysiology of psychosis and have been found to contribute to the prediction of clinical outcome in CHR participants. Hence, in the second part we extended the analysis to evaluate specifically the relationship of complement and coagulation proteins with psychotic symptoms and functional outcome in CHR.\n\n\nMaterials and methods\nWe carried out plasma proteomics and measured plasma cytokine levels, and├é┬á├éΓÇª\n\n','',2022,NULL,NULL,'2022-07-01',NULL,NULL,NULL,NULL,'1','Brain, Behavior, and Immunity','103','','50-60','Academic Press','Other','',''),(1390,'A network analysis of rest-activity rhythms in young people with emerging bipolar disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85126362489&doi=10.1016%2fj.jad.2022.03.007&partnerID=40&md5=aa229bffe24ab1dd24c926adcbbf72eb','10.1016/j.jad.2022.03.007','\n\nAims\nActigraphy studies of individuals with bipolar disorders (BD) suggest that illness progression may be associated with a range of progressive disruptions in 24-hour rest-activity rhythms (RAR). However, those longitudinal studies were undertaken in older adults with extended histories or illness and treatment rather than young people with emerging BD. To our knowledge, this is the first study to use network modelling to examine the statistical associations between clinical phenotypes of BD and different subsets of RAR markers.\n\n\nMethods\nThis study of adolescents and young adults (mean age 22┬áyears; 69% female) uses network modelling to examine which self-rated or actigraphic markers of RAR are more strongly associated with full threshold BD (referred to as Stage 2; N├é┬á=├é┬á15) compared with BD-at risk syndromes (subthreshold presentations referred to as Stage 1; N├é┬á=├é┬á25).\n\n\nResults\nNetwork analysis├é┬á├éΓÇª\n\n','',2022,NULL,NULL,'2022-05-15',NULL,NULL,NULL,NULL,'1','Journal of Affective Disorders','305','','220-226','Elsevier','Other','',''),(1391,'Understanding the vocational functioning of autistic employees: the role of disability and mental health','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85132661409&doi=10.1080%2f09638288.2022.2066207&partnerID=40&md5=8800ba42e68b673ccd982b6b784d7bb2','10.1080/09638288.2022.2066207','\nPurpose \nEmployment rates for autistic people are low, despite increasing employment-focused programmes. Given the reported complexities for autistic people in finding and keeping work and flourishing there, further exploration is needed to understand how best to help employers accommodate autistic employees.\nMaterial and methods \nWe assessed 88 employed autistic adults, without comorbid intellectual disability and examined whether self-reported disability and mental health symptoms were associated with two measures of vocational functioning: disability days off work and vocational disability.\nResults \nNearly half (47%) reported at least one disability day absence in the previous month. Autism severity and IQ were not associated with either measure of vocational functioning. Greater disability and higher mental health symptoms were associated with both types of vocational functioning. However, the\n','',2022,NULL,NULL,'2022-05-03',NULL,NULL,NULL,NULL,'1','Disability and Rehabilitation','','','1-Sep','Taylor & Francis','Other','',''),(1392,'Presenting a comprehensive multi-scale evaluation framework for participatory modelling programs: A scoping review','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85128940384&doi=10.1371%2fjournal.pone.0266125&partnerID=40&md5=563e927fc33b3eb11ff47850ba47f7b3','10.1371/journal.pone.0266125','Introduction Systems modelling and simulation can improve understanding of complex systems to support decision making, better managing system challenges. Advances in technology have facilitated accessibility of modelling by diverse stakeholders, allowing them to engage with and contribute to the development of systems models (participatory modelling). However, despite its increasing applications across a range of disciplines, there is a growing need to improve evaluation efforts to effectively report on the quality, importance, and value of participatory modelling. This paper aims to identify and assess evaluation frameworks, criteria, and/or processes, as well as to synthesize the findings into a comprehensive multi-scale framework for participatory modelling programs.   Materials and methods A scoping review approach was utilized, which involved a systematic literature search via Scopus in consultation with experts to identify and appraise records that described an evaluation framework, criteria, and/or process in the context of participatory modelling. This scoping review is registered with the Open Science Framework.   Results The review identified 11 studies, which varied in evaluation purposes, terminologies, levels of examination, and time points. The review of studies highlighted areas of overlap and opportunities for further development, which prompted the development of a comprehensive multi-scale evaluation framework to assess participatory modelling programs across disciplines and systems modelling methods. The framework consists of four categories (Feasibility, Value, Change/Action, Sustainability) with 30 evaluation','',2022,NULL,NULL,'2022-04-22',NULL,NULL,NULL,NULL,'1','PLoS ONE','17','4','e0266125','Public Library of Science','YMH team','Mental Health System',''),(1393,'Social and occupational outcomes for young people who attend early intervention mental health services','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85124711034&doi=10.5694%2fmja2.51425&partnerID=40&md5=25ccdff889411ff7bff0d939bc3d8029','10.5694/mja2.51425','In reply: We thank Rickwood and colleagues 1 for their comments about the generalisability of our findings to other headspace cohorts, which is a challenging question given the likely variability across services nationally. Based on data available, our sample is comparable to other published headspace cohorts on demographic and clinical characteristics including age (18.1┬▒3.3 in our study v 17.1├é┬▒3.4), sex (61.6% v 61.3% female), disengagement from employment, education and training (15.8% v 18.5%), and functional impairment (Social and Occupational Functioning Assessment Scale [SOFAS] score, 62.3├é┬▒9.03 v~ 62.7├éΓÇô64.7). 2, 3, 4 Our online Supporting Information highlights that the 1391 young people we excluded tended to be male, older, have higher rates of disengagement, previous hospitalisation and more severe disorders (ie, psychosis), a group that may be less closely matched with other headspace├é┬á├éΓÇª','',2022,NULL,NULL,'2022-03-21',NULL,NULL,NULL,NULL,'1','Medical Journal of Australia','216','5','265-265','','YMH team','Outcome Research',''),(1394,'Atypical sensory processing features in children with autism, and their relationships with maladaptive behaviors and caregiver strain','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85126360810&doi=10.1002%2faur.2700&partnerID=40&md5=f9617a19ce23475c47e5a8aed43e094b','10.1002/aur.2700','  Atypical sensory processing occurs in up to 97% of children on the autism spectrum. Children who are on the autism spectrum also commonly demonstrate challenging behaviors, and their caregivers report increased levels of strain in daily life. The aim of this study was to explore four sensory processing features; seeking, avoiding, sensitivity, and registration, and their relationships with maladaptive behaviors in children with autism, as well as with caregiver strain. Participants comprised 75 children with autism aged 7ΓÇô12 years (M = 7.81). Caregivers completed three questionnaire measures examining child sensory processing, maladaptive behaviors, and perceptions of caregiver strain. We found avoiding significantly associated with irritability. Avoiding also displayed the strongest relationship with global caregiver strain. Avoiding and seeking were strongly related to hyperactivity/noncompliance (components├é┬á├éΓÇª\n','',2022,NULL,NULL,'2022-03-17',NULL,NULL,NULL,NULL,'1','Autism Research','','','','John Wiley & Sons, Inc.','Other','',''),(1395,'Informing the Future of Integrated Digital and Clinical Mental Health Care: Synthesis of the Outcomes From Project Synergy','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85126461780&doi=10.2196%2f33060&partnerID=40&md5=b2fd79d35eec3817a194edb18cfd7840','10.2196/33060','\nBackground: Globally, there are fundamental shortcomings in mental health care systems, including restricted access, siloed services, interventions that are poorly matched to service users├éΓÇÖ needs, underuse of personal outcome monitoring to track progress, exclusion of family and carers, and suboptimal experiences of care. Health information technologies (HITs) hold great potential to improve these aspects that underpin the enhanced quality of mental health care.\nObjective: Project Synergy aimed to co-design, implement, and evaluate novel HITs, as exemplified by the InnoWell Platform, to work with standard health care organizations. The goals were to deliver improved outcomes for specific populations under focus and support organizations to enact significant system-level reforms.\nMethods: Participating health care organizations included the following: Open Arms├éΓÇôVeterans & Families Counselling (in Sydney and Lismore, New South Wales [NSW]); NSW North Coast headspace centers for youth (Port Macquarie, Coffs Harbour, Grafton, Lismore, and Tweed Heads); the Butterfly Foundation├éΓÇÖs National Helpline for eating disorders; Kildare Road Medical Centre for enhanced primary care; and Connect to Wellbeing North Coast NSW (administered by Neami National), for population-based intake and assessment. Service users, families and carers, health professionals, and administrators of services across Australia were actively engaged in the configuration of the InnoWell Platform to meet service needs, identify barriers to and facilitators of quality mental health care, and highlight potentially the best points in the service pathway to integrate the├é┬á├éΓÇª\n','',2022,NULL,NULL,'2022-03-09',NULL,NULL,NULL,NULL,'1','JMIR Mental Health','9','3','e33060','JMIR Publications Inc., Toronto, Canada','YMH team','Digital health','Models of care'),(1396,'Thalamic abnormalities in older adults with remitted early-onset depression using structural magnetic resonance imaging','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85122342957&doi=10.1016%2fj.jad.2021.12.067&partnerID=40&md5=ca4f945ff5915d9d58699931d272fec7','10.1016/j.jad.2021.12.067','\n\nBackground\nThe thalamus is a key diencephalic structure involved in major depressive disorder (MDD). Studies have consistently revealed abnormalities in thalamic volumes in older adults with late-onset depression (LOD), however abnormalities in older adults with early-onset depression (EOD) have not yet been well-studied.\n\n\nMethods\nFifty-nine euthymic participants with a history of EOD and fifty-nine matched comparison participants without a lifetime history of depression underwent neuroimaging, medical and neuropsychological assessments. Thalamic volumes were compared between groups. To investigate the previously-proposed right hemispheric (RH) dominance theory of MDD, we explored the bilateral, right and left hemispheric (LH) thalamic volumes. Multiple regression analyses were used to evaluate between-group and within-group effects. Correlational analyses examined associations between\n\n','',2022,NULL,NULL,'2022-03-01',NULL,NULL,NULL,NULL,'1','Journal of Affective Disorders','300','','150-157','Elsevier','Other','',''),(1397,'A systematic review and meta-analysis of sleep and circadian rhythms disturbances in individuals at high-risk of developing or with early onset of bipolar disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85126111855&doi=10.1016%2fj.neubiorev.2022.104585&partnerID=40&md5=4bf2a88645aa8d0b8151dd7dc3c52a65','10.1016/j.neubiorev.2022.104585','Sleep and circadian rhythms disturbances (SCRD) in young people at high risk or with early onset of bipolar disorders (BD) are poorly understood. We systematically searched for studies of self, observer or objective estimates of SCRD in asymptomatic or symptomatic offspring of parents with BD (OSBD), individuals with presentations meeting recognized BD-at-risk criteria (BAR) and youth with recent onset of full-threshold BD (FT-BD). Of 76 studies eligible for systematic review, 35 (46%) were included in random effects meta-analyses. Pooled analyses of self-ratings related to circadian rhythms demonstrated greater preference for eveningness and more dysregulation of social rhythms in BAR and FT-BD groups; analyses of actigraphy provided some support for these findings. Meta-analysis of prospective studies showed that pre-existing SCRD were associated with a 40% increased risk of onset of BD, but','',2022,NULL,NULL,'2022-02-17',NULL,NULL,NULL,NULL,'1','Neuroscience and Biobehavioral Reviews','','','104585','Pergamon','YMH team','Illness specific areas',''),(1398,'Premature mortality in early-intervention mental health services: A data linkage study protocol to examine mortality and morbidity outcomes in a cohort of help-seeking young people','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85125156659&doi=10.1136%2fbmjopen-2021-054264&partnerID=40&md5=3d9a36ab8ca5cdefe98607cf9c18be61','10.1136/bmjopen-2021-054264','\nIntroduction Understanding the risk of premature death from suicide, accident and injury and other physical health conditions in people seeking healthcare for mental disorders is essential for delivering targeted clinical interventions and secondary prevention strategies. It is not clear whether morbidity and mortality outcomes in hospital-based adult cohorts are applicable to young people presenting to early-intervention services.\nMethods and analysis The current data linkage project will establish the Brain and Mind Patient Research Register├éΓÇôMortality and Morbidity (BPRR-M&M) database. The existing Brain and Mind Research Institute Patient Research Register (BPRR) is a cohort of 6743 young people who have accessed primary care-based early-intervention services; subsets of the BPRR contain rich longitudinal clinical, neurobiological, social and functional data. The BPRR will be linked with the routinely├é┬á├éΓÇª\n','',2022,NULL,NULL,'2022-02-01',NULL,NULL,NULL,NULL,'1','BMJ Open','12','2','e054264','British Medical Journal Publishing Group','YMH team','Mental Health System','Outcome Research'),(1400,'Twelve-Month Cognitive Trajectories in Individuals at Ultra-High Risk for Psychosis: A Latent Class Analysis','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85131625058&doi=10.1093%2fschizbullopen%2fsgac008&partnerID=40&md5=bc6b5c81412d4943fa12362091dacc5f','10.1093/schizbullopen/sgac008','         Understanding longitudinal cognitive performance in individuals at ultra-high risk for psychosis (UHR) is important for informing theoretical models and treatment. A vital step in this endeavor is to determine whether there are UHR subgroups that have similar patterns of cognitive change over time. The aims were to: i) identify latent class trajectories of cognitive performance over 12-months in UHR individuals, ii) identify baseline demographic and clinical predictors of the resulting classes, and iii) determine whether trajectory classes were associated with transition to psychosis or functional outcomes. Cognition was assessed using the Brief Assessment of Cognition in Schizophrenia (BACS) at baseline, 6- and 12-months (N = 288). Using Growth Mixture Modeling, a single unimpaired improving trajectory class was observed for motor function, speed of processing, verbal fluency, and BACS composite. A two├é┬á├éΓÇª\n','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'1','Schizophrenia Bulletin Open','3','1','sgac008','Oxford University Press','Other','',''),(1401,'Transdiagnostic Clinical Staging for Childhood Mental Health: An Adjunctive Tool for Classifying Internalizing and Externalizing Syndromes that Emerge in Children Aged 5ΓÇô11┬áYears','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85130321129&doi=10.1007%2fs10567-022-00399-z&partnerID=40&md5=cc92eca17454541624650f2e267e8884','10.1007/s10567-022-00399-z','Clinical staging is now recognized as a key tool for facilitating innovation in personalized and preventative mental health care. It places a strong emphasis on the salience of indicated prevention, early intervention, and secondary prevention of major mental disorders. By contrast to established models for major mood and psychotic syndromes that emerge after puberty, developments in clinical staging for childhood-onset disorders lags significantly behind. In this article, criteria for a transdiagnostic staging model for those internalizing and externalizing disorders that emerge in childhood is presented. This sits alongside three putative pathophysiological profiles (developmental, circadian, and anxious-arousal) that may underpin these common illness trajectories. Given available evidence, we argue that it is now timely to develop a transdiagnostic staging model for childhood-onset syndromes. It is further argued that a├é┬á├éΓÇª','',2022,NULL,NULL,'2022-05-22',NULL,NULL,NULL,NULL,'1','Clinical Child and Family Psychology Review','','','Jan-14','Springer US','YMH team','Models of care',''),(1403,'Correction: Using Participatory Design Methodologies to Co-Design and Culturally Adapt the Spanish Version of the Mental Health eClinic: Qualitative Study','https://www.jmir.org/2022/3/e37679/PDF',NULL,'The correction will appear in the online version of the paper on the JMIR Publications website on March 4, 2022, together with the publication of this correction notice. Because this was made after submission to PubMed, PubMed Central, and other full-text repositories, the corrected article has also been resubmitted to those repositories.','',2007,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'1','J Med Internet Res','24','3','e37679','',NULL,NULL,NULL),(1404,'Editorial: Immune Associated Mental Illnesses in Adolescents and Young Adults: Pathophysiological Role and Therapeutic Perspectives','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85127702061&doi=10.3389%2ffpsyt.2022.871719&partnerID=40&md5=1a0e7e83aeb67201d2fa34dba4098ee8','10.3389/fpsyt.2022.871719','The immune systemΓÇÖs role in mental health has been discussed for decades, and immunological responses have been reported for many mental health issues. With the paradigm shift in psychiatry toward person-centered Precision Psychiatry (1), immune-mediated processes, too, are becoming more relevant as the current syndrome-based diagnostic concept fails to provide the necessary guidance in complex and/or treatment-resistant conditions. Immune and autoimmune processes appear to be particularly critical at early disease stages in childhood, adolescents, and early adulthood. Following a possibly life-long trajectory, innate and adaptive immune responses draw and re-draw the boundaries between the biological self and non-self and influence, so we content, many facets of what individuals experience as mental health. More recently, guidelines for autoimmune-mediated mental health disorders have├é┬á├éΓÇª','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'1','Frontiers in Psychiatry','13','','','Frontiers Media SA','Other','Neurobiology',''),(1405,'The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85116673880&doi=10.1016%2fj.bbi.2021.09.018&partnerID=40&md5=bdd3634bf2924dbbf9abe9a1693a66a9','10.1016/j.bbi.2021.09.018','\nBackground\nThere is increasing evidence that dysregulation of polyunsaturated fatty acids (FAs) mediated membrane function plays a role in the pathophysiology of schizophrenia. Even though preclinical findings have supported the anti-inflammatory properties of omega-3 FAs on brain health, their biological roles as anti-inflammatory agents and their therapeutic role on clinical symptoms of psychosis risk are not well understood. In the current study, we investigated the relationship of erythrocyte omega-3 FAs with plasma immune markers in a clinical high risk for psychosis (CHR) sample. In addition, a mediation analysis was performed to examine whether previously reported associations between omega-3 FAs and clinical outcomes were mediated via plasma immune markers. Clinical outcomes for CHR participants in the NEURAPRO clinical trial were measured using the Brief Psychiatric Rating Scale (BPRS├é┬á├éΓÇª\n','',2022,NULL,NULL,'2022-01-01',NULL,NULL,NULL,NULL,'1','Brain, Behavior, and Immunity','99','','147-156','Academic Press','Other','',''),(1406,'A multidisciplinary approach to evaluate the impact of emotional dysregulation on adolescent decision making','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85121522850&doi=10.1057%2fs41599-021-01013-3&partnerID=40&md5=ca3f4b710458c09e44217334ea9ef70b','10.1057/s41599-021-01013-3','Evaluating decision-making during youth is a complex area of research. Multiple factors influence the young person├éΓÇÖs subjective decision-making at this stage of development. Sub-optimal decision-making can have lifelong consequences. Longer adolescence, life stressors, drugs and alcohol and adverse events impact the young person, making them vulnerable to emerging mood disorders, such as anxiety and depression. Behavioural economics with its cognitive and multidisciplinary approach examines decision-making in youth with emerging mood disorders, but few empirical studies exist outside of a laboratory setting. Of the few that apply a multidisciplinary approach, most focus on other mental disorders. This review qualitatively evaluates the decision science literature to firstly, investigate complex factors influencing decision-making between adolescence and young adulthood. Secondly, it investigates├é┬á├éΓÇª','',2021,NULL,NULL,'2021-12-21',NULL,NULL,NULL,NULL,'1','Humanities and Social Sciences Communications','8','1','1-Nov','Palgrave','YMH team','Models of care',''),(1407,'Research to Clinical PracticeΓÇöYouth seeking mental health information online and its impact on the first steps in the patient journey','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85121761688&doi=10.1111%2facps.13390&partnerID=40&md5=a6a0188fb269ce6f4734560bed17538d','10.1111/acps.13390','  Background Online searches about anxiety and depression are recorded every 3├éΓÇô5├é┬ás. As such, information and communication technologies (ICT) have enormous potential to enable or impair help-seeking and patient-professional interactions. Youth studies indicate that ICT searches are undertaken before initial mental health consultations, but no publications have considered how this online activity affects the first steps of the patient journey in youth mental health settings.   Methods State-of-the-art review using an iterative, evidence mapping approach to identify key literature and expert consensus to synthesize and prioritise clinical and research issues.   Results Adolescents and young adults are more likely to seek health advice via online search engines or social media platforms than from a health professional. Young people not only search user-generated content and social media to obtain advice and├é┬á├éΓÇª\n','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'1','Acta Psychiatrica Scandinavica','145','3','301-314','','YMH team','Mental Health System',''),(1408,'Identifying pathways to early-onset metabolic dysfunction, insulin resistance and inflammation in young adult inpatients with emerging affective and major mood disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85120356132&doi=10.1111%2feip.13260&partnerID=40&md5=f3edb61f798098247e041839e7cac743','10.1111/eip.13260','  Aim Young people with common mood disorders face the prospect of shortened life expectancy largely due to premature cardiovascular disease. Metabolic dysfunction is a risk factor for premature cardiovascular disease. There is an ongoing debate whether metabolic dysfunction can be simply explained by weight gain secondary to psychotropic medications or whether shared genetic vulnerability, intrinsic immune-metabolic disturbances or other system perturbations (e.g. dysregulated sympathetic nervous system, circadian dysfunction) are more relevant determinants of premature cardiovascular disease. Thus, we aimed to investigate underlying drivers of metabolic dysfunction and premature cardiovascular disease in young people in the early phases of common mood disorders.   Methods We evaluated the relationships between insulin resistance (assessed by HOMA2-IR) and body mass index (BMI), sex\n','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'1','Early Intervention in Psychiatry','16','10','1121-1129','Wiley Publishing Asia Pty Ltd','YMH team','Models of care',''),(1409,'Thalamic abnormalities in older adults with early-onset depression using structural magnetic resonance imaging','https://alz-journals.onlinelibrary.wiley.com/doi/abs/10.1002/alz.053670',NULL,'  Background The thalamus is a key diencephalic structure involved in major depressive disorder (MDD). In particular, studies have consistently revealed abnormalities in thalamic volumes in older adults with late-onset depression (LOD). However, similar abnormalities in older adults with early-onset depression (EOD) have not been well studied.   Method Fifty-nine euthymic participants with a history of EOD and fifty-nine matched comparison participants without a lifetime history of depression underwent neuroimaging, medical and neuropsychological assessments. Thalamic volumes were compared between groups. Due to the right hemispheric (RH) dominance theory of MDD, we explored both bilateral and right hemispheric thalamic volumes. Multiple regression analyses were used to evaluate between-group and within-group effects. A correlational analysis examined associations between group and\n','',1994,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'1','Alzheimer\'s & Dementia','17','','e053670','',NULL,NULL,NULL),(1410,'Validation of a brief tool to assess and monitor suicidal ideation: The Youth Suicide Ideation Screen (YSIS-3)','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85114304086&doi=10.1016%2fj.jad.2021.08.053&partnerID=40&md5=136f1d53a318579a880513b98bf3279b','10.1016/j.jad.2021.08.053','\n\nBackground\n. Suicidal ideation is common in young people. Assessment and monitoring can help to understand its dynamic nature and inform treatment planning.\n\n\nAims\n. The aims were to evaluate psychometric properties of a brief screening tool - the Youth Suicide Ideation Screen-3 item (YSIS-3) and determine its correlation with the Suicidal Ideation Question-Junior (SIQ-JR) and measures of depressive and anxiety symptoms a.\n\n\nMethod\n. Cronbach\'s alpha (a) was used to evaluate internal consistency of the YSIS-3 in 1107 young people. Convergent validity was evaluated using network analysis based on individual item polychoric correlations. Structural equation modelling was used to understand latent constructs; pearson product moment correlations to validate the integrity of the underlying construct. and two-way mixed Intraclass Correlation Coefficient to examine longitudinal stability and Cohen\'s d to assess├é┬á├éΓÇª\n\n','',2021,NULL,NULL,'2021-12-01',NULL,NULL,NULL,NULL,'1','Journal of Affective Disorders','295','','235-242','Elsevier','Other','',''),(1411,'Body image distress and its associations from an international sample of men and women across the adult life span: Web-based survey study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118934497&doi=10.2196%2f25329&partnerID=40&md5=93aa96b1f8cb256cd98b6aa6f43122df','10.2196/25329','\nBackground: Previous research on body image distress mainly relied on samples that were small, generally homogeneous in age or sex, often limited to one geographical region, and were characterized by a lack of comprehensive analysis of multiple psychosocial domains. The research presented in this paper extends the international literature using the results of the web-based Global Health and Wellbeing Survey 2015. The survey included a large sample of both men and women aged= 16 years from Australia, Canada, New Zealand, the United Kingdom, or the United States.\nObjective: The main objectives of this study are to examine body image distress across the adult life span (= 16 years) and sex and assess the association between body image distress and various psychosocial risk and protective factors.\nMethods: Data were extracted from the Global Health and Wellbeing Survey 2015, a web-based international self-report survey with 10,765 respondents, and compared with previous web-based surveys conducted in 2009 and 2012.\nResults: The body image distress of young Australians (aged 16-25 years) significantly rose by 33% from 2009 to 2015. In 2015, 75.19%(961/1278) of 16-to 25-year-old adults reported body image distress worldwide, and a decline in body image distress was noted with increasing age. More women reported higher levels of body image distress than men (1953/3338, 58.51% vs 853/2175, 39.22%). Sex, age, current dieting status, perception of weight, psychological distress, alcohol and other substance misuse, and well-being significantly explained 24% of the variance in body image distress in a linear├é┬á├éΓÇª\n','',2021,NULL,NULL,'2021-11-04',NULL,NULL,NULL,NULL,'1','JMIR Formative Research','5','11','e25329','JMIR Publications Inc., Toronto, Canada','YMH team','Outcome Research','illness specific areas'),(1412,'Using Polygenic Risk Scores to Dissect Heterogeneity Between Major Depressive Disorder Subtypes','https://dro.deakin.edu.au/articles/conference_contribution/Using_Polygenic_Risk_Scores_to_Dissect_Heterogeneity_Between_Major_Depressive_Disorder_Subtypes/20639370',NULL,'','',1991,NULL,NULL,'2021-11-01',NULL,NULL,NULL,NULL,'1','','','','','Deakin University',NULL,NULL,NULL),(1413,'The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: an analysis of the NEURAPRO clinical trial.','https://europepmc.org/article/med/34624483',NULL,'\nBackground\nThere is increasing evidence that dysregulation of polyunsaturated fatty acids (FAs) mediated membrane function plays a role in the pathophysiology of schizophrenia. Even though preclinical findings have supported the anti-inflammatory properties of omega-3 FAs on brain health, their biological roles as anti-inflammatory agents and their therapeutic role on clinical symptoms of psychosis risk are not well understood. In the current study, we investigated the relationship of erythrocyte omega-3 FAs with plasma immune markers in a clinical high risk for psychosis (CHR) sample. In addition, a mediation analysis was performed to examine whether previously reported associations between omega-3 FAs and clinical outcomes were mediated via plasma immune markers. Clinical outcomes for CHR participants in the NEURAPRO clinical trial were measured using the Brief Psychiatric Rating Scale (BPRS), Schedule for the Scale of Assessment of Negative Symptoms (SANS) and Social and Occupational Functioning Assessment Scale (SOFAS) scales. The erythrocyte omega-3 index [eicosapentaenoic acid (EPA)+ docosahexaenoic acid (DHA)] and plasma concentrations of inflammatory markers were quantified at baseline (n= 268) and 6 month follow-up (n= 146) by gas chromatography and multiplex immunoassay, respectively. In linear regression models, the baseline plasma concentrations of Interleukin (IL)-15, Intercellular adhesion molecule (ICAM)-1 and Vascular cell adhesion molecule (VCAM)-1 were negatively associated with baseline omega-3 index. In addition, 6-month change in IL-12p40 and TNF-a showed a negative├é┬á├éΓÇª\n','',1990,NULL,NULL,'2021-10-05',NULL,NULL,NULL,NULL,'1','Brain, Behavior, and Immunity','','','','',NULL,NULL,NULL),(1414,'TH34. EXPLORING THE EFFECT OF DIAGNOSTIC PHENOTYPING AND DISSECTING HETEROGENEITY BETWEEN DEPRESSION SUBTYPES USING THE AUSTRALIAN GENETICS OF DEPRESSION STUDY','https://www.researchgate.net/profile/Ian-Hickie/amp',NULL,'Background There is increasing evidence that dysregulation of polyunsaturated fatty acids (FAs) mediated membrane function plays a role in the pathophysiology of schizophrenia. Even though preclinical findings have supported the anti-inflammatory properties of omega-3 FAs on brain health, their biological roles as anti-inflammatory agents and their therapeutic role on clinical symptoms of psychosis risk are not well understood. In the current study, we investigated the relationship of erythrocyte omega-3 FAs with plasma immune markers in a clinical high risk for psychosis (CHR) sample. In addition, a mediation analysis was performed to examine whether previously reported associations between omega-3 FAs and clinical outcomes were mediated via plasma immune markers. Clinical outcomes for CHR participants in the NEURAPRO clinical trial were measured using the Brief Psychiatric Rating Scale (BPRS), Schedule for the Scale of Assessment of Negative Symptoms (SANS) and Social and Occupational Functioning Assessment Scale (SOFAS) scales. The erythrocyte omega-3 index [eicosapentaenoic acid (EPA)+ docosahexaenoic acid (DHA)] and plasma concentrations of inflammatory markers were quantified at baseline (n= 268) and 6 month follow-up (n= 146) by gas chromatography and multiplex immunoassay, respectively. In linear regression models, the baseline plasma concentrations of Interleukin (IL)-15, Intercellular adhesion molecule (ICAM)-1 and Vascular cell adhesion molecule (VCAM)-1 were negatively associated with baseline omega-3 index. In addition, 6-month change in IL-12p40 and TNF-a showed a negative','',1990,NULL,NULL,'2021-10-01',NULL,NULL,NULL,NULL,'1','European Neuropsychopharmacology','51','','e212-e213','Elsevier',NULL,NULL,NULL),(1415,'Perceptions of social and work functioning are related to social anxiety and executive function in autistic adults','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85110329846&doi=10.1177%2f13623613211013664&partnerID=40&md5=b31b6a335db5e3d227d0ac0c5fc645c8','10.1177/13623613211013664','Autistic adults report concerns with social skills and unemployment. Despite anxiety and difficulty with executive cognitive skills being associated with autism, no studies to date have investigated relationships between anxiety or executive cognition with social and work functioning. This study aimed to investigate the associations between perceived social anxiety, perceived and objective executive function, and perceived social and work functioning in a sample of autistic people. A total of 62 participants completed self-report questionnaires of social anxiety (via the Liebowitz Social Anxiety Scale), mental health (via the Depression Anxiety Stress Scale), executive cognition (via the Behaviour Rating Inventory of Executive Function) and perceived social and work functioning (the Work and Social Adjustment Scale), and a smaller subset (n = 36├éΓÇô40) completed performance-based executive function tasks (Trail Making├é┬á├éΓÇª','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Autism','25','7','2124-2134','SAGE Publications','YMH team','Illness specific areas',''),(1416,'Active Ingredients for Addressing Youth Anxiety and Depression 1 Circadian rhythm sleep-wake disturbances and depression in young people: implications for prevention and early','https://scholar.google.com/scholar?cluster=3590975736457292012&hl=en&oi=scholarr',NULL,' A rate -limiting step in the prevention and early intervention of depressive disorders in young people is our insufficient understanding of causal mechanisms. One plausible pa thophysiological pathway is disturbance in the 24 h sleep wake cycle and the underlying circadian system. Abnormalities in circadian rhythms are well documented in adults with various depressive disorders and have been linked to core clinical features, including unstable mood, daytime fatigue, non-restorative sleep, reduced motor activity, somatic symptoms, and appetite and weight change. In this Review, we summarise four areas of research: basic circadian biology and animal models of circadian disturbances; developmental changes in circadian rhythms during adolescence and implications for the emergence of adolescentonset depressive syndromes; community, and clinical studies linking 24 h sleep wake cycle disturbances and\n','',2022,NULL,NULL,'2021-09-01',NULL,NULL,NULL,NULL,'','LANCET PSYCHIATRY','8','9','813-823','ELSEVIER SCI LTD',NULL,NULL,NULL),(1417,'Increased spindle density correlates with sleep continuity improvements following an eight-week course of a melatonin agonist in people with depression: A proof-of-concept study with agomelatine','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85112313915&doi=10.1111%2fejn.15340&partnerID=40&md5=748f32677732f4681cdb6da0a3b8a5af','10.1111/ejn.15340',' Sleep fragmentation and reductions in sleep spindles have been observed in individuals with depression. Sleep spindles are known to play a protective role for sleep, and there are indications that melatonin agents can enhance spindles in healthy people. Whether agomelatine, a melatonin agonist indicated for the treatment of depression, may increase spindle density sufficiently to impact sleep continuity in people with depression remains unknown. This proof-of-concept study investigated changes in spindles following agomelatine intake in young adults with depression and assessed how they may relate to potential changes in sleep continuity and depressive symptoms. This study was based on an open-label design. Fifteen participants between 17 and 28┬áyears of age (mean├é┬á=├é┬á22.2; standard deviation [SD]├é┬á=├é┬á3.4) with a diagnosis of a depressive disorder underwent polysomnography before and after an├é┬á├éΓÇª\n','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','European Journal of Neuroscience','54','3','5112-5119','','YMH team','Illness specific areas','Models of care'),(1418,'Association between lifetime depression history, hippocampal volume and memory in non-amnestic mild cognitive impairment','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85112415756&doi=10.1111%2fejn.15207&partnerID=40&md5=b313d922a99a43f746b71698f7b311a6','10.1111/ejn.15207',' Hippocampal subfield volume loss in older adults with amnestic mild cognitive impairment (aMCI) and depression history are associated with amyloid beta and tau pathology, thereby increasing the risk for Alzheimer\'s disease (AD). However, no studies have exclusively examined distinct alterations in hippocampal subfields in non-amnestic MCI (naMCI) in relation to depression history. Here, we used both longitudinal and transverse hippocampal segmentation methods using the automated FreeSurfer software to examine whether a lifetime depression history is associated with differences in hippocampal head/body/tail (H/B/T) and key subfield volumes (CA1, subiculum, dentate gyrus) in older adults with naMCI. Further, we explored whether differences in hippocampal H/B/T and subfield volumes were associated with structured and unstructured verbal encoding and retention, comparing those with and without a\n','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','European Journal of Neuroscience','54','3','4953-4970','','Other','',''),(1419,'Associations between 24-h sleepΓÇôwake patterns and cardiometabolic risk factors in youth seeking mental health care','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100853666&doi=10.1007%2fs41105-021-00314-z&partnerID=40&md5=1239b4a31faaae8ca634fb4b92c7772f','10.1007/s41105-021-00314-z','               One hundred and eleven youth with mental ill-health underwent systematic clinical, laboratory and actigraphy monitoring to report associations between 24-h sleep├éΓÇôwake patterns and cardiometabolic risk factors. Multiple linear regression analyses, controlling for medication usage and class, age and sex, found significant associations between: later sleep onset and BMI; standard variation (SV) in the sleep offset with both insulin values and the updated homeostatic model assessment of insulin resistance (HOMA2-IR) values; and the SV of the sleep midpoint with both poorer fasting insulin, and HOMA2-IR values. Further longitudinal research is required to determine the causative relationships between 24-h sleep├éΓÇôwake cycle patterns, and cardiometabolic outcomes.\n','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Sleep and Biological Rhythms','19','3','337-340','Springer Singapore','YMH team','Illness specific areas',''),(1420,'Brain structural abnormalities in obesity: relation to age, genetic risk, and common psychiatric disorders (May, 2020, 10.1038/s41380-020-0774-9)','https://minerva-access.unimelb.edu.au/items/ba6d3107-c14b-53ef-86fa-4fce187ecc4f',NULL,'','',2022,NULL,NULL,'2021-06-22',NULL,NULL,NULL,NULL,'','','','','','SPRINGERNATURE',NULL,NULL,NULL),(1421,'Using monozygotic twins to dissect common genes in Posttraumatic stress disorder and migraine','https://www.frontiersin.org/articles/10.3389/fnins.2021.678350/full',NULL,'Epigenetic mechanisms have been associated with of genes involved in Posttraumatic stress disorder (PTSD). PTSD often co-occurs with other health conditions such as depression, cardiovascular disorder and respiratory illnesses. PTSD and migraine have previously been reported to be symptomatically positively correlated with each other, but little is known about the genes involved. The aim of this study was to understand the comorbidity between PTSD and migraine using a monozygotic twin disease discordant study design in 6 pairs of monozygotic twins discordant for PTSD and 15 pairs of monozygotic twins discordant for migraine. DNA from peripheral blood was run on Illumina EPIC arrays and analysed Multiple testing correction was performed using the Bonferroni method and 10% false discovery rate (FDR). We validated 11 candidate genes previously associated with PTSD including DOCK2, DICER1 and ADCYAP1. In the epigenome-wide scan, 7 novel CpGs were significantly associated with PTSD within/near IL37, WNT3, ADNP2, HTT, SLFN11 and NQO2. These results were significantly enriched for genes whose DNA methylation was previously associated with migraine (p-value = 0.036). At 10% FDR, 132 CpGs in 99 genes associated with PTSD were also associated with migraine in the migraine twin samples. Genes associated with PTSD were overrepresented in vascular smooth muscle, axon guidance and oxytocin signalling pathways, while genes associated with both PTSD and migraine were enriched for AMPK signalling and longevity regulating pathways. In conclusion, these results suggest that common genes and├é┬á├éΓÇª','',2022,NULL,NULL,'2021-06-22',NULL,NULL,NULL,NULL,'','Frontiers in Neuroscience','15','','758','Frontiers',NULL,NULL,NULL),(1422,'Best Care, First Time','https://www.sydney.edu.au/content/dam/corporate/documents/brain-and-mind-centre/youth-mental-health/best_care_first_time_report_june2021.pdf',NULL,'\nThe Youth Mental Health and Technology team at the Brain and Mind Centre aims to change the way in which clinical care is delivered to young people with emerging mental health disorders. To do this, we are utilising sophisticated digital technology and systems modelling to shift the way that services deliver care, to modernise and connect the previously disconnected mental health system in Australia, allowing young people to seamlessly move through the system and receive the best care as required.\nThis work is made possible by the Bupa Health Foundation, one of AustraliaΓÇÖs leading charitable organisations committed to addressing the health needs of the Australian community to help people live longer, healthier, happier lives. The investment provided by the Bupa Health Foundation, and their ongoing support of and collaboration with the research team, speaks to the value, and progressive nature of this work.\n','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','','','','',NULL,NULL,NULL),(1423,'Effect of an online healthy lifestyle psychoeducation programme to improve cardiometabolic outcomes and affective symptoms in youth receiving mental health care: study protocol for a pilot clinical trial','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85110103901&doi=10.1136%2fbmjopen-2020-044977&partnerID=40&md5=e0063c1da535528d73694cf9627eb923','10.1136/bmjopen-2020-044977','\nIntroduction Worsened cardiometabolic profiles in youth with mental ill health have been associated with a number of modifiable lifestyle risk factors. It is becoming increasingly evident that clinical interventions need to be multimodal in focus to improve mental health symptoms and the physical health symptoms in this already at-risk cohort.\nMethods and analysis This 12-week pilot clinical trial examines the efficacy, feasibility and acceptability of an adjunctive online psychoeducation programme for improving cardiometabolic risk parameters and affective symptoms in a transdiagnostic sample of at least 44 young people aged 16ΓÇô25 years presenting for mental healthcare for mood and/or psychotic syndromes (including anxiety, depression, bipolar disorder and psychosis). Individuals will be invited to participate in a pilot clinical trial for a structured online psychoeducation programme incorporating nutritional, physical├é┬á├éΓÇª\n','',2021,NULL,NULL,'2021-06-01',NULL,NULL,NULL,NULL,'','BMJ Open','11','6','e044977','British Medical Journal Publishing Group','YMH team','Digital health','Models of care'),(1424,'Neurobiology Youth Follow-up Study: Protocol to establish a longitudinal and prospective research database using multimodal assessments for current and past mental health treatment-seeking young people within an early intervention service','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85108315704&doi=10.1136%2fbmjopen-2020-044731&partnerID=40&md5=057791f31991cc083ad0591e8c9ee3d3','10.1136/bmjopen-2020-044731','\nIntroduction Approximately 75% of major mental illness occurs before the age of 25 years. Despite this, our capacity to provide effective, early and personalised interventions is limited by insufficient evidence for characterising early-stage, and less specific, presentations of major mental disorders in youth populations. This article describes the protocol for setting up a large-scale database that will collect longitudinal, prospective data that incorporate clinical, social and occupational function, neuropsychological, circadian, metabolic, family history and genetic metrics. By collecting data in a research-purposed, standardised manner, the ├éΓÇÿNeurobiology Youth Follow-up Study├éΓÇÖ should improve identification, characterisation and profiling of youth attending mental healthcare, to better inform diagnosis and treatment at critical time points. The overall goal is enhanced long-term clinical and functional outcomes├é┬á├éΓÇª\n','',2021,NULL,NULL,'2021-06-01',NULL,NULL,NULL,NULL,'','BMJ Open','11','6','e044731','British Medical Journal Publishing Group','YMH team','Neurobiology',''),(1425,'Temporal dynamics of subjective sleep profiles predicting mood improvements during adjunctive light therapy combined with sleep rescheduling','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85125605243&doi=10.1016%2fj.jadr.2021.100106&partnerID=40&md5=18ded38944ccdf69d5d3753b672ff4a4','10.1016/j.jadr.2021.100106','\n\nBackground\nLight therapy yields inconsistent results in people with non-seasonal depression, which may in part be due to heterogeneous responses and the temporal dynamics of changes in sleep, daytime functioning and mood. This study assessed the timeline of the antidepressant effects of light therapy and sleep rescheduling relative to changes in sleep and daytime sleep-related factors, and sought to identify predictors of treatment response in young people with depression.\n\n\nMethods\nTwenty-four individuals with depression (mean┬▒SD: 21.2├é┬▒1.0 years old;17% male) underwent adjunctive morning light therapy with a wake-up phase advance over four weeks. They completed the Beck Depression Inventory-II (BDI-II) and Leeds Sleep Evaluation Questionnaire.\n\n\nResults\nOn average, BDI-II scores decreased significantly after four weeks of intervention (F(2,32)=3.5, p=.044, p2=0.18). After two weeks, improvements in├é┬á├éΓÇª\n\n','',2021,NULL,NULL,'2021-04-01',NULL,NULL,NULL,NULL,'','Journal of Affective Disorders Reports','4','','100106','Elsevier','Other','',''),(1426,'Obesity and oxidative stress in older adults at risk for dementia a magnetic resonance spectroscopy study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102444189&doi=10.1097%2fWAD.0000000000000434&partnerID=40&md5=5a88f6a748e43630e9e91b9cb4edfddc','10.1097/WAD.0000000000000434','\nObjective:\nThis study aimed to investigate the relationship between obesity and oxidative stress in older adults at risk for dementia. It also aimed to explore the influence of physical activity on the relationship between obesity and oxidative stress in this at risk cohort.\nMethods:\nOlder adults at risk for dementia underwent comprehensive medical, neuropsychological, and psychiatric assessment. At risk was defined as participants with subjective or mild cognitive impairment. Glutathione was assessed by magnetic resonance spectroscopy in the left hippocampus and the anterior and posterior cingulate cortex. Body mass index (BMI) was calculated and classified as healthy (BMI< 25 kg/m 2) or overweight/obese (BMI= 25 kg/m 2).\nResults:\nSixty-five older adults (mean age= 66.2 y) were included for analysis. The overweight/obese group had significantly greater glutathione in the hippocampus compared with the healthy\n','',2021,NULL,NULL,'2021-04-01',NULL,NULL,NULL,NULL,'','Alzheimer Disease and Associated Disorders','35','2','121-127','LWW','Other','',''),(1427,'Lifetime Prevalence and Risk Factors for Perinatal Depression in a Large Cohort of Women with Depression','https://www.researchsquare.com/article/rs-362347/latest.pdf',NULL,'\nBackground\nHistory of psychiatric disorders, particularly depression, is the strongest risk factor for perinatal depression (PND). Yet many women without such history experience their rst depression episode perinatally, whilst other women with depression history do not experience any episodes during the perinatal period. PND may itself be heterogenous, according to differences in psychiatric history. However, a comprehensive investigation of characteristics of women with PND, with and without a prior psychiatric history, has not been attempted.\n','',2022,NULL,NULL,'2021-11-12',NULL,NULL,NULL,NULL,'','','','','','',NULL,NULL,NULL),(1428,'Technology-enabled service models for quality improvements in Australian mental health care delivery','https://www.ijic.org/articles/10.5334/ijic.s4176/print/',NULL,'\nAn introduction (comprising background and problem statement): New health information technologies (HIT) are being rapidly developed to support the transformation of mental health services. The InnoWell Platform is a configurable and customisable digital tool that assists in assessment, monitoring and management of mental ill health and maintenance of wellbeing. Importantly, the InnoWell Platform is not just installed into a service, rather implementation is informed by participatory design methodologies, including service modelling to understand and map clinical pathways (both pre-and post-implementation), relationships to external mental health and social services, and key performance indicators related to safety and service quality.\nTheory/Methods: The InnoWell Platform is now being offered as part of standard clinical care in face-to-face and online mental health services across population groups, including young children and their families, young people, adults (including the veteran community) and older adults. During pre-implementation, at least two service modelling workshops are conducted to discover, evaluate and prototype clinical pathways (intake, assessment, treatment planning, treatment, progress monitoring, exit) which can be assessed against safety and service quality domains (ie accessibility, acceptability, workforce competence, efficiency, effectiveness, appropriateness and care continuity). The co-designed service models are updated quarterly to reflect changes related to implementation and impacts on workflows by role (ie health professional, service management or administration).\nResults: To date, service modelling\n','',2022,NULL,NULL,'2021-02-26',NULL,NULL,NULL,NULL,'','International Journal of Integrated Care','20','S1','','Ubiquity Press',NULL,NULL,NULL),(1429,'An implementation science protocol for technology-enabled person-centred mental health services reform','https://www.ijic.org/articles/abstract/10.5334/ijic.s4132/?utm_source=TrendMD&utm_medium=cpc&utm_campaign=International_Journal_of_Integrated_Care_TrendMD_0',NULL,'\nAn introduction (comprising background and problem statement): New health information technologies (HIT) are being rapidly developed to improve the delivery of mental health care; however, a range of facilitators, barriers and contextual conditions can impact on the adoption and sustainment of these solutions. Our implementation science protocol systematically guides the implementation of HIT-enabled solutions in traditional face-to-face and online mental health services, allowing for revisions over time based on retrospective review and constructive feedback from the services in which the solutions are implemented.\nTheory/Methods: The protocol is comprised of four phases. The primary objective of the scoping and feasibility phase (Phase 1) is to determine the alignment between the service partner and the quality improvement goals supported by the HIT-enabled solution. Phase 2, the local co-design and pre-implementation phase, aims to utilise co-design methodologies, including service pathway modelling, participatory design and user (acceptance) testing, to determine how the HIT-enabled solutions could be used to enhance the service. During implementation (Phase 3), the accepted HIT-enabled solution is embedded in the mental health service to achieve better outcomes for consumers and their families as well as health professionals and service managers. Using iterative evaluative processes, the solution is continuously developed, redesigned, and refined, adapting to the changing needs of the stakeholders, including consumers with lived experience and their families, and the service. This optimised HIT-enabled solution can\n','',2022,NULL,NULL,'2021-02-26',NULL,NULL,NULL,NULL,'','International Journal of Integrated Care','20','S1','','Ubiquity Press',NULL,NULL,NULL),(1430,'Piloting the ΓÇÿYouth Early-intervention StudyΓÇÖ (ΓÇÿYESΓÇÖ): Preliminary functional outcomes of a randomized controlled trial targeting social participation and physical well-being in young people with emerging mental disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85096172339&doi=10.1016%2fj.jad.2020.10.070&partnerID=40&md5=df162715ec2054d6707047fde3628fa4','10.1016/j.jad.2020.10.070','\n\nIntroduction\nYoung people with mental disorders present with diverse social, vocational, physical, and developmental needs. However, multifaceted interventions are rare. We examine the effectiveness of a clinical trial targeting social participation and physical well-being in young people accessing clinical services.\n\n\nMethods\nThe ├éΓÇÿYouth Early-intervention Study├éΓÇÖ (├éΓÇÿYES├éΓÇÖ) was an unblinded, two-phase, pilot randomized controlled trial offered as an adjunct to standard clinical care, consisting of group activities. Mixed effects models were used to examine functional outcomes over time measured by the ├éΓÇÿSocial and Occupational Functioning Assessment Scale├éΓÇÖ, ├éΓÇÿFunctioning Assessment Short Test├éΓÇÖ, and ├éΓÇÿBrief Disability Questionnaire├éΓÇÖ (items 7 and 8).\n\n\nResults\n133 participants aged 14-25 were recruited. 87 participants completed both arms and 83 participants completed a 12-month post-trial assessment. Functioning improved├é┬á├éΓÇª\n\n','',2021,NULL,NULL,'2021-02-01',NULL,NULL,NULL,NULL,'','Journal of Affective Disorders','280','','180-188','Elsevier','YMH team','Models of care',''),(1431,'Best Care, First Time: Optimising Youth Mental Health Services Using Digital Technologies','https://researchdirect.westernsydney.edu.au/islandora/object/uws:62529/',NULL,'The Youth Mental Health and Technology team at the Brain and Mind Centre aims to change the way in which clinical care is delivered to young people with emerging mental health disorders. To do this, we are utilising sophisticated digital technology and systems modelling to shift the way that services deliver care, to modernise and connect the previously disconnected mental health system in Australia, allowing young people to seamlessly move through the system and receive the best care as required. This work is made possible by the Bupa Health Foundation, one of AustraliaΓÇÖs leading charitable organisations committed to addressing the health needs of the Australian community to help people live longer, healthier, happier lives. The investment provided by the Bupa Health Foundation, and their ongoing support of and collaboration with the research team, speaks to the value, and progressive nature of this├é┬á├éΓÇª','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','','','','',NULL,NULL,NULL),(1432,'JMIR Aging','https://pdfs.semanticscholar.org/a2a3/b25f8bb64d01e916217accd70014be951ab5.pdf',NULL,'JMIR Aging JMIR Aging Volume 4 (2021), Issue 1 ISSN: 2561-7605 Editor in Chief: Jing \nWang, PhD, MPH, RN, FAAN Contents Original Papers Web-Based Cognitive Testing of \nOlder Adults in Person Versus at Home: Within-Subjects Comparison Study (e23384) \nAndr├â┬⌐e-Ann Cyr, Kristoffer Romero, Laura Galin-Corini........................................................................... \n2 Implementations of Evidence-Based eHealth Interventions for Caregivers of People With \nDementia in Municipality Contexts (Myinlife and Partner in Balance): Evaluation Study (e21629) \nHannah Christie, Lizzy Boots, Huibert Tange, Frans Verhey, Marjolein de Vugt........................................................ \n16 Attitudes Toward Technology and Use of Fall Alert Wearables in Caregiving: Survey \nStudy (e23381) Deborah Vollmer Dahlke, Shinduk Lee, Matthew Smith, Tiffany Shubert, \nStephen Popovich, Marcia Ory.................................... 32 Understanding Technology ├éΓÇª','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','JMIR','4','1','','',NULL,NULL,NULL),(1434,'Relationship Between Depression and the Impacts of the Responses to the COVID-19 Pandemic in Australia','https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/pt/covidwho-1498664',NULL,'(instance:\" regional\") AND (year_cluster:(\" 2002\") AND pais_afiliacao:(\"^ iUnited States^ eEstados\"))(instance:\" regional\") AND (year_cluster:(\" 2002\") AND pais_afiliacao:(\"^ iUnited States^ eEstados\"))(instance:\" regional\") AND (year_cluster:(\" 2002\") AND pais_afiliacao:(\"^ iUnited States^ eEstados\"))(instance:\" regional\") AND (year_cluster:(\" 2002\") AND pais_afiliacao:(\"^ iUnited States^ eEstados\"))','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Behavior Genetics','','','699-700','',NULL,NULL,NULL),(1435,'Phenotypic and genetic factors associated with differential consent to record linkage for prescription history in the Australian Genetics of Depression Study','https://www.medrxiv.org/content/10.1101/2021.10.26.21265507.abstract',NULL,'Samples can be prone to ascertainment and attrition biases.The Australian Genetics of Depression Study is a large publicly recruited cohort (n=20,689) established to increase the understanding of depression and antidepressant treatment response. As part of the recruitment, participants donated a saliva sample and were given the option to consent to linkage of prescription records for research purposes. This study investigates differences between participants who donated a saliva sample or agreed to linkage of their records compared to those who did not. We observed that older, male participants with a higher education were more likely to donate a saliva sample. Self-reported bipolar disorder, ADHD, panic disorder, PTSD, substance use disorder and social anxiety disorder were associated with lower odds of donating a saliva sample whereas anorexia was associated with higher odds of donation. Male and younger participants showed higher odds of agreeing to record linkage. Participants with higher neuroticism scores and those with a history of bipolar disorder were also more likely to agree to record linkage whereas participants with a diagnosis of anorexia were less likely to agree. Increased likelihood of consent was also associated with increased genetic susceptibility to anorexia and reduced genetic risk for depression, and schizophrenia whereas there was no significant genetic effect for neuroticism. Overall, our results show moderate differences among these subsamples. Most current epidemiological studies do not adjust, nor search, for attrition biases at the genetic level. The possibility to do so is a strength of samples such as the├é┬á├éΓÇª','',2022,NULL,NULL,'2021-01-01',NULL,NULL,NULL,NULL,'','medRxiv','','','','Cold Spring Harbor Laboratory Press',NULL,NULL,NULL),(1437,'The circadian component of mood disorders: the sleep-wake cycle, biological rhythms, and chronotherapeutics','https://scholar.google.com/scholar?cluster=10192288836779783548&hl=en&oi=scholarr',NULL,'','',2022,NULL,NULL,'2021-01-01',NULL,NULL,NULL,NULL,'','','','','','Elsevier',NULL,NULL,NULL),(1438,'Structural brain alterations associated with suicidal thoughts and behaviors in young people: results from 21 international studies from the ENIGMA Suicidal Thoughts and Behaviours consortium','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85137441667&doi=10.1038%2fs41380-022-01734-0&partnerID=40&md5=2f51644332fa8d90d5dd4f7fb3ab7b99','10.1038/s41380-022-01734-0','\nObjective\nIdentifying brain differences associated with suicidal thoughts and behaviors (STBs) in young people is critical to understanding their development and generating effective approaches to early intervention and prevention. The ENIGMA Suicidal Thoughts and Behaviours (ENIGMA-STB) consortium analyzed neuroimaging data harmonized across sites to examine brain morphology associated with STBs in youth.\nMethods\nFirst, we examined associations among regional brain structure and STBs, which were assessed in six samples of youth with mood disorders, using the Columbia Suicide Severity Rating Scale (C-SSRS; N=577). Second, we combined this sample with a larger sample (total 21 sites) in which STBs were assessed using various instruments. MRI metrics were compared among healthy controls without STBs (HC; N=688), clinical controls without STBs (CC; N=648), and young people with psychiatric diagnoses and current suicidal ideation (N=406). In separate analyses, MRI metrics were compared among HCs (N=335), CCs (N=768), and suicide attempters (N=254).\nResults\nIn the homogeneous C-SSRS sample, surface area of the frontal pole was lower in young people with mood disorders and history of actual suicide attempts (N=163) than those without (N=394; FDR-p<.001; Cohen├éΓÇÖs d=.334). When expanding to more clinically heterogeneous samples, we also found lower surface area of the frontal pole in those with a history of suicide attempts (Cohen├éΓÇÖs d=.22).\nConclusions\nLower frontal pole surface area may represent a vulnerability for a suicide attempt; however, more research is needed to understand the nature of its├é┬á├éΓÇª\n','',2022,NULL,NULL,'2021-01-01',NULL,NULL,NULL,NULL,'','Molecular Psychiatry','','','','Cold Spring Harbor Laboratory Press','YMH team','Neurobiology','illness specific areas'),(1439,'Predicting Quality Adjusted Life Years in young people attending primary mental health services','https://www.medrxiv.org/content/10.1101/2021.07.07.21260129.abstract',NULL,'\nBackground\nQuality Adjusted Life Years (QALYs) are often used in economic evaluations, yet utility weights for deriving them are rarely directly measured in mental health services.\nObjectives\nWe aimed to identify the best mapping models and predictors for adolescent Assessment of Quality of Life - Six Dimensions (AQOL-6D) utility and assess the ability of mapping models to predict longitudinal change.\nMethods\nWe recruited 1107 young people attending Australian primary mental health services, collecting data at two time points, three months apart. Five linear and three generalised linear models were explored to identify the best mapping model. Ten-fold cross-validation using R2, root mean square error (RMSE) and mean absolute error (MAE) were used to compare models and assess predictive ability of six candidate measures of psychological distress, depression and anxiety. Linear / generalised linear mixed effect models were used to construct longitudinal predictive models for AQoL-6D change.\nResults\nA depression measure (Patient Health Questionnaire-9) was the strongest independent predictor of health utility. Linear regression models with complementary log-log transformation of utility score were the best performing models. Between-person associations were slightly larger than within-person associations for most of the predictors.\nConclusions\nAdolescent AQoL-6D utility can be derived from a range of psychological distress, depression and anxiety measures. Mapping models estimated from cross-sectional data can approximate longitudinal change but may slightly bias health utility predictions.\nData\nReplication code, detailed results├é┬á├éΓÇª\n','',2022,NULL,NULL,'2021-01-01',NULL,NULL,NULL,NULL,'','medRxiv','','','','Cold Spring Harbor Laboratory Press',NULL,NULL,NULL),(1440,'Protocol: Neurobiology Youth Follow-up Study: protocol to establish a longitudinal and prospective research database using multimodal assessments for current and past mental├é┬á├éΓÇª','https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215251/',NULL,'Introduction Approximately 75% of major mental illness occurs before the age of 25 years. Despite this, our capacity to provide effective, early and personalised interventions is limited by insufficient evidence for characterising early-stage, and less specific, presentations of major mental disorders in youth populations. This article describes the protocol for setting up a large-scale database that will collect longitudinal, prospective data that incorporate clinical, social and occupational function, neuropsychological, circadian, metabolic, family history and genetic metrics. By collecting data in a researchpurposed, standardised manner, the ├éΓÇÿNeurobiology Youth Follow-up Study├éΓÇÖshould improve identification, characterisation and profiling of youth attending mental healthcare, to better inform diagnosis and treatment at critical time points. The overall goal is enhanced long-term clinical and functional outcomes. Methods and├é┬á├éΓÇª','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','BMJ Open','11','6','','BMJ Publishing Group',NULL,NULL,NULL),(1442,'Protocol: Protocol for a young adult mental health (Uspace) cohort: personalising multidimensional care in young people admitted to hospital','https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802707/',NULL,'\nIntroduction Currently, the literature on personalised and measurement-based mental healthcare is inadequate with major gaps in the development and evaluation of 21st century service models. Clinical presentations of mental ill health in young people are heterogeneous, and clinical and functional outcomes are often suboptimal. Thus, treatments provided in a person-centred and responsive fashion are critical to meet the unique needs of young people and improve individual outcomes. Personalised care also requires concurrent assessment of factors relating to outcomes and underlying neurobiology. This study builds on a completed feasibility study and will be the first to incorporate clinical, cognitive, circadian, metabolic and hormonal profiling with personalised and measurement-based care in a cohort of young people admitted to hospital.\nMethods and analysis This prospective, transdiagnostic, observational\n','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','BMJ Open','11','1','','BMJ Publishing Group',NULL,NULL,NULL),(1443,'Protocol for a young adult mental health (Uspace) cohort: Personalising multidimensional care in young people admitted to hospital','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099338183&doi=10.1136%2fbmjopen-2020-038787&partnerID=40&md5=566c8ce1c8483bfed17fe369568b72ae','10.1136/bmjopen-2020-038787','\nIntroduction Currently, the literature on personalised and measurement-based mental healthcare is inadequate with major gaps in the development and evaluation of 21st century service models. Clinical presentations of mental ill health in young people are heterogeneous, and clinical and functional outcomes are often suboptimal. Thus, treatments provided in a person-centred and responsive fashion are critical to meet the unique needs of young people and improve individual outcomes. Personalised care also requires concurrent assessment of factors relating to outcomes and underlying neurobiology. This study builds on a completed feasibility study and will be the first to incorporate clinical, cognitive, circadian, metabolic and hormonal profiling with personalised and measurement-based care in a cohort of young people admitted to hospital.\nMethods and analysis This prospective, transdiagnostic, observational\n','',2021,NULL,NULL,'2021-01-01',NULL,NULL,NULL,NULL,'','BMJ Open','11','1','e038787','British Medical Journal Publishing Group','YMH team','Models of care',''),(1444,'What solutions exist for developmental delays facing indigenous children globally? A co-designed systematic review','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85116271648&doi=10.3390%2fchildren7120285&partnerID=40&md5=3c97167233a33ab2a6cb094df53bbd0e','10.3390/children7120285','Early childhood is important for future cognitive and educational outcomes. Programs overcoming barriers to engagement in early education for Indigenous children must address family cultural needs and target developmental delays. This systematic review identifies culturally adapted programs to improve developmental delays among young children, in response to an identified priority of a remote Indigenous community. Five databases (the Cochrane Library, Embase, Medline, Scopus and CINAHL) were searched for English language papers in January 2018. Study quality was assessed, and findings were analysed thematically. Findings were presented to the community at an event with key stakeholders, to determine their inclusion and face validity. Seven relevant studies, published between 1997 and 2013, were identified by the researchers and each study was supported by the community for inclusion. Three studies included on Native American children and four studies included children from non-Indigenous disadvantaged backgrounds. Findings were reported narratively across four themes: storytelling to improve educational outcomes; family involvement improved development; culturally adapted cognitive behavioural therapy to reduce trauma; rewards-based teaching to improve child attention. Limited published research on culturally adapted and safe interventions for children with developmental delays exists but these four themes from seven studies identify useful components to guide the community and early childhood program development.','',2020,NULL,NULL,'2020-12-10',NULL,NULL,NULL,NULL,'','Children','7','12','285','MDPI','Other','',''),(1445,'What solutions exist for cognitive, emotional and developmental delays facing Indigenous children globally? A co-designed systematic review','https://www.preprints.org/manuscript/202010.0575',NULL,'Early childhood is important for future cognitive and educational outcomes. Programs overcoming barriers to engagement in early education for Indigenous children must address family cultural needs and target developmental delays. This systematic review identifies culturally adapted programs to improve cognitive, emotional and developmental delays among young children, in response to an identified priority of a remote Indigenous community. Five databases (the Cochrane Library, Embase, Medline, Scopus and CINAHL) were searched for English language papers in January 2018. Study quality was assessed and findings analysed thematically. Findings were presented to the community at an event with key stakeholders, to determine their inclusion and face validity. Seven relevant studies, published between 1997-2013, were identified by the researchers and each study was supported by the community for inclusion. Two studies focused on Native American children and five studies included children from non-Indigenous disadvantaged backgrounds. Findings were reported narratively across four themes: Storytelling to improve educational outcomes; Family involvement improved development; Culturally adapted Cognitive Behavioral Therapy to reduce trauma; Rewards-based teaching to improve child attention. Limited published research on culturally adapted and safe interventions for children with cognitive, emotional and developmental delay exists but these four themes from seven studies identify useful components.','',2022,NULL,NULL,'2020-10-28',NULL,NULL,NULL,NULL,'','','','','','Preprints',NULL,NULL,NULL),(1446,'The relationship between comorbid chronic pain and poorer self-reported antidepressant efficacy is partly mediated by genetics','https://espace.library.uq.edu.au/view/UQ:72a5a1b',NULL,'','',2022,NULL,NULL,'2020-10-16',NULL,NULL,NULL,NULL,'','','','','','',NULL,NULL,NULL),(1447,'Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial (vol 10, 393, 2019)','https://minerva-access.unimelb.edu.au/items/157e8e83-5193-5bd8-a496-7bd7bf9c32aa',NULL,'','',2022,NULL,NULL,'2020-06-10',NULL,NULL,NULL,NULL,'','','','','','FRONTIERS MEDIA SA',NULL,NULL,NULL),(1448,'Delineating the transition from subsyndromal to syndromal disorders and trajectories of social and occupational functioning of young people in Australia: A longitudinal study','https://scholar.google.com/scholar?cluster=10578495738191124966&hl=en&oi=scholarr',NULL,'','',2022,NULL,NULL,'2020-06-01',NULL,NULL,NULL,NULL,'','','22','','19-19','WILEY',NULL,NULL,NULL),(1449,'Pharmacoepidemiology of comorbid chronic pain and depression: Insights from a case-control study','https://scholar.archive.org/work/hlfegwhf3vhq3btywgibqixf3e/access/wayback/https://www.medrxiv.org/content/medrxiv/early/2020/05/24/2020.05.23.20110841.full.pdf',NULL,'\nBackground:\n The bidirectional relationship between depression and chronic pain is well recognized but their clinical management remains challenging. Here we characterize the shared aetiology and risk factors for their comorbidity using large population cohorts to advance understanding of pharmacological treatment outcomes. Methods:\n Participants completed online questionnaires about chronic pain, psychiatric symptoms, comorbidities, treatment response and general health (N= 13,839). Logistic regression models were used to examine the relationship between chronic pain and clinical and demographic factors. Cumulative linked logistic regressions assessed the effect of chronic pain on treatment response for 10 different antidepressants. Findings:\n Chronic pain was associated with an increased risk of depression (OR= 1.86 [1.37├éΓÇô2.54]), recent suicide attempt (OR= 1.88 [1.14├éΓÇô3.09]), higher use of alcohol, tobacco and painkiller misuse. Participants with comorbid chronic pain and depression reported fewer functional benefits from antidepressant use and lower benefits from sertraline (OR= 0.75 [0.68├éΓÇô0.83]), escitalopram(OR= 0.75 [0.67├éΓÇô0.85]) and venlafaxine (OR= 0.78 [0.68├éΓÇô0.88]) when compared to participants without chronic pain. Furthermore, participants taking sertraline (OR= 0.45 [0.30├éΓÇô0.67]), escitalopram (OR= 0.45 [0.27├éΓÇô0.74]) and citalopram (OR= 0.32 [0.15├éΓÇô0.67]) specifically for chronic pain reported lower benefits compared to other participants taking these same medications but not for chronic pain. Interpretation:\n The findings reveal novel insights into the complex relationship between chronic pain and depression├é┬á├éΓÇª','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','','','','',NULL,NULL,NULL),(1450,'T34. THE IMPACT OF ANTIDEPRESSANT USE ON THE TRANSITION TO PSYCHOSIS RATE IN THE NEURAPRO TRIAL','https://minerva-access.unimelb.edu.au/bitstream/handle/11343/273883/sbaa029.594.pdf',NULL,'Background: Schizophrenia (SZ) is a complex and debilitating mental disorder that affects approximately 1% of the world population and, according to the World Health Organization, it is one of the top ten causes of disability in developed countries. Neonatal hypoxia is a well-establish risk factor to SZ development, though little is known about the molecular mechanisms involved. Indeed, animals submitted to neonatal gaseous hypoxia show behavioral alteration and neurochemical changes resembling SZ features. However, the effect of chemical hypoxia induced by cobalt chloride (CoCl2) treatment is poorly understood. Remarkably, hypoxia induces an augmentation of adenosinergic system, an effect that seems to be relevant to neurodevelopment. Indeed, attention is being focused to adenosinergic system in the context of SZ. Thus, our goal was to investigate the effect of neonatal CoCl2 administration in distinct├é┬á├éΓÇª','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Schizophrenia Bulletin','46','Suppl 1','S244','Oxford University Press',NULL,NULL,NULL),(1451,'From the Population to the Clinic','https://books.google.com/books?hl=en&lr=&id=oR_dDwAAQBAJ&oi=fnd&pg=PA31&dq=info:LNhF93Y0rSgJ:scholar.google.com&ots=u-5fPucoTK&sig=gsHUJk4OaVel1E8OfVrg-u3Wlt4',NULL,'This chapter articulates a framework for bringing together developmentally contextualized mental and physiological processes to guide the characterization, staging, and interventions necessary in treating mental health disorders in youth. This framework spans from population-level risk identification to individual-level clinical care, drawing on knowledge about developmentally informed trajectories and clinical systems. At a fundamental level, it necessitates appreciating the influence of both inherited and acquired factors on brain specialization and the setting of trajectories during periods of plasticity and risk, all of which delineate adult trajectories in multiple dimensions. More pragmatically, it requires us to track a range of salient mental/physiological systems during a dynamic developmental period that includes both vulnerability and risk, to contemplate their utility in identifying enriched groups that might benefit from further individual-level assessment in clinical or community settings, and to translate findings into planning prevention and intervention programs and to informing clinical decision making.','',2022,NULL,NULL,'2020-04-14',NULL,NULL,NULL,NULL,'','Youth Mental Health: A Paradigm for Prevention and Early Intervention','28','','31','MIT Press',NULL,NULL,NULL),(1452,'Nick Martin and the Genetics of Depression: Sample Size, Sample Size, Sample Size','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084819459&doi=10.1017%2fthg.2020.13&partnerID=40&md5=42e6a938c931335f2f013efd02cb6ddf','10.1017/thg.2020.13','Nick Martin is a pioneer in recognizing the need for large sample size to study the complex, heterogeneous and polygenic disorders of common mental disorders. In the predigital era, questionnaires were mailed to thousands of twin pairs around Australia. Always quick to adopt new technology, NickΓÇÖs studies progressed to phone interviews and then online. Moreover, Nick was early to recognize the value of collecting DNA samples. As genotyping technologies improved over the years, these twin and family cohorts were used for linkage, candidate gene and genome-wide association studies. These cohorts have underpinned many analyses to disentangle the complex web of genetic and lifestyle factors associated with mental health. With characteristic foresight, Nick is chief investigator of our Australian Genetics of Depression Study, which has recruited 16,000 people with self-reported depression (plus DNA├é┬á├éΓÇª','',2020,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Twin Research and Human Genetics','23','2','109-111','Cambridge University Press','YMH team','Illness specific areas','Neurobiology'),(1453,'Defensive rhetoric in psychiatry: an obstacle to health and human rights├éΓÇôAuthor\'s reply','https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(20)30045-6/fulltext',NULL,'The Lancet Psychiatry that the three mutually reinforcing factors identified by Puras as obstacles to addressing the grossly unmet need for rights based mental health services are strawman propositions. However, all three obstacles├éΓÇödominance of the biomedical model, power asymmetries, and biased use of evidence├éΓÇöare substantive issues. Puras has consulted widely with service users, as well as mental health practitioners and other key stakeholders. 2 He cites diverse sources to support his assertions about the three obstacles.','',2022,NULL,NULL,'2020-03-01',NULL,NULL,NULL,NULL,'','The Lancet Psychiatry','7','3','231-232','Elsevier',NULL,NULL,NULL),(1454,'Cohort profile: Cohort profile: the Brain and Mind Centre Optymise cohort: tracking multidimensional outcomes in young people presenting for mental healthcare','https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170572/',NULL,'\nPurpose\nThe Brain and Mind Centre (BMC) Optymise cohort assesses multiple clinical and functional domains longitudinally in young people presenting for mental health care and treatment. Longitudinal tracking of this cohort will allow investigation of the relationships between multiple outcome domains across the course of care. Subsets of Optymise have completed detailed neuropsychological and neurobiological assessments, permitting investigation of associations between these measures and longitudinal course.\n','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','BMJ Open','10','3','','BMJ Publishing Group',NULL,NULL,NULL),(1455,'Interrogating the complexity and dynamics of youth mental health among a cohort with emerging mental disorders','https://researchdirect.westernsydney.edu.au/islandora/object/uws:59232/',NULL,'\nBackground:\n Efforts to intervene among young people with emerging mood and psychotic disorders aim to interrupt paths to chronic illness and disability. Yet a challenge for effective early intervention is the heterogeneous pattern of illness and diverse needs of young people. This study aims to interrogate the dynamics between syndromes, functioning and comorbidities over time. Methods:\n The cohort consists of 1962 individuals aged 12ΓÇô30 years (57% female), followed up for 3 to 24 months. They presented to the Brain and Mind Centre├éΓÇÖs youth mental health clinics which include primary care services and more specialised services. Results:\n This paper uses dynamic Bayesian networks, specifically probabilistic models represented by directed acyclic graphs (DAGs) to report on the dependence and causal structure of across five domains; social and occupational function; self-harm, suicidal thoughts and behaviour├é┬á├éΓÇª','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Selected Abstracts from the American College of Neuropsychopharmacology (ACNP) 59th Annual Meeting, 6-9 December 2020, Virtual Meeting','','','168-168','',NULL,NULL,NULL),(1456,'Protocol: Youth Mental Health Tracker: protocol to establish a longitudinal cohort and research database for young people attending Australian mental health services','https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282334/',NULL,'Introduction Mental disorders are a leading cause of long-term disability worldwide. Much of the burden of mental ill-health is mediated by early onset, comorbidities with physical health conditions and chronicity of the illnesses. This study aims to track the early period of mental disorders among young people presenting to Australian mental health services to facilitate more streamlined transdiagnostic processes, highly personalised and measurement-based care, secondary prevention and enhanced long-term outcomes. Methods and analysis Recruitment to this large-scale, multisite, prospective, transdiagnostic, longitudinal clinical cohort study (├éΓÇÿYouth Mental Health Tracker├éΓÇÖ) will be offered to all young people between the ages of 12 and 30 years presenting to participating services with proficiency in English and no history of intellectual disability. Young people will be tracked over 3 years with standardised├é┬á├éΓÇª','',2022,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','BMJ Open','10','6','','BMJ Publishing Group',NULL,NULL,NULL),(1457,'Youth Suicide prevention experts\' may have got it horribly wrong\'','https://espace.curtin.edu.au/handle/20.500.11937/79578',NULL,'Youth Suicide prevention experts \'may have got it horribly wrong\' Curtin University \nHomepage Toggle navigation Library Help Admin Toggle navigation espace - CurtinΓÇÖs \ninstitutional repository View Item espace Home espace Curtin Research Publications View \nItem espace Home espace Curtin Research Publications View Item Youth Suicide \nprevention experts \'may have got it horribly wrong\' Access Status Open access via publisher \nAuthors Whitely, Martin Raven, Melissa Jureidini, Jon Hickie, Ian Date 2020 Type Non \ntraditional textual works  Metadata Show full item record Citation Whitely, M. and Raven, M. \nand Jureidini, J. and Hickie, I. 2020. Youth Suicide prevention experts \'may have got it \nhorribly wrong\'. Australian Financial Review: Sydney. Additional URLs https://www.afr.com/policy/health-and-education/suicide-prevention-experts-may-have-got-it-horribly-wrong-20200606-p5506d \nFaculty Faculty of ├éΓÇª','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','','','','Australian Financial Review',NULL,NULL,NULL),(1458,'Sleep and circadian rhythm alterations in older people with depression','https://scholar.google.com/scholar?cluster=2109158977523760055&hl=en&oi=scholarr',NULL,'\nMaterials and methods: Thirty-four older people meeting DSM-IV criteria for lifetime major depression (mean age= 63.9 years), and 30 healthy controls (mean age= 65.7 years) underwent a 3-night protocol including dim light melatonin onset (DLMO) assessment and overnight polysomnography (PSG). DLMO and phase angle of entrainment were computed.\nResults: Participants with depression had a significantly longer phase angle of entrainment than controls (6.82 h┬▒1.45 vs. 5.87 h├é┬▒1.60, p= 0.02, Cohens-d= 0.62). There was a small to moderate yet non-significant difference in DLMO times, with those with depression having an earlier DLMO of 34├é┬▒27 minutes (20: 36├é┬▒1: 48 vs. 21: 10├é┬▒1: 48, p= 0.22, Cohens-d= 0.32). Sleep latency and latency to rapid eye movement sleep were greater in those with depression compared to controls (all p< 0.05).\nConclusions: In older people with lifetime major depression and mild├é┬á├éΓÇª\n','',2021,NULL,NULL,'2019-12-01',NULL,NULL,NULL,NULL,'','Sleep Medicine','64','','S159','Elsevier',NULL,NULL,NULL),(1459,'Associations between suicidality and subjective and objective sleep-wake disturbances in young people with mood disorders','https://scholar.google.com/scholar?cluster=5051004167732592613&hl=en&oi=scholarr',NULL,'','',2021,NULL,NULL,'2019-10-01',NULL,NULL,NULL,NULL,'','','28','','','WILEY',NULL,NULL,NULL),(1460,'S30THE AUSTRALIAN GENETICS OF BIPOLAR STUDY: WHAT HAPPENS WHEN WE PUBLICALLY ASK FOR VOLUNTEERS?','https://scholar.google.com/scholar?cluster=3563002229997874943&hl=en&oi=scholarr',NULL,'\nBackground: We present an overview of our experiences of recruiting participants for a new study seeking to find genetic risk factors influencing Bipolar disorder, and genetic markers that influence response to treatment.\nMethods: Recruitment was via a media campaign and prescription based mailouts focusing on recruiting volunteers from the general public who had been treated for bipolar disorder at some stage in their lives. The media campaign involved a physical media launch (held on the 20/11/18) with follow-up via television, radio, print and online interviews and a sequence of social media posts. The prescription based mailout was undertaken during the week starting 1/4/2019. Participation in the study involves reviewing the information and consent documents on the study webpage (https://www. geneticsofbipolar. org. au/), completion of an online questionnaire (based on the CIDI) and providing a saliva\n','',2021,NULL,NULL,'2019-10-01',NULL,NULL,NULL,NULL,'','European Neuropsychopharmacology','29','','S129-S130','Elsevier',NULL,NULL,NULL),(1461,'Bioactive and Inflammatory Markers in Emerging Psychotic Disorders','https://www.zora.uzh.ch/id/eprint/171651/',NULL,'Despite over a century of intensive research, no single biological marker has successfully translated into daily clinical practice. A key challenge in psychiatric research is that traditional diagnostic categories represent phenomenological constructs that do not necessarily circumscribe a biological homogenous entity, but encompass a whole range of disorders presenting with similar phenotypes. The clinical staging model shifts our focus to search for markers relevant to particular stages of mental disorders and provides a useful framework to differentiate overlapping and heterogeneous syndromes. The identification of such ΓÇ£stage├éΓÇ¥ dependant markers may be more meaningful and of greater prognostic and therapeutic value than our quest for categorical disease markers. In this chapter, bioactive and inflammatory markers in emerging psychotic disorders are discussed. Their specific role in brain development, psychiatric disorder onset and management are reviewed. Implications for future research are also provided.','',2021,NULL,NULL,'2019-08-30',NULL,NULL,NULL,NULL,'','','','','191-203','Cambridge University Press',NULL,NULL,NULL),(1462,'Pathways to late-life depression and related cognitive impairment: evidence from structural and functional imaging','https://scholar.google.com/scholar?cluster=7922453460057530350&hl=en&oi=scholarr',NULL,'','',2021,NULL,NULL,'2019-08-01',NULL,NULL,NULL,NULL,'','','31','','3-Mar','CAMBRIDGE UNIV PRESS',NULL,NULL,NULL),(1463,'AUTOIMMUNE DISEASES PRESENTING AS COMPLEX MOOD DISORDERS','https://espace.library.uq.edu.au/view/UQ:14f1600',NULL,'','',2021,NULL,NULL,'2019-04-01',NULL,NULL,NULL,NULL,'','Australian and New Zealand Journal of Psychiatry','53','','10-Oct','SAGE PUBLICATIONS LTD',NULL,NULL,NULL),(1464,'Associations between baseline characteristics of young people presenting for mental health care and the longitudinal emergence of bipolar disorders','https://scholar.google.com/scholar?cluster=8179013196423181766&hl=en&oi=scholarr',NULL,'','',2021,NULL,NULL,'2019-03-01',NULL,NULL,NULL,NULL,'','','21','','57-57','WILEY',NULL,NULL,NULL),(1465,'Brain structural correlates of insomnia severity in major depressive disorder: Results from the ENIGMA-MDD consortium','https://pure.mpg.de/pubman/faces/ViewItemOverviewPage.jsp?itemId=item_3221755',NULL,'','',2021,NULL,NULL,'2019-02-08',NULL,NULL,NULL,NULL,'','','','','S688-S690','Elsevier',NULL,NULL,NULL),(1466,'JMIR Mental Health','https://mental.jmir.org/2019/9/PDF',NULL,'JMIR Mental Health JMIR Mental Health Internet interventions, technologies and digital \ninnovations for mental health and behaviour change Volume 6 (2019), Issue 9 ISSN: 2368-7959 \nEditor in Chief: John Torous, MD Contents Original Papers Role of Moderators on Engagement \nof Adolescents With Depression or Anxiety in a Social Media Intervention: Content Analysis of \nWeb-Based Interactions (e13467) Carolyn Windler, Maeve Clair, Cassandra Long, Leah Boyle, \nAna Radovic............................................................ 2 Technology-Enabled Person-Centered Mental \nHealth Services Reform: Strategy for Implementation Science (e14719) Haley LaMonica, \nTracey Davenport, Katharine Braunstein, Antonia Ottavio, Sarah Piper, Craig Martin, Ian \nHickie, Shane Cross................. 15 Evaluation of eMentalHealth. ca, a Canadian Mental \nHealth Website Portal: Mixed Methods Assessment (e13639) Dahn Jeong, Michael Cheng, ├éΓÇª','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','JMIR','6','9','','',NULL,NULL,NULL),(1467,'Comparison of erythrocyte omega-3 index','https://scholar.google.com/scholar?cluster=13935457628473562335&hl=en&oi=scholarr',NULL,'','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','','','','',NULL,NULL,NULL),(1468,'Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index','https://docs.prosentient.com.au/prosentientjspui/handle/1/13613',NULL,'Prosentient Systems: Supplementation with the omega-3 long chain polyunsaturated fatty \nacids: Changes in the concentrations of omega-3 index Skip navigation DSpace logo Home \nBrowse Communities & Collections Browse Items by: Issue Date Author Title Subject Sign \non to: My Prosentient Receive email updates Edit Profile 1.Prosentient Systems 2.ISLHD 3.ISLHD \nresearch Please use this identifier to cite or link to this item: http://docs.prosentient.com.au/prosentientjspui/handle/1/13613 \nTitle: Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in \nthe concentrations of omega-3 index fatty acids and molecular phospholipids of people at \nultra high risk of developing psychosis Authors: Alqarni A Mitchell TW McGorry PD Nelson B \nMarkulev C Yuen HP Berger M Mossaheb N Smesny S Hickie IB Berger GE Chen EYH de \nHaan L Nieman DH Nordentoft M Verma S Thompson A Yung AR ├éΓÇª','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','','','','',NULL,NULL,NULL),(1469,'Genetic and environmental risk factors in the non-medical use of over-the-counter or prescribed analgesics, and their relationship to major classes of licit and illicit├é┬á├éΓÇª','https://scholar.google.com/scholar?cluster=9146857989822451895&hl=en&oi=scholarr',NULL,'\nBackground and Aims:\n\n The non-medical use of over-the-counter or prescribed analgesics (NMUA) is a significant public health problem. Little is known about the genetic and environmental etiology of NMUA and how these risks relate to other classes of substance use and misuse. Our aims were to estimate the heritability NMUA and sources of genetic and environmental covariance with cannabis and nicotine use, cannabis and alcohol use disorders and nicotine dependence in Australian twins. \nDesign:\n\n Biometrical genetic analyses or twin methods using structural equation univariate and multivariate modeling. \nSetting:\n\n Australia. \nParticipants:\n\n A total of 2007 young adult twins [66% female; ├é┬╡age├é┬á=├é┬á25.9, standard deviation (SD)├é┬á=├é┬á3.6, range├é┬á=├é┬á18├éΓÇô38] from the Brisbane Longitudinal Twin Study retrospectively assessed between 2009 and 2016. \nMeasurements:\n\n Self-reported NMUA (non-opioid or opioid-based), life-time├é┬á├éΓÇª\n','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','','','','',NULL,NULL,NULL),(1470,'Genetic risk for depression and treatment response in the Australian genetics of depression study','https://espace.library.uq.edu.au/view/UQ:2f0fee7',NULL,'','',2019,NULL,NULL,'2019-01-01',NULL,NULL,NULL,NULL,'','European Neuropsychopharmacology','29','','S53-S53','Elsevier',NULL,NULL,NULL),(1471,'Clinical, demographic, and genetic risk factors of treatment-attributed suicidality in &gt;10,000 Australian adults taking antidepressants','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85134220163&doi=10.1002%2fajmg.b.32913&partnerID=40&md5=f9b37eefe7df3d64c17830205b005222','10.1002/ajmg.b.32913','','',2022,NULL,NULL,'2019-01-01',NULL,NULL,NULL,NULL,'','American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics','29','','S99-S100','Elsevier','Other','Neurobiology',''),(1472,'Predicting the onset of bipolar disorder in youth cohorts: Evidence from clinical and twin and sibling cohorts','https://research.usc.edu.au/esploro/outputs/abstract/Predicting-the-onset-of-bipolar-disorder/99450767402621',NULL,'','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Bipolar Disorders','21','Supplement 1','11','Wiley-Blackwell Publishing Inc.',NULL,NULL,NULL),(1473,'The antidepressant effects of a multimodal intervention including agomelatine correlate with circadian phase advance in youths with depression','https://research.usc.edu.au/esploro/outputs/abstract/The-antidepressant-effects-of-a-multimodal/99451247202621',NULL,'','',2019,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','European Neuropsychopharmacology','29','Supplement 1','S340-S341','Elsevier BV',NULL,NULL,NULL),(1474,'If we\'re to have another inquiry into mental health, it should look at why the others have been ignored','https://openresearch-repository.anu.edu.au/handle/1885/206658',NULL,'Victorian Premier Daniel Andrews has promised to hold a royal commission into mental health if Labor wins the November state election. Last week├éΓÇÖs announcement comes a couple of weeks after the federal government asked the Productivity Commission to inquire ├éΓÇ£into the role of mental health in the Australian economy and the best ways to support and improve national mental well-being├éΓÇ¥.','',2021,NULL,NULL,'2018-10-30',NULL,NULL,NULL,NULL,'','','','','','The Australian National University',NULL,NULL,NULL),(1475,'Baseline Omega-3 Fatty Acids in Erythrocytes as Predictors of Functional and Clinical Outcomes in People at Ultra-High Risk for Psychosis','https://scholar.google.com/scholar?cluster=5348961889991989546&hl=en&oi=scholarr',NULL,'','',2018,NULL,NULL,'2018-10-01',NULL,NULL,NULL,NULL,'','','12','','68-68','WILEY',NULL,NULL,NULL),(1476,'Social rhythms and the sleep-wake cycle in young people with depression','https://scholar.google.com/scholar?cluster=18251090002093402042&hl=en&oi=scholarr',NULL,'','',2018,NULL,NULL,'2018-09-01',NULL,NULL,NULL,NULL,'','','27','','','WILEY',NULL,NULL,NULL),(1477,'P1-653: UNDERSTANDING THE RELATIONSHIP BETWEEN PHYSICAL ACTIVITY, DEPRESSIVE SYMPTOMS AND SLEEP QUALITY IN OLDER ADULTS AT-RISK FOR DEMENTIA','https://alz-journals.onlinelibrary.wiley.com/doi/abs/10.1016/j.jalz.2018.06.665',NULL,'\nBackground\nSleep disturbances are prevalent in older adults, particularly those with cognitive impairment. Physical activity is thought to have a beneficial effect on sleep, however, research pertaining to the conditions of activity is minimal. The current study aimed to determine whether sleep quality in older adults at-risk for dementia is related to the intensity (ie walking, moderate or vigorous intensity) and the frequency of physical activity.\nMethods\nIn total, 526 individuals ΓÇÿat-risk├éΓÇÖfor dementia (mean age= 66.4 years) were recruited through the Healthy Brain Ageing Research Clinic. Subjective sleep quality and physical activity were evaluated using the Pittsburgh Sleep Quality Index and the Active Australia Survey, respectively. Participants also underwent a clinical assessment to determine depressive symptom severity, body mass index (BMI), and medical burden.\nResults\nPoorer subjective sleep quality was associated├é┬á├éΓÇª\n','',2018,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Alzheimer\'s & Dementia','14','7S_Part_10','P592-P592','',NULL,NULL,NULL),(1478,'Concerns about the headspace model of youth mental health services [2]','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049511487&doi=10.1176%2fappi.ps.69703&partnerID=40&md5=1ceef6cb69b46e9d11ee72a00b3129d3','10.1176/appi.ps.69703','IN REPLY: We welcome the correspondence from Jorm; much of it is consistent with the issues raised in the original study. We agree that the results highlight the need for ongoing research on who uses headspace-style services and what actual short-and longer-term benefits are derived. However, some of the concerns raised by Jorm do not appear to recognize that this report was focused only on a specific subpopulation of headspace clients, namely those with clinical presentations that met criteria for clinical stage 1b (attenuated syndromes of major mental disorders with significant impairment). That is, our cohort did not include individuals presenting with less severe, nonspecific syndromes or acute distress that are not typically associated with functional impairment. Consequently, this cohort is not comparable to other individuals attending our own services (1) or to those included in the national headspace','',2018,NULL,NULL,'2018-07-01',NULL,NULL,NULL,NULL,'','Psychiatric Services','69','7','839-839','American Psychiatric Association','YMH team','Models of care','Mental Health System'),(1479,'S152. Stimulating Young Minds: Investigating a Next Generation Treatment for Depression in Youth','https://www.biologicalpsychiatryjournal.com/article/S0006-3223(18)31146-6/abstract',NULL,'\nBackground\nOne third of young depressed patients do not respond to antidepressants and are at risk for chronic treatment resistance. Repetitive transcranial magnetic stimulation (rTMS) is efficacious in treating depression, however, few studies have investigated patients at earlier stages of illness when providing optimal treatments are likely to result in better response outcomes. A subset of patients show inadequate response to rTMS and identifying features of patients that predict response is needed to inform personalised approaches.\nMethods\nIn this open-label study, 17 young inpatients and outpatients with depression (aged 18-30; 22┬▒3.8) were recruited. Neuronavigationally targeted high frequency (10 Hz) rTMS was administered at 110% of resting motor threshold on the left DLPFC for 45 trains of 4 seconds for 20 sessions over 4 weeks. Clinical interview, cognitive assessment and, psychosocial self-report├é┬á├éΓÇª\n','',2018,NULL,NULL,'2018-05-01',NULL,NULL,NULL,NULL,'','Biological Psychiatry','83','9','S407','Elsevier',NULL,NULL,NULL),(1480,'PREDICTORS OF REPETITION OF SUICIDAL BEHAVIOUR AND DELIBERATE SELF-HARM IN A POPULATION OF HELP-SEKING YOUNG PEOPLE','https://scholar.google.com/scholar?cluster=4945815533669562451&hl=en&oi=scholarr',NULL,'','',2018,NULL,NULL,'2018-04-01',NULL,NULL,NULL,NULL,'','','52','','88-89','SAGE PUBLICATIONS LTD',NULL,NULL,NULL),(1486,'Persistent pain and depression: examining clinical comorbidity and shared risk factors','https://espace.library.uq.edu.au/view/UQ:337bf30',NULL,'','',2018,NULL,NULL,'2018-01-01',NULL,NULL,NULL,NULL,'','','','','28-28','',NULL,NULL,NULL),(1487,'Tracking functional outcomes in young people with bipolar-type mood disorders','https://research.usc.edu.au/esploro/outputs/abstract/Tracking-functional-outcomes-in-young-people/99450747102621',NULL,'','',2018,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Bipolar Disorders','20','Supplement 1','41-42','Wiley-Blackwell Publishing Inc.',NULL,NULL,NULL),(1488,'Correction of: Using New and Emerging Technologies to Identify and Respond to Suicidality Among Help-Seeking Young People: A Cross-Sectional Study','https://www.jmir.org/2017/10/e310/',NULL,'\nIn the paper by Frank Iorfino et al,├éΓÇ£Using New and Emerging Technologies to Identify and Respond to Suicidality Among Help-Seeking Young People: A Cross-Sectional Study├éΓÇ¥(J Med Internet Res 2017; 19 (7): e247), a mistake was made in the final stage of copy editing. In the Introduction, the first sentence of the second paragraph should have appeared as follows:├éΓÇ£This is a particularly pertinent issue given that almost half of those who have died by suicide had contact with a primary care provider within one month of the suicide [12], and one-quarter of those with depression who die by suicide are likely to have been in active engagement with mental health services at the time of death [13-16].├éΓÇ¥\nInstead of the above, the first part of the sentence was incorrectly worded as:├éΓÇ£This is a particularly pertinent issue given that almost half of those who have died by suicide had contact with a primary care provider within one├é┬á├éΓÇª\n','',2017,NULL,NULL,'2017-10-30',NULL,NULL,NULL,NULL,'','','19','10','e8804','JMIR Publications Inc., Toronto, Canada',NULL,NULL,NULL),(1489,'Mental Health Promotion For the ├éΓÇÿin-betweeners├éΓÇÖ: the Rationale and Effectiveness of Community-based Mentoring and Coaching Schemes For Primary School-aged Children.','https://scholar.google.com/scholar?cluster=2954809028751178206&hl=en&oi=scholarr',NULL,'\nBackground:\nThere are relatively few research publications of mental health promotion initiatives for primary school aged children that are based in community rather than educational settings.\nAims:\nTo describe developmental frameworks and models of mentoring, coaching and mental health promotion and to summarize any evidence for the efficacy of community initiatives.\nMethods:\nAn umbrella review was undertaken of publications on theories and models, and a synthesis of findings from reviews of outcomes of mentoring, mental health promotion initiatives undertaken outside of school time for children aged 5-11 years.\nResults:\nDevelopmental mentoring on its own or in combination with outside school activities is potentially more flexible in terms of delivery and targets than school-based programs. Pooled effect sizes (range about 0.2-0.4) suggest modest but significant gains across several key domains (cognition├é┬á├éΓÇª\n','',2020,NULL,NULL,'2017-08-14',NULL,NULL,NULL,NULL,'','Journal of Preventive Medicine and Care','2','1','13','Open Access Pub',NULL,NULL,NULL),(1490,'International Cannabis Consortium','https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380510/',NULL,'International Cannabis Consortium NCBI NCBI Logo Skip to main content Skip to navigation \nResources How To About NCBI Accesskeys Sign in to NCBI PMC US National Library of \nMedicine National Institutes of Health Search database Search term Search Advanced Journal \nlist Help The PMC website is updating on 03/14/2022. Try out this update now on PMC Labs \nor Learn more. Journal List HHS Author Manuscripts PMC6380510 Logo of nihpa Drug \nAlcohol Depend. Author manuscript; available in PMC 2019 Feb 19. Published in final edited \nform as: Drug Alcohol Depend. 2017 Apr 1; 173: e1├éΓÇôe2. Published online 2017 Mar 7. doi: \n10.1016/j.drugalcdep.2017.02.001 PMCID: PMC6380510 NIHMSID: NIHMS1002133 PMID: \n28283211 International Cannabis Consortium Sven Stringer, 1, 2 Camelia C. Minica, 3 Karin \nJH Verweij, 3, 4, 5 Hamdi Mbarek, 3 Manon Bernard, 6 Jaime Derringer, 7 Kristel R. van Eijk, 8 ├éΓÇª','',2017,NULL,NULL,'2017-04-01',NULL,NULL,NULL,NULL,'','Drug and alcohol dependence','173','','e1','NIH Public Access',NULL,NULL,NULL),(1491,'22. The Effects of Antidepressant use on Clinical Outcomes in the NEURAPRO-E Trial','https://academic.oup.com/schizophreniabulletin/article-abstract/43/suppl_1/S15/3075380',NULL,'                    Background: The NEURAPRO-E trial is a randomized controlled multicenter trial of long-chain omega-3 polyunsaturated fatty acids in 304 young people at clinical risk of psychosis. The trial failed to replicate the earlier single-center trial in 81 participants (the Vienna omega-3 study). This analysis aims to investigate if antidepressant (AD) use during NEURAPRO-E influenced clinical outcomes.                    Methods: Secondary analysis of a RCT of omega-3 PUFAs versus placebo involving a total cohort of 304 participants. Randomization was stratified by total score on the Montgomery-Asberg Depression Rating Scale (MADRS score =21 vs. <21) as both depression and ADs may impact on UHR symptoms and illness progression. We determined the influence of AD use on following outcome measures: time to transition to psychotic disorder; measures of psychiatric symptoms and psychosocial functioning├é┬á├éΓÇª\n','',2017,NULL,NULL,'2017-03-01',NULL,NULL,NULL,NULL,'','Schizophrenia Bulletin','43','suppl_1','S15-S16','Oxford University Press',NULL,NULL,NULL),(1492,'Stimulating young minds: Investigating a next generation treatment for depression in youth','https://www.brainstimjrnl.com/article/S1935-861X(17)30273-5/abstract',NULL,'\nBackground: One third of young patients with depression do not respond to antidepressants and are at risk for chronic treatment resistance. Repetitive transcranial magnetic stimulation (rTMS) has shown to be efficacious in treating depression, however, few studies have investigated patients at earlier stages of illness when providing optimal treatments are likely to result in better response outcomes. A subset of patients show inadequate response to rTMS and identifying features of patients that predict response is needed to inform personalised approaches.\nMethods: In this open-label study, 17 young inpatients and outpatients with depression (aged 18-30; 22┬▒3.8) were recruited. Neuronavigationally targeted high frequency (10 Hz) rTMS was administered at 110% of resting motor threshold on the left DLPFC for 45 trains of 4 seconds for 20 sessions over 4 weeks. Clinical interview, cognitive assessment and├é┬á├éΓÇª\n','',2017,NULL,NULL,'2017-03-01',NULL,NULL,NULL,NULL,'','Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation','10','2','428','Elsevier',NULL,NULL,NULL),(1495,'Activation in bipolar disorders a systematic review','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014512983&doi=10.1001%2fjamapsychiatry.2016.3459&partnerID=40&md5=046982d03b4b6bfe25e3f1b4f9af042a','10.1001/jamapsychiatry.2016.3459','','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','JAMA Psychiatry','','','','American Medical Association','YMH team','Illness specific areas',''),(1505,'Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029460631&doi=10.1159%2f000477551&partnerID=40&md5=a62efaff5791a950cea712c91614222a','10.1159/000477551','','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Psychotherapy and Psychosomatics','','','','S. Karger AG','Other','',''),(1508,'Drought and Q fever: The association between trends in the incidence of infection and rainfall in rural Australia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118421177&partnerID=40&md5=af398333de515f1f7baf656d81711d2f','','','',2021,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','The Encyclopedia of Bacteriology Research Developments','','','','Nova Science Publishers','Other','',''),(1551,'Effect of (omega)-3 polyunsaturated fatty acids in young people at ultrahigh risk for psychotic disorders: The NEURAPRO randomized clinical trial','https://scholar.google.com/scholar?cluster=15393746086914117832&hl=en&oi=scholarr',NULL,'','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','','','','American Medical Association',NULL,NULL,NULL),(1557,'Data for the psychometric analysis reported in\" Validation and psychometric properties of the Somatic and Psychological HEalth REport (SPHERE) in a young Australian-based','https://espace.library.uq.edu.au/view/UQ:658929',NULL,'Data includes item level data, age and sex of the observations selected for the NIRT analysis (see manuscript).','',2017,NULL,NULL,'2017-01-01',NULL,NULL,NULL,NULL,'','','','','','The University of Queensland',NULL,NULL,NULL),(1558,'The longitudinal relationship between anterior cingulate glutathione and executive functioning in individuals at risk for dementia: a magnetic resonance spectroscopy study','https://research.usc.edu.au/esploro/outputs/abstract/The-longitudinal-relationship-between-anterior-cingulate-glutathione-and-executive-functioning-in-individuals-at-risk-for-dementia-a-magnetic-resonance-spectroscopy-study/99450700802621',NULL,'\nBackground:\n Oxidative stress is characterised by an imbalance in the redox state of cells, either via the overproduction of reactive oxygen species or antioxidant system dysfunction. Our prior work has shown, using proton magnetic resonance spectroscopy (1H-MRS), that glutathione (GSH), the brain\'s major antioxidant and a marker of oxidative stress, is associated with executive functioning in the anterior cingulate cortex (ACC). This study aims to follow individuals longitudinally to determine the relationship between change in GSH concentration and executive functioning in individuals\' at risk\'for dementia. Methods:\n Data collection is ongoing for this study and full results will be available for presentation in mid-2017. However, data to-date has been collected on 15 individuals\' at risk\'for dementia, that is, presenting with subjective cognitive complaints and/or mild cognitive impairment. All participants were recruited from the Healthy Brain Ageing Clinic at University of Sydney, and underwent comprehensive psychiatric, medical, neuropsychological assessment and an MRI scan where 1H-MRS data in the ACC was obtained. GSH data was reported as a ratio to creatine (Cr) to facilitate comparison between subjects and across time points. Executive functioning was assessed via the Trail Making Test-Part B (TMT-B; expressed as an age-adjusted z-score). Individuals were invited to return to the clinic for a repeat of all baseline measures after> 12 months. Results:\n Of the data currently available, the mean time between baseline and follow-up assessment was 3.5 years (SD= 1.2 years) and mean age at baseline assessment was 64.6 years (SD= 9.6','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Alzheimer\'s & Dementia','13','7, Supplement','P1383','Elsevier Inc.',NULL,NULL,NULL),(1559,'Heritability of hair cortisol and genetic overlap with psychological variables','https://www.zora.uzh.ch/id/eprint/141475/',NULL,'Background: Measuring cortisol in hair is a promising method to assess alterations of the biological stress-response which is altered in psychiatric disorders. While first studies indicate a contribution of genetic factors to inter-individual variance in hair cortisol concentration (HCC), it is unknown whether genes influencing HCC also account for inter-individual differences in psychological variables. The existence of such a true biological link would point at a causal involvement of the HPA axis in the vulnerability for psychiatric disorders.','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Psychoneuroendocrinology','83','','80','Elsevier',NULL,NULL,NULL),(1560,'Impulsivity and suicidal behaviour in young people: A systematic review','https://research.usc.edu.au/esploro/outputs/abstract/Impulsivity-and-suicidal-behaviour-in-young/99451468602621',NULL,'','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','51','Supplement 1','122-123','Sage Publications Ltd.',NULL,NULL,NULL),(1561,'24-hour patterns of motor activation: correlations with mood and energy states predictors of longitudinal course in bipolar mood disorders','https://research.usc.edu.au/esploro/outputs/abstract/24-hour-patterns-of-motor-activation-correlations/99450663202621',NULL,'','',2017,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Bipolar Disorders','19','Supplement 1','24','Wiley-Blackwell Publishing Inc.',NULL,NULL,NULL),(1562,'Trans-diagnostic Predictors of Outcome in Youth Mental Health Settings and their Implications for Preventative Interventions','https://scholar.google.com/scholar?cluster=2288416735640097839&hl=en&oi=scholarr',NULL,'','',2016,NULL,NULL,'2016-10-01',NULL,NULL,NULL,NULL,'','','10','','81-81','WILEY-BLACKWELL',NULL,NULL,NULL),(1563,'Mental Health eClinic (MHeC): Breaking Down Traditional Mental Health Care Barriers By Utilising New And Emerging Technologies','https://scholar.google.com/scholar?cluster=17437251045015113201&hl=en&oi=scholarr',NULL,'','',2016,NULL,NULL,'2016-10-01',NULL,NULL,NULL,NULL,'','','10','','204-204','WILEY-BLACKWELL',NULL,NULL,NULL),(1564,'The comparative associations of objective and subjective sleep disturbance with cognitive function in older men with comorbid depression and insomnia','https://researchers.mq.edu.au/en/publications/the-comparative-associations-of-objective-and-subjective-sleep-di',NULL,'The comparative associations of objective and subjective sleep disturbance with cognitive \nfunction in older men with comorbid depression and insomnia ΓÇö Macquarie University Skip to \nmain navigation Skip to search Skip to main content Macquarie University Logo Help & FAQ \nHome Profiles Research Units Projects Research Outputs Prizes Activities Press / Media \nImpacts Search by expertise, name or affiliation The comparative associations of objective and \nsubjective sleep disturbance with cognitive function in older men with comorbid depression \nand insomnia DJ Biddle, SL Naismith, KM Griffiths, Henrik Christensen, Ian B. Hickie, Nick S. \nGlozier Research output: Contribution to journal ├éΓÇ║ Meeting abstract Overview Original \nlanguage English Pages (from-to) 183 Number of pages 1 Journal Journal of Sleep Research \nVolume 25 Issue number S1 Publication status Published - Sep 2016 Externally published Yes ├éΓÇª','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Journal of Sleep Research','25','S1','183','Wiley-Blackwell, Wiley',NULL,NULL,NULL),(1565,'Motor activation and subjective energy as core constructs in unipolar and bipolar mood disorders: evidence from clinical and twin studies','https://scholar.google.com/scholar?cluster=9548816632751517365&hl=en&oi=scholarr',NULL,'','',2016,NULL,NULL,'2016-07-01',NULL,NULL,NULL,NULL,'','','18','','46-46','WILEY-BLACKWELL',NULL,NULL,NULL),(1566,'Internet delivered CBT for insomnia (eCBTi) as an adjunctive treatment for depression in clinical practice-a randomised controlled trial','https://scholar.google.com/scholar?cluster=16920075114320876679&hl=en&oi=scholarr',NULL,'','',2016,NULL,NULL,'2016-07-01',NULL,NULL,NULL,NULL,'','','18','','148-148','WILEY-BLACKWELL',NULL,NULL,NULL),(1567,'Response to: Size matters; but so does what you do with it!','https://research.rug.nl/en/publications/response-to-size-matters-but-so-does-what-you-do-with-it',NULL,'Schmaal L, Veltman DJ, van Erp TGM, Saemann PG, Frodl T, Jahanshad N et al. Response to: Size matters; but so does what you do with it! Molecular Psychiatry. 2016 Jun; 21 (6): 726-728. https://doi. org/10.1038/mp. 2016.9','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Molecular Psychiatry','21','6','726-728','Nature Publishing Group',NULL,NULL,NULL),(1568,'Size matters; but so does what you do with it! Response','https://pure.mpg.de/rest/items/item_2310319/component/file_2346720/content',NULL,'Fried and Kievit1 and Malhi et al. 2 commend the collaborative achievement of the Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) MDD consortium in analyzing sample sizes unprecedented in neuroimaging of depression. They also raise some concerns and provide additional interpretations of our results. Malhi et al. suggest that we should better exploit this vast data set to study the heterogeneity of MDD. MDD is a heterogeneous disorder, and the scope and extent of brain alterations depends on specific clinical characteristics of the sample studied. That is why we reported meta-analytic results of subcortical volume differences in depressed patients stratified by stage of illness (first episode versus recurrent) and age of onset (early versus late). 3 Compared to controls, hippocampal volume was lower in recurrent and early-onset patients, on an average, but not in first-episode patients or patients diagnosed after age 21. These findings indeed raise interesting questions: for instance, whether hippocampal volume reductions are detectable in earlyonset first-episode patients. Malhi et al. suggest partitioning our sample into finer subgroups to study these interactions. We agree that it is important to analyze between-subject differences across these complex interactions, but our study design did not allow for delineating these more complex interactions (for example, diagnosis x recurrence x age of onset). Our meta-analysis comprised standardized processing, statistics and quality control to harmonize methods in a sample of unprecedented size. In a mega-analysis, one can access all participant-level data. By contrast, our initial├é┬á├éΓÇª','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Molecular Psychiatry','21','6','726-728','Macmillan Publishers Ltd.',NULL,NULL,NULL),(1569,'The underlying neurobiology of key functional domains in young people with mood and anxiety disorders: a systematic','https://scholar.google.com/scholar?cluster=4029353716795023336&hl=en&oi=scholarr',NULL,'\nBackground: Mood and anxiety disorders are leading causes of disability and mortality, due largely to their onset during adolescence and young adulthood and broader impact on functioning. Key factors that are associated with disability and these disorders in young people are social and economic participation (eg education, employment), physical health, suicide and self-harm behaviours, and alcohol and substance use. A better understanding of the objective markers (ie neurobiological parameters) associated with these factors is important for the development of effective early interventions that reduce the impact of disability and illness persistence. Methods: We systematically reviewed the literature for neurobiological parameters (ie neuropsychology, neuroimaging, sleep-wake and circadian biology, neurophysiology and metabolic measures) associated with functional domains in young people (12 to 30 years) with mood and/or anxiety disorders. Results: Of the one hundred and thirty-four studies selected, 7.6% investigated social and economic participation, 2. 1% physical health, 15.3% suicide and self-harm behaviours, 6.9% alcohol and substance use, whereas the majority (68.1%) focussed on clinical syndrome.\nConclusions: Despite the predominance of studies that solely examine the clinical syndrome of young people the literature also provides evidence of distinct associations among objective measures (indexing various aspects of brain circuitry) and other functional domains. We suggest that a shift in focus towards characterising the mechanisms that underlie and/or mediate multiple functional domains will optimise personalised\n','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','','','','',NULL,NULL,NULL),(1572,'Sleep disturbance in mild cognitive impairment Is associated with alterations in the brain\'s default mode network','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84959877746&doi=10.1037%2fbne0000137&partnerID=40&md5=c6e67fa1cb27acf0c70e8be79a53b811','10.1037/bne0000137','','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Behavioral Neuroscience','','','','American Psychological Association','Other','',''),(1573,'Searching across the diagnostic divide: Towards a mechanistic understanding of disease progression through symptom and cognitive trajectories','https://research.monash.edu/en/publications/searching-across-the-diagnostic-divide-towards-a-mechanistic-unde-2',NULL,'Searching across the diagnostic divide: Towards a mechanistic understanding of disease \nprogression through symptom and cognitive trajectories ΓÇö Monash University Skip to main \nnavigation Skip to search Skip to main content Monash University Home Monash University \nLogo Help & FAQ Home Profiles Research Units Equipment Projects Research output Prizes \nActivities Press / Media Search by expertise, name or affiliation Searching across the diagnostic \ndivide: Towards a mechanistic understanding of disease progression through symptom and \ncognitive trajectories Rico Sze Chun Lee, Daniel Hermens, Jan Scott, Nick Glozier, Bridianne \nO\'Dea, Ian Hickie Research output: Contribution to conference ├éΓÇ║ Abstract ├éΓÇ║ peer-review Overview \nOriginal language English Pages 48 Publication status Published - 2016 Externally published \nYes Cite this APA Author BIBTEX Harvard Standard RIS Vancouver Powered by Pure, ├éΓÇª','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','','','','',NULL,NULL,NULL),(1574,'Implementation of Transdiagnostic Early Intervention Services for Anxiety, Mood and Psychotic Syndromes in Australia','https://research.usc.edu.au/esploro/outputs/abstract/Implementation-of-Transdiagnostic-Early-Intervention-Services/99450629802621',NULL,'','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Early Intervention in Psychiatry','10','Supplement 1','13','Wiley-Blackwell Publishing Asia',NULL,NULL,NULL),(1575,'MANAGEMENT OF DOCTOR-IDENTIFIED DEPRESSION IN AUSTRALIAN GENERAL PRACTICE: ARE THOSE IN SHARED CARE MORE SEVERELY ILL?','https://scholar.google.com/scholar?cluster=12865917468752458425&hl=en&oi=scholarr',NULL,'','',2016,NULL,NULL,'2012-04-01',NULL,NULL,NULL,NULL,'','','46','','39-39','SAGE PUBLICATIONS LTD',NULL,NULL,NULL),(1576,'Corrigendum to ├éΓÇ£lipopolysaccharide-stimulated interleukin-10 release from neonatal spinal cord microglia is potentiated by glutamate├éΓÇ¥','https://www.infona.pl/resource/bwmeta1.element.elsevier-a93a02f6-6517-3f97-91cc-34bec9f7902c',NULL,'[Neuroscience 175 (2011) 93├éΓÇô103] ├âΓÇö Close The Infona portal uses cookies, ie strings of text \nsaved by a browser on the user\'s device. The portal can access those files and use them to \nremember the user\'s data, such as their chosen settings (screen view, interface language, \netc.), or their login data. By using the Infona portal the user accepts automatic saving and using \nthis information for portal operation purposes. More information on the subject can be found \nin the Privacy Policy and Terms of Service. By closing this window the user confirms that they \nhave read the information on cookie usage, and they accept the privacy policy and the way \ncookies are used by the portal. You can change the cookie settings in your browser. I accept \nPolski English Login or register account remember me Password recovery INFONA - science \ncommunication portal INFONA Search advanced search Browse series books journals ├éΓÇª','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Neuroscience','','200','261','',NULL,NULL,NULL),(1577,'SS01-04-Specific experience from Australia','https://www.sciencedirect.com/science/article/pii/S0924933812756675',NULL,'\nThe disabling nature of depression, the frequency of treatment resistance, the threat of persistence or frequent recurrence and the commonality of discontinuation early and later in treatment due to intolerable side-effects provide constant challenges for those specialists prescribing existing antidepressant therapies. New treatment options are urgently required.\nThe new antidepressant agomelatine, a MT1, MT2 receptor agonist and a 5-HT2C antagonist with chronobiotic effects, targets the circadian system which is involved in mood disorders. Agomelatine was made available to Australian psychiatrists for compassionate use through a Special Access Scheme (SAS) prior to its registration in 2010. The SAS was restricted to patients with chronic or recurrent Major Depressive Disorder and those who had no possible therapeutic alternative.\nPsychiatrists were required to apply for approval to both the Australian regulatory\n','',2016,NULL,NULL,'2012-01-01',NULL,NULL,NULL,NULL,'','European Psychiatry','27','','1','No longer published by Elsevier',NULL,NULL,NULL),(1578,'Applying clinical staging to young people who present for mental health careeip_366','https://www.researchgate.net/profile/Tracey-Davenport/publication/225277733_Applying_clinical_staging_to_young_people_who_present_for_mental_health_care/links/5e3b4909299bf1cdb911388a/Applying-clinical-staging-to-young-people-who-present-for-mental-health-care.pdf?_sg%5B0%5D=started_experiment_milestone&origin=journalDetail',NULL,'\nAim: The study aims to apply clinical staging to young people who present for mental health care; to describe the demographic features, patterns of psychological symptoms, disability correlates and clinical stages of those young people; and to report longitudinal estimates of progression from less to more severe stages.\nMethods: The study uses crosssectional and longitudinal assessments of young people managed in specialized youth clinics. On the basis of clinical records, subjects were assigned to a specific clinical ├éΓÇÿstage├éΓÇÖ(ie ├éΓÇÿhelp-seeking├éΓÇÖ,├éΓÇÿattenuated syndrome├éΓÇÖ,├éΓÇÿdiscrete disorder├éΓÇÖor ├éΓÇÿpersistent or recurrent illness├éΓÇÖ).\nResults: Young people (n= 209, mean age= 19.9 years (range= 12├éΓÇô30 years), 48% female) were selected from a broader cohort of n= 1483 subjects. Ten percent were assigned to the earliest ├éΓÇÿhelp-seeking├éΓÇÖstage, 54% to the ├éΓÇÿattenuated syndrome├éΓÇÖstage, 25% to the ├éΓÇÿdiscrete disorder├éΓÇÖstage and 11% to the later ├éΓÇÿpersistent or recurrent illness├éΓÇÖ stage. The interrater reliability of independent ratings at baseline was acceptable (k= 0.71). Subjects assigned to the ├éΓÇÿattenuated syndrome├éΓÇÖstage reported symptom and disability scores that were similar to those assigned to later stages. Longitudinally (median= 48 weeks), transition to later clinical stages were 11% of the ├éΓÇÿhelp-seeking├éΓÇÖ, 19% of the ├éΓÇÿattenuated syndrome├éΓÇÖand 33% of the ├éΓÇÿdiscrete disorder├éΓÇÖgroups.\nConclusion: Among young people presenting for mental health care, most are clinically staged as having ├éΓÇÿattenuated syndromes├éΓÇÖ. Despite access to specialized treatment, a significant number progress to more severe or persistent disorders.\n','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','','','','',NULL,NULL,NULL),(1579,'O-10-Safety monitoring guidelines for treatments for major depressive disorder','https://www.cambridge.org/core/journals/european-psychiatry/article/o10-safety-monitoring-guidelines-for-treatments-for-major-depressive-disorder/3678055FE4B880D0E36420341AC1CC56',NULL,'IntroductionAntidepressants are amongst the most commonly prescribed classes of drugs and their use continues to grow. Adverse outcomes are part of the landscape in prescribing medications and therefore management of safety issues need to be an integral part of practice.ObjectivesWe have developed consensus guidelines for safety monitoring with antidepressant treatments.AimsTo present an overview of screening and safety considerations for pharmacotherapy of clinical depressive disorders and make recommendations for safety monitoring.MethodsData were sourced by a literature search using Medline and a manual search of scientific journals to identify relevant articles. Draft guidelines were prepared and serially revised in an iterative manner until all co-authors gave final approval of content.ResultsA guidelines document was produced after approval by all 19 co-authors. The final document gives├é┬á├éΓÇª','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','European Psychiatry','27','S1','1-Jan','Cambridge University Press',NULL,NULL,NULL),(1580,'the sydney law review','https://heinonline.org/hol-cgi-bin/get_pdf.cgi?handle=hein.journals/sydney33&section=34',NULL,'the sydney law review Page 1 volume 33 number 4 december 2011 the sydney law review \ncontents articles The Way We Lived Then: The Legal Profession and the 19th-Century \nNovel Nicola Lacey 599 The Rule of Law in the Shadow of the Giant: The Hong Kong \nExperience Anthony Mason 623 Romalpa Agreements Post-PPSA Anthony Duggan 645 \nAustralian Complementary Protection: A Step-By-Step Approach Jane McAdam 687 Anti-Cartel \nAdvocacy How Has the ACCC Fared? Caron Beaton-Wells and Chris Platania-Phung 735 \ncomment Depression and the Law: Experiences of Australian Barristers and Solicitors \nSharon Medlow, Norm Kelk and Ian Hickie 771 before the high court Providing Services to \nCopyright Infringers: Roadshow Films Pty Ltd v iiNet Ltd Robert Burrell and Kimberlee \nWeatherall case note Out of Sight but Not Out of Mind: Plaintiff M61/2010E v \nCommonwealth Hannah Stewart-Weeks book ├éΓÇª','',2016,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','','','','',NULL,NULL,NULL),(1581,'Genetic and environmental contributions to sleep behaviour in 12-year-old monozygotic and dizygotic twins','https://scholar.google.com/scholar?cluster=9762841628601557074&hl=en&oi=scholarr',NULL,'','',2015,NULL,NULL,'2011-10-01',NULL,NULL,NULL,NULL,'','','20','','54-55','WILEY-BLACKWELL',NULL,NULL,NULL),(1582,'Sign Up','https://scholar.google.com/scholar?cluster=10269206561664216967&hl=en&oi=scholarr',NULL,'','',2015,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','','','','',NULL,NULL,NULL),(1583,'Disclosure Statement','https://www.tandfonline.com/doi/full/10.3109/10398562.2011.603273',NULL,'\nIn response to a letter from a Journal reader, the Editor approached the authors of the article mentioned below and requested clarification of the authorsΓÇÖ conflicts of interest. The response to this request was as follows:\n├éΓÇ£At the conclusion of the article, How to tackle a giant: creating a genuine evaluation of the Better Access Program├éΓÇÖby Rosenberg & Hickie, December 2010, Vol 18, 496├éΓÇô502, we reported no conflicts of interest. However in the body of the paper (p. 499), we clearly drew attention to our involvement in an unsuccessful bid for the tender of the evaluation of the Better Access Program. Further, we clearly detailed Professor Hickie\'s direct role in conduct of the SPHERE Project (see extensive references). Evaluation of the SPHERE Project has been supported by a range of grants from the National Health and Medical Research Council and the National Mental Health Strategy. Collection of data directly from├é┬á├éΓÇª\n','',2015,NULL,NULL,'2011-08-01',NULL,NULL,NULL,NULL,'','Australasian Psychiatry','19','4','374-374','Taylor & Francis',NULL,NULL,NULL),(1584,'YES WE CAN-Create Mentally Healthy Communities','https://scholar.google.com/scholar?cluster=8902897846158376135&hl=en&oi=scholarr',NULL,'The Council of Australian Governments revitalised national mental health reform in 2006. Unfortunately, evidence-based models of collaborative care have not yet been supported.','',2015,NULL,NULL,'2011-02-28',NULL,NULL,NULL,NULL,'','Science','','','','',NULL,NULL,NULL),(1585,'Antidepressants in older people','https://scholar.google.com/scholar?cluster=9387133021408879455&hl=en&oi=scholarr',NULL,'','',2015,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','BMJ','343','7819','329-330','British Medical Association',NULL,NULL,NULL),(1586,'A RCT FOR FOLIC ACID AND VITAMIN B-12, AND PHYSICAL ACTIVITY IN THE PREVENTION OF COGNITIVE DECLINE IN OLDER ADULTS WITH ELEVATED DEPRESSIVE SYMPTOMS','https://scholar.google.com/scholar?cluster=11838073643330248654&hl=en&oi=scholarr',NULL,'','',2015,NULL,NULL,'2010-10-01',NULL,NULL,NULL,NULL,'','','50','','423-423','OXFORD UNIV PRESS INC',NULL,NULL,NULL),(1587,'\'Out of Cabinet, Out of Mind!\': What is the Real Future of the Challenging Areas of Health Reform under the New Gillard Government?','https://search.informit.org/doi/abs/10.3316/ielapa.572853049976121',NULL,'Doubts exist over the real future of the challenging areas of health reform under the new Gillard government and whether anything concrete and fruitful will actually take place or not. The need is for a Prime Minister in Australia who will tackle the hard issues like mental health and alcohol and drug services, aged care, dental health or indigenous health.','',2015,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','AQ-Australian Quarterly','82','3','14-15','',NULL,NULL,NULL),(1588,'The Role of Arginine Vasopressin in Human Social Cognition','https://scholar.google.com/scholar?cluster=15952953145441962481&hl=en&oi=scholarr',NULL,'','',2015,NULL,NULL,'2010-05-01',NULL,NULL,NULL,NULL,'','','67','9','92S-92S','ELSEVIER SCIENCE INC',NULL,NULL,NULL),(1589,'Deserved national recognition for an international clinical scientist','https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1751-7893.2010.00181.x',NULL,'Each January in this great Southern land, our Prime Minister bestows the honour of ΓÇÿAustralian of the Year├éΓÇÖon one of our citizens. Typically, the recipient is a Nobel Prize winner, an international sports star, a world-renown scientist, a celebrity or a social activist. In 2010, to the absolute delight of our wider community, this prestigious award was made to our esteemed colleague and editor-in-chief of this journal, Patrick Dennistoun McGorry. Although the award specifically recognized Pat├éΓÇÖs personal commitment over the last 25 years to the development of youth mental health services, it also signalled his wider impact on our community. In this country, we have witnessed a remarkable shift in the public understanding of the nature of mental ill-health, resulting in a recognition that mental health problems deserve to be treated in the same way as other physical health conditions. Although a broad range of factors have├é┬á├éΓÇª','',2015,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','4','2','105-107','Blackwell Publishing Asia',NULL,NULL,NULL),(1590,'the sy dne y law review','https://heinonline.org/hol-cgi-bin/get_pdf.cgi?handle=hein.journals/sydney32&section=3',NULL,'contents Page 1 volume 32 number 1 march 2010 the sy dne y law review contents articles \nThe New Racism in Employment Discrimination: Tales from the Global Economy Margaret \nThornton and Trish Luker Intentional Negligence: A Contradiction in Terms? Peter Handford \nThe Future of Financial Regulation: Enhancing Integrity through Design Justin O\'Brien Reining \nin the Constructive Trust Darryn Jensen comment Distress and Depression among Australian \nLaw Students: Incidence, Attitudes and the Role of Universities Norm Kelk, Sharon Medlow \nand Ian Hickie case note The Executive and Financial Powers of the Commonwealth: Pape v \nCommissioner of Taxation 1 Andrew McLeod 29 before the high court Charting the Limits of \nInsolvency Reorganisations: Lehman Brothers Holdings Inc v City of Swan 63 Jason Harris \nThe Paradox of Public Disclosure: 87 Hogan v Australian Crime Commission Judith Bannister ΓÇª','',2015,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','','','','',NULL,NULL,NULL),(1591,'Study protocol Protocol for a randomised controlled trial investigating the effectiveness of an online e-health application compared to attention placebo or sertraline in the','https://trialsjournal.biomedcentral.com/track/pdf/10.1186/1745-6215-11-48.pdf',NULL,'\nBackground: Generalised anxiety disorder (GAD) is a high prevalence, chronic psychiatric disorder which commonly presents early in the lifespan. Internet e-health applications have been found to be successful in reducing symptoms of anxiety and stress for post traumatic stress disorder (PTSD), panic disorder, social phobia and depression. However, to date, there is little evidence for the effectiveness of e-health applications in adult GAD. There are no studies which have directly compared e-health applications with recognised evidence-based medication. This study aims to determine the effectiveness of a web-based program for treating GAD relative to sertraline and attention placebo. Methods/Design: 120 community-dwelling participants, aged 18-30 years with a clinical diagnosis of GAD will be recruited from the Australian Electoral Roll. They will be randomly allocated to one of three conditions:(i) an online treatment program for GAD, E-couch (ii) pharmacological treatment with a selective serotonin re-uptake inhibitor (SSRI), sertraline (a fixed-flexible dose of 25-100 mg/day) or (iii) an attention control placebo, HealthWatch. The treatment program will be completed over a 10 week period with a 12 month follow-up.\nDiscussion: As of February 2010, there were no registered trials evaluating the effectiveness of an e-health application for GAD for young adults. Similarly to date, this will be the first trial to compare an e-health intervention with a pharmacological treatment.\nTrial Registration: Current Controlled Trials ISRCTN76298775\n','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','','','','',NULL,NULL,NULL),(1592,'Distinguishing early psychosis via mismatching/orienting biomarkers and cognitive/psychosocial associations: subtle differences in schizophrenia and affective spectrum psychoses','https://research.usc.edu.au/esploro/outputs/abstract/Distinguishing-early-psychosis-via-mismatchingorienting-biomarkers/99450769602621',NULL,'','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Early Intervention in Psychiatry','4','Supplement 1','63','Wiley-Blackwell Publishing Asia',NULL,NULL,NULL),(1593,'Comparing Weekday and Weekend Sleeping Patterns in a Younger Population with Mood Disorders','https://research.usc.edu.au/esploro/outputs/abstract/Comparing-Weekday-and-Weekend-Sleeping-Patterns-in-a-Younger-Population-with-Mood-Disorders/99451209002621',NULL,'','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Sleep and Biological Rhythms','8','Supplement 1','A61','Springer UK',NULL,NULL,NULL),(1594,'Comparison of at home sleep-wake assessment in psychiatric patients: Actigraphy versus sleep diary reports','https://research.usc.edu.au/esploro/outputs/abstract/Comparison-of-at-home-sleep-wake-assessment/99450677102621',NULL,'','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Journal of Sleep Research','19','Supplement 2','145-146','Wiley-Blackwell Publishing Ltd.',NULL,NULL,NULL),(1595,'Distinguishing early psychosis via mismatch/orienting biomarkers and cognitive/psychosocial associations: subtle differences in schizophrenia and affective spectrum psychoses','https://research.monash.edu/en/publications/distinguishing-early-psychosis-via-mismatchorienting-biomarkers-a',NULL,'Distinguishing early psychosis via mismatch/orienting biomarkers and cognitive/psychosocial \nassociations: subtle differences in schizophrenia and affective spectrum psychoses ΓÇö Monash \nUniversity Skip to main navigation Skip to search Skip to main content Monash University \nLogo Help & FAQ Home Profiles Research Units Equipment Projects Research output Prizes \nActivities Press / Media Search by expertise, name or affiliation Distinguishing early psychosis \nvia mismatch/orienting biomarkers and cognitive/psychosocial associations: subtle differences \nin schizophrenia and affective spectrum psychoses Daniel Francis Hermens, Manreena Kaur, \nIan Bernard Hickie Research output: Contribution to conference ├éΓÇ║ Abstract ├éΓÇ║ peer-review \nOverview Abstract Early intervention in psychiatry Original language English Publication \nstatus Published - 2010 Externally published Yes Cite this APA Author BIBTEX Harvard ├éΓÇª','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','','','','',NULL,NULL,NULL),(1596,'SHORT SLEEP DURATION AND PSYCHOLOGICAL DISTRESS IN YOUNG ADULTS Short Sleep Duration in Prevalent and Persistent Psychological Distress in Young Adults: The DRIVE Study','https://scholar.google.com/scholar?cluster=1599070835031388305&hl=en&oi=scholarr',NULL,'','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Sleep','33','9','1139','',NULL,NULL,NULL),(1597,'Delivering timely interventions: the impact of the internet on mental health','https://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22872074',NULL,'Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut ├¬tre utilis├â┬⌐ dans le cadre d├éΓÇÖune licence CC BY 4.0 Inist-CNRS/Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS/A menos que se haya se├â┬▒alado antes, el contenido de este registro bibliogr├â┬ífico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS','',2014,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Medical journal of Australia','192','11','','',NULL,NULL,NULL),(1598,'Distinctions in sleep-wake behaviour in young patients with bipolar disorder and ADHD','https://research.usc.edu.au/esploro/outputs/abstract/Distinctions-in-sleep-wake-behaviour-in-young/99451470502621',NULL,'','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Sleep and Biological Rhythms','8','Supplement 1','A59','Springer UK',NULL,NULL,NULL),(1599,'Comparing sleep-wake patterns in young patients with bipolar disorder and attention-deficit hyperactivity disorder','https://research.usc.edu.au/esploro/outputs/abstract/Comparing-sleep-wake-patterns-in-young-patients/99451443502621',NULL,'','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Journal of Sleep Research','19','Supplement 2','255','Wiley-Blackwell Publishing Ltd.',NULL,NULL,NULL),(1600,'Association between self-reported mood disturbance and sleep in young patients with psychiatric disorders','https://research.usc.edu.au/esploro/outputs/abstract/Association-between-self-reported-mood-disturbance-and/99451470802621',NULL,'','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Journal of Sleep Research','19','Supplement 2','253','Wiley-Blackwell Publishing Ltd.',NULL,NULL,NULL),(1601,'Hall KD, Heymsfield SB, Kemnitz JW, Klein S, Schoeller DA, Speakman JR. Energy balance and its components: implications for body weight regulation. Am J Clin Nutr 2012; 95: 989├é┬á├éΓÇª','https://academic.oup.com/ajcn/article-abstract/96/2/448/4576980',NULL,'Walker JG, Batterham PJ, Mackinnon AJ, Jorm AF, Hickie I, Fenech M, Kljakovic M, Crisp D, Christensen H. Oral folic acid and vitamin B-12 supplementation to prevent cognitive decline in community-dwelling older adults with depressive symptoms├éΓÇöthe Beyond Ageing Project: a randomized controlled trial. Am J Clin Nutr 2012; 95: 194├éΓÇô203.','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Am J Clin Nutr','92','','398-407','',NULL,NULL,NULL),(1602,'Cardiac Depression Collaborative Australia: A Strategy to Improve Screening and Management of Depression','https://www.heartlungcirc.org/article/S1443-9506(10)00912-1/abstract',NULL,'\nBackground: Although best practice guidelines recommend screening for depression, methods of implementation are less clear. To support participants in screening and management of depression, the Cardiac Depression Collaborative Australia (CDCA) was established in 2009.\nAim: To assess the impact of the CDCA on screening rates for depression in cardiac rehabilitation (CR).\nMethod: In 2009, 10 teams across NSW enrolled in the first phase of the CDCA program. The CDCA uses the collaborative methodology to bring together teams to share experiences and develop their knowledge and skills. As part of the CDCA teams have developed policies and procedures for screening for depression in CR using the Patient Health Questionnaire 2 (PHQ2+) and Patient Health Questionnaire (PHQ9).\nResults: To date 807 individuals have been screened from July 2009 to January 2010. At baseline, 101/123 (82%) of all\n','',2010,NULL,NULL,'2010-01-01',NULL,NULL,NULL,NULL,'','Heart, Lung and Circulation','19','','S257','Elsevier',NULL,NULL,NULL),(1603,'Associations between verbal memory and post-learning sleep in older adults with neuropsychiatric disorders; preliminary results','https://researchers.mq.edu.au/en/publications/associations-between-verbal-memory-and-post-learning-sleep-in-old',NULL,'Associations between verbal memory and post-learning sleep in older adults with \nneuropsychiatric disorders; preliminary results ├éΓÇö Macquarie University Skip to main \nnavigation Skip to search Skip to main content Macquarie University Home Macquarie \nUniversity Logo Help & FAQ Home Profiles Research Units Projects Research Outputs \nDatasets Prizes Activities Press / Media Impacts Search by expertise, name or affiliation \nAssociations between verbal memory and post-learning sleep in older adults with \nneuropsychiatric disorders; preliminary results R├â┬⌐becca Robillard, SL Naismith, Ian B. \nHickie, S. Pates, Naomi L. Rogers Research output: Contribution to journal ├éΓÇ║ Meeting \nabstract ├éΓÇ║ peer-review Overview Original language English Pages (from-to) A286-A286 \nNumber of pages 1 Journal Sleep Volume 33 Publication status Published - 2010 Externally \npublished Yes Cite this APA Author BIBTEX Harvard Standard ├éΓÇª','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Sleep','33','','A286-A286','The American Academy of Sleep Medicine',NULL,NULL,NULL),(1604,'Sleep-wake behaviour in young patients with bipolar disorder and ADHD','https://research.usc.edu.au/esploro/outputs/abstract/Sleep-wake-behaviour-in-young-patients-with/99450903102621',NULL,'','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Sleep','33','Abstract Supplement','A230','Associated Professional Sleep Societies, Llc',NULL,NULL,NULL),(1605,'Neurophysiological biomarkers of early schizophrenia and affective spectrum psychosis','https://research.usc.edu.au/esploro/outputs/abstract/Neurophysiological-biomarkers-of-early-schizophrenia-and/99451334402621',NULL,'','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Australian and New Zealand Journal of Psychiatry','44','Supplement 1','A58-A59','Sage Publications Ltd.',NULL,NULL,NULL),(1606,'The effect of age on neurocognitive ability in people with neurodegenerative disorders','https://researchers.mq.edu.au/en/publications/the-effect-of-age-on-neurocognitive-ability-in-people-with-neurod',NULL,'The effect of age on neurocognitive ability in people with neurodegenerative disorders ΓÇö \nMacquarie University Skip to main navigation Skip to search Skip to main content Macquarie \nUniversity Home Macquarie University Logo Help & FAQ Home Profiles Research Units \nProjects Research Outputs Datasets Prizes Activities Press / Media Impacts Search by \nexpertise, name or affiliation The effect of age on neurocognitive ability in people with \nneurodegenerative disorders D. Pandit, SL Naismith, Ian B. Hickie, TK Ip, BG Whitwell, Naomi \nL. Rogers Research output: Contribution to journal ├éΓÇ║ Meeting abstract ├éΓÇ║ peer-review 9 Citations \n(Scopus) Overview Original language English Pages (from-to) A281-A281 Number of pages 1 \nJournal Sleep Volume 33 Publication status Published - 2010 Externally published Yes Cite \nthis APA Author BIBTEX Harvard Standard RIS Vancouver Powered by Pure, Scopus & Elsevier ├éΓÇª','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Sleep','33','','A281-A281','The American Academy of Sleep Medicine',NULL,NULL,NULL),(1607,'Daytime napping in patients with Parkinson\'s disease','https://researchers.mq.edu.au/en/publications/daytime-napping-in-patients-with-parkinsons-disease',NULL,'Daytime napping in patients with Parkinson\'s disease ΓÇö Macquarie University Skip to main \nnavigation Skip to search Skip to main content Macquarie University Home Macquarie \nUniversity Logo Help & FAQ Home Profiles Research Units Projects Research Outputs Datasets \nPrizes Activities Press / Media Impacts Search by expertise, name or affiliation Daytime napping \nin patients with Parkinson\'s disease KM Kelleher, SL Naismith, SJ Lewis, Ian B. Hickie, M. \nPereira, Naomi L. Rogers Research output: Contribution to journal ├éΓÇ║ Meeting abstract ├éΓÇ║ \npeer-review Overview Original language English Pages (from-to) A276-A276 Number of pages \n1 Journal Sleep Volume 33 Publication status Published - 2010 Externally published Yes Cite \nthis APA Author BIBTEX Harvard Standard RIS Vancouver Powered by Pure, Scopus & Elsevier \nFingerprint Engine├éΓäó ├é┬⌐ 2021 Elsevier BV We use cookies to help provide and enhance our ├éΓÇª','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Sleep','33','','A276-A276','The American Academy of Sleep Medicine',NULL,NULL,NULL),(1608,'Mismatch and orienting biomarkers to distinguish symptomatology, cognition and psychosocial function in early psychosis','https://research.usc.edu.au/esploro/outputs/abstract/Mismatch-and-orienting-biomarkers-to-distinguish/99451484902621',NULL,'','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Australian and New Zealand Journal of Psychiatry','44','Supplement 1','A29-30','Sage Publications Ltd.',NULL,NULL,NULL),(1609,'Association between self reported mood disturbance and sleep','https://research.usc.edu.au/esploro/outputs/abstract/Association-between-self-reported-mood-disturbance/99451384202621',NULL,'','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Sleep','33','Abstract Supplement','A246','Associated Professional Sleep Societies, Llc',NULL,NULL,NULL),(1610,'The differential contributions of depression and sleep disturbance to quality of life in older people','https://researchers.mq.edu.au/en/publications/the-differential-contributions-of-depression-and-sleep-disturbanc',NULL,'The differential contributions of depression and sleep disturbance to quality of life in older \npeople ΓÇö Macquarie University Skip to main navigation Skip to search Skip to main content \nMacquarie University Home Macquarie University Logo Help & FAQ Home Profiles Research \nUnits Projects Research Outputs Datasets Prizes Activities Press / Media Impacts Search by \nexpertise, name or affiliation The differential contributions of depression and sleep disturbance \nto quality of life in older people Z. Terpening, Naomi L. Rogers, K. Diamond, Louisa Norrie, Ian \nB. Hickie, SL Naismith Research output: Contribution to journal ├éΓÇ║ Meeting abstract ├éΓÇ║ \npeer-review Overview Original language English Pages (from-to) A248-A248 Number of pages \n1 Journal Sleep Volume 33 Publication status Published - 2010 Externally published Yes \nCite this APA Author BIBTEX Harvard Standard RIS Vancouver Powered by Pure, Scopus & ├éΓÇª','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Sleep','33','','A248-A248','The American Academy of Sleep Medicine',NULL,NULL,NULL),(1611,'Comparison of sleep time and duration between sleep and wrist actigraphy in a population with mental health problems','https://research.usc.edu.au/esploro/outputs/abstract/Comparison-of-sleep-time-and-duration-between-sleep-and-wrist-actigraphy-in-a-population-with-mental-health-problems/99450858302621',NULL,'','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Sleep','33','Abstract Supplement','A231','Associated Professional Sleep Societies, Llc',NULL,NULL,NULL),(1612,'Instability of sleep-wake patterns in young patients with a mood disorder','https://research.usc.edu.au/esploro/outputs/abstract/Instability-of-sleep-wake-patterns-in-young-patients-with-a-mood-disorder/99450718102621',NULL,'','',2010,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Sleep','33','Abstract Supplement','A249','Associated Professional Sleep Societies, Llc',NULL,NULL,NULL),(1613,'A study of genetic influence on SPHERE (somatic and psychological health report) measures collected in adolescents and young adults','https://espace.library.uq.edu.au/view/UQ:239528',NULL,'','',2010,NULL,NULL,'2010-01-01',NULL,NULL,NULL,NULL,'','Behavior Genetics','40','6','795-795','Springer New York LLC',NULL,NULL,NULL),(1614,'Can a Healthy Brain Aging Group Program Improve Cognition in Late-Life Depression?','https://scholar.google.com/scholar?cluster=15233956257873802553&hl=en&oi=scholarr',NULL,'','',2009,NULL,NULL,'2009-03-01',NULL,NULL,NULL,NULL,'','','17','3','A119-A120','LIPPINCOTT WILLIAMS & WILKINS',NULL,NULL,NULL),(1615,'Pathways to schizophrenia. A new wave of prevention and early intervention strategies','http://www.mja.com.au/journal/2009/190/4/supplement',NULL,'Volume 190, Issue 4 Supplement | The Medical Journal of Australia MJA Basic Search \nAdvanced search search Use the Advanced search for more specific terms. Title contains \nBody contains Date range from Date range to Article type Author\'s surname Volume First \npage doi: 10.5694/mja__.______ Search Reset  close person_outline Login Individual \nLogin Login Create an account Purchase options Subscribe to the MJA COVID-19 Online \nfirst Current issue Archive Multimediakeyboard_arrow_down Podcasts Videos Writing With \nLight Careers Article typeskeyboard_arrow_down Editorials Research Research letters \nGuidelines and statements Narrative reviews Perspectives Ethics and law Medical \neducation Reflections Competitions Letters For authors Topicskeyboard_arrow_down \nAnatomy and physiology Anesthesia, analgesia and pain Cardiovascular diseases \nComplementary therapies Diagnostic techniques ├éΓÇª','',2009,NULL,NULL,'2009-02-16',NULL,NULL,NULL,NULL,'','Pathways','190','4 Supplement','','',NULL,NULL,NULL),(1616,'Also in this edition','https://scholar.google.com/scholar?cluster=3644026617659422694&hl=en&oi=scholarr',NULL,'','',2009,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Youth Studies Australia','28','1','13-20','',NULL,NULL,NULL),(1617,'EXAMINING SLEEP-WAKE PATTERNS IN PATIENTS WITH PARKINSON\'S DISEASE AND MILD COGNITIVE IMPAIRMENT (MCI)','https://scholar.google.com/scholar?cluster=18224789996734120471&hl=en&oi=scholarr',NULL,'','',2009,NULL,NULL,'2009-01-01',NULL,NULL,NULL,NULL,'','','43','','A59-A59','SAGE PUBLICATIONS LTD',NULL,NULL,NULL),(1618,'CAN A HEALTHY BRAIN AGEING GROUP PROGRAM IMPROVE COGNITION IN LATE-LIFE DEPRESSION?','https://scholar.google.com/scholar?cluster=12708533926080484722&hl=en&oi=scholarr',NULL,'','',2009,NULL,NULL,'2009-01-01',NULL,NULL,NULL,NULL,'','','43','','A59-A60','SAGE PUBLICATIONS LTD',NULL,NULL,NULL),(1619,'MAY YOU LIVE IN INTERESTING TIMES ALSO INTRODUCING A NEW DISEASE CALLED\" A PATHOLOGICAL ABSENCE OF DOUBT\'\'','https://scholar.google.com/scholar?cluster=7897279049925447260&hl=en&oi=scholarr',NULL,'','',2009,NULL,NULL,'2009-01-01',NULL,NULL,NULL,NULL,'','','43','','A14-A15','SAGE PUBLICATIONS LTD',NULL,NULL,NULL),(1620,'EARLY INTERVENTION, CLINICAL STAGING AND YOUTH MENTAL HEALTH: SYNERGISTIC PARADIGMS SHIFTS IN MENTAL HEALTH CARE','https://scholar.google.com/scholar?cluster=2880700272382384677&hl=en&oi=scholarr',NULL,'','',2009,NULL,NULL,'2009-01-01',NULL,NULL,NULL,NULL,'','AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY','','','A3-A3','SAGE PUBLICATIONS LTD',NULL,NULL,NULL),(1621,'Australian Financial Crises','https://espace.curtin.edu.au/bitstream/handle/20.500.11937/26053/132953_14591_Australian%20Financial%20Crisis.....ECONOMY%20REPORT%20v8.pdf?sequence=2',NULL,'\nResearch is focused on improving our understanding of ourselves and the world in which we live. This is essential to public policy and the delivery of strong community benefits from investment in health. The health impact of the global financial crisis has largely been overshadowed by the focus on the economy and finance. However, the health consequences may be felt long after the economy turns around.\nThe Australian economy has been more fortunate than most in shielding itself against the worst of the global recession. However, will the same factors that have served Australia well in this downturn protect us when considering our health and wellbeing? Will government strategies that aim to boost the economy benefit our health? Do we need specific policies and programs to avert any risk of harm to our health?\n','',2009,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','','','Jan-39','Research Australia Limited 2009, an alliance for discoveries in health',NULL,NULL,NULL),(1622,'EXAMINING SLEEP-WAKE PATTERNS IN PATIENTS WITH BIPOLAR DISORDER','https://scholar.google.com/scholar?cluster=14090788251590838497&hl=en&oi=scholarr',NULL,'','',2009,NULL,NULL,'2009-01-01',NULL,NULL,NULL,NULL,'','','32','','A358-A358','AMER ACAD SLEEP MEDICINE',NULL,NULL,NULL),(1623,'Does prolonged fatigue in adolescence predict bipolar disorder?','https://scholar.google.com/scholar?cluster=14590948004691455242&hl=en&oi=scholarr',NULL,'','',2008,NULL,NULL,'2008-10-01',NULL,NULL,NULL,NULL,'','','2','','A57-A57','WILEY-BLACKWELL PUBLISHING, INC',NULL,NULL,NULL),(1624,'Depression and primary care','https://www.mja.com.au/journal/2008/188/12/supplement',NULL,'Volume 188, Issue 12 Supplement | The Medical Journal of Australia MJA Basic Search \nAdvanced search search Use the Advanced search for more specific terms. Title contains Body \ncontains Date range from Date range to Article type Author\'s surname Volume First page doi: \n10.5694/mja__.______ Search Reset  close person_outline Login Individual Login Login \nCreate an account Purchase options Subscribe to the MJA COVID-19 Online first Current issue \nArchive Multimediakeyboard_arrow_down Podcasts Videos Writing With Light Careers Article \ntypeskeyboard_arrow_down Editorials Research Research letters Guidelines and statements \nNarrative reviews Perspectives Ethics and law Medical education Reflections Competitions \nLetters For authors Topicskeyboard_arrow_down Anatomy and physiology Anesthesia, \nanalgesia and pain Cardiovascular diseases Complementary therapies Diagnostic ├éΓÇª','',2008,NULL,NULL,'2008-06-16',NULL,NULL,NULL,NULL,'','Depression','188','12 Supplement','','',NULL,NULL,NULL),(1625,'A prospective cohort study of fatigue after adjuvant therapy for breast cancer','https://scholar.google.com/scholar?cluster=13177006526125437887&hl=en&oi=scholarr',NULL,'','',2008,NULL,NULL,'2008-06-01',NULL,NULL,NULL,NULL,'','','17','','S36-S37','JOHN WILEY & SONS LTD',NULL,NULL,NULL),(1626,'MJA policy on sponsored supplements','https://onlinelibrary.wiley.com/doi/abs/10.5694/j.1326-5377.2008.tb01605.x',NULL,'\nTO THE EDITOR: I am concerned that the Journal supplement ΓÇ£Early intervention in youth mental health├éΓÇ¥, published on 1 October 2007, may contravene the MJA policy on sponsored supplements. Item 9 of that policy (http://www. mja. com. au/public/information/instruc. html# Supplements) states:\nThe supplement├éΓÇÖs articles should not favour drugs/interventions/views/products of the supporting body to the detriment of other drugs/interventions/views/products. While many of the articles in this supplement are clearly scientific papers, a minority read more as advertorials and promote the interests of two of the supplement├éΓÇÖs sponsors. 1-3 The ORYGEN├éΓÇôheadspace approach to adolescent mental health differs from the approach of other expert organisations, including the Faculty of Child and Adolescent Psychiatry of the Royal Australian and New Zealand College of Psychiatrists (RANZCP) and the Australian Infant, Child├é┬á├éΓÇª\n','',2008,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Medical Journal of Australia','188','4','260-261','',NULL,NULL,NULL),(1627,'Depression in the modern world','https://search.informit.org/doi/abs/10.3316/INFORMIT.544499353911275',NULL,'Staying informed in the mental health field demands a capacity to hold the tension between opposing views of equal validity. In August 2007 the British Medical Journal published a feature from two eminent Australian psychiatrists on the question \'Is Depression Overdiagnosed?\' Professor Gordon Parker argued for the \'Yes\' position, and Professor Ian Hickie argued for the \'No\' position. Peer Review Editor, Associate Professor Robert King asks them to answer five key questions about depression in the modern world.  (editor abstract)','',2008,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Psychotherapy in Australia','14','2','','',NULL,NULL,NULL),(1628,'Medicine and the Community','https://scholar.google.com/scholar?cluster=16538622931277909736&hl=en&oi=scholarr',NULL,'','',2007,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','','','','',NULL,NULL,NULL),(1629,'Gene expression correlates of postinfective fatigue syndrome after infectious mononucleosis. Commentary','https://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18842114',NULL,'Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut ├¬tre utilis├â┬⌐ dans le cadre d├éΓÇÖune licence CC BY 4.0 Inist-CNRS/Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS/A menos que se haya se├â┬▒alado antes, el contenido de este registro bibliogr├â┬ífico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS','',2007,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','The Journal of infectious diseases','196','1','','',NULL,NULL,NULL),(1630,'Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? Commentary','https://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19071075',NULL,'Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut ├¬tre utilis├â┬⌐ dans le cadre d├éΓÇÖune licence CC BY 4.0 Inist-CNRS/Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS/A menos que se haya se├â┬▒alado antes, el contenido de este registro bibliogr├â┬ífico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS','',2007,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Journal of hypertension','25','10','','',NULL,NULL,NULL),(1632,'Somatoform disorders: neurasthenia','https://researchers.mq.edu.au/en/publications/somatoform-disorders-neurasthenia',NULL,'Somatoform disorders: neurasthenia ΓÇö Macquarie University Skip to main navigation Skip to \nsearch Skip to main content Macquarie University Logo Help & FAQ Home Profiles Research \nUnits Projects Research Outputs Prizes Activities Press / Media Impacts Search by expertise, \nname or affiliation Somatoform disorders: neurasthenia John Franklin, Ian Hickie, Tim Usherwood \nResearch output: Chapter in Book/Report/Conference proceeding ├éΓÇ║ Chapter ├éΓÇ║ peer-review \nOverview Original language English Title of host publication Tolkien II Subtitle of host publication \na needs-based, costed, stepped-care model for mental health services Editors Gavin Andrews \nPlace of Publication Darlinghurst, NSW Publisher World Health Organization Collaborating \nCentre for Classification in Mental Health Pages 286-301 ISBN (Print) 095780735X \nPublication status Published - 2006 Cite this APA Author BIBTEX Harvard Standard RIS ├éΓÇª','',2006,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','','','286-301','World Health Organization Collaborating Centre for Classification in Mental Health',NULL,NULL,NULL),(1633,'MAJOR ARTICLES AND BRIEF REPORTS-VIRUSES-Prolonged Illness after Infectious Mononucleosis Is Associated with Altered Immunity but Not with Increased Viral Load','https://scholar.google.com/scholar?cluster=909784906436310448&hl=en&oi=scholarr',NULL,'','',2006,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Journal of Infectious Diseases','193','5','664-671','[Chicago, Ill.]: The Institute',NULL,NULL,NULL),(1634,'Polymorphisms in the interleukin-10 gene are associated with duration of illness following primary Epstein-Barr virus infection','https://scholar.google.com/scholar?cluster=7493383232606411045&hl=en&oi=scholarr',NULL,'','',2005,NULL,NULL,'2005-11-01',NULL,NULL,NULL,NULL,'','','66','5','452-453','BLACKWELL PUBLISHING',NULL,NULL,NULL),(1672,'Can we track the impact of Australian mental health research?(vol 39, pg 591, 2005)','https://scholar.google.com/scholar?cluster=15376801718917435923&hl=en&oi=scholarr',NULL,'','',2005,NULL,NULL,'2005-08-01',NULL,NULL,NULL,NULL,'','AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY','39','8','743-743','BLACKWELL PUBLISHING',NULL,NULL,NULL),(1673,'Evaluating treatments for the mood disorders: time for the evidence to get real-Reply','https://scholar.google.com/scholar?cluster=10663376790362418738&hl=en&oi=scholarr',NULL,'','',2005,NULL,NULL,'2005-04-01',NULL,NULL,NULL,NULL,'','AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY','39','4','311-312','BLACKWELL PUBLISHING ASIA',NULL,NULL,NULL),(1674,'Depression: reducing the burden','http://www.mja.com.au/journal/2004/181/7/supplement',NULL,'Volume 181, Issue 7 Supplement | The Medical Journal of Australia MJA Basic Search \nAdvanced search search Use the Advanced search for more specific terms. Title contains \nBody contains Date range from Date range to Article type Author\'s surname Volume First \npage doi: 10.5694/mja__.______ Search Reset  close person_outline Login Individual \nLogin Login Create an account Purchase options Subscribe to the MJA COVID-19 Online \nfirst Current issue Archive Multimediakeyboard_arrow_down Podcasts Videos Writing With \nLight Careers Article typeskeyboard_arrow_down Editorials Research Research letters \nGuidelines and statements Narrative reviews Perspectives Ethics and law Medical \neducation Reflections Competitions Letters For authors Topicskeyboard_arrow_down \nAnatomy and physiology Anesthesia, analgesia and pain Cardiovascular diseases \nComplementary therapies Diagnostic techniques ├éΓÇª','',2004,NULL,NULL,'2004-10-04',NULL,NULL,NULL,NULL,'','Depression','181','7 Supplement','','',NULL,NULL,NULL),(1675,'The clinical management of suicidal behavior, deliberate self-harm and depression in young people. Are we missing the prevention boat?','https://scholar.google.com/scholar?cluster=4877762274700479125&hl=en&oi=scholarr',NULL,'','',2004,NULL,NULL,'2004-06-01',NULL,NULL,NULL,NULL,'','','7','','S42-S42','CAMBRIDGE UNIV PRESS',NULL,NULL,NULL),(1676,'CBS and CBT.-letter','https://search.informit.org/doi/pdf/10.3316/informit.374287161467618',NULL,'The authors discuss a previous article in the November 2003 issue on cognitive behavioural strategies and cognitive behavioural therapy. (non-author abstract)','',2004,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Australian Family Physician','33','4','199','',NULL,NULL,NULL),(1677,'General Practioners\'(GPs) understanding and use of Cognitive Behaviour therapy (CBT) in the treatment of depression: A focus group study','https://research.monash.edu/en/publications/general-practioners-gps-understanding-and-use-of-cognitive-behavi',NULL,'General Practioners\' (GPs) understanding and use of Cognitive Behaviour therapy (CBT) in the \ntreatment of depression: A focus group study ΓÇö Monash University Skip to main navigation \nSkip to search Skip to main content Monash University Home Monash University Logo Help & \nFAQ Home Profiles Research Units Equipment Projects Research output Prizes Activities Press \n/ Media Search by expertise, name or affiliation General Practioners\' (GPs) understanding and \nuse of Cognitive Behaviour therapy (CBT) in the treatment of depression: A focus group study \nPaul Anthony Ryan, Jeffrey Colin Richards, Marita McCabe, David Pierce, Grant Andrew \nBlashki, Grace Groom, Ian B Hickie Department of General Practice Research output: Chapter \nin Book/Report/Conference proceeding ├éΓÇ║ Conference Paper ├éΓÇ║ Research ├éΓÇ║ peer-review \nOverview Original language English Title of host publication Proceedings of the 1st ├éΓÇª','',2004,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','','','157-167','The University of Adelaide',NULL,NULL,NULL),(1678,'GP counselling.-letter','https://search.informit.org/doi/abs/10.3316/INFORMIT.374864783576622',NULL,'The first author comments on previous articles on counselling by GPs and gives his own personal experience.  The other authors reply noting that GPs should clearly communicate their level of expertise and refer to specialists when necessary. (non-author abstract)','',2004,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Australian Family Physician','33','1-Feb','7-Aug','',NULL,NULL,NULL),(1679,'Beyondblue: supporting community action for persons with depressive disorders','https://scholar.google.com/scholar?cluster=17800126534338202489&hl=en&oi=scholarr',NULL,'','',2004,NULL,NULL,'2004-01-01',NULL,NULL,NULL,NULL,'','','6','','23-23','BLACKWELL MUNKSGAARD',NULL,NULL,NULL),(1682,'Depression Literacy in the Australian Community-one year on.','https://scholar.google.com/scholar?cluster=17192247293552217042&hl=en&oi=scholarr',NULL,'\nBackground: Results from the beyondblue National telephone survey of 900 people in October 2001 showed that Australians do not see common mental health disorders as a major health problem, although depression was viewed as a major problem within the context of mental health specifically. Australians also had little knowledge about depression (prevalence rates, signs and symptoms) its effective treatments (pharmacological and psychological). There was also limited knowledge regarding behaviours that need to be implemented to obtain effective treatment in the community. Australians also held negative attitudes towards people who experience depression and its treatments.\nMethodology: One year on from this initial baseline study, the survey has been repeated (and extended) in October 2002 with an increased sample of 2000 respondents across the Australia.\nResults: In addition to evaluating the extent\n','',2003,NULL,NULL,'2003-10-01',NULL,NULL,NULL,NULL,'','','37','','A15-A15','BLACKWELL PUBLISHING ASIA',NULL,NULL,NULL),(1683,'Exploring the perspectives of people whose lives have been affected by depression, and the implications for beyondblue developments','https://scholar.google.com/scholar?cluster=8433121842407788302&hl=en&oi=scholarr',NULL,'','',2003,NULL,NULL,'2003-10-01',NULL,NULL,NULL,NULL,'','','37','','A19-A19','BLACKWELL PUBLISHING ASIA',NULL,NULL,NULL),(1684,'Determining relationships between psychological and somatic distress in older general practice attenders','https://scholar.google.com/scholar?cluster=9524422984550660148&hl=en&oi=scholarr',NULL,'','',2003,NULL,NULL,'2003-10-01',NULL,NULL,NULL,NULL,'','','37','','A15-A16','BLACKWELL PUBLISHING ASIA',NULL,NULL,NULL),(1685,'Structured problem solving in general practice','https://search.informit.org/doi/abs/10.3316/informit.375852331053307',NULL,'This is the third article in the series on psychological treatments in general practice. This month we discuss structured problem solving, a simple, evidence based psychological strategy that can be readily incorporated into general practice. Structured problem solving involves isolating patient problems and tackling them individually using a systematic approach. Patients most likely to benefit include those suffering from depressive disorders, anxiety disorders and patients who are overwhelmed by problems.  (editor abstract)','',2003,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','32','10','','',NULL,NULL,NULL),(1686,'GENES: STRUCTURE AND REGULATION-Isoform Heterogeneity of the Human Gephyrin Gene (GPHN), Binding Domains to the Glycine Receptor, and Mutation Analysis in Hyperekplexia.','https://scholar.google.com/scholar?cluster=3528116141085536866&hl=en&oi=scholarr',NULL,'Gephyrin (GPHN) is an organizational protein that clusters and localizes the inhibitory glycine (GlyR) and GABAA receptors to the microtubular matrix of the neuronal postsynaptic membrane. Mice deficient in gephyrin develop a hereditary molybdenum cofactor deficiency and a neurological phenotype that mimics startle disease (hyperekplexia). This neuromotor disorder is associated with mutations in the GlyR alpha1 and beta subunit genes (GLRA1 and GLRB). Further genetic heterogeneity is suspected, and we hypothesized that patients lacking mutations in GLRA1 and GLRB might have mutations in the gephyrin gene (GPHN). In addition, we adopted a yeast two-hybrid screen, using the GlyR beta subunit intracellular loop as bait, in an attempt to identify further GlyR-interacting proteins implicated in hyperekplexia. Gephyrin cDNAs were isolated, and subsequent RT-PCR analysis from human tissues├é┬á├éΓÇª','',2003,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Journal of Biological Chemistry','278','27','24688-24696','Baltimore [etc.]',NULL,NULL,NULL),(1687,'The pill that killed: a case study of reporting risk knowledge.[An earlier version of this paper was presented at the annual conference of the Australian and New Zealand','https://search.informit.org/doi/pdf/10.3316/ielapa.200312704',NULL,'This study questions the role some prominent Australian newspapers played in defining risk knowledge about the commonly prescribed antidepressant drug loloft. In 02001 New South Wales Supreme Court cose, 0 76-yeor. old man, who had strangled his wife of almost SO years to death and then attempted suicide, pleaded guilty to manslaughter on the graunds of dimin┬╖ ished responsibility. He was being treated for depression, and the court was told that he had taken fIVe times the prescribed dosage of loloft. The dedsion was the first in a criminal court in any country linking murder directly to loloft or asimilar medication.','',2003,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','Australian Journal of Communication','30','2','47-63','',NULL,NULL,NULL),(1688,'Does implicit sequence learning recruit fronto-striatal circuits in patients with depression?','https://scholar.google.com/scholar?cluster=15449509647204276064&hl=en&oi=scholarr',NULL,'','',2003,NULL,NULL,'2003-01-01',NULL,NULL,NULL,NULL,'','','55','','157-157','AUSTRALIAN PSYCHOLOGICAL SOC',NULL,NULL,NULL),(1689,'The effect of examination stress on the development of a primary immune response','https://scholar.google.com/scholar?cluster=7543802719288986807&hl=en&oi=scholarr',NULL,'','',2003,NULL,NULL,'2003-01-01',NULL,NULL,NULL,NULL,'','','55','','28-28','AUSTRALIAN PSYCHOLOGICAL SOC',NULL,NULL,NULL),(1690,'Sick, sleepy and sad','https://scholar.google.com/scholar?cluster=11219914827776962641&hl=en&oi=scholarr',NULL,'','',2003,NULL,NULL,'2003-01-01',NULL,NULL,NULL,NULL,'','','55','','95-95','AUSTRALIAN PSYCHOLOGICAL SOC',NULL,NULL,NULL),(1691,'The relationship between distress and the development of a primary immune response','https://scholar.google.com/scholar?cluster=13348858748954610506&hl=en&oi=scholarr',NULL,'','',2003,NULL,NULL,'2003-01-01',NULL,NULL,NULL,NULL,'','','55','','92-92','AUSTRALIAN PSYCHOLOGICAL SOC',NULL,NULL,NULL),(1692,'The pill that killed: A case study of how Australian media frame health risk','https://researchprofiles.canberra.edu.au/en/publications/the-pill-that-killed-a-case-study-of-how-australian-media-frame-h',NULL,'In August 1999, a 76-year-old man from the southern NSW town of Tumbarumba strangled his wife of almost 50 years to death and then attempted suicide. In the NSW Supreme Court in May 2001, he pleaded guilty to manslaughter on the grounds of diminished responsibility because he was being treated for depression. The court was told that the man had taken five times the prescribed dosage of the antidepressant drug, Zoloft. Justice Barry OΓÇÖKeefe in his decision said:├éΓÇÿI am satisfied that but for the Zoloft he had taken, he would not have strangled his wife├éΓÇÖ. More than 100,000 Australians regularly take Zoloft or similar prescription drugs, known as selective serotonin reuptake inhibitors or SSRIs, to treat depressive illnesses. Zoloft and similar SSRIs such as Prozac are prescribed to millions of','',2003,NULL,NULL,'0000-00-00',NULL,NULL,NULL,NULL,'','','','','Jan-18','Brisbane Graduate School of Business, Queensland University of Technology',NULL,NULL,NULL),(1693,'Advancing primary mental health care in Australia','https://scholar.google.com/scholar?cluster=4419502951307289741&hl=en&oi=scholarr',NULL,'','',2002,NULL,NULL,'2002-12-01',NULL,NULL,NULL,NULL,'','','36','6','A15-A15','BLACKWELL PUBLISHING ASIA',NULL,NULL,NULL),(1694,'The national coalition project: The empowerment of consumers and carers','https://scholar.google.com/scholar?cluster=9268401542119886090&hl=en&oi=scholarr',NULL,'','',2002,NULL,NULL,'2002-12-01',NULL,NULL,NULL,NULL,'','','36','6','A28-A28','BLACKWELL PUBLISHING ASIA',NULL,NULL,NULL),(1695,'Barriers to the delivery of mental health care in general practice','https://scholar.google.com/scholar?cluster=7339494995109066952&hl=en&oi=scholarr',NULL,'','',2002,NULL,NULL,'2002-12-01',NULL,NULL,NULL,NULL,'','','36','6','A32-A32','BLACKWELL PUBLISHING ASIA',NULL,NULL,NULL),(1696,'SPHERE: A National Depression Project-Reply','https://scholar.google.com/scholar?cluster=11944433400845014965&hl=en&oi=scholarr',NULL,'','',2002,NULL,NULL,'2002-02-18',NULL,NULL,NULL,NULL,'','MEDICAL JOURNAL OF AUSTRALIA','176','4','194-194','AUSTRALASIAN MED PUBL CO LTD',NULL,NULL,NULL),(1748,'Heterogeneity of quality of life in young people attending primary mental health services','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85134635405&doi=10.1017%2fS2045796022000427&partnerID=40&md5=5b5ef786d4c2bedbc57096649bd71749','10.1017/S2045796022000427',NULL,'',2022,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Epidemiology and Psychiatric Sciences',NULL,NULL,NULL,NULL,'Other','',''),(1749,'Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085208849&doi=10.1038%2fs41380-020-0754-0&partnerID=40&md5=56d59e65c3bf37f1780cb65781c6dae9','10.1038/s41380-020-0754-0',NULL,'',2021,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Molecular Psychiatry',NULL,NULL,NULL,NULL,'Other','',''),(1750,'Evaluating treatments for the mood disorders: Time for the evidence to get real (multiple letters) [2]','https://www.scopus.com/inward/record.uri?eid=2-s2.0-18044391654&doi=10.1080%2fj.1440-1614.2005.01573.x&partnerID=40&md5=9836cacb1939a6fecd5e183c700a725b','10.1080/j.1440-1614.2005.01573.x',NULL,'',2005,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Australian and New Zealand Journal of Psychiatry',NULL,NULL,NULL,NULL,'Other','',''),(1751,'Chronic fatigue syndrome clinical practice guidelines: Psychological factors','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037020990&doi=10.5694%2fj.1326-5377.2002.tb04935.x&partnerID=40&md5=e0d7f73176c45edbcd16b785f10ad801','10.5694/j.1326-5377.2002.tb04935.x',NULL,'',2002,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Medical Journal of Australia',NULL,NULL,NULL,NULL,'Other','',''),(1752,'Primary care psychiatry is not specialist psychiatry in general practice (multiple letters) [4]','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033584205&doi=10.5694%2fj.1326-5377.1999.tb123552.x&partnerID=40&md5=9682c87c47e119ed431ec58eacf4b481','10.5694/j.1326-5377.1999.tb123552.x',NULL,'',1999,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Medical Journal of Australia',NULL,NULL,NULL,NULL,'YMH team','Mental Health System','Models of care'),(1753,'Is there immune dysfunction in depressive disorders?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025681486&doi=10.1017%2fS0033291700036424&partnerID=40&md5=694ee15f24a2b386147a5c7d8cfef7a1','10.1017/S0033291700036424',NULL,'',1990,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Psychological Medicine',NULL,NULL,NULL,NULL,'YMH team','Neurobiology','Outcome Research'),(1754,'Lifetime prevalence and correlates of perinatal depression in a case-cohort study of depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85136064599&doi=10.1136%2fbmjopen-2021-059300&partnerID=40&md5=419b8ee24b7c8ba2543f752990b6ae33','10.1136/bmjopen-2021-059300',NULL,'',2022,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'BMJ Open',NULL,NULL,NULL,NULL,'Other','Illness specific areas',''),(1755,'Oxidative stress and depressive symptoms in older adults: A magnetic resonance spectroscopy study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84927617936&doi=10.1016%2fj.jad.2015.03.007&partnerID=40&md5=48394fa4dcd00e28fd47ba5924d70deb','10.1016/j.jad.2015.03.007',NULL,'',2015,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Journal of Affective Disorders',NULL,NULL,NULL,NULL,'Other','',''),(1756,'Short- and long-term impact of receiving genetic mutation results in women at increased risk for hereditary breast cancer','https://www.scopus.com/inward/record.uri?eid=2-s2.0-3543112175&doi=10.1023%2fB%3aJOGC.0000018822.56297.a6&partnerID=40&md5=14eea1934f828a9da4cc4a25ba8ed4bb','10.1023/B:JOGC.0000018822.56297.a6',NULL,'',2004,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Journal of Genetic Counseling',NULL,NULL,NULL,NULL,'Other','',''),(1757,'Conclusions about the assessment and management of common mental disorders in Australian general practice','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035898467&doi=10.5694%2fj.1326-5377.2001.tb143791.x&partnerID=40&md5=3e9882107afe3d0a7363aa2a68bc8b7f','10.5694/j.1326-5377.2001.tb143791.x',NULL,'',2001,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Medical Journal of Australia',NULL,NULL,NULL,NULL,'YMH team','Models of care',''),(1758,'Nefazodone for patients with chronic fatigue syndrome','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032911928&doi=10.1046%2fj.1440-1614.1999.00532.x&partnerID=40&md5=3ec2aef6292f48ecb30c306a412de74e','10.1046/j.1440-1614.1999.00532.x',NULL,'',1999,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Australian and New Zealand Journal of Psychiatry',NULL,NULL,NULL,NULL,'Other','Illness specific areas',''),(1759,'Chronic fatigue syndrome: Current perspectives on evaluation and management','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029094676&doi=10.5694%2fj.1326-5377.1995.tb124601.x&partnerID=40&md5=3920859962bb550d74ed5eff2490fff6','10.5694/j.1326-5377.1995.tb124601.x',NULL,'',1995,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Medical Journal of Australia',NULL,NULL,NULL,NULL,'Other','Illness specific areas',''),(1760,'Shaping Mental Health Reform ΓÇô Key Tasks for an Incoming Government','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85134583092&doi=10.1177%2f10398562221115637&partnerID=40&md5=1f38bbd8e62939970e9ca79642d5e94c','10.1177/10398562221115637',NULL,'',2022,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Australasian Psychiatry',NULL,NULL,NULL,NULL,'YMH team','Mental Health System',''),(1761,'Predictors of Chronic Fatigue Syndrome and Mood Disturbance After Acute Infection','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85135570915&doi=10.3389%2ffneur.2022.935442&partnerID=40&md5=f2e0ab4340873e860f45d13b3abef002','10.3389/fneur.2022.935442',NULL,'',2022,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Frontiers in Neurology',NULL,NULL,NULL,NULL,'Other','Illness specific areas',''),(1762,'Research priorities for COVID-19 sensor technology','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100204797&doi=10.1038%2fs41587-021-00816-8&partnerID=40&md5=99faff8b5216b4ef6dd056ee913b0fef','10.1038/s41587-021-00816-8',NULL,'',2021,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Nature Biotechnology',NULL,NULL,NULL,NULL,'Other','',''),(1763,'Technology-enabled mental health service reform for open arms-veterans and families counselling: Participatory design study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85096868583&doi=10.2196%2f13662&partnerID=40&md5=72bd31370c14537b7fd348fc6d73c3c3','10.2196/13662',NULL,'',2019,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'JMIR Formative Research',NULL,NULL,NULL,NULL,'YMH team','Digital health','Models of care'),(1764,'Clinical Staging in Psychiatry: Making Diagnosis Work for Research and Treatment','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099725459&doi=10.1017%2f9781139839518&partnerID=40&md5=8804758b18f54f8e54ede0570542b24a','10.1017/9781139839518',NULL,'',2019,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Clinical Staging in Psychiatry: Making Diagnosis Work for Research and Treatment',NULL,NULL,NULL,NULL,'YMH team','Models of care',''),(1765,'Identification of common genetic risk variants for autism spectrum disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062110842&doi=10.1038%2fs41588-019-0344-8&partnerID=40&md5=e086d2e7164652ee074a981559f44103','10.1038/s41588-019-0344-8',NULL,'',2019,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Nature Genetics',NULL,NULL,NULL,NULL,'Other','',''),(1766,'Prior suicide attempts predict worse clinical and functional outcomes in young people attending a mental health service','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048750437&doi=10.1016%2fj.jad.2018.06.032&partnerID=40&md5=0da93157bf5286f9b91cc27eedf6566f','10.1016/j.jad.2018.06.032',NULL,'',2018,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Journal of Affective Disorders',NULL,NULL,NULL,NULL,'YMH team','Outcome Research',''),(1767,'Using new and innovative technologies to assess clinical stage in early intervention youth mental health services: Evaluation study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054287103&doi=10.2196%2fjmir.9966&partnerID=40&md5=1e2e3f29e57e1c07529a4b50b2a0cd6d','10.2196/jmir.9966',NULL,'',2018,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Journal of Medical Internet Research',NULL,NULL,NULL,NULL,'YMH team','Digital health','Models of care'),(1768,'Australian Brain Alliance','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84994749972&doi=10.1016%2fj.neuron.2016.10.038&partnerID=40&md5=4f2678ad9c25a027c8d1a01ed208a654','10.1016/j.neuron.2016.10.038',NULL,'',2016,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Neuron',NULL,NULL,NULL,NULL,'Other','',''),(1769,'Ambulatory sleep-wake patterns and variability in young people with emerging mental disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84920982764&doi=10.1503%2fjpn.130247&partnerID=40&md5=7f90e9eef5f1a3c607c99d14532ca51c','10.1503/jpn.130247',NULL,'',2015,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Journal of Psychiatry and Neuroscience',NULL,NULL,NULL,NULL,'YMH team','Illness specific areas',''),(1770,'A systematic review and meta-analysis of proton magnetic resonance spectroscopy and mismatch negativity in bipolar disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84886775061&doi=10.1016%2fj.euroneuro.2013.07.007&partnerID=40&md5=d6c89d2bf1ad330ef462fc3478e9c516','10.1016/j.euroneuro.2013.07.007',NULL,'',2013,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'European Neuropsychopharmacology',NULL,NULL,NULL,NULL,'YMH team','Neurobiology',''),(1771,'Distress and disability in young adults presenting to clinical services with mood disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85015623951&doi=10.1186%2f2194-7511-1-23&partnerID=40&md5=e946065f8bf6617a8ffa8a0c916545f4','10.1186/2194-7511-1-23',NULL,'',2013,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'International Journal of Bipolar Disorders',NULL,NULL,NULL,NULL,'YMH team','Outcome Research',''),(1772,'Recognition and treatment of depression: A comparison of Australian and Chinese medical students','https://www.scopus.com/inward/record.uri?eid=2-s2.0-68349114800&doi=10.1007%2fs00127-008-0471-5&partnerID=40&md5=e0dacc0aad85ea70e91333ceae5d7fb4','10.1007/s00127-008-0471-5',NULL,'',2009,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Social Psychiatry and Psychiatric Epidemiology',NULL,NULL,NULL,NULL,'YMH team','Illness specific areas',''),(1773,'Reducing the Social and Economic Burdens of Depression (SEBoD) in Asia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-5644303372&doi=10.1111%2fj.1039-8562.2004.02103.x&partnerID=40&md5=0a138f6d6b60e03d6b189ee74d8203c7','10.1111/j.1039-8562.2004.02103.x',NULL,'',2004,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Australasian Psychiatry',NULL,NULL,NULL,NULL,'YMH team','Illness specific areas','Mental Health System'),(1774,'Epidemiology of depression in the Asia Pacific region','https://www.scopus.com/inward/record.uri?eid=2-s2.0-5644238794&doi=10.1111%2fj.1039-8562.2004.02097.x-i1&partnerID=40&md5=dc26b62bcce6d63c077eb30e38f43edc','10.1111/j.1039-8562.2004.02097.x-i1',NULL,'',2004,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Australasian Psychiatry',NULL,NULL,NULL,NULL,'YMH team','Outcome Research',''),(1775,'Australian and New Zealand clinical practice guidelines for the treatment of depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-3543112703&doi=10.1111%2fj.1440-1614.2004.01377.x&partnerID=40&md5=10731607597fcc1d0e99a543fa70e3c0','10.1111/j.1440-1614.2004.01377.x',NULL,'',2004,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Australian and New Zealand Journal of Psychiatry',NULL,NULL,NULL,NULL,'YMH team','Models of care',''),(1776,'Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0242268473&doi=10.1089%2f154099903322447738&partnerID=40&md5=cf35531dbaa67dae9914ca97e84e9ff7','10.1089/154099903322447738',NULL,'',2003,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Journal of Women\'s Health',NULL,NULL,NULL,NULL,'Other','',''),(1777,'\"Stress\" and coronary heart disease: Psychosocial risk factors: National Heart Foundation of Australia position statement update','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0346106072&doi=10.5694%2fj.1326-5377.2003.tb05193.x&partnerID=40&md5=f6bdcf0d66d21c49bc9bc3934ab78229','10.5694/j.1326-5377.2003.tb05193.x',NULL,'',2003,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Medical Journal of Australia',NULL,NULL,NULL,NULL,'Other','',''),(1778,'Monitoring awareness of and attitudes to depression in Australia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037141119&doi=10.5694%2fj.1326-5377.2002.tb04506.x&partnerID=40&md5=be00c72793ce52b90ac6b71429848fbc','10.5694/j.1326-5377.2002.tb04506.x',NULL,'',2002,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Medical Journal of Australia',NULL,NULL,NULL,NULL,'YMH team','Illness specific areas',''),(1779,'A twin study of the etiology of prolonged fatigue and immune activation','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035006624&doi=10.1375%2f1369052012209&partnerID=40&md5=e99ab2ef4c28f7ba71e253134fd5f3b3','10.1375/1369052012209',NULL,'',2001,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Twin Research',NULL,NULL,NULL,NULL,'Other','Neurobiology',''),(1780,'Can the Chronic Fatigue Syndrome be Defined by Distinct Clinical Features?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029145634&doi=10.1017%2fS0033291700037417&partnerID=40&md5=133ab042dd09f2c791b351206da32c03','10.1017/S0033291700037417',NULL,'',1995,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Psychological Medicine',NULL,NULL,NULL,NULL,'Other','Illness specific areas',''),(1781,'Chronic fatigue syndrome Role of psychological factors overemphasised','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028224650&doi=10.1136%2fbmj.308.6939.1297&partnerID=40&md5=9f80c1c69484926ad663787b176ec823','10.1136/bmj.308.6939.1297',NULL,'',1994,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'BMJ',NULL,NULL,NULL,NULL,'Other','',''),(1782,'Age and depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026055416&doi=10.1016%2f0165-0327%2891%2990026-O&partnerID=40&md5=d4d6b1d345a10bb4d298f170b5b16eb6','10.1016/0165-0327(91)90026-O',NULL,'',1991,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Journal of Affective Disorders',NULL,NULL,NULL,NULL,'Other','',''),(1847,'Measuring, Modeling, and Forecasting the Mental Wealth of Nations','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85136835052&doi=10.3389%2ffpubh.2022.879183&partnerID=40&md5=15d9a21ae50c07e214943e0766833f1f','10.3389/fpubh.2022.879183',NULL,'',2022,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Frontiers in Public Health',NULL,NULL,NULL,NULL,'YMH team','Mental Health System',''),(1848,'Dynamic networks of psychological symptoms, impairment, substance use, and social support: The evolution of psychopathology among emerging adults','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85132749698&doi=10.1192%2fj.eurpsy.2022.23&partnerID=40&md5=ff000a6c47ee776d24653dfb0ce0ca77','10.1192/j.eurpsy.2022.23','Background Subthreshold/attenuated syndromes are established precursors of full-threshold mood and psychotic disorders. Less is known about the individual symptoms that may precede the development of subthreshold syndromes and associated social/functional outcomes among emerging adults. Methods We modeled two dynamic Bayesian networks (DBN) to investigate associations among self-rated phenomenology and personal/lifestyle factors (role impairment, low social support, and alcohol and substance use) across the 19Up and 25Up waves of the Brisbane Longitudinal Twin Study. We examined whether symptoms and personal/lifestyle factors at 19Up were associated with (a) themselves or different items at 25Up, and (b) onset of a depression-like, hypo-manic-like, or psychotic-like subthreshold syndrome (STS) at 25Up. Results The first DBN identified 11 items that when endorsed at 19Up were more likely to be reendorsed at 25Up (e.g., hypersomnia, impaired concentration, impaired sleep quality) and seven items that when endorsed at 19Up were associated with different items being endorsed at 25Up (e.g., earlier fatigue and later role impairment; earlier anergia and later somatic pain). In the second DBN, no arcs met our a priori threshold for inclusion. In an exploratory model with no threshold, >20 items at 19Up were associated with progression to an STS at 25Up (with lower statistical confidence); the top five arcs were: feeling threatened by others and a later psychotic-like STS; increased activity and a later hypo-manic-like STS; and anergia, impaired sleep quality, and/or hypersomnia and a later depression-like STS. Conclusions These probabilistic models identify symptoms and personal/lifestyle factors that might prove useful targets for indicated preventative strategies.','',2022,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'European Psychiatry',NULL,NULL,NULL,NULL,'YMH team','Outcome Research',NULL),(1849,'Metabolic and clinical profiles of young people with mood or psychotic disorders who are prescribed metformin in an inpatient setting','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85134595061&doi=10.1177%2f10398562221115607&partnerID=40&md5=a88a24bf80096026ddc89dbba3b98e91','10.1177/10398562221115607',NULL,'',2022,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Australasian Psychiatry',NULL,NULL,NULL,NULL,'YMH team','Outcome Research',''),(1850,'A Dynamic Approach to Economic Priority Setting to Invest in Youth Mental Health and Guide Local Implementation: Economic Protocol for Eight System Dynamics Policy Models','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85130255146&doi=10.3389%2ffpsyt.2022.835201&partnerID=40&md5=4f738fc41b778be83d4d0c9c77f072e6','10.3389/fpsyt.2022.835201',NULL,'',2022,NULL,NULL,NULL,NULL,NULL,NULL,1,NULL,'Frontiers in Psychiatry',NULL,NULL,NULL,NULL,'YMH team','Mental Health System',NULL),(1851,'Missing in action: the right to the highest attainable standard of mental health care','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85132076961&doi=10.1186%2fs13033-022-00537-8&partnerID=40&md5=b65c1e0b61763eb562a5b9a7c36a3c7b','10.1186/s13033-022-00537-8',NULL,'',2022,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'International Journal of Mental Health Systems',NULL,NULL,NULL,NULL,'YMH team','Mental Health System',''),(1852,'Determinants of well-being and their interconnections in Australian general practitioners: a qualitative study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85134553887&doi=10.1136%2fbmjopen-2021-058616&partnerID=40&md5=ab1baad33c38694d847df022bcd35101','10.1136/bmjopen-2021-058616',NULL,'',2022,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'BMJ Open',NULL,NULL,NULL,NULL,'Other','',''),(1853,'Examining the prevalence of disordered eating in a cohort of young Australians presenting for mental health care at a headspace centre: results from a cross-sectional clinical survey study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85135983927&doi=10.1136%2fbmjopen-2022-061734&partnerID=40&md5=a6e14e2cd1eff08bd14861e309d09b0d','10.1136/bmjopen-2022-061734',NULL,'',2022,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'BMJ Open',NULL,NULL,NULL,NULL,'Other','',''),(1854,'eHealth Tools That Assess and Track Health and Well-being in Children and Young People: Systematic Review','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85130535755&doi=10.2196%2f26015&partnerID=40&md5=03a5daab47b7d17e69161f0b143f738b','10.2196/26015',NULL,'',2022,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Journal of Medical Internet Research',NULL,NULL,NULL,NULL,'Other','',''),(1855,'Rest-activity rhythms and tract specific white matter lesions in older adults at risk for cognitive decline','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85133039386&doi=10.1038%2fs41380-022-01641-4&partnerID=40&md5=8b99e05e364a585f789a216cb8e41066','10.1038/s41380-022-01641-4',NULL,'',2022,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Molecular Psychiatry',NULL,NULL,NULL,NULL,'Other','',''),(1856,'Irregular sleep-wake patterns in older adults with current or remitted depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85098066821&doi=10.1016%2fj.jad.2020.12.034&partnerID=40&md5=a366d93dca9e6e08b7adee2774468ac2','10.1016/j.jad.2020.12.034',NULL,'',2021,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Journal of Affective Disorders',NULL,NULL,NULL,NULL,'YMH team','Illness specific areas',''),(1857,'Association of polygenic score for major depression with response to lithium in patients with bipolar disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081737215&doi=10.1038%2fs41380-020-0689-5&partnerID=40&md5=04bf03fc4597fb277ca4eb93787e1b24','10.1038/s41380-020-0689-5',NULL,'',2021,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Molecular Psychiatry',NULL,NULL,NULL,NULL,'Other','',''),(1858,'Bipolar multiplex families have an increased burden of common risk variants for psychiatric disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075169356&doi=10.1038%2fs41380-019-0558-2&partnerID=40&md5=6bf26c038b95f8eee9a011e63b4a9e98','10.1038/s41380-019-0558-2',NULL,'',2021,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Molecular Psychiatry',NULL,NULL,NULL,NULL,'Other','',''),(1859,'Genome-wide gene-environment analyses of major depressive disorder and reported lifetime traumatic experiences in UK Biobank','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078355026&doi=10.1038%2fs41380-019-0546-6&partnerID=40&md5=253e94a09ff40ff860af7e5388f9b53d','10.1038/s41380-019-0546-6',NULL,'',2020,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Molecular Psychiatry',NULL,NULL,NULL,NULL,'Other','',''),(1860,'Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077675544&doi=10.1038%2fs41588-019-0537-1&partnerID=40&md5=4d971b19b4813e3e5f3c29ab9201c4fb','10.1038/s41588-019-0537-1',NULL,'',2020,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Nature Genetics',NULL,NULL,NULL,NULL,'Other','',''),(1861,'A phenome-wide association and Mendelian Randomisation study of polygenic risk for depression in UK Biobank','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084721245&doi=10.1038%2fs41467-020-16022-0&partnerID=40&md5=bb82b6a3dd826b9077e250c7dfeaf4ac','10.1038/s41467-020-16022-0',NULL,'',2020,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Nature Communications',NULL,NULL,NULL,NULL,'Other','',''),(1862,'Transforming Cultures to Enable Stage-Related Care of Mental Ill-Health: A Youth Mental Health Challenge','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85134915808&doi=10.1017%2f9781139839518.013&partnerID=40&md5=49dc1e1cbcfa7ba4610c403eb8532337','10.1017/9781139839518.013',NULL,'',2019,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Clinical Staging in Psychiatry: Making Diagnosis Work for Research and Treatment',NULL,NULL,NULL,NULL,'YMH team','Models of care','Mental Health System'),(1863,'Making better choices about mental health investment: The case for urgent reform of AustraliaΓÇÖs Better Access Program','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070287134&doi=10.1177%2f0004867419865335&partnerID=40&md5=752b9a34fb858ed392de37ab3abbba1f','10.1177/0004867419865335',NULL,'',2019,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Australian and New Zealand Journal of Psychiatry',NULL,NULL,NULL,NULL,'YMH team','Mental Health System','Models of care'),(1864,'Integrated analysis of environmental and genetic influences on cord blood DNA methylation in new-borns','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85067229888&doi=10.1038%2fs41467-019-10461-0&partnerID=40&md5=949f9cf6351ec1b756073269474b9642','10.1038/s41467-019-10461-0',NULL,'',2019,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Nature Communications',NULL,NULL,NULL,NULL,'Other','',''),(1865,'Homologous recombination DNA repair defects in PALB2-associated breast cancers','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070388252&doi=10.1038%2fs41523-019-0115-9&partnerID=40&md5=2b6a21b6cd5c46c94389cfb1ed4f4058','10.1038/s41523-019-0115-9',NULL,'',2019,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'npj Breast Cancer',NULL,NULL,NULL,NULL,'Other','',''),(1866,'Moving beyond neurons: the role of cell type-specific gene regulation in ParkinsonΓÇÖs disease heritability','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084784933&doi=10.1038%2fs41531-019-0076-6&partnerID=40&md5=29613816c6da6877a76721e2dbe7d8a9','10.1038/s41531-019-0076-6',NULL,'',2019,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'npj Parkinson\'s Disease',NULL,NULL,NULL,NULL,'Other','',''),(1867,'Parcellating cognitive heterogeneity in early psychosis-spectrum illnesses: A cluster analysis','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049327396&doi=10.1016%2fj.schres.2018.06.060&partnerID=40&md5=8ac83af0b677822eb1dbc1e8f0c4187a','10.1016/j.schres.2018.06.060',NULL,'',2018,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Schizophrenia Research',NULL,NULL,NULL,NULL,'YMH team','Outcome Research',''),(1868,'An app that incorporates gamification, mini-games, and social connection to improve Men\'s mental health and well-being (MindMax): Participatory design process','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071237023&doi=10.2196%2f11068&partnerID=40&md5=de3add7952070ec0331c7ead0088b42d','10.2196/11068',NULL,'',2018,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'JMIR Mental Health',NULL,NULL,NULL,NULL,'YMH team','Digital health',''),(1869,'Adolescent-onset depressive disorders and inflammation','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85083252831&doi=10.1016%2fB978-0-12-811073-7.00024-6&partnerID=40&md5=9a8608a9c4628dda099dfd45d1170fdd','10.1016/B978-0-12-811073-7.00024-6',NULL,'',2018,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Inflammation and Immunity in Depression: Basic Science and Clinical Applications',NULL,NULL,NULL,NULL,'YMH team','Illness specific areas',''),(1870,'Testing associations between cannabis use and subcortical volumes in two large population-based samples','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048677717&doi=10.1111%2fadd.14252&partnerID=40&md5=32a6a821e34af4f23f4fce2330eb5511','10.1111/add.14252',NULL,'',2018,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Addiction',NULL,NULL,NULL,NULL,'Other','',''),(1871,'Genome-wide interaction study of a proxy for stress-sensitivity and its prediction of major depressive disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058923883&doi=10.1371%2fjournal.pone.0209160&partnerID=40&md5=7a5cc77a375fdd64574569b05c62d5b1','10.1371/journal.pone.0209160',NULL,'',2018,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'PLoS ONE',NULL,NULL,NULL,NULL,'Other','',''),(1872,'Heritable DNA methylation marks associated with susceptibility to breast cancer /631/67/69 /631/337/176/1988 /692/699/67/1347 /692/308/2056 /45 /45/61 article','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85043262563&doi=10.1038%2fs41467-018-03058-6&partnerID=40&md5=4f68d1f17a68ddebb4c2cee2066f87c8','10.1038/s41467-018-03058-6',NULL,'',2018,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Nature Communications',NULL,NULL,NULL,NULL,'Other','',''),(1873,'Autism, early psychosis, and social anxiety disorder: understanding the role of social cognition and its relationship to disability in young adults with disorders characterized by social impairments','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055612450&doi=10.1038%2fs41398-018-0282-8&partnerID=40&md5=d4ffd15c9b6c09ca3b0a35d8f7c156cd','10.1038/s41398-018-0282-8',NULL,'',2018,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Translational Psychiatry',NULL,NULL,NULL,NULL,'Other','',''),(1874,'Genetic association of major depression with a typical features and obesity-related immunometabolic dysregulations','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85038239250&doi=10.1001%2fjamapsychiatry.2017.3016&partnerID=40&md5=d4f891a70840228e1e5f8185fdb678f2','10.1001/jamapsychiatry.2017.3016',NULL,'',2017,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'JAMA Psychiatry',NULL,NULL,NULL,NULL,'Other','',''),(1875,'Alcohol use in bipolar disorder: A neurobiological model to help predict susceptibility, select treatments and attenuate cortical insult','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937680450&doi=10.1016%2fj.neubiorev.2015.07.004&partnerID=40&md5=84eb0579406116fda33071b98b73e5db','10.1016/j.neubiorev.2015.07.004',NULL,'',2015,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Neuroscience and Biobehavioral Reviews',NULL,NULL,NULL,NULL,'YMH team','Neurobiology',''),(1876,'Cognitive dysfunction and functional disability in alcohol-dependent adults with or without a comorbid affective disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84928829183&doi=10.1080%2f13546805.2015.1014031&partnerID=40&md5=8930c4408cd32389e990857216dd0142','10.1080/13546805.2015.1014031',NULL,'',2015,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Cognitive Neuropsychiatry',NULL,NULL,NULL,NULL,'YMH team','Outcome Research',''),(1877,'Health correlates of insomnia symptoms and comorbid mental disorders in a nationally representative sample of US adolescents','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922009875&doi=10.5665%2fsleep.4396&partnerID=40&md5=c9d20e03d1911f711fbaa7bd3de46194','10.5665/sleep.4396',NULL,'',2015,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Sleep',NULL,NULL,NULL,NULL,'YMH team','Illness specific areas',''),(1878,'Let children cry','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930005747&doi=10.5694%2fmja14.01681&partnerID=40&md5=99d09581f814c7e662eec5b21b4c3923','10.5694/mja14.01681',NULL,'',2015,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Medical Journal of Australia',NULL,NULL,NULL,NULL,'Other','',''),(1879,'Do delivery routes of intranasally administered oxytocin account for observed effects on social cognition and behavior? A two-level model','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84920868879&doi=10.1016%2fj.neubiorev.2014.12.011&partnerID=40&md5=f1e171c6897976f3aab85e0aac441687','10.1016/j.neubiorev.2014.12.011',NULL,'',2015,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Neuroscience and Biobehavioral Reviews',NULL,NULL,NULL,NULL,'Other','',''),(1880,'Low birth weight in MZ twins discordant for birth weight is associated with shorter telomere length and lower IQ, but not anxiety/depression in later life','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84928600901&doi=10.1017%2fthg.2015.3&partnerID=40&md5=9ee750e86346fa4c616d671424b26b7a','10.1017/thg.2015.3',NULL,'',2015,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Twin Research and Human Genetics',NULL,NULL,NULL,NULL,'Other','',''),(1881,'Testing the role of circadian genes in conferring risk for psychiatric disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84897501910&doi=10.1002%2fajmg.b.32230&partnerID=40&md5=bbd4fbe6850863dea974decf9e059c42','10.1002/ajmg.b.32230',NULL,'',2014,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics',NULL,NULL,NULL,NULL,'YMH team','Illness specific areas','Neurobiology'),(1882,'Genetic effects on the cerebellar role in working memory: Same brain, different genes╬▒','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84891559938&doi=10.1016%2fj.neuroimage.2013.10.006&partnerID=40&md5=10774025b5ccdbec1cc288b04a63555d','10.1016/j.neuroimage.2013.10.006',NULL,'',2014,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'NeuroImage',NULL,NULL,NULL,NULL,'Other','',''),(1883,'The brisbane longitudinal twin study: Pathways to cannabis use, abuse, and dependence project - Current status, preliminary results, and future directions','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84873900107&doi=10.1017%2fthg.2012.111&partnerID=40&md5=e859e3affdc855941903e975ead77c0d','10.1017/thg.2012.111',NULL,'',2013,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Twin Research and Human Genetics',NULL,NULL,NULL,NULL,'YMH team','Outcome Research',''),(1884,'Making activity-based funding work for mental health','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84880451074&doi=10.1071%2fAH13002&partnerID=40&md5=8714770c5255cefe08392f534ad2d2de','10.1071/AH13002',NULL,'',2013,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Australian Health Review',NULL,NULL,NULL,NULL,'YMH team','Mental Health System',''),(1885,'Motor cortex neuroplasticity following brachial plexus transfer','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84933671754&doi=10.3389%2ffnhum.2013.00500&partnerID=40&md5=11abdef23ac9ad26ded8255180a45361','10.3389/fnhum.2013.00500',NULL,'',2013,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Frontiers in Human Neuroscience',NULL,NULL,NULL,NULL,'Other','',''),(1886,'Thoughts of death or suicidal ideation are common in young people aged 12 to 30 years presenting for mental health care','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84871476094&doi=10.1186%2f1471-244X-12-234&partnerID=40&md5=611bd44b8f623f136929973ae20b8f02','10.1186/1471-244X-12-234',NULL,'',2012,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'BMC Psychiatry',NULL,NULL,NULL,NULL,'YMH team','Illness specific areas',''),(1887,'Better outcomes or better access--which was better for mental health care?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84874414830&doi=10.5694%2fmja12.11247&partnerID=40&md5=ebc1852a82f7d3bb571d1cf82a4546f4','10.5694/mja12.11247',NULL,'',2012,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'The Medical journal of Australia',NULL,NULL,NULL,NULL,'YMH team','Mental Health System','Outcome Research'),(1888,'The impact of gender on early ill-health retirement in people with heart disease and depression','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863849267&doi=10.1177%2f0004867411427807&partnerID=40&md5=5b15cd74eec19108f9c8b8debf48215f','10.1177/0004867411427807',NULL,'',2012,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Australian and New Zealand Journal of Psychiatry',NULL,NULL,NULL,NULL,'Other','',''),(1889,'Don\'t give up on GWAS','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84855348536&doi=10.1038%2fmp.2011.94&partnerID=40&md5=92b06bbb9905b4ed3c64460ea8ab1704','10.1038/mp.2011.94',NULL,'',2012,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Molecular Psychiatry',NULL,NULL,NULL,NULL,'Other','',''),(1890,'Antidepressants in elderly people: Careful monitoring is needed for adverse effects, particularly in the first month of treatment','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84859007436&doi=10.1136%2fbmj.d4660&partnerID=40&md5=7021e4d9febe2119f604b573ec5aa49a','10.1136/bmj.d4660',NULL,'',2011,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'BMJ (Online)',NULL,NULL,NULL,NULL,'YMH team','Illness specific areas','Models of care'),(1891,'The 2010 Rudd plan: Will it actually deliver better health services?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-77952336300&doi=10.5694%2fj.1326-5377.2010.tb03612.x&partnerID=40&md5=f96bd242b9d7524c1447cfbdcfc2ef3e','10.5694/j.1326-5377.2010.tb03612.x',NULL,'',2010,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Medical Journal of Australia',NULL,NULL,NULL,NULL,'YMH team','Mental Health System',''),(1892,'Electroconvulsive therapy-induced persistent retrograde amnesia: Could it be minimised by ketamine or other pharmacological approaches?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-77956267259&doi=10.1016%2fj.jad.2009.11.018&partnerID=40&md5=c7f4ebad281e4bed4c7f3de4c25a7970','10.1016/j.jad.2009.11.018',NULL,'',2010,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Journal of Affective Disorders',NULL,NULL,NULL,NULL,'Other','',''),(1893,'New money for mental health: Will it make things better for rural and remote Australia?','https://www.scopus.com/inward/record.uri?eid=2-s2.0-34250687954&doi=10.5694%2fj.1326-5377.2007.tb01060.x&partnerID=40&md5=706f0f01fccbbaa34bf6da00cb2cb7f2','10.5694/j.1326-5377.2007.tb01060.x',NULL,'',2007,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Medical Journal of Australia',NULL,NULL,NULL,NULL,'YMH team','Mental Health System',''),(1894,'Predictors of cancer worry in unaffected women from high risk breast cancer families: Risk perception is not the primary issue','https://www.scopus.com/inward/record.uri?eid=2-s2.0-36448972741&doi=10.1007%2fs10897-007-9105-4&partnerID=40&md5=c23c7ab67272236c8aba66d028019611','10.1007/s10897-007-9105-4',NULL,'',2007,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Journal of Genetic Counseling',NULL,NULL,NULL,NULL,'Other','',''),(1895,'The contribution of general practice based research to the development of national policy: Case studies from Ireland and Australia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-33744912805&doi=10.1186%2f1743-8462-3-4&partnerID=40&md5=15de69e9e59a9b8d91eaad0745d6170a','10.1186/1743-8462-3-4',NULL,'',2006,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Australia and New Zealand Health Policy',NULL,NULL,NULL,NULL,'Other','',''),(1896,'A preliminary survey of undergraduate education on depression in medical schools in the Asia Pacific region','https://www.scopus.com/inward/record.uri?eid=2-s2.0-5644254905&doi=10.1080%2fj.1039-8562.2004.02101.x-2&partnerID=40&md5=49f724115b449d715952c7977a37b63e','10.1080/j.1039-8562.2004.02101.x-2',NULL,'',2004,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Australasian Psychiatry',NULL,NULL,NULL,NULL,'YMH team','Illness specific areas',''),(1897,'A review of the legislative mechanisms available to protect the social participation rights of people with depression in the Asia Pacific region','https://www.scopus.com/inward/record.uri?eid=2-s2.0-5644235777&doi=10.1080%2fj.1039-8562.2004.02102.x-2&partnerID=40&md5=76236ebd95f8e7d9727bcd6bcdd59a86','10.1080/j.1039-8562.2004.02102.x-2',NULL,'',2004,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Australasian Psychiatry',NULL,NULL,NULL,NULL,'YMH team','Illness specific areas','Mental Health System'),(1898,'Diabetes, psychotic disorders and antipsychotic therapy: A consensus statement','https://www.scopus.com/inward/record.uri?eid=2-s2.0-9144223056&doi=10.5694%2fj.1326-5377.2004.tb06443.x&partnerID=40&md5=a34b6d00ab6b228623dc6d213d14a151','10.5694/j.1326-5377.2004.tb06443.x',NULL,'',2004,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Medical Journal of Australia',NULL,NULL,NULL,NULL,'Other','',''),(1899,'Australian GPs\' preferences for education about depression and related disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-4444320254&partnerID=40&md5=b2ad9fdc0b7b83b032459ee40d90f98a','',NULL,'',2004,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Australian Family Physician',NULL,NULL,NULL,NULL,'Other','',''),(1900,'Influences of distress and alcohol consumption on the development of a delayed-type hypersensitivity skin test response','https://www.scopus.com/inward/record.uri?eid=2-s2.0-3242752634&doi=10.1097%2f01.psy.0000130962.28801.af&partnerID=40&md5=584ed1a2988c46ecae0116580e00614b','10.1097/01.psy.0000130962.28801.af',NULL,'',2004,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Psychosomatic Medicine',NULL,NULL,NULL,NULL,'Other','',''),(1901,'The neglect of somatoform disorders by old age psychiatry: Some explanations and suggestions for future research','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0141707034&doi=10.1002%2fgps.925&partnerID=40&md5=bbf040aea665c704144ef3aad1e47da6','10.1002/gps.925',NULL,'',2003,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'International Journal of Geriatric Psychiatry',NULL,NULL,NULL,NULL,'Other','',''),(1902,'Fifty years of medical specialisation: From foundation to fragmentation','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035148294&doi=10.5694%2fj.1326-5377.2001.tb143146.x&partnerID=40&md5=1d6b459c0423199298e0c433e487dbda','10.5694/j.1326-5377.2001.tb143146.x',NULL,'',2001,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Medical Journal of Australia',NULL,NULL,NULL,NULL,'YMH team','Mental Health System','Models of care'),(1903,'Depressed Australians: Should we worry? (multiple letters)','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035897334&doi=10.5694%2fj.1326-5377.2001.tb143358.x&partnerID=40&md5=88bf37206365ba5eccd9d5f80c995531','10.5694/j.1326-5377.2001.tb143358.x',NULL,'',2001,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Medical Journal of Australia',NULL,NULL,NULL,NULL,'YMH team','Illness specific areas',''),(1904,'Outcomes focused service delivery: Developing an academic-management partnership','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031748414&doi=10.3109%2f00048679809065524&partnerID=40&md5=8ca322d0927bb14df8bce216faa710b6','10.3109/00048679809065524',NULL,'',1998,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Australian and New Zealand Journal of Psychiatry',NULL,NULL,NULL,NULL,'Other','',''),(1905,'ECT Stimulus Dosing Techniques','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030080226&doi=10.3109%2f00048679609076088&partnerID=40&md5=d71bc1509d1c10a255eb2e8af2cfe7bf','10.3109/00048679609076088',NULL,'',1996,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Australian and New Zealand Journal of Psychiatry',NULL,NULL,NULL,NULL,'YMH team','Illness specific areas',''),(1906,'Psychoimmune networks in health and disease: Proceedings of the Third International Scientific Meeting of the Australian behavioural Immunology Group: Introduction','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028891942&doi=10.1016%2f0192-0561%2895%2990000-4&partnerID=40&md5=d2f3046612cd5a788771e9e1a113f4da','10.1016/0192-0561(95)90000-4',NULL,'',1995,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'International Journal of Immunopharmacology',NULL,NULL,NULL,NULL,'Other','',''),(1907,'The reply','https://www.scopus.com/inward/record.uri?eid=2-s2.0-58149324099&doi=10.1016%2fS0002-9343%2899%2980334-9&partnerID=40&md5=a9e42210dfc1724886a06c94f0249e85','10.1016/S0002-9343(99)80334-9',NULL,'',1995,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'The American Journal of Medicine',NULL,NULL,NULL,NULL,'Other','',''),(1908,'Combining lithium and sodium valproate for bipolar disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028235540&doi=10.3109%2f00048679409075856&partnerID=40&md5=de383292d1080b15a9cd5d2f1afd1d99','10.3109/00048679409075856',NULL,'',1994,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Australian and New Zealand Journal of Psychiatry',NULL,NULL,NULL,NULL,'Other','',''),(1909,'Evaluation of psychotherapy.','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027616905&partnerID=40&md5=631af225d0f95b8af18b27907b7f9415','',NULL,'',1993,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Australian and New Zealand Journal of Psychiatry',NULL,NULL,NULL,NULL,'YMH team','Models of care',''),(1910,'Ethical standards and clinical practice.','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027571161&partnerID=40&md5=3917ced15cda5efb1e8aea02f61fe1c8','',NULL,'',1993,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Australian and New Zealand Journal of Psychiatry',NULL,NULL,NULL,NULL,'YMH team','Mental Health System',''),(1911,'Sex differences in fronto-limbic white matter tracts in youth with mood disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85134055450&doi=10.1111%2fpcn.13440&partnerID=40&md5=f03056a689d0d361a3ded2ab17c15cb7','10.1111/pcn.13440',NULL,'',2022,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Psychiatry and Clinical Neurosciences',NULL,NULL,NULL,NULL,'YMH team','Neurobiology',''),(1912,'Evidence of a reduced role for circumscribed interests in the social attention patterns of children with Autism Spectrum Disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85135397190&doi=10.1007%2fs10803-022-05638-4&partnerID=40&md5=0dad9fac747cdc17f8cf7ea397dfc676','10.1007/s10803-022-05638-4',NULL,'',2022,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Journal of Autism and Developmental Disorders',NULL,NULL,NULL,NULL,'Other','',''),(1913,'Transdiagnostic clinical staging in youth mental health: a first international consensus statement','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084485744&doi=10.1002%2fwps.20745&partnerID=40&md5=6670c22deccc64224abde6f7ab4f7108','10.1002/wps.20745',NULL,'',2020,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'World Psychiatry',NULL,NULL,NULL,NULL,'YMH team','Models of care',''),(1914,'Circadian rhythm and sleep alterations in older people with lifetime depression: A case-control study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084169303&doi=10.1186%2fs12888-020-02606-z&partnerID=40&md5=f4ae793d7f13e6a45bbd0ce9470569e9','10.1186/s12888-020-02606-z',NULL,'',2020,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'BMC Psychiatry',NULL,NULL,NULL,NULL,'YMH team','Illness specific areas',''),(1915,'Co-designing the InnoWell Platform to deliver the right mental health care first time to regional youth','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85083251791&doi=10.1111%2fajr.12617&partnerID=40&md5=be9e22e8ac0f6707d8de811ea5d366c4','10.1111/ajr.12617',NULL,'',2020,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Australian Journal of Rural Health',NULL,NULL,NULL,NULL,'YMH team','Digital health',''),(1916,'Validation of the 21-item Depression, Anxiety, and Stress Scales (DASS-21) in individuals with autism spectrum disorder','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087943704&doi=10.1016%2fj.psychres.2020.113300&partnerID=40&md5=3511267d027e88990485775aba13383b','10.1016/j.psychres.2020.113300',NULL,'',2020,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Psychiatry Research',NULL,NULL,NULL,NULL,'Other','',''),(1917,'Clinical Stage Transitions in Persons Aged 12 to 25 Years Presenting to Early Intervention Mental Health Services with Anxiety, Mood, and Psychotic Disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071856446&doi=10.1001%2fjamapsychiatry.2019.2360&partnerID=40&md5=a0447d20758cc070b242d67319a9bcb1','10.1001/jamapsychiatry.2019.2360',NULL,'',2019,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'JAMA Psychiatry',NULL,NULL,NULL,NULL,'YMH team','Models of care','Outcome Research'),(1918,'Association between polygenic risk for tobacco or alcohol consumption and liability to licit and illicit substance use in young Australian adults','https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062850697&doi=10.1016%2fj.drugalcdep.2019.01.015&partnerID=40&md5=77991516e4eaf743c2678c1636069e90','10.1016/j.drugalcdep.2019.01.015',NULL,'',2019,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Drug and Alcohol Dependence',NULL,NULL,NULL,NULL,'YMH team','Illness specific areas',''),(1919,'The assessment of depression awareness and help-seeking behaviour: Experiences with the International Depression Literacy Survey','https://www.scopus.com/inward/record.uri?eid=2-s2.0-36348999845&doi=10.1186%2f1471-244X-7-48&partnerID=40&md5=b49529b149253e1e93a8201896276fca','10.1186/1471-244X-7-48',NULL,'',2007,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'BMC Psychiatry',NULL,NULL,NULL,NULL,'YMH team','Illness specific areas',''),(1920,'The economic burden of depression and reimbursement policy in the Asia Pacific region','https://www.scopus.com/inward/record.uri?eid=2-s2.0-5644287801&doi=10.1111%2fj.1440-1665.2004..x-i1&partnerID=40&md5=9e469691f01a749a2455d0435ac764fd','10.1111/j.1440-1665.2004..x-i1',NULL,'',2004,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Australasian Psychiatry',NULL,NULL,NULL,NULL,'YMH team','Mental Health System',''),(1922,'Adolescents and young adults who are not in employment, education, or training: Their problems are more than economic','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84884794375&doi=10.1136%2fbmj.f5270&partnerID=40&md5=43cd981e3d008f1db19f4a5f1ad1aabe','10.1136/bmj.f5270',NULL,'',2013,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'BMJ (Online)',NULL,NULL,NULL,NULL,'YMH team','Illness specific areas',''),(1923,'Recent advances in sleep-wake cycle and biological rhythms in bipolar disorder topical collection on sleep disorders','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84885187966&doi=10.1007%2fs11920-013-0402-3&partnerID=40&md5=b39adc33cfaa565876ee589b5171057c','10.1007/s11920-013-0402-3',NULL,'',2013,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Current Psychiatry Reports',NULL,NULL,NULL,NULL,'YMH team','Illness specific areas',''),(1924,'Psychosocial risk factors for coronary heart disease a consensus statement from the national heart foundation of Australia','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922270353&doi=10.5694%2fmja13.10440&partnerID=40&md5=8fe362dd41c03402d46cfd63b2c272ca','10.5694/mja13.10440',NULL,'',2013,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Medical Journal of Australia',NULL,NULL,NULL,NULL,'Other','',''),(1925,'SPHERE: A national depression project (multiple letters)','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037127926&doi=10.5694%2fj.1326-5377.2002.tb04364.x&partnerID=40&md5=067e61f1aa13d6d86da6b0d54568b0db','10.5694/j.1326-5377.2002.tb04364.x',NULL,'',2002,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Medical Journal of Australia',NULL,NULL,NULL,NULL,'Other','',''),(1926,'Measuring outcomes in patients with depression or anxiety: An essential part of clinical practice (multiple letters)','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037421265&doi=10.5694%2fj.1326-5377.2003.tb05055.x&partnerID=40&md5=021d40c881bb725326dafaa42eec64d3','10.5694/j.1326-5377.2003.tb05055.x',NULL,'',2003,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Medical Journal of Australia',NULL,NULL,NULL,NULL,'Other','',''),(1927,'The Chronic Fatigue Syndrome:A Comprehensive Approach to Its Definition and Study','https://www.scopus.com/inward/record.uri?eid=2-s2.0-84961449317&doi=10.1300%2fJ092v01n02_06&partnerID=40&md5=6629adda06dd70f6daff4df0593ce539','10.1300/J092v01n02_06',NULL,'',1995,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Journal Of Chronic Fatigue Syndrome',NULL,NULL,NULL,NULL,'Other','',''),(1928,'Treatment resistant depression in an Australian context I: The utility of the term and approaches to management','https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028360497&doi=10.3109%2f00048679409075841&partnerID=40&md5=0e3c66204e283505450771facbde59b4','10.3109/00048679409075841',NULL,'',1994,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,'Australian and New Zealand Journal of Psychiatry',NULL,NULL,NULL,NULL,'YMH team','Illness specific areas','Models of care');
/*!40000 ALTER TABLE `projects` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `types`
--

DROP TABLE IF EXISTS `types`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `types` (
  `type_id` int(11) NOT NULL AUTO_INCREMENT,
  `type_name` varchar(255) NOT NULL,
  PRIMARY KEY (`type_id`)
) ENGINE=InnoDB AUTO_INCREMENT=3 DEFAULT CHARSET=utf8mb4;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `types`
--

LOCK TABLES `types` WRITE;
/*!40000 ALTER TABLE `types` DISABLE KEYS */;
INSERT INTO `types` VALUES (1,'article'),(2,'other');
/*!40000 ALTER TABLE `types` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `users`
--

DROP TABLE IF EXISTS `users`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `users` (
  `user_id` int(11) NOT NULL AUTO_INCREMENT,
  `username` varchar(255) NOT NULL,
  `hash` varchar(255) NOT NULL,
  PRIMARY KEY (`user_id`)
) ENGINE=InnoDB AUTO_INCREMENT=4 DEFAULT CHARSET=utf8mb4;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `users`
--

LOCK TABLES `users` WRITE;
/*!40000 ALTER TABLE `users` DISABLE KEYS */;
INSERT INTO `users` VALUES (1,'user','password'),(2,'user1','pbkdf2:sha256:260000$OgCcPou8cL4a6sgX$612c9f408aa22c37bc642442fc9fd55584721d0ebdb56305aa60cef30a8c40b0'),(3,'user2','pbkdf2:sha256:260000$ljwy6IqBm2Ox24FL$df682a6df84251bbc614dd4c86565ee2443cbca4ca6c82849c38743ac5d83f97');
/*!40000 ALTER TABLE `users` ENABLE KEYS */;
UNLOCK TABLES;
/*!40103 SET TIME_ZONE=@OLD_TIME_ZONE */;

/*!40101 SET SQL_MODE=@OLD_SQL_MODE */;
/*!40014 SET FOREIGN_KEY_CHECKS=@OLD_FOREIGN_KEY_CHECKS */;
/*!40014 SET UNIQUE_CHECKS=@OLD_UNIQUE_CHECKS */;
/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */;
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */;
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */;
/*!40111 SET SQL_NOTES=@OLD_SQL_NOTES */;

-- Dump completed on 2023-05-22 14:02:16
